<SEC-DOCUMENT>0000320017-23-000055.txt : 20230814
<SEC-HEADER>0000320017-23-000055.hdr.sgml : 20230814
<ACCEPTANCE-DATETIME>20230814161018
ACCESSION NUMBER:		0000320017-23-000055
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		83
CONFORMED PERIOD OF REPORT:	20230630
FILED AS OF DATE:		20230814
DATE AS OF CHANGE:		20230814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LISATA THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0000320017
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				222343568
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33650
		FILM NUMBER:		231170132

	BUSINESS ADDRESS:	
		STREET 1:		110 ALLEN ROAD
		STREET 2:		SECOND FLOOR
		CITY:			BASKING RIDGE
		STATE:			NJ
		ZIP:			07920
		BUSINESS PHONE:		908-229-2590

	MAIL ADDRESS:	
		STREET 1:		110 ALLEN ROAD
		STREET 2:		SECOND FLOOR
		CITY:			BASKING RIDGE
		STATE:			NJ
		ZIP:			07920

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CALADRIUS BIOSCIENCES, INC.
		DATE OF NAME CHANGE:	20170808

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Caladrius Biosciences, Inc.
		DATE OF NAME CHANGE:	20150608

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NeoStem, Inc.
		DATE OF NAME CHANGE:	20060906
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>clbs-20230630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:f19b6d65-9ffc-4ef9-a859-121a4da9922b,g:65448069-d222-4f71-8ad3-a35814dee021,d:cf8a0af2f47148dc98c9ade30e1c2f8f--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2023" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:clbs="http://www.caladrius.com/20230630" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>clbs-20230630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-25">0000320017</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-26">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-27">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-28">Q2</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-29">false</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-542">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-543">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-548">http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-549">http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-552">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-553">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-113" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-633">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="clbs-20230630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-08-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">clbs:CENDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-15</xbrli:startDate><xbrli:endDate>2022-09-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">clbs:CENDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-15</xbrli:startDate><xbrli:endDate>2022-09-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">clbs:CENDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">clbs:CENDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">clbs:CENDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">clbs:CENDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">clbs:CENDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-05</xbrli:startDate><xbrli:endDate>2023-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:SanfordBurnhamPrebysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:SanfordBurnhamPrebysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:SanfordBurnhamPrebysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:SanfordBurnhamPrebysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:SanfordBurnhamPrebysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:UniversityOfCaliforniaAtSanDiegoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:UniversityOfCaliforniaAtSanDiegoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:UniversityOfCaliforniaAtSanDiegoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:QiluMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:QiluMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-14</xbrli:startDate><xbrli:endDate>2022-09-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:QiluMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:QiluMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">clbs:ImpiloMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-21</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">June 30, 2023</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.972%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Transition Period from __________________&#160;&#160;&#160;to _________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-33650</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">LISATA THERAPEUTICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:53.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">22-2343568</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">110 Allen Road, 2nd Floor</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Basking Ridge</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">New Jersey</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">07920</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(zip code)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">908</ix:nonNumeric>-<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">842-0100</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:34.255%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.628%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">LSTA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The <ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="margin-bottom:3.3pt;padding-left:6.75pt;padding-right:2.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3.3pt;padding-left:6.75pt;padding-right:2.25pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric> &#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No &#9744;</span></div><div style="margin-bottom:3.3pt;padding-left:6.75pt;padding-right:2.25pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric> &#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No &#9744;</span></div><div style="margin-bottom:3.3pt;padding-left:6.75pt;padding-right:2.25pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-21">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;&#9744;</span></div><div style="text-indent:20.16pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes&#160;&#9744;&#160;&#160;&#160;&#160;&#160;No&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:3.3pt;padding-right:2.25pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:331.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of August 14, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.001 par value per share</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">8,142,357</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shares</span></td></tr></table></div><div style="padding-right:2.25pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:3.3pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:3.3pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report (this &#8220;Quarterly Report&#8221;) contains &#8220;forward-looking&#8221; statements within the meaning of the Private Securities Litigation Reform Act of 1995, as well as historical information. When used in this Quarterly Report, statements that are not statements of current or historical fact may be deemed to be forward-looking statements, including, without limitation, all statements related to any expectations of revenues, expenses, cash flows, earnings or losses from operations, cash required to maintain current and planned operations, capital or other financial items; any statements of the plans, strategies and objectives of management for future operations; any plans or expectations with respect to product research, development and commercialization, including regulatory approvals; any other statements of expectations, plans, intentions or beliefs; and any statements of assumptions underlying any of the foregoing. Without limiting the foregoing, the words &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;forecast,&#8221; &#8220;outlook,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;likely,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;target&#8221; or similar expressions or other variations or comparable terminology are intended to identify such forward-looking statements, although some forward-looking statements are expressed differently. We remind readers that forward-looking statements are merely predictions and therefore inherently subject to uncertainties and other factors and involve known and unknown risks that could cause the actual results, performance, levels of activity or our achievements or industry results, to be materially different from any future results, performance, levels of activity or our achievements or industry results expressed or implied by such forward-looking statements. Factors that could cause our actual results to differ materially from anticipated results expressed or implied by forward-looking statements include, among others:</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain sufficient capital or strategic business arrangements to fund our operations and expansion plans, including collecting amounts owed to us under various licensing and other strategic arrangements, meeting our financial obligations under various licensing and other strategic arrangements, the funding of our clinical trials for product candidates, and the commercialization of the relevant technology;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to build and maintain the management and human resources infrastructure necessary to support the operation and/or growth of our business;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether a market is established for our products and our ability to capture a meaningful share of this market;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">scientific, regulatory and medical developments beyond our control;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain and maintain, as applicable, appropriate governmental licenses, accreditations or certifications or to comply with healthcare laws and regulations or any other adverse effect or limitations caused by government regulation of our business;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether any of our current or future patent applications result in issued patents, the scope of those patents and our ability to obtain and maintain other rights to technology required or desirable for the conduct of our business,&#160;and our ability to commercialize products without infringing upon the claims of third-party patents;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether any potential strategic or financial benefits of various licensing agreements will be realized;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to diversify our pipeline of development product candidates, which could include an acquisition, merger, business combination, in-license or other strategic transaction, and whether any of such efforts will result in us entering into or completing any transaction or that any such transaction, if completed, will add to shareholder value;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the long-term success of our recently completed merger with Cend Therapeutics, Inc. (&#8220;Cend&#8221;), including the ongoing integration of Cend&#8217;s operations and the advancement of their development programs;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the results of our development activities; </span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to complete our other planned clinical trials (or initiate other trials) in accordance with our estimated timelines due to delays associated with enrolling patients due to the novelty of the treatment, the size of the patient population, competition with other clinical trials for similar subjects, patient and/or investigator site availability and accessibility due to external macroenvironmental factors such as the COVID-19 pandemic and the need of patients to meet the inclusion criteria of the trial or otherwise; </span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which the COVID-19 pandemic and any future pandemic and/or their long-term effects may impact, directly or indirectly, our business, including our clinical trials and financial condition; and</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other factors discussed in &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 30, 2023 (our &#8220;2022 Form 10-K&#8221;).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The factors discussed herein, including those risks described in &#8220;Item 1A. Risk Factors&#8221; and elsewhere in our 2022 Form 10-K and in our other periodic filings with the SEC, which are available for review at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.sec.gov,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> could cause actual results and developments to be materially different from those expressed or implied by such statements. All forward-looking statements attributable to us are expressly qualified in their entirety by these and other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they were made. Except as required by law, we undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.</span></div><div style="margin-bottom:3.3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:3.3pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:3.3pt;margin-top:5pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART I- FINANCIAL INFORMATION</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Page No.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 1.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_10">Financial Statements:</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_13">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_16">Consolidated Balance Sheets at </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_16">June</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_16"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_16">0</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_16">, 2023 (unaudited) and December 31, 2022</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_16">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_19">Consolidated Statements of Operations for the three an</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_19">d</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_19"> six months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_19">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_19">, 2023 and 2022 (unaudited)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_19">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_22">Consolidated Statements of Comprehensive Loss for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_22">and six </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_22">months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_22">June </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_22">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_22">0</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_22">, 2023 and 2022 (unaudited)</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_22">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_25">Consolidated Statements of Equity for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_25">three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_25">six months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_25">June </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_25">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_25">0</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_25">, 2023 and 2022 (unaudited) </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_25">8</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_28">Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_28">six</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_28"> months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_28">June </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_28">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_28">0</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_28">, 2023 and 2022 (unaudited)</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_28">10</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Notes to Unaudited Consolidated Financial Statements</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_31">11</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 2.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_88">26</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 3.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_100">34</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Controls and Procedures</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_103">34</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART II- OTHER INFORMATION</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 1.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Legal Proceedings</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_109">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 1A.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Risk Factors</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_112">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 2.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unregistered Sales of Equity Securities and Use of Proceeds</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_115">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 3.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defaults Upon Senior Securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_118">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Mine Safety Disclosures</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_121">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 5.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Other Information</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_124">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 6.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibits</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_127">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Signatures</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:none" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_130">37</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 </span></div></div></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_13"></div><div><span><br/></span></div><div><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LISATA THERAPEUTICS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands, except share data)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-30">23,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">32,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-32">33,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-33">37,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-34">3,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-35">2,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">61,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">71,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-38">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-39">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquired license - intangible</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-40">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-41">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="f-42">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="f-43">528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-44">62,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-45">73,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" scale="3" id="f-46">775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-47">2,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-48">3,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-49">3,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">4,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-51">6,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-52">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-53">327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-54">4,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-55">6,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Commitments and Contingencies (Note 14)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-56"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-57"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stockholders' Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-58"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-59">0.001</ix:nonFraction></ix:nonFraction> par value, authorized <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-60"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-61">33,333,333</ix:nonFraction></ix:nonFraction> shares; issued <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-62">8,133,095</ix:nonFraction></span></div><div style="padding-left:27pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-63">7,866,799</ix:nonFraction> shares at June 30, 2023 and December 31, 2022, respectively; and </span></div><div style="padding-left:27pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">outstanding, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-64">8,132,357</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-65">7,866,061</ix:nonFraction> shares at June 30, 2023 and December 31, 2022, </span></div><div style="padding-left:27pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-66">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-67">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-68">576,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-69">574,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TreasuryStockCommonShares" scale="0" id="f-70"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:TreasuryStockCommonShares" scale="0" id="f-71">738</ix:nonFraction></ix:nonFraction> shares at June 30, 2023 and December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:TreasuryStockCommonValue" scale="3" id="f-72">708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TreasuryStockCommonValue" scale="3" id="f-73">708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-74">517,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-75">507,241</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-76">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-77">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Lisata Therapeutics, Inc. stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-78">57,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-79">66,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:MinorityInterest" scale="3" id="f-80">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:MinorityInterest" scale="3" id="f-81">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-82">57,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-83">66,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities, non-controlling interests and stockholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-84">62,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-85">73,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="text-align:center"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LISATA THERAPEUTICS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.237%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.871%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-86">3,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-87">3,234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-88">6,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" format="ixt:num-dot-decimal" scale="3" id="f-89">6,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-90">3,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-91">3,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-92">7,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-93">6,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-94">6,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-95">6,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-96">13,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-97">13,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-98">6,875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-99">6,720</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-100">13,719</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-101">13,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentIncomeNet" scale="3" id="f-102">668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentIncomeNet" scale="3" id="f-103">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-104">1,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InvestmentIncomeNet" scale="3" id="f-105">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-106">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-108">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-109">149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="f-110">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="f-111">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-112">1,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="f-113">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Net loss before benefit from income taxes and noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-114">6,357</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-115">6,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-116">12,544</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-117">13,331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-118">2,330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-119">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-120">2,330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-121">2,479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-122">4,027</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-123">6,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-124">10,214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-125">10,852</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:25.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less - net income attributable to noncontrolling interests</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" format="ixt:fixed-zero" scale="3" id="f-126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" format="ixt:fixed-zero" scale="3" id="f-127">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" format="ixt:fixed-zero" scale="3" id="f-128">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" format="ixt:fixed-zero" scale="3" id="f-129">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Lisata Therapeutics, Inc. common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-130">4,027</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-131">6,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-132">10,214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-133">10,852</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic and diluted loss per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lisata Therapeutics, Inc. common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-134"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-135">0.50</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-136"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-137">1.64</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-138"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-139">1.28</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-140"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-141">2.69</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average common shares outstanding</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted shares</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-142"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-143">8,021</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-144"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-145">4,035</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-146"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-147">8,004</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-148"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-149">4,036</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 </span></div></div></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LISATA THERAPEUTICS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.013%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.257%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.985%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.988%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-150">4,027</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-151">6,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-152">10,214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-153">10,852</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities - net unrealized gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-154">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-155">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-156">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="f-157">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cumulative translation adjustment arising during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-158">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:fixed-zero" scale="3" id="f-159">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-160">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:fixed-zero" scale="3" id="f-161">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-162">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-163">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-164">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="f-165">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss attributable to Lisata Therapeutics, Inc. common</span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">stockholders</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-166">4,025</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-167">6,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-168">10,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-169">10,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7 </span></div></div></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LISATA THERAPEUTICS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.610%"><tr><td style="width:1.0%"></td><td style="width:24.986%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.146%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.542%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.991%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.025%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.643%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Lisata Therapeutics,<br/>Inc.<br/>Stockholders'<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>Controlling<br/>Interest in<br/>Subsidiary</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-170">4,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-171">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-172">546,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-173">196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-174">457,242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-175">708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-176">88,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-177">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-178">88,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-179">6,626</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-180">6,626</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-181">6,626</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-18" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="f-182">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-183">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-184">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-185">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="f-186">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-187">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-188">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-189">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain on marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-190">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-191">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-192">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-193">4,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-194">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-195">547,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-196">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-197">463,868</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-198"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-199">708</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-200">82,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-201">254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-202">82,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:39pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Lisata Therapeutics,<br/>Inc.<br/>Stockholders'<br/>Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>Controlling<br/>Interest in<br/>Subsidiary</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-203">3,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-204">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-205">546,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-206">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-207">453,016</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-208">708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-209">92,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-210">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-211">92,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-212">10,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-213">10,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-214">10,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="f-215">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-216">960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-217">960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-218">960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from issuances of common stock</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="f-219">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-220">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-221">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-222">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-223">4,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-224">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-225">547,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-226">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-227">463,868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-228">708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-229">82,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-230">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-231">82,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.610%"><tr><td style="width:1.0%"></td><td style="width:24.986%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.146%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.542%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.991%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.025%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.643%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Lisata Therapeutics,<br/>Inc.<br/>Stockholders'<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>Controlling<br/>Interest in<br/>Subsidiary</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-232"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-233">7,999</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-234"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-235">8</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-236"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-237">575,137</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-238"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-239">52</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-240">513,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-241"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-242">708</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-243"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-244">60,957</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-245"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-246">254</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-247"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-248">60,703</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-249">4,027</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-250"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-251">4,027</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-252"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-253">4,027</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-51" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="f-254">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-255">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-256">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-257">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from issuances of common stock</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="f-258">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-259">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-260">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-261">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from option exercises</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-262">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-263">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-264">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-265">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-266">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-267">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-268">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain on marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-269"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-270">12</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-271"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-272">12</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-273"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-274">12</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-54" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-275"><ix:nonFraction unitRef="shares" contextRef="c-54" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-276">8,133</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-277"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-278">8</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-279"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-280">576,173</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-281"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-282">50</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-283"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-284">517,455</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-285"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-286">708</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-287"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-288">57,968</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-289"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-290">254</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-291"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-292">57,714</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:39pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Lisata Therapeutics,<br/>Inc.<br/>Stockholders'<br/>Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>Controlling<br/>Interest in<br/>Subsidiary</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-61" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-293">7,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-294">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-295">574,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-296">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-297">507,241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-298">708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-299">66,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-300">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-301">66,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-302">10,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-303">10,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-304">10,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-70" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="f-305">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-306">1,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-307">1,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-308">1,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from issuances of common stock</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-70" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="f-309">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-310">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-311">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-312">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from option exercises</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-70" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-313">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-314">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-315">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-316">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-317">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-318">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-319">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain on marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-320">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-321">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-322">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-54" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-323">8,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-324">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-325">576,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-326">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-327">517,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-328">708</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-329">57,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-330">254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-331">57,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9 </span></div></div></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LISATA THERAPEUTICS, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.831%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-332">10,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-333">10,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:38.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" format="ixt:num-dot-decimal" scale="3" id="f-334">1,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" format="ixt:num-dot-decimal" scale="3" id="f-335">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="f-336">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="f-337">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposal of fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="f-338">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="3" id="f-339">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accretion on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="f-340">426</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="f-341">900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-342">1,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-343">744</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="f-344">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="f-345">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-346">2,052</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-347">1,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-348">12,380</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-349">10,704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-350">60,836</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-351">30,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sale of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-352">64,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-353">60,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in Cend Therapeutics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="3" id="f-354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-355">10,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-356">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-357">235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-358">3,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-359">19,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="clbs:ProceedsFromExerciseOfOptionsFinancingActivities" scale="3" id="f-360">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="clbs:ProceedsFromExerciseOfOptionsFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-361">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax withholding payments on net share settlement equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="f-362">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="f-363">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from issuance of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="f-364">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="f-365">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="f-366">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="f-367">139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-368">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="3" id="f-369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-370">8,464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-371">8,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-372">32,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-373">24,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-374">23,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-375">33,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10 </span></div></div></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LISATA THERAPEUTICS, INC. AND SUBSIDIARIES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_34"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 1&#160;&#8211; <ix:nonNumeric contextRef="c-1" name="clbs:BusinessTextBlock" id="f-376" continuedAt="f-376-1" escape="true">The Business</ix:nonNumeric></span></div><ix:continuation id="f-376-1" continuedAt="f-376-2"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lisata Therapeutics, Inc. (together with its subsidiaries, the &#8220;Company&#8221;) is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. The Company's lead investigational product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to penetrate solid tumors more effectively. LSTA1 actuates this active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs more efficiently penetrating and accumulating in the tumor, while normal tissues are not expected to be affected. LSTA1 also has the potential to modify the tumor microenvironment (&#8220;TME&#8221;), thereby making tumors more susceptible to immunotherapies. The Company and its collaborators have amassed significant non-clinical data demonstrating enhanced delivery of a range of existing and emerging anti-cancer therapies, including chemotherapeutics, immunotherapies and RNA-based therapeutics. To date, LSTA1 has also demonstrated favorable safety, tolerability and activity in completed and ongoing clinical trials designed to enhance delivery of standard-of-care chemotherapy for pancreatic cancer. The Company is exploring the potential of LSTA1 to enable a variety of treatment modalities to treat a range of solid tumors more effectively. In addition, the Company has development programs based on its autologous CD34+ cell therapy technology platform that it is seeking to partner while incurring no additional capital outlay.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's leadership team has decades of collective biopharmaceutical and pharmaceutical product development experience across a variety of therapeutic categories and at all stages of development from preclinical through to product registration and launch. Its goal is to develop and commercialize products that address important unmet medical needs. The Company&#8217;s current development pipeline includes: </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LSTA1, the subject of Phase 1b/2a and 2b clinical studies being conducted globally in a variety of solid tumor types, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a variety of anti-cancer regimens.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger with Cend Therapeutics, Inc. and Name Change</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 15, 2022, the Company, then operating as Caladrius Biosciences, Inc. (&#8220;Caladrius&#8221;), completed its acquisition of Cend Therapeutics, Inc. (&#8220;Cend&#8221;), a Delaware corporation (the &#8220;Merger&#8221;), in accordance with the terms of the Agreement and Plan of Merger and Reorganization (the &#8220;Merger Agreement&#8221;), dated as of April 26, 2022, by and among Caladrius, Cend and CS Cedar Merger Sub, Inc. (&#8220;Merger Sub&#8221;).</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms set forth in the Merger Agreement and effective September 15, 2022 (the &#8220;Effective Time&#8221;): (i) Merger Sub merged with and into Cend, with Cend surviving as a wholly owned subsidiary of Caladrius, (ii) Caladrius changed its name to Lisata Therapeutics, Inc., and (iii) Caladrius effected a 1:15 reverse stock split of its common stock (&#8220;Reverse Stock Split&#8221;) prior to the Effective Time. At the Effective Time, each share of Cend's common stock outstanding immediately prior to the Effective Time was converted into the right to receive shares of Lisata&#8217;s common stock based on an exchange ratio of <ix:nonFraction unitRef="number" contextRef="c-73" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="f-377">0.5338</ix:nonFraction>, after taking into account the Reverse Stock Split (the &#8220;Exchange Ratio&#8221;). In connection with the Merger close, the Company issued an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-74" decimals="INF" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-378">3,772,768</ix:nonFraction> shares of common stock, based on the Exchange Ratio, to holders of Cend, in exchange for all of the Cend capital stock outstanding immediately prior to the closing of the Merger.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, Lisata assumed all of the outstanding and unexercised options to purchase shares of Cend capital stock under the 2016 Equity Incentive Plan (the &#8220;Cend Plan&#8221;), and, in connection with the Merger, such options were converted into options to purchase shares of Lisata&#8217;s common stock based on the Exchange Ratio. At the closing of the Merger at the Effective Time, the Company assumed Cend's stock options to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-75" decimals="INF" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="0" id="f-379">1,227,776</ix:nonFraction> shares of the Company's common stock. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Caladrius was considered to be the accounting acquirer based on the terms of the Merger Agreement and certain factors including: (i) Caladrius owned approximately <ix:nonFraction unitRef="number" contextRef="c-76" decimals="2" name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" scale="-2" id="f-380">52</ix:nonFraction>% of the Company's outstanding shares of common stock immediately following the close of the Merger; (ii) although both entities contributed to the new management team of Lisata, the Caladrius team provided a vast majority of the individuals on the management team and holds the chief executive officer (&#8220;CEO&#8221;), chief medical officer (&#8220;CMO&#8221;) and other senior management roles; (iii) Caladrius paid a premium to acquire Cend&#8217;s assets; and (iv) Caladrius was significantly larger than Cend regarding total assets, operations, and research and development activities. The Merger was accounted for as an asset acquisition as substantially all of the fair value is concentrated in in-process research and development (&#8220;IPR&amp;D&#8221;). Cend&#8217;s assets (except for cash and working capital) were measured and recognized as an allocation of the transaction price based on their relative fair values as of the transaction date with any value associated with IPR&amp;D with no </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><ix:continuation id="f-376-2" continuedAt="f-376-3"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">alternative future use being expensed as reported in the consolidated statement of operations. Operating results presented in the consolidated statements of operations and comprehensive loss prior to the Merger are solely related to Caladrius Biosciences, Inc. and subsidiaries.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coronavirus Considerations</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lisata's Phase 2b FREEDOM Trial of XOWNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. experienced delays in enrolling patients as a result of COVID-19. While early enrollment proceeded to plan with the first patient treated in January 2021, the impact of the COVID-19 pandemic contributed to a general slowing of enrollment, supply chain disruptions affecting the availability of qualified catheters used in the diagnosis of CMD and/or administration of XOWNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as with a contrast agent typically used in many catheter laboratories. In May 2022, the Company announced that enrollment in the FREEDOM Trial was suspended and that it intended to conduct an interim analysis of the data from not less than the first 20 patients enrolled using the 6-month follow-up data to evaluate the efficacy and safety of XOWNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in subjects with CMD. Following this analysis along with Key Opinion Leaders&#8217; input, the Company determined that execution of a redesigned FREEDOM-like trial would be the appropriate next step, but the cost of such a trial would be prohibitively expensive to undergo without a strategic partner. Accordingly, the Company&#8217;s board of directors concluded that XOWNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> development will only be continued if a strategic partner that can contribute the necessary capital for a redesigned trial is identified and secured. There can be no assurance that we will be able to identify such a partner and enter into an agreement with such partner on acceptable terms or at all.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reverse Stock Split</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 14, 2022, in connection with the Merger, the Company implemented the Reverse Stock Split, as authorized at the annual meeting of stockholders on September 13, 2022. The Reverse Stock Split became effective on September 14, 2022 at 5:00 pm and the Company's common stock began trading on The Nasdaq Capital Market on a post-split basis at the open of business on September 15, 2022. As of September 14, 2022, every fifteen shares of the Company&#8217;s issued and outstanding common stock (and such shares held in treasury) were automatically converted into one share of common stock, without any change in the par value per share. In addition, proportionate adjustments were made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options, stock appreciation rights, convertible notes and warrants to purchase shares of common stock, the number of shares issuable upon the vesting of all restricted stock awards, and the number of shares of common stock reserved for issuance pursuant to the Company&#8217;s equity incentive compensation plans. Any stockholder who would otherwise be entitled to a fractional share of common stock created as a result of the Reverse Stock Split received a cash payment equal to the product of such resulting fractional interest in one share of common stock multiplied by the closing trading price of the common stock on September 15, 2022. The Reverse Stock Split was effectuated in order to increase the per share trading price of our common stock to satisfy the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All share and per share amounts of common stock, options and warrants in the accompanying financial statements have been restated for all periods presented to give retroactive effect to the Reverse Stock Split. Accordingly, the consolidated statements of equity reflect the impact of the Reverse Stock Split by reclassifying from &#8220;common stock&#8221; to &#8220;additional paid-in capital&#8221; in an amount equal to the par value of the decreased shares resulting from the Reverse Stock Split.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-381" escape="true"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#8217;s financial position as of June&#160;30, 2023, and the results of its operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2022 and 2021 included in our 2022 Form 10-K. Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-382" continuedAt="f-382-1" escape="true"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><ix:continuation id="f-376-3"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-382-1">are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values and the valuation of the Merger which was accounted for as an asset acquisition as substantially all of the fair value is concentrated in in-process research and development (&#8220;IPR&amp;D&#8221;). Accordingly, actual results could differ from those estimates and assumptions.</ix:continuation></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-383" continuedAt="f-383-1" escape="true">Principles of Consolidation</ix:nonNumeric></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-383-1">The Consolidated Financial Statements include the accounts of Lisata Therapeutics, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation</ix:continuation>.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-384" escape="true"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Remeasurement</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The functional currency of Lisata Therapeutics Australia Pty Ltd. which is a foreign subsidiary of the Company is the Australian Dollar. The assets and liabilities of Lisata Therapeutics Australia Pty Ltd. are translated into U.S. Dollars at the exchange rates in effect at each balance sheet date, and the results of operations are translated using the average exchange rates prevailing throughout the reporting period. Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive income (loss) in stockholders' equity.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_37"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 2 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-385" continuedAt="f-385-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-385-1" continuedAt="f-385-2"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents include short-term, highly liquid, investments with maturities of ninety days or less when purchased. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-386" escape="true"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risks</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to credit risk from its portfolio of cash, cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. Cash is held at major banks in the United States and may exceed federally insured limits. The goals of the Company's investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the appropriate classification of its marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. All of the Company's marketable securities are considered as available-for-sale and carried at estimated fair values and reported in cash equivalents and marketable securities. Unrealized gains and losses on available-for-sale securities are excluded from net income and reported in accumulated other comprehensive income (loss) as a separate component of stockholders' equity. Other income (expense), net, includes interest, dividends, amortization of purchase premiums and discounts, realized gains and losses on sales of securities and other-than-temporary declines in the fair value of securities, if any. The cost of securities sold is based on the specific identification method. The Company regularly reviews all of its investments for other-than-temporary declines in fair value. The Company's review includes the consideration of the cause of the impairment, including the creditworthiness of the security issuers, the number of securities in an unrealized loss position, the severity and duration of the unrealized losses, whether the Company has the intent to sell the securities and whether it is more likely than not that it will be required to sell the securities before the recovery of their amortized cost basis. When the Company determines that the decline in fair value of an investment is below its accounting basis and this decline is other-than-temporary, it reduces the carrying value of the security it holds and records a loss for the amount of such decline.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost of property and equipment is depreciated over the estimated useful lives of the related assets. Depreciation is computed on the straight-line method. Repairs and maintenance expenditures that do not extend original asset lives are charged to expense as incurred. The estimated useful lives of property and equipment are as follows:</span></div><div style="margin-bottom:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-77" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-387">10</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-78" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-388">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-79" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-389">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life of lease</span></td></tr></table></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><ix:continuation id="f-385-2" continuedAt="f-385-3"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets consist of property and equipment. The assets are amortized on a straight line basis over their respective useful lives. The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds the fair value of the asset. If other events or changes in circumstances indicate that the carrying amount of an asset that the Company expects to hold and use may not be recoverable, the Company will estimate the undiscounted future cash flows expected to result from the use of the asset and/or its eventual disposition, and recognize an impairment loss, if any. The impairment loss, if determined to be necessary, would be measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses all share-based payment awards to employees, directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate, expected volatility, expected dividend yield and expected life of the options or warrants. Stock based compensation expense also includes an estimate, which is made at the time of the grant, of the number of awards that are expected to be forfeited. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the date of grant. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss Per Share</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic loss per share is based on the weighted effect of all common shares issued and outstanding and is calculated by dividing net loss attributable to common stockholders by the weighted average shares outstanding during the period. Diluted loss per share is calculated by dividing net loss attributable to common stockholders by the weighted average number of common shares used in the basic loss per share calculation plus the number of common shares that would be issued assuming conversion of all potentially dilutive securities outstanding. Diluted loss per share is not presented as such potentially dilutive securities are anti-dilutive to losses incurred in all periods presented. </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Stock</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treasury stock purchases are accounted for under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock. Gains or losses on the subsequent reissuance of shares are credited or charged to additional paid in capital.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development (&#8220;R&amp;D&#8221;) expenses include salaries, benefits, and other headcount related costs, clinical trial and related clinical manufacturing costs, contract and other outside service fees including sponsored research agreements, and facilities and overhead costs. The Company expenses the costs associated with research and development activities when incurred.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To further drive the Company&#8217;s initiatives, the Company will continue targeting key governmental agencies, congressional committees and not-for-profit organizations to contribute funds for the Company&#8217;s research and development programs. The Company accounts for such grants as a deduction to the related expense in research and development operating expenses when earned.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-390" continuedAt="f-390-1" escape="true"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In-process Research and Development Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upfront payments that relate to the acquisition of a new drug compound, as well as pre-commercial milestone payments, are immediately expensed as IPR&amp;D in the period in which they are incurred, provided that the new drug compound did not also include processes or activities that would constitute a &#8220;business&#8221; as defined under U.S. GAAP, the drug has not achieved regulatory approval for marketing and, absent obtaining such approval, has no established alternative future use. The Company accounts for contingent consideration payable upon achievement of certain regulatory, development or sales milestones in such asset acquisitions when the underlying contingency is probable and estimable. Milestone payments made to third parties subsequent to regulatory approval will be capitalized as intangible assets and amortized over the estimated remaining useful life of the related product.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><ix:continuation id="f-385-3"><ix:continuation id="f-390-1"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Asset</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible asset consists of a single asset, Cend&#8217;s license agreement with Qilu Pharmaceutical, Co., Ltd. (&#8220;Qilu&#8221;) acquired in the Merger, with a value of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="f-391">0.4</ix:nonFraction>&#160;million. The intangible asset is stated at fair value and is amortized using the straight-line method over its estimated useful life of 5 years. Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-392">18</ix:nonFraction>&#160;thousand for the three months ended June&#160;30, 2023 and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-393">35</ix:nonFraction>&#160;thousand for the six months ended June&#160;30, 2023. The intangible asset is reviewed for potential impairment when events or circumstances indicate that carrying amounts may not be recoverable.  The projected amortization expense is $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="f-394">71</ix:nonFraction>&#160;thousand per year for the next five years. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-395" escape="true"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates license and collaboration arrangements to determine whether units of account within the arrangement exhibit the characteristics of a vendor and customer relationship. For arrangements and units of account where a customer relationship exists, the Company applies the revenue recognition guidance. The Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations. At contract inception, the Company assesses the goods or services promised within each contract and assesses whether each promised good or service is distinct and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Taxes imposed by governmental authorities on the Company's revenue, such as sales taxes and withholding taxes, are excluded from net revenue.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. If licenses are bundled with other performance obligations, the Company would utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. There was no revenue recognized for the three and six months ended June&#160;30, 2023 and 2022.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Milestones</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the inception of each arrangement that includes milestone payments (variable consideration), the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company or the Company&#8217;s collaboration partner&#8217;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts the Company&#8217;s estimate of the overall transaction price. Any such adjustments are allocated on a cumulative catch-up basis to satisfied and partially satisfied performance obligations, with the consideration allocated to an ongoing performance obligation being recognized over the period of performance. For the three and six months ended June&#160;30, 2023 and June&#160;30, 2022, the Company has not recognized revenue related to milestones.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and for which the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized any royalty revenue from any collaborative arrangement.</span></div></ix:continuation></ix:continuation><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_40"></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 3 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:AssetAcquisitionTextBlock" id="f-396" continuedAt="f-396-1" escape="true">Merger</ix:nonNumeric></span></div><ix:continuation id="f-396-1"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger was accounted for as an asset acquisition as substantially all of the fair value was concentrated in IPR&amp;D. Cend&#8217;s assets (except for cash and working capital) were measured and recognized as an allocation of the transaction price based on their relative fair values as of the transaction date with any value associated with IPR&amp;D being expensed. The fair value of total consideration was $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:AssetAcquisitionConsiderationTransferred" format="ixt:num-dot-decimal" scale="6" id="f-397">36.1</ix:nonFraction>&#160;million. <ix:nonNumeric contextRef="c-1" name="us-gaap:AssetAcquisitionTableTextBlock" id="f-398" continuedAt="f-398-1" escape="true">The following table is a summary of the purchase price calculation (in thousands except per share data).</ix:nonNumeric></span></div><ix:continuation id="f-398-1"><div style="margin-bottom:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:60.25pt"></td><td style="width:1.0pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of common shares of the combined company owned by Cend stockholders</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-74" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-399">3,772,768</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multiplied by the fair value per share of Lisata common stock on September 15, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-74" decimals="2" name="clbs:AssetAcquisitionSharePrice" scale="0" id="f-400">6.25</ix:nonFraction></span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="clbs:AssetAcquisitionConsiderationTransferredEquityValue" format="ixt:num-dot-decimal" scale="3" id="f-401">23,580</ix:nonFraction></span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of Lisata's cost method investment in Cend</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-402">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental fair value of Cend's fully vested stock options</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" format="ixt:num-dot-decimal" scale="3" id="f-403">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lisata transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost" scale="3" id="f-404">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-405">36,098</ix:nonFraction></span></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The allocation of the purchase price was as follows (amounts in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:60.25pt"></td><td style="width:1.0pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="clbs:AssetAcquisitionCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-406">7,062</ix:nonFraction></span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net working capital (excluding cash)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="clbs:AssetAcquisitionNetWorkingCapital" format="ixt:num-dot-decimal" scale="3" id="f-407">1,690</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="clbs:AssetAcquisitionOtherLiabilities" scale="3" id="f-408">22</ix:nonFraction>)</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="clbs:AssetAcquisitionAcquiredInProcessResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="f-409">30,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="clbs:AssetAcquisitionIntangibles" scale="3" id="f-410">355</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-411">36,098</ix:nonFraction></span></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_43"></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 4 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="f-412" continuedAt="f-412-1" escape="true">Available-for-Sale-Securities</ix:nonNumeric></span></div><ix:continuation id="f-412-1" continuedAt="f-412-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="f-413" escape="true"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of available-for-sale securities recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:507.00pt"><tr><td style="width:1.0pt"></td><td style="width:94.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-414">22,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-415">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-416">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-417">22,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-418">44,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-419">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-420">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-421">44,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-422">10,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-424">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-425">10,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-426">7,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-427">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-429">7,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-430">8,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-431">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-433">8,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-434">4,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-435">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-436">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-437">4,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-438">4,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-440">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-441">4,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-442">6,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-443">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-444">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-445">6,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="f-446">605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-447">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="f-449">605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-450">7,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-451">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-452">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-453">7,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-454">53,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-455">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-456">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-457">53,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-458">64,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-459">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-460">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-461">64,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:MarketableSecuritiesTextBlock" id="f-462" escape="true"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated fair values of available-for-sale securities are generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:360.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-463">19,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-464">27,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-465">33,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-466">37,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-467">53,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-468">64,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><ix:continuation id="f-412-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="f-469" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our portfolio of available-for-sale securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:361.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-470">53,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" format="ixt:num-dot-decimal" scale="3" id="f-471">53,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than one year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" format="ixt:fixed-zero" scale="3" id="f-472">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" format="ixt:fixed-zero" scale="3" id="f-473">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-474">53,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-475">53,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_46"></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 5 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-476" continuedAt="f-476-1" escape="true">Property and Equipment</ix:nonNumeric></span></div><ix:continuation id="f-476-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-477" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:505.50pt"><tr><td style="width:1.0pt"></td><td style="width:363.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:60.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:72.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:fixed-zero" scale="3" id="f-478">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-479">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-480">589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-481">589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-482">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-483">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-484">661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-485">713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="f-486">428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="f-487">417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-488">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-489">296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s results included depreciation expense of approximately $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-490">60</ix:nonFraction>&#160;thousand and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-491">13</ix:nonFraction>&#160;thousand for the six months ended June&#160;30, 2023 and 2022, respectively.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_49"></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 6 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-492" continuedAt="f-492-1" escape="true">Income (Loss) Per Share</ix:nonNumeric></span></div><ix:continuation id="f-492-1"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2023 and 2022, the Company incurred net losses and therefore no common stock equivalents were utilized in the calculation of diluted loss per share as they are anti-dilutive. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-493" continuedAt="f-493-1" escape="true">At June&#160;30, 2023 and 2022, the Company excluded the following potentially dilutive securities (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="f-493-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-94" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-494">1,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-95" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-495">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-96" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-496">1,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-97" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-497">1,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-98" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-498">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-99" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-499">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_52"></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 7 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-500" continuedAt="f-500-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="f-500-1" continuedAt="f-500-2"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of financial assets and liabilities that are being measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price). The Company is required to classify fair value measurements in one of the following categories:</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 inputs are defined as quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 inputs are defined as inputs other than quoted prices included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 inputs are defined as unobservable inputs for the assets or liabilities. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><ix:continuation id="f-500-2"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financial assets and liabilities that were accounted for at fair value on a recurring basis <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-501" continuedAt="f-501-1" escape="true">as of June&#160;30, 2023 and December&#160;31, 2022 (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-501-1"><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:116.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-502">19,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-503">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-504">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-505">19,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-506">27,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-507">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-509">27,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities - available for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-510">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-511">33,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-512">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-513">33,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-515">37,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-516">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-517">37,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-518">19,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-519">33,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-520">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-521">53,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-522">27,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-523">37,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-524">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-525">64,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of accounts payable and accrued expenses approximate fair value as of June&#160;30, 2023 and December&#160;31, 2022, due to the short maturity nature of these items.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_55"></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 8&#160;&#8211;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="f-526" continuedAt="f-526-1" escape="true">Accrued Liabilities</ix:nonNumeric></span></div><ix:continuation id="f-526-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-527" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities as of June&#160;30, 2023 and December&#160;31, 2022 were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:507.75pt"><tr><td style="width:1.0pt"></td><td style="width:313.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:97.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries, employee benefits and related taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-528">2,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-529">2,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical and R&amp;D related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="clbs:ClinicalAndRDRelatedLiabilities" scale="3" id="f-530">924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="clbs:ClinicalAndRDRelatedLiabilities" scale="3" id="f-531">785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting &amp; tax consulting liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="clbs:AccruedGrantFunding" scale="3" id="f-532">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="clbs:AccruedGrantFunding" format="ixt:fixed-zero" scale="3" id="f-533">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities &#8212; current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-534">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-535">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-536">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-537">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-538">3,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-539">3,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_58"></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 9&#160;&#8211;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-540" continuedAt="f-540-1" escape="true">Operating Leases</ix:nonNumeric></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-540-1" continuedAt="f-540-2">The Company adopted ASU No. 2016-02, Leases (Topic 842) on January 1, 2019 and recognized leases with duration greater than 12 months on the balance sheet using the modified retrospective approach. The Company has an operating lease for one office which expires in 2025. The Company estimates its incremental borrowing rate at lease commencement to determine the present value of lease payments as most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. The Company's lease includes an option for the Company to extend the lease term and/or sub-lease space in whole or in part.</ix:continuation></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><ix:continuation id="f-540-2"><ix:nonNumeric contextRef="c-1" name="clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" id="f-541" escape="true"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities and right-of-use assets were recorded in the following captions of our balance sheet as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:325.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-Use Assets:</span></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-542"><span style="-sec-ix-hidden:f-543">Other assets</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="f-544">387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="f-545">487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Right-of-Use Asset</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="f-546">387</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="f-547">487</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Lease Liabilities:</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-548"><span style="-sec-ix-hidden:f-549">Accrued liabilities</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-550">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-551">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-552"><span style="-sec-ix-hidden:f-553">Other long-term liabilities</span></span></span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="f-554">223</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="f-555">305</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Lease Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="f-556">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="f-557">485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the weighted average remaining lease term for our operating lease was <ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-558">2.3</ix:nonNumeric> years, and the weighted average discount rate for our operating lease was <ix:nonFraction unitRef="number" contextRef="c-3" decimals="5" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-559">9.625</ix:nonFraction>%. As of December&#160;31, 2022, the weighted average remaining lease term for our operating leases was <ix:nonNumeric contextRef="c-28" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-560">1.5</ix:nonNumeric> years, and the weighted average discount rate for our operating leases was <ix:nonFraction unitRef="number" contextRef="c-3" decimals="5" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-561">9.625</ix:nonFraction>%.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-562" escape="true"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under the lease agreement as of June&#160;30, 2023 were as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:60.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="f-563">95</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="f-564">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="f-565">143</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="f-566">428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amounts representing interest</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-567">45</ix:nonFraction>)</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="f-568">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_61"></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 10 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-569" continuedAt="f-569-1" escape="true">Stockholders' Equity</ix:nonNumeric></span></div><ix:continuation id="f-569-1" continuedAt="f-569-2"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reverse Stock Split</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 14, 2022, in connection with the Merger, we implemented the Reverse Stock Split, as described in Note 1. All share and per share amounts of common stock, options and warrants in the accompanying financial statements have been restated for all periods presented to give retroactive effect to the Reverse Stock Split. Accordingly, the consolidated statements of equity reflect the impact of the Reverse Stock Split by reclassifying from &#8220;common stock&#8221; to &#8220;additional paid-in capital&#8221; in an amount equal to the par value of the decreased shares resulting from the Reverse Stock Split.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Issuances</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">At The Market Offering Agreement</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 4, 2021, the Company entered into an At The Market Offering Agreement (the &#8220;ATM Agreement&#8221;) with H.C. Wainwright &amp; Co., LLC, as sales agent, in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and sell shares of its common stock, having an aggregate offering price of up to $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" format="ixt:num-dot-decimal" scale="6" id="f-570">50.0</ix:nonFraction>&#160;million. Subsequent to the filing of our Form 10-K on March 22, 2022, the aggregate market value of our outstanding common stock held by non-affiliates was approximately $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:CommonStockValueOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-571">43.6</ix:nonFraction>&#160;million. Pursuant to General Instruction I.B.6 of Form S-3, since the aggregate market value of our outstanding common stock held by non-affiliates was below $75.0&#160;million at the time of such Form 10-K filing, the aggregate amount of securities that we are permitted to offer and sell was reduced to $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="clbs:SaleOfStockAvailableForSale" format="ixt:num-dot-decimal" scale="0" id="f-572">17,698,943</ix:nonFraction>, which was equal to one-third of the aggregate market value of our common stock held by non-affiliates as of September 21, 2022. During the six months ended June&#160;30, 2023, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-109" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-573">64,394</ix:nonFraction> shares of common stock under the ATM Agreement  for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="0" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="0" id="f-574">270,774</ix:nonFraction>.  Since inception, the Company has issued <ix:nonFraction unitRef="shares" contextRef="c-109" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-575">64,394</ix:nonFraction> shares of common stock under the ATM Agreement for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="0" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="0" id="f-576">270,774</ix:nonFraction>.  </span></div></ix:continuation><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><ix:continuation id="f-569-2" continuedAt="f-569-3"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger closing on September 15, 2022, the Company issued an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-74" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-577">3,772,768</ix:nonFraction> shares of common stock, based on the Exchange Ratio, to holders of Cend, in exchange for all of the Cend capital stock outstanding immediately prior to the closing of the Merger.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options and Warrants</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger and after giving effect to the Reverse Stock Split, the Company assumed <ix:nonFraction unitRef="shares" contextRef="c-110" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-578">1,227,776</ix:nonFraction> options outstanding of Cend. The options granted under the Cend Plan are exercisable at various dates as determined upon grant and will expire no more than ten years from their original date of grant. The Cend Plan stock options generally vest over a four-year term. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-579" continuedAt="f-579-1" escape="true">The following table summarizes the activity for stock options and warrants for the six months ended June&#160;30, 2023:</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="f-579-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:22.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.127%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrants</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aggregate Intrinsic Value (In Thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aggregate Intrinsic Value (In Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-580">1,391,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-581">10.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-110" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-582">7.03</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="f-583">187.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="clbs:CommonStockWarrantsShares" format="ixt:num-dot-decimal" scale="0" id="f-584">1,423,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="clbs:WeightedAverageExercisePriceWarrantsOutstanding" scale="0" id="f-585">42.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-110" name="clbs:WeightedAverageRemainingContractualTermwarrantoutstanding" format="ixt-sec:duryear" id="f-586">3.37</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="clbs:AggregateIntrinsicValueWarrantsOutstanding" format="ixt:fixed-zero" scale="3" id="f-587">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes during the period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-588">175,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-589">3.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="clbs:WarrantsGranted" format="ixt:fixed-zero" scale="0" id="f-590">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="clbs:WeightedAverageExercisePriceWarrantsGranted" format="ixt:fixed-zero" scale="0" id="f-591">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-592">82,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-593">1.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="clbs:WarrantsExercised" format="ixt:fixed-zero" scale="0" id="f-594">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="clbs:WeightedAverageExercisePriceWarrantsExercised" format="ixt:fixed-zero" scale="0" id="f-595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-596">142,694</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-597">3.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="clbs:WarrantsCanceled" format="ixt:fixed-zero" scale="0" id="f-598">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="clbs:WeightedAverageExercisePriceWarrantsCanceled" format="ixt:fixed-zero" scale="0" id="f-599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-600">2,520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-601">224.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="clbs:WarrantsExpired" format="ixt:num-dot-decimal" scale="0" id="f-602">2,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="clbs:WeightedAverageExercisePriceWarrantsExpired" scale="0" id="f-603">88.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding at June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-604">1,338,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-605">10.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-606">6.44</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="f-607">376.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="clbs:CommonStockWarrantsShares" format="ixt:num-dot-decimal" scale="0" id="f-608">1,421,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="clbs:WeightedAverageExercisePriceWarrantsOutstanding" scale="0" id="f-609">42.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="clbs:WeightedAverageRemainingContractualTermwarrantoutstanding" format="ixt-sec:duryear" id="f-610">3.17</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="clbs:AggregateIntrinsicValueWarrantsOutstanding" format="ixt:fixed-zero" scale="3" id="f-611">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested at June 30, 2023<br/>or expected to vest in the future</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-612">1,333,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-613">10.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-614">6.43</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="f-615">373.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="clbs:Sharesvestedandexpectedtovest" format="ixt:num-dot-decimal" scale="0" id="f-616">1,421,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="clbs:WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" scale="0" id="f-617">42.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="clbs:WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" format="ixt-sec:duryear" id="f-618">3.17</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="clbs:AggregateIntrinsicValueWarrantsvestedandexpectedtovest" format="ixt:fixed-zero" scale="3" id="f-619">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested at June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-620">1,222,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="f-621">11.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="clbs:OptionsVestedweightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="f-622">6.19</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="3" id="f-623">337.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="clbs:WarrantsVested" format="ixt:num-dot-decimal" scale="0" id="f-624">1,421,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="clbs:WeightedAverageExercisePriceWarrantsExercisable" scale="0" id="f-625">42.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="clbs:WeightedAverageRemainingContractualTermwarrantsvested" format="ixt-sec:duryear" id="f-626">3.17</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="clbs:AggregateIntrinsicValueWarrantsvested" format="ixt:fixed-zero" scale="3" id="f-627">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="f-628" escape="true"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023 and 2022, the Company issued restricted stock for services as follows (in thousands, except share data):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:483.75pt"><tr><td style="width:1.0pt"></td><td style="width:322.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:72.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:4.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of restricted stock issued</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-111" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-629">159,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-112" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-630">70,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value of restricted stock issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="f-631">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="f-632">973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vesting terms of restricted stock issuances are generally between <span style="-sec-ix-hidden:f-633">one</span> and <ix:nonNumeric contextRef="c-114" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-634">four years</ix:nonNumeric>.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="f-635" escape="true"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023 and 2022, the Company issued restricted stock units for services as follows (in thousands, except share data):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:498.00pt"><tr><td style="width:1.0pt"></td><td style="width:343.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:72.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of restricted stock units issued</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-115" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-636">188,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-116" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-637">91,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value of restricted stock units issued </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="f-638">567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="3" id="f-639">1,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-569-3">The weighted average estimated fair value of restricted stock issued for services in the six months ended June&#160;30, 2023 and 2022 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-111" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-640">3.00</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-112" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-641">13.76</ix:nonFraction> per share, respectively. The fair value of the restricted stock units was determined using the Company&#8217;s closing stock price on the date of issuance. The vesting terms of restricted stock unit issuances are generally <ix:nonNumeric contextRef="c-115" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-642">one year</ix:nonNumeric>, or upon the achievement of performance-based milestones.</ix:continuation> </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_67"></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 11 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-643" continuedAt="f-643-1" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-643-1"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize share-based compensation in the form of stock options, restricted stock, and restricted stock units.&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-644" continuedAt="f-644-1" escape="true">The following table summarizes the components of share-based compensation expense for the three and six months ended June&#160;30, 2023 and 2022 (in thousands):</ix:nonNumeric></span></div><div style="text-align:center;text-indent:18pt"><ix:continuation id="f-644-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:44.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.386%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-645">227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-646">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-647">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-648">359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-649">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-650">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-651">844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-652">769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-653">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-654">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-655">1,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-656">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="f-657" escape="true"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total compensation cost related to unvested awards not yet recognized and the weighted-average periods over which the awards were expected to be recognized at June&#160;30, 2023 were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" id="f-658">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" id="f-659">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" id="f-660">597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-128" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-661">1.63</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-115" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-662">1.06</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-111" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-663">1.81</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-664" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total fair value of shares vested and the weighted average estimated fair values of shares granted for the six months ended June&#160;30, 2023 and 2022 were as follows (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:378.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="3" id="f-665">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="3" id="f-666">385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average estimated fair value of shares granted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-128" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-667">2.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-129" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-668">0.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation Assumptions</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options at the date of grant was estimated using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#8217;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant and exercise of options for all employees. The expected term for the warrants is based upon the contractual term of the warrants.</span></div></ix:continuation><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_70"></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 12 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-669" continuedAt="f-669-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-669-1" continuedAt="f-669-2"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, including the net operating loss carryforwards (NOLs), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets.  Based on its assessment, the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-670">281.0</ix:nonFraction>&#160;million of Federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% over a 3-year testing period on January 25, 2021. As a result, $<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-671">168.8</ix:nonFraction>&#160;million of the $<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-672">281.0</ix:nonFraction>&#160;million of Federal NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-673">112.3</ix:nonFraction>&#160;million of remaining Federal NOLs.  The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact to the balance sheet or income statement. Losses incurred before the ownership change on January 25, 2021 will be subject to an annual limitation of $173&#160;thousand under Internal Revenue Code Section 382. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="clbs:OperatingLossCarryforwardsBeforeWriteDown" format="ixt:num-dot-decimal" scale="6" id="f-674">34.0</ix:nonFraction>&#160;million of Federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% on September 15, 2022. As a result of the ownership change, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-675">88.2</ix:nonFraction>&#160;million of Federal </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><ix:continuation id="f-669-2" continuedAt="f-669-3"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="clbs:OperatingLossCarryforwardsBeforeWriteDown" format="ixt:num-dot-decimal" scale="6" id="f-676">34.0</ix:nonFraction>&#160;million of remaining Federal NOLs.  The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact to the balance sheet or income statement. Losses incurred before the ownership change on September 15, 2022 will be subject to an annual limitation of zero while losses incurred after September 15, 2022 will not be subject to limitations. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, Cend Therapeutics had approximately $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-677">10.9</ix:nonFraction>&#160;million of Federal NOLs available to offset future taxable income. The Company performed an analysis and determined that there was an ownership change of greater than 50% on September 15, 2022. As of September 15, 2022 Cend has approximately $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-678">10.7</ix:nonFraction>&#160;million of Federal and $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-679">15.0</ix:nonFraction>&#160;million of state NOLs. The state NOLs will expire from the 2036 through 2042 tax years.  Using a fair market value of $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="clbs:FairValueMarketOfTaxNOLs" format="ixt:num-dot-decimal" scale="6" id="f-680">36.1</ix:nonFraction>&#160;million and applying an applicable federal rate of <ix:nonFraction unitRef="number" contextRef="c-136" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-681">2.54</ix:nonFraction>% Cend will have an annual limitation of approximately $917 thousand each year. The Federal NOL of $<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="clbs:OperatingLossCarryforwardsPostAcquisition" format="ixt:num-dot-decimal" scale="3" id="f-682">106</ix:nonFraction>&#160;thousand incurred in the post-acquisition period September 15, 2022 to December 31, 2022 is not subject to limitation, and does not expire. Cend&#8217;s wholly owned Australian subsidiary has $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-683">1.8</ix:nonFraction>&#160;million of NOLs which will be carried forward and do not expire. There is a full valuation allowance against the NOLs.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, the Company had State NOLs available in New Jersey of $<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-684">35.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-685">97.0</ix:nonFraction>&#160;million, respectively, California of $<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-686">10.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-687">69.5</ix:nonFraction>&#160;million, respectively, and New York City of $<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-688">1.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-689">13.0</ix:nonFraction>&#160;million, respectively, to offset future taxable income expiring from 2032 through 2042. In accordance with Section 382 of the Internal Revenue code, the usage of the Company&#8217;s NOLs is limited given the change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period when those temporary differences become deductible.  </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the FASB&#8217;s provisions for uncertain tax positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties associated with uncertain tax positions as a component of income tax expense.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, the Company&#8217;s uncertain tax positions were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-690">344</ix:nonFraction>&#160;thousand and $<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="INF" name="us-gaap:UnrecognizedTaxBenefits" scale="0" id="f-691">0</ix:nonFraction>, respectively. Due to the acquisition of Cend, the Company&#8217;s uncertain tax positions increased by $<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" format="ixt:num-dot-decimal" scale="3" id="f-692">344</ix:nonFraction>&#160;thousand related to Federal and state credits and certain state NOLs. The Company will continue to evaluate its uncertain tax positions in future periods. As of June&#160;30, 2023, the Company does not believe there will be any material changes in its unrecognized tax positions over the next year.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For years prior to 2019, the federal statute of limitations is closed for assessing tax. The Company&#8217;s state tax returns remain open to examination for a period of three to four years from the date of filing.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 5, 2023, the Company received final approval from the New Jersey Economic Development Authority (&#8220;NJEDA&#8221;) under the Technology Business Tax Certificate Transfer Program (&#8220;Program&#8221;) to sell a percentage of its New Jersey net operating losses (&#8220;NJ NOLs&#8221;), which were subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="clbs:ProceedsFromSaleOfNOLS" format="ixt:num-dot-decimal" scale="6" id="f-693">2.2</ix:nonFraction>&#160;million. The $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-694">2.3</ix:nonFraction>&#160;million of NJ NOLs related tax benefits has been recorded as a benefit from income taxes and the loss on sale of $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="clbs:LossOnSaleOfNOL" format="ixt:num-dot-decimal" scale="6" id="f-695">0.1</ix:nonFraction>&#160;million recorded in other income (expense).</span></div></ix:continuation><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-669-3">On August 16, 2022, the Inflation Reduction Act was signed into law. The Inflation Reduction Act includes various tax provisions, which are effective for tax years beginning on or after January 1, 2023. For tax years beginning after December 31, 2021, the Tax Cuts &amp; Jobs Act of 2017 eliminated the option to deduct research and development expenditures as incurred and instead required taxpayers to capitalize and amortize them over five or 15 years beginning in 2022. Since the Company is in a net operating loss position, the capitalization of research and development costs did not have a material impact on the Company&#8217;s results of operations for the year ended December 31, 2022. The Company will continue to monitor future impact of changes in tax legislation.</ix:continuation>  </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 13 &#8211; <ix:nonNumeric contextRef="c-1" name="clbs:ResearchAndDevelopmentTaxIncentiveTextBlock" id="f-696" continuedAt="f-696-1" escape="true">Australia Research and Development Tax Incentive</ix:nonNumeric></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-696-1">The Company&#8217;s Australian subsidiary, which conducts core research and development activities, is eligible to receive a refundable tax incentive between <ix:nonFraction unitRef="number" contextRef="c-145" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-697">43.5</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-146" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="f-698">48.5</ix:nonFraction>% (depending upon the income tax rate) for qualified research and development activities. As of the six months ended June&#160;30, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="clbs:IncomeTaxIncentiveReceivable" format="ixt:num-dot-decimal" scale="6" id="f-699">1.1</ix:nonFraction>&#160;million was recorded as an income tax incentive receivable in  prepaid and other current assets in the consolidated balance sheets, as the Company determined that the expenses met the eligibility criteria and the amounts claimed are expected to be received shortly after the related tax returns are filed.</ix:continuation></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_76"></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 14 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-700" continuedAt="f-700-1" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-700-1"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is subject to legal proceedings and claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not believe that the outcome of any pending claims will have a material adverse effect on the Company's financial condition or operating results. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Cend received a written threat of litigation on behalf of a Chinese entity called Lingmed Limited (&#8220;Lingmed&#8221;) claiming Lingmed was entitled to a success fee based on Cend&#8217;s Collaboration and License Agreement with Qilu Pharmaceuticals. Cend responded by denying that Lingmed is entitled to a success fee under the terms of their agreement. In May 2022, Cend was served with a complaint filed by Lingmed in the San Diego County Superior Court, alleging claims for breach of contract, fraud and declaratory relief. Cend&#8217;s response to the complaint was filed on June 6, 2022. Lingmed filed an answer to Cend&#8217;s response on July 11, 2022. At a Case Management Conference held on August 4, 2023, the Court set a trial date in the matter for August 2, 2024. The Company denies these allegations made by Lingmed and intends to vigorously defend itself.</span></div></ix:continuation><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_79"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 15 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-701" continuedAt="f-701-1" escape="true">License Agreements</ix:nonNumeric></span></div><ix:continuation id="f-701-1" continuedAt="f-701-2"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sanford Burnham Prebys</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2015, Cend entered into a license agreement with Sanford Burnham Prebys (&#8220;SBP&#8221;) under which Cend was granted an exclusive, worldwide, royalty-bearing license to certain patent rights and know-how controlled by SBP related to the development of LSTA1. At the time the license agreement was entered into, Cend&#8217;s founding shareholder was an executive at SBP. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. As consideration for the license, Cend issued a total of <ix:nonFraction unitRef="shares" contextRef="c-147" decimals="INF" name="clbs:SharesIssuedUnderLicenseAgreement" format="ixt:num-dot-decimal" scale="0" id="f-702">382,030</ix:nonFraction> shares of common stock, as adjusted for the Reverse Stock Split and Exchange Ratio. The Company is required to pay an annual license maintenance fee of $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee" format="ixt:num-dot-decimal" scale="3" id="f-703">10,000</ix:nonFraction> increasing to $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven" format="ixt:num-dot-decimal" scale="3" id="f-704">20,000</ix:nonFraction> on year seven of the agreement. The Company could also be required to make milestone payments to SBP upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="clbs:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" format="ixt:num-dot-decimal" scale="6" id="f-705">10.6</ix:nonFraction>&#160;million. The Company has also agreed to pay SBP royalties of <ix:nonFraction unitRef="number" contextRef="c-147" decimals="INF" name="clbs:CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales" scale="-2" id="f-706">4</ix:nonFraction>% of net sales of products sold by the Company, or through a sublicense, subject to certain reductions. Additionally, the Company is obligated to pay SBP <ix:nonFraction unitRef="usd" contextRef="c-147" decimals="INF" name="clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees" scale="-2" id="f-707">25</ix:nonFraction>% of any sublicensing income. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, Cend entered into a license agreement with SBP under which Cend was granted an exclusive, royalty-bearing license to certain patent rights and know-how controlled by SBP. The agreement provides Cend with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. The Company is required to pay an annual license maintenance fee of $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee" format="ixt:num-dot-decimal" scale="3" id="f-708">20,000</ix:nonFraction>, increasing to $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour" format="ixt:num-dot-decimal" scale="3" id="f-709">30,000</ix:nonFraction> on year four of the agreement. Further, the Company could be required to make milestone payments to SBP upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="clbs:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" format="ixt:num-dot-decimal" scale="6" id="f-710">23.2</ix:nonFraction>&#160;million. The Company is obligated to pay SBP royalties of <ix:nonFraction unitRef="number" contextRef="c-148" decimals="INF" name="clbs:CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales" scale="-2" id="f-711">4</ix:nonFraction>% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company is obligated to pay SBP varying sublicense fees, ranging from <ix:nonFraction unitRef="usd" contextRef="c-149" decimals="INF" name="clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees" scale="-2" id="f-712">10</ix:nonFraction>% to <ix:nonFraction unitRef="usd" contextRef="c-150" decimals="INF" name="clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees" scale="-2" id="f-713">25</ix:nonFraction>%, dependent on when the related milestones are reached. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements will expire upon the later of (i) the final abandonment of all pending patent applications within the licensed patents or (ii) the expiration of the last to expire patent within the licensed patents. The agreements may be terminated in their entirety by the Company at any time by giving SBP sixty days&#8217; prior written notice. The agreements may be terminated in their entirety by SBP if the Company, at any time, defaults in the payment of any sum when due and fails to make such payment within thirty days after receipt of written notice. The agreements may be terminated in their entirety by SBP or the Company (i) in the event of an uncured material breach by the other party, or (ii) in the event the other party (a) files for, or is involuntarily petitioned with, bankruptcy (other than dissolution or winding up for the purposes of reconstruction or amalgamation), (b) makes an assignment of all or substantially all of its assets for the benefit of creditors, or (c) has a receiver or trustee is appointed and is unable to secure a dismissal, stay or other suspension of such proceedings within thirty days. Upon termination of the agreements for any reason, all rights and obligations of the Company with respect to the patents and patent applications shall terminate and revert to SBP.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SBP owned <ix:nonFraction unitRef="shares" contextRef="c-151" decimals="INF" name="clbs:SharesHeldByThirdParty" format="ixt:num-dot-decimal" scale="0" id="f-714">382,030</ix:nonFraction> shares of the Company&#8217;s common stock as of June&#160;30, 2023 and is a related party. </span></div></ix:continuation><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><ix:continuation id="f-701-2" continuedAt="f-701-3"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">University of California at San Diego</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, Cend entered into a license agreement with the University of California at San Diego (&#8220;UCSD&#8221;) under which Cend was granted an exclusive, royalty-bearing license to certain patent rights related to the development of nano-particles to modulate immune response. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell and otherwise exploit the patent rights. The Company could be required to make milestone payments to UCSD upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="clbs:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" format="ixt:num-dot-decimal" scale="6" id="f-715">1.2</ix:nonFraction>&#160;million. The Company has also agreed to pay UCSD royalties of <ix:nonFraction unitRef="number" contextRef="c-152" decimals="INF" name="clbs:CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales" scale="-2" id="f-716">1.5</ix:nonFraction>% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company agreed to pay UCSD varying sublicense fees, ranging from <ix:nonFraction unitRef="usd" contextRef="c-153" decimals="INF" name="clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees" scale="-2" id="f-717">10</ix:nonFraction>% to <ix:nonFraction unitRef="usd" contextRef="c-154" decimals="INF" name="clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees" scale="-2" id="f-718">20</ix:nonFraction>%, dependent on when the related milestones are reached. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement will expire upon the expiration of the longest-lived patent rights. The agreement may be terminated in its entirety by the Company at any time by giving UCSD ninety days&#8217; prior written notice. The agreement may be terminated in its entirety by UCSD if the Company, at any time, (i) fails to perform or violates any term of the agreement and fails to cure the default within sixty days. Upon termination of the agreement for any reason, UCSD may terminate a sublicensee but will allow the Company to assign any sublicenses to UCSD provided a) that the sublicensee is in good standing upon termination of the agreement with the Company; and b) the sublicensee is not currently involved in litigation as an adverse party to UCSD.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Massachusetts Institute of Technology</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, Cend entered into a license agreement with the Massachusetts Institute of Technology ("MIT") under which Cend was granted an exclusive, royalty-bearing license to certain patent rights related to the development of tissue specific delivery of interfering RNA. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. As consideration for the license, Cend issued a total of 43,236 shares of common stock, as adjusted for the Reverse Stock Split and Exchange Ratio. The Company is required to pay an annual license maintenance fee of $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee" format="ixt:num-dot-decimal" scale="3" id="f-719">20,000</ix:nonFraction>, increasing to $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree" format="ixt:num-dot-decimal" scale="3" id="f-720">25,000</ix:nonFraction> for year two and three of the agreement, increasing to $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour" format="ixt:num-dot-decimal" scale="3" id="f-721">50,000</ix:nonFraction> on year four of the agreement and thereafter until the first commercial sale, and increasing to $<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale" format="ixt:num-dot-decimal" scale="3" id="f-722">150,000</ix:nonFraction> each year of the agreement after the first sale. Further, the Company could be required to make milestone payments to MIT upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="clbs:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" format="ixt:num-dot-decimal" scale="6" id="f-723">5.0</ix:nonFraction>&#160;million. The Company has also agreed to pay MIT royalties of <ix:nonFraction unitRef="number" contextRef="c-155" decimals="INF" name="clbs:CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales" scale="-2" id="f-724">2</ix:nonFraction>% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company is obligated to pay MIT varying sublicense fees, ranging from <ix:nonFraction unitRef="usd" contextRef="c-157" decimals="INF" name="clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees" scale="-2" id="f-725">3</ix:nonFraction>% to <ix:nonFraction unitRef="usd" contextRef="c-158" decimals="INF" name="clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees" scale="-2" id="f-726">20</ix:nonFraction>%, depending on when the related milestones are reached. In connection with the close of the Merger, the Company was required to pay MIT a change of control fee of $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="clbs:CollaborativeArrangementRightsAndObligationsChangeOfControlFee" format="ixt:num-dot-decimal" scale="6" id="f-727">0.3</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement expires upon the expiration or abandonment of all valid claims. The agreement may be earlier terminated in its entirety by the Company at any time by giving MIT six months prior written notice. The agreement may also be terminated in its entirety by MIT if the Company, at any time, (i) defaults in the payment of any sum when due and fails to make such payment within thirty days after receipt of written notice, or (ii) commits a material breach of its obligations under the agreement (aside from item (i)) and fails to cure that breach within sixty days after receipt of written notice. Upon termination of the agreement for any reason, the rights and licenses granted to the Company shall terminate and revert to MIT. Upon termination of the agreement for any reason, MIT may terminate a sublicensee but will allow the Company to assign any sublicenses to MIT provided that the sublicensee is in good standing upon termination of the agreement with the Company.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2023, in accordance with the provisions of the license agreement, the Company provided notice to MIT that the license agreement would terminate effective December 30, 2023. Until such date, the license remains in full force and effect.</span></div></ix:continuation><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-701-3" continuedAt="f-701-4">MIT owned <ix:nonFraction unitRef="shares" contextRef="c-159" decimals="INF" name="clbs:SharesHeldByThirdParty" format="ixt:num-dot-decimal" scale="0" id="f-728">43,236</ix:nonFraction> shares of the Company&#8217;s common stock as of June&#160;30, 2023</ix:continuation>.</span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_82"></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 16 &#8211; <ix:continuation id="f-701-4" continuedAt="f-701-5">Research Collaboration and License Agreement</ix:continuation></span></div><ix:continuation id="f-701-5" continuedAt="f-701-6"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exclusive License and Collaboration Agreement</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Cend entered into an Exclusive License and Collaboration Agreement (the &#8220;Qilu Agreement&#8221;) in which Cend granted an exclusive license to Qilu for the development and commercialization of LSTA1 in the Territory (defined as the Greater Area of China including China, Macau, Hong Kong, and Taiwan). Under the terms of the agreement, Qilu is solely responsible for the development of LSTA1 in its Territory. In consideration for the license, Qilu made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-729">10</ix:nonFraction>&#160;million to Cend, which was recognized as revenue by Cend prior to the Merger. In addition, Cend received and recognized as revenue a $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" format="ixt:num-dot-decimal" scale="6" id="f-730">5</ix:nonFraction>&#160;million development milestone prior to the Merger. The Company is eligible to receive additional developmental and commercial milestone payments up to $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-6" name="clbs:RevenueRemainingPerformanceObligationVariableConsiderationAmount" format="ixt:num-dot-decimal" scale="6" id="f-731">95</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-6" name="clbs:RevenueRemainingPerformanceObligationVariableConsiderationAmount" format="ixt:num-dot-decimal" scale="6" id="f-732">125</ix:nonFraction>&#160;million, respectively, tiered royalties on net sales ranging from <ix:nonFraction unitRef="number" contextRef="c-162" decimals="INF" name="clbs:RevenuePerformanceObligationPercentageOfNetSale" scale="-2" id="f-733">10</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-163" decimals="INF" name="clbs:RevenuePerformanceObligationPercentageOfNetSale" scale="-2" id="f-734">15</ix:nonFraction>%, and tiered sublicensing revenues ranging from <ix:nonFraction unitRef="number" contextRef="c-162" decimals="INF" name="clbs:RevenuePerformanceObligationPercentageOfSublicensingRevenues" scale="-2" id="f-735">12</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-163" decimals="INF" name="clbs:RevenuePerformanceObligationPercentageOfSublicensingRevenues" scale="-2" id="f-736">35</ix:nonFraction>%.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-701-6">Unless terminated early, the Qilu Agreement will continue in effect until the expiration of all Qilu payment obligations. Either party may terminate the Qilu Agreement if an undisputed material breach by the other party is not cured within a defined period of time, or upon notice for insolvency-related events of the other party that are not discharged within a defined time period. Qilu may terminate the Qilu Agreement in its entirety, at any time with at least sixty days written notice. All rights and obligations of Qilu with respect to such licensed patents and patent applications would terminate.</ix:continuation></span></div><div><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_85"></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Note 17 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-737" continuedAt="f-737-1" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="f-737-1"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Departure of Director</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 11, 2023, the Company announced that Erkki Ruoslahti, M.D., Ph.D., had decided to retire from its Board of Directors. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assignment of Tumor Penetrating Nanocomplex (TPN) platform</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 21, 2023, the Company entered into a Technology Transfer Agreement with Impilo Therapeutics, Inc. (&#8220;Impilo&#8221;), pursuant to which the Company will, subject to the satisfaction of customary closing conditions, transfer the rights to the Tumor Penetrating Nanocomplex (TPN) platform to Impilo (the &#8220;Transfer&#8221;). In exchange, on the closing date of the Transfer (the &#8220;Closing Date&#8221;) and pursuant to an Equity Purchase Agreement, by and between the Company and Impilo, to become effective on the Closing Date, Impilo will issue to the Company <ix:nonFraction unitRef="shares" contextRef="c-164" decimals="0" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="0" id="f-738">768,500</ix:nonFraction> shares of its pre-seed preferred stock.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25 </span></div></div></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; herein and under &#8220;Risk Factors&#8221; in our 2022 Form 10-K. The following discussion should be read in conjunction with our consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report and in our 2022 Form 10-K.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Our lead investigational product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to penetrate solid tumors more effectively. LSTA1 actuates this active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs more efficiently penetrating and accumulating in the tumor, while normal tissues are not expected to be affected. LSTA1 also has the potential to modify the tumor microenvironment (&#8220;TME&#8221;), thereby making tumors more susceptible to immunotherapies. We and our collaborators have amassed significant non-clinical data demonstrating enhanced delivery of a range of existing and emerging anti-cancer therapies, including chemotherapeutics, immunotherapies and RNA-based therapeutics. To date, LSTA1 has also demonstrated favorable safety, tolerability, and activity in completed and ongoing clinical trials designed to enhance delivery of standard-of-care chemotherapy for pancreatic cancer. We are exploring the potential of LSTA1 to enable a variety of treatment modalities to treat a range of solid tumors more effectively. In addition, we have development programs based on our autologous CD34+ cell therapy technology platform that we are seeking to partner while incurring no additional capital outlay.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leadership team has decades of collective biopharmaceutical and pharmaceutical product development experience across a variety of therapeutic categories and at all stages of development from preclinical through to product registration and launch. Our goal is to develop and commercialize products that address important unmet medical needs. Our current development pipeline includes: </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LSTA1, the subject of our Phase 1b/2a and 2b clinical studies being conducted globally in a variety of solid tumor types, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a variety of anti-cancer regimens.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Targeted Solid Tumor Penetration via CendR Active Transport</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many solid tumor cancers, including pancreatic ductal adenocarcinoma (&#8220;PDAC&#8221;), are surrounded by dense fibrotic tissue, or stroma. This limits the efficacy of current chemotherapies for these cancers. Emerging immunotherapy treatments, including checkpoint inhibitors, adoptive cell therapies such as chimeric antigen receptor T (&#8220;CAR-T&#8221;) cells, as well as nucleic acid-based therapies, such as short interfering RNA (&#8220;siRNA&#8221;), antisense oligonucleotides (&#8220;ASO&#8221;), and messenger RNAs (&#8220;mRNAs&#8221;) also face challenges in penetrating solid tumors. Many tumors also exhibit an immunosuppressive tumor microenvironment (&#8220;TME&#8221;), which suppresses patients&#8217; immune systems&#8217; ability to fight their cancer and can limit effectiveness of immunotherapies and/or contribute to metastases. These factors negatively impact the ability of many therapeutic agents to effectively treat these cancers.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To address the tumor stroma&#8217;s role as a primary impediment to effective treatment, our approach is to activate the C-end rule (&#8220;CendR&#8221;), or CendR system, a naturally occurring active transport system. Our lead investigational drug, LSTA1 (a specific internalizing R-G-D or iRGD peptide), activates this transport system in a tumor-specific manner (Sugahara, Science, 2010). LSTA1 enables more selective and efficient uptake of systemically administered anti-cancer drugs resulting in more intratumoral drug accumulation. The overall result is enhanced anticancer activity without an increase in side effects. While it is possible to couple/tether or conjugate some anticancer drugs to LSTA1, we believe that the co-administration approach is an advantage because it does not create a new chemical entity with its attendant development and regulatory hurdles, thereby providing an anticipated faster-to-clinic and faster-to-market product opportunity for a range of co-administration therapies. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical progress with other approaches to address delivery to highly fibrotic tumors, such as PEGylated hyaluronidase and hedgehog inhibitors, has been limited by toxicity and side effects. LSTA1 has demonstrated favorable safety/tolerability and activity in clinical trials to enhance delivery of standard-of-care chemotherapy for mPDAC. LSTA1&#8217;s cancer-targeted delivery may enable such emerging treatment modalities to treat a range of solid tumors potentially more effectively.</span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LSTA1 as a treatment for solid tumor cancers in combination with other anti-cancer agents</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LSTA1 is an investigational drug that actuates the CendR active transport mechanism while also having the potential to modify the TME and make it less immunosuppressive, thereby making the tumor more susceptible to attack by the immune system. It is targeted to tumor vasculature, endothelial cells, tumor cells and some intratumoral immunosuppressive cells by its affinity for alpha-v, beta-3 and beta-5 integrins that are upregulated on these cells. LSTA1 is a nine amino acid cyclic internalizing RGD (&#8220;iRGD&#8221;) peptide that, once bound to these integrins, is cleaved by proteases expressed in tumors to release a peptide fragment, called a CendR fragment. The CendR fragment then binds to an adjacent receptor, called neuropilin-1 receptor, to activate a novel uptake pathway that allows circulating moieties such as anticancer drugs to more selectively and effectively penetrate solid tumors. The ability of LSTA1 to modify the TME to enhance delivery and efficacy of co-administered drugs has been demonstrated in many preclinical models in a range of solid tumors with the results from Lisata, collaborators and research groups around the world having been the subject of over 300 scientific publications.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With regard to clinical development, LSTA1 is the subject of a completed Phase 1b clinical trial of 31 first-line metastatic pancreatic ductal adenocarcinoma patients, of which 29 were evaluable. Results from the trial showed that the safety profile of the LSTA1 combination regimen was similar to standard of care (&#8220;SoC&#8221;) alone with LSTA1 being well-tolerated with no-dose limiting toxicities. An Objective Response Rate (&#8220;ORR&#8221;) of fifty nine percent was observed, including a rare complete response, which compares favorably to the twenty three percent ORR observed in the &#8220;MPACT&#8221; clinical trial that served as the basis for approval of nab-paclitaxel for use in combination with gemcitabine for the treatment of first line, metastatic pancreatic ductal adenocarcinoma. A Disease Control Rate (&#8220;DCR&#8221;); (partial and complete responses plus stable disease) of over seventy nine percent was observed in comparison to a DCR of forty eight percent observed in the MPACT trial. Reduction in the level of circulating tumor biomarker CA19-9 was observed in 96% of patients versus 61% in the MPACT trial. Importantly, median progression-free survival and median overall survival of nearly ten months and over thirteen months were observed, respectively, vs. less than six months and less than nine months, respectively, in the MPACT trial. These results have been published in The Lancet Gastroenterology and Hepatology (Dean, et al. 2022).</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, LSTA1 is the subject of multiple ongoing and planned clinical trials being conducted globally in a variety of solid tumor types and in combination with several chemotherapy and immunotherapy anti-cancer regimens. The following diagram summarizes these studies.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><img src="clbs-20230630_g1.jpg" alt="Slide1.jpg" style="height:371px;margin-bottom:5pt;vertical-align:text-bottom;width:660px"/></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><img src="clbs-20230630_g2.jpg" alt="Slide2.jpg" style="height:371px;margin-bottom:5pt;vertical-align:text-bottom;width:660px"/></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ischemic Repair (CD34+ Cell Technology)</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CD34+ cell was discovered as a result of the deliberate search for a cell capable of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building new blood vessels after injury. A CD34+ cell is an endothelial progenitor cell that has the ability to stimulate new blood vessel formation at the level of the microvasculature. No other native cell discovered to date has demonstrated this same capability.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our proprietary cell technology using autologous (a patient&#8217;s own naturally occurring) CD34+ cells has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is restricted or reduced. Through the administration of CD34+ cells, we seek to promote the development and formation of new microvasculature and thereby increase blood flow to the impacted area. We believe that a number of conditions caused by underlying ischemic injury can be improved through our CD34+ cell technology, including, but not limited to, Buerger's disease, critical limb ischemia (&#8220;CLI&#8221;), coronary microvascular dysfunction (&#8220;CMD&#8221;), refractory angina, and diabetic kidney disease (&#8220;DKD&#8221;).</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HONEDRA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> for Treatment of Critical Limb Ischemia</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our randomized, open-label, registration-eligible study of HONEDRA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Japan for the treatment of CLI and Buerger's disease has, to date, demonstrated positive trends in both safety and efficacy. The HONEDRA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> study's enrollment, however, has been significantly curtailed by the COVID-19 pandemic's impact in Japan, including the States of Emergency in Japan that have persisted for much of 2020, 2021, and 2022. Due to the significant and continued operational and financial burden incurred as a result of these COVID-19 delays, coupled with the unpredictability of the timing of site enrollment re-initiation, we suspended further enrollment in the fourth quarter of 2021. Following study suspension, we completed all protocol-defined patient observations and completed the clinical study report. Data from the follow-up of all patients completed in the registration-eligible clinical trial in Japan have been compiled and are the subject of discussions with the Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) in Japan as part of the Japanese regulatory pre-consultation process and in preparation for the formal clinical consultation meetings which precede a Japanese new drug application (&#8220;JNDA&#8221;). To date, the PMDA has provided advice on how to prepare for the formal consultation meeting and has indicated their preference for additional clinical information to accompany the filing of a JNDA. Concomitantly, the Company has reinforced its efforts to secure a Japanese partner to complete the remaining steps of development/registration as well as eventual commercialization in Japan.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger with Cend Therapeutics, Inc. and Name Change</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 15, 2022, the Company, then operating as Caladrius Biosciences, Inc. (&#8220;Caladrius&#8221;), completed its acquisition of Cend Therapeutics, Inc. (&#8220;Cend&#8221;), a Delaware corporation (the &#8220;Merger&#8221;), in accordance with the terms of the Agreement and Plan of Merger and Reorganization (the &#8220;Merger Agreement&#8221;), dated as of April 26, 2022, by and among Caladrius, Cend and CS Cedar Merger Sub, Inc. (&#8220;Merger Sub&#8221;).</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms set forth in the Merger Agreement and effective September 15, 2022 (the &#8220;Effective Time&#8221;): (i) Merger Sub merged with and into Cend, with Cend surviving as a wholly owned subsidiary of Caladrius, (ii) Caladrius changed its name to Lisata Therapeutics, Inc. in connection with and immediately following to the Effective Time, and (iii) Caladrius effected a 1:15 reverse stock split of its common stock (&#8220;Reverse Stock Split&#8221;) prior to the Effective Time. At the Effective Time, each share of Cend's common stock outstanding immediately prior to the Effective Time was converted into the right to receive shares of Lisata&#8217;s common stock based on an exchange ratio of 0.5338 (the &#8220;Exchange Ratio&#8221;), after taking into account the Reverse Stock Split. In connection with the Merger close, the Company issued an aggregate of 3,772,768 shares of common stock, based on the Exchange Ratio, to holders of Cend, in exchange for all of the Cend capital stock outstanding immediately prior to the closing of the Merger.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, we assumed all of the outstanding and unexercised options to purchase shares of Cend capital stock under the 2016 Equity Incentive Plan (the &#8220;Cend Plan&#8221;), and, in connection with the Merger, such options were converted into options to purchase shares of Lisata&#8217;s common stock based on the Exchange Ratio. At the closing of the Merger at the Effective Time, we assumed Cend's stock options to purchase an aggregate of 1,227,776 shares of the Company's common stock.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Caladrius was considered to be the accounting acquirer based on the terms of the Merger Agreement and certain factors including: (i) Caladrius owned approximately 52% of the Company's outstanding shares of common stock immediately following the close of the Merger; (ii) although both entities contributed to the new management team of Lisata, the Caladrius team has more individuals on the management team and will hold the CEO, CMO and other senior management roles; (iii) Caladrius paid a premium to acquire Cend&#8217;s assets; and (iv) Caladrius was significantly larger than Cend regarding total assets, operations, and research and development activities. The Merger was accounted for as an asset acquisition as substantially all of the fair value is concentrated in in-process research and development (&#8220;IPR&amp;D&#8221;). Cend&#8217;s assets (except for cash and working capital) were measured and recognized as an allocation of the transaction price based on their relative fair values as of the transaction date with any value associated with IPR&amp;D with no alternative future use being expensed. The prior reported operating results prior to the Merger close are those of Caladrius.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Out-licensing Opportunities</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our broad intellectual property portfolio of assets includes notable programs available for out-licensing in order to augment or continue their clinical development. Our current long-term strategy focuses on advancing our therapies through development with the ultimate objective of obtaining market authorizations and entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. We believe that we are well-positioned to realize potentially meaningful value increases within our own proprietary pipeline if we are successful in advancing our product candidates to their next significant development milestones.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of the COVID-19 Pandemic</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to closely monitor the impact of the COVID-19 pandemic on all aspects of our business, including how it has and will continue to impact our operations and the operations of our suppliers, vendors and business partners, and may take further precautionary and preemptive actions as may be required by federal, state or local authorities. In addition, we have taken steps to minimize the current environment&#8217;s impact on our business and strategy, including devising contingency plans and securing additional resources from third party service providers. Our phase 2b trial of XOWNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States  experienced delays in enrolling patients as a result of COVID-19. In May 2022, we announced that enrollment in the FREEDOM Trial was suspended and that we intended to conduct an interim analysis of the data from not less than the first 20 patients enrolled using the 6-month follow-up data to evaluate the efficacy and safety of XOWNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in subjects with CMD. Following this analysis along with Key Opinion Leaders&#8217; input, we determined that execution of a redesigned FREEDOM-like trial would be the appropriate next step, but the cost of such a trial would be prohibitively expensive to undergo without a strategic partner. Accordingly, our board of directors concluded that XOWNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> development will only be continued if a strategic partner that can contribute the necessary capital for a redesigned trial is identified and secured. There can be no assurance that we will be able to identify such a partner and enter into an agreement with such partner on acceptable terms or at all.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beyond its impact on our development pipeline described above, the extent to which COVID-19 ultimately impacts our business, results of operations and financial condition will depend on future developments, which remain highly uncertain and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cannot be predicted with confidence, such as the duration of the outbreak, the emergence of new variants, new information that may emerge concerning the severity of COVID-19 or the effectiveness of actions taken to contain COVID-19 or treat its impact, including vaccination campaigns, among others. If we or any of the third parties with whom we engage, however, were to experience any additional shutdowns or other prolonged business disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially or negatively affected, which could have a material adverse impact on our business, financial condition and results of operations. It is possible that our clinical development timelines could continue to be negatively affected by COVID-19, which could materially and adversely affect our business, financial condition and results of operations. See &#8220;Risk Factors&#8221; for additional discussion of the potential adverse impact of the COVID-19 pandemic on our business, financial condition and results of operations.</span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_91"></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended June&#160;30, 2023 Compared to Three Months Ended June&#160;30, 2022 </span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the three months ended June&#160;30, 2023 and June&#160;30, 2022:</span></div><div style="margin-bottom:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.643%"><tr><td style="width:1.0%"></td><td style="width:52.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.251%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.251%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Research and development</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,875)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,720)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,330)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,027)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,626)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,599&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, net losses were $4.0 million for the three months ended June&#160;30, 2023, compared to $6.6 million for the three months ended June&#160;30, 2022.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2023, operating expenses totaled $6.9 million compared to $6.7 million for the three months ended June&#160;30, 2022, representing an increase of 2.3%.  Operating expenses comprised the following:&#160;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Research and development expenses were approximately $3.2 million for the three months ended June&#160;30, 2023, compared to $3.2 million for the three months ended June&#160;30, 2022, representing a decrease of $0.1 million or 2.2%. This was primarily due to expenses associated with our study start up activities in the current year associated with the LSTA1 Phase 2 proof-of-concept basket trial in various solid tumors in combination with the corresponding standards of care, enrollment activities for the LSTA1 Phase 2b ASCEND study and chemistry, manufacturing and control (CMC) activities for LSTA1 being offset by expenses associated with our Ischemic Repair programs (XOWNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Phase 2b study, HONEDRA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and diabetic kidney disease) in the prior year.</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">General and administrative expenses were approximately $3.7 million for the three months ended June&#160;30, 2023, compared to $3.5 million for the three months ended June&#160;30, 2022, representing an increase of $0.2 million or 6.5%. This was primarily due to severance costs associated with the elimination of the Chief Business Officer position on May 1, 2023, partially offset by non-recurring merger related costs in the prior year.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, to minimize our use of cash, we have used a variety of equity instruments to compensate employees, consultants and other service providers. The use of these instruments has resulted in charges to the results of operations, which have been significant in the past.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income (expense) is comprised of investment income from cash, cash equivalents and marketable securities for both three months ended June&#160;30, 2023 and 2022 and a loss on sale related to the sale of our New Jersey net operating losses (&#8220;NJ NOLs&#8221;) in the three months ended June&#160;30, 2023.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Tax Benefit</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In April 2023, we received final approval from the New Jersey Economic Development Authority (&#8220;NJEDA&#8221;) under the Technology Business Tax Certificate Transfer Program (&#8220;Program&#8221;) to sell a percentage of our NJ NOLs, which were subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $2.2&#160;million. The $2.3 million of NJ NOLs related tax benefits (&#8220;NJ NOL Tax Benefits&#8221;) have been recorded as a benefit from income taxes and the loss on sale of $0.1 million recorded in other income (expense).</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Six Months Ended June&#160;30, 2023 Compared to Six Months Ended June&#160;30, 2022 </span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the six months ended June&#160;30, 2023 and June&#160;30, 2022:</span></div><div style="margin-bottom:8pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.643%"><tr><td style="width:1.0%"></td><td style="width:52.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.251%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.251%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Research and development</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,719)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,330)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,479)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,214)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,852)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, net losses were $10.2 million for the six months ended June&#160;30, 2023, compared to $10.9 million for the six months ended June&#160;30, 2022.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2023, operating expenses totaled $13.7 million compared to $13.3 million for the six months ended June&#160;30, 2023, representing an increase of 2.8%.  Operating expenses comprised the following:&#160;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Research and development expenses were approximately $6.3&#160;million for the six months ended June&#160;30, 2023, compared to $6.5 million for the six months ended June&#160;30, 2022, representing a decrease of $0.2&#160;million or 2.7%. This was primarily due to expenses associated with our study start up activities in the current year associated with the LSTA1 Phase 2 proof-of-concept basket trial in various solid tumors in combination with the corresponding standards of care, enrollment activities for the LSTA1 Phase 2b ASCEND study and chemistry, manufacturing and control (CMC) activities for LSTA1 being offset by expenses associated with our Ischemic Repair programs (XOWNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Phase 2b study,  HONEDRA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and diabetic kidney disease) in the prior year.</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">General and administrative expenses were approximately $7.4 million for the six months ended June&#160;30, 2023, compared to $6.8 million for the six months ended June&#160;30, 2022, representing an increase of $0.6&#160;million or 8.1%. This was primarily due to severance costs associated with the elimination of the Chief Business Officer position on May 1, 2023, partially offset by non-recurring merger related costs in the prior year.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, to minimize our use of cash, we have used a variety of equity instruments to compensate employees, consultants and other service providers. The use of these instruments has resulted in charges to the results of operations, which have been significant in the past.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income (expense) is comprised of investment income from cash, cash equivalents and marketable securities for both six months ended June&#160;30, 2023 and 2022 and a loss on sale related to the sale of our NJ NOLs in the six months ended June&#160;30, 2023 and 2022.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Tax Benefit</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In April 2023, we received final approval from the NJEDA under the Program to sell a percentage of our NJ NOLs, which were subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $2.2&#160;million. The $2.3 million of our NJ NOL Tax Benefits have been recorded as a benefit from income taxes and the loss on sale of $0.1 million recorded in other income (expense).</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, we received final approval from the NJEDA under the Program to sell a percentage of our NJ NOLs, which were subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $2.3 million. The $2.5 million of our NJ NOL Tax Benefits have been recorded as a benefit from income taxes and the loss on sale of $0.1 million recorded in other income (expense).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32 </span></div></div></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Analysis of Liquidity and Capital Resources</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2023, we had cash, cash equivalents and marketable securities of approximately $57.6 million, working capital of approximately $57.1 million, and stockholders&#8217; equity of approximately $58.0 million.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023, we met our immediate cash requirements through existing cash balances.  Additionally, we used equity and equity-linked instruments to pay for services and compensation. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash (used in) or provided by, operating, investing and financing activities were as follows (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.737%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,380)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,704)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Operating Activities</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash used in operating activities during the six months ended June&#160;30, 2023 was $12.4 million, which is comprised of (i) our net loss of $10.2 million, adjusted for non-cash expenses totaling $0.9&#160;million (which includes adjustments for equity-based compensation, depreciation and amortization, a loss on disposal of fixed assets, and amortization/accretion of marketable securities), and (ii) changes in operating assets and liabilities using approximately $3.1 million.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash used in operating activities during the six months ended June&#160;30, 2022 was $10.7 million, which is comprised of (i) our net loss of $10.9 million, adjusted for non-cash expenses totaling $2.0 million (which includes adjustments for equity-based compensation, depreciation and amortization, and amortization/accretion of marketable securities) and (ii) changes in operating assets and liabilities using approximately $1.9 million.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Investing Activities</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash provided by investing activities during the six months ended June&#160;30, 2023 totaled $3.6 million and was primarily due to net sales of marketable securities (net of purchases of marketable securities).</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash used in investing activities during the six months ended June&#160;30, 2022 totaled $19.5 million and was primarily due to net sales of marketable securities (net of purchases of marketable securities) partially offset by our investment in Cend.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financing Activities</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash provided by financing activities during the six months ended June&#160;30, 2023 totaled $0.4 million and consisted of proceeds from the issuance of shares through our ATM Agreement of $0.3&#160;million, option exercise proceeds of $0.2&#160;million partially offset by tax withholding-related payments of $0.1&#160;million on net share settlement equity awards to employees. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash used in financing activities during the six months ended June&#160;30, 2022 totaled $0.1 million and consisted primarily of tax withholding-related payments on net share settlement equity awards to employees. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Requirements Outlook</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To meet our short and long-term liquidity needs, we expect to use existing cash balances, marketable securities and a variety of other means. Other sources of liquidity could include additional potential issuances of debt or equity securities in public or private financings, partnerships and/or collaborations and/or sale of assets. Our history of operating losses and liquidity challenges may make it difficult for us to raise capital on acceptable terms or at all. The demand for the equity and debt of pharmaceutical companies like ours is dependent upon many factors, including the general state of the financial markets. During times of extreme market volatility, capital may not be available on favorable terms, if at all. Our inability to obtain such additional capital could materially and adversely affect our business operations. We will also continue to seek, as appropriate, grants for scientific and clinical studies from various governmental agencies and foundations, and other sources of non-dilutive funding. We believe that our cash on hand and marketable securities will enable us to fund operating expenses for at least the next 12 months following the issuance of our financial statements. Our future capital requirements are difficult to forecast and will depend on many factors including the timing and nature of any other strategic transactions that we undertake; and our ability to establish and maintain collaboration partnerships, in-license/out-license or other similar arrangements and the financial terms of such agreements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 4, 2021, we entered into an At The Market Offering Agreement (the &#8220;ATM Agreement&#8221;) with H.C. Wainwright &amp; Co., LLC as sales agent, in connection with an &#8220;at the market offering&#8221; under which we from time to time may offer and sell shares of our common stock having an aggregate offering price of up to $50.0&#160;million. Subsequent to the filing of our Form 10-K on March 22, 2022, the aggregate market value of our outstanding common stock held by non-affiliates was approximately $43.6 million. Pursuant to General Instruction I.B.6 of Form S-3, since the aggregate market value of our outstanding common stock held by non-affiliates was below $75.0 million at the time of such Form 10-K filing, the aggregate amount of securities that we are permitted to offer and sell was reduced to $17,698,943, which was equal to one-third of the aggregate market value of our common stock held by non-affiliates as of September 21, 2022. Since inception we have issued 64,394 shares of common stock under the ATM Agreement for net proceeds of $270,774.  </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we continue to seek capital through a number of means, there can be no assurance that additional financing will be available on acceptable terms, if at all, and our negotiating position in capital generating efforts may worsen as existing resources are used. Additional equity financing may be dilutive to our stockholders; debt financing, if available, may involve significant cash payment obligations and covenants that restrict our ability to operate as a business; our stock price may not reach levels necessary to induce option or warrant exercises; and asset sales may not be possible on terms we consider acceptable. If we are unable to access capital necessary to meet our long-term liquidity needs, we may have to delay the expansion of our business or raise funds on terms that we currently consider unfavorable. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_97"></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any off-balance sheet arrangements.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our critical accounting policies and estimates during the three and six months ended June&#160;30, 2023, compared to those reported in our 2022 Form 10-K.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_100"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.<br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_103"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)&#160;&#160;Disclosure Controls and Procedures</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosure controls and procedures are our controls and other procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934 (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934), as amended (the &#8220;Exchange Act&#8221;) is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in the reports that we file under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer, who serves as our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well-designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Due to the inherent limitations of control systems, not all misstatements may be detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. Controls and procedures can only provide reasonable, not absolute, assurance that the above objectives have been met.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, we evaluated, with the participation of our management, including our Chief Executive Officer, the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on that evaluation, our Chief Executive Officer concluded that our disclosure controls and procedures were effective, at the reasonable assurance level, in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms and is accumulated and communicated to management, including the Chief Executive Officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34 </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)&#160;&#160;Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15, that occurred during our last quarter to which this Quarterly Report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35 </span></div></div></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_109"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as disclosed in &#8220;Note 14 &#8211; Contingencies&#8221; set forth in the Notes to Unaudited Consolidated Financial Statements, which are included herein, there are no material changes to the disclosures previously reported in our 2022 Form 10-K.<br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_112"></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the risk factors previously reported in our 2022 Form 10-K.  See the risk factors set forth in our 2022 Annual Report on Form 10-K under the caption &#8220;Item 1A - Risk Factors.&#8221;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_115"></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_118"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_121"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_124"></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. OTHER INFORMATION</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_127"></div><div style="-sec-extract:summary;margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Exhibit Index appearing immediately after the signature page to this Form 10-Q is incorporated herein by reference.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36 </span></div></div></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="margin-bottom:8pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:8pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.314%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LISATA THERAPEUTICS, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 14, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> /s/ David J. Mazzo, PhD      </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name: David J. Mazzo, PhD      </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title:   President &amp; Chief Executive Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Executive Officer, Principal Financial Officer </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and Principal Accounting Officer)</span></div></td></tr></table></div><div style="margin-bottom:3.3pt;padding-left:6.75pt;padding-right:2.25pt;text-align:justify;text-indent:15.75pt"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37 </span></div></div></div><div id="icf8a0af2f47148dc98c9ade30e1c2f8f_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf8a0af2f47148dc98c9ade30e1c2f8f_7">Index</a></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LISATA THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Index</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:522.00pt"><tr><td style="width:1.0pt"></td><td style="width:40.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:461.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101slackseveranceagm05.htm">10.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Severance Agreement, dated May 1, 2023, by and between the Company and David Slack.</span></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="clbs-ex311_20230630xq2.htm">31.1</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certification of Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:27pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="clbs-ex32_20230630q2.htm">32</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certification of Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:522.00pt"><tr><td style="width:1.0pt"></td><td style="width:16.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:502.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contract or compensatory plan, contract or arrangement.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">             </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38 </span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101slackseveranceagm05.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ex101slackseveranceagm05</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ex101slackseveranceagm05001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex101slackseveranceagm05001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">1   SEVERANCE AGREEMENT    May 1, 2023    PERSONAL AND CONFIDENTIAL  BY EMAIL  David Slack  Dear David:  The purpose of this Severance Agreement (the &#8220;Agreement&#8221;) is to set forth the terms of  your separation from Lisata Therapeutics Inc. (the &#8220;Company&#8221;). Payment of the Separation Pay  and receipt of the Separation Benefits described below is contingent on your agreement to and  compliance with the terms of this Agreement. Neither this offer to you nor the Company&#8217;s entering  into this Agreement shall constitute an admission by the Company.    1. Termination of Employment.    (a) Your employment with the Company will end on May 1, 2023 (the  &#8220;Termination Date&#8221;). The Company will pay you for your accrued wages through the Termination  Date of $24,133.62 on the Termination Date, which shall include payment for any accrued but  untaken paid time off which equals $22,321.50. You will receive no other payments from the  Company other than as set forth in this Agreement. In addition, you may elect to continue your  health insurance pursuant to the provisions of the Consolidated Omnibus Budget Reconciliation  Act of 1985 (COBRA), which notice shall be delivered under separate cover.    (b) The Company will not contest any application you may make for  unemployment benefits after the Termination Date and you may apply for unemployment benefits  directly from the State of California by accessing this website:  https://edd.ca.gov/Unemployment/Filing_a_Claim.htm.    2. Severance Benefits. If you sign and do not revoke this Agreement, as you are  entitled to do, in exchange for the mutual promises set forth in this Agreement, you will receive  the following separation benefits (the &#8220;Separation Benefits&#8221;):    (a) the Company will pay you $717,600.00 subject to all usual payroll  deductions (the &#8220;Separation Pay&#8221;), which amount consists of: (i) 12 months of separation pay totaling  $478,400.00, consistent with Section 8(a)(ii) of the Employment Agreement between you and  Company dated as of September 15, 2022 (the &#8220;Employment Agreement&#8221;) and (ii) the pro-rata  bonus payment totaling $239,200.00 consistent with Section 8(a)(iv) of the Employment  Agreement. The Company will pay the Separation Pay in equal monthly installments over a period  of 12 months following termination starting in the first payroll period after the Effective Date of this  Agreement (as that term is defined below and assuming you do not revoke your signature on this  Agreement as you are entitled to do).  Exhibit 10.1 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex101slackseveranceagm05002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex101slackseveranceagm05002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">2   (b) The Company will reimburse you for 12 months of the Company-portion of  COBRA consistent with section 8(a)(iii) of the Employment Agreement (assuming you do not  revoke your signature on this Agreement as you are entitled to do).    (c) You acknowledge that the table below sets forth a complete and accurate  list of your options, RSAs and PSUs and their vesting as of the Termination Date pursuant to this  Agreement, and that all remaining unvested options, RSAs and PSUs are forfeited as of the  Effective Date, and that you have no further rights to any equity in the Company or any affiliates.  You and the Company acknowledge and agree that your vested options will remain outstanding  following the Termination Date as provided below (assuming you do not revoke your signature on  this Agreement as you are entitled to do).    Grant Date Equity Award Number of  Shares Granted  Shares Vested  at Separation  Date  Time Period to  Exercise  Vested Options  After  Termination  Date  1/9/2023 Options-  NQSO  12,000 3,000 3 years  9/15/2022 Options-  NQSO  137,358 137,358 3 years  9/15/2022 Options-  NQSO  106,855 35,609 3 years  9/15/2022 Options -  NQSO  10,676 10,676 3 years  1/9/2023 RSA 24,000 6,000* NA  1/9/2023 PSU 12,000 0 NA    *Vested shares less net settlement which were previously sent to brokerage  account.    (d) You acknowledge and agree that the Separation Benefits referred to in this  Agreement are not otherwise due and owing to you under any Company employment agreement  (oral or written) or Company policy or practice absent your execution of this Agreement. You  agree that the Separation Benefits to be provided to you are not intended to and does not constitute  a severance plan and does not confer a benefit on anyone other than you. You further acknowledge  that except for the specific financial consideration set forth in this Agreement, you are not now  and shall not in the future be entitled to any other compensation from the Company including,  without limitation, other wages, commissions, bonuses, vacation pay, holiday pay, paid time off  or any other form of compensation or benefit.    (e) The Separation Benefits shall be reduced by all applicable federal, state,  local and other deductions, taxes, and withholdings. The Company does not guarantee the tax  treatment or consequences associated with any payment or benefit under this Agreement, including  under Section 409A of the Internal Revenue Code of 1986. You acknowledge and agree that you  are solely responsible for the tax designations of any consideration provided to you pursuant to  this Agreement. You and the Company further agree that any and all tax liabilities that may arise  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex101slackseveranceagm05003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex101slackseveranceagm05003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">3   out of payment of any consideration provided to you pursuant to this Agreement will be borne  exclusively and solely by you.  3. Employee Covenants.    (a) You acknowledge that as of the date you execute this Agreement (the  &#8220;Execution Date&#8221;), you have not filed any complaints, claims, charges, actions, grievances or  arbitrations against the Company1 or otherwise contacted any U.S. federal, state or local  governmental agency or commission that has applicable jurisdiction to regulate the Company  (each a &#8220;Government Agency&#8221;) regarding the Company.    (b) You agree that you have returned to the Company all Company documents  (whether in hard copy or electronic form and any copies thereof) and property (including, without  limitation, all cell phones, laptops and other company equipment), and that you shall abide by the  provisions of the Employee Confidentiality and Inventions Assignment Agreement you executed  on, September 6, 2022 the terms of which shall survive the signing of this Agreement. Further,  you agree that you will abide by any and all common law and/or statutory obligations relating to  protection and non-disclosure of the Company&#8217;s trade secrets and/or confidential and proprietary  documents and information. You shall not be deemed to be in breach of this confidentiality  provision (i) in the event such information is already in the public domain, (ii) in the event that  you are required to disclose confidential information in connection with a judicial or special  proceeding or pursuant to court order, (iii) if you share this information with any Government  Agency or participate in a government investigation, or (iv) if you obtain the Company&#8217;s prior  written permission to disclose such information. Also, notwithstanding any provision of this  Agreement prohibiting the disclosure of trade secrets or other confidential information, you may  not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure  of a trade secret that (A) is made (1) in confidence to a Federal, State or local government official,  either directly or indirectly, or to an attorney, and (2) solely for the purpose of reporting or  investigating a suspected violation of law, or (B) is made in a complaint or other document filed  in a lawsuit or other proceeding, if such filing is made under seal. In addition, if you file a lawsuit  or other court proceeding against the Company for retaliating against you for reporting a suspected  violation of law, you may disclose the trade secret to the attorney representing you and use the  trade secret in the court proceeding, if you file any document containing the trade secret under seal  and do not disclose the trade secret, except pursuant to court order.    (c) You agree that all information relating in any way to this Agreement,  including the terms and amount of financial consideration provided for in this Agreement, shall be  held confidential by you and shall not be publicized or disclosed to any person (other than an  immediate family member, legal counsel or financial advisor, provided that any such individual to  whom disclosure is made agrees to be bound by these confidentiality obligations), business entity  or Government Agency (except as mandated by state or federal law), except that nothing in this  paragraph shall prohibit you from participating in an investigation with a state or federal agency if  requested by the agency to do so. In addition, pursuant to S.B. 331, nothing in this Agreement  prevents you from discussing or disclosing information about unlawful acts in the workplace, such    1 For purposes of Sections 3 and 4, the term &#8220;Company&#8221; includes Lisata Therapeutics Inc. and any of its  parents, subsidiaries, divisions, affiliates (which means all persons and entities directly or indirectly controlling,  controlled by or under common control with the Company), and all other related entities and the former and current  directors, officers, employees, agents, successors and assigns of each applicable organization.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex101slackseveranceagm05004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex101slackseveranceagm05004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">4   as harassment or discrimination or any other conduct that you have reason to believe is unlawful,  or from engaging in conduct or disclosure as specified in section 3(e) below.    (d) You agree that you shall not make any statements that are professionally or  personally disparaging about, or adverse to, the interests of the Company and all other related  entities and subsidiaries and their former or current officers, directors, employees and consultants  including, but not limited to, any statements that disparage any person, product, service, finances,  financial condition, capability or any other aspect of the business of the Company, and that you  will not engage in any conduct which could reasonably be expected to harm professionally or  personally the business or reputation of the Company and all other related entities and subsidiaries  and their former or current officers, directors, employees and consultants.    (e) You agree that nothing in this Agreement prevents you from: (i) discussing  or disclosing information about unlawful acts in the workplace, such as harassment or  discrimination or any other conduct that you have reason to believe is unlawful; (ii) engaging in  protected activities under Section 7 of the National Labor Relations Act (&quot;NLRA&quot;), including  filing unfair labor practice charges, assisting Company employees in filing unfair labor practice  charges, discussing the improvement of terms and conditions of employment (including regarding  the terms of this Agreement) with former and current Company employees or union representatives  or other third parties for the purpose of engaging in concerted activity under Section 7 of the  NLRA; or (iii) making any necessary disclosures as otherwise required by law.    (f) You agree that by entering into this Agreement, the Company is not  admitting to and specifically denies any wrongdoing or violation of any law, and further, the  Company by agreeing to provide you the Separation Benefits is not admitting any liability and  specifically denies any liability or that you suffered any damages.    (g) You acknowledge that as of the Execution Date you have received all leave  to which you are entitled under any applicable Federal or state law, and you have been paid in full  for all wages and compensation and you are not aware of any injuries that would qualify as  workplace injuries for purposes of workers compensation.    4. Your Release of Claims.    (a) You hereby agree and acknowledge that by signing this Agreement and  accepting the Separation Benefits, and for other good and valuable consideration, you are waiving  your right to assert any and all forms of legal claims against the Company of any kind whatsoever,  whether known or unknown, arising from the beginning of time through the Execution Date.  Except as set forth below, your waiver and release herein is intended to bar any form of legal claim,  complaint or any other form of action by you, including but not limited to a class or collective  action, whether you seek to participate as a party plaintiff or as a class member (each a &#8220;Claim&#8221;  and jointly referred to as &#8220;Claims&#8221;) against the Company seeking any form of relief including,  without limitation, equitable relief (whether declaratory, injunctive or otherwise), the recovery of  any damages, or any other form of monetary recovery whatsoever (including, without limitation,  back pay, front pay, compensatory damages, emotional distress damages, punitive damages,  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex101slackseveranceagm05005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex101slackseveranceagm05005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">5   attorneys&#8217; fees and any other costs) against the Company, for any alleged action, inaction or  circumstance existing or arising through the Execution Date.    (b) Without limiting the foregoing general waiver and release, you specifically  waive and release the Company from any Claim arising from or related to your prior employment  relationship with the Company or the termination thereof, including, without limitation:    **   Claims under any local, state or federal discrimination, fair employment practices  or other employment-related statute, regulation or executive order (as they may  have been amended through the Execution Date) prohibiting discrimination or  harassment based upon any protected status including, without limitation, race,  national origin, age, gender, marital status, disability, veteran status or sexual  orientation. Without limitation, specifically included in this paragraph are any  Claims arising under the Federal Age Discrimination in Employment Act, the Civil  Rights Acts of 1866 and 1871, Title VII of the Civil Rights Act of 1964, the Civil  Rights Act of 1991, the Americans With Disabilities Act, the Genetic Information  Nondiscrimination Act of 2008, the Employee Retirement Income Security Act of  1974, COBRA, and any similar Federal, state, or local statute.    **  Claims under any other local, state or federal employment related statute, regulation  or executive order (as they may have been amended through the Execution Date)  relating to any other terms and conditions of employment.    **  Claims under any state or federal common law theory including, without limitation,  wrongful discharge, breach of express or implied contract, promissory estoppel,  unjust enrichment, breach of a covenant of good faith and fair dealing, violation of  public policy, defamation, interference with contractual relations, intentional or  negligent infliction of emotional distress, invasion of privacy, misrepresentation,  deceit, fraud or negligence.    ** Any other Claim arising under local, state or federal law.    **  Claims under any Company employment, compensation, bonus, benefit, stock  option, incentive compensation, restricted stock unit, and/or equity plan, program,  policy, practice, or agreement, including, without limitation, any equity award or  plan, or employment agreement, including the Employment Agreement;    (c) Section 1542 of the Civil Code of the State of California (&#8220;Section 1542&#8221;)  provides, generally, that a release does not extend to unknown claims. Specifically, Section 1542  of the Civil Code of the State of California states:    &#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR  OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER  FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM  OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH  THE DEBTOR OR RELEASED PARTY.&#8221;  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex101slackseveranceagm05006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex101slackseveranceagm05006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">6   (d) Notwithstanding the provisions of Section 1542 and for the purpose of  implementing a full and complete release, you expressly acknowledge and agree that this  Agreement releases all claims existing or arising prior to your execution of this Agreement which  you have or may have against the Company, whether the claims are known or unknown and  suspected or unsuspected by you and you forever waive all inquiries and investigations into any  and all of these claims.    (e) Notwithstanding the foregoing, this paragraph does not release the  Company from any obligation expressly set forth in this Agreement. Further, your waivers and  releases in this Agreement do not apply to any claims that cannot be waived or released as a matter  of law under applicable, federal, state, or local laws, including without limitation unemployment  and workers&#8217; compensation claims or entitlement to indemnity or claims to receive any  governmental bounties. However, you acknowledge and agree that you do not have any work-  related injuries or occupational diseases. You acknowledge and agree that, but for providing this  waiver and release, you would not be receiving the economic benefits being provided to you under  the terms of this Agreement.    (f) It is the Company&#8217;s desire and intent to make certain that you fully  understand the provisions and effects of this Agreement. To that end, you have been encouraged  and given the opportunity to consult with legal counsel for the purpose of reviewing the terms of  this Agreement. Also, because you are over the age of 40, and consistent with the provisions of  the Age Discrimination in Employment Act, which prohibits discrimination on the basis of age,  the Company is providing you with twenty-one (21) days in which to consider and accept the terms  of this Agreement by signing below and returning it to the undersigned. In addition, you may  rescind your assent to this Agreement if, within seven (7) days after you sign this Agreement, you  deliver by hand or send by email (with a confirmation from the recipient of receipt) a notice of  rescission to the undersigned. The eighth day following your signing of this Agreement without  rescission is the &#8220;Effective Date&#8221; of this Agreement.    (g) Notwithstanding the foregoing, nothing in this Agreement, including the  release contained in this Agreement shall: (i) prohibit or restrict you from filing or limit your ability  to file a charge or complaint with the Equal Employment Opportunity Commission or a state or  local equivalent, or any other Government Agency, (ii) prohibit or restrict you from  communicating with, providing documents or other relevant information to or otherwise  cooperating with, or limit your ability to communicate with, provide documents or other relevant  information to or otherwise to cooperate with, any Government Agency, including, but not limited  to, responding to any inquiry from such authority, including an inquiry about the existence of this  Agreement, its release or its underlying facts, (iii) limit your right to receive an award for  information provided to any Government Agency, or (iv) require you to notify the Company of  your communications with or inquiries from any Government Agency. To the maximum extent  permitted by law, however, nothing in this release or this Agreement shall be deemed to limit the  Company&#8217;s right to seek immediate dismissal of a charge or complaint on the basis that your  signing of this Agreement constitutes a full release of any Claims, including Claims of  discrimination, or to seek restitution to the extent permitted by law of the economic benefits  provided to you under this Agreement in the event that you successfully challenge the validity of  this release, provided, however, that you retain the right to receive, and the Company shall not  seek restitution of, an award for information lawfully provided to a Governmental Agency.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex101slackseveranceagm05007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex101slackseveranceagm05007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">7  505018474v.2    5. Entire Agreement/Modification/Waiver/Choice of Law/ Venue/Enforceability  / Signatures.    (a) You acknowledge and agree that except for the Employee Confidentiality  and Inventions Assignment Agreement, this Agreement supersedes any and all prior or  contemporaneous oral and/or written agreements between you and the Company, including the  Employment Agreement, and sets forth the entire agreement between you and the Company. No  variations or modifications hereof shall be deemed valid unless reduced to writing and signed by  the parties hereto. The failure of either Party to seek enforcement of any provision of this  Agreement in any instance or for any period of time shall not be construed as a waiver of such  provision or of either Party&#8217;s right to seek enforcement of such provision in the future. This  Agreement shall be deemed to have been made in the State of California and shall be construed in  accordance with the laws of that state without giving effect to conflict of law principles. The  provisions of this Agreement are severable, and if for any reason any part shall be found to be  unenforceable, the remaining provisions shall be enforced in full, provided, however, that if any  or all of the release in Section 4 is held unenforceable, this Agreement shall be deemed null and  void. This Agreement may be signed in counterparts, both of which shall be deemed an original,  but both of which, taken together, shall constitute the same instrument. An electronic signature  shall have the same effect as an original signature.    (b) By executing this Agreement, you are acknowledging that: (1) you have  carefully read and understand this Agreement, including Section 4 entitled Your Release of  Claims; (2) you understand that Your Release of Claims in Section 4 is binding and by  signing this Agreement, you give up certain rights; (3) you have been afforded sufficient time  to understand the terms of this Agreement; (4) your agreements are made voluntarily and  knowingly; and (5) neither the Company nor its agents have made any representations  inconsistent with this Agreement.    The offers in this Agreement will expire on May 22, 2023. The date you sign and return  this Agreement to the Company is the &#8220;Execution Date.&#8221; Once you return the Agreement, the  Company will countersign it and return it to you.    COMPANY    By:   Its: Vice President, Human Resources    Confirmed, Agreed and Acknowledged:        NAME    Dated:    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>clbs-ex311_20230630xq2.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic14838913c6147648a6a7d2da9f8b3ca_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS UNDER SECTION 302</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David J. Mazzo, PhD, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;I have reviewed this Quarterly Report on Form 10-Q of Lisata Therapeutics, Inc.&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by&#160;this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;I have disclosed, based on my most recent evaluation of internal control over financial reporting to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; August&#160;14, 2023 </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; David J. Mazzo, PhD&#160;&#160;&#160;&#160;       </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58; David J. Mazzo, PhD</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58; President &#38; Chief Executive Officer</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>clbs-ex32_20230630q2.htm
<DESCRIPTION>EX-32
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if22de1c39a36449698555747522146c2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Lisata Therapeutics, Inc. (the &#8220;Company&#8221;) for the quarter ended June&#160;30, 2023 filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, David J. Mazzo, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as amended&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition of the Company as of the dates presented and the results of operations of the Company for the periods presented.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58;&#160;&#160;August&#160;14, 2023 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:54.834%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.966%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; David J. Mazzo, PhD     </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David J. Mazzo, PhD</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President &#38; Chief Executive Officer (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>clbs-20230630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:f19b6d65-9ffc-4ef9-a859-121a4da9922b,g:65448069-d222-4f71-8ad3-a35814dee021-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:clbs="http://www.caladrius.com/20230630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.caladrius.com/20230630">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clbs-20230630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clbs-20230630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clbs-20230630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="clbs-20230630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.caladrius.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.caladrius.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParentheticals" roleURI="http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals">
        <link:definition>0000003 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofOperations">
        <link:definition>0000004 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss">
        <link:definition>0000005 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquity" roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofEquity">
        <link:definition>0000006 - Statement - Consolidated Statements of Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheBusiness" roleURI="http://www.caladrius.com/role/TheBusiness">
        <link:definition>0000008 - Disclosure - The Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Merger" roleURI="http://www.caladrius.com/role/Merger">
        <link:definition>0000010 - Disclosure - Merger</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleSecurities" roleURI="http://www.caladrius.com/role/AvailableforSaleSecurities">
        <link:definition>0000011 - Disclosure - Available-for-Sale-Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNotes" roleURI="http://www.caladrius.com/role/PropertyandEquipmentNotes">
        <link:definition>0000012 - Disclosure - Property and Equipment (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeLossPerShare" roleURI="http://www.caladrius.com/role/IncomeLossPerShare">
        <link:definition>0000013 - Disclosure - Income (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.caladrius.com/role/FairValueMeasurements">
        <link:definition>0000014 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilities" roleURI="http://www.caladrius.com/role/AccruedLiabilities">
        <link:definition>0000015 - Disclosure - Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeases" roleURI="http://www.caladrius.com/role/OperatingLeases">
        <link:definition>0000016 - Disclosure - Operating Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.caladrius.com/role/StockholdersEquity">
        <link:definition>0000017 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.caladrius.com/role/ShareBasedCompensation">
        <link:definition>0000018 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.caladrius.com/role/IncomeTaxes">
        <link:definition>0000019 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AustraliaResearchandDevelopmentTaxIncentive" roleURI="http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentive">
        <link:definition>0000020 - Disclosure - Australia Research and Development Tax Incentive</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.caladrius.com/role/Contingencies">
        <link:definition>0000021 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicenseAgreements" roleURI="http://www.caladrius.com/role/LicenseAgreements">
        <link:definition>0000022 - Disclosure - License Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchCollaborationandLicenseAgreement" roleURI="http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreement">
        <link:definition>0000023 - Disclosure - Research Collaboration and License Agreement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.caladrius.com/role/SubsequentEvents">
        <link:definition>0000024 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9954701 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerTables" roleURI="http://www.caladrius.com/role/MergerTables">
        <link:definition>9954702 - Disclosure - Merger (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleSecuritiesTables" roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesTables">
        <link:definition>9954703 - Disclosure - Available-for-Sale-Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.caladrius.com/role/PropertyandEquipmentTables">
        <link:definition>9954704 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeLossPerShareTables" roleURI="http://www.caladrius.com/role/IncomeLossPerShareTables">
        <link:definition>9954705 - Disclosure - Income (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.caladrius.com/role/FairValueMeasurementsTables">
        <link:definition>9954706 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesTables" roleURI="http://www.caladrius.com/role/AccruedLiabilitiesTables">
        <link:definition>9954707 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesTables" roleURI="http://www.caladrius.com/role/OperatingLeasesTables">
        <link:definition>9954708 - Disclosure - Operating Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.caladrius.com/role/StockholdersEquityTables">
        <link:definition>9954709 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.caladrius.com/role/ShareBasedCompensationTables">
        <link:definition>9954710 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TheBusinessDetails" roleURI="http://www.caladrius.com/role/TheBusinessDetails">
        <link:definition>9954711 - Disclosure - The Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>9954712 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerDetails" roleURI="http://www.caladrius.com/role/MergerDetails">
        <link:definition>9954713 - Disclosure - Merger (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails">
        <link:definition>9954714 - Disclosure - Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails" roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails">
        <link:definition>9954715 - Disclosure - Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails" roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails">
        <link:definition>9954716 - Disclosure - Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentDetails" roleURI="http://www.caladrius.com/role/PropertyandEquipmentDetails">
        <link:definition>9954717 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeLossPerShareDetails" roleURI="http://www.caladrius.com/role/IncomeLossPerShareDetails">
        <link:definition>9954718 - Disclosure - Income (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.caladrius.com/role/FairValueMeasurementsDetails">
        <link:definition>9954719 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesDetails" roleURI="http://www.caladrius.com/role/AccruedLiabilitiesDetails">
        <link:definition>9954720 - Disclosure - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesNarrativeDetails" roleURI="http://www.caladrius.com/role/OperatingLeasesNarrativeDetails">
        <link:definition>9954721 - Disclosure - Operating Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesBalanceSheetPresentationDetails" roleURI="http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails">
        <link:definition>9954722 - Disclosure - Operating Leases - Balance Sheet Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesFutureMinimumLeasePaymentsDetails" roleURI="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails">
        <link:definition>9954723 - Disclosure - Operating Leases - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesFutureMinimumLeasePaymentsDetails_1" roleURI="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1">
        <link:definition>9954723 - Disclosure - Operating Leases - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityEquityIssuancesDetails" roleURI="http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails">
        <link:definition>9954724 - Disclosure - Stockholders' Equity - Equity Issuances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionsandWarrantsDetails" roleURI="http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails">
        <link:definition>9954725 - Disclosure - Stockholders' Equity - Stock Options and Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails" roleURI="http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails">
        <link:definition>9954726 - Disclosure - Stockholders' Equity - Restricted Stock and Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationShareBasedCompensationExpenseDetails" roleURI="http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails">
        <link:definition>9954727 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationCompensationCostNotYetRecognizedDetails" roleURI="http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails">
        <link:definition>9954728 - Disclosure - Share-Based Compensation - Compensation Cost Not Yet Recognized (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails" roleURI="http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails">
        <link:definition>9954729 - Disclosure - Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.caladrius.com/role/IncomeTaxesDetails">
        <link:definition>9954730 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AustraliaResearchandDevelopmentTaxIncentiveDetails" roleURI="http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails">
        <link:definition>9954731 - Disclosure - Australia Research and Development Tax Incentive (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicenseAgreementsDetails" roleURI="http://www.caladrius.com/role/LicenseAgreementsDetails">
        <link:definition>9954732 - Disclosure - License Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchCollaborationandLicenseAgreementDetails" roleURI="http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails">
        <link:definition>9954733 - Disclosure - Research Collaboration and License Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.caladrius.com/role/SubsequentEventsDetails">
        <link:definition>9954734 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="clbs_SharesIssuedUnderLicenseAgreement" abstract="false" name="SharesIssuedUnderLicenseAgreement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsOutstanding" abstract="false" name="WeightedAverageExercisePriceWarrantsOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="clbs_RevenuePerformanceObligationPercentageOfNetSale" abstract="false" name="RevenuePerformanceObligationPercentageOfNetSale" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="clbs_ClinicalAndRDRelatedLiabilities" abstract="false" name="ClinicalAndRDRelatedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" abstract="false" name="WeightedAverageRemainingContractualTermwarrantoutstanding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clbs_WeightedAverageRemainingContractualTermwarrantsvested" abstract="false" name="WeightedAverageRemainingContractualTermwarrantsvested" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clbs_EPSAbstract" abstract="true" name="EPSAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="clbs_UniversityOfCaliforniaAtSanDiegoMember" abstract="true" name="UniversityOfCaliforniaAtSanDiegoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="clbs_CENDMember" abstract="true" name="CENDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="clbs_AtTheMarketOfferingAgreementMember" abstract="true" name="AtTheMarketOfferingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="clbs_WarrantsExpired" abstract="false" name="WarrantsExpired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" abstract="false" name="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_WarrantsGranted" abstract="false" name="WarrantsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_Sharesvestedandexpectedtovest" abstract="false" name="Sharesvestedandexpectedtovest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_WarrantsVested" abstract="false" name="WarrantsVested" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_IncomeTaxIncentiveReceivable" abstract="false" name="IncomeTaxIncentiveReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_AssetAcquisitionOtherLiabilities" abstract="false" name="AssetAcquisitionOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsGranted" abstract="false" name="WeightedAverageExercisePriceWarrantsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="clbs_OptionsVestedweightedAverageRemainingContractualTerm" abstract="false" name="OptionsVestedweightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clbs_MassachusettsInstituteOfTechnologyMember" abstract="true" name="MassachusettsInstituteOfTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsExercised" abstract="false" name="WeightedAverageExercisePriceWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="clbs_AccruedGrantFunding" abstract="false" name="AccruedGrantFunding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_ResearchAndDevelopmentTaxIncentiveTextBlock" abstract="false" name="ResearchAndDevelopmentTaxIncentiveTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" abstract="false" name="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_ProceedsFromExerciseOfOptionsFinancingActivities" abstract="false" name="ProceedsFromExerciseOfOptionsFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_ImpiloMember" abstract="true" name="ImpiloMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="clbs_CommonStockWarrantsShares" abstract="false" name="CommonStockWarrantsShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsCanceled" abstract="false" name="WeightedAverageExercisePriceWarrantsCanceled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="clbs_AssetAcquisitionNetWorkingCapital" abstract="false" name="AssetAcquisitionNetWorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee" abstract="false" name="CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_WarrantsWeightedAverageExercisePriceRollForward" abstract="true" name="WarrantsWeightedAverageExercisePriceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="clbs_AssetAcquisitionSharePrice" abstract="false" name="AssetAcquisitionSharePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="clbs_AggregateIntrinsicValueWarrantsvested" abstract="false" name="AggregateIntrinsicValueWarrantsvested" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_BusinessTextBlock" abstract="false" name="BusinessTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsExercisable" abstract="false" name="WeightedAverageExercisePriceWarrantsExercisable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" abstract="false" name="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" abstract="false" name="RevenueRemainingPerformanceObligationVariableConsiderationAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_FairValueMarketOfTaxNOLs" abstract="false" name="FairValueMarketOfTaxNOLs" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_LossOnSaleOfNOL" abstract="false" name="LossOnSaleOfNOL" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour" abstract="false" name="CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_WarrantsCanceled" abstract="false" name="WarrantsCanceled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_SaleOfStockAvailableForSale" abstract="false" name="SaleOfStockAvailableForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_QiluMember" abstract="true" name="QiluMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" abstract="false" name="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees" abstract="false" name="CollaborativeArrangementRightsAndObligationsSublicensingFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" abstract="false" name="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale" abstract="false" name="CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_SharesHeldByThirdParty" abstract="false" name="SharesHeldByThirdParty" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_AssetAcquisitionConsiderationTransferredEquityValue" abstract="false" name="AssetAcquisitionConsiderationTransferredEquityValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" abstract="false" name="CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_AssetAcquisitionIntangibles" abstract="false" name="AssetAcquisitionIntangibles" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" abstract="false" name="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment" abstract="false" name="AssetAcquisitionAcquiredInProcessResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_ProceedsFromSaleOfNOLS" abstract="false" name="ProceedsFromSaleOfNOLS" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_SanfordBurnhamPrebysMember" abstract="true" name="SanfordBurnhamPrebysMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="clbs_AggregateIntrinsicValueWarrantsOutstanding" abstract="false" name="AggregateIntrinsicValueWarrantsOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee" abstract="false" name="CollaborativeArrangementRightsAndObligationsChangeOfControlFee" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_WeightedAverageExercisePriceWarrantsExpired" abstract="false" name="WeightedAverageExercisePriceWarrantsExpired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="clbs_OperatingLossCarryforwardsPostAcquisition" abstract="false" name="OperatingLossCarryforwardsPostAcquisition" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_WarrantsOtherDisclosuresAbstract" abstract="true" name="WarrantsOtherDisclosuresAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree" abstract="false" name="CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_AssetAcquisitionCashAndCashEquivalents" abstract="false" name="AssetAcquisitionCashAndCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven" abstract="false" name="CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_OperatingLeaseRightOfUseAssetAbstract" abstract="true" name="OperatingLeaseRightOfUseAssetAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales" abstract="false" name="CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="clbs_OperatingLossCarryforwardsBeforeWriteDown" abstract="false" name="OperatingLossCarryforwardsBeforeWriteDown" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="clbs_WarrantsExercised" abstract="false" name="WarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues" abstract="false" name="RevenuePerformanceObligationPercentageOfSublicensingRevenues" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>clbs-20230630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:f19b6d65-9ffc-4ef9-a859-121a4da9922b,g:65448069-d222-4f71-8ad3-a35814dee021-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="clbs-20230630.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_296e2298-fcd9-4f53-afcf-01c68b460f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_54ddd25b-5de5-42ae-90ba-422034652dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_296e2298-fcd9-4f53-afcf-01c68b460f6e" xlink:to="loc_us-gaap_AccountsPayableCurrent_54ddd25b-5de5-42ae-90ba-422034652dd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f199e451-f880-4743-af07-30f725a7d20c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_296e2298-fcd9-4f53-afcf-01c68b460f6e" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f199e451-f880-4743-af07-30f725a7d20c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_057a8e97-2336-4ced-bb35-6abf3aab359d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c257514d-4b5f-4981-a806-0a82895d5b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_057a8e97-2336-4ced-bb35-6abf3aab359d" xlink:to="loc_us-gaap_LiabilitiesCurrent_c257514d-4b5f-4981-a806-0a82895d5b2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c2ccfc68-5f9f-4e38-9d23-b439a124bd13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_057a8e97-2336-4ced-bb35-6abf3aab359d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c2ccfc68-5f9f-4e38-9d23-b439a124bd13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e82d4d47-d59c-4c9f-934a-ec24af47bae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7fbb800e-c776-4ac3-9fb0-ca364c3fabec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e82d4d47-d59c-4c9f-934a-ec24af47bae6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7fbb800e-c776-4ac3-9fb0-ca364c3fabec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_2d434efa-aed5-4b73-aa04-595b2faa5bda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e82d4d47-d59c-4c9f-934a-ec24af47bae6" xlink:to="loc_us-gaap_MarketableSecurities_2d434efa-aed5-4b73-aa04-595b2faa5bda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4455fd18-80a1-47a3-879a-75950cb5cc58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e82d4d47-d59c-4c9f-934a-ec24af47bae6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4455fd18-80a1-47a3-879a-75950cb5cc58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2b00054b-e902-4b9f-83f9-d0a469fd69c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1732a4c1-04ae-4752-a47c-b2968676f3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2b00054b-e902-4b9f-83f9-d0a469fd69c5" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1732a4c1-04ae-4752-a47c-b2968676f3b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9bfb7d7a-40e3-40ee-9b10-ce944a0a93a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2b00054b-e902-4b9f-83f9-d0a469fd69c5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9bfb7d7a-40e3-40ee-9b10-ce944a0a93a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3ba35993-4356-4b3a-8f28-643ae67dc0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2b00054b-e902-4b9f-83f9-d0a469fd69c5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3ba35993-4356-4b3a-8f28-643ae67dc0f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b46f2c9c-8d75-4e87-ac8b-ef4cf3cf4299" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2b00054b-e902-4b9f-83f9-d0a469fd69c5" xlink:to="loc_us-gaap_CommonStockValue_b46f2c9c-8d75-4e87-ac8b-ef4cf3cf4299" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_54197b6a-f19b-496e-bf02-0bcb9c24c15f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2b00054b-e902-4b9f-83f9-d0a469fd69c5" xlink:to="loc_us-gaap_TreasuryStockCommonValue_54197b6a-f19b-496e-bf02-0bcb9c24c15f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_62fc87f2-f55e-4c3f-b5b5-a418935e5ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3371420f-d103-404c-9165-d23fa2b3dd84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_62fc87f2-f55e-4c3f-b5b5-a418935e5ef6" xlink:to="loc_us-gaap_AssetsCurrent_3371420f-d103-404c-9165-d23fa2b3dd84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5f014a61-1a7b-470a-a68d-7ebaf1c3048f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_62fc87f2-f55e-4c3f-b5b5-a418935e5ef6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5f014a61-1a7b-470a-a68d-7ebaf1c3048f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6a092e8a-e5ee-4507-afee-5b7e23348a79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_62fc87f2-f55e-4c3f-b5b5-a418935e5ef6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6a092e8a-e5ee-4507-afee-5b7e23348a79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_34a77d5e-66d5-4092-a19c-98fd78d52968" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_62fc87f2-f55e-4c3f-b5b5-a418935e5ef6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_34a77d5e-66d5-4092-a19c-98fd78d52968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fd5d060e-f3be-44b8-b72f-dbc706935def" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_daf1bff6-e429-4b02-aa13-913af76cae53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fd5d060e-f3be-44b8-b72f-dbc706935def" xlink:to="loc_us-gaap_StockholdersEquity_daf1bff6-e429-4b02-aa13-913af76cae53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_5ce9974b-c635-4cb0-9e3d-da3988ba598d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fd5d060e-f3be-44b8-b72f-dbc706935def" xlink:to="loc_us-gaap_MinorityInterest_5ce9974b-c635-4cb0-9e3d-da3988ba598d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a6b3ae36-78e3-4091-90dd-b74773548d84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9552a1b7-9794-4596-b964-92861e1f50f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a6b3ae36-78e3-4091-90dd-b74773548d84" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9552a1b7-9794-4596-b964-92861e1f50f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a980a939-bb72-4e32-8e95-792d507da37a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a6b3ae36-78e3-4091-90dd-b74773548d84" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a980a939-bb72-4e32-8e95-792d507da37a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cbf19710-b0fd-4436-8e04-91bfe177cb82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a6b3ae36-78e3-4091-90dd-b74773548d84" xlink:to="loc_us-gaap_Liabilities_cbf19710-b0fd-4436-8e04-91bfe177cb82" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="clbs-20230630.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2ad8a442-2607-42f5-ace0-bfa875646bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_816edf54-bdcc-43aa-9b71-d2ee0dfb0d62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_2ad8a442-2607-42f5-ace0-bfa875646bb8" xlink:to="loc_us-gaap_InvestmentIncomeNet_816edf54-bdcc-43aa-9b71-d2ee0dfb0d62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_395abe27-2c32-4e38-ba28-18f08c8d3997" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_2ad8a442-2607-42f5-ace0-bfa875646bb8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_395abe27-2c32-4e38-ba28-18f08c8d3997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_570ca244-5480-4408-99b3-b94bfc1a826f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c67b9e15-8a63-4455-9bc4-74b774aa2d45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_570ca244-5480-4408-99b3-b94bfc1a826f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c67b9e15-8a63-4455-9bc4-74b774aa2d45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9ea7e0fe-7605-4f6e-9e15-a4500fc1f3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_570ca244-5480-4408-99b3-b94bfc1a826f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9ea7e0fe-7605-4f6e-9e15-a4500fc1f3ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_355f9009-c11e-4707-9097-8f2c319e118f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f57d2411-f12d-42bb-9edc-19d86d222771" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_355f9009-c11e-4707-9097-8f2c319e118f" xlink:to="loc_us-gaap_ProfitLoss_f57d2411-f12d-42bb-9edc-19d86d222771" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_a52c3945-c8b1-4593-9b83-bb7840d6a30a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_355f9009-c11e-4707-9097-8f2c319e118f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_a52c3945-c8b1-4593-9b83-bb7840d6a30a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_59d118b9-f235-4a89-8776-6bc70a93c407" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b6cbfef6-0ac1-47a5-b643-9c7eafcd542b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_59d118b9-f235-4a89-8776-6bc70a93c407" xlink:to="loc_us-gaap_OperatingIncomeLoss_b6cbfef6-0ac1-47a5-b643-9c7eafcd542b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4e3ed954-f55e-4234-9516-6df1450f87c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_59d118b9-f235-4a89-8776-6bc70a93c407" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_4e3ed954-f55e-4234-9516-6df1450f87c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9b2e376a-1d11-4401-9be1-6c348a75d48b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3740fe97-656f-4780-9e8a-b39842e18de8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9b2e376a-1d11-4401-9be1-6c348a75d48b" xlink:to="loc_us-gaap_OperatingExpenses_3740fe97-656f-4780-9e8a-b39842e18de8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_786a15ff-e114-4e8d-9ce6-7fb0625e85c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_155038f0-af93-44ed-9d14-6b66fb191f08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_786a15ff-e114-4e8d-9ce6-7fb0625e85c7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_155038f0-af93-44ed-9d14-6b66fb191f08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_a31d6479-dd9e-4fc5-8ee5-b83c36acc315" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_786a15ff-e114-4e8d-9ce6-7fb0625e85c7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_a31d6479-dd9e-4fc5-8ee5-b83c36acc315" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="clbs-20230630.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0db3fff2-e010-4de8-ab62-1030384b3721" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8b589390-b7aa-4a0f-96af-5cd1c483fcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_0db3fff2-e010-4de8-ab62-1030384b3721" xlink:to="loc_us-gaap_ProfitLoss_8b589390-b7aa-4a0f-96af-5cd1c483fcfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bd5ef16f-b8b9-4c1f-bfa8-eaa5e87a2a12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_0db3fff2-e010-4de8-ab62-1030384b3721" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bd5ef16f-b8b9-4c1f-bfa8-eaa5e87a2a12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_65628e24-6fcc-4cb7-ac00-aa653da27737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e95e4864-2516-4399-8cc2-41fec0d53e34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_65628e24-6fcc-4cb7-ac00-aa653da27737" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e95e4864-2516-4399-8cc2-41fec0d53e34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4c82a160-067e-4a03-89f6-94e273317cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_65628e24-6fcc-4cb7-ac00-aa653da27737" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4c82a160-067e-4a03-89f6-94e273317cbf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="clbs-20230630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0be0c07c-b464-475f-b48f-02e77dd78715" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_ae292d75-2636-4ae7-903a-81d0f97e9784" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0be0c07c-b464-475f-b48f-02e77dd78715" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_ae292d75-2636-4ae7-903a-81d0f97e9784" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_ffeab44d-8e5c-42ca-b57a-452726b30452" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0be0c07c-b464-475f-b48f-02e77dd78715" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_ffeab44d-8e5c-42ca-b57a-452726b30452" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ef16b5d7-8260-4084-b668-4ef0181480d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0be0c07c-b464-475f-b48f-02e77dd78715" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ef16b5d7-8260-4084-b668-4ef0181480d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3c4acb06-04d9-4e1e-8c5c-469668aa5794" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0be0c07c-b464-475f-b48f-02e77dd78715" xlink:to="loc_us-gaap_ProfitLoss_3c4acb06-04d9-4e1e-8c5c-469668aa5794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_91dedb09-333a-4359-82c9-f80bb0653ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0be0c07c-b464-475f-b48f-02e77dd78715" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_91dedb09-333a-4359-82c9-f80bb0653ad0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_6c9e458b-34f1-485e-ba3f-8aa80aab3863" xlink:href="clbs-20230630.xsd#clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0be0c07c-b464-475f-b48f-02e77dd78715" xlink:to="loc_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_6c9e458b-34f1-485e-ba3f-8aa80aab3863" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_e70c06af-cc00-4291-abcb-1bb4143ec4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0be0c07c-b464-475f-b48f-02e77dd78715" xlink:to="loc_us-gaap_DepreciationAndAmortization_e70c06af-cc00-4291-abcb-1bb4143ec4e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_aa8d5dd7-e75f-4e94-958a-c46d01601662" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0be0c07c-b464-475f-b48f-02e77dd78715" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_aa8d5dd7-e75f-4e94-958a-c46d01601662" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6db0b09-4ec5-47bb-84fd-92c872f7b122" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_833a3758-f9ec-48ea-ac92-0121228b8a17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6db0b09-4ec5-47bb-84fd-92c872f7b122" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_833a3758-f9ec-48ea-ac92-0121228b8a17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_08ecd7ee-6299-4978-9c36-744328551668" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6db0b09-4ec5-47bb-84fd-92c872f7b122" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_08ecd7ee-6299-4978-9c36-744328551668" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ProceedsFromExerciseOfOptionsFinancingActivities_3b915f2d-de9f-4b46-adf1-6e85bb81894a" xlink:href="clbs-20230630.xsd#clbs_ProceedsFromExerciseOfOptionsFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c6db0b09-4ec5-47bb-84fd-92c872f7b122" xlink:to="loc_clbs_ProceedsFromExerciseOfOptionsFinancingActivities_3b915f2d-de9f-4b46-adf1-6e85bb81894a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_39ecbd80-d1e1-449c-9ba2-c9db0e24fd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_64573b5b-972c-4ae1-ad12-9eeff6ff100b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_39ecbd80-d1e1-449c-9ba2-c9db0e24fd7d" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_64573b5b-972c-4ae1-ad12-9eeff6ff100b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6ccb1040-a43f-4802-9b01-9469bfd48fff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_39ecbd80-d1e1-449c-9ba2-c9db0e24fd7d" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6ccb1040-a43f-4802-9b01-9469bfd48fff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_31e2a5a6-8883-411d-87a5-7ca4f3d4e4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_39ecbd80-d1e1-449c-9ba2-c9db0e24fd7d" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_31e2a5a6-8883-411d-87a5-7ca4f3d4e4fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ec3ebec6-b94e-4b55-b202-142f8eef74db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_39ecbd80-d1e1-449c-9ba2-c9db0e24fd7d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ec3ebec6-b94e-4b55-b202-142f8eef74db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e2b21424-e1bc-4438-9bb2-07ce9a7cf987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_43a935de-ee29-42bd-9343-b91b5c275d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e2b21424-e1bc-4438-9bb2-07ce9a7cf987" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_43a935de-ee29-42bd-9343-b91b5c275d1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_696f83dc-129f-4275-b27e-b362803922ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e2b21424-e1bc-4438-9bb2-07ce9a7cf987" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_696f83dc-129f-4275-b27e-b362803922ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7dc332e3-b53c-4e7c-9070-b1c264f7247e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e2b21424-e1bc-4438-9bb2-07ce9a7cf987" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7dc332e3-b53c-4e7c-9070-b1c264f7247e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3ef72788-f0f2-458b-b34c-3172c6e71422" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e2b21424-e1bc-4438-9bb2-07ce9a7cf987" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3ef72788-f0f2-458b-b34c-3172c6e71422" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d72cb000-9527-45dc-ae9b-9ecaecfcfe31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_06ad81be-84d2-44df-a8b7-5daaa348ae67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d72cb000-9527-45dc-ae9b-9ecaecfcfe31" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_06ad81be-84d2-44df-a8b7-5daaa348ae67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0e20d4f1-4cb5-44ed-b804-4df8678833f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d72cb000-9527-45dc-ae9b-9ecaecfcfe31" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0e20d4f1-4cb5-44ed-b804-4df8678833f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6080e756-0383-487d-bac5-24ddbd888638" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d72cb000-9527-45dc-ae9b-9ecaecfcfe31" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6080e756-0383-487d-bac5-24ddbd888638" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_29a40041-02cc-407c-9245-15c6fbe9099d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_cb197901-6981-4c2f-a22c-2d08837e1afa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_29a40041-02cc-407c-9245-15c6fbe9099d" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_cb197901-6981-4c2f-a22c-2d08837e1afa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_fbbc4251-ddc9-4ef9-948b-447d957b6116" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_29a40041-02cc-407c-9245-15c6fbe9099d" xlink:to="loc_us-gaap_MarketableSecurities_fbbc4251-ddc9-4ef9-948b-447d957b6116" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2dfa2fb8-a3c8-4a4f-8fde-0d4314ee4178" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_2e58dceb-3183-4ed2-aa68-4bea280c79f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2dfa2fb8-a3c8-4a4f-8fde-0d4314ee4178" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_2e58dceb-3183-4ed2-aa68-4bea280c79f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_373df808-4fe9-4609-a8c6-4b8bc6c2dedd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2dfa2fb8-a3c8-4a4f-8fde-0d4314ee4178" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_373df808-4fe9-4609-a8c6-4b8bc6c2dedd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2c861576-3f62-4094-9bad-12c3629130d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_f9b2343d-3568-4985-b467-c864279e08fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2c861576-3f62-4094-9bad-12c3629130d2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_f9b2343d-3568-4985-b467-c864279e08fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_6e5447a9-45a2-4dab-a81f-f8aa5a2d2679" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2c861576-3f62-4094-9bad-12c3629130d2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_6e5447a9-45a2-4dab-a81f-f8aa5a2d2679" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#PropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_490f5a0f-c738-4ea6-978c-a34f56fd2b97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d4b3f242-f342-47fa-81e4-291839f26d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_490f5a0f-c738-4ea6-978c-a34f56fd2b97" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d4b3f242-f342-47fa-81e4-291839f26d2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f1448536-b431-41e4-aab2-0c2a33147a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_490f5a0f-c738-4ea6-978c-a34f56fd2b97" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f1448536-b431-41e4-aab2-0c2a33147a92" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#FairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_99d4a7f0-1808-4d6f-af62-a6e883242b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_59f29e79-194f-4871-8267-e87413d85b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_99d4a7f0-1808-4d6f-af62-a6e883242b1b" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_59f29e79-194f-4871-8267-e87413d85b3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_5bf74c29-8853-4759-9c40-f2a1c688a0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_99d4a7f0-1808-4d6f-af62-a6e883242b1b" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_5bf74c29-8853-4759-9c40-f2a1c688a0cd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#AccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a394f973-e44a-4a90-be27-4ad3c5882ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_348879b8-ef85-4f66-ac00-6eacff325069" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a394f973-e44a-4a90-be27-4ad3c5882ec1" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_348879b8-ef85-4f66-ac00-6eacff325069" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_efa63884-2b68-45a5-b7cb-c57cddd02e34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a394f973-e44a-4a90-be27-4ad3c5882ec1" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_efa63884-2b68-45a5-b7cb-c57cddd02e34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ClinicalAndRDRelatedLiabilities_a0a2deaf-fc06-49f2-bbdc-6e3936d141e1" xlink:href="clbs-20230630.xsd#clbs_ClinicalAndRDRelatedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a394f973-e44a-4a90-be27-4ad3c5882ec1" xlink:to="loc_clbs_ClinicalAndRDRelatedLiabilities_a0a2deaf-fc06-49f2-bbdc-6e3936d141e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb5fa674-aa8e-4477-87e8-e3bffc399b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a394f973-e44a-4a90-be27-4ad3c5882ec1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb5fa674-aa8e-4477-87e8-e3bffc399b3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AccruedGrantFunding_108828d8-ecff-41da-9084-90bbc6ace7b7" xlink:href="clbs-20230630.xsd#clbs_AccruedGrantFunding"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a394f973-e44a-4a90-be27-4ad3c5882ec1" xlink:to="loc_clbs_AccruedGrantFunding_108828d8-ecff-41da-9084-90bbc6ace7b7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#OperatingLeasesBalanceSheetPresentationDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a054bdbc-d4fa-487e-b587-9cd57dc9d8db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bdb978a9-2401-4113-91e1-8731c22c53e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a054bdbc-d4fa-487e-b587-9cd57dc9d8db" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bdb978a9-2401-4113-91e1-8731c22c53e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_81d2e0a2-7afb-453c-a15c-af29acd1a939" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a054bdbc-d4fa-487e-b587-9cd57dc9d8db" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_81d2e0a2-7afb-453c-a15c-af29acd1a939" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#OperatingLeasesFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3480559e-53c1-475f-adb6-89645845a2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_b0d84f95-a6bf-4c5c-8f80-3193b00da4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3480559e-53c1-475f-adb6-89645845a2a7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_b0d84f95-a6bf-4c5c-8f80-3193b00da4c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_610e3659-dd08-4671-bf97-65f0fc9acfee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3480559e-53c1-475f-adb6-89645845a2a7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_610e3659-dd08-4671-bf97-65f0fc9acfee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_04df541d-cd13-4e81-87b4-a3bcbd2072ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3480559e-53c1-475f-adb6-89645845a2a7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_04df541d-cd13-4e81-87b4-a3bcbd2072ee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="clbs-20230630.xsd#OperatingLeasesFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b14be1f4-d1b9-4608-8d49-7b67a6333155" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_dce92cf9-0776-4524-99f9-42abd8945e95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b14be1f4-d1b9-4608-8d49-7b67a6333155" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_dce92cf9-0776-4524-99f9-42abd8945e95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b2edc835-c8fd-43e6-882d-efa8f00793f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b14be1f4-d1b9-4608-8d49-7b67a6333155" xlink:to="loc_us-gaap_OperatingLeaseLiability_b2edc835-c8fd-43e6-882d-efa8f00793f9" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>clbs-20230630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:f19b6d65-9ffc-4ef9-a859-121a4da9922b,g:65448069-d222-4f71-8ad3-a35814dee021-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="clbs-20230630.xsd#ConsolidatedStatementsofEquity"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_10a85934-ca65-431c-9a91-1f0ea4762496" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_10a85934-ca65-431c-9a91-1f0ea4762496" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_89a8c743-d85a-4974-81bf-ce89ee500c52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_89a8c743-d85a-4974-81bf-ce89ee500c52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2dac21b5-54ac-47b0-bde8-ec5d1d2ade65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2dac21b5-54ac-47b0-bde8-ec5d1d2ade65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_65287497-3018-47b8-a8e5-516fd12e66ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_ProfitLoss_65287497-3018-47b8-a8e5-516fd12e66ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ffb30f7e-12d1-492f-b1ed-cd8789af6a18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ffb30f7e-12d1-492f-b1ed-cd8789af6a18" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_816744a9-4c08-4e1a-ae2c-15968bc5c1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_816744a9-4c08-4e1a-ae2c-15968bc5c1ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_20fedbe7-b7a6-4825-92cc-abf2be0c2169" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_20fedbe7-b7a6-4825-92cc-abf2be0c2169" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_822c08e9-6722-4bfb-98e4-9bddea9233f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_822c08e9-6722-4bfb-98e4-9bddea9233f0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_2129e08b-71e8-45f8-896f-2d65fc415625" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_2129e08b-71e8-45f8-896f-2d65fc415625" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_78d23552-2502-4599-9e06-78235dc4c954" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_78d23552-2502-4599-9e06-78235dc4c954" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5d128a3a-af64-4538-91a7-510152da5b92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5d128a3a-af64-4538-91a7-510152da5b92" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_cec75768-4782-4db9-807e-5316fbe9e3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_cec75768-4782-4db9-807e-5316fbe9e3f5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d5920cad-450c-4429-8371-274a3db57e72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20ee9bce-9915-47b6-abfb-586ff211c4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a24a4d99-e2a3-4170-9dfa-f6b80d9b5995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_10a85934-ca65-431c-9a91-1f0ea4762496" xlink:to="loc_us-gaap_StatementTable_a24a4d99-e2a3-4170-9dfa-f6b80d9b5995" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cc39fa2e-8801-443e-98d7-d240dcc9f555" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a24a4d99-e2a3-4170-9dfa-f6b80d9b5995" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cc39fa2e-8801-443e-98d7-d240dcc9f555" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cc39fa2e-8801-443e-98d7-d240dcc9f555_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cc39fa2e-8801-443e-98d7-d240dcc9f555" xlink:to="loc_us-gaap_EquityComponentDomain_cc39fa2e-8801-443e-98d7-d240dcc9f555_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b08c3a65-d725-4dfc-ac8b-de5755c906ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cc39fa2e-8801-443e-98d7-d240dcc9f555" xlink:to="loc_us-gaap_EquityComponentDomain_b08c3a65-d725-4dfc-ac8b-de5755c906ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b08c3a65-d725-4dfc-ac8b-de5755c906ff" xlink:to="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a1ad4f44-3bce-4d3a-9843-38608b70e74d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:to="loc_us-gaap_CommonStockMember_a1ad4f44-3bce-4d3a-9843-38608b70e74d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_daf5265f-e2fa-4fed-ae54-f6d41469d70f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_daf5265f-e2fa-4fed-ae54-f6d41469d70f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_549da558-9a0e-4d35-a111-1831c7d9ed98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_549da558-9a0e-4d35-a111-1831c7d9ed98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9035ffff-964a-4a9d-97f9-9b765e1b25d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:to="loc_us-gaap_RetainedEarningsMember_9035ffff-964a-4a9d-97f9-9b765e1b25d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_cfd686e2-e04e-44f6-ba5b-52c6059c9dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:to="loc_us-gaap_TreasuryStockCommonMember_cfd686e2-e04e-44f6-ba5b-52c6059c9dd9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_250fc035-19a3-43d6-aea3-8e7c4f41a50a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b08c3a65-d725-4dfc-ac8b-de5755c906ff" xlink:to="loc_us-gaap_NoncontrollingInterestMember_250fc035-19a3-43d6-aea3-8e7c4f41a50a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/TheBusinessDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#TheBusinessDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/TheBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems_4d4b3398-2174-4d71-b5f4-0c76b46011ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_6f95f9d6-efeb-4b38-afbd-0f8d8845d4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_4d4b3398-2174-4d71-b5f4-0c76b46011ca" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_6f95f9d6-efeb-4b38-afbd-0f8d8845d4e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_50411f5b-ecf0-45ec-82ed-5e3b9cd95389" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_4d4b3398-2174-4d71-b5f4-0c76b46011ca" xlink:to="loc_us-gaap_SharesIssued_50411f5b-ecf0-45ec-82ed-5e3b9cd95389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_d8752a38-2e4b-4d06-b91d-1bf5c9f9d1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_4d4b3398-2174-4d71-b5f4-0c76b46011ca" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_d8752a38-2e4b-4d06-b91d-1bf5c9f9d1fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_a689ac43-6d48-440d-87e1-136c59a5f0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_4d4b3398-2174-4d71-b5f4-0c76b46011ca" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_a689ac43-6d48-440d-87e1-136c59a5f0d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable_c5ee0e36-af5b-4df4-acb0-b19eb26cfd53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_4d4b3398-2174-4d71-b5f4-0c76b46011ca" xlink:to="loc_us-gaap_AssetAcquisitionTable_c5ee0e36-af5b-4df4-acb0-b19eb26cfd53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_ebe5c5c0-7447-4fcf-b502-54c7d49c1581" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AssetAcquisitionTable_c5ee0e36-af5b-4df4-acb0-b19eb26cfd53" xlink:to="loc_us-gaap_AssetAcquisitionAxis_ebe5c5c0-7447-4fcf-b502-54c7d49c1581" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_ebe5c5c0-7447-4fcf-b502-54c7d49c1581_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_ebe5c5c0-7447-4fcf-b502-54c7d49c1581" xlink:to="loc_us-gaap_AssetAcquisitionDomain_ebe5c5c0-7447-4fcf-b502-54c7d49c1581_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_c7f8c445-23ff-4f20-9dd5-a5647f67eb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_ebe5c5c0-7447-4fcf-b502-54c7d49c1581" xlink:to="loc_us-gaap_AssetAcquisitionDomain_c7f8c445-23ff-4f20-9dd5-a5647f67eb6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CENDMember_011805a1-e2ad-4737-9f22-fa0b08966e22" xlink:href="clbs-20230630.xsd#clbs_CENDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_c7f8c445-23ff-4f20-9dd5-a5647f67eb6d" xlink:to="loc_clbs_CENDMember_011805a1-e2ad-4737-9f22-fa0b08966e22" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4e68066-1404-46fd-a484-2261f8375c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_995839b0-b9e2-409c-aae3-fa2d458214e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4e68066-1404-46fd-a484-2261f8375c6e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_995839b0-b9e2-409c-aae3-fa2d458214e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a54038d-8d1d-444d-af47-1a1a7a3a389a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4e68066-1404-46fd-a484-2261f8375c6e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a54038d-8d1d-444d-af47-1a1a7a3a389a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_103f76ef-def2-4c66-9cee-be672ece86e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a54038d-8d1d-444d-af47-1a1a7a3a389a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_103f76ef-def2-4c66-9cee-be672ece86e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_103f76ef-def2-4c66-9cee-be672ece86e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_103f76ef-def2-4c66-9cee-be672ece86e6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_103f76ef-def2-4c66-9cee-be672ece86e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6fc6a6d-aba3-458f-b3b5-0f45d706b200" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_103f76ef-def2-4c66-9cee-be672ece86e6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6fc6a6d-aba3-458f-b3b5-0f45d706b200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_56735390-a194-48d3-adb7-9b21d55a0898" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6fc6a6d-aba3-458f-b3b5-0f45d706b200" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_56735390-a194-48d3-adb7-9b21d55a0898" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_0b555058-79e5-4fb0-866b-c117275cb275" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6fc6a6d-aba3-458f-b3b5-0f45d706b200" xlink:to="loc_us-gaap_ComputerEquipmentMember_0b555058-79e5-4fb0-866b-c117275cb275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_4f5d557f-bbed-4c15-8d09-bd9b89f0e664" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6fc6a6d-aba3-458f-b3b5-0f45d706b200" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_4f5d557f-bbed-4c15-8d09-bd9b89f0e664" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_85d6e34a-5ba5-432e-b191-c19079e9d9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6fc6a6d-aba3-458f-b3b5-0f45d706b200" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_85d6e34a-5ba5-432e-b191-c19079e9d9b9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/MergerDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#MergerDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/MergerDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0d7099e0-b32c-4f84-bcb4-74de2e989dea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0d7099e0-b32c-4f84-bcb4-74de2e989dea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionSharePrice_247b28af-8986-41dc-80b1-a2325a7b75b9" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionSharePrice_247b28af-8986-41dc-80b1-a2325a7b75b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionConsiderationTransferredEquityValue_97cb65a6-2806-4ac7-b1af-08e2e4863c50" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionConsiderationTransferredEquityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionConsiderationTransferredEquityValue_97cb65a6-2806-4ac7-b1af-08e2e4863c50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_ebe62dd6-4e70-446b-8433-e69534dabe22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_ebe62dd6-4e70-446b-8433-e69534dabe22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_eb40843a-1414-4e50-b301-743eecebdd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_eb40843a-1414-4e50-b301-743eecebdd4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_d3f53068-6dcd-45c4-b4f8-6301d7030f57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_d3f53068-6dcd-45c4-b4f8-6301d7030f57" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_8d7ba96e-ac48-465a-9c0b-1c9de479ad93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_8d7ba96e-ac48-465a-9c0b-1c9de479ad93" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionCashAndCashEquivalents_a4506ccf-3669-4e43-b40a-c88c886e2773" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionCashAndCashEquivalents_a4506ccf-3669-4e43-b40a-c88c886e2773" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionNetWorkingCapital_f3c40a23-fe10-48b7-832a-a4c82ab4e93c" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionNetWorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionNetWorkingCapital_f3c40a23-fe10-48b7-832a-a4c82ab4e93c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionOtherLiabilities_eb20807e-8b36-47a9-ad97-3c3a480688cd" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionOtherLiabilities_eb20807e-8b36-47a9-ad97-3c3a480688cd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment_464ae879-be72-4138-a7cb-8b61f684d3d3" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment_464ae879-be72-4138-a7cb-8b61f684d3d3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionIntangibles_5b66568e-f2a9-477e-b9ee-c65a7009b70f" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionIntangibles_5b66568e-f2a9-477e-b9ee-c65a7009b70f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable_909e433e-f8bd-4a0e-aae7-0e06ae79eba3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_us-gaap_AssetAcquisitionTable_909e433e-f8bd-4a0e-aae7-0e06ae79eba3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_30140b8e-f13d-429e-83f9-55d4a2fcd24e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AssetAcquisitionTable_909e433e-f8bd-4a0e-aae7-0e06ae79eba3" xlink:to="loc_us-gaap_AssetAcquisitionAxis_30140b8e-f13d-429e-83f9-55d4a2fcd24e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_30140b8e-f13d-429e-83f9-55d4a2fcd24e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_30140b8e-f13d-429e-83f9-55d4a2fcd24e" xlink:to="loc_us-gaap_AssetAcquisitionDomain_30140b8e-f13d-429e-83f9-55d4a2fcd24e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_13009993-2f40-4dbe-9b78-f717f02a0fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_30140b8e-f13d-429e-83f9-55d4a2fcd24e" xlink:to="loc_us-gaap_AssetAcquisitionDomain_13009993-2f40-4dbe-9b78-f717f02a0fc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CENDMember_d97fdcb8-2133-42f9-bb6a-9f2dc115b3cb" xlink:href="clbs-20230630.xsd#clbs_CENDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_13009993-2f40-4dbe-9b78-f717f02a0fc1" xlink:to="loc_clbs_CENDMember_d97fdcb8-2133-42f9-bb6a-9f2dc115b3cb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dc0eca6e-62d0-4322-953a-27d859144be2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_83a90437-2510-453d-9962-df94f47443bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dc0eca6e-62d0-4322-953a-27d859144be2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_83a90437-2510-453d-9962-df94f47443bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_35a4d078-3155-4115-94ad-a049b4aec328" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dc0eca6e-62d0-4322-953a-27d859144be2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_35a4d078-3155-4115-94ad-a049b4aec328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_04478de3-0c2a-4524-9d37-ac98f36d3163" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dc0eca6e-62d0-4322-953a-27d859144be2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_04478de3-0c2a-4524-9d37-ac98f36d3163" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5eb2a0f8-9261-4183-9346-972a97a8bceb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dc0eca6e-62d0-4322-953a-27d859144be2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5eb2a0f8-9261-4183-9346-972a97a8bceb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6e2cb36e-f6df-4644-bc89-59cebdbf8084" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dc0eca6e-62d0-4322-953a-27d859144be2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6e2cb36e-f6df-4644-bc89-59cebdbf8084" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f0858b27-4272-4082-8105-21a8ab66df39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6e2cb36e-f6df-4644-bc89-59cebdbf8084" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f0858b27-4272-4082-8105-21a8ab66df39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f0858b27-4272-4082-8105-21a8ab66df39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f0858b27-4272-4082-8105-21a8ab66df39" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f0858b27-4272-4082-8105-21a8ab66df39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f0858b27-4272-4082-8105-21a8ab66df39" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_38a54f1b-a0bf-41f0-8bbb-6c4b745562f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_38a54f1b-a0bf-41f0-8bbb-6c4b745562f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_ee995bee-b24f-4e1b-870b-1923ea2f12e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:to="loc_us-gaap_CommercialPaperMember_ee995bee-b24f-4e1b-870b-1923ea2f12e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_506aeae9-9b25-4d89-8e17-c3d32c8ff477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:to="loc_us-gaap_MoneyMarketFundsMember_506aeae9-9b25-4d89-8e17-c3d32c8ff477" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_704320d5-5714-4b73-8430-da7abfcb4e06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_704320d5-5714-4b73-8430-da7abfcb4e06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BondsMember_30bde966-c574-499b-a736-13af669af1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:to="loc_us-gaap_BondsMember_30bde966-c574-499b-a736-13af669af1e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBillSecuritiesMember_e211bc7d-ca33-43d2-8872-4632bb640d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:to="loc_us-gaap_USTreasuryBillSecuritiesMember_e211bc7d-ca33-43d2-8872-4632bb640d73" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#PropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9ee1c7a-547e-4aea-88a6-feb29a6c0a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_dc750da0-73bc-453f-98d2-69049cf910ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9ee1c7a-547e-4aea-88a6-feb29a6c0a3e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_dc750da0-73bc-453f-98d2-69049cf910ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8758e20f-0c43-4995-9b28-596c97d72148" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9ee1c7a-547e-4aea-88a6-feb29a6c0a3e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8758e20f-0c43-4995-9b28-596c97d72148" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0beba8a9-e85a-4030-af0e-9b901d78fab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9ee1c7a-547e-4aea-88a6-feb29a6c0a3e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0beba8a9-e85a-4030-af0e-9b901d78fab1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_5cd32ed8-201e-4899-95e2-93b90a93f200" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9ee1c7a-547e-4aea-88a6-feb29a6c0a3e" xlink:to="loc_us-gaap_Depreciation_5cd32ed8-201e-4899-95e2-93b90a93f200" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0a71e9e2-e462-40f5-b272-43c9f7860f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9ee1c7a-547e-4aea-88a6-feb29a6c0a3e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0a71e9e2-e462-40f5-b272-43c9f7860f1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e17e9b1-0cc2-4178-b10e-4548aac8596a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0a71e9e2-e462-40f5-b272-43c9f7860f1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e17e9b1-0cc2-4178-b10e-4548aac8596a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9e17e9b1-0cc2-4178-b10e-4548aac8596a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e17e9b1-0cc2-4178-b10e-4548aac8596a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9e17e9b1-0cc2-4178-b10e-4548aac8596a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73c46783-0b07-4e27-af09-18dcb23ddc21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e17e9b1-0cc2-4178-b10e-4548aac8596a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73c46783-0b07-4e27-af09-18dcb23ddc21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_78290c5d-b668-4e6b-af5a-ab279d7662b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73c46783-0b07-4e27-af09-18dcb23ddc21" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_78290c5d-b668-4e6b-af5a-ab279d7662b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_c2b44359-4c90-4aa3-81c7-bda9662ad2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73c46783-0b07-4e27-af09-18dcb23ddc21" xlink:to="loc_us-gaap_ComputerEquipmentMember_c2b44359-4c90-4aa3-81c7-bda9662ad2b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3ba95b56-2c2d-49a1-9b8f-4e0bed7e3bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73c46783-0b07-4e27-af09-18dcb23ddc21" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3ba95b56-2c2d-49a1-9b8f-4e0bed7e3bd6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeLossPerShareDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#IncomeLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/IncomeLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_05cf9a04-cd14-4a98-9f9d-b303cbdbe040" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6d242d55-bb06-4062-9cf7-274cd523e06a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_05cf9a04-cd14-4a98-9f9d-b303cbdbe040" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6d242d55-bb06-4062-9cf7-274cd523e06a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_babb41c6-27e3-432c-9b6e-a78c26865d45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_05cf9a04-cd14-4a98-9f9d-b303cbdbe040" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_babb41c6-27e3-432c-9b6e-a78c26865d45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a904fa2-1387-4f89-82c2-325885c2c0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_babb41c6-27e3-432c-9b6e-a78c26865d45" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a904fa2-1387-4f89-82c2-325885c2c0ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a904fa2-1387-4f89-82c2-325885c2c0ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a904fa2-1387-4f89-82c2-325885c2c0ec" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7a904fa2-1387-4f89-82c2-325885c2c0ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_431a24cf-9b8e-4e32-b1b2-c294bd8aa406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a904fa2-1387-4f89-82c2-325885c2c0ec" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_431a24cf-9b8e-4e32-b1b2-c294bd8aa406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_03ba1a52-6a7b-4fb0-9597-ff3a67579f70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_431a24cf-9b8e-4e32-b1b2-c294bd8aa406" xlink:to="loc_us-gaap_EmployeeStockOptionMember_03ba1a52-6a7b-4fb0-9597-ff3a67579f70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_0d02cfe7-36d1-4687-858d-07b8802fbe41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_431a24cf-9b8e-4e32-b1b2-c294bd8aa406" xlink:to="loc_us-gaap_WarrantMember_0d02cfe7-36d1-4687-858d-07b8802fbe41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_82d5fbeb-d04e-4f01-9ea5-0444eb0f2fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_431a24cf-9b8e-4e32-b1b2-c294bd8aa406" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_82d5fbeb-d04e-4f01-9ea5-0444eb0f2fd7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9058a94-e99d-4f11-9577-b75c1508535c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_573dfa83-0d93-47f4-9b18-07aac7f17092" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9058a94-e99d-4f11-9577-b75c1508535c" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_573dfa83-0d93-47f4-9b18-07aac7f17092" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_b35d8003-e308-401d-8c7e-a2d2d28da5af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9058a94-e99d-4f11-9577-b75c1508535c" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_b35d8003-e308-401d-8c7e-a2d2d28da5af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_68259ebe-c0e6-4d00-8dda-ff90e4f9e44c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9058a94-e99d-4f11-9577-b75c1508535c" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_68259ebe-c0e6-4d00-8dda-ff90e4f9e44c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50fb7dad-eb2c-49b1-b7ea-b49bc6ef1d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9058a94-e99d-4f11-9577-b75c1508535c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50fb7dad-eb2c-49b1-b7ea-b49bc6ef1d2e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2d8022a-e351-433c-9caf-0adbc46b3a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50fb7dad-eb2c-49b1-b7ea-b49bc6ef1d2e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2d8022a-e351-433c-9caf-0adbc46b3a2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2d8022a-e351-433c-9caf-0adbc46b3a2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2d8022a-e351-433c-9caf-0adbc46b3a2e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e2d8022a-e351-433c-9caf-0adbc46b3a2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_55d4ed6a-9ab4-4135-a81b-1b81b8553210" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2d8022a-e351-433c-9caf-0adbc46b3a2e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_55d4ed6a-9ab4-4135-a81b-1b81b8553210" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0e8d9abb-0e8a-4fbd-a466-8afce8a8644a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_55d4ed6a-9ab4-4135-a81b-1b81b8553210" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0e8d9abb-0e8a-4fbd-a466-8afce8a8644a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3e276a18-a8c2-45eb-a6f6-657fa274509e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_55d4ed6a-9ab4-4135-a81b-1b81b8553210" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3e276a18-a8c2-45eb-a6f6-657fa274509e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3f8a6976-76fe-44b9-b70b-55f7fac0e9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_55d4ed6a-9ab4-4135-a81b-1b81b8553210" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3f8a6976-76fe-44b9-b70b-55f7fac0e9a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_edb41e2f-58ab-402a-b695-d9bd3ced48a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50fb7dad-eb2c-49b1-b7ea-b49bc6ef1d2e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_edb41e2f-58ab-402a-b695-d9bd3ced48a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_edb41e2f-58ab-402a-b695-d9bd3ced48a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_edb41e2f-58ab-402a-b695-d9bd3ced48a0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_edb41e2f-58ab-402a-b695-d9bd3ced48a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_93141099-0ded-4112-8794-cf2d7a2d1e22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_edb41e2f-58ab-402a-b695-d9bd3ced48a0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_93141099-0ded-4112-8794-cf2d7a2d1e22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_3e32255d-59d9-4002-914c-7a270605a19b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_93141099-0ded-4112-8794-cf2d7a2d1e22" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_3e32255d-59d9-4002-914c-7a270605a19b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#StockholdersEquityEquityIssuancesDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_bd08cdca-f1d9-4cfb-a088-e012255e6f47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_bd08cdca-f1d9-4cfb-a088-e012255e6f47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_d09ab95f-38c0-46da-bf2c-76323989f0e7" xlink:href="clbs-20230630.xsd#clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:to="loc_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_d09ab95f-38c0-46da-bf2c-76323989f0e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_b6661dac-c1a0-4d9f-b6d6-020719192e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:to="loc_us-gaap_CommonStockValueOutstanding_b6661dac-c1a0-4d9f-b6d6-020719192e8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockAvailableForSale_777baf47-fe39-4ca3-9d26-7bf2891e5482" xlink:href="clbs-20230630.xsd#clbs_SaleOfStockAvailableForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:to="loc_clbs_SaleOfStockAvailableForSale_777baf47-fe39-4ca3-9d26-7bf2891e5482" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a4d923b5-4162-45ff-9f92-00f76950f92a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a4d923b5-4162-45ff-9f92-00f76950f92a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_79f78bc5-c01b-445f-9114-deedadaeae71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_79f78bc5-c01b-445f-9114-deedadaeae71" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_24bd5dcd-4818-4dfd-b1c3-fc4792a4a9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_24bd5dcd-4818-4dfd-b1c3-fc4792a4a9d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_64ca7d7a-93b1-4a98-8a59-d49b1ca9fcea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_24bd5dcd-4818-4dfd-b1c3-fc4792a4a9d9" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_64ca7d7a-93b1-4a98-8a59-d49b1ca9fcea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_64ca7d7a-93b1-4a98-8a59-d49b1ca9fcea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_64ca7d7a-93b1-4a98-8a59-d49b1ca9fcea" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_64ca7d7a-93b1-4a98-8a59-d49b1ca9fcea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc78a5e1-9236-45da-a339-0489ea57e87b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_64ca7d7a-93b1-4a98-8a59-d49b1ca9fcea" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc78a5e1-9236-45da-a339-0489ea57e87b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AtTheMarketOfferingAgreementMember_fc00b652-4d90-4193-b40f-555280163962" xlink:href="clbs-20230630.xsd#clbs_AtTheMarketOfferingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc78a5e1-9236-45da-a339-0489ea57e87b" xlink:to="loc_clbs_AtTheMarketOfferingAgreementMember_fc00b652-4d90-4193-b40f-555280163962" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_ca26624c-840f-4135-8974-e757a10a351e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_24bd5dcd-4818-4dfd-b1c3-fc4792a4a9d9" xlink:to="loc_us-gaap_AssetAcquisitionAxis_ca26624c-840f-4135-8974-e757a10a351e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_ca26624c-840f-4135-8974-e757a10a351e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_ca26624c-840f-4135-8974-e757a10a351e" xlink:to="loc_us-gaap_AssetAcquisitionDomain_ca26624c-840f-4135-8974-e757a10a351e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_5f99287e-6a28-4a9f-9b95-6bc047404f19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_ca26624c-840f-4135-8974-e757a10a351e" xlink:to="loc_us-gaap_AssetAcquisitionDomain_5f99287e-6a28-4a9f-9b95-6bc047404f19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CENDMember_5a14da0d-db7c-4afa-aadc-08a64aebd16d" xlink:href="clbs-20230630.xsd#clbs_CENDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_5f99287e-6a28-4a9f-9b95-6bc047404f19" xlink:to="loc_clbs_CENDMember_5a14da0d-db7c-4afa-aadc-08a64aebd16d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4cb3877a-471f-40b4-bfc5-8f5d1edf7a39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2c19555b-2fb4-4140-afaa-a88e5777a408" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4cb3877a-471f-40b4-bfc5-8f5d1edf7a39" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2c19555b-2fb4-4140-afaa-a88e5777a408" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_85034456-b16e-4d27-9cc2-302849a77129" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4cb3877a-471f-40b4-bfc5-8f5d1edf7a39" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_85034456-b16e-4d27-9cc2-302849a77129" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_03597171-5007-4d6a-9b11-7d1ca02f9713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4cb3877a-471f-40b4-bfc5-8f5d1edf7a39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_03597171-5007-4d6a-9b11-7d1ca02f9713" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_89d1d7bd-e637-49d3-9605-f3b013dfd6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4cb3877a-471f-40b4-bfc5-8f5d1edf7a39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_89d1d7bd-e637-49d3-9605-f3b013dfd6d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8d15bd00-4547-41e3-ac54-d3a76e4e1ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4cb3877a-471f-40b4-bfc5-8f5d1edf7a39" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8d15bd00-4547-41e3-ac54-d3a76e4e1ccd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ddc4cbc9-1ee2-497e-a73b-665ab4841bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8d15bd00-4547-41e3-ac54-d3a76e4e1ccd" xlink:to="loc_us-gaap_AwardTypeAxis_ddc4cbc9-1ee2-497e-a73b-665ab4841bfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddc4cbc9-1ee2-497e-a73b-665ab4841bfe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ddc4cbc9-1ee2-497e-a73b-665ab4841bfe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddc4cbc9-1ee2-497e-a73b-665ab4841bfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b36cf5f-116d-403a-a892-ae71e0304493" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ddc4cbc9-1ee2-497e-a73b-665ab4841bfe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b36cf5f-116d-403a-a892-ae71e0304493" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_7209e785-0efb-4ec3-988f-b396009dbefd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b36cf5f-116d-403a-a892-ae71e0304493" xlink:to="loc_us-gaap_RestrictedStockMember_7209e785-0efb-4ec3-988f-b396009dbefd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c0b79df6-2314-4cea-8191-cdedc4bd6a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b36cf5f-116d-403a-a892-ae71e0304493" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c0b79df6-2314-4cea-8191-cdedc4bd6a8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7f7cf888-f75c-403b-88a8-5f94112c41e5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8d15bd00-4547-41e3-ac54-d3a76e4e1ccd" xlink:to="loc_srt_RangeAxis_7f7cf888-f75c-403b-88a8-5f94112c41e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7f7cf888-f75c-403b-88a8-5f94112c41e5_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7f7cf888-f75c-403b-88a8-5f94112c41e5" xlink:to="loc_srt_RangeMember_7f7cf888-f75c-403b-88a8-5f94112c41e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_75e4326a-0b26-47aa-9c04-a453928b08e6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7f7cf888-f75c-403b-88a8-5f94112c41e5" xlink:to="loc_srt_RangeMember_75e4326a-0b26-47aa-9c04-a453928b08e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6e208968-55ba-4662-a0e3-616ba0594e23" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_75e4326a-0b26-47aa-9c04-a453928b08e6" xlink:to="loc_srt_MinimumMember_6e208968-55ba-4662-a0e3-616ba0594e23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9b994bb7-f1fd-4c36-9992-08ff310264af" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_75e4326a-0b26-47aa-9c04-a453928b08e6" xlink:to="loc_srt_MaximumMember_9b994bb7-f1fd-4c36-9992-08ff310264af" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#ShareBasedCompensationShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_850d62ff-e6bc-4861-b92a-821e1d769eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5943c625-4076-4eed-9fa6-643832b6ccff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_850d62ff-e6bc-4861-b92a-821e1d769eb1" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5943c625-4076-4eed-9fa6-643832b6ccff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2d923b1-f28a-425a-ba3d-ab8f0aeb4d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_850d62ff-e6bc-4861-b92a-821e1d769eb1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2d923b1-f28a-425a-ba3d-ab8f0aeb4d5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_86e388d7-5619-4c7f-982f-2f399ef616f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2d923b1-f28a-425a-ba3d-ab8f0aeb4d5a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_86e388d7-5619-4c7f-982f-2f399ef616f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_86e388d7-5619-4c7f-982f-2f399ef616f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_86e388d7-5619-4c7f-982f-2f399ef616f9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_86e388d7-5619-4c7f-982f-2f399ef616f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8d17c455-4294-4f93-a063-431975b6f011" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_86e388d7-5619-4c7f-982f-2f399ef616f9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8d17c455-4294-4f93-a063-431975b6f011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_77776485-8f66-4ff9-8191-738651148c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8d17c455-4294-4f93-a063-431975b6f011" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_77776485-8f66-4ff9-8191-738651148c3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1e0f0fea-2122-4c77-a4af-2524ec4fa61d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8d17c455-4294-4f93-a063-431975b6f011" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1e0f0fea-2122-4c77-a4af-2524ec4fa61d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7c52856b-6aab-4056-b965-ffd60a78f0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8d17c455-4294-4f93-a063-431975b6f011" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7c52856b-6aab-4056-b965-ffd60a78f0a3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#ShareBasedCompensationCompensationCostNotYetRecognizedDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05b24960-25e0-4add-ba24-02f082494608" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cd19f483-f9c8-41b8-8bfc-94b4310b0cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05b24960-25e0-4add-ba24-02f082494608" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cd19f483-f9c8-41b8-8bfc-94b4310b0cc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_97b8b835-90f6-49b0-92b4-303ad2af51e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05b24960-25e0-4add-ba24-02f082494608" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_97b8b835-90f6-49b0-92b4-303ad2af51e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7aeb4697-3c53-4fc7-ae23-e2e2b64b27c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05b24960-25e0-4add-ba24-02f082494608" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7aeb4697-3c53-4fc7-ae23-e2e2b64b27c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e3252c24-6a49-42fe-a12c-eb9478c846c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7aeb4697-3c53-4fc7-ae23-e2e2b64b27c5" xlink:to="loc_us-gaap_AwardTypeAxis_e3252c24-6a49-42fe-a12c-eb9478c846c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e3252c24-6a49-42fe-a12c-eb9478c846c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e3252c24-6a49-42fe-a12c-eb9478c846c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e3252c24-6a49-42fe-a12c-eb9478c846c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83a6cbef-7c5d-436f-bc88-3a3ebd734f43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e3252c24-6a49-42fe-a12c-eb9478c846c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83a6cbef-7c5d-436f-bc88-3a3ebd734f43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2717f27b-6c6a-457a-b950-d866afb850ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83a6cbef-7c5d-436f-bc88-3a3ebd734f43" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2717f27b-6c6a-457a-b950-d866afb850ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6d6b6066-acf5-407d-9e62-41c02610e9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83a6cbef-7c5d-436f-bc88-3a3ebd734f43" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6d6b6066-acf5-407d-9e62-41c02610e9f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e1dc9ad5-4dd4-4530-8bbc-dba265911889" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83a6cbef-7c5d-436f-bc88-3a3ebd734f43" xlink:to="loc_us-gaap_RestrictedStockMember_e1dc9ad5-4dd4-4530-8bbc-dba265911889" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71bcbf91-3014-4493-8e28-84f43f3a7cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_41fbc8a3-310e-4bf3-9fc3-c668adc3a6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71bcbf91-3014-4493-8e28-84f43f3a7cfa" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_41fbc8a3-310e-4bf3-9fc3-c668adc3a6f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_61a65f67-bcd8-46b0-ab76-7385af5578f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71bcbf91-3014-4493-8e28-84f43f3a7cfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_61a65f67-bcd8-46b0-ab76-7385af5578f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39a95beb-2510-4ab2-9bac-f88a17980a01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71bcbf91-3014-4493-8e28-84f43f3a7cfa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39a95beb-2510-4ab2-9bac-f88a17980a01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_714dc6b7-820e-4285-aaf8-64bb95d086c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39a95beb-2510-4ab2-9bac-f88a17980a01" xlink:to="loc_us-gaap_AwardTypeAxis_714dc6b7-820e-4285-aaf8-64bb95d086c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_714dc6b7-820e-4285-aaf8-64bb95d086c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_714dc6b7-820e-4285-aaf8-64bb95d086c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_714dc6b7-820e-4285-aaf8-64bb95d086c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78d571cc-819e-4b5f-8a84-d94f02cde3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_714dc6b7-820e-4285-aaf8-64bb95d086c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78d571cc-819e-4b5f-8a84-d94f02cde3c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_713b3c6c-d72f-4f37-b97f-d905267e0ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78d571cc-819e-4b5f-8a84-d94f02cde3c1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_713b3c6c-d72f-4f37-b97f-d905267e0ea6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_OperatingLossCarryforwardsBeforeWriteDown_f0c3572a-ab07-403f-896c-f72851ee9e75" xlink:href="clbs-20230630.xsd#clbs_OperatingLossCarryforwardsBeforeWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_clbs_OperatingLossCarryforwardsBeforeWriteDown_f0c3572a-ab07-403f-896c-f72851ee9e75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_e0fff173-7dfd-4b24-bf4c-509144e76b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_us-gaap_OperatingLossCarryforwards_e0fff173-7dfd-4b24-bf4c-509144e76b0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1b926071-8fd4-4fc0-933a-2cbe9570fb09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1b926071-8fd4-4fc0-933a-2cbe9570fb09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_OperatingLossCarryforwardsPostAcquisition_af5024c4-4058-42f1-90c3-7e8afea1fe7e" xlink:href="clbs-20230630.xsd#clbs_OperatingLossCarryforwardsPostAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_clbs_OperatingLossCarryforwardsPostAcquisition_af5024c4-4058-42f1-90c3-7e8afea1fe7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_050e8b68-71e0-4b4c-913f-b3a314fc029d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_050e8b68-71e0-4b4c-913f-b3a314fc029d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_bb17eed7-8ede-4f8f-8017-5cd4e25579dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_bb17eed7-8ede-4f8f-8017-5cd4e25579dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ProceedsFromSaleOfNOLS_84caae5a-d495-46c4-a005-7acabd98538a" xlink:href="clbs-20230630.xsd#clbs_ProceedsFromSaleOfNOLS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_clbs_ProceedsFromSaleOfNOLS_84caae5a-d495-46c4-a005-7acabd98538a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b90d9ea2-37a9-4bf3-9cb7-49baaa73058d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b90d9ea2-37a9-4bf3-9cb7-49baaa73058d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_LossOnSaleOfNOL_7265903d-4607-4dc3-915e-ec8c01df57ac" xlink:href="clbs-20230630.xsd#clbs_LossOnSaleOfNOL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_clbs_LossOnSaleOfNOL_7265903d-4607-4dc3-915e-ec8c01df57ac" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_bb1724d0-5663-43d7-b87f-356e991597f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_bb1724d0-5663-43d7-b87f-356e991597f7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_FairValueMarketOfTaxNOLs_7ac9a7f7-31ac-4ecb-af7d-a3a566cf1d74" xlink:href="clbs-20230630.xsd#clbs_FairValueMarketOfTaxNOLs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_clbs_FairValueMarketOfTaxNOLs_7ac9a7f7-31ac-4ecb-af7d-a3a566cf1d74" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_2a5df577-c39c-48a8-b558-e0317adb09ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_2a5df577-c39c-48a8-b558-e0317adb09ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b6697808-94b3-460e-982f-6eee47b94287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_2a5df577-c39c-48a8-b558-e0317adb09ac" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b6697808-94b3-460e-982f-6eee47b94287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b6697808-94b3-460e-982f-6eee47b94287_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b6697808-94b3-460e-982f-6eee47b94287" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b6697808-94b3-460e-982f-6eee47b94287_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_3dfc4392-0d56-49a1-973a-367b29e54c51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b6697808-94b3-460e-982f-6eee47b94287" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_3dfc4392-0d56-49a1-973a-367b29e54c51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_9a946ab0-2891-4984-9db6-7e8c18d79dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3dfc4392-0d56-49a1-973a-367b29e54c51" xlink:to="loc_us-gaap_DomesticCountryMember_9a946ab0-2891-4984-9db6-7e8c18d79dc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_bf4a1e9f-486a-4a78-9b05-60dcab4daf57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3dfc4392-0d56-49a1-973a-367b29e54c51" xlink:to="loc_us-gaap_ForeignCountryMember_bf4a1e9f-486a-4a78-9b05-60dcab4daf57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f7a0bd22-2178-444a-b804-48bfcb495c85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3dfc4392-0d56-49a1-973a-367b29e54c51" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f7a0bd22-2178-444a-b804-48bfcb495c85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_5003c1a9-117a-4665-a892-eca50875b696" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_2a5df577-c39c-48a8-b558-e0317adb09ac" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_5003c1a9-117a-4665-a892-eca50875b696" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_5003c1a9-117a-4665-a892-eca50875b696_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_5003c1a9-117a-4665-a892-eca50875b696" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_5003c1a9-117a-4665-a892-eca50875b696_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_2e51f289-bd95-41de-ae35-748823cfc598" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_5003c1a9-117a-4665-a892-eca50875b696" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_2e51f289-bd95-41de-ae35-748823cfc598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewJerseyDivisionOfTaxationMember_c46ee447-c5d3-4ce0-827f-aa97d19bebe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewJerseyDivisionOfTaxationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_2e51f289-bd95-41de-ae35-748823cfc598" xlink:to="loc_us-gaap_NewJerseyDivisionOfTaxationMember_c46ee447-c5d3-4ce0-827f-aa97d19bebe5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_bf2091b9-7a80-44f8-87c9-24d2e1620995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_2e51f289-bd95-41de-ae35-748823cfc598" xlink:to="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_bf2091b9-7a80-44f8-87c9-24d2e1620995" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_80588a07-80d1-4ef6-8b8f-6455acc79198" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_2e51f289-bd95-41de-ae35-748823cfc598" xlink:to="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_80588a07-80d1-4ef6-8b8f-6455acc79198" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_26c1be5b-a8d3-4eb1-897c-4983e710eecc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_2a5df577-c39c-48a8-b558-e0317adb09ac" xlink:to="loc_dei_LegalEntityAxis_26c1be5b-a8d3-4eb1-897c-4983e710eecc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_26c1be5b-a8d3-4eb1-897c-4983e710eecc_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_26c1be5b-a8d3-4eb1-897c-4983e710eecc" xlink:to="loc_dei_EntityDomain_26c1be5b-a8d3-4eb1-897c-4983e710eecc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b1190116-9a3c-4f14-b9e3-3918408b8a46" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_26c1be5b-a8d3-4eb1-897c-4983e710eecc" xlink:to="loc_dei_EntityDomain_b1190116-9a3c-4f14-b9e3-3918408b8a46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CENDMember_464b0f0a-7dfd-4e3c-b67b-b69514fc7d9b" xlink:href="clbs-20230630.xsd#clbs_CENDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_b1190116-9a3c-4f14-b9e3-3918408b8a46" xlink:to="loc_clbs_CENDMember_464b0f0a-7dfd-4e3c-b67b-b69514fc7d9b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#AustraliaResearchandDevelopmentTaxIncentiveDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayLineItems_194736a0-8bf8-412f-bf08-450d439250c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxHolidayLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_90bea6d6-e1d9-4b37-b00c-18c31e2c41b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxHolidayLineItems_194736a0-8bf8-412f-bf08-450d439250c5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_90bea6d6-e1d9-4b37-b00c-18c31e2c41b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_IncomeTaxIncentiveReceivable_1184caa0-aabc-4698-a711-3cb4be8cd5c9" xlink:href="clbs-20230630.xsd#clbs_IncomeTaxIncentiveReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxHolidayLineItems_194736a0-8bf8-412f-bf08-450d439250c5" xlink:to="loc_clbs_IncomeTaxIncentiveReceivable_1184caa0-aabc-4698-a711-3cb4be8cd5c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayTable_2282e981-2607-4937-9308-c4f140cc6e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxHolidayTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxHolidayLineItems_194736a0-8bf8-412f-bf08-450d439250c5" xlink:to="loc_us-gaap_IncomeTaxHolidayTable_2282e981-2607-4937-9308-c4f140cc6e9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c2b04aa7-1dfc-4fbd-b335-4f2d27d37c90" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxHolidayTable_2282e981-2607-4937-9308-c4f140cc6e9c" xlink:to="loc_srt_RangeAxis_c2b04aa7-1dfc-4fbd-b335-4f2d27d37c90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c2b04aa7-1dfc-4fbd-b335-4f2d27d37c90_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c2b04aa7-1dfc-4fbd-b335-4f2d27d37c90" xlink:to="loc_srt_RangeMember_c2b04aa7-1dfc-4fbd-b335-4f2d27d37c90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_843551bb-b2fe-40f4-8e20-322581f25c1a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c2b04aa7-1dfc-4fbd-b335-4f2d27d37c90" xlink:to="loc_srt_RangeMember_843551bb-b2fe-40f4-8e20-322581f25c1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a28d45e2-69f2-4001-8031-63f88dd012df" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_843551bb-b2fe-40f4-8e20-322581f25c1a" xlink:to="loc_srt_MinimumMember_a28d45e2-69f2-4001-8031-63f88dd012df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_084464c2-7b1c-433a-8c1c-2f43dcea056a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_843551bb-b2fe-40f4-8e20-322581f25c1a" xlink:to="loc_srt_MaximumMember_084464c2-7b1c-433a-8c1c-2f43dcea056a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/LicenseAgreementsDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#LicenseAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/LicenseAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SharesIssuedUnderLicenseAgreement_7ad089b5-4a4d-4283-aea9-759afba9cf80" xlink:href="clbs-20230630.xsd#clbs_SharesIssuedUnderLicenseAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_SharesIssuedUnderLicenseAgreement_7ad089b5-4a4d-4283-aea9-759afba9cf80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee_503f4b8e-11f5-42ba-965e-bd7c9ad42351" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee_503f4b8e-11f5-42ba-965e-bd7c9ad42351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven_3c056636-4e45-43a5-a869-20dc27e58300" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven_3c056636-4e45-43a5-a869-20dc27e58300" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_6d790faa-4dba-4a82-80f3-42e390cb297a" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_6d790faa-4dba-4a82-80f3-42e390cb297a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales_94e8c87c-7ddf-4cc8-93a0-add8c5107e2d" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales_94e8c87c-7ddf-4cc8-93a0-add8c5107e2d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees_25908c2b-3e89-4a38-a15b-1308ff4ea133" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees_25908c2b-3e89-4a38-a15b-1308ff4ea133" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour_ae714541-3e52-4765-bcdc-dc7ac15e7010" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour_ae714541-3e52-4765-bcdc-dc7ac15e7010" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SharesHeldByThirdParty_af359a57-de30-41f7-9691-6d38858ff74e" xlink:href="clbs-20230630.xsd#clbs_SharesHeldByThirdParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_SharesHeldByThirdParty_af359a57-de30-41f7-9691-6d38858ff74e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree_3bde4996-8228-4a0a-ba7a-32e2381b6598" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree_3bde4996-8228-4a0a-ba7a-32e2381b6598" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale_0a31f97b-aa56-48a7-8057-62671a9a82e0" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale_0a31f97b-aa56-48a7-8057-62671a9a82e0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee_1cf8b18a-4b9a-4ed8-890d-0a6f733cfe9c" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee_1cf8b18a-4b9a-4ed8-890d-0a6f733cfe9c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0cbde638-3765-43c3-bed8-8a61d76638b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0cbde638-3765-43c3-bed8-8a61d76638b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_19e5122e-2695-4689-ab9c-ffd56bfce270" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0cbde638-3765-43c3-bed8-8a61d76638b6" xlink:to="loc_srt_CounterpartyNameAxis_19e5122e-2695-4689-ab9c-ffd56bfce270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_19e5122e-2695-4689-ab9c-ffd56bfce270_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_19e5122e-2695-4689-ab9c-ffd56bfce270" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_19e5122e-2695-4689-ab9c-ffd56bfce270_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6dba83a2-08d5-4c67-a810-155bc982bd35" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_19e5122e-2695-4689-ab9c-ffd56bfce270" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6dba83a2-08d5-4c67-a810-155bc982bd35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SanfordBurnhamPrebysMember_45b71765-66e6-439f-99b9-447fb703f74a" xlink:href="clbs-20230630.xsd#clbs_SanfordBurnhamPrebysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6dba83a2-08d5-4c67-a810-155bc982bd35" xlink:to="loc_clbs_SanfordBurnhamPrebysMember_45b71765-66e6-439f-99b9-447fb703f74a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_UniversityOfCaliforniaAtSanDiegoMember_a745f96c-3d10-452f-b247-b6d85e92d68e" xlink:href="clbs-20230630.xsd#clbs_UniversityOfCaliforniaAtSanDiegoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6dba83a2-08d5-4c67-a810-155bc982bd35" xlink:to="loc_clbs_UniversityOfCaliforniaAtSanDiegoMember_a745f96c-3d10-452f-b247-b6d85e92d68e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_MassachusettsInstituteOfTechnologyMember_5c1c9b04-0dd4-47ba-b658-2cbe4c1e7f36" xlink:href="clbs-20230630.xsd#clbs_MassachusettsInstituteOfTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6dba83a2-08d5-4c67-a810-155bc982bd35" xlink:to="loc_clbs_MassachusettsInstituteOfTechnologyMember_5c1c9b04-0dd4-47ba-b658-2cbe4c1e7f36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_8f70ca35-a843-4a98-9e73-f0e2fa84890d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0cbde638-3765-43c3-bed8-8a61d76638b6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_8f70ca35-a843-4a98-9e73-f0e2fa84890d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8f70ca35-a843-4a98-9e73-f0e2fa84890d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8f70ca35-a843-4a98-9e73-f0e2fa84890d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8f70ca35-a843-4a98-9e73-f0e2fa84890d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5bb42ae2-b0f9-48a7-92d8-469242b64a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8f70ca35-a843-4a98-9e73-f0e2fa84890d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5bb42ae2-b0f9-48a7-92d8-469242b64a8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_bc503005-9ff7-4ffb-a03a-0d198488f00d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5bb42ae2-b0f9-48a7-92d8-469242b64a8d" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_bc503005-9ff7-4ffb-a03a-0d198488f00d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ba90bf61-d35a-426d-bb9f-01dee2902887" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0cbde638-3765-43c3-bed8-8a61d76638b6" xlink:to="loc_srt_RangeAxis_ba90bf61-d35a-426d-bb9f-01dee2902887" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ba90bf61-d35a-426d-bb9f-01dee2902887_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ba90bf61-d35a-426d-bb9f-01dee2902887" xlink:to="loc_srt_RangeMember_ba90bf61-d35a-426d-bb9f-01dee2902887_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_048af262-b5ed-43aa-ab70-86e1cef5b664" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ba90bf61-d35a-426d-bb9f-01dee2902887" xlink:to="loc_srt_RangeMember_048af262-b5ed-43aa-ab70-86e1cef5b664" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8717b760-ec07-44a1-a9ec-bbed494cecbd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_048af262-b5ed-43aa-ab70-86e1cef5b664" xlink:to="loc_srt_MinimumMember_8717b760-ec07-44a1-a9ec-bbed494cecbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_49e8811a-805d-422b-9304-1277f8bec909" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_048af262-b5ed-43aa-ab70-86e1cef5b664" xlink:to="loc_srt_MaximumMember_49e8811a-805d-422b-9304-1277f8bec909" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#ResearchCollaborationandLicenseAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_5880ffd4-f34f-4234-90fd-21c958c70862" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_5880ffd4-f34f-4234-90fd-21c958c70862" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_423ebafa-2710-4bfb-bc99-26c6550a7932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_423ebafa-2710-4bfb-bc99-26c6550a7932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_d0eee75e-ad14-4bb2-89d9-73b968f17c1e" xlink:href="clbs-20230630.xsd#clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:to="loc_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_d0eee75e-ad14-4bb2-89d9-73b968f17c1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_RevenuePerformanceObligationPercentageOfNetSale_31bc4178-056c-4fae-80ec-17ce756aec03" xlink:href="clbs-20230630.xsd#clbs_RevenuePerformanceObligationPercentageOfNetSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:to="loc_clbs_RevenuePerformanceObligationPercentageOfNetSale_31bc4178-056c-4fae-80ec-17ce756aec03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues_65607e42-d3ba-40b4-b7c9-127103f46890" xlink:href="clbs-20230630.xsd#clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:to="loc_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues_65607e42-d3ba-40b4-b7c9-127103f46890" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd057c27-0d25-4b7c-a0e8-4fe05893d68a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd057c27-0d25-4b7c-a0e8-4fe05893d68a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_07d485a6-6c38-4555-a084-26af9a5b26c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd057c27-0d25-4b7c-a0e8-4fe05893d68a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_07d485a6-6c38-4555-a084-26af9a5b26c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_07d485a6-6c38-4555-a084-26af9a5b26c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_07d485a6-6c38-4555-a084-26af9a5b26c7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_07d485a6-6c38-4555-a084-26af9a5b26c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7b73072d-7499-47c1-8e21-3b2a9cd09524" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_07d485a6-6c38-4555-a084-26af9a5b26c7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7b73072d-7499-47c1-8e21-3b2a9cd09524" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_77e58420-6c55-48e1-b391-d9659bab436b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd057c27-0d25-4b7c-a0e8-4fe05893d68a" xlink:to="loc_srt_CounterpartyNameAxis_77e58420-6c55-48e1-b391-d9659bab436b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_77e58420-6c55-48e1-b391-d9659bab436b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_77e58420-6c55-48e1-b391-d9659bab436b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_77e58420-6c55-48e1-b391-d9659bab436b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6cb26d45-5773-4e0c-ab88-085a6bb0c125" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_77e58420-6c55-48e1-b391-d9659bab436b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6cb26d45-5773-4e0c-ab88-085a6bb0c125" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_QiluMember_22dab1ea-ff9b-4a33-ac6d-9a00b6f44aa8" xlink:href="clbs-20230630.xsd#clbs_QiluMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6cb26d45-5773-4e0c-ab88-085a6bb0c125" xlink:to="loc_clbs_QiluMember_22dab1ea-ff9b-4a33-ac6d-9a00b6f44aa8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_be5fce70-2b75-4c65-b702-2bb37176793c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd057c27-0d25-4b7c-a0e8-4fe05893d68a" xlink:to="loc_srt_ProductOrServiceAxis_be5fce70-2b75-4c65-b702-2bb37176793c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_be5fce70-2b75-4c65-b702-2bb37176793c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_be5fce70-2b75-4c65-b702-2bb37176793c" xlink:to="loc_srt_ProductsAndServicesDomain_be5fce70-2b75-4c65-b702-2bb37176793c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a6589626-75ae-4622-ba75-0d50d6604506" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_be5fce70-2b75-4c65-b702-2bb37176793c" xlink:to="loc_srt_ProductsAndServicesDomain_a6589626-75ae-4622-ba75-0d50d6604506" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_ef0594c6-47ac-4c66-9e3c-5f239976da73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a6589626-75ae-4622-ba75-0d50d6604506" xlink:to="loc_us-gaap_LicenseMember_ef0594c6-47ac-4c66-9e3c-5f239976da73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d5ee557f-b2fb-4051-843c-d2b429ea97df" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd057c27-0d25-4b7c-a0e8-4fe05893d68a" xlink:to="loc_srt_RangeAxis_d5ee557f-b2fb-4051-843c-d2b429ea97df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d5ee557f-b2fb-4051-843c-d2b429ea97df_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d5ee557f-b2fb-4051-843c-d2b429ea97df" xlink:to="loc_srt_RangeMember_d5ee557f-b2fb-4051-843c-d2b429ea97df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_39d293ce-ce44-43a8-9a3e-a23137f9f56b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d5ee557f-b2fb-4051-843c-d2b429ea97df" xlink:to="loc_srt_RangeMember_39d293ce-ce44-43a8-9a3e-a23137f9f56b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_12ac710f-4326-49bd-b294-c9b1d7b76878" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_39d293ce-ce44-43a8-9a3e-a23137f9f56b" xlink:to="loc_srt_MinimumMember_12ac710f-4326-49bd-b294-c9b1d7b76878" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_124738e4-2e12-401c-99d9-dd18be58cd21" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_39d293ce-ce44-43a8-9a3e-a23137f9f56b" xlink:to="loc_srt_MaximumMember_124738e4-2e12-401c-99d9-dd18be58cd21" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.caladrius.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_9ac5b13e-a5be-4581-9ca6-2ccdc5d89542" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_d0d59102-aa93-4fe1-9d11-9b8971274177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_9ac5b13e-a5be-4581-9ca6-2ccdc5d89542" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_d0d59102-aa93-4fe1-9d11-9b8971274177" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_2688e028-ff97-45b4-9753-6b0fa078a321" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_9ac5b13e-a5be-4581-9ca6-2ccdc5d89542" xlink:to="loc_us-gaap_SubsequentEventTable_2688e028-ff97-45b4-9753-6b0fa078a321" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_53319438-464a-4895-b7cd-78b70ffc80a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_2688e028-ff97-45b4-9753-6b0fa078a321" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_53319438-464a-4895-b7cd-78b70ffc80a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_53319438-464a-4895-b7cd-78b70ffc80a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_53319438-464a-4895-b7cd-78b70ffc80a5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_53319438-464a-4895-b7cd-78b70ffc80a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d58c0e23-2a75-4a95-93f8-ba69f2aca839" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_53319438-464a-4895-b7cd-78b70ffc80a5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d58c0e23-2a75-4a95-93f8-ba69f2aca839" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4776b6cf-5b56-4765-985e-07f1cf52a910" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d58c0e23-2a75-4a95-93f8-ba69f2aca839" xlink:to="loc_us-gaap_SubsequentEventMember_4776b6cf-5b56-4765-985e-07f1cf52a910" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0c0a0153-482e-4224-98ab-c4569d1167e6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_2688e028-ff97-45b4-9753-6b0fa078a321" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0c0a0153-482e-4224-98ab-c4569d1167e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_0c0a0153-482e-4224-98ab-c4569d1167e6_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0c0a0153-482e-4224-98ab-c4569d1167e6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_0c0a0153-482e-4224-98ab-c4569d1167e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_288db348-05ef-461c-8c64-942bf436e357" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0c0a0153-482e-4224-98ab-c4569d1167e6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_288db348-05ef-461c-8c64-942bf436e357" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ImpiloMember_ea1df6ff-415a-4487-818b-d92bf022bf8c" xlink:href="clbs-20230630.xsd#clbs_ImpiloMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_288db348-05ef-461c-8c64-942bf436e357" xlink:to="loc_clbs_ImpiloMember_ea1df6ff-415a-4487-818b-d92bf022bf8c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>clbs-20230630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:f19b6d65-9ffc-4ef9-a859-121a4da9922b,g:65448069-d222-4f71-8ad3-a35814dee021-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_b99b9d71-086d-4a6e-9bb1-3416257993cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_9c91e3b9-f868-42a5-95f6-3efd3b1b60e7_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_0101e936-c9c8-4106-acdd-6b81aac920ec_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_74400fa7-da13-4d72-8f7c-cd24f428354d_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_452f12bd-c4c1-413d-9cc1-dfe457358d1d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c7e05c44-4bb0-47f4-b701-2ed381d34f14_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_cce1b105-2003-45ac-8506-61e62bc1c1b4_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_Sharesvestedandexpectedtovest_4d24d207-6bad-43d7-ae8c-11f8d0d58ba3_terseLabel_en-US" xlink:label="lab_clbs_Sharesvestedandexpectedtovest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_clbs_Sharesvestedandexpectedtovest_label_en-US" xlink:label="lab_clbs_Sharesvestedandexpectedtovest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">shares, vested and expected to vest</link:label>
    <link:label id="lab_clbs_Sharesvestedandexpectedtovest_documentation_en-US" xlink:label="lab_clbs_Sharesvestedandexpectedtovest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">shares, vested and expected to vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_Sharesvestedandexpectedtovest" xlink:href="clbs-20230630.xsd#clbs_Sharesvestedandexpectedtovest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_Sharesvestedandexpectedtovest" xlink:to="lab_clbs_Sharesvestedandexpectedtovest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_d3a35d48-dd2f-4996-a3da-fedb29b872c8_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_529b1f04-70d9-4c71-800b-f8c59b5c8331_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_67faae76-6838-4394-b4c6-961011ed893c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b6966e0f-c4b6-4b9f-a18f-b5b5074cc364_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_981c5fb1-b899-4cbc-a5b7-9a296a8b1005_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_9d79f96e-c46c-4447-a542-5d2f59daf603_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_df45807f-2f92-4a75-bcb0-dbe214e17629_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_fe5196f4-f7f1-41fe-a255-4bd500d5079f_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_4f86d7e5-40dc-40b7-a5cc-039a772bd64e_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_7a2a6ebd-b3c8-4900-8c3c-8189d14c20f6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies (Note 14)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_17104bb5-0ecc-4e76-85fc-89cb1d7406ec_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e05b4ca5-1bd3-4fd7-80a7-4d9decbec9c4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4446c9b0-72c0-4ec4-86e9-6018f14bd758_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested and expected to vest, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_8afcf0e7-c532-4ff9-adc1-fd490b7edad6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_a8444b88-c036-433f-aaa2-4fba23e25923_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_849becc3-42f7-4a38-b793-2f5cbd8729f2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable_ab23fe8c-29a0-45f4-b0d1-6ee526c232e8_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Exercisable</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsExercisable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayLineItems_eb627eec-b6b8-449d-a5fd-50bc2a78f5f6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxHolidayLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayLineItems" xlink:to="lab_us-gaap_IncomeTaxHolidayLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_621f2e0d-3537-4408-9ca6-b2245f5af0c9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_b788305b-f560-4c76-89d5-ef6669d052e3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Caladrius Biosciences, Inc. common stockholders - diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eccfca40-d86b-4dba-8be4-5fde3b61df41_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_37a076a4-c133-491a-8616-7b6c1262d936_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_05715887-67bc-43aa-8b5a-dd84fcd3296a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_000bdb26-dafa-4698-9472-b08e4d710f93_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a62ce7c6-8b79-4ba6-a027-4f97abe20415_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, Beginning of Period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_87989fc2-d749-402a-bdd5-e4252cdd5be6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, End of Period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_516e1c07-ec71-436b-bbe0-56d5886f82fc_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ce97cb6d-dfb8-4dca-8430-15e727aba2a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_9ce818cd-3fd0-4ec9-8de5-b94dbb09143a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities - available for sale</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees_5719a8d7-9a94-432e-bf72-b551860e056f_terseLabel_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublicensing fee</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees_label_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Sublicensing Fees</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees_documentation_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Sublicensing Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees" xlink:to="lab_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_6e183cd0-ef51-4176-b888-dda6853ab547_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_06eaf7db-6f96-4bf5-92f5-d6f64aff9169_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average estimated fair value of shares granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_75e0a173-d0cf-484c-a1a1-bbb6ffe7bc5d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Lisata Therapeutics, Inc. common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_655843d9-1237-40b8-879c-89f32f7fb53d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_0ba8558d-1969-4958-9405-17061d871251_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1f767ce1-7242-49eb-8b83-25ca6d7233ea_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Remeasurement</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_98ae1f5d-158c-4cee-ba3f-be68adbbba4a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_eb388f69-15ab-4c78-a799-0833b9fbbac1_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Vested And Expected To Vest</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Vested And Expected To Vest</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Vested And Expected To Vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_f33dc7f3-cbda-4956-af31-05c62c976e66_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c569a084-9a6c-4657-9392-f25c1f4a4c3d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_fb44f222-090d-49f7-9e16-7253e4cfb047_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_label_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term warrant outstanding</link:label>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_documentation_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term warrant outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageRemainingContractualTermwarrantoutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:to="lab_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_3ae03e9f-8b26-44fa-b6cc-d4c490f44b3d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d4572c70-0df3-4882-8e5f-888716802ad9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_da510880-8cef-489f-af1a-154447975130_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ef4bc4cc-aaaf-4fcb-99ff-2c9f7f75bf9a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from option exercises (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_cae9bc87-840d-4e24-b3db-f2a6ef2e76ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee_5629b80e-42a2-4b5d-b84b-0d0bd5d5024e_terseLabel_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual license maintenance fee</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee_label_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee_documentation_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee" xlink:to="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0414d163-df1c-4551-aadd-2e8bb0bf98c0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting terms (years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_9ecd2d6d-b3c5-425f-bed1-00e381b12ffc_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Compensation Cost Related to Nonvested Awards</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a115d8a8-f40b-41c3-97e9-5df93b4958ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_17a9f4c0-d811-44b4-a1b1-538e46e2813c_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7af4b3e7-d2e6-45cd-b33c-77adef0c75fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_370a4db6-ac3a-45e0-b3f4-d67f9a016c5a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_9e6a41be-f7cf-436a-94ae-35d31c068066_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_04c42931-e71d-4ff3-941f-30d87ff89405_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bb6e9d1a-cfec-4372-9af1-2a36c10a42a2_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_d38d2f01-abcc-4143-81e8-590d68c2c188_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_fa9ec956-a01b-4a58-9f93-6728e33bcc1e_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_1b938974-9a2a-44f5-8e89-05c88ae80152_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b795aa1c-ea1a-45c8-b7ab-a20dc575f97b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_02815a92-6230-44ee-8207-39bf2eae5885_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_255227f4-5016-4477-a3ed-590bcc09148e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale securities - net unrealized gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_91b6d709-f594-41be-a4ec-a7cc24a19fcc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_79f56e63-ada9-40a7-b84f-fab218318b69_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ec0d4252-776c-408d-b899-d8a3407ab45c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_803b896d-d44e-404b-9b00-e15bea867d81_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee_bda11e64-bff1-41cf-97b1-4ec92e529362_terseLabel_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change of control fee</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee_label_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Change of Control Fee</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee_documentation_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Change of Control Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee" xlink:to="lab_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_e66e4f85-ffed-4b5d-b0d9-a9faaed9b448_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_f5d01faa-67b2-4749-91e9-134ed906817c_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_3008ccf1-9285-4421-a156-be4411f5a7af_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_ProceedsFromExerciseOfOptionsFinancingActivities_d3e38bd5-4dcc-43aa-9ce5-4d8b8471651f_terseLabel_en-US" xlink:label="lab_clbs_ProceedsFromExerciseOfOptionsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of options</link:label>
    <link:label id="lab_clbs_ProceedsFromExerciseOfOptionsFinancingActivities_label_en-US" xlink:label="lab_clbs_ProceedsFromExerciseOfOptionsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of options, Financing Activities</link:label>
    <link:label id="lab_clbs_ProceedsFromExerciseOfOptionsFinancingActivities_documentation_en-US" xlink:label="lab_clbs_ProceedsFromExerciseOfOptionsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of options, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ProceedsFromExerciseOfOptionsFinancingActivities" xlink:href="clbs-20230630.xsd#clbs_ProceedsFromExerciseOfOptionsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_ProceedsFromExerciseOfOptionsFinancingActivities" xlink:to="lab_clbs_ProceedsFromExerciseOfOptionsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_5c906ae8-5bbd-4c8d-aa81-502307175aab_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d5f92859-00f8-43d4-afc5-dbab94cfa5c7_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_7801ce5a-0887-44c8-9fe5-fe0027897d25_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research tax credit rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_47fd6e51-de25-4652-8499-392e1b680666_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_3e3792cb-d340-457e-aebc-33e63c91ff94_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d1b17da5-9de6-4288-be31-91910acc4caf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Lease Payments Under Lease Agreements</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_6adedf2b-7a30-45e5-bcdc-b0b9073069d7_terseLabel_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential milestone payments</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_label_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_documentation_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:to="lab_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AssetAcquisitionOtherLiabilities_2b082567-7d62-4f03-b44b-bf17a3e21c7e_negatedTerseLabel_en-US" xlink:label="lab_clbs_AssetAcquisitionOtherLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_clbs_AssetAcquisitionOtherLiabilities_label_en-US" xlink:label="lab_clbs_AssetAcquisitionOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Other Liabilities</link:label>
    <link:label id="lab_clbs_AssetAcquisitionOtherLiabilities_documentation_en-US" xlink:label="lab_clbs_AssetAcquisitionOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionOtherLiabilities" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AssetAcquisitionOtherLiabilities" xlink:to="lab_clbs_AssetAcquisitionOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionTableTextBlock_41027229-c7f6-4b49-bd09-e3343a065054_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionTableTextBlock" xlink:to="lab_us-gaap_AssetAcquisitionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_278925a2-c366-465d-9b65-d51459d96223_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_f28a6278-7a51-4bc7-9dcb-80923a1576c0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b8a7a77d-630f-4f1f-97b1-495816712eb0_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7147fce3-e43e-40df-8fd7-995501e88c8d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2e04bef0-2d10-448d-96ce-192427aa125e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_098e24c3-254e-43d2-9a1e-51e96cde459d_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e52e4dc1-e7d3-4feb-8a9a-a9d409a17008_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_88863fda-d7f1-4462-9c29-006707c4159f_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_6ba5ff3d-1d5d-40e4-86ef-74bd8384a28c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from contract</link:label>
    <link:label id="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_SharesHeldByThirdParty_c2885386-f631-475e-b8fd-0801e7ce0e08_terseLabel_en-US" xlink:label="lab_clbs_SharesHeldByThirdParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares held by third party</link:label>
    <link:label id="lab_clbs_SharesHeldByThirdParty_label_en-US" xlink:label="lab_clbs_SharesHeldByThirdParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Held by Third Party</link:label>
    <link:label id="lab_clbs_SharesHeldByThirdParty_documentation_en-US" xlink:label="lab_clbs_SharesHeldByThirdParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Held by Third Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SharesHeldByThirdParty" xlink:href="clbs-20230630.xsd#clbs_SharesHeldByThirdParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_SharesHeldByThirdParty" xlink:to="lab_clbs_SharesHeldByThirdParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4827ce32-7823-4705-af1e-250c2be68803_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_c31701ce-6b85-4cd4-938f-c81b585b3711_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_32342039-9515-447e-b85e-8a922feafbfd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_52cc31b3-1917-4333-b1c1-e5cb33f1ea53_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_IncomeTaxIncentiveReceivable_13096de3-96c5-4f7d-88de-95cc8e0b8a9e_terseLabel_en-US" xlink:label="lab_clbs_IncomeTaxIncentiveReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Incentive Receivable</link:label>
    <link:label id="lab_clbs_IncomeTaxIncentiveReceivable_label_en-US" xlink:label="lab_clbs_IncomeTaxIncentiveReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Incentive Receivable</link:label>
    <link:label id="lab_clbs_IncomeTaxIncentiveReceivable_documentation_en-US" xlink:label="lab_clbs_IncomeTaxIncentiveReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Incentive Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_IncomeTaxIncentiveReceivable" xlink:href="clbs-20230630.xsd#clbs_IncomeTaxIncentiveReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_IncomeTaxIncentiveReceivable" xlink:to="lab_clbs_IncomeTaxIncentiveReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_da06327d-e66e-492a-81c7-1203fe0db1fa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4757fe9e-f910-48fb-b9b6-af15f785af30_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Amounts representing interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_60d1c296-9e68-454f-8d5f-455f0839d770_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_985e0df9-c672-400e-a39f-ac0ff957b452_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ada38f43-b23f-4c08-a4ef-5e394e5126d7_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_34a3a77f-d05a-4c1f-b702-31cf2fa72d6c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_5ad51a29-ccf6-4a5e-ab88-4b6dde72665a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_7b494684-ef57-4d3a-8731-7ee8027dcbd1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities &#8212; current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_fb9cd51f-0cd3-45aa-b02a-91529797c731_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseMember_7076f59c-611d-44ce-9740-80ff3a22f616_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License</link:label>
    <link:label id="lab_us-gaap_LicenseMember_label_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember" xlink:to="lab_us-gaap_LicenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CaliforniaFranchiseTaxBoardMember_26f18335-28f5-40e2-b143-c954fc519f01_terseLabel_en-US" xlink:label="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California</link:label>
    <link:label id="lab_us-gaap_CaliforniaFranchiseTaxBoardMember_label_en-US" xlink:label="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California Franchise Tax Board [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:to="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WarrantsGranted_e324a443-641e-4ced-975e-5c4f71fadba7_terseLabel_en-US" xlink:label="lab_clbs_WarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Granted (in shares)</link:label>
    <link:label id="lab_clbs_WarrantsGranted_label_en-US" xlink:label="lab_clbs_WarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Granted</link:label>
    <link:label id="lab_clbs_WarrantsGranted_documentation_en-US" xlink:label="lab_clbs_WarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsGranted" xlink:href="clbs-20230630.xsd#clbs_WarrantsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WarrantsGranted" xlink:to="lab_clbs_WarrantsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_8fa146c6-9045-4555-a2e0-5344516aa3de_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_4b1fb77c-b304-4d7f-a9a8-a29c4e077fac_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_46cce891-b66c-4318-9d8b-c45260cf28de_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_16adb82c-32ed-47e6-bf00-8b952b553288_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_5408e18f-3694-43f1-807a-a2bfe117df98_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding_bae89336-6e1f-4860-90e4-53062751ea0d_periodStartLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Outstanding, Beginning of Period (in dollars per share)</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding_831f36f1-0eda-4262-96ea-e1a02c749ac7_periodEndLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Outstanding, End of Period (in dollars per share)</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Outstanding</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_30a9c0f8-bd4f-4e62-b732-5b3b0bbffcd0_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fda3e2e3-9115-49e0-b5bd-201f800f27a6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cac59882-8248-4eb4-90c6-7d6ef6fe2367_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_00b02275-9482-4bfb-ab4e-0c8564cc982b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_91124842-8e76-4afa-be95-cd1ea12a8424_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_7d9bab21-8c8e-4466-80fe-01a05586eb9a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7b896beb-cbed-4026-a63c-1db399c39443_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Share-based Compensation Awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_2e43e56c-04ef-40b2-98a3-7a09f731e415_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 738 shares at June 30, 2023 and December 31, 2022</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_cefe9284-2e46-4c82-9939-95a8e167f1d4_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_0148e332-39d0-41cb-ac39-f225a230be69_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, fair value disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_9827b182-e60a-4d64-8cae-89d1e5c64ba7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_69c26929-16e3-4f19-94c6-fc5087465e8b_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_56ac6334-b6a4-404e-b40d-c804780678b8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_fa1e36a8-1f08-47d1-8243-2c21bb067807_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_cabb386e-2f97-4e59-b638-eec5246c937e_verboseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Collaboration and License Agreement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_55077869-5106-4469-88d6-bc790759e4e8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_OperatingLeaseRightOfUseAssetAbstract_8c3daaca-52e3-4cf4-9c44-a58af2634812_terseLabel_en-US" xlink:label="lab_clbs_OperatingLeaseRightOfUseAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Assets:</link:label>
    <link:label id="lab_clbs_OperatingLeaseRightOfUseAssetAbstract_label_en-US" xlink:label="lab_clbs_OperatingLeaseRightOfUseAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset [Abstract]</link:label>
    <link:label id="lab_clbs_OperatingLeaseRightOfUseAssetAbstract_documentation_en-US" xlink:label="lab_clbs_OperatingLeaseRightOfUseAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_OperatingLeaseRightOfUseAssetAbstract" xlink:href="clbs-20230630.xsd#clbs_OperatingLeaseRightOfUseAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_OperatingLeaseRightOfUseAssetAbstract" xlink:to="lab_clbs_OperatingLeaseRightOfUseAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5f2e12e8-44e0-4373-bd1c-92ddcd7257b2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected weighted-average period in years of compensation cost to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionTable_70f2c721-6758-40c3-bc76-7d6ca5399307_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionTable" xlink:to="lab_us-gaap_AssetAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_44e7e2a6-f5a1-4a36-9002-06598a0509fa_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_2cae7ccd-e783-44ba-97d2-082a594915df_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a721330c-2a37-44d3-b2f4-41783376d0a9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_9770a504-3771-4a43-a864-efe01c20d9a5_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b276e487-4e54-48b8-9e3e-965a7e09830a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_7b73816e-c907-412f-b817-228b39121a68_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_99bf7814-0ee7-4f79-8bc6-b2cf8d8443cb_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested and expected to vest, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_label_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest</link:label>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_documentation_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:to="lab_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_cb69cbc8-7b03-4a2f-b961-4fd025181fa5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_677612a5-83ab-4fe2-b738-45a4df822305_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionTextBlock_3f4995b6-b018-4532-9d3b-15a3d968218f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionTextBlock" xlink:to="lab_us-gaap_AssetAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_6f50918a-c3a6-47ba-8c06-37b806e55a86_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_116996c8-3724-4782-a796-8fd8d7203484_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_bfa7461f-8c72-49c6-a01d-ab86167c649c_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_aed748f2-5163-4c6e-b7cb-44095bdeb719_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_da4fee60-dbb3-48fb-a064-c462d5159b77_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_3a37fbc7-1a02-480e-8ab8-2772c2ca37ab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_OperatingLossCarryforwardsPostAcquisition_21df3296-d207-45a5-b2b1-b420c90ff20b_terseLabel_en-US" xlink:label="lab_clbs_OperatingLossCarryforwardsPostAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Post Acquisition</link:label>
    <link:label id="lab_clbs_OperatingLossCarryforwardsPostAcquisition_label_en-US" xlink:label="lab_clbs_OperatingLossCarryforwardsPostAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Post Acquisition</link:label>
    <link:label id="lab_clbs_OperatingLossCarryforwardsPostAcquisition_documentation_en-US" xlink:label="lab_clbs_OperatingLossCarryforwardsPostAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Post Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_OperatingLossCarryforwardsPostAcquisition" xlink:href="clbs-20230630.xsd#clbs_OperatingLossCarryforwardsPostAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_OperatingLossCarryforwardsPostAcquisition" xlink:to="lab_clbs_OperatingLossCarryforwardsPostAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_c89a720f-c02e-4bdd-99dd-84929e22572b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_572fb90a-4eb3-4014-b6a9-68ac7048823f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceShares_3400dac6-2264-42a7-9ecc-975c9d6f5c68_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Shares</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceShares_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedBalanceShares" xlink:to="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding_d0c3c88d-cfec-4a67-ab92-41dc4900633f_terseLabel_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding_label_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Warrants Outstanding</link:label>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding_documentation_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Warrants Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:href="clbs-20230630.xsd#clbs_AggregateIntrinsicValueWarrantsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:to="lab_clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_fe71a7b7-c799-4f02-bba2-293dd0034ed8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7fc73bb9-0db7-4cb8-b6a9-7557451b7027_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0e5f087a-3722-4650-af86-8752336465dc_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0db67b7e-94c7-4793-a3e0-5117f41d257e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b8ab6dbb-9b32-4393-81e1-638283f2c54e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionLineItems_3300b0a2-c014-4e89-b23b-9108a085ab67_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionLineItems" xlink:to="lab_us-gaap_AssetAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_79299a3a-33b1-43ac-be31-f2bd71b73b0c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_25a1b0d6-0613-44af-be30-3cde5b801b19_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_0c71c3a5-e8f1-408e-a21d-99f50fc0585f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AtTheMarketOfferingAgreementMember_efc06087-417a-4b41-9e95-acc19edaacb3_terseLabel_en-US" xlink:label="lab_clbs_AtTheMarketOfferingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ATM Agreement</link:label>
    <link:label id="lab_clbs_AtTheMarketOfferingAgreementMember_label_en-US" xlink:label="lab_clbs_AtTheMarketOfferingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At The Market Offering Agreement [Member]</link:label>
    <link:label id="lab_clbs_AtTheMarketOfferingAgreementMember_documentation_en-US" xlink:label="lab_clbs_AtTheMarketOfferingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At The Market Offering Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AtTheMarketOfferingAgreementMember" xlink:href="clbs-20230630.xsd#clbs_AtTheMarketOfferingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AtTheMarketOfferingAgreementMember" xlink:to="lab_clbs_AtTheMarketOfferingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_fb0166a4-1f75-4381-a815-d5eac86b5c48_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6947adb4-3757-4830-bf26-9d7dd223a0ac_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_dfed3a98-280d-461b-adba-3b826ac6e8bc_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_d9863dd0-3976-4de5-b310-e5bb12acabc2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_15bcb83e-2051-492e-bc18-29908a3955f9_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_CommonStockWarrantsShares_8cd2d35d-2c94-4d9a-b48d-01c17575240a_periodStartLabel_en-US" xlink:label="lab_clbs_CommonStockWarrantsShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Outstanding, Beginning of Period (in shares)</link:label>
    <link:label id="lab_clbs_CommonStockWarrantsShares_58638e0a-2bdc-43cb-ac34-84ec54684123_periodEndLabel_en-US" xlink:label="lab_clbs_CommonStockWarrantsShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Outstanding, End of Period (in shares)</link:label>
    <link:label id="lab_clbs_CommonStockWarrantsShares_label_en-US" xlink:label="lab_clbs_CommonStockWarrantsShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants, Shares</link:label>
    <link:label id="lab_clbs_CommonStockWarrantsShares_documentation_en-US" xlink:label="lab_clbs_CommonStockWarrantsShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CommonStockWarrantsShares" xlink:href="clbs-20230630.xsd#clbs_CommonStockWarrantsShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_CommonStockWarrantsShares" xlink:to="lab_clbs_CommonStockWarrantsShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_d12d6d8c-f5b3-4008-9f62-fc3a6d76a2f2_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_8b8eb324-ee42-4fec-ae24-747e7ef9a0ce_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AssetAcquisitionNetWorkingCapital_2c702f11-9634-43d9-92f0-c08be999c9b9_negatedTerseLabel_en-US" xlink:label="lab_clbs_AssetAcquisitionNetWorkingCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net working capital (excluding cash)</link:label>
    <link:label id="lab_clbs_AssetAcquisitionNetWorkingCapital_label_en-US" xlink:label="lab_clbs_AssetAcquisitionNetWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Net Working Capital</link:label>
    <link:label id="lab_clbs_AssetAcquisitionNetWorkingCapital_documentation_en-US" xlink:label="lab_clbs_AssetAcquisitionNetWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Net Working Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionNetWorkingCapital" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionNetWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AssetAcquisitionNetWorkingCapital" xlink:to="lab_clbs_AssetAcquisitionNetWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_00c326ef-da83-481c-a48a-f4bff9509ed7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_396218c5-e905-41ac-a0c1-a3562c3426fb_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_e8fdef57-4ae7-4289-ace0-a007834adcc3_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_7c7be5b2-c5c0-4b37-b862-a438d97a2183_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lisata Therapeutics, Inc. Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2eedbbe9-5d19-48aa-8604-617744860553_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_329775d9-fc15-4a2e-80b8-01b40a6cedb6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_6cf4dca7-5a6a-4b7d-87b5-1af9c2cda15f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_fff6ff8c-4a39-4398-8234-b36f84220615_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8616e4b2-39f4-41cf-ad09-56b327513956_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6091fe26-7130-44b6-9001-9da4230f6d0b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_6677ebe1-3ba5-4096-85eb-2a583eea77d8_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour_08530527-3138-4dee-bb70-ebaa1efa5bfa_terseLabel_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual license maintenance fee, year four</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour_label_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Year Four</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour_documentation_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour" xlink:to="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_46dd3372-f779-4e0b-8c4b-c5d81fd94b1a_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_EPSAbstract_423723c8-6e5c-4721-86ed-d60520115245_terseLabel_en-US" xlink:label="lab_clbs_EPSAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and diluted loss per share</link:label>
    <link:label id="lab_clbs_EPSAbstract_label_en-US" xlink:label="lab_clbs_EPSAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPS [Abstract]</link:label>
    <link:label id="lab_clbs_EPSAbstract_documentation_en-US" xlink:label="lab_clbs_EPSAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_EPSAbstract" xlink:href="clbs-20230630.xsd#clbs_EPSAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_EPSAbstract" xlink:to="lab_clbs_EPSAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_97189e3c-b178-4c44-b732-83e1efea56b1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_e130d711-378f-460c-9ee5-dd428d444825_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayTable_7f815648-fc91-4a83-b479-8ee89fa03ea2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxHolidayTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayTable" xlink:to="lab_us-gaap_IncomeTaxHolidayTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2fee2db1-b975-42c6-ab54-b2dad836c602_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WarrantsOtherDisclosuresAbstract_fdf8cb80-2827-4b54-a5ff-864dba79a69a_terseLabel_en-US" xlink:label="lab_clbs_WarrantsOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Weighted Average Contractual Term and Intrinsic Value</link:label>
    <link:label id="lab_clbs_WarrantsOtherDisclosuresAbstract_label_en-US" xlink:label="lab_clbs_WarrantsOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Other Disclosures [Abstract]</link:label>
    <link:label id="lab_clbs_WarrantsOtherDisclosuresAbstract_documentation_en-US" xlink:label="lab_clbs_WarrantsOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Other Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsOtherDisclosuresAbstract" xlink:href="clbs-20230630.xsd#clbs_WarrantsOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WarrantsOtherDisclosuresAbstract" xlink:to="lab_clbs_WarrantsOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b40539b2-5c82-4804-a157-f025040e9c5f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_8c8ff6dc-1eba-4f20-963c-1b38571cbb6a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6997afc6-22d6-4291-8354-058f05acc0d2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common shares of the combined company owned by Cend stockholders</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b2030941-d6e5-4c3c-874c-98838d902ef1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_2284271b-f09f-4e4b-aab3-f0949b41df81_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_ec8bf2b5-ffb3-4583-9c83-d0552c1319c5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Risks</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_65790999-d03b-42fa-9121-7202fed478c8_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Percentage of Ownership after Transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Percentage of Ownership after Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_69763a1e-fdbc-4843-b3ee-57d1120ee560_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_e9f80757-b87c-4f9c-9467-35b7b92567f7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_632b0327-675c-46e8-810d-d7e872bf6d20_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryBillSecuritiesMember_49e13ddc-f3c8-49a0-bb0e-30d9ef258ab3_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryBillSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Bill Securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryBillSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryBillSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Bill Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBillSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryBillSecuritiesMember" xlink:to="lab_us-gaap_USTreasuryBillSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_731693b3-9301-43c1-af6f-df32e11740fc_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4037ab8d-07ff-4754-902b-f15392f7b955_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options, Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_db7ec903-d84c-4bcb-a6d1-3b7c828877b8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_2eb4bb4e-fdd1-45fe-853b-9a04612e50c3_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_23e96bdb-6860-44cf-87f2-e180b8a76a1a_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_c1bd2fd9-d669-4962-9d02-8a7603391f07_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_2625f39b-2c09-416f-aeaf-a841ee11cc5f_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_1fbc7d73-54b5-4c5b-8ab0-7297cc522fea_terseLabel_en-US" xlink:label="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York</link:label>
    <link:label id="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_label_en-US" xlink:label="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York State Division of Taxation and Finance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:to="lab_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_9a0ad326-38c2-444b-9114-91e0a9a7c710_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_8c580df8-eef3-4910-ac94-21108b55ca34_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_00f14d28-4f55-4c95-945f-f9aef25ffe39_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e9bdddbd-da66-48a8-9c7f-f89d34856ec8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_8ccd9ddb-d991-445d-ad62-69c855b6f166_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_aba66dca-2867-42e2-9d24-5906060e901e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_51182a62-da01-43dd-8cea-4a582a84e846_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_88de75b4-6ca1-4aa4-9229-7b8add4b02e8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_6eb33f9c-b6e8-496a-ae51-93ebcde77858_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_SharesIssuedUnderLicenseAgreement_a4ba303d-b522-4cec-a58a-93bb99da214f_terseLabel_en-US" xlink:label="lab_clbs_SharesIssuedUnderLicenseAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under license agreement</link:label>
    <link:label id="lab_clbs_SharesIssuedUnderLicenseAgreement_label_en-US" xlink:label="lab_clbs_SharesIssuedUnderLicenseAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued Under License Agreement</link:label>
    <link:label id="lab_clbs_SharesIssuedUnderLicenseAgreement_documentation_en-US" xlink:label="lab_clbs_SharesIssuedUnderLicenseAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued Under License Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SharesIssuedUnderLicenseAgreement" xlink:href="clbs-20230630.xsd#clbs_SharesIssuedUnderLicenseAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_SharesIssuedUnderLicenseAgreement" xlink:to="lab_clbs_SharesIssuedUnderLicenseAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_f1c6884b-ee08-406f-aae5-df7846be08c8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_7e9faca0-4edc-4d48-8e44-4ba8c65a3d6a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_SaleOfStockAvailableForSale_c4e57fde-1373-4362-8f36-ddc1e0f37f09_terseLabel_en-US" xlink:label="lab_clbs_SaleOfStockAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock Available for Sale</link:label>
    <link:label id="lab_clbs_SaleOfStockAvailableForSale_label_en-US" xlink:label="lab_clbs_SaleOfStockAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock Available for Sale</link:label>
    <link:label id="lab_clbs_SaleOfStockAvailableForSale_documentation_en-US" xlink:label="lab_clbs_SaleOfStockAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock Available for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockAvailableForSale" xlink:href="clbs-20230630.xsd#clbs_SaleOfStockAvailableForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_SaleOfStockAvailableForSale" xlink:to="lab_clbs_SaleOfStockAvailableForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_3517bbd6-aaa1-49ef-b91c-746f600a6644_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value, authorized 33,333,333 shares; issued 8,133,095 and 7,866,799 shares at June 30, 2023 and December 31, 2022, respectively; and outstanding, 8,132,357 and 7,866,061 shares at June 30, 2023 and December 31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AssetAcquisitionConsiderationTransferredEquityValue_34dc8c55-7c28-47e5-b1f7-96fcca73db06_terseLabel_en-US" xlink:label="lab_clbs_AssetAcquisitionConsiderationTransferredEquityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_clbs_AssetAcquisitionConsiderationTransferredEquityValue_label_en-US" xlink:label="lab_clbs_AssetAcquisitionConsiderationTransferredEquityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Equity Value</link:label>
    <link:label id="lab_clbs_AssetAcquisitionConsiderationTransferredEquityValue_documentation_en-US" xlink:label="lab_clbs_AssetAcquisitionConsiderationTransferredEquityValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Equity Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionConsiderationTransferredEquityValue" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionConsiderationTransferredEquityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AssetAcquisitionConsiderationTransferredEquityValue" xlink:to="lab_clbs_AssetAcquisitionConsiderationTransferredEquityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_11561e83-99ca-4ccc-88ea-368f60857090_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_7d37f2d5-70c6-4736-8344-5aa8acc1371e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, noncurrent, balance sheet line item</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_7a5d85b0-8e64-4021-bf90-c641210daa3f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven_4d1aec33-e5ad-4af7-a936-31106a611570_terseLabel_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual license maintenance fee, year seven</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven_label_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Starting at Year Seven</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven_documentation_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Starting at Year Seven</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven" xlink:to="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_d860ae91-ab0a-490e-8aa4-061f9d7a29c3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income, net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_LossOnSaleOfNOL_5661f2b6-20b7-4d1e-a23f-8b3d42d75fed_terseLabel_en-US" xlink:label="lab_clbs_LossOnSaleOfNOL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss On Sale of NOL</link:label>
    <link:label id="lab_clbs_LossOnSaleOfNOL_label_en-US" xlink:label="lab_clbs_LossOnSaleOfNOL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss On Sale of NOL</link:label>
    <link:label id="lab_clbs_LossOnSaleOfNOL_documentation_en-US" xlink:label="lab_clbs_LossOnSaleOfNOL" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss On Sale of NOL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_LossOnSaleOfNOL" xlink:href="clbs-20230630.xsd#clbs_LossOnSaleOfNOL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_LossOnSaleOfNOL" xlink:to="lab_clbs_LossOnSaleOfNOL" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_0b635f71-8bc9-4b22-8096-8049456482f0_terseLabel_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_label_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3d60b41f-9cda-4b0d-b845-f72258085f64_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c60e37aa-b61e-4e6f-9938-18224e541b25_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExercised_db504908-e2bc-4ca8-9d2a-1eaa5a39cc92_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Exercised (in dollars per share)</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExercised_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Exercised</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExercised_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_2e5687fb-eeea-4b57-a631-c8e600dc7968_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_15d94bc5-74fe-4a5a-9d23-58b4cd7fed49_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_1c2d8f05-44e6-493b-8f6d-1be9dc65b78d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Acquisition</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_2e597549-1f24-4bfc-ad8a-dbffb22488ac_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_68bd89b0-33af-4c97-b957-38405be11b5b_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-Sale-Securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_7f872101-a462-493b-9d71-f6ac6958fb5c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm_ff6fa489-4eee-49d1-b627-f93ef7f41375_terseLabel_en-US" xlink:label="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm_label_en-US" xlink:label="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested, weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm_documentation_en-US" xlink:label="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested, weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:href="clbs-20230630.xsd#clbs_OptionsVestedweightedAverageRemainingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:to="lab_clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WarrantsExpired_4fffffc2-4272-404b-896d-26080f8c7b92_negatedTerseLabel_en-US" xlink:label="lab_clbs_WarrantsExpired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Expired (in shares)</link:label>
    <link:label id="lab_clbs_WarrantsExpired_label_en-US" xlink:label="lab_clbs_WarrantsExpired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Expired</link:label>
    <link:label id="lab_clbs_WarrantsExpired_documentation_en-US" xlink:label="lab_clbs_WarrantsExpired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Expired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsExpired" xlink:href="clbs-20230630.xsd#clbs_WarrantsExpired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WarrantsExpired" xlink:to="lab_clbs_WarrantsExpired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_05f5c086-9ca4-4695-abfd-8ef568671916_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average estimated fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3fd26432-32ce-4159-96b4-b2776a2d43b5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WarrantsExercised_60f7e68f-7d72-47c6-bd7b-6691b305f0b1_negatedTerseLabel_en-US" xlink:label="lab_clbs_WarrantsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Exercised (in shares)</link:label>
    <link:label id="lab_clbs_WarrantsExercised_label_en-US" xlink:label="lab_clbs_WarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Exercised</link:label>
    <link:label id="lab_clbs_WarrantsExercised_documentation_en-US" xlink:label="lab_clbs_WarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsExercised" xlink:href="clbs-20230630.xsd#clbs_WarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WarrantsExercised" xlink:to="lab_clbs_WarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_e805890f-e267-4f01-864b-327b49c03798_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_d5ace1db-83ac-45b1-a323-7475e541d93d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_ImpiloMember_a5c0ffee-08d5-4fe1-8f4e-579c2d3e7528_terseLabel_en-US" xlink:label="lab_clbs_ImpiloMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impilo</link:label>
    <link:label id="lab_clbs_ImpiloMember_label_en-US" xlink:label="lab_clbs_ImpiloMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impilo [Member]</link:label>
    <link:label id="lab_clbs_ImpiloMember_documentation_en-US" xlink:label="lab_clbs_ImpiloMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impilo</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ImpiloMember" xlink:href="clbs-20230630.xsd#clbs_ImpiloMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_ImpiloMember" xlink:to="lab_clbs_ImpiloMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_c7f4fa1a-3f6e-44b6-924d-4d47ccd91392_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_6079cdb3-cb8f-44cb-b59b-83b4cc52c799_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales_4a588ae6-c53f-40ee-9ef4-0c23f969ebc6_terseLabel_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties, net of sales</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales_label_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Royalties Net of Sales</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales_documentation_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Royalties Net of Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales" xlink:to="lab_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_5cdb0ee4-3afa-45b0-b16b-a04f034b8f11_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_8600f738-4c69-4f8d-8929-5fc290108f93_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lisata Therapeutics, Inc. stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_847e9515-68c1-40bd-a0ba-4550a95849ee_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WarrantsVested_d156b9dc-94ad-4eeb-84bb-76adf698c51e_terseLabel_en-US" xlink:label="lab_clbs_WarrantsVested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested (in shares)</link:label>
    <link:label id="lab_clbs_WarrantsVested_label_en-US" xlink:label="lab_clbs_WarrantsVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested</link:label>
    <link:label id="lab_clbs_WarrantsVested_documentation_en-US" xlink:label="lab_clbs_WarrantsVested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsVested" xlink:href="clbs-20230630.xsd#clbs_WarrantsVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WarrantsVested" xlink:to="lab_clbs_WarrantsVested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_d36cf4c6-1b33-4504-925c-db66e198d979_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b5821e02-e8bc-40e0-b557-a0180a7e2eba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_bd3618ed-aa8f-425a-a006-a13d18262815_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8dc8e738-77bf-442a-8486-5533622cd865_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_54ac9424-b720-4274-865f-4faa9ba7b42c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_9f993746-8171-4495-adaa-478dcde3110c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f2727462-c8ce-471e-886b-08613c309328_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss before benefit from income taxes and noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_BusinessTextBlock_e581e82c-57e4-41f3-bc04-b7015d3f0e4c_terseLabel_en-US" xlink:label="lab_clbs_BusinessTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Business</link:label>
    <link:label id="lab_clbs_BusinessTextBlock_label_en-US" xlink:label="lab_clbs_BusinessTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Business [Text Block]</link:label>
    <link:label id="lab_clbs_BusinessTextBlock_documentation_en-US" xlink:label="lab_clbs_BusinessTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Business [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_BusinessTextBlock" xlink:href="clbs-20230630.xsd#clbs_BusinessTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_BusinessTextBlock" xlink:to="lab_clbs_BusinessTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_48ed0a1c-f606-4e47-bb4a-e41353a98af1_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal debt securities</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ed517e05-15c6-4ea3-8d1d-8a184fe4e1d0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_b09648cd-f226-49ea-a6c1-faaea9616ec5_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_a978658d-6fdc-4d18-9c0a-4b7a1fc30877_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested_bbe470b5-b9d6-4b8f-b5c4-abc8d5b82656_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested_label_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">weighted Average Remaining Contractual Term, warrants vested</link:label>
    <link:label id="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested_documentation_en-US" xlink:label="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">weighted Average Remaining Contractual Term, warrants vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageRemainingContractualTermwarrantsvested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:to="lab_clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6da65170-a1e5-4d5c-89eb-c47a7ccd1c7a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b6c05694-f440-43d0-b856-6fc7134a6abb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_b5762db7-fd83-489a-ae7c-4be0006af3c3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of Lisata's cost method investment in Cend</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2184aad8-701a-4934-8317-94357c31a113_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewJerseyDivisionOfTaxationMember_03e59958-8bca-4f53-9770-667111db9648_terseLabel_en-US" xlink:label="lab_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Jersey</link:label>
    <link:label id="lab_us-gaap_NewJerseyDivisionOfTaxationMember_label_en-US" xlink:label="lab_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Jersey Division of Taxation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewJerseyDivisionOfTaxationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:to="lab_us-gaap_NewJerseyDivisionOfTaxationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_43049cec-0f7b-429f-aaeb-23996127d7d8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_33fcba9c-917c-4c4d-b16b-fa0fcb333b88_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less - net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_5432f453-5105-44b6-bfd2-8460baece726_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5bab58da-16fa-4285-9dcb-a3a3b6cba520_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d116aa3-55ec-46a5-9953-f94f37a99ccc_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2bf227c7-eff9-4d57-a300-187dd54ad786_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding. Beginning of Period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9e18c3a4-a81e-468c-9521-205b3dfbf918_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, End of Period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_8a2e9318-1578-4536-8fec-f29dc9d11bcd_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_3603c777-8529-47d7-a513-6fa6dd3d0e63_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0dd855e0-70ba-431d-a13f-11d1ff25f04f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_cfd4e048-2a94-4f5e-a3a8-b0e8d047372d_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_66cb4955-14bb-45a7-afb4-dae116bc19a2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_e1180ac2-5950-479e-ba82-f8333ca7c667_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_2c13bb3b-6d4e-43fb-96ff-22a544bdd48b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_b5779571-fb81-48e9-b074-208b2a09e1a3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_ba0b0fb6-55e9-42ee-9061-494043f540c9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_5cc2eb2e-da77-4e22-8db1-9b8fbaa59568_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_417fd19d-e619-431c-b49b-6b78812e68e7_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b0f2bedd-b0f2-4189-96da-1cddf08763c7_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_335fcb52-37c1-4230-b8a2-b46aa83c7af1_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_UniversityOfCaliforniaAtSanDiegoMember_f6442a47-f5c1-47a1-872a-fa201de3890a_terseLabel_en-US" xlink:label="lab_clbs_UniversityOfCaliforniaAtSanDiegoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">University of California at San Diego</link:label>
    <link:label id="lab_clbs_UniversityOfCaliforniaAtSanDiegoMember_label_en-US" xlink:label="lab_clbs_UniversityOfCaliforniaAtSanDiegoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">University of California at San Diego [Member]</link:label>
    <link:label id="lab_clbs_UniversityOfCaliforniaAtSanDiegoMember_documentation_en-US" xlink:label="lab_clbs_UniversityOfCaliforniaAtSanDiegoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">University of California at San Diego</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_UniversityOfCaliforniaAtSanDiegoMember" xlink:href="clbs-20230630.xsd#clbs_UniversityOfCaliforniaAtSanDiegoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_UniversityOfCaliforniaAtSanDiegoMember" xlink:to="lab_clbs_UniversityOfCaliforniaAtSanDiegoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_CENDMember_5c835c1e-326f-4d1c-bad5-142c1a7f9ff2_terseLabel_en-US" xlink:label="lab_clbs_CENDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CEND</link:label>
    <link:label id="lab_clbs_CENDMember_label_en-US" xlink:label="lab_clbs_CENDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CEND [Member]</link:label>
    <link:label id="lab_clbs_CENDMember_documentation_en-US" xlink:label="lab_clbs_CENDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CEND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CENDMember" xlink:href="clbs-20230630.xsd#clbs_CENDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_CENDMember" xlink:to="lab_clbs_CENDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_6ecb1c9c-e395-4346-9a80-1696ce51959f_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_13f4ca83-9419-415c-b4f5-9670367d40e8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_27fdba16-46fb-4809-a920-312a379da3fe_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c2fcda59-70b0-482b-9ceb-f8306090321a_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_75af84f6-daa5-478c-bc46-639a916d3d09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option and Warrants Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e150753b-0bef-4684-a34d-38d61ef1f4f4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_6df2b36d-77de-4816-884a-7674173ae86f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_4242a8a8-b342-40d8-bd36-53911c640110_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExpired_f743c66a-5053-4daf-bc6a-05859c1c893f_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Expired (in dollars per share)</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExpired_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Expired</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsExpired_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Expired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsExpired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_adbbc89f-52dd-4128-bfb2-687ec6fd2a0e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental fair value of Cend's fully vested stock options</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_77b7cad2-2d51-4025-8810-b932280ae9ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax withholding payments on net share settlement equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_65b3a659-1b71-438a-8e82-f66a283c8d8e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_9e351506-6437-4c21-9e75-ad5062dad91e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets, balance sheet line item</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_c65e72df-caeb-4da1-88d0-aed831914320_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_8a438a22-bb2d-44a3-95b8-23458e72bf98_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_77d7eabd-8f80-486b-ae30-3ba53e63278b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_0a8cc1cd-6dca-45f4-b9ad-39e1cea73e73_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_82e0cc97-00e8-4ea1-8828-f77d3c2d0a8e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WarrantsCanceled_c2b9dcc6-ee6f-4836-bfeb-40396e036a9a_negatedLabel_en-US" xlink:label="lab_clbs_WarrantsCanceled" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Forfeited (in shares)</link:label>
    <link:label id="lab_clbs_WarrantsCanceled_label_en-US" xlink:label="lab_clbs_WarrantsCanceled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Canceled</link:label>
    <link:label id="lab_clbs_WarrantsCanceled_documentation_en-US" xlink:label="lab_clbs_WarrantsCanceled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Canceled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsCanceled" xlink:href="clbs-20230630.xsd#clbs_WarrantsCanceled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WarrantsCanceled" xlink:to="lab_clbs_WarrantsCanceled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d347731c-471e-4133-a58c-6650281cdf34_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Cend Therapeutics</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues_ba3677ce-988d-4903-b451-b372d603513c_terseLabel_en-US" xlink:label="lab_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of sublicensing revenues</link:label>
    <link:label id="lab_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues_label_en-US" xlink:label="lab_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Percentage of Sublicensing Revenues</link:label>
    <link:label id="lab_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues_documentation_en-US" xlink:label="lab_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Percentage of Sublicensing Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues" xlink:href="clbs-20230630.xsd#clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues" xlink:to="lab_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_587efc17-c842-4dfd-820c-50bd2337fd5f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AssetAcquisitionIntangibles_04d590dc-e25f-43ed-9dd0-03e802ad4dff_terseLabel_en-US" xlink:label="lab_clbs_AssetAcquisitionIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License</link:label>
    <link:label id="lab_clbs_AssetAcquisitionIntangibles_label_en-US" xlink:label="lab_clbs_AssetAcquisitionIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Intangibles</link:label>
    <link:label id="lab_clbs_AssetAcquisitionIntangibles_documentation_en-US" xlink:label="lab_clbs_AssetAcquisitionIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionIntangibles" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AssetAcquisitionIntangibles" xlink:to="lab_clbs_AssetAcquisitionIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_c3b775cf-1b64-4c70-b01b-d8b8dad4cc7e_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e8e317b4-311f-4bfe-b7ca-3e3fc5291403_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Share-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_fde21305-9ad9-462b-acd4-7504db0aaca7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion on marketable securities</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_0279b4dd-b806-4240-ada9-60ab8419a677_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, non-controlling interests and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_69b5ac26-fe8a-4f6f-b6fb-fa398fb25064_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_6c0430cc-e598-42e0-898a-5ca206ce9ce3_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_ff89fcf7-5788-4af1-8c7d-2fb54c40f356_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_RevenuePerformanceObligationPercentageOfNetSale_070b67ad-39e8-4d16-b94b-75890e93408d_terseLabel_en-US" xlink:label="lab_clbs_RevenuePerformanceObligationPercentageOfNetSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net sale</link:label>
    <link:label id="lab_clbs_RevenuePerformanceObligationPercentageOfNetSale_label_en-US" xlink:label="lab_clbs_RevenuePerformanceObligationPercentageOfNetSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Percentage of Net Sale</link:label>
    <link:label id="lab_clbs_RevenuePerformanceObligationPercentageOfNetSale_documentation_en-US" xlink:label="lab_clbs_RevenuePerformanceObligationPercentageOfNetSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Percentage of Net Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_RevenuePerformanceObligationPercentageOfNetSale" xlink:href="clbs-20230630.xsd#clbs_RevenuePerformanceObligationPercentageOfNetSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_RevenuePerformanceObligationPercentageOfNetSale" xlink:to="lab_clbs_RevenuePerformanceObligationPercentageOfNetSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_b93cead3-77ed-4564-a697-4df7ec6fce48_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_c2700eef-eef4-4c1b-b1b0-a3f82f2b00c8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Caladrius Biosciences, Inc. common stockholders - basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_6f742180-43fb-4d7c-b1a5-7fad1b6f5f95_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_fbdddd6b-4eba-48dc-8d68-fe98a3acaa8a_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Name of Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_40f13dbb-e51a-48c4-9b42-0a0888c1acaa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_10984a60-6aac-4c9c-80c0-0d1eb2ac3fc6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_1ab81ed6-5853-48ee-aed9-301acbd85973_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested and expected to vest, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_db0bddb0-69f7-4399-8ceb-297e53b97248_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_958d66a2-6635-46f7-a81f-fff5a52e369f_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8cd04a41-b1c3-4870-9f4d-3a42cc2593cf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current, balance sheet line item</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_1e7900c3-a26b-4818-9369-3bcb4edf473f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_9d33f8d7-fd0b-48da-963e-7e2dc6486d65_terseLabel_en-US" xlink:label="lab_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable consideration amounts, milestones</link:label>
    <link:label id="lab_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_label_en-US" xlink:label="lab_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:label id="lab_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_documentation_en-US" xlink:label="lab_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:href="clbs-20230630.xsd#clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:to="lab_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_FairValueMarketOfTaxNOLs_45d1ebca-4d81-408b-bf1e-e320f89f99d0_terseLabel_en-US" xlink:label="lab_clbs_FairValueMarketOfTaxNOLs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Market of Tax NOLs</link:label>
    <link:label id="lab_clbs_FairValueMarketOfTaxNOLs_label_en-US" xlink:label="lab_clbs_FairValueMarketOfTaxNOLs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Market of Tax NOLs</link:label>
    <link:label id="lab_clbs_FairValueMarketOfTaxNOLs_documentation_en-US" xlink:label="lab_clbs_FairValueMarketOfTaxNOLs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Market of Tax NOLs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_FairValueMarketOfTaxNOLs" xlink:href="clbs-20230630.xsd#clbs_FairValueMarketOfTaxNOLs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_FairValueMarketOfTaxNOLs" xlink:to="lab_clbs_FairValueMarketOfTaxNOLs" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AssetAcquisitionSharePrice_346bc6c1-d2d1-40ce-bc35-17314e1c33fe_terseLabel_en-US" xlink:label="lab_clbs_AssetAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiplied by the fair value per share of Lisata common stock on September 15, 2022</link:label>
    <link:label id="lab_clbs_AssetAcquisitionSharePrice_label_en-US" xlink:label="lab_clbs_AssetAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Share Price</link:label>
    <link:label id="lab_clbs_AssetAcquisitionSharePrice_documentation_en-US" xlink:label="lab_clbs_AssetAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionSharePrice" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AssetAcquisitionSharePrice" xlink:to="lab_clbs_AssetAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_0e247671-faa4-40bf-b91f-f03c725e62e4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_b05687b1-b213-4aea-87bc-8e7f589ce723_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_10bec0c7-e3d7-4d6c-bc34-4902108c399d_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2815fc9c-55a0-4912-9c53-53fc03ec3e53_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_30de3036-f92a-4b35-8efe-114a8c27bb07_terseLabel_en-US" xlink:label="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate offering amount authorized per agreement</link:label>
    <link:label id="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_label_en-US" xlink:label="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement</link:label>
    <link:label id="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_documentation_en-US" xlink:label="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:href="clbs-20230630.xsd#clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:to="lab_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree_01ef6818-0bb5-40c8-8c3b-866490c538b5_terseLabel_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual license maintenance fee, years two and three</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree_label_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Year Two and Three</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree_documentation_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Year Two and Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree" xlink:to="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_bf44a05d-5a66-49fb-91dd-ac4614cb2a6a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7da7aae0-1979-4d86-86f1-e894071e07c9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b7f66040-4a4c-4496-aae1-e5545cfd6044_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_c72bff20-7bde-49d0-93ce-3f268ea020cc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_ff14a4a4-709e-4447-a242-25207ede752a_terseLabel_en-US" xlink:label="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued liabilities and other liabilities</link:label>
    <link:label id="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_label_en-US" xlink:label="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities</link:label>
    <link:label id="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_documentation_en-US" xlink:label="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:href="clbs-20230630.xsd#clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:to="lab_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d097cf4d-cfb3-456a-b6af-789a9501485f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_OperatingLossCarryforwardsBeforeWriteDown_cc18ffd0-1b82-4b19-990c-ae5193f1f590_terseLabel_en-US" xlink:label="lab_clbs_OperatingLossCarryforwardsBeforeWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, prior to write down</link:label>
    <link:label id="lab_clbs_OperatingLossCarryforwardsBeforeWriteDown_label_en-US" xlink:label="lab_clbs_OperatingLossCarryforwardsBeforeWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Before Write Down</link:label>
    <link:label id="lab_clbs_OperatingLossCarryforwardsBeforeWriteDown_documentation_en-US" xlink:label="lab_clbs_OperatingLossCarryforwardsBeforeWriteDown" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Before Write Down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_OperatingLossCarryforwardsBeforeWriteDown" xlink:href="clbs-20230630.xsd#clbs_OperatingLossCarryforwardsBeforeWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_OperatingLossCarryforwardsBeforeWriteDown" xlink:to="lab_clbs_OperatingLossCarryforwardsBeforeWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_a1f0cf47-ff80-4332-91a5-c8b3c356a96f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward_a8e91996-3796-47dd-b784-11531199f982_terseLabel_en-US" xlink:label="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Weighted Average Exercise Price</link:label>
    <link:label id="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward_label_en-US" xlink:label="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward_documentation_en-US" xlink:label="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:href="clbs-20230630.xsd#clbs_WarrantsWeightedAverageExercisePriceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:to="lab_clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_5a8956b2-8692-4992-b4a8-47f421943083_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_6ede4dba-9fc2-4549-b42a-057908752630_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale_c468cbac-7f4d-4675-9c9c-25e03ae8985c_terseLabel_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual license maintenance fee, after first sale</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale_label_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee After First Sale</link:label>
    <link:label id="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale_documentation_en-US" xlink:label="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee After First Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale" xlink:to="lab_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_e7ce6803-383a-4e71-b644-199dbc61aa83_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_35def1e3-f3cb-4765-a481-4d8f315adab8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_9bad2707-85a3-41fa-bc27-058bda166590_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from option exercises</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_98ae0427-8b34-44e8-bf36-4d8b00d7f047_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_96204c7b-1db9-4d8e-b354-2d52487fe7e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b02052cf-ca61-4ea5-aac9-3fae316e38aa_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AccruedGrantFunding_1fda4760-ef2f-4d89-a4d1-c1dd94ad3cea_terseLabel_en-US" xlink:label="lab_clbs_AccruedGrantFunding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting &amp; tax consulting liabilities</link:label>
    <link:label id="lab_clbs_AccruedGrantFunding_label_en-US" xlink:label="lab_clbs_AccruedGrantFunding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Grant Funding</link:label>
    <link:label id="lab_clbs_AccruedGrantFunding_documentation_en-US" xlink:label="lab_clbs_AccruedGrantFunding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Grant Funding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AccruedGrantFunding" xlink:href="clbs-20230630.xsd#clbs_AccruedGrantFunding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AccruedGrantFunding" xlink:to="lab_clbs_AccruedGrantFunding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8a2d1a8f-9aea-4763-b7a9-57fb62979ccf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_e5a52046-12e4-4a41-8cc8-d6c8cb77a876_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lisata transaction costs</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Transaction Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c9e363e3-2488-4957-8c92-cb68507fbf47_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_326a5f6f-64dc-4457-b18e-0bd19c94f70d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9c88815c-0c5d-45d9-8b34-51cc9d481673_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_1f0e5aa4-0761-4361-9471-62da3fdf79bd_terseLabel_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested and expected to vest, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_label_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Warrants vested and expected to vest</link:label>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_documentation_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Warrants vested and expected to vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:href="clbs-20230630.xsd#clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:to="lab_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled_14a47242-fcf8-4dbb-881b-a4beb1c232e6_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Forfeited (in dollars per share)</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Canceled</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Canceled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsCanceled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_01715691-9e04-46ca-85aa-c5c749b0a6ae_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsGranted_dfdc1e59-d510-4234-9208-e392c4f91a1c_terseLabel_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Granted (in dollars per share)</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsGranted_label_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Granted</link:label>
    <link:label id="lab_clbs_WeightedAverageExercisePriceWarrantsGranted_documentation_en-US" xlink:label="lab_clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price, Warrants Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:to="lab_clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_SanfordBurnhamPrebysMember_1434d284-26db-4d72-a93e-2f0169c1fb4c_terseLabel_en-US" xlink:label="lab_clbs_SanfordBurnhamPrebysMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanford Burnham Prebys</link:label>
    <link:label id="lab_clbs_SanfordBurnhamPrebysMember_label_en-US" xlink:label="lab_clbs_SanfordBurnhamPrebysMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanford Burnham Prebys [Member]</link:label>
    <link:label id="lab_clbs_SanfordBurnhamPrebysMember_documentation_en-US" xlink:label="lab_clbs_SanfordBurnhamPrebysMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanford Burnham Prebys</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SanfordBurnhamPrebysMember" xlink:href="clbs-20230630.xsd#clbs_SanfordBurnhamPrebysMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_SanfordBurnhamPrebysMember" xlink:to="lab_clbs_SanfordBurnhamPrebysMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_fc2d3950-f59d-441c-b690-7beef386b58f_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_13e443fa-a25d-4568-b69f-6ad195317b04_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_a17894a8-b7ee-4c21-9083-7f4770362d57_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_15a158c7-7347-4834-92a1-cd7cf70c31ad_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_ClinicalAndRDRelatedLiabilities_2eb598be-24ec-47e3-a1b3-e35872a4607d_terseLabel_en-US" xlink:label="lab_clbs_ClinicalAndRDRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical and R&amp;D related liabilities</link:label>
    <link:label id="lab_clbs_ClinicalAndRDRelatedLiabilities_label_en-US" xlink:label="lab_clbs_ClinicalAndRDRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical and R&amp;D Related Liabilities</link:label>
    <link:label id="lab_clbs_ClinicalAndRDRelatedLiabilities_documentation_en-US" xlink:label="lab_clbs_ClinicalAndRDRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical and R&amp;D Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ClinicalAndRDRelatedLiabilities" xlink:href="clbs-20230630.xsd#clbs_ClinicalAndRDRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_ClinicalAndRDRelatedLiabilities" xlink:to="lab_clbs_ClinicalAndRDRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_MassachusettsInstituteOfTechnologyMember_168c02cf-5ac8-458b-ad2c-56ba4433b4c3_terseLabel_en-US" xlink:label="lab_clbs_MassachusettsInstituteOfTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Massachusetts Institute of Technology</link:label>
    <link:label id="lab_clbs_MassachusettsInstituteOfTechnologyMember_label_en-US" xlink:label="lab_clbs_MassachusettsInstituteOfTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Massachusetts Institute of Technology [Member]</link:label>
    <link:label id="lab_clbs_MassachusettsInstituteOfTechnologyMember_documentation_en-US" xlink:label="lab_clbs_MassachusettsInstituteOfTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Massachusetts Institute of Technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_MassachusettsInstituteOfTechnologyMember" xlink:href="clbs-20230630.xsd#clbs_MassachusettsInstituteOfTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_MassachusettsInstituteOfTechnologyMember" xlink:to="lab_clbs_MassachusettsInstituteOfTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0095e650-b3c7-43fc-8d00-cc4e70448fb1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of fixed assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_a5047a82-bfc4-44cf-ba89-d8c56804d88c_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_c26b9bbe-b747-43bb-bc59-3e3fae73cfa9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsvested_b3190c98-495a-41d9-994d-cd7dedc37c3a_terseLabel_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Vested, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsvested_label_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Warrants vested</link:label>
    <link:label id="lab_clbs_AggregateIntrinsicValueWarrantsvested_documentation_en-US" xlink:label="lab_clbs_AggregateIntrinsicValueWarrantsvested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Warrants vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsvested" xlink:href="clbs-20230630.xsd#clbs_AggregateIntrinsicValueWarrantsvested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AggregateIntrinsicValueWarrantsvested" xlink:to="lab_clbs_AggregateIntrinsicValueWarrantsvested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAbstract" xlink:to="lab_us-gaap_AssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_e7d072c8-a626-49f1-83a7-b158d51dca41_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_7c6df905-e620-4c22-8c55-8a8b7ac0a5fe_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salaries, employee benefits and related taxes</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_9e667387-b917-4b44-98bf-b0d067fdddfa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment_24280432-ef7a-4c38-b487-1bff926dcfe7_terseLabel_en-US" xlink:label="lab_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in-process research and development</link:label>
    <link:label id="lab_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Acquired In-Process Research And Development</link:label>
    <link:label id="lab_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment_documentation_en-US" xlink:label="lab_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Acquired In-Process Research And Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment" xlink:to="lab_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_2aaa1f90-7b11-42b7-82c0-05569db9a24d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuances of common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_a030f3ae-defa-4c3f-ac58-6626007d9772_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_39a992e2-602c-413b-aa3c-235e0cb111a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_667d2e15-2283-4b67-9817-25bc2d629550_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term for operating leases (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_11528c88-088f-4911-8eb2-92622c92b21c_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_bacfaa88-128d-4f04-a9b3-97a5c0bf3f7e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_7066b05d-5d4b-4e9f-9229-b09a68fff697_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_3c00b4a5-9f55-455a-9531-2f8487818092_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_56509f55-784f-4f69-91ba-0e023c6c013b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_3692f420-c7aa-4251-b79c-6ea871238ee5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate for operating leases (percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_55abdf68-1011-4ab0-9e26-c29cfbfc62e8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_ecc8ec10-4811-40ca-9294-6226b0e78f33_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_aa640d28-1f0b-475c-b29a-a22c997d142c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_dca772e2-7be4-4cc3-8b37-abf0c5f5c526_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_164998f9-1106-41b8-9c40-ed20b57e89ff_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_51ff0d8a-1716-41b5-a3bb-1dbba18b03a0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_7445a5b6-36ad-48f3-8b86-2b616ee5fc9b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_AssetAcquisitionCashAndCashEquivalents_9ef432ca-e811-482e-ba3b-59bc6d9e0fbd_terseLabel_en-US" xlink:label="lab_clbs_AssetAcquisitionCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_clbs_AssetAcquisitionCashAndCashEquivalents_label_en-US" xlink:label="lab_clbs_AssetAcquisitionCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Cash and Cash Equivalents</link:label>
    <link:label id="lab_clbs_AssetAcquisitionCashAndCashEquivalents_documentation_en-US" xlink:label="lab_clbs_AssetAcquisitionCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionCashAndCashEquivalents" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_AssetAcquisitionCashAndCashEquivalents" xlink:to="lab_clbs_AssetAcquisitionCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_a9508348-98d1-4fca-8ad3-f9ae2226129a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_e3bf1665-2341-4ad6-b1df-a6b779fa822d_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_ProceedsFromSaleOfNOLS_34b42b74-3f5e-4e42-b291-5f62e8e307ed_terseLabel_en-US" xlink:label="lab_clbs_ProceedsFromSaleOfNOLS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale of NOLS</link:label>
    <link:label id="lab_clbs_ProceedsFromSaleOfNOLS_label_en-US" xlink:label="lab_clbs_ProceedsFromSaleOfNOLS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale of NOLS</link:label>
    <link:label id="lab_clbs_ProceedsFromSaleOfNOLS_documentation_en-US" xlink:label="lab_clbs_ProceedsFromSaleOfNOLS" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale of NOLS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ProceedsFromSaleOfNOLS" xlink:href="clbs-20230630.xsd#clbs_ProceedsFromSaleOfNOLS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_ProceedsFromSaleOfNOLS" xlink:to="lab_clbs_ProceedsFromSaleOfNOLS" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_ResearchAndDevelopmentTaxIncentiveTextBlock_fd2897e1-dc9e-4cb1-ad2d-c72d31bd4067_terseLabel_en-US" xlink:label="lab_clbs_ResearchAndDevelopmentTaxIncentiveTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia Research and Development Tax Incentive</link:label>
    <link:label id="lab_clbs_ResearchAndDevelopmentTaxIncentiveTextBlock_label_en-US" xlink:label="lab_clbs_ResearchAndDevelopmentTaxIncentiveTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Tax Incentive [Text Block]</link:label>
    <link:label id="lab_clbs_ResearchAndDevelopmentTaxIncentiveTextBlock_documentation_en-US" xlink:label="lab_clbs_ResearchAndDevelopmentTaxIncentiveTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Tax Incentive</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ResearchAndDevelopmentTaxIncentiveTextBlock" xlink:href="clbs-20230630.xsd#clbs_ResearchAndDevelopmentTaxIncentiveTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_ResearchAndDevelopmentTaxIncentiveTextBlock" xlink:to="lab_clbs_ResearchAndDevelopmentTaxIncentiveTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d43a5638-a293-4af9-bf45-82fabe6ce407_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_1b2e1c3c-5b29-4d54-80cf-3eeef1ef1cab_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_5cbc9868-8e6e-47f9-9428-17e1d05226e4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_3f82121b-df7b-4b5d-bba0-b32243b0aa2a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_95689e5d-8494-446e-9a23-5f3766b7e6a6_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityAbstract_ce670b80-e0f8-4678-b3f1-b0bbe73b8f00_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liabilities:</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_bba537b4-1507-426c-ac04-b88ecf0603f9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_bad2326c-a913-4e82-b556-5698416dffbf_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8f3b6668-407e-43bc-930a-b3cc9a68f14b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_26c976e2-f7a3-4c93-aed1-818110116a0f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_60623f00-e074-496a-9070-ce53a15f0d97_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_32225c58-06c6-4102-b110-5374670b3b59_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_1d97543c-9aa0-4737-b870-a4d9527a69a0_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_409d31f6-c208-424e-bca8-ad42426fc637_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f2176e99-8c92-4b59-9397-9314a9a5eeff_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_7373a2b3-b12a-46ec-a350-11f0c4184a02_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BondsMember_570127e4-97ab-4155-bf82-bd4c6700adc8_terseLabel_en-US" xlink:label="lab_us-gaap_BondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bonds</link:label>
    <link:label id="lab_us-gaap_BondsMember_label_en-US" xlink:label="lab_us-gaap_BondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BondsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BondsMember" xlink:to="lab_us-gaap_BondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_e437b9d0-0da7-4387-b0cd-2d6d662c900c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_QiluMember_3eb01bce-957a-4b4c-b11f-3e60c9f6c351_terseLabel_en-US" xlink:label="lab_clbs_QiluMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qilu</link:label>
    <link:label id="lab_clbs_QiluMember_label_en-US" xlink:label="lab_clbs_QiluMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qilu [Member]</link:label>
    <link:label id="lab_clbs_QiluMember_documentation_en-US" xlink:label="lab_clbs_QiluMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qilu</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_QiluMember" xlink:href="clbs-20230630.xsd#clbs_QiluMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_QiluMember" xlink:to="lab_clbs_QiluMember" xlink:type="arc" order="1"/>
    <link:label id="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_0e61208b-2b7f-40ea-955a-8d48e6702cd3_terseLabel_en-US" xlink:label="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Liabilities and Right-of-Use Assets on Balance Sheet</link:label>
    <link:label id="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_label_en-US" xlink:label="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]</link:label>
    <link:label id="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_documentation_en-US" xlink:label="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:href="clbs-20230630.xsd#clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:to="lab_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_9cc066c8-7914-4943-bf4e-b1e6d158a898_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_e2a40976-0b18-4cf2-b016-a222224d5df9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c5977e18-c5ed-4bd5-afcb-c6cd14769f13_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3df8cc93-e459-4e36-ab67-293a67c917ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options, Weighted Average Contractual Term and Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_00f894c2-d5d9-4840-b020-900b3ee3f763_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_1a415cf3-4591-419f-9743-c30e77ced9c5_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_7d1b23e4-0b9f-45d0-9a4d-d4be60efa15d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non- Controlling Interest in Subsidiary</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>clbs-20230630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:f19b6d65-9ffc-4ef9-a859-121a4da9922b,g:65448069-d222-4f71-8ad3-a35814dee021-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.caladrius.com/role/Cover" xlink:type="simple" xlink:href="clbs-20230630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_51e02677-83ea-4999-94fc-921f495b28f4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_DocumentType_51e02677-83ea-4999-94fc-921f495b28f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_dc73995e-da5f-4cab-b0fe-16384291edca" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_DocumentQuarterlyReport_dc73995e-da5f-4cab-b0fe-16384291edca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0f0f8246-ad69-453a-abdc-cb6c48120870" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_DocumentPeriodEndDate_0f0f8246-ad69-453a-abdc-cb6c48120870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_f24d39ce-1de4-4074-a038-d5aabba4487f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_DocumentTransitionReport_f24d39ce-1de4-4074-a038-d5aabba4487f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_776d2cad-ee50-4f0e-b715-5eeb862637a5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityFileNumber_776d2cad-ee50-4f0e-b715-5eeb862637a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_dedbf529-bd0c-4e36-bf82-ceb49f5acd29" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityRegistrantName_dedbf529-bd0c-4e36-bf82-ceb49f5acd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c3349677-2792-462b-8238-cafa42a418b8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c3349677-2792-462b-8238-cafa42a418b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_fcc2a19d-8fcf-45ff-99e0-bd713ebbafe0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityTaxIdentificationNumber_fcc2a19d-8fcf-45ff-99e0-bd713ebbafe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_24157162-86bb-40ee-b8e4-3ea78fa82e82" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityAddressAddressLine1_24157162-86bb-40ee-b8e4-3ea78fa82e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1f8ad9da-8370-49d5-b96c-b7e82e7555c2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityAddressCityOrTown_1f8ad9da-8370-49d5-b96c-b7e82e7555c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7857e28a-a030-4058-9d9e-e982c34c2654" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityAddressStateOrProvince_7857e28a-a030-4058-9d9e-e982c34c2654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ca468505-4dfa-4443-a2ee-838e9660cf82" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityAddressPostalZipCode_ca468505-4dfa-4443-a2ee-838e9660cf82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_62edb892-cb1b-4d10-87df-fae06790a5b8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_CityAreaCode_62edb892-cb1b-4d10-87df-fae06790a5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_38a7baa2-9851-492a-8e07-080c7ac1756b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_LocalPhoneNumber_38a7baa2-9851-492a-8e07-080c7ac1756b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1dd267d3-0622-4309-897a-c89c3afd420d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_Security12bTitle_1dd267d3-0622-4309-897a-c89c3afd420d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_07187088-37eb-43c1-af85-845f6e28c959" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_TradingSymbol_07187088-37eb-43c1-af85-845f6e28c959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a96d9080-b7fd-463c-8a7d-eca446bda6d0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_SecurityExchangeName_a96d9080-b7fd-463c-8a7d-eca446bda6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_18c9e504-2a7c-41cc-ba11-997e40c39401" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityCurrentReportingStatus_18c9e504-2a7c-41cc-ba11-997e40c39401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_006cf62c-d73a-457e-85d0-e9c368f31fbf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityInteractiveDataCurrent_006cf62c-d73a-457e-85d0-e9c368f31fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_2b38a78c-7485-4987-94fb-5f9a8c31a0ec" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityFilerCategory_2b38a78c-7485-4987-94fb-5f9a8c31a0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_3816a797-0f87-4b38-92dc-e36df039abe6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntitySmallBusiness_3816a797-0f87-4b38-92dc-e36df039abe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4977028f-50cb-4f43-8920-01b7b4a54ecb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityEmergingGrowthCompany_4977028f-50cb-4f43-8920-01b7b4a54ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e3846023-75ed-49cf-a8d4-f779e798480c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityShellCompany_e3846023-75ed-49cf-a8d4-f779e798480c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_030b0f32-16d2-46fa-8005-97ad63fea506" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityCentralIndexKey_030b0f32-16d2-46fa-8005-97ad63fea506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4128ebad-fb93-49ce-be24-c47998ed9a06" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_CurrentFiscalYearEndDate_4128ebad-fb93-49ce-be24-c47998ed9a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_199fda66-2513-4db5-9343-6eb7abc80d44" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_DocumentFiscalYearFocus_199fda66-2513-4db5-9343-6eb7abc80d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_b69948c3-c3aa-4149-a85c-30f4b425a90d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_DocumentFiscalPeriodFocus_b69948c3-c3aa-4149-a85c-30f4b425a90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_dd2a25af-12f0-4007-a34a-6e317c4f1e97" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_AmendmentFlag_dd2a25af-12f0-4007-a34a-6e317c4f1e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_6f6d59bd-37f4-45fc-adbd-0d7d1ef1af0e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_98b77249-311e-41f1-b559-8712af60d6e2" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_6f6d59bd-37f4-45fc-adbd-0d7d1ef1af0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="clbs-20230630.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_685758ef-6bd5-489f-8f1b-5d0ff9a8c4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_bbb6a14d-962b-46f2-93a2-809cf459021a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_685758ef-6bd5-489f-8f1b-5d0ff9a8c4a1" xlink:to="loc_us-gaap_AssetsAbstract_bbb6a14d-962b-46f2-93a2-809cf459021a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_66768f54-f61d-43d9-adae-d5b77ff697be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bbb6a14d-962b-46f2-93a2-809cf459021a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_66768f54-f61d-43d9-adae-d5b77ff697be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_a28d5a5c-716e-4bed-a8b9-900f5aaedb22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bbb6a14d-962b-46f2-93a2-809cf459021a" xlink:to="loc_us-gaap_MarketableSecurities_a28d5a5c-716e-4bed-a8b9-900f5aaedb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8b019878-4915-4a8d-b9df-5283769667f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bbb6a14d-962b-46f2-93a2-809cf459021a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8b019878-4915-4a8d-b9df-5283769667f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7fd82536-cd97-425d-bb10-0be61cecdb88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bbb6a14d-962b-46f2-93a2-809cf459021a" xlink:to="loc_us-gaap_AssetsCurrent_7fd82536-cd97-425d-bb10-0be61cecdb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fa95508c-bfb8-4720-b96b-3ea0d2cab833" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bbb6a14d-962b-46f2-93a2-809cf459021a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fa95508c-bfb8-4720-b96b-3ea0d2cab833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7da86a29-24d3-47bf-b5b1-147f9dbf388f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bbb6a14d-962b-46f2-93a2-809cf459021a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7da86a29-24d3-47bf-b5b1-147f9dbf388f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_aeaf95b5-8deb-46fe-9324-1b9515fc9bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bbb6a14d-962b-46f2-93a2-809cf459021a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_aeaf95b5-8deb-46fe-9324-1b9515fc9bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_468399cc-45ce-4456-9210-dd12155ccadd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bbb6a14d-962b-46f2-93a2-809cf459021a" xlink:to="loc_us-gaap_Assets_468399cc-45ce-4456-9210-dd12155ccadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c5030968-a78e-4312-9b5e-5ca36378cd97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_685758ef-6bd5-489f-8f1b-5d0ff9a8c4a1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c5030968-a78e-4312-9b5e-5ca36378cd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_b96106a3-ff62-4a7e-b3a2-9617f8f3e903" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c5030968-a78e-4312-9b5e-5ca36378cd97" xlink:to="loc_us-gaap_LiabilitiesAbstract_b96106a3-ff62-4a7e-b3a2-9617f8f3e903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_649bfdff-4189-4b51-acc6-80a341534c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_b96106a3-ff62-4a7e-b3a2-9617f8f3e903" xlink:to="loc_us-gaap_AccountsPayableCurrent_649bfdff-4189-4b51-acc6-80a341534c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d0f7a26c-4f09-4834-a0b8-0628a053050d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_b96106a3-ff62-4a7e-b3a2-9617f8f3e903" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_d0f7a26c-4f09-4834-a0b8-0628a053050d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d0cd2738-c807-4e31-883c-1e2e11623ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_b96106a3-ff62-4a7e-b3a2-9617f8f3e903" xlink:to="loc_us-gaap_LiabilitiesCurrent_d0cd2738-c807-4e31-883c-1e2e11623ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_47c5e3ab-c863-463f-b7e6-e0cd68a4bc56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_b96106a3-ff62-4a7e-b3a2-9617f8f3e903" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_47c5e3ab-c863-463f-b7e6-e0cd68a4bc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4fb5fa6c-82aa-47e8-ad83-d6158d41563a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_b96106a3-ff62-4a7e-b3a2-9617f8f3e903" xlink:to="loc_us-gaap_Liabilities_4fb5fa6c-82aa-47e8-ad83-d6158d41563a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_5d10ab34-e97b-4140-9219-4c858a810c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c5030968-a78e-4312-9b5e-5ca36378cd97" xlink:to="loc_us-gaap_CommitmentsAndContingencies_5d10ab34-e97b-4140-9219-4c858a810c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_318ed857-4334-418c-9bec-004f7ae81e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c5030968-a78e-4312-9b5e-5ca36378cd97" xlink:to="loc_us-gaap_StockholdersEquityAbstract_318ed857-4334-418c-9bec-004f7ae81e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_da1b0789-c310-4ca8-9aad-5d9b22cbca4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_318ed857-4334-418c-9bec-004f7ae81e9c" xlink:to="loc_us-gaap_CommonStockValue_da1b0789-c310-4ca8-9aad-5d9b22cbca4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_213ddd9a-ffe2-4779-9b4a-913758cda849" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_318ed857-4334-418c-9bec-004f7ae81e9c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_213ddd9a-ffe2-4779-9b4a-913758cda849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_975947ec-f372-4561-b9b6-b64b2852ebda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_318ed857-4334-418c-9bec-004f7ae81e9c" xlink:to="loc_us-gaap_TreasuryStockCommonValue_975947ec-f372-4561-b9b6-b64b2852ebda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d6c8c4e4-c105-4bb8-bf6b-884e6ff7ffb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_318ed857-4334-418c-9bec-004f7ae81e9c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d6c8c4e4-c105-4bb8-bf6b-884e6ff7ffb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1d21d8e4-e0e1-422a-8523-0a81df19cf57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_318ed857-4334-418c-9bec-004f7ae81e9c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1d21d8e4-e0e1-422a-8523-0a81df19cf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_eb15450d-ef85-4e7c-90e2-1403efe9caaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_318ed857-4334-418c-9bec-004f7ae81e9c" xlink:to="loc_us-gaap_StockholdersEquity_eb15450d-ef85-4e7c-90e2-1403efe9caaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_86f39f94-6149-43e0-8b12-194996ca037c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_318ed857-4334-418c-9bec-004f7ae81e9c" xlink:to="loc_us-gaap_MinorityInterest_86f39f94-6149-43e0-8b12-194996ca037c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac50cea9-d280-4c95-828d-89aef3533582" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_318ed857-4334-418c-9bec-004f7ae81e9c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac50cea9-d280-4c95-828d-89aef3533582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_92daca8a-ca7b-40ba-b1d8-4a0cdaed73a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c5030968-a78e-4312-9b5e-5ca36378cd97" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_92daca8a-ca7b-40ba-b1d8-4a0cdaed73a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="simple" xlink:href="clbs-20230630.xsd#ConsolidatedBalanceSheetsParentheticals"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_886708a4-1759-4d3f-abf8-54f73376e6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_17bb1f0b-ccdf-4a3e-bd6b-e48d33450811" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_886708a4-1759-4d3f-abf8-54f73376e6f5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_17bb1f0b-ccdf-4a3e-bd6b-e48d33450811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_53c0ce8e-e411-4cef-affd-bcaaa8cc943e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_886708a4-1759-4d3f-abf8-54f73376e6f5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_53c0ce8e-e411-4cef-affd-bcaaa8cc943e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_413095e8-4adc-4998-81c3-3f400a645159" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_886708a4-1759-4d3f-abf8-54f73376e6f5" xlink:to="loc_us-gaap_CommonStockSharesIssued_413095e8-4adc-4998-81c3-3f400a645159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_29d61b4a-9b21-4358-8a68-a2c6ce39ee75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_886708a4-1759-4d3f-abf8-54f73376e6f5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_29d61b4a-9b21-4358-8a68-a2c6ce39ee75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_0bf5b494-0bfe-4577-8584-c7685df28ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_886708a4-1759-4d3f-abf8-54f73376e6f5" xlink:to="loc_us-gaap_TreasuryStockCommonShares_0bf5b494-0bfe-4577-8584-c7685df28ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="clbs-20230630.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_9a6fa0b9-d7a8-4328-9d07-fb06de1ca224" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_418667e2-e11d-4606-9038-a876133cf34b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9a6fa0b9-d7a8-4328-9d07-fb06de1ca224" xlink:to="loc_us-gaap_OperatingExpensesAbstract_418667e2-e11d-4606-9038-a876133cf34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_e7f657a1-3690-47a4-81a5-78edc9e5459e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_418667e2-e11d-4606-9038-a876133cf34b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_e7f657a1-3690-47a4-81a5-78edc9e5459e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_fdf2fd2c-8703-4b63-abfe-470339b07b25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_418667e2-e11d-4606-9038-a876133cf34b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_fdf2fd2c-8703-4b63-abfe-470339b07b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_db364a4a-513b-4640-88fd-d0e99aa9ffe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_418667e2-e11d-4606-9038-a876133cf34b" xlink:to="loc_us-gaap_OperatingExpenses_db364a4a-513b-4640-88fd-d0e99aa9ffe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_da30ddac-61fa-4447-87e8-e87687aebf7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9a6fa0b9-d7a8-4328-9d07-fb06de1ca224" xlink:to="loc_us-gaap_OperatingIncomeLoss_da30ddac-61fa-4447-87e8-e87687aebf7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_341e7cbc-00fa-4567-b55d-b7c42f095d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9a6fa0b9-d7a8-4328-9d07-fb06de1ca224" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_341e7cbc-00fa-4567-b55d-b7c42f095d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_25b67cf5-5972-4e99-bb52-c659677a16a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_341e7cbc-00fa-4567-b55d-b7c42f095d7d" xlink:to="loc_us-gaap_InvestmentIncomeNet_25b67cf5-5972-4e99-bb52-c659677a16a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_fb369669-a955-458b-9ce9-2198e1d0bf1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_341e7cbc-00fa-4567-b55d-b7c42f095d7d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_fb369669-a955-458b-9ce9-2198e1d0bf1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4f192de5-85da-43d5-b025-561cbb454f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_341e7cbc-00fa-4567-b55d-b7c42f095d7d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_4f192de5-85da-43d5-b025-561cbb454f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec0d01b4-8ff3-41bc-ba44-1a03ea8705d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9a6fa0b9-d7a8-4328-9d07-fb06de1ca224" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec0d01b4-8ff3-41bc-ba44-1a03ea8705d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4d759301-3593-4a2b-9128-0a27e2a9d3be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9a6fa0b9-d7a8-4328-9d07-fb06de1ca224" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4d759301-3593-4a2b-9128-0a27e2a9d3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8e39d46e-a476-4f63-b475-0d5342aca72a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9a6fa0b9-d7a8-4328-9d07-fb06de1ca224" xlink:to="loc_us-gaap_ProfitLoss_8e39d46e-a476-4f63-b475-0d5342aca72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_79fbf98f-9c6e-4332-b441-36355770312b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9a6fa0b9-d7a8-4328-9d07-fb06de1ca224" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_79fbf98f-9c6e-4332-b441-36355770312b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d56450a9-3cda-48dd-b34d-9c52355121bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9a6fa0b9-d7a8-4328-9d07-fb06de1ca224" xlink:to="loc_us-gaap_NetIncomeLoss_d56450a9-3cda-48dd-b34d-9c52355121bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_EPSAbstract_1eaba64a-8fcd-4a56-b3d8-7a852de244d6" xlink:href="clbs-20230630.xsd#clbs_EPSAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9a6fa0b9-d7a8-4328-9d07-fb06de1ca224" xlink:to="loc_clbs_EPSAbstract_1eaba64a-8fcd-4a56-b3d8-7a852de244d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d5bb3c61-5dfc-478e-b7f0-b94777ccc713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_EPSAbstract_1eaba64a-8fcd-4a56-b3d8-7a852de244d6" xlink:to="loc_us-gaap_EarningsPerShareBasic_d5bb3c61-5dfc-478e-b7f0-b94777ccc713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_31070895-e2d7-45f0-9070-bd2e6ef5f1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_EPSAbstract_1eaba64a-8fcd-4a56-b3d8-7a852de244d6" xlink:to="loc_us-gaap_EarningsPerShareDiluted_31070895-e2d7-45f0-9070-bd2e6ef5f1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7d3b13af-da73-48d0-b026-3258489cc936" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9a6fa0b9-d7a8-4328-9d07-fb06de1ca224" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7d3b13af-da73-48d0-b026-3258489cc936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_96c8a0bd-9a03-40f5-aa23-46b0934ff724" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7d3b13af-da73-48d0-b026-3258489cc936" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_96c8a0bd-9a03-40f5-aa23-46b0934ff724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_eaa69bc9-abab-464c-a6da-06de54dde861" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_7d3b13af-da73-48d0-b026-3258489cc936" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_eaa69bc9-abab-464c-a6da-06de54dde861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="clbs-20230630.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_939989cd-d0f0-4402-bd60-0486923fef25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_260bc183-1f9f-4c54-a7d4-312cfadf4171" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_939989cd-d0f0-4402-bd60-0486923fef25" xlink:to="loc_us-gaap_ProfitLoss_260bc183-1f9f-4c54-a7d4-312cfadf4171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3dc4c77c-2d62-4c90-ae3c-923c4dec31c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_939989cd-d0f0-4402-bd60-0486923fef25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3dc4c77c-2d62-4c90-ae3c-923c4dec31c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ab9f5783-6e13-4249-9740-e5eabf3bc02a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_939989cd-d0f0-4402-bd60-0486923fef25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ab9f5783-6e13-4249-9740-e5eabf3bc02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9ad2dc81-f62d-4e2f-8ba8-25ce7d0c5e71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_939989cd-d0f0-4402-bd60-0486923fef25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9ad2dc81-f62d-4e2f-8ba8-25ce7d0c5e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_42f8fa81-8fbb-433a-b6b5-fec76c3a3751" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_939989cd-d0f0-4402-bd60-0486923fef25" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_42f8fa81-8fbb-433a-b6b5-fec76c3a3751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="clbs-20230630.xsd#ConsolidatedStatementsofEquity"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_002c233b-bf67-49ec-90cc-3be5980860c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a24a4d99-e2a3-4170-9dfa-f6b80d9b5995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_002c233b-bf67-49ec-90cc-3be5980860c1" xlink:to="loc_us-gaap_StatementTable_a24a4d99-e2a3-4170-9dfa-f6b80d9b5995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cc39fa2e-8801-443e-98d7-d240dcc9f555" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a24a4d99-e2a3-4170-9dfa-f6b80d9b5995" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cc39fa2e-8801-443e-98d7-d240dcc9f555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b08c3a65-d725-4dfc-ac8b-de5755c906ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cc39fa2e-8801-443e-98d7-d240dcc9f555" xlink:to="loc_us-gaap_EquityComponentDomain_b08c3a65-d725-4dfc-ac8b-de5755c906ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b08c3a65-d725-4dfc-ac8b-de5755c906ff" xlink:to="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a1ad4f44-3bce-4d3a-9843-38608b70e74d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:to="loc_us-gaap_CommonStockMember_a1ad4f44-3bce-4d3a-9843-38608b70e74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_daf5265f-e2fa-4fed-ae54-f6d41469d70f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_daf5265f-e2fa-4fed-ae54-f6d41469d70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_549da558-9a0e-4d35-a111-1831c7d9ed98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_549da558-9a0e-4d35-a111-1831c7d9ed98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9035ffff-964a-4a9d-97f9-9b765e1b25d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:to="loc_us-gaap_RetainedEarningsMember_9035ffff-964a-4a9d-97f9-9b765e1b25d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_cfd686e2-e04e-44f6-ba5b-52c6059c9dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_5d8e2de9-c993-4f1f-9eaf-c8095c43ba68" xlink:to="loc_us-gaap_TreasuryStockCommonMember_cfd686e2-e04e-44f6-ba5b-52c6059c9dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_250fc035-19a3-43d6-aea3-8e7c4f41a50a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b08c3a65-d725-4dfc-ac8b-de5755c906ff" xlink:to="loc_us-gaap_NoncontrollingInterestMember_250fc035-19a3-43d6-aea3-8e7c4f41a50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_10a85934-ca65-431c-9a91-1f0ea4762496" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a24a4d99-e2a3-4170-9dfa-f6b80d9b5995" xlink:to="loc_us-gaap_StatementLineItems_10a85934-ca65-431c-9a91-1f0ea4762496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_10a85934-ca65-431c-9a91-1f0ea4762496" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_89a8c743-d85a-4974-81bf-ce89ee500c52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_89a8c743-d85a-4974-81bf-ce89ee500c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2dac21b5-54ac-47b0-bde8-ec5d1d2ade65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2dac21b5-54ac-47b0-bde8-ec5d1d2ade65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_65287497-3018-47b8-a8e5-516fd12e66ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_ProfitLoss_65287497-3018-47b8-a8e5-516fd12e66ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ffb30f7e-12d1-492f-b1ed-cd8789af6a18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ffb30f7e-12d1-492f-b1ed-cd8789af6a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_816744a9-4c08-4e1a-ae2c-15968bc5c1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_816744a9-4c08-4e1a-ae2c-15968bc5c1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_20fedbe7-b7a6-4825-92cc-abf2be0c2169" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_20fedbe7-b7a6-4825-92cc-abf2be0c2169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_822c08e9-6722-4bfb-98e4-9bddea9233f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_822c08e9-6722-4bfb-98e4-9bddea9233f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_2129e08b-71e8-45f8-896f-2d65fc415625" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_2129e08b-71e8-45f8-896f-2d65fc415625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_78d23552-2502-4599-9e06-78235dc4c954" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_78d23552-2502-4599-9e06-78235dc4c954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5d128a3a-af64-4538-91a7-510152da5b92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5d128a3a-af64-4538-91a7-510152da5b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_cec75768-4782-4db9-807e-5316fbe9e3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_cec75768-4782-4db9-807e-5316fbe9e3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d5920cad-450c-4429-8371-274a3db57e72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d5920cad-450c-4429-8371-274a3db57e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20ee9bce-9915-47b6-abfb-586ff211c4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_24ce07e6-552b-426c-9847-8fae5a005ad5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20ee9bce-9915-47b6-abfb-586ff211c4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="clbs-20230630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_d84fd683-a6e7-4061-8e24-67368a5626d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ae937ec2-cd25-4467-9a49-f34486e2c33e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d84fd683-a6e7-4061-8e24-67368a5626d3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ae937ec2-cd25-4467-9a49-f34486e2c33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b42792d3-b1f1-4f79-ab85-e45dcb3174e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ae937ec2-cd25-4467-9a49-f34486e2c33e" xlink:to="loc_us-gaap_ProfitLoss_b42792d3-b1f1-4f79-ab85-e45dcb3174e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e9923a67-bd89-4395-ad07-0abb9a8dd0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ae937ec2-cd25-4467-9a49-f34486e2c33e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e9923a67-bd89-4395-ad07-0abb9a8dd0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_54726d72-0ce1-40dc-92cd-b8ffd41d2af0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e9923a67-bd89-4395-ad07-0abb9a8dd0a8" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_54726d72-0ce1-40dc-92cd-b8ffd41d2af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_0ee7a2a5-159a-4ebd-b0a7-c5ed8b72d46a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e9923a67-bd89-4395-ad07-0abb9a8dd0a8" xlink:to="loc_us-gaap_DepreciationAndAmortization_0ee7a2a5-159a-4ebd-b0a7-c5ed8b72d46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_336cb571-8740-42b0-b036-b568d50a872f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e9923a67-bd89-4395-ad07-0abb9a8dd0a8" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_336cb571-8740-42b0-b036-b568d50a872f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_936a58eb-df40-4d54-915f-44edfdeec7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e9923a67-bd89-4395-ad07-0abb9a8dd0a8" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_936a58eb-df40-4d54-915f-44edfdeec7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5bae54a6-ea71-45c2-9f99-cb16b12533d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ae937ec2-cd25-4467-9a49-f34486e2c33e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5bae54a6-ea71-45c2-9f99-cb16b12533d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8837761f-f594-439a-a5cd-bb377ef36e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5bae54a6-ea71-45c2-9f99-cb16b12533d9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8837761f-f594-439a-a5cd-bb377ef36e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ecb89574-1e5a-4bc2-a765-1d256c1661b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5bae54a6-ea71-45c2-9f99-cb16b12533d9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ecb89574-1e5a-4bc2-a765-1d256c1661b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_162435da-30b7-4c08-97a5-b1851a68c719" xlink:href="clbs-20230630.xsd#clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5bae54a6-ea71-45c2-9f99-cb16b12533d9" xlink:to="loc_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_162435da-30b7-4c08-97a5-b1851a68c719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3838bf96-ef4b-432b-828d-fd6b739b4874" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ae937ec2-cd25-4467-9a49-f34486e2c33e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3838bf96-ef4b-432b-828d-fd6b739b4874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75905bad-eb97-411b-be8b-be2d4f7e3a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d84fd683-a6e7-4061-8e24-67368a5626d3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75905bad-eb97-411b-be8b-be2d4f7e3a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_75212371-6dee-4271-a61a-d8d15b38d151" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75905bad-eb97-411b-be8b-be2d4f7e3a1b" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_75212371-6dee-4271-a61a-d8d15b38d151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_cf8b656e-d994-4d31-808d-f324572d4694" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75905bad-eb97-411b-be8b-be2d4f7e3a1b" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_cf8b656e-d994-4d31-808d-f324572d4694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d6afc0eb-60f3-4c90-95bb-33f996b6c56c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75905bad-eb97-411b-be8b-be2d4f7e3a1b" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d6afc0eb-60f3-4c90-95bb-33f996b6c56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_de9bd36d-0439-42a3-b82f-00382f10a43b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75905bad-eb97-411b-be8b-be2d4f7e3a1b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_de9bd36d-0439-42a3-b82f-00382f10a43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_43eebb09-44ff-4cf5-a562-b1588d631665" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75905bad-eb97-411b-be8b-be2d4f7e3a1b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_43eebb09-44ff-4cf5-a562-b1588d631665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8c19e5e-b239-48b7-b34c-2ef0114f226d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d84fd683-a6e7-4061-8e24-67368a5626d3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8c19e5e-b239-48b7-b34c-2ef0114f226d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ProceedsFromExerciseOfOptionsFinancingActivities_857a5e8f-9212-4907-b690-393387c55d94" xlink:href="clbs-20230630.xsd#clbs_ProceedsFromExerciseOfOptionsFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8c19e5e-b239-48b7-b34c-2ef0114f226d" xlink:to="loc_clbs_ProceedsFromExerciseOfOptionsFinancingActivities_857a5e8f-9212-4907-b690-393387c55d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_eb2f5203-045f-4e56-946d-0bc50229082f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8c19e5e-b239-48b7-b34c-2ef0114f226d" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_eb2f5203-045f-4e56-946d-0bc50229082f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_48795be1-8d7a-4d8b-b45a-3d73ceb27aac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8c19e5e-b239-48b7-b34c-2ef0114f226d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_48795be1-8d7a-4d8b-b45a-3d73ceb27aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5976cdbf-e51d-455c-b2f8-95ebecb078db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8c19e5e-b239-48b7-b34c-2ef0114f226d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5976cdbf-e51d-455c-b2f8-95ebecb078db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b4511ff7-0719-4562-a398-96326b512f08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d84fd683-a6e7-4061-8e24-67368a5626d3" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b4511ff7-0719-4562-a398-96326b512f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_aa277084-652e-4e95-b4cf-6c51aadc6b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d84fd683-a6e7-4061-8e24-67368a5626d3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_aa277084-652e-4e95-b4cf-6c51aadc6b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ffd87067-8d4f-4b3c-bd97-cac85c00f133" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d84fd683-a6e7-4061-8e24-67368a5626d3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ffd87067-8d4f-4b3c-bd97-cac85c00f133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e7e5c42a-d0d1-40a2-8716-bbecfd458108" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d84fd683-a6e7-4061-8e24-67368a5626d3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e7e5c42a-d0d1-40a2-8716-bbecfd458108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/TheBusiness" xlink:type="simple" xlink:href="clbs-20230630.xsd#TheBusiness"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/TheBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f01e22e6-9a0a-4a29-8a2b-fd1801d9cb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_BusinessTextBlock_d1ad81e7-9385-4c64-af25-86daa1d67ed6" xlink:href="clbs-20230630.xsd#clbs_BusinessTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f01e22e6-9a0a-4a29-8a2b-fd1801d9cb8d" xlink:to="loc_clbs_BusinessTextBlock_d1ad81e7-9385-4c64-af25-86daa1d67ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="clbs-20230630.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7fdf0e22-49b8-4053-9d64-d7f34e336e03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_11882da0-b9d7-4c8a-a46d-be2292cada29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7fdf0e22-49b8-4053-9d64-d7f34e336e03" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_11882da0-b9d7-4c8a-a46d-be2292cada29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/Merger" xlink:type="simple" xlink:href="clbs-20230630.xsd#Merger"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/Merger" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAbstract_b14b0e08-a0ab-4e60-93db-b6c0cfa5bdcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTextBlock_c3f95242-1f79-46c7-9c84-a61a58fb494c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAbstract_b14b0e08-a0ab-4e60-93db-b6c0cfa5bdcc" xlink:to="loc_us-gaap_AssetAcquisitionTextBlock_c3f95242-1f79-46c7-9c84-a61a58fb494c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecurities" xlink:type="simple" xlink:href="clbs-20230630.xsd#AvailableforSaleSecurities"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_bf3d966f-cf90-488c-be65-d06f5b510b82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_beccc8d5-1c6f-4762-b70b-9a66b829b5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_bf3d966f-cf90-488c-be65-d06f5b510b82" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_beccc8d5-1c6f-4762-b70b-9a66b829b5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/PropertyandEquipmentNotes" xlink:type="simple" xlink:href="clbs-20230630.xsd#PropertyandEquipmentNotes"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/PropertyandEquipmentNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2733557a-7d8e-42b5-b5f4-a8c43568a4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_baf3a33a-c943-43cb-b45b-67417bc67701" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2733557a-7d8e-42b5-b5f4-a8c43568a4ad" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_baf3a33a-c943-43cb-b45b-67417bc67701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeLossPerShare" xlink:type="simple" xlink:href="clbs-20230630.xsd#IncomeLossPerShare"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/IncomeLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_135c97f7-7c83-43bd-ba1c-2b3f72a0623c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_f5bd234d-bceb-489c-ad64-bd9c0b84359e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_135c97f7-7c83-43bd-ba1c-2b3f72a0623c" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_f5bd234d-bceb-489c-ad64-bd9c0b84359e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="clbs-20230630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c9e0f401-9c8d-4e15-ae91-92aa7e8cd0af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_74f15c30-df19-4297-b07b-f9677d868829" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c9e0f401-9c8d-4e15-ae91-92aa7e8cd0af" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_74f15c30-df19-4297-b07b-f9677d868829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="clbs-20230630.xsd#AccruedLiabilities"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AccruedLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_6bb28892-4a7a-4a54-96be-655b2bdca6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_5c64f11e-8f1a-4d29-aab3-77b842293d37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_6bb28892-4a7a-4a54-96be-655b2bdca6a4" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_5c64f11e-8f1a-4d29-aab3-77b842293d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeases" xlink:type="simple" xlink:href="clbs-20230630.xsd#OperatingLeases"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/OperatingLeases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_583c7caf-6ce9-4484-a064-2cb63812ddb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_0790ec57-0063-40c2-ab9e-a383337b0a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_583c7caf-6ce9-4484-a064-2cb63812ddb8" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_0790ec57-0063-40c2-ab9e-a383337b0a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquity" xlink:type="simple" xlink:href="clbs-20230630.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_319060d6-8449-433c-a5da-92dbb07fdb40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b4da87ec-5bcc-45c5-b98e-d3f923e5217e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_319060d6-8449-433c-a5da-92dbb07fdb40" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b4da87ec-5bcc-45c5-b98e-d3f923e5217e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="clbs-20230630.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_868fd787-c0a0-4787-b3fe-cc87aaee97ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_80a06b2d-28a2-42a4-8738-c154b523685b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_868fd787-c0a0-4787-b3fe-cc87aaee97ed" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_80a06b2d-28a2-42a4-8738-c154b523685b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeTaxes" xlink:type="simple" xlink:href="clbs-20230630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a2f723df-c3ba-4913-85f9-b4b26f8410e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_452662aa-191d-4658-9fb0-8945499128f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a2f723df-c3ba-4913-85f9-b4b26f8410e9" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_452662aa-191d-4658-9fb0-8945499128f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentive" xlink:type="simple" xlink:href="clbs-20230630.xsd#AustraliaResearchandDevelopmentTaxIncentive"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentive" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9e0c036e-eb02-45b6-a59e-6f13b11f5c72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ResearchAndDevelopmentTaxIncentiveTextBlock_7ea1d4b1-9106-47d7-8290-005b90a84300" xlink:href="clbs-20230630.xsd#clbs_ResearchAndDevelopmentTaxIncentiveTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9e0c036e-eb02-45b6-a59e-6f13b11f5c72" xlink:to="loc_clbs_ResearchAndDevelopmentTaxIncentiveTextBlock_7ea1d4b1-9106-47d7-8290-005b90a84300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/Contingencies" xlink:type="simple" xlink:href="clbs-20230630.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_032ca4ad-d381-442c-9c3e-a8f2deeb903a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d3c5b97e-1459-4c0c-a3e6-79fe203db58e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_032ca4ad-d381-442c-9c3e-a8f2deeb903a" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d3c5b97e-1459-4c0c-a3e6-79fe203db58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/LicenseAgreements" xlink:type="simple" xlink:href="clbs-20230630.xsd#LicenseAgreements"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/LicenseAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4ac6b64b-d332-4347-94a7-fd10b350ef3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_92d605fe-7db9-487f-9e8b-84a553081fca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4ac6b64b-d332-4347-94a7-fd10b350ef3d" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_92d605fe-7db9-487f-9e8b-84a553081fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreement" xlink:type="simple" xlink:href="clbs-20230630.xsd#ResearchCollaborationandLicenseAgreement"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b970f3e-7f21-4d03-8fc6-1a7d1b159e22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_2f7f64a7-fbae-406b-839d-0d57ac715b47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b970f3e-7f21-4d03-8fc6-1a7d1b159e22" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_2f7f64a7-fbae-406b-839d-0d57ac715b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/SubsequentEvents" xlink:type="simple" xlink:href="clbs-20230630.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_73f2f03e-d683-468e-907e-e04db9fa9eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_743686b6-1a2f-4901-919b-3966c03e2714" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_73f2f03e-d683-468e-907e-e04db9fa9eb3" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_743686b6-1a2f-4901-919b-3966c03e2714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="clbs-20230630.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b17840a0-1cbe-4037-972a-4abedd7c9204" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_40fa2ce3-1b2a-4776-96a3-fb3b4fb89679" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b17840a0-1cbe-4037-972a-4abedd7c9204" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_40fa2ce3-1b2a-4776-96a3-fb3b4fb89679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_117a72bc-b617-4a77-8e00-1d23b0c77d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b17840a0-1cbe-4037-972a-4abedd7c9204" xlink:to="loc_us-gaap_UseOfEstimates_117a72bc-b617-4a77-8e00-1d23b0c77d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_09905574-8b90-4f9a-94a1-7dd82b75190b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b17840a0-1cbe-4037-972a-4abedd7c9204" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_09905574-8b90-4f9a-94a1-7dd82b75190b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_9b600dde-247e-4e44-b3ea-28698d3711f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b17840a0-1cbe-4037-972a-4abedd7c9204" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_9b600dde-247e-4e44-b3ea-28698d3711f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_4309deaa-3323-464e-923f-2590baa05ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b17840a0-1cbe-4037-972a-4abedd7c9204" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_4309deaa-3323-464e-923f-2590baa05ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3b701353-adeb-4b39-ab1a-bc98ae46eaab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b17840a0-1cbe-4037-972a-4abedd7c9204" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3b701353-adeb-4b39-ab1a-bc98ae46eaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_44ab87c7-1f45-4d2f-a892-6ce79da1993a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b17840a0-1cbe-4037-972a-4abedd7c9204" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_44ab87c7-1f45-4d2f-a892-6ce79da1993a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/MergerTables" xlink:type="simple" xlink:href="clbs-20230630.xsd#MergerTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/MergerTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAbstract_cf2efb55-ab89-44a9-8044-da5c829d74e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTableTextBlock_10f5bb9e-25ac-4089-85e6-7e9382e460c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAbstract_cf2efb55-ab89-44a9-8044-da5c829d74e2" xlink:to="loc_us-gaap_AssetAcquisitionTableTextBlock_10f5bb9e-25ac-4089-85e6-7e9382e460c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesTables" xlink:type="simple" xlink:href="clbs-20230630.xsd#AvailableforSaleSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_35d1f16c-2c73-491e-8566-5f1362df8692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_6b69e4a1-fded-448d-a739-2a8a46443bea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_35d1f16c-2c73-491e-8566-5f1362df8692" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_6b69e4a1-fded-448d-a739-2a8a46443bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_20dcd5af-6972-4525-999a-862c9701edf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_35d1f16c-2c73-491e-8566-5f1362df8692" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_20dcd5af-6972-4525-999a-862c9701edf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_feb92883-53b1-4cdd-a5e6-f7013d4504e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_35d1f16c-2c73-491e-8566-5f1362df8692" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_feb92883-53b1-4cdd-a5e6-f7013d4504e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="clbs-20230630.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9c155803-c959-43d8-b0cc-8602d7d17d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c803bcc9-9738-4b89-be44-3cac6eea10df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9c155803-c959-43d8-b0cc-8602d7d17d3b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c803bcc9-9738-4b89-be44-3cac6eea10df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeLossPerShareTables" xlink:type="simple" xlink:href="clbs-20230630.xsd#IncomeLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/IncomeLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c1a276dd-1658-43a7-851c-71533d25ce5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c0fdd6f6-15a5-4109-853b-4cd251143faa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c1a276dd-1658-43a7-851c-71533d25ce5d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c0fdd6f6-15a5-4109-853b-4cd251143faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="clbs-20230630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9816fac3-7792-42e3-80f1-8cae84eaa586" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_53c043f8-6cf0-4a02-8eed-6634764e023d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9816fac3-7792-42e3-80f1-8cae84eaa586" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_53c043f8-6cf0-4a02-8eed-6634764e023d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="clbs-20230630.xsd#AccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_a8f5293e-8b27-4abc-bbd2-c5d29d30a156" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_c454b66c-4b67-4879-950c-b4b9a726758d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_a8f5293e-8b27-4abc-bbd2-c5d29d30a156" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_c454b66c-4b67-4879-950c-b4b9a726758d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesTables" xlink:type="simple" xlink:href="clbs-20230630.xsd#OperatingLeasesTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b8d535f0-4849-4bc1-a25b-75d59f6f5fef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_e1209c28-d13d-4dfb-83fd-bdd17177add0" xlink:href="clbs-20230630.xsd#clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b8d535f0-4849-4bc1-a25b-75d59f6f5fef" xlink:to="loc_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_e1209c28-d13d-4dfb-83fd-bdd17177add0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_03a6d78e-2460-48b7-a028-8e54ca91b6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b8d535f0-4849-4bc1-a25b-75d59f6f5fef" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_03a6d78e-2460-48b7-a028-8e54ca91b6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="clbs-20230630.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c211a541-d17c-4bb9-86a2-749d000f0423" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9c136aac-69e8-4c0e-8d58-607987de8c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c211a541-d17c-4bb9-86a2-749d000f0423" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9c136aac-69e8-4c0e-8d58-607987de8c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_40b55f6d-4e3e-4efb-85d1-259302965a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c211a541-d17c-4bb9-86a2-749d000f0423" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_40b55f6d-4e3e-4efb-85d1-259302965a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_7d5ebb17-2cc5-4b7f-b68d-e73420f97336" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c211a541-d17c-4bb9-86a2-749d000f0423" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_7d5ebb17-2cc5-4b7f-b68d-e73420f97336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="clbs-20230630.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_d1e4ebb3-2fb3-4cdf-b3f1-952ddb414f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_19bb659a-4f4e-4448-a95a-f9cf9e332b92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_d1e4ebb3-2fb3-4cdf-b3f1-952ddb414f3d" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_19bb659a-4f4e-4448-a95a-f9cf9e332b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_4c39adc1-43eb-41b3-aeb4-4be92a2cac24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_d1e4ebb3-2fb3-4cdf-b3f1-952ddb414f3d" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_4c39adc1-43eb-41b3-aeb4-4be92a2cac24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7b70a492-d5d0-4eb9-870c-18f709f3956a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_d1e4ebb3-2fb3-4cdf-b3f1-952ddb414f3d" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7b70a492-d5d0-4eb9-870c-18f709f3956a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/TheBusinessDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#TheBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/TheBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b9f052cf-40db-4a6e-aa4d-b89c8708a3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable_c5ee0e36-af5b-4df4-acb0-b19eb26cfd53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b9f052cf-40db-4a6e-aa4d-b89c8708a3f6" xlink:to="loc_us-gaap_AssetAcquisitionTable_c5ee0e36-af5b-4df4-acb0-b19eb26cfd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_ebe5c5c0-7447-4fcf-b502-54c7d49c1581" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_c5ee0e36-af5b-4df4-acb0-b19eb26cfd53" xlink:to="loc_us-gaap_AssetAcquisitionAxis_ebe5c5c0-7447-4fcf-b502-54c7d49c1581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_c7f8c445-23ff-4f20-9dd5-a5647f67eb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_ebe5c5c0-7447-4fcf-b502-54c7d49c1581" xlink:to="loc_us-gaap_AssetAcquisitionDomain_c7f8c445-23ff-4f20-9dd5-a5647f67eb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CENDMember_011805a1-e2ad-4737-9f22-fa0b08966e22" xlink:href="clbs-20230630.xsd#clbs_CENDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_c7f8c445-23ff-4f20-9dd5-a5647f67eb6d" xlink:to="loc_clbs_CENDMember_011805a1-e2ad-4737-9f22-fa0b08966e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems_4d4b3398-2174-4d71-b5f4-0c76b46011ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_c5ee0e36-af5b-4df4-acb0-b19eb26cfd53" xlink:to="loc_us-gaap_AssetAcquisitionLineItems_4d4b3398-2174-4d71-b5f4-0c76b46011ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_6f95f9d6-efeb-4b38-afbd-0f8d8845d4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_4d4b3398-2174-4d71-b5f4-0c76b46011ca" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_6f95f9d6-efeb-4b38-afbd-0f8d8845d4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_50411f5b-ecf0-45ec-82ed-5e3b9cd95389" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_4d4b3398-2174-4d71-b5f4-0c76b46011ca" xlink:to="loc_us-gaap_SharesIssued_50411f5b-ecf0-45ec-82ed-5e3b9cd95389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_d8752a38-2e4b-4d06-b91d-1bf5c9f9d1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_4d4b3398-2174-4d71-b5f4-0c76b46011ca" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_d8752a38-2e4b-4d06-b91d-1bf5c9f9d1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_a689ac43-6d48-440d-87e1-136c59a5f0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_4d4b3398-2174-4d71-b5f4-0c76b46011ca" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_a689ac43-6d48-440d-87e1-136c59a5f0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1859e911-300b-4a7b-8e46-8c567c35b5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3f3fc95d-f13b-45ed-9b7e-cff013f09220" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1859e911-300b-4a7b-8e46-8c567c35b5d9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3f3fc95d-f13b-45ed-9b7e-cff013f09220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6b5b19cb-4049-41ed-906e-d1c09d5547c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1859e911-300b-4a7b-8e46-8c567c35b5d9" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6b5b19cb-4049-41ed-906e-d1c09d5547c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d2f69e35-5eb0-4bb4-a7d7-490953092a28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1859e911-300b-4a7b-8e46-8c567c35b5d9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d2f69e35-5eb0-4bb4-a7d7-490953092a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a54038d-8d1d-444d-af47-1a1a7a3a389a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1859e911-300b-4a7b-8e46-8c567c35b5d9" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a54038d-8d1d-444d-af47-1a1a7a3a389a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_103f76ef-def2-4c66-9cee-be672ece86e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a54038d-8d1d-444d-af47-1a1a7a3a389a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_103f76ef-def2-4c66-9cee-be672ece86e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6fc6a6d-aba3-458f-b3b5-0f45d706b200" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_103f76ef-def2-4c66-9cee-be672ece86e6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6fc6a6d-aba3-458f-b3b5-0f45d706b200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_56735390-a194-48d3-adb7-9b21d55a0898" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6fc6a6d-aba3-458f-b3b5-0f45d706b200" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_56735390-a194-48d3-adb7-9b21d55a0898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_0b555058-79e5-4fb0-866b-c117275cb275" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6fc6a6d-aba3-458f-b3b5-0f45d706b200" xlink:to="loc_us-gaap_ComputerEquipmentMember_0b555058-79e5-4fb0-866b-c117275cb275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_4f5d557f-bbed-4c15-8d09-bd9b89f0e664" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6fc6a6d-aba3-458f-b3b5-0f45d706b200" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_4f5d557f-bbed-4c15-8d09-bd9b89f0e664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_85d6e34a-5ba5-432e-b191-c19079e9d9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c6fc6a6d-aba3-458f-b3b5-0f45d706b200" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_85d6e34a-5ba5-432e-b191-c19079e9d9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4e68066-1404-46fd-a484-2261f8375c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a54038d-8d1d-444d-af47-1a1a7a3a389a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4e68066-1404-46fd-a484-2261f8375c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_995839b0-b9e2-409c-aae3-fa2d458214e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a4e68066-1404-46fd-a484-2261f8375c6e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_995839b0-b9e2-409c-aae3-fa2d458214e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/MergerDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#MergerDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/MergerDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAbstract_7d758d33-3f6c-4f67-bc91-fbef97dd385d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable_909e433e-f8bd-4a0e-aae7-0e06ae79eba3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAbstract_7d758d33-3f6c-4f67-bc91-fbef97dd385d" xlink:to="loc_us-gaap_AssetAcquisitionTable_909e433e-f8bd-4a0e-aae7-0e06ae79eba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_30140b8e-f13d-429e-83f9-55d4a2fcd24e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_909e433e-f8bd-4a0e-aae7-0e06ae79eba3" xlink:to="loc_us-gaap_AssetAcquisitionAxis_30140b8e-f13d-429e-83f9-55d4a2fcd24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_13009993-2f40-4dbe-9b78-f717f02a0fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_30140b8e-f13d-429e-83f9-55d4a2fcd24e" xlink:to="loc_us-gaap_AssetAcquisitionDomain_13009993-2f40-4dbe-9b78-f717f02a0fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CENDMember_d97fdcb8-2133-42f9-bb6a-9f2dc115b3cb" xlink:href="clbs-20230630.xsd#clbs_CENDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_13009993-2f40-4dbe-9b78-f717f02a0fc1" xlink:to="loc_clbs_CENDMember_d97fdcb8-2133-42f9-bb6a-9f2dc115b3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_909e433e-f8bd-4a0e-aae7-0e06ae79eba3" xlink:to="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0d7099e0-b32c-4f84-bcb4-74de2e989dea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0d7099e0-b32c-4f84-bcb4-74de2e989dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionSharePrice_247b28af-8986-41dc-80b1-a2325a7b75b9" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionSharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionSharePrice_247b28af-8986-41dc-80b1-a2325a7b75b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionConsiderationTransferredEquityValue_97cb65a6-2806-4ac7-b1af-08e2e4863c50" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionConsiderationTransferredEquityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionConsiderationTransferredEquityValue_97cb65a6-2806-4ac7-b1af-08e2e4863c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_ebe62dd6-4e70-446b-8433-e69534dabe22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_ebe62dd6-4e70-446b-8433-e69534dabe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_eb40843a-1414-4e50-b301-743eecebdd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_eb40843a-1414-4e50-b301-743eecebdd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_d3f53068-6dcd-45c4-b4f8-6301d7030f57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost_d3f53068-6dcd-45c4-b4f8-6301d7030f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_8d7ba96e-ac48-465a-9c0b-1c9de479ad93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_8d7ba96e-ac48-465a-9c0b-1c9de479ad93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionCashAndCashEquivalents_a4506ccf-3669-4e43-b40a-c88c886e2773" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionCashAndCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionCashAndCashEquivalents_a4506ccf-3669-4e43-b40a-c88c886e2773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionNetWorkingCapital_f3c40a23-fe10-48b7-832a-a4c82ab4e93c" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionNetWorkingCapital"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionNetWorkingCapital_f3c40a23-fe10-48b7-832a-a4c82ab4e93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionOtherLiabilities_eb20807e-8b36-47a9-ad97-3c3a480688cd" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionOtherLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionOtherLiabilities_eb20807e-8b36-47a9-ad97-3c3a480688cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment_464ae879-be72-4138-a7cb-8b61f684d3d3" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment_464ae879-be72-4138-a7cb-8b61f684d3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AssetAcquisitionIntangibles_5b66568e-f2a9-477e-b9ee-c65a7009b70f" xlink:href="clbs-20230630.xsd#clbs_AssetAcquisitionIntangibles"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_5255f14a-5d41-421a-a99b-966aaf17c530" xlink:to="loc_clbs_AssetAcquisitionIntangibles_5b66568e-f2a9-477e-b9ee-c65a7009b70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_6c0fecee-20d4-4cc5-8129-d529f3ca5815" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6e2cb36e-f6df-4644-bc89-59cebdbf8084" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_6c0fecee-20d4-4cc5-8129-d529f3ca5815" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6e2cb36e-f6df-4644-bc89-59cebdbf8084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f0858b27-4272-4082-8105-21a8ab66df39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6e2cb36e-f6df-4644-bc89-59cebdbf8084" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f0858b27-4272-4082-8105-21a8ab66df39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f0858b27-4272-4082-8105-21a8ab66df39" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_38a54f1b-a0bf-41f0-8bbb-6c4b745562f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_38a54f1b-a0bf-41f0-8bbb-6c4b745562f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_ee995bee-b24f-4e1b-870b-1923ea2f12e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:to="loc_us-gaap_CommercialPaperMember_ee995bee-b24f-4e1b-870b-1923ea2f12e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_506aeae9-9b25-4d89-8e17-c3d32c8ff477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:to="loc_us-gaap_MoneyMarketFundsMember_506aeae9-9b25-4d89-8e17-c3d32c8ff477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_704320d5-5714-4b73-8430-da7abfcb4e06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_704320d5-5714-4b73-8430-da7abfcb4e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BondsMember_30bde966-c574-499b-a736-13af669af1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BondsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:to="loc_us-gaap_BondsMember_30bde966-c574-499b-a736-13af669af1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBillSecuritiesMember_e211bc7d-ca33-43d2-8872-4632bb640d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de58d6e7-804d-4e82-b6f6-2ef351ca1db2" xlink:to="loc_us-gaap_USTreasuryBillSecuritiesMember_e211bc7d-ca33-43d2-8872-4632bb640d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dc0eca6e-62d0-4322-953a-27d859144be2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_6e2cb36e-f6df-4644-bc89-59cebdbf8084" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dc0eca6e-62d0-4322-953a-27d859144be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_83a90437-2510-453d-9962-df94f47443bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dc0eca6e-62d0-4322-953a-27d859144be2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_83a90437-2510-453d-9962-df94f47443bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_35a4d078-3155-4115-94ad-a049b4aec328" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dc0eca6e-62d0-4322-953a-27d859144be2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_35a4d078-3155-4115-94ad-a049b4aec328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_04478de3-0c2a-4524-9d37-ac98f36d3163" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dc0eca6e-62d0-4322-953a-27d859144be2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_04478de3-0c2a-4524-9d37-ac98f36d3163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5eb2a0f8-9261-4183-9346-972a97a8bceb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dc0eca6e-62d0-4322-953a-27d859144be2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5eb2a0f8-9261-4183-9346-972a97a8bceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_028c7caf-555f-4680-935a-17bfebe2ecdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_15e9a910-c80e-4711-bde7-0b350a9b8437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_028c7caf-555f-4680-935a-17bfebe2ecdd" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_15e9a910-c80e-4711-bde7-0b350a9b8437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_6cfc436b-6cd6-4d0f-a2c5-1b955a93d2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_028c7caf-555f-4680-935a-17bfebe2ecdd" xlink:to="loc_us-gaap_MarketableSecurities_6cfc436b-6cd6-4d0f-a2c5-1b955a93d2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_9deab375-d579-41e2-a649-9a29936aa6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_028c7caf-555f-4680-935a-17bfebe2ecdd" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_9deab375-d579-41e2-a649-9a29936aa6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_8abe0ebd-0553-443f-8d5d-e4f74a8c4584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_eebd0310-8194-4985-a740-e46cd8cc3c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_8abe0ebd-0553-443f-8d5d-e4f74a8c4584" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_eebd0310-8194-4985-a740-e46cd8cc3c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_0f16c146-ac92-448d-a306-3aa9a128c371" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_eebd0310-8194-4985-a740-e46cd8cc3c3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_0f16c146-ac92-448d-a306-3aa9a128c371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_d64b0dbf-d426-4f4d-b663-d177bc13dcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_eebd0310-8194-4985-a740-e46cd8cc3c3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_d64b0dbf-d426-4f4d-b663-d177bc13dcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f934198f-fd55-4c2b-8b5c-fc4d1f0b3ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_eebd0310-8194-4985-a740-e46cd8cc3c3b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f934198f-fd55-4c2b-8b5c-fc4d1f0b3ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b349cc3c-278e-4f13-8ed0-6a2ca82f6219" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_8abe0ebd-0553-443f-8d5d-e4f74a8c4584" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b349cc3c-278e-4f13-8ed0-6a2ca82f6219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_22d905f9-6fdf-4963-985e-d99feab55b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b349cc3c-278e-4f13-8ed0-6a2ca82f6219" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_22d905f9-6fdf-4963-985e-d99feab55b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_1e100029-c4ca-4ca7-accd-cabe7f383a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b349cc3c-278e-4f13-8ed0-6a2ca82f6219" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_1e100029-c4ca-4ca7-accd-cabe7f383a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c09a58b5-3b1b-4661-b571-5cef0e0dd3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_b349cc3c-278e-4f13-8ed0-6a2ca82f6219" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c09a58b5-3b1b-4661-b571-5cef0e0dd3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#PropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2506f44-b09a-4681-84c9-63d35f508376" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0a71e9e2-e462-40f5-b272-43c9f7860f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2506f44-b09a-4681-84c9-63d35f508376" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0a71e9e2-e462-40f5-b272-43c9f7860f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e17e9b1-0cc2-4178-b10e-4548aac8596a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0a71e9e2-e462-40f5-b272-43c9f7860f1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e17e9b1-0cc2-4178-b10e-4548aac8596a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73c46783-0b07-4e27-af09-18dcb23ddc21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e17e9b1-0cc2-4178-b10e-4548aac8596a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73c46783-0b07-4e27-af09-18dcb23ddc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_78290c5d-b668-4e6b-af5a-ab279d7662b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73c46783-0b07-4e27-af09-18dcb23ddc21" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_78290c5d-b668-4e6b-af5a-ab279d7662b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_c2b44359-4c90-4aa3-81c7-bda9662ad2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73c46783-0b07-4e27-af09-18dcb23ddc21" xlink:to="loc_us-gaap_ComputerEquipmentMember_c2b44359-4c90-4aa3-81c7-bda9662ad2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3ba95b56-2c2d-49a1-9b8f-4e0bed7e3bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_73c46783-0b07-4e27-af09-18dcb23ddc21" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3ba95b56-2c2d-49a1-9b8f-4e0bed7e3bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9ee1c7a-547e-4aea-88a6-feb29a6c0a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0a71e9e2-e462-40f5-b272-43c9f7860f1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9ee1c7a-547e-4aea-88a6-feb29a6c0a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_dc750da0-73bc-453f-98d2-69049cf910ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9ee1c7a-547e-4aea-88a6-feb29a6c0a3e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_dc750da0-73bc-453f-98d2-69049cf910ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8758e20f-0c43-4995-9b28-596c97d72148" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9ee1c7a-547e-4aea-88a6-feb29a6c0a3e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8758e20f-0c43-4995-9b28-596c97d72148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0beba8a9-e85a-4030-af0e-9b901d78fab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9ee1c7a-547e-4aea-88a6-feb29a6c0a3e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0beba8a9-e85a-4030-af0e-9b901d78fab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_5cd32ed8-201e-4899-95e2-93b90a93f200" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_a9ee1c7a-547e-4aea-88a6-feb29a6c0a3e" xlink:to="loc_us-gaap_Depreciation_5cd32ed8-201e-4899-95e2-93b90a93f200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeLossPerShareDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#IncomeLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/IncomeLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5af05125-55da-41b4-aff8-d28daf9d39d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_babb41c6-27e3-432c-9b6e-a78c26865d45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5af05125-55da-41b4-aff8-d28daf9d39d6" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_babb41c6-27e3-432c-9b6e-a78c26865d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a904fa2-1387-4f89-82c2-325885c2c0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_babb41c6-27e3-432c-9b6e-a78c26865d45" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a904fa2-1387-4f89-82c2-325885c2c0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_431a24cf-9b8e-4e32-b1b2-c294bd8aa406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7a904fa2-1387-4f89-82c2-325885c2c0ec" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_431a24cf-9b8e-4e32-b1b2-c294bd8aa406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_03ba1a52-6a7b-4fb0-9597-ff3a67579f70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_431a24cf-9b8e-4e32-b1b2-c294bd8aa406" xlink:to="loc_us-gaap_EmployeeStockOptionMember_03ba1a52-6a7b-4fb0-9597-ff3a67579f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_0d02cfe7-36d1-4687-858d-07b8802fbe41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_431a24cf-9b8e-4e32-b1b2-c294bd8aa406" xlink:to="loc_us-gaap_WarrantMember_0d02cfe7-36d1-4687-858d-07b8802fbe41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_82d5fbeb-d04e-4f01-9ea5-0444eb0f2fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_431a24cf-9b8e-4e32-b1b2-c294bd8aa406" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_82d5fbeb-d04e-4f01-9ea5-0444eb0f2fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_05cf9a04-cd14-4a98-9f9d-b303cbdbe040" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_babb41c6-27e3-432c-9b6e-a78c26865d45" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_05cf9a04-cd14-4a98-9f9d-b303cbdbe040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6d242d55-bb06-4062-9cf7-274cd523e06a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_05cf9a04-cd14-4a98-9f9d-b303cbdbe040" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6d242d55-bb06-4062-9cf7-274cd523e06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_eab297f4-cdf0-4b85-b666-7632f0149ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50fb7dad-eb2c-49b1-b7ea-b49bc6ef1d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_eab297f4-cdf0-4b85-b666-7632f0149ff2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50fb7dad-eb2c-49b1-b7ea-b49bc6ef1d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2d8022a-e351-433c-9caf-0adbc46b3a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50fb7dad-eb2c-49b1-b7ea-b49bc6ef1d2e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2d8022a-e351-433c-9caf-0adbc46b3a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_55d4ed6a-9ab4-4135-a81b-1b81b8553210" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e2d8022a-e351-433c-9caf-0adbc46b3a2e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_55d4ed6a-9ab4-4135-a81b-1b81b8553210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0e8d9abb-0e8a-4fbd-a466-8afce8a8644a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_55d4ed6a-9ab4-4135-a81b-1b81b8553210" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0e8d9abb-0e8a-4fbd-a466-8afce8a8644a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3e276a18-a8c2-45eb-a6f6-657fa274509e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_55d4ed6a-9ab4-4135-a81b-1b81b8553210" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3e276a18-a8c2-45eb-a6f6-657fa274509e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3f8a6976-76fe-44b9-b70b-55f7fac0e9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_55d4ed6a-9ab4-4135-a81b-1b81b8553210" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3f8a6976-76fe-44b9-b70b-55f7fac0e9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_edb41e2f-58ab-402a-b695-d9bd3ced48a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50fb7dad-eb2c-49b1-b7ea-b49bc6ef1d2e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_edb41e2f-58ab-402a-b695-d9bd3ced48a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_93141099-0ded-4112-8794-cf2d7a2d1e22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_edb41e2f-58ab-402a-b695-d9bd3ced48a0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_93141099-0ded-4112-8794-cf2d7a2d1e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_3e32255d-59d9-4002-914c-7a270605a19b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_93141099-0ded-4112-8794-cf2d7a2d1e22" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_3e32255d-59d9-4002-914c-7a270605a19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9058a94-e99d-4f11-9577-b75c1508535c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50fb7dad-eb2c-49b1-b7ea-b49bc6ef1d2e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9058a94-e99d-4f11-9577-b75c1508535c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_573dfa83-0d93-47f4-9b18-07aac7f17092" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9058a94-e99d-4f11-9577-b75c1508535c" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_573dfa83-0d93-47f4-9b18-07aac7f17092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_b35d8003-e308-401d-8c7e-a2d2d28da5af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9058a94-e99d-4f11-9577-b75c1508535c" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_b35d8003-e308-401d-8c7e-a2d2d28da5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_68259ebe-c0e6-4d00-8dda-ff90e4f9e44c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9058a94-e99d-4f11-9577-b75c1508535c" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_68259ebe-c0e6-4d00-8dda-ff90e4f9e44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#AccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_12b391e9-e3e3-4578-b8ee-0482de293706" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9c498d8b-a9d6-47d8-9095-110c70d2b172" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_12b391e9-e3e3-4578-b8ee-0482de293706" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9c498d8b-a9d6-47d8-9095-110c70d2b172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2734c6cd-2eb1-428e-b9c0-a4d1b72b0002" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_12b391e9-e3e3-4578-b8ee-0482de293706" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2734c6cd-2eb1-428e-b9c0-a4d1b72b0002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AccruedGrantFunding_9af53670-5462-4250-8db3-ad357cb7ade2" xlink:href="clbs-20230630.xsd#clbs_AccruedGrantFunding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_12b391e9-e3e3-4578-b8ee-0482de293706" xlink:to="loc_clbs_AccruedGrantFunding_9af53670-5462-4250-8db3-ad357cb7ade2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ClinicalAndRDRelatedLiabilities_6accb955-6d09-4097-865e-1a16aa9bb72c" xlink:href="clbs-20230630.xsd#clbs_ClinicalAndRDRelatedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_12b391e9-e3e3-4578-b8ee-0482de293706" xlink:to="loc_clbs_ClinicalAndRDRelatedLiabilities_6accb955-6d09-4097-865e-1a16aa9bb72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_843a1654-8aa4-4936-afa7-c1135a802d33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_12b391e9-e3e3-4578-b8ee-0482de293706" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_843a1654-8aa4-4936-afa7-c1135a802d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_dd89f037-4965-43fc-bad8-2aa2f2f746cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_12b391e9-e3e3-4578-b8ee-0482de293706" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_dd89f037-4965-43fc-bad8-2aa2f2f746cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#OperatingLeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_504b29f2-287a-419a-b0b3-2827111ae326" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_643c807b-40ef-49fe-81fa-b8ebde29ac28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_504b29f2-287a-419a-b0b3-2827111ae326" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_643c807b-40ef-49fe-81fa-b8ebde29ac28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_3de39bcd-b42b-4efe-a7db-9d7445cfe342" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_504b29f2-287a-419a-b0b3-2827111ae326" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_3de39bcd-b42b-4efe-a7db-9d7445cfe342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#OperatingLeasesBalanceSheetPresentationDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ceece1e1-8f45-49c0-9513-55b47b42e644" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_OperatingLeaseRightOfUseAssetAbstract_b802c650-c6f3-4dfa-be9d-a42c45d8b5e5" xlink:href="clbs-20230630.xsd#clbs_OperatingLeaseRightOfUseAssetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ceece1e1-8f45-49c0-9513-55b47b42e644" xlink:to="loc_clbs_OperatingLeaseRightOfUseAssetAbstract_b802c650-c6f3-4dfa-be9d-a42c45d8b5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5b041e90-65a2-4164-8661-615955ed2682" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_OperatingLeaseRightOfUseAssetAbstract_b802c650-c6f3-4dfa-be9d-a42c45d8b5e5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5b041e90-65a2-4164-8661-615955ed2682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_dcfe033f-2547-4285-b727-c9b03bdb73b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_OperatingLeaseRightOfUseAssetAbstract_b802c650-c6f3-4dfa-be9d-a42c45d8b5e5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_dcfe033f-2547-4285-b727-c9b03bdb73b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract_d740e2f6-858a-4b86-bf12-9b96105e4753" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ceece1e1-8f45-49c0-9513-55b47b42e644" xlink:to="loc_us-gaap_OperatingLeaseLiabilityAbstract_d740e2f6-858a-4b86-bf12-9b96105e4753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_40660b25-4ecb-49f4-afe2-020c1e605442" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_d740e2f6-858a-4b86-bf12-9b96105e4753" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_40660b25-4ecb-49f4-afe2-020c1e605442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_041aa810-efa3-48e1-9217-c8f58c578080" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_d740e2f6-858a-4b86-bf12-9b96105e4753" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_041aa810-efa3-48e1-9217-c8f58c578080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4435aee5-9fae-4a61-ab8c-ec13638e817e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_d740e2f6-858a-4b86-bf12-9b96105e4753" xlink:to="loc_us-gaap_OperatingLeaseLiability_4435aee5-9fae-4a61-ab8c-ec13638e817e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b6e79b9f-562c-48ac-b3e8-2d6066882412" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_d740e2f6-858a-4b86-bf12-9b96105e4753" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b6e79b9f-562c-48ac-b3e8-2d6066882412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_302974c4-2c22-4e4d-8597-7dbf099f337b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_d740e2f6-858a-4b86-bf12-9b96105e4753" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_302974c4-2c22-4e4d-8597-7dbf099f337b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#OperatingLeasesFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e21b4388-d8cb-4c77-88ea-3fc1212dda9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_32d4ba3b-e296-409e-a92b-680dbc8d5263" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e21b4388-d8cb-4c77-88ea-3fc1212dda9c" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_32d4ba3b-e296-409e-a92b-680dbc8d5263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_7f5127a3-9739-4c5b-82fb-55c164bd5a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_32d4ba3b-e296-409e-a92b-680dbc8d5263" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_7f5127a3-9739-4c5b-82fb-55c164bd5a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bab475fd-2e3c-4bbc-a6db-efddd329d825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_32d4ba3b-e296-409e-a92b-680dbc8d5263" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bab475fd-2e3c-4bbc-a6db-efddd329d825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0d90636d-d213-4bb4-a09c-b01531a4c3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_32d4ba3b-e296-409e-a92b-680dbc8d5263" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0d90636d-d213-4bb4-a09c-b01531a4c3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e4d6325-4da9-4e30-b533-813a3c2a959d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_32d4ba3b-e296-409e-a92b-680dbc8d5263" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3e4d6325-4da9-4e30-b533-813a3c2a959d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b8dcfec7-fbde-483d-8bd8-e197e8c554f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_32d4ba3b-e296-409e-a92b-680dbc8d5263" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b8dcfec7-fbde-483d-8bd8-e197e8c554f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a6192387-d64a-4565-9cad-9d780051e9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_32d4ba3b-e296-409e-a92b-680dbc8d5263" xlink:to="loc_us-gaap_OperatingLeaseLiability_a6192387-d64a-4565-9cad-9d780051e9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="clbs-20230630.xsd#OperatingLeasesFutureMinimumLeasePaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#StockholdersEquityEquityIssuancesDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a6ae2a5b-152d-4866-bf1c-df5f4ae2c011" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_24bd5dcd-4818-4dfd-b1c3-fc4792a4a9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a6ae2a5b-152d-4866-bf1c-df5f4ae2c011" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_24bd5dcd-4818-4dfd-b1c3-fc4792a4a9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_64ca7d7a-93b1-4a98-8a59-d49b1ca9fcea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_24bd5dcd-4818-4dfd-b1c3-fc4792a4a9d9" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_64ca7d7a-93b1-4a98-8a59-d49b1ca9fcea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc78a5e1-9236-45da-a339-0489ea57e87b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_64ca7d7a-93b1-4a98-8a59-d49b1ca9fcea" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc78a5e1-9236-45da-a339-0489ea57e87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AtTheMarketOfferingAgreementMember_fc00b652-4d90-4193-b40f-555280163962" xlink:href="clbs-20230630.xsd#clbs_AtTheMarketOfferingAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dc78a5e1-9236-45da-a339-0489ea57e87b" xlink:to="loc_clbs_AtTheMarketOfferingAgreementMember_fc00b652-4d90-4193-b40f-555280163962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_ca26624c-840f-4135-8974-e757a10a351e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_24bd5dcd-4818-4dfd-b1c3-fc4792a4a9d9" xlink:to="loc_us-gaap_AssetAcquisitionAxis_ca26624c-840f-4135-8974-e757a10a351e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_5f99287e-6a28-4a9f-9b95-6bc047404f19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_ca26624c-840f-4135-8974-e757a10a351e" xlink:to="loc_us-gaap_AssetAcquisitionDomain_5f99287e-6a28-4a9f-9b95-6bc047404f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CENDMember_5a14da0d-db7c-4afa-aadc-08a64aebd16d" xlink:href="clbs-20230630.xsd#clbs_CENDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_5f99287e-6a28-4a9f-9b95-6bc047404f19" xlink:to="loc_clbs_CENDMember_5a14da0d-db7c-4afa-aadc-08a64aebd16d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_24bd5dcd-4818-4dfd-b1c3-fc4792a4a9d9" xlink:to="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_bd08cdca-f1d9-4cfb-a088-e012255e6f47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_bd08cdca-f1d9-4cfb-a088-e012255e6f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_d09ab95f-38c0-46da-bf2c-76323989f0e7" xlink:href="clbs-20230630.xsd#clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:to="loc_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_d09ab95f-38c0-46da-bf2c-76323989f0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_b6661dac-c1a0-4d9f-b6d6-020719192e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:to="loc_us-gaap_CommonStockValueOutstanding_b6661dac-c1a0-4d9f-b6d6-020719192e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SaleOfStockAvailableForSale_777baf47-fe39-4ca3-9d26-7bf2891e5482" xlink:href="clbs-20230630.xsd#clbs_SaleOfStockAvailableForSale"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:to="loc_clbs_SaleOfStockAvailableForSale_777baf47-fe39-4ca3-9d26-7bf2891e5482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a4d923b5-4162-45ff-9f92-00f76950f92a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a4d923b5-4162-45ff-9f92-00f76950f92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_79f78bc5-c01b-445f-9114-deedadaeae71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_82636ad8-152e-4b66-bbcf-1417379c6dec" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_79f78bc5-c01b-445f-9114-deedadaeae71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#StockholdersEquityStockOptionsandWarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b6038201-af2e-4c44-b065-d55d6419c01c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_d72758a1-a0da-43e5-9150-03ffeb6df7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b6038201-af2e-4c44-b065-d55d6419c01c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_d72758a1-a0da-43e5-9150-03ffeb6df7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_230e5e7d-0bcf-4d0f-8c5e-7825a0c96848" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_d72758a1-a0da-43e5-9150-03ffeb6df7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_230e5e7d-0bcf-4d0f-8c5e-7825a0c96848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d7deba19-7d0f-4e89-b259-081f88fcc03e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_230e5e7d-0bcf-4d0f-8c5e-7825a0c96848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d7deba19-7d0f-4e89-b259-081f88fcc03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_47a5712d-2c0f-43c0-b61c-8520e3b41955" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_230e5e7d-0bcf-4d0f-8c5e-7825a0c96848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_47a5712d-2c0f-43c0-b61c-8520e3b41955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f24dc5db-c397-4a48-b600-0a8e8e4a0750" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_230e5e7d-0bcf-4d0f-8c5e-7825a0c96848" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f24dc5db-c397-4a48-b600-0a8e8e4a0750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_93f40525-7094-4313-986b-d620cac15987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_230e5e7d-0bcf-4d0f-8c5e-7825a0c96848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_93f40525-7094-4313-986b-d620cac15987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d9f9ab25-487b-4fa9-b53d-417ff7cdb94c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_230e5e7d-0bcf-4d0f-8c5e-7825a0c96848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d9f9ab25-487b-4fa9-b53d-417ff7cdb94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bb4a7fcb-e93f-4eaf-a08a-3eb89fdd085a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_230e5e7d-0bcf-4d0f-8c5e-7825a0c96848" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bb4a7fcb-e93f-4eaf-a08a-3eb89fdd085a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_978fb8b0-396b-463d-9896-98b45bd6b649" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_d72758a1-a0da-43e5-9150-03ffeb6df7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_978fb8b0-396b-463d-9896-98b45bd6b649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c50f8547-e54d-42fb-a387-781bfb582e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_d72758a1-a0da-43e5-9150-03ffeb6df7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c50f8547-e54d-42fb-a387-781bfb582e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cd629073-b2ea-489a-a8e5-e22a6b66e3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_d72758a1-a0da-43e5-9150-03ffeb6df7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cd629073-b2ea-489a-a8e5-e22a6b66e3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c80f193c-e14d-4f7f-87bf-93fedf05d402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cd629073-b2ea-489a-a8e5-e22a6b66e3d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c80f193c-e14d-4f7f-87bf-93fedf05d402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ed1133d2-6d5d-47f2-aa80-365cc6cfb563" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cd629073-b2ea-489a-a8e5-e22a6b66e3d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ed1133d2-6d5d-47f2-aa80-365cc6cfb563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_752904b7-85a3-49ad-9e26-14e5dca57275" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cd629073-b2ea-489a-a8e5-e22a6b66e3d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_752904b7-85a3-49ad-9e26-14e5dca57275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2480039e-595c-4001-bc68-b94a8a8aa467" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cd629073-b2ea-489a-a8e5-e22a6b66e3d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2480039e-595c-4001-bc68-b94a8a8aa467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_d619bc45-b37e-4535-8ae3-599f36935bec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cd629073-b2ea-489a-a8e5-e22a6b66e3d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_d619bc45-b37e-4535-8ae3-599f36935bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_abd293e7-c2d3-4982-9a80-f011c754e1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cd629073-b2ea-489a-a8e5-e22a6b66e3d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_abd293e7-c2d3-4982-9a80-f011c754e1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_bd69a1da-6751-42b3-9706-3131caf4edf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_d72758a1-a0da-43e5-9150-03ffeb6df7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_bd69a1da-6751-42b3-9706-3131caf4edf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_25706862-b1c0-469f-a7b4-2a087d5137b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_d72758a1-a0da-43e5-9150-03ffeb6df7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_25706862-b1c0-469f-a7b4-2a087d5137b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ab18844f-1e70-4f33-a1ca-6757df6566b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_d72758a1-a0da-43e5-9150-03ffeb6df7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ab18844f-1e70-4f33-a1ca-6757df6566b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_72036976-1335-45c0-b643-9df4fb17aeb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ab18844f-1e70-4f33-a1ca-6757df6566b2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_72036976-1335-45c0-b643-9df4fb17aeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_1007afbe-5c27-4c39-b96e-55ae32610352" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ab18844f-1e70-4f33-a1ca-6757df6566b2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_1007afbe-5c27-4c39-b96e-55ae32610352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_OptionsVestedweightedAverageRemainingContractualTerm_74ad00cd-48cd-4005-b732-a31c2e921aaa" xlink:href="clbs-20230630.xsd#clbs_OptionsVestedweightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ab18844f-1e70-4f33-a1ca-6757df6566b2" xlink:to="loc_clbs_OptionsVestedweightedAverageRemainingContractualTerm_74ad00cd-48cd-4005-b732-a31c2e921aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_42b294c7-abe5-4056-9f59-f751b584cb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ab18844f-1e70-4f33-a1ca-6757df6566b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_42b294c7-abe5-4056-9f59-f751b584cb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1a9aac80-4f24-4d84-a282-78c67328aa7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ab18844f-1e70-4f33-a1ca-6757df6566b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1a9aac80-4f24-4d84-a282-78c67328aa7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_b6dced5d-3846-49f0-bbe8-aab293f1bd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ab18844f-1e70-4f33-a1ca-6757df6566b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_b6dced5d-3846-49f0-bbe8-aab293f1bd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_b87f9426-5758-401e-9ff9-4d80c435de79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b6038201-af2e-4c44-b065-d55d6419c01c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_b87f9426-5758-401e-9ff9-4d80c435de79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d50f4cc5-f346-41e5-8b14-3242df4a03be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_b87f9426-5758-401e-9ff9-4d80c435de79" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d50f4cc5-f346-41e5-8b14-3242df4a03be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CommonStockWarrantsShares_140bf367-c42f-4478-90af-42980b9e37a4" xlink:href="clbs-20230630.xsd#clbs_CommonStockWarrantsShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d50f4cc5-f346-41e5-8b14-3242df4a03be" xlink:to="loc_clbs_CommonStockWarrantsShares_140bf367-c42f-4478-90af-42980b9e37a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsGranted_490dd676-96f2-42ee-8fa9-f4469240c0fe" xlink:href="clbs-20230630.xsd#clbs_WarrantsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d50f4cc5-f346-41e5-8b14-3242df4a03be" xlink:to="loc_clbs_WarrantsGranted_490dd676-96f2-42ee-8fa9-f4469240c0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsExercised_bb804530-5f87-4e1d-b758-99a0d54af2d8" xlink:href="clbs-20230630.xsd#clbs_WarrantsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d50f4cc5-f346-41e5-8b14-3242df4a03be" xlink:to="loc_clbs_WarrantsExercised_bb804530-5f87-4e1d-b758-99a0d54af2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsCanceled_bbd1685d-1ca1-4961-be9e-4801edf9e8ef" xlink:href="clbs-20230630.xsd#clbs_WarrantsCanceled"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d50f4cc5-f346-41e5-8b14-3242df4a03be" xlink:to="loc_clbs_WarrantsCanceled_bbd1685d-1ca1-4961-be9e-4801edf9e8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsExpired_7033f79a-bbf8-4147-81cf-6cbf8d2e7447" xlink:href="clbs-20230630.xsd#clbs_WarrantsExpired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d50f4cc5-f346-41e5-8b14-3242df4a03be" xlink:to="loc_clbs_WarrantsExpired_7033f79a-bbf8-4147-81cf-6cbf8d2e7447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CommonStockWarrantsShares_e8a59f28-b227-4821-9d4e-61d80d435f92" xlink:href="clbs-20230630.xsd#clbs_CommonStockWarrantsShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d50f4cc5-f346-41e5-8b14-3242df4a03be" xlink:to="loc_clbs_CommonStockWarrantsShares_e8a59f28-b227-4821-9d4e-61d80d435f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_Sharesvestedandexpectedtovest_3f89fa9b-ac22-477c-9a0c-0efc128446aa" xlink:href="clbs-20230630.xsd#clbs_Sharesvestedandexpectedtovest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_b87f9426-5758-401e-9ff9-4d80c435de79" xlink:to="loc_clbs_Sharesvestedandexpectedtovest_3f89fa9b-ac22-477c-9a0c-0efc128446aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsVested_a2ed328f-f7ab-43ad-a999-91f4bbaa5520" xlink:href="clbs-20230630.xsd#clbs_WarrantsVested"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_b87f9426-5758-401e-9ff9-4d80c435de79" xlink:to="loc_clbs_WarrantsVested_a2ed328f-f7ab-43ad-a999-91f4bbaa5520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_ed6afd7e-bf02-41e3-8fe3-5eb90a553fc4" xlink:href="clbs-20230630.xsd#clbs_WarrantsWeightedAverageExercisePriceRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_b87f9426-5758-401e-9ff9-4d80c435de79" xlink:to="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_ed6afd7e-bf02-41e3-8fe3-5eb90a553fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsOutstanding_faefd731-541a-494d-8280-1808245f0383" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_ed6afd7e-bf02-41e3-8fe3-5eb90a553fc4" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsOutstanding_faefd731-541a-494d-8280-1808245f0383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsGranted_f47c37d0-8c3b-497f-8579-4e077b95ddb0" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_ed6afd7e-bf02-41e3-8fe3-5eb90a553fc4" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsGranted_f47c37d0-8c3b-497f-8579-4e077b95ddb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExercised_fa44981b-d8c0-4bca-980d-c417b1220789" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_ed6afd7e-bf02-41e3-8fe3-5eb90a553fc4" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsExercised_fa44981b-d8c0-4bca-980d-c417b1220789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsCanceled_688968fc-8708-4fa7-a2a7-793e2fc5f6fc" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsCanceled"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_ed6afd7e-bf02-41e3-8fe3-5eb90a553fc4" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsCanceled_688968fc-8708-4fa7-a2a7-793e2fc5f6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExpired_1cae1863-f44a-4ec9-a4f9-e46479506a5a" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsExpired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_ed6afd7e-bf02-41e3-8fe3-5eb90a553fc4" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsExpired_1cae1863-f44a-4ec9-a4f9-e46479506a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsOutstanding_3049d3d5-d29c-4e10-aa28-4a7fe958b1e9" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsWeightedAverageExercisePriceRollForward_ed6afd7e-bf02-41e3-8fe3-5eb90a553fc4" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsOutstanding_3049d3d5-d29c-4e10-aa28-4a7fe958b1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_0ac6e1d8-26dc-4aea-b489-0ba0a0d0cd3f" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_b87f9426-5758-401e-9ff9-4d80c435de79" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_0ac6e1d8-26dc-4aea-b489-0ba0a0d0cd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageExercisePriceWarrantsExercisable_28f507a5-ac34-4547-9191-f1f675554de4" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageExercisePriceWarrantsExercisable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_b87f9426-5758-401e-9ff9-4d80c435de79" xlink:to="loc_clbs_WeightedAverageExercisePriceWarrantsExercisable_28f507a5-ac34-4547-9191-f1f675554de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WarrantsOtherDisclosuresAbstract_e9ea0bab-2eaf-4878-96d4-12f5aedf85ba" xlink:href="clbs-20230630.xsd#clbs_WarrantsOtherDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_b87f9426-5758-401e-9ff9-4d80c435de79" xlink:to="loc_clbs_WarrantsOtherDisclosuresAbstract_e9ea0bab-2eaf-4878-96d4-12f5aedf85ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_3f463339-cc98-49a4-89bd-73d27487582e" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageRemainingContractualTermwarrantoutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsOtherDisclosuresAbstract_e9ea0bab-2eaf-4878-96d4-12f5aedf85ba" xlink:to="loc_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_3f463339-cc98-49a4-89bd-73d27487582e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_3bfe5fcd-653e-4f85-9f77-2a0ffaca6781" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsOtherDisclosuresAbstract_e9ea0bab-2eaf-4878-96d4-12f5aedf85ba" xlink:to="loc_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_3bfe5fcd-653e-4f85-9f77-2a0ffaca6781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_WeightedAverageRemainingContractualTermwarrantsvested_49a5b475-3130-4126-83d2-c08af53d955b" xlink:href="clbs-20230630.xsd#clbs_WeightedAverageRemainingContractualTermwarrantsvested"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsOtherDisclosuresAbstract_e9ea0bab-2eaf-4878-96d4-12f5aedf85ba" xlink:to="loc_clbs_WeightedAverageRemainingContractualTermwarrantsvested_49a5b475-3130-4126-83d2-c08af53d955b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsOutstanding_640c1d76-ac6b-484d-8cc1-01623f435afc" xlink:href="clbs-20230630.xsd#clbs_AggregateIntrinsicValueWarrantsOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsOtherDisclosuresAbstract_e9ea0bab-2eaf-4878-96d4-12f5aedf85ba" xlink:to="loc_clbs_AggregateIntrinsicValueWarrantsOutstanding_640c1d76-ac6b-484d-8cc1-01623f435afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_511efcc5-98fa-43cb-a612-749f23d82cc1" xlink:href="clbs-20230630.xsd#clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsOtherDisclosuresAbstract_e9ea0bab-2eaf-4878-96d4-12f5aedf85ba" xlink:to="loc_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_511efcc5-98fa-43cb-a612-749f23d82cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_AggregateIntrinsicValueWarrantsvested_9f24b5d7-4bc8-4e88-9ea9-3cdbcc74f1f4" xlink:href="clbs-20230630.xsd#clbs_AggregateIntrinsicValueWarrantsvested"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clbs_WarrantsOtherDisclosuresAbstract_e9ea0bab-2eaf-4878-96d4-12f5aedf85ba" xlink:to="loc_clbs_AggregateIntrinsicValueWarrantsvested_9f24b5d7-4bc8-4e88-9ea9-3cdbcc74f1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_df85795a-f25d-4b19-aadf-48695b15e5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8d15bd00-4547-41e3-ac54-d3a76e4e1ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_df85795a-f25d-4b19-aadf-48695b15e5bb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8d15bd00-4547-41e3-ac54-d3a76e4e1ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ddc4cbc9-1ee2-497e-a73b-665ab4841bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8d15bd00-4547-41e3-ac54-d3a76e4e1ccd" xlink:to="loc_us-gaap_AwardTypeAxis_ddc4cbc9-1ee2-497e-a73b-665ab4841bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b36cf5f-116d-403a-a892-ae71e0304493" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ddc4cbc9-1ee2-497e-a73b-665ab4841bfe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b36cf5f-116d-403a-a892-ae71e0304493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_7209e785-0efb-4ec3-988f-b396009dbefd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b36cf5f-116d-403a-a892-ae71e0304493" xlink:to="loc_us-gaap_RestrictedStockMember_7209e785-0efb-4ec3-988f-b396009dbefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c0b79df6-2314-4cea-8191-cdedc4bd6a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b36cf5f-116d-403a-a892-ae71e0304493" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c0b79df6-2314-4cea-8191-cdedc4bd6a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7f7cf888-f75c-403b-88a8-5f94112c41e5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8d15bd00-4547-41e3-ac54-d3a76e4e1ccd" xlink:to="loc_srt_RangeAxis_7f7cf888-f75c-403b-88a8-5f94112c41e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_75e4326a-0b26-47aa-9c04-a453928b08e6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7f7cf888-f75c-403b-88a8-5f94112c41e5" xlink:to="loc_srt_RangeMember_75e4326a-0b26-47aa-9c04-a453928b08e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6e208968-55ba-4662-a0e3-616ba0594e23" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_75e4326a-0b26-47aa-9c04-a453928b08e6" xlink:to="loc_srt_MinimumMember_6e208968-55ba-4662-a0e3-616ba0594e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9b994bb7-f1fd-4c36-9992-08ff310264af" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_75e4326a-0b26-47aa-9c04-a453928b08e6" xlink:to="loc_srt_MaximumMember_9b994bb7-f1fd-4c36-9992-08ff310264af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4cb3877a-471f-40b4-bfc5-8f5d1edf7a39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8d15bd00-4547-41e3-ac54-d3a76e4e1ccd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4cb3877a-471f-40b4-bfc5-8f5d1edf7a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2c19555b-2fb4-4140-afaa-a88e5777a408" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4cb3877a-471f-40b4-bfc5-8f5d1edf7a39" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2c19555b-2fb4-4140-afaa-a88e5777a408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_85034456-b16e-4d27-9cc2-302849a77129" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4cb3877a-471f-40b4-bfc5-8f5d1edf7a39" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_85034456-b16e-4d27-9cc2-302849a77129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_03597171-5007-4d6a-9b11-7d1ca02f9713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4cb3877a-471f-40b4-bfc5-8f5d1edf7a39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_03597171-5007-4d6a-9b11-7d1ca02f9713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_89d1d7bd-e637-49d3-9605-f3b013dfd6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4cb3877a-471f-40b4-bfc5-8f5d1edf7a39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_89d1d7bd-e637-49d3-9605-f3b013dfd6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#ShareBasedCompensationShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_8d2e93d8-8707-43e4-b5b7-51aebf700fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2d923b1-f28a-425a-ba3d-ab8f0aeb4d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_8d2e93d8-8707-43e4-b5b7-51aebf700fbf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2d923b1-f28a-425a-ba3d-ab8f0aeb4d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_86e388d7-5619-4c7f-982f-2f399ef616f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2d923b1-f28a-425a-ba3d-ab8f0aeb4d5a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_86e388d7-5619-4c7f-982f-2f399ef616f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8d17c455-4294-4f93-a063-431975b6f011" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_86e388d7-5619-4c7f-982f-2f399ef616f9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8d17c455-4294-4f93-a063-431975b6f011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_77776485-8f66-4ff9-8191-738651148c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8d17c455-4294-4f93-a063-431975b6f011" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_77776485-8f66-4ff9-8191-738651148c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1e0f0fea-2122-4c77-a4af-2524ec4fa61d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8d17c455-4294-4f93-a063-431975b6f011" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1e0f0fea-2122-4c77-a4af-2524ec4fa61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7c52856b-6aab-4056-b965-ffd60a78f0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8d17c455-4294-4f93-a063-431975b6f011" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7c52856b-6aab-4056-b965-ffd60a78f0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_850d62ff-e6bc-4861-b92a-821e1d769eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b2d923b1-f28a-425a-ba3d-ab8f0aeb4d5a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_850d62ff-e6bc-4861-b92a-821e1d769eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5943c625-4076-4eed-9fa6-643832b6ccff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_850d62ff-e6bc-4861-b92a-821e1d769eb1" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5943c625-4076-4eed-9fa6-643832b6ccff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#ShareBasedCompensationCompensationCostNotYetRecognizedDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_deabb8d2-15e1-47a9-8f5e-39e47be22240" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7aeb4697-3c53-4fc7-ae23-e2e2b64b27c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_deabb8d2-15e1-47a9-8f5e-39e47be22240" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7aeb4697-3c53-4fc7-ae23-e2e2b64b27c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e3252c24-6a49-42fe-a12c-eb9478c846c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7aeb4697-3c53-4fc7-ae23-e2e2b64b27c5" xlink:to="loc_us-gaap_AwardTypeAxis_e3252c24-6a49-42fe-a12c-eb9478c846c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83a6cbef-7c5d-436f-bc88-3a3ebd734f43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e3252c24-6a49-42fe-a12c-eb9478c846c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83a6cbef-7c5d-436f-bc88-3a3ebd734f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2717f27b-6c6a-457a-b950-d866afb850ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83a6cbef-7c5d-436f-bc88-3a3ebd734f43" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2717f27b-6c6a-457a-b950-d866afb850ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6d6b6066-acf5-407d-9e62-41c02610e9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83a6cbef-7c5d-436f-bc88-3a3ebd734f43" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6d6b6066-acf5-407d-9e62-41c02610e9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e1dc9ad5-4dd4-4530-8bbc-dba265911889" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_83a6cbef-7c5d-436f-bc88-3a3ebd734f43" xlink:to="loc_us-gaap_RestrictedStockMember_e1dc9ad5-4dd4-4530-8bbc-dba265911889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05b24960-25e0-4add-ba24-02f082494608" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7aeb4697-3c53-4fc7-ae23-e2e2b64b27c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05b24960-25e0-4add-ba24-02f082494608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cd19f483-f9c8-41b8-8bfc-94b4310b0cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05b24960-25e0-4add-ba24-02f082494608" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cd19f483-f9c8-41b8-8bfc-94b4310b0cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_97b8b835-90f6-49b0-92b4-303ad2af51e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_05b24960-25e0-4add-ba24-02f082494608" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_97b8b835-90f6-49b0-92b4-303ad2af51e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b275c0ec-b080-4c03-a753-b229f9b21f34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39a95beb-2510-4ab2-9bac-f88a17980a01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b275c0ec-b080-4c03-a753-b229f9b21f34" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39a95beb-2510-4ab2-9bac-f88a17980a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_714dc6b7-820e-4285-aaf8-64bb95d086c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39a95beb-2510-4ab2-9bac-f88a17980a01" xlink:to="loc_us-gaap_AwardTypeAxis_714dc6b7-820e-4285-aaf8-64bb95d086c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78d571cc-819e-4b5f-8a84-d94f02cde3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_714dc6b7-820e-4285-aaf8-64bb95d086c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78d571cc-819e-4b5f-8a84-d94f02cde3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_713b3c6c-d72f-4f37-b97f-d905267e0ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78d571cc-819e-4b5f-8a84-d94f02cde3c1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_713b3c6c-d72f-4f37-b97f-d905267e0ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71bcbf91-3014-4493-8e28-84f43f3a7cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39a95beb-2510-4ab2-9bac-f88a17980a01" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71bcbf91-3014-4493-8e28-84f43f3a7cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_41fbc8a3-310e-4bf3-9fc3-c668adc3a6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71bcbf91-3014-4493-8e28-84f43f3a7cfa" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_41fbc8a3-310e-4bf3-9fc3-c668adc3a6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_61a65f67-bcd8-46b0-ab76-7385af5578f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71bcbf91-3014-4493-8e28-84f43f3a7cfa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_61a65f67-bcd8-46b0-ab76-7385af5578f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_56b19422-13ed-4c50-9bd5-c2637027f9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_2a5df577-c39c-48a8-b558-e0317adb09ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_56b19422-13ed-4c50-9bd5-c2637027f9bd" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_2a5df577-c39c-48a8-b558-e0317adb09ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b6697808-94b3-460e-982f-6eee47b94287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_2a5df577-c39c-48a8-b558-e0317adb09ac" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b6697808-94b3-460e-982f-6eee47b94287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_3dfc4392-0d56-49a1-973a-367b29e54c51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b6697808-94b3-460e-982f-6eee47b94287" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_3dfc4392-0d56-49a1-973a-367b29e54c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_9a946ab0-2891-4984-9db6-7e8c18d79dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3dfc4392-0d56-49a1-973a-367b29e54c51" xlink:to="loc_us-gaap_DomesticCountryMember_9a946ab0-2891-4984-9db6-7e8c18d79dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_bf4a1e9f-486a-4a78-9b05-60dcab4daf57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3dfc4392-0d56-49a1-973a-367b29e54c51" xlink:to="loc_us-gaap_ForeignCountryMember_bf4a1e9f-486a-4a78-9b05-60dcab4daf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f7a0bd22-2178-444a-b804-48bfcb495c85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_3dfc4392-0d56-49a1-973a-367b29e54c51" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f7a0bd22-2178-444a-b804-48bfcb495c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_5003c1a9-117a-4665-a892-eca50875b696" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_2a5df577-c39c-48a8-b558-e0317adb09ac" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_5003c1a9-117a-4665-a892-eca50875b696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_2e51f289-bd95-41de-ae35-748823cfc598" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_5003c1a9-117a-4665-a892-eca50875b696" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_2e51f289-bd95-41de-ae35-748823cfc598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewJerseyDivisionOfTaxationMember_c46ee447-c5d3-4ce0-827f-aa97d19bebe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewJerseyDivisionOfTaxationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_2e51f289-bd95-41de-ae35-748823cfc598" xlink:to="loc_us-gaap_NewJerseyDivisionOfTaxationMember_c46ee447-c5d3-4ce0-827f-aa97d19bebe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_bf2091b9-7a80-44f8-87c9-24d2e1620995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_2e51f289-bd95-41de-ae35-748823cfc598" xlink:to="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_bf2091b9-7a80-44f8-87c9-24d2e1620995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_80588a07-80d1-4ef6-8b8f-6455acc79198" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_2e51f289-bd95-41de-ae35-748823cfc598" xlink:to="loc_us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_80588a07-80d1-4ef6-8b8f-6455acc79198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_26c1be5b-a8d3-4eb1-897c-4983e710eecc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_2a5df577-c39c-48a8-b558-e0317adb09ac" xlink:to="loc_dei_LegalEntityAxis_26c1be5b-a8d3-4eb1-897c-4983e710eecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b1190116-9a3c-4f14-b9e3-3918408b8a46" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_26c1be5b-a8d3-4eb1-897c-4983e710eecc" xlink:to="loc_dei_EntityDomain_b1190116-9a3c-4f14-b9e3-3918408b8a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CENDMember_464b0f0a-7dfd-4e3c-b67b-b69514fc7d9b" xlink:href="clbs-20230630.xsd#clbs_CENDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_b1190116-9a3c-4f14-b9e3-3918408b8a46" xlink:to="loc_clbs_CENDMember_464b0f0a-7dfd-4e3c-b67b-b69514fc7d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_2a5df577-c39c-48a8-b558-e0317adb09ac" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_OperatingLossCarryforwardsBeforeWriteDown_f0c3572a-ab07-403f-896c-f72851ee9e75" xlink:href="clbs-20230630.xsd#clbs_OperatingLossCarryforwardsBeforeWriteDown"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_clbs_OperatingLossCarryforwardsBeforeWriteDown_f0c3572a-ab07-403f-896c-f72851ee9e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_e0fff173-7dfd-4b24-bf4c-509144e76b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_us-gaap_OperatingLossCarryforwards_e0fff173-7dfd-4b24-bf4c-509144e76b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1b926071-8fd4-4fc0-933a-2cbe9570fb09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1b926071-8fd4-4fc0-933a-2cbe9570fb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_OperatingLossCarryforwardsPostAcquisition_af5024c4-4058-42f1-90c3-7e8afea1fe7e" xlink:href="clbs-20230630.xsd#clbs_OperatingLossCarryforwardsPostAcquisition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_clbs_OperatingLossCarryforwardsPostAcquisition_af5024c4-4058-42f1-90c3-7e8afea1fe7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_050e8b68-71e0-4b4c-913f-b3a314fc029d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_050e8b68-71e0-4b4c-913f-b3a314fc029d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_bb17eed7-8ede-4f8f-8017-5cd4e25579dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_bb17eed7-8ede-4f8f-8017-5cd4e25579dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ProceedsFromSaleOfNOLS_84caae5a-d495-46c4-a005-7acabd98538a" xlink:href="clbs-20230630.xsd#clbs_ProceedsFromSaleOfNOLS"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_clbs_ProceedsFromSaleOfNOLS_84caae5a-d495-46c4-a005-7acabd98538a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b90d9ea2-37a9-4bf3-9cb7-49baaa73058d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b90d9ea2-37a9-4bf3-9cb7-49baaa73058d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_LossOnSaleOfNOL_7265903d-4607-4dc3-915e-ec8c01df57ac" xlink:href="clbs-20230630.xsd#clbs_LossOnSaleOfNOL"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_clbs_LossOnSaleOfNOL_7265903d-4607-4dc3-915e-ec8c01df57ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_bb1724d0-5663-43d7-b87f-356e991597f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_bb1724d0-5663-43d7-b87f-356e991597f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_FairValueMarketOfTaxNOLs_7ac9a7f7-31ac-4ecb-af7d-a3a566cf1d74" xlink:href="clbs-20230630.xsd#clbs_FairValueMarketOfTaxNOLs"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_fda4a4c6-80b2-492a-a52b-cb121e16507e" xlink:to="loc_clbs_FairValueMarketOfTaxNOLs_7ac9a7f7-31ac-4ecb-af7d-a3a566cf1d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#AustraliaResearchandDevelopmentTaxIncentiveDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3223700c-83df-4d3f-85ed-bcdc1849388a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayTable_2282e981-2607-4937-9308-c4f140cc6e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxHolidayTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3223700c-83df-4d3f-85ed-bcdc1849388a" xlink:to="loc_us-gaap_IncomeTaxHolidayTable_2282e981-2607-4937-9308-c4f140cc6e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c2b04aa7-1dfc-4fbd-b335-4f2d27d37c90" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxHolidayTable_2282e981-2607-4937-9308-c4f140cc6e9c" xlink:to="loc_srt_RangeAxis_c2b04aa7-1dfc-4fbd-b335-4f2d27d37c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_843551bb-b2fe-40f4-8e20-322581f25c1a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c2b04aa7-1dfc-4fbd-b335-4f2d27d37c90" xlink:to="loc_srt_RangeMember_843551bb-b2fe-40f4-8e20-322581f25c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a28d45e2-69f2-4001-8031-63f88dd012df" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_843551bb-b2fe-40f4-8e20-322581f25c1a" xlink:to="loc_srt_MinimumMember_a28d45e2-69f2-4001-8031-63f88dd012df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_084464c2-7b1c-433a-8c1c-2f43dcea056a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_843551bb-b2fe-40f4-8e20-322581f25c1a" xlink:to="loc_srt_MaximumMember_084464c2-7b1c-433a-8c1c-2f43dcea056a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayLineItems_194736a0-8bf8-412f-bf08-450d439250c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxHolidayLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxHolidayTable_2282e981-2607-4937-9308-c4f140cc6e9c" xlink:to="loc_us-gaap_IncomeTaxHolidayLineItems_194736a0-8bf8-412f-bf08-450d439250c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_90bea6d6-e1d9-4b37-b00c-18c31e2c41b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxHolidayLineItems_194736a0-8bf8-412f-bf08-450d439250c5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_90bea6d6-e1d9-4b37-b00c-18c31e2c41b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_IncomeTaxIncentiveReceivable_1184caa0-aabc-4698-a711-3cb4be8cd5c9" xlink:href="clbs-20230630.xsd#clbs_IncomeTaxIncentiveReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxHolidayLineItems_194736a0-8bf8-412f-bf08-450d439250c5" xlink:to="loc_clbs_IncomeTaxIncentiveReceivable_1184caa0-aabc-4698-a711-3cb4be8cd5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/LicenseAgreementsDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#LicenseAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/LicenseAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_01111c48-aad8-4bf7-97aa-e74140c22f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0cbde638-3765-43c3-bed8-8a61d76638b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_01111c48-aad8-4bf7-97aa-e74140c22f4b" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0cbde638-3765-43c3-bed8-8a61d76638b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_19e5122e-2695-4689-ab9c-ffd56bfce270" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0cbde638-3765-43c3-bed8-8a61d76638b6" xlink:to="loc_srt_CounterpartyNameAxis_19e5122e-2695-4689-ab9c-ffd56bfce270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6dba83a2-08d5-4c67-a810-155bc982bd35" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_19e5122e-2695-4689-ab9c-ffd56bfce270" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6dba83a2-08d5-4c67-a810-155bc982bd35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SanfordBurnhamPrebysMember_45b71765-66e6-439f-99b9-447fb703f74a" xlink:href="clbs-20230630.xsd#clbs_SanfordBurnhamPrebysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6dba83a2-08d5-4c67-a810-155bc982bd35" xlink:to="loc_clbs_SanfordBurnhamPrebysMember_45b71765-66e6-439f-99b9-447fb703f74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_UniversityOfCaliforniaAtSanDiegoMember_a745f96c-3d10-452f-b247-b6d85e92d68e" xlink:href="clbs-20230630.xsd#clbs_UniversityOfCaliforniaAtSanDiegoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6dba83a2-08d5-4c67-a810-155bc982bd35" xlink:to="loc_clbs_UniversityOfCaliforniaAtSanDiegoMember_a745f96c-3d10-452f-b247-b6d85e92d68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_MassachusettsInstituteOfTechnologyMember_5c1c9b04-0dd4-47ba-b658-2cbe4c1e7f36" xlink:href="clbs-20230630.xsd#clbs_MassachusettsInstituteOfTechnologyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6dba83a2-08d5-4c67-a810-155bc982bd35" xlink:to="loc_clbs_MassachusettsInstituteOfTechnologyMember_5c1c9b04-0dd4-47ba-b658-2cbe4c1e7f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_8f70ca35-a843-4a98-9e73-f0e2fa84890d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0cbde638-3765-43c3-bed8-8a61d76638b6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_8f70ca35-a843-4a98-9e73-f0e2fa84890d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5bb42ae2-b0f9-48a7-92d8-469242b64a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8f70ca35-a843-4a98-9e73-f0e2fa84890d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5bb42ae2-b0f9-48a7-92d8-469242b64a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_bc503005-9ff7-4ffb-a03a-0d198488f00d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5bb42ae2-b0f9-48a7-92d8-469242b64a8d" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_bc503005-9ff7-4ffb-a03a-0d198488f00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ba90bf61-d35a-426d-bb9f-01dee2902887" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0cbde638-3765-43c3-bed8-8a61d76638b6" xlink:to="loc_srt_RangeAxis_ba90bf61-d35a-426d-bb9f-01dee2902887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_048af262-b5ed-43aa-ab70-86e1cef5b664" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ba90bf61-d35a-426d-bb9f-01dee2902887" xlink:to="loc_srt_RangeMember_048af262-b5ed-43aa-ab70-86e1cef5b664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8717b760-ec07-44a1-a9ec-bbed494cecbd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_048af262-b5ed-43aa-ab70-86e1cef5b664" xlink:to="loc_srt_MinimumMember_8717b760-ec07-44a1-a9ec-bbed494cecbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_49e8811a-805d-422b-9304-1277f8bec909" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_048af262-b5ed-43aa-ab70-86e1cef5b664" xlink:to="loc_srt_MaximumMember_49e8811a-805d-422b-9304-1277f8bec909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0cbde638-3765-43c3-bed8-8a61d76638b6" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SharesIssuedUnderLicenseAgreement_7ad089b5-4a4d-4283-aea9-759afba9cf80" xlink:href="clbs-20230630.xsd#clbs_SharesIssuedUnderLicenseAgreement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_SharesIssuedUnderLicenseAgreement_7ad089b5-4a4d-4283-aea9-759afba9cf80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee_503f4b8e-11f5-42ba-965e-bd7c9ad42351" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee_503f4b8e-11f5-42ba-965e-bd7c9ad42351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven_3c056636-4e45-43a5-a869-20dc27e58300" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven_3c056636-4e45-43a5-a869-20dc27e58300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_6d790faa-4dba-4a82-80f3-42e390cb297a" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_6d790faa-4dba-4a82-80f3-42e390cb297a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales_94e8c87c-7ddf-4cc8-93a0-add8c5107e2d" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales_94e8c87c-7ddf-4cc8-93a0-add8c5107e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees_25908c2b-3e89-4a38-a15b-1308ff4ea133" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees_25908c2b-3e89-4a38-a15b-1308ff4ea133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour_ae714541-3e52-4765-bcdc-dc7ac15e7010" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour_ae714541-3e52-4765-bcdc-dc7ac15e7010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_SharesHeldByThirdParty_af359a57-de30-41f7-9691-6d38858ff74e" xlink:href="clbs-20230630.xsd#clbs_SharesHeldByThirdParty"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_SharesHeldByThirdParty_af359a57-de30-41f7-9691-6d38858ff74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree_3bde4996-8228-4a0a-ba7a-32e2381b6598" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree_3bde4996-8228-4a0a-ba7a-32e2381b6598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale_0a31f97b-aa56-48a7-8057-62671a9a82e0" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale_0a31f97b-aa56-48a7-8057-62671a9a82e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee_1cf8b18a-4b9a-4ed8-890d-0a6f733cfe9c" xlink:href="clbs-20230630.xsd#clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_68f15142-2143-4db5-be82-936561a0ae05" xlink:to="loc_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee_1cf8b18a-4b9a-4ed8-890d-0a6f733cfe9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#ResearchCollaborationandLicenseAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e27caef-5a84-48cd-8a8f-03e763b07e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd057c27-0d25-4b7c-a0e8-4fe05893d68a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e27caef-5a84-48cd-8a8f-03e763b07e4a" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd057c27-0d25-4b7c-a0e8-4fe05893d68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_07d485a6-6c38-4555-a084-26af9a5b26c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd057c27-0d25-4b7c-a0e8-4fe05893d68a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_07d485a6-6c38-4555-a084-26af9a5b26c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7b73072d-7499-47c1-8e21-3b2a9cd09524" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_07d485a6-6c38-4555-a084-26af9a5b26c7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7b73072d-7499-47c1-8e21-3b2a9cd09524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_77e58420-6c55-48e1-b391-d9659bab436b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd057c27-0d25-4b7c-a0e8-4fe05893d68a" xlink:to="loc_srt_CounterpartyNameAxis_77e58420-6c55-48e1-b391-d9659bab436b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6cb26d45-5773-4e0c-ab88-085a6bb0c125" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_77e58420-6c55-48e1-b391-d9659bab436b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6cb26d45-5773-4e0c-ab88-085a6bb0c125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_QiluMember_22dab1ea-ff9b-4a33-ac6d-9a00b6f44aa8" xlink:href="clbs-20230630.xsd#clbs_QiluMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6cb26d45-5773-4e0c-ab88-085a6bb0c125" xlink:to="loc_clbs_QiluMember_22dab1ea-ff9b-4a33-ac6d-9a00b6f44aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_be5fce70-2b75-4c65-b702-2bb37176793c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd057c27-0d25-4b7c-a0e8-4fe05893d68a" xlink:to="loc_srt_ProductOrServiceAxis_be5fce70-2b75-4c65-b702-2bb37176793c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a6589626-75ae-4622-ba75-0d50d6604506" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_be5fce70-2b75-4c65-b702-2bb37176793c" xlink:to="loc_srt_ProductsAndServicesDomain_a6589626-75ae-4622-ba75-0d50d6604506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_ef0594c6-47ac-4c66-9e3c-5f239976da73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a6589626-75ae-4622-ba75-0d50d6604506" xlink:to="loc_us-gaap_LicenseMember_ef0594c6-47ac-4c66-9e3c-5f239976da73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d5ee557f-b2fb-4051-843c-d2b429ea97df" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd057c27-0d25-4b7c-a0e8-4fe05893d68a" xlink:to="loc_srt_RangeAxis_d5ee557f-b2fb-4051-843c-d2b429ea97df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_39d293ce-ce44-43a8-9a3e-a23137f9f56b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d5ee557f-b2fb-4051-843c-d2b429ea97df" xlink:to="loc_srt_RangeMember_39d293ce-ce44-43a8-9a3e-a23137f9f56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_12ac710f-4326-49bd-b294-c9b1d7b76878" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_39d293ce-ce44-43a8-9a3e-a23137f9f56b" xlink:to="loc_srt_MinimumMember_12ac710f-4326-49bd-b294-c9b1d7b76878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_124738e4-2e12-401c-99d9-dd18be58cd21" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_39d293ce-ce44-43a8-9a3e-a23137f9f56b" xlink:to="loc_srt_MaximumMember_124738e4-2e12-401c-99d9-dd18be58cd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd057c27-0d25-4b7c-a0e8-4fe05893d68a" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_5880ffd4-f34f-4234-90fd-21c958c70862" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_5880ffd4-f34f-4234-90fd-21c958c70862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_423ebafa-2710-4bfb-bc99-26c6550a7932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_423ebafa-2710-4bfb-bc99-26c6550a7932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_d0eee75e-ad14-4bb2-89d9-73b968f17c1e" xlink:href="clbs-20230630.xsd#clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:to="loc_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount_d0eee75e-ad14-4bb2-89d9-73b968f17c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_RevenuePerformanceObligationPercentageOfNetSale_31bc4178-056c-4fae-80ec-17ce756aec03" xlink:href="clbs-20230630.xsd#clbs_RevenuePerformanceObligationPercentageOfNetSale"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:to="loc_clbs_RevenuePerformanceObligationPercentageOfNetSale_31bc4178-056c-4fae-80ec-17ce756aec03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues_65607e42-d3ba-40b4-b7c9-127103f46890" xlink:href="clbs-20230630.xsd#clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dfe0b04c-6218-4d7d-8040-37ec2cccf12f" xlink:to="loc_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues_65607e42-d3ba-40b4-b7c9-127103f46890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.caladrius.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="clbs-20230630.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.caladrius.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_857a3500-7eb2-466d-9a7c-06b7debc6107" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_2688e028-ff97-45b4-9753-6b0fa078a321" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_857a3500-7eb2-466d-9a7c-06b7debc6107" xlink:to="loc_us-gaap_SubsequentEventTable_2688e028-ff97-45b4-9753-6b0fa078a321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_53319438-464a-4895-b7cd-78b70ffc80a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2688e028-ff97-45b4-9753-6b0fa078a321" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_53319438-464a-4895-b7cd-78b70ffc80a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d58c0e23-2a75-4a95-93f8-ba69f2aca839" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_53319438-464a-4895-b7cd-78b70ffc80a5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d58c0e23-2a75-4a95-93f8-ba69f2aca839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4776b6cf-5b56-4765-985e-07f1cf52a910" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d58c0e23-2a75-4a95-93f8-ba69f2aca839" xlink:to="loc_us-gaap_SubsequentEventMember_4776b6cf-5b56-4765-985e-07f1cf52a910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0c0a0153-482e-4224-98ab-c4569d1167e6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2688e028-ff97-45b4-9753-6b0fa078a321" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0c0a0153-482e-4224-98ab-c4569d1167e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_288db348-05ef-461c-8c64-942bf436e357" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0c0a0153-482e-4224-98ab-c4569d1167e6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_288db348-05ef-461c-8c64-942bf436e357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_clbs_ImpiloMember_ea1df6ff-415a-4487-818b-d92bf022bf8c" xlink:href="clbs-20230630.xsd#clbs_ImpiloMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_288db348-05ef-461c-8c64-942bf436e357" xlink:to="loc_clbs_ImpiloMember_ea1df6ff-415a-4487-818b-d92bf022bf8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_9ac5b13e-a5be-4581-9ca6-2ccdc5d89542" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_2688e028-ff97-45b4-9753-6b0fa078a321" xlink:to="loc_us-gaap_SubsequentEventLineItems_9ac5b13e-a5be-4581-9ca6-2ccdc5d89542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_d0d59102-aa93-4fe1-9d11-9b8971274177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_9ac5b13e-a5be-4581-9ca6-2ccdc5d89542" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_d0d59102-aa93-4fe1-9d11-9b8971274177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>clbs-20230630_g1.jpg
<TEXT>
begin 644 clbs-20230630_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +0!0 # 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV/N\H01BO?/^"C_A+X@W'@>Y\4:+XF73_ VGV,=MK&CB[E1[QY;E$0B-4*.
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M6OSB\+W_ ,:?V\/BAK$NF>)IM"TFQ_?&/[9+!9:=$[$1QJD?+R,%/.,G:22
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MHESK%S=I((HW _?1RS,LI9#]Z,[L@-@$E37VE0 4444""BBB@ HHHH ****
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MY<XZUZ%_P48^"/COXK>-/"%WX2\,7VO6]II\L4\EHH(C8R9 .2.U'0?4[O\
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M,9. 65MWRD\AN.1@@]-C-\ _ 7]HKXGZ/8^(?&?QNU'PD][&+A-,TF &1%8
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M[ _CSP?=ZM;ZO=6\,UPEQ:QLB"!Y8V=<'G./,_.N<_X)2_9O^$ \=[=OVO\
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MO#X6\07HF\/:HL=E<7VSRXIK>4@PW(!)QLDX;DX D%>R_P#!5K[7_P *_P#
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MC9^Q+XK\9V]M]C_M/PCJIEMMV[RIDMYHY5![@.C8/<8->#?\$G_^1?\ B/\
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M[>1]GS)LQC_:\NE_;=LXM1_;@T2TG7?!.=)BD7U5G (_(U]0_L0_LCW'[/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \(_;2^%/B/XR_ ^Z\-^%;
M2.]U:2^MYUBDG2$;$8ECN8@5-^QG\+O$7P=^!6F^&O%%I'9:O#=W,KPQS)*
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M'M(_R+\?\SS_ /X69XC_ .B3>,/_  +T;_Y84?\ "S/$?_1)O&'_ (%Z-_\
M+"O0**/K-+_GQ'[Y_P#R8>TC_(OQ_P SS_\ X69XC_Z)-XP_\"]&_P#EA1_P
MLSQ'_P!$F\8?^!>C?_+"O0**/K-+_GQ'[Y__ "8>TC_(OQ_S//\ _A9GB/\
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M/^>G_CH_PH_M"X_YZ?\ CH_PH]K3_P"?$/OG_P#)AS1_D7X_YG,_\+,\1_\
M1)O&'_@7HW_RPH_X69XC_P"B3>,/_ O1O_EA73?VA<?\]/\ QT?X4?VA<?\
M/3_QT?X4>UI_\^(??/\ ^3#FC_(OQ_S.9_X69XC_ .B3>,/_  +T;_Y84?\
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M6%=-_:%Q_P ]/_'1_A1_:%Q_ST_\='^%'M:?_/B'WS_^3#FC_(OQ_P SF?\
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M_"CVM/\ Y\0^^?\ \F'-'^1?C_F<S_PLSQ'_ -$F\8?^!>C?_+"C_A9GB/\
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MSNT/]I+Q5X?_ &/+F\M?%=UJ'B^X\0_89;V[O3<W=G;O&75OG+,H;RG52?\
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M^93D(=VXMD=O\6K[XDR^ 9_B7XD^*6I^'M4\0VUC)X.\(>$K^>+S6EVLT4L
M52Y"MRP)YZD_*A0['Z"T5^</QH_::^(.H^ ]+\$KXF7POXLT'2UU#Q1J2WJV
M-W/<\>79PA2K&0*R&01]]PX"L#];_L>^,G\;?L]^%;V[UQM?U:.*2&_N)KO[
M3.LPD8[96)+!]A0X;G!7MBF*Q[/1110(***^/_VRO#_B_2]2N/$4/BOXBW&F
M2:=<#3M'\#6+1VNGSQ(I$M[.LN?+8DDDINP&PP"\@S[ HK\Y[_X\>.[SX$?!
M_P .V/Q GGU/Q5J\]A?^)+5I!=6\:RQ(L#2NJOO43AF<8)VKAB#D^F_#7Q-X
MK^#?[8P^%5UXQUSQSX:U?3_M"/K]T;JXM)!"T@;>>1_JV&!@$.I(R,T!8^RZ
M*^3OVIO#WC&QU3Q%XPUWXKW?@;P#I^ELFBZ=X<OY;:]N;\H-J2J% E#.#P&)
M QC:-S5X;X4^(/QF\?>+OA5\+/%WBO7_  D-5@DOIK^Q<VVISV_[TQ>9)@,#
MB$XR3D."P8XH"Q^D=%?GK\)=>^,7QAT?Q+X)_P"%F/HV@>#M: U?Q1=W3V^I
M266YP52<*>5\EW)=P?G +;1BJ_@+]ICQ3\']'^(FJR>(M8\;>#IKM].\&W_B
M61G>\N]Y D$K\F)$!9^0N0HPA8X06/T2HKX,_8A^)WB6^^/GBWP_XQ^(K^*)
M7L3]D2363<VL]QO1W^RKO*-M7?\ ZL8VJ<8 K[SI@%%%% @HKY]_:Z^/\GPI
M\/Z?X9T&^M;+QIXF;[-8W=[.L$%A$2%>ZDD?Y5"YP,GKSSM(/S#\$OVC/%7A
M#X&?&B]NO&USXF\4:8]NFEOJ.I->.D;2^2]Q$DC,2@,B'(&W)0'K0.Q^D%%?
MG)XA\6>/_@;X%^$?Q4B^)?B3Q1<^))1+J6A:G?-/:2(X$ACBC.0ORDIG&02"
MNWI7UO\ M$^$?'/CC1]#@\,>-(? ?AZ*?[3XAU(73VMV+9=I_<RJI"$ .3EE
M!XR<9! /9**_+K6/CS\5? /@GQO/X=\8:_K?@.\UD:5HGBC6V:6Z89D+-!*X
MR<I'@D8 )!4*QX]%AUCXN_#OXZ-\)_"OQ$U#Q%<>)-!2XMM0\6SO<?8+@PF1
MI5<J[+CRY  !C]XN0Q4$H=C] **_/C3/%GB_X+_'#2+2#XH>(?'.BZ%IBW7C
MV6^O)+_3[%AN,L<9;[K<*$&-^XA<\LHY'3?VE_%WBW]HKP/XIU;QW_87A'6-
M45SH%KKFRUL+))=BK=HKA%9AECY@R>O ( 86/TUJEJW_ ![K_O\ ]#5Q6#*"
M#D'D$53U;_CW7_?_ *&JC\2$MS)HHK&\8+K\GAC45\+O81^(&B(LWU3?]F63
M(Y?8"V,9Z=\5UFALT5\>_LC^,_&VI_'+XJ:3XP\37OB*?20T1C,S_9ED2=D8
MPP\*@.W@ #BO-='\3>/OBY\+?B7\59OB5XAT&^T&[/V'1M-O6@LDC7:^QXUP
M&X<*#U)7YMV:SYP/T,HKP[X?^,O''QH_9<T[6-!O+/2?&^I6;0I?WJD1+*DI
MC>;"H<%@C,,*0"PXP*^:]0\3?$7X0?$@6OA;X@:Y\0Y-"T.2]\6+J%Y)>Z=:
M3JCL\:LP.W[JX& V>">656Y=0/T%HK\W%^)_Q'\%?#GP+\7?^%@:]K.H:UK-
MQ;W>A7DY:P>-'(V+%]U-P1A\JC&\;=I7GK?C)8?%7P$]G=W/Q2UC4OBCK>L*
M^E^%O#=Y*]E]CVDY:V*J!@@#D%2 <[OF8+G\@/O:BOSO\=7GQFT_Q?XWUGQ%
M:?$C^P]."3O-H'B*32;*%54"1X]\,BR)D9Q&!M&2<]:^SOV?_%>F>-/@_P"&
MM5TB^U34;.2W\O[1K<_GWI=&*N)I/XF# _,.",$4XRN[ >A44458!12-NVG:
M 6QQGI7P9\:--^*OP^GM;FY^*>L:G\4=9UD-I?A?PU>2O9?8PI^9K8JH&" .
M05(!SN^9A,I<H'WI17QKK&M^.?C'^TP/AKJ'C+6/!=CHVB17-U_PCES]FDN+
MHP1-(P=>2N^;@'(VIP 3FNL_8F^*'B;Q?I_C;POXBU.;Q!<>&;\06VK73EGG
MC8R+M9N2V#$3DDG#X["DI:V ^GJ*^"_C1IOQ5^'T]K<W/Q3UC4_BCK.LAM+\
M+^&KR5[+[&%/S-;%5 P0!R"I .=WS,,6\\=?$KXG3?%S7-0\>:UX9O? =M']
MGTS0[AH+1Y4D99 ZKC>"8GY.3EQ_"-I7/Y ?H=17P=<>(?B#\0OA+;?%#QG\
M4+KP7X:BT:6'3[/P]>26EY>ZBC&-6D1557\QD+85N >-@!-<_<2?M#>(M)^'
M"7MOX\O$FMIS-_8=_)ILTL9<^5]HGV,B/A<[I5)*D=SFCG\@/T1HKYM_8O\
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MSX'O-7&EZ-XEUEFDNFYD+-#*XR<I'@D8QD$!6/#E+EW _2ZBOA&'5OBO\/\
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MD@GGFH_C=^QCH7Q(OO$GB+P[K.J^$O%NL6K0W#6-X8[*]8@#%S&%)*D* 0I
M/4@GK]&T4#N>/? ?X1:Y\/?@@O@C6)=+T*^030I?>$))<JK@?O\ ?<*29RQ8
MDE=H^7  &!R_@O\ 8HT'P#KAU32/B)\1+>66[2]NX5UQ$BOI%;<?/"0J9 W(
M.3D@GGFOHFB@#YPUC]@GX9:QXCN]0:;7[72KR\%_<^'+74=FFS3#=\Q39O'W
MF^ZXP&(7 XJQKW[%/A_7?'$OBS_A/O'VF:T5,4$VF:K#;_9(>0((=L&4B4'
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M/^%1^&_^>>I_^#F]_P#CU=E10%V<;_PJ/PW_ ,\]3_\ !S>__'J/^%1^&_\
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M )YZG_X.;W_X]7944!=G&_\ "H_#?_//4_\ P<WO_P >H_X5'X;_ .>>I_\
M@YO?_CU=E10%V<;_ ,*C\-_\\]3_ /!S>_\ QZC_ (5'X;_YYZG_ .#F]_\
MCU=E10%V<;_PJ/PW_P \]3_\'-[_ /'J/^%1^&_^>>I_^#F]_P#CU=E10%V<
M;_PJ/PW_ ,\]3_\ !S>__'J/^%1^&_\ GGJ?_@YO?_CU=E10%V<;_P *C\-_
M\\]3_P#!S>__ !ZC_A4?AO\ YYZG_P"#F]_^/5V5% 79QO\ PJ/PW_SSU/\
M\'-[_P#'JJ:G\)_#D=NI$>I9W=]8O#V/_36N]JEJW_'NO^__ $-5'=#3U///
M^%5^'O\ GGJ/_@WO/_CM'_"J_#W_ #SU'_P;WG_QVNMHKJLC0Y+_ (57X>_Y
MYZC_ .#>\_\ CM'_  JOP]_SSU'_ ,&]Y_\ ':ZVBBR Y+_A5?A[_GGJ/_@W
MO/\ X[1_PJOP]_SSU'_P;WG_ ,=KK:*+(#DO^%5^'O\ GGJ/_@WO/_CM'_"J
M_#W_ #SU'_P;WG_QVNMHHL@.2_X57X>_YYZC_P"#>\_^.T?\*K\/?\\]1_\
M!O>?_':ZVBBR Y+_ (57X>_YYZC_ .#>\_\ CM'_  JOP]_SSU'_ ,&]Y_\
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MZFN+^#UO\1O'GA?PCJV@R>,&U:/Q+,VH^(M3\3&32Y;".XE62(VCW+ECM"H
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MX(_$2Y^(_A>]NKZ^TF_U"QU":QG;28+JV"E","6WN566"3!Y0EAW#'/'H=:
M%%%% !1110 4444 %%%% !1110 4444 :.C_ /+;\/ZUI5FZ/_RV_#^M:5<L
M_B9F]PHHHJ!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4
MM6_X]U_W_P"AJ[5+5O\ CW7_ '_Z&JC\2&MS)HHHKK- HHHH **** "BBB@
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M[N:[NKEE&U?,FF=Y&"C@ M@9..M=3113 **** "BBB@ HHHH **** "BBB@
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MC_\ 3S\/^"?T<45_./11_J%_U%?^2?\ VP?V/_T\_#_@G]'%%?SCT4?ZA?\
M45_Y)_\ ;!_8_P#T\_#_ ()_1M)(D,;22,J(H+,S'  '4DUP%Q\?OA[:WC6K
M^*K(RJVTE-[IG_?"E<>^<5^1/[._@6U72V\2W4:S7,KM':[E!$2J<%A_M$Y'
ML![U[96E/@BA!M5J[EZ)+\W(_GCBKCV63YC4R_+X*?LW:4I7^+JDDUMM=O?I
MU?ZAZ?J%KJUG#>65S%=VDR[HYX'#HX]01P:L5^-7QR\#6WB+PK<ZHD:IJ6G1
MF995 R\8Y96/<8R1Z$>YKY<K)<"*6JQ/_DG_ -L?I_"&8T>+,O\ K=-\DXOE
ME&U[/?1W5TUM\UT/Z.**_G'HI_ZA?]17_DG_ -L?<?V/_P!//P_X)_1Q17\X
M]%'^H7_45_Y)_P#;!_8__3S\/^"?T<45_./11_J%_P!17_DG_P!L']C_ /3S
M\/\ @G]'%%?SCT4?ZA?]17_DG_VP?V/_ -//P_X)_1Q17\X]%'^H7_45_P"2
M?_;!_8__ $\_#_@G]'%%?SCT4?ZA?]17_DG_ -L']C_]//P_X)_1Q17\X]%'
M^H7_ %%?^2?_ &P?V/\ ]//P_P""?T<45_./11_J%_U%?^2?_;!_8_\ T\_#
M_@G]'%%?SCT4?ZA?]17_ ))_]L']C_\ 3S\/^"?T<45_./11_J%_U%?^2?\
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MGZW;V6CMT-%%%>R?GX4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5IX4O'U#1H_MURWV6=W#L^3)E\L </N'M3$?#?PJ^&-Q\3/@O\4=,T'X8_\
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M/^B8^#?_  06G_QNO7_UVP__ #YE]Z.G^U8?RL_"VBOW2_X9U^%'_1,?!O\
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M@_M6'\K/PMHK]TO^&=?A1_T3'P;_ .""T_\ C='_  SK\*/^B8^#?_!!:?\
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M*_\ "=L__C='^O6&_P"?$OO0?VO#^1GX'45^^/\ PS7\(O\ HE?@K_PG;/\
M^-T?\,U_"+_HE?@K_P )VS_^-T?Z]8;_ )\2^]!_:\/Y&?@=17[X_P##-?PB
M_P"B5^"O_"=L_P#XW1_PS7\(O^B5^"O_  G;/_XW1_KUAO\ GQ+[T']KP_D9
M^!U%?OC_ ,,U_"+_ *)7X*_\)VS_ /C='_#-?PB_Z)7X*_\ "=L__C='^O6&
M_P"?$OO0?VO#^1GX'45^^/\ PS7\(O\ HE?@K_PG;/\ ^-T?\,U_"+_HE?@K
M_P )VS_^-T?Z]8;_ )\2^]!_:\/Y&?@=17[X_P##-?PB_P"B5^"O_"=L_P#X
MW1_PS7\(O^B5^"O_  G;/_XW1_KUAO\ GQ+[T']KP_D9^!U%?OC_ ,,U_"+_
M *)7X*_\)VS_ /C='_#-?PB_Z)7X*_\ "=L__C='^O6&_P"?$OO0?VO#^1GX
M'45^^/\ PS7\(O\ HE?@K_PG;/\ ^-T?\,U_"+_HE?@K_P )VS_^-T?Z]8;_
M )\2^]!_:\/Y&?@=17[X_P##-?PB_P"B5^"O_"=L_P#XW1_PS7\(O^B5^"O_
M  G;/_XW1_KUAO\ GQ+[T']KP_D9^!U%?OC_ ,,U_"+_ *)7X*_\)VS_ /C=
M4]3_ &;_ (21VZE?A;X+4[NWAZT'8_\ 3.FN.L,W;V,OO0?VM#^1GX-45^Z7
M_#.OPH_Z)CX-_P#!!:?_ !NC_AG7X4?]$Q\&_P#@@M/_ (W6G^NV'_Y\R^]%
M?VK#^5GX6T5^Z7_#.OPH_P"B8^#?_!!:?_&Z/^&=?A1_T3'P;_X(+3_XW1_K
MMA_^?,OO0?VK#^5GX6T5^Z7_  SK\*/^B8^#?_!!:?\ QNC_ (9U^%'_ $3'
MP;_X(+3_ .-T?Z[8?_GS+[T']JP_E9^%M%?NE_PSK\*/^B8^#?\ P06G_P ;
MH_X9U^%'_1,?!O\ X(+3_P"-T?Z[8?\ Y\R^]!_:L/Y6?A;17[I?\,Z_"C_H
MF/@W_P $%I_\;H_X9U^%'_1,?!O_ ((+3_XW1_KMA_\ GS+[T']JP_E9^%M%
M?NE_PSK\*/\ HF/@W_P06G_QNC_AG7X4?]$Q\&_^""T_^-T?Z[8?_GS+[T']
MJP_E9^%M%?NE_P ,Z_"C_HF/@W_P06G_ ,;H_P"&=?A1_P!$Q\&_^""T_P#C
M='^NV'_Y\R^]!_:L/Y6?A;17[I?\,Z_"C_HF/@W_ ,$%I_\ &Z/^&=?A1_T3
M'P;_ .""T_\ C='^NV'_ .?,OO0?VK#^5GX6T5^Z7_#.OPH_Z)CX-_\ !!:?
M_&Z/^&=?A1_T3'P;_P"""T_^-T?Z[8?_ )\R^]!_:L/Y6?B-X=TN&YF%S>2Q
MQ6L9Z2,%WGTY[5W5K?6]\&-O*LH4X)4Y K]?_P#AG7X4?]$Q\&_^""T_^-UY
MK^T9^RWHOC#X=:;I7@GP]I?AZ[M=7AG$>E645LA25EAF=E0 '"[')ZXAK\<X
MR2XB<\8YS<XKW(:*,5I?NVWWTN[=$D?LW _B#@\IK4<OEAU"G4?[RHW=WL[/
MHDD[:=%=[W9\;_!_0_BK\*]:T7X@>'?"&L7UC(FX-!9O-#=6[?>1M@)"D#J>
MA ([5^F?@#QQ8?$3PK9:YIZ301W"_O+:Z0I-;R#[T<BGD,#^8P1D$&M70]'M
M?#NBV&E6,?DV5C;QVT$8_AC10JC\@*NUY.69;++HN*J-Q?1]^Z/S_C#B^GQ;
M4C6J850J0;2FF[N&ME).]VNC35M=-="BBBO</S4**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** +.G_ /'Y'^/\C6U6+I__ !^1_C_(
MUM5SU-R);A11161(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 5M0_P"/.3\/YBL6MK4/
M^/.3\/YBL6NBGL7'8****U*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** -'1_^6WX?UK2K-T?_
M );?A_6M*N6?Q,S>X4445 @HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "J6K?\ 'NO^_P#T-7:I:M_Q[K_O_P!#51^)#6YDT445UF@4444
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MY]]5_P#!1=__ !JMRB@##_X3&P_Y]]5_\%%W_P#&J/\ A,;#_GWU7_P47?\
M\:K<HH P_P#A,;#_ )]]5_\ !1=__&J/^$QL/^??5?\ P47?_P :K<HH P_^
M$QL/^??5?_!1=_\ QJC_ (3&P_Y]]5_\%%W_ /&JW** ,/\ X3&P_P"??5?_
M  47?_QJC_A,;#_GWU7_ ,%%W_\ &JW** .;OO%]BUJX$&J9XZZ3=#N/^F59
M/_"4V7_/'4O_  67/_QNNQU#_CSD_#^8K%KHIWL7$R/^$ILO^>.I?^"RY_\
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MI_$0]S#_ .$QL/\ GWU7_P %%W_\:H_X3&P_Y]]5_P#!1=__ !JMRBH),/\
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M>#->5)[BPUW0M/FTFXUNTO\ 5+1$BN[6 D2M'LD9LC!X=5SQC.1DYO,#U?\
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M_P"#?_ *[_\ DJJAPKF-2/-#E:\I(:R^M)75OO/U>T?_ );?A_6M*OR5MO\
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MU-S7^6/_ ($']F8CLOO/UCHK\G/^'LGQ=_Z%SP5_X WG_P E4?\ #V3XN_\
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M/^'LGQ=_Z%SP5_X WG_R51_J;FO\L?\ P(/[,Q'9?>?K'17Y.?\ #V3XN_\
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MO#^S<1V7WGZFT5^67_#T_P"*_P#T+_@W_P  KO\ ^2J/^'I_Q7_Z%_P;_P"
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M5'^J.:=H_>']FXCLOO/U-HK\LO\ AZ?\5_\ H7_!O_@%=_\ R51_P]/^*_\
MT+_@W_P"N_\ Y*H_U1S3M'[P_LW$=E]Y^IM%?EE_P]/^*_\ T+_@W_P"N_\
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MZ]!7L\T*7$+Q2+OC=2K*>X(P17Y:_P##T_XK_P#0O^#?_ *[_P#DJC_AZ?\
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MKR*$,#)=&S53(JO@=5#?*,CI7Z2WEY;Z=9SW=W/':VL"-++/,X1(T499F8\
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M\_X/_(_..BOT<_X<^_\ 56O_ "V__NNC_AS[_P!5:_\ +;_^ZZ7^M>3?\_\
M_P EG_\ (A_:.%_G_!_Y'YQT5^CG_#GW_JK7_EM__=='_#GW_JK7_EM__=='
M^M>3?\__ /R6?_R(?VCA?Y_P?^1^<=%?HY_PY]_ZJU_Y;?\ ]UT?\.??^JM?
M^6W_ /=='^M>3?\ /_\ \EG_ /(A_:.%_G_!_P"1^<=%?HY_PY]_ZJU_Y;?_
M -UT?\.??^JM?^6W_P#=='^M>3?\_P#_ ,EG_P#(A_:.%_G_  ?^1^<=%?HY
M_P .??\ JK7_ );?_P!UT?\ #GW_ *JU_P"6W_\ =='^M>3?\_\ _P EG_\
M(A_:.%_G_!_Y'YQT5^CG_#GW_JK7_EM__=='_#GW_JK7_EM__=='^M>3?\__
M /R6?_R(?VCA?Y_P?^1^<=%?HY_PY]_ZJU_Y;?\ ]UT?\.??^JM?^6W_ /==
M'^M>3?\ /_\ \EG_ /(A_:.%_G_!_P"1^<=%?HY_PY]_ZJU_Y;?_ -UT?\.?
M?^JM?^6W_P#=='^M>3?\_P#_ ,EG_P#(A_:.%_G_  ?^1^<=%?HY_P .??\
MJK7_ );?_P!UT?\ #GW_ *JU_P"6W_\ =='^M>3?\_\ _P EG_\ (A_:.%_G
M_!_Y'YQT5^CG_#GW_JK7_EM__=='_#GW_JK7_EM__=='^M>3?\__ /R6?_R(
M?VCA?Y_P?^1^<=%?HY_PY]_ZJU_Y;?\ ]UT?\.??^JM?^6W_ /=='^M>3?\
M/_\ \EG_ /(A_:.%_G_!_P"1^>WA>2"'Q-I+W./LRW<+2[NFT.,Y_#-?;5=?
M_P .??\ JK7_ );?_P!UUZ&W[#?BOP;X5M+;3_%-OXRN[<>6?-L_L$C(!\O+
M2R*Q[9)7MUI?ZS916DHQKJ_FI)?>TD?@GBGDU?/*>'QF77J.E=.*3O9V=UWV
MLTM=NQX;7@/[3TD)OO#Z+C[2L<S/Z[24V_J&_6ON;PW^R7X\U?4DAU.UM]!M
M,_/=37$<Q _V4C8DGV) ]ZY[Q9_P2FO?&6NW&J7WQ<'FRG"QKX;.V-1T5?\
M2^@_Q/>JJ<195AYVG77RO+\8IH^*\->',;A,XAFF.@Z4*:E9233DY)QM;>R3
MO=]E;R_,NBOT<_X<^_\ 56O_ "V__NNC_AS[_P!5:_\ +;_^ZZ7^M>3?\_\
M_P EG_\ (G]8?VCA?Y_P?^1^<=%?HY_PY]_ZJU_Y;?\ ]UT?\.??^JM?^6W_
M /=='^M>3?\ /_\ \EG_ /(A_:.%_G_!_P"1^<=%?HY_PY]_ZJU_Y;?_ -UT
M?\.??^JM?^6W_P#=='^M>3?\_P#_ ,EG_P#(A_:.%_G_  ?^1^<=%?HY_P .
M??\ JK7_ );?_P!UT?\ #GW_ *JU_P"6W_\ =='^M>3?\_\ _P EG_\ (A_:
M.%_G_!_Y'YQT5^CG_#GW_JK7_EM__=='_#GW_JK7_EM__=='^M>3?\__ /R6
M?_R(?VCA?Y_P?^1^<=%?HY_PY]_ZJU_Y;?\ ]UT?\.??^JM?^6W_ /=='^M>
M3?\ /_\ \EG_ /(A_:.%_G_!_P"1^<=%?HY_PY]_ZJU_Y;?_ -UT?\.??^JM
M?^6W_P#=='^M>3?\_P#_ ,EG_P#(A_:.%_G_  ?^1^<=%?HY_P .??\ JK7_
M );?_P!UT?\ #GW_ *JU_P"6W_\ =='^M>3?\_\ _P EG_\ (A_:.%_G_!_Y
M'YQT5^CG_#GW_JK7_EM__==07?\ P2&^RQA_^%L;LG&/^$<Q_P"W=/\ UJR=
M_P#+_P#\EG_\B']H8;^?\'_D?G517Z%?\.E?^JJ_^6[_ /=5'_#I7_JJO_EN
M_P#W55?ZT91_S^_\EE_\B/Z_AOYOP?\ D?GK17Z%?\.E?^JJ_P#EN_\ W51_
MPZ5_ZJK_ .6[_P#=5'^M&4?\_O\ R67_ ,B'U_#?S?@_\C\]:*_0K_ATK_U5
M7_RW?_NJC_ATK_U57_RW?_NJC_6C*/\ G]_Y++_Y$/K^&_F_!_Y'YZT5^A7_
M  Z5_P"JJ_\ EN__ '51_P .E?\ JJO_ );O_P!U4?ZT91_S^_\ )9?_ "(?
M7\-_-^#_ ,C\]:*_0K_ATK_U57_RW?\ [JH_X=*_]55_\MW_ .ZJ/]:,H_Y_
M?^2R_P#D0^OX;^;\'_D?GK17Z%?\.E?^JJ_^6[_]U4?\.E?^JJ_^6[_]U4?Z
MT91_S^_\EE_\B'U_#?S?@_\ (_/6BOT*_P"'2O\ U57_ ,MW_P"ZJ/\ ATK_
M -55_P#+=_\ NJC_ %HRC_G]_P"2R_\ D0^OX;^;\'_D?GK17Z%?\.E?^JJ_
M^6[_ /=5'_#I7_JJO_EN_P#W51_K1E'_ #^_\EE_\B'U_#?S?@_\C\]:*_0K
M_ATK_P!55_\ +=_^ZJ/^'2O_ %57_P MW_[JH_UHRC_G]_Y++_Y$/K^&_F_!
M_P"1^>M%?H5_PZ5_ZJK_ .6[_P#=5'_#I7_JJO\ Y;O_ -U4?ZT91_S^_P#)
M9?\ R(?7\-_-^#_R/SUHK]"O^'2O_55?_+=_^ZJ/^'2O_55?_+=_^ZJ/]:,H
M_P"?W_DLO_D0^OX;^;\'_D?GK17Z%?\ #I7_ *JK_P"6[_\ =5'_  Z5_P"J
MJ_\ EN__ '51_K1E'_/[_P EE_\ (A]?PW\WX/\ R/SUHK]"O^'2O_55?_+=
M_P#NJC_ATK_U57_RW?\ [JH_UHRC_G]_Y++_ .1#Z_AOYOP?^1^>M;?@FRUG
M4/%6F0^'_,&L&93;M&<%&'.XGL ,DYXQFON__ATK_P!55_\ +=_^ZJZCP3_P
M39U;X?-=2Z+\5+:"\N%"-=R>%A)(JYSM7==$ $]>.<#T%9U.*,JY&H5;OSC*
MW_I)O1S#!JHG4FTO)._R,NQ6X2QMUNWCDNQ&HF>)2J,^/F*@]!G-4?%4.JW'
MAO48M#FCM]6:!A;23#*J^./_ *Q['!P>E=Y)^R?XM^&EGJ?B+5/B7)XS@CAP
MVG-HRV87+KF1669AP,\;>A/I4LG['/C3Q9-;:_8_%>3PO#=V\<BZ1_8*72PY
M4'EFG&2<Y^Z,9QVS7RJQV"3]I[9<O>TK7[6Y;_A8_1I<39?]46(<GRMN/GM?
M\NI^7.K6U[9ZI=P:BDL=_'*RW"SYW^9GYMV>^:J5^E7C+_@F5?\ CS4DU#5/
MBC;?;P@CDN+?PP(VE Z%P+O!(Z9P...PKG_^'2O_ %57_P MW_[JKZN'%&5<
MJYJUG_AE_P#(GYM4Q^$YWR3NO1GYZT5^A7_#I7_JJO\ Y;O_ -U4?\.E?^JJ
M_P#EN_\ W55_ZT91_P _O_)9?_(F?U_#?S?@_P#(_/6BOT*_X=*_]55_\MW_
M .ZJ/^'2O_55?_+=_P#NJC_6C*/^?W_DLO\ Y$/K^&_F_!_Y'SO^R7I_B'^V
M-0O('\KPWMV7*R E99L?*$_VAGD^AP>HQ]1UTMG^P3XNTG1;;2=)^,,&CZ?;
MIL2&S\*(/<DLUR6R3R3GDU/%^SKXB\/:AIO@B;Q4VK:A>6LK)XD>PV;/OG>T
M/F')3Y>-XSQTS7S6*S7!8RJZE.JO2TEHNKO%'Z#D^>9?&E]7C-MQ3DVUIIJ[
M'RW^U?I_B*Y\-64]D^_P_"^;V&('<'S\COZH.GL<$YXQ\I5^J%I^PKXX@MY+
M:X^-2:E:2*4DM[[PI'(KJ1@@G[3D@CWKSR;_ (),"25W7XI+$&8D(GATX7V&
M;LG'U->K@>(<LP]/V4ZRTZJ,_P ?=/E<RSC XRM[:E-Z[IIZ>GD?GE17Z%?\
M.E?^JJ_^6[_]U4?\.E?^JJ_^6[_]U5Z'^M&4?\_O_)9?_(GD?7\-_-^#_P C
M\]:W/!.A:MXC\4Z=8Z'O74VE5HI4)7RBISYA(Z!<9S[5]W?\.E?^JJ_^6[_]
MU5TO@_\ X)KZWX#6Z.A_%R*RN+D!9+G_ (19))-H_A!:Y.!GT'IZ"LZG%&5\
MCY*VOG&5O_23:CF&#]HG5F^7K9._R,ZPBG@L;>.ZF%S<I&JRS!-@D8 9;;VR
M><50\66.HZGX;U*TTB\&GZE- R6]R1G8Q'!]OKVSGM7;Q_L@^*_A=;ZIXDU#
MXG7/C2".##Z;-I9MU7YUS(I$[@%1GC;R"?2M.;]A7QEXTN+;Q):?%^Y\*I>6
MT4BZ/'HOVF. %0<$M<*&8]2=HZX[5\I_:&!@_:.NN7ORRM?M;EO^%C]%GQ-E
M_P!36(;?*VXVZ[?Y=3\L=8TN\T75+JQU"%[>]MY#'-')]X,#S]?KWJI7Z<^+
MO^"66J>.K^*^UCXNPSWRQB-KB/PHL32 =-VVZ )'KC^E:OPC_P""57AKP-XX
ML=<\5>+CXVTZS/FIH[:2+2*64$;3*?.DWH.I3 SQDXR#]*^+<JC2YO:WDELH
MRU?E=+\3\UJYC@XN7LYMKIH[FM_P3$\-_$[1?A;=7'BFX,/@:[Q+H&GWB,;E
M<G+RH2?D@;.0I!W'++M!R_VI38XUBC5$4(BC"JHP /04ZOQ',,8\PQ4\2XJ/
M,]E_6_=]6?(5JOMJCJ6M<****\XP"BBB@ HHHH X3X\>)KWP7\%?'&NZ<_EW
M^GZ-=3V\F<;)!$VUOP.#^%?#OQ0\)VFG_"G]D73+/2[+4DOKVWN)+&_.VWNY
M;@V\DBS'8_RNTA#':W!/RGI7Z%>)O#]EXM\.ZIHFHQ^;8:C;26EPGK&ZE6'Y
M$UXMX#_9=L+CX8^$/#'Q*CA\0W_@ZYE&B:GI>HW=K(D(<&"0F-HV24*$& 6"
M[ 0QI#/G;P[XT@^ /Q@^.T%_>67PJNO[,L[NST[0[$ZII-LI,$?G1QCR-\S&
M50 4C4%V+9 P>J\-_';XN+\7)O">GS:SK3:CX-FU?2['QEIVG6ER]X$8QNOV
M,A5C9E V2MN'(./O5]&V'[-/PUL8O$*OX8CU.3Q"JIJEQK%U/J$]TJX*AI;B
M1W&"JD888*J>H%4[']E'X5:?JW]I1^$XY+LV#Z8S7%[<S*]JRE3$R/(58;3@
M9!( 7&,# !\Y>&OC=XNN-+UOPM\2?$?B33O$>H>%-0#>'_$WA>WM(KFY2"5F
MELKN#9F,*,;9%;.UOFR0*\M^#G[5FO\ A?X5^"_".CR77A/3M%TG4M4FU*XL
MDD;79H&EE^Q6S2*R*F"-\F-V00,$#?\ <FB_LN_#+0)$DMO#DDSQ6$FEV[7V
MIW=V;6U=65XH/.E;R5*NX_=[>&-37G[,WPTU#P?X<\+W'A>.71/#MP;K2[=K
MJ?=;2%BQ(D\S>P)))5F(/&1P, [H^8M/\>_M#^-/AGH?BNPN-:NM'U:QN;C6
M96M]#@M+6W;)22R(D:?Y%!!69&8\X .,>A_L(^";3Q!^REH4&OS-XCT/4?M
M.@ZK:VLUE#LO)CE5\H.V6 8^8SX(&W;7JN@_LO?##PWJ=A?67A=2VGO-)8VU
MU>W-S:6;2G=(8;>61HHB3S\B"N@^&_P=\*?".WN;;PG8W6E65PQ=K'^TKJ>V
MC8L6)CADD9(B23G8JY_"F(^./V?_  GH&B^+OVGM8L_#VCQZEX6U*YFT*X;3
MH'.F/']J*& ,A$8!1>%P/E%8UY\6?C!??L<7OQ0\1>-K'6#J%Y#;:?IL_A^Q
M=8 ET8WE<M$59FVLH4IP "#DU]M:)\$?!7AV7QE)IVB_9W\8.\FMG[5.WVMG
MW[C\SG9GS'^YMZ^PJA-^SG\/+CX5V_PWD\/;O!<$OG1Z9]MN!M?S#+GS?,\P
M_.Q/+=\=.*0[GRK\5OVF?&FG^&?&_B'P5XQUS4HO#E[;6K&S\.:?!HED2ZH]
MO*\[-<S2=B\05<D85001R'V%/B!/^U1J-\4M[Z/3-+UR">(E/(NHH3.K(<Y7
MYA@<YP>M?8WB#]D[X3^*/[3_ +0\'6[+J3K+>1V]U<6Z32*<B1ECD4;^OSXW
M'<V3\QSS?Q-_97T_4?">OZ1X @M/#5YXL>SL_$.J7=W<SR&PA&"(D8NIDV@*
M/N @DELT!<].^#/BBZ\;?"/P9K]\"+W4M'M;J?(ZR/$I8_B23^-=E5+1-'M?
M#VC6&E6,0ALK&".V@C'\,:*%4?D!5VF2%%%% !1110 4444 %%%% !1110!6
MU#_CSD_#^8K%K:U#_CSD_#^8K%KHI[%QV"BBBM2@HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
M1T?_ );?A_6M*LW1_P#EM^']:TJY9_$S-[A1114""BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD_ZA?_D2C_BI/^H7_P"1* -RBL/_ (J3_J%_^1*/^*D_ZA?_ )$H W**P_\
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M\5)_U"__ ")4$FY16'_Q4G_4+_\ (E'_ !4G_4+_ /(E &Y16'_Q4G_4+_\
M(E'_ !4G_4+_ /(E &Y16'_Q4G_4+_\ (E'_ !4G_4+_ /(E &Y16'_Q4G_4
M+_\ (E'_ !4G_4+_ /(E &Y16'_Q4G_4+_\ (E'_ !4G_4+_ /(E &Y16'_Q
M4G_4+_\ (E'_ !4G_4+_ /(E &Y16'_Q4G_4+_\ (E'_ !4G_4+_ /(E &Y1
M6'_Q4G_4+_\ (E'_ !4G_4+_ /(E &Y16'_Q4G_4+_\ (E'_ !4G_4+_ /(E
M &Y16'_Q4G_4+_\ (E'_ !4G_4+_ /(E &Y16'_Q4G_4+_\ (E'_ !4G_4+_
M /(E &Y16'_Q4G_4+_\ (E'_ !4G_4+_ /(E &Y16'_Q4G_4+_\ (E'_ !4G
M_4+_ /(E &Y16'_Q4G_4+_\ (E'_ !4G_4+_ /(E &Y16'_Q4G_4+_\ (E'_
M !4G_4+_ /(E &Y16'_Q4G_4+_\ (E'_ !4G_4+_ /(E &Y16'_Q4G_4+_\
M(E'_ !4G_4+_ /(E &Y16'_Q4G_4+_\ (E'_ !4G_4+_ /(E &Y16'_Q4G_4
M+_\ (E'_ !4G_4+_ /(E &Y16'_Q4G_4+_\ (E'_ !4G_4+_ /(E &Y5+5O^
M/=?]_P#H:H?\5)_U"_\ R)535/\ A(OLZ[O[,QN[>9Z&JCNAK<DHK(_XG_\
MU#?_ ")1_P 3_P#ZAO\ Y$KJN:&O161_Q/\ _J&_^1*/^)__ -0W_P B47 U
MZ*R/^)__ -0W_P B4?\ $_\ ^H;_ .1*+@:]%9'_ !/_ /J&_P#D2C_B?_\
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M/_\ J&_^1*+@:]%9'_$__P"H;_Y$H_XG_P#U#?\ R)1<#7HK(_XG_P#U#?\
MR)1_Q/\ _J&_^1*+@:]%9'_$_P#^H;_Y$H_XG_\ U#?_ ")1<#7HK(_XG_\
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MT_5+FSQ?:K/?VVEZ;)+)9Z9"^-MO"T@#%1@G[JC+'"COZG5K8 HHHH ****
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MC7^V;=?#D/\ Q*Y-;L3(+QFS*ZV=B^T1@' -PGF*2!QBO>YE>Q]$?6E%%%6
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M99&"(N$4GEB!G&!WJQXH\5:1X*T*[UG7=1M]+TNU0R37-P^U5 &<>Y] ,D]
M#7P)IO[/7B"3X3>,]7\4>"+W6O'4?B>P:>XFL&N+FXM8_),[0 KF56)DW&/.
M_!Z@5]?>/KSPT/@ZT5KX;OY+"6SE@TG3;7PQ=O);RB)UCQ;+ 7M\= S(@&1S
MR*:DV!WOA7Q1IGC7P[IVO:+<_;-*U"%;BVN/+:/S(VZ':P##Z$ UJUY'^RS>
M/%\%?"NAW>FZMI>J:/IT%M>6^J:5<V123!R%,T:B3&.2A8#CU%>N52U0!111
M3 *\T\6?M$>"?!NIZM97MWJ%RVC!6U:?3M+N;N#3@V"//DCC94.#G&<@ Y%>
MEU\M^#]>D^!R_%K0_$?A'6=?O]4UR]U?3H;'29KN+7(+@+LB\R.)D##[K*_0
M'H14MV ^E;77M-O;.QNH+^WDM[Y%DM9%E&)U8 J4Y^;((Z>M4=-\<:)J_BS6
M/#-I>^;K>D1PS7MKY3KY2R@F,[BNUL@'[I..^*^-?%7@_;=?%-/%WPWO(]8U
MG0+&+P?8Z;IDE_#8$6^/LMM+%#LA:*<J6P$Z;NG--UGX,^*=0B^)VJ:]X>U3
M4O%UKX,T>+3]0C@ED>74$MU\XV\BC]Y*'09*$GD^O,\S[ ?<<]];VLD4<T\4
M,DIVQK(X4N?0 ]3R*R/&7CC1/A_I":IK][]@L7N(K59?*>3,LC!$7"*3RQ S
MC [U\<^,O"]Q-??%-O'/A+6/$/B/6_#^GQ^%;O\ LF:\99!:A6CBD6-O(D6X
M(9@2I[GUKDM-_9Z\02?";QGJ_BCP1>ZUXZC\3V#3W$U@UQ<W%K'Y)G: %<RJ
MQ,FXQYWX/4"CF?8#]$*\^\6?'3PKX0\17VA7#ZAJ&JZ?9?VA?6^E:=/=FT@/
M1Y3&I"YY.,YP,XQBOECP'X)A\+^.-"O?"'P^UR[\WQ3YWE>(/"=[I%_I]JP(
M:1=1CD6$VZJ %@D7D<%>:]D^+WB^ZL?%VK>&O"WA35- N]6B1-;\=6OA6\NP
M8PF%2$V\#F>8*Q 9R$3GDGBGS: >VZ'XNT;Q)X7M?$>G:C#<:'<V_P!KBOL[
M8S%C.X[L;<#.<XQ@YQBN?^'_ ,:O!OQ0O)[7PWK!OKF&!;HQ2VD]LSP,Q598
MQ*B^9&64C>F5SWYKAO$VDZCX,_9:FTKX3Z3=WDUIIXM+*SU:PD2Z:(OMF<V\
MZH6DVF1PK* QQA2" ?$?@WI'B'X6_%#3-#\-Z9XH/@R[N+<S>*M:\-W[7\5J
MJ,1I;(\&V./S6W>:BHBAF.[-',U8#ZA\7?'+P9X(U:^TW5-2NFO=/MA>7L>G
MZ9=WWV.$@D/,8(G$0(!/SD<<UV&BZU8>)-(L]4TN[AO].O(EFM[JW<,DB,,A
M@1VKR#XV^(KC5H=:\.^=\0_#.RSD2.Z\.>'UU"WU+S$QA9(X)V0KRO+0'YCS
MT(Z?]G?2=6T'X)^$--US1H?#^IVMDL,FG0$E80K$+G+,=Q7:QRQ.2:=]; >K
M:/\ \MOP_K6E6;H__+;\/ZUI5SS^)F;W"BBBH$%%%% !1110 5YA\5/BAJG@
M;XA?##0K&WLYK/Q/J<]E>O<([21HD!D!C(8 '(_B##':O3Z\_P#B)\*?^$^\
M:> -?_M3[#_PBM_-??9_L_F?:M\)CV[MPV8SG.&],4 >:V'[;7AO4SHYMO _
MC:6+6KZ;3-*F6RM2E]<Q.%>-#]IXY/WGVKA6Y^4XUA^UWX9NM*\*7.F^&_$^
MKWWB/4+K2[;2;2T@%U#<V^/-CE$DRH,==RNR\'GBJOA']E7_ (16S^&\'_"4
M?:O^$.UJ_P!7W?V?L^U_:3(?+_UI\O;YGWOFSCH,T>$_V5/^$7USPAJ/_"4?
M:?\ A'_$&JZ[Y?\ 9^SS_MJD>5GS3MV9^]@[O04#T)_ W[87A/QUJF@VL/A_
MQ1I=MK5]+I=IJ&I6,20&]C3<]NVV5G##INV[,@C=P</OOVPO!NG^!?#WBN33
M-=;3M;U&ZTRVB6WA\Y)(#)O+CSL!3Y38()/(R!57PW^RI_PC^G^!K7_A*/M'
M_",^)KOQ%N_L_;]I\\R'R<>:=FWS/O<YQ]T9KCM8_8?U75-+T?0(_B+%!X5T
M?4[W4[&Q;00]P&N"Y*R3_:!O"[VQA%ZG.>, :'63?MN> M-\-VVLZOIOB+0X
M+[2_[6TV&_L4$NHQ>8L>V$)(P+[F488J""&!*\UW/@'XVV_B_P ;7W@[5/#^
MI^$O%-M81ZJNGZFT,GGVCMM\Q'AD=3M?Y64D$$CKV\A^(7["MK\0O#WP^TRY
M\8RVC^#]$.EV]Q#I_P TLP"&.XP9<* R#,?S9!(W \UVVE_LUQ^*?B'<>-?B
MH^@^.-3_ ++BTFTT_P#L8"QMHU<NTNR9Y=TC,3\W&T$@9S0&@S4OVO\ PKH^
MK>)8+OP]XFBTCPWJJZ1J^OBSA:QM)68*K,1-YA0DCE4)&1D#(SCZ#^VQH?C#
M5-(TWP]X$\7:E>ZS<W5KIN]+*&*Z:WQY[!FNN$4'.X@ D$#G(KE]%_93\2^*
MKGXG:'X@U4^&_ &O>*?[071;.U@=[ZU3RV0I,KDPJQ15*E<@1C&,G.]X1_92
MN/!.D^!+KPAXOM#KW@Z\U-8+B[TYFL[F&ZE836\D2S!E*'@,'ZJ<CG@U';2Y
MS.N?MK:]XC\66FB>"O"5W8FVBU!M8;5[.VNYX9;14,T<<*ZA ,)N.YFD!;C8
MK=:IZ;^V]J=UJB&=;1-#DLM'N(;J/0V-S+)=RE'5H3?[8UXX(D<KU(?I7:>$
M_P!C<^'_ !)-XBNO%QO-9U"#6#J;KI^V.:YU *&DC'FG8D810$.XM@G<,US5
MI^P%]EL[6#_A.]WD6^EP;O['QN^QRF3/^OXWYQC^'WH#0[S3_P!M3P+/H]MK
M&H:;XBT+1+J:\M[?4M0L4\F::V5FEC7RY'8G"-@XVD@C.00+_P +?VG(?BU\
M1K;PYIOA:^TFQFT&/Q MYK%S$D\L$C[8S'#"95(/&=\B,,_<->=?$3]C#5[W
MX%Z+X5T#Q1'<:UX=U&^UBTDEMGMEO))C*PAW),&BQYF-^XYQR ":M_LX_"WQ
MU\-?&&@6]IX9G\-^%3I/EZ__ &Q;Z()9KI4 B%O)IRB60!MV7N"20<_>H%H:
M/Q;_ &QD\.V=S_PAOA[4-62S\20>';K7;NS#:8LYD GB!6992Z@D!@A3=@9.
M>>B\5?M41>&[>T$OP]\96<^JO<6^CR:C9VMNEY-$I;!22Y62,$ L/-5"R@XY
MP*YSQ7^QYJNL:?K6@:3\0O['\(ZKXD'B>6PDT<3W44Y<.\<=QYZ@(7 8?NRP
M('S'G./H7[";Z7KWAB\NO&&G7<6BW=Q=2W<?AQ4U;4S+O_X^KYKAV=E#X!VA
M>!\O3 /0ZCX9?M3:UXF^&>B:]JWPS\57M]<:8^IW5QH=I;#3_*4G+Q22W8ZX
M.(BWF_*3LP5)]L\"^--,^(O@_1_$VC2/+I>J6R75NTB;7VL.C#L0<@CU%?,,
M/["VM+9V5E<^/]%UFQT[16T/3K;6O"9O(K-&D+_:(XWO/+%QSM\S9C 'R]Z^
MB?@[\._^%3?#'P[X0_M#^U?[(M1;?;/)\GS<$G=LW-MZ],F@1V5%%% @HHHH
M **** "BBB@ HHKQ_P#:TT#Q-XF^ OB33O"<-Y=:I+Y!>UT^39<7%N)D,\<9
M!!):,.-H.6&1SG! /0+3QYH5]XVO_",%]O\ $-A:1WUQ9^3(-D,C%4?>5V')
M!X!)]146N7WA?X5Z!K_B:]AM-#TY=VHZK>6UI\TC  -+((U+2-@ 9P3@"OB:
MZ\&II/B+XOZCX#^#OB"3PS?^'].MXM&O-+O])BNIA*OG;$4)*X5<%XTP7VOU
M#9-%/A3JOBF'XVZ99> V&FS>&[>;2;>#P;<:'9S:A$&7S;6VN6=A,$9EW@JS
M9/R\\A5C] ]-U"WU;3[6^M)/-M;J)9HI-I&Y& *G!Y&01UJS7P7XVT6VU+3]
M%L-.^#LT6D67A%X8[J_\#ZI?-]N;'FVT%BAACMIBQ+FZ;[QZ,<5]2_LQVNM6
M/P \"VWB&"^MM9@TV.*YAU*-TN$*D@*ZN P( '6@1Z?1110(**** "N1^)OC
M[0/ASX>BU3Q%J*Z=9R7,=M$?+>62:5\A8XXT#.[G!PJ@G@\<5UU>1?M%_"_5
MOB-IOA*]T&ZLH-:\-:];ZS;0ZEN%M<[ P:)V569,AN&"M@CIZ5'<:W.,\(_M
M8>$_$7_"5W-X)M*TK1]8BT:UF:"XDN;^9TR%6U\D3*X8,NS:Q^4GBF^/OVL/
M"_A;PC_;6CVM_P"(9(]6CTFYL_L%Y;26LI=%<3!H"T;@."J.JF3D+D@XXV/X
M#?%@-XMU&#6]%T2_\0>)K?5[K3]&U6ZMTGLDC*O;&\6 2Q,?E)=$YYZ9Q6-I
M?[-/B_4_!WQ%TU]6T$:_?>);'588%U2\OHX3 (Y!!<7$Z&8L8RAW$-]X< '
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MHW^(O"">%3$NFX$!6&./[1GSOFSY>=G'7&[C- :#[']KJ/Q=JG@#0O!GA?\
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MC_5'*^TOO/Z>_LW#]G]Y^IO_  ]/^%'_ $+_ (R_\ K3_P"2J/\ AZ?\*/\
MH7_&7_@%:?\ R57Y944?ZHY7VE]X?V;A^S^\_5BQ_P""K7PEM=^_P[XT.[&-
MME:>_P#T]5;_ .'LGPB_Z%SQK_X V?\ \E5^3E%0^#\J;NXR^\7]F8?L_O/U
MC_X>R?"+_H7/&O\ X V?_P E4?\ #V3X1?\ 0N>-?_ &S_\ DJOR<HI?ZFY5
M_++_ ,"#^S,/V?WGZQ_\/9/A%_T+GC7_ , ;/_Y*H_X>R?"+_H7/&O\ X V?
M_P E5^3E%'^IN5?RR_\  @_LS#]G]Y^L?_#V3X1?]"YXU_\  &S_ /DJC_A[
M)\(O^A<\:_\ @#9__)5?DY11_J;E7\LO_ @_LS#]G]Y^L?\ P]D^$7_0N>-?
M_ &S_P#DJC_A[)\(O^A<\:_^ -G_ /)5?DY11_J;E7\LO_ @_LS#]G]Y^L?_
M  ]D^$7_ $+GC7_P!L__ )*H_P"'LGPB_P"A<\:_^ -G_P#)5?DY11_J;E7\
MLO\ P(/[,P_9_>?K'_P]D^$7_0N>-?\ P!L__DJC_A[)\(O^A<\:_P#@#9__
M "57Y.44?ZFY5_++_P "#^S,/V?WGZQ_\/9/A%_T+GC7_P  ;/\ ^2JTO#O_
M  5$^&'BK5H=,T[PSXREO9LB**2VL8]Y SM!:[ S[9YK\BJ?#-);S)+$[1RQ
ML&1T."I!R"#V-3+@W*[:)W]2HY9A;KF3MZG[)O\ M]^'&U"#3U^'GCZWN;A_
M*BGN=-MOLR,> 9)$N6"J.I(R< X!KFO"'[5]G\&]%DM-?\/^)O$[7]Z\T+>'
M[..Y:-F +^8'D3 )Y!&?XLXXS\^_!SQ-J_BSX?Z;J.MVK6]XZ[1(W'VA!]V7
M';=^N,C@BNVKYF648.CS47#3KKV[,_1L-PO@)8.=*#=JG*[O=6V_-GLWB#_@
MHQX&\*:2FI:SX*\;Z;:R.(X_M%M8+([>@3[9NZ<]*Y?_ (>R?"+_ *%SQK_X
M V?_ ,E5^;OQR\5ZWXF\?W\>LP26/V%V@M[%CD0IG@^A+##%AUR,< 5Y]7T-
M#@_+94U*HG=]I'P&)RG!4ZLH4D[+35ZGZQ_\/9/A%_T+GC7_ , ;/_Y*H_X>
MR?"+_H7/&O\ X V?_P E5^3E%;_ZFY5_++_P(YO[,P_9_>?K'_P]D^$7_0N>
M-?\ P!L__DJC_A[)\(O^A<\:_P#@#9__ "57Y.44?ZFY5_++_P "#^S,/V?W
MGZQ_\/9/A%_T+GC7_P  ;/\ ^2J/^'LGPB_Z%SQK_P" -G_\E5^3E%'^IN5?
MRR_\"#^S,/V?WGZQ_P##V3X1?]"YXU_\ ;/_ .2J/^'LGPB_Z%SQK_X V?\
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MRUT[?YG\L\38' 97F=7 9>YN-)\K<[7<ENTDE9=KW;WOK9%%%%>@?*A1110
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MDL?$C>'%T&\UMCO$DT]KA6!X4AF4$[SR>WT902%%%% !1110!XE^VC\/]?\
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M/[6K:R;5E%/>RN]7M>^VG<_&_P#X=_\ Q[_Z$/\ \K%A_P#'Z/\ AW_\>_\
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M^R'\<?BG;VUS-\(#I>N6_P @NH?$.G2)-'_=8&8$8/(.3W]>/-?^'=W[0?\
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M ,K6G_\ R17[544?Z\9E_P ^X?=+_P"2#^UJ_9?C_F?BK_P[N_:#_P"B?_\
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M_P#\76Y10!A_\(9I?]VZ_P# Z?\ ^+H_X0S2_P"[=?\ @=/_ /%UN44 8?\
MPAFE_P!VZ_\  Z?_ .+H_P"$,TO^[=?^!T__ ,76Y10!A_\ "&:7_=NO_ Z?
M_P"+H_X0S2_[MU_X'3__ !=;E% &'_PAFE_W;K_P.G_^+H_X0S2_[MU_X'3_
M /Q=;E% &'_PAFE_W;K_ ,#I_P#XNC_A#-+_ +MU_P"!T_\ \76Y10!A_P#"
M&:7_ ';K_P #I_\ XNC_ (0S2_[MU_X'3_\ Q=;E% &'_P (9I?]VZ_\#I__
M (NC_A#-+_NW7_@=/_\ %UN44 8?_"&:7_=NO_ Z?_XNC_A#-+_NW7_@=/\
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M .!DW_Q='_"*Z=_=N?\ P,F_^+K7HHL@*^E^$=,D\W<MUQCI>S#U_P!NK_\
MPAFE_P!VZ_\  Z?_ .+JUH__ "V_#^M:5<L_B(>YA_\ "&:7_=NO_ Z?_P"+
MH_X0S2_[MU_X'3__ !=;E%0(P_\ A#-+_NW7_@=/_P#%T?\ "&:7_=NO_ Z?
M_P"+K<HH P_^$,TO^[=?^!T__P 71_PAFE_W;K_P.G_^+K<HH P_^$,TO^[=
M?^!T_P#\71_PAFE_W;K_ ,#I_P#XNMRB@##_ .$,TO\ NW7_ ('3_P#Q='_"
M&:7_ ';K_P #I_\ XNMRB@##_P"$,TO^[=?^!T__ ,71_P (9I?]VZ_\#I__
M (NMRB@##_X0S2_[MU_X'3__ !='_"&:7_=NO_ Z?_XNMRB@##_X0S2_[MU_
MX'3_ /Q='_"&:7_=NO\ P.G_ /BZW** ,/\ X0S2_P"[=?\ @=/_ /%T?\(9
MI?\ =NO_  .G_P#BZW** ,/_ (0S2_[MU_X'3_\ Q=<#KGC[X>^'_%U[X8F?
MQ#>Z[90QW%S9Z3IVK:@T,<F=C,;>-U .#W[5ZU7SG:_#OQ+K'[5OQ"U6VU?Q
M%X1TN;1=-CAU/3;.V:&\==^Z,/<VTJ$KW"8(SSVH ]4\/KX;\33-%9VNOPLL
M*3DZA:ZE9+M;. &F5 6XY3[R\9 R*W/^$,TO^[=?^!T__P 77QW\?OAMXLU'
MQ1\<?L>B:YKJWWA'2;2TODT]G:_FCGC+A#%&$>3 +,J 8YX I_C?P3XB\!ZY
M\1M*\-?#S5=?\)7GA/3&&CQ&]BM+F\$RI*=T1#22!"6DC0[Y I!SDY!GT_XY
MOO!?PUTF#4_$=[=:=8SW45E'+]HNY=TTC;47"%B,GN1@=R*SO'7BSP'\.]4T
M[2]6N-4EUC45=[32]+%_?W<R)]YQ#!O8*/[Q '!YKXDUWX>^++[Q)XC@T'P1
MJEOH$E_H,R1Z/X,OM%L9I8ISYDL=K*SM\JGYG.W.,E1U/U#XR:Y^&W[5\/CO
M6=.U&[\*:EX4.CQZCI]A/>_8KB.X\THZ0JS(KJ>#C!(QZT =')\6_A0-%T#4
MX=<O;Z+7I)8=-M]/&H7=W</&#YJBVB#2@ICY@4&WOBNI\#WG@OXDZ'_:_AO4
M)M2L1*\#LMW<QR12J<-')&[!XW'=7 (R..:^7O _P[BM5;Q;XB\.?$'PKJ&L
M>*M6UO1-7\+Z>\USI-K.4'DW-LJ2.!*(MVUH&7!&2,U]"_LWZ]XZU[PCJ\OC
MB.\9H=6N(=)O=4T]=/O;RQ7'ERSVX \MB=PP50D ':.I!'>_\(9I?]VZ_P#
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M%=._NW/_ (&3?_%T?\(KIW]VY_\  R;_ .+K7HHL@,C_ (173O[MS_X&3?\
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M<_\ @9-_\71_PBNG?W;G_P #)O\ XNM>BBR R/\ A%=._NW/_@9-_P#%T?\
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MS2_[MU_X'3__ !=;E% &'_PAFE_W;K_P.G_^+H_X0S2_[MU_X'3_ /Q=;E%
M&'_PAFE_W;K_ ,#I_P#XNC_A#-+_ +MU_P"!T_\ \76Y10 44C,$4LQ"J!DD
M\ 5Y(O[6'PI:Z2,>+$-L]Z--75/L-U_9QN",^6+SRO(SCG_6=J!'KE%<EJ'Q
M"_LSQ-?:5+X=UPVEII[:@VMK;QFP<*,F%7\S<9,=BH'O57X-_%O1_CA\/[#Q
M?H5M?6FF7CRI'%J,:),#&[(V0CL.JG'/2@#MZ**\Z\1?M >"?#'C:Y\(7=]J
M5SXEMK9;V;3M,T.^OY(X#C$A\B%P%Y'.>,C- 'HM%>-W'[67P^<^!GTF]N?$
M-KXPU(Z58W6FQ+M@G!0$7"R,CQX\Q3C:6P<XY&?9* "BBB@ HIKNL:LS,%51
MDLQP /6O.=*_:'\ ^)(_&/\ 8.O1^()?"=LUUJD>G1LX10K-A)"!'(3L8?*Y
M&1@D4 >D45R/PG^)FE_&+X?Z3XOT:"\MM,U)7>&*^1$F4*[(=P5F Y4]">,5
M5USXP:'H/Q+TOP/*EU/J]YI\^JSS0B/[/I]I%P9KAV<%%9OE& W/7 YH [BB
MO+?#O[3WPS\5:QINFZ=XE\R74YY+6PN)K"Z@M+R9#AHX;F2)896SP CG)Z9K
MU*@ HKSCQ!\<M)\/_&/1_AL=)U:^US4K#^TQ<VRP"U@MP[JSR-)*K?+L)(56
M.,8STK*M_P!K+X4W5]%;Q^+$,4MZ=.CU$V-R-/>X SY8O#%Y!./]O% 'KE%>
M?Z+\>O GB+P9XC\6:?KGVCP_X=FF@U2\^R3K]G>%0T@V,@9L!@?E!!SQFL_P
M9^TU\-/B#XJL?#>@^)TO=;OK,7]M:M9W$)EA*[MP:2-5SMYVYW8!XX- 'J%%
M>,^*/VL/!7A_P;#XKLH=5\1Z VKG0Y[S3+9$^S708+M=+AXF(R?O(&'!KV:@
M HHHH K:A_QYR?A_,5BUM:A_QYR?A_,5BUT4]BX['F6J?M)?#[1KS58+S5[R
M&/2;W^SK^\_L:]-G:W&X+LDN1#Y2<LO)?'(YKTM)%DC5T8,C#<&4Y!'KFOE[
MP3\!KSQ_J'Q>T[Q-J/B;0_#FJ>+)ICI5O%#;0:G !$P?S'@,I1BNTF.100,>
MM<)K?[/6JZIX1^.][I'A:XMO%-UXA:+3;B2U*3SZ:IB,B6S.5)5T,JG8PWCY
M<GI5<S[%'V!XE\=Z#X1\+:CXCU34HH=%T]-]U=1!IA&,@=(PS$\C@ GFK&C^
M*;#7;@PV0NY!]GBNEGDL9XX'CD&4*2L@1SCJJL67N!7Q;K7PSU:^\%_$VY\.
MZ'J5O!=^%X=._L?3/!-SH=M=3K,K1LL,MS)++.J;U++'MP1\^>N9\4/A'XC\
M3_$ZSCG\(:Q?Z-<0^%X+EET^9HFC3BX5F"X 0$[N?E[XI<S[ ??=4-%UJWUZ
MS-U;1W<40D:/;>V<UK)E3@G9*BMC(X;&".02*^(M6^ USH+>/-3T+P;J=IJ5
MCXZL3H+V=G,&M['S%:5K4*/EB)>3<4^7@9^Z,9?PA^".KZEXXN/^$G\%ZM_9
M\>D:ZT1OK">./SWNR8>2 "Q5BRCZ,.0"#F?8#] *^9OCC^QNOCWQ'?>)/"6L
MQZ#JNH;OMMI<!A;SEAAF#("RENK##!B2>._S;-H/CGQ!\+]33Q%\,=67Q='I
M-I:V.HWOAO4]7U2\9&8*\-QYBQV'EA5R,%FR25;-=+<_#W6? W@_QQ\6YK&X
MT'XA:+XIAO=-O-7MY8S?PM$D;P!6QO64S2 [>I&,CMP8S"4,PI^SKQNM_-'G
M8[+\-F5+V6)C=?<T_)G5^'_V/=)^$MO-XR^*OB6S;P_I!2>:UTR&:>.3YP!Y
MA,>\KD@%53)SU%?0FH?M2?#71Y_LVHZS?:9>%86CL;[0[^"YF65BD;10O 'D
M!88RBD9QZUYOXV^$>M>&_P!BO7O#D=I=:WXNU*W%_J*6<+S3W-]-.DLQ"J"S
M$$D<#HG2L;X^_LYWFH:1X5\3)J7BKQ;XM@U#2[.&:6&!VTRV$V^5XX8+=$&#
MR7D5N%&>,U&"R^AEL'##1M??JV9Y=E>%RN#AA8VOOU;/:[[]H[P1IFI6.G7D
MGB"SU&^+"SL[CPKJL<]SM&6\J,VP9]HY.T''>NN\%>/-!^(FB_VKX>U&/4;(
M2M [*C1O%(IPT<D;@/&X[JP!&1QS7C?Q+\ 6VE^)/#FI:[K?Q,UG5+8R_8/%
M&AZ?:SOIFX?O(GBM+4,RR +G?!(ORXRN3E_A.\^*7C+X!_$*WOOMZ>(F.H6O
MAN_OK1=,O[N#R\02R1#:(9"Q8 D(> <#K7J7=SU3V.]\<:)I_C#3?"UQ>^7K
MVI6\MU:VGE.?,BCP';>%VC&1P2">U'C+QQHGP_TA-4U^]^P6+W$5JLOE/)F6
M1@B+A%)Y8@9Q@=Z^ =?\!S:=?>&;SPI\&O$U[<0^$6LO$%K=:;?6,5S=ED#E
MY$"M.WWV8(3YBD#)Y ;XE^$FJ:]K7C"ZLOAS-/I5H-(F@73_  5<Z5!+LN%%
MR;:UG+R$F/ ?;@N%R5P,F.=]@/T=HKX,^.>B3>))/&O_  CWPJNK.);"SM_#
M]TO@_5+N\G51P;9LQQZ8L1&-FS)Z[6SS]N^$6NF\)Z*;X2B^-E 9Q,"'\SRU
MW;@>0<YSFK4KL#6HHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#1T
M?_EM^']:TJS='_Y;?A_6M*N6?Q,S>X4445 @HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KG_#OCS0O%FL:_I6E7WVJ_T&Y6TU&'R9$\B5
MD#A<LH#?*0<J2*\H_:X\-ZQXC\,^#UM=*U#7O#=KXDM+GQ'I.F(TLMU8+NW
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@"SI__ !^1_C_(UM5BZ?\ \?D?X_R-
M;5<]3<B6X4445D2%%%% !1110 4444 %%%% '&?&CP_JOBOX1^,]&T1BNKW^
MD75M:8;:3(T3!1GMDG&?>OA>Y\::!=_L"6GPK@4O\27NETM?":PEM26[6^\Y
MF,&-ZC8"V_&.<9SQ7Z-UR'C[X3^%_B;-I$_B'3Y;B[TB9KC3[RTO9[.YM9&&
M&,<T#HZY &0&P<#T% SY"\*Z+J7AO]J)])UB3SM6L?A)';7<F[=NF2-%<Y[\
M@\UXW^SQK5CX)\1_ GQ'KURFE:%_8^N6W]H7.5A\WSKO$>[IN.]<#J=PQUK]
M-O"_B70?$5I-'H&M66M1:?)]CG>SO5NVAE0 &.1@S'>.,ACNYYK:I#N?!'[#
MNJ>%[?PS\.+74?&_B#1_$-QJ6JG3?#EA/*NGZH!]\W"K&48J,E=SKR.,UV4U
MGX@O?^"AWBN/PWJNFZ1?_P#"'1%KC4].DOH]F^#($:3PD-G:=Q8C@C:<Y'V+
M7+>(OBMX)\(ZA+8:[XPT#1;Z*)9Y+74=3@MY4C8[5<J[ A22 #T)-,5SX<^+
MW[,^B_"O6/@AX2O[^7Q.-?\ &<MYK%S<0K"ET\AMU=5B!(1"J@;<GJ>>F."T
M'6+?0_&/B7PA-X6T^\\)0?$"\2WO==%W-H.B#=@"6S@=(Y-P'RB0A5VG&,L1
M^H\<BRQJZ,'1AE64Y!!Z$&G4@N?D=X+T^QU77-4M)_&GAW2['1O%MU)I_A_Q
M7IE[%X8NRZM@O]Y;8 (=J2-NP>O'/2>#?$$GC'Q=X'M/$VDZ1X"^%=C;7EKI
M;>(XKW5?#ES>?,6E3SKB(@,C8CW2%5*_*,GC]3:*!W/G7]G+2?"/A#]G6Z@U
MKQK:>+OA^US)Y-_XBTR33;&*U<H%@"WCMOA#D[6)*G=@9(KYY^'?Q"\#Z)\0
MOVI2GB;P_8:;J=B8='VW\$<-V!#.JI;_ # /C*@!,]17Z(44Q7/RI^%NL>%/
M!>A? ?6_"DR6WC/3;Z^OO%TUH&$T>F+(&E-U@?ZOR<;-W!!XSFOLCX#:';ZG
MX.\9_%_XCP6L<GC6%KNXM=1C#PV.BQH1! ZMD%3'EWXPVX9'%>O?%;X8:;\8
M/",GAK6;R_MM)FGAFN8["18S<I&X?R7+*W[MB!N"X) ZBNLAACMH8X8D6**-
M0B(@P%4#  'I0%SX$\5?$KP7^TAXK\):1H>M>%_A_P#"GP7J*ZA";S4+:PO=
M2GCSLBM;0LK1(>0&8+]_=C(VUY+XN\16UW:^%?$5OHFD^!?$*>-T\ZQ6"_DU
M^W4D[GN]1N)265N<(5'3@\,!^K-% [GQ?^T5H6I>*/VN#H^C@G5;_P"&>HVU
MJH?83*YN54;NV20,US'PQ^*GP\T7]DWP[\._$7A:3Q5XMAU!M/N/ *HT>H27
M7VAY/,,>-R@ AMQX[9SQ7UCKWP/TK7/C+HOQ+&KZM8:]I=C_ &:MO:M ;::
MN[LLBO$S<ER"593@#!'6O1J!'YL?!7PMJ%U^Q_\ '.]M_$>LZ#9VE_JBR:#
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M\_Y?<A?V1#^=G[X_\-*?"+_HJ?@K_P *&S_^.4?\-*?"+_HJ?@K_ ,*&S_\
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M?ZBX;_G_ "^Y!_9$/YV?OC_PTI\(O^BI^"O_  H;/_XY1_PTI\(O^BI^"O\
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M(OBS3/$^MZ;=OX@TR$P6>I6.JW=C- A+$A6@E3&=S<]<$CI2"Y\*^.OBI?\
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M'^O'_4-_Y/\ _:A_:W]S\?\ @'\]5%?T*T4?Z\?]0W_D_P#]J']K?W/Q_P"
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M444 %%%% !5+5O\ CW7_ '_Z&KM4M6_X]U_W_P"AJH_$AK<R:***ZS0****
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M %G3_P#C\C_'^1K:K%T__C\C_'^1K:KGJ;D2W"BBBLB0HHHH **** "BBB@
MHHHH P_^$QL/^??5?_!1=_\ QJC_ (3&P_Y]]5_\%%W_ /&JW** ,/\ X3&P
M_P"??5?_  47?_QJC_A,;#_GWU7_ ,%%W_\ &JW** ,/_A,;#_GWU7_P47?_
M ,:H_P"$QL/^??5?_!1=_P#QJMRB@##_ .$QL/\ GWU7_P %%W_\:H_X3&P_
MY]]5_P#!1=__ !JMRB@##_X3&P_Y]]5_\%%W_P#&J/\ A,;#_GWU7_P47?\
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M_C5;E% &'_PF-A_S[ZK_ ."B[_\ C5'_  F-A_S[ZK_X*+O_ .-5N44 8?\
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M7=EY,@\N*3A&WE=ASZ!B1W% B;_A,;#_ )]]5_\ !1=__&J/^$QL/^??5?\
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M4O\ A*;+_GCJ7_@LN?\ XW1_PE-E_P \=2_\%ES_ /&ZUZ*ZM30R/^$ILO\
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MZ*-0,C_A*;+_ )XZE_X++G_XW1_PE-E_SQU+_P %ES_\;K7HHU R/^$ILO\
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MZ*-0,C_A*;+_ )XZE_X++G_XW1_PE-E_SQU+_P %ES_\;K7HHU R/^$ILO\
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M "BBB@ HHHH **** "BBB@ KG_B':S7O@#Q-;V\4D]Q-IEU''%$I9W8Q, H
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MN9QVSQ9^&G[1/C/XP>%=+\1>&_ &GSZ)J4\EOY]MXBAN;S3L,RK-<VKI"N.
MQC2<O@^]>9-\'_B9XRTWX)Z9??#^'3A\/+4M?'6-7M?LNIO'$D<<,7DF=MLF
MP;FDC  )&#6#XV_97U7Q+J/A[4OAS\+=1^#7C47ZRZAKL'B"W.GV\.#O$20S
ML[C.W 6&+/?TH#0^C/V7?BYKOQE\ ZGJ_B&'3X=0LM:N],_XED,D43I$5 ;:
M\CD$Y/\ %7L%?-/[ P*_"/Q(&;<P\6:EEL8S\R<U]+4Q!1110(**** "BBB@
M HHHH **** "BBB@#YJ_;VM_MGPK\+0?9;>^\WQ;IJ?9;HXAFRSC8YVMA3T/
MRG@G@]*Y;XEPZW\'O!FD3^%O#?A/X8:WK7B73])EN/#$,5XDUO(S ^9OM(,D
M$G P?9ADU]%?&!?!\?@2]N_'5AI^H>'K1XY94U*Q%Y$CEPB-Y91N<OC('&3[
MUX/IOQ&_9NT?_CPT[PW8_O8Y_P#1O##1_O(R3&_%N/F4DD'J,\5Z6&P.*Q,'
M.A2E);72;_)'KX/*LPQU-U,)AYU(IVO&,I*_:Z3UU.%\9?&[XAV,'BGPOI_B
M?[/J^E>-M-T&WUUM/MVE:UND)Q)&4\LLI'557.!5WQ)XU\<+J7QEA/Q%U'37
M^'>FV\VGAK6S5KZ1H#.9KD>0 RLP$85 H ]3DGOYOC5\!;FZN+F:32);BXNH
M[Z:9] E+RW$?^KF8F#)D7^%CR.QJEXF^*?[//C35H=4UY=(UC484$:7-[H<\
MK[0=P4DP\@'D Y -=?\ 9.8?\^)_^ R_R.[_ %=SG_H#J_\ @N?^1\Q?%CQ'
M=^,/'DNNW]L+2^U.P\)7D\"@@1R2.'90#S@$GK7:?!GXH>/-?\13^']-\2V_
MAS38;#6]3:'3M$L45Y8;IE0X$0 )R-QQEL'/)W#V[7OCE^S]=R7>KZO)H]W,
MJ))/=W/A^:60K#\R$DP%CLZKZ=JY?3?VNOV6-&NFN=/U31K&X:.2%IK;PO=1
MN4D;=(I*VP.&;EAT)Y-"RC,+W5"?_@,O\CBQ&68_"-1Q%"<&_P":+7YH\2A_
M:;^(?QBLYK)O&%KX4DF@TP0QQW]GHUN27_TIY99W2Z;<%.TVC$ $ ]:_0ZRC
M2.S@2)S)&L:A7:0R%AC@[B26^I))KX5OOBC^RUL\3V>B_%+6/">@^)51=4T'
M1-&DCLI@J[3M5[!VBW \^6RYKU[0_P!NC]GGP[HMAI5AXX\FQL8([:"/^R-0
M.V-%"J,F#G@"JCE.8K?#S_\  9?Y')]7K?R/[F?25%?/7_#P#X"?]#Y_Y1[_
M /\ C%'_  \ ^ G_ $/G_E'O_P#XQ5_V3F'_ $#S_P# 9?Y!]7K?R/[F?0M%
M?/7_  \ ^ G_ $/G_E'O_P#XQ1_P\ ^ G_0^?^4>_P#_ (Q1_9.8?] \_P#P
M&7^0?5ZW\C^YGT+17SU_P\ ^ G_0^?\ E'O_ /XQ1_P\ ^ G_0^?^4>__P#C
M%']DYA_T#S_\!E_D'U>M_(_N9]"T5\]?\/ /@)_T/G_E'O\ _P",4?\ #P#X
M"?\ 0^?^4>__ /C%']DYA_T#S_\  9?Y!]7K?R/[F?0M%?/7_#P#X"?]#Y_Y
M1[__ .,4?\/ /@)_T/G_ )1[_P#^,4?V3F'_ $#S_P# 9?Y!]7K?R/[F?0M%
M?/7_  \ ^ G_ $/G_E'O_P#XQ1_P\ ^ G_0^?^4>_P#_ (Q1_9.8?] \_P#P
M&7^0?5ZW\C^YGT+17SU_P\ ^ G_0^?\ E'O_ /XQ1_P\ ^ G_0^?^4>__P#C
M%']DYA_T#S_\!E_D'U>M_(_N9]"T5\]?\/ /@)_T/G_E'O\ _P",4?\ #P#X
M"?\ 0^?^4>__ /C%']DYA_T#S_\  9?Y!]7K?R/[F?0M%?/7_#P#X"?]#Y_Y
M1[__ .,4?\/ /@)_T/G_ )1[_P#^,4?V3F'_ $#S_P# 9?Y!]7K?R/[F?0M%
M?/7_  \ ^ G_ $/G_E'O_P#XQ1_P\ ^ G_0^?^4>_P#_ (Q1_9.8?] \_P#P
M&7^0?5ZW\C^YGT+17SU_P\ ^ G_0^?\ E'O_ /XQ1_P\ ^ G_0^?^4>__P#C
M%']DYA_T#S_\!E_D'U>M_(_N9]"T5\]?\/ /@)_T/G_E'O\ _P",4?\ #P#X
M"?\ 0^?^4>__ /C%']DYA_T#S_\  9?Y!]7K?R/[F?0M%?/7_#P#X"?]#Y_Y
M1[__ .,4?\/ /@)_T/G_ )1[_P#^,4?V3F'_ $#S_P# 9?Y!]7K?R/[F?2VC
M_P#+;\/ZUI5\R:;_ ,%"/@!;^9YGC[;G&/\ B3:@?7_IWJ[_ ,/$?V?/^B@?
M^474/_D>N:>49CS?[M/_ , E_D0\-7O\#^YGT=17SC_P\1_9\_Z*!_Y1=0_^
M1Z/^'B/[/G_10/\ RBZA_P#(]1_9&9?] T__  "7^0OJU?\ D?W,^CJ*^<?^
M'B/[/G_10/\ RBZA_P#(]'_#Q']GS_HH'_E%U#_Y'H_LC,O^@:?_ (!+_(/J
MU?\ D?W,^CJ*^<?^'B/[/G_10/\ RBZA_P#(]'_#Q']GS_HH'_E%U#_Y'H_L
MC,O^@:?_ (!+_(/JU?\ D?W,^CJ*\ U3]M3P$^E6M[X:-[XE2X&Y66UELT"^
MI\Y%;GJ,*0?6F^'/VS?"5\TW]NV-]H$4:EQ,L;7BG Z;8E+Y] %-="R',W3]
MK["5O37[M_P/CJG$^34<5]2J8F*J7M;6U^S=N5/YGT#17SBW_!1#]GU6(/C_
M  1P0=%U#_Y'H_X>(_L^?]% _P#*+J'_ ,CUS_V1F7_0-/\ \ E_D?8?5J_\
MC^YGT=17SC_P\1_9\_Z*!_Y1=0_^1Z/^'B/[/G_10/\ RBZA_P#(]']D9E_T
M#3_\ E_D/ZM7_D?W,^CJ*^<?^'B/[/G_ $4#_P HNH?_ "/1_P /$?V?/^B@
M?^474/\ Y'H_LC,O^@:?_@$O\@^K5_Y']S/HZBOG'_AXC^SY_P!% _\ *+J'
M_P CT?\ #Q']GS_HH'_E%U#_ .1Z/[(S+_H&G_X!+_(/JU?^1_<SZ.HKYQ_X
M>(_L^?\ 10/_ "BZA_\ (]'_  \1_9\_Z*!_Y1=0_P#D>C^R,R_Z!I_^ 2_R
M#ZM7_D?W,^CJ*^<?^'B/[/G_ $4#_P HNH?_ "/1_P /$?V?/^B@?^474/\
MY'H_LC,O^@:?_@$O\@^K5_Y']S/HZBOG'_AXC^SY_P!% _\ *+J'_P CT?\
M#Q']GS_HH'_E%U#_ .1Z/[(S+_H&G_X!+_(/JU?^1_<SZ.HKYQ_X>(_L^?\
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M35_")^*&A>/9;.(F[T_05U/3/$=Q'$%BD=8X9(4;Y0K'_1\9)P!6[X#N]?\
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MNR-D([#JIQSTKMZ_)[X-PW5]I_PDMO&&H:/I/PX_L_4C9W'BBPDO-&.H&YN
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M5_">C? ?5/!6D:YJ"ZIK":'X>U/=?SKRH8S-)LC5OF$:84&O'_\ AG7XK_\
M1,?&7_@@N_\ XW7K8"M&E&?M:B2;NDY*32LM+W?6[WZG31DHI\SZZ:W_ *U/
M/:*]"_X9U^*__1,?&7_@@N__ (W1_P ,Z_%?_HF/C+_P07?_ ,;KT_K>'_Y^
M1^]&_M(?S(\]HKT+_AG7XK_]$Q\9?^""[_\ C='_  SK\5_^B8^,O_!!=_\
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MY'[T'M(?S(\]HKT+_AG7XK_]$Q\9?^""[_\ C='_  SK\5_^B8^,O_!!=_\
MQNCZWA_^?D?O0>TA_,CSVBO0O^&=?BO_ -$Q\9?^""[_ /C='_#.OQ7_ .B8
M^,O_  07?_QNCZWA_P#GY'[T'M(?S(\]HKT+_AG7XK_]$Q\9?^""[_\ C='_
M  SK\5_^B8^,O_!!=_\ QNCZWA_^?D?O0>TA_,CSVBO0O^&=?BO_ -$Q\9?^
M""[_ /C='_#.OQ7_ .B8^,O_  07?_QNCZWA_P#GY'[T'M(?S(\]HKT5/V</
MBU)G9\+O&C8Z[?#]V?\ VG3O^&:_B[_T2OQK_P"$[>?_ !NCZYAO^?D?O0>T
MA_,CSBBO1_\ AFOXN_\ 1*_&O_A.WG_QNC_AFOXN_P#1*_&O_A.WG_QNCZYA
MO^?D?O0>TA_,CSBBO1_^&:_B[_T2OQK_ .$[>?\ QNC_ (9K^+O_ $2OQK_X
M3MY_\;H^N8;_ )^1^]![2'\R/.*Z7X:Z'!XD\=:/I]TN^VEFW2(>C*JEROX[
M<?C71?\ #-?Q=_Z)7XU_\)V\_P#C=:7AKX$_&/PSKUCJEO\ "KQHTMK*) I\
M/7@##NI_=]QD?C2>,P]OXD?O1YF:>TK8"O2PLTJDH247?:3B[/[SZ351&H50
M%51@ #  I:GFTO5=/M;235M%U30I;F/S%M=6LI+68#OE)%!X/'I3M/TR]U:X
M^SZ?8W6HW.TL+>RMWGE8 9.$0%CQZ"LO:0<>=/3OT/\ ..IAJ].N\-.#51.W
M+;6_:W<^3_CWH-MH?C^0VJ"-+V!;MD48 8LRM^97/XUYS7M_Q*^#GQ=\<>++
MK4E^%/C9+8 0VZMX=O,B-<X)_=]223^-<O\ \,U_%W_HE?C7_P )V\_^-UI'
M%X>VM2/WH_T*X:IU\)DV$H8V7[V,(J5WK>VS\ULSSBBO1_\ AFOXN_\ 1*_&
MO_A.WG_QNC_AFOXN_P#1*_&O_A.WG_QNJ^N8;_GY'[T?2^TA_,CSBBO1_P#A
MFOXN_P#1*_&O_A.WG_QNC_AFOXN_]$K\:_\ A.WG_P ;H^N8;_GY'[T'M(?S
M(\XHKT?_ (9K^+O_ $2OQK_X3MY_\;H_X9K^+O\ T2OQK_X3MY_\;H^N8;_G
MY'[T'M(?S(\XHKT?_AFOXN_]$K\:_P#A.WG_ ,;H_P"&:_B[_P!$K\:_^$[>
M?_&Z/KF&_P"?D?O0>TA_,CSBBO1_^&:_B[_T2OQK_P"$[>?_ !NC_AFOXN_]
M$K\:_P#A.WG_ ,;H^N8;_GY'[T'M(?S(\XHKT?\ X9K^+O\ T2OQK_X3MY_\
M;H_X9K^+O_1*_&O_ (3MY_\ &Z/KF&_Y^1^]![2'\R/.**]'_P"&:_B[_P!$
MK\:_^$[>?_&Z/^&:_B[_ -$K\:_^$[>?_&Z/KF&_Y^1^]![2'\R/.**]'_X9
MK^+O_1*_&O\ X3MY_P#&Z/\ AFOXN_\ 1*_&O_A.WG_QNCZYAO\ GY'[T'M(
M?S(\XHKT?_AFOXN_]$K\:_\ A.WG_P ;H_X9K^+O_1*_&O\ X3MY_P#&Z/KF
M&_Y^1^]![2'\R/.**]'_ .&:_B[_ -$K\:_^$[>?_&Z/^&:_B[_T2OQK_P"$
M[>?_ !NCZYAO^?D?O0>TA_,CSBBO1_\ AFOXN_\ 1*_&O_A.WG_QNC_AFOXN
M_P#1*_&O_A.WG_QNCZYAO^?D?O0>TA_,CSBBO1_^&:_B[_T2OQK_ .$[>?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHK8\T*I:M_Q[K_O_ -#5VJ6K?\>Z_P"__0U4?B0UN9-%%%=9H%%%% !1110
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M_P =_P#KT?V/_P!-O_'?_KT<\0NC.HK1_L?_ *;?^.__ %Z/['_Z;?\ CO\
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M<\0NC.HK1_L?_IM_X[_]>C^Q_P#IM_X[_P#7HYXA=&=16C_8_P#TV_\ '?\
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MM+0N& /ID=^: )Z*Y_Q+X\T+PAJ>@Z?J]]]DO-=N_L.G1^3(_GS;2VS*J0O
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M^CV.J6,@FLKV".Y@D'1HW4,I_$$5<K\M_A?^V+\6-/\ #/AGX<^$;/3;BZB
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MH_$+7_B5\-=0U7Q)?_VC?Q:Y?V:3>3'%B*.4JBX15' [XR>YH#4W? /P2B\
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MJ[%F*#>%] W7%>!_MP?"NX^*'P3F_LVU:ZUG2+N*]M8XQEW!/ER(/;:Y;_@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%<?K'Q>\(:#\0](\#:AKD-MXKU:%I[+3F1RTJ#=SN"[5SL; 8@G!QFNPH X
M[XK?"G0OC%X4;0=>6X2%9X[NVO+&;R;FTN$.4FB?!VNN3@X(Y.0:Y)?V9_#N
MK:QJ.K>,-5U?Q]J-YI<FBK-KSP 6UH^=ZPI;Q1*C,#S)C?QP15O]H3XN:C\)
M_#.BC0M-M]5\3>(=6@T/2K>\=EMUGESB27;\Q10I)"\GU'6N4U/XR>-?AG\3
M--\'^,3H6LIK^DWM[I&JZ18SVFRYMHS+)!-$\TN5VXPZN#Q@CG- S<L?V9-'
MCN/"J:MXJ\4>)=*\+W27FD:3JUS;M!;RIQ$Q:.!)9/+'"^9(V.^:]"MO"/FZ
M/J^EZWJU[XHL=3,J20ZI';JJ0R+M:!1#%'E,$CY]S<\L:^5/"?[8GBO6/!O@
M;78]9\#^)]>UZ_BM+CP'HEG,FJPJSLK,'^UR[=JKO)DB5<=QQ6YXD_:FUS3?
M&WQ5TJ?QCX!\(P^$9E33K+7K*:6ZU,&'S"%VWL9)R-OR1L?F'&>H&IW^G?LF
M^'K73M!T2]\2^)=;\'Z%>+?:?X8U&X@>SC=69D5V6$32QH6^5))&48 .1Q5S
M7OV3_ /B;XO:A\1-4MKJ\U;4-/DTZYL7D06DB/"8&?:$WAS&2N0_0],\UT7P
ME^(^O>/O#>@7VL^"-4\.3:AIJ7LT\TD!MXI"<>5M,HG#$?,-T0 !P6S7G>D?
M%SXE?%.^^(5[X&C\-Z7H7A74)])M(]:M)[F;5KJ!29<O'-&((\E0I"R'.<^E
M :FW/^RSI=]X3G\,7_CCQK?^'SISZ5;:=+J4*0VL#*% "I"OFE5 "F?S-N,C
MGFE\0?LJ^']8U.TU*Q\2>)/#NHP^'D\,27>E3VPDGLD P&:6!]C\<M'L->9_
M"/\ ;<U?XG>*+Y;;P+?:IHD'A^+56@T58C=6TP9DG61[BXB1T#(P0(N\^G6M
MOPI^V]X7US0=:UN!K[7K=M=M]$T73[+21:7-U/.I:.(&2Y<.>#F1A"!C[IR,
M@:EO3OV#_ &F6<%M%J_B1DA2RC4O<VY.+69I8\_N.[,0WJ,8QUKU3XA?!_2O
MB%K>A:Z=1U3P_P")-$,GV'6=&F2.XC23'F1L)$>.1&P,JZ,/3&37GTO[7VD0
M^*/^$,?PCKX^(AU!; >%0;4S$&'SA<>:)O*\GR^=V[(/&.]<!KW[:'B?3?&O
MCG3+GP-J?AO3/#NB)?2MJ.F13W5M,)@CR,GVZ)+BW;.U&A;))#9V@T!J>CW7
M['_A2^U.379M>\2/XSDU2+5CXK^TP"^$L:%$4*(?($85B-HBQBF^'?V/?"OA
M_5++4W\0^)M6U&V\1_\ "4&ZU"Z@=Y[S9L(?; N4([#!]"!Q68W[<7@/2_AB
MWB_5[?6;1;?5UT&ZL7LXDNEN3&)"XB$S@1;<MD.QP,<GKTW@+]I;3_&GB#PK
MIEWX7UOPU'XMLI;_ ,/WFIFW,=]'&H=AB.5VC?8RN%8<@]>U :B^'/V5?!7A
M7QUX[\6V!U!=4\86\UK>JTL9CMTF.9?( CRI9L,=Q;D#Z5B1_L3?#S^U?A_J
M$TFK74W@NU6TLA-/%MN45V=#<8B!8JSDC84_&L[X@_M#:OX=^/FK^!G\6>"?
M ^C6>BPZG#J/BBU>1KB9W*F)3]L@7H,\ G@\&J7PP_;$OO&>GZ5I<G@C4-;\
M9W5K<ZB;71 D%O+812&-+Q3<R(424_<0EF]\$$@:F]X=_8S\,>&;WP:UOXI\
M52Z7X1OVU'2=&EN+06D4K.7.X+;J\G)(R[EL'&ZO2_A1\*=)^#WAJXT31KB]
MN;2>^N-09[YT>023/N8 JJC:#TXS[FO*_"'[;GA'XB"[/A'POXN\3?8+>&XO
MX]/LH#-:^82-AA>=9964@[A"D@XX)JSJ/[9WA#2[[Q )O#WBL:3X>OX].UC6
MO[.C%I8/(^U&D!E$FW/7:A9<C< 2 0-3WZBOGRW_ &SO#3:?I6NW'AKQ!9^#
M-8NY['2_$4T< ANYHU<@"/S?,19#&ZHS*,D#.T9(2U_;8\'+X9T;Q+K7AWQ3
MX8\-:S%<2:?JVJ6D!BN#"K,R!(9Y)%)"MM+( V.#0!]"45X+)^V)X9L/!+^+
MM5\+>+-(\.-IZZA:ZE-903P789E5(E>">18Y6++A)C&>?8UUW@'XW0^,/&MS
MX0U3PWJOA+Q)'IL>L16>IO XN+1VV;T:&1QE7^5E.",CKV /3**^,1^V-XH/
MA'Q5KA\1^ H]9TG6[C3+/P2;&=M3U%$F6-/+*WA;>^[ (@*@@GIG'K6O?M66
MOA'2!J>N_#KQOIE@MS%8RWLUC!% +J101&GG3QR,N\[!+L$9(^]CF@+'NE%?
M*OPQ_;2U#Q$(]+UOP5?W/BG4M>OM+T?3](^S(DT=O@R>8TETVQHUQO8X0EAL
MW8;'NOPI^*FG?%K0;V_LK.\TN[TZ_GTK4=-U ()[2ZA($D;;&93U!!!(((/M
M0!VM%?+'_#QCX;?] 3Q5_P" EM_\D4?\/&/AM_T!/%7_ ("6W_R175]5K?RG
MV'^I^?\ _0)+\/\ ,^IZ*^6/^'C'PV_Z GBK_P !+;_Y(H_X>,?#;_H">*O_
M  $MO_DBCZK6_E#_ %/S_P#Z!)?A_F?4]%?+'_#QCX;?] 3Q5_X"6W_R11_P
M\8^&W_0$\5?^ EM_\D4?5:W\H?ZGY_\ ] DOP_S/J>BOEC_AXQ\-O^@)XJ_\
M!+;_ .2*/^'C'PV_Z GBK_P$MO\ Y(H^JUOY0_U/S_\ Z!)?A_F?4]%?+'_#
MQCX;?] 3Q5_X"6W_ ,D4?\/&/AM_T!/%7_@);?\ R11]5K?RA_J?G_\ T"2_
M#_,^IZ*^6/\ AXQ\-O\ H">*O_ 2V_\ DBC_ (>,?#;_ * GBK_P$MO_ )(H
M^JUOY0_U/S__ *!)?A_F?4]%?+'_  \8^&W_ $!/%7_@);?_ "11_P /&/AM
M_P! 3Q5_X"6W_P D4?5:W\H?ZGY__P! DOP_S/J>BOEC_AXQ\-O^@)XJ_P#
M2V_^2*/^'C'PV_Z GBK_ ,!+;_Y(H^JUOY0_U/S_ /Z!)?A_F?4]%?+'_#QC
MX;?] 3Q5_P" EM_\D4?\/&/AM_T!/%7_ ("6W_R11]5K?RA_J?G_ /T"2_#_
M #/J>BOEC_AXQ\-O^@)XJ_\  2V_^2*/^'C'PV_Z GBK_P !+;_Y(H^JUOY0
M_P!3\_\ ^@27X?YGU/17RQ_P\8^&W_0$\5?^ EM_\D4?\/&/AM_T!/%7_@);
M?_)%'U6M_*'^I^?_ /0)+\/\SZGHKY8_X>,?#;_H">*O_ 2V_P#DBC_AXQ\-
MO^@)XJ_\!+;_ .2*/JM;^4/]3\__ .@27X?YGU/17RQ_P\8^&W_0$\5?^ EM
M_P#)%'_#QCX;?] 3Q5_X"6W_ ,D4?5:W\H?ZGY__ - DOP_S/J>BOEC_ (>,
M?#;_ * GBK_P$MO_ )(H_P"'C'PV_P"@)XJ_\!+;_P"2*/JM;^4/]3\__P"@
M27X?YGU/17RQ_P /&/AM_P! 3Q5_X"6W_P D4?\ #QCX;?\ 0$\5?^ EM_\
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M_P"2*/\ AXQ\-O\ H">*O_ 2V_\ DBCZK6_E#_4_/_\ H$E^'^9]3T5\L?\
M#QCX;?\ 0$\5?^ EM_\ )%'_  \8^&W_ $!/%7_@);?_ "11]5K?RA_J?G__
M $"2_#_,^IZ*^6/^'C'PV_Z GBK_ ,!+;_Y(H_X>,?#;_H">*O\ P$MO_DBC
MZK6_E#_4_/\ _H$E^'^9]3T5\L?\/&/AM_T!/%7_ ("6W_R11_P\8^&W_0$\
M5?\ @);?_)%'U6M_*'^I^?\ _0)+\/\ ,^IZ*^6/^'C'PV_Z GBK_P !+;_Y
M(H_X>,?#;_H">*O_  $MO_DBCZK6_E#_ %/S_P#Z!)?A_F?4]%?+'_#QCX;?
M] 3Q5_X"6W_R11_P\8^&W_0$\5?^ EM_\D4?5:W\H?ZGY_\ ] DOP_S/J>BO
MEC_AXQ\-O^@)XJ_\!+;_ .2*/^'C'PV_Z GBK_P$MO\ Y(H^JUOY0_U/S_\
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M;?\ 0$\5?^ EM_\ )%'U6M_*'^I^?_\ 0)+\/\SZGHKY8_X>,?#;_H">*O\
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MC'PV_P"@)XJ_\!+;_P"2*/\ AXQ\-O\ H">*O_ 2V_\ DBCZK6_E#_4_/_\
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MY_\ ] DOP_S/J>BOEC_AXQ\-O^@)XJ_\!+;_ .2*/^'C'PV_Z GBK_P$MO\
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M$7AC4/'*>!/'4'AK1/&%Q)>WEC>:.;R2RN95*S36L@GC"E_EX=7 P"/2N/\
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MH\<GBKPO'J=LUEYK20+Y+3*5EBW%!('P5P-HI?\ AXQ\-O\ H">*O_ 2V_\
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MSC_AXQ\-O^@)XJ_\!+;_ .2*/^'C'PV_Z GBK_P$MO\ Y(H^JUOY0_U/S_\
MZ!)?A_F;\G[(-O-\)=:\'MXF=-2N?$DOB?3==BL=LFFW32*Z;4\P[MH#+G<N
M0W05QWB?]@^]\475_+=>.=-N)[[6AK,VJ7GA@7&J<$'[,MTUSE(01PJ*N,X)
M(ZZ7_#QCX;?] 3Q5_P" EM_\D4?\/&/AM_T!/%7_ ("6W_R11]5K?RA_J?G_
M /T"2_#_ #&3?L-)_:RW:^)-'U""SU>_U:PM-<\-+?1#[65\Z*X5K@+,HV(4
M*K&589R>E>W_  ?^%T/PH\-7&FI)ILT]S=/=32:3HMMI5N&8 !4AA'W5  !=
MG?U8\5XG_P /&/AM_P! 3Q5_X"6W_P D4?\ #QCX;?\ 0$\5?^ EM_\ )%'U
M6M_*'^I^?_\ 0)+\/\S\G/\ A9NJ?\\+/_OA_P#XJC_A9NJ?\\+/_OA__BJY
M&O8IO!VBK^Q]:>*QI\?_  D3^.YM+;4,MO-JNGQ2"+&<8WL6Z9YZU_1-;+LO
MH\MZ*]YI?>?:2XFS:-KXB6IQ?_"S=4_YX6?_ 'P__P 51_PLW5/^>%G_ -\/
M_P#%5W'[.W@W1/%N@_%^?6-.BOY='\%W>HV#2%AY%PLT"K(N".0';KD<UZS\
M,_AWH.L?"#PI<_#SX?\ A+XI^*KB.5O$EKKVKR1ZC;2B0A8H+47$/R;,$.F\
MDD\<5P8BEEF'E*,J&S2Z):J^K;22Z:]3&?%6:P;3Q$OP]3YN_P"%FZI_SPL_
M^^'_ /BJ/^%FZI_SPL_^^'_^*KII/AAJ/Q(^/W_"&Z/X1D\!7=[>B%M$O))9
M!I4:H&E>1Y?GV(H>0EOX1QGBN\^,O@WP#X3NO#7Q*^&^FQ>*/A_#>-H6H:;J
MI<H;ZV7:'E*,&"7,06=<$<[^F,#66&RR,X4_8KFDK_Y)N]M;.VMG9ZE/BG-4
MU'ZQ*[]/ZU/'?^%FZI_SPL_^^'_^*H_X6;JG_/"S_P"^'_\ BJ^A?$OQ"\!Z
M+\%?!'C2+X(^"WOM>U'4K.>!WO?*C6V%OL*_O\Y/G-G)/08K#^!/P3\&:YX)
M.I?$&Z_L6]\>74F@^#220EM.IW-?2#.3"LPBM\\_ZR3TR.?V>7QI.M5PW*D[
M=&VTVG9)O:S;\D1_K7FRBY2KR7W'BW_"S=4_YX6?_?#_ /Q5'_"S=4_YX6?_
M 'P__P 57N'B[]G/0?$_P?&L^$+A[+XC>#A%I'B_P7-&WVE[C[1]G%Q !DMN
M=T! R#['AOIO]GW_ ()::!I^D6NJ_%>ZGU75ID#MH6GSF*WM\@'9)*OS2,.^
MTJHYQNZUR8G%9%@Z3JU:=G=JUM6UV\K--.]FFM3.IQAF-./-+$R].I^>G_"S
M=4_YX6?_ 'P__P 51_PLW5/^>%G_ -\/_P#%5[O^WB/A)X4\;6?@;X6^&]/T
M]M&).KZI:RR2F2<C MP[.V0@SN/]XXZH:^6J]C!X' 8RA'$+#\JEJD][??UW
M.FEQ/F]6"G[>2OZ'7?\ "S=4_P">%G_WP_\ \51_PLW5/^>%G_WP_P#\57(T
M5V_V1@/^?2-?]9,W_P"@B1UW_"S=4_YX6?\ WP__ ,51_P +-U3_ )X6?_?#
M_P#Q5<C11_9& _Y](/\ 63-_^@B1UW_"S=4_YX6?_?#_ /Q5'_"S=4_YX6?_
M 'P__P 57(T4?V1@/^?2#_63-_\ H(D==_PLW5/^>%G_ -\/_P#%4?\ "S=4
M_P">%G_WP_\ \57(T4?V1@/^?2#_ %DS?_H(D==_PLW5/^>%G_WP_P#\51_P
MLW5/^>%G_P!\/_\ %5R-%']D8#_GT@_UDS?_ *")'7?\+-U3_GA9_P#?#_\
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M  LW5/\ GA9_]\/_ /%5R-%']D8#_GT@_P!9,W_Z")'7?\+-U3_GA9_]\/\
M_%4?\+-U3_GA9_\ ?#__ !5<C11_9& _Y](/]9,W_P"@B1UW_"S=4_YX6?\
MWP__ ,51_P +-U3_ )X6?_?#_P#Q5<C11_9& _Y](/\ 63-_^@B1UW_"S=4_
MYX6?_?#_ /Q5'_"S=4_YX6?_ 'P__P 57(T4?V1@/^?2#_63-_\ H(D==_PL
MW5/^>%G_ -\/_P#%4?\ "S=4_P">%G_WP_\ \57(T4?V1@/^?2#_ %DS?_H(
MD==_PLW5/^>%G_WP_P#\51_PLW5/^>%G_P!\/_\ %5R-%']D8#_GT@_UDS?_
M *")'7?\+-U3_GA9_P#?#_\ Q5'_  LW5/\ GA9_]\/_ /%5R-%']D8#_GT@
M_P!9,W_Z")'7?\+-U3_GA9_]\/\ _%4?\+-U3_GA9_\ ?#__ !5<C11_9& _
MY](/]9,W_P"@B1UW_"S=4_YX6?\ WP__ ,51_P +-U3_ )X6?_?#_P#Q5<C1
M1_9& _Y](/\ 63-_^@B1UW_"S=4_YX6?_?#_ /Q5'_"S=4_YX6?_ 'P__P 5
M7(T4?V1@/^?2#_63-_\ H(D==_PLW5/^>%G_ -\/_P#%4?\ "S=4_P">%G_W
MP_\ \57(T4?V1@/^?2#_ %DS?_H(D==_PLW5/^>%G_WP_P#\51_PLW5/^>%G
M_P!\/_\ %5R-%']D8#_GT@_UDS?_ *")'7?\+-U3_GA9_P#?#_\ Q5'_  LW
M5/\ GA9_]\/_ /%5R-%']D8#_GT@_P!9,W_Z")'7?\+-U3_GA9_]\/\ _%4?
M\+-U3_GA9_\ ?#__ !5<C11_9& _Y](/]9,W_P"@B1UW_"S=4_YX6?\ WP__
M ,51_P +-U3_ )X6?_?#_P#Q5<C11_9& _Y](/\ 63-_^@B1UW_"S=4_YX6?
M_?#_ /Q5'_"S=4_YX6?_ 'P__P 57(T4?V1@/^?2#_63-_\ H(D==_PLW5/^
M>%G_ -\/_P#%4?\ "S=4_P">%G_WP_\ \57(T4?V1@/^?2#_ %DS?_H(D==_
MPLW5/^>%G_WP_P#\51_PLW5/^>%G_P!\/_\ %5R-%']D8#_GT@_UDS?_ *")
M'7?\+-U3_GA9_P#?#_\ Q5'_  LW5/\ GA9_]\/_ /%5R-%']D8#_GT@_P!9
M,W_Z")'7?\+-U3_GA9_]\/\ _%4?\+-U3_GA9_\ ?#__ !5<C11_9& _Y](/
M]9,W_P"@B1UW_"S=4_YX6?\ WP__ ,51_P +-U3_ )X6?_?#_P#Q5<C11_9&
M _Y](/\ 63-_^@B1UW_"S=4_YX6?_?#_ /Q5'_"S=4_YX6?_ 'P__P 57(T4
M?V1@/^?2#_63-_\ H(D==_PLW5/^>%G_ -\/_P#%4?\ "S=4_P">%G_WP_\
M\57(T4?V1@/^?2#_ %DS?_H(D==_PLW5/^>%G_WP_P#\51_PLW5/^>%G_P!\
M/_\ %5R-%']D8#_GT@_UDS?_ *")'7?\+-U3_GA9_P#?#_\ Q5'_  LW5/\
MGA9_]\/_ /%5R-%']D8#_GT@_P!9,W_Z")'7?\+-U3_GA9_]\/\ _%4?\+-U
M3_GA9_\ ?#__ !5<C11_9& _Y](/]9,W_P"@B1UW_"S=4_YX6?\ WP__ ,51
M_P +-U3_ )X6?_?#_P#Q5<C11_9& _Y](/\ 63-_^@B1UW_"S=4_YX6?_?#_
M /Q5'_"S=4_YX6?_ 'P__P 57(T4?V1@/^?2#_63-_\ H(D==_PLW5/^>%G_
M -\/_P#%4?\ "S=4_P">%G_WP_\ \57(T4?V1@/^?2#_ %DS?_H(D==_PLW5
M/^>%G_WP_P#\51_PLW5/^>%G_P!\/_\ %5R-%']D8#_GT@_UDS?_ *")'7?\
M+-U3_GA9_P#?#_\ Q5'_  LW5/\ GA9_]\/_ /%5R-%']D8#_GT@_P!9,W_Z
M")'7?\+-U3_GA9_]\/\ _%4?\+-U3_GA9_\ ?#__ !5<C11_9& _Y](/]9,W
M_P"@B1UW_"S=4_YX6?\ WP__ ,51_P +-U3_ )X6?_?#_P#Q5<C11_9& _Y]
M(/\ 63-_^@B1UW_"S=4_YX6?_?#_ /Q5'_"S=4_YX6?_ 'P__P 57(T4?V1@
M/^?2#_63-_\ H(D==_PLW5/^>%G_ -\/_P#%4?\ "S=4_P">%G_WP_\ \57(
MT4?V1@/^?2#_ %DS?_H(D==_PLW5/^>%G_WP_P#\51_PLW5/^>%G_P!\/_\
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MB1UW_"S=4_YX6?\ WP__ ,51_P +-U3_ )X6?_?#_P#Q5<C11_9& _Y](/\
M63-_^@B1UW_"S=4_YX6?_?#_ /Q5'_"S=4_YX6?_ 'P__P 57(T4?V1@/^?2
M#_63-_\ H(D==_PLW5/^>%G_ -\/_P#%4?\ "S=4_P">%G_WP_\ \57(T4?V
M1@/^?2#_ %DS?_H(D==_PLW5/^>%G_WP_P#\51_PLW5/^>%G_P!\/_\ %5R-
M%']D8#_GT@_UDS?_ *")'7?\+-U3_GA9_P#?#_\ Q5'_  LW5/\ GA9_]\/_
M /%5R-%']D8#_GT@_P!9,W_Z")'7?\+-U3_GA9_]\/\ _%4?\+-U3_GA9_\
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M]F=F?EY(R>?>N3^R\/'X:4=+6;O=6M:SU:M;H]]=VS/ZO!;17ZZ'5:UXGO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
G%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>clbs-20230630_g2.jpg
<TEXT>
begin 644 clbs-20230630_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +0!0 # 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV/N\H01BO?/^"C_A+X@W'@>Y\4:+XF73_ VGV,=MK&CB[E1[QY;E$0B-4*.
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M6OSB\+W_ ,:?V\/BAK$NF>)IM"TFQ_?&/[9+!9:=$[$1QJD?+R,%/.,G:22
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M[5'QPN? 7P?UF?0]!MWD6&ZL+AK4RQ1D![J:=?G5"?NA>S*,%C4?B#QK\?\
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M5>B2,@+K^#;A^% '5T444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM\*X]$O)X;S7[Z=K[4[F#)0RD!1&I(R515 R>I+' SBO:Z*!W"BBB@04444
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MSQ'_ -$F\8?^!>C?_+"C_A9GB/\ Z)-XP_\  O1O_EA7H%%'UFE_SXC]\_\
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M^%7&O3EJJ$?OG_\ )C4XO["_'_,YG_A9GB/_ *)-XP_\"]&_^6%'_"S/$?\
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M%'_"S/$?_1)O&'_@7HW_ ,L*Z;^T+C_GI_XZ/\*/[0N/^>G_ (Z/\*/:T_\
MGQ#[Y_\ R8<T?Y%^/^9S/_"S/$?_ $2;QA_X%Z-_\L*/^%F>(_\ HDWC#_P+
MT;_Y85TW]H7'_/3_ ,='^%']H7'_ #T_\='^%'M:?_/B'WS_ /DPYH_R+\?\
MSF?^%F>(_P#HDWC#_P "]&_^6%'_  LSQ'_T2;QA_P"!>C?_ "PKIO[0N/\
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MS.9_X69XC_Z)-XP_\"]&_P#EA1_PLSQ'_P!$F\8?^!>C?_+"NF_M"X_YZ?\
MCH_PH_M"X_YZ?^.C_"CVM/\ Y\0^^?\ \F'-'^1?C_F<S_PLSQ'_ -$F\8?^
M!>C?_+"C_A9GB/\ Z)-XP_\  O1O_EA73?VA<?\ /3_QT?X4?VA<?\]/_'1_
MA1[6G_SXA]\__DPYH_R+\?\ ,YG_ (69XC_Z)-XP_P# O1O_ )84?\+,\1_]
M$F\8?^!>C?\ RPKIO[0N/^>G_CH_PH_M"X_YZ?\ CH_PH]K3_P"?$/OG_P#)
MAS1_D7X_YG,_\+,\1_\ 1)O&'_@7HW_RPH_X69XC_P"B3>,/_ O1O_EA73?V
MA<?\]/\ QT?X4?VA<?\ /3_QT?X4>UI_\^(??/\ ^3#FC_(OQ_S.9_X69XC_
M .B3>,/_  +T;_Y84?\ "S/$?_1)O&'_ (%Z-_\ +"NF_M"X_P">G_CH_P *
M/[0N/^>G_CH_PH]K3_Y\0^^?_P F'-'^1?C_ )G,_P#"S/$?_1)O&'_@7HW_
M ,L*/^%F>(_^B3>,/_ O1O\ Y85TW]H7'_/3_P ='^%']H7'_/3_ ,='^%'M
M:?\ SXA]\_\ Y,.:/\B_'_,YG_A9GB/_ *)-XP_\"]&_^6%'_"S/$?\ T2;Q
MA_X%Z-_\L*Z;^T+C_GI_XZ/\*/[0N/\ GI_XZ/\ "CVM/_GQ#[Y__)AS1_D7
MX_YG,_\ "S/$?_1)O&'_ (%Z-_\ +"C_ (69XC_Z)-XP_P# O1O_ )85V>FW
M$EQYGF-NQC' ]ZNUF\123M["/WS_ /DQ>TC_ "+\?\SS_P#X69XC_P"B3>,/
M_ O1O_EA1_PLSQ'_ -$F\8?^!>C?_+"O0**7UFE_SXC]\_\ Y,7M(_R+\?\
M,\__ .%F>(_^B3>,/_ O1O\ Y84?\+,\1_\ 1)O&'_@7HW_RPKT"BCZS2_Y\
M1^^?_P F'M(_R+\?\SS_ /X69XC_ .B3>,/_  +T;_Y84?\ "S/$?_1)O&'_
M (%Z-_\ +"O0**/K-+_GQ'[Y_P#R8>TC_(OQ_P SS_\ X69XC_Z)-XP_\"]&
M_P#EA1_PLSQ'_P!$F\8?^!>C?_+"O0**/K-+_GQ'[Y__ "8>TC_(OQ_S//\
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M'M(_R+\?\SS_ /X69XC_ .B3>,/_  +T;_Y84?\ "S/$?_1)O&'_ (%Z-_\
M+"O0**/K-+_GQ'[Y_P#R8>TC_(OQ_P SS_\ X69XC_Z)-XP_\"]&_P#EA1_P
MLSQ'_P!$F\8?^!>C?_+"O0**/K-+_GQ'[Y__ "8>TC_(OQ_S//\ _A9GB/\
MZ)-XP_\  O1O_EA1_P +,\1_]$F\8?\ @7HW_P L*] HH^LTO^?$?OG_ /)A
M[2/\B_'_ #//_P#A9GB/_HDWC#_P+T;_ .6%'_"S/$?_ $2;QA_X%Z-_\L*]
M HH^LTO^?$?OG_\ )A[2/\B_'_,\_P#^%F>(_P#HDWC#_P "]&_^6%'_  LS
MQ'_T2;QA_P"!>C?_ "PKT"BCZS2_Y\1^^?\ \F'M(_R+\?\ ,\__ .%F>(_^
MB3>,/_ O1O\ Y84?\+,\1_\ 1)O&'_@7HW_RPKT"BCZS2_Y\1^^?_P F'M(_
MR+\?\SS_ /X69XC_ .B3>,/_  +T;_Y84?\ "S/$?_1)O&'_ (%Z-_\ +"O0
M**/K-+_GQ'[Y_P#R8>TC_(OQ_P SS_\ X69XC_Z)-XP_\"]&_P#EA1_PLSQ'
M_P!$F\8?^!>C?_+"O0*JZA,\$*LAVG=CI[&FL12;M["/WS_^3#VD?Y%^/^9Q
M/_"S/$?_ $2;QA_X%Z-_\L*/^%F>(_\ HDWC#_P+T;_Y85TW]H7'_/3_ ,='
M^%']H7'_ #T_\='^%:>UI_\ /B'WS_\ DRN:/\B_'_,YG_A9GB/_ *)-XP_\
M"]&_^6%'_"S/$?\ T2;QA_X%Z-_\L*Z;^T+C_GI_XZ/\*/[0N/\ GI_XZ/\
M"CVM/_GQ#[Y__)AS1_D7X_YG,_\ "S/$?_1)O&'_ (%Z-_\ +"C_ (69XC_Z
M)-XP_P# O1O_ )85TW]H7'_/3_QT?X4?VA<?\]/_ !T?X4>UI_\ /B'WS_\
MDPYH_P B_'_,YG_A9GB/_HDWC#_P+T;_ .6%'_"S/$?_ $2;QA_X%Z-_\L*Z
M;^T+C_GI_P".C_"C^T+C_GI_XZ/\*/:T_P#GQ#[Y_P#R8<T?Y%^/^9S/_"S/
M$?\ T2;QA_X%Z-_\L*/^%F>(_P#HDWC#_P "]&_^6%=-_:%Q_P ]/_'1_A1_
M:%Q_ST_\='^%'M:?_/B'WS_^3#FC_(OQ_P SF?\ A9GB/_HDWC#_ ,"]&_\
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M_1)O&'_@7HW_ ,L*Z;^T+C_GI_XZ/\*/[0N/^>G_ (Z/\*/:T_\ GQ#[Y_\
MR8<T?Y%^/^9S/_"S/$?_ $2;QA_X%Z-_\L*/^%F>(_\ HDWC#_P+T;_Y85TW
M]H7'_/3_ ,='^%']H7'_ #T_\='^%'M:?_/B'WS_ /DPYH_R+\?\SF?^%F>(
M_P#HDWC#_P "]&_^6%'_  LSQ'_T2;QA_P"!>C?_ "PKIO[0N/\ GI_XZ/\
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M'M(_R+\?\PHHHKSS **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ]X3?Q3XHUKXIZEI5Y>7,5MX.\->%KZ:,W&9,%)80J[V"D98$\GDGY4)S:7
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MR45^76L?'GXJ^ ?!/C>?P[XPU_6_ =YK(TK1/%&MLTMTPS(6:"5QDY2/!(P
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MOBNLT-FBOCW]D?QGXVU/XY?%32?&'B:]\13Z2&B,9F?[,LB3LC&&'A4!V\
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M17R9^UYH7BO3=2N/$$/BCX@3Z;)I\XT_2/!5DT=M831HI$M[.LG^K))))3.
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M <QQQG(7Y25SC()!7;TJ.<#]!Z*\B_: \*>-?&FDZ+!X;\8P^!] BG^T:_J
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MN[AD"JVSSUC3S$PP(8KGD@]*]SIB"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** *VH?\><GX?S%8M;6H?\ 'G)^'\Q6
M+713V+CL4M:TU]8T>]L8[ZZTU[F%HA>63*L\.X8WH65@&'4$@\UX;X/_ &-]
M#\"ZT=3TGQ_\0+>66[2\NX5UI$CO9%;=^_"1*9 >0<G)!/->_P!%:-)E'SY\
M9OV/]$^(=]XA\0>']7U3PKXJU:U:&=K*[,=G>L0!BXC"DE3M (4@'J03UZGX
M'_"C6O /P7'@S5Y--T2]42PI>>$WDR%<#]]ON%)\XDL22NT<8  Q7K5%+E5[
M@> >#_V-]#\"ZT=3TGQ_\0());M;R[A76D2.]=6W?OPD2F0'D')R03S4.K?L
M,_#?5_$%U?M-KMMIEW>"^N/#]MJ&S3I91GYBFW>/O-]UQ@,0N!Q7T+11RKL!
MX#KG['.@ZWXTE\4_\)UXZT[6"#'#+INJ0V_V6'H((=L&4C4<!0>GKR:76OV,
M_"FL7QOX_%/C33-3GLEL=0OK+6<3:D@ !-PS(V\MM!(&%)Y(S7OM%'*@.4^&
M/PQT#X0^$;;PYX;MGM]/A9I"99"\DLC8W.['JQP.F!Q@ "NKHHJ@"BBB@#P#
MQ-^Q7X*\1:OK5W#KGBK0K36I1-J.DZ5J@CL[IPQ.7C9&)&2<#.!_"!6[XR_9
M2\!^+M!\-:9%%J/AY_#:>7I>H:+=F&ZMUW;B [!LY;G)!())!&37L5%+E78#
MYZ_9G_9[\1_ _P 4^+)M5N=%UBQU1VDBUA9+B359CORJSEQY87!8G;DECDD\
M8N>)/V0=&\3^/+KQC/X^\>6>OS%@ES8ZK% ;>,D_NHBL&4C . H/UR<FO>:*
M7*K6 \*\9_L=^#_&\VG7EWK?BBUUJVL!IMQK-KJ8%YJ$.S81<NR,')4D$@#(
M.#D  4O$'[$_@K7-#T/1(=;\3Z-HNCC=;:?IM_&L1G+%FN'WQ,6E)/WL\  *
M%'%?05%'*@/!]2_8^\.:UIMG%J?C#QQJ>JV-U]JLM=N];,E_:'"_)&Y3:%RN
M1\I())!&:ZKX0_L\^&/@UJ&K:GIEQJFL:YJA_P!+U?6[O[1<RKG.TL%48SSG
M&3W)P*].HI\J ****8!7'>,/@_X*\>->3:YX6T?4+^Y@,#:C<:?!)=(NTJ"L
MCH2"N>/2NQHH \4\-_L@_#OP[\,]4\#FRN-2TW4IQ<7%[=M&+TNO,?[V-$.$
M.=H(.-S#D,17 ^&?V0=:^'OQP\/>*-'UBU\4^'=/ACMPOB^ZGGOK)!D-]F\M
M5C)"D[ W"[CQG!KZIHJ>5 >1_&C]FW1_CGJ5A<ZYXF\36%O8@&WL-*O(HK=)
M 2?-VM$Q\SG&[/ '&.<YNK?LE^&/$O@W^P/$/B/Q;XD>.[^VVFKZMJWGWUD^
MT*1#(4VA2!]TJ1GGJ!CVZBGRH#P&U_8O\'V/AG6M)MO$'BJ"XUR;S-5UA=1C
M-]?)\Q\F1VB(\LEBQ 4%CC<6P!2Z/^QGX4TW0+C0+SQ3XTUSP]);FW31]2UG
M-I!\P821QHB!7!'';YF!!S7OM%+E0'AO@C]D'PAX-\6Z1XBN-9\3>*;_ $>-
M8]-7Q!J(N([,+]WRU5%P%[*<J/3.*]RHHII); :.C_\ +;\/ZUI5FZ/_ ,MO
MP_K6E7-/XF9O<Y'XG?#O_A9GA^+2O^$F\1>%?+N%N/MOAF_^QW+85EV,^ULH
M=V2,=57TKRSX6_L7>%OA'K'VS1O%OC*:RD9S=Z-=ZG$;"^W1LA$\*0J).&/4
M]0*^@:*@1\:?%#_@GU UG8K\.M8D6QBU(7TWA;Q1J,[Z.PQCY1"OF!N,$EBQ
M!(W"OH7Q]\(1\5OAG8^%-;UG4/#D1AB6_3PI,MO'+B/:T(,D;GR<YPN 2  >
MXKT:B@9X/X,_8\\+^$='O-#N/%/C+Q)X8NK&2P;P]K6L>98(C$'<D4:)L<$9
M5@1@DD<\UG>#_P!AOP-X+U>/5;37/%-WJ-G:R6NE7%[J$<ATD-O^:V'E!59=
M[%=P8 G=C=S7T310%SYR\*?L/^&_!NJ37FG^/_B$$NKE;F_M&UJ,0:BP.66Y
M581YJMDAMQY#$9YK;^)'[&7PM^(T>EI_PC]MX7^P3^?N\-V5K:&XZ?)-^Y;>
MG'3CJ:]RHH"Y7T[3K31["VL;"UALK*VC6&"VMXQ''$BC"JJ@84    <"K%%%
M @JCKFF/K6C7UA'?W6EO<PM"+VQ95G@W#&^,LK ,.H)!Y[5>HH ^=O!?[%.@
M^ =<.J:/\1/B+;RRW:7MW"NN(D=](K;OWX2%3(&Y!R<D$\\U'\;OV,="^)%]
MXD\1>'=9U7PEXMUBU:&X:QO#'97K$ 8N8PI)4A0"%(!ZD$]?HVB@=SQ[X#_"
M+7/A[\$%\$:Q+I>A7R":%+[PA)+E5<#]_ON%),Y8L22NT?+@ # Y?P7^Q1H/
M@'7#JFD?$3XB6\LMVE[=PKKB)%?2*VX^>$A4R!N0<G)!//-?1-% 'SAK'[!/
MPRUCQ'=Z@TVOVNE7EX+^Y\.6NH[--FF&[YBFS>/O-]UQ@,0N!Q5C7OV*?#^N
M^.)?%G_"?>/M,UHJ8H)M,U6&W^R0\@00[8,I$H. H/3KDY-?0]% 7/']>_93
M^'?B;P3/H.IZ/%>W]Q;K!-XHGMK>36I6&,S/=-$2TIQRQ'<UUOPD^$^@?!;P
M39^&/#L++9P%G>XF6,3W+D\R2LB*'?&%W8SA5':NSHH$%%%% !7AGQ$_9!\)
M?$'QCJ7B>/7?%'A75=4@-MJ+>'=3%NEY&0 5D5D?(.T948!/)!/->YT4 >(Z
ME^QU\-=2^%6G^ ?[/O+73+"=KRVOK>Y(O([AAAIO,((+$8R"NW@?*,#'&_!?
M]E?Q)\'_ (]:MXI?5=-\5:!?0M"FJZ[<W$^NPKLP$#8$1R0H+'G:N!MY!^H*
M*!W/#/BE^R7HOQ:\=P^+-5\:^-+#4;4@V,6EZC#!%88 &8!Y)9"2,D[LD]^F
M(O$G['?A3Q;HV@0:IXE\87>NZ)([V?BJ35]VK!6<OL:8H05!/R_+E>Q&3GWB
MB@#YQNOV$_ <G@&#P?9ZWXITK1S.UW?"ROX@^IS':%>Y+0L&VA1M50J@DG;D
MYKJO!7[*_A/PO;O:ZWJ&M?$:Q5$CM;/QS/%JD%B%!&;>-H@L9((!P.B@5[)1
M0%SQWX??LI> ?AG\3M5\<Z+9,FI7P816;Q6XM=/W=3;(L2F(XRO#'AF'>O8J
M**!!1110!S?BGX:^$/'%Q!<>)/"NB>()X$,<4NJ:=#<M&I.2JEU) SV%>9_#
M_P#8Y^&_P]T_Q;8P6$VK6_B9&AN_[2$)>*%B2887CC1HTSM. >J(>JBO<**
M/C7Q%^P?J'AWQEX/U3P-K4&O:+HD[3#0?'E[/-:VQ+A@;=8$' /.UN"5!8L,
MBO?/CE\ ],^/ND6FDZWXA\0Z5I4+%Y++1;F*&*Y;(*F4/$^[;C@= 3G&<8].
MHH'<\)M/V/O"TG@S5?"VN^)O&/C#1KV.%(8/$&L>>-/:+.Q[8*BB-AG'0@@
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M:XSD''! KYVC_8/\.0^*)/$J?$CXE)XBD3RWU===C%VZ[0NTS>1O(V@#&>@
MKZ8HK(D^;_C-^Q7H7Q!N/$&O>'=<UCPMXMU2S:WN);6]*6E^VU1_I2!265@H
MW!2 3R03UZ_X#_"+7/A[\$%\$:Q+I>A7R":%+[PA)+E5<#]_ON%),Y8L22NT
M?+@ # ]AHH&?.W@O]BC0? .N'5-(^(GQ$MY9;M+V[A77$2*^D5MQ\\)"ID#<
M@Y.2">>:AUC]@GX9:QXCN]0:;7[72KR\%_<^'+74=FFS3#=\Q39O'WF^ZXP&
M(7 XKZ/HH"Y\\:]^Q3X?UWQQ+XL_X3[Q]IFM%3%!-IFJPV_V2'D""';!E(E!
MP%!Z=<G)J]XT_8W\(^-KC1[^Y\0>++'7]/L!ILFO6.JA;Z_A"E?](D9&#L02
M"0 2#@\  >\T4!<XSX2_"7P[\%?!MOX9\,V\D-A$[2O).^^6:1OO.[8&6. .
M     !BNSHHH$<;_ ,*C\-_\\]3_ /!S>_\ QZC_ (5'X;_YYZG_ .#F]_\
MCU=E10.[.-_X5'X;_P">>I_^#F]_^/4?\*C\-_\ //4__!S>_P#QZNRHH"[.
M-_X5'X;_ .>>I_\ @YO?_CU'_"H_#?\ SSU/_P '-[_\>KLJ* NSC?\ A4?A
MO_GGJ?\ X.;W_P"/4?\ "H_#?_//4_\ P<WO_P >KLJ* NSC?^%1^&_^>>I_
M^#F]_P#CU'_"H_#?_//4_P#P<WO_ ,>KLJ* NSC?^%1^&_\ GGJ?_@YO?_CU
M'_"H_#?_ #SU/_P<WO\ \>KLJ* NSC?^%1^&_P#GGJ?_ (.;W_X]1_PJ/PW_
M ,\]3_\ !S>__'J[*B@+LXW_ (5'X;_YYZG_ .#F]_\ CU'_  J/PW_SSU/_
M ,'-[_\ 'J[*B@+LXW_A4?AO_GGJ?_@YO?\ X]1_PJ/PW_SSU/\ \'-[_P#'
MJ[*B@+LXW_A4?AO_ )YZG_X.;W_X]1_PJ/PW_P \]3_\'-[_ /'J[*B@+LXW
M_A4?AO\ YYZG_P"#F]_^/4?\*C\-_P#//4__  <WO_QZNRHH"[.-_P"%1^&_
M^>>I_P#@YO?_ (]1_P *C\-_\\]3_P#!S>__ !ZNRHH"[.%OOA+X;6U<B/4L
M\?\ ,9O#W'_36LG_ (57X>_YYZC_ .#>\_\ CM>CZA_QYR?A_,5BUT4TK%Q.
M2_X57X>_YYZC_P"#>\_^.T?\*K\/?\\]1_\ !O>?_':ZVBM+(HY+_A5?A[_G
MGJ/_ (-[S_X[1_PJOP]_SSU'_P &]Y_\=KK:*+(#DO\ A5?A[_GGJ/\ X-[S
M_P".T?\ "J_#W_//4?\ P;WG_P =KK:*+(#DO^%5^'O^>>H_^#>\_P#CM'_"
MJ_#W_//4?_!O>?\ QVNMHHL@.2_X57X>_P">>H_^#>\_^.T?\*K\/?\ //4?
M_!O>?_':ZVBBR Y+_A5?A[_GGJ/_ (-[S_X[1_PJOP]_SSU'_P &]Y_\=KK:
M*+(#DO\ A5?A[_GGJ/\ X-[S_P".T?\ "J_#W_//4?\ P;WG_P =KK:*+(#D
MO^%5^'O^>>H_^#>\_P#CM'_"J_#W_//4?_!O>?\ QVNMHHL@.2_X57X>_P">
M>H_^#>\_^.T?\*K\/?\ //4?_!O>?_':ZVBBR Y+_A5?A[_GGJ/_ (-[S_X[
M1_PJOP]_SSU'_P &]Y_\=KK:*+(#DO\ A5?A[_GGJ/\ X-[S_P".T?\ "J_#
MW_//4?\ P;WG_P =KK:*+(#DO^%5^'O^>>H_^#>\_P#CM'_"J_#W_//4?_!O
M>?\ QVNMHHL@.2_X57X>_P">>H_^#>\_^.T?\*K\/?\ //4?_!O>?_':ZVBB
MR Y+_A5?A[_GGJ/_ (-[S_X[1_PJOP]_SSU'_P &]Y_\=KK:*+(#DO\ A5?A
M[_GGJ/\ X-[S_P".T?\ "J_#W_//4?\ P;WG_P =KK:*+(#DO^%5^'O^>>H_
M^#>\_P#CM'_"J_#W_//4?_!O>?\ QVNMHHL@,'2_A/X<D\W,>I<8Z:Q>#U_Z
M:U?_ .%1^&_^>>I_^#F]_P#CU=!H_P#RV_#^M:5<T_B,WN<;_P *C\-_\\]3
M_P#!S>__ !ZC_A4?AO\ YYZG_P"#F]_^/5V5%0*[.-_X5'X;_P">>I_^#F]_
M^/4?\*C\-_\ //4__!S>_P#QZNRHH"[.-_X5'X;_ .>>I_\ @YO?_CU'_"H_
M#?\ SSU/_P '-[_\>KLJ* NSC?\ A4?AO_GGJ?\ X.;W_P"/4?\ "H_#?_//
M4_\ P<WO_P >KLJ* NSC?^%1^&_^>>I_^#F]_P#CU'_"H_#?_//4_P#P<WO_
M ,>KLJ* NSC?^%1^&_\ GGJ?_@YO?_CU'_"H_#?_ #SU/_P<WO\ \>KLJ* N
MSC?^%1^&_P#GGJ?_ (.;W_X]1_PJ/PW_ ,\]3_\ !S>__'J[*B@+LXW_ (5'
MX;_YYZG_ .#F]_\ CU'_  J/PW_SSU/_ ,'-[_\ 'J[*B@+LXW_A4?AO_GGJ
M?_@YO?\ X]1_PJ/PW_SSU/\ \'-[_P#'J[*B@+LXW_A4?AO_ )YZG_X.;W_X
M]1_PJ/PW_P \]3_\'-[_ /'J[*B@+LXW_A4?AO\ YYZG_P"#F]_^/4?\*C\-
M_P#//4__  <WO_QZNRHH"[.-_P"%1^&_^>>I_P#@YO?_ (]1_P *C\-_\\]3
M_P#!S>__ !ZNRHH"[.-_X5'X;_YYZG_X.;W_ ./4?\*C\-_\\]3_ /!S>_\
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MPJOP]_SSU'_P;WG_ ,=H_P"%5^'O^>>H_P#@WO/_ ([76T460')?\*K\/?\
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M1X@U[Q)^SZE@FL:7_9ZSB]U+3[17?3\V2J"_FQ21IE@5_>+W('-*_D!MV7Q
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M?X=Z]JN@Z=#K-W9W.OIOTEM5T>]L(M0& 1Y$MQ"B29#+C:QSN&,Y% CU"BN
M^"_QJT3XZ>&[_6]!M=0M+6SU"739$U&-$<R1A2Q 1W&WYA@YS[5W] !1110
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M_P#@#9__ "57Y.44?ZFY5_++_P "#^S,/V?WGZQ_\/9/A%_T+GC7_P  ;/\
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MZFY5_++_ ,"#^S,/V?WGZQ_\/9/A%_T+GC7_ , ;/_Y*H_X>R?"+_H7/&O\
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MX4?]"_XR_P# *T_^2J_+*BC_ %1ROM+[P_LW#]G]Y^IO_#T_X4?]"_XR_P#
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M</NE_P#)!_:U?LOQ_P S\5?^'=W[0?\ T3__ ,K6G_\ R11_P[N_:#_Z)_\
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M_P#_ "M:?_\ )%'_  [N_:#_ .B?_P#E:T__ .2*_:JBC_7C,O\ GW#[I?\
MR0?VM7[+\?\ ,_%7_AW=^T'_ -$__P#*UI__ ,D4?\.[OV@_^B?_ /E:T_\
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MP_\ C]?LA11_KIF'\D/NE_\ )!_:E;LOQ_S/QO\ ^'?_ ,>_^A#_ /*Q8?\
MQ^C_ (=__'O_ *$/_P K%A_\?K]D**/]=,P_DA]TO_D@_M2MV7X_YGXW_P##
MO_X]_P#0A_\ E8L/_C]'_#O_ ./?_0A_^5BP_P#C]?LA11_KIF'\D/NE_P#)
M!_:E;LOQ_P S\;_^'?\ \>_^A#_\K%A_\?H_X=__ ![_ .A#_P#*Q8?_ !^O
MV0HH_P!=,P_DA]TO_D@_M2MV7X_YGXW_ /#O_P"/?_0A_P#E8L/_ (_1_P .
M_P#X]_\ 0A_^5BP_^/U^R%%'^NF8?R0^Z7_R0?VI6[+\?\S\;_\ AW_\>_\
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M=+_Y(/[4K=E^/^9^-_\ P[_^/?\ T(?_ )6+#_X_1_P[_P#CW_T(?_E8L/\
MX_7[(44?ZZ9A_)#[I?\ R0?VI6[+\?\ ,_&__AW_ /'O_H0__*Q8?_'Z/^'?
M_P >_P#H0_\ RL6'_P ?K]D**/\ 73,/Y(?=+_Y(/[4K=E^/^9^-_P#P[_\
MCW_T(?\ Y6+#_P"/T?\ #O\ ^/?_ $(?_E8L/_C]?LA11_KIF'\D/NE_\D']
MJ5NR_'_,_':S_P""?OQT-RGVGP(P@!RVS5[ D^P_TBN\M_V,_B=I?A/Q+K6O
M:%'X;L]$L#=Q027<%Q)=[>65!#(X4*@9B6(Z  ')(_4VHKJVBO+:6WGC66"5
M#')&PR&4C!!]B*^,X@Q$N)+/'17NIJ-G)*+?6W-J_6^Q]?D7'69\/NV$C!*4
MDY/EO*27V;N]EOLKZW/S!_9W_9-U?]H30=8U2SUF#18K*X6UA^TV[2).^PNX
MW C;M!C['._MCG[^_9E\#?$3X6^%7\(^-;K3M8T[3P!I.I6-P[LL/_/"1713
M\O\ "><#*YP%K4^ OPML_@WX+T_PS9R"=899YGGQ@RL[LP)]PNU?^ BO5*^+
MR_*:>"C">JJ6UUT=^GR_0]'C3CS%\15\1@URRPO->G>*YHVT4D]'>6K=[[V"
MBBBO</R(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** *VH?\><GX?S%8M;6H?\><GX?S%8
MM=%/8N.P4445J4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 :.C_\ +;\/ZUI5FZ/_ ,MOP_K6
ME7+/XF9O<****@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !5+5O\ CW7_ '_Z&KM4M6_X]U_W_P"AJH_$AK<R:***ZS0**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH LZ?\ \?D?X_R-;58NG_\
M'Y'^/\C6U7/4W(EN%%%%9$A1110 4444 %%%% !1110!A_\ "8V'_/OJO_@H
MN_\ XU1_PF-A_P ^^J_^"B[_ /C5;E% &'_PF-A_S[ZK_P""B[_^-4?\)C8?
M\^^J_P#@HN__ (U6Y10!A_\ "8V'_/OJO_@HN_\ XU1_PF-A_P ^^J_^"B[_
M /C5;E% &'_PF-A_S[ZK_P""B[_^-4?\)C8?\^^J_P#@HN__ (U6Y10!A_\
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M$QL/^??5?_!1=_\ QJMRB@##_P"$QL/^??5?_!1=_P#QJC_A,;#_ )]]5_\
M!1=__&JW** ,/_A,;#_GWU7_ ,%%W_\ &J/^$QL/^??5?_!1=_\ QJMRB@##
M_P"$QL/^??5?_!1=_P#QJC_A,;#_ )]]5_\ !1=__&JW** ,/_A,;#_GWU7_
M ,%%W_\ &J/^$QL/^??5?_!1=_\ QJMRB@##_P"$QL/^??5?_!1=_P#QJC_A
M,;#_ )]]5_\ !1=__&JW** ,/_A,;#_GWU7_ ,%%W_\ &J/^$QL/^??5?_!1
M=_\ QJMRB@##_P"$QL/^??5?_!1=_P#QJC_A,;#_ )]]5_\ !1=__&JW** ,
M/_A,;#_GWU7_ ,%%W_\ &J/^$QL/^??5?_!1=_\ QJMRB@##_P"$QL/^??5?
M_!1=_P#QJC_A,;#_ )]]5_\ !1=__&JW** ,/_A,;#_GWU7_ ,%%W_\ &J/^
M$QL/^??5?_!1=_\ QJMRB@##_P"$QL/^??5?_!1=_P#QJC_A,;#_ )]]5_\
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MJ7_@LN?_ (W7/V?Q<T=;S4K76U7PK)IMG#>7G]L:E8+]G60X D$=PY3G'S,
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M??5?_!1=_P#QJC_A,;#_ )]]5_\ !1=__&JW** ,/_A,;#_GWU7_ ,%%W_\
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MBTTB\\+Z-)-;644J"_E29?M:J<8DG:(-N ^=LD');!POBI\+_P#A87Q+TUO
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MO7/ ?Q ^&/PB^$\GB?P:/#5A\,[V?6+O4I-3M91?3-.LD%M D+LY>1V"'*@
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M^ T'_P >KT,-E^*QB<L/3<DNQ[>7Y)F.:QE/!47-1T=NA]"T5\]?\-O>!?\
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M]"YXU_\  &S_ /DJC_5[-?\ H'D'U+$?R,^U:*^*O^'LGPB_Z%SQK_X V?\
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M_#T_X4?]"_XR_P# *T_^2J7^KN9_\^)!]3Q'\C/LBBOC?_AZ?\*/^A?\9?\
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M>-/^P)>_^B'K\R*_3SXH6<^H?#/Q=:VL$ES<SZ1=Q10PH7>1VA<*JJ.222
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M?^B5^-?_  G;S_XW1]<PW_/R/WH/:0_F1YQ17H__  S7\7?^B5^-?_"=O/\
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MNU_Q/./VG/'>J^%?"UOIVG02PIJA:*;4%Z1J!S&#V9AGD]@<>WR%7U]JU_\
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M9?\ @@N__C='_#.OQ7_Z)CXR_P#!!=__ !NCZWA_^?D?O0>TA_,CSVBO0O\
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M ./R/\?Y&MJL73_^/R/\?Y&MJN>IN1+<****R)"BBB@ HHHH **** "BBB@
MHK#_ .*D_P"H7_Y$H_XJ3_J%_P#D2@#<HK#_ .*D_P"H7_Y$H_XJ3_J%_P#D
M2@#<HK#_ .*D_P"H7_Y$H_XJ3_J%_P#D2@#<HK#_ .*D_P"H7_Y$H_XJ3_J%
M_P#D2@#<HK#_ .*D_P"H7_Y$H_XJ3_J%_P#D2@#<HK#_ .*D_P"H7_Y$H_XJ
M3_J%_P#D2@#<HK#_ .*D_P"H7_Y$H_XJ3_J%_P#D2@#<HK#_ .*D_P"H7_Y$
MH_XJ3_J%_P#D2@#<HK#_ .*D_P"H7_Y$H_XJ3_J%_P#D2@#<HK#_ .*D_P"H
M7_Y$H_XJ3_J%_P#D2@#<HK#_ .*D_P"H7_Y$H_XJ3_J%_P#D2@#<HK#_ .*D
M_P"H7_Y$H_XJ3_J%_P#D2@#3U#_CSD_#^8K%HOO^$B^RON_LO''3S/45D?\
M$_\ ^H;_ .1*Z*>Q<37HK(_XG_\ U#?_ ")1_P 3_P#ZAO\ Y$K2Y1KT5D?\
M3_\ ZAO_ )$H_P")_P#]0W_R)1<#7HK(_P")_P#]0W_R)1_Q/_\ J&_^1*+@
M:]%9'_$__P"H;_Y$H_XG_P#U#?\ R)1<#7HK(_XG_P#U#?\ R)1_Q/\ _J&_
M^1*+@:]%9'_$_P#^H;_Y$H_XG_\ U#?_ ")1<#7HK(_XG_\ U#?_ ")1_P 3
M_P#ZAO\ Y$HN!KT5D?\ $_\ ^H;_ .1*/^)__P!0W_R)1<#7HK(_XG__ %#?
M_(E'_$__ .H;_P"1*+@:]%9'_$__ .H;_P"1*/\ B?\ _4-_\B47 UZ*R/\
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ME'_%2?\ 4+_\B4 ;E%8?_%2?]0O_ ,B4?\5)_P!0O_R)0!N45A_\5)_U"_\
MR)1_Q4G_ %"__(E &Y16'_Q4G_4+_P#(E'_%2?\ 4+_\B4 ;E%8?_%2?]0O_
M ,B4?\5)_P!0O_R)0!N45A_\5)_U"_\ R)1_Q4G_ %"__(E &Y16'_Q4G_4+
M_P#(E'_%2?\ 4+_\B4 ;E%8?_%2?]0O_ ,B4?\5)_P!0O_R)0!N45A_\5)_U
M"_\ R)1_Q4G_ %"__(E &Y16'_Q4G_4+_P#(E'_%2?\ 4+_\B4 ;E%8?_%2?
M]0O_ ,B4?\5)_P!0O_R)0!N45A_\5)_U"_\ R)1_Q4G_ %"__(E &Y5+5O\
MCW7_ '_Z&J'_ !4G_4+_ /(E5-4_X2+[.N[^S,;NWF>AJH[H:W)**R/^)_\
M]0W_ ,B4?\3_ /ZAO_D2NJYH:]%9'_$__P"H;_Y$H_XG_P#U#?\ R)1<#7HK
M(_XG_P#U#?\ R)1_Q/\ _J&_^1*+@:]%9'_$_P#^H;_Y$H_XG_\ U#?_ ")1
M<#7HK(_XG_\ U#?_ ")1_P 3_P#ZAO\ Y$HN!KT5D?\ $_\ ^H;_ .1*/^)_
M_P!0W_R)1<#7HK(_XG__ %#?_(E'_$__ .H;_P"1*+@:]%9'_$__ .H;_P"1
M*/\ B?\ _4-_\B47 UZ*R/\ B?\ _4-_\B4?\3__ *AO_D2BX&O161_Q/_\
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M]IWL5MY[#&53>PW'D<#U%;E !1110 4444 %%%% %;4/^/.3\/YBL6MK4/\
MCSD_#^8K%KHI[%QV"BBBM2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#1T?\ Y;?A_6M*LW1_
M^6WX?UK2KEG\3,WN%%%%0(**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y[XA^,K;X=^ _$'BB
M[B:>VT>PFOGA0X,@C0MM!P<$XQGWKH:Q_&'A6P\=>$]8\.ZHC2:;JEI)9W"H
MVUMCJ5.#V.#Q0!X)8_&[XC>%K#X8>)?&$7A^Y\/^.;ZVT]].TNSFAN=*DND+
MVQ\UYF$PXP_R)@].*X+P_P#ME>+-2\'VFN_VKX)U77)=<.F#P#IUG.-7GB^T
M&/?&PNW(.T;\M!MP.O2O3]%_9O\ $MPOP]TGQ9XQLM:\+>!IX[K3[6STQ[>Y
MO)H4*6SW,AF9?W8(X51N/6ET/]E$:#\,= \-VWBC;K6@^(F\1:?K@TX?NY&F
M9VB,7F\JR.R'YQG(..,4BM#@?$'[6_B33;[XH@^(_ NE7/A/59;'3/#>H64S
MZCK"J!M$96\4[V)V K"PSVQFOJOPOJMQKOAK2=2N["72KJ\M(KB:QF^_;NZ!
MFC;@<J20>!TZ"O&KS]E:UU#PS\4=)N?$#-)XSUG^W+:[CL@KZ5<+L:(K^\/F
M%60'.4R,CC.:]OTV&YMM-M8;RX6\NXXD2:X6/RQ*X #.%R=H)R<9.,]33$6:
M***!!1110 52U;_CW7_?_H:NU2U;_CW7_?\ Z&JC\2&MS)HHHKK- HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"SI__'Y'^/\ (UM5
MBZ?_ ,?D?X_R-;5<]3<B6X4445D2%%%% !1110 4444 %%%% '&?&CQ!JOA7
MX1^,]9T12VKV&D75S:87<1(L3%3CO@C./:OA:[\$^'[?]@>V^*T3O_PLH72:
MF/%GVAAJ)NOMWDE3,3N("979G'RYQD9K]&V4.I5@&4C!!&0:^=_'7[%_AG5[
MW0[GPE/#X8M].U1]5FT*]AGU'1+R5EQEK$W"1H1V,>W@D$'C ,\Y\+_%#Q1X
MG^.']F:T+6%+SX71ZM=0?V? LRW3Q(7_ 'P3S<98_)NV^U><?L<?%7Q3H-[\
M'/!=CJGD>&=3TK6+R[L?L\3>9,D]T4;>5+C!1> P''2ON#_A3_A>Z\93>,;W
M3$G\5W6E_P!D76H1331I);G&Y!%YA502.O+#^]7+I^R7\*H=+T+3X?"[VT&A
MB==/>VU.\BFA68DRKYJS!V5BS95F(^8C&#2'<\Y_9'^)WQ=^+?@?PUK^I:EX
M?U71FO[Z#6KB_@:'4-J'$(ME@58< XW;QG%<)XPT?3=:_;\\4V^J> /^%C0#
MPE"RZ5Y-E)Y;;H0)<7<L:#&2N02WS\#&<?1?A7]E_P"&7@G4?#M_HOAK['=^
M'GGDTR3[?=2>0TPQ*</*0^[_ &LX[8KJ;7X6^%[/XD7?CZ'3-GBR[LAITVH?
M:)3NMP5(3RRVP<HO(7/'6F(_/G7?A'X_^'-E\"_#^NZDV@:I>>-IIM*MDG2^
M;1+=S;A(PS!HV*D,P7YER?<UW_AO]J#QC>>(M7\#:IXZU:;7K/Q==:581Z%X
M=LKC5M4MHS@*&DV6L&WJSM&<YXP%-?8_C'X7>&/'VL>'-5U[3/M]_P"'KK[;
MIDWVB6/[/-E3NPC -]U>&!''2N2F_96^%<]]?7S^$H3J%YJ+:M+>?:[@3K=,
M<M)')YFZ/)Y*H57@<<"D.Y\G>&?VAOC_ .(KK4[2"/Q!JF@^'_$ES8ZO?Z'H
MVGSZ]' !^[B, 5H"P(;+(A&1C=TSJ^$_VJO&_P 3/'/AKP#X5\2ZUKTUO8W-
MWK&JZ;H&GZ?JTTJLRK 8+V7[.GE_(79#ELX &#7T98_L;_"#2M2;4=/\)-IF
MI_:3=K?V&JWMO<QR$,"8Y4F#H"&/RJ0O/2K\/[*?PKM+738;/PHFFRZ=+)/;
M7^G7US:WRNZ[79KJ.19G+#@[G.: NC)^'>@?$;XD_ _5/#OQ8GU#PEK\DTEH
MVK:+<6L%W<6HVLLV8C+'$S#<C!>P.,9!KP[P#H&AS?M2>#K/X%6#6_A3PK9R
M67BW7[(8LM0^7Y8I)!\MQ,#SNY.6ST3(^H8O@/X$M_AG<?#^WT!+/PE<C$]A
M:W,T)FR027E1Q(Q.T9)8E@,'(XJMX/\ V??!O@%;"+0%U_3;2Q</;V,?BC5#
M:K@YP8&N3&R^JE2#W%,1\[WFO:EX7_:8_:=UC1R1JMAX1MKFU8)O(E2T1E.W
MO@@'%<Q\,?A3\/=:_9-\._$3Q#XJ;PIXMFU!M1N?'^]I-0CNOM#Q^69,[F!4
M!=I..<XSS7T1X3^#OB;PW^U!XY\?R'2+KPQXEL;:T$?VJ47D!AB1<F+R2C!F
M4C_6# .>>E:=O^R;\*;6^BN(_":"**].HQZ<;ZY.GI<$8\P69E\@''^QBD,^
M-/@KJGBB3]C_ ..?]F6&C:QH4]_JCW6K3ZG+;7'-M%N>*W6VD5QMPPS*N22.
M,9/F_P )]4\2^ ?&FE_$GP]&UY;^$?#FEW.L:>BDO<:?*/+GQC^Z"&YX&-Q^
M[S^E^B_ 7P)X=\&>(_">GZ']G\/^(III]4L_M<[?:'F4+(=[.67(4#Y2 ,<8
MJ'P;^SS\/?A_)?-H7AU+3[=IR:3<K)=3SK+:H"%B*R.PQ@GG&3W- 7/A2TU"
M'5OV)+R^MR3;W7Q*$T988)5I4(R/H:_3&OFSXL?LHQS?"/3?A]\+M-TK0=(7
M6XM8N3J>I71V,C*3LRDS.6 Q@LH&!US7TG3$PHHHH$%%%% !1110!6U#_CSD
M_#^8K%K:U#_CSD_#^8K%KHI[%QV"BBBM2@HHHH **** "BBB@ HHHH ****
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M_CW7_?\ Z&KM4M6_X]U_W_Z&JC\2&MS)HHHKK- HHHH **** "BBB@ HHHH
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M_P#<]?'E%'^J^4?\^?\ R:7_ ,D'^H'#?_0+_P"3U/\ Y(^P_P#AX1_U(/\
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M\N3_ .Y*_..BN_\ U4R;_GQ_Y-/_ .2/+_L["_R?B_\ ,_1S_A\%_P!4E_\
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M?Q?^9^A7_#VK_JE7_EQ?_<M'_#VK_JE7_EQ?_<M?GK11_JOE'_/G_P FE_\
M)!_9^&_E_%_YGZ%?\/:O^J5?^7%_]RT?\/:O^J5?^7%_]RU^>M%'^J^4?\^?
M_)I?_)!_9^&_E_%_YGZ%?\/:O^J5?^7%_P#<M'_#VK_JE7_EQ?\ W+7YZT4?
MZKY1_P ^?_)I?_)!_9^&_E_%_P"9^A7_  ]J_P"J5?\ EQ?_ '+1_P /:O\
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M\[YY)RISSF@+'I7B3]IRT\,_%2Q^'DW@/Q9=>)M0CDGL8;4Z:4NH4WYE#M>
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M&"_B!_T&/#?_ ($W'_QBOO2BC_6[-.\?N#_B)&?_ ,T?_ 4?!?\ PP7\0/\
MH,>&_P#P)N/_ (Q1_P ,%_$#_H,>&_\ P)N/_C%?>E%'^MV:=X_<'_$2,_\
MYH_^ H^"_P#A@OX@?]!CPW_X$W'_ ,8H_P"&"_B!_P!!CPW_ .!-Q_\ &*^]
M**/];LT[Q^X/^(D9_P#S1_\  4?!?_#!?Q _Z#'AO_P)N/\ XQ1_PP7\0/\
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MX/[2Q'=?<?EE_P .L/BO_P!#!X-_\#;O_P"1:/\ AUA\5_\ H8/!O_@;=_\
MR+7ZFT4?ZW9IWC]P?VEB.Z^X_++_ (=8?%?_ *&#P;_X&W?_ ,BT?\.L/BO_
M -#!X-_\#;O_ .1:_4VBC_6[-.\?N#^TL1W7W'Y9?\.L/BO_ -#!X-_\#;O_
M .1:/^'6'Q7_ .A@\&_^!MW_ /(M?J;11_K=FG>/W!_:6([K[C\LO^'6'Q7_
M .A@\&_^!MW_ /(M'_#K#XK_ /0P>#?_  -N_P#Y%K]3:*/];LT[Q^X/[2Q'
M=?<?EE_PZP^*_P#T,'@W_P #;O\ ^1:/^'6'Q7_Z&#P;_P"!MW_\BU^IM%'^
MMV:=X_<']I8CNON/RR_X=8?%?_H8/!O_ (&W?_R+1_PZP^*__0P>#?\ P-N_
M_D6OU-HH_P!;LT[Q^X/[2Q'=?<?EE_PZP^*__0P>#?\ P-N__D6C_AUA\5_^
MA@\&_P#@;=__ "+7ZFT4?ZW9IWC]P?VEB.Z^X_++_AUA\5_^A@\&_P#@;=__
M "+1_P .L/BO_P!#!X-_\#;O_P"1:_4VBC_6[-.\?N#^TL1W7W'Y9?\ #K#X
MK_\ 0P>#?_ V[_\ D6C_ (=8?%?_ *&#P;_X&W?_ ,BU^IM%'^MV:=X_<']I
M8CNON/RR_P"'6'Q7_P"A@\&_^!MW_P#(M'_#K#XK_P#0P>#?_ V[_P#D6OU-
MHH_UNS3O'[@_M+$=U]Q^67_#K#XK_P#0P>#?_ V[_P#D6C_AUA\5_P#H8/!O
M_@;=_P#R+7ZFT4?ZW9IWC]P?VEB.Z^X_++_AUA\5_P#H8/!O_@;=_P#R+1_P
MZP^*_P#T,'@W_P #;O\ ^1:_4VBC_6[-.\?N#^TL1W7W'Y9?\.L/BO\ ]#!X
M-_\  V[_ /D6C_AUA\5_^A@\&_\ @;=__(M?J;11_K=FG>/W!_:6([K[C\LO
M^'6'Q7_Z&#P;_P"!MW_\BT?\.L/BO_T,'@W_ ,#;O_Y%K]3:*/\ 6[-.\?N#
M^TL1W7W'Y9?\.L/BO_T,'@W_ ,#;O_Y%H_X=8?%?_H8/!O\ X&W?_P BU^IM
M%'^MV:=X_<']I8CNON/RR_X=8?%?_H8/!O\ X&W?_P BT?\ #K#XK_\ 0P>#
M?_ V[_\ D6OU-HH_UNS3O'[@_M+$=U]Q^67_  ZP^*__ $,'@W_P-N__ )%H
M_P"'6'Q7_P"A@\&_^!MW_P#(M?J;11_K=FG>/W!_:6([K[C\LO\ AUA\5_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 6=/\
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M_P#\76Y10!A_\(9I?]VZ_P# Z?\ ^+H_X0S2_P"[=?\ @=/_ /%UN44 8?\
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MP@NC_P#/&X_\#)__ (NC_A!='_YXW'_@9/\ _%UOT4!=F!_P@NC_ //&X_\
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M_P"!T_\ \71_PAFE_P!VZ_\  Z?_ .+K<HH P_\ A#-+_NW7_@=/_P#%T?\
M"&:7_=NO_ Z?_P"+K<HH P_^$,TO^[=?^!T__P 71_PAFE_W;K_P.G_^+K<H
MH P_^$,TO^[=?^!T_P#\71_PAFE_W;K_ ,#I_P#XNMRB@##_ .$,TO\ NW7_
M ('3_P#Q='_"&:7_ ';K_P #I_\ XNMRB@##_P"$,TO^[=?^!T__ ,71_P (
M9I?]VZ_\#I__ (NMRB@##_X0S2_[MU_X'3__ !='_"&:7_=NO_ Z?_XNMRB@
M##_X0S2_[MU_X'3_ /Q='_"&:7_=NO\ P.G_ /BZW** ,/\ X0S2_P"[=?\
M@=/_ /%T?\(9I?\ =NO_  .G_P#BZW** ,/_ (0S2_[MU_X'3_\ Q='_  AF
ME_W;K_P.G_\ BZW** ,/_A#-+_NW7_@=/_\ %T?\(9I?]VZ_\#I__BZW** ,
M/_A#-+_NW7_@=/\ _%T?\(9I?]VZ_P# Z?\ ^+K<HH P_P#A#-+_ +MU_P"!
MT_\ \71_PAFE_P!VZ_\  Z?_ .+K<HH P_\ A#-+_NW7_@=/_P#%T?\ "&:7
M_=NO_ Z?_P"+K<HH P_^$,TO^[=?^!T__P 71_PAFE_W;K_P.G_^+K<HH P_
M^$,TO^[=?^!T_P#\72-X)TEN&CNB/>]G_P#BZW:* ,#_ (071_\ GC<?^!D_
M_P 71_P@NC_\\;C_ ,#)_P#XNM^BF%V8'_""Z/\ \\;C_P #)_\ XNC_ (07
M1_\ GC<?^!D__P 76_10%V8'_""Z/_SQN/\ P,G_ /BZ/^$%T?\ YXW'_@9/
M_P#%UOT4!=F!_P (+H__ #QN/_ R?_XNC_A!='_YXW'_ (&3_P#Q=;]% 79@
M?\(+H_\ SQN/_ R?_P"+H_X071_^>-Q_X&3_ /Q=;]% 79@?\(+H_P#SQN/_
M  ,G_P#BZ/\ A!='_P">-Q_X&3__ !=;]% 79@?\(+H__/&X_P# R?\ ^+H_
MX071_P#GC<?^!D__ ,76_10%V8'_  @NC_\ /&X_\#)__BZ/^$%T?_GC<?\
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MP@NC_P#/&X_\#)__ (NC_A!='_YXW'_@9/\ _%UOT4!=F!_P@NC_ //&X_\
M R?_ .+H_P"$%T?_ )XW'_@9/_\ %UOT4!=F"O@?2%.1%< ^U[/_ /%T[_A#
M-+_NW7_@=/\ _%UN44@N8?\ PAFE_P!VZ_\  Z?_ .+H_P"$,TO^[=?^!T__
M ,76Y10!A_\ "&:7_=NO_ Z?_P"+H_X0S2_[MU_X'3__ !=;E% &'_PAFE_W
M;K_P.G_^+H_X0S2_[MU_X'3_ /Q=;E% &'_PAFE_W;K_ ,#I_P#XNC_A#-+_
M +MU_P"!T_\ \76Y10!A_P#"&:7_ ';K_P #I_\ XNC_ (0S2_[MU_X'3_\
MQ=;E% !1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **\[\1?'+0?#/QA\
M.?#>ZL]5DUW7K:2ZMKB"TW6J*@<D.^<@_(>BD#(W$9KT2@ HKQ']KSXB:_\
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M+"4VE*I)15]KR=E??37L>DT5^;?_  UW\6O^AL_\IMI_\:H_X:[^+7_0V?\
ME-M/_C5?;?ZEYA_/#[Y?_(GZM_Q"W.O^?M+_ ,"G_P#('Z245^;?_#7?Q:_Z
M&S_RFVG_ ,:KTG]G/]HSXA^//C+X>T+7?$/V[2KK[1YUO]BMX]VVWE=?F2,,
M,,JG@]JY\1PCCL-1G7G.%HIMV;Z*_P#*<>-\-\VP.%JXNI5IN-.+D[.5[15W
M;W%KIW/MNBN!USXY>$O#_BZ]\,33:M>Z[90QW%S9Z3H%_J#0QR9V,QMX'4 X
M/?M71>'_ !E8>)IFBL[?5866%)R=0TB[LEVMG #31("W'*?>7C(&17Q)^4FY
M117/^'?'FA>+-8U_2M*OOM5_H-RMIJ,/DR)Y$K('"Y90&^4@Y4D4 =!114%]
M>0Z=9W%W</Y=O!&TLCX)VJHR3@<G@=J )Z*Y;PG\3/#_ (XL]'O-#GO+^QU:
MT-[9WJZ=<K;O$&V_-*T81&ST1R&/4 BNBM+ZVU",R6MQ%<QJVTM"X8 ^F1WY
MH GHKG_$OCS0O"&IZ#I^KWWV2\UV[^PZ='Y,C^?-M+;,JI"\ G+$#WK0EURW
MAUR#26CO#=30M.LBV4S6X53@AIPGEJW/",P8]0#0!H4444 %%%% !113)ID@
MB>61@D:*69F.  .230&VK'T5\*_&C]H;6OB!K%U9Z3>S:=X;B<I#%;L8WN%'
M&^0CDYZA>@&.,\UY_P"&?B!XB\'ZE'?Z3K%W:SH02!(61_9E/##V(K]"H<&X
MJK052I449/[-OS?3[F?C>+\3,#0Q3HTJ+G33MS)I?-*VJ[7:N?I517GWP3^*
MD7Q6\%QZDZ+!J5NWD7T$8(59 ,[ES_"PY'IR.U7_ (7_ !4TCXL>"4\4Z7%=
M66FM-<0D:@J1NIAD:-R=K, ,H2#GIUQ7PN(P]3"U94*JM*+LS]8P>+HX_#PQ
M6'E>$U=/^OQ.RHKE/#_Q8\#^+'O$T/QEX?UE[.(SW*Z?JD$Y@C'5WV.=JCU/
M%<UXJ_:8^&OA?P3J_BA/&&BZY8Z:H\R'1]3MKB:20@E8D'F &1@K$*2"=I]*
MYSL/4**Y;1_BAX5UKP+!XQBU_38O#4D0E;4IKR(00Y(!5Y Q165CM(W<-Q4,
M/QB\!7.DWVJP^-_#DNEV$BQ7=ZFK6YAMW8X59'#[4)/0$C- '7T5Y#XH_:P^
M%OA?4/#EJ_C#1]236[HVR76G:G:RPVH 8^;.WFC9'E2N[GYN*T[?]HKP N@V
M^K:KXETG0H+B>>"!+S5;.5I?*.'93!-(I &"?FRN1N"GB@#TNBN4;XL^!UO(
MK0^,O#XNI5B>. ZI!O=91NB(7?DAQRI_B'3-8&D_M#>"-:^+FH_#FVUBW;Q#
M90K(?])@,4LF6#V\>)"[3)L)=-N5% 'I5%<)'\;/"$.JZKI^J:[I>@W&GWC6
M6-1U>R4SNJ!V*JD[,N >5D"..NW'-=CINJ6>M6$%]I]W!?V4Z[XKFVD62.1?
M564D$?2@"U1110 4444 %9VK>(M-T%0U_>PVN[E5=OF/T'4U4\:>(O\ A%_#
MMU?* TP 2)6Z%SP/RZ_A7BWAGPGJGQ$U"YN9+G:H;,UW-EB6/0 =S[< #\*_
M-^)>*J^5XNEE65T/;8JHKI=$M=7]SZJR5VSZ#+\MAB:4L3B9\E./7JSVK3?&
MVA:M.(;74X))CP$8E2WL <9_"MNO"_%?PEO?#>G/?6]VM_!$-TH$91U'KC)R
M/7FNP^$/B^?6K.?3;V0RW%JH:.1CEFCZ8/K@XY]Q7%DO%N82S..39_A51K35
MXM.\9>6[[/52>NFC-L9E=!8=XO!5.>"WONOR_(]$HKSS1_CQX1U*^\4V]Y?I
MX?3P[JXT2YNM:FAMH9KDH'41,7^;(/ ."<'BJ7Q&_:2\ ?#/PM8:_?:_9:C8
MWUVMG;?V9>6\K2L7579<R*&6/>I<@G:#DBOU4^9/4**X;5OCG\.]"FT^._\
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M"]1110 4444 %>9_M%?%Q?@C\*=3\3K&D]Y')%!:V[GB61W Q^"[V_X#6/\
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M?C?Q5KFOZ/9RVFD:CJ$ED7T[S%VO+&J6RH\A7@M,LGTSS7DGPU^+_CFQ\:>
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M\-Z]X>T/3KC7M0?3!;:5XMMM5O["49V&YMXH]J*V.JR-C///%=9^RC\0M?\
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MZU-K5GJGQ#DM['38'61M&MY1+-.0<[)'7Y57.,[2Q(R..M?=\<:0QI'&H1$
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M0=:UN!K[7K=M=M]$T73[+21:7-U/.I:.(&2Y<.>#F1A"!C[IR,@:EO3OV#_
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MM_T!/%7_ ("6W_R11_P\8^&W_0$\5?\ @);?_)%'U6M_*'^I^?\ _0)+\/\
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M4?5:W\H?ZGY__P! DOP_S/J>BOEC_AXQ\-O^@)XJ_P# 2V_^2*/^'C'PV_Z
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M&/AM_P! 3Q5_X"6W_P D4?\ #QCX;?\ 0$\5?^ EM_\ )%'U6M_*'^I^?_\
M0)+\/\SZGHKY8_X>,?#;_H">*O\ P$MO_DBC_AXQ\-O^@)XJ_P# 2V_^2*/J
MM;^4/]3\_P#^@27X?YGU/17RQ_P\8^&W_0$\5?\ @);?_)%'_#QCX;?] 3Q5
M_P" EM_\D4?5:W\H?ZGY_P#] DOP_P SZGHKY8_X>,?#;_H">*O_  $MO_DB
MC_AXQ\-O^@)XJ_\  2V_^2*/JM;^4/\ 4_/_ /H$E^'^9]3T5\L?\/&/AM_T
M!/%7_@);?_)%'_#QCX;?] 3Q5_X"6W_R11]5K?RA_J?G_P#T"2_#_,^IZ*^6
M/^'C'PV_Z GBK_P$MO\ Y(H_X>,?#;_H">*O_ 2V_P#DBCZK6_E#_4_/_P#H
M$E^'^9]3T5\L?\/&/AM_T!/%7_@);?\ R11_P\8^&W_0$\5?^ EM_P#)%'U6
MM_*'^I^?_P#0)+\/\SZGHKY8_P"'C'PV_P"@)XJ_\!+;_P"2*/\ AXQ\-O\
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M_P! 3Q5_X"6W_P D4?5:W\H?ZGY__P! DOP_S/J>BOEC_AXQ\-O^@)XJ_P#
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M27X?YGU/17RQ_P /&/AM_P! 3Q5_X"6W_P D4?\ #QCX;?\ 0$\5?^ EM_\
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M_P"2*/\ AXQ\-O\ H">*O_ 2V_\ DBCZK6_E#_4_/_\ H$E^'^9]3T5\L?\
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MEC_AXQ\-O^@)XJ_\!+;_ .2*/^'C'PV_Z GBK_P$MO\ Y(H^JUOY0_U/S_\
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MZY#.(I4@NK[5X(0I$S7(<F-G*IN#)G*9 &3GJ/\ AXQ\-O\ H">*O_ 2V_\
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M[(-O-\)=:\'MXF=-2N?$DOB?3==BL=LFFW32*Z;4\P[MH#+G<N0W05QWB?\
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MVLV_)$?ZUYLHN4J\E]QXM_PLW5/^>%G_ -\/_P#%4?\ "S=4_P">%G_WP_\
M\57N'B[]G/0?$_P?&L^$+A[+XC>#A%I'B_P7-&WVE[C[1]G%Q !DMN=T! R#
M['AOIO\ 9]_X)::!I^D6NJ_%>ZGU75ID#MH6GSF*WM\@'9)*OS2,.^TJHYQN
MZUR8G%9%@Z3JU:=G=JUM6UV\K--.]FFM3.IQAF-./-+$R].I^>G_  LW5/\
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M /%5R-%']D8#_GT@_P!9,W_Z")'7?\+-U3_GA9_]\/\ _%4?\+-U3_GA9_\
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MX6?_ 'P__P 57(T4?V1@/^?2#_63-_\ H(D==_PLW5/^>%G_ -\/_P#%4?\
M"S=4_P">%G_WP_\ \57(T4?V1@/^?2#_ %DS?_H(D==_PLW5/^>%G_WP_P#\
M51_PLW5/^>%G_P!\/_\ %5R-%']D8#_GT@_UDS?_ *")'7?\+-U3_GA9_P#?
M#_\ Q5'_  LW5/\ GA9_]\/_ /%5R-%']D8#_GT@_P!9,W_Z")'7?\+-U3_G
MA9_]\/\ _%4?\+-U3_GA9_\ ?#__ !5<C11_9& _Y](/]9,W_P"@B1UW_"S=
M4_YX6?\ WP__ ,51_P +-U3_ )X6?_?#_P#Q5<C11_9& _Y](/\ 63-_^@B1
MUW_"S=4_YX6?_?#_ /Q5'_"S=4_YX6?_ 'P__P 57(T4?V1@/^?2#_63-_\
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MLW5/^>%G_P!\/_\ %5R-%']D8#_GT@_UDS?_ *")'7?\+-U3_GA9_P#?#_\
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M  LW5/\ GA9_]\/_ /%5R-%']D8#_GT@_P!9,W_Z")'7?\+-U3_GA9_]\/\
M_%4?\+-U3_GA9_\ ?#__ !5<C11_9& _Y](/]9,W_P"@B1UW_"S=4_YX6?\
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M?V1@/^?2#_63-_\ H(D==_PLW5/^>%G_ -\/_P#%4?\ "S=4_P">%G_WP_\
M\57(T4?V1@/^?2#_ %DS?_H(D==_PLW5/^>%G_WP_P#\51_PLW5/^>%G_P!\
M/_\ %5R-%']D8#_GT@_UDS?_ *")'7?\+-U3_GA9_P#?#_\ Q5'_  LW5/\
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A%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex101slackseveranceagm05001.jpg
<TEXT>
begin 644 ex101slackseveranceagm05001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %5+G2]/O+F*YNK"UGGB_P!7++"K,GT)&15NB@ HHHH **** "BB
MB@ ZTR**."%(88TCB10J(B@!0.@ '04^B@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&UW5'C:.R\\^5&D:A$0R8Y.-Q) QDUM>)+"ZU?P?JVG0J@N[NPEA12V%WLA
MY],F@";P\Q?PUI3,26-G"22>2=@K2JEH]M)9:)86DV/-@MXXWP<C*J ?Y5=H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4E Q$RR%!\V,\?(<D]":Z_2=0TK2+VVT/1()##<W$L[E;9TAMDVES\Q '+#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHRA3!^8_-@_>Z?[-!_L7QCXOTV_TZ8W']E>:+F6,$(3D;(FR!DAQO'ILSW%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ I%14!"J%R<G QS2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#U# @GMV- '145P/PJ\4:MXOT.[U+59HR\5R8$CBC"K@*K9/?/S5:\2>/(=
M\:Z%HCJ/)O687$I'$9;B,9_WNOH"#WH [2BL3Q??W>E>$]2U*QE$=Q:0-,FY
M RL5&<$'M]*H?#O6=0\1^#;/6-2F5[BY,F41 JH%=E&._;N: .JHHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8'((C (I\L$4X EB20#IO4'% 'D,\T7_  S4H\U,_957[PZ^<./K4<^KVI^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %5K[3K+4[<P7]I!=0GDQS1AU_(U9HH
MS;;P_HMG*DMMI-C#)']QX[=%*_0@<5-J&DZ=JRQ+J-A;78B;?&)XE?:?49'%
M7** *UIIUE8O.]I:00/</YDS11A3(WJV.IJ2*U@@A:&*%$C9F9D5< EB2QQ[
MDDGZU+10!0BT/28+*:RBTRSCM9\^;"L*A),]=RXP:BLO#>B:=+%+9Z39021
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$GBKQ#XGTJ>YMXY;1HXH$EC9GAC:)2)4PZX.XL<CG@#/2NNT..6'0[.*:_\
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MU+0X]*UA+,,3:$&VN8@P&],=""0,'GD>E:7Q#_Y)YKW_ %YO_*@#:TJ[FO\
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M:=+T>**1$6XD)FN-G3S'.Y@/8$X'L!6I0 4444 %%%% !1110 4444 %%%%
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M+/<16L*GIOD<*"?89S^%5[)_%(UHQ7ZZ2VF*6Q-%O663(&W"$D#!SG).>,4
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M,K6[%[ 8M6,SYB&,''/IQ]..E4-,BU/5M6BU/6=)CTXV2R1VT7GK,S%R 7W
M<#:H '^T<]!71$A022 !W-&1C.1CKF@!:R=?TZ76M/?2N4MKGY;F7//E9^95
M[Y8<9Z $GK@'5R"2 1D=16<FI_VIIE[+HLD$L\320Q/*3Y1E7CDCG:&X./0T
M 2'1M.;4;74#:I]JM8FA@D&1L0]0!T[5>J*W,OV:'[28_/*#S/+)V[L<[<\X
MSG%2 AAD$$>HH SK?0--M-5FU2&W9;V< 2S>:Y+@= V3R!V]*=JNB:;K<<*:
MC:I.(9!)$22I1O4$$$5?#!LX(.#@X-&X;MN1NZXSS0!@7&F1>'(+F^\.^'H;
MF]N)$\V&.58=PX!(+<#  X&,XJYHFG/964SW"1I=WDSW%R(CP';L#QG"A5SQ
MG&>]:991U(&/4U5NM3M;.\LK2:4">]D:.!.[%5+$_0!>ON/6@"C_ ,(IHO\
M9MQIWV+-G<R&2:$ROMD8G))YYR>3ZU.V@Z:]Y9WCP.UQ9J5MY&F<F,'@@<]Q
MP?7O6E2;@&"Y&3T% &(O@[PZNN'6ETFW&H%]YE /+?WMN=N[WQFK \/:6L]]
M.MNPEOP!=,)G!E &!GGL./IQ6F2!U-*"" 0<@]Z ,=_"NB26%I8OI\;VUF^^
MWC9F/E'&.#G(&.,=*UP H    X %+10!DIX9T>.Y>=+,*9)?/>,.WE-)G.\Q
MYV;L@'.,Y&:FN-#T^ZU2'4YH&:]A4K%*)7!0'J!@X /?UJ^&!) ()'4>E+0
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M6X'.<\#TJ*'PGH5O<_:8=.CCN/)\CS59@^SG^+.<\GGKSUK8#*2 ",D9Z]J
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M7-(DC6Q$B0B .LCJWEY)V$@Y*\G@\4 )X;NK2]\,Z9<6 D%H]K'Y(E^^%V@
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M:P1J(59$.R7 SACV/?!]*HZ_X>TFU^&UCJ$%E$EY.-.\RX&=[G>@R3ZX8\T
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M8MN)5>57.V93R<AFY'H,\UL^.;IX;SPW!-QIESJ:1W>?NM\IV*W^R6QUXX%
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M<!$8;SU8YYR: .\,T0F$1D3S2,A-PSCUQ5/6M8L] T:ZU2_<I;6R;W(&2>P
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ME:ZA:26MY;Q7%O(,/'*H96^H-8NJ>()E\0VWAW2HXI-1EA-Q+)-DQVT(.-S
M8+$G@*"/J*F>?7;/4-/CE^QW=I/,8YY8HFB:$;&(.TLP(+ #.1C/0YR "_:Z
M78V44D=M;1QK+Q(0.7XP,GJ>*A@\/Z1:V<UI!IMM%;39\V%(P$?/7('!S5QK
MNV2Y6V:XB6=AE8BX#$>PZTZ2XAB)$DT:$*7(9@/E'4_09'- %(:#I(TMM+_L
MZV^P,,&V\L>7C_=Z5'%X9T.#2FTN+2K1;!FW-;B(;&/J1W/UJ]]NM D+FZ@V
MS'$3>8,2'_9]?PI\MQ!!GS9HX\*7.]@,*.I^G(H +>WAM;=(+>-8X8QM1%&
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M10!0GT32[F>VFFT^W>6U&+=S&,Q#_9_N_A3I=(TZ?4%OY;*%[Q5V+.4&\+Z
M]0*NT4 97_",Z']ADL?[)L_LDC[W@\H;&;KDKT)KF-7\,SW.OW$UWX7TO6K-
MTC2U=Y1');HHY0AE.1N+'(/?IQ7>44 8_AO14T+3I+>.&*V224RBVA<M'!D
M;5)QQQGH.2>*V*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT?3-8C2/4]/M;Q(VW(MQ$KA3ZC(XI]QIUC=V0LKFS@EM0 !"\8*#'3 Z<=J
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MW&*\VO;NRGTG2+VP>*&T?Q,CIYS[KAW\\AV)R-HZC;@G;C)[5ZZ %    '
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#[BX=P R\C"C/;MC)H [:BO,[C2[FROO!>FW.N75^RW=S;RW$<KQ^8JQN0I
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M&:#JUI9VUY9&1;(8MW$TBR1CT#AMV/QK>HH KV5E;:=9Q6EG"L-O$,(B]O\
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MW:[3;PM;VD1()4,07<^[84 =@/? MZ9I-CH\$L-A;B".69YW4,3EV.6/)[T
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M_M&A02S0$?*7,C!LC]/PKH5\,:.ES),EGM\V83R1"5Q$TF<[S'G86R <XSD
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MG=G[WKS]>: .<EMSXJ\2>)])NKBU22U,<<$<T#.\,;1*1)&0ZX.XL<@9X'/
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M3^-7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *Q?%>LS^'O#=YJ\$$=P;5/,:)W*[AD=" :VJY7X
ME?\ ).==_P"O8_S% "W7B#7=/T5-7FT:VN;41":9+2Z8RHF,DA60!L#MD5O:
M9J=IK&EV^I64HDM;A!)&_3@^OH>U4'U*STCP;'?W\BI;0V2LY8]?D''N3T ]
MZ\_\):=]A\,>#M*U&&634)FN;F#3Y6"PE3D[I00?NA@0 ,Y;ZD 'I^HZE:Z5
M8O>7<HCA4@9/<DX 'N20*MD@#).*\:N8(I?AOJD-PD$JV?B,Q0#;E8D^TH,)
MG.U<$C'H<5U-XMO<^.V\/.-.BLTTU)+.UN+;S(G)=Q(54,HW#"CN<9Z<Y .\
MH) &36)X3TX:1H2:>NI/J"6\CQK,PQ@9^YU.0O3KVQVK(O)5O_BA%I&HQI)8
MII)N+>&5<I)*9-K-@\$A0,>@)]: .IU&^BTS3+J_GSY-M"\SXZ[5!)Q^596C
MWVN7TUI<W$%D=,N[19PT999('(!"')(<8/WAMZ=*XUK7'AGX@:7+&LVF:>9C
M8"4;A"3!O*KGH%+<>F:[?PG:6UIX6TP6UO%")+6)W$:!=S%%R3CJ?>@"GXC\
M2RZ;>'3+&.(WILI;W?.Q"JB8' 'WF)/3C@$U;_M35$L+K?I:O?Q3B"&**7]W
M-E58/N(^5<,<\'&TXSQG*\=Z'IFO:5<^:[1:GI]NUQ;SQ';)$""/Q4[2"/Y5
M+X7UR^-MJUIX@E@-SH\XAEO8QMCF4H'#8[-@C(]: %T;Q)JC^)9/#^O:;!:W
MAM_M4$UK,9(I4#!2.0"""1U__7-X@\4C1M5TG3H;?SY;V\B@E;.%A5\X)]SM
M; ]C^)!$S:E<:]+&IOIK<V]A:.X1M@R^#GHSD9/H /0UP^NW.OVT?A_[9X:E
M2Z;6X9Y)3>0G[1-M8;1@_*,<#/ "@4 >MUA6NOSS^,[O09+-8D@M%NDF\S<9
M SE>F..A[FM>&X63:C[8[CRP[P[P63/T]^,URUO_ ,E=OO\ L"0_^CGH M>)
MM:UW1[6ZO[#2K6XLK*,RSF>X*22*!N;RP%(X'<GD@\>NA<:AJ%QI=K/I%E')
M/<QK(HNY#&D2D _/@$YYQ@#\JK^+=(FUK0+FV@U26P95+[T"%&(Y <,#E>.1
MD9'7(I_AZZO=8\'Z;<WK/;7MU:(\C1J RL5'(!! ]<$=Z &>%M=N=<LKLWUD
M+2\LKM[2=$?>A9<'<K8&0015O6]:MM#LTGG5Y))9%AMX(QEYI&^ZBCU_0#)-
M8/@J.^TRYU[2+R\-W:V%T&ANY  [>8OF.'(X+ MDG_:JIXEMEU#XC^$UN))/
ML)ANFA:*0INEV#^)2#G;DC!]: .H>[U.VTR2YGLXI;H[1%:6[D_,3@ N<<9(
MR<# !/-8^F^)=7C\3Q:#K^F6]M-=0O/:3VDYDC<+C<IRH((!!Z8J#PW-<:7X
ME\3Z;/>2RZ19>3-!)=2ES!O0LZ%V.2!@'D\ ^]:5I%%>:XFN796(^6;:PBD.
M&"L06<@]&;:..H5>>20 #H*,C.,\U2UFXN+30]0N;1-]S%;220IC.YPI*C\\
M5YQ?1QK\*M(\2:7@ZX@M9DNE_P!;/,[JLB.W5@Q9@0>./:@#U3('4T5YY#H>
MGZKX\\8VU] 9X/LUHWE.[%=Q63G&>OIZ=JW/AW<2W7P]T.6>1I)#;*"S')."
M0/T% &[/J-K;W]K8R2@7-UN\J,=2%&6/T''YBLKP]KEWJNI:Y:W<,$7]GW8@
M3RF)W H&R2>_/H*QO$5A8S_$[PRUQ:6\F^UO-YDC4[MH0KG/7&3CTR:Q+K2;
M+48OB-+=PB5[>5Y(=S'$;BV4A@.S @<]: /4R0!D\"BO-X+Z75-7\-Z;J$]J
M8KK0H[B-;V$RI/.=N_C< 6"X(SG@GUKJO"6EKHNESZ>FHF]2&Y?;\FT0@X/E
M+R>%SQSQG':@"Q?W>L1WSQ6%E:O;) )&FN)F3+$M\J@*<X"Y/U%8WASQ/K?B
M#1=,UA=*LUL[Q\.J7+-)&NXKNQLP<$9Z]*ZN?_CWE_W#_*N0^%1/_"L-%QR?
M+D_]&/0!V>1G&>:,BO+=$LE\3>%K'6Y]6M;34+>X\Z>YCMC]ICF#G=&S;\D'
M[NW&", #I6AI7A[3-4\=^*UO87F2VNK2:%3,X\M_*#;A@]<_U]30!Z%D>M&>
M<5XW<:39M\.?%MXT9:YL=4O&M92[%H"DHVE#G@\=1U[UTTUA;:9\0?"EQ9H8
MYM0@NEO) Q+3XC5AO)ZD'F@#LK(Z@9;O[<MJ(Q,?LWD%B3%@8WY_BSGIQTJY
MD>M>47%O&O@WXD1@OMBOIV3YVR"(D(YS6HNGVVE^,_!<]FACFOK>XCNI-Q+3
M@0AAN)ZX(X]* /0\C.,\U5AU&UN-2NM/BE#7%JD;S*/X ^[:#[_*3CTQZUY?
M.UN]MX?U;3>89_$:*M_.P-S<!I65P2 ,)U4 DY ' KH-!TW3S\2?%SFTMPP6
MS*.$ 92\;[B".03W(ZT ==IAU$V>=46U6YWOQ;%BFW<=OWN<XQGWJX"#T->1
M:?>267@+0;?>ZV5UXA>VNWW'_5&>3Y6/H2%!]B1WKI9[%-.^)%E9Z=$(K'4=
M/F-];0_(GR%0LF!T8EMN>XH [C(]:*\9T_3[>#X;>%M:16_M*/4H56Y+DN%:
MX*E0<_=()R.AKV:@#D[3Q'K-]XHUK1;>PL,Z6(2TLEPZ^9YBEA@!#CIS5K2/
M%/VS7;G0=2LC8:M!&)A%YGF1S19QOC? R,]00"/SK+\-_P#)4O&_^Y8?^BFJ
MG?NFH_&33Y[5@T6BV$K7\R\JA<$*A/KSNQ0!Z%D9QGFJMKJ-K>75W;6\H>2T
M<1S8Z*Q ;'UP1^=>96HAAN/!6H6 V07-\ZK=3.#=72,CDM*0 ,$@''/;H>*>
MB)H]E\0]0TRUABOK:X?R)(XP&C!A0DK^K4 >J9![]**XC3-&LGU31->L=5LX
MD=&C5+*V*?;59<XD.]MQ7!;)Y!SFNTBFCG3?%(DB9(W(P(R.M #Z*X[Q_:K;
M6MAXE2(/-HUTD\N%R6@)Q(/P!W#T*UST%R+#Q1J:V]M$MKXG@SIC!,C>I$;'
MW5@PEQTQ0!V=WKEW;>-=-T7R(/LMY;S2^;N)<%-O&.@'S>]:NH&]&G3G31;M
M>;#Y(N"1&6[;L<X^E<9JNCV(\>>%M+\D?8H]/NT\H$@,H\O@XZ@]_7O6%+;Q
MQ?#3QU91[DMK'4+I+:-6($2@(P4>P+'CWH ]80MY2F7:'VC=M/&>^/:L+Q+K
MEWHMQHJV\$$D5_J,5G*SL=R!\G( _P!T]_PK%^TP7?CK3='U-8Y+,Z,)K:&8
M QR3;L,<'AF"@8] 3ZU0U_2K'3])\,Z7975Q/:Q>(XH]SRY9,B0E%88P%S@8
MZ8QG(H ](SFBN*\-6EOI7Q"\1Z?8Q""S-M:S^2G"ASO#,!V)P,^N*V?%EI<W
MV@26UG<P07+RQ&+[0"8Y6#AO+?'.UL;3]: $\8:U=>'_  I?:M90P32VR;]L
MS$+C..W7KTX^M;<;;XU8XR0":\HUB]CF\!^,[2;1CI&IP0QF[MD8-$<_=>,C
MC!"G\JW9+"UT;XC^'I+-/):^L;H7;[B3-L$;*7)ZD$GF@#O,C.,\USUAKE_=
M^*M=TAK>V5;"&"2!@[9?S WWCCC[HZ#\ZX=#;B/PCJFF@^3<:UM2]G8&ZND?
MS-Q<@#Y3C&#G@+G&,5U6BG/Q.\4X_P"?2R_E)0!I^#];G\1^%;/5;F*.*:<R
M;DCSM&V1E&,^RUH7QU$/:?8%M2AG N?/+ B+!SLQ_%G'7CK7.?"__DG>E_6;
M_P!'/3?',:_VEX2F&X/_ &W$GWCC:4D.,=.H'Y4 =CD#O17G":'I^I^+_',%
M[ 9X5AM66.1V*AC$YW8SUSR#VYQ530]4-W%X"L-6D\RRN].D;$QRL\ZA0@;/
MWL+N(![D'J!0!V?C/7+OPYX6N]6LH8)I(-IVS,0,%@N>.O7U%;]><^,=,L-'
M^&WB:TT^>5XO/65HF8%;=GD0F-   JC@[>V[WK4FCC7XNVWR*!-HDN_C[Y$J
M=?7B@#LJP/[<NQX\70C#!]D?3VNUE#$N6$BI@]@.3ZUP$.H_8_#?V=)?+T^[
M\6R6EPZ-A5MS(3MR.BG 'T)K;O+2'1_B7/-I5I%%-_PCD\BQ1(%5G65=ORCC
M/ 'X"@#T/(SC/-%>;:%IMOJ^D>&_$,>L6L,\<D3R7$%L1-.[85X97WG=N)P>
M.HSQ7HTL230O%("4<8(!(X^HH ?D>M&0._6O$XM&@_X4U8>([=IAKMIB2UNA
M*Q<-YY4(!G&#G&.Y.>M;?BX6U[9>,KF!!-<6EN@FGN6'^BR+'N5( !D<G).1
MR>,T >HT5Y_K\::7)X?\:%%?[,J0ZBV,YAD4+YA]T8@Y]":I>+;**;X<:OK1
MC\N?4+F&Y5E^4B,RHD8/U3!(/=FH ]-S1G(R*\_OM"TZ'XF:=;QV^V"_T^X-
MY&';%P59"#)S\QY/7KWK&2]?0_"6OP6\GV?3[;Q+]E8\E;>V9XRP !!"_,1@
M$<,>E 'K((/0T9'K7!W'AVVM)M2O8M1MD2\TJ0&RL8##%)MY$W#GD9 SW! K
M#L]/MK'0_AUJMNA2_FGMH))]Q+/&\+90G^[P..@H ].M]1M;N]N[2"4/+:%5
MF Z*S#('UQ@_B*GFF2W@DFD.$C4NQ] !DUQ7A&PL8?&GBZ2.TMTECO8Q&RQJ
M"NZ%2<>F3DG\:Z;Q!;P77A_4([B&.6/[.[;9%##(4D'!H SM$U;6M7&F:DMM
M:?V1?P&8@$K-;Y&4SR0^>AP!CWKHP01D'->56ABT_P &> [>."."RU.:VCOW
M10OF_NR55R.H9L9SUQCO6S/8K8?$";3["/RM-OM(DFN[:+Y$5U<*K@#[I(..
M.N/:@#O,BBN&^&>BV$?A71M:$3-J,MCY3SM(Q)0MG;C..H';^M:GC%[1HM*M
M;GSI)+B_C$-LC!4N' )VR$@_N^,GC/ P#TH Z7((R#Q1D5Y'=Q;/#'Q&LV\N
M..VE\R.&W8K'&QA5CM'IGKZGM6S_ &;::;XU\'RVL>R2_M;F.[<L29U$*L ^
M>N#TH ]#HKS181X?U;6?"$4(5=:83Z<^W.%?Y9E_[9@%P/2O1K:VAL[:*VMX
MUCAB4(B+T % $N0._6@D 9->8>,%M+RU\9W%LOGSVD""6XN6'^C.L>Y5@ &0
M>02<CD\9K3M[R'4_&UEI>K^7/ VBQW%M#. R2REB)&P>"P 'N!GU- '>49&,
MYXKSNZ%AHM[X5T!;R6?0Y+NYBE:YDW*TBKF.)FP 5#,0!ZJ!VJ'QQHNFZ7X'
M\2QV$TP+2Q7#0*^([=F=1A    1DD<]<]Z /2J*\^\2Z#IFB:AX<N+"W\F:Y
MU^$SREV9G)C<'))/7 SZGGK5/5KR?3-;^(-QIAV7$.F6\B^7U5]LF6QZ@<_A
M0!Z;D>O2L#QAKEWX>T%M0M(8)626)&65B,!W5,@#K][U%8,&EVT<VE^)-,U&
MS!%O((HK*V*?;P4)"R'>Q8C&<GD'.:YR_AL=3^#EIKDBQSZC+/;RS71 \PRF
MX4.">N!DC'0 #T% 'L%8'AW7+O5;_6[:[A@B.GWGV=/*8G<-BMDD]_F]!6_7
MFMGX;TG7]1\:C58RRQZ@=DAD9?)/DH=XP< CU]J /2JK:CJ%MI6G7%_>2B*V
MMXS)(Y[ ?UKS;P_-=SZE\.;O4-WVVXL+L2R-]Z4!$V%CW.WGGU-4-8@MI/!7
MQ%011/'!J3-$NT$1D)'ROH>3T]Z /8%(90PZ$9I:K6%M;6EG'#:0Q0Q*.$B4
M*H)YZ"K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %4]2TNRUBS:TOX!/;/\ >B9B%;Z@'G\:N49Q
M0!DQ>&-%B:%AIT+F @Q>;F01D="H8G'X5-J>A:7K+6[:C917#6[%XF<<H3UP
M1V/<=#6AFF^8F0-ZY;( SUQUH R1X5T$6=[:#2K46]\^^YC"8$C9SD_CR,=#
M3=1\):!JUG;6E]I5O-#;?ZD$$&/UP1SSW]:O1:I:3:M<:9'*&NK>))95!^X&
M)"@^_P I./3'K5H2(SLBNI=>J@\B@".UM;>RM8K6UA2&")0L<<:X50.P%5]0
MTBPU1H'O+</) Q:&56*/&3P=K*01GO@\UF^&=;O=6N=<AO8X$-A?M:Q^2#@J
M$5LG)Z_-[5O/(D:%W=54=23@4 47T33I-+?36M5^QR9\R($@/GKNP<MG)SGK
MWJQ965OI]K':VJ&.",!43<2% & !D\#VJ<LH )(P>G/6A75P2K!@#@X.>: ,
MS5O#^G:R&:YB99C$T(GA<QR!#U&X'D>QR/:DG\-:-=:6=,GT^*2S:3S6B;.'
M?KN;G+'/.3FM7H,FFAT9BH92P&2 ><4 8NE>#O#NB7OVS3=(MK:XVE/,C7G!
MZBM.[L+6^-N;J!)3;S+/%N_@D&<,/?DU/YB>9Y>]=^,[<\X^E55.H?VQ(':U
M_L[R5\M1N\[S,G<3VVXQ[YH I_\ "/VQ\5_V\(8X[D0& R*3NE!Q][L ,?CG
MVJRFBZ?'JSZHL!%\Z[&F\QLE>NWKTSVZ5F>+=>NM#L[6:R%M(TEY!!*LN20L
MCA<@ CGGO714 9,GAC1I=1GOWL4-Q<8\\[FVRX&!N7.UNG<5+J6A:;J\EM)?
M6PDDMB6@D5V1HR>N"I!&<"I;?5+2ZU.\T^&4//:+&9@#D(7W8'UPN<>XI-,:
M_&GJ=5>T-T&8,;7<(\;CMQNYSC&??- #O[+L?[-ET[[+&+25&22(#APWWL^N
M<G)ZU&VB::^FVVGFT06ML$\A 2#%M&%*D<@CU!S5WS$^;YU^3[W/3ZTH8,H8
M$%2,@@\4 9T_A_2KG39=/GLTDM9GWRQN2?,;U8YRQX'4GH*IZ;X+\-Z/?)>Z
M?H]K;W2 A947E<C!Q^!K<1TD7<CJR^JG(IU !65;^&](M+@3062(1(9E0,WE
MK(>KJF=H;D\@9YK361'SL=6P<'!S@US-QK>L:A?ZM:Z"MB9-+DBC9+L-B=F4
M.P# C9@$#.&YH UAH.FK>W5XMN5N;M0L\BRN#(!T!YZ#MZ5/IVFV>D626=A
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M=N><?2@#)'A;1187-C]A'V2YD,D\/F-MD8]2PSR3W]>*F;0-,>ZL[E[<M/9
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ML$$SJCD<(,YV+[*21UXZ=JWJBMK:"RMH[:UACA@B4*D<:A54#L *EH ****
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MYHXV"ZM:#+J#A3*,]>Q[U7N+#3[[XJVUM+;036JZ$^(2H,?$ZCE>AQZ>H]J
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M /5J9)-%%CS)$3/3<P&:C@O;6YEFBM[F&62!MDR1N&,;>C =#]:PO&^@'7=
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MM]*5+N6\;<BJ5=D6)..3GELX!V\$U6N[<)X*\*^+[>-;B^T:U@EG( 9Y(&B
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M&<Q-R5&#P_(Q6C)<00AC+-&@0!FW,!M!Z$UYSJUM8CPSX%E@AMPZZII_S1J
M064$\CUX/Y5<M=$TN_\ B3XIBN["WFC:TM7,<B J6(D!8CIN]^O7UH [SSHM
MRKYB;F&5&X9/TI4DCD+!'5BO! .<5Y+I#!O"WPTN)B"RW_E"1NH&R4!<_@!C
MVJQJMX]KJ'Q)GTMAYR6UH28#\PPC!R,=P-WT(H ]/CN8)G=(IHW>,X=58$J?
M?TI[R)$NZ1U0=,L<5Q>EV.B7>N:+K.GZQ$\@A>*&&T1$$L17.) O.%P#SC!P
M.]=-K>CVNO:-=:9>H'@N(RAR,E3V8>X/(H NF:(!294PWW3N'/TIK7$"3K T
MT:RL,K&6 8_05POA.>77&L--U&W47'APM'=93Y6G ,<;+Z@IN?ZE:R[%8-6^
M%&OW6IJHU>&2[DN93Q)%<(S&/!Z@J @&.V!0!ZAYT>]D\Q-RC)&X9 I//B\O
MS/-3RQQNW#'YUP.DF8>/]$FU-5CO9O#/^D%@ 6D#QE@?<<US<\-G<_#G4618
MF6/Q*WE.F/D!NE&5(Z<'M0![''+'*&,;JX5BIVG.".H^M/JEIND:?H\4L6G6
M<-K'+(976)=H9R "<?@*NT %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML3=BPSTJ4WL%I:P/>WENA=0/,9PBNV/X<F@!EEI&G:<VZSLH(&V[ 8T PO\
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M= >IH V],L(],TRWLHV+"),%R,%VZEC[DY)^M16VAZ597)N+73K:&8L6WI$
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MHNE3W,MS+IMG)/+'Y4DKP*6=,8VDXR1CC% '%+:Z?J7Q'T662&WN1+H<C.2
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MT&T@U+3[(:C;O(WGQ@.3N=F!#8!R V*Z)-+T^.^:^2QMEO&X:X$*B0_5L9H
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MB:5<:>NGS:99R62G*V[P*8U/LN,"D30])CBGB32[)8YU"2H(% D4  !ACD
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M%+6Y)('8D]^M=Y;Z/IEI=-=6^G6D-PQ):6.%58D]3D#/-)_8NE;YW_LRSW7
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:,.N?H:GHH @M;*UL8?)M+:&WBSG9%&$7/T%5CH6D,Q9M*L2QY)-NG^%:%%
M$+6=J]M]F:VA:WQCRB@*_ETIL%C:6T+0P6L$43?>2.,*I^H%6** **Z+I2%2
MNF62E#E2(%&T^W%3W-E:WJ!+NVAG53D"6,, ?QJ>B@#*N=%BN[BR1TBCL+*0
M3Q01K@-(,[21T 7.0!U.#QCF5-(MUUV35_+B%RT)A#)&%8J2I.YNK'Y%QZ 5
MH44 (0&!! (/!!I@MX0L2B*,"'F(;1\G!''IP2..QJ2B@"O+86<]PEQ+:023
MI]V1XP67Z'&140TC3 DB#3K3;(<N/(7#?7CFKM% %2;2]/N+-;.>PM9;53E8
M'A5D'T4C%++IMC/'%'-96TB1#$:O$I"#V!'%6J* *R:?917)N8[2W2<\&58P
M&_/&:6XL+.[='N;2"9T^ZTD88K],]*L44 5XK"S@N'N(K2".=_O2)& S?4]3
M3;73-/L97EM+&VMY)/OO%"J%OJ0.:M44 5VT^R>2:1[2W9YP%E8Q@F0#H&..
M1]::=,L&LFLC8VQM&^] 8EV'ZKC%6J* (8K2VAM!:16\4=L%VB%4 0#TQTQ3
M;/3[+3H3#8VEO:Q$[BD$812?7 %6** *UWIUC?E#>6=O<;/N^=$K[?ID<4DF
MF6$IB,EC;.80%C+1*=@'0#CBK5% %0:7IX,Q%A:@S K+^Y7]X#U#<<_C2QZ9
M81;/+L;9-D9B3;$HVH>JCC@>U6J* *0TC3! 8!IUIY);<8_(7:3ZXQUJW'&D
M4:QQHJ(HPJJ, #V%.HH J+I>GK?&]6PM1=GK.(5\P_\  L9I;S3;#41&+ZRM
MKKRSN3SXE?:?49'%6J*  # P.E4I]'TRYN6N9].M)9W0QM+) K,5(P5)(SC'
M:KM% %6ZTRPO;9+>[L;:X@3!6*6)75<=, C I9M.LKF...>SMY4B_P!6KQ*P
M3Z CBK-% %9=/LENA<K9VXN ,>:(QOQTZXS4YBC,HE*+Y@4J'QR <9&?3@?E
M3J* *MYIMAJ/E_;;*VN?+.Y//B5]I]1D<4LNGV4\Z3S6=O),F-LCQ*67Z$CB
MK-% %6\TVPU$1B^LK:Z$9W)Y\2OM/J,CBG7FGV6H0""]M(+F$$$1S1AU!'?!
M%6** (;>SMK3?]FMX8=YRWEH%W'ISCK3;JPL[XQ&[M(+@Q-OC\V,/L;U&1P:
ML44 5'TK3I(VC>PM61G,C*T*D%SU8C'4^M*NFV*W"W"V5N)E "R")=P X !Q
MFK5% %$Z+I1GEG.F61EE(:20P+N<@Y!)QR<\U)=:987TD4EW8VUP\1S&TT2N
M4/L2.*M44 5I-/LIKE;F6TMWG7&V5HP6&.F#C-3NBR(R.H9&!#*PR"/0TZB@
M"M:Z;8V+,UG96]N7^\88E3/UP*;%IMC:W,UY;6%K'=R@[Y4B57D_WF R:MT4
M <IX4\+OIBWLFJ6.GO=27\UU#-'^\90[%@,LH((SVKHY+&TFNDNI;6![B,%4
ME:,%U!Z@'J!5BB@"E_8^F;8E_LZTVPC$8\A<(,YXXXY]*FDL;2:ZCN9;6![B
M,$)*T8+J#U /45/10!5_LRP^S1VWV&V\B)@T<7E+M0^H&, T7.F6%Y<17%U8
MVT\T)S%)+$K,GT)&1^%6J* "JJZ;8)?-?)96RWC##7 B42$>A;&:M44 5+C3
M-/O+B.XN;&VGFCX226%69>_!(R*LNB21M'(JLC AE89!![$4ZB@! JA=H4;<
M8QCC%5+?2--M(9HK;3K2&*8YE2.%5#_[P Y_&KE% %9=-L4M)+1+*W6VD!#P
MB)0C9ZY7&#5A$6-%1%"HHPJ@8 'I2T4 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%1RSQ0@&65(PQP-S 9XS_(&@"2BH;:
MZM[VW6XM9XIX6SMDB<,IP<'!'N"*D26.7=Y;J^UBK;3G!'4'WH =1110 444
M4 %%(S*B,[L%51DDG  JI_:VF_\ 00M/^_R_XT 7**J_VG8;X$^VVVZ=BL(\
MU<R$=0O/)^E6J "BBB@ HHJHNJ:>]TUJE]:M<KUA$REQ^&<T 6Z*16#J&4@J
M1D$'@BEH **** "BBB@ HHHH **** "BBB@ HJ 7EJ;M[07,/VB-!(\6\;U0
M\!B.H'!YJ$ZQI@L&OCJ-H+-25,_G+Y8(."-V<=>* +M%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%017MK///!%<
MPR308\Z-'!:/.<;AVS@]?2@">BH;6[MKZV2YM)XKB"0926)PRMVX(X-34 %%
M%0W5W;6,/G7=Q%!%N"[Y7"KDG &3ZD@4 34444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 445!+>VL-S#;2W,*7$^1%$S@-)@$G:.IX!/X4
M3T444 %%%(2%4LQ  Y)/:@!:*J66J6&HF46-];7)B.)!#*K[#VS@\5;H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTN23[4WVIF:X9XBC2D[>23S@Y)SU% %N;QSJJZ9K=_%H,31:-=20W(:\P61
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MBVTU&Q6SU/38VAN85?>F<95U.!P1R*ZA=:D6^L-#L4C>]>Q%U(\I(2*,84'
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MPM;S(\S!'5HA'N5MN>,9Q@>F:Z#Q3H\NO^%M1TJ*5(Y;J QJ[@[0??VK8HH
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M=U(O:3IIRW'VEVD9&=I5 ^1=IX&.,GI^==//%Y]O+%G&]"N?3(Q4E(2 "2<
M=2: //D\*>(O^$,T71733?-TV[@DW"X?#I$V[.=G!/3&./4YP-.^\,7NJ^*=
M2NKI;=-.OM(.FMLF)D4EF);&W'\6.O:MVW\0:-=RB*WU:RFD) "1SJQ))P,
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MO.*M^&]'U+1M2UM9_LK6-Y?R7L4B.QDRX7Y2N,#&#SDY]JZ2B@#F]5TG4?\
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MY/2N^7.T;@ V.0#D4 +1110 5%=&86LIMC&)MIV&0$J#VR!SBI:1AN4CU&*
M/)[B_P!1U+X2:3J&H.D\T]]:R@KPS$W&3G/'T[5U\/B>\L_$.H:;K=O:Q)!I
M_P#:*2VSLX$08JRMD#)&.HK'C\&Z^G@6Q\.M+IK-97,3I()' 9(Y-^3\IY/
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M=K>Y:9F]AE%VY]>3CMGD &%K_B^_T."]O9[6VAM[:Z2&.VF;$UU&2@:5"#@
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MY6XM20O+%2A!)P01Z]^@KI:Y/3M"UF'QDNM7']FQ6[Z<EF]O;[R8RKLP"D@
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MVJU<*PCF3."",Y4YXZGKFG*BU)I?UK84:B:39T-%8%EKD^H:/I5Q;^3]IO)
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MKI]I':V=O%;V\8PD42!54>P%3T4 %%%% !1110 4444 %%%% !1110 4444
M%4-3T72]:B2/4]/MKQ$.4$\0?:?;/2K]% %6PTZRTNV%M86D%K #GRX8P@SZ
MX'>K5%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%(DN)W0'Y5;G '0<9R./>NXP/2C ]*GVL;6M_7W%>S=[W_K[SSDB'^SUM/\
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MTW(7'NJEP?JIKG?"5M<^*-"U+[7K5MIVJVFM&\GEEA+3JXP!SO'R]5 QV(H
M]M-W;*9 ;B(>6"7RX^4#J3Z4DM[:00+/-=0QQ/C;(\@"MGI@FO)O[#L-=^/'
MB*QOX?,M'TU&DB#%0YQ#UQCUS]0#VJ7Q.NC:5XG.E64Q$T.@R6_V>ZD'V:"$
M#(QNY:0X'&?<GM0!ZL]S!&BN\T:HWW69@ ?I1'<V\LSPQSQ/*@!=%<%ESTR.
MU>!7<AG_ &;K/S'WM'>;5W')4>:V![<5T>G6EOIGQNT6&QA2WCFT0-*L8QYA
MPY);U/RCD^E 'K+7=LERML]Q$L[C*Q%P&/T'6EENK>"2..:>*-Y#A%=P"Q]
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M;66%YHKF&2),AG1P0I'J17F]C\0?$VOZ1+J^@Z3ILUL)9HA#<3[)$VA2A)+
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M^6_MX-T<=Q*02P#$8R.H'0>P%;5 !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(S!5+,0% R2>U
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MI]S9_:EGA22&4;GV/(JY ##'WNI!H ZBBH;B[MK0*;FXBA#'"F1PN3Z#-34
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M+EEE,5@=2A6]DVA@D1#8+ \;=^S.:Z^HY[>&Z@>"XBCFAD&UXY%#*P]"#UH
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M9DB5BJ]P..GM4&K:#9ZO#:03V]N8K:59$W1 LFW& G]WIC([=/4 &HRJZE6
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M^@;&0* /)XIK6/X-Z'$\D2R)JB *2,J1=G/'; KK;".R7XJZV9$MP7L+5D+
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M72]/D#V6GVMNP!53%$J[0>H&!QGVIL>A:3%JC:I'IEFE^V=URL*B0YZ_-C-
M',^$8[2'Q?XM4) DPOXQ&, -@PJ>/R)_.KOQ'CCD^'FMF1%8I:NREAG!QU'O
M70)IUE'J$E^EG;K>2*$>X$8$C*.@+=2*6\L;34;<V][:P7,).3'/&'4_@>*
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MT^XGN+/2[.WFG!$LD4"JS@]02!S2#P_HHM)+4:/IXMI&WO#]F38S>I&,$^]
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MW)#/,P8LH8]"  5'0'T K;IJ(L:*B*%10 JJ, #T%.H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
M,US7;#P]IQO+^9(T+!$4L 78G  _SP,FM.N/^)H0>#'=PNU+NU)9NBCSTR:
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M3'+I=NTJ%1AR6?)([]JY+3K.TA^&'@J]C@B6Z_M6T)G"C?\ ZX@_-UZ<8]*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\E=R = #C(I&TG37OA?/I]HUX,?Z085,G'3YL9JY10 R2*.90LL:NH8, PR
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M?[&TLB$'3;/$/^J'D+\G^[QQ^%.ETG39[^._ET^TDO(_N7#PJ9%^C8R*N44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N5\,WS:SK'B'4Y
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M4,6M@ GSCF$F(R=-OS#C'45F6G@DI/KIL[=-)L]4T]K9K..3<GG,&!E"CA0
M0..O/ J&'0?$\R>%!<6NG0_V+(!(!<LWFJ(C'N!V<9Z@8/U% %'2-2U?1_\
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M\OEV>HVEQ)C.V&=7/Y U=KQY;"?7/ '@ZTT:PN/[5@:WE6]\AHTMU ^9O,(
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M=A<^7/-;I >(98W?:0<#NN3QSD^M='X<U7^W/#>FZIM"M=6Z2LHZ*Q'(_/-
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MG)W"6.)P48C^$'GW(!XK1U[QA?:%;7M]<64$5M:W*0I#-)MENT)0-)'VP-_
MP<[3R* .F@OM.6\_LJWN+87,$08VL;#=&@P!\HZ#D"I+*_M-2MOM%E<Q7$.Y
MDWQL&&0<$9]B*Y8[A\7Y3&JE_P#A'Q@,< GSSC)P<?E5*#QK=Q^%],U*#1K5
M?MFJFQ>".; C)F9,K\H#$X/7;R: .^HKEK7Q1>6^L:MI^LV<$365F+]'M)&D
M#1'<"#N ^8%?Q]JJ'QAJ:P>';I=/M)8M=($2&=D,!9-ZAF"MN^4'H!@_G0!V
ME%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %<[XPT"ZU[3K1M/GC@U"PNX[VU:4$H73/RMCG!!-
M=%4<\\5M"\T\J11(,L\C!54>I)Z4 <7=>&M:UW7GO=4BL;:UN-(ETV>*&X:1
MUWMDLI* 'I_^NK&B:5XL6SCT?6[C3GT^&/RC<VY?SKA , $$84XQDY/IWS70
MZ=K6F:MO^P7T%PR9W*C@LN#C)'4#(ZU8GO+:VE@BGGCCDN'\N%78 R-@G ]3
M@$T >?2>$?%'_"$-X35M,E@@DC^S7KS.K-&LJN R!#@@#J">G3O6Z='UNT\8
MW.K6:V+PZA:Q0W'FR,# \9;YE 7YQANF5^HK:OO$&C:9<""_U>PM)BH;RY[E
M$;'K@GI4B:QIDFGB_CU"U>S)VBX292A.<8# XSGCZT <'IW@GQ'HVD^';BRG
MT\ZOI$<L#Q.[^3<0R')4MC((/3C%;FM:%KNLZ!")9K+^TXKZ"\2$,P@41L#Y
M>[!;G!^;'4],5TUK>VM]&SVMQ',JMM8HP.T^A]#[5/0!R<_A[4K_ ,7+J5XM
MD;*329-/G2.9]^7<,2 4Q@8QU&>O'2J,7A/5Y?!R>$+U[5[!"L7VU9&WO;JX
M8#9MP'P OWL#KSTKL[:\MKQ)'MIXYECD:)S&P(5U."I]Q4=IJFGZ@[I9WMO<
M.@RPBD#$#IGCMD'GVH Y^UT'5;;7?$U\$L3#J<4*6ZB=P5\N,I\WR<9SGC-4
MK+POJ47AG3="U33]+U*R@M/(FB:9OOC[KH2G'&<]".,&NMEU73X;U;.6]MTN
M6P!$T@#$GIQ[]O6K= &1X9TB;1/#-EI=S<&XD@C*%R2>"20H)Y( (4>PKGO#
M6BR1>!=4\'R.([BW6YM59AUCE+F.3W!#?FI':NM.JZ>+X6)O;<71./)\P;LX
MSC'KCG'I3;Z\TW3Y(KB^GM[=R"J/*P4D=2 3VXR?IF@#E%\.>(9(/"BS+I@;
M1I%:4)<2?.HB\OCY.2<Y[8Z<]:CU'P5J>J7OB:5[BVMAJ3VLUG-%(SO#) !M
M+ J!@D=B:[I'61%=&#(PRK*<@CU%.H P="7Q/(ZOX@.G1")=H2Q9V\UO[S%@
M,#KA1GKUXK>HHH RM7AU9KFQGTIK<^2[&>*=V594*XQD X.<'.#TK&N/"\VN
M^(_[5U2W@M$2QELA'!*7>42<$LVT  #.!SR2>.E==10!Q_AO3/%VFPVNDW]U
MITFG6>U4NXM_GRQK]U2I&T'  )R>/?FL;PW::GJ?AGQ+I=M';)#>:I?0_:7D
M.8U9RK'9MY(!..>>^*](90RE3G!&.#BLG0(M$C@NO[$\KRA<.DXB8D><#\^<
M_P 6>I[T <U/X/U>*XU:ULGL9-/N],2QM9+EW\RT58BA55"X(8\DY'/8X J;
M3O#>NV^J^&+JX&G&/2K%[28).^6W*@RN4YQL[D=?:NVHH X'6/">OWY\46\<
MNGR1:M'BWN9W?S85"@>5M"X"Y!.0>Y."36C;Z%K<'BJQUG-@P_LQ;&Z3>XV%
M9-^4^7YNN.<>OM76T4 >?GP/JL^C7\,L]G!??VVVLV,D<C2(K[MP5\J#C&1Q
MGKGVK;;2-0U+7K#6K^WM89=-@E6V@2<N&DD #,S;1@ +@<'J3[5TM% 'GT/@
M[7(O >C:%G3C<V%Y'.[_ &A]C*DN_ _=YR>G2NQUJVNKW0KRTM5A^T7$#Q#S
M9"J LI&<A2>_I6A56YU&SL[FUMKBX2.:[<I C'F1@,D#\* ,_P )Z9>:+X7T
M_2[[R#-:0K"6@D+*V!C/*@BN5U7P?XCOM.\1V"RZ;)_:%V+F"[FD?S-@=66)
MAM^4+MP""?ISFN_N;F"SMI+BYFCA@C&YY)&"JH]233;.\M]0LX;NTE66WF0/
M'(O1E/0B@#D?%M@FMMH\$=_%#K45UY9-LV62-T(G7U \O)R>X7IFNSCC2&)(
MXU"H@"JH'  Z"J=OHVFVFI7&HV]C;Q7MSQ-.L8#O]3^ I+W6]+TZ80WNHVMO
M(5W;)90IV^IST'O0 [5KX:;I-U=D%FCC)1%&2[]%4#N2< #U-<IX>LM9\)Z?
MX6T.*.REM3$RWH9F\Y9#ER4QQM!)R3[=R*[")[2_2*YB:*X123'(I# $9!(/
MKU'YU/@;MV!G&,T 4M9TR'6M%O-,N!^ZNH6B8^F1U^HZ_A7)OX%NKBQT%[F]
M#:E;2'^T9Q_R\1.FV6/IR"%11[+ZUW55=0U&STFQDO;^X2WMH\;Y7. N2 /U
M(% &-JVCZC>>,-!U6W%K]ETY9Q())65V\Q0OR@*1QCN:P[WPAKEUHOBVR7^S
ME?6KGS86-P^(P55?F_=]?ESQZUW]% '%W.A>(K#Q&NNZ*=/>2ZM8[>^M+F5P
MA*9VNCA<\9(Y'_UK-WH6LW&O^'-1>6SF_LYIWN6:1D+&52N$7:>%SQD]!^-=
M710!SOA[1]0TW7->O+L6ODZC<K/$(969EP@7# J/3/!K)U?PQKU[J'B0126$
MEMJMGY$$UP[^9;#RRI0*!C:6.<@CKD@]*ZM-7TV2[^RI?6[3[B@C$@R6'5?J
M/3K5F:>* (99%7>P10>K,>P]30!R.E^'M<MO$&D:C<C3S'9Z4;&18YGW%B5.
M1E.1\OJ.M5CX3UMO"GB?2B-/$^KW=Q/$PN'*HLN.&_=YR,=AS[5W=1Q7$4S2
M+'(K-&VQU!Y4^A';UH Y2#P_JNF>(8=;LUM97GL4M+ZU:9E!*?=='V\]P00.
M*J7G@N_.EM/:R6S:LVLIK#([,(F93Q'NQG 7C..3S@9X[9YXDFCA:11+)G8G
M<@=3CT]_<50/B'2!I$VK'4(/L$+%))]WRJ0VT@_CQ0!S-QX<\0W>JZW?R#35
M.I:4+)8Q,^(W^?\ BV<@;NN!GT%2-X:UDV/A" +8;M%>-IR;A\/MB,?R_N_?
M/./2NP2YA>=H5D4RJH8IGG:>A^GO4M '.>&]&U+1M1UI9FM7L;R_EO8G1F\S
M+[?E88P,8/.3G/:JFK:'KMKXM_X2#P^]E(;BW6VO+6\=D5@I)5U90>1DC&.E
M==3)IHK>%YIY$CB0%G=S@*!W)H Y2Y\/:NFN:9XA@GM[C4H(9+>[A<F..6)S
MNPAP2NT],CGOBJ6M^#-1U72?$C1FS34];,*$/*WEPQQ8"C<%)8]2>!U]N>MT
M_6-/U1[B.RNDEDMV"S1\AXR>1N4\C/;UJ]0!RVI:-K-YXITS5H191):6D\+
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M6-HZ MYJQA=@[D'^'\,4 ;-%5=/U&SU6S6\L+F.YMG+*LL9RK$$@X/?D&K5
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MC8VVHW5JD4:N[&%3&&(>1L GEL'C@**6TT2R\1Z797WB31=.N-2,6UV>W##
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MW0;VU-L(M.G>:02R,&?<A3 PI]<T 8MA>ZO>:IXSAO+BWDM[7]RJ*C#:IAW
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MT. >3[<>G47/BAI;NWLK!=DTMDEZTDEM).$5R0B[8^<G#<Y&,=\UGCPMJ_\
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M1FNQKGO!FB7WA[P^NGW\UO+(LTL@: -C#NS]_P#>KH: "BBB@ HHHH ****
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M!QO=HXU5<]LL0,UMWNNZGHFKZ1;ZH+26UU.7[,LMO&R&"<C*@Y8[E.",\=*
M.HJE9:1I^G3336=G#!).=TK1J 9#ZMZGWKGK'Q1?+%XDAU1;:._TE_W<<,;8
MEC9<QO@MD[CQ@=",9I9M;\01>)K#0_)T[S;FP>X:4[\)(I4'C/(&[IGGU% '
M6T5YZ?%WB7_A&M8U(6VEB71+B:&Z!$A6X\O!.P9^3Y2.26Y[5MW7B>2>_2PT
M_P#=R_8TNWD>TEN0H<D(NV/']UB23Z8SG@ W)=+T^?48=0ELK>2]A4I%<-&"
MZ#T#=1U/YFK=<*WB_7ULM >71H;:ZO[TV<\-R73# ,0RY&0I"YR<GG&#2S>(
MM=%EXNL9GLHM1T>V6>*Y@B8HRO&SCY6;[PVD9SCH<=J .YHK%\(M=/X2TI[N
M9)I'M(6#*A4X,:]<L<GWX^E3>(=571M#N+O?&DO$<)E8*OF,0J9)Z#)&?09H
M OV]S!=(SP2I(JNT;%#G#*2&'U!!%2UYOX&NK/0_&&I^&;;4H[ZTNHUU"TE6
M82$O@+,I()Y)&['IFNFN-;O;CQ/=Z'IXMX9+6R6Y,EPC.'9R0H ##@;>3SUH
M Z*BO/X_'&M3^%] UB/3[$'5;^.U\II'^56)7.<=<J>>>"#@UIG7M8M[V/1[
MTV:ZF87N7EM;6:XC6/?MC^0?-DX.<G QWSP =;4<\$-U \%Q%'-"XP\<BAE8
M>A!ZUR%MXOU!K"QAO]-DL]4NKF6W :VE92L:[C*L8&\J1C ]3R>*JZAXPU_3
M?#GB"\ETR/S=,*-!<2P2PQ7,;=PC?,&4\$9_&@#J]-\/:-H\C2:;I5E:2.,,
M\$"H2/3('2M*N0NM=\0V?BBPTMX--:/4X97MB-X,#1A2=YS\XPW8+SQ[U#;>
M,[NWTS5?[3@@?4+'44T]?LRN$F9RFQ@O+#[_ "!D\'% ':T5QS>(]=M[O4(6
ML%N((K%KJ"\-I-;1AUZQ.'R<XY!!]JK6?BS7##X6O[RWL!8ZT8XFCBW^9&[Q
MEPP).-N0>,9'J: .TN[NWL+.6[NYDAMX5+R2.<!0.YJFOB'1WFLX4U&V>6]B
M,MLBN"9D SE0.M<YH#ZIJ?B+Q7:W]U:SV\5PL"QO;$J%,0*C!;&/FY!SGGD5
MMP^&-/A&EJL2;=.):$F-=VX@]\<#DG P,X[#% &M!/%=0K-!(LD;=&4Y!J2N
M2L+MK#XF:EHR_P#'O>6":DB]DD#F-\?[V%)]P3W-;VM75[9Z1//IUHMU=K@1
MQ,X5>2 222. "2?I0!?HKC[/Q5>SZGK6GH]C>-9V:75O<0JR1R9W J>6S@KU
M!JE9^,-<>P\,:K=VVGBQUB:*WDBBW^8C2*2'!)QC(Z8)]_0 [>ZN[>QM9+JZ
MF2&")=SR.<!1[TEE>6^H64%Y:2"6WG021. 0&4C(/-<M?ZS?ZUIOB0:8;5+7
M3_-M&\]&9II%3+@$,-H&=N<'G)^NAX%_Y$'P_P#]@^#_ - % &W/<16L1EFD
M")D#)[D\ #U)/ '>H8]3LY=4FTU)U-Y#&LLD6#E48D ^G8USWVQM1^)YL&.;
M?2]/$ZIZS2-MW?@@('^\:M6NM7TWC/5=&:"V$=M:13PN"VYRQ888]AQV'>@#
M2L];TV_M8;FVNTD@FE:&.3! 9P2I7GOD$>_:M"N6T"[D\9>!Y'U"&&)[DW$+
M+!D*NV1D!&><_*#GUYXJ?P)K,WB#P3I>HW)S<21%)6_O.C%"?Q*Y_&@#HN@R
M:I:=JUAJZ3OI]U'<+;S&"5DY"N "1GOU'2N<U"ZU8_$[3;&&\A2S.GS3")H2
M>0Z DD,,GT/;G@YKG[/5-8T73O&NIZ;%9-%9ZS<3RK<;B9 $C)5=I&TX[G/T
MH ]0IKHLD;(ZAD8$,K#((/8US5WXFDFU!+#3_P!W+]C2[>1[26Y"AR0B[8\?
MW6))/IUSQH>&M3OM6T2*YU+3Y+"\W,DL+J0,@XW+GG!'(S0!>L-.LM+M5M=/
MM(+6W4DB*&,(H)ZG JS7+:QKNLV_BVTT/3K:Q875I),DL[-\K(5'(';YN@Z^
MHK#N/'>MV?AO79+FPLAK&BW,<,Z*S>5(KE=CJ.O(;.">U 'HM%<K-KFM6.HV
M>EWL>G"]U.Y=;+R=[+'"B;W:0'&YATX(!R.E2V7B2:#Q'J&AZT;:.2VM1?1W
M4>8XW@)VDL&)VE2,'D@]>* .EHKE_$'BZWM?"VIZIH5YIVH3V,7F.BSAU4>^
MPY_E2/J?B>"W6XN+?2U@GFBVRJ[8M82I+O+N(#$$ #:1U]J .IHKSC5O%>J7
MO@;Q7+;SV\5UIDCP"YBB;;+&54AE!;*MANN2.,BNBGU#5[&/3HGDL8X)(F::
M_EC(1" -B!/,R6;)YSVZ<T =+16'X0UR7Q'X:MM2GB2*9VDC=4SMW([(2,\@
M';G!Z9K<H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ K)\2>'[7Q/HDVF7;.BN0T<J?>B<'*L/<&M:
MJ.J:SI^C112ZA<"%)9%B3*D[F8X P!ZF@#/LH_%$<"VUY+I<C*-IO4+AF]S%
MC&?^!X_E5>Z\.W=OXFMM?TN>-[A;3['<PW3D">/.Y6W '# ^QR#CBNFHH XG
M5/!5U>^']7M8Y[<:AJUVES<3-NV)L9"J*,9( 0#)QU)]JU+C1M0N/&.G:WFV
M6*UM9+=XM[%B7*DD';VV_C[5T5% 'E_BK1;[1O GB0W$MN3?ZM%>1F,L?++S
M1#:<@9QMZ]_:NNGT.\U76;34=0>&W:QAE2V6V<N1)(H5I"2!C & ,=SS6Q?:
M;8ZG"(;^SM[J('(2>,. ?7!JPB)%&L<:A44855& !0!P5IX+U^"S\/0/J&F[
MM'N3(K+"Y\Y2K*6;G[YW9QZY.:OIX8U,6GBJ$R6F=;9VC.]OW6Z,1\_+S@#/
M;TKL** .'UVWLH_ L?AB^O;8:NEI$EK%%*/-:5<+$Z*<-]]1].>:ZS2K :9I
M=O9AS(8DP\AZR.>68^Y))/UJ1["SDODOGM(&NXUV).8P9%7T#=0/:K% '.^*
MO#USK)TV]TZZCMM3TRX\^W>52T;9&&1@.<$=QS67/X4UW4-4U:^N-1L[5]0T
ML6.+9'+1,"Q#!B1_>]/RZUVU% '%V7A;6XM6\/7T]WIB#3+>2V>&"%PI1@HR
MN3U.WV ]ZC_X0:\FT/6-'FU&*."XO7O;.:&,^9#(T@D4MDX^4C''4>E=Q10!
MRT&AZ]JVEW5AXHO[*2*:W>W"V$;)OW#!=RQZXZ  #))YXQEMX4\33Z3HNFW.
MH:8R:3>03Q7 C<O*D6=NY<@ XQG!Y]1W[VB@!!G R03WQ7GR>"-?32;*P.I:
M>_V'55U".9X7+SD2%\R'/7YL<=<#D5Z%10!Q^M>%+W7XS;7_ -A?9=+-:WZ[
MEN+=0P8A1CKP1G<!R.#CGL*** .-M?">I:9I>JZ%8W-M_95\\K122;O-M5ES
MO4*!A\9)&2.O.:L7OABX%[X:.FFW2ST3.V.5FW2+Y?E@9 XP.<\YKJJKWU];
M:;937EY*(K>%2\CG.% [\4 6!G'/6N>@M/$5BEY#&^G7D4UQ-+"9V>,PJ[E@
MIPK;\9_V?3WJ^VO::EKIMRUQB'4G1+1O+;]X77<O;C('?%:5 '"MX!N=.T/0
MXM#U%(=4T=Y'BFFCS%+YI)D5E'123QCIC\:K>-+?6(_"$<NJ7=J]_+J-F%6W
M1A!%B48 !.3R<D]_;%>AU5OM,L-3C1+^RM[I$.Y5GB5P#ZC(H S(]'N;SQ);
M:SJ0@1[.!X;:&!RX!?&]RQ YPH &..>3GCGX? >I)X/@T4ZI!%<:==?:=-N8
MHCE7#LP,@)YR'(('ZUWBJJ(J(H55&  , "J&IZU8:0J?;)]KR'Y(T4L[<@9"
MCD@$C)]Z ,9])\2:CH&HVVK7FGF[N;5[6-+572% XP7;.2S>W &,=\U#-X9U
M.2U\+1"2TW:*Z/(2[?O=L9CP/EXR#GOZ>];YUS2QI<FIG4+<6,6?,G+@*A!P
M0?0YXQUSQ3='\0:1X@ADETF_ANUC;:_EGE#[@\B@#$F\*WEWJ7BF66>".WUR
MS6U4IEFAVHR!B, '._.,CI3[?PY?W=KHMGJSV@MM)>.5?L[,QG>-<(3D#8!U
MQ\V2!SZZ=KXIT*]U9M*MM4MI+X9_<JW)QUQV.,'./0U8OM:T[37*7=R$8)YC
M *6V)_>; .U?<X% '-6?AGQ'HVH7EOI.JV2:+>7#W&V>%FGMBYRXCP=IY)(W
M=/0]]*ST.]MO&EYK+/ ;6XM([8)O8R#820Q)'.=W3]3701R)+&LD;J\;@,K*
M<A@>A!K'U+Q;X?TC4$L-0U>UMKI\8CD?!&>F>RY]\4 ;5<\VC7Q\=IKP:W^S
M+8&R\O<V_!D#[^F.V,?K6S=WUK86XGN9ECC9@JGJ68] H'))[ <T6M_:WML;
MBWG5X@2K-TVD=00>01W!Y% &?<IXB_M63[+-IG]GN@"&5'\V)NYP#AQ[96J&
MHVVHZ!HNG6OA^2V+QS@21W*EFN Q);;MZ,6))/0<G@"MBQUG3M2D,=I=)*^S
MS%&"-Z9QO7/WE_VAD>]79)$AB>65U2- 69V. H'4D]A0 ZN.?3?&RZI<WL5Y
MH!,F5B\ZWF8Q1]E!#@>Y..3] !TECJ]CJ3,MI<!W50Y4J5.T]& (!*G!P1P<
M4TZWIHOOL9NT\_S!%CG:),9";NF['.W.?:@#-N-"NUU;3M;MYHI=3M[4VEQY
MN42XC.">0#M(<;AP>I'N*R^'=6T_1;]-*O+5-6U&Z:YN;F9&VJ6[( <\ !1S
MZGK7544 <UH]AXHM'2.\N=&%G#$PCALX)$+/CC<S,W'4G'.:HVVE>.(99G.I
M:#ON'S+.+64R!>P7+[?E!X&,=SDDD]G10 #I7+>'+$Z%XAUZPDXBO[LZE;,>
MC[P!(H]U9<X]&%=336C1]N]%;:=RY&<'U% '"R^"M6;PEK7AY+VS,%[/*\$A
M1@R*\F\[NN2.F!]<]JU[K0]0N_%&BZLYM5BL()H98P[$OY@4$@[>VW\<]JVM
M3U.ST>R:\OI?*@5E0OM+<LP4< $]2*MT <7H7AGQ'H2C1X=7M&\/QN3"S1-]
MJCC)SY8;.WVW<D#ICC':444 %<H="UB+QQ=>(8&L62:S6T6&1W! 5MV[(7K[
M8_&NKHH Y?6-%US6]%U>RN;BSC-Y;_9X$C+[(@<[F8XRS'([#I[G*7.@:E/J
M?AF\W6@&D!_,7>W[PM'Y?'R\8'/Z>]=310!YSXJT6\T_P_X[U*X>W,6IVZNB
MQL2T>R,)@Y'.0,^WO6]!HU[JYT&?4S;+;Z=MN$6%F8S2[-JL<@;0 Q.,GG'/
M'/0WEC::C;FWO;6&Y@)R8YD#J?P/%5[R[T[P[H[W,^RUL+91GRXSA 3@851Z
MGL* .9D\$3:A8^)['49H5@UFX%Q&\)):%@%"]0,X* ]O2KXT/4]4GTA]<DM&
M&F2_: ;<L?/F"E58@@; ,DX&><<\<]+D8SGCK5+3-8L-82Y;3[@3K;3M;RD*
M1MD !(Y'/##I0!S%Q::5XC\=:;J&FW\5P+6!OMOV:171PKAH5<CN) 6'^Z:U
M;K1;V;QM9:W&UO\ 9[>TDMC&S,';>5);ICC;TK8L["ST^-X[*T@MD=B[+#&$
M#,>I..]6* .*'A+5/^$=\3:8TMGOUFYGG5PS8B$H ((V\XQ[9]J6Y\,:];:A
MI^KZ+?64.H16265W!<JSP3HIRK9&&!!)_/'UW)_%6AVS2^?J,4:1,4DF8$1*
MPZJ9,;=W;&<YXK7!! (Z&@#EM1\/:M?/H<TEW;33V-[]LG9MR*YVLNQ!SM4!
MN,D].<DDTC>%[R?5O$\\TT"V^M6B6R["2T6U&3)X .=V?;'>NKHH RO#=A?:
M9H-G8ZA-;RRVT20AH%(7:JA1UY).,]NM-O;"^NM?T^X_T<V%IO?RV9MYD(VA
MNF. 6&.^[MBKEUJ=G97MG9W$NR>]=D@7:3O*KN/(&!P.]6Z .8\4^'K_ %;4
M=%U#3)K:WN],N#*)9MQW(1AH\ =&&,G/:L+6?MFK>,KM;"[T03V5K';S07QD
M1E+Y=@K(5+(05SD8X^M>B50OM#TG4Y4EO]+LKN1.%>>W5R/H2* .3_L_5O$6
MDZ;"L>DVYTG5(I@UJ[&WE6( @1_+P/F*GT*GK6EK_A_5Y]<L]?T&]MK?488#
M;3172LT,\1.[!V\@@Y((KIT1(HU2-51%&%51@ >@JK=ZI9V4R0S2GSG4N(HT
M:1]HZMM4$X]^E '.ZOX8UC4;*PO(]6BB\065P;B*81'R/F7:T>W)(0K@=<]3
MWI-6\/:_KWA+4=.U"]L?MU\BQ_N5=8(5!SD Y9F/<G';TYZF"[M[FT2Z@GCD
MMW7>LJL"I'KFG6]Q%=0+-"VZ-^5;!&X>HSV]^] '/WFBZC>>)]"U8FU1-.CF
M22/>Q+F15!P=O;;GW]JRY_!%Y?6OB"&XNXK=]1O$OK:: EFMY4"[<@@9^X/S
M-=E-=002PQRR!&F;;'NZ,WIGIGV[X/I3IYXK:%IIY%CC7JS'@4 <W!IGBFZT
MN[AUF^TZ2=[=X(5M4=$8L,>9(3DDXZ  #K[8J'PIJ?\ 8WA:Q$MGNT2:&1V+
M-B41H4P/EXR#GOBNF&JV1U2/3/-87DEO]I6(QL#Y>0N<D8')Z=?:KM '/:5H
M=]IGB?6+X7-NUCJ,B3>7L/F*X0)C.<8XS70U#'=02W$MNL@\Z( NAX(!Z'!Z
M@\\].#Z5*0&4JP!!X(/>@#F--L6OO'NH^(,?Z/#:)IMNW:3#EY&'L&(7/JI]
M*N^+-&N=?\/S6%G<I!,SHX,@)1]K!MC@<E3C!K:551 B*%51@ #  I: ./3P
MWKG]OWVJR76GDWFG+:-"D;J%8%L8.3Q\W7'.,8%0#PCJB^&_#.EB:S+Z-=0S
MM(6;$HC!  &WC.??&.]=%JGB32=&W_;[HQ",*96$3NL08X4N5!" GNV*U 0P
M!!!!Y!% '&)X6UG3KO78M+N[(Z;K#R7#I<J^^"9UPY7'# ]><8_GO>&=+N-%
M\-:?IEU-%-+:0+#OB4J"%&!U)]/_ *U:U4;+6=/U"^O;*TN1+<615;A I^0L
M"1R1@\ ]* ,2>R.F?$./63Q::A9"RD;LDRMN3/H&!9?J .XJQ;Z-?0>,]0UO
M=;-#<VD=ND6]@P*%B"3C'.[\/>M]T25&21%=&&"K#((IU '*:)977@[P=-;W
M317$T3S21"#),KR.S*@!'7<VT5?\':&WASPCINE2,&F@BS*1TWL2S8]LDUM-
M&C.KLBED^Z2.1]*S)O$FD6]^]A->JEVB[VA*MO"YQNQCI[]* *>IZ'?3^+=.
MUNQN;=/(MY+:9)D)RC,K97!ZY7O67_PB6J'0?%&G&6SW:U<33*X9L1"10I!^
M7G&WVSGM74V.JV.IF5;.Y65H2!(HR"A/(R#5R@#B[KPQKMMJ%AK&B7UE#J$5
MDEE=P7*L\$Z*<JV1A@02?SQ]>ITZ"ZM[-1>W(N+IB6E=5VID]E7)PHZ#GW/)
M-6Z* .)ULW0^*6A&T6%Y!IUSE)6*AAN3N <'OT/2C5?!=YJ.A:Y L]LNHZS<
M1S3RMNV1+&5V(O&6P$ R<9))]JW+=_#^J:_=&&&TGU73]@FE, \R+=G:-Y'L
M>AK:H YW7] NM6ETC4[:6&WU;3)3+%NRT;AAM="< X([XX]*DM-!:;7;K6M4
M2W:XGM%LE@C)>-(0Q8@E@-Q8GG@< "MZB@#G?$'A>&_\,ZCI6E6UE9R7T?E-
M(L80 >IVCG'I[U%K6A:KJ-KHCV]Q:)=:=.LTD,NYH9L*5YQSD9R..#^==/10
M!P[^"M2N;#Q59W.HVI36CYB-'"P*/L5><D_+\O3D\]:M/H'B!M9TG5?MVGM-
M;6SV\L+Q.8TW$?/&,YW<8YQD<<5UU% '/^#]"O/#NC-I]W<PW 6>62-HD*G:
M[L_S9/7YNW3WKH*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *X_XEEAX5B**&<:A:;03@$^<O?M
M785C>*-#?Q#HILHKA;>59HIXW9-Z[D<, 1D<'&.M &*?$FL:'XF33_$(L7L[
MNVFN+>XM$93&8AN=&#$Y^7D'CZ>D-UXMU6R\(VGBZ2.V;3I/+EFLUC;S(X)"
M "'W8+ ,"1MP>>G6MD^'Y-4U./4-;,#M#;26T5O!G8HDP)&)/))  Z# SUS6
M9!X-O?\ A&4\+7=[#/H\;J!+M(F>%7#",CIV"[AV[ \T /.L^(;[Q3K&C6#Z
M;$EK;PSP3RQ.Y^?=PP##/W>N1CT-5;+QIJ-[I/A'4!#:HNL7 M[F,HQ*G:Y)
M0[N.4Z$'K6S;:)?6OBS5-:26V9+RWBA2$A@4\O=@D]\[CQBL:#P1J-IX4T+3
MH+^U^W:-=BX@E>-O+E'S95AG(X<]#VH MS>*-3M[_P 6VXM8;K^R+>&:V2&-
M@\F]&8AOF.<;1TQWJ]X9UPZZ9+BVU.QU"P\M2KP1F.1),G<KJ6)'&,<#O5*W
M\,ZW;ZMK>IKJ]LMSJ44"KMMCB-XP<'[WW>2,')/J*N:7X<-KXGNM>ECMK>XN
M+9;>2*USMD(;<9&R!EN@'' SR>P!T5<KK6M:U;^+=/T73DL=E[:S2B6=6)1D
MV\D C(^;IW]1755Q.OFY'Q/\.&T,)E%E=DI*2 PRG&1G'UP>G2@!NG^*-?EL
M];L+BTLFUK2;F**616V0&*3!$Q#,#PF6*Y[58TWQ#JNIZAK^EV<ME/<644,M
MG<M ZQR^8&.&&[D97[RG&#[<LU'P5=7ME?3)?11ZK>7T-[(QC+0GRL!(BN<E
M %&?4\^U6+72[K0M?U/Q)JVKV2VMS;1+<#RC&J&/<!ABQPOS=\DGTZ4 1Z7X
MGO\ 5_#FCSP&U35+RX\BXB:%ML+)GSAMWY&T*<$GD[?6JK^(/$MQ)XHBM6TR
M)M'<>6TD+OYB^4)-I&X8)SC=^E6O#&F6$OB76M?T^?S;*YD"P;&S$7*KYTB8
MX(8J@)]4:I8/#>H0S>)I?M%L3K)R@PW[D^6(^?[W SVYH H1^*M:\OPQJDR6
M(T[6I8H&MD1C+$9(RP;S,X/(Z;?Q/6I+[Q1J]S!J5QH=N)FLKE[>.V:SD?[0
M8SM<>8"%4YW =>@)ZX#W\):B=#\,Z<MU:YT2>&8N5;]]Y:E0,?PY!]Z6/POK
MVEZU?RZ)K-O!INHSFXF@N+<R/#(WWVC.0.>O/ ]#0 K:[K]WXL;1;5+*U5]+
M2]5[B)W>(L^TJRAAN(QTR.O4XP<._P#$>LZOX/T"]6>"TN)M:BM+I4B+*Y6<
MKQ\P(7*9(ZGID=^IBT"\@\8-K23PO"-.6Q6)RQ<[6+!BW<Y.#Q[UDIX(U!/"
ML&EB_MA=6NIC48)?*8H6\TR;67.<<D<&@#MHA((4$SH\H W,BE03[ DX_,U!
MJ33KIETUK*L4ZQ,4=TWA3CKC(S^=30+*L""=UDE ^=E7:">^!DX'XFEFC$T$
MD3$@.I4D>XH X#P]XAU"S\%^&5FG@N;_ %ATB@9XV&S(+.[_ #?/@ ]-N21T
MZUK/KFJ6OB*Y\/74EMY\MBUW8WB0D#Y3AE="W)'!!! (JE!X%OD\,Z5I\FIP
M?;M'F26PN(X"%&W/#@MD[@<'!';\=N#0IKC7&UG4VA^TBT-I%'!DK&K'+-D\
MDD@=A@#OF@#G_#.IZXGP\T:^,]I,URR-/<SC8+>-BQ>1\O\ .<^F.O2I%U^X
MUCPUXRM;GRW;3XIHDFCC:,2HT.X$JQ)!Y^AZBFP>"=9M?#VBZ?'JUHTNCW2R
MP!K=O+D1=P <;LEOFSD="/QJW%X3U2/_ (2;?J5K)_;28'[@KY;F,1D_>/
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M99"!G;@$')Z#FM%00H#-N(')]:6@#A_^$SN3?>$W2:R.GZW'^\;R'WQR%05
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MD+H4PO)V@ ]3G)]*BMO#.H:3/K$6E7=NMCJ<KW&V9&+6TKC#E<<,#U .,>M
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M,T1:*XB( *NN<CH#P>/Y=9I-M?V]LS:G=I<WDAW.8D*1IQPJ*22![DDDD_0
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MO%7@R6WO%M[>_LYKGR#%O56$:')Y&>)"!Z5WU &3?>)=(TVXF@NKO9) @DE
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MH][-;Y,#;+E8P&X4-E6*MZGD>] '=T5SUGK<FK3Z*=-N(GM[FV-W<.T>3Y>
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M6#Q;H]T\Z6TEW,UO(89A%8SMY;CJIPG!]J *K^'+Z77="U)[ZW_XE<$D+1B
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6'XGUQ]%MK%(
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MP,$Y.3SZ#BK$7AF[AU/Q#>C482=81%VFU/[G:FP?Q_-Q].: *,7BR\O;3P>
MJVS:ZA::<#(B(BW[5SQECP,YX!X-7/"VJ:MJ.HZU;WTMO);Z?=M:Q/' 5:3
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M@6.",\ D+P. .*UIM4\4V*ZTS0;K."P:ZM;RZB0$2*#F)E1QD$<@\8[YI/\
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MM7A@.C [L]/H.E;%8V@>'XM#?494,?F7]Q]HD2&/9&AVA<*N3Z9)[DGZ5LT
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M5:L([G5"\8E(SY:)N=R >"V  ,\<YYQB@#TRBN/_ +3UB+Q1?>&#>AY9=/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *S-=TRXU?3_ +'#=I;([J9=T/F>8H()3[PX.,'V)K3HH RO$.C?\)!X
M=N](EE2,74?EO(8]V/<#(Y!Y'/'O7(^)T?3--T'1M2\0"W"N2=1GM%:!PB85
M)58E2Q+ C) ^7/4"NWCU6REUB;2DG4WL,*SO%W",2 ?T_4>M6RH8$, 0>H-
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M_-QZT ;E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4450UG
M5[70M*GU*\$QMX%+/Y41<X'L.GU/% %^BHK:X2[M(;F,$)*BR*&ZX(R,U+0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %<_X[_Y$'Q!_P!@^;_T
M UT%9^MZ5'KFCW6F33S0PW,9BD:';N*D8(&01^E #M%_Y 6G_P#7M'_Z"*O5
M6L+3[!806@FDF$*! \F-Q &!G  _2K- !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
=44 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex101slackseveranceagm05002.jpg
<TEXT>
begin 644 ex101slackseveranceagm05002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JI<Z7I]Y<Q7-U86L\\7^KEEA5F3Z$C(JW10 4444 %%%% !1110 =:9%
M%'!"D,,:1Q(H5$10 H'0 #H*?10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5S]CJ#Z]K.J10S2166G2?908C@R3[07)/HH90!ZY)S@8Z"N/
M\!PO:3^*;.;B9=<GF(/4I(%=#^(/Z4 9W@KQOIT7AK2+;6-5D?4+AY(S-,KL
M"YD;:K28V@XQ@$CC'M71W.I/I/BFQL9I&>TU42"'<<F*9!N*Y_NLN2!V*\=<
M#A;6T.H?"9?"BP2#67E:(V[Q,K0MYY;S&R.%"_-NZ'H,DXKI_%T#W7B3P=:Q
M9,JZ@UPQ]$CC.XG\P/Q% '8T444 %%%% %>_BGN-.N8;6;R+B2)DBEQGRV((
M#?@>:XG4(]0M/'NAZ,FNZF;6[MIY)MSIN+(!CG;QUKOJX;6I5_X6QX=EPQBA
MM;E)9 I*(S ;0S= 3CO0!'KCWWA_5O#8N-;NY+:349%D,C@;X_+9@'V@;B",
M#Z#O74:?XDTK4[:\N+>Y*I9,5N1/&T+0X&?F5P"!CG-8?C%A_P )'X2.&*Q:
M@TDA"DA%\M@&8]AD@9-<_JUI>:C??$"'3HW>>9;*2W4 J)_+4%U4]^FWCN:
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M@GA>)]AX# ,!D9XR.]8_B37+M?$.D>&M,E$%WJ&^6:YVAC! @R2H/&XG@9!
M]*B\-W6AZUJJZGI=A?&>. Q27=XLRF($@^4#)U.<DXR!CKR,U_%=C=:=XRT7
MQ;;VTUU;VL;VM[%"A>18FSAU4<G!)R!SB@#9O-%OH8H7TO5+U94GB:5)I?,$
MT8<%U^;.TE<_=Q5F^\1Z9ISW"SS2'[, UPT4#R+"",Y<J"%XYY[<]*2W\0V-
M^$737-Y(Q'RHK (.Y<D?+CWY] 37,Z'<KH-_XIT[6DD#75_+>6[&,L+J*10
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M4(8I;6Y>6WF5XT<!5V-M/!/+>X[XK=G\5Z3; R2S2"U6;R&N_*8PK)G;@OC
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MMT4 <+;:E:VGQ3UF2=G5)-,MBK^6Q'WGX.!P3V'?%8<^D76G>!X4-G<AKKQ
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MX@>:.+[*Y9D^THV1@$$ *W()Z5UEXY?XGZ1<K#.8%TV:-IA"^Q69D*@MC )
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M#)<V4\$4[V\DD;(LT8!:,D8##/&1UJEHND-I-LXFO9[Z[E(,UU. &? P!@
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M &&& /!&,]/2M^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "LS7->L/#MB+S47D2 NL>Y8V8 L<
M#) P!D]3BM.N2^(T4UQX3,%O;7%S*UU;L(X(6D;"RJS'"@]@: -.W\46-S&Q
MC@O1+Y[01P26S1R2LH#$J&Q\N#G<<"JLGCG1H=,EOY#<K%!<_9;A3"=\$N0
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M=E"_GQQ7[[+2Y>,B*=L9 5O<=,@ ]LUJWEY!86KW-S)LB3&3@GDG   Y))(
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M62?[,+SR_P!SYF=NTM]1C.,9[UDW337'Q(T2\6RO5MQI\Z/(UL^U&=D*ACC
M) /4\=\5@>'X$M=/7PQK'A*XNM2MY&1+A[7?;3KN)64R'@ #!/?CCGB@#L=>
MUNU2RU.TC%Y)+;VY:X>T!!M\J2I+ @Y[X7)QSC!I/ DTMQX#T.::1Y)7LXV9
MW8EF..I)ZUSUC-=Z#J/BO3;[3[Z4ZA<RWEG<06SRI*KH!L+*"%*[0/FP*W_
M4<T/@71H+BWFMYH;9(WCF0HP('H: &Z/XL34]2UJ&:UFM;?3IO+,LJ[5 5 S
M,QSQUX]JMQ>*=/DNK*&1;B 7_P#QYRS1%4GXS@'L2.0&P3VKD+G2-1OD\>:+
M':W,5QJ,IFMIFC(B=3$H W].2NTCKSTZU:OEG\5:-X<L8[&[MKRVO;>XNA-;
MO&+;RN7^8C!]!@G.<],T =S=W=O86DUW=2K#;PH7DD<X"J.IKBM1U9KGXB^$
MDC74;9)A=,T4VY(Y5$)*G;G&02>" PSR.E:OQ TV_P!6\%WUMIL?FW0,<JPY
MQYH1U8K^(%8UUJCZWXN\(:A;:7JB0P-<_:/.LI$\DO%M ;('?C(X]Z .CN_%
MFF6<<T\AG-E;R^3/>)&3%$^<$$]< \$@$ ]2,&H/$&IG0;C3]564M97-S':W
M2;LJ _"2#T(; ..H)]!7+Z9;WNG_  _U?PC>6%W+J0%U! 1 S)<B4L4</C:!
ME^<D8QS5SQAI,T7P[T?PZ'\V[DFLK-''\3*5+-] $8_04 =_15&WU,7&K7FG
MBTNXS:JC&>2+$4FX$X1NY&.?2KU !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5U.#1]*N=1N5E:"VC:201)N;:!DG'TJ6QNX[^PMKR(,([B)94##D!@",^_-
M$]%%% !137=8T9W8*BC+,QP /4UFW&O6MMX@LM%D2?[3>)))$P3Y,(,M\WKR
M.F>M &I1110 44U'61 Z,&4C(93D&AG52H9@"QPH)ZG&<#\ ?RH =167I6O6
MNL7>HVUNDZR6$PAF\U-N6*AN.^,$=<5J4 %%%-9U4J&8 L<*">IQG _ '\J
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M%%% !167?:]:Z?K.FZ5,DYGU!G6%E3Y 54L<M]![UJ4 %%%% !1110 4444
M%%-=UC4L[!5'<G IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:^&Y/,TXZEJ+WZZ:=UL&B"'?M*AW(^\P!(!&!R3C- './X@UA?!7B^]&H/\
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M*$ZG!PWN: )K+Q-K4&A7%Q<W)NGFUG^R[*41(N]/,V^:.BDD9QVR/2N@T?\
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M0++7]-U*.!I[@O\ 9944P^0'*E"0I;=M&<YZ^@KLE&U0N2<#&3U-<GI_@?\
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M2!R".QR 1^%<NNI^*G^';>*T\0.US923.ULUO&(YXTF92'P,YP.,8Q@<9YH
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M4D$R?#OP&5NY'DDU#3F0RJ"(R5X   R![G/O0!ZL>!533+YM2TZ&[:SN;-I
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M@>P;2-7TR[N+BZM]3NGNY-VU6CE8@Y0@#&" 1UZ5T](QPI(!8@=!U- &-;:
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M-J$>H1ZQ=1W:VX@8[$*2@,6RZ8Z\]L?J:B3PN%BU.3^T;G^T-24)/>JJAU4
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MJ(R7EU-)NFF!4KRW0  \   >E4;7P,L$VBS2:WJ,TFD!DMRWEC]V5V[#A?0
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MUOHOFV+&>@(!4XX.1SG-:^B^![70YT$&J:G-80OOM[":<-#"<Y&!C) /(!)
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M+_TB,<@.K*5)'8@"@#/^&:/'X7N$>0RNNI78:1@ 6/FMR<<<UK^,?^1'U_\
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M#4+FUD6(Q%(PC(ZYSR&4\CL1[U+I&E6NB:5;Z=9J5@@!"[CDDDDDGW))/XT
M9WB2XEB?38TOS;QRW.V2&)29KD;6(2/'(YP2>, 'D5Q5WKVMIX%\27$>H74%
MSINL_98&D",_E%XAL<\YP)#R#G@<UW6M^'8=:N=/N_MEU9W=A(TD$]L5W#<-
MK AE(((]JRIOA[I\UAJED=2U-;?4KE;J91*I(<%3D%E/4HIYSTXP,T 0WTFI
M:3K.G:,-3NKUM5EGG+2ND;(L:*3&C!> 2<^N 0/6M7PU;ZY:/J$&KSI-!YH>
MR)EWRK&1RKG S@C@\G\J?K_A>U\165M%=7-U%<VCB6WO8'"31OTR"!CGN,8J
MWH^D+I-NRM>75[/(09+FZ<,[XZ#@  #L  .3W)- $VJ1&?2[F,2R1$QD[XSA
MACFO.=!U&XT;X>>$8+>ZF635YX+3S&P1 IW%M@(QD@8&<]<]J]+NX#=6DL E
MDA\Q2OF1XW+GTR"/TK 7P3IP\+6_A^2XNY;:U*M;3,RB6!E.59651R/<4 5'
MN;_2_'-MHBWUQ)8:G9RR1ER'DMI8\9(9@<J01PV>?RJCX*AU;6_"EEK.H>(+
MYWGMY4>% BKD2'#?=SGC'T..*Z>WT(1WC7\][<7-_P"1]G2X=4!B0G)VJ%VY
M) ))!Z#MQ3=%\.1:%X=71;2]NS @98Y)"AD0$DG!VXZD]0: .'\-7]SH_P -
M?"RVT\IEU2>*T!=P!$#O8[<C@G;CG/)K=:#Q)I\6NO)?&*Q-FTUF6F$T\,JC
MG!9>5/'7.*NCP+IA\(Q^&II[N:SAP8)&=1+"P)*LK*HY!/I4]IX56#3;NUN-
M7U*]FN83 UU<2*TB(>H7Y=H]SC)[]!@ Y*Y:YU.S^&]U<7UUYUR8VE9'QN8V
M[,6QC[V>_N?6M2:YUG7Y]?MM,N)()=/F^RVKK<!-KB-6WNNT[@6;OQ@<#.36
MK)X-M&TG1[!+^^C.D.K6EPC)YBA5*@'Y=I&TXZ5'>^![6?6GU6SU34]-N)D5
M+K[). +@*, MD'YL<;AS0!4L]2U+5?$L.@W]P('M-,2YO#9N5\Z9FVX5NH08
M)XQR1GIR?#F)X;/Q!%),\SIKETID?&Y\%>3CC-:-[X0M)]2LM1L;NZTV]M(?
MLRRVQ4[X?[C!PP8=^1G-6M \.P>'UO1!=74_VRY>ZD\]@<.W7& /04 /\2SS
M6WAR^FM[^"PF6/Y;J==RQ\@9QW/H.><<&N;L=3U-?%VI:7:O=>2VD"[MH]0(
M)$N]E#==P4X&0V",=!73Z]HEMXBT6XTN[:5(9MIWQ-M=65@RD'U! -9?_"%6
M[ZC)?SZKJ<UU+8M8RN\JCS$))S@* ",\8P/4'G(!G>$M=^W:PEC>3ZC9ZK#:
M-]JTZ_\ ^6CY7][&>A7AA\O'/05VQ.U23VYK(MO#Z1ZE:ZA=7EQ>W-I"\,#S
M! 55L;B=JC).T<_IR:V* /.4UC5-3^&\_C*VU"6&]19KN.'(,(CC=OW13OE5
MY/7)X(Z5)K&=6\5>!;T3W-O]L6>38C@>7FWW<<=><&MU/!5E%;7=A%=W4>E7
M<AEEL%*^7ECEE4[=RJW< ]SC&:N:CX<AU'5],U(WEU!)II<V\<.P(-R[6R"I
M)XXZT ;"C:H&2<#&3U-<4;9W^,3_ .EW(4:,LH02?*#YY!7&.AP,UVU8]WX=
M@N?$<.N+=W=O=1V_V9EA90LL>[< P()X;G@CT/% 'G(FU'2_ _B/7+'5+BWE
ML-9NI(X(POEO^_P0^02V03W%=?>7U_J_B75=(M7EBCL8(2##<")]\@8[R<'(
M&  .G7.>,2OX$LI/#NHZ(^HZ@UKJ$[7$S9CW[F;<V#LX!/M4FJ^#(-2U.WU2
M'5-1L-2CB$#W5I(JM-'G.'&W:?R_I0!I>'1JRZ#:IKDD$NIHI6>2 Y1B"0#T
M'.,9XZYK4JO96<5A9QVT)<H@^\[%F8DY+,3U))))]35B@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFMUF4(XP 3GU).0 >]=*?MNG_$*TT]M4O+BVU&PG>6.5QA'1EPR  ;>&(P*
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M201U'''/04 =M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,&JA\'V(;4$@NKRWL]1<R7=G$ZB*1F&&/*EEW#KM(K?DD2*-I)&"H@+,S'
M'4FDAFCN((YHFW1R*'5O4$9!H $ACCA6%$58E4(J 8  &,5RD7P[TN&RL[-;
M[5/L]C="YM$^T\0$9^5>.GS'KDCL17744 8,?A6VBGUB9;V]WZLH6X)9#C"[
M!M^7CY>._P"?-9NH1Q:3HD7@^TT[4=0%Q9M;P2/"&A1<; )'&  !SZX'KBNP
MHH JZ;I\&E:7:Z?;+M@MHEB0>P&/SK*U_P )6.OW=K>O<WMC?VH*Q7=C+Y<@
M4]5)P01[$5OT4 <Y?^"]-U#3;2U:>]BGM)?/AOHY_P#2%D/5MY!R3WR,?D*Q
M]#TU(_'/B2TG6\N+:YLK>$SW*N?/(#AQOP 3\PZ<>E=W10!RD'@&PABTR-]2
MU69=,E$EIYEP/W8"E0G"CY0#]>G.*T8?#%G'J.KWC3W,K:LBQW4;LNPJJE1C
M"@C"DCK6U47VF'[7]E\Q?/\ +\S9WVYQG\Z .:;R/!VE6>CV]EJ^K+,K0P@)
MYP4*H"H[<!%QP"1V.:U?#>BQ>'O#MEI<*JH@C ;;T+GEB/Q)K5JCK.H-I.C7
MFH+;M<?9H6F,:L%+!02>3["@"#6=!@UQ[%I[BXB^Q7*W40A*C]XN<$Y4YZGC
MWJ*+PW##JNJ:C'>WBSZDB)-RF $!"[1MXP"?SYJ]I-]_:FC6.H>7Y?VJWCGV
M;L[=RAL9[XS5R@#.T/1X- T>WTNUEFDM[==L9F(+!?3( JFWA6T_M+4[Z*ZO
M87U)0)XXY!LW!=FX @\[>.<COC/-;M% '-_\(99?V9I&GB]OA!I,R36N&3(9
M 0N3LY !-,NO NG3ZW/JD%[J=D]U@W<%I<F.*X(XRX SG'<$5K7&HS/ID%[I
M-JNHB9HRH641@QL1EP3UP#G'>M&@!J(D4:QQJ%10%50,  =JP(?"4%A>7$^D
MZC?:8EPYDEM[<QM$SGJP61&VD_[.*Z&B@#(O_#6G:GI$FFW:R2)(XE:8N?-\
MP8(<-V88&.P QC'%.M="C@O/MLUY=7=ZL)@CN)]FZ-"<G:%4+DD DXYP.U:M
M% '+GP-IY\,2>'C>WWV&27S6^=-^=_F==G3=S_\ 6J_/H4!UNVUR:]NS<6<#
M1*/DVE&P6R N3G Z?A6S534;B\MHHFLK'[8[3(CIYHCV(3\SY/7 YQWH X?P
M-X?%_P"#([34I+](3=3236$T8C1OWS,H(*AMI&TXS@_B1707O@O3KW4-3NVN
M;Z(:G"(KR"&?;'+A=@8C&00..#@]P:L#7V_X3%_#YLF&+ WJS^8/F&\)M"_4
MGDGM3O#>O'7[6]E:T-JUK>RVC(9 ^3&<$Y ]: *]OX/L[:YT>=+V_9])B:*W
MWR*V58!6W97G(4#MC'&*C:WM?!L5_J:)JM^;^Z$DT4$0F;>V%W!5 (& !72T
M4 87A?28].M;RZ^R"UGU*ZDO)8NZ[C\H/O@ D=,EJNZUHMEK^FO87R,T3$.K
M(VUXW!RK*>Q!K0HH R;;0DAN_MDU[=75Z(3!'<S^7NC0G)VA5"Y) ))!S@=J
M=X?T*W\.:2FFVD]Q+;QLS()RI*[B6/( [DGFM2JFIW%W:Z=--867VVZ09CM_
M-$?F'/3<>!0!1U+PU:ZEK-KJWVF\M;NWC:'?;2[/,C8@E&X/&1GC!]ZSD\ Z
M9%ID6GQ7FH+;PWOVV,><K;9 Q< 94\!B3ZGN374C) )&#W%+0!@W.E0:;JMU
MXG:2_N;E+/R6@B56WQJ2P55"@ELDGKWJ#P_:1:AK5[XH.G36<EW#';QK<1[)
M2BY)9E[$D@8/9!ZUTM% %+5]*M=<TBZTR]5FMKF,HX4X./4'UK*MO!UI;ZI9
M:DVHZG/>6D+0"2:XSYB$@X8  <$#IC/?-=%44-S#</,L,BNT,GER8_A; ./R
M84 9>E>'8M'DU"2VOKQFOYVN)?,*'$C  L/EXX XZ<=*JV_@VRMO#%SX>2]O
MC8W </N9"X#DEP#M[DG\^*Z&1TBC:21@J*"S,QP !U)I(9H[B".:)MT<BAT;
MU!&0: ,6;PM;3G1R][>!M).;<@IR=NW+?+S\O'_UZ;-X0L+F[UBXN)KF4:O"
M(+J-F4*44$+MPH(P">];]% '-6O@JRMKW2[QM0U2>XTY&CB>6XSN0@?*P  Q
M\HZ8SWS3E\$Z1]BU2QE^T3V6I2/++;22Y1&=MS% ,8^8 ]\'IBK/B77V\/65
MO<BS:Y66YBMSB0+LWL%![YZU?%Q>'5VMC8XLA '%WYHYDW8*;.O3G/2@#&L/
M!EI96-S:R:GJMZ)K=[99+NYWM#&PP0G  [<X)X%78/#\27J7MQ>7=W=16[6\
M4LQ0-&C8+8VJ.3M')ST^N=>B@"GI6GC2M,M[%;FYN1"NT374F^1^>K-WJY11
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;3M%AUME(8E2">G0\>U:%KK%]K-]H&FRLK_:=#2_D4W+V_G2-M!^9 2<<G'
M^;/85T:^%=/4:J!)<_\ $U_X^_WOW_EV\?W?EXXQ5>^\#Z-?Z=IUG(+E#IJA
M;.XBG9)H5QC <<XP .?2@"SX6LM1T[39K/4M06]DBN'\MMY=HXSAE1V/+, >
MIZC%<Y,6B^.ELUT<13:(R69/0N),L![XR?I79Z;IMMI5DEK;!]BDDM(Y=W8]
M69CDDGU-0:QH.GZ[#$E]$Q>!_,@FC<I)"_\ >5A@@T 7Y3$$'G;-NY<;\8W9
M&W\<XQ[UY_93W/B3PCKFLM?7=MJ$-Q<BW,4[(+;RB=B[0=IX +9!SD^V.QL]
M&CMI$DEN[N\DC_U;7,N[9VR  !GW(SR>>:J2>$]->XOI$-Q#%?G=>6\4I6.=
MB,$D=B1P=I&>^: .4M+Z^UW7?"4MS>7ENFIZ1+-<P03-&I8"/D =,[CR.>>#
M5,6UR_A3QD6U?5<Z)=70L&%XX:/9&)%W,#E^3CYB>*[^7P_92ZQ9ZI^]2XLX
MS% $?"(AQE=O3!P/RJLOA+3ELM4M!)=&'5'9[L&7_6%AACGMD#'&* .:E:\U
M?Q3X<@EU2^A@O]'>:XCMYC&&8"/D8^Z?F/(Y],54M+F\T^'Q!H-UKEZ(++4[
M:*TN"3)<2K*%?[.K9!W'[N[.1G/05I7FBM%XZ\/Q6RZBEI8V$L"W4:,1&Q*[
M%+;2IX!'.1Z\UOW7A#2;S2WL)HYB'N1=M.LI$OG@Y$F\<[OY#@<4 <M!<7Z7
M7CFQ,UW:Q6UE#<6T?VIG>!FB<G#9.,E0< D9Z5#:&[LK;P#JBZG?RW&H&&"Z
M66X9HY$> MRF=N00#G&?4FNK7P7I*SWLZF\\V^@%O<.;IV,B@$9.2?FP2,]0
M#QBGGPEIQMM*M_,NO+TIE:S'F_ZLJ-H^N!QSF@#GGU&?PKXEUC3[JXNKJ/4(
M!<Z4)[EVS)D(T"DG@[F4C'9O:NTTNR;3M+MK22XEN9(HPKS3.7:1L<L223R:
MP8P_B37[6>ZT2YLX=(GD>.6[5099,%%,>"<K@ELG'(7&><=30!YIXPO+A+#Q
M3>V&H7D]Q9;"DD4K0QV+*JDQC!_>,<Y/&,-@FMP7QUCQL^BW<TL=O#I<=TL4
M4K1F5W8AF)4@D+@ #IEB?3%N\\#:+?2ZF\R7(34AFYA2Y=8W;&-^T'&[@<^V
M:=J'@G2-1%BSF\AN;%-D-U!=.DP4]07SD@^] '+^)DO-#L?"D?VF?7+RSU-\
M%B%DF(BD*H3D\XP,]3BM W"7WPXU;7;/5KV2YGLY[CS%G=?(D52=BID[-I&,
M=>.O-;\WA739ETY1Y\:Z=)YML$E/ROSEB3DL3DY)SG)]:B_X0[2P-62-KF.+
M52QNXDF(1RPPQ _A)'!(P30!S-L+JPU'P->+J5_+)J4?E7:37#-'(/L^X?)G
M:"".H&?4FGV4]SXD\):[K#7UW;:A#<7(MS%.R"V\HG8NT':> "V0<Y/MCIV\
M*V#?V5F2Y_XE7_'I^]^YQMY_O?+QSFDD\)Z:]Q?2(;B&*_.Z\MXI2L<Y(P21
MV)'!VD9[YH Y==6O!)X/\37MQ<0VFIP"VOH?/=8DDD3,<@7.!R",_P"T.]0:
M%J%U-_:OAVXN;];NZNXYK*26ZD,HLY<N"&)RI54<?7 .:[W4M&L-7TLZ9>6Z
M/9DI^ZQ@?*00/IP*<VDV3:U'JYA'VV.W-LLG_3,L&Q^8_4T <M<2?8_BE/*B
ML_D^&RRJ226Q,>,GD]*IZ3#K&M:-H'B"WU*.WE8QW%U,U[(Z3JWWXC%@(O)P
M,?=(KK_["M/^$A_MS=-]M\C[-G?\OEYW;=O3KSGK6;I_@31-+U)KRT2YC0R>
M<MI]H?[.DG7<(\[<YZ>G;&* .9GF/B?P1XOU.ZN+E986O(88XYV184B4@+M!
MP2<9;(YW8Z8JY%<W$2^"X;AY4T:;3L3>4S#,HB4IOV\[<;O;.,]JV[GP/I%Q
M<ZC,INX%U)6%W#!<,D<K$8+%1QN_GWS6%K^B16NI:7;?V=KATRRLS%;7>EW,
MC3(Q(RCX;=MVHN.H_*@"HEYJ^B>&YY[FYO E[K:VEM)>3N#'9M)A6)8$H2,C
M<1G!!ZUT^DZ5J>G^)9II+Q$T^XM\"Q:ZDG(E5AF16< @8."!WP:JZ5X;COM+
MU"QU+^T[K2+M$"6^K3>9*""2S YW*/N8!.05)XK6T+PS8^'U;[-)=SN5""2[
MN&F94'15W'Y5]A0!'XLF6+285.H36?FW<,8$"DR3Y8?NDP006 (SD8&3TKDA
M=:A''\0+3[1=VJ65I'<6J"Z9W@9H'8X?J.5!P#@<XKN-;T.R\0626MZ)-L<J
MSQ212%'CD7HRL.A'-9__  A.D>9J$@^U[]1@$%T3=.3(H!7)R3S@D9ZX/&*
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MC=,[-:1.1 GEL%.X _Q$=<Y[\5U%KHMG;?;&8//+>@"YEF.6D & #C   )P
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M>2SA)5[PJN-SON&U5ZG/4D<$XK.N=0U/_A4OB*5M0NX[JPOKB&*5+ABZJLH
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MVKZE)J$>HJFY[IBK(;HH59<X8$'J<GT('%=1JEQ.WBO5[34I;R.S_LZ-]/\
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M&BE=G*!L1LRIN'(W,!TZXQW- '445YKXCTO4=$\*>*W_ +7D2)H%N+6VMYY
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M*AFD9GYZDL223WR3FJ6F>'M-TC39=.M86-G*7+PS2-*#NSN^\3P<G(]ZU**
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MN_"]M%:^&--6%2H:VB<Y8GDH,]:5?#6DK<ZE<?9G:34D\N\WSR,)5V[0"I;
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M ! #@;@>@KH-3M8]'\0:-H5K.ZVFIRW-Q(+R>259955,)DMG!RQVYP2*V_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBWC$DZ0;!Y8.=H)9@,G!P!^.,C( GE^(O^?K2_\ P&D_^+H\OQ%_S]:7_P"
MTG_Q=5+#QA8Z@VB"*WN@FLQR/;.RK@;%+$-\V0<#T-4=9\3:5=^%=9GO;+4#
M:65R;2ZCB8))N4J<@J_3++SG\* -GR_$7_/UI?\ X#2?_%T>7XB_Y^M+_P#
M:3_XNJ4OB&[3QL=$339I($L/M)D1TRY+A0>6& ,$>I)Z8&:DL_%EK?:"=6BL
M[P*+G[*;=@@E$GF>7M(W8!W'N?>@"SY?B+_GZTO_ ,!I/_BZ/+\1?\_6E_\
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M2<9W^U6_+\1?\_6E_P#@-)_\72>*O^10UG_KQF_] -:] &3Y?B+_ )^M+_\
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MPW@>8LWGCRIU9W 4H&/"@#&0,$#&>:[:@#)\OQ%_S]:7_P" TG_Q='E^(O\
MGZTO_P !I/\ XNM:B@#)\OQ%_P _6E_^ TG_ ,71Y?B+_GZTO_P&D_\ BZUJ
M* .>TRZ\0:EIEM>K-ID8GC#A#;R'&>V=]6_+\1?\_6E_^ TG_P 72>%O^16T
MS_KW7^58/C36#H^L:9-J?VU/#K)(MQ-:,Z^7,2NPR%"&V8W=.YYS@4 ;_E^(
MO^?K2_\ P&D_^+H\OQ%_S]:7_P" TG_Q=<EXE'D_#3Q!?:?K5S=6TF)[*XCN
MV9HTVHNS>#DC(;@D]>:ZBW\46<VJW&G2V]W:RPVQNU:XCVK+"#@NN"3P<<$
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M[MRXP>]3Z=X@MM0U6ZTLPSVU];(LCPS[<LC=&4JQ!&01UX- !Y?B+_GZTO\
M\!I/_BZ/+\1?\_6E_P#@-)_\77/>+9O)\;>%H)=0N;6RNS=+<JEX\*/LB!3.
M&&.?3K4?A7Q!/'+X@%S>2WVD6MZD&G73?.\Q;@QJW\>&( )]>30!TOE^(O\
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M2MFLB\_Y&G2?^O>Y_G'6O0 4444 %%%% !1110 4444 %%%% !1110 4444
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MKUD:1_R%M?\ ^OU/_2>&@#7HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** ,C_ )G _P#7A_[4K7K(_P"9P/\ UX?^U*UZ "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#(\5?\BAK/_7C-_P"@&M>LCQ5_R*&L_P#7C-_Z :UZ
M .)UY->T'Q/-XCTRP&KV4]M'!=VB'$\00L0T?J/F.5[G],O4K_2]1\':)=:
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M%%% !1110 4444 %%%% &1XJ_P"10UG_ *\9O_0#6O61XJ_Y%#6?^O&;_P!
M-:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9'A;_ )%;3/\
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M +4K7K(_YG _]>'_ +4K7H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG_I/#0!KT444 %%%% !1110 4444 %%%% !1110 4444 %%%% &1_P S@?\
MKP_]J5KUD?\ ,X'_ *\/_:E:] !1110 4444 %%%% !1110 4444 %%%% !1
M110!D>*O^10UG_KQF_\ 0#6O61XJ_P"10UG_ *\9O_0#6O0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% &1X6_Y%;3/^O=?Y5KUD>%O^16TS_KW
M7^5:] !1110 4444 %%%% !1110 4444 %%%% !1110 5D0?\CAJ'_7A:_\
MHR>M>LB#_D<-0_Z\+7_T9/0!9UC4?[*TFYO!!+.\:$I#%&SL[8X4  GDUQ7B
M3PU=P^"X[JUU.]N;_3Y%U"V3R4(>X#%FP%0/\Q9N,]^:]#HH X?7M1_M5?"%
MY':7B_\ $RCGFC:V?= OE.#O&.,%@,FJFJ65]<ZOXWL;:"X6?5-/A%I((F$;
MXB=2-^-HYP.3GFO0Z* ."TR[TO5S#??V+JT.HV=M(LIO%GQ;;EPR+N)#DG
M&>.>*U_A_#Y'@31HGMW@FBMECD22(HRL.H((!ZUTU% !12*RNH92&4C((.01
M2T %%%)N7?LW#=C.,\XH 6BBB@ HHHH **** ,B\_P"1ITG_ *][G^<=:]9%
MY_R-.D_]>]S_ #CK7H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "LC2/^0MK_\ U^I_Z3PUKUD:1_R%M?\ ^OU/_2>&@#7H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,C_ )G _P#7A_[4K7K(
M_P"9P/\ UX?^U*UZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#(\5?\
MBAK/_7C-_P"@&M>LCQ5_R*&L_P#7C-_Z :UZ "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH R/"W_(K:9_U[K_*M>LCPM_R*VF?]>Z_RK7H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "LB#_D<-0_Z\+7_ -&3UKUD0?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M49()]*U=-U"SU?38-0L)5FM9UWQNHZC^A[8[4 5/^$J\._\ 0>TO_P #(_\
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M+V!I[42$'S%7!93C[K@,"1SP>IP< $O_  E7AW_H/:7_ .!D?^-'_"5>'?\
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MS_A*O#O_ $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:KWOB:"UFU%8;22XBTQ
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M(_\ &M1BJ*6(X R<#-<_;>)V?Q!;Z3>Z/=V)NXWDM)92C+*$P6!"DE3@@X-
M%S_A*O#O_0>TO_P,C_QH_P"$J\._]![2_P#P,C_QK5P/048'H* ,K_A*O#O_
M $'M+_\  R/_ !H_X2KP[_T'M+_\#(_\:U<#T%&!Z"@#*_X2KP[_ -![2_\
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M9PP'8'-:E !1110 4444 %%%% &1XJ_Y%#6?^O&;_P! -:]9'BK_ )%#6?\
MKQF_] -:] !1110 4444 %%%% !1110 5RG@3_CTUS_L-WO_ *,KJB RD'H>
M*H0:'IEK:W-M#9HD%T6:>,9Q(6^\3[GN>] &<PMM7UNRU.26-;*Q9A:%F \Z
M9QLWC_9 )5?[Q8GH 3G>.")F\-W,;J]O:Z[;F<J<A/O*"?3#,H_&M6R\%^&=
M-O(KRST.Q@N(CE)$B 93ZBI-.\-:?8PZC%]E@\G4)C-- $^0D@ \'J3C)/\
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M6E?^ TG_ ,71Y?B/_GZTK_P&D_\ BZUZ* .3\2QZ^/"VK>;<Z:8_L<VX);R
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M(_\ GZTK_P !I/\ XNCR_$?_ #]:5_X#2?\ Q=:]% &1Y?B/_GZTK_P&D_\
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M@ HHHH **** "BBB@#(\5?\ (H:S_P!>,W_H!K7K(\5?\BAK/_7C-_Z :UZ
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M KHZ* ,B\_Y&G2?^O>Y_G'6O61>?\C3I/_7O<_SCK7H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LC2/\ D+:__P!?J?\
MI/#6O6-I3HNKZ^&=0?MJ=3_T[PT ;-%,\Z/_ )Z)_P!]"CSH_P#GHG_?0H ?
M13/.C_YZ)_WT*/.C_P">B?\ ?0H ?13/.C_YZ)_WT*/.C_YZ)_WT* 'T4SSH
M_P#GHG_?0H\Z/_GHG_?0H ?13/.C_P">B?\ ?0H\Z/\ YZ)_WT* 'T4SSH_^
M>B?]]"CSH_\ GHG_ 'T* 'T4SSH_^>B?]]"CSH_^>B?]]"@!]%,\Z/\ YZ)_
MWT*/.C_YZ)_WT* ,O_F<#_UX?^U*U)>8G_W361YL?_"7D^8N/L'K_P!-*TYV
M$D#I'<)&[# ?@X_"@#S7P])+\/[72II'9O#&J0PL[,<_8+AU&2?2-R?P/IW<
M)6N?$G@33ICFP?[7<[/X9)4!*9]=N<BNYM]*LU\.QZ)>21WEJMN+=A( -Z!=
MO..^!U%4!X4TM=#TW34N)$;3&#6=TKCS8F'0YZ'C@@C!':@#,^*;/:>%8-4M
M<C4+&]@DM67[VXN%*_0@D$=ZKW[:[X/U75-3MK$:UX?OIC<7,,)'VBV?:%<@
M'AUPHX[8[8R;"0ZI<^(43Q4L5S8VD@GT^6Q0^2T@SAI4RS!QG(_@Z]P*VAI5
MU;O=_8]=:*.ZE:5DDB23RBW7R^F/QW#/.* .3MKVRU3QSX/M[)R^B1:4]S9*
MPP#(/D&1_>51^!S6G\27DM+?0-1M<K?0:O D)7JP?*LGT8=1[5I_\(GI$6FZ
M5:V<K6LNE<V=RC@R(2,-G/#!N=P(Y]N*L'1TN]1M;[5;Y+M[-B]O$J".)'QC
M?MR26QD DX&> * -RBF>='_ST3_OH4>='_ST3_OH4 /HIGG1_P#/1/\ OH4>
M='_ST3_OH4 /HIGG1_\ /1/^^A1YT?\ ST3_ +Z% #Z*9YT?_/1/^^A1YT?_
M #T3_OH4 9?BK_D4-9_Z\9O_ $ UKUB^*I8SX1UD"1<_8IN_^P:U_.C_ .>B
M?]]"@!]%,\Z/_GHG_?0H\Z/_ )Z)_P!]"@!]%,\Z/_GHG_?0H\Z/_GHG_?0H
M ?13/.C_ .>B?]]"CSH_^>B?]]"@!]%,\Z/_ )Z)_P!]"CSH_P#GHG_?0H ?
M13/.C_YZ)_WT*/.C_P">B?\ ?0H ?13/.C_YZ)_WT*/.C_YZ)_WT* 'T4SSH
M_P#GHG_?0H\Z/_GHG_?0H ?13/.C_P">B?\ ?0H\Z/\ YZ)_WT* ,OPM_P B
MMIG_ %[K_*M>L7PO+&/"VF R+_Q[KW]JU_.C_P">B?\ ?0H ?13/.C_YZ)_W
MT*/.C_YZ)_WT* 'T4SSH_P#GHG_?0H\Z/_GHG_?0H ?13/.C_P">B?\ ?0H\
MZ/\ YZ)_WT* 'T4SSH_^>B?]]"CSH_\ GHG_ 'T* 'T4SSH_^>B?]]"CSH_^
M>B?]]"@!]%,\Z/\ YZ)_WT*/.C_YZ)_WT* 'T4SSH_\ GHG_ 'T*/.C_ .>B
M?]]"@!]9$'_(X:A_UX6O_HR>M3SH_P#GHG_?0K(@EC_X2_4#YBX^P6W?_II/
M0!M44SSH_P#GHG_?0H\Z/_GHG_?0H ?13/.C_P">B?\ ?0H\Z/\ YZ)_WT*
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M@(.P\@XK5_X1O0O^@+IW_@*G^%1^*O\ D4-9_P"O&;_T UKT 9G_  C>A?\
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M_0%T[_P%3_"M.B@#,_X1O0O^@+IW_@*G^%'_  C>A?\ 0%T[_P !4_PK3HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6
M1I'_ "%M?_Z_4_\ 2>&M>LC2/^0MK_\ U^I_Z3PT :4\331%$GDA)_CCVY_4
M$53CT.Q@L!9PQLD7G+.^&):1PP;+L<EB2!G/6M&B@"GJNFPZQI=QIUP\BP7"
M&.7RR 64C!&<'&15>YT-+C2K:P%]?0BW*F.:";9)\O !(&",=B"#6I10!G)H
MMJL/ELTLC&9)I)'?<\K(05W'T! X&!Q5?6?#=OK=U;W$U]J-N]N"(Q:730@$
M]3QWQQ]*V:* ,2+PM81Z7)82RWERKS+/Y]S<-)*LBX*L'/((*C'_ ->G2^&K
M2:SOX'GNO-O\?:;E9-LL@ P!D  #'& !U/J:V:* .>L?"-M83"5-3UB9EC9(
MQ<7SR+'D8W*#P& S@^]167@BQL98&34M9DCAD$BP2ZA(T9(.>5S@\\UTU% !
M1110 4444 %%%% &1_S.!_Z\/_:E:_6LC_F<#_UX?^U*T+W[3]DE-F\*3A24
M,R%ES[@$']: ,P>%M,6"2UB%Q#92$E[2*X=(CGD@*#P#W48!R>.:R_$VCRW.
MJ>&8[.QF^QV-RTDC6S",0IY;*N.0>"1P.U2>#/%Q\4Z6ZSPK9:O JFXMF!(
M891U&<E&!!'/M[U'_P )7>1V>CVQCMI]8U:5T@C162-%3)=VR2<*!G'<D#CK
M0!KS>&M+N=,O+"X@:6*]8/<L\C;Y&&,$MG.1M7&.F!BG)X>TZ/4K74 DYNK6
M)H8I&N)&PK'+ Y/S9(!).2:S=5US4/#,EG<:L]K<Z;<3K;R300M$UNS<*Q!=
M@RYX/0C/>FVNO:AK&KZQ9Z;<:?!)ILWD_9KF-FDD^4'>2&&U23@'#=,^U &A
M;>%M)M''DPR+ L_VA+;S6,*29SN"9P.><= >0,TV3PII$L.IPO%,8]4.Z\7[
M3)^].,?WN. !QCBJ4WB6\0Z%IB6T8US4X!+)&^?+ME"@R,PZG!. ,C)[BGZA
MKE[X>U#3DU9K:>QOYQ:K<01-$896SM# LV5.",Y&..M %M_"VF2)+&PN3#-&
ML4T1N'*2HHP P)].#W(X.:V@   !@#M110 4444 %%%% !1110!D>*O^10UG
M_KQF_P#0#6O61XJ_Y%#6?^O&;_T UKT %%%% !1110 4444 %17, N;:2 R/
M&)%*EDQD ^F0:EHH RK3P]86OAT:"R-/IXB\@1S'/[O&-N0!^?6GV>B6UI=-
M=/)-=7)A$ EN&#,(P<[1@ 8SR3U/&2<"M*B@#&L_#-A9"UC0S-;6<ADM;9V!
MC@8Y'R\9X!. 2<9XQQ56T\+QFVOH+R>[EBFO?M< EG+R6[ @@JW\/S#( XQZ
MY-='10!E2:!;SQW9EN;MKBZB$+W2R^7*J D@*4 "X))X'.><U+8Z/#9Y=I[F
MZG,?E^?<2;G"^@(P!VZ 9P,YP*T** ,C3O#\&GF(O=WUZ8"3";R<R&/(QQZG
M!(R<G!(SR:UZ** ,CPM_R*VF?]>Z_P JUZR/"W_(K:9_U[K_ "K7H **** "
MBBB@ HHHH **** ,=?#T)FE:XO;ZZ@DF\_[-<3;XU;.1CC.T'HI)''2G7.@Q
M76HRW;7VH*DR!)+9+DB)@/\ 9ZK[[2,UK44 8U]HS3ZQI-U;33V\=CN!CBEV
MQ,A&-I0<$\#'H,^U"^&-/4R1CS1:27'VIK/</*,N[=NQC/WANVYQGG%;-% &
M1>^&[&^GNI',R+>(L=Y%&V%N%7@!N,].,@@D<'(JQ?:1;:C$MO<EVLP #:@A
M8WQT# #)'^SG![BK]% " !5"J  . !VK)@_Y'#4/^O"U_P#1D]:]9$'_ ".&
MH?\ 7A:_^C)Z ->BBB@ HHHH **** "BBB@!DL8FA>(LZAU*ED8JPSW!'0^]
M9MCH4-F\$DUW>7TEN"(7NY0YCR,$C &3CC)R<$C/)K5HH HZMJ$NF60N(=.N
MK]MZKY-J%+X/?YB!@?6J6A:%;V.BSVTUG%&;Z66XNH!@KNE))4]C@$+[XK;H
MH YK3_ VDZ=;36@DOKBTDB>%+:YNGDCAC8$,J ]."1GKCOR:=:^"]/L[BQN(
M[O46GL86AAD>Y+$(<?*0>"!M'&.W.:Z.B@##M/"UG8Z##H]O<7<=O!()(6$@
MWQD-NX..1GL<]<=.*O6&EP:?+=3HSR7%TXDGFDQN<A0HZ  8  X J]10!D7G
M_(TZ3_U[W/\ ..M>LB\_Y&G2?^O>Y_G'6O0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %9&D?\ (6U__K]3_P!)X:UZYJUG
MU.+7-=6RL(+B,W:$M)<F,@_9XN,;#[<T =+161]LU[_H#V?_ ('G_P"-T?;-
M>_Z ]G_X'G_XW0!KT5D?;->_Z ]G_P"!Y_\ C='VS7O^@/9_^!Y_^-T :]%9
M'VS7O^@/9_\ @>?_ (W1]LU[_H#V?_@>?_C= &O161]LU[_H#V?_ ('G_P"-
MT?;->_Z ]G_X'G_XW0!KT5D?;->_Z ]G_P"!Y_\ C='VS7O^@/9_^!Y_^-T
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M#7HK(^V:]_T![/\ \#S_ /&Z/MFO?] >S_\  \__ !N@#7HK(^V:]_T![/\
M\#S_ /&Z/MFO?] >S_\  \__ !N@#7HK(^V:]_T![/\ \#S_ /&Z/MFO?] >
MS_\  \__ !N@#7HK(^V:]_T![/\ \#S_ /&Z/MFO?] >S_\  \__ !N@#7HK
M(^V:]_T![/\ \#S_ /&Z/MFO?] >S_\  \__ !N@#7HK(^V:]_T![/\ \#S_
M /&Z/MFO?] >S_\  \__ !N@#7HK(^V:]_T![/\ \#S_ /&Z/MFO?] >S_\
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M_P#C= &O161]LU[_ * ]G_X'G_XW1]LU[_H#V?\ X'G_ .-T :]%9'VS7O\
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MFO([:*ZM+F=!_JW8HV\+@$J03QC(('O69>VXU'3-$O\ 2]*OK:#1=11_L]Q
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M ,CQ5_R*&L_]>,W_ * :UZR/%7_(H:S_ ->,W_H!K7H **** "BBB@ HHHH
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M18903ZF3R^.X!K-FLVTWXB3:O<6\DMG>Z<MN)4B,GE.C$E2 "0&#<'ID8]*
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M."1GW/K4M%% !1110 5D0?\ (X:A_P!>%K_Z,GK7K(@_Y'#4/^O"U_\ 1D]
M&O1110 4444 %%%% !1110 4444 4=6TTZK9"W6_O+(AU?S;.0(_';)!X/>K
M%I:0V-I%:P*5BB7:H))/U)/)/J3UJ:B@ HHHH **** ,B\_Y&G2?^O>Y_G'6
MO61>?\C3I/\ U[W/\XZUZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDBCM=625YCB)4U60F0_[/S\_A5J]TWP]IQC%W/<1-)G8IOIRS8ZX ?)QW]*
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M_BZ/^$9TS^[=_P#@=/\ _%T :]%9'_",Z9_=N_\ P.G_ /BZ/^$9TS^[=_\
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M7_T9/6O61!_R.&H?]>%K_P"C)Z ->BBB@ HHHH **** "BBB@ HHHH ****
M.(\6Z!<:SXCMKC3;DVNKV-FT]E-GY=^\ HP[JPR#]:DT'Q''XCUK39'A-MJ%
MM;W4-[:/]Z"4-#D?0]0>XKHSITIUT:E]I&P0>1Y/E]LYSG/7/X8[=ZK2>&[,
M>)CXAMP(=1:U:U=PN5<$J06'<C;CZ'V% ''>.K@WTUS?VDDWVO0'26R1(W*R
MRJ0TH) P05PGL0U=_IFH0:MI=KJ-JVZ"YB65#[$9_.HM)TU],TI;)KC[0X+L
M9GCP79B6)8 \DDDGI5/PMX>/AC2O[-2]>YME=GB#H%,88DE1C^')X]* );S_
M )&G2?\ KWN?YQUKUD7G_(TZ3_U[W/\ ..M>@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *R-(_Y"VO_P#7ZG_I/#6O7-6N
MC:=J.N:[+>6D<TBW:*&;L/L\1Q^IH Z6BL:3PUH$,;22V%ND: LS,<  =R<U
M4TS3/"FM6?VO3;>UN;?>R>9'DJ2#@X/>@#I**Y*>W\+6VLSZ=-I\,?V:S^V7
M%PQ CB0L0 Q)X)PQ^@HTE/!>N320Z:EI/+&H=DVLK;3T8 X)'N.* .MHKD[N
MU\+V6LQZ;-IT0<VLEW+*<!(8D(&YR3QDGCZ&H]);P/KMU);:;]CN)T7>8P&#
M;?[P!QD>XXH ["BN-,O@1=6_LLO8B\\SR=G./,_N;ON[O;.:2_N/ 6F:C]@O
M9+"&Y!"LC$_(3T#'HN?<B@#LZ*Y+5X_!>A,B:DEI [J75,,S%1U; R<>_2M"
MTT'PW?6D5U:6=K-;RJ'CDC.58'N#F@#=HK(_X1;0_P#H&P_D:/\ A%M#_P"@
M;#^1H UZ*R/^$6T/_H&P_D:/^$6T/_H&P_D: ->BLC_A%M#_ .@;#^1H_P"$
M6T/_ *!L/Y&@ _YG _\ 7A_[4K7KD_\ A&]&_P"$K,7]GP^7]AW;<'KOZUHS
M^'/#]M!)/-86Z11J7=CG"J!DF@#;HKCM,E\":S=+:Z>]A/<,NY8P2&8>H!QG
M\*(Y? DVJ_V9&UDUWYAB"#=@N.J[ON[O;.: .QHKG[/1?#-^)C:V=M*()F@D
MV@_+(IPRGW%%CHOAG4K;[39V=M-#O9-Z@XW*Q5A^!!% '045D?\ "+:'_P!
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M'[2#PK'X?RXM%M1;,8V*,5VX)R.A/)_&JFD>#[+19;=K2_U8Q6XVQV\E\[1
M8QC83C H XADB;]G@2C!E-N)M_\ $9_.SG_>WUTOC>1=0TQO"MC#')JNKJ Z
MA>(8\C?-)Z 8P.Y. *O)X%T9+L2C[7]F$_VD6)N6^S"7.[=Y?3KSCIGM1<>"
M-.GU:[U-+W5;:YNR#,UM?/&&P, 8!Z#TH LZI!K-IIT47A^WT^:=(?*9[Z1E
M. /EQM4[N_!(JA\-VM1X&L;>U$R_9C)!*LP&Y90YWCCC&XG&.V*O7OA6VO3
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M)-=-<M?/-#*RF&=F+9B;J N<#V^M '&_$,^5KNOB'Y8IM(L_M>WC.;O;S_P
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M10 4444 %%%% !1110 4444 %%%% !6;<^'])N[F2YN+"&2:3!=R.6P !G\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHJM<ZA:6EQ:P3S*DMU(8H5.?G8*6(_($T 6:*S[
M[7=*TR>&"^U"WMI9CB))9 ID/HOK^%37VHV6FVAN[ZYBM[<8S+*VU1GIDGI0
M!:HID4J3Q)+$P:-P&5AT(I] !1110 44C,J*68@*!DDG@"JFFZK8ZQ;-<Z?<
MI<0K(T9=,XW*<$4 7***I0:OI]UJ=QIL%U')>6RAIHEY* ],]NW2@"[1110
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M2!KIYVFC2$NA=86.<[P2N#P,CGDD]*L:AXIU.1-4?1K=9WT^9H! UE-(;EU
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M_P!YE4_A0!2_X2Z6RU#Q9_:4,*VNB10RH8<EY Z,V"3WX %%YXDU71X='O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %<'J/@75;S3_ !#IT>KVRVNJ7?VM&>W+2JVY3L+;L;1M
M '&<5WE% ''S^&-<M?$4VM:-JUI%/?11QZA%<6S-&[(,+(@# @@<8)^I-.U3
MPIJ7]IZ?K.C:JD6JVT#6TSW<9>.YC8[B&"D$?-DC'TKKJ* .5U#PK>WHTS4/
M[24ZYI\[3I<-$1$VX;7CV9RJ%0!UR,9Y.<R3^%3J<NKW>I2H+O4=/.G#R02L
M$)#9 )Y8EF))XZ 8XR>FHH XF'PGKKR>'9;O5;'=HK$*(K9L2+Y>SG+9W$>F
M /0TX^#M0;PYXCTIKRVW:S=37'F!&_="3&1C/S8QUXKM** .87PWJ$?B/3=8
MBO;='AL/L%RAB+;TW!LH<C!R.^<9[ULZ7%J,,,PU.ZAN)&G=HFBCV!8R?E4C
M/) [U>HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*OE?$K5I=*2+[1)X<62+RP,/)YC[3[]%_2@#MA?V;79M!=P&Y R81(-X_P"
M]:)K^SMO,\^[@B\L!G\R0+L!Z$YZ9KS"X$=[\$M/NK$G^UH6A:"0?ZT7OFA6
M]]Q8MGZFMJPTG3KOXG>(DNK*VE!L;5G1HP5+'S S8/?'?K^= '>(ZNBNC!E8
M9# Y!%<G<ZWK1^((\.V\NGQV[:<;Y99+9W<8DV;3B0 ^N?TH^&#M)\-]%+,6
MQ$R@DYX#L /R%9M_:QWGQJ@BDEFCQX?8YAF:-L^?ZJ0<>U &UH_B*[F\57_A
MO4H8/M=M MS'<6^0DL;''*DDJP/;)K=6_LWO&M%NX#<J,F$2#>!_N]:\YTQ9
M]&^)&N:9H\S:@MQIQNIIYCYDL$XR$C:3J1TPIZ9IOA]="UWP]X;FFUR87]E/
M$XMXS$LXN1PZL-N\@DL6SU')/>@#T>74;&'/FWMO'AQ&=TJC#GG;UZ^U/N;N
MVLH?.NKB*"+.-\KA5S]37EITC3'\/?$EVLK<M#/=&(F,?NR(%8;?[OS<\>@]
M*O1ZHD?B70HM4U(V=O<:#$;6>39L>8G]X,N"-Q79_DT =;XH\20>'_#LNI(\
M,CML6!6<;7+,J@]>0-P)QVJO:G71K<#/KFESZ1(Q,:B+$TIVG*@@[>" <C)Q
MG/2N4\0:9I6F?"VYM]-NGN[./4(C%+*591FXC+",J -H.1Q[UN>([:WA\?\
M@IXX8D?SKI-RJ <>0QQ],T =!I_B'3-4O[ZSM+J*22SD\N3#@Y; )QZXS@^^
M1VJY;7]G>%A:W<$Y7KY4@;'Y5Y]9PZ=(_C^RNKJ.R$UTT?FC :-&@3+ >G4_
M@:UO#=WJ</BF72M=L[5M06Q$D6HV?"7$*O@!E_A8%NG3DXH Z^6>*';YLJ1[
MV"KN8#)/0#WJ%M3L$LQ>-?6RVQ.!,95"$]/O9Q7)_$*TM;BX\*F>&-RVN0QD
ML.2A23*Y]#@9'>JE]_9VA^/K/3GFBTC39=/<V92.-8C,9"91\RD!B-OIZ=Z
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MX=&U3_A)X;4Q"-==N"J1D8 PG0#M2ZM]EB^*NCR7'DHK:9<?-)@ D/'W/?%
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M/09))P,XK5L[*TTZU2VLK:&VMT^[%"@11] .*C35=.DLVO$O[5K5#M:99E*
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M8QR^,FI[:ZM[V!9[6XBGA;I)$X93^(IEQJ%E:31PW%Y;PRR?<22559OH">:
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MQIAT+2#;QVYTNR\F)BT<?V==J$]2!C@_2K#WUG&81)=0(9@3$&D W@#)V^O
M)X[52N_$NCV>B3ZP^HVSV,(.Z:*57!(_A!!Y;MB@#1@MX;6!8;>*.*).%2-0
MJCZ 5)573M0M]4L(KNVECDCD4'*.& .,XR.XJU0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6?KFI
MC2=)FNAM,W$<",<>9*QVHOXL0*T*@N;*TO55;JUAG"G*B6,-@^V: /.O%6A:
MOHOAFPU:.\L[B?P_*+P%+9HY)@3^^RQD(^8%B>.?:M/Q5JEG/%X4UR&_M_LW
MVU9HXYI1&LRM&W\1^4,H)(R1SQU(KLYK6WN(/(GMXI8>/W;H&7CIP>*YW7?#
M]W+)8MI%KI3VEN7,NG7<6V*5F  ?*@X8#(Y4CYC0!SLNFZ?/HGCO6@^GS?;[
M:1TCB=)3"%AQEF7(#,PW8![#G-1:E#9Z1\/_  WJD%ND$!:Q;4;FWB4N80N=
MS$@[@'*GG-=3I/A:WCNGO+S2-(M7>(PFWLH@48%@V7)5=QRHQ\HQSUSQT$=G
M;16QMH[>%(""#$J +@]>.E 'G.NQ:?)IGB+5] U>?5-2GTT+<-;R1LGEAAU\
MM0-^W?C/. :T],'AG7=9TC4[36Y-0N4@DCB@0PX6%E^82HB A1P,'HQ'K78V
M=A9Z=#Y-E:06T1.[9#&$7/K@4RWTK3K3SOLUA:P^?_K?+A5?,_WL#G\: /(Q
M9V2_ TW"PPB5+_*R@ ,N+W P>H^4G\#767]LEC\2[%--AA@F?1+E56-0H8AT
MV@@>AKKO[&TOR?)_LVS\K.[9Y"[<^N,=:>-,L%G2<65L)D "2")=R@<#!QQ0
M!YMX=DT'7?#GA^*\URY_M*QGC86*M$DZW2G##;LWD$[B23R,DG@FD&G:>VD_
M$MC:6Y,<DX0[!\G^CJ>/3GGCN*]*33;".^>^CLK9+MQAIUB42,/=L9--&D:8
M!(!IUH!)_K!Y"_/]>.: .#6Z@BUWX?7-W-&B-I,^9)& !/E1'J>]=KXCN+:T
M\,ZI<7D<DMK':2M*D1PS)M.0#V.._:K7]G6(2%!9V^R!MT2^4N(V]5XX/TJP
MRAE*L 5(P01P10!YA8WMH?&?A _;+#R7TR>)(8'#+&A6/9&6)RY^N,XZ4[P_
MI<#>%_%MSIUE VJ6^HZD+*18P7B?Y@H0]5Z\ >OO7H<6E:="L2Q6%K&L.[RP
ML*@)N^]CCC/?UI]M86=EN^RVD$&_[WE1A<_7% ' :#)X;UV#PS=1:Y/->V>W
M[/9QM"LD3;<.K*J!MH .<\8'TKI/'\<4G@#7O-1&"V,K+N&<,%."/>MF#3;"
MUNI;JWLK:*XE_P!9+'$JN_U(&34MQ;0741BN(8YHSU210P/X&@#S]K6TL_$7
MP[>WABB:2.<,R* 7!ML\GOS@_6JFG/#>_"WQ/;:MM_M&*6\-Z'^^)MQ:,^O3
M9M^@Q7HG]DZ=F(_V?:YBXC/DK\G?CCBG2:982WBWDEC;/=+C;.T2EQCIAL9H
M X.QEEL_&GA=M:E2.[;P\R3-,0"TVZ+(YZMG-=-XY-^/ ^L_V9O^U_97V;/O
M8_BQ[XSBMN6UMYY8I98(I)(3F-W0$H?4'M4M 'GNM?9K_2O!%WH93SQ?6_V8
MQ=1!L/FKQ_"%'S#VJ.QGMHI/B%;O+$DYGE98R0&V_9EYQZ<5WEMIEA9SR3VM
MC;02R??DBB56;ZD#FEDTZRFDEDEL[=WF4+(S1*2X'0$XY% 'FL%M:VN@_#.Y
M@ABCG>XMU:15 9@UNVX$]3GBD@FT?5+?Q+HGB76Y+*X_M&8S6S-$C2)OS$R;
MD+-\H0#!)X'M7HYT?3"L:G3K0K'R@\A<+]..*?+IMA/>1WDUE;2747^KF>)2
MZ?1B,B@#B+?2=,O/B?=6UW9Q7"'0H&:.Z17+-YC LXZ%L8R:CU6Q-EXKU70H
MX,VGBFV#1X3*QRKA)CZ?ZLA^>I7'>N\&GV2W9NQ9VXN3_P MA$-__?6,U.8T
M:19"BEU!"L1R,]<'\!0!Q'@>2ZU&&"UU&,^;X?5["1F7B28':&'_ &R"\_\
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M%'#$@PJ1J%5?H!4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9H\!P68*<;L=0"<X/>N>O8[6V^(G@];988@]E=KB, ;EVH0..HZG\ZE^'5U
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M3,%4LQ  &23VKC(;"X\5VNJWT5Y8_8-45K5%DMFE/D)N0$,)% R2[CC^(>E
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MU4^PQ1+#%.FR:))%SG:Z@C/XT >8WUKH5E'X-M]/_P"0>VLM)#]H;.]2CDL
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MITR+J+VWS&W)C= 6X.-K$$CJ,CU%>N"*-6W"- WJ%YH\J,(4"+L;.5QP<]:
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MEB1X_P"XR@C\J ,7PE::7::.XT;S6L99WECDD8D2%N2RY_A)SCMW'!K>H
M & ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *@O+VVL+<SW<R0Q A=S'J2< #U)/ '>IZY;QUJ-
MMIFFZ=-=00LC:C"JW$X)CM&R2)FP1TQZ@9(S0!O6.IV6IK*;.X60POY<JX(:
M-NN&4\@_6F7VL:?IS,MW<K&53S'X)V)S\S8'RKP>3@<&N0\&7<#^.O%L:7CW
M+2M:RI(Z8,B^2!N& !C/ /0\=>M1^+&>UUS4-0TC6;>UU."R3[5I]Z 8+R$;
MRH]0>6&1ZCUH [.\UC3["));FY5%=#(N 6)4=6P 3@9&3T&:B/B'2 ]DG]H0
M$WPS:[6SYP_V<=?PKA7UNVTOQ4MWXB-UI-IJ>EVIM7WNJ1.H8O"Q'<%\\U>U
M'0K:/X?6\_ANUEA.E3'4-.24L6;:Q8CYN<.I; _VA0!VIU&S6ZFMFN$6:",2
MRJW&Q#G#$],<'GV/I5:#Q#I%Q+-$E_")(8_-D60["(_[_P V,K_M#BN5UQ;W
M4_AWJ>K6MM,US?\ E70MQ_K/LZLI"?4Q@G'J[5)HVI>$];U:VUC3[NXN[NV@
M</--+)BVC8<B3=P#G P>>I' S0!OP>+O#URY6'6;-R(&N#B48$8."V?2K$&O
MZ5<&<)>Q*;=!)*LN8RB'HQ#8^4^O2O.]$NM.M/@1'=/807ZPP,DT./[TW.['
M( X8^RU=L-6LC\2FN7U9+N*?0<+<! L3$2DD(0,;0/4G'.3Q0!V$'BS0+FXM
M;>'5K5Y;O_4*K_ZSZ?7''KVJS?ZWINEEA>W<<15=[YR=B]-S8^ZO7DX'%>66
M=S90_"GP7^^@1DU:U9OF *D2G<3[@=:WK?7-+TCQ/XHTOQ*ZQKJ4JRV[2H62
MZ@:)4V+@'.,$8]S0!W%WJ]A8PI+/<H$D4NFW+EE'5@%R2!D<].:FMKVUO;..
M\M;B*:VD7>DJ,"K#US7GEYJ-CX>\7V[ZO]ITK2;K2X8;*169$A9&8F)MO0X8
M'\*[#PI9Z;9:%''H\$L6GL[O")68E@3DL-W(!.2/8Y[T 1R^-?#,)C$FNV(\
MR0Q(?.!!8<'GIU[]*JZE?WUO\0]"LH[Q_L-W;7+R6^U=I9 N#G&?XCWQ7(63
MZ3+X+\<6,_D/<RZE?HL& 9)'+'RPJ]2=V,>]:4>=/\7^!+&^N(_MD&E313!G
M&?,V1#]2#CUQ0!V?_"0:3]L6T^W1>:\I@7KM:0=4#="W^SG-077BS0+)KI;C
M5[1&M2JSKY@)0G. 0._!./:O-+O6K"ZTC2IHY8[%+?Q'&\VG1I_QZ@3MEY20
M2&/)Z@<X .,UTFG7>GMX[\;2O-;C-I:C+D X\MMPY_#(^F: .\@GBNK>.X@D
M26&50Z.AR&4C((/<517Q!I+WB6BWT1EDD:%.NUY!U0-T+#!R <\5C?#:5)?A
MUHFQPY2V"-@YP1V/O7"RZW87>D^'IXI8[*.W\0QM+IL:<6@\R3)E)!(8DD]0
M/F. <9H ]+N?%WAZS^T>?K%HOV9@DP\P'8QYP<=^#].]7Y]3LK>UBN9+F/R9
ML")E.[S21D!0.6)'/&:X2TNM/;Q-\0Y&FM\-! "S$ [?L^".??@^]96BZK%I
MI\!:CJ$ZKI"Z4UK]H8_NX+@JOWST4D#;S[^] '7>$=8GU37O$T37[7EK:W,2
M6Y9578#&"RX '(8D<\\<UT&H:G9V.(KBZ\J61&*A%W/@=6"@'@9')&!WKE/!
MM[:77C/Q@;69)$DN+>1"G1QY*@L#W&>],BU>WT3XH:T-;N$M8KVUMO[.GG;:
MC(@;>@8\9W-G% %WP3KS7?@T:GJNHK-_I4Z?:7*J&42LJ8P .1@#'6NBL=5L
M=2:9;2X622%@LL>"KQD\C<IP1GW%>3:5=>1X=\/WZY.F:?K]P]Z I B5GD".
MP[*NX'VR*Z+5K6?5_%^IWF@3+(#X?EMI)H7!1IV),2[AQN')]@1ZB@#L8=?T
MJXOTLHKZ)KB0,8TSCS .NP]&QWQG%.36]-DO$M%NE,TCM'&,'#LH)95;&"1M
M.0#Q@UPOAN_\,Z_%H4.Z]EUG3V0BQ>20-:2*-KEAT"CGKP>!U.*;I%S-INK:
M2NDZC#JVBWEZX6QF -SI[L'+,I'55RP.>@/OF@#T#4-5L-*CC>_O(;997$<?
MF.!O8G  '<U%I^O:5JUS<6]A?P7,UOCS4C;)7/0^X]QQ7.?$^2W3PO EP\8#
MZA:_*Y'($JD]?;.:H:M+]H^(U]!IMS$MY-X8DC@*N!^\,A*?CSGZ4 =BFOZ4
M]W':K?1&65RD?.%D8=55NC$8.0#GBJMGXJT^]\37VAQ.?.M%CW,00&=MY*CC
ML%'/O[5PMS-!K/PFTK1[!E37(3:P1VW2:"XC=0[%>JX 8DGMSWKHM*NH;7XI
M^)+>>0)-=V]FT"$',@57#$>H'<]J .LN[ZVL(U>YF$8=MJ#JSMUPH')/!X'I
M4$.M:9/IK:A'?0-:*2K2[\!6!QM/H<\8ZYKE_%&J)H'CG0]6U,LFD&VGMC.5
M)2"9BI#-CID+C/UK.UZ>R6VTG6M)M=NB1ZVMW?2QQD++E<&?'=0Q'/MGIS0!
MW$&N:7<1W+I>Q*+7_CX$A\LQ \@L&P5'UJM!XKT"YN;6VAU:UDFNQF!5?[_T
M_IZUSURT%W\0O[7LKF%K&#1Y([VX1P8R2V8U+#C/WC[#ZBN7M;FRA^&'@;]]
M C)JUHS?, 5(D.XGZ \_6@#L=4U\7OC'_A'(M1DLHQ8M*9H -_G&0(J\@\#!
M/OD5K6NLVFGQVFG:GK$,]_E8'G*>6LLN.G'RAC_=SGVK$6^M#\9'07,)8Z&L
M8&\?>\\G;]<$'%<UH]QH5YHC>&?$37S:U!<N)-/\R13/)YA=73'&#D'=T')/
M'- 'H<WBSP_!<M;2:O9B99E@*>:"1(W1?K_*M"\OK73X1-=S+$A8(I;JS'HH
M'4D^@YKC_#CV-Q\2/&2[K>60M9E1D$G;%SCZ$#Z&KOC?4[734T9KJ*!5?4$"
MWEP"8[1MK8D/(YZ@9..<GI0!T-AJ5GJ<4DEG<+*L;F.0#@HXZJP/(/L:Y6X\
M2KHOCW48-6U=8M+33HIXTFVJ$=I&! P,GA?<]:@\"74+^)/%D"W,D[M>1RAY
M$VLRF) &X &#VXY[5)+<65C\6;J?4)8+=)-&C2*2<A Q$KE@I/4X(R* .JCU
MC3I=,CU*.]A>SD *3(X*MDX &.ISQCKGBJQ\4:&NGSWSZI;1VUN_ES/(^PQO
M_=8'!#>V,UYJ()/#^G6>K30W,/A\:_=7.V$,K06\B%(Y,#D+DD_1AZU<\2/X
M=G\$>+-4T>:2?[;;QI->/*[)/(O"JN[JP'IZC\ #T*T\0:1?:E)IUKJ%O->1
MKO:%'RP&<$^^#P?2B37]*BOH[.2^B6>23RD!. TG]P-TW?[.<URE_=6(\>^"
MA;W%N ;.[5=C#&"D>T<=B0<?2L+P_<:%?:%;>'=>:^;7;2?:^G&60,\RN2'7
M'&#][=T&23Q0!T^HZ\-0\83>'8=3DL42R\P30J-_GM(5 Y!X7;G'0YI;7Q#;
M:!X5U/5+_P 1?VX;65A)+%&H D"+^Z4)P.>>^,\GBH[>]M?^%Q7L?VF+?_8\
M4>W>,[A,Y*_7!''O7-R217?@GXD1VSI*YU"YD"QG<2NQ.>.W!Y]C0!ZC87L.
MH64=S"P9'&>.Q[BJTFOZ5%=+;27T2R-+Y()/R^9_<W=-W^SG-+I=[#J6A0SZ
M?.DB-"!'*O*D[>Q[\_UKS>WEAN?@Y<^'KD#^W8@]L]DQ_?&Y\PLI ZG)(;=T
MZG/!H ]$N_$NB6$\\%SJEK'- @>6,R L@)P,@=_;K5ZRO;74;**\LIXY[:9=
MT<L9RK"N(L)8(/BJ4N[F![F'P]$DDC,,[Q*Q;\<<GVJY\+YH9/!<:0R(PCN[
MD84@[09G(^G!!H Z"?Q!I-K=&WFOHDD618FSG:CMC:K-T5CD8!.>13;OQ)HM
MA<S6UUJ=K'/#'YDD9D&Y5R!DCW)&!U->8^*=7L[GP]XKMXG2QE@U13)8QIF2
M4K+'F>0D$A2!D$8' Y.:ZA+ZPG^+Z3"> C^P/E9B 0?.)[]/E.?I[4 =(WB;
M1%LK.\.I6_V:\;;;2ALK*W3:/4Y[=:NM?VJ7T5DTRBYE0R1QG.64=3^&1^8]
M:\]\-:5!XE^&^HZ;!.BS+?W+V\B,/W,@F9XV&.G.#]#5ZPDU?Q-X2U;5C;O:
MZI/8/8VT9X*R*I#D>F9<CZ(M '5Q:_I4UW':QWT1EE)$0S@2D=0C=&([@$U!
M=>+?#]F;D3ZO:(;9@DP\P$HQR<''?@_3O7$7D]OKWPY\/Z=ICJNKPS6B1VXX
MEMI8RHD++U7: ^2>WUJY:7-A_P )9\07>:W_ -1;J69EZ" AAGTS@'WH [F;
M4[*"UBN7N4,,P!B9/F\S(R-H&2W'/':EL-1L]4M%NK&YCN(&)&^,Y&1P0?0C
MTKRG3=4@TO3/!.IZC<3IHXTM[.2Y@=L6\QV$;RO(R%VUW_A.#1UMKVZT196M
M;NY:=IW=F$\A W.N[MVR."0: -&^UW3--D=+N\CB* -)G)$8/0N1PH/J<"J6
MK>*].TG5=+T^:3,E^S%6 )545&;=D>I  'OGM7.Z%?6NFW_B_3O$,L<4LU_+
M<J)R!Y]LZ*J;<_> "[<#..E8VG17'A^S^&[:V[0>0;E)&EX\O?$WEH?0X(7'
MJ,4 =%9>*(],\3^)X=;UA5LK62V%MYP5=@>+>P&T#/)Z^G6NKGU.RM[:*YDN
M$\J8 Q%/F\S(R-H&2W'/':N$M;NP?Q+\0Y'FM^8(!EF .W[/@CGWX/O6/I^J
M6^EV'@K4]2N)X]'_ +(-F]S [8MYSY9&\KR,A,?A0!Z3_P )-H?V*"\.JV@M
M[B3RHG,@&]\XV@=<YZCM4^GZQIVK6DEW87D-S;QNT;R1MD*R]17G'B%?#T/A
M:.?33_H5[KUO</+/(Q6X;>OF.N_JN.IZ<&O4HEB";H@FU_GRF,-GO[T <)K?
MC0:GX&U[4=#O)+6XL3((W"#<0A"DD,IP"<^_3I74:=X@TN^NAIT.H02W\<0>
M2%6RP'0GWP>#CI7FT]]:Q?#'QGI\DRI=QWMYNB;AEW2Y7/USQZ\XZ&N@O;NQ
M7QUX(\B>#;]DNE C<8P8TVCCU(./I0!UJ>(-)DO$M4OHC+)(T4?7:[K]Y5;H
M6&#D Y&#5>Y\7>'K/[1Y^L6B_9V"2_O =C'G!QW]?3O7FC:W876E>&+B*6.S
MB@U]#)IL2<68W29\PD%MY)SU .3@<9K>M;K3V\1?$61IK?#0PC+,!E?L^".?
M?@^] 'H:3126ZSQNKQ,N]70Y#+C((QUXJE:Z]I=[83WUK?136L&1+,ARJXZY
M/MW]*S? ,J3> -!*2*^VRB1L'."% (/N*P;FPN]/\6WGA^WA8Z5XA/VLNOW8
M2I N5/\ OKM_%Z .RFUO3H(897NEVS)YD852S.@ZL% SCD<XQR*:VO:4MM:7
M)U"#[/>.$MY0^4D8G  /3)/:N:2[&D?%'46U21(+:^L(5L9I2%3]V6WQ@G@'
M+;L>E<Q<VKV'A2[OV!32_P#A*DOH#CY4MO-7+CT0G)'L<]Z /4X]2LI=1ET]
M+A#>1()'AS\P4G ;'IGO5JN#L=7L+SXL3SVURDL#Z&@25.4?$SDE3T8>X]#Z
M5V&EZI9:UIL.HZ?,)[2<$QR!2NX D'@@'J#0!C>-O^$@AT&6]\.792[MAYC6
M_E(XF0?> R"0V.GY8YJ*77FUOPUIDOA_4'6[U+;Y$I1&*@?ZPNN,?*,@XQ\V
M!WKJB0!DG KSOX?C38O&'B^*S>':MXOD(CY"JPR^P9X!;KCT'H* .VEO;?2[
M>%+V\9Y&^52R@R2D<G"H.?P%1-XAT=--346U&#[$[;!/N^3=G&">QSQ@]^*Y
MW4+HZ7\4[2\U%Q%IUSI;6MO/(<(D_F;F4D\ LH'UVXKF-;LY3X7\=WUJI;3+
MF_MY[?8,JVQHS-(N.H)!Y'7:: /4O[2LO[3_ +--P@O3'YHA)PQ3^\/4<BL?
MQMXA/AOPY/=Q.JW3%8X=PS@LZJ6_ -G\*Q/[:T[4?BGH\]E=QW$#Z7.B2QG<
MC,70X#=#T/3I5KXI7$,'@>=9940O<6^T,V"V)D)Q] ": -#2+N*'69H#XA:]
M2[C$MM:SH!(FW(<JP W+TXQQ5Y_$VB16,][)JELEO!*8)7=\;9!C*'/\7(XZ
MUSGB'4;*P\?>&-3NKJ&*P:VNXA<NX$>\A"!NZ<X./7%<CJ=_:2> ?'R&4*TF
MLLRI("K,"T6.#SV/Y&@#O]0\>Z#9RP0PWT5S-)>K9LL1+"-CRQ8CI@9^OYXH
MCQ*NG^-]434=6"Z4EA!<0K*% 1G9LXP 3PO?)IGC>6RMH/"]^C01V4>M6\DD
MZ8"*GENH8D<8Z#/TIMA?6$GQ6U68SP?\@F##.0"!N<L.>1P02/SH ZX:MIYT
MZ+4%NXFM)@#%*K9$F>FW'4GT'-5#XHT-=.DU!]4MDM8Y#$[N^W:X_@(/(;VQ
MFO+]'U"+3_!W@S4YY)O[)M+B[BO)+9CFW+LXC<[>0!DCZ-[UH>*F\//X \3Z
MAI$CRI?&#S;J25F6XD5QPN[J0.I'\P< 'I6GZOIVJM<+87D-R;:3RIO+;.QO
M0U%+X@TF"[^S27T2R>:(#G.T2'HA;H&.1\I.>:N6HMC"LEH(C%( 0T6,,,8'
M(Z\ 5Y%XAUBRN= UM(Y$L7M]:1I;"-/GR)TW32D@D;L9!&T=!R: /5;_ %G3
MM+S]LNDB(0R,,$E4'5B!T7W/%86H:I=+XZ\,PVE^7TW4(+J1XDVE'V(I5@P&
M3][UQTK&C\0:;H_C7Q!#X@D$-KJL4$EE-,AV3Q"/:T8XZ@D_+WW'UJAXKB,V
MM>$]/T.:/2;@65ZMM&_RF,%(]BL.J[@"/49..10!WLOB;1(+.:\FU*WCMH7,
M<DKMM4.#@KD]6R,8ZU+::]I-_J,VGVFH037<*[I(D?) S@GWP>#CH:\]\1>)
M-+UGX.ZG' L-G<0(MO-8[AF&19%!4#N,C@CK^=:NLW%NWQ"T".PN;=)7TN[C
MA*., D)L'';@X^E '6'7]*6[2V:^B$CR&%<GY6D_N!NA;_9SFE_M[2_/O8?M
ML9ELEW7*#.81ZMZ5YL)8=0^#0T# &NQ!;;[$3B=;E9 0<=>OS;O3)]:Z#78;
M_1?%6FZA9Q^?)JMJ=+N"%RHF +Q2,/0?O,^U '5)KNF26,%ZEY&UK<.$AE7)
M5V/  /?-8OAK4KN36?%$.H7S306-XJ1-*%41Q^4K$< # R>365X.L+NRU&;P
MW<)(UEH-P\MO,_\ RT209B&>^T-*#Z$+6->R27=K\0DTT_:;A;Z";R86R\D:
M"(N!CV5A^E 'I%GK>FZA=O:VUVCW"()#$<JVP]& .,K[CBN9\4^)UCNM!CTK
M52K3ZO!;RHB@I-&6PX#$<X( .T\9YK*N+G1/$]E=7_AFXO+[7(]-GCA<RR9M
MPR'Y6SP&+8 '7/(Z9JC>>(-%O?"?@N*VN(5EL]3L5FM_X[<IE6#+U7!!Y/6@
M#TF\US3-/DD2ZO(XC$%:4G.V(-T+GH@/8G%#:YI8LX[M+Z&6"4D1O"WF;\==
MNW.<=\=*\ZU74],LM7\8Z1-J]A;KJH56:_9HVB9X0I*C:0ZA2".5Y!'O5F]U
M#3="U_0KJ[U&8^'Y-)%G;ZC!*2@E5@3N9>FY0.?5?;@ ]$L;^TU.SCN[&XCN
M+>0922-L@U8K!\)VVE6^ES/HL<JV5Q</.LDC,?.9L;G7=R 3GV.,C@UO4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4A (P0"/0TM8WB?Q%;^&=)-[.DDA:18HU1"V68@#) X'/\
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MD.JV5P+LQSC;:,4G9@56,CD@DC' YJ&SU[3;^]-G!<YN?+\Y8WC9"\><;UW
M;E]QD4 :6!2%%8@E02O0D=*S$\1Z1)?168O%$LV[R2RLJ2[>NQR-K8]B:I3^
M._"]L-TNMVH7S3#N#$@.,9R0, <CGI[T = R*XPZAAZ$9H;.T[0"V. 3@5A7
M?BJRM?$]IH>V5I9X&G,BQ,R@ J!@@<YW?ACGJ*W'=8XV=L[5!)P,\?2@#!\+
MZ#<:)%?K=26\S7-]->*\8(*>8V2O/IZ]ZZ"N$TO59O%%SJ4\6L76GO8:DZ1A
M8CY1MX]H8.& !+?,>3D9'I746OB#2[R[CM8;H>=*ADB5T9/-0=60L ''NN:
M-+:O/ Y.>E+BL2/QAX>FO([2+5;>2>2X-JBH2<R@ E<CCH1[=JLZ_K5OX>T2
MZU2Z61HK>,N5C4L6..!QT^IX'>@#2I-J^@ZYZ5Q&K>(I1JOA*\COY+:QNY9!
M=1,NQ#B%FR=P#<'WQ73:?K^E:I9W%W9WL;P6[,L[ME/*(&3N#8(XYYH TL4C
M*KJ5905/4$<5GV>NZ;?WSV4%P?M2()3#)&T;E#QN 8#*^XR*N7-S#9VSW%Q(
ML<2#+,W:@"0 #. !GK0RJV-R@X.1D=#65)XFT>"WNI[B]%O':A3/]H1HBF[.
MW(8 \X.*99^*]"O]6.EVNIP2WH4L(@3D@=<'H2.X'3!H V H P ,>E"JJ*%1
M0JCH ,"LRX\1:3:726\]XL;-*(0Y1O+\P_P%\;0WL3FG:AK^F:6T@O+KR_*4
M/*0C.(E/1G*@[ >>6P.#0!HA%#%@H#'J0.32!$#%@JAB,$XYK'N+VQE\2:9$
MFM%)VBD=+&)@5N%(!W-P3@ 9!R.M<_)K#^(O$6N:3#JMWIHLHX1:S0Q,,.RL
M[.X(P1P!AL @''7- '=48K T'4+&+09KLZ\=1MTFDWWDQ  .[E1@ 8!X%:%C
MK-AJ5Q/;VTY-Q;X\V&2-HY$!Z$JP!P>QQB@"Z$4.7"@,>"<<FG8&<]ZQ?%NN
M?\([X8O]21=TT,+M""A8%]I(SCH,U@1/']LTB]E\7W]O'=/$OV*1 /M,_<#<
MN0IS@@ #I@C% '<,JNI5@&4]01FEP,8QQ6)=>+] LI;N*?5(1)9[?/1<L4SD
MC@ _W3G'3'-6Y-<TV.VM+C[4KQW@S;>4ID:88W?*J@EN.>!TH OJBHNU5"KZ
M 8%+@5D-XHT1-,CU%]2@6TDD\I'8D9?.-N.N<\8QD5)I_B'2=5O9[.QOHYKB
M!0SHN?NG@,,_>'N,B@#3Q2;%W[]HW8QG'.*S$\1:2][#:+>+YLS,D)*L$E9>
MJJ^-K$8/ )/%5M/U+3A=:W<KKOVF&"13.DCKY=GA.0#@<<9/)H W:0@$8(!'
MO6=9ZWI^I7$EI;7+"Y$0E\MXVC?8> X#@9&>^"*R? =]>7^B7;WUU)<S1ZA<
MPB23&2JR%1T '0=A0!U&!GIUIK(KXW*&P<C(S@U#>7UM81+)<RA S!$ !9G8
M]%51RQZ\ 56M]>TNYL)[Z.]C^SV[F.=GRAB8=58-@J>G!&>: -$@$8(R*155
M5"JH"CH .!6?;:[IMU-/"ER$F@022Q3(T3HG]XJX!V^_2J47C3PY.UH(M6@?
M[6_EP$9PS;BN,XP,D$#.,]LT ;V*38N_?M&[&,XYQ6?>:[IUA)(EQ<%3%CS"
ML;LL>>FY@"%)]_45 EU:2>+W@36':Y2S^?35(**-X_>GC(;D#KT[4 ;&*,5P
M_COQ,EKH#MI>IS0W27<4.Z&,E')D573>5(R 6X!!&#Z&NHU'7-.TK=]LN"FQ
M/,DVQL_EI_>;:#M7@\G X/I0!H 8&!3=B[]^T;L8W8YQ63>>*]!L#$+G5;9#
M+"9TP^[=&!G<,9XZ8]>U(_BS0X[9;C[>K0F!;DO'&[A(FZ.^ =BG!Y;'0^E
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M*:@\':[_ ,)'X6L=1<;;AD\NX3&"DJ_*XQVY!/T(H W JKT '&.!VH "@
M#L*R[OQ+H]BTOVF^2)(9!%+*5/EQN>0K/C:IY'!/<>M077C'P[9$B?5[92(/
MM&%;=^[R!NXSZB@#<HQ63=>)M'LX%GFO (3&LID5&=41ONLY (0'L6Q5B[UB
MPLHT>6<L)$,B"%&E9D'5@$!.WD<].10!=95=2KJ&4]01D4N!C&./2LE_%&A)
M!93MJMJ(KW_CV;S!B3Z>PP<^F*KCQIX=-O<3#4X]ML^R5=C;U.,_<QN(QDY
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M!JGBNQTS6=)TYA)(VH;V#QQLZA%0MD$ Y).W@=CFMUG5$9W8*BC)9C@ >IH
M545,[5 R<G ZFD$: DA%R3DG'>L-?&OAM_L^W5[=A<2^5&PR5+;MN"<8&2"
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MRK%3<JW(('.T$D=N^*ZC5G%S\1WCLKB-9YO#D\,+JXQYC2*4&?7N/;FN_HH
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M4E0>."?7@ P-6C3P[XR\-74H\O0X+.6Q$K?<MY#MVESVW!0N361K&G3W]O\
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M,RS06,5R]U/']T*Z!5C)_O$\[>HP>E<E<R[?@[KNDM%.+Z.ZF5H3"P.6N2P
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MVS&Q4/<+Y$@95/1@I7++P>0"*\UM)%3P!H=I)%,DMOXB5I4EB8%5%R[$G(Y
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MZ^AU)46*ZDB>1VC\LMN8@99R .,9Y)(K4O?%FCZ>UP+BXD"VNPW+K [+!O\
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M[6 DV\1)R2@R3]* )**YC3?%]KJEQK<+Q7=O#I\IA,C6\@. BEFSC@Y;@=<
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M?*;,H:%5!7CYLD$<5ZC10!Y_>R*VJ^ )%5RD&\RL(VQ$# 4&[CY?FXY[TQ9
M-7^(;E)-D\$7DGRVQ*1;[#MX^;YN..]>AT4 >9_/;Z!\.[M[>Y,5D\:7(2!W
M:(_9RGS* 2/FXZ56\574^HV/C&Q;3[RWN/+!@M[:T8?:5\M?WLDBCYB.1C.
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M:F"<7,5_"7A\EMZA;C<25QD +S7KM% '&:;<1I\2M?N6W"![&V"2E#L8KO+
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M]:0"\M5.FJ0<A_*8B20'_;8#/^X*/BC_ ,DWUGC/[M./^VBUT]C9PZ?90VD
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M[W$HGC>1)#;.J$*VTC<1@'VZ\CUK+E0:QXYTK6[19A9:=9SB>9H77S#)M"H
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M&L;4W;Q=_P (P+2UN8+BUU"*]NA+ \?V945MR,2!R20H Z]>@S0 MSXH;7-
M\6QPQ7MF^G">.&55>-@4B#9+#H=Q.!UQC-7/#/BJPET_0--FEN3>75C&8Y9(
M7V3.L8+@2$89AR3SZ]ZQ8Q<6NG^/]/DL+XSW4]S-!LMG99%>%57:P&&)(Q@9
M-*ZS?9OAX!9WF;0I]H'V63]SB H=_P OR_,<<T =9J'BK2],WR7+RBVBE$,U
MTL3&*)R0,,PZ<D GH#P<5!?^-=%T^^N;*5[I[FV5'ECBM)'(5C@,,+RON..G
M/-<AIRP6+:AX=UWPW?WUR]W-);NL+207:22%U);[JX+<YZ8K>TI'B^)FJ,;6
M=(6TZWA27R'$19"Q90Y&.,CO0!U&I7HT_3I[LQR2>4A;;&A8G\!S7%^&;N"X
MT32?%&H:CJ4-R80+A&+^5=/+]U1&00V&/R[![5V.KOY>C7K;7;]PX"QH78D@
M\  $FO/%LM1_X5[X/N(+*[:71KBWGN[,PLLI505;"D DC.0.] '=6_B*PGNK
MFT/GPWEM&)I+:2%O,\L]&4 '<,\?+GGBLR+XA>'I[0W<<UVUJ+=[DSK9RE-B
MG#<A>HZX[#KBJ[QC5/'=AKMJLPLK"PE2:8PNOF,Y&U ",MC#$X'!P.M8^C07
M$7P+GL'LKQ+P6%Q#]F:V<2%VWX 7&3G(_.@#IQXWT3[3:P/+<1_:XC);R/;2
M!)L#<51L89L'H,^@YJ]H^OV.N&Z2U\Y)K201SPW$+121DC(RK '!'(-<E=B5
MG\ ,+2\(MF#3XM9/W0\@I\_R_+\QQS6EX?$@^(/BR5K>X2*?[)Y4KP.J2;(R
M&VL1@X- '17VJ6UA)!#(7>XG)$,$2[G? R2!Z#N3@<CU%9\GBBRET*_U"S\V
M5[/>DL/E-YD<BC.UUQD?7ICFLO6DN=,^(.EZ[)#-+IC64EC,T2%_L[E@X<@9
M.#@#/;O52*QE6X\;:VL%P+;4H4BMHQ"V^4I"5+A,9Y8X''.,]"* +?@V!M5T
M_2-?DO=36[>S4W22.XAN&=0=VUN."3@KCTZ5MZEXCT_2S<B8S2?98O.N?)B+
M^0G)W-CIP"<=<#.*K>"=Z>"=%@EBFAF@LHHI(YHV1E94 ((8 ]:P(=0F\,^+
MM?M]2TN_NK359DN+2>VMFG5_W:HT;8'!&T8SQCTH ZN37[ ):&"1KI[N+S[>
M.W7>TD> =_LO(Y..H'6J<WC/0X-#?6'N9/LD<ODR$0N6BDSM*.N,H<D#YL=1
MZUBLMWH_CVTU>[LWCTZ[TI;,^2A=;217W!6V@X4@XSTR*PM<TF\/ACQ?>0V=
MVPU;4()+6V2W=G94:/<^P#(SM8\CH!ZT =N?&6D+J,E@QNUN5C\V.,VDF9US
MC,0V_/SZ?7IS33XUT1?#\VM233I:02F&;=;OOBD!P5=<94Y('/'(K/OV:3XE
MZ'<I;W36Z6%PCS"W?8K,4*@MC )P>M<GK DC^'_C[S;:XB$NK-/'YL#IYB%X
M@&7<!D$@T >@6/B_1]0ULZ1#-,MV4,D0F@>-9U'5HV8 ./<?4<4Z7Q7I4$]N
MDLDJPW$_V>*Y,3>2TN2-N_IU! /0^M8^J6__  D7BOP[<6*3*FG&::>=HF3R
MPT>T)\P'S$D9'8*<]JP?#*6Z:9:^&M7\,7DNKV;"/,D+M;OM/RS>9]T#&#ZY
MX )H ZVY\<Z);-?J6O)'T]@+I8[.5C$,9+$;>% YW=/3-:3Z[9 6WD&2Y:YA
M^T1+ A8M%Q\_T^8>YSQFN0@$HO?B S6EX%N0OD$VLG[[%N$.SY?F^;CBJ<6G
M176@>&DEEU71M5L]+18;^*"0>6P50T4BE<$9 .T]<''N =J?$NGF.Q,1FFEO
MHC-;P)$?,9  2Q!QMQD=<=<=:S=4\<6=OHFF:GI\<UW#J%Y%;(RQ-\F9 K;A
MU!'S #J2*Q8-2UDR^'4UO3;F#SK.3S[BQM&,AEW +&2H)B#* QZ<X&1@UCVM
MM>Q?#S38FTS4%?3M?6XGC:W=G$8N68D#DOA2#D9^IYH [TW^FS^+K&$W%_'J
M!LY'CMF61(FC)7+,",%@<#U%27/BS2;17FEEE%I'-Y$EV(F,,;YVX+>QX)Z
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M""J\X;=D'_Z]7;VUCM[[P>;'1;BRM8K^6=H8[9CY*,C@,^T$*22"0>F>>AH
MZK3_ !1I>HVU].DLD L&*W27,31/%QNRRL <$<BB#Q+83:D=.9;F&\,)GCBF
M@9&EC'4ID<_3K[5Q&K:;J.IWGCV*QM+CSKC[%+:F2%T2?RE4LJL0 >5V]>];
MGAZ\TO6-0MKRW\.7UK=VR-YLU[;NAM\C!12WWB3V';.<< @&7:WL?B:/7;J_
MO-9L?L&HR+%-:"5/*AC"C;M ().6)!!//L,:C>*;/1]&\-1V"WU[;ZB\<4-Q
M*K2/LP3ECU+$ X'X]JK>&FDBTCQ>);2\C:;4KR:)7M9%,B, %*@KSGVK+C@N
MK?P9X"F>QO?^)==P&[C6UD,D0$;J24 W8!(Z#O0!Z<C!T5P" P!PPP1]13JS
M[;5DN=5ET\6EY')%"DQDDAQ&0W\(;H6&.16A0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% %;4+:6\T^>VANI;225"JSQ8W1GU&
M>*@T?2AI-HT;74UW<2-OGN9\;Y6P!DX  X   '05H44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %8_B?0O^$ET&XTEKDV\5QM#NJ;FP
M&#<<X'('K6Q10 R(2+$HE=7<#YF5=H)^F3BGT44 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3SG_ $G[%-Y8 ."2=O !!R3Q6_!/#=6\=Q;RI+#(H=)$;*LIZ$'N* )****
M"BBLS4]<M],D,/DW%U<B%K@P6R!G$:G!;!([G&.I[ X- &G167HFO6NO6<EW
M:Q74<"OM#7,#1;QM#;E#=5YZ_6M,$,H(((/(([T +1110 45F3Z[9VVOVFBR
M";[7=H\D?[L["$&3\W3N.F>M:= !14<\RVUO),X<JBEB$0L?P Y-81\9Z4-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCICQG4O$-SJJ6XVVR2Q)'LXQEB.7;'&2>YXS6SJ%H+_3;JS+E!<0O$6 R5W
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M47:K(<C:<'ON'M0!SVD>,M2UFQT2T:%X]0NEN?M36HCR/(<(=GF';\Q(/.<
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M1RD9$6[)9L'@D ' /<BN>G:71?B=/=W%W->1P^')I@)0H8!95)&5 SG'IWH
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M\0A95N.SKC@8   ]!^-=/10!RTW@UM1T&]T[6-9O+^:ZB$7VEE2,QJ"&&U5
M Y ))R3@9Z"I+;PI/%K]MK4VMW=Q>Q6C6KEXXPLBE@PR !@9&>.3ZUTM->1(
MP"[JH)"C)QDG@"@#)\.:#_PCMA+9K=-<(\\D^YT"D,[%F'';)I/$6@+K]O9J
MMY+:7%G=)=031 -M=01R#P1AC6S10!R;^"-YUXG6+MO[:A6*XWHAQA-A88 Y
MV].P].E67\*L\N@2'4&W:,"(L1#]YE-GS<_W?3'//M71T4 <;+X! M=7T^SU
MFZM=+U/S&DM!&C"-W'S%&(R%/I^1%=3I]I]@TZWM/.DF$,8C$DF-S #'. !^
ME3R2)#$\LCJD: LS,<  =2:=0!B7_AT3Z_#KEE=-::C'";=VV!TFB)SM=<CH
M>000?K56[\&6EWX>O-+-S,DMW<B[ENP%WF8,K!L8Q@;5&/08]ZZ6B@# 'AN7
M_A(;/67U.26>VMGMP'B7#AB"Q.,<Y QC  J@_@&UGT?4=.N;Z=_M=\VHI/&
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MKE0K_*Q&< G@XR/8T 8EUX<D5=6OQ?S1:I?01PFYLX K(J$XVJ2>3DY)/IT
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M< X-:"2)*I:-U8 E25.>0<$?@013J .;;PJSRZ!(=0;.BC$.(A^\^39\W/\
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MD@\*7$>NPZU)KEU-?):&T=GBC"R*6##Y0!C!&>.3ZXXKIJ* .03P*L?A;3]
M74Y?L]E<+<1RF)=Y*OO4'MC/M6D/#,?_  D=UJ_VR4+>0)#=VH5?+FV A2<@
MD##'@'FMVFQR)*NZ-U902N5.>0<$?@010!RNB>"GT62.!-=OYM(@?S+?3Y I
M6,@Y +XW%0>0,XX'6FQ>!OLFIW<ECK=_:Z9>2F:YTZ,*49F^]M8C<@/?;CZB
MNKFD,4,D@1Y"BEMB#+-@=![U%8737VGV]TUM-;-*@<PSKM>//9AV- $X
MP!T%88\.&'Q'?:S:ZA-"][%&DT&Q61F0%5;IG@'H",_I6[2,=JDX)P,X'4T
M<DG@58_#&FZ$NIR^1I]REQ%(8EWL4?>H/;&2>WI4EWX,D;7I]6TS7+W2Y+P*
M+V.W1&28J,;@'!VMCC(K6T'7;?Q!92W5M#-$L5Q);LLP ;<AP>A/>M2@"*W@
MCM;:*WB!$<:A%!.3@>I/6LJ\\/+=>)K77(KZ>WGA@:VD2,*1+&6#;3D$CD=1
MS]*E\0:];^'=.%]<P3RQ&1(SY*@[2S!03DCC)%6OMS?VP+#['<[#!YWVK:/*
MSNQLSG.[OC'2@#E4^'BQZ;;:<FNWRVME>K>6:;(SY+!R^"2OS<D]?7I6I?\
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MU4R";/#H0H XSD=..E<UI&LZI=>![6ZN=86.=M3>":X>,>9)&)F79&JJ?G(
M  'K70Z)X9ETD#S]:U#46B0QVYNBI\E?4  ;F_VFR?IDYH+X!MH]%M=/BU2^
M1K2^-_;W V;XY26)XVX(.]N".] '.:IJ6HW7AOQ[837=[&FG1JUN9"HE"/"'
M*,5ZC/XX.":VQ?WD%QH>@P3W,IN+%[J20/&LA"[%"*2  /F)Z9X'/6KP\#VC
M/KAGU"_G7681%<J[KU";-XPHP<=N@]*;?>!X;ZPTY&U;4$U'3CFVU%&595!
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M=6MJ\B3;58DJN>01CGZ50T:.P\1^)U\4V]I/&D-I]FBEGB:)I&+$D[6Y^4<
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M\2Q[XPN3(I!)W$G/8 C SR;/]J:OJ^K7>E#S8)K.SMWF^Q2H,32*Q)!<<J,
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M! !YYYKH:QO#7]H?V:_]H7<MW^]/D3SVXAD>/ P60 8.=W8'&.*V: "BBB@
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M((!( ..#R,RWGB."VN+R&&TNKQK) ]T;95/E9&X [F!)V\X7)QCU&>$UO"_
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M3YQ!()=OS$J&R,$\8(KD-/U?48M<\**+^YNXM1\]+NX;B"Y(B+AHE/*@$<$
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M#Q!JND?9)H9-.6)F>0KB02!B"N">/E[\\]* -.WB:"WCB>>2=E&#))C<WN<
M#\A6#_PAUHC:C';7EW;66I.TEU:1%=C,PPY4E2R[AUP?IBK>O:^F@_V=YEI-
M,M[>Q68="H$;2-@%LG./H#T[5L4 8FH>&+:_N]*G6YN;4:6VZVBM]@0';MY!
M4\;>,5M8RNT\\8.>]+67J6LBSO8-/MH/M6H3Q/-'!O"#8F,DL>G+ #W/ID@
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MX^U(X=6:27GYG+*2?O'T'Y"N@HH YI/!=I#'K,-O?WT%MJQ<SVZ&/RT+C#%
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MM;!'.00?4$ T <GI-W>KXZ72UFU&*RN-&-QB[DWN9%D5?,4,6*9#'Y3CW K
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MEG 2)]X<E.,\D="3C)Q@\UJP^'8(/$1UL7=VUR;86I5W4H8P<@?=SG))SG-
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M/ S*Z#^V]/62RGBD/_+>,8&[Z_*3]30!V%%>:6,NI:I;>%&L]0U/[=,W_$X
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M'SA*L7GDA"&WJJYZ -SQ^.:Z>B@#%G\,V5WJS:E<RW$L[6C63JS *\+<LI
MZGG/7\*HVW@/2;;^S")]1<Z:Q-J7NV.Q2NW8/]G''TXS7444 96G^'[+3-4O
MK^V:=7O9#-+$928]Y !8+T!.!S3-2\-6.IZO;:H\EU!=V\;0B2WG:,O&3DHV
M.HSSV-;%% ',1^ ])ATZ"PBEO4MX+S[;$HGSLD#%AC(. "2<=\\YJW<Z7!IF
MHW?B55OKN\6U\IH8=K&1%RP15P.<DD<YYK<HH YW0+1;S5;WQ)+ILMC/>11P
M)'<(%E\M,G+@$X)+$8]%6M36-(L]>TFXTR_0O;7"[7"M@\$$$'L00#^%7J*
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M)! NR/SGWLJCH,]P/>J\'A^WMM7U#5(;FY6ZOU59CN4C"@A<#'& 3_7-:U%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBLG6=?AT;RT^Q7U]<2 LMO
M90>8^T=6/( '/<\]LT :U%9F@Z_8>(],%_I[N8]YC=)%VO&XZJP/0BM.@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
3 "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ex101slackseveranceagm05003.jpg
<TEXT>
begin 644 ex101slackseveranceagm05003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JI<Z7I]Y<Q7-U86L\\7^KEEA5F3Z$C(JW10 4444 %%%% !1110 =:9%
M%'!"D,,:1Q(H5$10 H'0 #H*?10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %07M[;:?:O<W<JQ0K@%CZDX  ')))
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M"L]P@A8M''Y\AW%<9QA@>G>O3K^.74M!NH[5FAEN;9UB9P5*,RD*2#R.H]Z
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M%JL-Q:^;"T95[0Q$;V;(^4  X/?(QUK3\16&HV/C"TO])C<KK$!TZ[9/^63
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MWQ"@:^%P\<VAPVL4L<+R"65)&W+\H/."#SZUSMH67P#X<@EM;E)(?$2S2QO
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM4\5?#/5;ORA#JNLVRR+$&^ZB@;(P?1@"?K(:ZG6M%GUB6W"ZM=V=LH9;B"
M*!<*V."2,COR.>3TZUK(BQQJB*%10 J@8 'I0!PNI.WBVV\,16EM<0W5MJ$%
MW<K)"R&U6,'>K$@8)/R@=\YZ"LN[DELM.^(.DR6-Z]W>O<7%N([9V62-X% 8
M/C;P0>,YSP,GBO4** .?T754@LM!TV2TOEFN+,<M;,JQ%$&0Y.-I],]:Z"BB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MADD:46R?.6$BG=LXR> .<=\F@#N/'WBK_A#O"=QJ:1K)<EA#;HWW3(V<9]@
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M2;R2\\6Q9> =R'^)>>M7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBJSWL*WR68R\[+O*J,[$Z;F] 3P.YYQT. "S115:
MSOH;T2B,E9(7\N6)QAHVQG!'T((/0@@CB@"S1110 4444 %%,FD\J%Y-COM&
M=J#)/T%97A_Q+I_B:">?3O.,<$IAD,L1C*N,97!YR,B@#8HK-TW6K?5;B[AM
MX;E3:R&*5I(BJAQU4'OU[9K2H **** "BBB@ HJIJ>H0Z5IES?W"R-#;QM(X
MB0LVT#)P*=IU]%J>F6E_ &$5U"DR!QA@K*",^^#0!9HHHH **** "BLO6]>M
M=!AMI;M)V6XN$MT\I-V&<@#)Z 9-:E !1167H^NVNMR7Z6R3H;&X-M+YR;/G
M !X'7&&'7% &I1110 444UI$5@I8;B"P7N0,9('XC\Z '45F:)KMKKT-U+:I
M,@M;I[603)M.],;N/3GO6G0 44UG5,;F"[C@9.,GTIU !1110 4444 %%%8>
MI>*;339+E?LUY=+:,BW3VL8?R-_(W#.X\$$[0< B@#<HHK,UO7;30=(NM3NA
M+)!;#,JP+O8=^G;J.N.M &G13(I!-"DJYVNH89]Z?0 444C,%4L<X SP,F@!
M:*S-#URUU^SENK1)D2*=[=A,FUMR'!X^M:?2@ HI$=7171@RL,A@<@BEH **
M** "BBB@ HHHH **** "BBB@ HHHH **:KJZ[D8,,D9!SR#@_K3J "BBLK6O
M$-EH5BEW<B:2)YE@!@3?ABVWD]!SQS0!JT454TV_&I6IG%K=6V)'CV7,>QSM
M8C./0XR#W% %NBBB@ HJE<ZM96FJ66FS3A;N]#F"/N^P M^AJ[0 4444 %%%
M% !1110 4444 %%-9U09=@HR!DG'). /SIU !14%Y>06,'G3OM7<%4 9+,3@
M*!W)/&*?YRA5W@JY0OY9P6P,9X&<XR.GK0!)169H>N6OB"RDN[1)DCCG>!A,
MFUMR'!X^M:= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWV6T?S!(E<*V0?EY/3GGKVK:M_$%UK6OZ?I$4[68DTA=2GDB52S%V"JB[@0
M/F).,]/>IU\(,+'7[4ZBQ76W=YSY(S&74(=O/]T#KFG_ /"(B*;2KVUOVAU+
M3K;[(MQY0*S0\?)(N>>@/!'/Y4 8%QK?B-M'\465O>$ZKH$RNDZPI_I,)7>
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M['6]'2<F:;S#;R& 6[0;B"N<^8& '7USQCBN@E\-R3:QHVI27Y\S2HY(T01
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M9>2:;+I<300F.-7!B8 %"&_W1@_SH 3P?J5[J(UU+VX,YL]6FM869%4B-0A
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M;W. !GZ 5RB>!(X_#=MI"ZG.#:7POK>X$:[DDWE^1T(RQKJX8S%"D;2/*R@
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MDCGJS&%R3^9H ]$I"<*3@G Z"N)N-0UO7I->CTB6X@FL+EK6U,;Q!!(J*V9
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M^1%&% W"0A23ZBNRL(9[>P@AN;EKF=$ DF8 %V[G   H L45S=SJ$^H>,Y-
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M3LL%S-+'-'M&' A=ASC(P5'0UM4 <M>>"EEUZ?5M/UC4-,DNPHO([5EV3X&
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MT;V5I;_3G@:%@H7Y48(%P,Y^8]SG-'A?15U#PSX<DO+Y[F&R@AFB@*J-LJH
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M!]^:MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?\B-X?\ ^P;;_P#HM:VZI:1IL>CZ1:Z;%-++%:Q+#&TNW=M48 . !T'I5V@
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ME9"KP%BP4C&X$9W'//7/2@#TNBO.+C6]0\,3^,X5O;B]BT^T@N;7[6WF&-Y
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MNSSR@^9*SCB[//)Z^I[UV:O>Z5\1;*S;4[JYMK^QFEECG8%$=&7#( !MX8C
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MJL "".^0 .?2L?Q!X;2ST/51865W?MJ<Z/?1+/\ .RY&]TR1\X4< $#@=>E
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHKG=/OCX@UG5D621+'3I?L:B-RI>;:#(Q(Y^7<% ]03
MZ8 .BHKSGP5XVL++PKH\&K7=V\\\DD37<T<CQ^897VJ\I&-Q&.I_*NFN]1?1
M_%6GVDDC-9ZMYB(&.?*G0;N#Z,N[CL5&.IH Z"BBB@ HHHH **9-$LT+Q,7
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M?Y=Y&.C#OWJ7PW=66JR:=%-X6O;?5K,@S/=V[+';,!AF5SP<]L<G/IFN^HH
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M^V<-=++(HE\KRC,@<[9"G\)8<X]ZWJ** "BBB@ HHHH **** "BBB@ HHHH
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M-Y2A'7]Z),;2NU=W!SGCK0!UFH^-=+T[4KG3WAOYKNVB65XK>T=VV$XW 8Y
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M#>^>W&2 :NN:6NMZ+=Z8\[PQW4;12.@!;:1@XSQ4^GVAL=/M[0RF7R(Q&'8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,6AZ;($9RFKVC;$&2V)!P/>I)K9M2\;VFN);7,=IIUC+&SO Z/*\A&%5" Q
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MU+"SGMKAK<!MDCJF,Y(PN01FIM(@OM!T_P 0Z+=Z?=W+SW-Q/9RQ0ETN%EY
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M8-GE%HBO5B,C)ZCC^5;/CS2;[6/"[Q::HDO()XKF.(G E,;AMN??'YXKIJ*
M./NX)/$WB/PY?0VEW;0Z:\MQ.US T3*63:(QN W$D\D9&%Z\BN=FL-33X?\
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MFXMO.0IYUL^R1/=3V- ''^'-%N;'Q5?:;E#HNG3M>6:@\I).I^3'8)F0@?\
M3131HJ7GARY\1V%YI]W<I>7LU[9RPPM(LPE _=DCA2",?-@<^E=7I.E0Z/9?
M9XI9YV9M\L]Q)ODE; &YF[G  ^@ J]0!YI;Z#J'A:#P*\EI<WJ:6EQ%=_9$,
MK(TJ<8 Y*ALC-;O@Z*^CUKQ-+=Z=<VJ75\)XFE PR^6H['D\=N/>NNHH XKQ
M=I4.HZN)5CU2RU"WM0UIJFGQNYW%FS$P4$$<*<'CYCR*@MX]8?Q5X4N]3LYO
M/@TV6.]EBA)C25PF!D#'\)Z<"N\HH \SB_MO3]*UU[/3;W-QXB-P^VW/FFT8
MIEX@PY;Y3CN.N*NZ+;W-GXG\3W']D:C%:7EI;M#)*I=F*HX.3DL6)(XY/KBN
M_HH \O%AJ"?#+PQ8'3KW[7:WEJT\(MVW((Y S$\=,?GVKT749+D:1=R6$2RW
M8@=H(Y!@,^T[0<],G%6Z* /,K*+4I]=\'ZG)H^KM+ LZ7TDZ!=DCQ!>%SA4!
MST &.F35NRM[ZST7Q5HTFEW;WE_?7CVP\DF*1)B=K&3[H'.2"0?;->A44 <(
M-(N-,\2^";9(;B>#2[&:VGN4B8HI,<:KDX[E3].]8JV^K:=X"\0>$Y]'U">]
MQ<_9IX82\=PDC,P;?T!^8Y4\_6O5:* /-KFWN]+UVRU>\\,W&J6%UIL-M+$D
M"336LL98CY,_=(8]#]:[C0XEBTQ2FF1::CL76U1%4H#TW!>-QZG'3..<9K1H
MH XO3VN=%\2^*'N-,O91?3QS6AAA+I,!$J[=PX4Y&/F(JI+X2GTWX4VVGF>.
M/4M)3[=#-GY8IT8R8S_=Y*_0UW]8^I^'H=6U*WNKB^OUAB7:]G'/M@FYS\ZX
M^;\^1P>* %\.6]Q'I"W-[&([Z]8W5RO]QV PG_ 5"I_P&LG7H+R'QWX?U.*Q
MN+JVC@N8)&@4'8S[-N[)X!P>:ZVB@#SI;6\.D?$"+[!>;]0DF-HIMW_?!H @
MQQ_>']:KRVEWIE[H6KW/AVXU6Q.D16%S;I;"2:VE0Y#!&Z@Y(./3/IGTVB@#
M+T&-$TXO'I4>EQRN9%MEC5& ..7"\;CC/TP.HK4HHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)
M\0>(+3PW8QW=['.\3RI#F%-VTL0 3SP,FM:N.^)C%/"D;JC.RZA:$(N,M^^7
M@9H O6/C*TO-9FTF6PU&SO4A,\4=S"%-Q&#C*8)S]#@_KB#3?'NG:E9+?K9:
MA!IWD2S/>S0@1((V(*D@GYN,@ <].H(#;BUDU;QIIFM+;7$5II5M."\D+*\K
MR!0$52,D  G.,9(QGG&)8>&=2U+X,S>')()+/42D@"3#'S><9%&>F#P/QH Z
MM?%%NFH6-I>65W9&_!^RR3A-LC 9V?*QVMCG#8S]>*73O$]MJ/\ :P%K=0/I
M;F.X2?8IR%W<88C&.03@5BW\%[XL'AU)=/N;*6QOHKZ\,R;1&8U;Y%/1\L1R
MN1C.<=*DU;P_>OXUBNK)!_9VJ6X@U7Z1D,A]]REHS[&@"S<:II=UXB\-?:].
MO8]0N4FDLFD&T1?N\N'PV,[<<<XSVJ]%XDAGE'D6=U+;&[:T^TIL*"16*G(W
M;@-P(SC]""<[7[:ZE\<>%KJ&TGDM[1KDW$J)E8]\>U<_4^G3O6/_ &/=)XBB
MU/1+:_TR_EU$_P!H6Y!^RW,&\AI3GY=Q4 C!W9/3O0!NZ=JNB1:QXFN$AFM)
M[0Q-J,TY(5L1Y4@9. $'H*L+XJMENM/AN[.[LTU$[;2:=5V2,1D*<,2K$<@,
M!GIUXKF+WP]?ZU<^/+0036ZZHD M)I%(20I$%//8;ACGL<C-7+RVO_%.G>'[
M*;3KFSN+.]@NKTS)M6+R@<A6Z/N/ VYX.3B@"[/X]LX8M4DCTK59ETN0I=^7
M"HV *&+\L,C!Z=?;%:K^(;9I[>"SAFO99[7[6B0E ?*X ;YV'7/']*Y5+&_^
MP>/(SI]T&U%Y3:#RS^]#0A!CT^8=\4RXT2+4-)T6"^T_5+.\L]-B6#4;)6$T
M$P&UHSMZC@'D%>O(XH [RQNUO]/MKQ$>-+B)9520890P!P1V/-9-YXKM;6*^
MN([.\NK73W*74\"J5C*@%N"P9MH/.T''/<$5;\.C4U\.V UHJ=2$*_:",?>_
M#C/KCC-<KI-IJ.@6'B#19].N;HW-S//8S1)N2=9>=K-T0@D@[L#TS0!/XNUQ
MY!X;CL8);JPU&^B+O$R;+B,H["/YF'7"DYP".,]JZ'2=)M=#L+C^S[2>-)G-
MQ]D\P'8Q RB#.U1D= <9)[5R5SH-[I.E^"-,BMY[LZ7=1R74L2$JBA&5C[\M
MT'.*]!!W*",\C/(Q0!Y9KNNW'B3X1W>JW5I-:N+D%&$@VD"ZV;1M;)PHP<@9
M[5W%EXGM[O7I-'DL[RTN! ;F)KE%59H@P4LN"2,$CA@#STKAVTK65^%%SX>.
MCW?VZ*Y(4 *1+_I7F94@]-O<X]!FNBU*RN=0\>VEPEM<K9MI,]J]QY9 1Y&4
M@'//0&@#0D\8V,+Z>\MM=1V.HS+!:WQ"^5([?<_BW -C@E<5NW$,=Q;R12KN
M1A@BO/O"MM>6=K9:'?\ @V-+^RVQ-J1AB-NR)P) V=Q8@=,9SUQSCT&XE$-O
M)(4=]H^ZBEF/T H \M\$WWA^3X>6-QK5^\M\XD60&\D\UB9651PV<XV@5VUQ
MKUOH-[IF@R07]U=36[>2Z1AO-\M1G))ZG(]N>2*P? XN=%^']GH^J:'J)GB6
M42PK"&#!I&8 '..A%7+J/4KSQCX5U&?3ID6&"Y^T[5RL!E5=BD]R,8)'&1G@
M4 3?\)]:G3KV[71]69M/D=+V 1)OM]HR23OVD8.?E)/M5N\\9Z?:7>GVR6U[
M=2:A;FXM?L\.X2J #@9(YPP]AGDBL*"ROA8^.T.GW0;49)6M 8C^]#0A!CT^
M8=\53CDETW7_ (?I<6ER)(-*N(9HUC+.A6.)3\HY.".V: +^M^(K+Q-\//$S
M01W=K<V-O*D]M./+EAD"$C(4\CN.2#6[9ZQ#9:;HUDL4MQ>W%HKQP1;=Q547
M<Q+$  9 Y/4C&:YS4-$O9]-\<ZC%9S"76X5@M;;;\[!(B@8C^'<2>O0 9QTJ
M9;'4-.\0>'_$"V=Q-;+I?]G7D*(3)!R&#[.K#<,'&?49H UIO&^GP:+J&HM:
M7Q.FR>7>VJHIF@/J1NP5QSE21CGL<:LFL1))IJ+;SR-J!_=[-AV +N+-\W3'
M<9[>HK'T31&EUSQ+JUW;E+?5S%$MO*,%HXX]A9AVW9/!YP!G'2J?@;2;VU%U
M%>S":'36DTW3Y <DPALDD^OW$]O*H T[GQE8VBVUS+;W0TZXN!;I?@*8MY.
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M5V-22Z5S!LYV_:?,SGI]WWKK98;F3XF6.HI:7!LUTN2!IC&0JNTBL <\] :
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5S'C;2+[4[#3KG34$MWIE_%?) 6"^<$R"F3P"0QQFNGHH Y1[.?5_%
M^FZZUE<V]OIEK,H650))9)-HVA<]  >3W(QFN:AT368_A?I.D'2;G[?;WZ2R
M0ADX1;@R$YW8^[[UZA10!CV^MSR^)I](FTN>")8//@NV92LP&W<,#D$%P.>N
M#Z5/KDVH6^EM+I=L;FZ66(B$,%WKYB[QD\#Y=W-74MXDGDF5 )9  S]R!T'T
MZ\>Y]:DH X36-%_M_P 3:'J5EH]Q87]G=K-<WLJ+&?) .Z,D$[RW XR ,\^M
M>RL]6T'6-4L'\+KJMO=WDMU:7JM&%42-N*R[N0%)/(!SV!KT.B@#A(KA[#XJ
M78>VEF_XDD"L;:/(4B1_X<YP?TJE<>&-4MO#\=S%8O+=OXC76IK.-UWHADSL
M!)"E@H&><9S79Q:#!%XCFUP7%P;J6$0,I*[-@)(&,=B2<YS6K0!P%Y;:KI?B
MZ[U4^&FU:QU6&$O&AC,MK*B[<'<<$$8R0<9'YV[VPU)_$GA*Z_LO9%9O<O<B
MWV[(!(A55ZC<03R0/4UVE% '$6MCJ,>I>-9GTVY":@$-J?E_>XA"''/'/KCB
MJ-EI.JV-MX%NY-,N&_LBWE@O(D*F1"T00$#/S#([9..U>BTFY=^S<-V,XSSB
M@#S[6?"FIZW'XAU.");>\O/LILK><CYA;MO'F8X&XY&.PQG'(&KH]W?7D;S2
M^$SI+11,)-WEEY'(QMCVGI_M'';W(ZVB@#F_ -E>:;X)TRPO[62VNK:+RY(W
M(/.3R""012>+M'NKY](U*QB\ZYTJ]6X\C(!EC(*NH)XW8.1GTKI:* .4^PW,
MOBZY\4)8S!;?2S:0P-A9+A]_F'@]!P%&>Y/89.UH6J/K.CPWTMG)9RN722WD
M8,T;HQ1AD<'E3S5]U#HR-G##!P<'\Q2111P1+%$BI&@PJJ, #V% '+^)K[56
MO%T^W\.WU]IQ7-Q)!+$OF_\ 3/YF!V^OKTZ9JOJ]CJGB30K.\_LEK"^TW48K
MRULY94+2+'U4E3M&X%@.?3)';LZ* .4^PW-]XP7Q')97"6]A8/#;0,%$LTCG
M+$#. , *,D9)/;DTK'5O$#Z@;JY\'WPO)CY2R27$/E6\9/088G'0L0,DCT
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M!*GE6+"8'\&^0'TW>M:OB/2-3NOAE?6$=JUQJU]'OECB('[UV#,,DCA>@YZ
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M0KMO$4>JZ38WFE:H=1Q>;&'V:[M@Y!=QD@DI@]FW'IW'H5(S*BEG8*H&22<
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MU8-QG(^\,9%8FAV.L:()M F\+Q7FV:0VFJ'RS$8V8L#)GYLKGH 2<?C7HU%
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M(KJ2%'569 &!VEB!GYAU(J&SM=3C\?W^K3:7,MK+IL4"NLD;9D5F8@?-G^+
M) H M6WB^VOM"TG4K2TN)&U.40PPD8*/\V[>>0H&QLGGIQ6;K'C6>+PAK]_9
M6)6_TJ1[:6.1P51P =X/\2X8$< GIQ65IFE^)M,\'Z#8?V7<%(+R4ZC:0W$:
MR2Q,SLNUM^,99<C(SC'3--/AC69?#WC73(])CM1J,AFLU69-C91 $ '0_*<Y
MP,^O6@#T/3YII[&*2XA,,C*,J6#?CD5FZ=XA%_KFJ:2]G);7&GA&8RNN)%?.
MUEQ_#P>>W2K^ERW$VFP/=6CVDNT PNZLR\=RI(_(FN8\8:-/=:]H]UI\XAN;
MHOIUWZR6K*78CT*[20?5J -.'Q0EQ!IHCLY/M>I*TEM;EP/W:C)D9NRX(]3\
MPX]*TWC>WMM-UFXFL9ENM&(-Y:;EW!2,JZGHRD<CIWZ4S6](O;;Q5HVOZ;;&
MYAM(9+2XM8RJMY38(9,D#@@9&>1TK/U+PM?:Q#XNOA#Y%QJUFEK:P2,-V$0X
M+$$@%F/KP ,^@ .BE\11PZUH^G-;29U2.1X901A=B!B&'7H1TJUKFJ'1=%NM
M2^RRW26R&1XXB-VT<DC/7 YKDU@UV_\ $'A*_DT*:VAT])X[D2SQEE+1JF<!
MCE<].<GG@<9[J1$EC:.10R,"K*1P0>U & ?%<:ZEH=I]D<IK$1DMYQ(NP84.
M0>^<'CUJEXHUZQ7PQK,VJ:++>Z;:RB&1%9")<%>>2. Q /?(/'%8/_"$ZQ%X
M9>-6234='N<Z)EO^64<A9=Q]64["/15K;\6Z%?3_  WNM%T^!KR^E15.UE3>
M^\,[DL0!D[C^- ":Y!$GQ0\)2K&HD>"^5F Y(")@'Z9/YT>#88X/$_C&.%%1
M!J$9"J,#F%2?U-3ZK9ZC=^-_#6I1:=,;2TBN1<.7C'EF54"C&[)QM.<9_&G^
M&;&_M/$?B6XN[&2""]NDFMY&="'41JAX5B1R.XH UM3U8V%W8V<5K)<75Z[K
M$!\J+M7<2[8.!CV))-<3XOUBUU_P4+[[*\<UEK$-O)&X#-'(DZJX4CK^'7-=
M%XGBU>34](-I92WVE!Y/MUM#*L;,2!Y9.XC<@.<KGGC(/2N67PQKO_"*ZSIZ
MZ3'%(=<^WV\23IMDC\Y7VIT X&!NV_A0!U=CXM,VOMHM]I%YI]V\+3VHF9&%
MPB]<%6(##T)JKHOB+1K3PS/J%KITME";^2 6H"F26X,FW  .,LWO@>N!4[6%
MUK'BK3-:FLIK2#3()A'',5\R624 $85B  %/4\D^@S7,#PQK[>$U$5@8M2L-
M=;58+>65,7"^8S!=RL0"0W?N* -!)'_X6_;RW5BMG)_8LK.X<,KCS$P=W'(Z
M'(_.M(^/;!)],9XL66I3+!;W"RJS;F^X73.5#=CVXR!5&2SU;6_&%O?S:+=6
M5E)I4UE*TTL6^-G93G"L<CC_ /51X6C\26%K9Z%?^'X$-D%B_M02H8Y(EP P
M7[VXJ,8/?D^E &[XUABG\#:ZLL:NHL)V 89P1&Q!^H-8>A^+AI]CX<L+_2;R
MVM+R""WMKY]AC>78,*0#N7..,@9KJ/$%E-J7AO5;"WV^=<V<L,>XX&YD(&3]
M37,+I.H:SH_AS2KG3IK)=-FMYKJ29D()A'"IM8YW,!SQ@9[\4 ;6F>)DU"?6
M();1[2;2GVS+-(O.5W!AC/RD<@UJ:9>/J&F6UX]M);&>,2>3(1N0$9 ..^*Y
M3Q)H<MSXQTV6SE5$U&%K74XB/];;H0^?S_=D^D@KM: .8O/&4=DMQ<OI\YL+
M:^6QEG)"L'+!=P0]4#,!G.>N :DNO%4D7B"ZT2UT:\N;R"W6X4!XU616) (8
MM@#@]<'VKD]<T;Q+JNF:O!<Z*]W?C4$FM;DW$>PVZRJRK$"?E.T<@@9Y))/%
M=%:VNIK\0;O5I=+F2UDTN.W#B2,_O%=F(QNS_%C..M "GQW;G0=)UF/3[AK3
M4)UMBQ95^SR%RG[S)X&X$9&?UK=_M$G7#IBV[-M@$[S!AA 20H(ZY)4X^AKE
M_#OAJ6;X;2^'M<M'M6D^T!PSHVT/*[JP*DC(R#]16EX'M[X>'8;_ %259M0O
M41Y)%'!4*%3&?50&/NS4 :FK:L-,^R1K;R7$]Y.((43@;L$Y9OX5 4\_I6+/
MXY@M?#^KZG+IUR7TFX:WNH(V0D, #N!)&5PPYZ^U3^+(]8=M+.G6TMW9+<YO
M[>"58Y)(]IP 6(&-V"1D9''3-<E<>'-<_P"$:\9:9!H0C.I7'F6B13QA2&5!
MCJ,8VG/3VSUH [&V\4>;XAM])N=,NK3[7"\UI-*5(F"8W# )*G# X/Z'BN4^
M(FL)K7PXU>XMM/-QIZMY<=T67[RR!2ZKUVY!&<Y]L<UN7]CJ-WXO\,WRZ;.M
MK:6]S'<.9(P8S(J <;LG&TYQFN8DT/Q)!\-+_P %_P!BR3SQ QVUY'-&(IHS
M)N!.6#!L<8QVZT >K=JYA?&41:PF?3YX[&_O38P3,0&\P%@"R=0I*'!SGID"
MNCA=Y($>2,Q.1DH2"5/ID<5YD^C^)KRSTB:^T-Y]7LM8CN;JY:YC/FQAF_U7
MS?*F"OR_+TZ$Y- &[I=K /BAXEC\E-DUA:F1=HPY)DSGUS4GPN54^'U@BC"K
M+<@#T'GR5+86>HP>/]8U.73I1:7%G!%'(LD9#,FXD ;L_P 0QD#\*D\ :??:
M3X1M[#4;1[:YBEF8JSHV0\KN,%2>S"@#1O-:,>HR:=8VK7EY%")Y4#A%122%
MR3W8@X&.QSBJL'BRWN[/2GM[2Y^UZF',%I,OENNS[Y?/W0/7G.1C.:R]0MM<
MT/QO<:UINEMJECJ-M'#<0Q3(DD4D9.UAN(!4AC3M3TS6O[=T'Q(MJL\]JLT-
MW90N,B*3IL+8#%<#/3/:@"W)XTMX+'6I)["Y6\T9=]W:*5+;-NX.I) 92 3G
MKQTJ,^-=EYID4NBWRQ:G&6M) 4/F.$W[-N<KD="V!ZX'-9NJ>']0U!/%FIQV
M,@N=3TX6%I:ET#D!&&YCNVC+-ZYP/?%2W.FZK)-X+==+G(TT[KO]Y%^[_<F/
M^_SR<\9XH TK?Q@KVFMO<:5=0W>CC=<VH=&8J4WJRMNVG*Y[]JKKXZ4#1II=
M%ODM-61?LTP*-F1DWA-N<\\@$X''IS5.32]6.I^.)AI<YCU2VCCM#YD7[QEA
M*'^/CD]\<5'-I.KG1/!%NNE3F72IK=[M1)%\@2(H<?/SR>W:@#;LO%]N[ZQ'
MJ=I+ILNDHLUPLKJX\ME+*P*D@_=/'K3CXJ6WN=,74+":TM]3<1VTS.K8D(RJ
M2 ?=8CIC(]ZP-5\,:CK>L>+H7MI+>UU2Q@@M[EG0J7CW'D!BP&2.W3-6KC3M
M5\2:;H-A?Z;+9265W#<WDKNA0F('B,JQ)W'&.!@$YYX(!//X[9(M9DAT&_E&
MD2%;KYXUVJ%#%A\V#P<@#)XYQQ74V=U%?64%W 289XUE0D8RK#(_0UQ":5JX
ML_'$9TJ<-JC2&T'F1?O,PB,?Q\<C//:NI\-P3VOAG2[:Z@:"X@M8HI(V()#*
MH!Y!([4 <UI,MMI/CGQU=F,K##!:3R"),DXB<L0!U)Q^-;%GXH-QJ=II\^G2
MV\U[9M>6V9 =RC&5;^ZWS#U'O60^G^((M>\97FGV;0RWUK"NGSR/&5:2.-AT
MW$CDC&1CUJKINDZN/%/A_5/[ EMTCM98+R2>YC>7>VSYW()+#@XY)]EH TW\
M>0Q^&+C77TRX6&UNFM;F$NF^%@X0EN<8R1WZ<UT U%FU=+ 6Y.;?SY)5<%8\
MG ![\D''^Z:YFX\'2WGB76(9PI\/ZE&MQ+%GDW.TQGCTQM?/]X+Z5I>"]*U+
M3-#0:RZR:C@1.PY_=QC8G/N!N^KF@#2U?5AI:VH%O+/-=W"V\*(.-Q!.6/\
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MV4L,5Y!'<QK)/ N=_EL&P,_+_$#C/3N ;-UXOEBTSQ$T6G'^T=$CWRP-*"C
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M;3?#$FMZ/)/+=7ENL$A9"(YRN5D.#D?Q'@?E5N?Q?*-5U;3;30[VYNM.2-W
M>-5=7#'();'0=.ISTX-9>I6.M7^B^%$&BSI-8:A;3W$7G1$HD:%6.=V"<G@
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M^)/C$11H@9+)F"C&24?)^M '945G:MJCZ:+1(K22YGNYQ!&JY"J2"=SM@[5
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MK</<7D:L&D=MS;=QVACW(7 )[D5J3W$-K"TUQ-'#$OWGD8*H^I-24 >;^(]
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M=:]3HH 9"TCPHTL8CD(RR!MVT^F>]>:Z!%J&I>"O$&CVM@S->7]];I<LZ")
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MEKQDQ") %B4Q[$#,>,@<G&>3@9QFNHT6.>#1;*"YA,,T,"1NI8-R% ."#TH
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MGYN4V ;6B,F/O$9.[& >.G-66TN\U#Q(/$$]C) ;:P>VM[9I$,CNYRQ)!*@
M  <]STXH IV?CV>YL=#U*31'AT[59TMQ,;D%HY')"_)CE<C&<CZ>L=S+?W7Q
M4-C-:6DUHNCMB.2<XV/,%9L;#\Q"@;>F!]ZJ<7AO6HO _AC2?L.;O3+^WGG
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M TRJ'58V0E6Y'\0/-7?&.D3ZA=:'/:W"VNIF9K1VC.=T$B'S@/H!N!/0@>M
M'1:+J,NJZ9'>R6ZP+*28PLF_<F?E;.!]X<CV(K0ID4200I%$@2-%"JH'  X
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M"8W1RQ!%WMP 5&T   <G(]* /6J*YRW\272^*#H^I:=':++:M=V\RW'F956
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M0S>>'7<FP[0<GH>.,5/8>)9YO$T^@W-K MVED+Q3!<;QC=M*-E058$CZ@]J
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M;PN0-Q7KCD<^]6: .*@TWQ3H&NZFNDV]C?:7J-RUTK7$YC:UD?&_( .Y<C(
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M1D>A!%/N+B"T@>>XFCAA09:21@JJ/<GI0!3T-+V/1[6/4((H;B.-4,<4F\#
M ZX'IZ5H5';W$-U;17%O*DL,J!XY$.592,@@]P14E !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8?
MBS6[OP[H<FJ6UDEW' 09U:0H4CS@N,*<XZD>F:W*@O/LK6SPWC1"&8&-ED(
M<$'(Y]LT 9UQK1BU"WB00/:FT>[N;CS#B)!C! QSNR<<CA36/<>,[FST"S\2
M7%A&-%N&0N1(?.AB<@)(1C!ZKE1TSU-,\&>'D3PE<6]U<R74-XKV\,K<-]C&
MY8E'MM)8?[]5X_"NL7/@R+P??_9FLXRD+7J2'+VZ.& "8X<A0O7 ZY/2@#<M
M-?N;KQ!K>DBUA#Z=%#+')YIQ*) Q (V_+C;[]:L>%]:/B+PU8:NT @-U'O\
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MXM[;!FC90<-&=P&']!GD'M4MWXDU73[G1/M6G6RPZK<I;A5G)> LI;YOEPW
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M!AW_ %-7ZP/%NO7/AS2HKVVLX[K?<Q0,K2;2-[!<@8P3SW(H WE4*H50 H&
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M4%U4Y ;'(![C-<2WBSQ+<Q:X^GZ+8.=(NGBD5[IOWJJBMA,+]X@GK@#CKS@
M[JBN3T_QB=3U3P_';P)]CUFSDN49B=\10+E3V/+8_"J5[XWU"S\->(M2%A;2
MS:/?-:E?-95=1L^;H>?GZ9[=: .YHKD;_P 3ZEH[P#68M/T^&\NO)M[EI6>.
M)=A;]Y]W#9&WJ!SUXYEOO$6I:;!H\EQ;6K_;M36Q;RW.-C,VV13WRJ@X]^M
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M,E1EB>2#WS\W-=_68OB/16D*+JMF2&VY\Y<9],YQGVH Y=O"6M/X7\4:6?L
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MD<>N1JL#)(S&,B+RQN&T<<9X-=K10!GZ)#?6^D6T&HBW%S'&J,+=F9!@ =2
M3TST'7';)T*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *1W6-&=V"JHR23@ 4M9/B*RO]1TI[*Q
M^S@3L$G,SLN8LC>HP#RRY7/;.: //4UJ"Q\9Z1XI&I0R0ZU(UE<P"8$PQM_Q
M[G;GCH-WH6-=]KNMOIE[I-A!&AN-2N3"DD@)2,!2Q) QDX& ,CD]:B\5^'O^
M$@\*WFE10VZ33Q@(S$JL; @A@0,\$#L,^U<_X@759K7P]HMU<Z2VL^89SY[N
M(YO*7&]7&&1MS*<+SUYQF@"XGC.\M)/$0U*TMS'HI5#) [ SLX4Q@*0<9W '
MYC@U9M]?UK^WX+"33C<6US"[+<I:3P)!(HSLD+@Y![,,<]JS(M(OM5L=5\+Z
MK;:;;_;(#.;K39WE99-R[6DW@-N)P02>0A':MC1+7Q;'L&N7FFRBW4A/L@=6
MN&Q@&0D84=\*#S@]L$ PK7QQKDGAK2_$$UA8)93W8MKB-9',@#3&,,O;CC@]
M>>E;UQK>I7MSK$&APVSOI>$83@GSYBF_RUP1MX*C<<\GIQSB)X,UA/ -GX>\
MRQ,]O=K.9?,?:0)O-QC;G/./U]JO/X?\1:;XFOM3T*ZTX6VI['NK>\#GRI57
M;OC*XW9'4'% %B;Q%JEIKF@V]]9P6MGJD>UBQ+/!<!-WE$@[3GG!]CQ6MI=]
M<WUSJ#.(OLD-P8(&12&?: ')Y[-N7_@)K#\80V=QX9;1Y-21M94126AWKYQN
M P\MPO4 MUQP!GL*Z73;%--TVWLT8N(4"ESU<]V/N3DGZT 4-:ULZ?>Z9IMN
MB/?:E,T</F9VHJ*7=SCK@#IQDD<CK66_BC4+/4M6TBZMK:34+2Q^WVSH6CCN
M(N0<CYBI##&,G/M5WQ+H$^JW.E:E831Q:EI<YE@\W.R16&UT8CD CN <>E5Y
M_#U[>WVI:M<+:IJ%QI_]GP1+*S1QH26)+[0222/X>BCUS0!+X5U76]:LK34K
MZUL8;&ZLHYHQ$[&02,,G(/&W'(YS3O%FO7N@0Z;):6<-S]KOX;1@\A4C>V..
M,9^IX]ZM^&=.N=(\-:=IEV8FEM($@+1,2K!0 #R!C..E8?Q&\W[!H7D;/._M
MRSV;_N[MYQG':@!UIXFUJV\27.AZQIUJUPUFUY9-92,5F"G!C.[&&SCG@46/
MBJ_/B'2M*O4LFFU"UDE>* D-:2HJL8W.6#?>QG Z=*GOO#E_J]_=ZC<3Q65V
M=.DL;/[.[/Y)?EI"Q"G.0N !Q@\\\9]EX6U^&^\,W4DNDQC1X98'BA5\.KJJ
M[@>.3MZ8&,]30 _2_$'BC6EO9+>TTJWAL[VYM)GD=W.8\A64#&1GKDC.>V.<
MVR\2:Q8?":UUZX2TOY9!&["4,OWY0"3UW'+9_AKI?"^AWVDVVJPWS6Y%[?3W
M:&!V;:)3G:<J.GKWK#/@W7#\-QX6:XT\R1F-(I@7 V)('R>#R< 8[>IH Z*X
MU>[NM<N](TK[.L]G;I-/+<*67<^[8@4$=0I).>..#GC.O/$>K6MKX:DOM'@M
MY]1O4MKB*27>T#$-RN.#PIYSQGI2:AH&O6_B@Z_H,]@LMU;I!?6MX7,;;<[7
M5E&<C)'('%3:SH&JZA'H6VYMIIK"_6]GDE+('(#950 <#Y^,G@ =>M %63Q#
MXFO-:U[2]*T[3?-TPQ;7GF?$@=-X' 'S'CT ]33].\7W6M:'I&I6MM#9P78E
M^UW%T<QVC(=NTC<I)9N!R.!5326U)?B'XS^P16LF39@^?*R;6\C@\*<CVXI\
M/@S4=)?P_P#V7=6LZ:<LWGQW88*\DIR95"Y^8$M@'L<9% &?JGBO5=3\!1ZA
M:/!:S_VFME<%59@X$X0E.00#[Y."1[UTE[KUW#J7]D0F(WL=L+B:86DLR#<Q
M55"(<C.UN2>,=\\8G_"$:Q_PBNH:4U[8M.^I_;[9PCA3^^$F'ZD9Z8&<>IJ_
MJ>@>(EUVV\0:-=Z>NH-;"UO+:Y5_(E0,64@C+ J21GO[=* -GPUJMYK&B176
MH:=-I]WN9)8)49>0<;EW ':>HX[U6U?6;BQ\6>']-6UMW@U!YE:9F)="D9;Y
M1C SQSGUXK5TZ&[ALU%_.DUTQ+2-&I5 3V4') '3WZ]ZR=:T:^O_ !-H.I6Y
MMQ!IKRO(LCL&?>A3C"D<9S[T 8LWBWQ"UIXDGM[#35&B3.&$DKMYB+&'(& /
MF()Y. ..#UKLM.O%U'3+2]12JW$*2A3U 8 X_6N67PQJPL?%D!:RSK;R-$1*
MW[O=&(_F^3G &>/I[UT>B6D^GZ%865SY9FMK=(6,;$J=J@9&0.N* ,7Q%XAU
M+23J,D<5I;VUG:B:%[HD_;'PQ:- &!& HYP?O=.*WM*OAJ>D66H*A074"3!"
M<[=RAL?K7,:GX8UFZUK79[>[LC:ZK9"V5KA6,EMA"I5 .-K$Y/(Y['%;_AVQ
MN],\.Z?87KPO/;6Z0LT(.T[5"\9Y/3VH IW6MW4OBE] L!!'-'8_;'EG4L#E
MRJJ ".X))SZ<5D:9XXNK_0=*NY+&WAO-5NS:VT0E9E4J6#NW X&QC@=>!D9X
MKZZE]JOC>6/2)M*>>PLUBECNY989%,A+'#1G<P*A>#P.W).%71[[7=*LUBAT
M[3]1T&^5K0VCE[60!1E.@(!#%3QP1WZ4 :R:]J4?B.X\.W*6OVYK3[797"HR
MQ2J#M*LN25(/H3D'/M4.D>)[[5O#%G>+';Q:I-=FTDMF5B(G5B'4\YRJJS>X
M'O5^TT:YG\2C7M26".>*U^RP002&14!;<S%BJY)P!C' '?/$6F^%QIWBW4]6
M6?-K=8ECMATCF8;9'^I"I^;4 4=1\5Z@4U.31[3[2=.E,/D?9)I#<NH!<*Z#
M:G7 SNY':FW'B?7[C7XM*TS3+2.2?21J$?VUW5D;<HVR*!D$9(P._<8Q2KX?
M\2Z1KVH3:#?:<=-U*8W$L5ZCEX)2 &9-OW@<9P2*NQZ%J,7C:WUCS8);6+3?
ML#>9(WFL=X?>?EQGC&,]\^U &=_PDGB2>_\ $%A;V.F)/I,<3[GE=E?=&7(X
M /;';'O3CXRO[B+PI-9V%N4UQ"6$LI!C;RB^.!TR.OZ5;@T'5(-;\37W^ALF
MK1Q+"OFL"A2,I\WR]\YXZ=/>L^S\):O:VWA&$O8M_89;S")7_>@H4X^3C@YH
M D@\1>)KBXUW34M=+^WZ448S%I/*D1TWJ O7/4$YP/>K$'C/[=I>@R00&.ZU
M:W:XQY3S"%5 W':G+<LH'3KG/&#+:Z'JEMKOB34,6;)JJ1+"GFME"B%/F^3O
MG/'3WZUD1^"];LM#\.MIU[9Q:UHB-"A?<T%Q&P 96X!&< \=,?D /O/&FMV/
MAV^O9]&"SV=[';[Y4DACN(W=562-6&?XN03QCJ:U+;7-8_X2R;0KV"QC>6Q-
MY:RPEV"8<(5?.-W)!R,57UK0/$&N^&);.[N;#[=//#(P0NL,2QNKA5X)8DCD
MG'7VJ\VCZ@_CFVUT_95MX[!K1HQ(Q?+.'+#Y<8&,?K[4 5?AU>ZEJ7A&WOM2
MN(IGGDF8%4*MGSGSGDC'H!C JYXLUFXT6UT^6&UMYTGOX+>3SF/R!W W  <D
M?48]Z;X-T34/#NBC2[N:VEA@DD\AH0VYE9V;+9Z'YL8'IUIWBW1KW7+&R@LF
MMU:"]ANF,SD B-@V!@'KC\* *D^NZY-XLU#0K"TL%,%I'<13SR.1\S,/F  _
MN]!]<]CGMXWU!O!>D^)%M;:.WFG6&_#[F^SCS#&TBX(R PZ'L>M;$&CZE#XT
MO=<(M##/91VRQ^:VX%"S9/RXP2V*AT#PK):>!6\-:L8)4=9HW:%B0RR,S=P,
M$;OTS0!;U/7VTN74KF7RVT_3K033%5.\N<D(#G&< 'I_$OK5.W\0ZP-=L+6?
M37GL[Q'WRPV<T?V1P,@.SC#*>@/R\]J?9>$B? LGA_4[HW$]S;F.YNEZLY4*
M&'T 4#_=%)H%AXM@$-MK>H:?+;6PPDMJCB6XP,+YF>%]3C.2/3.0"+P[XHN?
M$:0SVDU@RMO6YM=K":S8 [0X+<\C!.![>V1H^O:W#X UO6[HV=]);RW;>6ZL
M@(1V!'4\8& /UK3M?"MY+K^D:S?Q6$&H62LMS=6;MNO,H5PP*C R=W)/3 J&
M'PEK$'A/7=!6XL6BO6N/L\AW@@3,3E^#R-QX'7U% &E+XCG^U^'M.@CB2YU6
M!YS(ZDI&J(K$!00226  SP,FJ=AXHUN]T[6GCTJWFNM.O38JL4I D<%07((X
M4*P;&2>"/>L_6X+Z2^\.Z+;3:4-3L;5IVBN9)$!P!&K)(F'!^]P!]>@RC:7K
M>JZ'?^'UBTFSN(9(KG?:3/)!.2Y9HYL@-EMN3UR&Y]P#1MO%%[=WFO:;#/83
M3V-HEQ!=PHQC;<&R"NX\@KV;GVK,M?$.KZ;\,=)U>X2TOGF^S;S+N! D91N(
MYW-EL]JUK3PYJ_\ PDM_J5W<6"P7U@EK)% KDQE=V N>"/FZ^V,#K5%_".N2
M?#^T\.//IQEMG@"R!G"E(G# G@G)V@8[>] &])K-U>^(+W1M+-NDMA#')<37
M",X#29V(%!'922<\9'![8,GCV];1+6Z@TV 7:ZNNDWL#RG$<F\*=AQR#G()Q
MC/>M5M"U&Q\67&OZ9]E?[?;I%>VL\K(-Z?<=7"GH"1@CWK/NO!=[_94$-K+;
M-=/K*ZO=O(S*K.'W;5 !., +D^F>] &GI.N:E)XJOM"U6"T62*VCNX9+5F(*
M,S*5;=W!7KQGT%=)7,2:1JD7B^]U]&L4C?3!:1B21CM=69PS?*/ERV#ST&:T
MO#=SJ5WH4$VK+ +TEU=K<$1N Q 9<\X( /XT 0WVLS'Q'#H%AY2W;6K7<LLR
MEECC#!1\H(+$L3W& #7.ZAX[U"Q\/^()38VQU71)DCN(R["-U?&R1>,\@YVD
M\8/-;6J:#>?\)79^(]+> W4=NUG<03L56:$MN&& .U@W/0Y]JRM7\%WNI:%X
M@C22U74]<EC:9V9O+B2/:$4?+EL!>N!DL>G2@#I]+?5W:Y.JPV<2^8/LXMW9
MCLQT?('S ^G%8NL7C7GC_1-"S_H\<$NHSKV<J0L8/L&);Z@>E=1"93"AF5%E
MQ\P1BP!]B0,_E7,:W9-9^-=%\0_\NZQ26-TW]Q7PR,?;>,$_[0H L2ZS=+X[
MCT06ULL4FG27,=P26?(=5P1Q@<YQGG Z53T[Q1J%SI.M&YAM8]5T^[-HMNH;
M:[G CZG.'W#![9]JNS:-?/X\MM<4V_V2*Q>T*%VWG<X;=C;C^'&,TV3PN&\;
MKKR3[('@ N+<?\M)DR(W/T5W'X+0!3\7W<VBS>']8W+YRWT=G<E!A7BER&&/
M0,%8?3WKKZY;Q;8MKE[HFD1#(2^COKD]DABR>?\ >;:!^/H:ZF@#D;#6]1U3
M2_$VV&TM+JPO);=2FYPP5%.XG@EN?;M1\/;9Y/!.@SW:6TC1VB&V<1?/&"N#
MR2>3WQBGZ7H&JV%MXD5_L;2:I=27$.)6PF] N&^7MMSD5I>%=,NM%\,V&EWA
MA:2TA6'?"Q(< 8SR!B@"MXDUR^T._P!)<);_ -F75RMM<3.&W0LWW3P<8)P,
MGH2.M1ZMXH?1UUF\FCCDL-.2-%"@AY+A\?N\YQCYH^<?Q^W,WC!](G\/7VFZ
MK=11BYMWV1;QYC$="BYRS!MN,=\53D\'G4?A\WA_4+E_M=Q&))[KJWVC<'+^
M^'[>@Q0!+=Z]J6C:QI5IJB6KV^IN8(YK=67R)\956!)W X(!&.G2J$GC'44\
M(^(-6\BU-QI%Y/;[,-LE6,@9ZY!.?>M Z+JFK7.CR:Y]C4:9+]H_T9V;SY@I
M56(*C8!DG'/..>.<:]\&Z[)I?B;1[:YT\66K7$MS'+)O\Q6DP2A & ,CKD_3
MT .[@D,UO%(1@N@;'U%87]M7VIZKJMCH_P!E4Z;L21[E6822LN[8-I&T 8RW
M/)Z<<[5E%-#8P17#(TR(%<Q@A20.V:Y^'0M2TCQ-J>IZ4;6:VU0(\]O<2-&8
MY5&-ZD*V01U!QR.M '-:EXA?Q'#X,U2SM ET=4>-K:5\".58Y%92P'0$=0.G
M;M6C-XIU^!?$&E7T-E;:O8Z>U_;3P!GAEBY&=IP0P(QSW]NLS>"KBRTS1$T^
MX@DN]-OFOI//!1+AW#;^1DK]\XX/05?D\-3:A<:O?W\D4=Y?V!T^-8B72"+#
M=R 6)9LG@= /<@%32M3UBW\)^'G?[-(+FWC:>^ER$MH_)#;G!8%F)XX(&35=
MO&=W+X'UW5EL[.XGTNXFMW!9A%,$Q\X')P01\N?QH7PQXB2R\,C[3ILDNC_(
M]NWF>3*HC"*^<9WK@D<8&?;-,/@[6CX<\3Z4UU8.VKW,L\<@#H$\P#.1STQP
M.?K0!HW_ (BU6'7M%TRTL[-QJ5K+*)))&&QD52<@#I\P]<^W6KGA76[O6;?4
M8]0AACO-/OI+.4P$['*A2&7/(R&'!JK)H6J2^(O#^I'[&(]-MI894$K$L750
M2OR]MO?KGM5CPSHU]I%UK4EV;<KJ%^UXGE.S%-RJNTY4?W>OO0!4\>WNI66G
MZ9_9]Q'#Y^IVT$I9"25:0<#!&!QSZCCBL^[_ +27XIQ"U%J]Z?#Y!>3<L:_O
MQS@9)^F>_6M[Q;HEUKFE6\5E+#'<VUY#=Q^=G8QC<-@XY -5X]&U8>-8]=E-
MDT8TTV3(KLI+%]^X?*>.,=??VH I6/C:6X\/V,\]LB:E=7LE@8XE>1%DC+[G
M  W%=J$XZ\@9'6M/0-9U*^U/4+'4+"1$M]C07JVTD,<ZL.0%?D,IX/)KGU\#
MZNN@)#%>VMMJMIJ<FHV<Z%G3+LQ*." <88@X_P#K5U6BQ:YM>?79K/SR JPV
M0;RE'<Y;DD_H!]: .=^)][/%HNF:;#(\2:MJ<%C/(IP1$Q.X ]LXQ],UU[:=
M9MIITXVL7V(Q^5Y&T;-F,;<>F*S_ !1X=M_$^B/I\\CPN'66"=/O0RKRK#_/
M0FH[/_A*! MO>II6\#:;R*5R6_VO**8!]M^* (4OY+?58/"VE-$);.Q266>X
M4N%7.Q%V@C)."3R,8[YK&N_'E];^&]2NQI]O_:.EWRV5W"TAV99U4.G'((8$
M D8YK5N?#U]:>*H=?TN6*61K06=W!=2%1*H.5<.%.&!]L$'M6=J?@N]N_#VJ
M6T,MK_:&JWR7EQ([,$38Z%47 )( 0#)QU)]J +4FO>((?%0T-[33BUU:-<VT
MBR/B+:P#!^/FZC&,9]NM4)?'&J6_A.]U%]/M7O;#4SIUPB2,$8^8J;D!YYW#
M@D?6MJ?1]1F\:V.M@6H@@LWMGC\UMQ+E6)'RXXVX]_:N1\3:-J&C>!]>%PUJ
M6OM:BO8C&[,$WSQ_*V0.F.HZ^U '20>)-9L_%]MHNMV-HD>H12264MI(S?,@
MRT;[@,G'.1@?TAM_%VH)K&B6=_!:1R:F\B2VB$F:S8(74.=Q#9 ]%K0N-#OM
M6UJUU*^>&U>RMYH[5;>0R$22@*TA)5>@& ,=SS6%9>#_ !#!;^'$DN=*5]'N
M&8LBR'S@R,I=CQ\YW9([G)W4 23>+O$+67B2YM[#35&B3N'$DKMYB)&'(& /
MFP3R<#IP>M:4_B>\AU;P\3% FDZPH"S,#OCE*;E0\X^;H#ZCI59?#&K#3O%E
ML6LMVMO(T1$KXBWQB/YODYP!GCZ5'X@M;8>!(_#]Y>6R:Q%;0BUCAE!D,ZD"
M)T!P>7 [>M &];RS:R=7MYH[62Q20VT6^(N)"%&_<"<, Q*XXR5-9VI:C:>"
MK#1]-CDAM+6:0P?:[A,Q1$*6^8*5 +'IR .?3%;VEV(TS2[>S#F0Q)AY#UD<
M\LQ]R22?K5;6;.\O&ACA@LKJS972ZM;LD+(#C!'RMR"#U'?\0 6-*GNKC3DE
MO1!YQ9^8#E&4,0C#D]5VG\:QM=U_5;#Q-I>CV%E:R_VA%,R232LNTQ@'D =/
MF'3)/3CK5KPIH!\.:,;#>-AGEE2)&+) K,2(U)Y('KQGFL;Q,;E?B/X2-HD3
MRB&]^25RH(VQYY ./R- %.?QWK%CH?B3[9IUF-8T(H9461O)DC<91UXST['\
M^U7M:U_Q!I&BRZA>Z=ICPM<VZ0H)79E1V5?F&,%@2.AQ3-6\'7VI:1XC_>6J
MZEKGEHY+MY<,: !0#MRQZD\#EO:M'Q/HFI:[X8BTZ(VD5SYL,DA>1M@\MU;
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MOD3RUN3&/,"^@;KCDU:KF;+6M6C\:'0]3CLC%/9->0/;!@4VN%*,6/S?>!R
M/I73'...M !17GY\4^+;K3M=O+&RTD_V1>S0O'(9"9DC"DA<$8;!/)XY QWK
M1B\9'5OL<>F#R7GT^.^9Y+22YV"0D*FV,CG*MDDCH.N> #KZIWVE:?J8B%_9
MP7(B8/&)D#;&'0C/0^]<A)XN\0QZ=H4DNCP6UW?7_P!AFBN-ZX.&(=0>0I"Y
MYR><8-6&UOQ1:Z]I6BW<6D&XO8+B1I8O,V*4(P0"<XPPR.Y[CK0!V0 50 ,
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M#4H[1[#4)HX)DA1E>V:0?*=Q8AU!X/"^OM0!T5MI.G6=Y->6UE!%<SX\V5$
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M:RVNG31RF:+=ON?+^YN4C"<X)P6SCMFNBU/4[31[%KR^E,4"LJ%@A;EF"C@
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M'+[LXQU.,?C[5T-% !7$R>$=4DTCQ38F:S!UN9Y5;<W[D,H4@\<X"Y[5VU%
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MU1BA\Z&%SEHQV/4@-VST-:$7AVXMO%ZZS;R6ZVT>FC3X[;:<A0VX'=^F,=*
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MN@4*;7ST'.2,G)]*@T3PIKNAXTN#7(F\/HY:*-H#]I1"<^4'SC';.,XZ8XP
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MEC+B11(2P&".<9Q^5=7:ZS)JM[I']FW,<EI/:?:[AS'DE#@(!S\I8[O7[C4
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M\.7FMSSZC;ZO:E8H)%^R7101F=",\KDX93P>@/'% &_GG'>BN*M'U67XG:S
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M10^'ED<CT$SD_P J@NO%6KVG@RV\8GR'M'$<\UB(^5@=@!M?.=X!!.>#SP*
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MW''88')ZG&,E?A_-_P (M#I;:JJWEI?&_L[R.WV^5*79^5+'</F(ZCBNXHH
MYBS\/:L/%<&OW^IVLDJ6)LWA@M616!?=D$N2#D#U^E/\2>&KG5;_ $_5M+U
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MDFM:O:K!>7\DZRM&8@KRDL4Y8Y[T[P/HEOI.EW$]LLBQ7EQ)- DF<QP%B8T
M/1<$L!VWFNEEABG0)-&DB@@X=01D=#S5&;6[*#7;;1G:07MQ&\D:^4VTJO4[
ML8[CC- %/Q-H-QKT6G)!=QVWV.]BO,O"9-YC.0O## -13>&[F?Q7/K+7Z+'+
MIQT\Q1Q$,HW%MX?=UR?2NBHH X:T\#:K;VWA^%]<@/\ 8LI,)2RV[X]A3YLN
M?GP>O3U!K0B\,:A:2ZU%9ZE#'::M.]Q(6@)EA9U"MM.[!X'&1P?6M^/4K22V
MEN5F46\9(,QX0XZX/<9XSTJ/3]8LM5TE=3T^4W-HX8H\:'+;25. 1D\@_6@#
M'F\);-0\.2Z?<Q6UKH:NL<#Q%RX:/R_O;ACCV/-5(?".KZ;JUZVD:_\ 9=*O
MIVN)K9[8.\3MRYB<GY<^X('H:ZRVN8;RW2XMY%DB<95U/!J&?48;?4K2P=)C
M+=!S&RQ$H-@!.YAPO7C/6@!-0TZ+4-&NM,<LL-Q;O;D@Y(5E*]_8URT'@_6"
M?#YNM;MG.BO^[$=F0)$$93YLOG<0>H('M7:T4 <B/"%Z-,\369U* _VY))(6
M^S']SO0(1C?\W 'IS36\'W]M?Z5JFFZG!%J5G9+83F2W+17,(Y&5# J0><@U
MV%% '$'P!-/I>KVEUJ_[V]U#^T8)X(-C6TXVX8?,<CY1Q[GGO6C#H6NSZ5>0
M:MKD-S=36SVT;QVNR- PP6*AOF;IW ';J:Z:D)"J68@ #))[4 9V@:;+HV@6
M&F33I.UI D E2,IN55"@XR><#UKGM1\%7UY-XC2'6$BL];C D1[;?)&P38,-
MNQMXZ8^A'6K\WCG1X;BVB87C?:U5[5TM799U) W*0.0,@_0@UT3N(XV=@Q"C
M)VJ6/X <F@#F(/"]_'K6C:C+J<$ATZT>V9/LQ7S-VW)!W\8VC'6FV,5KX(@U
M.ZUK6+1;?4M1>X5WC,01Y /DR6.>%]N];FC:S9Z]IB:A8.[VSLZ*SH4)*L5/
M!Y'(/6KDL,4ZA98TD4$, Z@@$=#0!S7@;1(-(TB:2W618KNXDFA23.8X"Q,:
M 'H,'..VXU/XO\.W'B?2XK&&]BM%6>.<N\!D)*'('WAWKH:* (Q&9+?R[C8Y
M9=KX& ?7BN2T/PCJ^B;-.3Q 9-!A?=#;M;CSE3.1&9,_=_#...*[&B@#BV\%
MZC:QZ[9:9JT$6EZOYLC036Q=X9)%(;8P8#!ZX(.*2;P5J4":-=:7K:6VK:;:
M"R:9K;='<0C'RNF[CD9R#U_3M 01D$'MQ2T <KJ7A;4=1L],235XVNK34([^
M6:2VR)'3HJJ&&Q<<=SQZY-6-0\/W\_BFTURRU*.!X[1K26*6W\P%"P;<GS#:
MV1U.1TX.*Z*B@#AHO =]%X3L]"&LQ,MK?"[25K7J!*9 I <<Y/)].W>NJU?2
MK?7-%NM+OANAN8C'(4X(SW'N#R*KW?B;2[+55TR:2X^VLAD6&.TED+*."1M4
MY'TJQI^L66IS7$-LTWFV^WS8YH)(F7=G'#J#S@_E0!CP^&;VXATFVUB_ANX-
M+E2:,QPE'F= 0C/EB!C.2!U(!XZ59T70;K2];UF_EO(IDU*99O+2$H8RJA0,
M[CG@#L*WJSM3UNRTF>QANVD5[V=;>#;$S N>@+ 8'?J>U #-7TZ]O+BQN+"_
M6TEM9&<[XO,60%<;6&1QSG@]A52#0;BX\26^N:I/ \]K \-M%;QE57>1N9B2
M2QX  X YZYK?HH X;_A [Z/P_P#V5%K2*EO?B]LR;7(4^:9-LHW?.,GMMZ5?
MM_"=X-8UB^N]525=5M$MYXX[;9M95905.XX7#G@Y.>_KU59SZW9)K\>B%I!?
M20M.JF)@I0$ G=C!ZCH: .:?P/?MX>TBT76Q%JFC%18WD5MA555V;60L=VY>
MO/X>O1Z-8ZC:Q/)JNH+>WDF S1Q>5&BC. JY/J<DG)_ "M.LZ^UNQL+I+65I
MI+ET\P0V\#S.$SC<0@) SQD]: *#>'[N/Q?/KEI?QQI<6J030/!N)*%BI#;A
M@?-R,'VQU%"U\%3Q> [WPO/J887 EVW,4)0KYCESD;CD98CJ,CBNBTW5['5[
M>6>RG\R.*0Q2$J5VN "000"",C/I5V@#DH?">I/KECJE_JMO*8;)[*>&*TV)
M)&Q4_+\QVGY>>OL!6:_@'5AX6D\,QZ[!_9:2H]LTEH6FC59 X1FW@$#'H/PK
MOB0!DD >]+0!R5_X6U9?$+:WHFM1V5S<Q)%?1RVWF13;>%<+N!# <=?_ *_2
M6MJ]MIZV[7$DL@4[IG^\S')+<=.2>!P.@JS10!RT/A2:XU32M0U:XMKBYTZ)
MX_/B@*/<;DV?/DGC!)QSSSQT-?0_".KZ(4TZ/Q 9-!B?=#;-;CSE3.1'YF?N
M_AG''%=C4<\R6\#S2;MB L=B%CCV !)_"@#DX/".J:;JU^VDZZ+72M0G:XFM
MFMP\D;M]\Q/GY<^X./2M&W\/W$'C*77!>1>0]DEF+;R3N"JQ8'?NZY)[5I:1
MJMIKFE6^I6+L]K< M&S*5)&2.A^E7: ./3PEJ^G:S?3:-KXM--U"8W$]L]L)
M&CD;[[1L3QGW! ]#6@WAR>/Q=#K=I?+%$+)+*:!XM[.BN6!#;N#R0<@\>_-=
M!10!A^*-"G\06=I;P7<=MY%W%=%GA,FXQMN P&&.:R[_ ,'7]W>Z^\6L1Q6V
MMVPBG1K;>\;",I\C;N%YR00>^",YK?L];LK[5[[2X&D-U8A#.KQ,H&_.W!(&
M>AY'%:- ',WGA22_\&6VAW%^1<VPA,5Y%'L,;QD%649.#QCKW-2KX2LH_$]A
MK$+&,6EF;40#HV.$8_[H+C_@0]*Z&B@!DHD,3")E63'REUR ?<9'\ZXZW\!,
M/ T/ANZU(.]K+Y]K>10[&BD#EU;:6(."<?2NTHH P8]#O+G5K/5-4N;:6ZL8
M9$MEAB*HKN &<Y8DG P!V!/7/#O"FA3^'-'.GS7D=T!-)*KI"8\;W+D$%CW8
MUN44 8.I:!<W7B?3]:M+Y+=[:&2WE1X=^^-RI^4Y&ULKU.1[5FCP;>_V+XDT
MXZG!_P 3N>68N+8_N?,4*1C?SPH]*["B@#CKSP?J:W>G:GI.LQV>J6UHME.S
M6^^&YB'(RF[((.3G-=-IUI-9V:QW-TUU<$EI9F7;N8^BC[H[ >@[GFK=% '"
M/X$U&'1M7T&PUB"/1[_S&CCEMB\EN7Y958, 5R<\C/\ .M5O#-Z^L^']0?48
M6_LB&2(I]F(\[>JJ3G?\O"CUKIJ3()(R,CJ* .7F\*W.H7.FOJ=W;SG3KL74
M-PD!6; )*QEMQXY )[@=!UJO8^#]3TJ]N[?3M=\G0[N=IVM3;YEB+'++')GY
M0?H<=N>:[&B@#GG\-R2^+I]9EN87MIM/%@UJ83DIN+9W;O<CITK/M_!5PGAU
M?#-QJ*3:(CC:#$1,8@^X1%LX[8W8Z<8!YK3'C'1A<1QR3R1130R3PW,D9$,J
M(,N5?IP!GW'(S34\8Z8^LPZ28KY+R;:8T>T< H02'SC 7@CGH>M %?7O"]SK
M]MJ.GW=U;2:?=NK1AX"9+7"J#L.<9RI(.!@L>O2GS>'+Z+Q3)J^G:E'!'<VT
M=M<QRP>8V$)*LC;@ V&(Y!'?!KI:J2:C#%JL&G,DQFFC:56$1* *0#EN@//2
M@#D;7P)?VN@>']+&KP-_9%Z+M7-H?WA!8[?O_P"V>?I6EK_AF^O=:M-<T;5%
MT_4X(3;R&2'S8IHB<[67(Z'D$&NGK.MM;LKO6;S286D-W9HCS*T3* &SC!(Y
MZ'D9% $NF6D]G:!+N[:[N7.^68KL#-_LJ/N@   >W.3DU<HHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ K"\3ZW)HUO816X3[5J%[%90LXRJ%R<L1WP >.YQ6[6/XD\/P^(M-2V>
M9[>>"9+FVN$ +0RH<JV#U[C'H: ,TZKJ.F>,;;0;JY^TV^I6LDEK<M&HDBDC
M^\K  *1@@C@>G-4OA[#=!O$+RWAE0:U=J4,8&6#+\V?Z=*W+?1)WU>'5M2NH
M;B]MX&@M_*@,<<>X@LV"S$D[0.O &/>F^&] N-!_M$2WT=TM[>2WAVP&,HSD
M$@?,<CB@"/6KV_BU>&VCO$M+1[9V1HD$MQ),",*(\'* 9)('IR*D\&ZS/XA\
M(:9JMTJ+/<1;I @PN02#C\JCO?#MU-XK37+/53:EK3[)-$8!)N0,6!0D_*V3
MW!'M4WA/0'\,>'K?2&O3=K;Y".8@F%)) P"?7KF@#F-)N-7ANO&]TNIB26TN
M&\L30AE^6%6 P"" .F ?<YJUI^H^*9O"$.NOJ.FDW-A!*L<L7EI"S;2\C/GG
MY23C &>/KH_\(I<Q7FO26VJB.#5\LT+VP;RW*!"=VX9&!G''/?L63^#IKCP/
M9^'3JFR6S$/DW20<9B(*[D+'/W1GF@#/B\8R:=?>(ENY9;NQTVQCO89)(?*D
M;.X%>@!!*C!P.O>J?B$:G-'X+O;V]23[1K%M)) L0"QLR.1L/7 &0<DYX/'2
MMAO!4EWJFH7>IZJ;F/4; 6=U EN(P<;L%3DE1\W3DY'7M5<>"M7DL='LKGQ$
MDL.DW<=Q;N+("1E0$*KG>03@@9 '?.>P EUKOB#4X-4N- @D:6RNWMH(=D1C
MF,9PP<LP89.<8Q@8ZUU4US>+HDEU'9_Z<+8R+:E@?WFW.S(XZ\9KG?\ A#]1
ML];O;O1O$,MA9:A+YUU:FV63]X?O/&Q/R$_0\_A727-F9-)FL;>9[<M T,<H
M^9H\K@-[D=: .3T+Q?%>VUS?'5#.MG9237UC-"(KB"5<'&W .W 8=^W)J2SU
M3Q1<RZ+?06DD]I>%#>1,L2I#&XR'C8-N.WC(.<CL*OCPJ+O6$U/59;>XG6SD
MLV,%N8O-1\;B_P QSP.!VR?PK:#X2U31O)LY/$<UUH]LP-O:M;JL@ .55I,Y
M91QQ@= .G% #++5->\0:*NMZ-/;J&NF6*SF4!'A20HQ9L%@Y"EAC@<#!ZU&+
M_P 2ZCXPUO2;34;*V@L1:RQLUJ6)5]Q93\W<#K[# &:DL?!=[I=W=06.O20Z
M'<S-,]AY"ED+'+*DF<JI^F1V(/-:=AH-Q9>*M4UHWT<B7Z1(T @*E!&"%PVX
MY^\<\?E0!@R:_P")-4TR75= M))F2Z>.&U98A%-&DA1MSLP8,=I.1@#@8/4S
M:4VH3?$_6EEOY/)BL[9E@9%PJL9#M'X]^I_*I;?P9J&GZC=C3/$,UKH]Y,T\
MMC]G5F1F.7$<A.4!^G';GFM)/#LD'BV;6[:_\J*XMXX9[;R0=VPG:0V>/O8(
MP?J* ,SQZUZLOAM;6^>WCFUB"&1%4$-PS G/H5''2J;V^HR_$[4(+*^CMY_[
M%MPUR\(<Y\Q^0N0.3_\ J].C\2:"^O6]B(;S[)<65Y'>0R&+S%W)D8*Y&00Q
M[BH+?P]>0>*+C6SJ4<CS6:6GEM;?W22&)#CG).1@?A0!DZ7XDU75/"&B:C+-
M;6IN)WAO9QC< C.O[I#G+,RCC!ZG@UAZYK^J:E\,_%3F[>*73[V2S$HA\MY8
MODX8$?*2),' '3M6Y:> KRPT_1(K;6T6YTBXFFBE:TRCB7=N5DW]?F."#Q4C
M> GET;Q%IDVL2R1:Q.;C=Y"@Q2$+DG'WN4'''&?K0!UUM'+% J3SF>09S(5"
MY_ 5RWPZNGU3P_<ZU,<S:C?3RL3V57,:+] J 5TUE%<PVD:7=R+F<#YY1&$#
M'V7)P/Q/UKG?#>GSZ#!J.@QR)"?M$L]A*Z;D:*0[L8R,E6+ C/3![T <UXY,
M>MG4;FWFE6^T4J=,V1.P,Z$/(<@8.<*GL5:N^T+5K?Q!H%EJD&#%=PA]O7:3
MU4_0Y'X4:)ILVDZ-#8R7*7$L8.9Q%L\QB<EF&X\DDD\]3VK'\.:&_@O3KV.?
M4DN+%YWGBA2V*&(N<[$^8Y&>BXSDT 1?#V[DDTG4M.<DKI6J7%C$3_SS1LH/
MP# ?0"K%OJ^I'QWJFDNT,MM!81W,"(FUMS,PP6).?N^W7I4W@_1YM(T>5KI0
MM[?W4M]<J#G:\C9V_@,#\*/^$=N/^$IOM:^WH!=68M/)$!!0 DAMV[KECVH
MR_"?B:37+R&*34MM['$W]H:7<0"*6"3C[@P"4!R/XNHYJ]XPU;4]).BG3I+=
M1=ZG#:2B6,L2KYZ'/'3T[]J?;^&9GUC2]4U*\AN;O3HGCCFBM_*>7<NTESN.
M1C/ XR<^U6/$>@S:[_9GE7B6PL;V.\&Z$R;V3.%^\,#DT 8MO>>))?%6I^'F
MU:V^2UBNXKL6@W1ABRE N[!Y7.3V]<Y#-+\2:KJ?A#1]0EGM;9YKEX+VXX!
M1G3,2'.79E7 P>IX-;46@747BRZUT7\),]HMJ(3;'Y0I+ YW\\L<\?E6-:^
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M$[,Q(*YPP.X@CC-7;_PGJ.K>&;_3-1UWS[J]58Y+D6H5$0'.$C##!ZY))_0
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MLRI#*X .W=@G# 8X&>>>E:-[X5NKN71I?[6S+IUR;IY)K?>9Y""#G#*%&&(
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MLW!>&/7D]L]ZI^*-:ETF+3K>U*K=ZE>QV<3N,B/=DL^.^%!P/7%8=O;7=O\
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M9Y8EWPRQXW!@@4,N"".AS4'@2\\0:YI&GZWJ.JPO!-'*KVJ6P7+"0A6WYR,
M$8QCIWYH [.JFF:A'JE@EW'#<0JY8!+B(QN,,1RIY[<>U69 YC81L%<CY69<
M@'Z<9KSA/%.OR?#S2-76[@^VSZD+:9C ,,IN&C  Z+P!V)_'F@#TFLW6-<LM
M$^QF\$O^EW*6T6R(L-[G R>@Z]ZYS^W]1T'Q+J]GJMZ+ZSM](_M166%8VCVL
MRL@QU'&1G)]ZR?$#ZE?^'?"FJW5_N^UZK8S26JQJ(T#N&4*<;N,@9).>>G8
M] 34(Y-6FTX0W DBB64RF(B(AB1@-T)XZ5;Q7+P:EJDWCO5M(-U$+>*PBGMQ
MY/W&9F'/.6^[ZBN>TKQ+XA7P+;^+;[48)TDM_+%DMLJ@RM,$1R^1P,\C@8[Y
MYH ])HKC9M3\1:+>7%]=6]S<Z)#92SSM<_9UDBD12PV>6>58#&""0>]6]._X
M2&[CT74TU""2WNHQ)>V[H J*Z;E\HA=V0<#YB<CTH WKV^@L+*XNYBQBMU+2
M>6A=@ ,]!D]*;IFH0:MI=KJ-MN\BZB6:/>,':PR,BN'\.I=MI/C:2YU&XN=E
M_>0[90G.V- &X4'. !@<8[5%;ZEJ.B?#WPCJMO=&/38H+5-101JQ$3*!O!(R
M,$C/MZ8H ](HK)L;FXO->U!DN"=/MU2%4VKAI<;G(.,X 9!UZ[O2M:@ HKG_
M !!K,UGJNB:/:N(KC59W3SBH/EQQH78@'C<> ,Y'.<'%94^N:OIVNZOH3W2S
MNFF'4K*[EA7<H!*LCA=H/."" .#SF@#M:*Y?P;+KFHZ58:QJ>J13PWEA$_V9
M+8)LD(!+;@><CMC'I6AXL:=/".KRVUS+;31V<LB2Q8W JA/&0?3Z^F* -=2K
MJ'4@AAD$=Q2XSUK@],U2ZLM+\&Z'%>.9]6M@_GNB$PQ1P*Q51C!.< %@>ISF
MM32=7OH?&=_X;OYOM02U2]M;DHJN8RVQE?: ,AAP0!Q0!U%%1SM(MO*T(0RA
M"4#G"YQQD^E</IWB'5!X@\.V<FH"\74H)Q<L(0(%E1 V87"@LN<CJW&.<T =
MY17F4_B#Q./"_B+5UU6!7T?49XDC%JN)DC8#:V>0",].<]^U>E0R>;#')C&]
M0V/J* 'TC,JC+$ >I-86NW=Y!J5A#'>K:VDJR>9Y*"2YD< ;5C0JV1R23CC
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M917FZ>)]=N_#NA:K;7BI>:CJ0M)K)H%98078$ <-N0+DY;UZ<8]'4,$4,0S
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MP3^2J*)-LS*&(((R-@./NY['BNN;PE(-5T_4H-7N+>YMK/[#(T<:$31 Y'#
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MB$84L &<@$Y8@8SP.3@<T >=/'<'X/>*9I[^YN2;BZ7$VP\B;&[(4')QZX]
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M@C5TDA!R%9&&..Q[?E0!1EO_ !#IE_X2M-1OX9+B[GE@O1;QKY<H5&96&5W
M\+G&!UJ"[US6(3X[CBU YTB%)K1GA0E,P&0C@#//KFMG4O"8O+/35M]1N(+W
M3[@W$5VRK(S.00^X'@[MQZ8QQC XJM_PA)/]OEM8NG;6X5AN"\:' $>PD8 Y
MP3[#/3B@#*?4O$-O/X3G&L[UUA1%/"]LFQ"8=X=< -NR.YP<] .*&\3ZGH"^
M+H+R[.HG2OL[6TTT:(W[X8 ;8%! ;Z<5NR^%'E700=1(_L8AHCY(_>$(4^;G
M^Z>V.:27P;;7=[KTM[<-/!K44<4\&P*$"*54J<Y!YS]?2@"*W7Q.FOP*'N6T
MN6%UG:\$&Z&0#*L@CZ@]"#7,6GB#Q)_PA.C^)9M8\QVOE@FMA;QA)D:X,9R<
M9!QC!!'3H>M=;HGAB^TK8+KQ#>:DMNI6T2XC0"+C&6*X+G!QDGN:J+X%">$K
M;PZ-4D^SV]P+A9?)&\D2>8 ><8W'TZ4 0Z9%<O\ %37=VHW1CCL[9EB.PK@F
M3Y?NY '7@@\\DUM^+XWD\(:N([B2 K9S-NC"Y("-P=P/!]N?<4B^'3'XH?7(
M[^:-YH$AN(%5=DNPDJ<D$C[QX!J]J]@VJ:1=V F,(N8FA:0+N(5@0<>^#0!P
M[7>IZ'\-O#EU9ZG+ND^P1L)(HSB-]BE%PHP,'J<GWK4NG$?Q;MG;[JZ%,3^$
MR5:NO"+7?AC3]#?466*R:$I*(1N818V \X_A&?7VJX^@,_BN'7FO/WD=H;3R
M1$-K(6#$YSG.0/PH YVRU7Q/K.F:3K>F).1<2)+-;2F 6Y@8\A2#Y@8#')[@
MY'8.N=0O?$NA>*[F&_DM(+)[FSABC1"'\M/F9]P).XDC (P,=^:NZ7X&;2)V
M@M=<OAHGF&5=+*H44DYVA\;MF?X1U[YR<ND\%-'=ZNVGZO<6=GJV][JU$2NO
MF,,,ZD\KGOZ^W& #0\%_\B+X?_[!MO\ ^BUK<JAHFEC1=$L],6XEN$M8EB22
M4*&*J,#H!V%7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *J:G?-ING37:VES=F( ^1;)ND?G'RC(
MSUS5NN9^(-_?:5X(U'4--NVMKFW565U16ZL 1\P/8T =*#D XQ[&EKC]4N=5
ME\?V.DV^K2VUG<Z=+,ZI$A965D&5)!YY[Y'7BK7@C4+V]TW4(;^Y:ZFL-2N+
M,3NH#2*C?*6P ,X/8=J .FHKB/%.I:E:OKKV^IR![2P$]K;V:*6A8*[,\Y8;
M<$@8&>0#@$UU.C7<E_H6GWDV!+<6T<K[>F64$X_.@"#1=>M]<;4%@AGB-C=-
M:RB90"7"@DC!/'S"M6O/-,N+FUT_QU-9WMM93KK$FVYN?N1_)%DG@Y.,X&#S
MBKNF:AJ-SXNU/14O;Z.U;38[FWEN8T$L;EV4L 1T. <.,Y'04 =M17ED_BO6
M+?PEIUY-J-S_ &A87[0:Q''%$2T4;XE;&W@ -&01_>'UKJ=1O-8EM-;O]&ED
MN1$J0VENH3#,N#(Z$CDX)4 DC<AXYH ZJBO.I?$YNO"GB/4-(UJ]2XL;4.+6
M[A59[250Q(967D'CKGH<&M:YU748_$?@Z);Q_(U&*;[5%L3#E8=X.<9!SZ&@
M#H[2_-U<WD+6=S +:01B29 JS< [D.>1SC/J*M1R)+&LD;*Z, RLIR"#T(KS
MJ_O]3N_#WQ!@GU.X/]GF06[H%1E40!]O Z9/7K[UV/AB%X?#6G*]Q+.3;1L&
MD"Y V#@;0.!^= &M17$6FHZGXCTK7=1LM1ELY;.ZGM[.-%0H/*XRX();<<Y]
M 1C!Y.?'X@UCQ!=^$&M=1DT^+6K*X>>..)&V.B+\RE@3U8XSD=.* /1Z*R;N
MZE\/>%+B[NIGOI;"S:621E"M,44DG X&<5RVHZQJ^D^$-)\5?VA)<F0V\EY;
M%%\IXYBH(0 94J6&#GMSF@#N9[E(4E.#(\2;VBCY?!SCCWP?R-5-"UFW\0:)
M:ZK:)(D%RI9%E # 9(Y )]*YC0H)_P#A8GBXMJ%TZ1"UQ&Y4J0T3';]W( ).
M,$>^:YSP[<ZII'@3P=J-OJ<HAEO(;22S\M/*:.21E.3C=N[YSCVH ];HKA[C
M4-;UY]>32);B":PN6M;4QM$$$BHK9D# D@LV/3&,<U%<3^([WQ78:0VKG3S<
MZ,\\ZV\:.(I@R*2A(Y&3WSQGH>0 =[16)XAEO=.\&:C<6]ZRWMI8R2K<>6I+
M.B$Y*D8Y(].]<G+J/B+28/"VN2ZP]Y;ZC-;6UW9-"BH!*HPR$#=D'DY/.>PX
MH ]'HK@M*N=:N]2UZ>XUZX%KH^I'$201_O8EC5BC<=.>",'KUXQ7N-=UE?AU
M#XTAOV-P$6ZDLRJ^2T1;!BZ9&%/WLYR/3B@#T6BN0AU"]\3:GKEG97\M@+!(
MHX-BKGS'CW[WR#D#(&.G!SGC#9-3U:36+3P_-*[W4>FBZNY;$HAD<OL^7?T4
M%2>.<D=!P0#L:*X2/5?$=BFD:-JC;K^\N9T\^!H_,>&--XZ_*'.0#QT!QR<A
ME[J_B/P[IUZMZZNMS?06VES3E&DC$IVMY@7@[>2/7O0!U,^O6\'B2TT-X9_M
M%U"\T<FT>7A,9&<YSR.U6K"^:^%SNL[FV\B=X1]H0+Y@7'SKR<J<\&N/NK*:
MT^*7A\/?W%RKV%WCSMI*L-F2" .O''08XK.N]?UR+P%XNOEU63[;INISP03>
M5'GRT9%"XVXZ$\XSF@#TRBN/6ZU73?'FE64^J2W=MJ=I.[PR1HJQ/'L(*8&0
M,,1@D_6L.Z\1:U/H-Q=P7\D&NIJWV4:<JH<(9-H0(0<_(=^[\>G% 'IE5-2O
MFTZT\];.YNSO1/*MD#/\S 9P2.!G)]A5B%'CAC220RNJ@-(P +'U(''/M7-^
M/-0O]+\/)>:?=M;R+=P1MM16WJ\BJ1R#C@]J -C4=5AT^6V@,<DUU=,RP01X
MW.54LW+$   =2?3UI=(U-=7T];M;6ZM269&ANH]CHRD@@CIU'4$BN4\2VDTO
MQ)\*[-0NH?,BO=OEB/\ =X1,[<J>O?.?;%=-X@EU&#P_>R:3$9;]8\Q(,9)[
MXSQG&<9XSB@#3HKSO_A)C>>&?$M]I>LWT=U8V7F"SO(56>TE578[@R\AOE]>
MAP16E-J^I)JW@D+>/Y6I(XNX]B;9"("X/3(.[T(H [*LJSUZWO=?U#1DAG2X
ML4CDD:10%8/G&WG)^Z>U<_I]UK7BC0I-8TW519W/VR18('0&%8HY2A5QC)+*
MI.<\$C&*KBSNK_XD>)(;74IK#-A:$RP(I?/[S&"P( ]>,^XH [VLK4]=BT^X
M-K%:W%[>"!KDV]L%WB,'&?F(')X ZFJG@?5KK7/!>E:E>L&N9H?WC 8W,"5)
MP/7&:QH[.8_&"Y/]H70 TB.3 $>-OGO\GW?N_K[T ;4'BN&7P_>ZU)IFIV]M
M:J7*3V^R21 H8LJD],'OCH:MIK:RV.DW<%C>31:CY97RT!\E77<&DYX Z$C/
M)KE(M0O[WPIX]BOKMKG[)+=V\+,BJ5C$"D#Y0!W-*;^_T_0_  M+MHH;J2UM
MIX@BD2(82W4C(^Z.AH [ZBN":;7+_7_%U@NO7%O#IZ026QBABW*6B9\9*GY<
M]>,GCD=R+Q/J-SHO@RXN9?L]OJH O[M !M;RR57)X7>_&?P&* .]JI<WS6]_
M96HL[F47)<&:- 8X=JY^<YXST'7FN?\ "-WJ=YJ&M_:K^2ZL+:[,%F[(@#K@
M$G< "Q4DKGIQZBI-;U"_M/''ABTANV6SO6N5G@V+AMD193G&>OOV% '3T5P<
M7B&Y3Q/_ &7JUY>:9?/?D6RR1K]EO(-WRJC8/S;<9Y!W<=\#;\<WM[IO@K5;
M[3[IK:ZMX#(DBJK=.V&!% '0T5PEW/K=KXH\/6R:Y,T6L0S+,C0QE82D8<-&
M-N0>H^8M[YZ4RUU75X-/\5V#:U&)M,N42WO[Y5!1'5&.[:N"1D@<<DCB@#OJ
MRM:UZWT,V N(9Y!>W4=I&T2@A7<X&[)&!7+1>)[K2=;U])VO)]/L])748DNU
M59,@N#C ! .T<,,@]A5+7DOKK0_!^J76I2RRW6JV,TT051%ESN 48R N<#GD
M=<F@#TNBN&GU#7->_MP:/+<03V-T]K:^6T0C#HJG,@8$D$G\L8YYKK(OM<VB
MQFY86]ZT ,I@(8))MYVD@@C.<9% %VBO.(/$6LR^ O".K-J#B[O+^VAN6$:8
ME1Y"K C;QQZ8J[YFM:EXJ\4Z8NO7%M;V<-O);F**/<A='.,E3QD<\9.!R.X!
MW596G:];ZEK&J:9%#/'/IQC$IE4 -O!*[>>1@=\=:Y72?%5_K-GX0L7G\FYU
M6U>XNKB-0&*QJ,A01@%B1DXX .,<$44U&;POJWQ"OS,UU+;)9M&\X&<F,A0V
M,9 R/<@>O- 'IM%<I;P>)4UZT9;B<Z9+$Z7?VIX2R/C*/&%'KD$'C':JG@-]
M;U?3+/6-0UR690]S$]MY$:K)B5E5B0,@C';C&..N0#MJ*Y+Q;K5SHM_9S7"W
MT>B&)_M%U8QAVADRNUG&"=F-W0=>N:KQZY=7EWI&D6M])>B733>2WEJT:-/A
ME0$%N ,DDX&<X''- ':U4U34(])TNYU":.62*WC:5UB7+;0,G R.U<J)_$=E
MHD46K:E#;R#4Q&)L!YY[4Y*JJHI'G'IP.@)]ZJ0:I?7OA_QS97DDSK8K,D'V
M@+YBHT&[:Q7@XR??UH [;3;Z/4]+M+^%66*ZA29%?J R@@'WYJU6-X1_Y$S0
MO^P?;_\ HM:V: ,9O$EJOB5= -O=?;FA^T ;%V>5NV[]V>F>W7VK9KB)@3\;
M(0#@_P#"/-SZ?OQ6'<:OXB3P=XAUH:]/Y^D:E/'"@@B"RI'(%VR?+R,?W=OK
MS0!ZG134??$K],KFO/;;7=5@U+PT6U)[W[==R6]Y)&B_99/E=@(B0&^7:,,.
M#SDDT =SJFHQZ3I=SJ$T<LD5O&TKK$N6V@9.!D=J=IU['J>F6E_$K+'<PI,B
MOU 900#[\UP]Y?7?B;PGXLOEOYK:&V-U:V\,87;MC0@E\@DECGZ#&,'FI-#U
M2>ZD\->'()WMHQH,5_/)'C>XPB*@)!P,DDD<\"@#H+3Q1!?6NL36UC?2/I<K
M0R0",>9(ZJ&P@SSG(QG%:\=PCPP.X,+3 ;8Y<!LD9VX]0 >/8UYK92W^D^'_
M (A7%MJ$@O+2]FE2X9$+';"A&1C'H.E7M1%W>^*O KG4KN(W%K.[^64QN$*G
M=@J1D[B.<^V* .W@OFFU.ZLS9W,8MU1A<.@$4NX'A#GDC'/UJW7#2^)+[2=:
M\:27,[75KI=G!<6T!55VED=BN0 3D@<G-,U+5=6T30=$\0_VC)=">6W6]MV1
M?+=)<#* #*E21CGD=<]: .\HK@VEUO4/$7BW3UUZXMH+"."2V,4,>Y"T;-C)
M4_+D<\9/'([]%X1U.XUGPAI.HW1!N+BV1Y"HP"V.3CM0!J74YM;.:X$,LQBC
M9Q%$,N^!G:H[D]!52?6;>TTB#4;J.: 3>6%@=0)=\A 6/&?O9('7 ]<5'XEG
MN;7PQJES9W#07$%K++'(%5L,JDCA@1VKC/$9NM1\'^#+R6^G66>]TXR% GS.
MVTE^5/.>?3V- ';:7JYU*6[A>PO+.:UD".MR@ ;(R&5E)5ACT/'>M*H! XL_
M(^U3&3;M\\A=^?7IMS^&/:N(TS6=6?2+[0[O4I6\1P:@+,3^7&"5<[TE"[=N
MWR@S8(_@- '?45R=I>W>O>(-=TV/4;BTBTKRH$:$)O>1DW&1LJ<]@!TX.<\8
MPK/Q7K-Y8>')I;GRKE]:;3+Y8XU\N<+ORPR"1G:.A'>@#TFJ>I:E;Z5:K/<%
ML/(D,:+RTDCL%51[DD>WKQ6+H^H7TOCKQ%IL]T\MI;16LD$;*H\LN'+ $ $C
M@=<UG_$2WDE_X1QDNYX@=;M4VH$P"6/S<J>1^7L: -G3_$C7^KOIK:)JMK)'
MN\R6>%?*7&"/G#$'(/&/0]*L:+KUOKC:@L$,\1L;IK643*%)<*"2,$\?,*R9
MKS4+3X@Z3IG]H2RV4]A-(\<B)EG0H Q(4>I]O:L&TUB30M/\:7L(!E.OB%"<
M84R"%-QSQQNSSZ4 >DT5S.G1>(8/$BF625]'E@(D6[DC,B3 \%-@Z$=0>G:K
M'B*YN(;G3(X[\6T$LS":*)2UQ/A"56,8/?!8\8 ZB@#>K*77K=O%#:!Y,ZW2
MVGVOS&4",IN"\'.<Y/IVK-\#ZI?:GINHK?R/))9ZE<6B-*%#[$;Y0VW@L <$
MCTJM(2/B\"" 1X?;!;I_KQUH ["BO.[/7-5BU?PPC:E)>+J$DT-Y*B*+:1A&
MS PY ; (X(&".Y-1W>K:_;Z?XHTM=6N6UNRN$?3W$,1:6*0 QKMVX/1P3CC&
M: /2**Y+3]8N]>MK2]TB[=D73//:)PFV69QB-6.WC!5\XQVK-T/Q!)J37%L^
MIZA9ZK;V#FZT^\B19%E&W$J?+@KPPXR,$<"@#OZJ0WS3:G=69L[F,6ZHPN'0
M"*7=GA#GDC'/UKAT\0:N_A'P3J1OW%QJ%[:PW9$:8F5\[LC;QT[8JW+?:E/K
M7C73I-2G$%K9026QC"JT)=)"V"!_LCD\T =M'(DL:R1NKHPR&4Y!IU<UX B>
M/P)HK/<RS>990L!)M^3Y!P, <?7)]ZZ6@ HHHH **** "BBB@ HHHH ****
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M 4IY9()!)&<Y YSVK=HH P_&3JG@G7 S %["=%'=F,;  >I)[5F^'-%6_P!
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MA]_:VJZ'IVN:AKEU<,Z3(]N501MB5@&.!G(QZXZ#MST%OH0CO?M]S?7%U?+
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M_LP3#[.&)SP,9VYYVYP>^1Q727ME;:C9365Y"DUM.A22-QPP- $L801J(\!
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MUD^'- @\,Z)#I5K<7$T$.=K3L"PR22. .,DUK4 %%%% !1110 4444 %%%%
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MG(_"O,=.M!%X:^(LGGW+E+F^C DF9@1Y"\D'J>V?2@#T;3;U=2TNTOE0HMS
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MY"NUX@A#9 R<Y/S<8X%7[:YNO$^K^(-/:_EM&T](88/LDI4+(\6_S3C!89.
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MNME4Y)&<GJ.* /1J*XC2=7N]2\:V :6:.UO_  \MZ]J7.U)&=1D=P<''%7_
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MZX)'H.P%1MX*LVT73]+;4-1:&QFCFA9I5+;H\; <KC P. ![YKI:* ,6?PW
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MY%++M\OG&/ESD9)SGO6Y10!C0>&[=;JVN;NZN;^2UA>& W6P[%< -]U1N)
MR<_J:I:-X(T_0YU-M>ZB]I$Y>"QFN-T$+'GY5QGC/&2<'GKS735E>)-;'AS0
M+O5FM9;E+9-[1QLH./7)/3\S[4 5HO">GH^L>>\]U%JYS=13E2I.W;QA01P
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MEJI92R9ZY&5(_D:Z.3PK8MJ&D7<,MQ;?V3&T=I#"5$:JRA2""I)R !UK<HH
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MH C?PTA9O*U/4(EDM5M9$#HP=%W8)W*?F^8\C^E5-0\":7>-ITEK/>Z9<:?
M+:"XL9MCB(=$)(.1]:Z>B@"M86,.FV4=K"9&5,DO(Y=W).2S,>2223FJ.H>'
MK74-9L]5:>ZANK5&B!@DVB1&()5N.F0.F#6O10!S8\&6?]F:OIYOKXP:M*\U
MUEH\EG #8.SC( 'X4S4/ UC?R6%RE_J-I?64(MTO+681RO'_ '&^7!'X5T]5
M[^Z-E87%T(7F\F,OY<9 9L#/&2!0 EA8PZ=91VL!<HF?FD<LS$G)9B>22223
M5FL_0M577-"L=42(Q+=PK*(V.2H(SC-:% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<9\3X%F\(A
MB\JE+VVQLD9<YF0<X//7OT//6NSK/UO1K37])ETZ]\P0R%6W1MM965@RD'L0
M0* .4U6TO)?'=AHL.M:G;64^F3NZQ3G<"'4 ACDYYZG)[50\37-Y8Z7XADM-
M8U"[N--MX_*DCE,:VA1 3YA!"R.QRQ&T\$9QQ77IX9MDUFTU7[9>M<VL+0(7
MD#!E8Y;=D9.2,]?IBJE[X&TJ^FU5Y)KY(M47_2H([@K&S;=N_'][&/;CI0!5
MCU.;6O&2:-+/-#;0:6EXZP2M$TTCMC[RD':H'0'JW/05S6DW]QHND7]I!.Q>
M[\62V1GEDVMM//+X."=NW.,_-GK797'@S3Y9["ZBNK^VO;&+R8[N&?\ >O'U
M*N6!##/."..V*8/ >B'2=1TV9;F>WO[AKF7SIV9ED)SN4]B,#GKZYH =HNG:
MQI^OW9N;R-M,GB#0VKW<EQ)'(" Q#.H.T@CC)P<>M9_B[4;S2M66YNK;4)M"
M^R[9)=.F99+63<<R.BD%EQCGD#:>.:W=#\/0:&C[;R_O9F 7S[ZX,KA1T4$\
M ?0<]\T^\T1;N_ENTOKRV>6 6\BPLNUT!8CAE.#\QY&#0!S,6IS:SK-MH]K=
M_:K5-(ANUE6\DMFN"Y*^9N0%CC:.,CEN<\8CM[G6;&^\/>&=8U-99;J2Y,US
M;R$/(D:ADC+X!#88$D8)"^YK8U#P)H]['IP@:[T^;3HA#;7%C.8Y$CQC9NYR
M/K[^IJ74/!FE:EI-K82FZ1K63SH+N.<BX23N_F')+'OG/Z"@#G_%L&J>'_!F
ML26_B&Z:1;J&6V^;]Y!&\J+L9R2S#EL'(/Y5;U$7>CZQI>D1:E>7?]KW,TKM
M=W10C9&#Y:.JY0$\X'H0,9K4N?!MA=Z#+I$]U?213.LD\SS[IIF4@C<Y!Z%5
MX&.E6=<\,V/B+38;/4&G9H'$D-S&_ES1N.C*P'!_#% '#>,-,U:S\">)8M2O
M_-MA)#-91+=R221*S@,KL0"ZYSC.>_I7ID%NMM;""-Y2!G#22&1N?=LD_C6,
M?!^G2^'[O1[J:\NX[L 3W%S.7F?'W?F/3&. !CVY-:]I:"SLTMUFFEVC'FS/
MO=CZDGO^E 'F5[J>K1_#7Q9=+J]Z+JRU6XBAG\SYPBR*H7..!@]L5T?^F:5\
M1M-M1J5Y<P:C93O-%/)N0.A0AD7HOWB,"KC^!].DT34=(>ZO6M-1N&N;@;UW
M,['<V#MX!(!P/3ZU?D\/0S:U9:M+=W3W5G&T49)0*5;&[("\YP/RXQ0!@_$.
MV2<^&2TDRYURVC_=S,@P=V>A'/ P>H[57FTW[9\4;FS%Y=P1#085+PS%9& F
M<#Y_O>^<Y/KUSU6MZ':Z_:16]TTT?DSI<120OM>.13PP/YU##X;MX-;;5H[N
M[%TUJ+3+.K#RP21U4DG))R><]<T <;H_B+4[GP]X7L9;EI9[^[N;>6>28Q-(
ML)DVKO )#':O(&3@],YKJO#MCJ^G7^I17]Y'-9R,DEG";AYY8 00P9W )4D9
M&<XY%0-X!T>3PZNB2-=/;QSFX@D\W$L$A8MN1@!@Y)/?K6KHVB0Z+ Z)<W=W
M+)CS+B\F,LKXZ D]ADX P.3ZF@#$$\OB'Q3XATE[VYM4TZ*&. 6\S1D-(A8R
MG:06P<  \?*>.:KQWEZ_BC2?"]YJ<DZQZ;)<W-U"3"US(KB,#*G*X^8D ]<?
M2M75O!VGZKK":L+F_L;X1^4\UC<&(RI_=?'4?K[]*GO/"^GW)T^2(S6EQIV1
M:W%NP#H",$?,"&![A@<T <+KFK:KIVC>-].6_NRVC&":RN_-;S%64!MC-_%M
MY'.3@\UU&I7-S%\0M!M8KJ=(+NSNC+&')5B@3:=IXR-Q[5IR>&--GTK4-/N%
MDG74<F[E=OWDI( R2, 8 &   ,#BJL'@RRAU"POY+[4KB\L4>.*::YR2&P.<
M  XQTQCKG- '-:!87FL:)J5[?:]JTAM;J^@6)+@HKH"RC=CDD=1@C'YYWOAS
M;I#X!T5U>5C+:1L=\C, <=@3P/85J:/X>M=%M+JUAEGFAN97FD69@?F<Y8C
M'4GI3M!T*U\/:<EA9RW#P)P@GE+E%[*/0"@#D+;3]4U_6?%=BWB/5+=;2Y1;
M4PRA-C&)6&<#E03]T8SSG/&*%EK.L:[8^ YY=3NK6346GANQ 0HDV(_S=.IV
MY]!G(%:NAZ9->^*_%KO+JEE#=7$>TK$8UF01*I(9T]<C*D']*Z&?PK82S:2\
M3SVRZ3_QZ1P%0J?+MY!!S\O'- &+IWFS>*[GPQ/J.H2VNF6$;B1[EEFN'D9L
MNSI@G:  /J<YXK)M?$VIQHFAW5W(2/$+:5]O. [PA=X&?[YX3/7G/7FNVO\
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M1".9F<C<=N3@ +@'OO:@"&UG;5?&.K:%+<W<=II5I;B-8[AT>5I Q+LZD,<
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MDR DC>HQGDGICK6;#\/M)@MK"W%UJ;1V$_G6H-VW[K@C8,?PX)]_>@#.6ZU
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MF&Z1G@D615=HR5[,I*L/P((_"I:\=MXY=.^"5W?6%[>VURMQ(%>.Y?@?:RO
MS@<$YQC/>NQU/3UTJ6S@&MZK,]]?>8;0REY+G$9S&AROEIQO/('&.AQ0!V-8
MUSKYMO%EAH9LV(NX)9EN-XP-F,C;U_B'I7#)XBU/3?#VM0-<RI(/$"Z=#+)*
M96M8I-A/S-R=H9L$],CTK6OK&+3/B;H,D+W,@.GW9V2SO+RNSD;B2"<\_04
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MDK(N<-DYZ9/'3GI5FX\,65T;I9IKI[:[E$MQ:F0&.1ACMC('RC(! /?-;5%
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MJEC)9SF18WP2T;E&!!!!!'(.0*M44 9 \.6$C73WH>^DNH!;2O<X):(9.S
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MD$#K@'D D@'D#@4Z[\*:=>:Q-J;/=1RW$0BN$BG9(YU7.W>HZXR?PX.:W**
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M ?Y/*!R%VXQC//K6K10!1M-*@LM0OKV.2=I+UD:19)2RJ57 V@_=]\5>HHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KGM)U%M<UW59 Y%EID_V.-0<!Y@H,C-ZXW!0.V">XQT-<
M/X5T^5(/&6CNQCN)-4N)%8_W)D#(WZG\C0!MKXMTQKFQC/G+#?R&*TNBG[J9
MQGA3G/.#@D 'L34=EJ+6/BZ?P_*[/%+:B]M&8Y*@-M>//< [2/9B.@%8_@[5
M+]-)TSP_>>'[V'4-/5+>666'%N%0;?,63HV5'&.<GTR:M75N]W\6;"2,?)8:
M5(TK#H#(^U5_':Q_"@#KZ*** "BBB@!DL2S0O$Q<*PP2CE3^!!!'X5P.@ZG)
MX2\0ZMH?B#4;J=65KW3[RZF:3S8 /FCY/WEQT')SGTKT&N'\>VSW6L>%7BL+
MFY^RZHD\SQ6KR"./!R20#WV\>U &OI$!TC3KO5]6O+F/S=]Q(ES<NZ6L?4(
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M659$+22(@.#\IZ\X [\4 =5J7B>QTVXNX&CN)WLH!<W0@0-Y,9SAFR1G[K'
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M \4J%'4]&4C!'Y5Y?_8'B"+PS%.T,LE_X8N-FFH"<W44;G<<?[<150/]D^M
M'=W'B6PM!.9EG4Q726:C9_K9GQM5.>>HYZ#OC!Q"_B_3HK'4[F6*[0Z6P6]A
M\K,D(*[@V 2"N#G()XK-UQ=2T?PWIBP6LMQ(]ZCZA);0^=)$'):22-<'G<<
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MXNU3[9]AEC\@EX)MP!5\<#&1WY[9H ZBJUI8Q6;32+EYIVWRRM]YSC _  8
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MI%.&5AV(K1H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0312':RMY99"&4D$'KU^HK(;3/%%G8Z/JQ2YU671]1G,<4N%N)[-UV!CGK(
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M$.8]P\Q69F7C/(#?0]B:I>'?#DE_\+6\/ZI;RVD[>?GS%P8V,KNC@^V5/X4
M=?\ VDG]L_V8()FD$ G:4;=BJ20 ><Y)!QQV-&KZI#HNDW.I7*2O!;1F201)
MN;:!DG'TK'\$)?3Z%'JNJE#J-^B/(4Y&Q5"ICV(!?ZN:L>-?^1$\0?\ 8-N/
M_1;4 4[?QYI\VI:=:2V6H6T>H@?9+J>$+#*Q&=H.<Y],C![$\5/J7C&QTNVF
MO9;:Z?3H)O(GO8PICC;=M.1NW$!N"0#SGT-88M)O$FC>$+6*TN(A936M[<2S
M1E501)P%)X8L2!\N>,YQ5/2K&\T:YO=%O/!XU)GNI9+/4!%&T3I(Y8>:S<KM
M+'/!/' Z9 .DN_&MI;:K=Z;#IFJ7EU;)'(RVT ?<CG 9>>0,?X9JY%XDAGE'
MD6=U+;&Z:T^TIL*"16*G(W;@ P(SC^8-9FF6UU#\1M5N7M)EM)K&"&.?RR(V
M="Q8#T'S#':LG^Q[J/Q%%J>B6VH:9?RZB1J%L5/V6YAWD-*<_+N*@$8.<GIW
MH Z2\\5VMK%?7$=I=W5I8.8[JX@52L949;@L&;;GG:#CGN"*;=>,-/M]0L+.
M&"[NWO[=KBU:WC#+*H /!)'J/89Y(K"TFTU'0=-\0:'/IUS=-<7%Q-8S1)N2
M=9<D*S=$()(.[ ],TW3]!O-%USP=;>1-/#IFGS6]S<HA**[A,?AE3].,T =7
MH.O6_B"SFG@AGMY+>=[:>"X4!XI%QE3@D=P<@GK5;Q;K$NDZ9;QVK!;W4+N*
MQMF(R$>0XW8_V5#'\*I^#;:YMKOQ&;FUG@6YU62YA,B$!XRJ $?BIX/-1>/[
M9S!H6I ?NM-U>WN)_P#9B)*,WX;@?IF@#:GOK31/L>GQQRS7-P6$,*$&23:,
MLQ+$#CJ6)ZD=R*R=0\:Q0:!KEW:V4[7^DJ?M%E,55XSMW*Q.[!4CG*DY'3FF
M^(;&^MO&&B^(;:WENK:WCEM;J*(;G1'P0ZK_ !8(&0.<= :S-2\/7VJKXRU*
M"VD1M3T];2TAD&QY"J-\Q!^[DG S@\<XS0!'K5_))J?@?4KFWNXYGG</'D,9
M,P,<A48CDGZ^N*Z6Q\6V-W:ZG+<0W-C)ICA+J"Y4;TR 5QM+ [@1C!.:P;B.
M_O+GP7/_ &3>Q+8REK@/&"8U\DIDX)_B/3KCFJ>IZ!JFK7'C>*WM9(VOGM)K
M)YTPDQA525Y]67'..OI0!U:>*;<:Q_95U8WEK>/ ;B".14;SU'4*48_,/0XJ
M/P_XPMO$AMWLM.U);6XB>5+J6$"(%6VE2V3\W?\ /G(-4O#]T;J5+AO!KZ1)
M;H3/)+;H&+8QMBV_,V3WP!@>_$WPZM+K3_ VG6-]:RVUU;AUDCE7!&78CV/!
M% %KQIKMQX<\)WVIVML9YHDPO*@(2<!CD\@$C@9S^M8.O7;0^//"=Z]I>)))
M%>AK8$.[$(NT85BO<\Y[\D5M>/M.N]6\#:K8V,)FN9(AY<8."Q# X'O@5GWO
MVW4/&7A74AI=[%;V\=T)S)&,Q>8BA-V">I!Z9QWQ0!?A\:Z=)HEYJ<L%W;_8
M[G[)/;2H/-6;*@+@$@Y++@YQSUJ>/Q3;&75()K.[AN=-B6:: JK,R,"0R[6(
M/0]^U<H8_$%C:^*)M.T^[$EUJZ3IB,"1[?"*[1[N-^%.,\]ZDM+*]M_$>OW4
M>B7\5I?:7&D3R$.[.H<8;YB2Q+#U/KB@#;L_'5A=MI#?8=0BM=5VK;W4L2B/
MS"I8(?FSG /.,>]=37FXT[45\)>!K0Z==_:-.O;:2[01',2HC*Q/KR1TSFO2
M* .;E\:6$3,YMKIK1+[^SWNPJ[%FW;<8W;L;CC..OMS3KCQ?;Q:M?Z7!IFI7
M5Y91I*T<,2_.K9P5+,!V[XSVS7':S:Z_JFF70O-$OY]1M]6CE1E*^2(%F!7R
MANY)7J<9ZY/05TFG)=1>/]9U&>PNH[:>RMT1S&6!=-Q91C/3</8]J .AT;5K
M77='M=4LF8VUR@=-PP1[$>H.15ZN7^'=G=:=X&TZQOK:6WNH ZR1R+@@EV(]
MCP1TKJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *"0!DG HKG_&UYIMCX3O9M8L)KW3PJB:&+&2-
MPQW'&<=#0!T%%8-]XFBL-=AT5-.O9[F:V:>+R@FUPI (!+#!Y[X'O68?B!#_
M &/=:B-%U-DL)7BOT"QYM2A^;)+8;U^7/'7% '8T5S]WXKM[;6+33(K&\N9K
MNV:Y@:%5VR*,< EA@_,.N![UGGQ_%_9%YJ"Z)J;#3Y7BOXP(\VQ3[V26PW'/
MRYX]* .PHK(N=?@1X8;2)KN>:#[2L:.J8C/1B6( R>!]#Z&J=GXTTW4-*L[R
MU2>2:\G:VBM, 2^:N=RGG V@$DYQCZB@#H\C..] ((R#D5Y]HEP$\=>,YIM/
MGC*VMJ9+?*LS\29*G.""/<?A6MH^OZ5:^&M 72=/G2'4!Y=C:#&5 5F.YB<
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M(!RIVD$9_GQ5&7XA6T=AJ%\NC:F]OIMT]O>.%C'E;<;F^_\ ,.>BY.!DXXH
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M=+5&F2,1@%64MN!+ 8P.G4YX'!Q;3Q38SV&E7-HDMQ)JJ[K2!0 [#;N8G)P
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MW>@:M>?#CP]!;VS1ZKH[6EP+65@OF/" "F[)'/.#].E=_2.ZHI9V"J.I)P*
M.5DLI]>\7:'K!L[BTM]+BG8_:%"L\DJA=H )X !)/3IC/.(H/#M[;>.;R2,*
M-#NRE_(N?^7I05QCT/R/GU05V%(S*N-S 9.!D]30!R-WIMY<_$9[K[+.MB^C
M/9&Z&,+(T@;IG/3OBN8ET_Q$/AFWA-] NI+^T>*-)HGC\F9$F5@RDL#T'0CC
MO7JH=2Y0,-P&2N>0*6@#@+NVU/2/%^H:B?#3ZO8:JL3@)Y1EMI50(58,<;2
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MAUK2SFN%M=4CN9RF/DC57!/)&?O#@5U5% '&V=I?P>*O%UX^GW'V>]AMUMG
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M^Z"\C).<GH!CGM2\+1>(]/M+30;[P_ #9[81JHE0Q/$O 8+][<5&,8Z\GTH
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M6#EMH8Y8G&,#(R<^M &IJ'C[3]/@^VO'OTU;C[/)<+*FY3NV%]F<E W&>O<
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M5<_,?NX(#8QP.2:R+71=>3PSX*M)-&F$VE7L4ERHFB.U$1E)^]@DEN@SQ^5
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M/[%>V7F)O*,BJ60[MI(*YQGD4 ;4GC2W@LM:>>PN5O-'7S+JT4H6V%=P=22
MRD ^_'2EM/&"SZKI=G/I=W;1:I$SVEQ(4*NRIO*D Y7CH2!G%9&JZ!J.H+XK
MU2.QE%QJ6G"PM+4N@<@*WSM\VT9+#OG ]\5+-INJO?>"95TJ?;IH;[7^\B_=
MYA,?]_GGTSQ0!MV?B3^T)(Y+6R>6SDNGM?/60$HR%@2R]AE<#OR,@9JK!??V
M3X[_ +$'%GJ%HUU;KVCE1L2*OH""&QZAO6L:/P]>'Q%9ZOIVG7.D:BUYG4BD
MJ_9KJ#)RQ4,<LPQCC()Y]:T;RVDO_BA97$2%H]*TZ1I".\DIPJ9]<*Q_+UH
MZ^O.X;R71_B'XL?3M&GOY7@LY&AMBB?POEB6(&?89)/;K77>'=7N=9TUI[W3
M7TZYCE:*2W:42;2/1AP>OX'([5D1VVHZ3XXUG4AID]W:ZA;VZQ/;NGRM&&!5
M@S#&=PP>E $EMXYL;RUT2ZM[:=H-5N#:H3@-#* V5=<\8VGIFIY?%]I;7&OQ
M75O-$-%BCFF;((D5U8KMYZ_+WQUKG9O"VJ:5HFBS06OVV\M-8;4KNW@=02)-
M^Y4+$ [=XZXS@U9@LM;&O>*-0E\/B2'4;:V6*WEFC82;%8-&W.,D-CNO7DT
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M-14<;]O7/ SGD\^QK*;XA,OAYM:.A70M+:4PWY,J V[*^QMH_CP>>,#!]<@
M';45@:KXGAL;V:RMUMYKJ&%9I$GNE@&&SM4$@Y8[3QTZ9(R*SH/B#:WL6@RV
M.FW=Q'K(D$1!12C(I+(03URN,\#OF@#L**XF_P#&MZOA?Q%<PZ9]GU31]R2P
M2S!E7Y RN& ^88.<<>G'6NHTB:YN-)MI;J,1RM&I(#[L\#G.!UH O4 @C(.0
M:R?$5Q,FFBTM7*7=](+6%AU0L#N<?[J!F_X#6)\.KV<:-<:!?.6O]#G-G(3U
M>,<Q/]"N/RH [&BN7OO&26UKK-Y;V+W5IH\GE7;K(%<L &?8I&&VAAG)'?%3
MS>*X$CLD$4<5W=P&X2&[N4B58P0 6<;ASD8 S^&#0!T-%<7'\1;6;2;.^BTV
MYD,^I#3)8T=#Y,V<8SGYACD$<'CI6A:>+H_MFK6NJV3Z;)IL"W3EY%D#0D'Y
MLKW&TY'\Z .DHKGX?$-X]]I\,FC3I%J$;O!*'W",A=P6; Q'D=,%N>*BL?%P
MO-!U34GL&@ETZ62&6U>0%]Z?P\#&3D8ZYR* .EI"RKC) R<#)ZFFPM(\*-+&
M(Y"H+(&W;3Z9[US7AN__ +=U/6=5E(\FTO'L;4'HBQ@;W'NS$\^BB@#J*SM8
MT2QUVUC@OHW812"6)XY&C>-QG#*RD$'DUS[_ !"L$?3IBD3:??SK!%,ERK2*
M6^ZSQ]0I]<DC(R!4\WC,V^L7VD3Z8Z:A L;VT/G#_3 [8S&<=!WSC'?C) !K
M:=H-KIL@E$UY=3 862\N7F91WV[C@?AUK4K)NM8>*_M],@MEFU*6 SM$9=J1
MH" 2SX)ZG P.>?0U13QA#_9EK/<V<ME=W,[VR6UVPBPZ9W$L>-F 3N[\8&3B
M@#I**XF7XCVL&E:S=/822SZ3)&EQ%;S)(A#_ ''5^,J?ID>E7H_%\J^)(-'O
M]&N;)KQ'>PEED4K<%!DJ<9V-CG!H ZBBN8\$ZWJ6NZ==76H6\<>+N:-=DFX#
M:Y7;C Z8Z]_05JZGJLEC=6-I!9O<7%X[(G)6- JEB7;!VCC X.2: -*BN7A\
M;6LFC/>R0>3*FH'36CDE 03!MOW^FWOG'X9XK;TZ[N;K[2MU9_9I()?+&)-Z
MR#:K;E.!Q\V.G4&@"[16%K'B0Z3KFEZ6-.N+B34?-$;QLH *(6QR<YX'7 YZ
M\5F)XUO9(=51/#T[7VE.1=0?:$"A=H<,K_Q$J>!CMSCC(!V%%8">)A>1:0VF
MV4EPVIVYN8VD)CCC0*I^=@&P?F  P>]9[>/8!X;L-933;ETNKP6;1JRDQ/YA
MC.>?F&0<8'/M0!U]-DDCB ,CJ@)"@L<9)X ^M<_9>*?,UB_TW4[!]-EM+87@
M:2575H"2"Q*\ @J<CGZUS/BS49-7M?"FH?V6$M9M9LWMIW<&15+Y!9<?*&'/
M!/;.* /2**YC6?%[:3'JMS_9DLEGI907,K/L+;@"?+!&'P&&<D>U,N->U+_A
M8%GI%O;1M8OI[W)8RX+_ #HN<8XQD\=\]J .JHKCM1^(6GZ? ;XI%+IR7'D2
M2)<KYJ_/L+B+J4#=\YQSC%7]1U@7S:IIUGIR:@EI%B[#R!5)9=PC4$'<VW!P
M<#D<^@!T$<B2H'C=70]&4Y!J*X2"[BGLI'_UD95T5]K!6!&>.1WYKG/AK_R3
MC0O^O8?S-8[7%QI?Q-UY]+T=KZXET^V=HHG2($[GRS,W&>@[D_F: .QT71+'
M0;+[+8I($)W,\LC2.YQC)9B2> ![ 5HUQP\?P2:)I^JQ:=-Y%Q=BRN!*X0V<
MI;;B3@\9[CU'K71#47;76TU(-RI;B>2;?]S)(48QU.UOR- %^BLW6M9AT6V@
MEEVEKB=+>(.^Q=[=-S=AP>>:P/%/B35],\,7MU#IR07,5U';%FFRNUR@\Q#M
MY^_CD#!!],4 =C16%=:[>078LH]++W2VC7<NZ;;$JAL!1)M.6/I@<=36+J'C
M*[NK'PM>Z1:@VVL7**WFR;7 VLVSH1_"03[>_ !V]%<QJOC*'3C>I'#!-+8(
M'NHWNUC;)7=L0$?.P4@]AR.<]-O2M2M]8TJUU*T+&WN8EE3<,'!'0CUH N45
MS]QXED;^TWTW3VOH=,<QW++*$9G"AF6,8.X@$9R5&>,U4G\<P%]#&G:?<7Z:
MS'(]LZ,JC*H6VG)R#V.< <\\8H ZNHI[FWM@IN)XH@QVJ9'"Y/H,U%IUQ/=Z
M=!<75F]G/(@+V[N&,9],C@UQ48?6O'7B6PU?3X)[".SMHF66;(BC;S&)''4\
M$XP1@<\"@#OZ1F5$+NP55&22< "N,@\=:;:#1XXX8QIM[(EK;2)<AY$R/D+Q
M]54XZY)&1D U7\9ZN-8\$^)!::<EW96T4T#SO( ?,52"R+@Y"'J<CH<9QR =
MVK*ZAE(92,@@Y!%+7+0>(8-.TS2;!#;M>/81S;;BX$**@4#)8@\D\  'H>F*
MJ1_$6UFTO3;V#3+J7[9?_P!GM&C(3%-S\N<\],@CC&,D4 =I39)(XE#2.J D
M*"QQDG@"N>B\1ZE++#:-H$L%\\,L[QSS@1HB-M'[Q0P+-D$#'3.:Y[Q)JEGX
ME\+>%M;A@*B76+1H_,4;X_WNUAGZC\: /1*:LD;LZHZLR'# ')4^_I3JX#P_
M>6_A]O'%XEI(\5OJ9<06T>68F*/A5'J30!W]9FM:#9:]#!%?>?LAE$J^3.\1
M)P1@E2,C!JC%XCN&UB\T>73@-1@LUO(XX[@.DJ$E<;BHPV1C!&.1S5$>.D;0
MM&U=; _9]3N5MANF \AV8J-_'J"#CH: .KC2&VACAC5(HD 2-!P  ,  5)68
M\R:G?7VE36@>UBC3?+OZLW.W&,A@,'.>,J1[9_@S5YM3TN[M[N0R7>F7LUA-
M(>LAC/RN?<J5)]\T ='117':C\0M/T^!KXI%+IT=QY$LBW*^:OS["XBZE W?
M.<<XQS0!V-9NL:%8:[#"EZDF^!_,AEAE:.2)L8RK*01Q63J'C%=+UR72[NQ:
M-S;-<6DGFY6[(('EIQ]_)'R^_>M&YUI[9M/M6M/^)G?;C':^:,*%&6+/C@#(
M!(!Y( S0!+INAVNFOYJRW=S-C:);NX>9@.X&XG;T&<8S@9K2KG%\6QPZ=<W&
MH6,UE/!>?8O*E.%ED)&THYP"A!SN., 'TJFGCVW6;5K:6T\RZTZT-X4M+A)4
MEB'4JQV\CN" ?3- '7T5QL7CTB;1I+S1+NTT[5O+2WO7D4KYKKE591R >@)Z
M^F*L^&];U35-?UZWN[6.."SNA FV7.T;%/IR3G/MT[9H ZFFF6,2B(NOF$%@
MF>2!U./3D5SGC?6M0T32+>;3X4=YKR&!G=]NP.X''!R3G'MG/M6+>236OQ4M
M;F'3!)?3:'(&BB=1N83)C<YQP!WH [^H+>TAM4=8EP9&+R,3EG8]R>I/ 'T
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MD9.6) )&,<UT=% '*>#O#EYHEK<6U_()(X&:UL3G)%J&++G_ &CNP?9%K/\
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MYL1XET.XRK?VA+.GJT$PRK#\=P^JFNQJ%[6&2YCN60>=&"JN#@X/4'U'L>.
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M?$2^U8V$ALI-.CMDD$D>6=79NF[.#NQ731R)+&LD;JZ,,JRG((]0:4D $DX
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV2[2T:XB%RZEEA+C>P'4@=<5-7"^(FGMOB9H<UA8I<W;Z?= (7$8;F/&YL'
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MC@J.N",@GD?C0!TE0W-W;640DNKB*",L%#2N%!)Z#)[U)(Z11M([!44%F8]
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M-G::Y<R3_OQ$53Y,[!M.2!S@[1[FNMO-8@7Q=H-FVF12F]AGDM[UB-\05 6
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M0-]TD=1G!J>@#E?'.D:EK=GIL&G6Z2-;ZA#=NTD@0;4)) ZG)IRZ=J/_  L
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MQNCB=$D+9P%^7CZGVJQKGAGQ'J<7B>V:WLK@Z@F+.[EN#F&/:/W(7;QR#SD
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M&XTF_BN9F\\[61"Q^4[>IW=\=*W+;2]3@\<:EK+00&UN+.*",";Y]R%CR,8
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'_A1_P (9X7_ .A<TG_P#C_PK<HH P_^$,\+_P#0N:3_ . <?^%'_"&>%_\
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M6J "BBB@ HHHH **JWFHV>G^1]KN(X?/E6&(,>7=C@*/?-6J "BBB@ HHHH
M***H?VSIW]I)I_VI/M4A8(G/SE1EE!Z$@<D Y% %^BJ]Q?6UK/;03S*DMRYC
MA4_QL%+$#\ 3^%6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9(CVB [5_=_[1R1SU.[%<_+HFHVNO)<:4MY#*+BW2X\QE>VO855 TC G*2*
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M9V\,$4S;#</%-YQS@\# " GU/;!(!TLGBC188+J:>^6%;0J)UF1D:/=]W*L
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M1D<4VW\0:7=7D5I%=@W$T8EBC9&4NA_B7(&5XZCBN<UFTE?6=3OKJPE&FR:
MUJ[-(B9?<Q*9R2#@XSC&:@T*6YMM2LIM2T?5TOXK V-NTD<2QO@;RN5D;YF\
ML<G X[9H [VBJ6D:@VJ:7!>-;26SR [H9""R,"01D<'D=1UJ[0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG62W,<D38RN4D7.".AQ6T-0MQXC2T>_F69;%IFM6CQ$5W*/,WE>HSC /<\4
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M7BBX2'^S+L$_-+:;,MG'0C:,'L7]Z[:JD.F6%OJ%Q?PV<$=Y< ":=8P'D X
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBLS5]:3247%E>WLS L(+.+>^T=2<D
M #ZGGMF@#3HK.T/6K+Q#I,.I6#.8)<C#KM96!P58=B""*T: "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ JO?"\-G+]@, NMO[LS@E ??'.*L5F7
M^F75W?0W-OK%Y9K&I1X8EC9),]R&4\^XH Q?AY<2MX?N+*ZLTMKW3[R6VNA&
MQ*RRY#M(">S;\UUM5-/T^#3;8PP;CO=I))'.6D=CDLQ]3_\ 6& *MT %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ex101slackseveranceagm05004.jpg
<TEXT>
begin 644 ex101slackseveranceagm05004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JI<Z7I]Y<Q7-U86L\\7^KEEA5F3Z$C(JW10 4444 %%%% !1110 =:9%
M%'!"D,,:1Q(H5$10 H'0 #H*?10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDEB*0&Y)G@>(>4.K98 8YKA%EMF\6:U--!J>H6-UH !>2W<&X ,A8#Y0%R.
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MH [L:]IS6,%X)G,=PYCA7RG\QV!(*A,;LC:<\<8)JF_C+08M-EOY+[9!#/\
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M"0QGC<HQ\PSQQGGCK5;2/&.C:[<00Z=+/+Y\;R1O]G=4(5MI&XC /MUP1ZT
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MDF\GS28]WFH P7IG'>M.;Q9I-N!)+-(MKYWV<W?E-Y(DSMP7QC[W&>F>,YH
MVZ*RQX@L#J]SI0,YO;:$3R1B!_N$X!4XPW/'&:BMO%.EWFB1:Q;R3R64LHBC
M<6[[F8ML "XS][CI0!LT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %0?9(S?"[8LTJH43)X0'&<#WP.?:IZ* "BBB@ HHHH ****
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M)&W&>@)K2UBY72/&\NIZAI]_=:1J-G#''<6L<CF"1"_RLJ\@$/GIU_&O0J*
M/-[J'^P]9\-:U;Z+/:Z)"+F*6WAA+/;>;C;(R#)&<<]QGGFM3PM,9_'7BNY%
MM=QP7)M&AEEMGC5PL6#@L!SR.#SS7:44 <AXL#GQ5X2=(9Y$AO)'E>.)F6-3
M$R@L0,#D@<UEP[Q)\0B;:Y N>8,V[_OO]'"?+Q\WS<<5Z'10!B>#PR^#-%CD
MCDCDCL88W21"K*RH 00>1R*Y*RM[FQUVSN/#\MXL%U?D7^C7<3%(068O-&6
MV#^(8X;(QZ5Z110!Y;I0M[6"[\,:[X>O[R^%S*8?W3O;W:-(75RWW5'/.>F/
M7BM*UU"3PQXIU^RU73+VXM=3F6XM)K>U:=908U0Q' ."-H'/&/2O0** .(O1
M/9^.O#M[+ITZ0'3IK?9;0F18I"4(0E1A1@$9.!QZ5CW^E7^M0_$.QLH9XYKU
MXFMF>-D68+&@8*Q !R5*_C7I]% '!ZFY\6Q>&$M+:XAN;;4(;RY62%HS:K&K
M;U8D#DDA0.^<]!FJ"K*?#WQ$B^RW7F7<]R;=?LSYF#0*JE1CYLL".*]+HH S
M/#I)\-:6"KHRVL2LKJ592% ((/(.:Y7Q-'IGC72FM["RN!JZ3H()Y+-XI+9E
M<9<NRC  !/7GH.:[VB@#CK:%[7XNWSR#Y+[28VA8]"8Y,,H]QN4_C6-YD&D>
M(==TW7M&U&[AU"Z:XM)K>&26.='508R%X!&,<\8Z\5W][I\5ZT$I)CN+=]\,
MR_>0D8/U!'!'?ZX-6Z .%\>61D^'UIH]O;+;S7-Q:6T,$9R(SO4[0?10IY]!
M76:U#)<:%J$$2%Y9+:1$4=22I %/DL(IM0BO)B9'@!\A3]V,D8+#_:(R,]@2
M!C)S;H \U2V?7/ OAG08+>X6_MGL_M'F0.GV7R<;RQ8#!X('KGCC)ID#6^F:
MMK>C:_H6HWAO+Z:XM'AA>6*YCD.X(<':",X.[ KTVB@#A_L\D?Q'L%2VEMXD
MT)[7?%$QBBD+H0@?&. #^58MK!<M\*KGP?<V,_\ ;4<;VBPF)BLC%R5E#8P4
MY#%L\8->I44 <3K^F:GIE]X?U32D-S>PQ_V9<''WHW7Y7;V6158^Q-1>&]!O
M=)\27>CLLCZ-:RC4;::0Y+/(I4H?7#"1OJ5-=W10!1MM4CNM4OK!8+E)+/9O
MDDB*QOO&1L;^+'?TJ]110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 57>\A2\CM,EIW7?L49VK_>/H,\>_;O5BN,\):B)Y/%NLW1),6I
MS09_NPP* H'_ (\?JQH Z'6=<L]!MHI[WSMDLR0KY<9;YF( R>@&3WJU#>PS
MW4UJ&*SPX+QL,':<X8>H.#R/0CJ"*\XU^ZU'6? FDZW/>E4O+ZTF-FL:[$1I
MEV@'&[</ER2<'G@<8Z'Q5<OIOBSPI>1'!GNI+&4#^-)$S@_1D4_A0!UU%%%
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M(65U' ]E%9%[XFG@\3W&E7NH2Z3.US&+ 2PK]GNHOEW .5/SGYQC(Q\O!YH
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MFAW;NS6ODYDC5SEXTDW<*<GJI(R>:O3>&@?$MGK-I>/:F"T^QO D:E7BW!@
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MK8.L%U$LT8<88*PR,^]7* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYUL>7IFK2P)!]F3$Z"-2$8]5&6'(YZYSQB+0/%K3RD:CJ%W!J-G:22ZAI5W
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M::4NB$H6QNQ@#D[1UX'8"@"'6?\ D<_ ?UNO_2<TD&NW^D:QXATW5[Z6Y>&
M7>G'RXU:2)OEVC"@%P^%YZY7BM>Z\.276J:)?O?D2Z2'V 1#$A==C%N?[OIW
M_*LMFTGQEXHTZXM8YI/[%FE,TSPO&H<8 C^8#=\P#\9QL'K0!U&F0W<&F6T=
M_<FYNUC'G2[57<^.<   #/2L5]3N=4\97FAV]W):06%K'-,\2J7D>0G:!N!
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M\1J\4"J76-<@ -MV9)R?O=\8BN-4\1^'[.\6^?S(KB^M[?3I9'1IHUE;:^_
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M*4M$NBI$'&,\ ;C@XR>Q-7?#>@IX:TA-,ANIKB%'=D:8+N&YBQ'R@=R:UZ*
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MVGZG%?W5E>60=%D@"'<CXW*0P([#G%93?#^V.D7FF#5;\6]U??;3DHQ1]X?
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ML6M;8L0\LD\C-@%G=BS' X')Z#H*T*** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9K<N)KS1_'>FZ3!>73Z?JUK/\LDAE:WEB .]6?)P0<8.1F@#L:*\FM-0UE/
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M2J@?*<\>I'7-5K.?Q%XE\/P:[I=Y#;71N&D#2WKB$1K(08GB"%?NC&>N><T
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MO"12_O+J+4&FCNKF1B(;O$3.&CC)^4 C@@*"/4&M#P)9B+5O%4GGW+E-7DC
MDF9@1Y<?)!/)]_3B@#MZ*YOQO!J3>'9;S2;BXCN[(BX\N&0KYZ*<O&<>J@X[
MYQ5*3Q"EW#=>(=/FEET_3M*:X\M9#MFE9/,"L/55 S_UT'I0!V-%>=:CJ.I:
M9X$TGQ;!J%Q/=D6TUU$SDQ3I*5#($Z+C?P5 /'.:TK*YNI?$?C2Q>\N#;VL=
MNUNOFG,1:)F;:>HY&?\ ZU '9T5@>";RXU#P3HUY=S--<36J/)(W5B1U-;]
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MTH MUAR>&+?^U;O4;.\O+&:]4+="V9-LQ P&(93AL<97!K9E9TB9DC,C@9"
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MU( ZDTGBC7&\-^';S5Q:-="V3>T0<)D?4_X5%>>(6M/$.B:4;)F75!*1/Y@
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M]]T06-"H5LY !/3I5I[*&Z\?^%IIC*TDND2L["9P21Y>.A]S]<\T >AU"+N
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M:"2/4I)(_.\W!C*H6^[CG./6C2M>EU#Q)K6D26@A_LWR<2"7=YHD5FSC Q@
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ML;62-@Q=(3.YBC8]2J$[0>3VX[8KHJ@:\MUOX[$RC[3)$TRQ]RBE03^;+^=
M&%<^!="N9-0)AN(X]0R;J"&YD2*5CU8H#C=[X]^M;UI:Q6-I%:P!A#$H1 SE
MR .G)))J:B@#G+/P-H%AJSZC;6CQR-)YWDB9_)$G]\1YVY_#CM5E?"NEJ-3
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MM7(7%Q.OP?UB?[3.)[;4I5BE\UMZ 7(4 -G/3CZ5WFC>#="T"Y:XTZS,3\[
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MR[-ND;&3R>.@X'% %ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***YW2-1.N:[JTQ8_8],N/L<*YP#*J@R.?7!8*/3!]:
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MF[D@MX923+)*7?</G;CE6/)' K=T_4%U!9S]GGMW@E,3QS  @X![$@C##G-
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MI^IW4]K?(^ER*E[;^6ID@##*L0&P5([@F@#IZ*HOJB)<6,'D3,]X"R[=I"
M$EOFZ<CD9ZCU%9LOB_3X'LWEBN5LKR<6\%\57R7<Y 'WMP!(.&*X/KC% '04
M5RUQX\TZ#^T]EEJ<YTQ]MT(K;[@V[BW)'&.?4]@:-1\6O#KOA^SL;&:ZMM4C
MDG6:,I\Z+'N 4,PY^922<<=,]@#J:*QSXCMS.RQ6MU-"ET+-[B,*464L%P?F
MW8!(!.,5>U*^73-.GO7AFF2!"[I"H9]HZX&1GB@"U16/'XCM9M&T_5(8+B2&
M_:-8$4+O._[I(W8]SSQWZ&H[SQ39VB7LJVUW<VU@Q2[GMT5EA( + @D%MH()
MV@X_.@#<HK(7Q)8/JNGV$?F.VH0-<6LR &.1% )(.<]&';O4ND:W;:S]M$$<
MT;V5RUK,DJ@$.H!.,$@C##F@#2HKC/%6IW"^*O#VD&QN)[*Y>=YHTV8N-D1(
M7EAD G)!P.!UHTO7])T.:YT"QM-:N7M+A%DC\EI3")3D<DY$:_RZ9YH [.BN
M?N?&&GVMM+>M%=/IL4QAEOT0&)&#;23SN*AN"P4CWI]UXKL;;6CI"6]Y<7GV
M7[4BP0Y$B;@ORDD \GKTXZT ;M%<D?B'I(TG^T_LFI&UCD,=T_V?_CT8-M(D
MY['KMS@<]ZWY=4CBU>VT[[/=.UQ$\JSI$3$H7'#-V)SQ0!>HK%\5ZV?#WAVY
MOXT$EP-L4$;=&E=@J@^V2"?8&J.N_P!EZ3HUA#K!O;GS;R$>=%N#//N&&8@@
M 9QQTQP!P!0!U%%<WK.H-H&NZ5/N/V/4[D64\9/"RLI,;CT.5*GUR#VK?NKJ
M"RM)KJYE6*"%"\DC' 50,DF@"6BN UO5&O?%_@YTM=0MDFN9&4RG:DJ>4QY4
M,<'D'Y@#S['&O9:UH=K>^);U/M4+VCHU^TP;&0GR[%)X^7'0#.10!U%%92Z]
M C78O;>XL%M(!<2O<[-NP[N058CC:<CZ>M01>*;9]3M]/DL[V"XNX6GM5E11
MYZKR0/F^4X(.&VF@#<HKG!XTTT^&[?7A%=&QFF\C.P;D;S/+^89Z;ACC-6[W
MQ%;V<MZBVMU<BQ56NF@"GRLC< 06!/'/ /!H V**Q[[Q';V4MZBVMU<_84#W
M1@"GR@1N&06!)QSP#Q5>2]TK_A.5MVCN_P"U8].=PP#^48=ZY &<,V2.@)]Z
M .@HKDA\0]):Q6^%KJ/V+[0;:6X-OA(&W[/G)/ SZ9(R,@9K8O-?M[6_FL8H
M+B[NH(/M$T5N%)C0D@9W$<G!P!D\4 :M%9VB:W9^(-,34+#S3;2?<>2,IN'J
M,]1[^QK1H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "N)\*:?)$GC#1I6,<TFISS*W_ $SG0,C?S'U4UVU5GL86ODO0"EPJ
M>664XWIUVMZ@'D=QSCJ<@'!^%(I([?3]&O\ P7Y6IV!1)+Y[6,VY"8'FK)U+
M$#C SD^F:UKFW>\^*]E+&/W>GZ6[2L.@:5\*OUPC'\*Z^J]I90V?FLF6DF??
M+(W+.V,9/X  #H * +%%%% !1110 5Q7CJUFN]7\+O!87%R+/4TN)GB@9Q'&
M 03D#UQP.>*[6B@#G?&^CW7B+P5J.G6+;;F:-6B#?+N*L'"G/3.W'/K6;J$=
MQXMG\-E;"[LWL;Y+Z[-Q"T?E;$8>6"1AR6('RY& 3Z5VE% 'EU[:ZG;Z#XXT
M1='OYKB^NKBYMY(XLQ/'(JXPW<\$;1S^N/1--,W]B6NZ!XIA H\J7 (8#H<9
MJ[10!Y4(]:O8?#5[>:'JK:C::H'O04"I&-KC$:[L!.5^8#'J2:FU*0PZSXHL
MH],ULV.I.L5RUC9BY5B8@'96#?(Q!VD$-C&>^!Z?7.1^$5MKN>6QUO5K.&XF
M::2VBE1HR['+$;T9ER23P1UH Q7>*\\0>"[S2[*].FV27,4A-LX^SCR_+57!
M&00RD'TQS3-5@FT?QO?WUYX;FUK3=3BB\N2VMEG>WD1=I4J>BD8.>E=U:VT5
MG;I! I6-<XR2223DDD\DDDDD]2:FH \ZU;3[G2]4TC61X62[TX6LEK<:;:0(
M[VNY]ZLJ=">S8[YKK_#R1BQDFAT=-*BFD+K;^4L;D8 W.J\!C@^^,9YX&M10
M!R%HEWIOQ$UVYEL+I[6^MK8Q7$4>Y!Y8<,#CG/(P "37,P:=J*?"O1=-;3;T
M7L&H1R2P?9VW*JW!<GITVG->JT4 >:>*(]8U:'Q582Z3J$V^#_B7"!-L+IY8
MRS'(W/GC:<D8&!UK1,=_'XG\,:I_9-ZT(TZ6VD4("T3G85W\_*#M//YUW5%
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M/<0:MK,MZ\<.3+9J5.R0;3G=\JYVY^^1S0!K^)-:TN3PK?2ZWI=_]CBG2&>
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M)]LL5SG$LB[7 ]EP_P#W\JQ90W2?$O4[U[.X6SFL88(YS&=K.K,2/7^+KTH
M+;Q=IEAX+CU5(-0>QM7%HWF;6F4J_E9;+<_-W!/K44Z!/B]9,&?Y]'F+ L2,
MB5!P.@_"N8N]-UM? 6L^'(]#O9+L7[2I( HCE1KD2 J<\\=NV#G%=7+#=R?$
MK3]0^PW*VJZ9) \A4$)(SJP4D$]@>1D>] '6U0U?5[?1;2.XN%D?S9D@BCC
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M-3%\]N]RUG)&B21QJ^S+;F Y(X )SUJ:W\5V%[9Z7/91S7#:G&TMM$NU6*J
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MS33I87F,9 5W96 .>>@/TH L^#/$%UXDT/[?=64EN6FF"DLA4A974*,'.0%
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M"Q"D$X_GD5D74MM>?$GPOJ%JP>*[TZYD609^=<1E3^1_6@#M\@YP>G6LK2-
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MZ5.T5X0(QY850S-R^",'H,GCG'% '7T5D3^(;9;NPL[5&N;J^A:XA12%'E@
MEV)Z#Y@/7)^N&^'_ !%#XABN7@M+JW^S3-!*)PHQ(IPR_*QZ'^8H V"0,9/7
MI2USVO7FFPZ[H%O?Z?-//+<M]CG7&R*38V2?F!^[GL:JW'CA(I=8BAT34KB3
M22/M*H(QA2N_<"7P?E[=3Z4 =715>PO8-2TZVO[9BT%S$LT9(P2K $?H:L4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5RWCG2]1O[#3;O2HA<76F:A%>BV+!?.5<@J"> <-QGTKJ
M:* .*MCJ5Y\0K;6CHE];V/\ 93V[-,8PRN9 W*AR>Q''/MCFJ&F:-/\ \(?)
MIFL>'9KF&?4YI)H"5WK$[NZR*0W4';T.>N*]$HH \RF\-^(X]$/V&2XO%TO5
M8KW2X+^0>;)$JX:-F/099MN><#M707UWK&O>%=70Z'<V9FL98(;>9D,LLC*1
MGAL*H]2<G/08YZVB@#A]9TW4KSX1?V1#I\QU%K"*V^SY4$. H/.<8X/.:LW%
MK?3>.= U!=/N!:V]E-%-(=O[MWV8!&<_PGIFNOHH \]CTS5/^$<\<VITNY$V
MIW%R]HI*?O%DB5%/WN.1WQ5@Z?J1U7P--_9MQY>G0RK=GY?W1:#RP#SS\WIG
MBNZHH \^73-4_L?QW =,N1)JDL[6:Y3]Z'A"#^+CD=\<5+#!KBW.B6EUI%U<
M:4FEI$\"2(H2Z& ?.RPW)M''4=>"<5W;,J*6=@JCJ2< 4M 'E]CH>N6W@;PM
M;OH\_P!ITC54GFMUDC+O&&DRR_-C^,=2.];\VGWUY\0?MDMC/%92Z(UF\P92
M$D:0-CKG@=\8S78T4 ><0:+K#_#F3P7<:?(+Q5^R+=#:8&BW\2YSGA?X<9R.
MG>MBQL+NR^(%U>"QN#8#2H;6.?Y3N=&8D8SGH1SBNOIN]=^S<-Y&=N><>M '
M,_#^QO=,\(6]EJ%I);7,4LQ9'*GAI68'()'1A4)LK_1?'U_JZ6DUWIVJ6T22
M& !G@EBR!E<Y*D$\C//7UKKJ;O7>$W#>1D+GG'K0!YM>>&M4@T1WBL)9;J^\
M1+JLEO&R9AC$BG!)(&[:HS@GDGZUZ4IW*&P1D9P>HH9E12S$*H&22< "E!!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;_8]5\/QZ4PB:.XN1+&XD)4K^Z"\C).<GH!CGL 8GCS5UUOP0+VWTYI+!KR
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M.5HVC<@].X(Z@]1[5SFI6,^LZ/!!J_AI)K6XG+2VD<B&2V4+\K[L@%]W7:>
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MNJG<%#%$!^\P!!(X'.,YXJK+XWLC)HGV*SNKV+6$=K:6';@E4+%2"00>,<X
MYR>#572++5?#.JZ_$FG37]IJ%V]_;2PN@P[@;HWW,,8(&#R,?E6;I_A34="?
MP1:0VKW46DFX>[FC= JM*C#@,P)&YCVZ4 ;L'C2$Z7J]U=:==P7&E2B&XM!M
MD<L0"NTJ<$'<*N6>MK?:S>:%>V7DW45NDY4N)(Y(G)7KQW!!!'YUR]SIWB>%
M_&%QIEC+#/?7$$EJQFC!D151) I#':Q ;!..OK5K1],U&T\<R:JF@/:6$^EI
M"<SQF02*[,=^&.7.1SD^[=J +/PO54\ 62*,*LUR /0>?)4?Q7C0_#?5IMH\
MV)$:-_XD/F+R#VJ[X T^^TKPG!8ZC:/;7$<LS%6=&R'E9Q@J3V84WXB:=?ZS
MX(U#2]-LWN;JY5515=% PZDDEB.P- '06%O#:V$$-O$D4:H,*@P.E8.J^,H]
M+BU*Z;3YY++3)4BNILA3EMIRBG[P&X9Y'MFIFU;66M(H+?PY?13OMC,LTMOY
M<6< N=LA) Y. .<5RGB;1?$>LV'B>RGTAKR>63.FW#7$8B2$;<*JDY5^&R<#
M.>N * +M_.^F_%B6>QTR6]N9="!\J JA<^?U9F( X'4^PK8LO'&GWNBK??9[
MB*Y-Y]@-BX E%SG'E]<>^<XQS5:2VU2W\;VVO-I4TEO+I7V22.&1&>&3S-XW
M L 1CC()Y]N:RKOP?JHMO[8MXD.J#6QJWV/S  4QL\K=TW;><],D\XYH ZB'
MQ)_Q-Y]'NK&6'44M_M,42.K+<1YP2C$@9!X(./RJ#PUXL?Q-':W-OH]Y#87$
M+2I=2E-NX-MVX!SGWQCK]:A-A=:CXMM?$$EA<016%E)%%#(4\V61R,\!B  !
MCDC)/H,F3X?Z??:1X)T[3=2M'MKJV1D=&=6S\Q.05)&,&@"_XHACF\*ZLLJ*
MX%G*PW#."$."/>O+$:VG\%>&X/##9\6E()<VA.X+QO:<CC9V.[O7K'B&.>?P
M[J-O:V[W$\UM)%'&A4$LRD#EB!WKC(O"VK)X0T&\L[4VGB;1(%C1)'3;<*!A
MXF921M;MD\'TH ['5-;@TR>WM3L>[N%9HXVD$:[5QN8L>@RRCN<D<=<<9XLU
MZQ\4_"[Q'(D&R:R+0S12$,8Y58<@C@CG@CUJ]K4.O2:II/B6RT)IIH(9+6\T
MR::/>4<JVY&!*DAE]>:E\166LZW\/]5MDT<07EZFR&R22/<@XY=LA<\$\$X&
M/>@#9N-;DMKN'3;6QDNKG[&;ILML0("%QN(/S$]![<D5B7WC6>YM?"]WI%F[
MVVL7"J3(ZJX&UFV8]?E.3TX]^)+Z#6KCQ#:>=I$EWH[6(58&FC58KC=R91GY
MAMQC&['89K#T[0-?L_"?A&.32':ZT>^WSVZSQ[F3#C<"6V_Q#C.: .J@U'3V
M\<W%O)IC6^IQZ:LKW<A7#0[SA003P&W=<=*CE\:V\&FVVL2V4R:)<2*BWNX?
M*&.%D9.H0G'/7D9 JK/H^H7_ (ZO;F>REBL+K1!8-<+(A"R%V8X&=V,-UQU%
M9JZ%K5[\/$\&7E@T<R!+5KT.AA,*N#Y@YW9VC[N,Y]N: -^?Q9*-;U#2+31+
MVZO+.))<!XU616S@ABV .._/MU-.M?&-GJ&G:-<V<1:75PQMXIG$>-HRP8\\
MC&.,Y^G-5K&QO[3QYK&H'3IS92V<$,,@>,[VCW9&-V1]X8S6%I7AN<^"-%T+
M7O#DMQ'")O/\N6/S+=]^Y'1@_H2..?;% '?:=>/?60GEMI+9][HT4A!(*N5Z
MC@@XR/8BIKBXBM+:6YG<)#$AD=ST50,D_E6/X1L=3T[05M=4N)II$ED\EIW#
MRB'<?+#L."VW&:/$L-W?)::;%837%G<3+]MD1T4+$.2N"P)W$*#C^$F@#F_#
M-_J6G>.+FSU=V":_ -1M4;CR74;6A^H0)G_=KKKW5Q!J46F6L!N;^2(S^7O"
M*D8.-S-VR3@8!)Y[ FN8\8^%I5MM/U#PWISRZO87B3P@3  KT=6+MP"/3T%2
M:I#KMEXLL_$^G:1+>136/V*\L/.C66+#EU8$MM/)((S0 FI^,[TZ=H=S8:7/
M$;[4TLYDN,(\9#'<H!X.=A&[I@^O3M8V9HD9TV,0"5SG:?3-<?XCLM<U/3=&
MO!IX>ZM-6AO7LHI4W+$H8;0S$*6YR><=0#QFNOB9VB1I$V.5!9,YVGTSWH Y
MN&^.L^.K[3CS::-#$SIV>>7+ GUVJO'NV>H&,V7P7</>22B1L'Q''JH^?_EF
M$ (_//%6](M7TSXE>(?-&$U6WM[J ^OE@QN/J,H?^!"NNH \RUJ._P##'C'4
M/$&B0E["W@@.I:?$,>9&V_,B#H&7;GWY]ZZ1'TO6O$VAZI:K!<0SV%S+'*%!
MW8:  GW&2.>1DU?LDNO^$HU.:6PFCMI8H4CF9D*N5WYX#$C[PZBL31O!\_A[
MQQ)=6#G^PI;:9DMLC%M.[QE@H_NL$SCH,&@"#P5:6Z>-?&3+#&##>1+%\O\
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M:_;(HY'\L)#A?F<@''+*. <D^@)K$U?Q?J@TK3)K72Y+6:?5XK"=+EBI4^8
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MPSGY@O5CN'(R/?/%0VOAW5;[P-IOA*]T]K98#"EU<M*C(R1N&_=[6+$MM Y
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MY1%:JUM=6T\:3VT^6R V\<<(>"1ZUUEK?V=]YGV2[@N/+.U_*D#[3Z''2K%
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M;A6)5\,"2I#;2 <=^I]/KGT\%Z+#<R2P1W=NLCEW@@O9HX68\DF-6"\^F,4
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M7>BQS0PZI.9[!64H5$:;ADC!7OT_"NHN?%$ECJ&B:9:Z,\AU*V>2#9*J*FQ
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M;B*=4<HS1.&"L.H.._M7,W>JZO\ \+(MM(BBMFL#ITDY5IF4M^\12Q^4C(Y
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MQ*60LV_CY-H4D]?09J&'QY#&-56^MXT:Q,6R6WF\R&X\PA5VN0,'<0"#TZT
M=A17(+XTF74KFQ:QM[ATLVNH9;.Z\R)]OWHV8J-K=QUR*KIXZO\ ^S]!U.30
M@+'5WCA39= RK+(I*C:5 *DC&=P^@H [>BN5A\8/:WFLVVN64=D^FVJWA:"<
MS+)"=W3*J=P*D8Q38?&,C:U8V#VEM*M\CF*2TNO-\IU&=DOR@+GH""1GCWH
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ME]F6))X&WL>>!D Z:BN*O/'[6GAW5;\Z63>Z5<K;7EIY_"EF 5E;;\RG<".
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M=H8QIA3R 1R<<G'O6:WCT7-MX?N=+TUKJ+67>--\PC,3JK$JPP>A4@GMSUH
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M8A( 8,K8&00PZ@53U;Q/J5IXE_L.PT5;RX>Q:[B=KH1AMK!=IX..O7UQZD@
MZBBN-O\ QRUM:WLT%K:RR6!V7%LUX%E=P 76-0IW8S@9QD@CWI[^,;ZXUH:9
MI>B?:)9=.34(7FN!$"C-@!QM)7H?4YQ[D '1ZGI5CK-BUGJ-M'<6[$$HXZ$=
M"#U!'J*K:;X<TO291+:PRF0#"O/<23%1_LF1CM_"N:3XB22:-:7@T607+:HN
ME7=J9QN@F+8(!QANO'3K6DWBF[MI(;+4+.RL=3E$D@CFO1Y0B5@H;?MR2Q(P
M,=CG&* .HHKC+3Q_%<VUH);:*TNI[V6R/VB;$(=%SE9-OS!AC;P,Y]JT;CQ,
M]E!917UO;VNH7<LR)%+<8C"QDY<N5S@C:1QGYQ[D &EJVAZ;KL$<.I6JSK&V
M^-MQ5D;U5E(*GZ&C3=#T_2=QM(7#L,&2:9YGQZ;G)./;-<K-\0I8-'OKLZ2)
M)K&\CMI1%<9C<2,%62-ROS YZ8&,5J0>(]2?Q#<Z)<:7!!=?8C>VC?:BZNH;
M:0^%^4@D=-PYZT =-17$>&/$NLW7@G3=2N-/%Y=7TX1##(Q WR-EI/E^1%'I
MNXQTJ/5/&E\?#GBE[*"U34-&&UI%G+QD%-P=3MY89^Z>XZT =K-=VUO)#'/<
M11/.^R)7<*9&QG"@]3@'@5-7(W&L36TGA>+4M)MIY;V<1QS^=YA@;RR=PW(#
MN(!].O4U<L/$LMQK&MZ=>VD-F^F(LN\W!82QL"0_W1@<$'K@T =%6'=>$-#N
M]1DOWM)([J4@RO;W,L/F'U8(P#?CFJLGBIXEL;>>&TM=1NK8W+17-UM2%,@
M%MN2Q)Q@#LW/'-*U\?17-E9M+;1V=U<7DED?M$VV%71=V1)M^8,,;>!G- '7
M6]M#:6Z06\211(,*B# %2U4TVXNKFS\R\M1;3B1T,:OO&%8@,#@9! !Z=ZMT
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3D]* .<L]+U6W\2^)=1DLXS%J,,"0!9@3NC1E.<XP"6X]A63;>&-;@\.^$+
MVL1ET:[2:X(F&&559?E]2=W?'2O0J* .0TW2-7\.:EKBV-M%>6>I7+WL+-*$
M,,SCYPX/5<@$%<GVJG8>#[S1;[PA%:(LUIHT-PEQ*7"L[2@9*KZ;LGKT/>N[
MJI>:KIVGNB7M_:VSR?<6:94+?3)YH QO#.EW^GZKK\]Y D<=_>_:82L@8A=B
MKAAV/RY[TDVF:@?B);ZPENAL8]/>S9O, ;<SJ^0OH-N*Z*.6.9-\4BNF2-RG
M(R#@_K3Z .*@TWQ3H&NZFNDV]C?:7J5R;I6N)S&UK(V-^0 =RY&0!^E0L]Y:
M?%D!(3>NOAZ-92K*C,?/;Y@#@=>V1UKNZR+NQT;3;^7Q%>.MO.D0BDNI;AE4
M)NX4Y;;C<>F.IH Y6Z\(ZHMA T$,,EY-KZ:Q=+YNU$ 8'8I(Y.T 9P.<FM7Q
M#I>N1^(+#Q%H,=O/<10-:W-E<2;!+$Q##:PR P8?Y[]9UHH Y:]L-4U2QABU
MG2;*_MIRYNK)9 ?)&%V;&8#<PPV3\OWCCH*PX_!^OZ58:5=Z5/'+>Z7<W#06
M=U,67[+*1^Y+^H"K@],^N*]%HH XK7],\2>(?"TD$]I:PW<UQ!(MLEQN2%(Y
M YR^T;F..PP./<F\VF:A)\0(-9^S*MD-,:S8F0;P[.KYQZ#&.M;']NZ1NV_V
MK8[LXQ]H3.?SJ_0!YS:^&O$]GX*TO1UALW_L^[4S0"Y(6]@#,2I.WY0<J<'.
M<'/I4LOA/6[I/&,+PV-O'K-O&+?RY20CK$$"D;1QQU_3T]!IDLL<$32RR+'&
M@W,[G 4>I- ''WNDZY?'PO+)96Z/IMR)KA$N-V%$93 ) R><]AVS5O7_  Q-
MJ?B33-3MI5B0(UKJ"G_EM;D[PO\ WTN/HYK=L=3L-321K&\@N5C;9)Y3AMC>
MAQT-6R0 23@#J30!R?B+2M<A\1V?B+0$M[F>.W:TN;.XD\L2Q%MP*M@X8'UJ
M2]L=4U.PABUC2K*_MYV<W5D'!$(P-FQF W,"#D_+]XXZ"N@L[^SU")I;*ZAN
M8T<QL\+AP&'49'>K% &#X0T6XT'0S8SRNR">1[>)Y#(8(2WR1[CUP/\ #FMZ
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "LO7=:CT6UMW,?FW%U<QVMM%NVAY'.!D\X &23@\ ]
M:U*Y_P 7:!/KNGVALIHXK^PNX[VU:3.PNF?E;'.""10 Q?$-Y;^(QH5]:0"Z
MN+=KBRECD(CFV_>0Y&5(X/?(_*H/"?B35_$MK9Z@^D06VG3QR;I/M.YU=7*@
M;=HR#CK['@<9F_LJ^U#Q%9ZY?6T,#V%M+';VZS;RTDF-S%L<#"X'7J3QTIW@
MC2+[0/"MKI>H"#S[<O\ -!(75@SLW<#^]B@#1UW6;?P_HMUJET&:*!0=J]78
MD!5'N20/QK,G\17NE:QIEEJUG D6IL8H9H)2PCF R(VR!G/.&'<=!5OQ7H"^
M)_#-YI)F,+3*#'*!G8ZL&4_3(%9\FD:IKMUHDFLP6UN-,G%U)Y,I?SI@I5=O
M PN6+<\\ 8[T <Y+J.JZMX)\>'4Q;,D#WL";&8["D8  !'3C.<YR3Q6SH_B#
M4+.Y\-Z9>:?#'::E:;;>5)RTBM'$&^==N " <8)J!O#&N1Z1XMTN);%H=6FN
M9K>5IF# S*!AAMXV\\@G/M5J70=7DOO",XBM0ND*PN!YYRQ,7E_)\O/KSB@"
M*]\>/%:-J-E9I>627!A:&,L;AT#[#(JA<<$$[<\CG(Z58?Q-K<_B/4](T_1K
M:9K$6\GF2794/')G)^[PV!TZ<'GH#4TC1?%>@R3Z/92:?)HSS/);W4CL)K9'
M8L5V8PQ!)QR!Z^E:FF:1J-IXVUK59DM_L=]%!'&5E)<&,,,D;<<[O7M0!TAS
M@XZ]LUYE-J.JZMX&\=MJ8MF2"2]@38S'88XPH"@CIQG.<Y)XKTVN$;POKB:-
MXMTJ-;%HM6GN9K>5IF# S ###;QMYZ$Y]J +&D>(-0M+SPYI=YI\,=IJ5IMM
MY4G+2*T<08[UVX&1G&":%\4S6UEXLO(]&M4GTB4F1$FQ]H"QA]Q;9UQ@=.V,
MU)+H.K2:CX2N1%:A=(5Q<CSSEBT7E_)\O/KSBJTGAG67LO&4'EV8;6RWV<^>
MV$S$(_F^3VSQF@"TOBS4H-/AO+[2H(UOC;Q:<B7.6FEE'W7^7Y .I//&>IJI
M:_;/^%Q*+V*W5_["?:\!.''GIU!&00<^O]*L:OX9U/4?"NBPP26\&KZ1+!<0
M[F+1.\:[2I. =I!/:I+/3->G\<6^OWEI8VT(TYK.2)+II&!,@?(.P _=Z<=>
MM '3W<LD%G--#&LLB(65&?:&([9P<?E7"+\0=4CT/2_$5UH44>B73(L\BW6Z
M6'>=H?;MP5S@=<GT%=W=_P#'E/\ ]<V_E7G/AK2;[Q'\+-$T>:&&*QD2)YIQ
M+DM$CA]JKC[QV@<\#D\]* -WQ%XOO-"M]3O9-/C2SL'15%Q+L>[! +&+C'&?
M?)!Z5+JGB758/$J:+INE6]S+-8/>0R27)0'#*,,-O'7MG)QTY(Q]:\*>(=1A
M\46B_8)EU/FVNYI6\R),#$.W;@*"#R#W)P36O#H^LGQGI^LSQ68ABTYK254G
M8L&9U;*@KR!MQSC/7 Z4 0:)JVO7GC37;2ZAM%CM;>UQ"LS8C+*[<';R2>">
M. .M)I?B^ >%K>_.GP6<MS?R6D5M&_R>8'<$E@OHK,3BKUKI&J6/C?5M4A6U
MDL=1A@#%I&$B-$K# 7;@@[ASGCT-847@S6T\(V]I'/:6^KV&I/J-I('9XF8N
MYVO\H."'(/% %\^.9;2+6C>V&X:="L\=Q!O\F92<=2N5*D\]>.:WM'U&YU!Y
M7;[)-9F.-[>[M9=Z2[BVX>V,#N?O?A5")?%=UIL\MY#IL-WA5BM$E9XG&X%R
M[E>X!  !QD]<\0^&_#']C:]J%_;6T>G65W$@-A%)N3S03ND '"\$# ],\4 =
M#J$EQ%83R6JQM.J$J)&*K^8!_E7G_A?4$LO ?AB\O[&VN;V1T@TUB^7,LNX,
M68K\G&22,\ UZ%>K,]C.MNB/,R$(KMM!)'<X./RKB(_!FJ_\(/H>G&2UBU;1
M)X[BW<2,T4C(3\K':" 0<=.* -M/$-Y!XC.@WMI +N:V:XLY8Y2(Y@IPR'()
M5AP>^1^50>$O$FK^)K2SU&328+;3;F%V\S[3N=75]H&W;T(!YSVZ#BIAI-]?
M>([;7KVVAADLK62&VMEFW9=R-S,V.!A0!P>I/M3_  1H]]H'A.RTK4!!Y]L&
M4M!(65@6+ \@>M #O&VHWVD^#=5O].,:W,%NSJTF?E&.2,=3Z5SFLR7O]M>!
M9Y+:*2\,LP55E.&S;G&6(R/4\'VS76>)]*EUSPOJ>EP.B2W5N\2,_P!T,1QG
MVK$FT77KN_\ "]Y-!8H=+=VG1+ACPT1CPIV<GG/;TYZT /M_&<D%EKAU>SBA
MN])N$@=+>4NDID"F/:2 1DL!R.*L:=XFN;CQ(NDW%I&\<T!FBNK4NR*P/,;Y
M48..0>_H*RKSP;J6IR>*UFE@M5U66">TFCD+M$\*KM+#:.Z \$UMZ$?%,SH=
M?33[=85QBS=G,[=-QR!M7OCDYQTQR ;%_<26MA<7$,2RR11EQ&S[0V!G&<''
MY5Q"^/\ 5(])TC7;S0XHM%OC&DLJW.Z6$OP&*[<;,\=<^PZ5VNI?\@J\_P"N
M#_\ H)K@?#NDWWB/X:>']*GAABL2D$DTPEW%XT8.%5<<,2H!SP.>M '1P^);
MJ6[\26OV.$2Z.$*GSCMF#1[^?E^7CCO5 ^-;^6W\+R6NDPR-KL190UR1Y3>6
M7P?EY'3GKC/!IUQH6N6_B'Q#/8QV<MIK,,?[V65E:!TC*8VA?FSP>HQ52R\+
MZ[;0^#4>.Q8Z&K+/MN&^<&(Q_+\G7G/- %H>*/$9UI-#.@V:ZDVG_;"3>GRE
M/F;,$[,X^F>HZ<D%AX]^U:4IGT_R-8_M'^RVLC+\HGZD[\?<V_-G';'-1W<E
MU%\7T:VMUG_XD.'0R;#CS^HXP><<<?T,5SX&O9+(WT,\":V-7_M902?*W?=\
MHG&=NP ;L=><4 :Q\436&MW&DZK:*)ULVO;>2V8LLZ+]Y<'D./3G(-&D^*6U
M"Q35&-D^E&S>YDN+:8N8&7:3&PQUP6YX^Z>!39='U+4-:_MR6.&UN[:PEM[*
M+S/,Q(_)=CC&!@ #GN?:LZ/P5]JUF:]:R@TI+NQFM=0BM)=R73.  P& !CYC
MN(!.>E %F#QG<27VD@V"26FI,$_<,SR6Q894R#;C!Z$@\'UZUV%<AX;LO%]C
M#:Z5J<FG-9685!>PNQEGC7[JE",*2  3D]\>M=?0!R$WC&Z;P]<>)+*PCN-(
MMW?(\TB62)&*O(HQ@8PQ"GJ!U&<53U[4+R[\8>#)+ 6\MI<?:)X-\K*)/W!P
M6^4XP&..O7M2V7A;6--\+:CX3@^S/I\_G1VUVTA#10RD[@R8Y9=S8P<'CI5V
M]\.WT6N>%YM.BMS8:+'+&1+,5=E:(1K@!2.,=S0!TMG96UC$R6UM% KNTKK$
MH +MRQ^I/>N7U3QI+;QZC-IUK#=+I\QB>$NPEG9<;P@"D#&2!GJ0>G!/85Q4
M&D>*="UO4ET<Z=<Z7J-RUT#=.ZO:R/\ ?X ^=<\@9'U'6@"RWBK4KGQ$ND:?
MI4+-+IJW\,MQ.8\!FVX==I*D<\#/;IS4=OXX\WPO8:E)8A+V[OQIHM_,RBS^
M84.6Q]WY2>GM5F/1M3A\=#6#Y,UJNE"QW-*1([A]^XC;@ ].M<W<:-J.F^$X
M-!N$TU]0O=6::WB>=@L@\QIB X4%& 'W@/IR10!TD'B74!XAU+1YM-CE:PMA
M<F2"4[IE8':%0K][*D8+>E1V/BNZ?Q!I>E7]I;Q3:C:O.(XY29+9E"L4D4CT
M;KQR#Q6=;1:XDE_82Z7;:=J&J6TBQ:C!?M<.'5,*6W*&"C/!' )Z9-)8>&]?
MAU+PQ>26VEVZ:9%-#<)'.[%MZJ#)G:,DE2<'\6.> "Q?>.9X- U#7K:PBET^
MRO&M6C>4K(X#B,OG! ^8_=P3CG/:M"76)X_&&EZ9<Z5:B:XLY9EN!-O:,KMW
M(#L!P21SWQTKE;*UU6\CO-2M-'TG4M*N[U[Q#_:,D$<@5_E9H]I3/R@DGJ1D
M\UT0M-1U?Q-H/B2*VBCM([%P\<DI$@,H4] I!QC'6@#.F\=ZO'H>J:N-$MOL
MVEWLEO=*;L[F5&"DQ_)R>2>=OXUT-SKTC^(X]"L(XS<M9&^:28D*$W;%  Y)
M)S] ._2N<D\)ZW+X,\2Z.4LA<:I>SW$3>>VU5D8-\QV9R,=A2ZO%JE[XIMAI
MEK83WFG6 2YC-[)!)&9#P-ZC+*0F<$<=>N* .A\)^()_$ND&_FL4M!YKQ!%G
M,AW(Q5L_*,<CCK3?&FK'1/#<M\VGP7T221*\4S8'S.J@XVG."0<<=.M'A.65
M+"73IM)ATU[%Q'Y4$_G1G(W9#8!SSD@C/.><TGC;1[[7_#$^F:>(/.EDB;=-
M(54!)%<] ?[N/QH BOO$.J1^+F\/V6F6\KM8&[CGEN2J_?"88!21WZ9SQTYQ
M<\+:X_B#11>36PMKA)I+>:)7W*KHQ4X.!D<9JF=*U,^/8]=\FW^RC3#9E?..
M_>9 ^<;<8XQUJ3P=I%_HNFW=O?K 'EO9KE##(7&V1RV#D#D9Q0!>UC6!IC64
M$<0FO+Z?R+>,MM!."Q9C@X 52>GH.]9ESXHN](M-5FUC3#&+-XTMY86REX9,
M!0F>00Q .>G6G^+]"O\ 5H=/O-(GBBU33;D7%OY^?+DX*LC8Y (/6JFJZ!K7
MBKPS=VNJR6UC=OY;VL=NYD2%T;<&9B!NR< \<#U- %R7Q#>:;KVGZ9JEI JZ
MD'6VG@E)42J,F-LCN.C#KCH*Q)?'NK1Z#J&M'1;86NFWLEO=+]K)<JCA"8_D
MY/.>=M:\FDZEK6IZ/>:K;6]M_9C-/LBF,GFS%=HP<#"C)///3CUQ9O".MS>!
M_$&BE+(7.I7LUQ$WGML59)-_)V9R.G2@#I;C6KF?5KO3-)@AFN+.!)IWF<JH
M+YV(,#))"DD]ACKFJ9\62^1IL,UE]AU*\@>=X+ICBW52%.=HR<EA@<9&3QC%
M4[G1O$>G>*)-=T6.QF%_;QPWUG<S,@5TR%=7"G. 2,8_^L_6-"\0K?:7KNEW
M-I-JUK')#<PSY2*>-V#%5(R5VD#&?09]P"M)X]OHM#%ZVB_OTU)=/E0RE5;<
MP DB)4;U.>,XI-1UKQ3%X@\/6<]G86HNKR=3&ERSB54B8KEMHP.<XQG('2K6
MN:-XBUK0[6.46/VT7\-TT0F811)&P;8&VDL3CK@=?:KOB+2-2OM4T#4]/2V:
M;3IW>2&>4HK*\90X8*>1G/3F@"IJGC*6W74GT^V@N3ISF.2%G8/.Z@%ECPIZ
M9P,]2",#J;L7B.35+Z*PTNW7SC9I>3FZRODJ_P!Q"H&=QP<CC '?I69%I'BG
M0]=U%]'.FW6FZE-]I9;IW1K:8@!R  =RG&<9_+J97T+6]*\6G6],-O?I>6D=
MM>Q7$IA8NGW9%(5AW.1B@!GPT+GP_J!EB6*3^UKO=&K9"'S#D \9 KH=8O[N
MQCM19V37,D\ZQ,V2$@4@DR.1_",?F0.*S?!NCZEHMA?PZB+;=/?SW*&"0M\L
MCEL'(&/UIWBS2]4U)=-;3A;S1VUT);BSN)"D=PF" "0#T)!P01Q[4 4K3QS$
MVE:M<W$,;RZ?>"S46TNY+AVV^7M/;)< ]<<]:OMJ>O17MS:2Z7!@69N(;M)&
M,(<'!C?C.>^1U'I7.S^"=9O[7Q);SSV=NVH745[:30LS&.5 F 01T!3&>^<X
M'2NCTE/$EY&W]NI8VH6(Q[+.1I/-8C&\D@;1UPO/7D\4 <S;>)=1A^%=IKFI
M6%IJ/FB)G624_-OD W$%2.&(./;K737&OW-IXSLM$GM(EM;V"22"Z\TY9TQN
MCV[>N#GKTKFSX3\0/\,H_##)IXN83%&D@G?:RI('W$[,@D#&,''7/8=#XKT*
MZUW2K5K*5+35+2XCN;:8_,(V!PP]P5+#'?B@"CXA\1W%GX6U'4Y=)M+NTAN1
M"D<DIQ(HD";R"IZ/V]LYZ4^ZU36!\3+?2X1;&R_LN2X",[ D^;&I8X!Y'0#W
M//-3>+/#MSJ7@E]!TE80Q$2(9Y"H54=6Y(!)/R_K2W>D:J?&UAKMJEJ8_L#V
M=PDLK QY=7W+A?F^[C''UH CL/%EQ-9>(&OK*&VO-'D9&MUF+[QMW(V=H.'S
MQQ726CSR6D3W4213L@,D:-N"MW .!GZXKDK_ $FWU/X@6%Y9W:F,VQ;4(HR&
M641N##DCH0^?J%([5V= &'_;L_\ PF;Z ;:/;_9YO8Y_,//SA-I7''KG-8DG
MCN\7PTFK+I,;M_:9T^2(7'3][Y>Y<J,Y]#CZU?U/2M6B\:VNO:9#:W"-8M8S
M1SS&/8-X<."%;/<8XK"'@_7QX6.ED6#3?VQ]O#^<R@IYWF8(VG!/3&3]: -Z
MV\3W,&OW^EZU:6]H+>Q_M!)H9S(OD[BK;LJ,,,=N*YWQ5J-]J^A^&]1:R@BL
MKK5K*6(%R98U,@*D\8Y'4#IGJ:VM1\-7NJ^*KR[N$A33KO1GTQ]LI,BEF+%@
M-N,<XZUDOX=\63>&M)T2:'3&.EW=NZ77VE@)XXF!7*[/E.  >3S^@!L:KXPD
MMSJ?]FV\%PVFML>*1V#SN%#,B84X." ">IXQWJ*?QAJDVJV=AIFBI))>Z:;Z
M'[3.8BI!4;'&WY2-V._..G)#5TCQ1HGB'4+C11IUSI^IRBXDBNI71K:;:%8@
M@'<IP#C@_3O<_L755\;:=JS&":VM]/:TED:0K([,RL7"A<8RO3/>@#I+=I7M
MHFGC6.9D!D16W!6QR >^#WKS[5M1O?!GBW5=5U/2Y+_0=2$>Z\@7>]H%7:4=
M?[F<GTY/4FO1:PA_;]IJ&HG[+;7ME-*&MU^T%'C&Q05(*D8W G@]^AH SK'6
M=$T/POI[:++#/9WMTZ684[4!=WD(/!*A1NXQGC&*8GC@VR:O_:-D<6"QM%-;
M[C'=;R%55+ 8;<0I'/7.:SU\!:A9^'(AIMQ:VVKP:H^JP( 3;HS9!A'&=FTX
MS@?05HZCH>O>*O#%]9:R]II]Q*B_9TM7:18W5@X=F(&>5' Z#/)SP ::ZCKR
MZFUE-I<&R2U,T5U'*QB20''EOD9[Y!'7T%<I:>*-2C^$G_"0:G86>H[AYCQR
M2D!PTI'(*D<$C ]!UKJ=$_X2><H=>2PMQ$NTBSD9_/?&-QR!M7KQR<]QCGFO
M^$0U\_"Z;PH5T_SU BAE$[;642;]S?)P<8&!GZT =5=:U*^OG1-.CB>ZCMA<
MS23,0D:EMJC Y))!], 9]!6%<^/IH?#UU?+I:F\L;];"\MC/C8Y=5#(=OS [
M@1G;5Z?1M2M?%Z>([&*&7[1:"UO;1I=I^4Y5T;&"1R"#CBLO4O!NI7&@ZE'!
M]E.HZGJ4=]/OE81QJCH0@.TD\(!G Y)H V]/U^_?Q;+H6I6$$#M9_;;>2"<R
M90.$*ME1ALD=,BM^6,2PO&690ZE=RG!&?0^M<\=)U)_'\&N&*W%FNFM9L/.)
M<,9%?(&W&.,=:Z2@#A=8\(^'8]0T33+'0]/AEFN1,\B6ZAUAAP['=C/+>6I_
MWS7=5E0:?.?$]WJ=QM\L6Z6UJ <D+DM(3Z9.T?\  !6K0!SS:]>WUSJL6BVD
M%Q_9C^5(9I2OG2[0Q1< XP"!N/<].,US?B7Q%)K_ (.T'4]+1!:WNI6JNDKE
M6#"8#80 >-RX)]NAK:L=&U70-=UF?3HK>[L=4E^U!))C&T$Y&&S\IRIP#D<C
MT-4+GP9?6GA'1-%TTV\SV5]%>32S2&,.5D,C8 4]23CT% '7V=G' \MTUK;P
MWESM-P\(SO*C RV 3@>M<[+J>KGXG)I2BW-@NF&?878$YE52QXY88X'3D\\U
MU:%B@+J%;'(!SBN<O-(U-?'=OKEFMK);FP-E,LLC*R?O ^Y0 =WIC(H Y+2=
M>O\ PUH'B+4K?3H)["TUR[:XW3;'V&4 ^6H4@D9SR178:GXF,.I3Z=8_9C<0
M0),[7#LJY?.U1M!.3M))[9'7/&!+X1UN7P5XCT8I9"YU2]FN(F\]BBK(X;YC
MLSD8["KMWH_B73_$7]N:(EC-]LMHX+ZRN9F4;DSM='"GH"1T_P#K '0>'=8.
MOZ#:ZDUG-9O,IWV\P(:-@2".0,CC@]QBM2JUA'=1V:"^E22Y.6D,8PH).<+G
MG Z#//%6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *K7FHV.G*K7U[;VRN<*9Y50,?;)JS6!XUM8
M;WP?J-M.@>*1%5@?]X?K0!MS3Q6\+332I%$HRSNP50/<FJ;Z]HT=NEQ)JU@D
M,APDC7*!6^AS@UR?AK4;OPWJO_"&:[,TH*$Z3>R?\O,0_P"6;'^^H_,?AG,\
M2JI^%/A0%1CS=-XQ[+0!Z9%+'-&LD4BR1L,JR'(/T-9[>)-"24Q/K6G+(#@H
M;I 0?IFM.O+_ .W-/\/^-_'UWJ5M+-;%;%75(=ZG,1&&)^4 D@?,0* /3T=9
M$5T8,K#(8'((IK31)*D32(LDF2B$\MCK@=\5R_P[T2^T'PC%:7[*)&E>9(4D
MWK C'*H&Z''MQS7,^,M2*:FOBJVO4(T"\6!;82#,L1^6X(7URP7_ +9GUH ]
M1HJA?W5V^BO=:+'!=7+QA[=97VQOG!Y([8YJZA8QJ7 #X&X Y - #J*XZ3Q?
M>R^&KGQ/86D$^E6[R'RBQ$LL,;%7D!Z#[K$*0<@=1FBZ\5ZK<Z[#INB6%G<+
M=:7_ &A;33SLH8;E W +QU[9ZCIS0!V-5;G4K*SAN9KFZBBCM5WSLS<1CKSZ
M52UW5I=$\*7VJS1IY]M:M*8P<KO"\#/IGC-8SW4WA_X8'4/L\5]<)9?:KI;A
M\"9V7=(3P<Y)/'X<4 =+)JEC%)9QO=PJ]Z2+8%A^]XW?+Z\<TG]K:?\ :+N#
M[9#YMF$-RFX9A##*EO0$<UB7FNS0:OX7MS86SQ:F6_>ECNA81%OE7'X9S^%3
M:/J\E]XI\0:9-96\/V'[/^]C;<9@ZL06X'0 #'UYH W)X8[JW>&3)CD7#;6*
MY'U'-0Z;IMGI%DEG80^3;1_<C#$A?89/ ]JY_P '7K+J&OZ"Q)32KP+!_LPR
M+O1?HN2![ #M4VHZ_J<'B^#0K2QM7$]G)<1S2S,,%64?, O Y[9SQTH Z6BN
M!/C37O\ A'-4U,:78;]&N)8;U3.V)/+/S>5QQ\ISEORK;U+7KV)U:UAMX+0V
M0N1>7A_=LY/RPC!&&(YSSVX- &Q<ZG8V=S;VUS=PQ7%RVV&)W :0^PZFK,DB
M0Q/+(P2-%+,S'  '4FO.=:\06^J:9X%\07 2TAEOUGD\Q^(AY4F?F].*ZN/4
M]3ETJ]U$VEOY 1I+2&1F1Y4 R"_!VY&>,$],XY  -:SO+>_LXKNTF2:WF4/'
M(AR&![BIZXA/%]]'H7A2ZM=*M2NL-'%Y8E*"(LA8 #'3Y>O;T-6[3Q;=6[>)
M8M9M(4ET2);AC:.666-D9QC< <_*10!UE%<?_P )3JL=YX=B-E93+KB%TQ,R
M>00@D()VMO\ ES@X7D=LUT6L7EU8:3<7-E9/>W* >7;H<%R2!U]!G)]@: +U
M%<OIWB6YNO$&HZ+BRNI[:U2YBF@D*HV6*E&^]M((Z\]>@K)LO'.KSZ)H6N3:
M9:1Z?J-S';2*LS&5"[E P&,8!QWR?:@#OJ*YVSUZ[/C"_P!#OXK>!(K9;JUD
M4G,\9)#'G@;3@$<]0:T=#O;G4=(AO;J..,S@O&J9_P!6?NDY[D8..V<=J -&
MBN)G\5Z\\GB..TTRP#:*P+&6X8B1?+\S POWB/7 'O5X^+ENH]+CLXPD]_8B
M^S)&\@BC.W *IR22V.PX//0$ Z.YMXKNVDMY@6BD&U@&*Y'ID<U%IVG6FE64
M=G8Q>3;1\)&&)"CT&3P/:N:L?&-W<VEI!/I;VVK7-])91Q2ADC;8I9IE+ $I
MM&1QDGCWJQ/XCU#2;747U?3U!@GB@M)H20EV9"%7 Y9<,<'K[9Z4 =/17(KX
MLU"VO[Z"ZTR6YMX;%[R*YMK>5%9ESF(AQ][C@YY]!4NG^)YKO2Y=6A:SU"P2
MR>YW61.\2* ?*()/.,\\'CH* -K^QK#^U_[6\@_;_+\KSO,;.S.=O7&W/..F
M:OUS6C^(KG5+/[?;&SU&S:T:8&R8[Q*,$1$$]3D\G'3H*K6/BJ]/B#3-)O8;
M3S[^UDF,43G?:2*%8QR=<\-UXZ=* .NHKC-)\1>)M;>[-II>FQQVE]<6<IEN
M7.3'P"N%Y&>"3CKTXJ;3?%=WJ7A6WOTMX$U.6[^QM9L3B.4/M92>N5 +$^@H
M ZVJESJ=C97-O;7-W#%/<MLAB=P&D/HHZFFZIJ<&C:/=:E>-B"UB,LA4<D =
M /4]JXKQ%/JESJ'@NXO8;6.*;5(Y-D9)>%C&Y"DGAN"<D 8(Z'- '<PZA:7%
M[<V<-S&]S:[?/B5LM'N&5R.V15FN2'BB6VO_ !<)=,BW:-!%,/(8L]P#&SC)
MP,< #OCGK4L'BM5TFYUF:YLKO2(;0W'VFR)SN'6,J2<'IUQG/08H Z@D $DX
M ZFJMCJ5CJ<<DEA=PW,<<AB=X7# ,,9&1WY%9=MJ&N_VEIZ7.FPM9WD3-))"
M_-FP (5R?O@],@#D=*YK0=:B\/Z/XGO'C\QSXCN(88@=OF2.ZJJY[<GD]AF@
M#T.J6IZ1IVM6OV;4K*&ZA!W!94!VGU'H?<5DMK]YIOB73](U6* IJ2/]FN+?
M( D09,; Y[=&SSCH*KZ!XHN/$2P3V;631.SI<09/G69 ;:'&>>0 >!UXSUH
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MRL8Y89"Q*$E.""P[$'%=E10!Y\?A]<)I5]'IL\6F3'4(]0T^!&,D-M(B@8Y
MX8[L@# R.N*ZC1$\0N3-KS6$;A-B06)=D)XRS%L'/' '3GDYXV:* .<US1]1
MOO$^@:E:"U\C39)7D$LK*S[T*8 "D<9SUJIJNB:_:>*7UWPY-8O]J@2"\M+T
MLJML)V.K*"01DC'I7744 <=J7A[Q -3TK7=/NK*;5;:.2&ZBN-R0S1N0Q52
M2NT@8ZYQS[Y%CI-SKEW\0M*N)88[J[\F(O&#L1C;C'7D@<?7VZ5Z15*TTBPL
M;RXN[:V2*XN"#-(N<R$="WK0!R\>A>)+G6?#6H7O]F1?V4LJ2QQ2.^X/&$W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "LV/4_M6M3Z?:A6%HJFZD/\ "S#*H/?'S'T!'7/&E7&> 09U\5?:%#2-
MKUTL@89RH"A1]-N* +1US6M2EOI-"M[*6.POS9RP7)96EVA2[*X.%P6P 5.<
M>^*W=*U.WUC38;ZVW>7(""K##(P)#*?<$$'W%<I\/M.L;>?Q)-!9V\<J:U<P
MJZ1*"J#9\H(' ]NE2^ "_F^*4Y\E->N1'[9VE@/^!$_K0!V5%%% !1110 R7
MS?)?R=GFX^7?G&??%<WX2\37>N7.JV6I6D-EJ&G3^5);(Y<[2,J^2!E6YQQV
MKIZ\]\=V"P>*?#NH6LTEM<:C<#2[MHC@RP."2#[C'!ZC/L* .JT+4=0U07-Q
M<0VR68E9+:2)F)F4'&_!Z X..N>O3%:X()(!!QUKE_'UU<Z-\/=3FTH&*2"%
M43R1@QIN56*XZ84DCTQ69KME:Z;JOA*^T"**)[F]2UD$  $]LT;,Q;'W@ NX
M$].M '>45Y--';Q_#OX@QLD:I#JEYY:D !#A-N/3KQBO3]-.=*LSG.8$_P#0
M10!:I 0PR""/45SOC66S71K>"]:<K<WL$,44+!?/D+@K&Q((V''S>V:YS2X[
MF#6_'ME;SVMA+]E@>+R3MAMY6AD^;\,*2<#.,XH ]%!!) ()'7VHR,XR,UYQ
MI>A-JS>#[F+36MEL[<MJ$C87S<QC R#F0E_F![<D\G%.T#0;"YU[Q3<O:>?<
M6&JB:T5G;Y)!$I!'/<G^5 'HNX;MN1GKB@L 0"1D]!7F.@V-MX@\-Z%KK:O:
MP7L$T<LMS#;8N'GSAXG;>2=Q.-N.>,#&*6"SA\6V7B!-0U&SM+RUU&99)W@_
MTBT5'_=LKEQM7:!@@8Z]<F@#TZJFH:E:Z7#%)=RA!+-'!&.[.[!5 ]>3^0-3
M6I)M(2TC2'8N79=I;CJ1V^E<A\1[2VN+/06N+>*7&M6B9D0-\K/AASV/<=Z
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MOFZ<X!- '<9&<9&: P)(!&1U%>6:+I-M!X;\2ZU;6QDU73+[4C82%F)B(W
M#.#]#U_*M31M+L;Y/#GB"UU6TB9=H5K6W*R76Y?FCE8N2QZDY&003ZT =_N&
M[;D9]*"P&<D#%>6:1:1>*/"L6J7>JVMGJ-M=-+<7*6Q^U03+(?D+;\X(PH7'
M(( %:%MH>FZGXR\<6U[:K<0;+5A'(2RAC$Q+8/?/0]LG% 'H>1G&1D]J"P!
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MQ^I)^G2J7C#6KC0O#-_?V1MFN[>$RK'/DA@.O (-;-K(TUI#*V-SQJQQZD4
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M\$-S!)!/$DL,BE7C=0RL#U!!ZBJ5AH6F:8ZO:6JQLB[$)8MY:_W5R3M7@<#
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M7.!GM6'X0UJ[US2KFXOE@6:&]GM_W((7$;E0>2?2@#E;'P1;2K'&O@Z+1[M
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M^FZ98Z19K::?:QVUNO(CC&!5N@'(R.E% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<UXTELEL=-@
MO%DD:XU&".WA60(DLN=RK(2#\GRY/!SCCFNEJIJ.EV.KVAM=1M(;J L&\N5
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M=!\TX$:,-YZL<\Y-94NDW&MZ#K6CJD5SJ,NLL\>H^8A4 2 DDD[@54%-H';
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M-@?^]CIGWH YRST^UTOXJSVVFPQ6<=QH?FR+$H4-()L!R.[8)Y-86EZ(^O\
MASPW9FWAFGM-0\^ZOBZ,EQ$&?>0<[F\SC@CW/05Z%=Z+;%IKVRMK6/5OL[10
M74D>2O'R@GJ5S@XKB;7P,EQ:I:W7@[2[.Z5 C:C%=9PV/]8H50V[/(!QSWH
M])50JA5   P .U<5I@AU?QYXJL=7@CG,,=NEM%,H8"W9"6*@]BV<D>P["NU4
M;5 R3@8R>IJE>Z+INHW$=Q=V<4LT:E%D(PP4]5R.<'TZ4 >5QVK77AKPK'?;
MIHXO$IM;:9V.][8&0*-W7'&/H!7J^FZ78Z/9+9Z=;1VULK,PBC&%!)R<?B:C
MN=$TN\CMH[G3[:5+8@P*T8Q$1T*CMCVJ^!@8'2@#B_'MG'8MIGBV.W1Y]'N
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M06.H2[=Q,<B@*Q/^RX _X$16=H5FUM?ZCX.N["*)-1N$U)(Q&-J6S_-)&?\
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M&7]W&=H;;(R_*"<] *S=(BLXOBEXE+QP)(;>S:,D '<1)DCW-<?9V-G%\*M
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M,L#;9F$JD1GT;G@_6@#F]"\+Q6VJ0ZD/#^F:+)"&&VQDW-+D8PQ"J-HZXYY
M/&.>L=$EC:.15=&!5E89!!Z@BH/[0LOLWVG[9;^1G'F^:NW/IG.*6]>9;">2
MV>-91&61G4LN<=P",C\: (/[#TD:8--&F68L0<BV$"B,'.<A<8SGG-6+2RM;
M"'RK2WB@C)W%8U"@GU/J?>N;T75M2UCP1HNIM?VEI=W)B>:26,;'!;E%&1@D
M<"NBN=1L;.1([J\MX'?[BRRJI;Z GF@#%\=:3>Z[X1O=+T^)'N+C8!YCA5 #
MJQR?H*U++2["U0O#IT%L\B!7547.W^[D=O;I61J.MWEAXXTW3Y)[=--N+2>:
M3<F&4Q[>2Q.,?-Z"M:\NOM6B3W&FZC:QEHF,5VQ$D2'^\><$#ZT 36.F6&F(
MZ6%E;6J.=S+!$J!CZG Y-16NB:78W!N+73K6"8DG?'$JG)ZXP.,]_6L?5-7U
M&Q\1>%[..XMY+74'D2X*Q<N5B+ J<X )'3'XUI?;397FJW%_JEF+"%(W6/ 5
MK88.XNV><D9' Z=Z -&2"&9XGDB1WA;?&S#)1L%<CT."1^)J"ZTO3[Z:*:[L
M;:XEA.8GEB5RA]5)''X54T[Q+I.I:9:WT=];QQW,:NBR2J&&0#@C/7D<5HFY
M@%P+<SQB<C<(RXW$>N.M %.[\/Z/?WHO+S2[.>Z5=HFDA5GQZ9(S1-H&CW.F
MKILVEV;V*'*V[0+Y:GU"XP*NS3Q6T+33RI%$O+.[!0/J33(KVUGM?M4-S#);
MX)\U) 4P.O(XH 6UM;>RMH[:T@C@@C&U(HE"JH] !TK*UQ->N9H[/3$LTLIX
MV2XN9782PYXRB@8)QG&3U_74@O;2Z=DM[F&5T5698Y Q 894G'8CIZU0D\1:
M:FOC0Q=PB_,!E*EA\O("@C/4YR!UP/I0!HPVT-O:1VL4:K!&@C6/' 4# 'TQ
M5:QT;3-,<M8Z?;6S$8S%$%XSG''09[5B>%?$<E]97)UB\M$N5U*XLX@,1B38
MVT!5)))_$UT%UJ%E8E/M=Y;V^_[OG2JF[Z9- %6;P[HMQ=7%U-I-E)<7*;)I
M6@4M(OHQQR.!^5:$44<$2Q0QI'&@PJ(H  ] !6;J7B+3-*U#3[*[NHHY[YV6
M-6<# "LQ8YZ#Y<9]2*T9KB&WA,TTT<<0ZN[ #\S0!!+I6G7%Z+V:PMI+H1F(
M3/$I?8>J[L9QR>*K_P#".Z)]D6T_L?3_ +,C;UA^S)L#>H7&,^]6S?V:VZ3F
M[@$+G"R&0;6/H#G!I)]0LK:>."XO+>*:3[D<DJJS?0$\T 5[[0-'U.6"6_TN
MSN9(.(FF@5R@]!D<"M&H?M5N+G[-Y\7GXSY6\;L>N.M+!=6]TA>WGBF4':3&
MX8 ^G% %6ZT32KZ4S76G6TLIZR/$"W3'WNO0"IH]/LH;#[#':0)9[2GD+& F
MT]1MZ8I;F_L[,H+J[@@+_=$L@7=],]:5;VT>4Q)=0M(%WE!("0OKCTY'- &/
M?>'K2S\,:IIVA:9:V[W<$D82%%B4LRE06(],T>%] M])T;3DETZW@O[>V2&1
MT52=P4!B".Q(SVSWJQK'B&QTKP]>ZN)X9HK>)W4+*,2,JD[ ?4XKF+WQ3J.E
M:9%JSZIIEW;7<44:0X"M%<.Z XP>44.203G@<\T =7)X<T2:2ZDET>P=[O'V
MAFMT)EP01NXYY //I4T>D:9#>_;8M.M$N]NWSUA4/M]-V,XK/LKR>P-U<:KK
M6GS:;(RFSN"5C;H=RL?NGD<$>^:UWN[9$B=[B)5E_P!62X ?C/'KQ0!3E\.Z
M+/-<S3:18R2W0VW#M;H3*/1CCGH.OI4S:5ISW-O<O86K3VR[()3"I:)?13C(
M'TI7U73H[-+Q[^U6U?A9FF4(WT;.#4SW5O';?:7GB6WV[O-9P%QZYZ8H @MM
M(TVS2=+73[6!;@DS".%5$A/7=@<_C3;+1M,TX,++3[:W#+L/E1!<KZ<=O;I6
M-X?UZYU3Q7X@LFN;6XLK-;9K9[=>,2*Y.3DY/ 'X=*Z"ZO+6QB$MW<PV\9.-
M\KA!GZF@"I_PCNB?99+7^Q[#[-(V]X?LR;&;U(Q@GWK0CBCAB6.)%2-1A548
M 'H!49O+401SFYA$4A 23>-K$],'OGM4::E8R),Z7MLRP';,1*I$9]&YX/UH
M K3>'-#N;EKF?1M/EN&^]*]LC,?J2,U;L["STZ$Q6-I!;1DY*01A!GUP!2?V
MA9?9OM/VRW\C./-\T;<^F<XJP"" 0<@]"* ,^VT#1[*_EOK72[.&[FSYDT<"
MJ[9ZY(&>:0>']%%O-;C2+ 0SMOEC^S)MD;U88P3[FL;7O$DEIK>AVFG7UE(E
MS?BVNHAAY%!5CU#?+]W'(KHGU&QCNUM'O+=;EONPM*H<_1<YH K7GA_1M1M8
M;6\TJRN+>#_5120*RQ_[HQQ^%2W.CZ9>P0P76G6D\,./*CEA5E3'3:",#\*E
MGO[.V+B>[@B,:;W\R0+M7.,G/0>]-.I6 -N#>VP-S_J!YJ_O?]WGYOPH :^D
M:;)=0W3Z?:M<0#$,K0J6C'^R<9'X4Q]$TF66ZDDTRS>2[ %PS0*3,!T#G'S=
M!UJ:ZU&QLF1;N\M[=G^Z)950M],GFI)[F"UB\VXGCACSC?(X49^IH CL].LM
M/#_9+6&#?C<8T )QTS].U.O+*TU"W:WO;:&Y@;K'-&'4_@>*=%<P3Q"6&:.2
M,C<'1P1CUR*CM=0LKY7:TN[>X6,X<Q2!PI]#@\4 02Z#I$QC,FF6C&./RD/D
MK\J?W1Q]WVZ5>1$CC6.-55% "JHP !V%06VH65ZS+:WEO.5ZB*56Q^1JS0!3
M.DZ:UZ]ZVGVINW78TYA7>R^A;&<>U,30])CL);"/2[)+.7F2!8%$;_5<8-7Z
M* *UGI]GI\;1V=K% C'+"- -QZ9/K18Z=8Z9 8;"SM[6(L7*01A%+'J<#O5F
MB@"G?:3IVIO"]_86UTT#;HC/$KF,^HR.*9_8FE?9+FU_LVS^SW3EYXO)7;*Q
MY)88Y/N:OT4 9=OX;T.TQ]GT>PCQ'Y0VVZCY.3MZ=.3^=./A[13:1VATBP^S
M1MO2'[,FQ6]0,8!]ZTJ* *7]CZ9]K-W_ &=:?:2GE^=Y*[]O]W=C./:F+H6D
M)I\M@FEV2V<IS);K;J(W^JXP:T** *3:1IC26DC:?:%[,8MF,*YA'^QQ\OX5
M'_8&C;+A/[)L=EP<SK]G3$I_VN.?QK1HH H?V'I)>V<Z79;K48@/D+F(?[/'
MR_A7&1^$KN6:9-6\*^'M3N))7=M3DDVLX9B067RR00"!@'''6O0J* *FEV*Z
M9I5K8JY=;>)8PQ[X'X\5%/H6D7-Y+=SZ79RW,L9BDF>!2[H1@J21DC'&*T**
M *":'I$<T$R:79++;J$A<0*&C7T4XX'L*IWMA<:3:L_AC2=+6ZFF!G60>2K*
M<Y8E5)+=.OO6W10!1TBP;3M/6*1UDG=VEGD48#R.2S$#TR<#V JW+%'/$T4J
M+)&XPR,,@CT(I]% &:?#VBFR2S.D6!M4;>D'V9-BMZA<8!I\NAZ3/=B[FTRS
MDN5C\H2O I8)C&W.,XP2,5?HH SY-!TB6R@LGTRS-M;G,,7DKMB/JHQ\OX5*
M=+T]K V#6-L;,C!MS$IC/?[N,5;HH H/H6D.ENCZ79,EM_J%-NI$7^[Q\OX5
M)'I>GPWTE]%8VR7<HQ).L2B1_JV,FK=% &%>65[I%M%%X5TO2HQ+,6N%DS"H
M!'W\(.3G%:.EV"Z9IL%HK[R@)>0C!=R<LQ'J6)/XU<HH BN;:"\MI+>YACF@
MD7:\<BAE8>A!ZU3B\/Z- 8C#I-C&8HS%'MMU&U#U4<< ^E:-% &;_P ([HGV
M1+3^Q]/^S1MO2'[,FQ6]0,8!]Z==:#I%]=075WIEG// ,1220JS(.P!(K0HH
M KV5A9Z;:K;6-K#;0+]V.% BC\!5BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N>\76DE[8V45
MKJ*6-\+Q'M'E3=&\JJS!&'H0#^.,<UT-07=E:7\0BO+:&XC#;@DT8< ^N#WH
M \JU^Z^W^$]135M+M[+4K/6[47;PMF-G8Q9D1NJY3&>X[UKZOHZZ7X]L)?#5
MK%;7+Z5=_:8[= JD!1Y)8#C.\\'OCVK<\6^'9M2\/1Z7I%I9QK]JBG9&/EIA
M'#G@*<DXK?L;"TL8S]ELK>U+@%UA0+D^^!SB@#SOP^/#^NZ)X9F?7;C[?92Q
M,EK&T*S+.!AT8;-Y4G<6R>1DD]Z=HEWH6J>&]6TWQ)+&-034I6NX6EV3/()<
MQ%,$,> BKCTP*] ATC3;>_DOX=/M([R3[]PD*B1OJP&30^DZ;)J*ZB^GVK7R
MC"W)A4R >S8S0!S$,4*?&*ZV1HK2Z$C2  98^>PR?4XQ5/PQ;6DVD^-4DAA=
M/[7O%(*@C&U>*[7^S; WAO/L5M]J(VF;REWD>F[&:CBT;2X4E2+3;.-9AB15
M@4!Q[\<_C0!YKIFI1Z;H_P -Y;^18]):%UED<XC2?RP(BQZ#^/&>AY[5LZW+
MX8LK"XDM8Q<+>ZO;M(R7)$!NBP(+,"0%&T%@!W'?IV9TC36L&L#I]H;-NMN8
M5\L_\!QB@Z3IQTX:<=/M38@8%L85\O&<_=QCK0!Q&@W4?_"9>-8WO;6:22"V
M;,.%5F$3AL#)Z8 /)Z5EJP_X5-X*.1_Q_P!A_P"C:]+&DZ:I<C3[0;XQ"V(5
M^9!T4\<J/3I3#HFDM;I;G2[(P1MN2,VZ;5/J!C - '*^*'_X13Q/:>*H;=I+
M>ZC^P7\<2Y9F/,+?7=\F?]H5U.B6#:;I,,$NTW#;I;AEZ-*Y+.?^^B?PQ5"2
MPUF^UKRKP6$>AV\J30+#N,TA4 J'!^4 /AN/[H]ZWZ //]*O+:YU?QS;:PT0
MNUE*[)R!_HGEC9C/\/WB?=O>L#0]5@M-,\!&\U VFG-8S1"X4H4CN?EVABP(
M4[=X&?4^]>I76D:9>W4=U=Z=:3W$0Q'++"K.GT)&10^D:9+IXT^33[1K(<"W
M:%3&/^ XQ0!YMXBTC1+7PK>-IUV]]'+K5O,TK,A2.5Y4WB,H !QUQZ_6M^"Q
ML[3XLM;6UM!##-H!,D4:!5?$X R!P>"175-H^F/9Q6;Z=:-;1?ZN$P*43Z+C
M I?[)TW[1]H_L^U\[;L\SR5W;<8QG&<8[4 >5VETNF_#W2Y2[0:9'XAD%X\2
M@B.+S9-I(((VA]AZ=A6_=Z7H-V-<N;7Q)*\VH6T4=S<1O$\,9W 1LP10,DG'
M)Y7-=M#I6G6]M);0V%K';R_ZR)(5"O\ 4 8-,@T;2[:Q>Q@TVSBM'.6@2!1&
MQ]U P>E '/>&+W4U\2:CINN65JNJ):PR&^LR?+N80SA"5/*L"6X^O84[7[VS
MC\9Z/;DQ1:@MM/)%<7+D111_*&^7(WN<=,C R<]JZ6TL+.P5EL[2"W5L%A#&
M$S]<4EUI]E?/"]W9V]P\+;HFEB5S&?5<C@_2@#R"W6RN?A[H\3-!,T/B14&,
M916NFZ8^Z"*[&TL+*W^*>HV4-K!';3Z'$98$0!'/FNO*C@\<?2NH?1-)D0H^
MEV3(9#*5:W0C>>K=.I]>M,NM-CB2>\TVPL!JHB(AEEB ^;' 9@-VWZ4 <7H$
M$T-Z? D\3-;Z;="Z61A\LEGG?$N>Y\S"GV0UW]X<6-P3_P \V_E6?HEC?Q>=
M?:NUL=2N0BR"VSY<:*#M12W)Y9CD]V/I6I+#'/$T4T:21N,,CJ""/<&@#R<1
MPO\ ";P7*Z(7COK+8Y RN91G![5>\57EC,?',$#003QV"1W;W+[FF/E,T:QJ
M2-HYZ\Y)Z=Z[XZ)I+6Z6YTNR,"-N2,VZ;5/J!C -/DTG39;@W$FGVCSF,Q&1
MH5+%,8VYQG&.W2@#@42QU7Q+X'6Z$%W$^DS963#JSA8NHZ$@C\Q[50OM+M[7
M0/B1%:P1C1EPUK&%'EI.(<R[!T&&P..A!':O3)M'TRXM(K6;3K22WAQY43PJ
M43'3:,8'X5(^G6,ED+-[.W:U P(&B4H/^ XQ0!QFHD?VY\/.1RTN/_ 8U#;V
M\*>)?B+%'%& UM;,451RQ@<YQZYKM6T?3&,!;3K,F 8AS O[L?[/''X5)%IM
MC!<R7,-E;QSR_P"LE2)0S_4@9- ' VFDQZ[\)M&_LTPMJMA:6]W:LN"5GC4$
M _7!4Y]:Z#PI?KXE+>)O):))H4M[='&"JCF3\Y"5]_+!JWJ%EJEC#;6WABVT
MFUA9V^T><A4)D<,BH,$YZ@XS6GI]E%IVGV]E#DQPH$!;JV.Y]SU/UH Y?Q/<
MO!XY\)+<\::\LZDM]S[1L_=9]_O8]S6%KED%U3Q\L4:-IS:-YTR$ HMUL?!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLYRDD3SE9)F #,L8"GD X&>I!'O72V-VE_I]M>1HZ)/$LJK(NUE##.".QYH
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M<074LC"2UWG++LQ\^"3CD>YKMZJV6HV6HB5K*[AN5AD,4AA<,%< $J2.^"*
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MA^!Z8.,]>]:4FF>(?$^@W^G>(([/3UGMF@"VDAEW.>DAR!@#'"\YR<FNNHH
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M+<VZVUY9W,ICW;"2CJP!Y&XC_/'75236-,D^U;-0M6%I@7!$JXAS_>.>/QH
M?IZ7BV:'4'C:Z8EG$6=BY_A7/) '&3UZ\=*M5#:7=O?6L=U:S)-!*NY)(SE6
M'J#4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<M\0-1U'2_#!GTUXXW:XAB=VSD*\BJ=N.AYZ]A
M74U@^,=%NM>\-S6-D\2W/FQ31^<2$)217P2 2,[<=* $?6KR36ET.WCMO[02
MU^U7$C%C'&I;:H X))(/I@#Z5)X;\0?VY%>Q3V_V:^L+EK:ZA#;E##D,IP,J
M001Q6=)HFKV_BF'Q);+:23S6GV6^M/-95P&W*R/MY(Z'(&1SQTK1\/:(^ER:
ME>7!0WFI71N)A&253@*J D#. .N!DDT 0'7;Y?%USH3V]NG^A_:[29G;$N&V
ME2,<8.,XSP0:IZ)XNN=<\-6.HP6]L+RZNS;&W\PE4()W?-CDA5+=.1]:M^*/
M#<FNW.EW%O<?9YK69ED<=6MY%*RH/<C&#V(S3=*\+?V9XMU+4XY5%C<!9(;9
M1@1S, LC8]PB8^K4 <Y;W^IZ5KGCJ[TRRMI_L]Q'/)Y\I0$+;J2JX!RQP>N!
M]:W;GQ-YL_A.5-.ADM]88,DLC_/ 6B+\#'7'&<^O%01^'=863Q<Q2R_XG(_T
M?]^WR?NA'\WR<=,\9]*C7PSK*VG@Z+;8DZ)L^T'SW^?;%Y?R_)[YYQZ>] %^
MX\1:E<V^IW6B:='>1Z=<-;F)G(DN'0CS G9<9(&<Y(/ X)RKJ2^'Q5=]/M86
MNI- 0XN9-BI^_/WBH)/I@?G4]GH7B;0M9U./2)=.ETK4;IKL-<EQ):R/]_"@
M8<9Y R*OQZ+J</CHZR/L\EH-,%D-\S>:S!R^XC9CG..OO0!=\*ZX_B+P_!J$
MMN+>8O)%+$&W!71RAP>XRN?QJM8^(+E_%.J:+J$%O;?98%N8) Y/GQ$D%^0,
M;2,'W-+X,T>^T+0WL;_[/YGVF:8&"0N"'<OCE1R,XK-\6:9:Z[K6C1VMZJ7J
M3R07"Q,"6M2A\Y&] <*,]BP]: +<'B:[G_LBT^S0IJ.J1O.B%CLBA4 [VXR2
M<K\O')//%5+OQK=6-GXACGLH1J>B1B=XPY\NXB*Y5E.,@\$$'.#W-7]=T&[F
MU_2=>TLPF[L \3P2L42:%QR-P!P01D<8]:IW?A&?58?$EQ=/%!>ZQ:"TC5&+
MK"BJ0N3@9)9B3QZ 9ZD O3>(IX=<\.V7V:,PZO'(Q?>=T12/?TQR#T[5I:S>
MW=A8>;9637EPTB1K&#@+N8 LQ_NJ#D_2N8BT/Q+<ZKX8OKN/3(1I*RI+''.[
M[PT83<#M'/?;CC'4YXV/%^E:CJ^C1V^FR0B5+F*62&=BL=Q&K9:-B 2 ?H?2
M@#.A\8W#KXEB2"SNY]%A28/#,5CF5D9L=&VD;&&.?PI+;Q=J::+;:MJ&FVT-
MK>PVWV,1SEG>67 VL-O"C.<C)QZGBJY\-:^;_P 27&W3%75[".W2-97 B94=
M,9V\CY\YQVQ@9XLW/A;4+WP#INCFXAM=5TY+=K>>-B\8EA VDY .#CTXSWH
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M:S02,YB==A3<"H[Q@\>M:%MIOB76=,N=/\3-I\,,ML]NWV!F8S%E*ECN V@
MDXYYQTQ@@&%XHU#4-5T7PSJ,EK;Q6=UJ]E+&FXF6-2X*$GH21U QC/4UW&N7
MTVEZ%?:A!&DCVL#S[') 8*I8C(Z=*XQO#?BR?P[I&C3KI;?V5=V\D=UY[CSH
MX6RN4V?*< 9Y//YUVVJ6)U/1+VP9PANK9X2PY"[E(S^M &(WBFX4^%G^R1&+
M6PH;YSF$F(R<<<CC':LZ?QCKGV3Q%<6^D66-$F=9=]TW[Q%0.=N$^\03UP!Q
MU[10^'?$TL7A9+E-,C_L250P2=V\U5B,>X':,$Y^[@_7M5A?#6LC3_%]N5L=
MVM/*T!$[83?&(_F^3MC/&: -7_A)#?7VG:?IL:&YO+(7[--G;#"< $@?>))P
M!D="<\8/,^&=9;1;3Q1<WD$8N9/$+0+%&QVM(ZQ*.<9QW/&<9X)J['X9UW3-
M3T76; 64MW;Z:FFWMK),RI(BG(9'V$@@^J]*@/@K6KG3M:22YL[6\N-5&JV,
ML3,XBE7;@,"HX^7&??IVH TE\6:C'=ZG:OIJ3FVLC>07*>9'#(!]Z-BRG:XZ
M]\CTJ[X7UG6-<M+:_N]/MK:QNK..>)DG+/O89(*XP!W'/IWX$,5MXJU#2+V/
M55TR*>2V>"*&VE<H[,,;V8KD8[  ]3D^FEX7T^[TGPQINFWHA\^TMT@8PN65
MMJ@9!(!YQZ4 4M=UZ_TV:\\JV@BMK6U\_P"TW;E4G<[L1*1T.%Z\]1Q5*3QE
M>2?\(NUEID4B:[$77S+C:8F\K?@_+T]_8\&EU/0-;N/$NH7<#V,UG>6(MHFN
M7;?9G#!MB@8(;(SR#P/3FE8^%]>MX_!RRC3S_8BLLVV=_F!B\L;?DY/?G'I[
MT 6XO%.LOI_B"/\ LNVDU;1I &@CF;RYT*!QM)7(;!Z8ZCWK1MO$,E_9Z#-8
MK!,=37S'^8XCC";F8?0[5P>[#I4.DZ==Z1XA\0ZKJ+V<5IJ,L+QL)SE-J"/#
M94#G&>O?%5?!>B16%YJUU;SF6P-U)%IZ_P ,49;=(%]C*6'_   4 =!K-[=V
M%B)+*R:[G>5(E0' 4,P!=C_=4')^E<]'XSG\CQ,JP6EW-H<2S;X9RL<Z%&?T
M;:PVD8Y^M:7B_2M1U?2(8--DA\R.ZBFDAG8K'<1J<M$Q )P>.QZ8KG-2T75[
M&W\9ZI=BP6VU#2<>7 S%HVCA==HR ".?O<=.@[ %I?&FK6SZ%=ZEI%O%I.KM
M%"DL5P6DBDD7*EUQC:3Z$X'7GBFOXO\ $<\&MRV&A6<G]D73PRJ]VV9555;Y
M/DY;!/7 ''7L[3-(OM>\->%8;R*WAL[-;:[=TE+-*40%% P, G!.3VP,YS57
MP\-4ENO&EO806S"75946664KY;&) 25"G( P>#STXZT 27FJ6^N>(?A]JMLI
M$5T]Q(H;JN;=L@_0\?A6BGBJ*RU'Q6]_8PVT>CI#))+"V]YPR%AG@<XP /?K
M41\(W=C=>$8].^SO9Z&'$AFE97DW1E,@!2.Y/7VIL_A"\U*_\7+?-;QV6N11
M1Q-%(S/&8TV@E2H'7!Z]L4 :]OJ.N#5+&&ZTN,VEW$SO+!(3]E8 $*^?O9SC
M(QR.G>LN/QA>Q:AHT-_90VYU2=H?LAD_TBVX8HSCN"%YZ8SU-6=#M?%H@BM=
M9GT^-+9"@GM69GN#MPK,& "CN>N2.PZX5MX2\31V.@Q2_P!E>?IE_P#:)9O-
MD9KK*L#(QVYW?-TYSZB@"/3;S7+#4_&,NB:9:W?E:F9)%FG,98")/E0!3EOK
M@=.O:S?ZO;^(-0\ :O;(5CNKJ1U5NJYA?*GZ$8_"M2UT?6]+U+7FLTLI8M4G
M\^*:25E,+% I#)M.[&W(P>>G'6J[^#[JQ_X1.VTO[.]IHCLTC3RE7DRA4D *
M1G+$]?:@!^I^,[F*&_N=,LTNTL9VA:##F6<J</L*J0,'(&<YQVKK;>87-M%.
MJNJR('"NN&&1G!'8UQUMHGBG0]8U&/1YM-FTF_N7N@;HN)+5W.7P ,.,\@9'
MU%=BJO%;*BL99%0 %SC<0.I('?Z4 >:>#=5_L[1M?0:3=72?VU= LD:F, N!
M\V3G ZGCI7576K1:1=1>']+2&-[:T63]ZKLD:9*HN%&>=K?0#OFF>"M#U/0;
M74H-16T/VJ_FNU,$K/@2$':<J.GK46MZ+KL'BB/Q!X=DLY))+86MW:7C,J2*
M&+*RLH.&!8_A0 EEXRGOK+28O[,>UU;499(A;7&Y5C$8R\F2 2N,8X&=P'')
M&5IFIMHWB[QWJ.JI&HM;:SD<P9(D 23! /0G@8]>]:.K>'M=N;G1=<M[BTDU
MK3I)&>%RR021R !HU."1@ 8)')R2.<5 WA'5-5OO$[:I]DM[;6[2&$""5I'A
M:-6 /*@'EL]NE %Z'Q/J/]N65C)IZ30WL;E98!)MMY%&0LA*XP>@8=QTJMH_
MBS7]5TU]330H&M(OM*R1Q7):9GC+!50;<$$C&3@YSQP,W-"A\8(L4.MR:88[
M9<>;;.Y>Z(&!NR,(.YQGD>E4]+\-:W:>!-2T4W-O:W\[7#6]Q;RLP4R,S#)*
M@C&[&1GUH MZ=XGN9?$]OHE[%:^;/9&Y/D2$M ZE0T;@]_FZ\=.E0_#T 6.N
M # &N7G'_;2J]AX=UV'7]$U)X-)MHK.SDM9;>"1R%#%3N4[1G.WH<8]6K5\(
MZ/J&BV^IQWXMLW6H3W:&"5GPLC9P<J.10!-/K4]QK\^BZ8D)N+:W6>XEG)VI
MO)"+@<DG!.>PQUS6%/X^N%T#[=%I:&[@U-=-O;9I^8I-X7Y#CY@<@C.WK6E/
MHFH6'C*;7],$,\=Y;+!=VTLAC.Y#\CJV#V)!!QZUE7W@S4GT26&U-FU]=ZNN
MJ7)DE944AU8(I"DGA0,D#N?:@#K=*EU26WE.K6MM;S"5@BV\QD5H^,') YZ\
M8[5C:;XHFU>^FBLA:/\ 9[U[:YM6<B>%58KYA'<' .,=#U.,5TZEBBEP V.0
M#D _6N+N_"M[J>L:?J%S;65MJ%G>B7^T;:4B26W#$B-EVC)*X4@D@<D'M0 S
M0]<UQG\5W-Q;QWOV&\DCAMK<MO)6)"J+D=\\GU)X[5?L?$UW-XE;0IDLGNFL
M#=JT,AQ&X8*8W')R"PY_2J$_A;7U@\5VEC>6MO'JTK7%M<AW$B.R*I4@#Y1\
MOW@2>>E2Z=X?UN+Q3IFK20:5:V\&GO9R6UN[L(P75LK\HSG;[8]Z *GAOQ5?
MQ>#(M4U;R9YKF]D@@"%AND:=U /!PH [9.%[FMO1O$-Y>>(+G2KJS^1(!/#>
MPQN(G&<%#N'#@]LG(YXK!B\$ZT/")T?[7:07-E?&]TZY0LV7\UI%,@(&!\Q4
M@9]?8]/H8\12L9M>%A"538L-DS.K'C+L6 QTX ]3DGL 97B8#_A//!1P,_:+
MH9_[8-3==\87NB07E[/90Q6MM=I;I#-)MFND)0&2/M@%^F#G:>15[7-'U"_\
M3^']1M5MC;Z;)*\HEE96;?&4PH"D<9SR:Y[5?"'B.^T[Q'8B339/[0NQ<07<
MTC^9L#JRPL-ORA=N 02/;G- '1OKM['XP?0GM[=%DLS=6D[.W[TA@K(1C@C(
M/&>#5'1?%]UK7AJWOX;>U%]->FT^S"4LJD,0WS8YP@+].E6O$?AR[UV/29TN
M$M;ZTFS)+$3_ *IU*2HI]U/!]0#Q2:9X5&F^+[_4XI%6PGC1XK51@)/MV.X'
M;Y%4?BU '35C:MJ=[:7T-O;P0QP-"\LM]='$,9! "'!')SZC@'K2:;?:M-XB
MU2SO(K/[%"$:VDMV8L <Y63/&[C.!T'U%4]6TG6)O%UAJEF;.XLX;=X3!=.R
M^3(6!\Y  <MCY<<<=QDT 9H\>74WAG0-8M]+C?\ M.^2SDC^T<QL79"5XPPR
MIZD=15VW\6SVFH:W::];6]M_9MJM[YEM*TBM$=W'(!W J1TYS6-:^#O$%OX:
MT32V;37?3=6%Z6$SJ'02.^/N'D[\8[8ZG/&CJ7A*]UC7=<ENC;QV&IZ:MB&2
M5FD1E+$-MV@=6Z9[4 9OB6[U*^/@V[NK6WBM[C6;:545B9(B5<JK'HV03G&,
M$8YZUVNMW5]8Z-=7>G6J75S"AD6!V*^9@9(! //I7(RZ#XLO=.\/V=W'I6_2
M+Z&=IUN'_P!(2-6&=NSY201W//I7=2SQ6\)EGE2)!C+NP4#MU- &#:>(Y-1T
M[0;FR2"5M4P[#<<1H$+.W_ 3A?JPZ53E\6WLNA7WB#3K*&XTVSDD&QG(EGCC
M)#NIZ#[K8!SG'49IO@W1(K'4M8N[><RZ>;J2.P3^&)20TH3V,N1_P"H++POK
M&E:'JOART-K)IUTTWV6XDD(>W27.Y63;\Q4DD8(SWQ0!I6?BDW_B2ST^WBC>
MSO=+.HP7&XAL;E !7_@6>M6O#.N2Z[9WDL\"0R6M]-:$(Q8-Y;;=W([UE2^&
M=0TK6]%O=#2UFALM/.FO%=2M&1'E2K@A3D_+R,5=\'Z-J.B6VI1:@]LYN=0G
MNHV@)^Z[9Y!'!]LGKUH QIFU"/XIZH-+M[>2Y;1X#FXD*1C]X_)P"3^7XUHZ
M=XKO-6\.:1J-KIP1[Z1XYV=LQ6@3<'9CQD93 Z=1R*FBTC4XO'=[K8CM6M9K
M%+5%\Y@^Y69LD;, '=CJ:P+'PCXBL-$T"U']G3G3KN::>U>=Q#<*[,RDG9G*
M%L@$$9&: +Z>-+^X\*:UJME8VUU<:3<RPR1QS'9.J ,70X/\+9QST/-;D>LO
M<R:4;4P2PW=N;F63) 6(!3N'U+ 8/N>U4O"^AZEI5QK@U%K.2"_OGND\G<2=
MZJ""". -OJ<Y[4>$_"S>'["[M+B?[1&TC16P_P">=MN8I&?<;VY]QZ4 4!XX
MN9(M.O[;3S<Z?>S*GEQ)(9HXV^[*?EVD="1VSU-6/B> ?AOK>1G]R#_X^M5O
M#NB^+-#ABT-KK3Y-'MVVPWF6^T"'.0FW&W=CC=G@>M;GBW19?$7A74-)@E2*
M6YBVJ[@E0<@\X^E &8OB75;#Q)IVG:OI=O!9ZD62TG@G,C(ZKNV2 J "0.V1
MGN>M5KCQS.+./4[&P^V6)N/*,,22-.T>_:9%PNT],[?3N#P-(Z3J&KZII-YJ
ML-O;1Z:S3+##,9?,F*E0<E5PH!)'<DCICG,T70O%6@^9HMI<Z>^B>:[07+E_
MM$$;,6*!<;6(R<$G_"@"SJGB^XB&J-I=K'<G37,;1,'+W#A0S*FU2 ><#.<G
M(P!R3_A*]3NM>M-,L=)B'VO3/M\;74S1LGS*-LB[<KC)X&<G'3DU$-%\3Z+X
MAU&;0Y--GTW4IOM$D=XSJUO*0 S+M'S X!QQ^'6K8T35(_&UIJ^ZWFMH=,-D
M[/*5D=RZL7VA< ?+TSWH N^%M<EU_27N+FW6WNH+B6UGC1MRAXV*DJ>,@XS6
M;=>(]<D\2ZEH>F:59R36L$<Z2SW3*C*Q;KA<@_+@ 9'N*M^$-'O]%M-0BOQ;
M[KB_GNT,$C. LC;L'*CD5D0R7L?Q5ULVEO%./[-M@RO*4(.Y\8X/'7- %K2_
M&-WK.B65U;:88;B2ZDM;T2MF.R:,$NSD8R. !T^\.14!\9277@S7]2^P6EVV
MES302QB;,,ZH =P.#P0PX/YU"W@[5K.WTM[.2SNI$U">_P!0M9W:.&>27)R"
M%;[A(QD=L]:3_A$]>_L'Q9IS/IS-K$\LL+AW4+YB*IW?*<8V^^<]J -PZ_)+
M>Z;I5C%#]MN;/[9)OSL@B&!G Y)+$ #(Z$YXYR_ !G-]XL^TQQQS?VP^]8SE
M<^6G(^O7\:6?P]K=IK6D:]IPLY+R"P&GWEK+,RI)'D,"C[3@AN>5Z5?\+:/J
MFEWVN3Z@+0+J%X;I!!(S%<JJX.5']WK^@H DO=7D@\;Z;I1L+=A<6LTL=T7^
M==NW*XV\ Y'<_2L&;QUK*:%JVKC1[06^E7LMO<H;IBSJC!24^7D\D\X^E;FH
M:/J-QXWTK6(5MC:6=O-"X>5@[&3;R!M(XV^O>L.3PCK<G@_Q+I!%@+C5;V>X
MB;SWVHLC X;Y,Y&.PYH [S>7AWQ8)9<KNZ=.,UYMI5Q>C1O&E[?66GWL5KJ=
MS.\4Q+!GB1" ,CH HP>V.E>BVJS)91+*B"94 958E<@=C@<?A7*Z7X9U--)\
M4:??&UC76+BYFC>&5G,8E0* 05'3&: +3^*+A9/"Y^R1F+6P WSG="3$9...
M1QCM6=I*K_PE/CY=HP3;Y&/^G<5%#X=\32KX6^TQZ9%_8L@#A)W;S5$1CW [
M1@G/W<'ZUIV6B:M:ZUXHO62S*:IY9MU$[94I'L^;Y.,]>,T /^'?_).]!_Z]
M$KIZQ/"&EW>B>%-/TN^\DSVL0B+0N65L=^0#^E;= !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!(
M))P!U-%<U\0)+J+P'K3VKHC"SEWE@<[=ISC'0T :MGKNEZA>/:6E]#+<(@D,
M8/)0]&'JON,BM"N/M]0>S;P_8^19/K%];E(9_+.(8$168GG)YV_*" 2>V*;<
M>+[ZQ7Q#9W%G;OJ6D6OVQ-KLD5Q#M)W#@E2""".>>] '945A>'-0UK4[=+S4
M;6S@M+BVBF@\F1FDRRY8,",#MC!/7O5W6KR\L=->:PL_M=SO1%CW8 W, 6/L
MH))^E %R>>*V@>>>5(HD&YW=@JJ/4D]*H'Q%HZV-K>MJ5L+:[<);R%P!*Q.
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MK<JG(!\]\@&MW7=8&CVUL5C$MQ=W,=I;H6P#(YXR>P !)^E &I17,7GB'4-
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M2$U33],8WNK+:*T,KOL1@2K %1\V PZ_SH ZNWMX;6WCM[>)(H8U"I'&H55
MZ  =!4E<EJ?BJ]$FJII%MY[Z:WEF-K6:3[1($#E%9!A.& R<\]@.2V3QB[W]
ME8XATNZN[%+N*+4D93([$@PCD89<<]3\PP* .OHJ&U>:2S@>XC$<S1J9$'\+
M8Y'YUR_B:^U:#QAX7LK*>".WN99RZNA.YDA8C)!''/3UQZ4 ='::I87]S<VU
MI=PSS6I"SK&X;RR<X!QT/!XJW7G<5SJMGXQ\<S:5!:/+$MI*QN68*=L&< +S
MD^O;WK<C\2W=]I6BW]K!#:VU_;?:)[NY.8[;Y5(4C*Y)+8'(Z&@#J**\XU+Q
M9JFJ>!['4;,P6LTFJ1V=QC+!@)]AVGC ..<]B1[UZ)#YHA3SRAEQ\Q0$+GVS
M0 ^BN?U'6[RP\6Z7ICQP"RU%)!'.02RRHN=AYQR,D'V(]ZSM-\6WE]IVMDI9
M_P!HZ???8HX4W%78L%0DYSAB?PP>N* .QHKGAK-_J&KZAI>F?9!-IL<?VB6=
M6*O*Z[@B@$$#&"3DXSC!K*@\=37=AHEW%9QQF\U/^S+NWD)+02C=NPPX(&WT
M[CZ4 =E--%;0O-/*D42#<SNP55'J2>E1V5]:ZE9Q7EE.D]M*,I(AR&'3(K'M
M-:N+KQ-K>BS11>79012QR)D%A(&X(/IM_&N;\':T=-^'WA*QMT22_P!1!A@5
MSA5"[F=VQV51T[G XZ@ [F'5+"YU">P@NX9;NW4--$C@M&#TW>G2F1:/80:I
M+J<=N%O91MDFW'<P[ \\@=AVKEM#%X/BEKPO3 T@T^VVO"I4.NY\':2<'J,9
M/2NQO+J&QLI[RX;9!!&TLC>BJ,D_D* )J*XV]\4:Q:Z7I&K?9;,6NI75O"+=
MMWF1)*PPQ;.&.#RN!@GJ<<WK;7[VXUCQ'IOEVX?2TA>*3#8?>C-AAGC&,<'W
M]J .DJIJ6J6&D6;7>HW<-K;KP9)6"C/I[GVKGK+Q/J&HZ!H>HQVUO;1W\+37
M-U,V8;0!<C(RI.XX Y'>L#Q'KS^(OA!KMU-%&DL,KVS^6248I,HW+GG!X- '
MH,VHV=O?6MC+<1I=70<P1$_-(%&6Q] :BU+6],TA=VH7D5N,!B7/W03C)]!G
MC)XK-U#69[3QAH6E?9(&AOHYV$Y8F1"B D 8XSD<Y-8FD1W]YX_\6V]R;*6'
MR;2.1)(F92ACD(4 GIR<@]<T =VK*Z*Z,&5AD$'((I:X_3?%%XVA:R;BVM8-
M2TN<VJV<8.UFX$0'(X?*@=.OM76P^;Y">>4,NT;]@.W/?&>U #Z*P-;U?4+&
M\>*!+6WM4M3-]LNSE))<D"$ ,#G SGGJ.#64OCN.32?#MW*UOIRZQ$S^?<Y:
M*)U ^0D%>6)."2/NF@#M**J:;+=3V$<E['$EP2P81'*$!B 0?0C!_&K= !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %8_BK3+K6O#&H:79F%9KN%H0TS$*H88)X!S]*V** .2OO#>H
MS2>']3MGM4U72%,9C:1C%/&RA74MMR.F0<''H:2^\+WNH)K][)]E34=4L/L$
M2"1C'!'M89+;<L26)/ Z >]==10!0T.TN+#0K&SNO*\ZW@2%C$Q93M4#(R >
M<51\7:/?:WH@M=/GACF6>.4I/GRIE5@3&^.=I[UNU2U/5K#1K47.HW4=O"6"
MAG/4G@ #J30!S]AH.N6WB35-6E?3BE]:11>2A<;'0, N<?=^;[V.WW15 >#M
M77P'H^@![$W%A<0RM(97V.L;[QCY,Y/3V]Z[RB@!%W%1N #8Y .1FL'Q5X>D
MU^WL3;7)M;NTNEECG7[RH<K(!]49OQ K235K"35GTI+J-KZ.+SG@4Y94R!D^
MG)%7: .:LO"<=AXQGU>"14LY+>,+:J.%F4%/,'I^[POXFL75_!VO7\'BBTCN
MM/:'5SOBN)MYEC   B( P$!'!!.,GCFN_HH \]U2+5M0\46]O8RZ/+J&G6(%
MQ'+++ R-(<_(Z'<1A1D'CH>IP)#H^HZ[X>&G0QV&E:CHUY'-9RV3F6W\Q1G!
MR >C$,.>N>>E=9J7A[1M9D234M*L[N1!A7GA5R!Z9(Z4_2[K3)4GL]+,(2QE
M-O)%"FU8G !VXP!W'2@#*@M_%DVGS2WMQI<>H *L,-OO\CA@6+EADY Q@#@$
M]<\,T'PQ_97B*_U:.WMK".[A1'L[1RT;2 DF0Y50#@@<#U/>NGJI9ZG9ZA-=
MQ6MPLLEI+Y,ZC/R/@'!_ B@"+7+&XU/0;^QM+HVMQ<0/''..J,1@'CFN8LO#
M6OPZQH.H2'2(ETZTDM9((/,VX;;RIP.NWN!C/\5=O10!P$G@S69/ .H>']]@
M+BZNVG67S7VJ&F\W!^3.>WZUI'0M:T_Q==ZYI9L7CU.*);ZVN)778\8VJZ,%
M.>.,$#/KZ=%IVIV>K6GVJPG6>#>R;USC<I((Y]P:MT <]X,T2^\/Z#]@OY;>
M603RRJT ;&'=GYS_ +W_ .NG>+O#\WB'28H[.Z%K?VES'=VDS#*K*F<;AZ$$
MC\:WZBN;F&S@:>XD6.)<99O4G 'N22 !W)H YJXT#5_$GA^_T_Q+/9Q&Y@\E
M8[#<40Y!WDM@DY P.,8/)S2?V#JVJQ:-;ZX;/9IEPERTEO(S&XDC!"'!4;!D
M[CR>F/>MW3=8L-768V-P)#!(8ID*E'C;T96 (/U%7J .-B\-:LEAXLMR;+=K
M4DKPD3/B/?&(_F^3MC/'T]Z67PUJSVGA.(?8MVBO&\Q,SXDVQF/Y?D[YSS]/
M>NQHZB@#S[PZFJSW7C2WL$M-LVK2H)9I&!C8QH"=H4[AC!QD=/QJQ+X-U/1+
MC2;SPK=6HGLK(6$T-]N\NXB!W DKR&#$G\?SZRRTC3]-DFDLK.*!YVWRM&N"
M[>I]3[U=H Y+5M!US4[?1FEGLI+FTU*._G^9T3"@CRXQ@G&#U/?)QS@.?0];
MC\2:WJUK)91M>VD4-OND8E'CW8+#;T.[L>U=710!PLW@FZFNM7O;(VVBW-_I
M[6K+92,R/*3GS6^5<$=,@9^8FIK#PWKL6O:'J,QTF".QM'M)8+<.0%)4Y3(&
M<[>^,?[5=I10!P\/A/68/".N: )K!H[QKC[-(6<$"9B<OQP1N/ SGU%67\-:
ME;ZEHNM6;6O]H65G]AN8'D81SQ<'A]N00PR/E]JZ^B@#B-7\&WVI:/XDVO:I
MJ>NF-9"7;RX8XP%4 [<L< G.!RWM6E=:+J=UXJT+5B+18K"&:.5/.8LQD"C*
M_)VV]^N>U=+10 5YVW@SQ&=*6R-UIDCP:LNH+<R>9YESB3?^\XX(''&> !QB
MNYOM2M--C#W4I7=G:JHSLV!DX502<#DX'%/L+^TU2QAO;&XCN+:9=T<L9R&%
M &!9:+JMKXGUS57^Q2)?P0Q1J)&4AHU89(VG .[U.,=ZQ+3P1K6FZ5X:EL[B
MQ_M;0Q)%M=W\FXB?[P)VY4^G!YKT*B@#F="T75K/Q3K6KW[60CU%( (H&9BA
MC4C&2!D<GG';H*Z*>>&V@>>XE2*)!N>21@JJ/4D]*DJAK4^EV^D7+ZRUN-/V
M$3?: "A7T(/7Z4 <[X<TBU_X2[6M6LKGS;!Y!Y2(08Q.ZJ9G4CKG:G/KO'K4
MMEH&K:%>ZRNE-9RV6ISO=H+B1D:WF<8?@*0ZD@$#*^GO71Z?%9PZ?;II\445
MIL!A2)-JA3R,#M5F@#BG\&W>E1>%SH3VTCZ&LL92[9D699%P[94'!R,].]:/
MAG0]2TG4M;N;Z>UE34+H7""%6!!V*ISGI]WW^M=)10!C^*=+N];\,WVG6-T+
M6YGC"I*<X'()!QS@@$'V-8]GH&NP^*[;6Y/[*C1---DUK!O"IAPP"G'3CK@8
M]#7844 <9IG@VX_X5U/X5U.:%2XE"SVS%L%I&D!P0.02..^*OZ#:^+$>%-?O
M-.>*W& ]F'WW!Q@%]V O7.!U..@&#TE% "-G:=H!;' )P,UP,G@S69/ 6H^'
M_,L!<7=V\ZR^:^U0TWF8/R9SV_6N_HH Y<:'J>G^*[K7=.%K(-1@CCO;6:9D
M DC&$='"'/!((('K[51N_!-U_P (R]K:7%N=2DU0:M(\@(B>7S Y7C)"X 4'
MKQ7;44 1P>=Y"?:#&9L?/Y8.W/MFN=U#1=8D\8PZO9SV;VHLS;&.ZW$P,6R9
M$ X)(P",CH.:Z:B@#C-,\&W2?#5_"NIS6[R>2\4<L&["G)9&YYR#@].U.D\$
MR2W.@W4EYFYM"_\ :$F,?:U?YV'T\Q5./[N178TV21(HGDD8*B*68GL!UH Y
MS4M&U>3QC;:Q936;VR6AMC%=;B86+9,B <$D8!&1P.M85CX,UVTT#PYIS3:=
M(VD:A]J+!W7>@+\?=/)W_ACO7=6%_:ZG807UE,)K:= \<B@X8'OS5B@#E=?T
M+6F\0VGB#P]<VB7L=N;6XM[S=Y4T6[<.5Y!!)[=_SWM,BOHK3.I3Q2W;MOD\
MD$1IVVJ#S@8ZGJ<GC.*N44 8'BKP_-KEO8RV<Z0:AI]TEW;/("4++U5L<[2"
M1Q20:/=W/B./7M0CMX[BWM&M[>WBE9U!8@LQ<J.N  ,<#/7/'044 <[X1T;4
M-#L[V"^^S,9[V:Z5H)&;'F-NVG*CIGK5WQ+IMUK'AN_TZRNS:7-Q$4CFY^4^
M^.<'IQZUJT4 <;9>'M=A\2Z?K$G]DQ)!IS63VT&\*HW*PVG'0[<=!C/1JI#P
M9K(^'T?AW?8?:$N_/\WS7V8\_P ['W,Y[?K[5W]% '&>,;2UUYM-LK>_CAUJ
M&\4+]GD#21(RGS@>X'EECD@<[?6NPBB2&)(HE"1HH55'0 < 57ATK3[?4)]0
MALK>.\G $MPL8#N!TRW4]!5N@#G_ !GHMYX@\.2Z99- DDDD3EYV( ".K]@<
MYVX_&F?V/J1\=+KVVT\@::;,Q^<V[<7#Y^YC'&/U]JZ.B@#S#6='O-,^&^LZ
M7/):RW<VH).J6\A8CS;I& ((!'7'O74ZGHNJCQE;:]I;6; V364\=RS+M7>'
M#KM!R<YX./K6RVCZ:^IC4FL+9KX*%^T&(;\#ISUJ[0!YZ/!>N+X7.E>?I[R_
MVM]O#EG4;?-\S!^4\GI[>]=!XET;4-8DT1[;[*OV"_CO91)*PW;58;5PI_O=
M3Z=*Z*B@#CI-!\2:5XDO[[P_=:<UCJ3K+<6]\'S#*%"ETV]<@#(.*GUOP]>Z
MM;R6%Y;V&J6+VJH#=N4D2<;MT@PAQG*]"",5U5% %'1K&32]$L;"6X:YDMH$
MB:9^KE0!G\<5F>(=%O[_ %C0]3TZ2V$VFS2,R7&X*RR(4.-HZC.<=_45T-%
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M(9U&3'(K!E;'U%4(=$UO5]+NK+Q1>6<D<UN]OLL$90VX8,C%C][T &!SUXP
M5[OQ/JFDV6D:MJ$-HVGW\L44T<*L)+7S/NG<6(< D \+ZCTJ-_$7B*YU#Q+9
MV<&F1OI!C*--YCAPT?F8(!')X&>,>A[2Q>&-3N]'TS1=7GM9;.PEB<SQ%M]R
ML7*!E(PG(7)W-G!Z9XFM] U*#5/$UYNM&&KA/*7>P\LK'Y?S?+SD<\?3WH S
MXO&&KM:>&]6DM;)--UB:&W:$%C-&TBG#!ONXR.F.G>GMX@\57VI:_8:59:4)
M=+E15,[N1*&0.%&,?,<]> /?LG_"(ZH/#/AK2EEL_,T>Z@G:0NV)1%G  V\9
MS^'O4.B'4_\ A-?&@L$M&W3VXS.[+Y;>0O. #N'MQTZ\\ %JP\=#6-,T22TA
M,-SJ4$LS!H'G$(C(5_E3!;YB .G&3[&M>>,=?L/#-Y?3Z3&ES:WR6P:6.2*.
MXC=U59$5N1][H3QCJ:DG\#7>G6&A-X<U".'4=(1XU>Z0F.Y63F0.!R,MSQT_
M6K6L^'M=UOPS)97=Y9-?3SQ2N4#K#$L;JP5!R3G;R3Z^P% $MMKVK0>+9]&U
M*WM'5M/:^MS:;MPVN%,;;OO'D8( ^E,\,>*)_$207-O<6%Q$86:YMHE9)[67
MC$;!F.?XAG Z>]376AZG/XO76HY+:)!IKV04.Q8,S!MX.WL0!C\?:J@\)7=W
MK=MJ]R;2RU"*UE@FNK$MNN6==H9@0,;3\P&6YQSQ0!':^+=276]#L;^.R634
MC(D]K$"9+-U0NJLVXAC@8(POK4?AW4-<>7Q9/-=6MR;2_DCCC:)HQ\L28P=Q
MPN.V"2<G/-167@[7X(O#2R7VF*=%D;&R%SYJLA0N>>7.<X]<G)K5L?#VIZ==
M^(3#<6DEKJ<SW$:LK!U=D52&/(VC;G@9/M0!7T_Q=/>:1X71(;>/4M<C+J-I
M\J%43<[8SDX& !D<GK1/XJU*QN]<TNY@M9-1L+$ZA;R+N2.>'G.5RQ4AACJ<
M^U00>"K^VT;PWY-S;KJV@96&0[C%,C+M=6XRNX=^<8[U>NO#=Y?2ZOJ,YMEU
M&^T_^SX45V:."/YB<MM!8EF)Z#H![T 4K3Q5K?F>%[F]MK 6.MJB%(=_F1R-
M%O#9)QM.#QC(]37;UQS>%]4-AX4MQ)9YT1XVD.]OWNR,Q\?+QD'-='8IJ:W=
M\;Z6V>W:4&T6%2&5,#(?/4YSTH O4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSX,\*3);#; LCY$0]%&./PIM_IGC'5;F&YO_  9X5NIX0!')-(6( Z#)[>U
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !36=$*AF52QPN3C)]!3JY?P[?G6M:U[49,M%8W;:?;)C.T1@&1A[LQ_)0*
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MNP'KS]*T+3QM;RZ$U]=VPM+I+YM.>V>8;1.&P1OP!MQSG'0'@]* .JHKCO\
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MS]0NU66:4C!8;0J<'I\BKGW)]:OZOX<TG7I;235+)+EK1B\.]CA2<9R <$'
MX.16I0!5U/[2=+NA911RW7E-Y4<IPKMC@'V-<KH/AR31O$-SJ.FZ=-INGS6I
M$VG><A22XW AD4,57 !&<C.1Q7:44 >9#1]1TWX>:!X?GL(9=6BO%,<'VD(S
M;&:0O$XSM('<CU'<9U-.DU&.ZU"*]\-SVVHZE;MBY:]BG\XHN IQMV !N. .
M3W//4:OH6FZ[#''J-JLPB;?&P8H\;>JLI!'X&HK73]'\/!65EA:9UA66YN&=
MW8]$#R,2<GHN: .47P]K*>$_".G?8,W&DWMO-<CSDQMC!!VG/).>.GX5KPZ?
MJ,/CO5-7-BS6D]A';Q$2)N9T+'IG@'=74LRHI9F"J!DDG  J.VN8+R!9[:>.
M>%L[9(V#*<'!P1[B@#SV'PUK<7@#P]HQL0;S3[Z&>8"9-NR.3><'/.0>*=J4
M6IW?BC6KC2M&^VVTT4=G<M;:BMNS%5RR2!E.6 <#<I&!QG.<>BUAW'@_0[G4
M);]K22*YF.Z5[>YEA$A]6", Q^HH F\.7*7&BQ(NG-IWV8FW-H65A%LXP&4D
M$<=15#Q9I>H7MSH=YIT$=Q)I]^)WB>01[D*,IP3W&X&NAM[>&U@2"WB2*)!A
M408 %-EN[:":&&:XBCEG8K$CN 9"!DA1WXYXH YJPL-4MO&6MZK-8$P7=K!%
M'Y<J'+QAL]2, EN/ISBL.W\,ZW!X'\+Z2;$&ZTS4(;B<"9-NQ'+':<\D@C ^
MOX^CT4 <)XH\-7>O75U+'I9M]4B=#IFK03*C1C:N?,P=Q ;?QALCTKNE!"@,
M<D#D^M+10!STVF/JWB9Y-5TJ.73K>#9:&;9(I=CEW*G.#@(!QTW=,UE'P_=Z
M-\08=5T/2HH],GM/L]]'$R1AB#E'5>,D=#G'%=M10!YG/:ZE>ZEKSV7A\:CI
M5]<E)/LVI+"D^P!&#*RYSN5@Q4@'&.<9.P([[6/$?AG6[;2WAL[.&YAGC:1
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M/*0*20HR 222K=N /H#D:GINO:YX.;0=4TJTFO)H!$]W]H#0JV,>;@C?N'7
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M55LX;&2WDS*-P9V5L@=P-N.M-^(&CZAXA\(7>D:;%&T]R8_FDDVJH5U;GO\
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MYR,>U;%8OA>??I M3I0TLV3_ &8VJ2B1$PH(VL.HPP]\YS6U0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !116'XLUN[\.Z')JEM8I=QP$&=6E*%(\X+C"G..I'IF@#<HK'N-:,6HV
M\*+ ]J;1[NXN/,.(D&,$#'.[)QR.%-8]QXSN;30+3Q)/81C1;AD+D2'SH8G(
M"2$8P>JY4=,]30!V%%8%IK]S=>(-:T@6L(?3XH98Y/-.)1(&(!&WY<;??K6.
MGCN\GT/PWJ4&D1O_ &U.(/+-SCRF(8C^'D?+U[>AH Z>#1-/MM6GU2*)UO;A
M0LLAF<[P.@()Q@9...*O.ZQHSNP5%&68G  ]:I:=-J<NE+)J%G!!?_-F&.8L
MG!./FQG!&#TXS7-:+XKUO7-&755T*U6R:*<L'O/FWQNRA<;.A Z^N>,8R ==
M:W5O?6L=U:31SV\J[HY(V#*P]012W%Q!:0//<S1PPH,M)(P55'N3TKE;+Q9&
MOAGPW/;V$4,VL,D,%NAQ'#E2QY Z  \ <G XZB"]UV[U.V\6Z-=V$"?V;9.)
M)DF)$F^(LA"%>.,Y^;@COUH V9_#?A[6YTU<VD4LLZ*PN8)&0RKCY22A&X8Q
MC.>*V+:U@L[=+>VA2&%!A41< 5PWASQ!?Z;I?@ZSN=/A73]0M8;:*99R95<0
M[@67;C!VGH2?7TK1\+:IJ^H:_P"(H[X6Y@M;T0H$=OD C4@ $<]<DY')Z4 =
M;17)ZWJFKP>.]!TVT%O]DN(KB5E=V4NR*!R0#P-_ ]?PJ63Q+>W5MJMYI%C#
M<V^F3/"ZR2E7G:,9<)@$#'09ZD'H.: .GHJEH^J6VMZ/::G9DFWNHA(FX8(!
M['W'2N<;QC=V]WI(O=/CMDU.\-JEL\I%Q$,L%D9<<@[?PW#DT =A17,P^)YK
M[5KRRL([622RO$MYK9Y2LX0E=TH7'W0&)'J!U[41>)YKW5[VRL([626RNTMY
MK:24K/L)7=*!C[H#$CU ZCI0!K:AHFGZI<VMS>1.\MJ^^!EF=-C>H"D#/O6A
M7(:KXSDMUU*33K:&Z&G2&-X6=A).R@%@@"GD9P,]2",#J6W'B[59M:BTS2M&
MCFDN-+&H0&XN#$<%@-KC;\IY/KSCIR0 =C17(>']5UN]\:Z_:7J6RV]HMLHC
M25CY>Y&?CY?F))Y/'0>E;6K:C=V=S9P6MH'6?>9;J4D16RJN<N1ZG@#COSQ0
M!JT5P[^/I_\ A$QK,6FQ3.FH?89D2X^7/F"/<AQ\P.01G'7K6E:^(-5?Q)=:
M'=Z=:Q7/V+[;:E+EF5EW["KG:,'..@(YH Z:BN4T[Q=<ZAX5.I"PBCU$7?V-
MK$S'Y)?,V;"VWKSNZ=.:Z#4;N6PTFXNTM)+J:&(N+>#EI& ^ZOUH MT5S%AX
MFNIO$S:%<06ANC8&\4PSDA&#!3&XQD'YAS^E9">/=4/AV'7Y-%MX[!;LVUR/
MM1,BCSO*W(-N&P<=2,\\=Z .]=UC1G=@JJ,EB< "H;.]M=0MEN;.XBN(&)"R
MQ.&4D$@X(X.""/PK)EUFXN]:O=)TN""62QB1KEYW(4,X)6,  \D#)/;(X.>,
MOX69_P"%>:?E-A\VYRF<[?\ 2).* .QJM_:%G]O^P?:X/MFPR>1Y@WA!CYMO
M7'(Y]ZYC6?&-WHT5S>7&GQQ6D%ZMJL<TI2:X4E5,L8Q@@%NG< \BBX51\7[(
M[1DZ)-DXZ_ODH ZBSO[/4$D>SNH;A(W,;M$X8*PP2I([\BENKRVL8#-=SQP1
M XW2,%&?3FN6\ J%_P"$G"@ #7[K@?\  *A\0SZF/B-X:A@CMVC\J[>-7E90
MQ"("6PIP1N(&,]3TH ["TO+:_M8[JSN(KBWD&4EB<,K#V(J:N3MM5>.VU9?#
M6E6AM=,N)(WCW>7Y\P&^14 ! Y;&3U.>@YJ!_',UV_ATZ/IT=U%K<<K0M+/Y
M9C9$+%6&TX /!()Z' /% '8K&B%BB*I8Y; QD^IIU<A!XEU^77?[#?1;.*__
M +.6\)-X3&"7V8)"9['H#VZ50/CW4QX6_P"$@;18%M;68PWR&Z.\%9/+8Q@+
M@@'GYB/3W(!WU%<SJ/B>6+6[S2+&.U>^MK99X[>XE*-=;MW$?';;UYY/0=:W
M[J[BLK&:\N6\N&")I9&/\*J,D_D* )ZJWVI66F0^=?7<-M'S\TKA1QUZUS=Q
MXPNK'2=.UR]L(TTB]>,,5E)EMUDQL=AC!'(R >,]ZK32ZC+\6A;F&V>!=&8A
M'E;&QIP&.-OWCM QTXZT =7/JVG6MBM]/?VT=HX!6=Y5",#TP<X.:N5Q/Q&L
MK6R^&%_:VMO%#!"(1'&B@*@\Y.@[5K:IXC^SZI-IEG]F^U0P+-(UR[!!N+!5
M^4$Y.TY/88ZYH Z"BN2M/&K7MCH173I;:_U:9X1!<Y40E 2Y)QDC"\=,Y'2E
MM?%FH2MK\3Z,)9M')0I;3%GN'*AD"KMX!!]21Z&@#JR0JEF( '))[5!9WUIJ
M$)FLKF&XB#%"\+AEW#J,CTK"TWQ)-<>*I/#]Y%:F867VO?;R[@GS!6C8$<$9
M'/<=A53X<@+H6H*H  U:\  [?O30!V%5Y;^S@O(+.6ZA2ZGSY4+. \F 2<#J
M> ?RK(NM=O)K[4[/1[2*XFTV-3-YLA7?(R[EC7 /.,9)Z;AP><8NJW#WOBSP
M#>36CVL\KW+/#+C?&3;L2I^E '<U@:EH?AK5-<47D-N=6,.\;)3',T0.,G:0
M2N>.>*SM6\8W>D"2ZN=/CAM4OULUBFE*S3(653*@Q@KEN!W SD5?;5F'C[^R
M#IUOO_LUKF.[W_.P$BKL/R_*,G/4]J -JTL[:PMEM[2%(85Z(@P/<_7WJ>N!
ME\>:LGAN^UT:+;?9M/NY(+I#=G>51]A*?)@GOSBMF/Q%J$7BJQTJ_P!/AA@U
M&&62TDCG+N#'M)60;0 <,#P2.W/6@#I:*YG0O$\VOM!/:1VLEJ\TD4Z+*?.M
M=H;&]<=25 QQC(Z]:U-8O[NQCMA9V37,D\ZPEN0D*D$F1R/X0!^9 XH TJ*X
MZ+QY#'H.OZC=01O_ &-,8G-K)O2?A2I4]L[@#UQ[U;/B'4K?Q/IVBW%A:N;Z
M!IUFCG8! I&]<;3N(R"#D9]J .FJ!+VUDO9;)+B)KJ)5>2$."Z*>A(Z@'!KE
MI/&-W:W6E?;=/CMX]1OC9I;22$7$8RP60KC!4[<X'0,.35J'6I6\4Z[8II5L
M+BSM8I5F$N&N V[ 8[<KC!]>M '345PMEXYU*?3O#^JSZ1!%IVK7$=L2+DM+
M&\A(4[=N"N1CKGGH*U%\437>L7UA81VLDUC<QPRVTDI69D.TM*!C[H#''KMZ
MB@#IJ*Y/1M4U>[\>^(;*X%N;.S6V5%5VRBLKL"!CECD9Z=!UQ1XIU35K/Q'X
M:L[#R/(N[F02!W92Y6)B%) .%[]\D#IW .C@U"SNKF>VM[J&6>WQYT<<@9H\
MYQN Z9P>OI5FO/(+C4K+QUXRDTNQMIYQ!92.)IC&@Q&_&0I))[< >I'?9B\:
MP7>F:+/!&D=QJMN;A4F8[8E4#=D@9."P Z9]J .JJ&YN[:R@,UU<101#K)*X
M51^)K)\,Z]-KD%X+FS:VGM+AH6(R8Y0.CH2!E3^E8&@RGQ!\2/$5S>#S(]&,
M5K91-R(BP)=P/[Q(Z]<<4 =E;:C97JAK2\MYP<X,4JMG'7H?<59K+O--T^+4
MTU^54BGM8)%DF Y,1&2&]0-H/MSZUAW'C.YL] L_$EQ81KHMPT98B0^=#%(0
M$D88P>JY4=,]30!V%%<L_B+6+CQ%JVBV&EVC364,4L<LUT0CA]W7"$@_+TY[
M\UG1>/+^;0-*U_\ LB*/3+J:."?=<YE1F?RR54+@J&]2"?04 =U17(W'B;7)
M=?U?1M,T6VFGL(XI%DFNRJ.KACS\N0?EP!TZY([KIGC&?6M&TV\LM,>.2YED
MBNC,W[NR,8.[>0.>1@=,Y[4 =;17#2^/IT\':CK<6GP3R6%ZUG*B7'R.0ZH'
M1MO(.X'!Q]:U(/$.ICQ2=$O-.MX6GLWNK1TN"^=K!2LGRC!^8'C(^M '2T5R
M>G^+KJ\\,WU_)I\46I6ETUFUCYY/[X.%52VW^(LN#CN*Z.ZO8].TR:^O66..
MWA,LQ7D*%&6QZ]#0!9JK?ZG8Z7#YU_>06T?/S3.%''7K7.3^+;NPL-+U:_L(
MH]+OWC0E)29+;S/N,XQ@CD XZ9[U4>34)OBU+;/#:R6XT9?D>5B/+:<ACC;]
MXA1D=.!S0!VL4L<\*2PR+)$ZAD=#D,#T(/<4^LB^E?0]/LK72=,#HTJ6Z)&-
ML=NF#EVP.% 'YD=*P'\=3IX?\0W\=G;7,^BRE'\JX_=S+M#!E;!['I[=: .V
MHKEH?$VI+XATW3KW38(8=4@DDM72X+NK(H8B0;<#(/8FFV'BVXGTS79KRQBM
M[W296B:U68OO(4%"#M'#Y&.* .GG\D0LT_E^4GS$R8P,<YY]*B@N+/5+'S;>
M:*ZM9@RAXV#(XY!Y'![BI(/-DM8_M44:2LH\R-6W*#W ) S^5>?_  YU2;_A
M"]$T[3(8;F9%<W1>0JMNAD?!) .6/9?3G@4 ==HMAH.@L^BZ1':VTBKY[VT;
M?/@G&\@G)'&,GTK7KFX]7E;QM?:4-,MA<1:>EPESYGS2J7("D[<J 0?6L:T\
M>ZG/H6DZ[+HT$6G7ETMM+_I),B%I#&&4;<$ @9R03SP* .[DD2&-I)75$499
MF. !ZDU':7=M?VR7-I/'/ ^=DL3!E;G'!'7I6++K5S?ZCJ6GZ7;6\_\ 9ZJL
M[3N55Y&7<(UP#VQECTR.#SBC\,/^2;:)QC]RW'_ VH ZZD=UC1G=@JJ,EB<
M"N-E\9W\&E^))Y-,MA>:'+A[8W)'FQ[0P<-MXW \#';%;%IK4FH/I(MX8)8;
MZU-U*XD.(TPN,<<Y+ <XZ'TH U+.]M=0MEN;.XBN(&)"R1.&4D$@X(XZ@BIZ
M\L\+:_?^'O NGW2Z=!)I:ZA)!-(9RL@#W+*&10I! +#J0>O'>NJ\0^*+[1H]
M5N%L(EM=.A60274IC%V2I8I$<=0!COR<8[T =317&7>NZK/XR\/6]DL L+RR
MENMDCLK,0%^\0#T#\#U_"KMAXHFU6^N(K&.UD%M>M:W$!E(GB57*F0KCH<9
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M5U:66K6+6]W!#=6DRC*2*'1QU'!JIIGAO1M&D,FGZ?#!)C;O RP'H">0/84
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M </>:AJ6J_!4ZAJ3QS23743J4R&)^V#(YX [#VKM(/$E];^*+C2=7MK6"+[
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MA#6I/"'B31R=/$^K7L]Q&_GOM19&#8/R9R,?C[4S5H=4U#Q3;0Z:NE2WVFV
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MGDYX -^BH;/[3]B@^V^4+KRU\[R<[-^/FVYYQG.,U-0 4444 %%%% !1110
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MRW:W)*\;"5\1;XQ'S\G. ,\5TVGZOI^J2726-TD[6LGE3;,X5\9QGOP>U7:
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MD;''[ME.Y<%^ "3@<G@YA;3-;U/1=6\-E-)L[F15N/M%C-)(C,7!99MP#9<
MC.3D9]*[;4=(TW5XEBU*PM;R-3E5N(E<*?49'%265A9Z;;"VL;6"U@7D1PQA
M%'X"@#FK+0=;A\6KKDTFFA&TT6CVT(<!2KE@%)[<]<?AWJ]X-T6\\/>&X=+O
M7@>2*25@\+$A@\C/W QC=C\*VYYXK6!YYY%CBC&YG8X %9I\3Z*NG65^=0C%
MK>NL=LY!_>LQP !C/6@#"M/#GB/1=6U%-'O[ :1J%RUTPN4=IK9W^_L ^5@3
MR,D8]^]Z30;\^-8=8CEA^RQZ<UC\TC&7)8-O^[C(QTSSUKI:* //;;P9XBBT
MW0[5[W2R^E7_ -I\W9(3<##@N_\ M_-R.Y_BK8CT#5(M>\2:@#9LFJP111*9
M6!0QJR@M\O?=GCICO7554;4[-=632VG O7A,ZQ8.3&" 3GIU(H Y+_A$M6'A
M;PUI2O9&72+J"=W,K[9!%T ^7@G/X>]:$FD:K#XLU'7HWL8TETX6T0DD8['0
MLP9OE'RY;GGH*ZBB@#*\.7.HW>A6\VK+ +TEP[0 B-P&(5E!YPP /XUJT44
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M@8! Y]SZ4 4]8\6ZKH[O-<164:KJ*6ZV1!>5X&<()=RMA<DY *^W6M4ZU?\
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M%(XZYS[=*U+3PUKD>O:3JTUWIH:SLGM'@@A94VDJ1M.>/N]<<#L:J-X*U1O
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M7=0KJ,Y7(;."3C'>MJSU?5X?&_\ 8FI-9RPW%BUY"UO&R&(JX4H26.[[P.[
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M^BN5O-7UMO'+Z!9O8Q0-IINTFEB9V1O,"<@,-WTXZ^V#A/XO\2IX-O-=;^S
MVE7,D%U$(G/VGRY-C%3N_=\?[W/I0!Z/17,7^OW4^KWFF::WE26D$<CR&T>?
M+R;BJX4C  7)]<\8Q6<_B?Q&(O# FTZVLKK4YG@NK>=6)C958Y4@]#M!QR<'
M&>] '<50NM9L++4[/3KBX"7=Z6$$>TG?@$GD# X!ZUR]MJWBFZU'7]'6YTL7
M6F>7(MV;9]LBR(65?+W\'((+;C]#67=ZQ>>(/^%?:K!%!'>74DKA7)\M6,#
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M;49I["Q,4D;."MYM5BID&.3EB>*H?"I?-\!VNHR/YMYJ$LMS=3'K)(9&&3]
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M '"CP-J(\ W?A3^U+8PR;D@E^SD%$,A<[OF^9N<<8'UK5N?#MXOB&U\06-Q
ME^MK]DNHI%/E3QYW#!'*D'OSQQ6SJFIVFC:=-J%](T=M"I:1U1GVCUPH)JQ;
MSQW5M%<1$F.5 ZDC&01D4 <CJ7@F>]T'4K..\A2]U.\2[N;AHB5!1E*JJYZ
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MCTC+@8#?CUXZUL4 <IXWN=)O='N_#]Q=Q?VG=0AK2V60"4R;OW;*.O#@'/8
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M"C*N]F&, *.G XK1T[7KFX\3:CH[73WEH-,6[BGE@\MLEF4@8 #*< @X_$T
M=-I6IVNM:7;ZE9,S6UPF^-F7:2/H:B@UNRN=<N='C:3[9;1++(K1,H"L< @D
M8/0],UYKH^J>(/#GPTT+7HKJTETNWCB6>Q\@[S$S[2PDS][)SC 'UQSTDEY'
MIWQ(U^^E!,=MH44S =2%>0G^5 ';T5QEGJGBBYET6^@M))[2\*&\B98E2&-Q
MD/&V[<=O&0<Y'85N>*;V[TSPMJFH6+Q)<6MK).AE0NIVJ6QC(]* ->J]]>P:
M;8SWMR7$$"%Y"B,Y"CJ<*"37'C6M>L=-TZ[O+JWN7UAK:&VAAMPI@9D9W.2P
M#\+QG'/MQ4LMQK_V/Q';:E;2-IHL'>UNIA&LF[80R,J'!]0<"@#?&OV3:=IE
M^@G>#4FB6 I"S']X,J6 ^Z,=2>!6I7GUKJVH:3X,\!?8Y(5BO'LK2=7CW,4:
M/)P<X'W?3O5^]UO6M2EUI-#242:=*;>$+'&R32A%8B0LP(!+!>,8ZY/0 '47
MVH6^GQQM.QW2N(XHU&6D<@G:H[G )^@)[5%I&L6FMVCW%H9 (Y6AE26,H\;K
MU4@]Q7&Z]_:EYK_@>6XD-C<S2R&2W"JXAD\AMW/\7<5U^N7[Z1X;U'4!AY+2
MTDF&1]YE0G^8H M0W4$]S-%$=[Q861E'"GKMSZ\YQVS[U8KB[!=4L_A1:7.D
M2J=4^P+>9D3?YTC+YC@CU8L>?7%0_P#"72MK?A9HKT-I>KP#S,Q#='(RYC!;
MMO(<8]5- '4ZMK=CHBVIO6D474Z6\6R)F!=C@ D# Z]\5;GM;>Z"BX@BF"G(
M$B!L?G7 ^+)[R[\/V-VTRR)+K]L;0,H4",384DCJ#C.?0BM*/Q!J6C^(=:L=
M6N8KRWM=,&IQO%!Y1507#)C)S]W@GF@#L0 H    X %5-4U2TT?3;C4+QW6W
MMU+2LD;.5 &>B@FN8M-3\47$^C7D-K)/:7FTWD;I$J0(RY#QL&W''&0<Y'I6
M# ;Z7P7\0I+O4'N0D]_#AT49VQ* <CIP ,=* /3+6XCO+2&YB),<T:R)D8."
M,BI:X/3-3UC3-0\)6L]U!+8ZI;&(P+#M,)2$.I#YRV<8.<?2AO$'B35-*.KZ
M#:23D7++%:%8A%-$LA0Y<L&#8!.>@Z8/4@'>45Q7]H>)=1\7ZSI%GJ%E:PV<
M=M-&SVI<X?<2I^;DD#K[<#G-;WBC7%\-^&[W5FC\PP* B$X#.S!5!/IN(H F
MO-;LK'5[#2YVD%U?EA !$Q5MJEC\V,#@=,YK1K@M8MM0@\<^"FO+\7(::XW+
MY00*_D-G;C^'V.3QUI6\0>)-4TK^V-!M))\7++%:%8A%-$LA0Y<L&#8!.>@Z
M8/4@'>5G7&MV-KK=EI$K2"\O%=H5\IMK!!EOFQCCTSGD5BG4]6UR;78M'N8[
M6339/L\"R(&$LVP.=Y.<)E@O'/!.>U5=4:X;QUX&:\2-+HPWAF6,Y4/Y*;@"
M>HSF@#M:*X+5?$VK:9,DTES"TG]K):O:0Q^9&L#N%7<X&5D((;!/?[M6;J_\
M2WOC+4]$T_4;*UB@M(;F*1[4N1N9@5(W<YV]>/IW !VE)D9QD9/.*X/Q!XFU
M;1X[V[-S"9+:_BB2SAC\Q#;LZ*#(X&4<[B0,CMP:G$EZOQ5O%DU%Q:0Z3'.(
MC&"JJ9&# ?7:#GK^0H [:H);*TGE$LUK#)(.CO&"1^)KB9/$^L2>!?\ A,K:
M6/RU!N/[/:,;3 '(QN^\'VC.<XSQBI9]8\0:IXKDTK2=0M+6WETF._@EDM2[
M(6<C!&[G@=>,9Z'K0!W%%<?:Z]>Z;XAUK3M=O%,=O:"]LY(X@N^$9#GOEE88
MQ[CBNBT<7W]D6S:FX:]:,--M4 *QY*C'IT_"@"U/,MO;R3.&*QJ7(52QP!G@
M#DGVJ#3IK:]LX[^VA,:W2++EX]CD$<;@><X]:;K$]Q;:+>W%H\:7$4#R(9$+
M+D GD CT]:XYO$NNR:3X*N()[42:QY:7/F0D_,T1?(P1QD=/U% '=S2K!#)*
MP8JBEB%4DX SP!UJ&PO8M2T^WO85D6*=!(HE0HP!]0>17+:=K&M+<^*=,N+N
MWGN=+2.6WN3;[01)&6PR!NQ4CKWJM:^)M5DTWP3=M-&6U=TCNU\L8.8V?*^A
MR* .[HKB+WQ#J]O<>-889X#_ &/:Q7%J9(<_>B=R#@C/W< _SIMKKFNP:CX4
MDO+NVFM=:CV20)!M,;>3Y@8-GDY'/ '/ H [FDR,XR,]<5R%MJFO:_H\NKZ)
M/;H5NWBM[291LDB20HQ=L%@QVL1C ' P>M1:?_:,OQ/UV,ZBQBAL[8I$T8*J
M&,GR_GSGJ?RH ZK3M2AU."2:!9E6.5X2)8BAW*<' /4>]6ZX"/7O$EYX#U;5
M+6:!M3L+NX4*L'R21Q.00%R2#M!(Y/-;L>N"\:SN[2[+:>MA]MN#L4EE(^3Z
M$X<G']W'>@#<6TMDN#<+;Q+,W60( Q_'K4U<1::SXGOH-%U6SLY)K>]:-[JV
M98ECC@<9W(^[<67(Z_>YX'2N@\4:XGAKPS?ZP\?F?98MRIG&YB0%'TR10!KT
M5R.IZMJWAR]T.6\NH[RUU&Z2RN$$07RI7!VM&1_#D$$-D].:AT*_\2ZQK&IH
M^HV4=MINJM;NBVIS-$$4[0=WRGGKSU]L$ [&2&.4H9(T<HVY2R@[3ZCT-/K"
M\3:W)I*Z;;6^S[5J5ZEI$[C*QYR68CO@ X'J16>^JZG8^+!X>N+OS8[ZS>>S
MN_*421.APRL -K#!!!P/0YH V]7UVQT.VBN+UY%CEE6%2D;.-[': 2!@<GOB
MM*O(=][/\&-+NKBZ-S+/>6T@\P 88W.3DCDY/>NL&OZEHWBC4K'5;F*\M8M)
M;4T:*#RS'M8JR#DY'<$\T =E17%VFJ>*+F71;Z"T>>UO"IO(G2)4AC<9#QL&
MW';QD'.1T J/0[SQ1KMSJ?\ Q-;*WBL-4GM"%L\F1%48ZMQ@D'OG)H [BF32
MK!!),X8K&I8A5+' &> .2:\WG\9ZM;>#[34KBZ1+ZVU%K35(D@#;51R)"H[8
M7# GC!]Q7575_J#MK-Q8W47D6=L!$)(@ZF;;O8\$$KM*=^I/IB@#9L+R+4;"
MWO(5D6*>,2*)$*, 1GD'D&K%<%)XPNK;POX9U/499;>TO[</?7\$ ?R'* KD
M8(522><'&/?-7F\0W971K""Y2]GU 3R_:[-4(,,9X* G;DADZYQAN#0!U%W>
M06,:R7#[(BP4R$?*I/3)[#W/%3USNA_VQJ%GJ=AXBL_W/F-%#*P0&XA8?Q*I
M(##D'H#Z57^'.I7&I^![&2Z<R7$!>V=SU;RW* GWP!0!U59NI:[8Z5+8Q73R
M!KZ=;> I&S*SMT!8# []3VI/$3W$?AO4I+6X:WGCMI'255!*D*3QGCM7 7*W
M8\"_#]C<B::34-/:,R+@+F(X!QR?YF@#U*BN&/BG4="NO%$.JS1WRZ7:1WD#
MI%Y1;>&^0C)XRHP??O5^UNO$Z:[IX:WDN-.G1A>-(D4?V=L95H]K$E2>,')[
MYH ZJBN;\=:MJ.A^%YM1TQX5FCEB4B5-VX-(J<<\'YNN#]*JW6I:WI=]9Z7<
MW:7=SJ4\KQ/;6ZH8840$J S8+9(P3VR<'I0!UU%<.?$/B'2K6:#4[11+/J,-
MEIMU,$'F+*?O.B,>4P>F-W'2KVIZGJ_A>UUC4M0EBOM*MK030,0$F\WH4(4
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MOWU"&XAA\MK>8MO!&6.<'],UV-% &%%H5U/JEIJ>J7D%Q=V44D=MY5N8T5G
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M/<:/=2-=M'D"-0,&)CCG<X3CN%:MO5TU<ZWI+Z=?&.V5R+JU-N&65#CYB_\
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M:PW"/:% SR1%4?<,C8W1L=\=#0!)>VJ7UC<6DA(2>)HF(Z@,,'^=<H/!=_\
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M4GDGDGV  +/AM=8DM5OM3U*.YCNK>&2.!+<)Y+%<M\P/S9R.H'3MTJGX@O\
M4;?4I(8=0%M"+)I(4MXQ+/),">64JV(P,<\<GK6[IEH]AIEM9R3"9H(EC\P)
MMW!1@'&3SQ6/>^%I;CQ'<:M;ZK-;+=6JVMS"L2ON522"K'[I^8]C0!@CQ/KE
M[IW@JYM[BV@;6"$N5,&X;O*9LCGID=./K5NQO/$5S/XIT2/4TEU#3C$UG=-
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MY$B=4=E(#,NX#\,C/YUSMGX,MH_ W_"*7MPUU:"(Q"0)L<#.0>I&0>0?8<4
M5'U'Q%I%_/>74%S<:)%92S3M<^0LD4B*6&SRSRI Q@@D'O5G37\0WUOHFK17
M\#P7:++>VKH B1NFX>40N[() ^8D'VI^D^&+Z"$P:WKT^L0+&T44<D*Q@*PV
MDL1R[;21DGN>,\U#H/A"\T00VC^(+F[TFV;=;6;PHI3!RH:0<L%Z@<=!V&*
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M'O0 44A(4$GH.:X*SU?Q/K>DZ;KFDI.?/E$CVTI@%NT!8@J#GS P&.?7/&.
M =]17#"ZU[4/$'BS3H];:UBT]8&MFBMHRREXR^/F!!&>N>>!@CO0@\0:\V@^
M%/$,FI C4;JVMKBS6!!&RR':6SC<&SSP<=L4 >D4UG5,;F W' R>I]*Y2SU#
M4/$MYK\=EJ,E@NG71LX!'&C;I%4$N^Y3D9;&!C@>IXYI=9OO%'_"":BUW<64
MES=3QS10;-@DCCD4L RG/(.,Y !]>: /1DOUDU:73_LMR#'$LOGM%^Y;)(VA
MN[#&2/<5<KCI-?O=-\6Z]#=W!GT^PTE;Y(A&JD'+[N0,DD)_]:J%_K^LZ;X(
MT[Q@;XS*ZP3W5EY:>68I2H*H0-P*[Q@DG.#F@#T"BN(^TZ]J/BKQ+I<.MFU@
MLX;>2W:.VC+(75SCY@01D#.03QQBFZ=X@U+5?#7AB_FOH[47L;&[$*;IYF"G
M B3:PY();C@#M0!TVOZY:^'-&GU2]2=K>$ L(8]S<G'^<UI Y ([UY=J^K7N
MK?!_Q,U^[23VMQ-:[V559E24 %@O&['7'%>H)_JU^@H =6-;>);2\;6%@M[Q
MY-*.V:,0_.YV[@$7J21TZ9S575=6N'\6:=X>M9S;F:WDNYYE4%@BD*%7<",D
MGDXZ#WR.9L'O],;XB30WQ:\MG65+B2)23MMPRY  '0 =/PH ]#M+C[79P7(B
MEB$L:OY<J[73(SAAV([BI6=5*AF +' R>I]*X6]\37UAHGAS4+][Q--N;%9+
MZ^M(5=HI2B%2XVG"'+Y('7';@U=2DN;_ %;P,\>ORSQW$TY\^V$>R0B)R'P5
M(S@XP>!SQGF@#T6BN(MIO$.I^,=>TR+7?LUMI[VDD>+1&+*ZEF0Y['&,]>F,
M<@UX=8\3:YHT.M:(DYD>X)2VD, MWA60J5))\P-M&<_WNV* ._HKA+SQ+<6W
MB>;3-1O[C297NXQ8-)"IMKJ'Y=R[RI.\_..HP2,4M]XDN+;Q/-IFHW]QI,CW
M48T]WA4VMS%\NY=Y4D.?G'48R,>X!W5-=Q'&SD,0HSA1DGZ#O3JYB/4KK6_%
M>KZ5;WLEE!I4<*LT*H7DED4MD[@0%  XQR2: -70M;M?$.DQZE9K*L$CN@$J
M[6RC%3D?536E7F?A&YO;3P'HRIJ$5LCZC<I<R*FZ:0>;+\L2;6RQ8#C' S1=
M>*-=C\ ^*;V.\:.]TF_D@AFEA0N8QL(# #;NP_7';I0!Z917%7UQKUGXSTO3
MEUHM;ZK;SEE-LG^CM&%.8^,\AL?,6]>>E066LZT-%\1VTFJV_P!JTS4!;QW]
MVJI^Z.QB6"C:7 8@<8)QQ0!WE%<7I6O:E_;_ (@L<W-Y%:V<5U:)<Q+'*S,'
MRN  <$J,9 /-9UOKVM7EIX3N+35C)/JS%;R 0QL(OD+.5&,J$8;3DGKSS0!Z
M+17"2:MXBURRU"[T+[0EQ;WDD%M'B#R'$;[2)-QW_-@GC&,C'3);KOB:]T_5
M9K34[NXT6.>"/[!=B))+8RE?F61RIP=W'88&: .]QD8-(  , 8'M2@@C(.0:
M1@Q1@I"L1P2,X- "T5Y<-6\73^"K_P 10ZY&)=-GN";<VB;)XXI&!#'J/E'&
M,=.ISQT6F:W?:AXS%G]ID6QN=$BOTB*)F)W<C@[<G ]<T =?17F@\2Z^_@W2
MK]-1474NMBRE=X$.^/[04 (  ' '3!^E;NFW>K0>-M1T*ZU-KN)K".\AEDA1
M6A8NR%0% R. 1G)]Z .AT[4DU#3DO6M[BT5BP\N[C\MUPQ7D'IG&1[$4Z6_$
M6J6]A]ENG,\;OYZ19B3;CAF[$YX'?!KS6ZU+5-:^&N@7]WJ4ZW4VKQQS-"J*
M) +HJ,C;V"C Z<<YKJ[F^U*T\=Z/I7]H/)9W-E.\@:- Q=-N&) _VN@ 'M0!
MU5%</9:UJMM)XETF_OY)M3MID^P.8XUWQRX$)P%P?GR&)!Z5:GU'4KG7+K0[
M>XOBUC:0O)<6ZP"2223=R1)A0 %' '4^W(!UU%97AQ]8?0K;^WXHH]3 *S>4
M05;!.&XX&1@X]:I^)-8GL[_1M)M)/)N-4N6C\[:#Y<:*7<@'C=@ #((YSSC%
M %ZWUVTN?$%WHJ).+JUA69R\>U2K$@8)Z]#[5IUY_;1WMC\0_$92]6>==&B>
M"2[VJJ'=)@.5 ^4'OC.*ETO7-2_X2C2+!M0EO+>_T^62262!50RIM^>(A5)7
MYCUX(Q@T =W17ET^N^)5\$:SKHUK$^EWTZ)&+:/9,B2[=K\9QC^[@^YKHC?:
MOIWCC1K.XU(W5IJL%PS0&%$6%HPK H0-V/FQAB: .OHKSV7Q!J]I=:+(^HBZ
M>ZU?[%=)!$IM51B^U4<J&+*%&<$\A@>PJQJFOZC]K\61B_.G/I-NDMFFQ")0
M8RV]MP.X%AMP,8QZT =U17$P:WK$SZ)I<_VD7UYI[7UR8(XDD3[@\L!SM&"Y
MR>3\H]3B&XU3Q5H^AB75+>YEBBU K+<6J1O<?8]I*N47*[@VT-@=,D>M '>4
M5B^%]1BU723>6^JKJ=N\K>5.%"L%XPK  88?2MJ@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M K+\0:'%X@THV,L\L&)$F26/!*NC!E.""",@<5J44 81\-K>3R7.JW1N[EK5
M[1&1/*6*-_OE1DX9L#)SV&,5EVO@22 :'OUZ\D.C,1;'RHU_=E"FT\==O&X_
MACK78T4 <E!X'-GJ-VUEK5Y;:5>S-/<:<BH59V^]M<C<BGN!^8J6_P#!<&I7
M^L7%W<"6/4[9;9X6B&(PF=C*<YW G.?Y5U%% %#1[&XTW3(;.YOY+YHE"B>5
M0'8#INQU/O7,?$R1%TC28S<B!VU>U(?(RH#\M@^G7TKMJ* .?E\,Q:G)=7.I
M77VF6YLGLE:%/+6.)_O;1EOF/&22>@QCO1M?!,L-QH=Q-KUY-)I"O'#^ZC4-
M&RA=I 'H!SU^E==10!QEFVD^,/%EAKEBDSQZ9%+&T[Q/$'=B J88#=MPS>Q*
MUL7-IJ3>+K.ZM[^<6"PLES:%!Y1X;#!NN_=MX'0*<XR,[=% !6%9>'Y['7]5
MU>/4 TNI",21M#\J>6I5=O.>_.<Y]JW:* .:T_P;:6W@V3PO=S/>6#JZY90K
M@,Q;J.,ACD'Z5+;>&Y-^F_VEJ+7ZZ:=]L&B"$OM*AY"#\S $X(P.2<9KH**
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M <XZ<X]CUKJJ* ,&VT"\L;?3HK75,"RM?LA66 ,DR#: 6 8?, O4$=3Q5/\
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MEG,)[6ZA +1./8\$$=0>M;=% '(S>!OMUWJ5SJ.L74[ZA8?89E2-(UV_-R,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ***;)(D,3RRNJ1HI9F8X"@=230 ZBLS0=
M=L_$>E+J-B)/L[2/&ID7:3M8J3CTR*TZ "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KDO$OB#3[?5X=*U$W*6BH+B;R[2643<G;'E%/&1EL]>!R
M":ZVB@#A?A7J=K>^&I[>!I#)#=SN^Z)U&'F<K@D 'CJ!T[XKNJS=#T6WT#3O
ML-J\KQ^;)+F4@G+N6/0#C)-:5 !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
8% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ex101slackseveranceagm05005.jpg
<TEXT>
begin 644 ex101slackseveranceagm05005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JI<Z7I]Y<Q7-U86L\\7^KEEA5F3Z$C(JW10 4444 %%%% !1110 =:9%
M%'!"D,,:1Q(H5$10 H'0 #H*?10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ2.W^T2+$[+#_P ]" <+^/2O+[&]%SJ?@>_\B]Q$TR3Q1V3QPVC- 0(D0+@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5I%TNKWEY+MU6X@-Q(DDRQ#S2J"1\$*.@&37H$L@AA>0J[!%+$(I8GZ =30
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M0 4444 %%%% ","5(!*DCJ.HJ*UM8K.#RH@<;BS$G)9B<DD^I)J:B@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/%=7LKO)<$S(KHJF.-CE%( '(7&??-:E !1110 4444 %%%% !1110 4444
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M^*+S6[?4'C^V0QI/;F(%6:,$*<]0/FY Z^M91\"2'PL^A?VK^Z>\^UF7[/\
M-GS/,QC=C&[]*[*B@#GKK1YH/$7_  DS7)E>WL'MS:PV^3(N0YV_-G<2HQ^7
MO7":+<RK;1W&E^,K274F4O\ 89=,CDN2YY,;D;7)R<%B!Z\5ZY28&<X&3WH
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MTZ@#G_$7AEM?MK)QJ$EEJEC)YMM>VZ#*,1AOE).5(Z@FH+SPG=:EX:OM+O\
M6I;FYOE$<]VT"KA!T5$4@+W]>I]L=/10!RVJ^$+F]O;#5+#69-.U>U@^SM<Q
M0!TFBSG:T;'!YY'/!/TPMWX1GGFTF\BUJ=-2L)))&N9(E?SC(H5\IP!P !CH
M!7444 <K8>$+O2_MC6FNSA[C4#?@RP*PW,,,K 8W _ACMCK27/@2RO['5XKN
M8BXU.9)Y)K9/*\J1  C(,G!!&223DDUU=% '-6FA:M::?=-?^)+F\O/L[Q6]
MP+5%\C(^\(U^^V0.N>G&,G.GH$>H0Z':QZI.T]XH(>5E"LPR=I8#@-MQG'?-
M:5% '%W3:-XS\4::;-GGDT6YD:YE$;HJ$<"(D@9RX5N,C$9]16QJWA[[=K%C
MK-G=?9-2LU:-9#'YB21MU1UR,C/(P1@UH6]^+C4;VS%K=1FVV9FDBVQR[AGY
M&_BQT/H:N4 <U=>#K:_TC6K2[N&>YUC!N;E%VX*J%0*O.%4 8!)[Y/-,A\*7
MIUO2M7OM=EN;FPBDB(6W2-9 ^WMSC[O/4G/45U%% %#4[*ZNS:O9WOV62";S
M#NC\Q9!M92K#(X^;/7J!7!>,='MM!T.$+=Q17.H:_;W4DBJ$57W*"50DX "@
MG)/<DUZ92%0W4 _44 8B^'H[W4)-0U2:*]D>T:T18XO+C6)^7P-S$EN,G/0#
M'?-#0?!][HIAM7\17=WI-LP-M921("F/NAI!\S!>PXZ#MQ75T4 <A:>"9M/O
MKM+'7;F#1KN9IY=.$2GYFY8+(>54^@_ CK6I'H,L?BVXUX7B[IK1;7R##PJJ
MQ8'.[KDG\*GTS7K75M0U*R@2=9=/D6.;S4V@EEW#'?&/I6I0!S>F^%Y].TS6
M+(:DLG]I3S7#.;?!C>7[V!NY'7 _4U3G\"%]&T2VM]6EM=1T5=EG?QQ D+M"
ME60G# @#/3I7844 <M?^$+C4--MTGUJ=M3@O([Q;TPKC>F0J^6,#9@GCU.<D
MYIUMX2N+;4-9O?[9EDDU6%(Y0\"X5E0IN&,=CP/SS73T4 <FW@R0^'=$TA=3
M 32;B&>.3[/DN8ON C=^>.OM5;Q"VC^+]1@\.J[SWMC>1RW6R-U$" 9;+$8P
MZG9@$YW^QKM:,4 %%-1UD0.C!E(R&4Y!IU !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<YXWN-4L/
M#-QJ6DW,D4UGB>1$1&\V($;Q\P.#MR01Z5T=-DC26-XY%#(X*LIZ$'J* .)/
MBAX/'EM$^IO)H=Y8F2(F- B3!?,VE@N?]40V,]^^>+4EUJT-GHQNM5:(7<DC
MSKY2FY(*EHXHU5""1QN.,\$Y%2+X!TD>&]/T1C*\-E<I<*['+.5/*D^A4E/I
MQVJ]K7ATZKJNF:G!J$]E=V'F*CQHKAD< ,"&!'88- ''W7BC75^&>OZDEZ8]
M0TR]FMTF>%"[*D@4;@!MW8/4#'%=%KFHZAI'BW0Y'OG&C7TC6LL7EIA)BN8S
MNV[L,01UZXJ"3P!&^@:QHW]K71M]4N6N)"Z*63<P9@IP.20.3GV K;US0HO$
M&@2Z5>S,/,"GSXAM974@AE]""* ,2_UV^L[..YCGEE&J:HMI9+MC_=1\_,N0
M 2VQBI8D?,O7G-_1!X@BUR\COQ+)I+1*]O)<F+SDDSAE/E\%>X)Y[59USPS8
MZYH*Z3(9+>*(HUO) VUX&3[C*>Q%&B:+=Z;F74=8N=5NMOEK+,B($3T"J ,G
M R3DG H AUZZNXM4T^"._P#LUM*LN^.!0]S,X VA%*L-HR2QXQQSBN3'B?7Y
MO ND:BEZL=Z^KK93.T"GS%\\Q\@< X SM]\8KKM4\.-?:_9ZS;:E<65U;PO;
MMY:(PDC8@D88$ Y .:RD\ +%HT6EQZO<F"+4!?QEXU8JP<N%]QN)SGD^U $+
M:[J'A[Q%K=MJ-^^HV=MI']J)OB1&0AG#(-H'!VC&<GWK,U\:A>:%X0U2[U%Y
M&NM6L)I;<(@B7>P8!<#=\N<9).><^W5S>%TN_$%SJEW<"5;FP_L^:V\O"-%D
MD\YSG+'\/SK*7P!,-,L=,?Q%>M9:?=1W%HIBCWQB,Y52Q'S8[<?@>P!TNNRW
M%OH.H3VDPAN(K=Y(W*AL$*3T/TKC;;6-=L_"VDZS=ZJ;J35H[.WCMQ;QJ(I)
M2,R \9.">#QN]!Q7;ZC9M?Z7<60F,9GB:(R;02 1@G'3.*QY/!]K=>#(O#5Y
M<2RP0Q)'%.@"2)LQL8$?Q# YH @LQXABU6^2[\Z31WLRT;W9A\Z.8=5'E\%2
M.>>0:P/#.KW%IX-\%Z7:B7S=0@<EX=F\+&I8A=YVY)(ZYXSQFNITSP[?6=O+
M]NUZZU&Y,1ABFGB11$IZX5<9)P,DDGCZYSW\ P-X9TS24U*YBN-*??8WT0"R
MQ'W[$$'!'&>* (S<>*++2-8^V74%LD<T9LKV^:/>(F(#AP@*[AR%XY)&:CL=
M;UE]7\2Z?:M/=M;6$=S8+>1+&YD8.-I "_*64?> /6K]WX-?4-$>TOM:O)[]
MI8IA?E$5E:-MR80#;M!SQWR>:!X.D.HW]^VN7IN+ZR%K*P2->0& <8'&-W '
MISF@#(L/&D8T[5+\:A=RSZ=8/+<Z5?PK%/'*N"#PHRIZ9Y R/6M*SD\3MJFE
M7,9GFL)E/VY;GR%4 KE7BV'=P>Q)X]^:O'PM#>7[WNK2I>3-9/8';#Y8:)R"
MV[!.2<>P'. ,U7T'PA/HK0PRZ_?WVGVO_'K:3J@$>.FY@-SX[ \#CC@8 *WQ
M/\X>!KJ2&ZF@*RP!O*(&\-*BD'(/&#VQ[\<55UFUNC\0_#EO%J$HF-C> W3Q
MHSXS'R  %SZ<8]C73^(M$A\1Z%<Z5/-)"DVTB2/&Y65@RD9]U%4SX;F?7=-U
M:75))9[&&2(!XEQ('P6)QC'08QC&.] '.V?BG5+;1+JWN9VN[V/7CH\5SL17
M9200Q'"[MI('09QFM_1AXABU^ZCO?.DTAX0\+W1A\Z.7."O[O@J1SD\@\55?
MP':W&E:M87=[-(FHWIO_ #(U"/!,<89#VQM&,^_-:>AZ)=Z:3+J.LW.JW(3R
MTDF1$")P2 % R3@9)R>!0!SGBEVE^*?@RTN/^//_ $F9%/W6F5/E_$<8^M=Q
M<6\5U;O!.@>)QAE/>L[7_#UIXAM88[AY89[>436US VV2"0=&4_S!X-)!I>H
M.JQZEJQNX1U1+=8O,]G()R/88![\<4 9-GJ&H>);_7XK/49+!=.N?L<'EQHV
MZ0*"7?<IR,G&!C@>IXQ+7Q;K6L6/A"ZAN([-]1NI;6\B$(=2R*X)&><93(&?
MSKJ/^$:>UUJ^U+2]0:S;4 OVJ(Q"168# D7)&U\?4'N*B?P;;QIH45E<M;0Z
M/(984V;_ #&(()<YYSN)XQR: ,BSD\076L>)-$/B&95T\0RP77V:+SCYB%MI
M^7;M!4_PY.>HJI#XEU[4M-\$SP7L5O)J^Z.Y_<!@2(V.X>G(S@8_*NIM_#LM
MMK6L:G'?_O=32-'0PC;'L4JI7GT)SFN0U72D\.W'@?18=4 -I=R>7-(JY5/+
M;&X9P02=O;.?7F@"[#JWB+3-2\1:%<ZK:W,]O8K>V.H7B+$J*Q*D2;1C (ZX
M[?E;TK6-0E\9OHXOKF:TETK[7'+=0*C"02!"R@*IVD'HPZCCBK^H>#+?5K'5
MH[^ZD>ZU-$CDN(E">6J'**B\X .3R3DD\],%OX4N(M>@UJ77+J>]CM#:N7BC
M"2*6##Y0!@9&>#D^M '*6FO^(_\ A"='\23:QYCM?+!-;"WC"2QM<&,Y.,@X
MQ@@@<=#UKI)-5O='\>&TU/4&;2;ZU>6SWHBK')'S(A8*"?E^89/0'K35\"A/
M"=MX>&IR?9[>X%PLOE#>2)/, /.,;O;I46O'2_%VH0>'2DL]U8W<<UTP@=$B
M51D_,1@AP=F 3]X^E '0>'VO9='BN+^>22:X)F59$53&C'*(0H'(7 /OFN9M
M[2X;XMZD5U.Z7&EPN!MB(P97^3[GW1_WU[UW58<?A^6+Q5<Z\M]F6>W6V,+1
M?(J*2PQSG.2>??I0!RVEZUKJZ'J?B*_U@RV^E7%ZCVBVR 7"Q[@@+#E2"!T_
M&K6HZSK&B^']&\1/?M=1SR0"]M3&@CV2X&8\#<"I88R3D=<]:W-'\+PZ9I6H
M:;<3F]M;Z66659$"_P"M)+KQVY_^O4%IX0$-C8Z;=:C+=Z;82I);PR1@-\AR
MBNW\07C& .@SF@#*%UKVH:YXML$UQ[:/3A"ULT5O&67=$7P=P((SU[\#D=Z<
M.OZ\=%\):_)J8(U*ZMK:XLU@01%9<@L#C<&SSUQVQ740>&Y+?4];OTOSYFK*
M@D4PC$>Q=B[>?3USS^54O^$*QH&C:0NI.(M)N(KB&3R1N8QG*!N<8]<8S0!N
MZY-<VVAWTUE-:P7*0LT<MTVV)#CJQ]!7,:5K&H2^,CI OKF:TFTG[4DMS J,
M)!(%+* JG:0>A';CBNCU_18?$6@7>DW4CQQW*!6>+@J0001^(%9D'A2YCUVW
MUJ77+J>^BM&M7+Q1A)%+!A\H P,C/!R?7'% '*6?B#Q'_P (5HOB2?6/,=[Y
M8)[86\825&G,9R<9!QC!! XZ'K722:M>Z/X[:TU346;2;VT>:SWHBK')'S(A
M8*"?E^89/0'K35\"A/"=KX>&IR?9[:X%PDIB&\D2>8 ><8W'TZ5%KITOQ=J,
M'AXI+/=6%Y'-=,(71(E49/S$8(<'9@$\,?2@#H/#[7LFCQ7%_-))-<$S!9$5
M3&C'*(0H'(7 /OFN6\#.USXT\;W%SS=I?)",]5A4'8!Z CFN]KG[[PN)-=.M
MZ9?2:=J,B"*=E0/'<*.F]#U([$$&@#;:WB>YCN&0&:-61'[@-C(_':/RKSSP
MO=75K\-]-:VO8;,-J4R32N,N8S<296-<'=(> !@]37<VUA<(QGNKS[1=;2J-
MY86.//H@/TZDGW%<['X"$.AV&G0ZM<1R:?>F]MKD1KN5V+%@RGAA\[>E %:P
MUS5I;+QA!]JE$NEG=:S7$*>8JF$2 ,H !Y]1G!YYJ)]<UN33_ LL6HJCZJL:
MW9:!6WDP%RWMR.@Q6O#X.,$NN2#5[IVUB,)-YB(=IV!"PP!SCH.@]#0/!Y6V
M\/P#46VZ&5,!,(_>838-_/\ =/;% &79/X@NM:\2:&?$4RKIXAE@N_LT7G?O
M$)VGY=NT%3_#DYZBN@\&ZM<:[X/TK4[O;]HN( TA48!;H3CMG&:;;^'9;;6]
M8U2._P#WNII&CHT(*Q[ 54KSZ$YSUJSX<T5?#N@VNDI<-/%;+LC=U ;;G/./
MK0!R7B;Q!J^DVFKWT.I>9-9WL0CM[:)7ACA+(NV9F7(<[B<!LC*D<5=U.?7[
MSQY<:'8ZU]AMVTH72.MLDC1OYNWC/7IW]3]0Z\^'R7=EK%B-:O(K+4KDW9@5
M$/ERE@Q.XC)&5'%:T'AV2'Q0NNMJ,DLHLQ9,CQKAD#;\DC'S;CVX]J ,NVU3
M6_\ A)?%.GI.MV]G8P2V431J@\QED."1UR5'4TSPMKYUN\>W75KN.]BMB+K3
M[ZW1)H9<KAP HRO7N1R/6M-_"[-JNM7XU"1'U6V%LX1 /*"JP5E.>HW$\_I4
ML/A^3^UXM6N[Q)[^"V:VAE$ 0;6()+@'YCE1TP.N!S0!Q\?B77Y?AUH>JKJ*
MB^N-36WGD,"D.IN6CQCL, #CGW[UNV%_JUCXVU#1[F^?483IJWT(>-$9'WLA
M0;0/E.!C.3[TD?@01^&;'0EU23R+.[%VDAA&\L)#( ><8W$]NE7;W29;+6;S
MQ0)9KF=-.-O]D@B&7527 7DG<6_GTH YF'Q#KE[I'AF\M=4/V[4[W[/=VHA1
MA"OS%R%QN'E[<')^O:O1)HGEMVC2>2%R,"6,+N7W&X$?F*\LT22XBLXAHGC&
M2YOQ&/\ 09=+1I&?KLD;:K@9ZLQ'J37JL@D:)A&X20CABNX _3C- 'D^EW>J
MZ)\$8]5T_5)4G0G8DD<;*N;DJ<?+GG=GG/MBNINKS5],U_2]#FUAIY-8GFE6
M86Z(;>*.,,R(.026(P6R0,]3S3AX$'_"#GPI_:DGV3=D3>4/, \SS,=<?>]N
ME:NL^'5UE=/G>Z:#4=/E\VWNXD&5;&&!4]58<$4 <_=:WK&FZGXAT1KTRR6^
MEG4K&[>)2ZKR"C@ *?F'!QTZYJK_ &KXBAL/!NI?VSYAU?R+>>![9/+!DA+;
MQ@!MP(SUP?0#BNFD\,B>/4Y;B[WW^HVXM9+@1 ".( C:BYX^\QY)Y/H *KOX
M09].T"S_ +18)HLD<D#>2,R%%*+NYZ;2<XQ0 SP[>ZE'XLUW1+Z_>^BM8[>>
M":6-$<"0-N4[  1E>..]3ZSJ\X\4:1X?MIC;F\CEGFF506"(!A5R",DGDX/
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M.MLI ;<#\O'08/O6I;^([_6)=#LD$JR7>CIJ4YMF1'8MM  += "23CGIVSD
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MP">X&$.Z1^%4_+U4K)G&.0.U<AJ]]J6I?"K59[O4KAYX-5:#S$"IO07*H%(
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M%H(U2[^S177VI7VIOW>9YF/NXQNYZ5UM% &(OA[;XFDUT7\WVE[06ACV+L"
ME@>F<Y)/6LJ+P!!;V-A!;ZM?136%W)=6]P!&65I-V]2"NT@[CU%=A10!RH\"
MV9M-=M);^^EAUC+3*[+\C%0"P(7K\H// [ 58N/"ANAI!GU:\DETR83I(RQY
MD?:5^8!<8P2,#'Y\UT5% '/GPNL&J7]]IVH7%C_:.#=11JK*S@8WKD?*V.IY
M!]*:WA"S2YT.2TGEM8M%#"VAC"E3N7:=V02>/?KS7144 8^E: NEZOJFHK>3
M3/J+K)*CJH5650HVX&>@'7-)K'AZ/5]2TW4!>7-K<Z>TGEO!M^97 #J=P/4
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M, Y/UK=TS5H='\2>*K'66:.>^G^TV<C(6%S"8PJJA ^8KC&!SS0!L^$-;W>
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M[/&FS4;J20G PID8AC[%<8/I0!I:;KVC:=X>TR2;7S=PW+^3;W=R?GG8L1V
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M&V(6 "?EY#MR6;[V<XYP!Q75VMY;#XJ:C.TJI&='A!9_EP1(Y(.>A ()'44
M;NF^+-"U>[BM=/U&*XFEB:9%4-\R X)SC'7MU[]*TKN\@L8?.N)-B9"C@DLQ
MZ  <DGT'-<I\+?+'P]TQ%"K)&)!(N,,I,C'D=NQI/'TDED^AZM)#=3:=8W;-
M>"V9@Z(T;()/E(.%+<X[&@#9;Q;H4>GW5]+J*106C^7<>:K(\3>C(0&!]!CF
MD_X2[0?MDEH=2B69(S)M96 90<':2,-R<8&3FN)\0-H%[X'\4:EH<4\AO;:.
M-[N5I2;EQPJJ).6*CN/7'8XUM4N+23QQX(=)(F1(;KY@00NZ)0O/;)&!ZXH
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MSB!M003FW^TB+8V\QY !VXSSD8'4YZ5S-]IMY9>,KG1[:(G2O$8^T3$=(63
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M4=0E:*UB&7=8V?'X*":IVWBO2+H7!BFE/D.D9S X\QG&5V<?/D _=STSTYH
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M'&<&@#1IDT9EB9%D>(L,;TQD?3((K'?Q=HB+IC_;"T6ILJ6<J0NR2L>B[@,
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MV4SW6KZL=4O2IB27R%A6./.<!5[DXR>^T>E;=81\7Z-'#J$D\\L#:< UU%)
MXDC4C(;;C)4CN,BK&D^(M-UR::*PDE<PHDC%H712K@E2I(PW0]* -6BL;Q-K
M3:+I<;PJK7EU<1VEJK=#+(V 3[#EC["I9M0M-%%I93SSSW5QN\M IDDF*C+-
M@= /P R .PH U**R8/$FEW6FV]_;SM+%<2F&)5C;>T@SE-N,@C:V<],$]*N6
M&HV^I0R26_F 1R&)Q)&R,K#J,, : +58,>@W*>-9M?-Y$8Y+-;3[.(3D*'+
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M4A0""" 1S6G10!POBZU2377N['4+S2=9M[)3#<I&7ANEW.?)9<$,01G'7Y^
M:B$U]%XK\*:EJ.G30O+I4D$J6\#.L4S>6=AP#MZ'KP,=>*[^B@#R/5KJXO\
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MB411EV6-9 6.T9)Q[57CN!+\5$O?)N$MSH?E^9) R@-YV[:21PVWG!YKM:*
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MR=K.[E\B-UA8XDW;=K#'RG<".>XKE=,N;VTLO"-C=:=J,5HNEB*::"S<S+,
M@\DD#=&IP3D8R0.0 :G\,:$^K?#6_P##]]:75I(TURH-PA4JQE9T8$_>P=IR
M,CW/- ';RZG!#J$=E()%D>%IMQ7Y%1< EFZ#J.O^-48O%.FR:A9V;>?$U\";
M226(JD^!D[3ZXYP<9'3-8FG6&L:[X'U)]2B-MK&H6+685CC9M1D!/^\Y=OHP
M]*J>&KFTU+^S;6Y\*7=OJUD5\Y[JV(B@91@NLAX.<<;>>?3)H ] KSRR\2V_
MA_Q-XM6_EU&Y@@N82B(DEP84,(9B<9V+DGT%>AUQ.GSG1O%_BI[VSO"EY)#+
M;>7;/()PL(4A2 1G(Q@D?E0!T?\ ;^GR6=I<VLK72WB;[98%W-*H&20.P&1D
MG&,@=345IXGTJ]TUKZ&9]B3FV>(QL)5F!P8RF,[L]OQZ<UY_;Z)?>#[7PS=7
M^ESW]G!:3VUY#:*97MFED$H(4?> QM./3Z5HZU9%]%L]8T?PY,MO;ZFMY-9"
M+RY[J/8R.^SKN^;@'DXS0!T[^,](@M]2DN6N('TT!KJ%X&,D:D9#8 .5([CC
MWI]GXMTN^U2VT^,W"RW41EMWD@9(Y@ "VQB,,0#GBN7U3[%JGA'Q!=:1X>O(
M)+BP>W$DEFRSSN0<(%P6('KTYX[U9N1*^O\ @.9;2\,=M'-Y[?99,1;H-@W?
M+\OS<<T =Y6%?^+M*TY[SSGF:*Q=$NYHXRR0,V,!C^(S@'&><5NUY5XM.H:I
MIGB^PDTO41<AO]$AM;9A%-&%7]ZSJ,2,<$;23@  #(- '>7GBC3;'5_[*D-R
M]Z8#<+%%;NY= 0/EP/F.3VSC!SC%9Y^(&A#3?[0W7AMT<QW#"TD/V8AMI$O'
MR8/K5))9)OB1IM]]BO4MO[&DB,CVK@*[2(P4G& < G!Y'?!XK#:"Z?P!XWMA
M87WGW>H7;V\1M) TJN1M*C;D@T >A7NL6]FXB"37,YC\WRK:/>VS^]]/3UYQ
MG%9Q\;Z#]FTVX6[D>+4B5MG2!R&(SE>G#<$;>N>U<O=2-I'B6'4[_1[^]TN_
MTZ"$206[N]M+'N^5D'S '=Z=:GO[58;OPBUEHD]E:QZC)<-!%;,?)1D<!GV@
MA2202.V>>AH ZK3O$^F:C!?RK));_P!GMBZ2ZC,30C;NRP;H".<US>KZU]K\
M:>$!;G4((KB:8E9 \<<\?DL0=N<9!QPP!YZ5DZ]I.I:O/\0+:QM;D2WD=F;9
MGA=$G\M1O56( /3;U[UH7VL'7-=\(7MOI>J(+>YD:Z22RD4P%HF7!RO.">HR
M* .GU#Q7IFF"26Y:86L4HAFNEB)BB<D##-]2 3T!X)%2ZAK-G')-8XN9Y4A\
MR9;126BC.<,2.A.#@#YC@X%<-IR1:?)J/A[6_#%Y?W#W<TEM*MN9(+I))"ZE
MG^ZN"W.>F*T]*FN/#7C378M0L;MH-2:&:SN+:W>5#MC"&,[0=I&.,X&* -'X
M;7,UY\/M)N+B>2>:1)"TLK%F;]XW))Y-7O%_B$^&?#TVHK;23N&6- JY"LS!
M06]LD?7I6?\ #..>W\ :9;W-M/;31!PT<\91AEV(X/;!%2?$6UN;SP+?Q6EO
M+<3!X)!%$I9F"S(S8 Z\ F@#/UO5?LOCKPS<F6^CM[B"\\RUP_SE57;^Z'5N
M3VSS6NWC?14\/W.M2/<QVMK*T%PK6S^9%(" 59<9!Y'7CD<UF:C.][X]\*7T
M5G?"WCANQ([VL@$>]4";N/ESM/!P1WQ7-ZK;W<WA'Q[;1Z??M->ZD9+:,6<F
M95(C&5^7D?*WY4 =]'XKTN2.=\W*"*=;=0]NZF9V&5$8(^?/J.W/3FGQ>)K"
M0WT96>.YL4$EQ;/&1(J'D,!_$.O()Z>M8WBZ*[EF\.:Y9V]Q<6VGWGFW%ND3
M>9Y;H4+A,9)7.<8SR:CET^76_&=SK%G'(MJFC/9"22-H_.D=RP # $A0.O3+
M>QH V_\ A*=+^R:3=^9+]GU5TCM)/*;#,XRH/]W(!ZTZ^\3:=8/>B0S2+8(K
MWCQ1EQ;J1D%L<].<#) Y->?P3W,OA3P58KI6J>?IFHVPO%-G(/*V*X;J/F'?
M*Y'J1D59U:ZBLO$'BFS":G#;:DL<<[QZ;)=+N,0#,C(<*=K 88'D9Z<4 :>M
M:Y _BCP?J5M=W@L;E[D-'ME43 0DK^Z(!8Y/''.1C/%=3HNO66NQ7#VGG(]M
M*89HIXC')&X ."I]B#7(.]I-K'@231XKN?3++SXC(+:0^4HA,2A_E^4[A@@X
MK4\*K*OBSQ9(]O<Q1SW44D+RP.BR*(E4E20 >0: .GO+I;*RFN6CDD$2%RD2
M[F;'8#UKSS5_$LNL>"]"UL-=6!DU*U,@5VC0QM)R#SAUQ7HMTC26DT:C+-&P
M ]R*\MC6[;X:^&K Z9J2W-E?6@GC-G)E?+DRYQC)  SGH<\$\X ._P!.\2Z=
MJ5[>6<9G@N+1!)(EU T)\LYPXW 97@\TV+Q3ILE_9VC&>(WP)M)98BL<^!G"
MGUQR,XR.F:YG6;"ZU;QIK4-M#<HEYX;-G%<- ZQ^:7<XW8QG# TGAFXM-1&F
MVEUX4NX-7LBGG/=6Q$4#*,%UD/!SCY<<\^F30!Z#7G\]S&OQ1O=.OM6NK?3Q
MIJ7"1&_>)1(7()'S#L.G2O0*X!I%A^+%]?7-A>O9'2T@686$LB&02$D A3V/
M6@#<M+ZPTO3M0U6*_N[[348DD.UR8RF0^TY)*\>^"#5VP\16&IR6B6AEE^U6
MPNHV$9VB,]"Q_ASZ'GKZ&J,6LVUG;:@UCI%]]EA^<*+.1#/*Y)*HA7./5L8^
M;V-8OA>SN?!_B*;1GM99M.U!1=0W%O;.8[:4GYH2<<)W7)XYSUH Z.Z\5Z79
MNAG:9;9Y_LWVORB81+G;M+?7C/3/&:=J7B?3M+%TTQF=+,!KMX8BZP C(W8]
MN<#) YQ@UPV@PQ6U@?"^M>%KN[U*"5D25[<O;7"[R5D+_= Y!.>>..>*TK"_
MN?#>OZ_IFI:/J%Y#J-ZUW:36UL94F#JH,;'HI&W'S8&/:@#K(?$.GW&JC38G
M=[EK3[9& AVR19 W*W0\D5C:MXZM+;P\-3L(+BYW7@LL>41Y;[PC;@?0G\35
M6]DGTKX@Z;J=U8W!MYM(:TS:0/,J3>8K;/E!P,9P3@<5SOV34'\ :BATN^6:
M+7S=&$P,7:/[2&)4#[W&?NYZ4 =S-J&FS>*=(BEEOX=0>&9H("KI&ZX&XN,;
M21@8[C-2W?BO3+))YI6F-K;2^3<721%HHGS@AB/0G!(R!W(K'U*62[^('A6\
MCL[T6\<%V))&MG CWA FXX^7.T\'!'?%9.F17>F^"-<\+7UC=2ZAFZC@VP,R
MW8E+%'#XV]7YR1MQSB@#KKSQ7I5CJB:;(]Q)=R0&XCCAMW?S$! ^4@88\]L]
M\XJWHVM6>O:>+VQ9S'O:-ED0HZ.IPRLIY!!KC]-TZYTCQCX<MIHKF5++0C:2
MW*P.T?F9CP-V,<[36EX"26.'7A-;7$!DUFYGC$T+1[XV;*L-P&0: .AU="^C
MWF))(V$+LKQN492 <$$5R'A#3KO6_ 6FW[:YJD6I7$&\W/VEG ;)Q\C94CVQ
M77:Q)Y>C7IV2.3"X"QQEV)*G   )-<CX,U5M&^'^F6<NEZJ]_!!L-JMA*K%L
MGC<RA1]2<4 3>&/&QGT*Z.O%$U*POSIDPA4GSYMVU=BCNV>GL3P*U+SQC96V
MD:S>);W+SZ2I-S:&/$B';N&>V".=P)&*Y.'2M8\,>&FO;FT,VH:KK(O-0^S0
M_:&LT<DDQK@[F7 Y .-QZXIJV5W/)\0;>WT[4\:A8(;1[F-\R_Z.R_>;N6/W
M>H]!C@ [:Q\013:)87EQ%,L]TJA(1$0TCE-QVKZ=3GI@=:9'J4'B33[M=+N9
M;>_LY#&5D4JT,P' =3U4_B".A[CD=0>Y_LWPGK0T:_NK/3XFM[VT\AEF :-!
MO5#@G:RX]^<<<UU?APZ>\=YJ-EI+Z=!-M+23P^5),5!RS*>< ' )YZ]L$@%K
MPUK<?B+P[9ZJB>69T^>//W'!*LOX,"*DUK7;#P_9+=ZC(\<+.L8=8V8!F.!D
M@8')ZG K"^&5K+;^![6252GVJ6:Y13V1Y&9?S&#^--^)S^7X+=RK-MO+4[5&
M2?WR< 4 :5AXQTC4-3GTZ-KJ.[AB\X136LB-+'_?0$98?2H].\<:'J@1[:6X
M\AXI9?M$ENZ1*L9(;<Y& >,X/;'K5*[A&K^.M%U:VBF%MI=M<M<3-"Z[C(JJ
ML8!&6(PQ( X^IK"TS1=0U3X*7>B0P7%MJ#+.!%/$T3$F9G ^8#[PP,^] ':0
M>)M/EO;2U<3V[WJEK1IXBBS@#/RD]#CG!P?:N5T;Q-;Z#<^*CJ,^H7$-OJC#
M<%DN/(B\M.6/.U1S^N.AJQJ1D\6P>&8[>TNK>YM=0@O+H30/']F$:G<I) &2
M2% &<YST&:H".X;0?B%%]AO=]Y-<&V4VDF9@T*H-OR\Y8$4 =7?W^E/XCT&&
M6ZNUNY_->S2$N(9AY9+;R/E;"C(!.02*YC1?%=IX?F\3#4Y]1N(H-7D <1RW
M'D1;$P6;G:N<XS[X[U*RSG5?A[)]CO=MK#*+AOLLF(2;?8-_'R_-QS3]-D?2
MY?%]G=:?=R37M]+-;1+;NRW"/&JC# ;>2"#D\=\4 ;M[J>D7&N>'@;RZ\^Y\
MR6R$!<0S@QDDL1\K#;R 3GI4.F>+8]3U#6[>2SO(8-/E\K>(&+$! Q/RY(//
M ZXKGXM'N]$N?A]82PW$[:<)1=2PPNZ1EH2HRP& -QQ6EH;3:=XC\6Q7-E>
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M,\L]&4#.X=OESSQ7GEAI^J1^!O#MS'87ADTG6)+NYLV@99&B,LG*J0"Q"N"
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M>ZM(8XKF:!Q#-+Y8RJR'@M_/UK5G\8:7;R2EA.;:&[%E-=*@,<<Q(&T\YZD
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M.,%;<L 0&YR>""=H.,\U'=^*'@\9VNAQV-Q*DEH]PTJ*"&^9 ,<]!DY/T]Z
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.RN9M3AF26SFTQ5>Z2X"C8C*6#94D$$ ]#V-5_&,^IV^BQOI=M+.WVF(3B!
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MM_L[;MOVOS<].FSG].M '<V7B>SO-;?26MKRVN1";B,W,.Q9HP<%EYSP2."
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M1/JMH4*NR;E,H!#+G!Z=\U9OK[4KOQ-9B;2-3_LB:S+(L*!7,V_[LK @JNT
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MVCDA>ZA8*B2@<_Q!F"G . 1U]#C<M=76UT^PM(+6>\N_L4<QA@* JF  268
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M/>N:T^UN[;QK=ZC'HFHQ65SI"Q"28AW+J[$[_F+;CD#')Z=.WH%&021GIUH
M\QATO4XOA_X1L&TV[^UV&HVTMS$(^8TC<ECZ'@CIUK9\7Z7>-KFDZCI,HANK
MS=IESG@M ZEMP_VDVEA^-=K6/8^'K6SUBYU/[5>W,\K,RI<7!D2#=C(C4\*#
M@?RZ4 :D$,=M!'!"@2*-0B*.B@# %24 @]#FB@ HHHH **** "BBB@ HHHH
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M*#P/KR3V'?A-+L_$FE>!M"L5TR\'DWK_ -HV\$B+,T+.[#8VX#&67."#V]:
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MHZ5;RZ'=QPWY96F:1,P-@E5903DD G@\?GB'QWIUYJ7ADQV%NUQ/%<P3B%2
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MD$5T= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHH0P4;5QN9CV49 [G)'%<SK/C.]CT2.XL]+GAN/[5CT^=9R%V'S%!*GHX8'
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MN: .@5E<95@PZ9!S2UYEX&\2_P!B>!?#L4^FW)LIYC:F\!4*CO*P7Y2=Q&<
MG&/K716GB2^D\::WIT]ILL-/MX7WAP2 PD)<CKR !@9Z>] &LV@P-XD373<7
M NT@-L%!79Y9;<5QM]0#G.:U:Q=)UY]5-G(EBRVE[ ;B&X657  VX5L=&.[H
M,C@\UM4 %9NM:);Z[;107$]W"L<HE#6MPT+$@$8)4YQS7&0ZO>VGC^QUBXF)
MT;7@UC;J>D9C),+?]M/G(_WJ[34M6CL+BTM$C:>\O&800J0,A1EF)/10,9/N
M.#F@"[;V\-I;16]O&L<,2!$1>BJ!@"I*XC7?&=];^'+NYM-+F@N[>^2QF$Q
M"%G5=Z'^,$,,'\^G/9P/))"KRQ&)R.4+ X_$4 24C,%4LQ  &23VKG+KQ:D-
ME?:A;6$UUIUA(\=Q/&RY^3[Y13]X+SGD=#C-97BO5Y;J^\*QV4'VK3KZ[$N5
M=0MPOE.RK@]NC<\<"@#MT=)$#QLKH>C*<@TZL_2-(LM'MI([&U%JD\IN)(E8
ME5=L;L#. ..@XKGK&,0_%K4U5Y2KZ3#(5>1F )E<'&3P.!P.* .QHKA;/[%K
MOB[Q58:XD;M:^4ENDW_+* QYWIGH2V26'/3G@5B6'C+4Y_ GARTBGEDU75;B
M2T6Z1-[^5$S!Y0.[;0.O&3D]* /5:*YG0=5T""/4+>WCDLKC3P#>K=IB8#&0
M[L<E\C)W9-8\#7LWQ3TR[O#)']HTRX:.V;I"F^/ (_O'JWN<=A0!W36\3SI.
MR!I$!",>=N>N/2I**YC7]>U'3_%6@:9:6?FPWK3-(WF*"^R-CM&>G)!S[8H
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MT.7V%0B;2<C)SGC@#N>.LR#GGIUHH Q/%J:Q)X;N5T($WQ*857",R;AO"L>
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MI5EH]G]EL+9;: NTGEH3M#,<G'H,GH.*YJ\T6]MO$7A)K*QEGL-'AFBEE\Q
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M- NO+T^9X=04S(# R-AMO]_'7C ]ZV;_ ,0RP73V]EI[7)CLOMKR2.8H]F2
MH;:<N<'CCZUS#:!K3^#/%NF_V9(+K4[ZYFME,T>"DI&TD[N,8Y_K5NXT[7KC
M58EGTI;K3FTY(H8Y;A%2VG&=S.N3N)XPP#8QQC)H ?J'B^\N%\*7&D6JM:ZQ
M*"WFR;7QY;-LZ''3D^V.^:T8-4L?^$UOK>;3!;7T&G)-+>N5^:+<?E!'. 0Q
MYQTZ5SMGX?U^V\.>#@VF*UUHUP/.MA<)DIY;)N#?=ZG.,GC\JU9]#O\ 4/&6
MISW-H\5A>Z.+ SI(AP^YB2!G.,-P<=N@H LR^-$M],L]:N+!X]$NG15NO,^>
M-7.$D=,<(<CD$D9&0*=-XLNCK6JZ39:%<W-UI\<<G,R(L@?<<YR<?=X[G/08
M)K%_X1_6=0\ P^#;^Q\LH(K:2^65#$T,;J=RC.[<54#!4<]\5K65AJ-KXVU_
M4FTZ4VEU;01P,LD>7,8;/&[(SN&,_I0!M:%K$&OZ%9ZK;*RPW40D57ZKZ@_0
MY%:-<YX#TV]T?P7IVFZA;F"ZMD*.N]6!^8G(*D\<UT= !1110 4444 %%%%
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MK6L0:+8I<2JTCRS);P1+UEE<[549]SU[ &@#1JO-?V=O<Q6TUW!'/+_JXGD
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MM=[,S1\*A ^5B>G(YYKJO"\]_P"%/AM;3>)Y'-Q;(=RLX9P&?$:%B<9Y4<G
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MJ3GY1@D\XY[\\UU= !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS_""N,=<8ZUAW?A?Q%-X3\4Z:;& W&J:FUU!LN!MVED/.<8'R''?GH*]+HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX\X9QQE7*YXZ9[]J/$W@O3=3\*7EE8:-907DD.+=DC2-HY!RIW 9&"!G';-
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M+>3,HW!G*G@=P-M8[>'?$:Z+XF@M!%;W.H:D;R#$^-\1*!HV8<J2JD9'KUH
MVK7Q//+K.J:1)9P->65LEROD7&Y'#$C:25!5@1Z'@@TGA7Q)J7B2VM+Y]&6U
MTZYMO-2<W(=M^[&W;@'&,G/MTK.LM$UJV\47&J+IEC;VDVEK:BWAGYB968A1
M\H!SN'/ 'OWV/!6F7FB^$-.TN_C1+BUC\MMC[E;GJ#0!S_C[R$\6>#)9K<SJ
M+N8%%B\QF'E],=ZU8M2T:SBU3Q"=,DL3IX:V<M!Y3RKMC<?*0.[ #/OZTGB;
M2-3U'Q+X=OK.V1[?3;AY9B\H4L&7;A1W/7KBM3Q)HH\0>&[_ $L2>0]U'A9
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MA<[?E^8$-@=/PJCX<TSQ;H5O'X>,=C+IENQ6#4_./F+#G(4QXY<#C.<#WQR
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MG$?A/7X_A[:Z"UO:M<V]^)@RS_*R"<RY.1P3G '/U[5Z*Q=H"5&V0KP#V.*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M..: .?TH)XJU?Q3!J3S![.[^R6Z)(R&",("'7!X9B6.[KP!T%8,5WJEW\/\
M0_%MS)/-=Z5,S7:H[ 75LDC(S%0<$A0'!/H?6N^N?#>FW.HR:ALFANIHQ%-)
M;SO$95'0-M(SCL>H]:J:O)>6,%OHNCZ$9H)X&A64%%@MN,#>I.2N#G '.,4
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M.T[D[6N"K+C.,$'GUH ]@E,@B<Q*KR ?*KMM!/N<''Y&LCPEKDGB3PQ9ZM-
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MPJK\2((I_AYK8E0.$MF=<]F'0UCZOI]L-7\"6D2M%"\LY81,5/-N<\CD9]J
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M%IMOLIC52?;=6[KG_( U+_KUE_\ 0#6+\/I$A^&VB2RNJ1I9*S,QP% '))H
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MT$0(P=H4@=..G3BM.BL'2]<NKWQ7KFD3V\,<>GI T;HY8N) QYR!C[HX_4T
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MJ"(]BCE<$YY_N@=SBQIFN75YXMUK1Y[>&.*PC@>)T<L7$@8\Y Q]T<?J:WJ
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M:[;Q0:C;^<D4@EC(=D9''1E92"#]#5$^"_#Q6^4:<JB^4)<A)'7S  !@X/?
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MD@M[I=LP5VRZ_P!TL3G')XSCD^M2MX8TAK:QMS:MY-BP:U3SGQ"1P"OS<8'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ&EYJ\.E75A-;37-G]KAWLK!H\@$''1AN''3WK,^',:0Z1JT4:A436;Q54=
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZDM0=(U<>'/ ]I_94YFTNYMWNU#Q_(J1LC'.[GD]J]#I&=40N[!549))P *
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M[1Y;=KBVED=6$JJ0&! .5/(.#V].E8_B>V\0>)/ ^I6W]D&&ZNA&D%GY\99
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MC3KD7MP7D1MTBH0$3:QR-S9R<<#UZ $4OCYUTS5=0BT"\>'2KJ2"[S+&"@0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA'I0TE1=3:G"UQ"COY82-<;F<X)&"0N #S]":A3QK9Q6FKMJ,#VMWI+JES;
M[RQ?_5E#QN#Y &<<]<4 =(TT22QQ/*BR29V(6 +8&3@=Z?7 :BUU)\3_  E)
M>:;#:R-#>8DCF\PL/+'RL=HY'XCG@UTGB^[O+'PCJUU8JOGQ6DKAC)M*81CN
M'!R1Z<?6@#4AO;6XGD@AN89)8N)(TD!9/J!TJ266.")Y9I%CC0%F=S@*/4D]
M*XK2 MEIWAN\_L*.359K9+.":*1MJQ&,.6D<+\H^4\8//3J:GN?%EK?>#]>O
M;K2/M*:=+-:WEH)%='V %B&.,J00>F?:@#L%8,H92"I&01WIJ312221I*C/&
M<.JL"5/N.U<A>Z[J4'B'POI^GV5LMG?6\LVPS%3\D8^3A2 !N!]R.V.<?3]2
MG\/:SXXN-/T?[5%;W23RHDBPJJB!6;''+=3@#\1QD ]*HJOI][%J6FVM]!GR
M;F%)DW==K $9_ USMQXR>U:WFFTN2.QGU+^SDDDDVREBVP/Y97[FX==V<<XH
M ZJBN7F\67IUK5M*L="EN+G3XXY,M<(BR!PQZ\X^[QU)SVQ4EMXPMK[2M%N;
M.W:2YU@$VUL[;<;1ERS8. N.2 >V!S0!T*S1/*\2RHTD8!= P)4'ID=LX/Y4
MYF5$+NP55&22< "N'\(B0?$'QEYMG':R$69=(FW*3L?Y@<#.>O(!J?X@75]#
M'H<%M#&\-QJ]K')NE*[_ )BP0C:?E)49/Z&@#K+:ZM[R'SK6XBGBSC?$X89^
MHI%^RV0CA4Q0B1B(TR%WMR3@=SU-<Q+?KH%QJTMEH$:2K;B_OY/.,<<C8(VH
MVTAFPASPHZ9ZT^\\0:?=3^%+A])-PFINLEI/)M_T=FC+9QR=VW/3\Z -G6-#
ML]=A@BO3-L@F6=!'(4^=3E3QZ&M%1M4#).!C)ZFN6B\6WUUKM]I=GX?N)FL;
MF*&XD-PBA4<;M_O@'.T'/TXSM:SJ\&BV*W$JM(\DJ000IC=+*YPJC/J>_89-
M %TS1"<0&5!*REA'N&X@=3CTY%/K@4DEC^+T4U[906CC1)6>6*7>KJ)4Y+%5
M.1CN/2KH^(%IY^EN8H6LM2F6&&2*Z#RQE_N&2+'R@^N3C(R!0!V-,\Z+S_(\
MU/.V[_+W#=MZ9QZ5S%YXR>Q_TB;2Y$L!J(T_S))-DA8MMWJA7E-W?=G'.*K+
M%'#\8II(XE#OH(9]H +GS\<^IX YH Z^*>*<,894D"L48HP.&'4''<5)7#1>
M+[/2O".J:U:Z T,=MJ$L,]O&Z*3)Y@5G8CU8]LULVGB2>3Q0-$O=+DLVFMVN
M;:4S*_F*K ,& ^ZPR#C)^M '045Q\_CM8]%AUN'37GTN:[^RQR+,!(3O,8?:
M0 %+#'WLX(.*ZZ-F>)&=#&Q4$H2"5/IQQ0 VX@CNK:6WE!,<J%' 8@D$8/(Y
M%4M&T.PT"Q^R:?$R1YW,7=G9CC&2S$D\ #V JIXE\02>';>UN39B>VEN([>6
M4R[!#O8*&;@_+D\GZ5:FU&8:I-9167GK%;B9V60 Y8D*N",<[3W[?2@"]#/%
M<PK-!*DL3<JZ,&!^A%25R&B>)].3PCHD^G:8MJ-2D,-E81D* <L3D@8  4L3
MC\SUT;37([[6KOP]J=DD%ZD G$>_S8IX2=NY20,X/!! _&@#;BFBGC$D,B21
MG.&1@0<'!Y'O3Z\^\":E)IOPX\-PV]E)<S74CP(%R$3YY"6=@#M4!3V/.*GU
MGQK>?\(3XAU"PM8XK_2YGM90TVY$8 ?.A ^;A@0"![T =M)/%$\:22HC2-M0
M,P!8XS@>IP#5"70K277XM:9IOML41A0B0A0A()7;TY(%9.I:HD&H^'(=3T:.
M6XNKDK#,) ZV[[&.X$@') /8?6K$_B2:3^TWTO3OMT6F.8K@^=L9G50S)&-I
MW$ CJ5&>* -#6M$L]?L19WWFF#>KE8Y"F2I!7D<\$ U?1=B*NXM@8RW4URS^
M.8)9=!&G:?/>PZTDCP2*ZK@HA8J03UXP>@'/7&*T/#VOOK3:A!<61LKVPN/(
MGA\P2#E0RL& &00?2@#;ILD:2QM'(H9&&&4C((K+O=:,6L1:19P+<7[P-<LC
MR>6D<8(7<S8)Y)P  >AZ8K$O_%4]]X0\0S65N;?4],CGBN89)<&%EC)#JP!W
M#H1TS[4 =3;W=G)(]M;W$#20\/%&X)C]B!TJQ7,>$=+@?2-&U.XT^"*^BL(X
M8IHY"S-$44\\#J><<X]>:Z>@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *X6YTC7+;6/%:VFG1W%MK,2M#<&=5$;"'RRK*>
M<Y&1CCGDBNZHH X&RT+6H)? IFT\8T:W>*Z*3H<9@\H8R1GGD^W<T7.G7]GI
M_C^[NK1H8+^"2:!BZMD+;[#D G!R,UWU8^LZ1HUTZZAJIV+#$T;.]RT49C;[
MRN P5E/HV10!S1TS4SIO@;5K"R^UOIEN!-;>8L;%9+<(2"W&0>U/M-)UV"X\
M43W&CVEPFHW,$B6[3JPEC"HLBG(Q]T-R<<CI7<KC:-N-N.,=,5 M]:-'/(MU
M 4MR1,PD&(B!D[CVP.>: .$B\%W<6C>)].TV*6RT[4+3R[.PN9@XBF(;<1@L
M%4Y7C)[].*[+0_M@T:U2_M5MITC5#$) ^, #DCCUZ5>BECGB26&19(W4,CH<
MA@>A!'44^@#AM)L_%GAVYO-(M-.M;S39;F2:TOGN0GV=9&+%73&6P2>G7U':
M_9Z?J-MX[U35'LI'M)K*&".0/'N=D+$\;AC.[C^E=510!YI9>'-=MO"OA33W
MTQC<:7J@N[C$T>/+!D/RG=R<2#CCH:Z37M.O[OQ7X:OK:T:2WL)9GG;>@P'C
M*# )YP3D_P!:Z>HA=6YNC:B>(W 7>8MXWA>F<=<>] '%Z38>*/#E]J.F6>GV
MUWIUU=R7-K>O<A/LXD.XJZ8RV"21CKZCM?M]/U&#X@7FJO9R26;Z=';+*'CW
M.Z,S$XR, [OS]*Z6"YM[I&>WGBF57*,8W# ,#@@X[@]JEH \UM/#>NP>$O#F
MG-IK&XT_6!>S@31X\L2N_!W<G#CCV-=%!8ZA'\0;[5VL)/L<NG1VR,)$R75V
M;INZ'=@>]=110!YG9^&/$=AX<T>>TM8EU?2+ZXG%M+,NRXBE9RRA@3@[6')[
MBM?Q!:^(_$G@C5;6;2X[6ZNXUB@LQ<HY3G)=WX'/H,]/?CM:BDNK>&:**6>*
M.28E8T9P"Y S@#OQZ4 <S>6&I77C+P[J2V$BVUG;SQSEI$RID"@8&[G&WG^M
M5-(M_$'AK1-;CBTNWN)%O9[FV+7:HLRR2;LDD?+A22<^E=M574)[&WM&?49K
M>*VR,M<,JIGJ/O<=J %TZ[:_TNTO'A:!IX4E,3=4+*#M/N,XKB[30M;@\,ZS
MX;-B ;Z>YV7OFH85CF8DDC._< QXVX)QSCFNZBECGB26&19(W&Y70Y##U!'6
MGT <A9Z)>:?XZM+F&S<Z7;Z.NG+,9$SN#A@<9SC Q]>U5[>T\4>'=>U2+3M,
MM]3TS4;IKN.5[H0FVD<#>'!!++D9&T9KMZ* .%U31O$-WJNHQW%K!J5K/IZP
MVDTDPC2VEVL'8I@_,Q((('  &15.#0O$VEVWAC5K/3X9K[3;#^S[NP-R 98L
M+RK_ '00RYQ^M>C5%'<V\L\T$<\3S0X\V-7!9,C(W#J,CIF@#D?$EAK^N>&8
MXFL$%V][!/\ 9HYE(AC1U8@N<;F.T]..<=LFVNGZ@WQ'36#9.MC_ &5]D+F1
M,B0R!^@.<8XSZ^W-=110!S/BS1;Z^N='U73%62\TJZ\X0.VT31LNUU!/ ;'0
MGBEM],N;KQ<_B2YLY+?R;#['!;,Z&1B7WLQVL5'0 ?-ZYQ72T4 <QX%T[4-)
MT!K+4;0P3"YFE'[Q7!#R,XY!Z\U%J]AK,_BU)1917^DFTV1)).$2"?<2792#
MNXP 0"1CMDUT\=S;S3S0Q3Q/+"0)45P6C)&1N';(YYJ6@#G/ FFZAH_@[3]-
MU.W2&XMD,95) ^1D\Y' ^G-9.FV/B?PYJNJ6-CIUM?:=?7DEW;W;W(C^S&0Y
M977&6 /(QU]>>.YHH Y&UTK5- \7:IJ4%L^HV6JQPM+Y;HDD4T:[<X8J"K#G
M@\'MBEL/!J?\(;J6C:@4\W5)9[B?9RL<DC%AM]=OR\^HS76U5.I6(OA8F]MA
M>$9%N95\PCK]W.: .;M_#-_J'@"[TO6+A1JNH6Y6YF7D"3:%7ZX"KGU.?6IM
M!N_%TRPV^LZ5;VOV=?WUU%<K)]J(&!L3'RY."2Q_GQU%% 'FLGAK7'^&NHZ&
M-.(OKB]:9%,T>W:9Q+R=WH,?6K^M:1K^IZEK:OIT5U:7EB(]/::X519L8R'!
M7GYBQSN'L,@5W=% '!V>C:VE]X*FGTW8NDVLD-ULG1MI:)4&.1GE<G'X9J"[
M\,:Q?Z/XVL_L@A?5IO-M"\J$-A%&#@G!ROZUZ'10!4TU[J2PA:\MA;3E1NA$
M@?;]2./RKD=.T76=#TO6M"ALA=6]U+-)970E1502Y^64$[OE)/*ALBNYHH X
M>[\-WMA'X/LM/M7NK?1I5::7>BY C*' )ZY.<5UNI7$-MI-W<7)B2%(6:3SS
MA ,<[NO'K5NJEZ+"Z4Z9>FWD^U1L/LTI!,J#[WRGJ.1GZT >=Z3'JNCV.E2Z
MMX4NWM-,7S(V74(I$MLC!98^&. 2 "6(' YK>TO3=7\-:CKL5M8&^L]1NGOK
M>1947RY' W)(&(.W(!!7=QVK2MO#&@Z(HN )8X8/F47-[*\,6.A"NY5<=CCB
MMU'22-9(V5D8 JRG((/<&@#@-/\ !E]X6E\-WFG*+YM/M)+.\A5PC2*[;RT9
M8@<.2<$C(HUGP5?ZY!XAU!-MIJ-^]L]K%(P(008*ARN1ECGH3CBO0:* .)DM
M_$6K>*/#6J7&B+9I8BX%RKW:-@NBKE=N<C(X[^N.^_XHM;F^\+:I96<!FN+J
MUD@C7<%&64J"22..:UZ* .)N].UXZ1X:@CT\S6]H%CU&P,Z)YP$853NSAE#<
M[3UXXJA'X<UV/PSXQTS^S(%;5+B:6U$-PNW$D:J!R!@#;['T%>BT4 <9>:3K
M']I>$M2MK%9&TZ&:"YA>95*;XU4-GD$ KVR<'I44>CZLI\:$Z>__ !-L_9?W
ML?S?N1'S\W'(S]/?BNXHH RO#-K<6/A?2K*[B,5Q;6D4$B[@WS(H4X(/3BN'
MNO#WB>[L0+G2X+G48-6CNC>/=+F>)9=RJ@Q\@"X&TXZ< DUZ;10!R=A8:I;>
M,->U.;3V\B\MK>.(I*ART8;/4C@EN"?3G%<]IWA?Q#I.E>$[V"R274-$6:"X
MLC.H\Z.3J4?.,C@\X_Q]-I"0H))  Y)- '*>'[#5X_&.O:I>:>MM:W\=L(\S
MJ[@QJ000O'\7KV[U+XQT_4-2.B"PLVG^R:I!>3'S%7")G(&2,GGC^==%;W$%
MW"LUM-'-$V=KQL&4X.#@CW!J6@#B-9TK7=0UO4]^GQ7EC<V(CL3-.JK9R;6#
MY7G+$D?,,],9 JM#H>N+IW@F&730'TAT-R$G0X58C'QDC)R<X';O7H%17-U;
MV<#3W4\4$*_>DE<*H^I- '.Z!I^H6GBSQ)>W-FT5M?RPO YD0Y"1A#D Y'(R
M/Z4[QMHM_K&EV4NEF,W^G7T5]!'*VU963/R$]L@FNEHH X=],UK6?%T&HW>D
M_8K-]*FLI@]TC.A=@<@+D'IQ_2I/#$?B_3K2TT&^TZU%O9A8AJBW (DA7@ 1
M8SN*@#G '7GH>O%S;FZ-J)XC<*@D,6\;PI. V.N,]ZEH \RU'P[XFOM/O([C
M3(+F_74TN([Q[I<RP+*&5$!'R *,8.!QGDFND2PU/_A8@UB2Q(M/[)%HSI*I
M_>^9O. 2"5[9P.>U=310!YK<>&M<F\!Z_I*Z<1>7VIR7,*F:/;L:99.3NX(
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MTZ_L_$7B.ZNK1H8+^Y2:!BZMD+&J'(!.#D9KH9[JWM51KB>*$.P13(X7<Q.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!QGKFO0Z* .9;2[[5?$&EZS?VD=L=+BF\J!9@Y>610I.<8"@ @=SGH,<X/\
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M[='S&B%<;-Q W'&23@=?:LCP-IESIOA4RFX^V7,JD6TDOR[H$RL )[#;AO\
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MMEJ MMYN9IE:"1G!#N7P<J,$9Q2>(='U#4==T"\M%MC#IUP\THEE968%"F%
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MSSYVQ1$@+D#DDDD8R.A.>@-7_A*;N#3[!=0TW[%J=W<20+"[%D&P$F3*C)7
MR!C.2![UG3^'/$%C?Z1K6DM8M?VVGKI]Y:SRL(I8P<@JX7((.3R._P"=K6_#
M^O:A::=J-M>VB:_87#7$88-]G(9=K1?WMNWOUSD\9X -#P[KUUJMWJ5G>630
MR6;J$N$1Q%<(PR&3< <C&".<'O6_7/Q_\)4='N[B1=,75651;VP=S F#R6;
M8DY/08X'N:WDW;%WXWX^;;TS[4 .HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ I H!) &3U/K2T4 %%%% !1110 4444 %%%% !1110 4C
M*KH4=0RL,$$9!%+10!C6?A+P]I]V+JTT:RAF#;E9(@-I]5'0'Z5LT44 5=0T
MVRU6T:TU"TANK=N3',@9<^N#WJ#3-!TK1MW]FZ?;VQ<89HTPQ'H3UQ6C10 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !117.^+O$LGAS3GEBLY))6AD:*9ES LBC*K
M(0<C=V/3W% '145@Q^*$DT*;5DTO47@BEV!5A&^1>,R(I.2G)ZX/!XJOX5\5
MMXA\R)K1]\9D+W$2$08$A5%!8Y+%0&.!@<]#Q0!TU%%% !1110 445E^(]97
M0/#]YJ1B,SPI^[B7K(YX5?Q)% &I15+2-3@UK1[/4[4YANHEE7VR.A]QT_"K
MN: "BBB@ HHJI>ZC:Z>ULMQ*%>YF6"%>[N>P_ $_04 6Z*P+#7+NY\9:MHT\
M,"06=O#-$Z,2S;RWWL\#[O3]:WZ "BC/&>U% !17/S>(9KKQ#/H>CP1S7%HB
MO>7$S$1P;ONK@<LQ'.. !W[5-%J&KQZPFGW-E;E7MI)H[J.1@C.K( A4C*_>
M)ZGI]: -JBL+P?K=QXB\,6VJ7<444TKRJR19VC9(R#&?916Q<F?[),;3RC<>
M6WE>:3L+XXW8YQG&<4 2T5!9FY-E ;T1"Z,:^<(22F_'.W/.,YQFI\CUH **
M*,\X[T %%&:IVYU$ZC>"Y6U%D-GV4QEO,/'S[\\=>F.U %RBD).T[<;L<9]:
MJZ8;\Z= =4%LM[C]Z+8L8\Y_AW<^G6@"W111F@ HHHH **,TA. 3Q^- "T5@
M^%M;N];CU;[9##$]EJ4MFHA)(*H%Y)/4\GTK>SGI0 449K EUR[C\=V^AF"#
M[)-8R7(EW$ON5E7&.@'S>] &_11GG%&<4 %%!..M8'B_7+OP]HJW]I!!*?M$
M43B5CP'=4R .I^;U% &_111TH **J:AJ5KID"37<H17E2%/5G=@J@?B:MYQ0
M 454NM1M;.[LK6:4+/>2-' G=B%+G\ %//T]:MYH ***,\XH **,TR65((7E
MD.$12S'T Y- #Z*YO1-7UG6%TS4DM[3^R+^$RL,LLUOD93)R0^>AP!CWKI <
M]* "BL#5=<N[#Q5H.EQPP-:ZD\RR2,QWJ4C+C Z=ASS]*W\\XH **,T9YQWH
M **P$UN[/CV307@@%J-.^V)(K$N3YFS![#OZ]N:/&>MW?ASPQ<ZK9P0320%,
MK,2!AG"YXZ]?44 ;]%&0** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "L;7_  U8>(+=A<*4N1#)##<I]^$.,,5SQG'>MFB@
M#(_X1?1#IT]@VG0M:7$_VB:$CY7DR#N(Z=5''2F:+X8L-%E-S&IEO6$BM=.
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M[B9!')(CLI*#HO!Z#L.W:H'\*:%)HG]C/ID#Z:&W+;L"54]<KS\O4],=3ZT
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M@>?4XKL-5T%3;ZE>:5! NLW%LT*S7#,RMQP&!SE?8@CVKD]/\%6KM$(?!_\
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M/8QRVLC^8Z/EBSYSN)/);/?.:BE\*Z#-=QW4FE6K31Q"%6*<;!T!'0X[9Z4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8,6Q@K'&[YN>PS]:TX?% ;Q#:Z5<:;<VRWT;R6=Q(5(FV %AM!RO!!&?T/%
M'045A:=XD_M1K26ULVDL;J:2%+A9 =A0-RZ_P@["!UZC.*W: "BLF\UU++Q'
MINCR6\A;4%E:*92-H\M06!'7N,5E77CB"TTG7+^33;IO['G\B>-&0DG:#N!)
M'R_,/?VH ZND9E12S,%4#)). *Y^V\4^;X@MM*N=,NK3[9"\UI-*5(F"8W#
M)*G# \_H>*Y?XAZPFM?#K5Y[;3S<:>C>6ET67[RR!2ZKU*Y!&<YZ\$<T >DT
M5A:CXDBL;B2SMXDN+J"%9I(VG6( '.T MU8[3@?F1D9S4^(-E<P:'-8:?>W:
M:R)/LY38,.BDLARW!RN,].^<"@#KZ*JZ;=37NG07-Q9RV<LBY:WE(+1GT..*
MBUG58]&TQ[V2&:8*R(L<*Y9F9@JC\R.: +]%<]'XI N-8M9]/F6\TN%)Y(HG
M5Q(C D%&)7^Z<@X_&J=GXY2Y_L2:32;R"QU<K'!=.R8$C*6"E0=V#@C.,<>G
M- '6T5AZ9XC74-5U;3GLY+6?32OF>:ZX<,"59<?PD#J:OZ3?G5-*MKXV[VXN
M$$BQR$%@IY!./4<T 7:,BLKQ-K']@>&=2U4(':U@:1%/0MCY0?;.*R/"_A^S
MN_#EC?ZQ!%J.I7L"7$]Q<H)&W.-VU<_=49P ,#B@#K**YV)K?PE:16"O-=27
MEXZV<+.6=BV7(+,?NJ-QR>P'4\4J^*XTN-3LKFQGCU&P@^TM;(RMYT1_CC8D
M C((.<$&@#H:*X]/'J&UT:]DT:^2PU4I'#."C$2.I*KM!W<X(SC&?;FK<'B_
M,VK6UWI%W;W>FP+<M!OC=I8CG#*0VW/RG(S^= '2T5QD7Q"B*Z1<W&C7]MIF
MJ>6D-])LV+(XR%(!W =MQ&#VXYJYJ/C*+3HK^[:PG:PL+I+6YGR%(9MHRJG[
MRC>N3D=\9Q0!T]%<[>>*7M_$<NA6^D7ES>+:?:DVM&J2+NV]2W'.>N.G .:I
MMX\MQX;LM<&G7)MI[C[+,"R@VS[_ "_GY^[NXR/:@#KJ*H-J1&MQ::MNSEH#
M.\H88C&< $=<DYQ]#Z5?H **P-5\40Z?/=6\$*W,]I$)9T,Z1X!!(4;NK$#.
M.G3D9%4T\=V=S)H@LK"\N4UB&26V= @&47+*<MPP/'.![T =717'CQS*UEJ<
MB>'[YKG2Y&6]@\R,>6H4-N#9PV5.0!SQVXS9NO&MO%<:/#;:;>W9U>W:XM#$
M$ <!0V.6X/S+UP!GKQ0!TY( R3@"D5@RAE(((R".]<'JOB&V\3>!O%EK<:?+
M:7VG6DRW%I<[6:-O+9D8$9!!QD$>E;&FZPEGH_A_3HHC<7]U8H\<08* BHNY
MV/91D#H3DCCK0!TM%<M+XUBBTO5[DZ;=-=Z0V+VR4KYB+C<'4YPRE>0?0'CM
M6DVN QZ2\%LT_P#:7*".1?D79OW$GJ,<9]2/6@#7HKC)?B"J:3?:FNAW[6NG
MW4EO=DM&#%L8*QQN^;!/09Z=:TH?%(;Q!9Z7/IMS;I?QN]G<2%<3; "P*@Y7
M@Y&?T/% '0T5R5]X_P!/L(DO'CWZ:;C[.URLR;E.[;OV9SLW<9Z]\8YJ2?QE
M(NH:Q86NA7US<:6L;RJ'C4,K*6R"6QT' ZG/3@T =317&7_C&YFD\*RZ39M+
M::P^\LSJK;?+9MF#T/ R?;'.:[)22H)&"1R/2@!:**P;_P 2_9SJ(LK":^&F
MKNNO*8 @[=VQ!_$^W!QQU'.>* -ZBL3_ (2..>XMK2PMI+B[GM!>>5(?*\N(
M]"^>02> ,$\'IBLZ?Q[90>'Y]5^PW;&VNA9W5N N^WEW!<-SR,L.5SG(H ZR
MBN9/BZ9-<?1WT*^6\> W%JN^,B= VTY.["8R.IZ>^!5=_'UM%X<DU>73;Q3!
M>FQN8!L9H90X0@G/(R1RN>O2@#KJ*YJR\8)+XA.C:CIEWID\D+3VSW!0K/&O
MWCE2<$#D@\@5 ?'E@D^F,\)%EJ4RP6]P)58[F^YO3.5#=CVXR!0!UE%<=-X]
M*6NKW,6@ZA)'I,[1W?S1C8JJ&9A\V#P<X&>G.,BM:3Q'$][!9V$/VJXFM!>J
MAD$>8B<#&>I/IP/4CB@#;HK";Q%))-9VUKIL\EW<V7VTQR-Y:QI\HVEN?FRV
M,>QSBL74?&T\^C>&]1T>S=X-7O8H29&560$DE,=,G8PST% ':[UW[-PWXSMS
MSCUIU<W'J%C)X\2TETIXM5&EF;[6Y4CR?,4% 03_ !'N!T]ZCG\:V\&E+K9L
MYFT0R^6;Q6!(7=M\S9UV9[]<<XQ0!U%%<W<^*V37[C1;31[NZNXK9;E-KQJD
MB,Q (8M@#@]<'VK1\/ZW!XBT.VU2VCDCCG#?NY!\R,K%6!^A!% &G2,RH,LP
M49 R3CDTM<7\2$B6RT*Y>'?)#K=H5*KEL;^0/KZ4 =I17-6'C".76+G2M4TZ
MYTFZAMS=(+ED99(1U8,A(R.XSQ2-XQAAM=/U"YL9H=*OW1(;MF!V[_N,Z]55
MN,'G&1G% '345RT_C&1=1UBPM="OKFXTM8WD4/&H964MD$MCH.!U.>G!J:'Q
MA:7#^'S%;S-!KBDP29 V$(7(8?08XSS0!T=%<Y)XQM+?^W1=6\L/]C-&LQ+*
M0_F %=IS[CKC&:T["_N+FZGM[BR,!BCCD619 \<@;=]T\=-O.1W% &A03@9-
M%8GC&&*?P5K:2QJZBQF8!AG!"$@_4&@#:5@ZAE(*D9!!X(I:X30?%PT[3/#5
MC?Z3>V]G>6]O;6]^^PQO*8QA2H.Y0>Q(&?IS6AJOCJQTN"ZN_),]E:3>3<2)
M,@=2&VL50G+!3P>G0X!H ZNBN9E\7EM9N=*L='O+RYAMDN4*O&J2HQ."&+8
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M(Z,9)"FU57:3QR22<=!Z\9OAJU\5Z#:IX;;2X)K.W8I;ZM]H4 0Y)&Z/[Q<
MXQT/'/>@"_/XSN1>:W:VF@7,\VD[&E#3(@963?D')[=!R?7%7%\5V]RFBBRC
M1IM7MVN;=+B7RAM 4D$X/S?.. .Q]*SK?3-4BUKQC=-ITGE:DD0M2)8\N5B\
MLY^;CGGGM^548O#DMQX3T'1-:\.M=PVUIY<S1S1B6WF4*%9&WC@_-R#V&10!
MT;:_=?\ $M@32I1>7IE_=R/A(?+Z[W .,\8P#G-8.K>-KN7P8-5TNT$<QOEL
MIEDD'[IO-$;;2!\WL>.N>V*AAT?Q1:VOA^WO(GU>SA$ZWD#W"ASEOW)D).)
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ME=6(CT]I;A%2U<HP?<O/SECPP!Z 9 S0!IW/C)([K0H;;3+JY&LP--;NK(O
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M ["BJ&B:A+JNC6M]-;&VEF3+P[PX4YP<,."..#W&*OT %%%% !1110 4444
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M9B,;O+CP=V,XY*Y(./>9O%LTVOQZ38:4]P\VG"_@E><1JRE@H!X)4<]>OMZ
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M=- DWR0QQL&V[R 68XZX Y]N;8TK4'\?RZNUNJ64FEBSR9 7#B0OG'ISCK0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR <?K0!8HK"\1:[<:)<:.D5K%+%?ZA'9N[2$&/?DY QSPI[BM)9+\ZM)&T$
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M\GBO7_$^ESW5O'+:.D4"21,SP1M$I$J8=<$L6.0,\ 9QBNPT2.6+1+.*:_\
MM\D<01KO;M\XCC=C)ZX]>:H:IX+\/:U>0WE]IRR7$*"-9$D="4'\+;2-P]CF
MMR.-(8DBC14C0!551@*!T % 'GFG(GB;PYXEOK]W34H+RZBCE#E7L_+_ -6$
M/\.  3CKDYSFJEZ#KFE_#W4=5@5KRZNHA,2,;P8I#T]^OXUW,_AC2+B\N;I[
M9@]T +E8YG1)\<?.BD*W''(.1Q4NH:!INIS6DMW [/9N'M]DSH(V'0@*0,T
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MK L <@<*.GI6)IQ:WUKP1<6@D6"]\Y6NI9/WUZAA+AY5'') 89)(SVZ5WO\
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M57G@25@O0%E!X_.K=>;VTW]H:UHNAW,EG]F;089H(;R RQRN>'PNY06"A?7
M)QWJ270M2T_2;&QTV^M==?3[F9S87GR+-'@#RP26&4+C!.0,X[4 >B45SG@W
M4;"Y\/)]EMY;$+<S1/:W! :*7>S-&/4 DXQVQ6W?"9M/N1;RK%.8F$<C=$;!
MP3[ T 6**\QTS19M7L/"+Q6<\-Q#\^IW19D$Z;#DF0$>9O;# @GUXJ6.Q_X3
M ^)8+J_M+>\M;^2)97@+3VB+CRW1MXVC SD#!.[.>: /2:*\\CTNVU'XCQVU
M[+)>P2^'8Y)-[,JSMYN-Q3/ . =O3IZ5CZ;J,MIX6\/V$MRL6GR:U<V<DEP"
MZ;%:7RXV^894D*,9[8/&10!ZW17FNO\ A]=&\,^+]FI*4FLOM*V-K&T,=NP4
MC<H#G&XCD="15J[T?1M-TK26"W)N]4N+4/$LQ(O9$0D+)NR G4M@=@,'@4 =
M?KU_/I>@7^H6T,<TMK;O,$D<J&VJ3U /I6)/XIO8;+PI<BUMRNLRPQS$N<QE
MXR_RCOT/4US]F)+?2_B-9$1110HY2"$GRXBUME@O3O[#GL*FO?\ D7OAO_U^
M6?\ Z3M0!Z-17G^I2Q>"O&D]\+??9ZW;E(T Z7:9(C'H) >G=A76Z+80Z+I-
MI8%XQ+M^<C \R0\L0/KGZ"@"_/-%;023SR+'%&I=W8X"@<DDUS^J>)IK:?PX
MUG!%)9ZO<)$9)&(=0R%P0N/0>OX5-XV@BN/ VNI-$DBK83N ZY 8(2#]00#7
M(WUC:KHGP_@AC6%)KVW:3R?D))MVR<CG)]>M 'IE%>9?Z!H-U\0+,W%QI^E0
MP6L@^RGYHFD1@QCST9B%_&K>EV@MOB.EBUE;VEK<Z$QEM(V#*^)54&3  +8)
M'0^F30!W&GZA;:G:_:K.42P^8\8<="48H<>HRIJU7%?"RTM;?P1:RPP11RR2
MSAV10"P6>0#/K@4WQ#%9ZEXBU"V$8O+B#2_WD5R1Y%LK%B'48),AQVQPHY'%
M ';T5SW@2XENO >AS3RM+*UG'N=CDDX[FN>TO0;#4_'WBM;Q)IEM+JSF@4SN
M C^4&R,'USUXY/J: /0JP=,URZO/%NM://;PQQ6$<#Q.CEF<2!CSD#'W1Q^I
MKC-'LCXH\+6NN2ZO:V>HP7)FGNTM2;B*17.8V;S.G;;C&,8'2KM[>7.G^)/B
M!>60)NH-*MY(L#.&$<I!QWH ]$HK@M)T:WN)/#_B&TU>TB!4 M;6Q#WH=>4D
M8R'<<Y.2"003ZUB3/"T'AW5]-+/%/XA1%U&9Q]IN5>1PRG &(^J@$] .!0!Z
MQ17FVN/+I.KWFHZGI\6I:)+>QN-0MV'VBP92@",#R4#+_#_>.>M/^Q_\)?J/
MBG3[N[M(KJVNC%%YMN7FMHMB[)(VWC;SEL@=>N: /1JP?&.MW7ASPM>:M:6\
M,\EN 2DKE1@L!G@<]>G'UK1TO<FB6>;HWS+;I_I!7:9_E'S8[9Z_C7E-^MKK
MOP2O=>NT2;592TDTY'[R-Q-C9GJ%"X&WICZT >Q Y -+7%0M%K/Q$UC2]6AC
MGM[6QMVL[>90R,K[O,D"G@G.U<]L>YKFK;5+VTLK?2KN["Z4GB2?3TN+H&16
MA56,:.=P++O^7D_PX/&10!ZU17 W/AFXL+;7+;3]:M();[R)([,0&.WA?>!C
M 9L"4C:0.N35[P;>QR:IJEG<:*='U6)(3<VT9#0NOS;9(R.,'G/T]<T =A17
M$>*+**Z^(?A2*4R^7-'>+*BRLH<"-<# /N?KGFN:GO)?#_ASQ3:6+R6]C!KD
M<&48C[-!)Y9?:?X1R>G3=0!ZY56RU"VU%9GM91(D,K0LR]-Z\,/P/'X5R.JV
M,>D>-O#?]D01PPZAY]O>V\2@1S1B/<&91QE3WZ\XI?AI8V=MI&H/!;0Q2?VE
M=QY1 #L64X7CL..* .WHKBM:F-_\0(-#N9+,6SZ:9H(;R RQS2>80^%W*"P4
M#'7 )]ZS[_PK#%X(FT[^U6N[ZSNC_9\RQ_-'+D%( "3N7)P020!U^[P >AR2
M)%&TDCJD: LS,<  =2345C>0ZC86][;,6@N(EEC8C&589!_(UPNG-9:QX"\0
M7-W;1_VI)'.-3AD09BG13\F.?E&%*^O7J35&*:'3O"O@6T0VMI9:BL0NW>+,
M<C_9\H) "N=S =3S@9R,B@#T^BO+_%.@+HOA#Q<$U)626!+E+&VC:&.V;IE0
M&. V"2.F16E)80:/\0O#<EDKK)?V=TMT3(29]BHR[LGD@DT =!XRURZ\-^%;
MW5[2WAGDME#;)7*C!(&>!SUZ<?6MZO&]06UU[X(:AKUY&DNJR[Y)IR/WD;B;
M&P'JJA<#;TQ]:]B*J\95@&5A@@]"* *]EJ%MJ*S-:RB1(9FA9EZ;U^\/P/'X
M5:KQ^"1-!^'&LW>GPI:N=8FMI9X5"O% ;C:V".0 IP/3-=3JMFFB^,_#$NBQ
M);K>R2V]U#"-J31",L&8#@E2.&Z\XH [>BN/^*"@?#_49<8DB,3(XZH?-0$@
M]N,TW4%C_P"%JZ5&IVF;2[CS0C8+?,@!./QP: .RK!@URZ?QS<Z#);PK!'8+
M=I*KDLVYRF", #[I]?K7FS:?!#\+KG6%,O\ :%EJCFVG,K%HL787Y>>X)SZ]
MZV/%VHW>E_$&\N;>!I+<:+ +UXP&DBMS/)O=%(PQ ]>V3SB@#T^BO/?%5AIB
M:+X5&DGR[.36+,1O;RL Z,>N0>2>#D\U5NS)X7UWQ@NAQF,)HJ7B1 E@)LR#
M?@]\ $^N* /3**\UU."*R\*^&==T7C4FGM!YR'Y[L2X#K(>KYR2<]",\4NJ6
M<&F>)=;T5X%:'Q#:K)8CIMG!\MU!ZC&Y9..GS&@#TFBO/_!S+K5KING7D""X
M\/B2&[ &,3J3&I!]U#.?<J?2N9NM-MT^''B;4QYIO=/U6Y:TF,K%H2LP *\\
M''4]30![-14%S++%832PIOE6)F1?[S 9 _.N'\-6>E:WX5\/^()KR1-026.:
M:\B8"668G:T3G!)4L<;?0#&* .AT?7+K4/$NO:7<6\,2Z:T C:-RQ<2(6R<@
M>W&/7K6]7G<ES;VFN?$>>[NIK6!8+7?/!_K(P;<C*_[7/'O1I,!L/B#I<$5M
M'907.C2;H8GRS[73:TA  +\GD9[\F@#N=/;4&6X_M&.V1A.X@\AB<Q?PELCA
MO4#BK=>/W\0'PM\;J))?W&KW(C/FMD 2* "<\C''-=!JFB6-O\1- BB21$U*
MUNUO0)6_T@($9=YSSR3_ "Z<4 >@45YEI]A<'2?%.BZ5<0VRV^LJMG#<$F$C
M$;F$]PC'(P/[Q]:WO!VH6[W&KP3Z2=&U"V:-KRUW*81E3M=&'&TA3^(H Z^L
M76=<>PU/3=*M8HI+[4#(8O.<JBK& 6)P"2>1@#KZC%;5<WXKT'2?$S6FF7TL
ML%\%>XL[B!]DL10J&*G_ ($O'^% %W3=1U*;5;NPU"QBA,$4<B3PRETF#%AP
M" 5(V].>O6M>O/-,NM>L]0U;PEX@NEU#9IK7=MJ,68Y&CSMVO@\-G^1Y-<__
M &1';?#;PWXFL9)QKL1M!'-YS$RAW5#%C.-I!Z8[>YR >QT5YPME_P )A=^*
M+*[O+2&[M;QHHVEMRTUK&%7RY(VWC:.K9 Y.<YJSIKV^L>+;G1=9G34(X=)M
MGM/.3"SA@WFS!3_$3M&>W;O0!V=\VH*]I]@CMG4S@7/G,05BP<E<#ELXZ\5F
MZEK%U_;BZ'I@@%\;)[PO< E H8(JX!!Y)//;'0US.LV-OI]IX+@M;ZZNX[?6
MH[<332EF=0),AL8!P5 SC^$5:;3+!_C&2]G;L?[%$^3&/]9Y_P!_Z^] '2:%
M/K=Q;22:Y9VEI*6'EQ6\QDPNT9W$@#.<].U:M>4W5]<:+H?CZXM)9D,6J1KY
M@<L\<;"(.03SD*S$>E=;)IF@Z7<C6K6\:RC>PD4K:D>7+&!O\T@ [F4=&]P.
M<B@#J:Y6T\3:A<1^)]UE;";2)2D2"5ML@$8?);'OZ?XUS.EQK:>)/ TUI$(+
M>\M[@&5G!GNT\G>'FP,$DX;&3@GK6EIO^O\ B'_UW/\ Z3+0!UGAW4I-9\-Z
M9J<R*DEW;1S,B=%+*"0,_6M*O,9-.8_#'POK]K!YMYH]I;W7EX_UT(0>8A]?
MER1[BNKT":TU:[O?$T93[/.JPVTI&,Q)G<_MERP^B+0!T=<Y;Z]?ZK>ZG'I%
MK:21:=<&VD^T3LC2R  L!A3M'(&3G//%=$"&4,I!!&01WKA-4\*'4=2NO$/A
M'5GTO61(T5POWH;AT.TB1/7CKZ'.,G- '7:/?2ZEI,%W/;&VED!WP%MQC()!
M4GN1BKU>9#Q5=:WIGA1M06WL8[^[G@NQ(A>!Y8PRJI&X95F!(&>H'7%+K5L_
M@_3=1\O55%E=W]F;FWMXC"EC"[[9"GS':' /3&.W6@#TMW6-&=V"JHR6)P *
MS'O[G4-%M[[0A;3&<QNAN&95,1(R> 3G;DBL74?#VBVW]J36^U!>:8ZM8(%\
MB0)R)=@'WN0,^E<K<6=M!\'?#TT$:Q2EK!W,1V[RSH"6 ^]QGK0!ZQ17%P&'
M6_B'K^F:O!'/!9VMO]C@F4,A5PQD< \9W87/;&*Y,K<S:1I=K<W%R\5GXO\
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M>E6^FV!7[/:((5 ;)&!W]^Y^M7J "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y7Q_IEYK'AZ.QLK%
M[QFNX9'1711L1PS9W,.P-=510!GVND64'F2I#*LTT81Y))W>4+_=WEB0!D\
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M[N0%FD,C'S .@()Q@=O2I++4[749+Q+642&TG-O*1R X56(_ ,!]<BK096)
M()'!P>E &)I?@_P]HNH27^FZ5!;7,F<NF>,]=H)PN?;%1_\ "$>&MCI_8]OM
M:83[><!\YRO/R\]A@&N@I%8,,J01ZB@#+/AO23-))]E/[V02R1^:_ENXQABF
M=I(P.H[#TJ'5/!_A[6M1CO\ 4=*@N+I  )&R"P'9L'##V.:I66MZQK,@N]*A
MLVT^/4'M)HIMRR&-&VM(K XSD$A2O([U<UOQ"-,OK#2[2 76J7[,((2^U551
MEG=L'"CZ$D\"@#; "@   #@ 5@3^"/#=S)=O+I43?:VWSH&8([9SN*@[=WOC
M-/NKW7-.-JTUO9W<4UQ%#(\!:,PAV"[MISN'/J/IC-;FY=VW<-QYQGF@#-N/
M#VEW,EM(UKY<MLA2&2!VB=%/50R$''MG%.N-!TJ[T<Z1/802:>1CR"OR]<Y^
MN><]<\U0&MW@\??V"\4 M#IIO%D!)<L) F#V Y-74O+RQT[4;S5_LVRW>65/
MLNX_N%&5W;OX\=<<4 06OA+0;+2)-*M].CCLI'5WC#-EF4@J2V=V05&.>,5?
ML],M+!Y9((V\V7'F2R2-([ = 68DX&3@9[GUK)T74-<U$Z??RQ6/]EWMH+C"
M;EE@9@&5222'&#U 7I70!@PRI!![B@"C<Z-87FI6VHSPE[NUR()/,8&//7 !
MQSW]:BA\.Z3 M\JV:LM\2;I9&9Q,2,$L&)!..*T]R\_,.!GKVHR"2 1D=10!
MGZ?H>G:8ZO:P,'2/RD:25Y"B?W5+$[5X' P.!Z4ZQT33=,NKJYLK..&:Z<R3
M,O\ $QY)]LGDXZT_3SJ!%S_:/V7(N'\C[.6_U7\._/\ 'ZXXJVK*PRI!'J#0
M!F:WX;T?Q'#%%JUA'=+$VZ,MD,A]F!!'YT^+0=,MUL5@M%B2PR;98V*K&2""
M< X)()Y/J?6M L%&6( ]352]U.TL)+6.XE"R74P@A3N[')X^@!)H AAT#3(+
M^\OH[4"XO1BY8NQ$HQC# G!XX'' J#_A$]!_L1]&.EP'3G.3 P)&>QR><CMS
MQVK8+*" 6 )Z GK5674[6'4[?3GE'VNX1Y$C'7:N,D^W(% &?#X0T&#19-'B
MTZ-+"5MTD(9OWA_VCG+=!U/859.@::U[9WC0.UQ9J5MY&F<F,'@@<]QU]>]:
M)90P4D9/09ZT%E!P2 3VS0!@3^"/#=S+=O+I43?:VWSH&8)(V<[BH.W=[XS6
M[##%;PI##&L<:#:J*, "G9&<9Y]*6@#+A\.:/;M?&/3H!]O+&Y!7(EW?>R#Q
MSW]:?I^A:=ICH]K P:-/+C,DKR&-./E7<3M7@<# X'I6C10!!>V5MJ-E-9WD
M*36TRE)(W&0P-9=MX1T&SFMYH-.19K=62*4LS.H.,_,3G/ YZC'%;=% &+_P
MB6AG2Y-,-EFQDD\QX#*^UFSG)&[UY^O-3KX?TQ=0>_\ (<W;P^0TK3N6:/\
MNG+=._UYZUIT4 8:>#]"CLK>S2Q*VUM*)H(A-(%CD'(91NX(.>1ZU<CT33XM
M4DU-(#]LDC\MY3(Q+)V4@G&/:M"B@#*LO#>D:?)&]K9B,1,7BC\QC'$QSDHA
M.U#R?N@=3ZU>FLK:>[M[J6%'GMMQAD(Y3<,''U%3T4 5X+&VMI+F2"%8WNI/
M,F9>"[;0N3[X4?E6;_PB>B'3KC3C99L[F0RS0F9RLC$Y)/S<Y/)]:VJ* &11
M+#$D2;MJ# W,6./J>36/:>$/#]CK#ZM:Z5!%>NQ<R*#PQZL%S@$\\@9YK;HH
M RCX;TAIK^5[,.VH+LN][LPF&, ,"<' X'IVJ&U\(:!9S6LT&F0I-:*5ADR2
MR@X[DY/08STQQBMNB@#%/A/1&L+JQ-EFUNY?.N(C*Y65R<EF^;DDX)]<#TJP
M^@Z=)?6EZ\+M<VBE8)&F<E >H'/?OZ]ZTJ* ,?\ X171MEROV0XNI5FF_?/E
MY%((?.[[P('/7BGR^'-)N+"[LI[3SH+S N/-D9VEQTRY.XXQQSQ6K10 V.-8
MHUC10J* J@=@*I:AHNGZI-!->6PDFMPWDRABKQ;L9*L""I.!R*OT4 8\FCVN
MG:?J#6%I)+=7$15F:4R2RG!"@O(V2!GC)P*R?!7AF/3O#.D1:C820WUG&,Q2
MS>8B28P750Q0$Y/(&>3ZUUU% &'J?@[P]K&I)J.H:5!/=H /,8$;@.@8 X8?
M7-2ZSX6T3Q \#ZIIT5P\'^J<DJRCTRI!Q[=*UZ* ,VZ\/Z7>1V<<UHOEV3*U
MLB,R+$PX!4*0 0.E*="TXZQ_:WD-]OV>7YWFOG9G.WKC;GG'2M&B@#-M_#^E
MVIO3':#%\2;I79G$Q(P=P8D'CCZ57TKPEH.B1SQZ=ID,*W"E)1RVY3U7YB?E
M]NE;5% &#;^"_#EK]E\G28 ;5R\!.6*'IP2>GMT]JM1^'-*B^W;+9E^W_P#'
MUB9_WO;GGTX^G'2M2B@#G+V'4=(MK32/#NC1R6DD;1F>2ZPEIP OR-DLO7@>
MF.]7GT*R'AD:&MK'+9K;BW$,C%590,8)'(^HK5HH HZ-IJ:/H]IIT;;DMXP@
M/;CTZX'H/2JTGAC2'EGE6WDA>X8O.;>XDB\TGJ7V,-WXY]*UZ* ,V[\/:1?Z
M,NCW.G6\FGJ JV^S"KCIC'3ZBF6?AK1;#1Y=)M].@6PESYL)&X29Z[B<DG@=
M?05JT4 9.C^&=&T""6#3-/BMXY1B3JQ8=@2Q)QR>.G-0CP?H"Z8NFKIR+9K(
M)1$KL!N!R#P>W;T[5N44 9UYH6G7UQ!<SPO]I@0QQSQS/'(%/5=ZD,1[$TRX
M\.Z3<V]G;R6:^39N)+=$9D$;CHPVD?,,GGKR:U** *$.BV%OJLNIQPL+V5 D
MDID8EE'0$$XP.WI4]]8V^HV<MI=(9()5*R('*[E/!!P1P?2K%% &9+X?TNXT
M/^Q9K02:=M5! [L0 N"H!)R,8&,'C%3Z?I5EI<92S@V;@ S,Q=V Z99B2<=L
MFKE% %:\T^TU VYNH%E^SS+/%N_@D7.&'N,FLC4O!'AO6+Z2]U#2HKBYDQND
M=F)..!WKH** *FFZ99:/816.GVZ6]K%G9&G09))_4FK=%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %<C\0+V2TL-(C+%;*YU6W@O6!P/)).03V4D*#[''>NNJ"\L[;4+26TO((Y
M[>4;7BD4,K#W!H Y"XL4T[XEZ;;Z=!''9ZA83_VA;1H!&0FW8Y7IG+;<]QQ2
M?#S3[*!O$4T-I;QRIK=W$KI&H94#+A00.![=*ZFRTBQT\/\ 9H-C.H1G+LSE
M1T7<23@9.!GC-&GZ-I^DF8V%JMOYSF20(3AV/5B,\D^O6@#EO%5A97/Q"\(&
MYM+>42?;%?S8U;<!#D YZ@')%94VD:?JVN?$'[;;I<+&D#1A^55OLW# =-P[
M'J.U=_J.CZ=JWD?VA90W/D/YD7FKG:WJ*A'A_2EDO)!9J'O1BY8,<S#I\W//
M''TXH X*PU*6\;P78ZC<VX@N]%\Q#>Q>;'-< 1]1N&6VYQGU/<UV'A+28M$M
M+ZQ@U#[5$MV[B-4VI;;@&\I!DX49R!GC-6+KPKH5[I$6E7.F6\MC$<Q0LN1'
M_N]U_"K]AI]II=E'9V-M';VT0PD4:X H XG0_P#B6?%_Q-!>':^J06\]FS<>
M8B*58#W!/3T&:[J6:%9(X'8;YLA5[G Y^@]_<>HJMJ>CZ=K$21ZA9Q7 C;=&
M7'S(WJIZJ?<4ZRTJRT]6%M#M9QAG9V9R/0L23C\: . T7PY;^(/!/B?1RJ@G
M5KU;=SSY3A_D(/L0/PR*UO"EY%XLBTZ^GM$1],MS!*A0#R[K[KJ/3:%_*0>E
M=1I^DV&E+*MA;) LSF20)G#.>K'W/<]ZFM[.WM$E6WA2(2R-*^P8W.QRS'W)
MH \SAC6'X:>/HD&$2^U!5&>@' %>C:/_ ,@2P_Z]H_\ T$577PUHZ65U9K81
MBVNW+W$63ME8]2PSR3W]:T+:WBM+:.W@39%&NU%R3M'I0!POPM_T&TUS1;H[
M=1M-3E>9&^\RO@K)[@^OM6M\0-5N=.\%ZS)ILC"^AMPV8_O1HS %L]B%W$?3
M/:M?4/#^E:I=1W5W9(]S&-J3J2D@'IO4@X]LU9M]/M+6V:WAMT6)\[UQG?G@
M[L]2?>@#B]<L[73;[PAJ'AZ..*2>_CMF, QY]LZ,S;L?> "[LG..M8K"UU_X
M:^+M1U&*.75$DO!*9 "\!CSY: ]5 4+Q[GU->BV&@:7ICH]G9I$4!6/!)$8/
M4("<*#Z#%5[OPCX?OKNXNKG2K>2:Y79.Q7'F#&/F X)]^M ')13K?>)-,T>\
MELQ VAP2VL5Y!YL<KDD28&X#=@+ZG&?4UU7A+38](T,:?#J+W\5O*Z)(PX49
M^X.3D*<CJ<8QVJ6_\*:!J=A;V-YI%I+;6W^HC\L 1_[N.E:=K:V]E:Q6MK#'
M#!$H6..-0JJ!V % '$:+;VGB6^\7P:Y"DMQ#?O;J)!\T-N$7RRF?NY^9LCOS
M7/NLFK?#[P/>:S#'<7DFK6D32S(&:2(RD#)/4,H4GUS7I5WH&E7UVUW<6:-.
MR>6[@E3(G]U\$;E]CD4^^T73=3C@CO+2.9+=@\*MG$;#H0!T(['M0!96UMTM
M?LJP1+;[=GDA $V^F.F/:O(/LMI!\"M4>&"&.9YY59D0!F"WA !(Y(''TKV1
M%"(%&< 8&3D_F:QV\*:"\%U =*MO*NY/-G0)@2MG.6'?GGZ\T <Y/8P:+\3+
M(Z9;K')=Z7<M,%)S.ZLA4N?XFR3R>>:RM!LK;Q!X:T36Y-8MH+Z">.6:XBML
M7)GSAXG;?D[B<;<<C&!C%>A?V)IQOX+XVP:[@39%,S,61?0'/3^=5H?"F@6^
MM-K$.DVJ:@Q+&=8_FR>I] 3Z]>: +6L2V4.D73ZDJM8^65G#C*E#P<^V#S7G
M]YI6I_#>:UO=#U"2Z\/S74<,NE7)WF/S& !A;KU/3\\UZ1=6L%[;26UU"DT$
M@P\;C*L/0CN*H0>&](MIX9HK) T!S"I9F2(],HI.U?P H Y2SM],M/B%XPO+
MB&&$06EK-YRQC?&2DF]E.,[CZ]ZR]-2&VU[P%<6D:06US'<!7=@T]Q$8"X:9
MA@$DX8CG![UZ++HFES:G_:4MA;O>^7Y7G,@+;.>/U/YFJ<'@[PY;" 0Z-9IY
M$GFQ?NQ\C>H_/I0!P,7EZ-X7\>WVG6\4%W#JL\:20Q@/'%B+<%(P0 "QX],U
MTVF:-8+K^E:W9:I9(LL+Q)#86_EI=H5R"_S'.W&0?P[UTD6B:7#?75['86ZW
M-V-L\@09D'3!^N!GUQ5?2/"^AZ#/--I6EVUI+-P[Q)@D=<>P]AQ0!C^.+MX;
MOPY:R\:=>:FD5V3]UAM)1&_V2V,COC%0)8I9?$U["S@C73+[2FEO;4(/*WA]
MJOMZ9()!]0/:NNOK"TU.SDM+ZWCN+>3[T<BY!]*CM-*LK%)5MX=AE $CEV9V
M X&7)W<=N>* .5^&=C9P:)>3PVL$<QU"[C,B1@-M$S87([# XJMJW_$M^,^C
MZA=G;9WFFO902-]U9@Y;;GL2#QZUV.FZ/I^D1O'I]LEO&[%V1"0I8]3CID^M
M2W^G66JVC6E_:PW-N_6.5 PSZ\]_>@"6:>*W"F5PN]PB^I8] *\IU]K671[_
M %73L'9K\?\ IMPP,YE$R*RQX *HHR!DDXSQCFO2K'0].TUP]M;X=1A6=VD*
MCT!8G ]A52;P?X=G>[:71[1VNVWSDQCYVR#GZY )QUQ0!E/M?XOQ<Y!T!^A_
MZ;K6'I=G;/X"\;P201R10ZAJ)C610P4J#M(SW':N\70]-34$OTM$2Z2(0I*N
M05C_ +@QT7VZ5''X=TB*SNK2.R1;>[8O<1@G;*QZEAGDGOZ]Z .%3R++2/A]
M9"WBATS4?*^V[$"K-)]G!C5\?>W-SSUVU:OK(67C+7-.LXPFEW.A&ZN((_E1
M)PY56 'W2R@YQUVYKLVT'2WTD:6]E$]B,;8&&57'3;GIC'&.E.CT73XK6>V6
MV'EW Q,69F:08QAF)R>..3TXH \KU#P_ID7P075UMO\ B82:7;*]P7;<1N0X
MZXXZ?3BNJDTVTTGXHZ2+&$0_;=/N1=%2<S%60@N>K-R>3S72MX=TA]'&D-81
M-IPQBV.=G'(&/3/..E2-H>G->P7K6P:ZMUV13%V+(O< YZ']: //+)K"U\)^
M)+:[:X6"7Q++;QQP.%:1C(FV,EN IQ@Y_AS6UX85K3XB>(K4K;0*UK:R&WMN
M(U<[Q[9. ,G SQQ71'POH;6-U9-IL#6UW)YL\3 D2/G.X_[6>_6I+/P]H^GW
MBWEIIMM#<K%Y0E1 &"YSC/XGF@#'\7VFHW%WIL^EI97D]L)I&TR\.%N4.T$J
M>@9<@ GCYS7*S#2-6MO!4L6E+!'_ &O+!);7,:L8B!+OBZ<J&' ]A7I%[I5E
MJ$T$US#NF@W>5*KLCINQNPRD$9P/RJ*X\/Z1=Z?#87&G6\EK"XDCB9,A6&?F
M'OR>>^3ZT >>^+5L+K3?&4]BB2-:0QI)/<$$0.D8*);@#*CH<Y'S'@&M.>UL
MKOXA^'+BZM[>5I-(F>1Y$5MS*8\$D]QS]*ZF?PIH%U=3W,^DVCS7$?E2L8Q\
MRXVX/X<9ZXJ5O#FC.+$-IEJ18?\ 'J/+'[KZ?D* . M+.'Q7HFJR7^J6ME?V
MM_,9[CR/])M"DI*;7+\ (% XQC(ZYJ?Q,+C3;S5=4O+&#6M$?RA=,H"W6GE4
M7E01@KR'P,8+'WKLY_"F@76LIJ\^DVLFH(01.T?S9'0GL2.Q//%33>']+N+J
M:YEM%:2<JTWS,%E*@ ;USAL #J#TH 6.PTMM>.JHJ?VF]J(2WF'=Y.[</ESC
M&>^*T:J#3+(:LVJ"VC%\T/D&?'S&/.=OTSS5N@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*J6&GP:=ID.GPKFWA3RT5N?E[#WXXKS?PJF@07GBS^TM*6X$.M7 0C37G"(
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M6(QEL85RQ8,I'!. <'.,U4UOPYK$?AKPGI=K;2:A-I-Y:3W$JR(H*Q A@-[
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M(8]0N=(NI[+=<('60C;AR#U;;@9^M4O!?AC1=4@\6P7.F6C;==NHHG$*[HE
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MF[N;22W7!5,LR%=QR0 ,GM3O"UM<V/A;2[*\@,-Q:VL<$BEE8$JH!(()XXH
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MG_ 6& /2@#NEGA>0QI*C..JA@2/PIDE]:0SK!+=0),WW8VD 8_0=:X;5+_\
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MH&22< 5%:VT=G9P6L((BAC6-,G)P!@?RKG/&EI/KUC_PC5I.T$MY%))+*O\
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M\:NH9"VUE!P>#PQQ^%</X8T+2+WQ7XVM;G3+.6 74**C0J0H,7('''X4 >C
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M))[;Q4KR)&I:1U11W8X%<+K'AJUF^'3VMY:1Q7%Y/'/.50;HY99E+%3CJ-Q
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M9(T5$6)0%48 X%6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *Y[QQIE[K7A#4-+T^$27%U'Y:EG"
MJO(.23_2NAHH IZ8DL>EVJW$'ESQ0JC+D-@@ '!';BL>PT--0O=0O=>T>UDN
M)9L0^<J3;(0,*H/;^)B/5CUK975=.>\-FE_:M= X,(F4O_WSG-27%[:6A N;
MJ&$MR!)(%S^= '*^&=$U'P_XGUM(;*.+0+V83VZI(H,,FT!_D'16([=,#CTE
M\9>%9]?N-*N[&?[-=6LQCEE4X)MI!ME4>^.173P75O=*6MYXIE'4QN&'Z5+T
MH SM6T6TUC0;G1YTVVL\)APG&T8X(^G!'TK+THZ_I&BP:9-IRWUS;1B&*Z2=
M4BE51A6<'YE.,9 #>U;D.HV5Q+Y4%Y;RR?W$E5C^0--75-/=RBWUJS $D"92
M0!U[T <?<^#;RU\ ZSI5MLN]6U=Y)KF;(1#+(<D\\A0.!UZ>]37_ (;U-K31
MM7TN..W\0:9$D+)(X\NYBP \;,,\=P>Q[5U']LZ7_P!!*S_[_K_C3Y-2L8D1
MY+VV19!E&:50&'J.>: )+:266V5YH##*1\T98-@_4=:P;'1%U&_U"]U[1[62
M:24+;^<J3;(5&%4>ASN8CU;J:WX+JWNE+6\\4RCJ8W##]*EH X[PWH>H^'_%
M>M"WL8HM OI%FA1)%!AE"@.0@Z*V/PP.*EUK2M2N_'GA_5K>T#V>FI<+,QD4
M,WFH%&T>V.<XKIY[F"U0/<3QPH3@-(X49_&HFU/3T1'>^ME5QE&,R@,/;GF@
M"U7+?$'1]0\0>$Y]*TV!9)YY(VW/($50KJW)Z\X]*Z*:^M+=4::Z@C$G*%Y
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M L% +*1DD]N:NQZC8S3>3%>V[RGC8LJEORS2M?6BW(MFNH!.2!Y1D&[GVZT
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M:W\1Z&D"W$RB'4K2:0JDZ#[K @'YUZ XY'% %/5HT/QA\.N44L-/N><<]O\
M$_G5WQK:2>(+3_A&H+G[.UU"\TTH.-J*/D'XR%?J%:FWVD:M<^/=)UQ+: 6E
MI:R0R*9_G)?'(&,8&/6K=AHK7FH:C>Z[IEE)++*!;[L3;(5&%7E>#G<Q]VH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4451U?58-&T]KN>.>4!@JQ6\9DDD8]E4<D]3] : +
MU%9NBZPNMV;W*6-_9JKE-E];F%SP#D*><<]:TJ "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ K#\2>&QXACMBNJ:AI\]J[20RV<@7#$8RP(YX)&.
M.":W*R]2TFYO;VWNK;6;ZQ,2E6C@V,D@/JKJPSZ&@"AX.O\ 5+FROK'672:^
MTV[:U>X1=HG&U75\=B5<9%='5:QL8=/MS%#N.YB[NYRSL>K,>Y/_ -8<59H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
$B@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex101slackseveranceagm05006.jpg
<TEXT>
begin 644 ex101slackseveranceagm05006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K,\0:L="T*
MZU(0?:#  1%OV;B6 ZX..OI6G6%XQL;K4O"=_:6,)GN9%79&&"EL.IQDD#H.
MYH 9#X@OX-4M++6=(6R%XQCMYX;D3(9 I;8WRJ5) )'!!Q6A;:[I-[?26-KJ
M5K-=1YW0QR@L,<'CV[^E85U!J_B74--6?29M*L[*<W3R3S1/([A&5%41LV!E
M\DDCI[UF6NA:O<:9H&BMIK6#:3D2W_F(4?$+QYCVMN.\L&.0,<YR: .LC\2Z
M'*UP(]7LF-LI>;$Z_(H."3ST!X)I=9UVST6PO+F=P[VMN;AH$8;RN< X/0$\
M9/%<C-H^KZAX170AX?BMI[72WM1<S21D-)M50(BI)"L5R2P7M^%V6'7]1U:_
MU.#1EM2VFK;Q0W\D;"5Q(696",V 5) /XD4 :EKK>J^>(]1T:.".2%YHKBWN
MO.B&T [9&V+L)!X/(.#S5EO$VDVUO:-?ZC96DMS"LRHUPI&".H/&1V!Z&N5L
M]"N?[0\S2?#USH5O]GF6[A>XC\JX9D(14C1V4$,0=V%X&.]9=TMQH.@ZY:SV
M<5U)+HMNDX^T1#[*5@*;7!;)7()!7=DDB@#T&X\2Z':SI#<:O912OMVH\Z@G
M< 1W[@C\Q1XBU=]#T9[Z.V%S()8HDB,FP,9)%0?-@XY;/2N5?PYJ$_A_Q1&M
MF#-J.G0PVP+*#(RV^W')XPWKBMOQGIESJOA*2SM[1KN4RV[M '52ZI,C,,L0
M/NJ>] %NUU+5$\Z;6-.L]/LXHFD>=;[S N/4%%P,9.<]JE@\1Z)<B<P:M9R"
M!E64K,IV%CM7//<\#WKE)-&:71-:L].\'W>FW%WITT*22W$+*[%2 O$K8R<<
MXQ[UIWOAIM0U012P!+&317L7=2!L<NI4 => "0>@Q0!T%SJEA9>=]JO;>'R(
MQ++YD@78A) 8YZ D$#UQ5"7Q+9%-.EL9(KV&]O!:>9%*"$;:S$GW&W&..M<I
M)X;U^]T-;^_C8:R;^"XGAMY4W-'"NQ51FRN<YD&>,MCBIK;P]J4MW#>_9KV-
MGU6*>1KR>)I?+2!TWD)A0<L!@$D@#.* .OM]>TF[OI+&WU*UENH\[H4E!88Z
M\>W?TI+'7]'U.?R+'4[2YEV;]D4RL2OJ,=1R/SKDM/T?518>'=*ETIK;^QI-
M\UZ9$*2A8W3]WABQ+ELG(&.<YK.T+3-1U_PEX9MH-/?3H[73W/VQG3:_F6[1
MKL"DMR7#G(&"O>@#T"QUS2M3GD@L=1M;F6(9=(I0Q SC/';/&:H:SXF72+J]
M@-J9?LNERZCD28W!#C9TXSZ_I6%X:T/48=3TE[RTU&(:=;/$7N;B Q*2H7;$
M(QN93C/S;<8'>KGB;1-0U"_U26UM_,2?0+BSC.]1NF8Y5>3W]>GO0!9B\3:A
M!)8OJVBK:6E[(D4=Q#=B8([_ ' XVJ0">,C/)%=#!=6]T)#;S1RB.1HGV,#M
M<<%3Z$>E<C+!K6NVNF:9/HDVG6UO/!-<3W$\3;A$P<*BQLQR64<G&!FNKM))
M)!-YEHUOME95!93Y@!X?@]_?GUH QH/$ET=5L[:[TF2UM[Z62&UD>7,A**S9
M>/'R@A20<GMG&:KZ3XBUW6;2&]M] M1:2L0'?4<,%#%2=OE^QXS51K'5=0\1
M:;=RZ-]BO[6<_:=125/*EMP&&Q0&+-NRIPRC!&>PSD^']!;2[:U6[\$7DM]#
M*7-TEU!M)WDA@#*#Z=J .B'B76+BYU(6'A]+JWL+EK=F%Z%D<JH8[4*8Z,.K
M5-_PDMQ?06L^B:4][#/:BZ,LTOD(JDX";MK9?@_+QC')&:S[)]>T:\UN.#P[
M<77VJ_DN()Q<PI$0R(!NR^X<J?X35"?2M>T_2=+\.QZ==WFF1VV;^>RFBC>>
M0DEHAO=2J<DDCD@@#'- &K>^,+J+08==L](6?39;9)P\ET(WRW1-FTY;) &#
MR3Q5J3Q#J$MU%I]AI"RZBMLEQ=QS77EQVV_.%+A6+,2&X"]L\<4VZTZXU"Y\
M.1C3S:Z=:N;B>!F3]TR)B)"%)!P6SQD?(*;<PZCHWB>\U6TTV;4;2_@B26.W
M=%EBDCW '#LH*D,.^01[T *?%%V8[2W719DU6YFDA%K/+L1?+&6?S,'*8(P0
M#G/3KA%\6R7 MK:ST[S-4EFFA>UDG"+$8<>82X!X^9<8'.X<#G%/4+76=0L[
M6]U#3)?M$=V\D4>GW*I<VD17 ^8D(Y/\0SC#<9Q5+2_#^I:#<66L)I\]Q(9K
MMKBT2=7F19BA4[G8!F'E+N^;JQQG% '8:-JB:QIJ7:Q-"^]XI8G()CD1BCJ2
M.N&4\]ZQO^$HU*ZAN+[2]"-YID#NGF_:=DLVPD,8H]I##((&67..*31?#VHQ
M6L4]QJ5W8S274UW-:6YB9"9)6?8Q*DG (4E2.^/6JNGC7_#NE2:)::))>/$\
M@LKQ9HUA*LQ93)E@RE=V" ISCCK0!I>(/%D.@P6$K6LLPN3OD7[C00  O*P(
MS\NY<CCK4WB?Q+!X:TIKQ[>:ZDVEHXH5)R!C)+8PJC(Y/X9/%8\GAC5-:U>]
MN=3U"XLT%HEA']E6$K.A4-*Q#J^T,QQC@X09[4LFDZS/\,[O1)X3)J$<#VL1
M,B_OU4X1\YP,J 3G'.: -/4]=U"VUZ+2=.TN*\F:U-RS2W7DA5#!<?<;)R:M
M:)K7]K+=1RVKVE[9R^3<V[L&V-@,"&'!4@@@UEZHFIV7C.'5;31[C4+?^SVM
MF\B6)2KF0-SO=>,#M3+#0=4NY-2U&ZO+G1[J_N$D\JT:-V2-(PBJQ964D\L<
M>H&: -'6/$L&DZIIFG>2\]Q>S+&0IP(D)(WL?J, =^?0U#-X@U"YO[RVT728
M[U+)_*GFFNO)4R8#%$^5MQ (SG R<9K%U3PAK?VZ*YL]8,[2:E%<2M+;)NC1
M00#G(R%'\( ZDXY-7X%U7PYJ&JQV^C3ZE:WMRUW!);RQ*49P-R.'9<#<"01G
M@^U $EYXNEB&FI;Z6WVB]@>=H;V<6Q@"E%PV0>27P/7!-/N/$.K+JT6F6NB0
M371LENY@]]L"98KM!V'=R.O%4[JSU!FL[G6?#-GK,[6C1RM;B,M$Y;.S]ZP&
MS&!N'.1TP:PE\)WEI=:9_:7AZ76XH=*2V/DW$8\J02,VW+NI("D#/M0!WNA:
MLNMZ5'>K \#%WC>)B#M='*,,C@C*G!'6N?D\:7\5K?ZBVAH=+LKN6WEF2\!D
MQ'(8RPC*#/(SC=3M \.:G;Z/!!+J-[I:13RO#9V[QR".$ME(V9E;.T<<'OC)
MP*YJ?PI=R0ZO"/"DS:G/?W,]IJ?VN)$C+2LT4G$FX;<@XVYXQ0!V-[XGGBU*
MYMK'3#>1VCK'<,)PCEBH8K$A!WL%921D=>YIC^(M7FU75+33M"BNHM/E6)W:
M]$;.3&LG"E,=' Y:N>U3PI=F778AHZW]YJA22UU,-&OV63RU4L<D,NUEWC8#
MG(':M:V.MZ-KFO-%X?N;^.\N8YH9TN(41L01H=VYPP^93_": +]WXQL+?P@/
M$"12R(Z'RK;&)&D&<QX[$%6SZ!2>@K<M+C[7907.W;YL:R;<YQD9Q7!R^!M7
M3P_MCU-/MBV5RAMQ"'0RS,[OL9B,9+!<GL.V372:;HNHQ0:8]SK5XKV\")+;
M1)$L4A'K\I;T'#=J "P\40:CJ^I6,%K.$LH$F\Z52@EW%Q\H(S@%"-W?G'')
MKZ)K^NZS9V%\-!M8K*[1)0YU#<ZHP!SM\ODX/3/XU8.G77_"5:I>^5_H\^FP
M01ON'S.KS$C&<]'7GIS7+^%=#.DVND17'@B\2^MXXDENQ<P%0X #/@2YQU/3
M/M0!OP^+FEU&*,Z=ML9K^33X[CSP9#*FX',>.%RC<Y)Z' %5HO&.IOI<NL'P
M^&TN%Y0\D5X&E"1NR,WEE!G[I.-V<5F6GAR_BU6VD.DR)JT>I-<7&LF5-LL!
M8DK][<<IA-A7 QGL#4ME!XCMO"USX?B\/RK/,]RBWDMS#Y*K+*[!R Y<X#@X
MV]J -35/&8LI+M[6Q%U9V-K'=W4WGA#Y;Y(\M2#O.%)Y*^@)-2R^(M5EUG4+
M#3-$BNTLO+WR27OE,Q= P 4H?7N:YW5/"=PDEW;G1Y=4?['#;Z5>+,B?8RB!
M>=S I\XW[E!)SCMBM2U&NZ+K^K3?V'<ZD+L6Y6XAGA169(@K9#."/FSVH T8
MO$MQJ-A9SZ3I,MQ).9!*D\GDK;M&=KJ[ -AMV0  <X)Z<U%#XNDU&#3O[)TT
MW-U>6SW1BFG$2Q(I"G+8;)+' P,'!.0*I0:9J.FZ(EI?:/'JT%]+<7&H6\#J
M62223S%"[RJL@R0><\ ^M5](TK6O#S:??/I\U\1:36KVL,R&2W4R[X5W.P#!
M5.PG/8=10!K7_C&&W\+6NLVME+=2W9"PV>X*[-@EUSSRH5\_[M3:EXE>&/1C
MI5G'?MJS'R-\_E+M\LR9)VMV'I6%IOA/5VGTR.YNYM/CTZV>19;4Q.7N)G9I
M  ZMPJ\9P,[CCO5";PMJ=M;Z;IMQI$VL:=I>H3-$!+$K2V[Q-MZLH!5WVXXX
M48&* .QTOQ ;M=234+46-QIK#[0OFB1 I0.&# #(P>X!%'ACQ$OB/3Y+AK1[
M.>-PKV\C990RAT/XJRG\QVKDD\,:K)8:II]GILNDZ7JL\$;6QN$=X(^?/EX9
ME&\!5"@GU(ZUH7/A/5HM5G6UU>\EM]4LS;7=U(L*O;E#F,A45,Y4R)P,C(YX
MX -W1/$L&NZCJ=M;0N(;)D59R>)MV>5'IE2 >_7I6W7*>&M!U72?$.IS75U'
M)920P1PA(%C#;%(X )VA1QCOGVKJZ "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JI<Z7I]Y<Q7-U86L\\7^KEEA5F3Z$C(JW10 4444 %%%% !1110 =:9%
M%'!"D,,:1Q(H5$10 H'0 #H*?10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKJC+=PK!]BN5E;S9L!MZ(PW X!^Z-N,GM4_Q!RW@+68E5GEEMFCC1%+,[$<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML+JZ2TO+J16CR\:RIY3$%D.,],C(K=U'Q1IFE"9[IYO(MW"7$Z0L\<).,!F
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M$95U.5)!!##/8B@#E-&UG2M0\80:A>WEP-2^R&T@C?3IK9",[V.7SECMX&>
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M$,\E?E.3TR1C/.+V@7MCJMW:W(\)7=C>VBLTTMU9E/LYVD,(V/+$G ^7MU[
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M)#.;*"7R)KQ8R8HWS@@GK@'@D @'J1@TW4_&.E:5J#6$HNY;H6QNA'!;.Y=
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M?F.]I(/+WHH7=Q\N2#UQ[XK)>"Z;0/B%$+"_\R]FF-JOV23,P:%4!7Y>>0:
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M=6=SPN,\YZ8[GBK,ZC0_%NL1ZMX>N]1L=2:.:UN+2U,X!$:HT3 ?=^[QGC%
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M+AHM3(%N53D@J6!/H-H)S[5@ZYI%^/&4%QI\;?9=7M39:@Z\>6$.Y9/J4,B
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MAGM? .DVUU;SV]Q#%LDBGB9&4Y/8@5U% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%9>O:]:^';
M%;V]BG:W,BQL\2!@A8X&[D8!)QGI0!J5C:SH!U6[M+ZWU*[T^]M0ZQRP;6!5
ML;@RL"I'RCMGBKDVIQP:C:V+0RF6XC>0$ ;45<;BQSQC<OYUF'QAIJQVMRZ7
M":?=2B&&_9!Y+L3@<YW $\!B #Z\B@"_I^EO:2>?=7]Q?W6TH)I@B[5)!(54
M  !(&>YP.>!6C65#K]M/J6I:?'!<&ZT]$>6/:/F5P2I4YP<[3Z5/H^K6NNZ1
M;:G9%S;7"[XRZX.,XY'X4 7J*XWQ_+]E?PU<^=-&!K5NCB-VPR$,2"H^]R!V
M)]*U+3Q=IMP-5\Y;FR;2T$MTEU$498R"P<#G((!]^.E &]16)9^)[6\OH[+[
M+=PW$UK]KMTE51YT?'*D,0#R.&P>:2R\56-_H=YJT,-R(+1WCE1T D#)PPVY
MZCTZGMF@#<HK(O?$$-F)0+.[N)8(1/<10*I:%#G&[+ $\'@$GCI5W3=1M=7T
MVWU"QF$UK<('C<<9!_E]* +5%4;_ %6#3YK>W99)KJY+""WB +OM&6/)   Z
MDD#D=R*S)/&>E0Z5J-_,+F/^S6V7EN82983C/(&1@CD-G:?6@#H:*R]'UZWU
MIYQ;VUY&D01A+/ 424.,@H3]X<=OZT:[K]EX=L5O+_SO):18P8XRV"Q &3T
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MA81L]O=1Q*RS1NK893M/!!'7./?FK]YXHT_3=4M]*:*\DNIH#-$D<#/O5<<
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M)7"ID!4!Z$ #&.2:D-G>MX.\=VHT^]\^^OKJ2UC-L^95=%"D<=R#].]>F44
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M0,^W-<;<6M[XB\%:1X?DTZ\M=1AEMDN3+ RI"(F!9UDQM;(7C:3G</?'HE%
M')>'XYX_'?BJ>2UN8X+IK8P2O"RI)LBVM@D=C^?:NMHHH \JO[;4X?#'C;0U
MT;4);J\O;FY@>. F.2.0@J0_0GMM'/MUQOQ+<MX_TF]>PO(X$T=X)':!B$D9
MT8*2,C.%-=M10!Y/=V%_+X*UVS73=0,]SX@:YBC%M(&:(SH^\<=-H)]:Z7PO
M+?:!=76@WEO>W%A%F:QU 6[MO1CN,<F!G>"3SW[\UV=% 'E,-AJ"?"G1M.;3
M;X7L.H1R20?9GW*JW!<GITV\UT6F"Y\/^+M?EN[2\FLM4>.ZMKB"W>7!"!6C
M8*"5(P,9&,5VE% 'GD7A&^A^&,EFJ&/58IWU*UC')AF$AD1!COCY3CU-)-X?
MUB37+#4A"RMK<+6^LQ[B1"GWU'U"!HL^I![UZ)10!R6IPS'XD:%<I:W#6T%I
M<1R3)"Q1&?9M!(&/X3]*7P1#/!-XC\^UN(//UB:XB,T+)OC94 89'^R:ZRB@
M# \93ZE;>'S)I=K)<2^?%YBQ1B218MXWLBG@L!TZ\\]JY>UM[F#Q%XDG32=5
M%K>Z7$L,LR,[.RB0$')+;B6'R]1W %>CT4 >:_9+U?"?@.V.GWOG6%Y;/=(+
M9\Q*D;*Q/'8D4ZU&HZ+;^+=&NM*U"X>^N+J[L[BW@:2.995X4L.%8=,''M7I
M%% &)X.CG@\&:-;W-M+;SP6<44D<HPP94 /'U%;=%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4
MM2U.#2XH6E5W>>98(8TQND=N@&2!T!/)[5=K!\6V=KJ&EPVE]ILU]:2SJ)?(
M!,D( 8B1=O.0P'3GGOTH 2\\66^GV4EU=V%]"D5VEI(I5"5=MNT\-RIWKR,U
M:?Q!:1>()-&ECFCG2T-YYC >68PP4G(.<Y/0BN(O-&U]_!.J6>Z]U**VOX)M
M/^TKBYEA1HV8$'!)!# 9P3CW%:6_4;SQZNKQZ'>K9MHLD"F=%7YS(& 9<\9Q
MC'7VH Z"T\1Q7GV=DL+U8;FW-S!-L5ED0;3P%8D$A@0"!^AK'3XEZ.UE9:@;
M34TTVZ?R_MKV^(HFW%0'.>.1U (&>><BJ?AO1[C2_$-F^BIJ-IH\T4C7VG7B
MMY=L^!M\HMW+$Y"DC ^E8>AV\WB#X,VOAZVM+@W%UF(2/$?*1?/),A?[N  >
M,YR,8H ]!U+Q'!IPO"EG=W@LD#W1M@A\H8W<[F&3MYP,G&/49%\2V5PEG_9Z
MRW\EW;_:HH[?:#Y7'S$L5"C) Y.<YXX..4FM)]!\6:H;OPO-K>GZD\<UO<00
MQRO$XC5&1]Q&!\H(.<?KB:YBU7PYXJM-:BT22YL+C3EL[BUTU S6KJY==JY&
M5^8@D8]>.!0!:O/'8EM="N-*L+F>+4[W[.Q8(C1E=VY-K,/F^4CTZ\]*V=0\
M2PV$=TZV-Y<_8XQ)=B (3 "N[!RPR=O.%SQCU&<7Q''JM[%X=U/^RIR;755N
M)+6+:TL<11U!/."<D$X/&>^,UGRP76C^*]4EOO"<VKV6JO'<02P0QRO#)Y:H
MT;[B !\HYSC^@!UG_"2V%PEB+ 2WTE]!]HACM\!C%QER6("C) Y.<G'K6'\.
M)3-;>(VVSH!KEP EPQ+H L?RDDGITZFJ[VNI:#XTL]9_LAY;"XTT64L.GQ[_
M +(X<N,*.J\XR!UYXK0\#P7MO)XA-YI]S:"YU::YA,P4;D8*!T)_NGV]Z -V
M_P!7@L+FVM/+DGO+G<8K>+&Y@H^9OF(  R.2>X'4UES>-M,@T?4M0EANU;3'
MV7EKY8,T1ZC(!Q@CD,#@^M5=;L[VQ\<Z5XBAMYKJR6UDLKI(5+O$&8,KA1RP
MR,''/UK$US0KZ\T_QKJ4%G<&36(8;>TM_+(D?RTQO9?X<DGK@X'/6@#MM(UI
M-8>X$=C?6Z1;"LMS#L28,,@H<\CUI'UVW3Q&NAM!.+I[9KE&PNQT4@'!SG.2
M.H%6].8OIMLQ1XSY2@I(I5E..00:YG6H[RP\?:7K":==WEH;&:T?[*@9HW+J
MRE@2, X(ST]: +$WCK3+?1;G5);>]6&VO6L95\H%DD#!#G!QC) SFK=GXIM+
MK6;C2Y;:\LYXK?[4INHP@EA!P77DG@XR" >>E<+<:9K$G@OQ!9-H]XMS<Z^U
MU$@4-OC^T*Y(P>F%/)QGC&:Z2]CNF^(D.HQ6-Q+:KHTL&]H6VF1G5PAR.X']
M* -FS\1)?&V,.GWOE7<!N+>4B/;*HP1_'P2&! ;'Z&JB^-=.;PY9:ZL%V;*[
MF$"G8NY&,GEC<-W3<.V:Q/#>D7&F>(;)]%CU&STB:*1K_3;Q6\JV?'R^46[[
MB<A21@'VK$6QUF+X>VWAX:%?O>6&HH\C!%".HN=X*'/S9!^@YR1W /0;OQ'!
M;37T<=I=70L=HN6@"'RRRA@""P)^4@\ \'ZU3O?&EG::G?:;%IVJ7EY9HDCQ
M6UMN+*V>5R1D<=?<8S6!XDTJYNM4O]2TBUU/3?$,?EK;30J3#>KL4A9>J8!+
M*22,;>IJU97WV+XGZ^9X)Y-VGVFXV\+2 ,-_&%!//.#TXY- &]9>+--U/2+'
M4+ RW OF*00(H$C,N=RD$@#;@YR<<=>1F.W\8:9-;7TDJSVT]C.MO/:RJ/-$
MC8"* I(;=D8P3FN,;PQJFCZ?I6K#2!J!AO[NZN]+ 5F6.X/ 4'@L@"\#OGZU
MHZOIU]JOA\:AHGAT:=/:WMO>PV<T:0S7)B))#A20.#P"<\'U% &[=>,([9=5
MA.F7BW^GVGVLVLAC!DCY^8,&*XR#GG/L:?I'B1[CPUI-[>VLZWE]%&(X5V;I
MW:,.2@#8"XW'YB, <XJ%K_4/$V@ZG%'HUY8+)92Q*M\JI(\K*0  "?E'/)QG
M(QT-<W<6&K/X6\*7R:!-<2:*JQ76FW"KOF3RA&[*"2"0>1GK0!UD'C#3'@U1
M[D36<NELJW<$ZC>A893&TD-N[8)S6'=7DEQ\4O#N^SO;0M:73,D[@JXVKC 5
MF (YST/-5]:TR\UWPO<7.C>'/[-FBN+>YBMIXDAFN3$^XA@I( ],\Y!Z<5;D
MN;[6/&_AK4XM#U.&V@@N4G:XB">4SA,9R?;\>V>: -KQNF[P-KIW.K)8S2*R
M.5(8(2.0?6LO0_&-E##H>E75I?VYNK>..WNIH-L,T@0?*K9SD]L@9[9K>\3V
M<^H^%-8L;5-]Q<64T42Y W,R$ 9/'4US36-SK^F>%].%C=6QTVXM[FZ>YB,8
MC,*_=4G[Q9L#*Y&,\],@'0:9XFMM3_M0):W4#Z;(8[A)PBG<%W<?,>,="< ^
MM:.G7HU'3K>]6&6%9T$BQS !P#R,@$XXKD/$.BW+>,[5K%E%MK4!MM3C)ZQQ
MX;>/<J6CSVWBNX P,#I0!CZ;XA@U/5=2TY+6ZAN=.*B99@HSN!*E<,<@@9ST
MJ.+Q1:SVMA)%;733:@&:VML)YCHHR7^]M"X(.2>X[D5B^+=)O#XCTR]TN01R
MZBK:7>C."82I?S!_M)M;'UJ;6=.NM-\8Z+KEI:23Z?!;26-Q# NYH4;!5U4<
MD9 ! YQV- %R7QKIT.DZG?26]VK:6^R]MBJ^;#QD$C=@@CD$$Y[5?EU^VAUG
M3=,>&<2ZC&\EO)A=A"*&8'G(.".W>N0U7PW?:M;>-=0M[>1'U6TC@M(9!L>3
MRT/S$'IDG !P>.<9J;S-1U/Q3X0OTT/48;:TBN4G,R*AC+1HO()X&1^/. :
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M/)GMY[>/<8V5-I1P2-O;!/% %CX7R&7X=:7(S.Q;SCN<DL?WS]<UL#Q!;_\
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MBN/&6FP3Z1$D5Y.=6A,UHT,)8.H3?^9!'Y\X&36-XA35[W6-:L)M,O+FRDL
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M^ZW0E!GGGYO3-0?8+K^U?&,MSH4UY9ZA+:^7"ZC$\:JJ28R1@CDC..@KOJ*
M.(\/V.H^'#JYL8]1O-%CMT>QL[IOWHE&[='&6Y"8VXSWZ9[]E;2O/:0S20M#
M(Z*S1.02A(R5..,CI4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBLK;QM!X^4E1QV[5EV-[J6I1^%&L-6OS>7.?[716!,8"9<LK K'AQ@8 SG%
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MU-W>I\4_L/VR5K-]&:<6[8V+()E7/ ]/7/4T =717 >&]:G;6['3-;?4+'7
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M[1S;M<VO]E1M#;^1+MS&P 96/)(.T<\'WJE-\/=+FM;RT^VZDEK<W/VL0I<
M)#+O#DH,=R.AR/3%=;10!BP>&X+;6YM6CO;S[3-;K;-N96&Q<[>JYR"2<DG.
M><UG_P#" :4-!M-)6YOE6RG-Q:7*R*)H'+%B58+W)/!!Z_2NJHH Y^S\)P6>
MJ76IC4M1EO;F!8))9)%.0N<':%"YY/;'M4$?@>PBT?2M+2]OA;:7<+<VWS)N
M#J25R=G(&3Q[UT]% ',ZKHC63ZQKMD+R]U&>R,/V42*JR!0=JC !!R3R#FN9
MTBQ=8;:'1=:\7K=0JBK;7]L5@0# P^^,#:!V#$XZ9KTRB@ H(!!!Z&L70M?;
M6;O5K=[-K9M.NOLQS(&W_*&SQT^]TYK:H Y5/ .G1Z'%HZ7VHBSAF6:)3,I*
M;6W*HRIX!Y]3W)K2/ARV?Q =9EN+B6X:T^QM&^SRVBSN((V^O/7].*V** .8
MT;P-I^AW*M;7NIO:1N7@L)KDM;PMZJN.W;).#SUYKIZ*BAN8;B2=(I%=H)/+
ME _A;:&P?P93^- #I4:6)D61XBPP'3&5]QD$?I7/P>"=+A\*_P#".2/<SZ>O
M,8E<;XCN+ JR@$$,<YK:U"^@TS3KF_NFVV]M$TLC 9PJC)_E6?IFK:C>WR1W
M&D&"TFMA<0W23AQSCY'& 5;!SQD=>: 'VV@QPW27D][=WEY'"T$-Q<;-T2G&
M=H50N3@9)!/ [5#IOA73].\/SZ&6FNK";S-\=P5/#DEAD =22?Y5N5%<W,-G
M;/<7$BQQ(,LS=J .>TCPE!X;C,MM=ZIJ)MXV^R6UW=;TBX^Z@P ./ER<X!^M
M<AI-FYL8XK34_&=EJF"YLC WDQRDDD;I(RFS<3R7Y'>N[NM?:V\66&AFS8K>
M0RRK<>8,#9C(V]?XAZ5M4 83>&D?4QJT=Y<66I2P+#=26FS;/CIN5U8<<X/!
MQQFFW?A#3KG2++2TDN+>VM)UN$$+#<TBMN#,6!R=V2?4GFM34+B\MHH6LK'[
M8[3(CKYHCV(3\SY/7 YQWJW0!CQ^'HHM?N-96]NQ=SP+;MRFT*N2,#;U!)/X
MURVMZ!#H6BZ/I$']N/ID-V\[W=D=\]L<,1PBY(+.W.&Q^6/0:BDN889X89)%
M66<D1J>K$ D_H* .-TBPN;@72VVL>)+G3IK62-VOT$4JN<!3"61&# ;N3QTK
MI?#]C<:9H=M9W5Q-<2Q!AYDS[WV[B5#-_$0I SWQ5?0]?;6+[5[5[-K9M.N1
M;G,@;?E0V>.G7WJ_=7%Y%>6<=O8^?!*["XF\T+Y"A20<'ELG P/6@"W6/-X<
MM9?$)UM+BZ@NF@$#K%( CJI)4L,<D$GV]0:V** .7_X06P_X1LZ#]MO_ +$9
M_//SINW;_,Z[.F[G_P"M6@?#T#>(5UMKNZ:Z6U^R8)388R=Q!&WKD9S_ $XH
M\1^)+#PQ96]U?L5CFN8[=<=BQP6/L!DGZ5L4 8=GX7M[633GEO+R\_LX$6@N
M60^7E=N<JH).W(Y)Z^M;E%% '+_$5))O &KV\,4LTTT&R..*,NS,2.  ,U;T
MW18)#I^H3W5W=O;18MA<A1Y188)P%4[L<9;)QGU.=VB@#D4^'>EQV4%DE]JB
MVUK=B[M8Q<\6[!BV%XZ9)ZY([$5KZ?X>@T[6K_58KJZ>:^""9)&4J=@VKCY<
M\#WY[YK7HH Y%?AWI264-DE]J:VUO=B[MHA<8%NX8MA..F2>N2.Q%85U C>)
M-4>[N?%NDSR3A(ET^.26*>-%"JX8(XR<<],=^Y/I=% '+6WAN?4;72KC5=0O
MS=:?,\MNQ\L.020IDPI!;8<'''X\U>O?"]G>Z\-8^TWL%P8/LTJV\VQ9HP20
M&XSP2>00:V)IH[>"2>9U2*-2[NQP% &232QNLL:R(<JP# ^H- 'G&K^'(=#D
M\(Z3I\NI-;VM^TAG ,K0*48 D[2H&2!@C'KGFNND\,6LUMJ<<US<R3ZE%Y-S
M<DIYACP0$&%VJ,$]!W)Z\UMUSMWXGFM_%2^'XM+>:Y>U-VCB954QAMO?H<]J
M ''PE:LFC*;V]QH^/LO*=EVC=\G/R\?_ %^:Z"L_3M0N;N>Y@NM.ELY(-I&Y
MU=9 V>5(^A%:% $=Q;PW=M+;7$:R0RH8Y$8<,I&"#^%<K'\/K!+.RLSJFK/:
M6-RES:0M<+B$KG: =NX@9[DXQQBNN)P,GI6!JWB>/3TT2:WM_M=MJMW%;),L
M@4*) 2&QC)X!- #G\+6RZG>7UG>7MC)>J%NEMW7;,0,!CN4D-CC*D'\:AU3P
M3I&I6.G6T?VBP;31BRGLI/+E@&,$ \\$ 9SG-='10!AIX9ABM+:*+4-02:"?
M[1]J,H>65]I0[RRD$;3C&,# QC%7=+TFWTI;DPL\DMU,9YY9,;I'( R<  <
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M2. &3RR JMD\8Z'@5-\/;&&WN/$SQM/E-;N8P&G=AC"'D$D$_P"T>?>M/2?
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MI+CPSIUUX;70)Q-)8HB(F93O4(04PPYR"!S[4 <[KFGI)\0?#%FL]S'%]BO
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M-%M/#^F)IUCYHMHRQ19'+E<DD\GGJ2?QIFJ>'[#5[VRO+D3">S+^4\4S1G#
M!E.T\@X&1[4 <%-8FX'Q#N5O;VWDM9VFA-M.T6)%MU8,=N"W0<'(]JU)M0O9
M[_X?737DZF^4FYC20A)2;<MDJ.#S70+X4T]8]50276W5<_:_WOW\C:<?W?EX
MXQ2_\(II_P#Q*?WES_Q*1BS_ 'OW/EV\_P![Y>.<\4 <Q<ZE<Z;XC,.NI?10
M3ZDILM4MIV:W*[QM@E0'"=-IR,$\^]>AUBGPQ8LS+))<R6S71NS;22;H_-W[
M\XQG&[G;G&>U;+KO1EW%<C&5ZCZ4 <3KMJ?$UYJMJ^F7-Y91VS6,4D31 +*V
M&D;YW7)4B,#T*M4W@O6-0U/P*\3*!KFG+)93)(>D\8PN?K\IS[FNCTK2H-'L
MS:VSS-%O:3]](7.YF+,<GGDDG\:Q;GPU'I,&N:CH\,USJ5_$S202W!$<[[2!
MD< =>V/K0!S>GC4-5MO";VEUJ@NY.=7;S9%&W8=Q8_='SXVXZ@\<5>TNPGU+
MQCXDCGU;5/)TZ]MI+>*.Z91_J@Y4^JDDC;TYJCI6B?NK>'2?^$QL;F$*J+>7
M#""+&/O!B59?]E<Y[8ZCN-/T&TTW5+[48'G-Q?,K7&^3<&*C"G'; XXH XS2
MAK/B3PYIOB&UU&.TN3+]HEG:]D9-H8[XFBQL"@<>V,YSDU,!JOBQ=?6UNOLU
MW:W\EK;S+>R1FV\O&T^6HPP/4Y/.['0#&Y;>!-$M-7DU"W2YC$DOGO:K<.+=
MI,YWF/."<\^GM2WW@;1;_6I-59;J"XF %RMM<O$EP!T$BJ1N_K0!C)%=7_Q
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ML9FO75?($>X%@#G._ P!CJ0>@K9U31K#6-,;3KV /;'&%4E2A'*E2.01V(H
MYJ<3Z5X_LM+MY[I]-U2RF:6%YW8PO'CYU8G<N=P! .,\]:P+?4M0D^&'A74&
MU"\-W)J%NDDWVA]TBM.5(8Y^8$<<YKT*RT:WL[HW;2SW-V8Q")[A]S!,YVC
M  SR>,G SG K&'P^T(6HM#]M-JEP+B&#[4^R%@V[Y #\O/IS[T 9D>GS:O\
M$#Q#8S:OJD5K!%9S1QP73)L8[R<>@XY'0Y]ACN9X5N+>2%FD574J6C<HP^A'
M(/TK.M- L[+6KG5HGN#=7*+'*7E+*RK]T8/ID\]:U: /(KG4]3M_"@M?M>H3
MZSH%_(UYMNY%:XMHB'9FYY#(Z8]SQWKJKZ^BO-'UO78=:FL+)X%@MKI6:1%
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MXIMEX;L[*6R?S;F?["A2T%Q)O\D$;3@XR3CC)).* )/$=PMKX;U&9M1_LX+
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MT8NI$D"8.#DE5SD9Y.2>@JKK-AJ6C>'K6VEUR>5TUZ!8C#,^889'4B)R2=^
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M1P#C/7GJ,\$<5SM[J]YX8TCQO!8W-QY-C>6Z6[RR-*UNLRQ[R"Q)P-Q(SWH
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M*V,L=O:6F98Q(P N'X,;#/)0*W7^^#4WB/4&7Q3X<T:25HK._:=I=K%?,:-
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M(\V*)S#"K$D?:"P.=S8P  2,$C .:S[*]UR\\%^%=32!]85;5FO;/S]DTXX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"L[6=$L=?LA9Z@DCP;U?:DK1Y*G(.5(/! -:-% &3K7AK2_$.GQ6>I0-,D+!
MXI!(RR1L.C!P<@U _@_1I= DT22&9[*9@\P:X<O*PQRSYW'H._85NUS8\0ZC
M>W%PVD:;%=VUI?\ V*X#3[)"1C>ZY&,*6Z$Y.#[9 )M8\'Z/KK6LE[%,;BU&
M(;F*=XY5'<;P<D?6G7'A'1KA-/'V>6(Z?N^S/!.\;J&^\"RD$[N^3S1XEUV?
M08M.DBM$G2ZOH;1RTA4Q^8P&X#!SW[BMR@#GX?!FBVJ.MK#/;[KLW@,5PZ[)
M2",KSP/F/ X.>15F7PQI-SIM[875J+F&^;?=&9BS2M@ $GJ" HQC&,#&*UZ*
M .?LO!FC6.FW%A'%</%<*$D>6YD>3:#D*')RH'8#%:-GH]K9W;W8,LUT\8B,
MTTA=@@)(4$]!DD^_?-7Z* ,V]T*QU#5;+4KA93=6.XV[+,RA-PPW .#D<<U5
M'A+21;:G;A+CRM49FO%^TR?O2PP>_&1QQCBMRB@"O8V<.GV,%G;[Q# @2,.Y
M8A1P!D\FL5_ ^@OIMWIQMY_L=U+YLD(NI N=VXA1N^4;N<# S4T&NSR>-+G0
M)+1$2*R6[299"Q<,Y7!&!CH>YK<H RW\/V$FK6^J/]H:\MXC#'(9WX4]1C.#
MG ZU6B\(Z3!:3VT27*1SW7VQR+J3=YV<[PV<@YYXXK=HH I6.EVVGRW$T0=Y
M[@@S32-N=\# R?0#H!QU]338M'M8=8FU1#/]JF01N6F8J5&2 %)P,$GH.YJ_
M10!D:CX:TW5-6L]4NDG-Y9Y^SR1W#IY>>N I Y[^M<9/HPGUW4YM1T+Q!'=W
M%RS)-I5X4AEC "H<B10&VJ,[@.?:O2JP[_79[+Q;I&C?9$:'4$F<3^8=RF-0
M2-N.^1SGUH @L/"T31Z7=:G+=SZAI_F&WE>Z<M&KD\,00'.W"DD'.*FUKP?H
MVOWT%]>0RK>0KL6>WG>%]G]TE2"16E:2WTEW>)=6T44"2 6SI+N,J[1DL,?*
M<Y%6Z ,+5?!^B:QI]I9W-GMCLSFV>%VC>$_[+ Y']:67PCH\VF6VG/#-]GMY
MA<+BX<,T@.0[-G+'/<DUN'...M8?AK79M=35//M4MGL=0EL]J2%PVP+\V<#K
MGTH L?\ "/V/]M'6/W_VXP?9O,\]_P#5YSMQG'7GIUJF?!6@OHMSI$EHTME<
M2F9XY)G8B0G)96)RISSP:DU'79[#Q5HND?9$:'4A-^_\P[D,:;L;<=^.<^O%
M;E &!#X-T:'1KG2O+N)+>Z&VX:2YD:211T4N3G')X!QR?4U.WAG37NM-N6%P
M9=-4K:L;A_D!&T]^<CCG/%;%5M1OX-+TRZU"Y)$%M"TTA R=J@DX_*@"K8Z!
MIVG:E>7]K$Z3W;F28>:Q0N< L$)V@G R0,G%1:GX9TW5=2M]1F2>*^@4HEQ;
M3O"Y0]4)4C*^U,TK4M7O+N%KG3(8]/N+43QW$<^XHQQ^[92 <X.<CC@UMT 8
M$7@S0HM*N],%HS6MU,9Y4>9V_>$YW*2<J<]QCI5^QT>UL;AKE3--<M&(C//(
M9'V Y"@GH,\\=>^:I_V[./&ZZ UH@B:P:\6X$I).'5-I7''4]S6Y0!FW^A6.
MI:C97]RLIN;$LUNR3,H0L,$X!P<CCFH8_#&DI+J<C6[2_P!I@"\6:5G67 P,
M@G XXXK8HH R=/\ #MAITEO)'Y\K6R&.W^T3-)Y*G@A=QXX&,]<<9Q3[#0-.
MTS4+R]M(GCFO)#+*/-8H7.-S!2< G R0.<56T?79]2U_7-,FM4A_LQXD#I(7
M\P.F[/08XQQ6Y0!C7OA;2;_5CJ<\$GVEX?(EV3NBRIV5U! 8<GK7,:IX8@L-
M8\)6.FV=\-/L)IGEDB:1C$&C*H=_)ZX&.< <C%>@5 MY;O?R62R@W$<:RN@Z
MJK$@$_4J?RH YKQ3HB0^"]>M]/MI[B^U"%E9AF229RNU<GL ..P%7M#T2UCM
M--NI$N6GMH D*W3L3 2H# !NA[9.3C@'!K>J"WO+>ZFN8H90[VT@BE _A;:&
MQ^3 _C0!CRZ?!X:AU/5M-T^\O;NY=9)H(YBS3-D#(#' ('IV%2^'[!HGO]4N
M+,6MYJ4PEDBX+(JJ%16(X)P,GKRQ&36U10!2U;2;/7-,FT[4(C+;2XW*&*G(
M((((Y!! -5)_#.FSM9R[9X[FS!$-RD["4!OO OG+ ]]V>>:V** *MAI]MIMN
M8;6/8K.9')8LSN3DLQ/))]363>>"]#O[O4+B>VE)U!-EU&MPZQR\;0Q0';N
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M?9]XN)%\R+.=CX/SC/9LUMUA^&]=FUPZLL]JEN]A?O9X20N&VJIW9P.N[TH
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M\O@?M4]K<R2DC&6-NI)Q[]:CMK6]\7:+J%ZNJPV.H6]_,OVGYS)9^7(<+C<
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M=22Q3,MVZO<1>>_ERL  -R9V]% /'..<T^?PYI5SJS:I-:!KMX?)=M[;73G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ&1N6Q[9.!Z  5I4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#12-=VJ%(96GD)53U'WN<XYSUK2HH Q?^$3T,07\"V 6*_9FN461P'+<MT/
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M.I*(,G /!VYXS[T >GNZ1@%V503@9.*JWNIVFGS6D-Q*%ENYA#"G=VP3P/0
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M=)EU33L;!XAC(N[A@UP\OG*K!, ;4 R "22HZ"NLC(;XP2D$$'0(R"/^OAJ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:;AWBC )'7'L/8<5I+<0NX1)8V<KO"A@3M]?I0\\,<J1/+&LC_=0L 6^@[T
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ML!70?\(WH?V*2S_L>Q^RR/O>'[.NQF]2N,$^].O?#VC:B;<WFEVDYMAB$R1
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX>!Y]/M)7MQB%GA5C&/]G(X_"B/2=-AEGEBT^T22X&V9UA4&0>C''/XU<HH
MHQZ-I<4=K''IUHB6C%[=5A4"%CU*C'RGD]*O444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMU[4GABW\7Z5:6N@7=G9FTL]L2:HMQDO"O0"+&=VT <G Z\XYB70]7_LWQI
M; A]8DE:U_>IC#1",;N>.1GOQ0!9OO$6IR^*?#EMIT-NUAJ%M+=#S)F1GPBG
M!PIP '![Y/ICGL:X@:)K4-YX0O8;.)WTVSDM+J*2<+M+(B[@1G(RA]\$<5V]
M '*^)=8U:Q\3>'+"PAMVAO9I1)YDS(7*Q,=IPIP.ASSR ,#K5N3Q#<SS:E%I
M.G)>G3B(Y]UQY>Z3:&*)\IW$ CKM&2!ZX@\3:7J-SK/A_4].MX[@Z?<R-)$\
MOEY5XRF0<'IG-5M,TS5O#FMZT]O9?;K+4YOMD9CE5##,5 =6W$?*2 01DCTH
M W]#UFT\0:+:ZK8LQM[E-R[A@@YP0?<$$'Z5)JM\VFZ3=WRP-.;>)I?+5@"P
M R>35'PGH7_"-^&;/2VD622(,TCJ."[,6;'MECCVJWK<,USH5_;V\1DFFMWC
M1,@9+*0.3VYH YM?'-T(-"NY=!D6RU@(D+I<JSB5TWJNW &#@C<2/<"KEIXL
MF,^MVM_I,D%WI4*W!AMY//,T;*Q79P/F^4C&.O>LJ30M7/A_P;9BP)FTBXMY
M;H>:F,1QE#MYY)SD=/PJ34-&\02:[XFO=-3[-)?:?';V=PTBY61-W) )(SNX
M/:@#4LO$DEUKT.B:AIT<$MU8F[0+-YF%R R.I52#\P]0>:P/ NHM9>'4L-/M
M$N;E]1NOW D\L11><XWL0#@<8 []NE3:?HFLP>)='U4:);6L$-E+;W$:W09]
MS%"6)Q\Q.T]^>I(K.TCPGKVA&#5M/LE35!>2B[@,ZB.ZMI)&< G/#KG@X]N1
M0!U.J^+%L;B[M;=+.6ZLXEDGCGO1#DL,A$RI+-@9Y '(YYXU=#U>#7M%M-4M
MDD2*YCWA)!AE/0@^X((KFI[3Q+H_BJ]U;2--AU"SU5(C<6LURL+V\J+L#!N0
M05 SC/3\^NLEN5M(_MCHUR1F3RQ\H).<#V'3/4XH CU34K;1]+N=1O'*V]O&
M9'(&3@=@.Y/05FQ:W?QZK;VM_H[V\$\#S"YCE,B1%>2LIV@(<'C!(/-2^*=$
M/B+PQJ&DK+Y3W,6U)#T5@05)]L@5GZ4?$VJ6GV/7M/M[&-8FCGEBN!*;DE2N
M5 'R#G=R<\ >M %8>/[;S=+E$$$ECJ,RPQO%=!YH]_W&DB ^53W^8XR,BI+3
MQ;JFI:C>VECX=>3['>_99Y)+M$"#:&#]#GKR!D@>O2J_AB#Q?I=K:Z!>65F;
M2SVQ)JBW&=\*] (L9W;0!DG Z\XYO^%].U"PU7Q!->6ABBOKXW,#>8K?+L5<
M$ \'Y<T 9WASQ3J\_A#^UKW3Q=32W<D,4=M(S$DSL@!&WY47CYN>!G':M6R\
M2M>W>N:=+8(;O2U0O'#.)$E5U)&&(7!^4@@C\ZYRWT#Q38>#CI%M;PAK?4#*
M0EUM-Y TS.R X^3(8#D^OXW](T?5]/\ $>N7W]DVT-I?6D"Q103KE&C5QLQ@
M#/S9)X ]Z $M/&$%CX6\-W=CH)CM=4F2VBMX'51"6W8 X&?NGT'O6SHGB&?4
M=8U+2;[3_L5Y9".3"S"59(W!VD' P?E((_4US%OX;UJ'PEX0TTV.;C2;^*XN
M<3)@HF[.TYY)W#'3H:W].TZ_A\>ZMJDMJ4L[JVAAC?>I.Z/=G(!S@[N/I0!T
MU<AI^IZGJGC#Q'I5[:VCZ?:) FSS2V%9';.TIABV1D9&,#KWZ^N5MM-U73O&
MFO:@EG'/9:C% RNLP#*T:%2NT]221SD#'Y4 <WX)\27&C>"/"L<NELVGW4B6
M9NO. 99'=@IV8Y7/&<@^U=)KGC";1H-4NVTIFLM-=$EEEE,;2[@"3$"I#X##
MN,D$5A0>&=;A\!>'-'-B#=Z=?0SS 3)M*1R%S@YY)!X_&C7_  YXCU:W\3VK
MV-O<M>C_ $"[EN /)BVC]TJX.TY!R> <Y)X% &Y<ZUJW_"P[+2K>&V:Q?3WN
M?FF96;YT7<?D/(R<#ODY(KJZY%],UI?%VD:RMG;LHT][.Y3[1_J275@V<?-]
MW''?\ZZZ@#"U'Q!+IWB;3-*ELE^SZAO6.[,V '5=Q0KMZD=.>>:9>>*$L%U&
M6>VS!:W$=K"8Y,M<3.%P@!  Y<#.?7T-1^.[%;[PI<LLGE7EJ5N;.0=5G0YC
MQ[D_+_P*JFM>$[N^\&6]A;SQC5;:=+Y97R$DN0^]B?0,Q;Z9'I0!?_X2*>VU
M^WT;4;&.WN;R)Y+.2.X,D<K(,LA)0%6 YZ$8_*L]O')'@L^(_P"S?W:7)MY8
M//Y'[[RL@[>>>>W%66TV]USQ%HNJ7UBUBFEK*_EO(KM)*ZA>-I(V@9.3@DXX
MKF+CPSXE_P"$*U'PU#IUNW^G>?#<M<@"9#<B7IC*D#.<^G&<T >G5S'Q"N[V
MR\":O-9!0XMG#.9"C(I&"5P#D\^WUKI8RYC4R*JN1\RJV0#]<#-87C73[S5_
M"&I:;80^;<W41B0%PH&>Y)[4 9EO=1Z5KN@"XT6TCO-2A:S6YM[@L4C1/, (
M*+D?+^%2:AJZ:SIOB[2KFR13IL!1B7\Q9-T1=2,@8QQ^-)K>FZM._AK4[.P\
MVXTN8M-:/,J%E:,H2K9QQG/O56WT;75N?&,\]C /[6B06ZQW )W"$)@Y X!Z
MDXZ' H RKB*,^#_AK,8U,BWFGJ'QR 8CD9].!78V/B"6X\5:AH5S9+;R6T*3
MQ2&;=Y\;$C<HVC !&#SP?7K6!-H6KMX9\'6*V.9])N;66Y'FIC;$A5MISR3G
MCI[XJWXTT>34+_19[&Y^S7[3M:,PZM;R(?-''<!=P/8CWH Z'1=1EU72XKZ2
MW6!9LM&%DW[DS\K9P.HY'L16A38XTAB2*-0D:*%50. !T%.H **** "BBB@
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MN,N5!QW/''. >^A:>-5_LG4;C4K1+6[L+X6$D*S[D>1BH0AR!\IWCDC@9]*
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MMVL=2AM\NTI#Q-&K#;MQSG<.<\>];J:A9R7SV*74+7<:[W@60%U7U(Z@59H
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MSNUC6>WMXX7\MRRDJH&02!Z>E9FH:/J?_"<6.N6(M7A6R>SG6:1E9 75PR@
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M&>T<N(B40-)CA2V 3Z9KC-+\'7C?#)_"NI20PSE)$6:W<NH)<NK<@'@D<>U
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MA\2ZK_;=C9R:;YT%ZC_O8895%K(!D+(S+@J>FX <]J3PQXBUWQ"8KE]-LH+
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M8GART_XE.G75U;VOVM+1(XY8T^98BJG;D\]1R.G K;H **** "BBB@ HHHH
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MAO+&"%B\5K-%SNP0/O'J ,  ?2NDT-/$CMYOB!]/C*)M6*P+LKGC+L6 QTX
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M]JZ:B@#G/"FBZCH0U"VN7M7M)+R:X@:,L7(D?=A@0 ,9(XSGVQS?\2:.FO\
MAV^TMFVFXB*H_P#<<<HWX, ?PJUIVHV>K6,=[87"7%M)G9(AX."0?U!%6J .
M-D\%2RWF@WCW8-S;;QJ3@8^U*Q$C#Z>8J\?W216AK>C:A?\ BC0-2MOLWV?3
M7F>422,KMO39\H"D<9SR:Z*B@#CU\.:Q;W'BA(&L7M=7+2Q%W=75VB"$, I
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M/09)/2NRHH I:3!<6NDVEO=+$)H8DC;RG+*2 !D$@']*NT44 %%%% !1110
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M]O>@#O3G!QUK@YO&>I6WA+Q+JR:=9"XTJ_EM_+$C;&";?F)QEC\WM7=C.T9
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MG0Y95N"7?9,J('^0=5)4]R>?7M;N?%>J3:IH=IIMA:LNK6+W4;SS,-A"J?F
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M$M7MM/\ "8AGL?MFA QMO+F.5#'Y9(P <]\?K7:-Y@B.T*\@7@$[03^N/UH
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M#W(#9XSTZ8 *$=SJMIXQ\<SZ3%:-)$+65C=,VTX@SM 7G)]<\>]=IH6J#6]
MT_5!'Y8N[=)MF<[2P!QGVK$AT#5(M7\3WO\ H975TC6%?-;*%(]GS?+WSGCZ
M>]:GA?3+C1?#&G:7=-$TMI L)>)B5;:,9Y H R+K7_$$WBC4M#TNQT[S+:VC
MGCFN9GVD,6'S #.?EZ#W.>QSD\?:E/H>E7<6EP+=SZJ-*O())2/*ER0=IQR.
M.IZ9Z&IXWOD^*^L&RBMY?^)9;AEFE,?\3X((5ORQWHG\%WT>FZ9#:S6KW,6L
M#5[N21F022;F9E4 ' ^; )[ =: -"'6]8.JVV@W*:?'J\D,MU+)%O>*.!7"J
M=IP2S$CC(Q@GVKG/%FORZIX$\8Z7?0)%J.EA(YA&24=6(9'7/(R.W.,=:Z?5
M=!O'\3V'B/3'@^V0P-:W$$[%4FA8[L!@"00W(X.?:LS5O!E[J6C>(PLEJNIZ
MZT8E8LWEPH@"JH.W+8 /.!DL>F* +UOKNJV_BNRTC4+:T6WOK62:V:%V+HT>
MW*N3P<AAR/UZUS7B;69]9^&7C+[3:P6[V=Z]IMA)(;8T?S$D#).?05U-SHNI
MW/BO1-7(M%BL()HI4\UBS&0*"1\O;;WZY[5EOX*U"[\,^)])N+BUB;5[R2[B
MDC+.(]Q4[6! _N]1Z]* +C>(M;TWQ1I^GZO8V:V.IL\=M+;2LS12*NX+)D8.
M0.HK)U3Q-JTW@CQ?=6Z6MC=Z;=S6P:,%\JJKEL\?,=W7'''%=$=(O]5U73+_
M %=+6$:<6DBAMI6D#RLNW<2RK@ $X&#R>O%90\'ZC/X?\5:9<36L;:S<S7$3
MQLS",NJ@*V5'3:.1Z]* +%WXDET>71]/O[RQM7O879;R>)O)++MVQ_>&&(8G
M);^'IS72:=)=3:?!)>QQQW++F18SE0?8]Q6%/I.KWEE;VNI6ND7]JUOY=S:R
M,ZIO&-K*2K>_8=1CISH>&-&?P_X;LM*><S-;J5WDDX!8D*,\X&<#V H KG6;
MS4-=U#2]*^S(=.2,SRW"LP:1P65  1CY<$MSU'!KC?#>M76B?"O0KB.SMY?-
MU!H)5E8_N]]TXRH Y()]173?V!K&F>+[_5]'ELY+75%C^UP73,ICD0;0Z%0<
M\=5./K65%X*UJ+P/8:$;BP>:VOA=&3+JNT3&7'0Y))QVQ[T :FH^*9X]?O=&
MM);*&^@A22WM[L$&\+ GY&W <$8[G.>E7+C6;^\U35-.T9+?SM-B0R-<*6$D
MCJ66, $8XQEB?XAQ5'Q+X9O?$EO?65W;:=-!, ;.>1V$MF^P LN%YPP+#D9Z
M'KQ%+X;U_2_$DVJZ!>V4B7T,45[%J ?EXUVK(I7OCJ./KZ #KSQ-K\6H>'[!
M-(M8+K58)F>.XG)\B1$#$$J.F2.1DGVZU/9ZWJW_  EMMHVH6-@L[:4UVTD$
MC']X'52H)'"Y/OVIUWH&J3>(O#VHB>WF73%G\]I696E:50"5 !"@8R!GIQ[U
M--HVH-X[BUV/[,;:/3VL_+:1@Y)</N^[CMC]?:@#GI/'&O)X3N?$1T_3Q;V5
MV\-Q#YCEW59=AV'H#WR>OH.^Y'KNK6WB^TTC4;:S$%_;RS6[0.Q:-H]N5<G@
MY##D 5D2>#-7D\ ZIX>,EB)[VYDF67S'VJ'E\PY&W.1TK:O-'U*[\7:-K&+1
M(K&&:.2/S6+,9 N<?+VV_CGM0!CS>,]2MO"7B75DTZR%QI5_+;^6)&V,$V_,
M3C+'YO:M2'7]5A\66&EZC:VBVVHV\LMN878O&T>TD/G@Y#=OUZUES^#M7G\+
M^)M),EBLFL7LMRC^8Y$:N5X/R\D;?QSVK6N]$U.Z\3Z%JG^B)'I\,T<JB5BS
M&15&5^7MM[]<]J *+^+]1M+[2$OK>TA.H7QM'L<YGMU.[8[,&(.0H.,#[W7B
MG:'>ZU<^,_%$$L]M+%9O!'%$49  8MZ@')QRW)P<^W K-@\%^(X])TBR>]TQ
MGTS4Q>^>5D+7/+Y9_P#:^?ISGU%=!8Z)J>G>+-:U.*6TDM-1$4A1MRR!TCV8
M[@ X!SR>V.] &=I7C.6Y\*Z)=_9(([_5KI[:&!"1&A#N"Q[D!4)]SQQGBU)X
MEU"PUN[T6\@MI;L637MG,FZ..95.&5@=Q5@?0G(/:LRU\"ZC!X3T>R^U6J:K
MH]XUU;3*6:.3+LQ1A@$ AB#C/3/M6Q+H-]?:K-K%VEJEXM@]G;0)*S(F\Y9F
M<J#D\# 7@ ^O !E6?C+69+'PSJEU96*V&L316[)&[&5'D!*L.VW(Z<GW[#N)
MI4@ADFE8+'&I9F/8 9)KB1X2U=?#/AC2P]B9-'NX9Y',KXD$8(P/DX)S^&.]
M=K/"ES;203+NCE0HZ^H(P10!QUQXQU"W\*P>+#:P-I+E9'M@&\](&;:'W9P3
M@@E<>V>*L/X@UNZ\47^BZ=:Z>!#:17,,\TCD$.6'S  >G0?7/:JD'@_5!X2/
MA&XN+:32PPC6[#L)C!OW;"FW&['R[MW3G':M2VT2_M?&5]K"+:&VFLX[:.+S
M6##86()^7&#NQ[8[T 6_"FMMXC\,6.JR0B&2=6WQ@Y"LK%3CVRIK)O+W5S\3
M[+3X;F!;+^S9)_*:,G)\R-220W)]/3)ZYK0\&:+=^'O#%MI5X\#R0-(=\+$A
M@SLW<#'WL?A3-1T34)/&5CKEC-;!([22TG28-G:S*VY<=3\N.<4 <A8ZOJVA
M:5XQU.PMK26"SUNZFF6=V#2*-F0N.AQSD_E767OB22343I^G +,EJER\CVLL
MZKO)V+MCY&=I))/''!SQEGPEJ[>&O$^EE[$2:S=S3QN)7Q&) !@_)R1C\<]J
MENO#GB&TU:TUG0[G3TO#9I9WMK=%S#*J9*LK*,AAD]J -[PWJEWK.AP7E_IT
MVGW;%EEMY592I!QD9 .#U'UKF+YM47XIWHTB*T:Z;1(?FNV81J/.?J%&3^GU
M['L].ANH;-1?3K/=,2TCHI5 3V4'.%'0?3)YK%NM'U*'QDVO6'V2=);%;.2"
M>1HBNUV8,&"MG[V,8'UH HZ;XNU/4]%65=.B@OH-0:PU N^8;4H,O)U!9<8P
M,C[W6HXO',BZ#KE[-'!*VE7BVYF@#&-T;9^]VY)P ^2 3PO!YI+CP9J$-K9R
M6-U:RW:ZH^I7D=P&6&X=P>,#)&WC;G/W0>M36/A[Q#IUQKD\5UILCW]W'<HI
M1U!P$#HW7 *JP'7KGCI0!9EUZ]'AO5M5@;3=2MK>V,]O+ Q6.8!6+ \M@C'3
M/?MVKS>,!;0>'DN);33_ .U+/SA<7"$PJ^U"(A\PP3N)&3T7OFHHO!DUO:>)
M190V=D=8M_)6TBD8PQMM96D^Z.3NZ!1]WWXMC0M1.C:=I=U::9?V4-DMM<VT
M\C!6=0 KJ=A[ \8[]>.0#H-.ENIM/ADO8XX[EE_>+$<J#['N*R6UF\U#7-2T
MK23;(^G)&9I;E&<-(X+*@"D8X );)Z]*L^%]&;P_X;L]*><S&W4C=DD %B0H
MSS@ [1[ 50&A:AIGBR_UK2C;31:E'&+JVN)&CVR1C"NK!6[<$8]\T <SXH\1
M7/B#X5WM[ B6DL<ZVM[ ^6*2+.BLJL"..?3D'M7H5K;,A-Q<QVQO679)-#'M
MW*"2!R2<#/KW-<EJ/@J[?P/=:'936QN[VZ^UW-Q*65?,,HE;  /'&T>U=I$9
M#$IF5%D_B5&W ?0D#^5 '(>)O%>I:##JMV8+2*WL0I@BN"2]Z, N4(;Y<9QT
M/([5I7.O32>([/1+)8XY9[)KUIIU+*%#!0H4$9)+9// '?-8>K>#]<OAXGMH
MKRP:#6%!CFF#F6/"@"/C@(",@\XR>#FH-5BU2\\1:=8VESH[ZEIMCNFCG>6'
M:9#@&-T.\C"$$=.A/48 +NG^-[N?1!=W=C#%<2:@=.A2%GD#2*S!F("YP I8
M 9)Z<5J:'K6IW>M7NG7UC((8HUE@OEM98(Y0>"A5^C ^A.1Z5A?V-J.N:$VE
MHNGZ9J&D74=S97%@YEMQ(,G# @'/)W#G[P/.<5M1+XJCTF\NM1O-(BOUA*VZ
MQ>8+96_OR%N3T'3ISUS0!TM%4-%N+RZT6SGU"-([MX@950$+GU /(SUP>1FK
M] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%<G\1;O4++PJ9;"Z2!FN8(I"8RQ97D52 <C'7GKQD
M<=: -\ZOIXUA=)^U1_;VB,H@'+;!C)/IU'6KM<)J@U)?B3HZPO:O>G2K@&5X
MV6,?O$YV[B3]-WXBIK+QI='0V>]@A_M-=5?2?W".T;2*3\X49;&T$XZG&,C.
M0 =K5>\OK33K<W%[<Q6\((&^5PHR>@Y[^U8NB:OJUUK=[87]F3;1QK+;WR6L
MENCYX*%7).X>H/(]*Q4E;5?C/-;77S0:3IHEMHCT$DA&Z3'K@[: .K@U[2[F
MXCMX[V(3R'"0OE';@GA3@D8!Y]JDU+1],UB)8M2T^UO$4Y5;B)7"GVR.*?=Z
M=;7L]I-,@,MI+YL+]U;!4_F"17*MXLU2Z\*W7BG38K233H&E=+9T;S)H8V*L
MP<-A2=K$#:>WKP =996%GIMLMM8VL%K O(CAC"*/P%6*X_\ X2?4[_Q)9:?I
M<=D+2^TK^T()YPY9<L@&Y01D8;IG\168_C'Q(OA74]7^SZ6)-&N9H+M")"+C
MRVPWE\_)QTSNY[4 >AT5R-YXAUN7Q7%HNEV]@$GTTWL<UR7.P[U7Y@,9'/0>
MHY&*KZ9XLUJ^TF[CEL+6/5;#4!97K;\01)P3.-Q!*[3G;G- ';45PZ^,M0.F
M>*Y(TLKF?1$\V.95=(YD,7F#Y<DYX(X.#UJ6V\2ZVFJ^'$OH;#['K43;5A#^
M9"XB\P$DG!!P>,<>IH [.BN1L?$]\A\26VK"UCO-*.^)88FQ+$RYC?!;)+'(
MP.A&,\UTEJ;XZ9$;H0?;C&"X0$1A\=!R3B@!--U.SUBP2^L)Q/;2%@LB@@$J
M2IZ^X-6ZX.V\<W"^"-*UR^CM[7[7>/;SS+$SPVRAY%#$ YP=BKG(Y;/M75Z-
M=7%[9-//-:3HTA\F>T_U<L>!AA\Q]^_:@#1HKA/^$C\6WQU]-,L])WZ3<F,+
M*9&\Y0BMM&"/F.>IXZ<=Z1/&NJ:I)X9_LBULU36[::0&Y9CY3QJ"0<8R 3^.
M.V<@ [RBN6LM9UC4=1NM(C;3X;_3K>%KV7RWDB,T@)"HNY2% &<D]P,5E3>.
M-2/A/^VH;6VB:QOOL>K0R*TGD[7"NZ$$9 R#@]CUXH [ZJFFZG9ZQI\5_83B
M>UESLD (#8)!Z\]0:JF]O9]7FM[-K9[>&V5V+*<F1L[0&!QC R>,\CUKG=+\
M:75[X6T"Y-O;KJFLSM!%&H/E1[6?<Q&<D!5SC/)QTSP =5%J^GSZK-ID5U&]
M[ @DEA7DHI. 3VIVF:G9ZQI\=]I\ZSVLN=DB@@'!(/7W!KD-/&H)\5-5%P]M
M+.-'A\IHT:-2/-?&X$L0<Y[U#%XUU=_!.AZU'9V)GO[];66++!5#3,@V^^!U
M/?G':@#T"BN6L?$&IP>)-3TC5X[5_L]DM_"]FK#*%F4H0Q.6!7J,9]!69_PF
M&LOI/AS4X8;!XM;N%@6$JX,)<,RY8$[L!2#\HH [RBL;Q3?:KIGAV[O](A@G
MN;9#*89E8AU'+ 8(YQDCUQCO4,>NO>3:0UC/;R6MS;-=W$IC/$0 P1\WRDEN
MAST/I0!OT5Q$WB_4QX0'BZ""V?3 ?--H4;SC!NV[@^[&['S8VX[9[UIV6OW5
MYXMNM)0VYMO[.CO;>81MN^=B &&[D<9XQUH Z2J<NDZ=/J$5_+90/>1#$<[(
M"Z?0]16=X/UJY\0^&;?4KJ.*.>225&6($+\DC(",DG^'UK#G\5ZU;Z;XG#I8
M?VEHTH\N+RGVSQ,H*'[^=S<@ =QCF@#N:J:?J=GJD4LME.)DBF>!R 1AU.&'
M/H:RK#6[G53I+V,EM+#<V?VN=C&PP#C8!\WRY)/7/W6KE-:\2:S??#;6;Y)+
M:SN;>_>S?R8V8,@F$9P2W!.>OZ#J #M=2GT*_O8M!U(6MS/,#*EI-&),A>=V
M""!CWK5551%1%"JHP !@ 5PNN#44^('A=4>UEO3:7H\PHR1C_5\[<D\#MGGU
M';;\)ZU>ZQ:ZA'J,<"WFGWTEG(UN"$DVX(8 DD9##C)H Z"BN+TZXURX\?>)
MK=;^U,=M#;"&.2V8A0RR,!PXYR>3SGVJA+X[U*#PEI^L3BQAE_M#[%J,+1.?
M((<JQ7Y_X0,\]1SQ0!Z'17.:KXBFTK^UKQUBEL+"*-0JH0[SOC";LD8PT?;^
M/VY@MM:UTZ_%8M9K<VEQ ["Z6RFMUMY5&0K[\[@>Q&.>U '545YW:>-?$$GA
MG2/$,]MIJVES>+;7$*!S)AIC&&4YP,<<$'/J.E:-G<:U/\1==M5O[;R+>TMS
M%&]LQ"AO,(Z..<CD]^.!B@#LZ*XW3?%.IWGAFYEFCM(]<@OC8M;!&V++O"J/
MO9(*D-GTSZ5T!U[2(;Q=/GUC3UO\JA@-PBN7., (3G)R,#WH TJ*Y$^)-5U#
M2=5U;2([-K:PFECC@F1B]R(OOD,& 3)! ^4] 3UX@'C#4-1U30(=)@M/LNL6
M4ERCW!;=&5"GD#TW=!UQU'6@#M:*XJS\9W::->-J$$!U&WU8Z4/LZ/Y<CDKA
MPO+8VMDCD\8[UI:/K&KW'B"YT^]LR]F(!-#?I:2VZELX,;+(3\W<$'&* -^>
M>*VA:::14C7JQ]^ /KGC%9NI^)]#T:>&#4]5M;26891)I K$>I!Z#W-9-Y>-
M??$ZPTAC_H]CI[Z@5[-(S^6N?H-Q'UK0UVSTRWT?5)KFS2<W:;9$*[FG8J%1
M![G@ >M &P]Q#%;FXDFC2 +N,C, H'KGIBH(]3LIM.&H17,<EFR[Q,AW*5]<
MCM[].]9>AZ/)I/@:RTF]*SR6]F(Y,_,,A>0/8=!]*J_#?_DG.A?]>H_F: .H
M5E=0RL&4C((.013)YXK:!YIY%CB0;F=C@ 5RW@R[9-0\0Z$?]7IE]B ?W(I%
MWJ@]@2P'M@=JLG6;_5M1UBSTDVL<>FXA=[B-G\V4KN*C##: "!GGDGCCD O:
M7#HFH,NO:;!;2/<KQ>)'AI%SCKC)%:U>=^#=0OK+X>>%UMEMHK:2)_M-Y<D%
M+=1NV_+N4L6; &#Q5C_A,-:G\%:AK-I;6DEUIEW-#<(8GVRQQMAG1=P*G;\V
M"3T(H [RBL,ZQ/<:A9)I[07%L]F;N9E0DLIQY>WYN-QW8SG[IK/\+>)Y_$9M
MYHKJPEC,3&[MD1DGM).,(P9CD9W#.!TXZ\ '0WNIV>G/:I=SB)KN800 @G?(
M02%X^AJW7/\ B36KS2+_ $*."&W>&^U!+65I,EEW*QRH''\)_/I69)K_ (CN
M=<\1Z98Q:9&=,CADBDF$C;@Z,V& (Y. ,\8]\\ '9T5D^'=6?7_"]AJH189+
MNW63:?F",1SZ9&:Y2Z\;:Q:>$=4U*6.Q&H:7?-;7-N(G(*AA\R_/D_*=_IC/
MIF@#O+FYAL[:2XN95BAC7<[N<!13+"^MM3L8;VSE$MM.H>.0 @,#WYK(N-0G
MO))XK>6WDL5T[SI7$9RS.#LVG=C! )Q@XX]:Y'PQK>KZ-X4\&,T5DVF7K0V)
M3#><I=3M?=G;C(^[C\?0 ]"BU.SGU.YTZ.<-=VR(\T6#E5;.T^G.#5IF"J68
M@ #))[5RI\536>N^)8=0AA6RTBSBNE>+)=U(<D'/&?EX'OUJS9WWB.6XTJ=[
M2SEL+Q"]P(LJ]IE=R_,6_>?W3A1ZT :VFZM8ZQ!)/I]REQ%'*T3.F<!UZCWJ
MY7E5AK.K^'_#?B/5K**R>TL];NWFCF#%Y5,H!"D$!2 >ISGT'?TC5);A-&NI
MK.5(IUA9XWDCW@$#/*Y&?SH NT5P.@>(;^T\'>&5GFAN=0U?RXX&:-EV94L[
MO\QW8 )XVY) XZUMV>NWD/B^3P[JBP/)):_:[6Y@0HKJ&VLK*6;# X.<X(/:
M@#HZ*Q+S5[B3Q&NA:>88[A;7[7--.A=44MM4!0RY)(;OP!WS6>/$6KPIH^G7
M]E;VNMZE/+$J[M\2I&"S2X!R05 PN<Y;D\4 =717'S>*=2L=0UK2+F&TDU"S
ML#J-K*@9(YHAD'<N6*D,,=3G/:JUGXKUS;X5O+V#3_L6MB.-HX0_F1R/$7#
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M8'USQ@]#J]WJ-EH_G6=M#->916#/B.,$@.YR1E5&3C()Q0!IT5Q5OXNOI?\
MA)X8_L-U)I-O'<P3QJR1S*R,V",MT*$9!P<]J99^*M<W>%KJ]@T_[%K:HC)"
M'\R.1HMX;).-IP>,9'J: .POKZUTRREO+V=(+>)=SR.< "GVUS%>6L-U;OOA
MF19(VQC<I&0>?8UQ.MZS?Z[X1\4SZ>;5+&UBN;4"6-F>;8A$C!@P"\Y X/3/
M>ND\-$KX/T<JNXBPA(4'K^['% &O17%6GBS4UUO0[&_2R#ZD94GMH03)9NJ%
MPK.&*L<#!& >]6?[>US4].O-2T&UM+B*WNF@BM9<A[@(^QV$FX*G(;&0>@]<
M  ZRBN;FUG4]0OM8L]$6U$NF*JG[2A?SIF3>$&&7:,%1N.>3TXYBF\1WQNK7
M33;BRU)K%;NY5K>2[$)8[0F(R,\AN<@?+WSP =317!R>,/$45AHK2Z-#!=WF
MHFPECGWH"<,0Z C(4A<\Y(]#BB3Q-XAM[K7=$U 6$&I6VG-J%G=6T;-&\8R#
ME&;.X'CKCOCU .\JO?7]KIEE+>7LZ06\2[GD<X %9'@I[R7P7H\MY<)-))90
MNK+&5.#&OWLL=Q]3QGTKE(;G5;OPU\06O[V&=(9+R *L!4C; H&T[R N.V"<
M\YH ]%MKB*\M8;F!]\,R+)&V,;E(R#S[&I:X/1=;U?31X0L[F*R.G:E:K"@0
M-YL3+#N!+9P0<=,#'J:GO?%NJS6E[>Z+9BZ6UN7@6U^QS.UP$?8Y$J_*IR&Q
MP>G/7  .UHK!\5WM[;>"-4U"PD^RW,5D\ZF6/<5PA;&,C#=L\X/8UF6FN7=A
MIN@Z:\L<M[>6GG"5+2201QHB9RBL69LL!G('4]L$ [&L_4M!TC6"C:GI=G>,
MGW#<0*Y7Z$BN2O?&'B'3_#EY>3:5$MQ:WT=NKRQ21)<QNZJKHK<@_-R">,=Z
MMZAKGBC2;[2[:[M](D.H7[6Z&)I!MCV%ESG^+(.3S]* .MMK:"SMTM[6"."%
M!A(XD"JH]@.!4M<7:ZUXHNM4UO1D&D"]TX12)<F.3RW21254INSG*D$[OPJ%
M/'P?0?#FI7)M].BU5&\VYG1GAA=1PIP1C<<X)/130!W5%4]*FNKC38I;PP-,
MQ;YK<_NW7<=K+R>"N#U[U<H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K$\6Z)-XA\/3:?;SI#.9(
MI8WD4E=R.K@$#G!VXK;HH YDZ)JLGBW3];FELW%O9R6\B+N7<78,2.#@#:![
M]>*RF\"W\VCZA;M?PVUZ^KMJ]E<0@L(92<A6! R.H]\]..>[K)O?$NDZ?=+;
MW5T48S+ 7\MRB2, 51G VJ2"."1U'K0 S1+;7ES-KUY9R3!=B16,;)&!W8[B
M26.!Z <^M5-:\-7$^OVOB'1[F*VU6"(P2"9"T5Q"3G8^.1@\@C\C7251GUFP
MMM6M-+FN M[=AC!%M)W!1EN<8&!ZT 1VT>K3R1OJ!MK=$.3%:R,^\^[$+@>P
M'/'.,@\[:^$-1T_0M1\-VEU;_P!CW;2B*5]WFVT<F=Z!<8;JV#D8SR#76WMY
M!I]C/>7+[(((VDD8*3A0,DX')XIUO<17=K%<PMNBE02(V",J1D'!YH YV+PW
M<6?BNQU*T^SK8V>FG3XX69MVW<I!SC'&T#%9Y\'ZH_A;Q%I#3V8DU>[GN%D#
M-B(2G)!&.<?AGVKMZ* .!9-0M_B?IL<*6KW$>@,LB/(RJP$RCAMI(YP>A]/>
MK%YX+OI++S;:\MQJ4FK+J=P)4)@E*C B('.T +@^JYP.W26UMHU_='5+>VLI
MKE':$W2Q*7#*Q5EW8SP016E0!Q$OA'696\5%[ZQ?^W;=8B!$R^6WE>63U/ '
M;OZBK<GAO4GG\+2>9:#^Q0?,&YOWN8_+XXXXY_3WKK** .*N[72O$OC?3+W3
MK^*X-G$_V[[-(KHZ*ZM$CD=")!N _P!EJ[-RX1C&%+X^4,< GW/-0VEC9V"N
MMG:P6ZR.7<0QA S'J3CJ?>K% '(:+X=UC1?#-AI22V$YMYY6G5]PCN(G+L5/
M!VG+CL?N^]:/A;PZGARUO8HQ'&EU=O<K;PD^7 " -B9QQQGH.3T%;U% ' >'
MTU276O&D5@;4"342@DE9@8F\I!NP =W;C*].O/&A%X/FT_4?##:>\ LM$AEA
MVRL=\OF*%)X& >,^^>U=)::7I]A+++9V%K;R2G,CPPJA?ZD#FK= '-/H-]8>
M++O7=)>W<:A"D=Y;7#,@+(,(ZL >0.",<^M6-,\,6UGH-[IMR1<?VA)-->-M
MVB1Y2=^!V&#@>P%;M5=1U&TTJPFOKZ80VT*EI'()P![#F@#-\-:)/X>\.16+
M7 O+M%^>:0X\P@!5SQV557_@-<Y!X#U&W\*Z)9PWUM'JVBW#3VMQM8QR9+$J
MZ]0"&QQZ5W5M<17=K#<P-NBF19$;&,J1D'GVJ6@#EK'0];C\6SZ_=SZ>3+8)
M:FWB5\;E9F'S'MSUQ^'&3F0^"M5A\'Z1HGVBS:33[];LRY8!PLID"XQQDG&?
M;WKO** .4O;.YTOQ)J'BRZE@CLH]+\AT3<[H$+2;\8&>N,?K7+Z0FL:1IME?
MQ2>%K](UWQB-Y%ED9^6$8!9!(Q)'R@ D^E>CS:G9PZG;Z9+)BZN8WDCCV$AE
M7&[G&!U'6F6NA:18W+7-GI5C;W#=98;=$8_B!F@":^U"QTVW$VH7=O:PLP3?
M/($4D]!D\9KFO ^A6MAIE[+"[2VEY/)]E5^B6N]BBK_LDL[#V<5T]W8VFH0>
M1>VL-S%N#>7-&'7(Z'![U'J.H6FCZ;-?7DGE6MNNYV"%MH^@!- '*6W@W4+?
MPO/X3^UP/H[LR1W!+>>D#-N,>W&">2 V?PXJ]<>'M1M_%D>KZ1/9Q0O8K8S1
M3HQV*K%E9,'D\D8.*Z=6#HK*<JPR*6@# \':%=^'/#T>FW=S%<,DLCJT:%>'
M=GP<]3\WH*2[\,)<^,;771,51+<Q3P <3,K;HB?]TES]=OI705%<W,-I;27$
M[A(HU+.Q["@#$\+>&5\,6EY!'+YJR3NT / BAW%DB'L"S?\ ?1K&/@F_F\&:
MUHDMU;)-?7CWD4J!BJEI1)M(.. 1C/O77Z=J%KJNGP7]E+YMM.N^-]I&X>N#
MS5J@#F)=$U:Y\3Z-K%Q-9,;&&:.5$W+O,F,[<YQC:.O7VJQX:T6\T>?6'NG@
M=;^_>\7RB24W!1M.1SC;U]^E:,NLV$.L0:2]P!?3HTD<6TG*KU.<8%7J .?M
MM"O;/QGJ&KPW,'V._BA6:)D)D5HPP&TYQ@[N<_\ UZJ_\(3:R:IKTT\I>SU6
M,J+;'$3NH65Q[MM3GM@^M=510!R\?@Y9? )\-7MV\DLL(6:Z7[QER"']\$#'
ML!4FBV/BJ$(-:U*PN1;J1$+:-XS.V,!I221^"CKSVKI** .#C\%:K'X%L/#W
MVBS,MK=K<&?+88++YN,8XY..OO6PNCW=CXNO-?\ MEK%97-K$ETD@.Y#'N.5
M;(&,,<DCM724UT61&1U#(PPRL,@CT- '':98:;JOCVYU_3+Q+BT6WC\TPN'B
MDN<,JL".K+&Q!]G%=0^EZ?)=?:GL+5KC<&\TPJ7R.ASC.:JZ?>Z-!?R:#I_D
MPSVT0E:VABV*BDXSP-O7TK5H Y"U\+ZGI,6L:?IMS:_V=J,LDR&;=YEHT@^<
M  8<9Y )7'O4D7A26QUOP_/8M MAI%H]JL<C'>X<*-V0,9&W/OD]*ZNB@#A9
M/ ][=:9K-O+>Q6]Q=ZI_:EG<098V\HV[000,@;>ON>*W]#M?$"L9M?O;*614
MV)'8QLB'IEFW$Y;CM@#GKGC;HH Y;4K$Z?X]T_Q#_P N\]FVFW#=HR7#QL?8
MME<^I%)JFF^+)]=^V6-WHPMHABWBNH)7,9Q@M\K ;CTSV' ZG/4LJNA5E#*P
MP01D$4 !0   !P * ,ZV@U1=$,5Y/;W&HNK;G13'%DDX ')  QZDXJKX5TN;
MPYX5L],O98&^Q1;#,A(5E'.3D<5HV&IVFIBY-I*9!;3O;RY0KMD7[PY SUZC
MBK+QI(NV1%93V89% '->$=.DCN-:UJ9&1]6O#+&K#!$*@)&2.Q(!;_@0J*/P
MYJVE^)-3OM(N[/[%JA62XAN48F*4#;O3;U!'4''UKK** .!TWP5K>EV'AE(M
M1L99M'$JM')$_E.'&-PYSN7G!XZGIWT=&LD\(VNI#7M6T\6M_J$L\;28B!,A
M+%26.">#P/0]>W1?VG:?VQ_97FG[;Y'VGR]A_P!7NVYSC'7MG-/N[&TU"-8[
MRU@N41PZK-&' 8=" >_O0!S/@G0AIGAJ?[--*1=/(;5Y?O1V^6\E?H%.[_@1
MI]KX8N9/$FG:Y?)90WMI"\<TUIN!O"R@?."!@#KC+<XYXKJZ* .?\2Z+>:Q<
MZ-):O BZ??)>,)2<OM##:,#C[W7VZ5#;Z%J-OX@\0ZD&M635(HDC0NP,?EJR
M@DXYSNS[8[]:Z:B@#&\*:3<:#X8L-*N9(I)+2,1>9'G# =#@]*JMX3@?Q;>:
MO))NMKJW5)+4CY6E 9/,/_;-BOXGVK4BUFPGUB;28[@-?0Q"62(*?E4G .<8
MZ^]7Z .;T'PS-H'A272H[@7-PP=1+*2 5QL0'C^% @_"LQ?"&J)X:\-:4)K,
MOHUW#<-(6;$HCS@ 8XSGKSC'>NWHH Y5_"LUYKOB"XO7A-CJ]FEHT<;'>BJ&
M&<D8R=Q^F.]'A[1O$VG0VUAJ6JV=Q862A86AB9)IPHPHD). !QG YP,GKGJJ
M* .$D\&:I+X0U[1&N+,2:I>2W E!;$8D?<1C'.,8]\]L<]D;=Y]--M/M5WB,
M;E#D#(QQG%3331V\+S2MMC098^@JOIFIV>LZ=#J%A,)K68$QR!2-P!(Z'GJ*
M .0A\$:DOAK1K-]0M5U'1)4DL9HXFV$*,;7!.2&'!QT[5O6FC3R^(O[>U'R%
MN4M?LL,,#%U12VYF+$ DD@=A@#OFMRB@#EM=\.ZK)XCM?$.@7EM!?QVYM9XK
MM&:*:+=N&=O((.3_ )Y34O"]_?+I6H#4(SK>G7#7"2LA$+[QM>/;DE4*X&>3
MQGDDUOZAJ=II:V[7DIC%Q.EO%A"VZ1CA1P#CZGBK= '+W'AR[OKC5=3N#;+J
M-YI_]GPHK,8X8R222V 6)9L]!T ]ZJGPKJ?]E^%;,2VF=#DB=V+-^^\N,QX'
M'&0<]Z[*B@#D-1\*WFLW=L]_]B,EIJ'VJWOX]PG2(2%Q%C'IA2=V,<XS3_\
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MMJC&"X6->-@S\H^8KU/*\<5H:_X<U*[UJSUW0]1BLM3@A-O(L\9DBGB)W;6
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ML;1VH PY/%^M)X,\2ZKLL3>:3?3VZ#RV\MDCP,XW9R<YZUH0ZWK5MXKT>PU
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MK-[H.DPWMF(&)NH8729"V5=PIP0PP1G/>KFC6FJP1O-K-]#<W<@ VVT9CBC
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MUEH;QM%$,D4D$?E>:)5RJD9./FXSGH: .JO-:L;#4K'3[B5EN;YBENHC8AB
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MXA52Q#D@;LEE !X('7H#4?%,\/B6\T9KV'3KI3']@2ZB_=WBE06(<D#=N)4
M'@@=>@ .THKD-0U[5;R[UBVT96673F$2?Z/Y@EFV!\,=PPOS <<]3FH'U[Q)
M+KNA:=Y5I8/J%C+--'-&7:"1-N>0V&&6X''UH [8G R>E%>7ZYKNM7GPX\0^
M;>11WFG:B;"6:&+:)TWH,X).W(DYZ]*]*A2X2V"33))/@YD$>T$]OES_ %H
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M!:0I GEVBA8 1G9@;1CWQQGW-9&B 7_B+6=5Q^[1UT^W/^S'DN1]9&8?\ %
M&[!/%<P)/!(LD4BAD=#D,#W!IY( )/05R7A:Z>'Q9XKT/_EWM+B*YA']T3IO
M91[;@Q_X$:O7.KW%WXK.@6,JP&"T%U<SE-S#<VU$4'CL22<\8'?( -'2M9L=
M;AGEL)6D2"=K>0M&R$2+C<,, >,U?KSCPQ=:G8:!KTD3V?V@>(IUN;B4[(XD
M+J'D )[#)"Y_.M/3M<UG4Y?$NG6,T+W>G>4UG//;,GF[X]P5UR.X(W#'!!H
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MR  \&\J2)"PP^!GT[8/4@'=U%':V\4\D\<$232X\R14 9\=,GJ:Y$:IXCO\
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M:]61+<CR7)0@8+'</D'IWKK;-+F.UC6[G2:XQ\\D<>Q2?9<G _$U/10!QO\
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M",QZ\@7$<!!@(CV Y+'=P >U=8K;D5L%<C.#U%+0!1TBTN[+2X+:]NH[F>-
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M<6ARNZ3S" -_K^E79O#%]%XE;7=,U6*UNKF%(;Z.2U,D4^W[K ;P58#CJ?\
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M)X5AVF,(A08;<<\,<\5FKX)OAH6B:6^MQNNDW4,\3FS^\(ON*0'_ #.>>V*
M+>AZEJB^+M6T/4KJ*[6""&ZAE2'RB Y8%2,G(!7@]:U/$-U>6>D/-926T4@=
M \URX5(HRP#MSP2!G ]?RJO:Z#/;^+KO77O8W%S;);F 0$;0A)!W;CSECVIW
MB;07\0:=#!#>FSGM[F*ZAE\OS%#H<@,N1N'MF@"AX9URZO\ Q%KNES3//!8B
MWD@FF@\J1A(K$AA@="O!P.#5_P 2:S)I,%A' $^TZA>QV43.,JA;)+$=\*K<
M=SBJ^D^&[K3O$M_K,VK&X:^AB2:(6ZH-T88 @Y.%^8\=?4FK/B?P[%XETD6;
M7$EK-%*EQ;7,0RT,J_=8#OWX]Z ,O5M7U?PGIVMZGJ$D5]IUM DEHQPDID)V
ME'V@#;N*\@9P>])J>K:MX<O=#EO+I+RTU&Z2RN$\H+Y4K@[6CQSMR""&R>G-
M61X6N-2T>\L?$>J'4VNH3 6CA$"QKURJ@GYL@'))Z#@=U@\-7<RZ5'J^HQWL
M6F2+-#MM_+:215*HTAW') )/ &3S[4 <[-K_ (G?1_%=['J%E&=$NIA&!:9$
MJ1QJ^TY;@8)YY.3VQS/XGDNM1U+P3=171@6YNU<1A P1C"YSSUX.*TAX.NO[
M+\1V)U2(C6Y9)'?[*?W6] A ^?G@#'O4MUX5O+@>'L:I"IT9E<?Z(3YQ"%.?
MGX&T^_/Y4 $>IZHOCZ30VN(&MO[)%U&WD8/F>9LRWS<CC.!CK^-8NCZQXKU'
MPC)X@;4K!!##=Y@^QDAVC=PK9W#'W<8Y_&ND.@77_"8-X@6_B!-C]B$!MR0!
MNW[L[^N>V.GYU6TOPK<Z9X.NO#_]I1R><)E2?[,1L$I9FRN_GECCD4 8G]O^
M)(K'PEJ+7MG(FLF&"6W:WP$:2(N)-P.20021P.<<=:T]-U;6X]8\1Z1//;WU
MQ8V\5Q:2-'Y(8NK_ "/@G !4<^AI\GA"Z?2_#ED-4B T26*1'-J3YIC0H 1O
MXX)S[TZ]\'27^H:_<3:D%BUBS6T9(X"K1!0P!#;CD_,<\<^U %+3/$.H/XFT
MS37OENXK^PDEDE$ "),FW/E,  Z?,?7H.:S=#OM9LO ?B35DU(3W5M<7KJ;B
M$,"8V;G@CJ%QZ#TK<M?".HQZKHNHW.NB67387MRL=FJ+(C!1Q\QVGY1D\^P6
MB+P;<P:)KFDQZN/LNI/.R!K8$PB8DMD[OF(R<=/<&@ A\0W=]?Z%H\4PAN;S
M3?M]S<! 2J@*,(#QDLW<' '3GC)U/Q;K6G:9XLM/-MSJ.AI'-%<M#E9HI%RN
M5! #C!!/3VK;?PC*K:)>6VH)%JFE0_9UG,!,<\1 !5TW9[ @AN#3-0\&G4=*
MUN"2^1;[60JW-R(,JJ*-JJB;N !ZD\DGV !%%JVM6?B[1;.]NK>XM=6MYF\J
M.'88'C56X;.6R&P<X]>.E=9,DDD+K%+Y3D85]H.T^N#6#/X<NI];T/4GU&$'
M2XY$\L6QQ+O4*QSOXX QU_&N@D#F-A&RJ^/E++D ^XR,_G0!Y5I.H:OH?P?O
M=7LKZ,RPRW#*DT 8 _:'!.01R<YYR/:NGN=4UO3=4T[3+F^MI;C6;DBW9+?:
M+6)(R\@Y)WGH 3ZY([5&O@6Y_P"$$NO"[:O&8YV<_:/LA#*'D+L,;_4\5JZS
MX;?6+;39#>"#5-.E$UO=)%\H;&""A;E6'!&?QH RY=>U;3]=U7099XIIDTTZ
MC8W4D7\(.UDD52 2#T(QP:S4\1>)$T7PGK#7EG(NK2P6TML;? !E0D/N!SD$
M9P,#M[UTK>')I[B_O[F[B;4KJS^Q)*D!$<,622 N[)))R26[#TYHGP9<G0?#
M^EKJL0&C7$,Z2&T)\WRP0H(W\<'G^E $VB:EJB>+M4T/4KJ*[6&WBNH9DA\H
MJ'+ J0"<C*\'K]:A^)TEU#X U*6UNGMV 16* 9=6=5*Y[ @UI6V@SP>+[O76
MO8W6XMDMS ("-H4D@[MQYRQ[5-XET-/$GAV\TAYV@%RH E5=Q0A@P.._('%
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MP .O6@#H[&*:&U19[CSY,??V!>/3 JQ45LDT=NB3R))*HPSHFP'\,G'YU+0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !117,^.]4U+1O#GVW3)HHYEN(8SYD>[<'D5<>W7K@T =-1
M7'W-]K6FZI::--?O?7%^T]PLMM;Q1/#"@3Y%#MM)W-U.3C/'<5)]8\4Z3HMQ
M+J=G<M%#?JOVF&.)Y_LA!)<HF5W*< \8P<XXH [NHYY1!;R3,KL(U+%47<QP
M,X [GVKC$\5%]*LGT_5X=175-36SM;HH 84*;FWJ /G&UL @<E<CM6G,OB'3
MH-;D?4()[9+?S;&:6,&5&"DL'50JD9 P??G- &Y8W:W]A;W:1RQ)-&) DR%'
M4$9PP/0U8K@9/%E]:^%?#.JZA)<QV=Y;"34+ZU@5S"Y12I*[2 I);) XP/6I
MM0\33Z=H^D7TNH27.E3O+]IU6PA638N3Y1*[2 ".&..",4 =;J&H1Z<MNTD-
MQ+Y\Z0#R(B^TL>&;'11W/:K=<1J.O:C;:)X=N[+5K:[CO-5AMY+B.)2)H7D(
M&,<*=H /'7/2K\&I7NOZYKEA97SV,>F,D"/'&CF25EW$MN!^49 P,'@\], '
M4$ C!Y%(JJBA54*H&  , 5YS'XQUS4-)\.W$+VUK<W.JG3;U##O4NN_++D]/
MD!QUYQFM[PYJ&IGQ-KVBZC>"\6R$$L,WE+&VV16)4A>."O!]Z .H9E498@#U
M)I:X[XB?:1IND_9[V:W#ZM:1N(]OS@R#KD'H0#CIZYJS'J-YJ/BB^T""_E@7
M3;6)YKA8XS++))G'52H  R<#DGMCD ZBD+*" 2 6. ">M<[X/UN[UBROX=05
M/MNFWTME-)&NU92F"' [9!''K6=K27;_ !.T&&/4;B*%[.Y?RD"%05V#/*GJ
M#W_#'- '1:3KMGK4E\EIYV;*<V\WFQE#O !X!YQR*TJ\O675K2+Q[J&F:@EH
MUE?27&# )/-*PHVTYZ*0,<<\]?7H&\17NIW]EI]HES$\NF1W\KVHB+C><*!Y
MIVX&&SP3TZ=P#L**Q_#,NMRZ.!X@MTBODD9,J5_>H#\KD*2 2.HSU%4EU*^_
MX6)-HQN2;)M*%VJ[%W)(9=G!QTP.AS0!TM%>;'Q3KY\'6>H1WD/VEM:^PR,\
M ^>/SS&.G X'/'Y5I_\ "0:CH/B/6;35;T7UI;:3_:B,L*QLF&9608ZCY>,Y
M/O0!TFKZ[9Z(;,7GG?Z9<I:Q>7&6&]S@9/0#ZUI5YIX@;4K[0O"6J7=_N^UZ
MM8326RQJ(TWN& 4XW<9 R2<\]*U;O6->U<ZU_82W"2Z?<-;6ZHL!CDD15)$G
MF-NP2V/EQ@<Y- ';45PMSJ/BB\\46FCQWMOICW.CFZD7R%F,$P95.#G#8)(]
M,>O%-G\27EKK\FCZGJCZ=>>;$MD\ENHMKU,)OPQ!PY.\8W#'R]><@'8IJ$;Z
MM+IPAN!)'"LQE,1$1!)& W0GCI5NN:M-4U!OB%J.DS3(]E%817$4:QA2K,[*
M<GJ?N_\ UJYP>*-=N_#>D:O;7:QWE]J?V.6Q:!66(&1E*@<-N4*"<MZ\ 8P
M>CNBNNUU#+Z$9%+7%B[\0WWC#5]%BU>*VBM[2":*5+12RLVX'AB0?N]\^P'6
MJNE>,-1U/0O#"E'^WZJDS2O;JFX"+ABH<A02=IYS@9XH [ZLU]<LT\0Q:&?.
M^V2P-.O[LA-BD _,>#U'3-<M-K_B/1=/GBU. >=<ZC#9:7<S^7N<2G&9%C.,
MI@GC&>.E.:VN;;XL:4)[Z2[1M+N"IE1%93O3/W0 1T[>O- '<U3U+4[;2K=9
M[HR[7D$:K%$TK,QZ *H)/Y5<IK(CE2R@E#N4D=#@C(_ G\Z ,!?&NCR75S:H
M-1:XM55IXETVX+1AAE2PV9&0.*LV/B;3=1U9--MFF:9[-;Y6:)E4Q,0 02!G
M.?YU@^'?^2J>-/\ KE8_^BVJ*\M;E_BK]FT^Y6R(\/A1(L0<HHG. JGCTZY'
MM0!W=%<!IGB[4[C0-'AE_>ZG>W\]D\T*(I(B,A+JK$*&(0<'C)S@XP=_P_)X
M@&H:C!JT,C6*E&LKB8Q"5@1\RN(SC@]#@9% '08P,"JFI7Z:7IT][)#/,D*[
MC';QF1VY[*.M96OZQ<6NKZ7I%HDWFWHED9X1&75(PN=OF$+DEAUSP#QZ<_JV
MK^+M'\%:_>7.V&>R?=97,R1L\L1(^\J':&&>N,'TH []3N4-@C(SR,&L[7-=
ML_#VG&^OO.\D.J9BC+\L0!G' Y(Y.*S-0U:[_P"$LTK15F:T@NK26<W"JI:2
M1=H$:[@0."6/&>![UQVLZEJVJ_"S6;G49XIME_';P.D.P2+'<HN_()R&QV Z
M&@#U:LS6]?L?#^EOJ-Z93;HP0F&,O@D[0#C@<G'.*Q(;W6+;QR=%N]2$]O>:
M<]S&R0*AMW5POR]<C#9^;/2N,D^U2? J]N;B]FN7EN"<2[>&^V\G(&>>ISGV
MQ0![#17*6^H:O9>/HM)O;Y+NUO+&2Y11 (_)='484CDJ0W<D\=:T/%FN-X>\
M/37T:*\Y9(85?[ID=@JY]@3D^PH LW.NV=IKECH\OG?:[U7:'$9V$(,M\W3I
MV]Q6E7":E:WEM\2?!_VG49+M6CO/]9&BE6\H9QM X/'!R1CK45QXCU>RN]*:
M2^2>6YU@65S!!$&MHXV9@H63:#O "DC<><Y H ] HKD8];N])\7ZG8:S?$V+
M6?VVQ?RU7"+GS5) Y9>"/8UO:(+XZ/;/J4C/=R)OD#*J[">=O  XZ?A0 NH:
MM!I[Q0E)9[F8,T5O" 7<*,L1D@8&1U/<#J13]*U.WUG3(-0M/,\F8$J)$*,,
M$@@@\@@@BN3U*VN)/BQI>W4)XP=-G90J(=@WQY494\'WY]Z?#K.K:[HNLZOI
MEZ+8V=Q/%:VYB5DD$7'[S(W?,0?ND8!'7N ='>:[9V.LZ?I4WG?:;\N(<1G9
M\JECENG0=.M%CKMGJ.KZCID'G?:-/\OS]\94?."5QGKPIYZ5Q\FKKK^L_#O5
M5C,7VHW$A3.=I-N<C\\T_P#M5-"\5>/]5D0R+:6EG+L!QN(CDP/Q- '?T5Q&
MHZUK&AZ7HNMSW@NX+N:&*]MO*5502X^:(@;OE)'#%LBFW&L:Q:W_ (GTN;42
MMU;VZ7>F/Y*?.C9 4C'S'S %]\C% '<U4L=0COVNE2&XB^S3M WG1%-Y !W+
MG[R\\&N<\/ZY=:_I^@20W;K+)"\U^#&G5?D9",?*?,X&,<*W?FLFX\2Z]'X/
M\87PO(/MFE7\T,$GV<;1&BH0-N>OS'DYH ]$HKCH]3UJQ\8:):7=_'<VNK6T
MS&$0!! \:JP*D<G.<'/Z=*RK[Q3K;>&M4U>UN1%>VFJ&S33S"K CS%0*1C<7
M(;=P<>V* /1J*C@65($6:022A0'=5VACW.,G%<?;:_?Z9J7B/3M7NWFGM8A<
MV!6-%,L+#"X '+A_E.>,D<4 =I17)Q:EJ4OB&T\,R7Y2ZBTW[;>7<<:;G8OL
M"H""H&=QZ'C'N:PM1\6ZU9:%XBB:X4:EH=Y#$)Q$NV>*5DVEEQPVUCG&.0/I
M0!Z317-76IW\7C^UTF*X'V2XTZ6?8\8.V165001@X^8\9JAX*N_$.MVEOJE]
MJT)MTFN89+9+4#S=LC*K;LY7&.G.1[T =I534]0CTNP>[DAN)E0J"EO$9'.6
M X4<GKS[5E>+M7NM%T^VNH8[DVOV@+>2VT0DDAAVM\X4@Y^8*#P< GBL+5_$
ME[#X N=<TC6[>]5;F,17/DJ28VD1-I& %8;CG([=!0!WM%<S>ZI>2^-5T);E
MK&W_ +.:Z2=54M*^_:0-P(PHY(QGD=NO-)XF\3/X(TC6&N[5+B\U**W(^RX#
M1M+L!&6/# 9SCH>/6@#TNJFF:A'JEBEW'#<0JS,NRXB,;C:Q'*GZ<>U<]IU_
MK$'C6_T&\U".[1M/2]@E-N$\HEV0K@'D<9Y.?>L)/%/B!_AYI.KK=P?;9]2%
MM,Q@&&4W#1@ ?P\ =B?QYH ])J.2W@F8-)#&[ 8!9037+6.I:O9^-;[1KV[&
MH1'35OX=L*QE&WE"@QU!P,9R?>L:/Q+KMWH?AK4K6_3[3JUZ+:>U-NK+"#NW
M;0,-E-O.3ZT >C45%/,MK:R3RGY8D+N0.P&37"7'B364\!1>,XKE6&!<OIYC
M7RS"6QM#8W!PO.[.,@\8Z '9:AJL&GO#$R237,^[R;>$ O)M&6(R0, >I'4#
MJ12Z3JEOK.F0W]J)!#+G EC*,I!(((/((((KD-2CFN_B;H$L.H7$23:=<21@
M(GR#]WP,J>O?.3Z8KL]061]/N%BG>"0QMME0 LIQU&01^8H JZOK]CHD-O+=
MF4K<7"6R&*,N-[-M )' Y]36G7D>+I_A)X;GDNY)Y9KZR<><!A6,WJ ">?4D
MUV&GW^L0>-K[0;O4$NT?3DO8)#;A/*8NR%< \KP#R<^] '0Z9J$>J6*W<<-Q
M"K,R[+B(QN-K$<J?IQ[5;KSVR\5:P?A_8:S<B:=VO98[Z:T@5GBA621=ZI@C
MC:@/!X)/6NH\,ZC'JNF/=P:K'J=L\I\B=5"D)@?*P &&!SV':@#:JIIVIV>J
MP2364ZS1QS/ Y7LZ,58?F*I^)=1?3=%D: N+J=A;V^R,NP=N-P4 D[1EB!V4
MUQWA.6T\-^.[S0+1+B+2]4@6ZLQ/!)%B9 %E4;P"20 Q- 'I%%<M=ZM>W'BZ
M]T9;S^SHK?3UN8I0BDRL6(+?,"-JX&0/7K6 GB7Q/)X2\+ZFUS;0W.JZC#!(
MAM< 1N3CJQX.W/8D-VZT >D5');P3,&EAC=@,99037(F_P!:MM6B\/2WUQ>7
M0MGO);NU@ACDV&3:BA7.SCG)P<\=*ABUWQ':V^F:9JMJR:G>W<T22P^47>"-
M"XD"EM@<C P3@<G!X% '<48YS7GVL:MXOT;POXCNYOW0LPLMA=W"1-)(A^\K
M+&=H*GH<<^E7+R^\0V?BS2-/&JPO#J\$^5:U7%LT:JV4YRV0<?,2,\^U ':T
M5P$'BO5-.T[6K>[F6]O+/58M/MYS&J%Q+LVEE!"Y7>?0' Z=:T$G\56^H7JE
M93IILFDCN+U8#)#..VV)AN4CU&0>] '7TFY2Q7(W 9(SR!_D&O.;+Q#XA71_
M"&M7.HQ2QZI<P6UQ:BW501(&^?=UW CM@>W<Z?AM+MO'_BSS=1N)8X);=5C<
M)C:T6X#A<@ L<8Q[YH [2BN>\:76J:=X9N=1TF8I-9@32($5O,C!^<<@X.W)
M'TK,_P"$G>/QW8VIU R:-?6)EB;RU"K-C>%+XZ&/YL=?P- '4ZAJ$>G) TD-
MQ*)IT@ @B+E2QP&;'11W/:K$DJ1JQ8DE5+%5!9L>P')KB]3U?6]/T;0KQ;P;
MK_58(Y%E@7<()7^5., $+@$XSG/2GZ>EV_Q4UE6U&X,,5E;LL1";0"S_ "_=
MR!GG/7U- '2:)K5IX@TJ/4K'S#;R,ZKYB;6^5BIX/3E36A7DFB:AJ^B?#O3]
M7M+Z-;:+4GCDM#"")4>[9&RQY!^;C&.G>NSBU.\UWQ%K>FV=\]C%I8BC#QQH
M[22NNXD[P1M P,#!///2@#J**\[LO&.JWL/AZ1V2&>75I-,OXE0%'*!\LN>1
MG:._<U+K.K:I(OCVQ74)8TTVPCGM9(T0.A:*1F&<=,J!GJ!WSS0!WRLKJ&4A
ME(R"#D$4M8_A6*2+PMI8DN))RUK$P+A1M&Q>!M X'OS6Q0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !6-XGT%O$>D?V>+O[,IECE+B/><HP88Y'<"MFB@#GO$7AA]=%A<PZC)8:K8
M,7M[R",':6&&!0GE3@<$]J='H6I1VT#'79)=12<32W,D"[9 %9?+\M2 %^;/
M!SGG.:WZ* .0N_ %G>:=?1/=-#>W5ZNH+<VR>7Y,Z@!61<GL.<DDDGGTT+?0
M-0_LV[BU#6GOKVXA, N&MU18T(YVQJ>IZDYYP.PQ6_4<\OD6\DVQY/+0MLC7
M+-@9P!W- &#8^';[3-/TFTM-50+I]NUL1+;;DF0A0-RAQR-G4'N:;I_A:71K
M:TATO4$A6(SM+');[HI3*P8_*&&T C@ \ XY[[EC="^L(+L0S0":,/Y4Z;)$
MR,X8=C[58H Y%_ T:Z/I^GVMZ(%M-1&HDB#(:4.7VA<C:F3C'H!SZWCX;FMO
M$%WK&EWZ6LM]&BW<4D'FQR,HPK@;E*L!QU(/I6K?WXL!;$VMU<>?.D'^CQ[]
MF[^-O11W/:K= '+2^"XEM-&MK.\,,>F7?VP%XM[32G=DL<CJ78G'K5^PT&2R
M\3ZGK)O%D^WI$C0^5C8(P0N#N_VCG^E;5% &/XDT(>(--CM1=-:RPW$5S#,J
M!MKHP89!ZBJLGAF:/7(];L=1\K4&MQ;W330>9'<*#D$J"N&!Z$'IQ6O>WXLI
M[2(VMU-]IF\H-#'N6+@G<Y_A7C&?<5;H SM&T>'1K66*-VDEGG>YN)6&#)*Y
MRS8'3L .P JIJOAYM1UW3=6@OY+2>R62,A8U;S$?&1ST/RC!K<K*U+Q!9:7/
MIL4PFD_M&=8('B3<FY@2,MTQ@$T 98\(3"R\16QU)2-;=VE;[/\ ZK<@0[?F
M_N@=>]0W?@F=_P"RKK3];EL-5TZV%H+N. .LT(Q\KQDX/3/7KGVQU]% %/3+
M%["T$<MU)=3L=\L\@ ,C'O@< 8   Z "LS4O#D]SXEM]<L=3:RN%MC:3#R5D
M$D6[<,9^ZP/?GZ5L7%W%;-"CDEYG\N-%&2QP3^@!/X5!/JUO!#>3;99([/\
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MN;!GA:"_@L?*W[6W%57=M(!5/F'!R1VKI])UVTUN6_BMXYE-C<?9Y1-'M^?
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MVY ME1'#$'[N>!D#OD^HZ5=\,:"_AS2FL#=_:4\Z256\K8078L1U.>2:VJ*
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M'&<5K:O8RZGI5Q90W;VAG0QF:-064$8.,]#[T >9>);L2QKXTM8+U[^QO1/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6@ZNJ,MB]OK:-+81Q_,,3IF:4D$_-U!&!T')KV.C ]* .&L;VQD^*^I3^="
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M4 >7;>0R'*; GWCC"X'/ _#U.D*@D$@9'0^E $-C$L%A;0K&T2QQ*HC9MQ4
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MCT_[=I5T+BVWF,N%*X8=000#Z?G6E5:RLH[)) A9WE<R2R-C+M@#)QQT 'T
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M;PK9Z;8Z#%%I%O+!8%G>%92Q+ L3N^;D G) ]#6U110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5
M+4]8T_1K=9]1NX[>-W"*7/WF)P !WJ[7&_$]HO\ A#7CDVG?=6V$(R6 F0MQ
MWP 2?:@#;MO%&C7EM)/:WRS)'.;8B-&9C(!DJJ@98XYX!XYK \9^(1/\/=3U
M30=4DBEMF"%XAM=&#JK(P894X/3@]*C\9W<>FZWH&MW*W#Z(BSQ7,UH[CR3(
M$V2'8<E?E(S[UD>)UT63X<>(KO1()A%?O$WGR-(6NI-ZY*A^3@=QUP?3- 'H
ME_JMGIN!<R/N*EPD432/M'5MJ@G R.<8YJ'_ (2'239VEW'>)-%>9^S>2ID:
M7 ).U5!)P <\<8YKC]9U6RT;QTVH:Q)=)I&H6$4=M>VTDHC1T9R48QGOOR,_
MXTR6XTG1)O#EO8Z>^F:?/)<M!?2Q/))#D#A0X)1I,D_,#P.F3P =I%K^ESZ<
ME_#="2W>3RE*JQ8OG&S;C=NR#QC/%/BUK3YK2>Z6XVPP/Y<ID1D*/Q\I# '/
MS#C'>O--+73[GP_?65Y>WVGRKXCN'@O=I1K>0EV1V+#&" 00?[W.,U->W>N3
M>&I;B\C&HKI>LPRS7>GJ4-] JC+J%/WER,[3C*>U 'HMAK6GZG/<6]K.3<6^
M/.ADC:.1,]"58 X/8XP:6_U>RTU@MS*P<H9/+CC:1]HZMM4$X'KTK!\,S^'-
M7U>75]$CN;B4V_DRWLKS$ ;@1'^\/)ZGCI^-9UYK,/A?XBZC/K?F1Z?J=G E
MK=>6SHK1EMT1P#@DMF@#K?[<TPV-M>I=I+!=?\>[1 R&7C.%502QP"< <8/I
M4)\3:*NESZD^H1):6[%)G?*F-AU5E(W!O8C-<G<-%I'B?PSJHLOL&@"WN+95
M\ORTM6=@5=UP-@<#OC&<'%9VNP>9;?$#5K=@=/OK**"%EY6XF6,@E/[W55R.
MISZ4 =Y:^)]%O=1&GVU^DET8S*J!6^91UVG&#CN!R.]4](\9Z;JD.JW#L]M;
M6$\D;2W$31C:@7<Q+  '<3QUQCBL*ZN+;_A)_A^T<L>Q(;@$J1A08 H!],D8
M'N*RTU&/3?#/C6WFT[[;/'JUQ,]K+ S)Y;R)M=@!RH!W8!Y"GZ@ ]#M==TV\
MGG@BN"LT$8EECFC:)E0]&PX!V\'GI67INOZ+I^@17<OB WEK+</''=7!R78N
M1L& ,@'@<=JP-)U"W?XG_:A>SW<,^AJ%NI(2J,1,2=N% "@=_P!2:P/-@;X2
MB$LI?^V<F,]=OVO=G'IMY^E 'J&G>(=)U:]GL[&]2:X@ 9T (^4]&&1\R^XR
M*:GB/29+Z&S6[ FG+" LC*DQ'4(Y&UB/8FN5U4_:_B/<16<Z":?PW+#%(K<>
M8T@*C/KCGZ<U1\,WGA[5[/1=,NK+4&UW37BW64SW ^S2Q@ R<G8% R1Z\#J<
M4 =!XW\10V/AC619ZC-;WUK Q$D$181R;<JK-M*J3D<$@\CU%;^G7'_$CM+F
MXE_Y=D>21S_L@DDUY@NJ167P^\5^']4+1ZVIO':)T):?>699%X^9<$<]L<XK
MTO1)XSX;L)B2D8M4),@*8PHSG.,4 9NF:_HNG>'+*YF\0&\MKB9HH;RY/S3,
M9",# &<'C..@K1TWQ#I6KW5Q;6%XDTUO@R( 00#T(R!D'U&17F$$L'_"H]$@
M=EWKK"EXVZA?M;,<CTVG/T-=?'<0O\8'9)4(;0U0,#P6\XMC/K@YQZ4 :NK>
M*;72=?TS29(YVEO?,8LD+L%55)XP#DYQP.@Y..*P]/\ %,.D:_XHCUS5I#;V
MUU$L'F+N*(8E8\(O"@MR<>F34_BF=++QSX2O9PXMT^UQLZH6 9HUVKP.IP<>
MM94,]L;OXCL9(_WJ@*21\X%N%X]?FR/KQ0!UNI7]@VHZ*AUIK>2:7?!#"P(N
MP5/!X.5[YXZ5:EUW3H+G[.\[;_.6 L(G*"1B $+@;0<D<9[UP*W,/]E_#3=*
MNZ)HO,R>4Q;E3N]/FXY[U)>RRZ;K5Q>:#J(N!+J:K>Z#=*&+R>8%,L7\2] _
M<<$]L4 >EUQ=GXKNW^(;:;<*%TF\A>/3Y/[\T+$2_GD_@@]:W/$VKKH^CNZS
M)'=3D06Y?H)&(4,?]E<[C[ UQ_C'P[+I7A"TO[+5IYIM$>.YLDE6(!RN 5RJ
MACN7/?D^M '?WE_:Z?'&]U*$\QQ'&,%F=CT50.2>#P/0UG#Q;H!CNG.J0)]D
M!-PLA*/%@X.Y2,CZ8KF?$^N:=<6OA;Q)'<F(17>]-\;-&NZ)MZ2;02K8R <'
M![8R116_T6]\-^.+VSU>VNKS4+>222WB) C_ ')C10& +$XZX&2<8H [6U\6
M:%>FX%OJ44AMTC>3 / ?[F..23Q@<YXZU8L]>TR^^UB&Z"M9_P#'RDRM$T(Q
MG+*X! QSDC%<5J[-'\/_  MJ%K!+<6EA):RWD=H2)!$L95L;<'*E@<>U0ZI%
MI?B#P[K>H^$[>ZO+R2U19+EY)LS!'5O*&\Y)VANG3('>@#MX/$>DW%U):K=[
M)TB\XI-&T1,?]]=P&Y?<9%54\;>')%M&3582EV_EPN%;:S9*X+8P,D'&<9[5
MBZ%J?A;7M4L]3L8[R6]LXW\R6ZDG_P!"4KA@Q<[<D\8Y]>U<JCP?\*/LX"4\
MW[<I,1'S?\?>XY'7[O/TH ]/T_Q%I.JWTUE97J2W,*AWC"D94G&Y<CYESW&1
M2+XCTEKZ&S^U@2SL4A+(P25AU5'(VL?8$US&JR"Y^)426EQ&)9=!GBCD5N [
M.I09]>X]JR_#%WH&IZ=HVC7UCJ#:[IKPAK&62?$$L?R^;UV!0,D=L''?% '8
M3>-_#=O'-))JT.R"4PRLH9@C#&<X!P!D<].>M+J'BNSL?$6GZ.4F>2[C>7S$
MA=E"J!C! .221TZ#KC(KC5FMF\._$D!XR\UQ<^6,C,@,"JN/7+9 QWJVMW%;
M:]X%O92YMSIDT'F(A<>84CPO ZG!X]J .^N[VWL8A)</M5F"* I9F8] %&23
M[ 5R?C+76/AC[=I.H3P-!?P03;4V'F1 RL&7(X;MBK_C2"RN=.L8KR^GT]S>
M*;:]A./L\H1RK'/&W *G/'S5QFL7U_=>![Z#5GM;F6/5[>-+VW3:EZBO&3)M
MZ< 8../E/I0!Z)I_B+2=4N[BUL[V.6>W4-(F",*>C#(&Y?<9%):>)-)OKJ"V
MM[O=)<*SP9C95F5>I1B ' _V2>.:Y?4;R&/XF33QHMV!X=D B0@^<WF[A&/<
MC/'H:PK#4[:YU;P'>I)(8T,T;P06S+#:,8"!$H"YR#QR2>,\ T ='I][J4L_
MC:!]3N&-G*!;2$)F(>2'P!MQU/I5_P .^(((/!7AV\UB]Q/?Q01+))DF69UX
M''<\UC:9=0#4/B QF0*T@923]X" +D>OS<?6KWA75M/TWP!X8%ZYS*D%H@$9
M<B8K@ X!VG@\GI0!TNLZK;Z'HUYJEV3Y%K$9& ZG'0#W)P/QK'U&Y%MX4\_6
M]9DTN>Y\MGFA8 PL2#Y: @Y_N],GFJOQ2MYKGX<:NL*EF18Y64=U216;] :9
M\3)HI?AW>%&#><T!C Y+_O4;@=^ 3^% &MK.J/H6HV%Q+(6L+VX6TE5O^64C
M#Y'!]"1M(]P>.<Z&J:M8:+9->:E=1VUNI +N>Y[#U-<Q\25^W>%+6WMF#RW>
MH6L<!0YRQD!R#] 34OQ1Q_PK;6<C(V1_^C%H U[/Q7H5_J<^G6VIP27<"EWC
MR1\HZD$\,!ZC-,M/&'A^_O8+.UU2&6>X,@B10?F*9W<XQQ@_7'%86IK9ZSXQ
M\+W6E20R#3O.EN)HB-L,)CVA6(Z9)&%/H?0UF^'[:74OAUXGL],91?37-]Y8
M'!)=FVG_ ($, &@#M8?$>DW%U!;QW8WW&?(9D94FQU\MR-K_ / 2:YJR\3Q:
M/XF\51:WJTAM;6: 0"1=QC5H@S85%Z GDX],FLZ]GA\2>#?#NFZ<=NJPW-H3
M;XQ)9M&1YC.O50H##)ZY&.HJ:WN+;^W/B([21XDBB"L2/G M]IQZX;CZ\4 =
M3J>H:>]WHH.M-;-/,)+>.%@1=@J<*>#E3G.>.E<]9^+;;1/$GB>'7M9;[/;W
M,*VXE&2BM$&. B] 6ZX],FLE+F$>'?AJK2J&AG@\P$\IB%E.[TP2!S6OI]Y8
M:7XS\8KJK)"+IX'B25>;B,0!2$!^_P Y&!GGB@#?U+4M-FFT4C7#;?:+A7MU
M@<$78(.%/!RISGMTZTFG^*;74?$VHZ+'%.'LA&"[0N SL&)YQ@  #!.,Y.,U
MP\=C+H?ACP#87_[JXAU99GC<\Q1L)2 WIC>H/O71Z-.EK\3?%%O,'62[2T>
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M=U>\;; IB;+'&<=.. 3SCH?2C4;"VUC2;BPND+6]U$8W4C!PP_0UR?@U-5O
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M(=5^'NM(2-\EN41>[,>@ [FLWQ7>6TMKX-D2>-E&KVTA(;.%"."Q] "1D^]
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M8V?Y\$ C=@$ =><@5!ID=I:>*HXAXEU2:2>)YK?3+DL0B$+DMN&XX/3<<C-
M'7T5R/A/49EE\4MJ6H22PV6J2(LMPPQ'&(T..P &36Y9Z_IU]J#V$,TBWB1B
M4P30O$Y0G&X!P,C/&10!I456O[^UTRS>[O)EA@3&YSZDX  ')))  '))J&PU
MFQU.XN;>VE8SVQ430R1-&Z;AE258 X(Z'I0!?HJ"[O+>PMFN+J58HEP"Q[DG
M  '4DD@ #DDUS7B+Q!!=^%/$7]EW\]OJ&G6CRNOEF*6,["RY5US@XZX^AH Z
MRBN<T'Q1IEW'INFM?%]1EM$DPZ-B4A1OPY&UB.X!)'>K9\4:.+I+<W9R]Q]D
M63RG\LS?\\_,QMW9XQGKQUH V**P;SQGX>L+NXM;C446>W:-)4$;L4+DA<X!
M[CKVXSC(J>\\3Z/I_P!H-S>;([9Q'/*(W:.)SC"LX&U3R.I[CU% &O16;+KN
MG1013><\HE0R1K!"\KLHZMM4$X''..XJQIVHV>K6$5]87"7%M,,I(AX/;\\\
M8H M451O=8LK"80S/(TQ0R>5#"\K[!QN*H"0,\9JK-XJT*#3[._DU*$6EXZQ
MP2@DAV)QCCISUST[XH V**HZ5K%CK=J]SI\YFB21HF)1D(9>HPP!J/4=?TW2
MC*+N=P88_-E$<+R>4G/S/M!VC@\G'0^AH TJ*SY=;T^**VD^T>:+I-\ @1I6
ME7 .Y54$D8(YZ<CUJM+XLT.'16U>34(UL4<QM(5;*N#@J5QN#9XP1F@#9HK#
M_P"$PT$7LUF;_$\4?F;#$X\Q<XS'Q^\YX^7- \8: =&;5CJ*+9)*87=T9660
M'!4J1N!R1P1WH W**QK#Q5HFJZI-I=EJ"/>QH7,>UERO3<I(PP]QD5C>%-9-
MMI6OW.L:C))%::S<VZS3G)"*RJB@ >X  ')/3F@#7UK1M0OM0L]0TW519W-J
MKH$E@\Z)PV,Y7*D'C@@]SZU8T_3;J*Y%[J5W'=7@C,2M%!Y2(I() 7+'DJN<
ML>@QCG);Z]IMW]M2.X9)+, W"2Q-&\8(R"58 X(Z'%9FG>(=#TSP[I<DFNR7
M5M=/Y-O>79)>=BQ')P._&2 ,"@#IJ*Q(?%FCW,&H2V\\LIT]=UQ$MO() ",@
MA"H)!QP1Q4GAK74\1:%:ZDD4D7G1ARCQLH&1G )'S?49% &O16?)K>GQ:PND
MO,XOFB,RQ"%SN0=2#C!].O7BH(/$VDW.F76HPW+M:VKLDS^1(-C+PPP5R<=\
M#B@#7HK"74=/;Q3(%U2[:ZCT_>^G!6*!-P/F;=N=_.W&<]L5RNO>+Y=9^&FH
MZQI<U[I\T,N$81M&2HG\L?,1C)'4*<@T >CT5E6/B/2=1U273;6[WW<4?FE#
M&R[DSC<I( 9<\94D5+KFKPZ#HMWJEQ'+)%;1M(RQ(68X&>W3ZG@=Z -"BN"U
M;Q%+))X0U)+RXM+:ZN@MU$R-$C PLYSN )&<8[&NIT[Q%I.J6]W/:W8V6;%;
MCS4:(Q$#/S!P"!CG/2@#4HK,M/$&FWNH_P!GQ3NMV8_-6*:%XBZ=-R[P-P^F
M:/$;S0^&]2GMYY()H;:26.1,95E4D=00>: -.BN(T?[;J/@?3=0F\27D%_>6
MT15SY>WSG "_+LZ;B.*ZJ]U:SL)4AF>1IG4NL4,3RN5'5MJ G'OC% %MT26-
MHY%#(P*LK#((/8U5TVP&F6:V<<K/;Q?+ K=43LN>X'0=\8SGK5&/Q;H<MG;W
M:7NZWN+C[+%((GVF7.W;TX.>.<5;&LZ>=3GTXW&V[@A\^1'1EVQYQNR1@C(/
M(/:@!TNG)<ZG!>7#>9]FR;>/& C$8+>[8) /8$^M4?%NA2^)?#EUI$5TEK]H
MVAI6B,F &#<#(]*ELO$NDZA=06UO<L9;F(S6^^%T$R#&60L &'(/&>#GI67X
M/NKN?4O$T-U>37*VVIF*(RD'8GEH<#   R3TH Z>(2")1*RM)CYBHP"?89-/
MKD?B5J%]H_@F[U/3;R6UNH'BVL@4@AI%4Y!!'0FM&6REAN[-8M?NS,TH(AE,
M;+*@Y<$!,_=SSD<XH W:*Y^X\;>'K9+MGU#(M'\NX\N&1_+.,DG:IX (R>@]
M:GC\5Z)-J5O81WZO/<C,!"-Y<G&<*^-I..V<T ;-%<Y=^//#-D)S/JJ 02^5
M+LC=]C<$YV@\<CGISUJIK^H3_P#"1^$9+'4)/L=[<NKI$P\N9/*9@<CKV[XH
M ZZBLJ^\1Z5ISSK<W+ 6^//=(7=(<\C>R@A>"#R1P<]*?)K^F1:I:::UR?M5
MVA>W18W82*!DD,!M( ]Z -*BLB_\3Z/I:7CWMV85L@IG9HGPN[ISCDGT&:B/
MC#01>O9M?A9UC,@#1.!(N<?(<8?D@87)H W**R['Q%I.I:;/J%M>*;:W=DF:
M16C,;+U#*P!!Y'!'>F1^)](DENH6NFAEM8A-+'<0O$XC_O!7 )7/&1GF@#7H
MK!M?&?A^\N+*&WU .UZ/]';RG"N<9V[B,!L?PDY]J33/%-OJ?B34](C@N4-B
M8T+O;N S%2QYQ@#&,9QGMD8H WZ*P/&7B/\ X1;PY-J"0B:Y9UAMXB<!Y6.%
M!]NY^E(^BZL-,+IKMT=6";A*0ODE\=/+QC9GC^]COGF@#H**Y#0?B#I6H^&]
M.U+49XK&>Z=H&B8G E7(8>PXSD]JTK/QEX?O[:]N(-23R['FY\Q&C:,>I5@#
MCWQ0!=UFUU&\L/*TO4AI]SO5O/: 3#:#R-I(Z^M2Z;8+IMBELLCRL"SR2OC=
M([$LS'''))/%9=KXV\.7FH6EC!J:-/=H'@!1U60$9 #$8W8(^7.?:K5]XCTK
M3GG6YN& M\>>Z0NZPYY&]E!"\$'DC@YZ4 :M%9&H>*=%TN:"&[U"-)+B-I8@
MH+[U R2-H.>.GKD8ZUFV?CG3=0U^+3[1+J6%[(78G6UE(8,P"X&W./O9)XSQ
MG.: .IHK&;Q7HJZ,=7-X18+(8FF\E\*P;:01MR/FXY[TEWXLT2QO;BSGO?\
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M.,[=Q& V.=I.?:MZ@"EJ]M?W>FRPZ9J L+ML;+@PB4+@@GY3P<C(_&C2M/\
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M659L(P"EAD8)&"".XR*T: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD6.T=(;=C$H$2*%X ((Y)Z<FNC\%2(VM^+ #_K-4,B?[2^6@W#U&01D5V-%
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MF) 1E<$]#@GH.HKIK>=+F!9HQ(%;H)(V1OQ5@"/Q%>4W,,\W@3Q:L5M<._\
MPD#72QK"VYHO/C;>HQDC )R/0UZI:W*7ELEQ&L@CD&5\Q"C8]<'D?C0!-6;K
MU]-8:3*]J%-Y*1!;*W0RN=JY]@3D^P-:5<Q='^W/%:VD=U<VJ:9'YJR1Q@>9
M,^5X+J5.U<@X_P">GM0 O@/6KC6?#$7V\G^T[*1K.]!ZB6,X)/U&#^-7K[Q3
MI&GBZ:XN'$5FRI<RI$SI"QQ@,P! /(SZ9&<9KE;)7\*_$VXA\R[NK'6;=9)I
MFBR(KE>!N**% 9?UQFLG4;O3K6Y\6:'<W5W9V>HWA:5FT^:9E+(GF,C("N#V
MSTZ\]* /17UZP6"&5&FE,ZL\<<4#M(RKP3M R!TY([CU%4SXT\/BTL;K^T%\
MB^D,4#^6^"XSE3Q\I&#P<=*Y;4KZST_Q'INM&*]NO#EUIB6L=S9&1O)=')&X
M)\V"#CIU%&IPV4,?AA].TR:SM3KBW91HGW;-C RN#RF21U]B<<@ '9:;XETO
M5%O3!.Z&Q/\ I*W$3PM$",@L' (!'.:9#XHTJ:\CM!+,LTL+3PH]O(IF1>I3
M*_-]!S[5Q.N6%WJVK>/+2P23SKNPMD@.TA9F0/N0,>">0.O>NFT+Q)9^(YK-
MHM)N8[R!#YYN;1H_LA*_,H9AR20!A3TY/2@#1MO%&D7F@RZW;W,CZ=%NWR_9
MY 1M.&^4KN.#Z"M9'$D:NH8!@"-RE3^(/(_&N$BTF[L_&UUHD48.B7\JZNQS
M_JV4_/'CT:01MZ8W"NICU^SD\1RZ%MN%NXX1-N:(B-UXSM;H2,C(_P#KT :E
M9NOZS!X?T&]U:X!:.VC+[1U<]%4?4D#\:TJY#XH6LUU\/=2\E2[0^7.RCNJ2
M*S?H"?PH GU:6&P\+*^OZK>6DL[Q&:XM&8%9"P(1-H.U<X7W'4Y.:NW%UI[>
M+[.U?4+M+\6TA2S0L(9$R,LW&"1QCGC)K)^([_:? DRVZO,TTMNT:Q(7+ 3(
MQ( ]@32:A(LGQ/T*9 [0BPN%:0(2@+E"H+8P"<&@#3TW4W@\37GAVYD:1T@6
M\M9&.6:$L5*L>Y5AC/4AAG)R3OUQTD+W/QABFC!\NTT4B9AT!DE^53^"L?PK
ML: *&L:S8:#ILFH:E.8;6/&Y]C-C/3@ FJ5GXOT._P!8;2H+PF["&1%>)T$J
MCJ48@!Q]":S?B?\ \DVUO_KBO_H:U!J<<.O>)_#%QIX++ISRW%Q-L*B%#'MV
M'/1B2/EZX!XH UK3QIH5]?1V=M=R2323/ !]GD #H,L&)7"]#UQG!J9/%.D2
M36J"X=4NW\NVG>%UBF;T5R-I)QQSSVS7+^';2>_\+^,;"VWP75W?WQ@:1"F1
M)D(XR.0?6J=RLGB#X<Z5X>AMYH-9B:UA>%HF5K9HF7?(>.%VJQ![Y ')H T;
M;Q%'HOC/Q:NI7MY-;0+:O#$$>8QJ49G*HH.%Z9.,=,GI6WJ>JZ1<+H4S:K<P
MI=W44EFUJ6"W)(.U'(!&T@Y(..GM6+92K'XQ\;RR*ZQRV]L(W,;8DVQ,&"G'
MS8) X]:Q8=Z>"/A_"\,XEMM1MVG0Q-NB55<,6&/E R.3ZT :UOXGM]!\8>+(
M]5U"[DMH6M6ACV/-Y2F,LY"J#M7)Y.,=/:MS4M8T:[AT.?\ M>XBBN[N)K-[
M1F"W#'.(W(!^4\Y!QT]JS+*ZBTCQ[XIEOXYHX[Q;5[9O)9A.$B*L$P/F(/&!
MS[5@G2;G1?"?@^RN()$ECUU+N2%$+?9XB\C<XS@*& )Z9H [2Q\4Q7OBW4M#
M6VN5^QI%^\:W?#,V\GG& N%&"<9.<9KH*X[37>T^)VO"6"XVWUM:&WD6%BC!
M%<-\V-HQD=3WKL: ([BXAM+:6XN)4BAB4O)(YP%4<DDUG6_B/3;B^BLO,EBN
M)HS+"D\#Q>:HZE=P&<=QU'I6=\0--OM6\#ZE:::ADNBJ.L8_Y:!75BOX@$5F
MZI+'XKU+PO/IJRJ]I>?;+EGC9#;QA&#(^1PQ) V]>IZ"@#9M?&FA7E^EE;W4
MDD[W#6N!;R8611DACMPO?KC.#CH:WZX[P$P#^) 8W1I-:N)DWQE=Z-MVL,CD
M'!YKL: *6JZK9:)ILNH:A*8K6$9=PC-@?0 FJ-MXLT:[%R8;F1A;M&K?N'&\
MO]P)Q\^<'[N:J_$ ,_@+6HD1WEEM7CC1%+,S$<  <FLCQ/Y__"/^&]5M;2YN
M[73YXY;FWM]RR^68F0E0,'*[NGUH Z2'Q1I,T=XWVAXWLG5+B&6)DD1FQL&P
MC)W9&,9SGBJNL>+[/2]$U._$%U))81AG@-NZMD@E<Y'W>.6Z#Z\5@3IX;U?1
MM1O8M*U'['<^1%/>%)EG8^8NTJ&!8^6<-G&..,\U1N8-;N/"?B[2VN7UJV2R
M LKX18EFR&)C)'WRO'(_O>O  .O;QCI-M%8"]FF@GO4)BC:UE4N57<P *Y[<
M#OQC.:BMM<T;5]>TJ6VU*]$\UK+)!:[72.5,C+.I7&1CCGO6'?7T5YKG@:ZC
MAN?)A>4R,]NZ[ 8"H+ C*C=P"<=/3FM'56_XNAH#A'*1V=RCN$)56;9M!.,
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M.6:U^&FJ^$K^VF?646YMTB\LDW+2,S)(IQ@J2X)/;!SB@#T :U8'6'TD2O\
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M@\BNHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHJM?7]MIMJ;BZDV1[@HP"2S$X"@#DDD@ "@"S
M161;>)=,N);^%Y6MIM/0274=RNPQH1D,<\%< \@T0>)=/FO[:S?SX)KM"]KY
M\+()P!D[2>^.<'!QVH UZ*YF7QYH<5O>S[KQX[*8PW)2SE/DD $EAMRH&>I]
M#C.*MP^+-)GU:VT^.2;?=JQMIC XBGP,D(Y&&..>* -NBN:F\>:'#!>S;KR1
M+&4Q76RSE)A( )+#;D*,]3Z'&<59B\6Z1/JEK81RS%KL$VTQ@<0S$#<0CD;6
M..>* -RBL4>*M+.GZE?;YO)TR1HKO]PVZ)E 9N,9( (.1FFW'B[2+6YL[9Y9
MS->0&>W1+>1C(F ?EP.3R.!S[4 *V@RGQBOB#[8@"V9L_L_D_P !</G=NZY'
MITK;KF+WQ+HFI^#]1OI;J]M[*/?;W+112)/ PX8$ ;E(XY]ZU&U:SLX;.%3/
M/+/%NAB12\KH ,L?S&2>Y'<T :=%8</BW1[C3[2\M[AI5NYC;PQ+&?,:49RF
MT\@C!SG &*H:SXXM+'PGJ.LV<,T\EI*UL\)B(,4P(&''8 D?7/'6@#JZ*YZ^
MU+3)=;T*.XGU&WNYI)3:PA)(TE(1MPDXP< 9 //0U'<>.]#MQ?DM>2?8'V70
MCLY6,7&2S#;PH'<\>F: .EHK.GUNQA^Q!9#-)? M:QQ#<TH"[B1V  P<G Y'
MJ*9I'B#3]<\\6+S,UNYCF$D#IL<'!4E@ 2#U )H U*@%I%]M-VVYIMGEJ6/"
M*<$@#W(!/K@>@J>LLZ_8_P!MS:/^_-]%!]I,?DMS'G&0<8//''>@#4HK%M?%
M6F7FB#5[=KA[,R^2&$#[B^_9@+C/WN.G6J\6IZ:GB/5VBFU"6^MK6,SVNU]B
MK\VTHI !)YY'% '145YKK'B>36O 6F:Y$]U8,U_;EMK-&IC:8#!/1AMZ]J[3
M3?$>GZIJ5SI\'VB.ZMT61H[B!XBR$D!U# 97((S0!K4444 %%<S>>/="LGO4
M=[N1[%PMRD5G*QBXSN8;>% Q\W2K%SXRT2V_L[-S)(-1C:2T,,#N)0%W<$#D
MX_AZY(&* )+70[A-;EU"]U:XO8Q(SVELZ(J6VX8."!ECC(!/0$^N:VJQ8O$]
MA<06[VZ74TL\/VA;=(&\U8\XW,IQMYX&>O;-1S>,=%ATBVU7[1(]E<2B%)(X
M7;;(3MVL ,J<\<XYH WJ*IS:G;P7L=HZS&:2%I@$B9AM7&>@Z\CCJ<\5CZ'K
M&C6WA.+4+:_NI]/:5UCENB[RNYE*[0"-Q.[@#&>E '245P]GJKS?%2ZBWW\<
M":-YKVLV_"OYH^94Y!RN/N_3KFKFG>)O#^E>%X=06_O9=/ENGB2>Y61VWF0@
M@DC*C=D#=C@4 =9161IWB33M3U.XTZ$W$=U!&)3'/ \1>,G ==P&5R,9JM)X
MST:*&WN'DN/LMU*8;>X2W=TFD!(VKM!)S@XXP<<9H Z"BD5@RAAG!&>1BFRR
MQP0O+*ZI&BEG=C@*!R23Z4 /HK@M=UU;OQ%X2-G)J$,5S>]P\<5Q%Y;'..AY
MVGD ]ZZ2]\4:;8?:GD:9X;-MMU-%"SI < _,1Z @G&<=\4 ;-%9]QK5G ;=4
M=KB6Y0R0QVZ[VD08RPQQMY')XY'J*HP^,=%N+;3[B*XD:*_N/LL+>4W^NY&Q
MN/E/!Z^E &]162_B338[G4K>2299=-C66Y7R')5&SAA@'<.#TSTJ@GCO0G%@
MYFN$@OU!M[A[=Q$S%=P3?C&[';U&.O% '2T5CZ;XFTW4YKZ&-IH);(!IX[J%
MH65""0^& ^4@'GVIL?BG37U"WLG^T0RW4;26IE@91.JC)V<<D#G'7':@#:HK
MEQ\0- -NMR)KDVWG_9WG^RR;(GW;?G./DYXYQ4[>)P/&W_"/BTN,+:>>TOE$
M@DN%7&/X1\V2>/RH Z&BLJV\0V5W<6T<2SE+IF6WF\H^7(5!)PWT4XSC..,U
MJT %%5K_ %"VTRU-Q=R;(]RH, DLS'"JH')))P *I6_B*PGNKFT;SX;RVC$T
MEM)"WF>6>C* #N&>/ESSQ0!K45@Z-XPTC7YX8].>XE$T33)*;=UC(5MI&XC&
M>G'7FMZ@ KF;3PUJ>G2RQV7B.X2QDF>;R9;:.1T+L6;;(?<G[P-;%[JMM8SP
MVS^9+=3!FC@A7<[*N,G'8#(Y.!R!U-8>M>.+*R\(WNMV"271@<P&+RR&BESM
MQ(#@K@D9S^'44 =):6L5E:I;P@[%SRQR22<DD]R223]:FKA]:U;[+XZ\-W!F
MOH[6XM[OS+8B3YV4+M_==2W)QQGFN@L?$^EW^E3:C'-(D,$I@F66)EDCD! V
M%",[LD #J<C% &Q3)D:2%T20QLRD!U )4^HSQ6.OBO2Q->P3FXM[BSA%Q-#+
M ^_RO[Z@ [E^F<=\4NC>*=,UZ58[ W#AK=;A9'@=49&]&(P2.A Z'/H< #]#
MT6;2XY)+W4IM2OI0J274R*A*KG:H51@ 9)]22>:T!:1?;?M;;FF"&-"QX13@
MD >Y )^@]!4]8&J>,M(TC4)K"Y:Z-U%!]H:**UD<E,XRN!\W?ITP<]* -^D9
M5="CJ&5A@@C((K&O_%.FZ=#-/+]H:"W"M<210,RP @$;\#C@@D=0""0*R;NZ
M=_B3H)M[R5[2ZT^XD,:RDQ/C9M8+G'1NM '2Z?8IIMJMK"[&WCXA1N?+7LH/
M<#M[5;/3CK6)=>*]+LY$\^25;=Y_LWVKRB81+G&TOTZ\9Z9XSFK%GKUC?ZM?
M:9 9OM=B%,Z/$R[0WW<$C!S@XQ0!8LM/BLFGD!+W%P^^:5NKG&!]    /ZY)
MMUC?\)/IYCLRGGO+>,XMH1$0\NS[Q ..!ZGCIZBH)/&FAQ:1;ZH]S(MK//\
M9U8PO\LF[:5?CY<'/7'2@"QXHT-O$GAZZT@70MDN0%>3R]Y !!X&1Z5JPK(D
M*+*ZO(!AF5=H)^F3C\ZQ[7Q5IUY<WMM"EY]IM(A,T$EJZ/(AR R*P!8$C%-\
M)>(?^$FT"#4OL\D/FY8*R$#;N.,$\-P!DCO0!NT45@"_TS_A,;F(7-\=0AL
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M[D!3'&1D/D$@C /0TL/B6R>_M+.:*YM9+Q2UH;B/:)P!D@'/!QSM;!]JY_Q
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M46DC^*.AHL\PCFL;DO%YK%"5*8.W. >3SBMW0"3X>TX-'+&RVT:LDL91E(4
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M9AE1SM(8\^M,U:/41K7AKQ(NF3K9VDEPEQ:1Q[I8HY5 $A1<Y.1E@,D9[X-
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M]GGBM6L'P9+(WA#2HI;2YMI+>TB@=+B(QMN5 #P><9!Y[UO4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 445@^,KO2[+PM>2ZRET]A@"46N[?U&.5(QSCG(H WJ*P[[Q38Z=K$>D-
M;WLMY);F>-(H"V\ @8![GGZ#N16=J?B]9_ >JZUI4%R)K>.>,I(BJ]O*@.=X
M)[$#IF@#K:QI] \_Q3;:[]LD62W@:W6$(-I1B"V>^<@5B:.-/TU--U5H+^+4
M;VW6V%KY@)O'VAS(5W$%@ QWL1QG/:M8>+M.6VU22:.ZAFTM=]W;-%F5%QN#
M84D%2 3D$B@#>HKDI/B%I4.F2:E)9:JEDL4,JSFT.QQ(<#:V<<$X/./3-6V\
M962:L^F/9:DET8C- C6Q_P!)4'!V<]LC[VW YZ4 =%17/0^,]+FT274RMS$(
MKK[&]O)'B59]P41XSC))'?'/6B3Q9 MKK)2QNS>:3&))[1M@<AE+*0P8J00#
MW['C/% '0T5Q,GB"RU#PAH=]KUI>QF[EM63R<@-*VTJV4;A-QZ,1]*Z*[UR&
MWO9;*"VN;VZAB$LT5L%)C4YVYW,!DX. #GCI0!'K>@+J\UI<QW]W8WEF6,,]
MLR\;@ P96!5@<#J*FT_27M)?/N]0N=0N@I199PB[%."0JHJ@9P.<9XZUG2^-
M]%CTW3=062>6VU"=;>%HH6;#DD;6'8@@\=>. :MZ1XCM=7O[VQ2WN[:[L]AD
MANH]C%6SM8<G(.#[^HH V**YO6O$EQIOBC1M(ATZ>9;T3.TB%.0B9VJ"PYR5
M))QQTSVLWGB>TM!>NEM=W4-@<7<MNBLL)P&(.2"Q ()"@XH VZ*AM+J"^M(;
MNUE66WF021R*<AE(R"*Q;CQCIUM;&^>.Y.EB;R6U!44PJV[:2>=VW=QNVX]Z
M .@J&*UAAFEF13YLI&]V))(&<#GH!DX'3D^IK"U+QGI^FZI-IOV34;J\BMA<
M^5:VQ<NF[;E?7OSTXZYP*V+W4K73M-DU"\D,-O&@=BRG(ST&.N<D#'7/% %N
MBL:+Q';G58],N;6ZL[R:)I;>.=5_?A?O!2K$9'<$@^U<;K/B*Y\1?#GQ1<R6
MEW9&U:=(F64+CRSMVDHV2<Y)'3ZT >ET5SNE^)[.;4+/2'@O(9YK;S+>6:+;
M'.% W;#G)QD'D#CFG7?B_3[(13317(L);C[,+\*IA$F=N#SNQN&-VW;[T =!
M17-2^-K!-4N]-AL=3N;JTEBBF2"U+;?,Z,<XPO3GWXSSA'\<:='H-YK+6MZ+
M6SN&MK@>6N^-U(!RN[H"0/UZ<T =-15"354BO8+5K:X+S0-/E%#!%7&0<'.<
ML ,9SGCH:Q=!UO1;?PS9SZ9'=FVNKN2"WAE),LDN]]P^=N.5<\D<#\* .CNX
M#=6<]NLTL#2QL@EB.'3(QN4^HZBJ>BZ,FC6K1F[N;RXD(,MU=/NDD(&!D@
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M3S+=^ZRJ=R'_ +Z K:HH \XFT/7KJ]TC7!"T5_JL;6FJQ@G]Q Z@KCT*;/\
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M%+W2/,$4DJAHI#T5U(*Y]LC!]C6CI>F0Z39"VA>:4Y+R33OODE8]69NY_P
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M=-HC,:M\BGH^6(Y7(P#GL*V/%\FK1>')WT6%Y;L.F5C ,GE[AOV9XW;<XS0
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M-O8(]Q<29$9A#,1@9['=SC\:LVOB'[9Y)ATR]*W%JUU;L3'ME4;> =_#'>,
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M#=HKEIO'5E%IT.J)97<VFSW7V6*XBV?.^XH#@L,*6! )_+'-=/&YDB1RC(6
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M\0:=I$UG<EM0+"&X&SRMRC)4DMD'';'/:DNO$MI9'4VN8IXX=/*+)-A2LCN
M51 #DM\R\$#[PH VJ*PT\2(FL0:5>V-Q:7=S$TMJ)&1EFVC+*""0& Y(/YFJ
M;^.;*/PM<>(#8WOV:VG:"6,!/,5E?83C=@C=Z&@#J**YK4_&":?K4^D1:/J5
MY>16HN@ENB'S$+;<KEO7/7'3C.:Z1&WHK;2N1G!ZB@#*TK0(=)U'4;Z*ZN99
M-0D$LRRE-NX *",*". !UK6R,XSS7.ZMXLCTO6ETE=+O[N[>V>YB6!5(D"D
M@$L.>>^.G<D QZ=J6FW?C*9?[+N;75O[-CEDEGP/W)8X3 8\AMV>.U '35EZ
MUHD6MQP1RWM_;"&3S/\ 0[EH2XQC:Q')%9,GCJS2PL=12QO);"_N/LUK-'LS
M(Y)"_*6& Q!P3^.,UCV]ZVE_$/Q/-:Z9=W<KV=I(8(=N[I(2268*/IG)[ T
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MQ9R#M!P#QD]!W. NKVVHZ=XO;7(O#[:QI]_:QPS0J$\ZWD0MM(#'!!#8//\
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MCC+!=VV16(R>!PIJA-9ZK!XRL_%$>FS/#/8&RN[19$,L #[T?KM;T(!..V:
M-W0]>M]<CNA'%)!<VDQM[FWEQNB<?3@@CD$=13]3U?[!=V-G%;27%U>NRQ*/
ME1=JEF+MV&![DDUG^'-'GM-5US6+F,PRZI<(ZP$@F-$0(N[!(W'DG!/45'XH
MCU=]3TC[)937NE!Y/MUO!*L;L2H\LG<RY0'.1GGC.>E $,WCRU@\.3ZN^G79
M%M>&QN(EVDQ2APAR<\C)'(R>>E6[;Q.\^N7&CRZ3=6]VMJ;NW61T_?QAMIY!
M.TY(X/K7&R>'=?7PAKNE1Z&5DN-:^UP)%/%L,7G))QDC  4CG!Z<5U+V>H2?
M$BTU4:=,+%=+>V>8O'\KM(KXQNST4C('6@":Q\7Q7_A9];CL9UVS&#[(S*)?
M,#^7L/. Q;@#/<>M=&A8HI9=K$<C.<&N+M]"EA^(EXL$J_V5((]3F@Q]VZ^:
M,?@V-_\ O(*[6@#@_")B\;/J6O:K&MU +Q[:QM91NCAB3 W;3QO8Y))YZ <5
MIV+>']/\5745E="WN!;?O[$(RI&JG(D"XP@Y.2.#Q5/0M(U'P9J6I6UO9R7V
MAWMPUU"8&7S+5V^\C*Q&5X&",GU'>F)H%]J_BS7=1N+:6SL;_2A8(967S"><
ML%4G P>^#[4 :,GC2""PL]5GLIX]'NY%2.\+#Y0QPCNO54;C!Y/(R!5VU\0"
MX\47FA/9RPSVT*SB1V7;+&Q(#+CGJ,'/0URQT/6-3^'T'@V^T]X9D$-M+=AT
M,/DQNIWKSN)*J !@')YP.:V/%>@W][J>DZEI#B*[B9[2X?.#]FE&&/N5(##W
MH N?\)3"+2TD>#9->NXMHGE50Z+UD+= O0CO\R\<UEO\1;&+2;R]:QN6DLKM
M;2ZBC9'\MF("MD'YE.1@@$^U/\4Z3J-O?:)J^AZ?%>C3%D@DL"P3S(7"CY">
M 5V"JGB.TUS6_",D<.@F">6YMWCLUEBWJD<BNS.VX+DX. ">@]3@ T9_&<MG
M<6D%YX>U*![N[:U@!,3;\+N!X;O^0P<D8IT?C-19ZY)<Z3=PW.C*'N;4-&S%
M"F\,IW;2-H/?M3?$UGJ%]JWAJXM=.FECM+W[1<8>,&-?+9<<L,G+=LUEWFDZ
MQ)?^.G32IV35;..&S;S8OWC+"R'^/@98=>U &D/' 672?-T6^2WU6,&UE!1M
M\A3>$VYR,C@$X'T'-6+/QA;NFLC4K2;3IM("M<QR,K_(R[D92I(.<'CUXK(G
MTO5VM/!*+I4Y;3)(VNQYL7[L+"4/\?/)[9XJ#4O#.JZOJ7C.,6SVT6IV]LMG
M<NZ%2\()Y 8L 3CMTS0!N0^,H#KEOI,]HR7%W"\MJ(YHY/,V#+(<'"OCGDX]
MZI0?$**?2['5?[&OH]-N;G[,]PY0>2QD,8RN[)&0,D<#/4\U9T&]UV[:/^T?
M#*::\"DSR"6-_.;!&(@#P"><DC'3G.1S::!KJ_"^UT4Z//\ ;X[X3-%YT. @
MN?-SG?C[OZT =-:Z_J-QX^O]'-EBSMK:)PXD7)WEOG/_ 'S@#\>]=17*P66I
M6WQ#N]1&GN]E?6,$?G>8@$+(S$AAG.<-Q@$>_>M_4[BZM=-GFL;-KRZ5#Y4"
MLJ[FQQDL0 ,]>: .%\5:O?6/B.S\213$:-I5T+"Z0=&64 22'U"L8Q]5:NTU
MK6;70]+>_N=S(&5$2/!:1V8*JCMR2*P_^$.TZZ\)O9WEC.]Q-;L)LR#S&E8$
MLW#;=Q8ENN,UB21:U+\*XM*US1W.JHT-M%&;F,-,P<;7C96/SA1GG'(.>,T
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MYQO;-,\K/*NV3Z 8; _Z:4>(+1]3\>^&(8AE;#S[VX(_@7:$3\V)_P"^3Z4
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MO-%;QQO&Y4D$* >5)'ZUH4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4GT.!)YU6<,LBLK/\AQ_=7N!R<5;?Q0B7'A]#:.8]:7]V^\9C/EF3##Z#J*
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M16\P(1N! ^Z?F![U6B\9;I=*>?398+35+EK6W=WQ*&&[!>,@8!VG&">HSUH
MZFF/+'&R*\BJ7.U QQN/7 ]>E<Q=>,C9:U>Z3<::Z7D4*RVJ>:/]-#-M CXZ
MYX.<8^F2)M;U&VM]4\/0ZAI FGN;K;!+N5EMI=C'()Y)P#VH Z2BN4E\87)O
M-;M+/0;F>?2=AD5ID0.&3?D')[=!^>*;%XY65-%O!I5PFEZM)'#%=.Z@K(XR
MH*=<9!&?Z8) .MHKGXO$QEN-?MQ9$3Z/L+CS?EE#)O&#CCCU'7\ZJ?\ ";(T
M7AV2+2KJ0:W'OBVNGR'RR^TY/7CV'O0!KZIH5MJ]W8W-Q+.LEC+YT'EN %?!
M&[ISP2.>*U*Y&/QE?2G5;:/P[.VHZ8P^T0?:$V;"NY6#]R1VQVYQ70Z/JD&M
M:-9ZG;!A#=0K*@8<@$9P?<4 7:*P-6\40V%Y/96ZV\UU;Q":5)KI8!@YVJ"0
M<L<'CITR1D5GMX^M3HVCZU%9R-I6HR+$URSA?LS%BO[P8X&01D<9_"@#9A\.
M:=#KTVM!)7O)<<R3,R(=NW*J3A3CC('KZFM:N4UKQ-?V_@K5=;LK% 8$<V[2
M2\2(,@2@8Z=P._L.:L'Q(;*TTZ"[2!-0NH3(B2W(1-JA<NSD<<L!@ G)^I !
MT=%<4GQ&M7T^*X33;B23^TUTR>.*1&$<A8 $'/SJ0<@@<^U7!XMNC-K%E)I#
M6^HV%J+N**6=2LT9S@[ESC!4@CGVS0!U-%87@[4;W5O"FFWU_&JS3V\<A96S
MORH.<8XZ]*W: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *AO+2"_LI[.YC$D$\;1R(?XE(P14U9NM
M:#IWB"WA@U&)Y(X91*@25H_F (ZJ1G@GB@#F_"&@SR^%+R#4;LW!N(GL(;A1
MR;5-R1GZD%FSWW"J8\/ZU?\ @&+P;?6)C*".V>_61#$T*.#O49W[BJ@8*CGO
MBN_BBC@A2&%%CBC4*B*,!0.  /2GT <@;#5]-\<:G?6FFBZL]2M8(Q-YZH('
MCW##@G<00V<J#6'IWA[7[7PQX,LI=*;S]*O5GN52>,X0!QW89/SC@>G6O2Z*
M "N(MK3Q)X;\1ZN-/TJ/4]-U2X^UQR?:EB-O*5 8.#R5X!^4&NWJ.&XAN%9H
M)HY55BC%&# ,."#CN/2@#E&TK5M*\9KKL4!U&&[L4M;Q(61'21#D2*'(!4Y(
MQG(]ZR=3\*:I)X=U?R+,R7^JZK'>M"LJ 0QHZ$*22 3M3G&>3Z#->BT4 <M-
M8Z@_Q#L]66PE^Q1Z;);._F1Y#LZMTW9P-N/K7.7/AW79O"6OZ>NE2?:+[6S>
MPJ9HL>49DDY.[@X4C'J17IE1PSPW,0E@E26,D@/&P89!P>1Z$$4 <U<6.H2_
M$'3]66PE^Q1:?) [F2/(=V5AQNSQM(-8$_AG6[GPGXFLQ8>7=76L-J%JCRIB
M1/,1PN03M)"$<\<CFO1%N(7GDA26-I8P"\88%E!Z9';.#^524 <9#;ZY<^.[
M379M&-O:KIDELT;7$;2*QD5L'!QGY>QQTY[#'7PYKH^&-OH9TM_MZ7HF9/.C
MV[1<^;G.[TX^OYUZ74<L\,&SSI8X][!$WL!N8] ,]3[4 <K<:1?7OCV6^DLI
M4TZ?1C8M+YB95S)N/ ;.,'&?7\ZK^%(O%>EV%IX>O-,A6&RQ$-46X4I)"IXQ
M'][<5P.< =?8]M10!YCJ^@>)M2T[4X;C24NKX:BD]O=M<IAX%E5E2,'[F%'(
M. >3DDUT<%AJUMX]N-4^P*]I>V$,3NLZ_N71F)7!Y;(;@@8]<5U=% 'FW_")
M:U=>&+Z$6XMM1BUQ]6LUED4I)^\WJI*DXX)'UQ6_+I][K?B31M8N=.FLH]*C
MF<12R1L\DLBA=HVL1@#/)(R2*Z:6XA@V>=-''O8(F]@-S'H!GJ3Z5)0!YHWA
MS73\,;C0_P"RW^WO>F8)YT>W:;GS<YW?W>/K5_Q3X>N==N+J>+1Y[?5854Z9
MJEO<1QNAVCY9"&S@-NSPW'3W[RB@".!9%@C69P\H4!V P&..3BN7U#PS<7/C
M5;Z(I_9=[;*FI1'_ ):/$P,7'?.X@]L+CO7644 <KX,\/7GA^UNH;Q_-6&1K
M>QP<D6JLS(#[_,0?95]*PI/#&M77@+Q-I9L?*O+W49;NW1Y4PZM*) ,@D X&
M.>]>CT4 <C=6FKWWC#P[JKZ4\4-K#<+<#SXV,9D"A1UYQMYQZ\9J?PEI]_87
MOB![VS>!+W4GNH"71MR%57G:3@_*:Z>B@#E_%&D7\^M:%KNFQ"XGTN60/;;P
MIEBE7:^TG W# (R0/>J5_H=_J.H:YK?V&2.>XTDZ9:VK.F]LEF+,0VT<L .3
MP#]*[6B@#)\+VUS9>%M*L[R!H+BVM8H)$+*WS*H4D$$C'%9WC'3K_4?[#^PV
MC7'V358+N;#HN(TSG[Q&3STKIZ* .4LK'4K;QIXAU)].E-K>6]O' PDCRS1A
M\\;N,[AC/Z5SFF^'/$>BZ3X3O;?31/?:/'-;7-B9T4RQR8^9'SMR, \XS7I4
M=Q#+))''-&[Q'$BJP)0^A':B2XAADBCEFC1Y3MC5F +G&< =SCF@#SVSM;S6
MM=\?V<L*6MU>6%M$(R^X(6AD R1]><?K4D.G>([E_![2Z(+<:0^VX$EU&2?W
M)CW#:3\O/'?V%=?::%966L7NJP^=]KO0HG9I20X487Y3P, GI6G0!PS:/JQN
M?'#_ -FR;=6B5;3]['\Y$'E\_-QSSSV]^*EU#1]4N?A,-#CL6_M(Z?':>49$
MP&"A2=V[&./K[5VE1R7$,4L44DT:22DB-&8 N0,G [\<T <7J%CX@T[7K#7]
M+TM;X/8+97E@\Z1NNUBRNK$[3@LP(S_]:YJNG76M:=;6^M^'XKVVG9VFMH94
MWVIP-A5R5R?O9((Z\9 YZRB@#!\(:;J&DZ$+34)YI2DTGD">0/(D.[Y%=AP6
M ],^G:JOB:PU"[U_PY<V=B\\-C=--.XD1<*49. S D_-FNF=TB1GD9411EF8
MX %$<B31)+$ZO&ZAE=3D,#T(/<4 <SI]AJ$7Q!U;4I;&1+*ZM888Y3(A^9"Q
M.0&S@[N..U9>FZ+K.BZ'K/AV.P-U#<23FRNQ*@0++DXD!.X%23G .1TKN$N(
M9998HYHWDB($B*P)3(R,CMD5)0!Q-IX<O-*\1^&A;VTDUAI>FO9R7&]!EF"8
M.TMG^$YX[U631-8_X1SQK9G3)!-JUQ<R6H\V/E9(P@R=W'(R?:N_HH H:)%-
M!H5A!<1-%-%;I&Z$@X*J >02.U<1XCT+Q%JR^)[233([T7,>--N7N%"1)L V
M!#RKYSS@9SR0 *]"EGA@V>=+''O8(F]@-S'H!GJ?:I* .-@T_5V\7Z+J4VF,
MD%OILEM,5FC;:[%2!U!/"\X'4\9ZU-X7T6YCLO$%IJ]@8X=0U&YG5'=&#Q2]
MCM)P<9R*ZRLW6M"T_P 06L5MJ,3R112B90DK1G<,CJI![F@##\ :7<V6DR2W
MET+IE8VEK-CK:Q,RQ_B<L<]P16WXAT2W\1Z!>Z1=$K%=1["PZJ>H8?0@'\*T
M(88K>"."&-8XHU"(BC 4 8  ]*?0!S&AW&O:5I$.G:GI,UY/:H(ENK.6(I.H
M& V'=2K8QD$8SWKG+;P3K-MX(TR%1#_:VG:H=3C@\SY7^=CY9;H"58\],]^]
M>E44 <PNF76K^+M.URZLI;&+3K:6...9T+O))M!^XS#: OKR3[<Q6/AJZL_&
M]_=JRC1IV6]6+N+LJ8V./3;\Q]R/2NLH) !). .] '$&U\2>'_%&J3:=I$6K
M:9JDJW _TE87MY=H5MV[JIV@\9(JTVG:M_PG>E:E+:>;!#I\EO//&Z!1([*W
MRJ3NVC:1TSTZUU,,\5S$LL$J2QMT=&# _B*!<0M<-;B:,SJH=HPPW!3T)'7'
M!H YBRL=1M?&WB#4GT^5K6[MX(X&62/+F,-GC=QG<,9_2L#3_#NN6OASP98R
M:6_G:3>B:Z FBP% <9!W<_?'Y&O2J* .5T^RU&U\<Z]JCZ?*;2ZM[>.%EDCR
MYC#9XW<9W#&?QQ7-:?X;\2Z1X;\+W5KI\<FJ:+Y\4UC).@%Q%*>=K@D C"D9
MQW_'T[<"Q7(R.2*6@#B/$EGXA\0^"[VW.D+;W=Q)#Y5F)T8QJDBLS.^0,G!X
M&>@]3B]/8ZA-\0M.U5;"0645A);R2&2/*N[*PXW9.-O.*ZFB@#E_ VG:EHVB
MOI>H6BQ""XF,<HE#"8/*S@@#H,-WP?:KGB."[OQ9Z?'827%C-.IO75T $:\[
M<,P)RP4'_9+?2MRB@#A_&'A1C:V%[X:TN,:O8WB3PE&6,%1]Y6)(^4CT]J;X
MBDU&?Q)I-UINCRRW]M:R/,D-W%'/"KD *V[*,APWJ<KD8P<]U6-J?A?2]5OD
MOYDGBO53R_M%K<R0.5SG:2C#(^M ')/IE]J'A]K'3-)ETO6=,O8]36&]E207
M+LSDEG0D'=\X/3''08K7N'\1ZWX:U6*YT)=/EFLI;>*U^TQR/)(ZX#;AA54?
M7)ST&!GI;#3K;38#%;(P!.YF=V=W/JS,26/N35J@#A9-(U8P^"5&FR9THJ;O
M]['\N(3&<?-SR<\=ORHTBS\4>&[[4M+M=+AO=/NKN2YM;YKE4$ D.XK(GWC@
MD].OMV[JB@#C_&NE75P=&O--NQ!J\-R+:.4CEXY1MD&!Z*"_MLK=NOM6DZ?9
M6^D::MTB210&/SA'Y4/0OD]=H'3J:A70M%TW5[O7WC6*ZE&99YIFVKP!D!CM
M7@ 9&*V000"#D'H: "L7Q=:76H>$M4L+*W:>YNK:2"-0RK@LI&26(XYK:J-;
MB%IWA6:,RQ@,Z!AN4'H2.W0T 8-IH\U[\/X]"OHWM9GTT64OS*VT^7L)!4D$
M5B-H>LZQX-T_POJ6GF!H'@CN+P2HT;QQ,IW)@[LL% P5&,GTY[F&>&YB$L$J
M2QDD!XV# D'!Y'N"*!/";@VXEC,P7>8]PW!?7'7% $E>;R^'M>'@GQ+H*Z8'
MDNKFX>VE6X3$@DDW X)X &<YYZ8![>D44 <C>:=J5SXL\+WZZ=*+:Q@N$N6:
M2/*&1$4<;N<%3G'ZU1\-6GBK0;5/#;:5;S6ENQ2WU;[0H A))&Z/[Q< XQT/
M'/>N\J..XAF>1(Y8W>,[9%5@2A]#Z4 /8D*2%+$#H.IKS:3PYKDGPSUC1!IC
MB^NKN62)#-'C:\WF D[N,#]:]*HH Y34;'4[KQMH6IPV$BVUK;7$<KO)'\C2
M!<<;LG&WG'X9KFTT+Q//;:%/=Z,DNJ6.IK/>74EVA:=0'&Y3V0;A\O&.RUZ?
M10!Q/B/1=8UHR:K;6\EMJNER@Z2OF(0_3>6.[H_*D'&  >I(J?6K75]5NO"]
MV-)D1[.\%Q=Q^=&?+&QE(!W?-RV?I^5=?2,P52S$  9)/:@#D+/3M3@U_P 7
M7CZ=+Y.HK#]E(DCRY2+8<_-QSSSVK+&@:TG@OPEIO]F2&ZTR]MIKE1+'@+$3
MN(.[G.>/Z5Z##-%<0K+#(DD;C*NC @CV(I] '#S:;K=IXB\3O;:7]IM]9@C,
M4_GHJQ,L10JX)SGN, CW'6JMCH6MP6W@:.73#NT@$76R>,[1Y1C&,D9.3GCM
MWKT*D)"@DD #J30!R%GIVIP>(O%MZ^G2^3J"0BV(DCRY2(H<C=QR>,]JTO!5
MA=Z5X.TO3[Z PW-M (I%W*PR.X()&*UOMUI]G2X^U0>1(P5)/,&UB3@ 'H23
MQ5B@#B]0M/$&B^,;O5M)TM-6L=2BB6>#[0L4D,D8(# MP5(/(Z_UT=0L+_6K
M*WTC4K-?L=TK-?R1.NU1G*Q+R&/8%@.W;.5Z.HS<0BX%N9HQ.REQ'N&XJ#@G
M'7'/6@#AX]'\177@#6?#5[ 6F2&6WL;J25#]HCZ1[\$[6Q@'\_6B]L?$L-QH
MGB"PTF.2[M;9K2ZTU[E SQ-M.5?[H8,N>O3%=Y10!Q.NV6OZSINE2/I0CFBU
M6WNVM8YT)ABC8$Y8D!F//3CMGN9I](U*Z\::I>_8VCM+K2!9),TB<2!G/(#$
MX^8=JZR.XAF>1(IHW:([9%5@2AZX/H:DH Y_P7;:A8>%-/T_4K,6L]I D!7S
M5?=M&-WR\ '''.:Z"BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "L3Q/XA_X1K38KTV4MTCSQPD1
ML!MWL%!]3UZ 5MUQWQ,+KX4B,:AG&H6A52< GSEP,]J +%KXPE3Q$^CZUI3Z
M6[V[7-M*TZR++&OWLE?NL!R1S]>F8%\?6YNM*)@A:SU.58HGANA)-&S#*>9&
M!\H/KN.,\U+?Z#/XDUZWO;VV>RMK6SN+=%=U:1WF 5C\I("A1QSDD]!CFOX9
MC\7V%K::)J%C:"WLPL?]II< ^=$G0"+&0Q  ))&.3[4 3V'B[4M3OKN"T\.3
M.EG?O9W#FZC78 H.X ]>3C /'!SSQ23XA7#>';37VT&1=-DN/(G;[2I>+]Z8
MP0N/FYQGD=>,]:T?"UAJ.F7/B"2[LF1;S49+R#;(C%E*JH4\\-\OTYZUSX\,
MZX/A<GA_[ /MXNA*1YR;-OVCS>N?3CIUH Z>T\27+^)7T6^TIK65[5KNV83K
M)YB!@I#  !6R1QDCWKF[_P 3S6WP^UC5-$TJWT^6*_DMY4+@%7,@1I!M7!8D
M_P!<G&#NW%AJ$OC^QUA;%_L<6GR6[DR)N#LRL.-W0;<?6L)_"NLW/@'Q!I)M
M4BO+O4)+N!7E4JRM,) "1G!P,4 :VHZWKL/C#0M,6SLUCN8IY9%%TQW% !C/
ME] &!Z<GTQRFJ^/;;3X;NZ@A@N;:SG,,RB["SL5;:Y2/!W '/4C.#CME^HZ?
MK=SXC\/:W%80;K:.XBN(#<?ZKS NT[L?-C;S@?3-5--LO%?AW4+_ $ZQL+2]
MTRZNI+FVNY+GRS;>8Q9E=,$L 22,=?49X -J37?[0OKC3=,LXKXPVZ2W'G2^
M6@$@)1/NMEB!G&, 8YYK,^%G_).].Q'Y8\RX^3^[^_DXI(=+UO0O&>I:A9VJ
MZE8ZLD)E)F6)X)8UV9(/!4CGCD>GK=\!Z7J.B^%8-/U."**>.65L1R[\AY&<
M9XX^][T 8$%Q>Z9\0O%K:/HHOIGALW:-9EA7.U\DL>Y^G/<BM)?'R3:5H^IP
M:<WV2_NA9S-++L-I*6*X<;3QD8S].F:L)8ZII?C36-4AT\WEMJ,$"(8ID4QM
M&&'SAB.#NZC/TJ.+PG;6_@*_T?5)X_\ 21-<74R\+'([%RRY[*<8_P!V@#>C
MU&2779]/2W4Q00I(\_F=&8MA=N.N%)Z]"/6N=\>0QF[\*3&-3*NNVZA\<@%7
MR,^G _*M/P=:7MOX<MI]3?S-2NU6>Z<C!+%0 ,>RA1^%0>+]-O\ 4I-"-C;&
M86>J17DQWJN$0,"!D\GYO_KT ,USQ?-HT.JW1TIGLM,*":664Q&7< 3Y0*D/
M@$=QSD5;E\121^*+71C9J$O+5[BVN6FP)"N,IMV\'D'Z<^U<QX@\.^(M53Q/
M;/8V]T;Q,:?=2W 'DQ[0/*5<':<@Y/ .>3P*V==T/5-4T72)[3RK36K">.6,
M[MZH#\D@)XR-C$D=R* 'Z=XODU#1+Z]33XUN;6]-B;7[3DF4.$QNV\9+#'L>
MU=0NXJ-P ;'(!R :Y'3_  @^F>,3=VSA=(:".1H2<DW,:F,-^*-D^K &M:#5
M-0;Q7<Z7/IZ)9" 36]TLP8OC:&#+_#RQQZ[30!B?$1$5?#5QY'F2QZ[:[-JC
M?U;@$^N!WJ]:>+@MYK-KK%D-.?3(%NG83"57A8,=P( P1M((_+-+XPTV_P!3
M&BBQMC-]DU2"\E^=5PB$Y R>3SQ_.LS4O#%[K/B#Q#Y\#06.IZ8EG'/O4E74
ML<E0<X^8?E0!HR>+9;-=*NM1TW[/I^I2)%%,)M[1.XR@D7: N>F06P?SII\6
MW*GQ#&=+07.BJ)&B^T_ZY"I<,IV\9 /X@CBJ+Z+K&M:#I&B:K9+;_8YX'NKE
M959)5BY'E@'=EB!]X#&3U[WM8\-7%[XNLM2MY%2TEMS;:DA_Y:QJP>, ?[V5
M/^RQ% %RQ\1/J-GHEQ;6L3C4T\T@3G]S'MW%ON\XR%(XY8#WK)N/B%:0QVUX
MD4$VG3W AWQW0,Z@MM$ABQ]W//WLX(..U6O"7AF?09]12:17M%F=-.0?\LH&
M/F$?]],1]$%9WANQ\6Z!;)X<^Q6LNGP,4M]5^T %8<Y ,6,EP#@=!T_$ V]/
M\1R76N:OI5S9QVLNG(DF]I\B5&!(8?*,+P03V-1OXJ$5OIRSPV]O>WT+3I#<
M77EHD8QRSE<@_,HP%)R?8FH/$7AFXU+Q%IFHV<BQJ4>SU$'_ ):VK?-M_P"^
MEQ_P,TGB;3=:BUW3?$&@PPW5Q;126UQ9RR>7YT3E3\K'@$%0>: *9^(B#1&O
MQI4LDD.H+83Q1S*RJQ8 ,C8^=3D8('/M74:5=W]Y;ROJ&FFPE65D2,SK+O08
MP^5Z9].V*YKQ#8>(=<\/0+)81)=F^@N/LR3J5ACC<,07.-S'!Z#'..V3M:QJ
MNHZ?=:5]FTU9[6YG6&Y9I@KP[B "%YW=23CH%/UH NZM?G2](N[];=I_LT32
MF-6"E@HR>3]*YZS\:3SS:"USHSV]EK*J(9S<!BLACWA2H'0@'!S]0*W=>@GN
MO#^HVUM%YL\]M)%&NX#+,I R3VYKE6T/5_[,\%P"P)DTB2)KK]ZF,)$8SMYY
MY.?I0!K3^*9FMM3O-.TX7EIILCQ3MY^QW9!F3RUVD-CIR1D@@50NO%-]=^(O
M#$>D1V\VFZG!-<JSS%&DVH.#\IV@;P<<Y([8Y33='UCP_%KFF6UF+RUOKB6Y
MLY_-51$91RD@)S@'G*AL@]*B7PIJ&BW'A Z9%'=QZ1;SVT_F2^7DR*HW]#QE
M3D=>: ,_3]2N/#^J^.+C3M(6ZBMKM9Y465855! K-C@Y;J<8_'UZ&]UZQGU#
MPL[:4+E=2;S+6YDVYMR8B^0.3DKQQCZU0CT75@OC0&P;.KY-K^]3G,(C^;GC
MD9^GOQ31H>KB#P0GV YT<+]K_>IQB'R_EYYYY^GOQ0!9G\:7P?74M?#[S-H[
M#SM]TJ!EV;\C@\XZ#\R*T3XJ@E.A1V<!EGUF$SVZR-L"QA Y+$ ]F P >3^-
M946CZJD_C-S8-C50/LO[U.<0B/YN>.>?I[\5F7%EJEK9^$-/MM-CGU?2K3=(
MB7:Q2QA8UBW*Q#*48YR".<#C@T =7X>\12:[-J,+Z>]J]A<-:S$RAU,BX)V]
M"1@@@D#K4>L:E;6WBOP]93Z4L\MU),+>[8K_ *.RQEFQWR0,=NM0^$I9()+R
MPN=#ETRZ9OM<K/<I/YY<D%RR]\KC! X QP.%U_3;^[\5^&[ZVM3);Z?+,\[;
MU! >,H, GGDY/M0!2G\<7JQ:[);>'Y)1HTA%QONE3*! Y(X.3@]/U'2NKL;N
M/4-/MKV'/E7$2RIG@[6 (_G7')HNK"U\:1FP.[5V<VO[U.=T0C&[GCD9^E=-
MX=MI[/PWIEI=1>5/;VL<,B[@?F50IP1VXH XY]3U+7/#OCF+5+2U-O:-<P(%
ME+[-D"D  J,\DMNR.3TJYX=\27%E8^%--NM+:.TO[..&"Z\X$[UA#8*8X! .
M#GZ@4BZ'K5M;>,;%+*.6+599IK:83@$F2)4"E3TP1DG/TS0^B:L;;P6@L#NT
M@H;K]ZG&(C&=O//)S]* +<7B6PL;KQ9=/I/V632Q&]U*FTO<_N]RDX]%P.2>
MO:MK3-2NKZ<B6U@%NT*RQ7-M<>=')DD$ [1R, _B*P;?3-8MM9\67J:=&XU
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MIK.'SQ-B6-PX9V  P<  #..2<]!>L+KQ/?V<QU31X+$I"RB&*Z65IY", @X
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M @^%ZA?AYIJJ  'G  [?OI*SKN6YT_XJW\FEZ4+RYET6)C&)%A4GSG^9F/T
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MAO88Y[&>*:-9(VC8,CC((QW%<<VB:QK/AS2M!U2R6#[)- ;JZ65625(B"/+
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M?F>95E6%500H6V\'+=3C'XUU5UXLM4-E';-;&>[M1=H+NX$"+&<8RV"<DG@
M'H?2L9-$U<6?C6(V!#:NTAM?WJ?Q1",;N>.1GZ5"-'\2:/-H>KZ78Q75Q!ID
M>FWUA+.L98+R'1^1P<]>Q_( Z?PSXAB\2Z2;V.!H'25X)8F8-M=3SAAPPZ$'
MN#6S5/3&OWM/-U)(HKB1MWD1-O6(=EW8&X]R<=2>U7* "BBB@ HHHH ****
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M^$_^1-T/_L'V_P#Z+6G:EK7V75;/2;6%9K^[1Y%5WV*D:8RS$ GJ0 ,<D]J
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRNT8GD>WB>0R&"$GY(]W? _GCG&:T[[5M.TL*;^_MK4/]WSI0F><=SZU<!!
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MI-X3<2'W!0?=SC..!71P6NA:1J<EW'/'#>:E($8O=,3.XX  9CDCIP..E;5
M'G&N^%O$>IV?B>S,%E</?R;K.]EG(9(OE(A"[?EP5/.0"3GFMVXTW5KCQEHF
MK/:1"&TM9HIPDP.&DVXVY R!MY)Q]*Z-[VUCO(K-[B);J56>.$N [*.I ZD#
M(J>@#SV3PSK4G@[Q3I7V6(7.JWUQ/!^^&U5E8$;CV(QS@'M6L^D:NGB[2=9@
MMX#&NG-8W"238,1+JVX8!W?=(QQ^%=910 5P=CX:UG3/">I>$8HH9;28316E
MZ9 !'#*3G>O4LNYL8R#QR*[RB@#D;7P_=Z;XQT^[MK?=IEEH_P#9RDR#>2&4
M@X],+CKUJUX-TN_TBQU"&_A2-Y]0GNDV2!AMD<L!]1WK=%[:F^-B+B+[6(_-
M,&\;PF<;L=<9XS4] '/>,](O=8T6&/3UC>YM[R"Z6.1]@?RW#%<X.,@5633M
M6/CV#6YK.,6ZZ6UHXCF!(D,@?C.,@8QGCGM7557EO[2&\AM);J%+F?/E0LX#
MO@$G ZG !H X%/".OIH6ZW^SV^K6>LRZG:!Y-T<BN6S&Q'(RK$'^?IU^BRZY
M=!I]9M;>Q. J6T$WF\]V9L#\ .G.2<\:]% &+XMT>?7_  GJ6E6SQI/<PE$:
M0D*#UYQ5%]+O];O]%FU"T6R@TR3[04\T2-+-L*K@CHHW$Y/)XX%;8UC3&MKJ
MY74+4P6I*W$HE4K$0,D,<X! (ZU;CD26-9(V5T8!E93D$'H10!YM_P (OXH?
M3[".>TL)KZSU>.]FO&NCNO%5V(S\OR@!@,<XQP*T=>\+WNN71G;3XK;5H;E6
ML]7MY0I2(,"0X&&/&X!<$'CD<UW5% '*'2]7C\9:QJT$$:QW&G);6[M("?,0
ML067^Z2PJOH_AB2T\5Q:Q:Z>NCH]NZZA;PRAHKF0XVE5'''S'<0#R..M=G10
M UUWQLN<;@17G4?A?Q"G@#3= >TM3/8W4+!TN,ATCDWEN0,9& !SWS7<Q:SI
M<TKQ1:E9R21@ET6=25 ZDC/&*F%_:-?FQ6ZA-V$\PP!QO"Y W%>N,D<^] ',
M7VD:S<>,;K5;1%MDET5K&&9G!:.8N75BH_A&1_A67I_ASQ#'?>%KN33["%]-
M\Y;L_:B[3,\>PRD[>22,X.2<]17H=017MK-=SVL5Q$]Q;[?.B5P6CW#*[AU&
M1TH P?#&DZGH^HZY'<16YL[O4);V&9926._;\I7'&,'G-=(S*JY8@#U)I:I:
MKI-AKFG26&I6RW%K(06C8D X.1TYZB@#F_!>AC3;_5I(Y_-L(;F2#3DQQ#&6
M#RJ/;S,K_P!LZJV'AO6=)\-:IX6@AAFL[@SI9WAE $4<N21(O4LI9L8R#QTK
MM;6UM[&UBM;6%(8(E"QQH,*H'8"IJ .,?P[J.BZ_HM[HUM#>6]IIATQXYI_*
M*J"I5\X.?N\CK63)X4\0GPEJ>F&WM'N+G63?1LL^%V><).01P3MX&3UYQ7I-
M% #48M&K,A1B,E2<X]N*=5*WU?3;N\DL[:_MIKF-=SPQRJS*,XS@'.,\5=H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ K'\1Z]%X?L8+B8QJL]PEN))6VQQEL_,Y[#C\\=.M;%9>N
MV]U=6D4,%I:WD+2XNK:Y("R1;6R!D$9SM//IU% &-XAUZ[T_P=JNI7ND6=Y'
M;, (O.S%<1$*0XRISRW3V/-:5YKCIX@M-#M(D-U/:O=,\I(1(U(7H.I)/M@
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M[\\5JUS7B+3-7N]<TB\LH[6ZL[8R>?9W,IC4L0-DG"MDK@]1WXH S7\?3?\
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M^/J'!&QE &2WRYR.,'!- ';T5BZ#J&J7ESJ<.IVUK']FN"D+VSEE9#R <_Q
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M=LHB3=@[3D'K@CO7277B>]M=3T'3K72H9?[4MGDC/VC8(RB!MI&WA?F'(R<
M\5E?\(QK[Z!XNLI(K$2ZU/))#MN&(3>BK\QV=!M_'T%:+Z)JSZ[X6O3!;B+2
M[>6*X'GG)+HJ_+\O(&W/..M #8_'#6WAO7-1U2Q$5SH]PUM-#!+O61OEVE6(
M'!WKU''-6_\ A(=1@\5VFA7%A;,US;FY$\<Y 55(#+@KR1D8Y&?:L#4-,OM-
MT;Q4MXFGJ=;O +-)9"ZLT@2-48;1@\9SR!U[5;TD:MI6LVCZEX?MU\X"S2[C
MU1KB1%ZA0KJ#MXR<'/&3G% '<UP_C^[EFU3PUX<5VCMM6O&%T5."\48!://H
MV0#7<5SWBSPV^OV]G/9W"VVIZ=<"YLYG7*AAU5A_=(X- %[5= T[5M#ETF>V
MB6V:/8BJ@'E''!4=B.U8115^,2,%&3H#9('7_2%K6M[CQ!<Q"*XT^ULI",/.
MMSYJCW1=H)]MV/QZ&E-H^IMX]&L1"%;0:6UB',F9 YD#[MN,$#'K0!7B\8W:
M7^BPWVG):C597B6W>4BX@P&*LZ$=#MY],]ZE@U^0:QXIACTBV6YTR*&0NLN#
M=!D9AN;;D8 QWK"M?"OB=+30%EATS[5IM_Y]Q.;AV:[RK*9&.S.?F'!SGU&*
MV(]$U:/7?%5[Y-L8M5@BCMQYQR"D;)\WR\ [L\9Z4 5D\;ZF-/\ #^IR:+%]
MAU=XH5"7695DD4E>"H7;D8SNSWP.E7(O%MW:W6N6NK:=''/IEF+Y1:3&42Q$
M,<#*J0V5(Z5GGPQK0\+>%--$-J9](N[>:<^>=K+$"#M.WJ<]\5?FTC6U\5ZQ
MJ]I':J+C35MK8R2DD2J6*EAM^Z2P]>E &EHFLW&KF*9%LYK&:#S4N;68N V1
M\A! P0#U]CP,5MUR.A^%VT_Q5+K%O91:5!-:F.YM()=R33;@0X4  8 (S@$[
MN@[]=0!C7NM.NO1:'8Q1R7KVS74C2L0D488*"<#));@#V)SZX=[XGN]0\)^)
MDAMDM=5TN.:*YC,QPF(RRR(P7)!&",@>^*O:EHM_#XRMO$NF+'.WV0V5W;2/
ML+Q[MRLAQC<#V/4=ZK2^&;XZ3XHE5(#J>O*RE/,(CB7RO+0%L<X')XZG'O0!
M<\(V*R>']$O+NRM%NH;"**"6,[F$91>,E1C..@S]:Z2LWP_;7-CX?L+.\1$G
MMK>.%_+?<I*J!D' XXK2H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK*U_6ET6T@81":YNKB.UM
MHBVT/(YXR>P !)/H#0!;&I6+:D=-6[A:]6/S6MPX+A,@;B.H'(K,GTGPWXJ*
MWSV]I?/"S0BXC/S*5."NY3G@YXK"A^WK\75%TELT@T*3RWB)4/\ OEX(.2,'
MZ_TIUIXT6#PG_:MQ9VUB&U)[-\$F*$^85,CD 9&1G/&21TZT =A96-KIULMO
M9V\<$*\A(UP,]S]?>K%<Y-XBN++3UEN(K:>6YO8[2P:WD_=W&]5*OGG:/OYZ
M_=.,TR[UO7--@UE[G2H)4L;7[3!<)(8XYP%)9,?,0PQ[@^U &_>WMMIUG+=W
MD\<%O$NZ220X51[FI04EC!&UXW'U!!KAKWQ1KD?@NZUZ[T33I+(V,5S'$UR2
M6W#+!AM([@@>G>M2_P#$6HV_B+2](M=/MI!?VLDR2O.5VE N01MX'S#IG/M0
M!;MO!WAVSN1<6^D6L;AMX"K\JMUR%^Z#]!6I/?VEM=6UK/<Q1SW198(V;#2%
M1DX'? KC!XPU]M%UJZ72K#S]$FE2[#7#!)0BA_W?RYR5/\6,<=>VG<^(BVM>
M%8TL(7M]65W2>1OWD.(2^ ,=Q@9SZ\4 =117#S^+]=,'B*2VTFQ_XDDK"3S+
MEL2(L8<[<+]X@]\ <=>VK+X@NYH[":T@AM[2ZLOM;WMXV(H\[=L9P1\QW>O0
M=Z .CJN;^T745T\W,0O'B,RP;OG* X+8],UPE]XMU/5?#'A;5-/2&U&I:G#!
M/&S%CD2$8!'\)*'/?!Q70#69D\<0Z1<V5JN=,>Z^UJY+<.JE<$#"Y.>ISQ0!
MT=%<;-XRNU\,?\)5!912Z.K%C%N(G,(;;Y@/3/\ %M].^:GE\3:I<>)Y-&TR
MQLY%;3TOH+F6X8*RLVT;@%R.AX&?J* .KHK&\*ZX_B+P]!J,MN+>9FDCEB5M
MP5T<H<'N,KFMF@ HK"EUJYN]>O='TI8/.L88Y+B6?)4,^2B #GD*23VR.#GC
M#D\?7+:'9WMOI:&X;55TN\MWGP89=^TA3C#>Q)'44 =S5'5-&TW6[9;?4K*&
MZB5MRB1<[3Z@]0?<4:5)J<EHQU:WMH+D2, MM*70IGY3D@'/X5@^+=1U6TUO
MPW:V$D"0W=Z4E#YRY$;, 2.B\9]SC\0#=TW1=-T=&6PLXX-^-S 99L=,L>35
M^N=&N7^HWVIVFD0VKOINV.5IV;;+,5W%%Q]T $?,<\GIQ5SPUKT'B70;;5((
MWB$N5>)_O1NI*LI^A!H UJ*P_$?B&+018":2&!;RX\C[3<9\J$[68%NG7;@<
MCKUXJO<>([BQM;-+N& 7M[<O#!Y99XRB@MYG )(VC.!W(&>] '25'//#:P//
M<2I%"@R\DC!54>I)Z5R47C6>W@U0:CI[K):30PV\J1ND5V92 FW<,@@G##G'
MO3X_$%[=:C>Z3=V6^!K%YHKV&&18\\@QMN'#=P<\CTH ZBTN[>_M(KJTF2:W
ME7='(ARK#U!J:N!\ :K/<>$]!L-+6"806B"]E=CB$D951CJYZX[#DD9&>^H
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MJ:=I-]:+;F*ZM3(V-P"!&1BG)X?/"XW#&<9/64A(4$D@ <DF@#'\*:-+X?\
M#EKIDT_FM#OQ\Q8(I8E4!/)"@A03Z=NE;-9UEKNEZC>/9VE[%+<)&)3&."4/
M1QG[R^XR*T: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[EC97\QO-2-58@<C!P3S]!CO0!Z 2 ,DX%4M.U:PU>.>33[I+A()F@D9.@<
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MJCAP%4Y))(Y)(Z^P%=!IVN:?JMQ=6]I,QN+1E6>&2)XWCR,C*N <$=#T-:%
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MM92[VDQ@G&PKM< ''(YX(Y'%,N-9T^UU:TTN:X"WMV&,$6TDN%&YN<8& .]
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MA0/>NEHH R/#.G7VD^'[/3[^:WEDM84@5H%(7:BA03D\DXR>E:]%% !1110
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MO]GD R =Y.Y6Z#N#7._#K5I[GPWI^D:3-:BXMI)I;UIT+B.-II-H # ECCZ
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M_P <:*V%4>F(LK]236OX@\/W6H2://IES!;2:9/YJ0S1EXG&PK@@$<@'@]J
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MJ?3;9+F\2,F&%W"*S>Y)&!WZ]JPH?#&H7-AI6G:O>6]Q:Z;-'*)(T(>X,?\
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MUF2 3$AB+[WQG)&$X&>I'-7+VZ\7VFF:TT5O833VF)+&0HV+I-N64H'RK \
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ J'[+;_:OM7V>+[3MV>=L&_;Z9ZX]
MJFHH *JKIMBMZ;Q;*V%T>LXB7>?^!8S5JB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ (R,'
MI52VTO3K*9IK6PM8)7^\\4*JQ^I JW10 4444 %17%M;WD)AN8(IXB02DJ!E
M..G!J6B@!    !@#H!2T44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !115;4-0M-+LI+R]G6&"/JS>IX  ZDD\ #DT 6:*K6=T]W#Y
MC6EQ;@\J)PH8CUP"2/H<'VJS0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %<)XE2YU3XE>']+6<0V]M;37XW)O#2@A%.,XRN<CKC/2N[K,U/1(-
M2NK.]$LEO>V3,T$\>,@,,,I!!!4CJ/88P: ,OPOK&HW.KZ[HFJ-'-<:7+'MN
M8TV"6.1=RY7H&&,''%=/5#3M*ATY[J56>6YNY/-N)Y,;G8 *.@      _GDU
M?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
'"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ex101slackseveranceagm05007.jpg
<TEXT>
begin 644 ex101slackseveranceagm05007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K,\0:L="T*
MZU(0?:#  1%OV;B6 ZX..OI6G6%XQL;K4O"=_:6,)GN9%79&&"EL.IQDD#H.
MYH 9#X@OX-4M++6=(6R%XQCMYX;D3(9 I;8WRJ5) )'!!Q6A;:[I-[?26-KJ
M5K-=1YW0QR@L,<'CV[^E85U!J_B74--6?29M*L[*<W3R3S1/([A&5%41LV!E
M\DDCI[UF6NA:O<:9H&BMIK6#:3D2W_F(4?$+QYCVMN.\L&.0,<YR: .LC\2Z
M'*UP(]7LF-LI>;$Z_(H."3ST!X)I=9UVST6PO+F=P[VMN;AH$8;RN< X/0$\
M9/%<C-H^KZAX170AX?BMI[72WM1<S21D-)M50(BI)"L5R2P7M^%V6'7]1U:_
MU.#1EM2VFK;Q0W\D;"5Q(696",V 5) /XD4 :EKK>J^>(]1T:.".2%YHKBWN
MO.B&T [9&V+L)!X/(.#S5EO$VDVUO:-?ZC96DMS"LRHUPI&".H/&1V!Z&N5L
M]"N?[0\S2?#USH5O]GF6[A>XC\JX9D(14C1V4$,0=V%X&.]9=TMQH.@ZY:SV
M<5U)+HMNDX^T1#[*5@*;7!;)7()!7=DDB@#T&X\2Z':SI#<:O912OMVH\Z@G
M< 1W[@C\Q1XBU=]#T9[Z.V%S()8HDB,FP,9)%0?-@XY;/2N5?PYJ$_A_Q1&M
MF#-J.G0PVP+*#(RV^W')XPWKBMOQGIESJOA*2SM[1KN4RV[M '52ZI,C,,L0
M/NJ>] %NUU+5$\Z;6-.L]/LXHFD>=;[S N/4%%P,9.<]JE@\1Z)<B<P:M9R"
M!E64K,IV%CM7//<\#WKE)-&:71-:L].\'W>FW%WITT*22W$+*[%2 O$K8R<<
MXQ[UIWOAIM0U012P!+&317L7=2!L<NI4 => "0>@Q0!T%SJEA9>=]JO;>'R(
MQ++YD@78A) 8YZ D$#UQ5"7Q+9%-.EL9(KV&]O!:>9%*"$;:S$GW&W&..M<I
M)X;U^]T-;^_C8:R;^"XGAMY4W-'"NQ51FRN<YD&>,MCBIK;P]J4MW#>_9KV-
MGU6*>1KR>)I?+2!TWD)A0<L!@$D@#.* .OM]>TF[OI+&WU*UENH\[H4E!88Z
M\>W?TI+'7]'U.?R+'4[2YEV;]D4RL2OJ,=1R/SKDM/T?518>'=*ETIK;^QI-
M\UZ9$*2A8W3]WABQ+ELG(&.<YK.T+3-1U_PEX9MH-/?3H[73W/VQG3:_F6[1
MKL"DMR7#G(&"O>@#T"QUS2M3GD@L=1M;F6(9=(I0Q SC/';/&:H:SXF72+J]
M@-J9?LNERZCD28W!#C9TXSZ_I6%X:T/48=3TE[RTU&(:=;/$7N;B Q*2H7;$
M(QN93C/S;<8'>KGB;1-0U"_U26UM_,2?0+BSC.]1NF8Y5>3W]>GO0!9B\3:A
M!)8OJVBK:6E[(D4=Q#=B8([_ ' XVJ0">,C/)%=#!=6]T)#;S1RB.1HGV,#M
M<<%3Z$>E<C+!K6NVNF:9/HDVG6UO/!-<3W$\3;A$P<*BQLQR64<G&!FNKM))
M)!-YEHUOME95!93Y@!X?@]_?GUH QH/$ET=5L[:[TF2UM[Z62&UD>7,A**S9
M>/'R@A20<GMG&:KZ3XBUW6;2&]M] M1:2L0'?4<,%#%2=OE^QXS51K'5=0\1
M:;=RZ-]BO[6<_:=125/*EMP&&Q0&+-NRIPRC!&>PSD^']!;2[:U6[\$7DM]#
M*7-TEU!M)WDA@#*#Z=J .B'B76+BYU(6'A]+JWL+EK=F%Z%D<JH8[4*8Z,.K
M5-_PDMQ?06L^B:4][#/:BZ,LTOD(JDX";MK9?@_+QC')&:S[)]>T:\UN.#P[
M<77VJ_DN()Q<PI$0R(!NR^X<J?X35"?2M>T_2=+\.QZ==WFF1VV;^>RFBC>>
M0DEHAO=2J<DDCD@@#'- &K>^,+J+08==L](6?39;9)P\ET(WRW1-FTY;) &#
MR3Q5J3Q#J$MU%I]AI"RZBMLEQ=QS77EQVV_.%+A6+,2&X"]L\<4VZTZXU"Y\
M.1C3S:Z=:N;B>!F3]TR)B)"%)!P6SQD?(*;<PZCHWB>\U6TTV;4;2_@B26.W
M=%EBDCW '#LH*D,.^01[T *?%%V8[2W719DU6YFDA%K/+L1?+&6?S,'*8(P0
M#G/3KA%\6R7 MK:ST[S-4EFFA>UDG"+$8<>82X!X^9<8'.X<#G%/4+76=0L[
M6]U#3)?M$=V\D4>GW*I<VD17 ^8D(Y/\0SC#<9Q5+2_#^I:#<66L)I\]Q(9K
MMKBT2=7F19BA4[G8!F'E+N^;JQQG% '8:-JB:QIJ7:Q-"^]XI8G()CD1BCJ2
M.N&4\]ZQO^$HU*ZAN+[2]"-YID#NGF_:=DLVPD,8H]I##((&67..*31?#VHQ
M6L4]QJ5W8S274UW-:6YB9"9)6?8Q*DG (4E2.^/6JNGC7_#NE2:)::))>/$\
M@LKQ9HUA*LQ93)E@RE=V" ISCCK0!I>(/%D.@P6$K6LLPN3OD7[C00  O*P(
MS\NY<CCK4WB?Q+!X:TIKQ[>:ZDVEHXH5)R!C)+8PJC(Y/X9/%8\GAC5-:U>]
MN=3U"XLT%HEA']E6$K.A4-*Q#J^T,QQC@X09[4LFDZS/\,[O1)X3)J$<#VL1
M,B_OU4X1\YP,J 3G'.: -/4]=U"VUZ+2=.TN*\F:U-RS2W7DA5#!<?<;)R:M
M:)K7]K+=1RVKVE[9R^3<V[L&V-@,"&'!4@@@UEZHFIV7C.'5;31[C4+?^SVM
MF\B6)2KF0-SO=>,#M3+#0=4NY-2U&ZO+G1[J_N$D\JT:-V2-(PBJQ964D\L<
M>H&: -'6/$L&DZIIFG>2\]Q>S+&0IP(D)(WL?J, =^?0U#-X@U"YO[RVT728
M[U+)_*GFFNO)4R8#%$^5MQ (SG R<9K%U3PAK?VZ*YL]8,[2:E%<2M+;)NC1
M00#G(R%'\( ZDXY-7X%U7PYJ&JQV^C3ZE:WMRUW!);RQ*49P-R.'9<#<"01G
M@^U $EYXNEB&FI;Z6WVB]@>=H;V<6Q@"E%PV0>27P/7!-/N/$.K+JT6F6NB0
M371LENY@]]L"98KM!V'=R.O%4[JSU!FL[G6?#-GK,[6C1RM;B,M$Y;.S]ZP&
MS&!N'.1TP:PE\)WEI=:9_:7AZ76XH=*2V/DW$8\J02,VW+NI("D#/M0!WNA:
MLNMZ5'>K \#%WC>)B#M='*,,C@C*G!'6N?D\:7\5K?ZBVAH=+LKN6WEF2\!D
MQ'(8RPC*#/(SC=3M \.:G;Z/!!+J-[I:13RO#9V[QR".$ME(V9E;.T<<'OC)
MP*YJ?PI=R0ZO"/"DS:G/?W,]IJ?VN)$C+2LT4G$FX;<@XVYXQ0!V-[XGGBU*
MYMK'3#>1VCK'<,)PCEBH8K$A!WL%921D=>YIC^(M7FU75+33M"BNHM/E6)W:
M]$;.3&LG"E,=' Y:N>U3PI=F778AHZW]YJA22UU,-&OV63RU4L<D,NUEWC8#
MG(':M:V.MZ-KFO-%X?N;^.\N8YH9TN(41L01H=VYPP^93_": +]WXQL+?P@/
M$"12R(Z'RK;&)&D&<QX[$%6SZ!2>@K<M+C[7907.W;YL:R;<YQD9Q7!R^!M7
M3P_MCU-/MBV5RAMQ"'0RS,[OL9B,9+!<GL.V372:;HNHQ0:8]SK5XKV\")+;
M1)$L4A'K\I;T'#=J "P\40:CJ^I6,%K.$LH$F\Z52@EW%Q\H(S@%"-W?G'')
MKZ)K^NZS9V%\-!M8K*[1)0YU#<ZHP!SM\ODX/3/XU8.G77_"5:I>^5_H\^FP
M01ON'S.KS$C&<]'7GIS7+^%=#.DVND17'@B\2^MXXDENQ<P%0X #/@2YQU/3
M/M0!OP^+FEU&*,Z=ML9K^33X[CSP9#*FX',>.%RC<Y)Z' %5HO&.IOI<NL'P
M^&TN%Y0\D5X&E"1NR,WEE!G[I.-V<5F6GAR_BU6VD.DR)JT>I-<7&LF5-LL!
M8DK][<<IA-A7 QGL#4ME!XCMO"USX?B\/RK/,]RBWDMS#Y*K+*[!R Y<X#@X
MV]J -35/&8LI+M[6Q%U9V-K'=W4WGA#Y;Y(\M2#O.%)Y*^@)-2R^(M5EUG4+
M#3-$BNTLO+WR27OE,Q= P 4H?7N:YW5/"=PDEW;G1Y=4?['#;Z5>+,B?8RB!
M>=S I\XW[E!)SCMBM2U&NZ+K^K3?V'<ZD+L6Y6XAGA169(@K9#."/FSVH T8
MO$MQJ-A9SZ3I,MQ).9!*D\GDK;M&=KJ[ -AMV0  <X)Z<U%#XNDU&#3O[)TT
MW-U>6SW1BFG$2Q(I"G+8;)+' P,'!.0*I0:9J.FZ(EI?:/'JT%]+<7&H6\#J
M62223S%"[RJL@R0><\ ^M5](TK6O#S:??/I\U\1:36KVL,R&2W4R[X5W.P#!
M5.PG/8=10!K7_C&&W\+6NLVME+=2W9"PV>X*[-@EUSSRH5\_[M3:EXE>&/1C
MI5G'?MJS'R-\_E+M\LR9)VMV'I6%IOA/5VGTR.YNYM/CTZV>19;4Q.7N)G9I
M  ZMPJ\9P,[CCO5";PMJ=M;Z;IMQI$VL:=I>H3-$!+$K2V[Q-MZLH!5WVXXX
M48&* .QTOQ ;M=234+46-QIK#[0OFB1 I0.&# #(P>X!%'ACQ$OB/3Y+AK1[
M.>-PKV\C990RAT/XJRG\QVKDD\,:K)8:II]GILNDZ7JL\$;6QN$=X(^?/EX9
ME&\!5"@GU(ZUH7/A/5HM5G6UU>\EM]4LS;7=U(L*O;E#F,A45,Y4R)P,C(YX
MX -W1/$L&NZCJ=M;0N(;)D59R>)MV>5'IE2 >_7I6W7*>&M!U72?$.IS75U'
M)920P1PA(%C#;%(X )VA1QCOGVKJZ "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JI<Z7I]Y<Q7-U86L\\7^KEEA5F3Z$C(JW10 4444 %%%% !1110 =:9%
M%'!"D,,:1Q(H5$10 H'0 #H*?10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOEG;/.RNCOCO&1M SZ8(]:YC6O$FI:)\3_#EA<7UPEA<6!DNK<+YF^0+(!@
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MAOB/_H?=3_\  :+_  H_X0WQ'_T/NI_^ T7^%=K10!Q7_"&^(_\ H?=3_P#
M:+_"C_A#?$?_ $/NI_\ @-%_A7:T4 <5_P (;XC_ .A]U/\ \!HO\*/^$-\1
M_P#0^ZG_ . T7^%=K10!Q7_"&^(_^A]U/_P&B_PH_P"$-\1_]#[J?_@-%_A7
M:T4 <5_PAOB/_H?=3_\  :+_  H_X0WQ'_T/NI_^ T7^%=K10!Q7_"&^(_\
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M0#6/^A]U[_OI: .1U+2M:MKCX917]M=W%SI\A:]DCB>00J7CVAF (X"X_P"
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M;*ZDLH+4^9,+=RD;$/MR<8!R5^E:O_" :Q_T/NO?]]+1_P (!K'_ $/NO?\
M?2T 97Q"L[RP\<^'/$2VE[<Z7;*\%R++=OBW9&[Y>1][M_=QWJ'6_"?AW4=!
M@M[:RU338KBZENX+XI*[1S;5R[JV656QCG'*@]\UM_\ " :Q_P!#[KW_ 'TM
M'_" :Q_T/NO?]]+0 >"]7U:P\(Z=_P )%!=SW=Q>FUBDC@8NR$X6208! X/S
M'G&">M=U6-X=T2ZT2VFBNM:O=5:1PPDNR"4&.@QVK9H$%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1G#%<;HV(S@-R1GIZ8- '=T5R5]JE_I&AZ/')J*W5[JM[%;"[VILC\S+$J
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M- &]'KUI)XEDT$).+N.V^U%FCPA3=MX)Z\^W8UJ5P=S:7<WQ3-M;ZE+;R?\
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MF?-7(4;F'!'L: .QHK/T1+Y-'MCJ<S2WCH'E+*HVD\[?E ''3/M6A0 4444
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ME=>74.$+#>02%SR0,9/ZC\Z=0!@3>')+C6M'U.2__>:9')&B"$!9 X"MGGT
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M1=;TN35+QX=4N3=%F"9BD+*V1@<_,HZ\>F*ZBTAEM[6.*:Y>YE ^:5P 6/T
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M,NCRVI-QJVGPK(/-^7:[#:=J$;CP.N!4MWK&HP-X.-OJT5U!?W AN98HU*W
M\MFW XXR5Z#%:=AX6;1[:TMM*OS%!;VY@:&>(2))EBQ8@%<')/3CD\5 O@FW
M@M="M;2[>&'1YC/$#&&\QSNSNZ<'<W QUH S=5U_4?/\6K]O.GR:3 DEG'L0
MB4>7NWG<"6#-E>.F/6FRZEXC6^\'6SZCY$FJQRF[1K9<HPAWX]BI./J!G/(K
M-O+J.;Q3JDK^)KK1;L7.R.UN;!)BRHH57C+H3M;!("GOZFNDM=$U#5)=#U;4
MK\B[TUYFC_T;R_.#Y0,ZDY4E,' Q@D_0 &)<:[KMCX>\9Q?VH9;O19,V]W)
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MTVYOI@S)!&7*J,EB.BCU)/ ]S5JLS6-*EU46JI>&"."=)V3RPPE*'*ALGH"
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M4;A;JZ%FUD&2+RLQL06W<G).!Z <X'-9$/@!TT_2;*37[UX-*NDGM (HP45
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MF7;^_N3\D:E@&/0Y.,X&#DXKG++6M3DUKQ#IR7EP8K>QBNK66[@59$+;P?E
M&1\N<,,UT7B/0H_$6D&Q>YEMF$J31318)1T8,IP>#R.E9R>$)4U:[U-M:NI+
MF[LQ:S;XDVMC=AL #&-QP!^.: .=LM;\01Z/X-UJXU8SC5+B"VN;7R$5&$BM
M\V0-P8$9X('M6NFMWFB^*M8L=:U"66T-G]MT]O+1?D7(D3A1N8'&!SD$5/\
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MLP6M1;HJA\YW[ASG'&.G/M775E^'=&'A_0K72EN&N([9=D;LH5MO8''!K4H
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MC(PFP\'^,>E4-2U75M%\/:+XB_M"2Z\Z2W%[;LJ^6Z2X!V #*E2PQSTZYZT
M=[17$P:GJ;W7C>U;4)B-.V&T?8FZ+, DQ]W!Y]0:W_"MY<:CX1T>]NY/,N+B
MRAEE? &YF0$G XZF@#7HKEM?N;T:P]O%J,B1_86>*ULU!G\W<?WC%AM"   9
M(!.>O%8*>(-<O]&\#W<>HF"75)!%=;84*O\ NV.[!'!RO8X]J /1ZRM1UZWT
MW5],TV:&=I-1D:.*1%&Q2JECN.?0>AKCI_%&H^&(/&:W-W)J0T@6\EJ]PJAL
MS+PK;  0&QVZ58UNPN;7Q;X+>?4I[HM=RB02!=I?R6^9< ;>_'3I0!WU9&O^
M(K3P]HEQJL\<UQ!;G;(+<!F!SCN1W(K5D4O&RAV0L" RXRON,\5X^\4P^!^N
M32WEQ.7GG&)B#@BZ/.<9)/?)- 'L7445QIO=2TCQW:6=QJ<UY:7UC/.\3QHH
MB>,J?DP 0,,1@D_4U3L+_P 3ZUI6D:[ISN#.Z33PRR1_9S WWD  W @8P>N0
M<^E '?5DS>(+9=2ETZT@N+^\A ,\=LJXBSTW,Q503Z9S[5K5P7PD=IO"EY<3
M\WTVI7#79/WO,R,@_AB@#J].UJVU*]NK...XBN;14:>*:,J5W[MO/1ONGD$C
MWK2KG_%^K+X9\-:GKT4"/=10*B[NYW83/L&<G\36;J]YJ7AK4?#\_P#:,U];
M7]XEA=1RJO+2 [9$P!MP1R.F#^- '945YL][K]QHGC*Z'B"YCDT>[N/LQ2&+
MD1Q*X5OEY7Z8/)R3VNC4]8M]3\)7TFJ22Q:S\EQ:&-!$F82X*<;@01W8YH [
MRBO-X7\3ZM8^)Y+?Q)-!-I>H3QVH%O%APB*P5_EY7G'&.I)SP!>L]<OM=M=%
MN6O'@6]TSSC9V*CSVF) WY886,<X)(&2 <T =U17FD7B/7;[PAX+U%-1\FYU
M&_CM;HB%"L@/F<D8X/R#H0.36MISZQ)KOB7P_P#VW<NT,$$UI=RQQF2)I V0
M0%"D94<8Z9H [6BN&T/7+_6=%TBQ-Y-%K"W+PZDP5-R&'_6Y&W&"2@&!QY@K
MN: *NHWC:?IT]VMK<71B7<(+==TC^RC(R:L(V]%;:5R,X;J/K7/>/+V]TWP3
MJE_I]TUM=6\)D2155NG;# BL_4[O5G\9:'IUOJLMO:WMC-)*J1(2&0)\RDCK
M\QZY'M0!V=17,XM;66<QO((U+%8QECCTKS^T\3ZG9Z/=6<]Z9[I?$7]C0WDJ
M+N5&*D.P "E@I(Z8SC-=1%8ZG9WU^9=3^U:;);9BBF ,L<@SN.X 94C''KZ4
M 7=#U>#7M%M-5M4D2"Z3S$60 ,![X)K0KR_0]0O=-\#> &M+IXDNKR&UGC"J
M5>-A(2.1D'Y1R"*U;_Q1>:'K'B^2:9[FUTVQ@N;>!U4!7</D9 !P2%ZYQ0!T
MVK:];Z/>:;;3PSN=0N!;1/&H*JY!/S$GC@'IGI5J"^:?4KNS-G<Q+;A")Y$
MCFW GY#GG&,&N%UZUO%E\$W=SJ4UR\NJPF5&"A"YC<Y4 ?*!R ,]#SD\UH1Z
MEJK:[XTL_P"TI-EC;P26A\M,PEHW8_PX/('7/% ':T5YM9ZKKD.E^"M8GUB:
MX.J306US;-$@C821L=W W;@5!SG'L!Q5G5]?U!9/%BOJ#:?=:;&KZ=" O[T;
M-P;!!\S<^5QVZ#F@#T"FM(B,BLZAG.%!/WC@G _ $_A5'0_MIT2R?47=[QX5
M>;>JJ58C)7"@#C./PKF?$,$\GQ+\,JE_=0I);W9V1E=JE53D J>3N().?;%
M'0Z1KUOK%WJ5M#!/%)I\X@E\Y0,L5#9&">,$5JUYB8]0$_Q O+'5)K&2TN//
M3R40[W6W5@&W _+QT&/K6Q%XAOM7N])L(Q,CW&CIJ,_V9D1V+D  %N@!SG'/
M([9R =M16+X876X]+>+7GCDNHYG6.12"SQ=4+[0 &P<''I6U0 4444 %%%%
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MU"MM( (& *SK;P'';KHP;6]2E.D,?LI;RQMC*E-APO/RG&>OH177T4 8^DZ
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M\<6FK:@FDO*9O[+WKY(8G) .-P3/.W.#WR*ZVFRR)#$\LKJD:*69F.  .I-
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M*.I'<BKJ,616*E"1DJ<9'Y4 5-,T\:;9^3]HFN9&;?+/.P+R-ZG  Z #
M JY110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!!Y4B,H!CP!M&&/'/XU<NO!=O?>'[C2;S5-2G^TLC3W3R(97VD%1DK@*".@
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MN5*"67   ^[@     =!]:FG\-Q7&K:5J4E_>&?3%=80/+VMO 5MPV<Y '3%
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M02H[/=!EV1$8PI&<\Y[>E>7W=S>:O\/-*EO[NY>>+7DMRXE(9E6YVC=C[Q
MY]1GK76W4UW9?$/0K".^N6LIK*X9X'?(+)LPQ.,D_,>I- '745YU!J6H:W\/
M+[Q7!J%Q;:A']HN((UD/EQK$S8C:/[K95.21G+=1Q4MO?:CKOB[2HSJ5Y9VF
MH:!]MDMH65?+<O']TXR#\V,G)ZXQ0!Z!17G%AJ6OOX/E\@W6IR6&L36TX679
M<3VT;L,*W&7^[TP2 :Z;P?JEGJVG74]E>74\8N64PW@836QVKF)MW/!R>_7J
M: +,FOI'XL@T!K28236SW*SDKL(4@$#G.?F[@?C6Q7$:U;/=_%#2H$N9;<-I
M5QN>$@/CS$X!/3Z]?IUK,LO$.IVNA?86O'GF/B*32$N9Y,/Y88D9?!^8@;<X
M[^M 'I5%<)J%KXBTG3_$=Q_:?DV7]G23VD8NFGFAE123AI$SL/'4G!Z8S5;[
M3J6E>']$OFUB[N;C6VL[9A/(%CA+*6)3Y25+8VYYY.>M 'HE%>>ZW>^(?!NF
M:[JQN(9+$6JM:V\MR]Q)#,75"V64$I\P)!)P1[U>UJ6\\-:EX=N;6^NKJ&^O
M8["[BGE,@D\Q21(,_<(*YPN!@]* -?4O$36MS>6MAI\VHW-E$DUS#"P#*KYV
MA0?O,0I./UY%;4,GG0QR;'3>H;:XPRY'0CL:XGP]8(GQ+\5-]HNCY2V; &9B
M&RC\-Z@=L]*W/%DFJ0Z.LFE027$BSHTT$,FR66$'+JC=FQZ<]<<T 2^)=?3P
MUH[:C+:37$:R(C"(J-NY@H)R>F6'3-;%>6:_JMIJWPRUR6RN[M]M_;!K>^#>
M=:'S81Y;!CGJ">IZ]:Z"&6\TKXB?V>VJW-Q:76ER73BZ8%8Y$D4;EP %&&.0
M.* .SK!MO$ZW5WKENNGW(DT@H)$+)NEW)O&WYL=,=37+6.J7\.K^$V34+N[C
MOY)HKJY=B(;O]VS!HXR?E (X("@CU!K1TC_D;/'O^];_ /I,* .ET'5X]>T*
MRU6*)HH[J(2*C')4'UJ&SU]+SQ+J&B_9)HI+**.4R.5VR!R<;<$\?+WQ]*S_
M (=?\D[T'_KT2L>33)-5^)6OVZ:E>6*_V?:DO9L$<G,F/F(.!].O\P#OZ*\S
MTGQ)K-S;Z5HEU.)KI]1O+*6Z\PPFX6W!QA@#M)R.1S\IY&<UUGARSUFPN=2A
MU.[BFM&D62R3SVFEB0@[E=F4$C(X)R>O/% '05D:)KZ:W/J<*VDUNVGW1MG$
MI4EB%#9^4D8^;UK.U#49;WQY:>'!-+!;+I[W\QB<HTIWA%3<,$ <DX.3QVSG
ME+*_N/#UOXH6WN&:67Q#%:K/,_*+((@6+$'D*2,D'L3F@#U.BN%U&37_  NF
MKZOY\3Z;'ISR):37<EPXN%Y#*64':1U&?I5FTL=?_M'2M0@U&,64D9%Z);UI
M1.&4;7C4H%1L\X& <XQ0!V-%>3SWFLK\/M;UO^WM0^VZ9?SB AU"L$FV@. /
MF!'&.GH/7I))+[2O'VB0_P!IW=S!JEM<FXAF8%%:,(RE% ^7[Q'';\Z .TJ"
M]N39V4UR(9)O*0OY<>-S8[#) _6N"TZ;Q%XBT#3O$.G7D-O/)+Y[F6]?R3$&
M.Z)HMFT8 QGKD9S5V&ZF\3GQ4TEY<VZ:?/)96\<$I3840$R,!]XEB>&R,#IU
MR =/H6K1Z[H5EJL4311W40E5&.2H/8UH5S7P]_Y)YH/_ %YI_*L^?4I?#OCJ
MY34+NYDTR_L6GM%>0D1R1<R1J.Y*D,/H0* .UK(\3:\GAG0;C5I;6:YC@QN2
M(J",D $Y(XR1TR?:L:Y2[M!H=G=:E=---YLEQ90R,9KA]H("R;@51">I(!^7
M)R>>8U+4+R_^#/B'[=+)++;W<MLK2$,^U)P%#'N0.,]\4 >ESW<\6I6ELEC+
M+#.KF2Y5E"P[0" P)R<YP,>E0Z_JZZ#H=WJCVTMQ';1F1TB*AL#J>2*Q]6N[
MRW^(7AJVCO)A:74-T9;<8V$HBE3TR?O'J:YG4KJ;Q/\ #'Q%K<UY<QN5NEAA
MCE*I''&2H0KT8D DD@GYN,8% 'I5I.+JS@N I42QJX![9&:FJEI SHEB/^G:
M/_T$5PIU+4!X-\<S?;[KSM-OKI;23S3NB5(T91GN 2>N: /1ZRO$>MIX<T&Z
MU:2UFN8[9=S)$5!QZ\D<?F?:N8FGU*[\6>';,:O>0VU[I4DLR1E1EE"<@XZG
M<>3G';'6LF^N[N;X6^-+2[NY;K[!=W-I%+,=SF-2I7<>Y^;&: /3XI/-A20#
M&Y0V/K3ZXZYOKN^\20Z#"2(HM+2Z95NFMV<LQ7(903A=O08^]SFJ5P_BG1]$
ML!J(DU=;:XD%ZNFS$7#0X_=G@*69<C(&">/>@#OJ*\_?6;B7PUI>HZ0^H:UI
MBW$S7B02%+OR\MM7J&)0D @$$X':NE\)ZA:ZEX?BN;._EO86DEQ)/GS%^=B$
M;/.5!"\^E &W17"26^I:MX]UK2_[?U&UM(K6VGC6W9%*,6;@';T^7GN?6H8Y
M?$/BC2;O4-)NTM;V.^EC@9[QUCB6.4KL>((5;*KDYR?FZ@8% '?3.T4+NL3R
MLHR$0C+>PR0/S-9WAS6XO$>@6FKPPO#'<J66-R"P 8CG'TK"TV\G\3:YKMO+
M>36\6G&.WA2UF*?.R;FD)'WN3@ Y&%Z<US'AFZNK+PC\/_L]S+&+B]:"=58[
M9$_>M@CIU H ]8HKSO4_$E_H5[X[FCFDF33[>TDM8I6+K$\BMD^N,X./:N@:
MQNM+N8=4AUF>>T2UD^T6T[F3[2X7<K(2<(>#PHQCM0!TE4=9U,:-HUWJ3V\L
MZ6L32O'$5W%5&3U('05Q^F#Q'JVF:#K]I?01M,8Y[SS+UVBEB8?.@CV;5(S@
M$'(QR3UJK=W4WB?P/XLU26\N8O)^V06\44I58TB4C#*.&+8).[/WN,8H [_3
MKQ=1TRTO50HMQ"DP4G)4,H./UJ5)HGEDB1U:2/&]0>5SR,UG^&?^14T?_KQA
M_P#0!7"VMVWAU?'^L1/<3S65T3&DLS,K'R4QN&>0"?P P* /3J*X/5KJ_P!!
ML/#VL6VH7-TUS=6\%Y'+(72X67@LJ]$8$@C;@=J[2_MGO+">WCGDMWD0JLT3
M89#V(^AH L45Y1)XDOHO#>AWTMU>?:M-NC#K<:S-@QHXCD9O?<RL,=B>PXV_
M%5W?)X1\2ZW8:E=6^S*VICDR (\*Q .<9;=R.P&.IR =CJ5W/969FMK&6]DW
MJODQ,H;!8 G)(' .?PJ<S1"=8"ZB5E+JF>2H(!/_ (\/SKA/%$&IZ'X7EU&'
M7]1DGFNK4L'9-JAG565?ERJG<>,U8:S#_&-R;BY'_$E67:)F SYY&,9QC@<=
M#0!UEC=SW3W8GL9;40SM%&9&4^<H PXP> <]^>*MUYC<ZIJ\?@KQQ.-7N_M.
MGZC.EO/E=RHJIA>F .3T K7634-,\:^'(SJEW<Q:K;7'VB*9@4#(BLI10/EZ
MD>XZY/- ';T5YC?:KK-QHNK-#>W4/B:'5/)M[2)_^6?F*% C.5*F,EMY![G/
M%>E01M#!'&TKRLJ@&23&YO<X &?H!0!)17FMUJU_;OI%Y;ZE=7;3ZZEK-=(Q
M6VDB>1E\I8R<':,#<!U4_,>:M^7J6I>)_&%@^NZC%;VD5N\ A=4,9:-VX('3
M(_'C)- '?UD:7KZ:GK6KZ8+2:"336C5S(5._>NX$8)XQC\ZY/2/$=]K,/@[3
M;BY>-]2L7NKN:,['EV* %!'3).21@\<8S5[PC;?9/'/C.'SI90LMH5:5RS8,
M.0"3R<=.>>* .UJI?W<]H+;R+&6[\V=(G\ME'E(>LAR>0/0<\UA>,+W4-/DT
M^YAL[R\TQ#)]NBL)"LXX&QU (+ ?-D ]QZ5BWNL/)H7A2]TG7+FXMKG688'D
M. 98VD;*/D9R,!3TZ'B@#T*BN'U74KC_ (2+7K/4+V>Q@AL8Y-,,4A3S&(;>
MPQ]]@P4;3GCMR:SYIO$4.F^"_MFK7T%]?W2QWB,L8(W1,Q& HZ$=#G'<&@#T
MBBO-YM=U#PU_PFL(OI[N/3DMI;5[MM[1F92#DXY4'G%:[0ZYH^I)JOVI&TI+
M65KNWEO7G:5E0LK1Y0!3P<@$#';B@#:\1Z^GAW3X[R2TFN$>:.$^65&PNP4$
MY/3)[ UJ32-%"\BQ/*RC(C3&YO89('YFO+=<$^J_#32]=N;ZX>ZN[FTGE19#
MY6'F7"!/N@+D<XS\O).37JIZ&@#+\.:W%XCT"TU>&%X8KE2RHY!8 ,1SCZ5J
M5XUIJ:IH_P (M,\3:?K-XDUC&'%D2OV>1/-(*%<9).>N<YZ8XQU\VJ2>&O&M
MS_:=Y<OI>H6;3V@DD)$,D8+2Q@>I7##/H0* .VHK-T&VNK;1K=;V662Z<>9+
MYCERC-SM!/9>@^F:TJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ***CN+B*U@>>>18XD&69N@H S=
M.\-Z9I>C7&DVT&+.X:5I$)Z^83D?3!P/8"LNV\!:?;C2O^)AJLATMB;4O<_<
M0KMV< ?+@X]?>M&37Q'XNM] -G(#-:O<K<%QM(4J" .O\7?%;- &1I'A^'1I
M=0DM[NZ<W\[7$OFE"!(0 6&%&. ..G%9I\!Z<=(_L[[9?A5O?M\4RR*)(I\D
MEE(7'4G@@]:ZFB@#GH/!VG0W>IW+3WLS:G (+I99R5D 4KGZX)'H.P%1MX*L
MVT?3],;4-1:&PFCGA9I5+;H\; 25Q@8'  ]\UTM% &+/X:@?67U:UO+NRO9H
MA%/);E,3JOW=RLK#([$ 'MTJ*?PAI\MKI=K%+<V\.FSBY@6)EYE&?F8L"6)W
M-GUR:WZC-Q$MREL9%$SHTBIW*@@$_FP_.@#$F\)VL]_J=XU[>B748DAFV.J[
M57.W;A<@C)YS5NST2*VU,ZE-<SW=[Y'V=9I]@*QYW$ (JCDX)^E6;&YNKA[M
M;FQ:U6*<QQ,TBMYR ##C'0')X//%6Z ,S6M"L]=MX8[DR1R6\JSV\\+;9(9!
MT93R/P((/I40\.P%;UY;NYFN[R$6\EV^SS!&,X50%"@?,QZ=36Q10!0T;2HM
M$TFVTVWEFE@MD$<9F(+!1P!D =*AOM!@O];T[5I+FY2?3]_DJA79\XPV05).
M0!W^E1Z%KXUJYU6#[');-I]U]F82.&+':&SQP/O>IK9H P(_"EM'_;&V^O<Z
MOS<DF/KMV_+\G'R\?_7YIG_"'6*VNDQQ7-W%<:2GEV=VC)YJ)MV[#E=K+@ 8
M(/3UKHJ* ,.?PEI=YI6H6%ZDETNHL'NII6'F2,  IR  -NU<8  QTJM;^#+>
M+4=-O[C5M5O+C3E=8&GG7[K  AMJC/ Z]3W)XQT,]Q%;(KS2*BLZQ@L>K,0J
MC\20*DH PK3PM;V=KJUO%?7NW5)7FG8E,AW #%?EXR !^%0S>#;*?PM#X=>]
MO?L,/EA,,F_"$%1G;T! _*NCHH YW5O!UGJFJ0:HM]J%EJ$47DM<V4PC>9.N
MU^"",\]!3KCPAI\UYI]W#<7MI/91M$KV\V&D1CEE<D$MD\YZYYSFM'5-1DTY
M+?R;&XO99Y?*6. J"/E9BQ+$  !3W[BL.W\:2W=SJ=M;^'=2EGTU@MPBR0Y!
M*[@!^\YX]* 'KX#TI-#GTE9[X02W7VM&\_+PR!]X*$C PV>H)/<FKS>&[=M9
ML-4:\O&N+&)HHPSJ0P;&[=E<DG [_3%,TSQ*FI^(+O2ELY8O(MHKD2NRG>LF
M<8 SCIW_ "K=H YT>#;!%OH(KF[AT^^D,ES8HZ^4Y;[V,KN4-W"L!5MO#MN?
M$,6M)<7$=Q%;&T2--@C6,D'&-OJ >O:M>B@#G;7P?;65OY5OJ6H1M]N:_$@>
M/<)6#!OX,%3N/!%:>F:1;Z6UU)&TDD]W+YT\TF-TC8"CH !@ # ';US6:/$L
MUQ<YT_2Y;RR2]-C-/'(-T;@X9]A'* \$YSP>,<UT- &3/H$,_B*#6S=7*7,$
M+0(BE-FQB"1@KGD@=^U9[>!=)ETC4=,N9+JX@OKIKR0R.H9)B<ET*J,'(IVJ
M>*+G1O"PUF_T6:*02B.2V\Y"8]TFQ26'!!R#QGK724 <Y!X/MHM)O+";5-4N
MS=PFWDN;J<22B,C!525P <]AD^O J>Y\*:=?>%T\/WAFN+..-$C=V D3;C:0
MP Y&!S^>:W** .?LO"%C;Z?<V=[=7VJK<Q&&1]1G\UO+_NC   [Y R2!SP*D
ML?#%O:-8^=>7EZEA_P >B73(1$<;0?E4%B%) +$GGUYK<HH R++P]#8:[?ZO
M'=W3SWP03HY0H0@(7 "@C )[_7-6M2TU=2C@'VFXMG@E$T<MNP#!@".X((PQ
MX(J[6'J7B"6WO;JQTVP.H7EI;K<30B7RSM8D*%.#ECM;CCIUYH @O?!=AJ%A
M?6MQ<W9-_-'/=3*4#RLFW8/NX &Q>@'3G.35BX\,VMWK*:I<7-U),MJUF4)0
M(T;?>! 7/) .0?I6M;RF>VBF,3Q&1 QCD&&3(S@^XJ6@#E+?P!IUO%ID?]H:
MK(-,DWVN^Y_U:[2NS@#Y<''][WK0@\-06]]JUW'>WGFZH%\_)3 VKM!7Y>,+
MQWK0EN;I-4M[9+%I+62-VDNA(H$3#&%*]3G)Y'I5/7-?AT?0]1U..%KP6 )F
MBB8 @A0Q!)]B/7K0!/HFD0:#H]OIEM+-);VZ[(S,06"]AD 56N?#D,NM2:M;
M7UY97<T*PS- R$2*N=N0ZL 1D\C%:=I/]JLX+@+M\V-7VYSC(SBIJ .>U#P7
MH^H:';:44FMX[63SK>>WE*S129)+A^3N))))SDFK^CZ-%H]NZ"ZN[R:0@R7-
MY+YDCXZ G@ #G   Y/<FM*B@#$UGPQ::S?6>H?:+JRU"SR(;JT<*X4]5.X$,
MI]"*J+X%T@V6K6ER]U=Q:J_F7(GFS\^!\RX P?E!S[>G%2ZCXI-AXCM]#32K
MNYNKB%IXC$\84JO!Y9A@U9T'Q)9>(!=I;I-!<V<ODW-M.H62)O?!((/8@D&@
M"OI7A&STVWFAGO=0U198C!G49_-VQ'J@X  /&>YP.>*BT3P39:#(AM]0U2:"
M'/V:VN;G?%;Y!'R+CL"0,YQFNEIDTT=O!)/,ZI%&I=W8X"@#))H YP^"+!O#
MU]HC7M\;2^F::;+)N+,VYL'9P">:NS>'(;C5],U.6]NVN-.1TAY0*0X ;<-O
M.0!Z=.,5L*P=0RG((R#2T <M:> M,L=2EN;:[U&*TEE\]].6YQ:E\YSLQGKS
MC./;'%3S^#K*35[S4;:]O[)[Y0MW%;2JL<^!C)!4D-CNI!KHJC@N(KF,R0R*
MZ!V0E?[RL58?@01^% %+0]&M_#^CVVEVDDSP6Z[$,S[FQ]?\*-5T.QUE[%[V
M+>UE<K<PD=G4$#/MST]A6C10!C:MX;M=6U*QU%KF[M;NS#K'+;2!2R-C<K9!
MR#@>_O6>W@+2SH>HZ.+K4!9W\YGE7SPQ!+;B%)!P,\YZGN:ZFB@#'N/#T-UK
M.FZI+>7;7.GJZQ<H%(< -N&WG( ]/;%9D_@#3I%U2"&^U&ULM3W-<V<$JB(N
MP^9@"I*D^@.#W&.*ZNL;5-?&F:WI&FM:22#4I7C68, J%4+<CJ3Q_P#7H T;
M&TCL+&"TB:1HX4"*9&W,0/4US]WX%T^[?5@;W4(K;5=S7-K%,!&7*A2X&W.<
M =\>U=110!A1>%;6'4M.OTO+WS=/MS;PAG5AL.,YRN3G []N*KMX)L7TG5M-
M>]OC;ZK.UQ<_,F2S8W8.S@' _*NEHH YS5O!EEJ[6,[WNH6U_9)Y<5]:RB.;
M8>JDA<$?A_,U97PW#$EG]FO[Z"6UW_OA('>4OC<9"ZG=G ^G;&!5K5M6BTF*
MW+KOFNKA+:"/.-\C9P">PP"2?0'KTI-)O[R^CN!>Z;)8S03&+:SATD  (=&X
MRISW [T 4X?"UM:B%K2\O+::.6:9YHV3=,\I!<N"I4Y('   P,8P*OZ5I5MI
M%M)#;[B99GGED<C=)(YRS'  Y/H *O44 9-OH$%OXCN=;6ZN3<7,2Q21L5\O
M:N=H VYXR>_>LQ_ >F'6+G4(+S4K:.[?S+JSM[DI!<-W++C//?!&:ZFB@# G
M\)6CZ])K%K>7MC<SHL=RMK(JI<*O W J>0. 5P?>JJ> M,B\.V&CPW=_&EA.
M+BVN%F'FQ.,\@D8Q\QXQCFNIHH YV#P9I<5SJ<\SW5T=3A6&[2XEW+(%4J"0
M,<\GZ9XQQ2Z%X0M-"*!+_4KQ(E*6\=Y<>8D"GC"# [<9.2!QGDUT-% '+:7X
M#TS1[WS+2\U(68E\Z/3FN2;:-\YR$QG@\@$D9YHG\":?++JI@OM0M+?5 _VN
MUMY5$3NPP7 *DACWP0#W!KI4N(GN)(%D4RQ!2ZCJH.<9_(U)0!5TVPBTO3;>
MP@>1HK>,1H96W-@# R:SD\*Z<FI:G=EIW34A_I-J\F87.W83MQU*\=<>U;=9
MVJZM'IAM(MGF7-Y.(+>/=M#/@MR>< !22<&@"C8^$[2RCL8'N[RZM;!P]I;W
M#JRPD A>0H9MH)QN)Q^ K?K/TB_NK^VE:]TZ6PGBF:(QNP<-CHZ,.JG/!P._
M%:% &,/"^E ZT?(_Y#/_ !]\_>&S9@>G&3]2:2]\,6-[X6'ATO-#8"%8"(B
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M%P3&JD."22=V<@XXQ7?5S5]X'TJ]UN75EFO[2XG %RMG=-"ER!P-X'7CCC%
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M+.Z:%;@#@!P.O''&* ,N.[U/6M<N=&GGC=[33[=V-M?26PDDD#;Y%**2RY
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MDL<EF9BS,3ZDDFKE !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M><O&ZF,MO5>B%=O\( _K6TW^V?$WANTU^UU".SN_/:=YVO)"B*KG=$T6-FT
M8_#/7F@#TFB@]*X+0%F\4>%+#Q"VLW-G>FX:XFD65BB*KL#"8\A=NT8Y';/)
MH [VBN)THR>++OQ,EU=W=O)9W[V5LL$[Q^0JHN) %(R2Q)R<^G2L'3M6U77H
M/ 5S=7]W;RWSW,5T()"BS!$<!L#C)VYSVSQCB@#U2FR2)#$\LCA(T4LS,<
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MB[4K/4-)L+CP^8[G5"X@0WBG:57<0V%XX],T^\\67M@UDMSHIB:XU2/3FW7
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M#9&ST]9$@WM)M>5GPS').6)/))-.U?2;/7-,ET^_B,EO+@L%8J000001R""
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M382MN2/(.&C(X*G!Z8Y'O6PMJ-)\=>%C:SW.=1M+E;L23,XEV(C*<$X!!)Z
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M(/:^&](N-%O=3@DU))X)72>&T56 M0000"S$[6() X P: .A8L$8H 6QP"<
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MG[4)9V<2,FPJV"< C)Z <<=* .WHKC_B/YB^'+>6*XGAD6_ME#12E<AI5!!
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MKLVOV5Y-/:I;26U[-:%$DWC]VVW.<#K]*VZXSX;0K;Z/JT"%F6/6;Q 78LQ
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M<AE=9#F/'39@;=G3VS0!ZG17G\=G_:_Q$DM[][M8)]"BGFM1<R*HD:0@C@Y
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M[?V<I6U)GDRBD %2=V64@ 8;(XJ_J.G6VJV9M;M':(LK_)(R,&5@RD,I!!!
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M(S*G]U26)4?3'04OA?7+C7;6_DN;>.WDM;^:SV1N7!\LXSD@9S]!6[0!A?\
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M=.*S[+7]4U9XKS3+*WFTPWLEK+OD*RJJ,5,H[$9!^7KC'/87O$^K3Z%X:O\
M5+:WCGDM86E\N1R@( R>0#^7ZT /'A[3%U8:HD,B7BV_V9729U"Q==@4':!G
MGI5)O!&@-8)9?9)1"ES]K0BZE#I*<Y97W;E)R<X-;5G.;FQMYV #2Q*Y Z#(
MS4] &''X/T*(:AY=D4_M!/+NMLT@\P8 /\7&0.2.3WS3Y/"ND2VNG6SP3&'3
MF5[1?M,H\HJ,*0=V3@<#.>*V:* (KBWAN[66VN(UE@E0QR(PR&4C!!_"LZP\
M-Z;ISP-!',WV92MN)IWE$((QA Q.WCCCMQTK6HH YZY\$>'KO6FU>73Q]KD(
M,I61U24CH70':WXBM^2-)8VCD171P596&00>H(JMJ+Z@ENATV&"6;S4#+.Y4
M!,_,00#R!G%6Z ,+1O!VA:!<M/IMF8GYVAI7=8P>H16)"Y]L4]/"FCQRRLEL
MZQS3>?);B9_):3.=QCSMSD ],9&>M;55[YKM+"=K&.*2[$9,*2L51GQP"1T&
M: *IT'3SK,FK^7*+Z2'R&E$\@_=YSMQNP!GGIUJK!X0T:UM8+>VAN(4MYFGB
M*7<N4=L[B#NSSDY'0Y-;$!E-O&9U19BH\Q4.5#8Y /<9K/\ $>ISZ-X=U#4[
M>".=[2!YO+D<H"%!)Y /I_\ JH CG\+Z1=:6^G36I>!Y_M#'S7#F7.=^\'=N
MR!SGVZ4^'PYI=OJT>J10RK>1P?9UD^T2$>7G.W&[!&>>1UYJWIMTU]I5G=NH
M5IX$E*CH"R@X_6K5 &)>>$M&O]2GU">V<SW$8BGVS.J2@# WH#M8@'@D<?A4
M=UX*\/WFB6VD36&ZSM2#;@2N'B(Z%7SN'YUOT4 8K^$M#ET$Z+)8J]B6WE6=
MBQ?^_OSNW>^<T6/A72=/U--2BBG>]2'R!/-<R2L4SG!+,<\^OH*L:C>:I%>6
M]OIVG07*NCO)+/<F%8\%0!PC$DY/I]VL#1O%VLZUISW\&@VOD17;6TJK?L9!
MM?:S*OE $#KC(SB@#H=5T2PUN.!+^)Y%@E6:,+,\>UUZ-\I&2.U,3P_IT>JS
MZFB3+>7$8BDE%S)\RCH,;L#&3TJKX=UVYUBZUF"YMHH&T^]-L!'(7# (K9R0
M/[WI6[0!0TC1['0M/2PTZ)HK5"2L9D9]N3DX+$GJ2:OT44 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5SOC"6V6PL8+B:X!N+^&.."$@?:6SGRF)XV'!W>P[]#T54-6T73]=M%M=2
MMA/$DBRH-Q4JXZ,&4@@^X- 'F]UJ=_H%EX_%KMMOLCVK116S%DM_,1?,9,@8
M."6Z#D=*ZNYT[3]*(UW1YF28V$HAMX6S'>$(75G'5F&/O9SSUYK5MO"VAVEQ
M=3PZ;"LEW&(IR06$B@8P0>#D=3U/?--T3PIH?AUY'TJP6W9QM+;V<@9S@;B=
MHSV&!0!S_AZPTW5/#_AOQ!]OECO0(Y)KJ-QON9'&UXY#@Y&\XQVQQC%9U@J>
M(_!GB'5+YF35H+B["SAB)+-HB=BH>J@ *<#KDYZFNMT_P;X?TK4WU&QTR*&Y
M9BVY6;:K'J54G:I/3( J:;PQH\]W<7+VA#W6/M"I*ZQSX_OH"%?TY!S0!PT,
M$GB/7O"?]KM<9U#0Y7NXEF=%<XC[ C;USQBM70[:SU;Q)X@TJ^C\V'25M[2T
M@E<L8HO+SO!/.YC_ !]>!S753:'I\^K0:I)"YO+=2D4@E<;%/4  XP>XQS4-
M[X8T?4-434KBSS>*GEF6.1XRZ?W6VD;Q[-D4 <#X7:VD\#^"[&5I9IYI9S%9
M;@([G:9,^:2/NKD-WYQP:IWQF'PR\91-*\1LM8DC@2&9@L2[HOD7I\HW-P1C
MGI7H0\$^'%T^TL4TQ$@LY#+;A)'5HV/4A@=W/?GFAO!7AUK:\MO[,C6"\<27
M$:.RJY&,< \#@' XR!0!AW%JNA_$BR.GB4M>:9<O.C2L_GNA0J3D]>2,^]1>
M&K6PU_PGH?B">_EBU%)EGGNXF DDDW$-"QP24).W9],5UQT'3FU*VU%HI6N[
M9#'%*T\A*J>H^]@YQSGK52U\&^'[+6'U:VTR*.\=S(6#-M#GJP3.T-[@9H Y
M2*QE\8IXB2;4K:UO+74985F:!FGLU0_NV1O,7:"!G@ ')SFO0;$LVGVQ:?[0
MQB4F;;M\PX'S8[9ZXK(O_!?AW4]7&JWFEQ2WN &DW, ^.F]0<-^(-;U '!:Z
M;;P]XV6]NHC)I^LV<EN\?7_2$^90/0NN1@=2HJEX2C>:WC\'ZC&K7FE7K2W3
M9)WQ##QMNZG<70<]0K"O0KNPM;XVYNH$E^SS+/%N_@<9PP]QDT1V%K#?SWT<
M*K<W"(DL@ZN%SM!^FXT <*+:.77_ (AVLVZ:#[);-Y<KEP,PN3C).!GG%93V
M5NGP[\!+"GE&?4-.:1HSM8DKR<^OO7HT&A:=;:A>7T=N?M-Z MRS2NPE & "
M"<<#@<<523P9H$=G;6B6!2"VF$\*+/(-CCHP.[/';T[4 9&@6T6E?$;7-.L]
MZ6CV5O<F(NS 2%G4L,D\D 9]:Z+Q'!%<^&=4BGC62-K63*L,@X4FGPZ)80:O
M)JL<3B]E01O*9G.Y1T!!.,#Z5>=%DC:-U#(P(92,@@]J /*Y+*W3X>> 4A3R
MC/J&G-(T9VL6*\G/K[U9O)9?#&K^-$T?>BQ:1'>1QEBX67]X"X!)YP 3ZXKK
MT\&Z!'9VUHEB4@MIA/"BSR#8X^ZP.[.1V].U78]"TZ+5)M26!C=SQ^5+(TKM
MO3LI!.,=>U ',Z9HB->Z'K]GK-K%$R;6%O;L#?JZ\"0F0[F&"V2"1@UV]86D
M>#?#^@WKWFF:9';SOGD,Q"YZ[020N?;%;I&01Z^E 'F%C-;1^%]?CN;BYB6?
MQ-/"BVQ >9C,N(\G@!NAR1P35_1M/^U>*?%NB7$,=M:2VMJPMK9R4B9E<%EX
M&&X!R .0/K72-X/T%].NK!['?:W4WVB5&FD.Z7.=X);(;/<8-367AK1].U$Z
MA:6*1W;1B)I=S$L!GKD\GD_-U.>M 'F3W\R>'])N&@$E]X5N"FK 9^:)'\LY
M'\1929 3_=)[UUU[9SZKH=_J6ERV\=SJ-S&]MYQ(CGB1EVH2/X9 I/N' -=1
M_9&G[;]?LL>-0)-UQ_K?D"<_\! %)<Z/87>G1Z?-!_HL6SRT1V39LQMP5((Q
M@8Y[4 8'@N_@N;G5;9M)ETG48'C-W9$AHT)4[6C(X*L >F.0?6G_ !!U*?3/
M#<;PR/#'->007$R':8H6<!R#VXXSVS6_9:;:Z>TSV\;>9,099))&D=\# RS$
MDX'0=JDO+.VU"SEM+R!)[>92LD<@RK#T(H Y#4+4:+X^\.II48AMM12XAO;:
M,8C=43<KE>@8'C=U.<4WP-IUG!KOBJ2*VC1XM59(V Y5?*3@?G73V&AZ?IL@
MDMXI#(L?E*\T[RLB?W5+DE1P.!Z#THT[0M.TJXN;BRA>.6Y?S)B9G;S&_O$,
M2,^] %?Q9!%<^$-8CFC61/L<IVL,C(0D?J*X>YLK=/!?P]CA3R1/?6+R&([6
M+&!LG(Z'WKTZ6*.>%XI4#QNI5E89# \$&L5/!V@QVMI;)9,L-I*)H%6>0;''
M 8'=G(' ]!P* .3'V30-7\;V@O+C3],CL()]\3%FA=U<,Z9S\QP/QQ4NEVYM
M?'VG6@M$M+6ZT63S+<2;C+M= &D  7?@G)&>IY-=;+X8T>>YO;B:T\V2^B\F
MYWRNPE3L""<8&>/3M45IX/T"RN;2Y@TY!/:*5AD9V9E!QP22=V,#&<XQQB@#
M%^%]E:VWA4R0P1QNUW<H2HP2JS. /P%;/BVVOKS1EATZ2W%T9XV2&X)$=P%.
MXQ,1V8 _UXJ[INAZ;I$MQ)86BP-<2&27:206)R< GC)YP,"I=0TVUU2!(;N-
MG1)!(NV1D*L.A!4@@B@#RS7Y['4/A[XEBDT>33;^TNK=[BREPRP.S1J#&1QM
M*@],=3ZUUNI6>GR^*+728(%N7CL)'^P2D+;1(T@'FMP3OR"!@'OTZUNR>'=*
MFL+RRFM!-!>\W/FNSM+P -S$[N !CGC'%0/X1T&2>UF?3T,MK&8HVWMDH3DJ
MW/S@G)PV>2: /.H(TU3P)\/Y[\?:9CJ\<)DE.YBFZ48R>V%7\A70/:CQ#XG\
M0:%+-:1K9Q0QVL,T#.8XFC!\R/#K@[B1N'(PHS72+X.\/II*Z6NFQK9I,)UC
M5V!60'(8-G(/)Z'O3=4\&>'M9FMIK[3(Y)+9!'$ZLT9"#HN5(R/8\4 6_#\$
MEKH-G;S:B=1DA3RVNRNTR[21DC)].N3GK7/>+EBT;Q%HGB23"V@E-E?;C\H2
M0820]AM; SZ-78Q11P0I##&L<4:A411@*!P !V%17UA:ZG9O:7L"3V\F-T;]
M#@@C]0* /-M%9DN]5\+SP&)M5G2\M Q.Y;23)89Z@H$8#T9ABMT6\:?%D6PW
M_9WT!LPER4'[Y5X7.!QQQ76-86K:C'J#0J;N.)H5E[A&()'YJ*KG1; ZT-8,
M+?;Q%Y(E\U_N9SMQG&,\XQUYH \K%E:V_P #-9DAACC=IYD)48.%NB /P%=3
M-:IHGQ(T\V E+7FFW+7"-*S>>Z%"I.3UY(S[UO/X-\/R6MW:MIR^1>2>;/&L
MC@.V<] >!GG XSSBK9T'3FU*VU%HI6N[9#'#*T\A*J>HY;G/?/6@#SO?]N^$
M!\4K,RZ[&C77VU3B02K(<IG^[QMV=,=JW]++2_$B]CN(@@GT2"6: _=WM(X;
MCUXQ^%= GA?1X[B29+3:)9O/>(2OY329SO,>=F[(!SCJ >M.U#PYI.J:C#J%
MY:"2ZA0QK('9<IG.U@" RY[-D4 >906\%]X \'27*B=AXB6(/(=QV&YD!&3V
MP /PKU^**.&%(HE"QH JJ.@ [5CCPAH(TC^RAIT8L_-$PC#L") <[@V<@Y]#
M6Q##';PI#$@2-%"JHZ "@#CM20R^.;N+4[>6]TY],7R(HHS+Y+[F#949*LW&
M&X^Z0#P:P=0TK4-(^&6C)J<]S_::W]JTY:Z=^6F48/S$'Y<#'3.<5IZ]H)OO
M%-U=:IX5N-4@9(X[2XL+M8G50,D.#(ASN)YR1C%:^G>$;-]&-CJ-O.;7[1]H
M@M9+R20V^ N!OW9.""W4@%N.F: ,_P 0O!X7\;:;XAF^73[R-[*Z/58I,;HY
M /4[2I/TJIXKL&L? T$[!X+N74;>>58W*@-),N4(!P0 =O/I7<WFG6E_:I;7
M<*SPJZ2!9"3\R,&4^^"!4>JZ/8ZW;+;:A"9H5<.$$C*-P.0?E(Z'F@#DKG3+
M?4?BK=6ET9Y+6314D> SOL9O.(Z9Z8 XZ<5CV$M^WPUTI8I99H8-9\FXCWDR
M36RW#+Y8[L<;>.X!%>@C0=.&J-J8BE^VM#Y!F^T29,?]W[W3//UYZUS?B'PM
M#!I-G8:;H0O]+6[-Q=V8N2LA."0T;.V =QR>03^)H L:!I$L?C'5M2BBN+?2
MVCB6UA9GC3S,'S&$1( 'W>HY()'K6MXLOKK3/".KWUEG[3!:221D#.TA3S^'
M7\*QO#/AZ*QU-;VRTJ_T> (RR0W5Z93,3C'R"1U '7.0>V,5V#*KJ590RL,$
M$9!% '$:;H<;WFAZ]9ZS:QPNFUA;V[ WZNO20F0[F&"<D$C!J/PAI&G'7_%J
MFSAPFH>6HV]%,*9'TY-;^D>#?#^@WKW>F:9';SOGY@S$+GKM!)"Y]L5:LO#^
MFZ?/=S6L4L<MVVZ=A<2$NW3)RW7WH \VTR6/1?AH+RWV6OG:NUO<W0!_=P&Z
M(8D@@XQQP0>>"*V-:L+SPM;:QKFF:E;([Z7(4L+6U*1EUP?/ WL,@,,\8/&:
MZZU\,:/9Z7/ID-D/L,^[S+>1VD1MW)X8GJ>:9HWA30_#\,T6F:>D*3#;)N9I
M"R_W<L2=O)XZ4 9MAHVC2/HNKVEW(GF0&/\ =OD7X=,_O>[D8+9SD<U4^&-E
M:VWAZX>"".-S?W4>5&/E69@!]!6WH_A#0= N7N-,TZ.WE?(R&9MH)R0H)(4'
MT&*MZ?H>FZ5/<SV-HL,ES(9)2I)RQ.20"<#)Y.,4 <[\5((I_ASJIEC5S&$=
M-P^Z=ZC(_,TRY\@_$+3O#LL"+I(TR6YBMR/W<LWF $$=&VKDX/\ >SZ5UE_8
M6NJ6$UC?0+/;3KLDC;HPJE+X9TB:UM+=K0A;-BUNZ2NLD9/4AP=W/?GGO0!B
M^$#<6GB/Q1HZN[Z;97$+6FXD^7YD>]XP3V!(P.V:G\>:F^F:-9MYK06UQJ%O
M;W<RMM,<+/\ .<]L@8S[UT%E86VG0M%:Q;%9B[DL69V/5F8Y+'W)I;ZPM=3L
M9K*^@2>VF7;)%(,AA0!QWB>VC\*Z5KNKZ',\-W)IY9+.+'E*5(!F"@<, PY[
MXJOK-O'I5OX4U;0R5N)[VVMY'5B3=PRCYO,/\9Q\VXY(P375Z1X9T;0K66VT
MZQ2**8;9 S-(77H%)8DD<GCIR:+#PUI.F/"UK;,H@SY"/,[I#G@[%8D)P2.
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MV;=LAR<[B6QG_$USNGV@TOX-MXFL$E.M16L\27/F,62-IR&P,XX&6Z<')]:
M/8Z*X'7+.VTJ]\)ZCX?C2*2YOXK63R>/M-NZ,6+X^_@+NR<XY-5]B^&O%6LZ
M'!"BIKL:SZ?E 0LAQ'*F.X7(DV] ,T =U<'4!J%F+9;8V1W_ &HR,PD''R;
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M@F8 -)&K$#IDC-1QZC:RZG/IR2AKF"))94'\*L2%S]=II=._Y!=I_P!<4_\
M017#PVMO:_$+Q=>6]A;O=PV%O-!^Z&3*5DY'N3@$]Z /0:*\HN523X0V7B:R
M;.O1K%<+>K_K9)S(%=6/5@22NT\=!C@5ZLA8HI88;'(]#0!@^&M<N]8N-:BN
MX(86L+]K51$Q8,H16R2<<_-Z"M_I7F-IX<TK76\:OJ:L?)U.4QR^:R^01"AW
MK@X!'K[5#H-]>ZW>:'IFN2VI>;0XYXH]0MS*L[EV#-C<H+[ AYR<$^IH ]4H
MK"\)Z:-'T8Z<NI-?I;S.JR%2/+&<^6,DY"YQUXZ=JW: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MY;Q_IEYK/A^.QLK!KQFNX9)$#HHV(X9L[F'4 UU-&0.IH S[72+*#S)4AE6:
M:,([R3,\@7LN\L2 ,G@'&:73]&T[2]/-A96J169SF#)*<]1@YX.3GZU?R,XS
M3=Z9 W+DYP,]<=: ,ZP\/Z7ICQM:6H3R@5B!=F$0/4(&)" ^BXJY+96T]W;W
M4L*//;[O)D(Y3<,-CZBI6=$QN95R<#)QDTI8#J0* *5UH]A>:A;7]Q!ONK7/
MD2;V!CSP<8/&1P?6HH?#VEP3B6.UP1,9PAD8H)"22X0G:&R2<XSS4^IZE#IF
MCW>IR_/#;0/.VT_>"J3Q^59NCWFN74UM=72V!TRYM%GS$&62&0X.PY)#C!^]
M\O3I0!?MM%TZTN[NZAM@LUYC[0Q9F\W P-P)P<#CZ<5%8>'=*TR2-[2T$?E9
M\E2[,L.>NQ22$S_L@5IJRNH96#*>A!R*175ONL#P#P>U &6/#6D"*]B%I\E\
M2;I?-?$Q/!W<\Y''TXH_X1K2AY)2W>,PPBW1HYY$(B'(3(8';STZ5J(ZN,HP
M8=,@YH5T9F564E>" >E #8((;6WCM[>)(H8U")&@PJJ.@ ["J=]HFGZC=17=
MQ ?M,2E$GBD:.0*>J[E(./;I5X2(7*!U+#JN>16!X:UV[U6?6HK];>)K'46M
M(_*SAE"*PSD\GYCZ4 7[O0-*OM*72[BRC:P4 "W&53 .1D#KSS5^&)8(EC3=
MM48&YBQ_,\UA:SK5[IWBCP_IT4<#6NHRRQRLV=Z[(V<;>W8>M;Q=%95+*&;H
M">30!2NM$TV]U&#4+BSCDO(%*Q3$?,HSG&?KR/0\BJO_  BNB'3KC3S8@V=Q
M)YLT)D<K(V<DD9Y)/)]<"MFJ>JZI::-ID^H7LHCMX5W,3U/H!ZDG@"@"+^P]
M._M""_,!-W;IY<4K2N65>XZ]#W]:;:>'M+L9(7M[7;Y)+0H9&9(B<@E5)(4G
M)Y [GUJE?ZW>6GC31](6.W-G?0SNSG)<&, \=@/F]^E;ZLKJ&4A@>A!S0 V:
M%+B%X9 2CC:P#%3CZCFH+'3[73+)+.SB\JWC&$C#$A1Z#)X'TJPCI("496 .
M,@YI20!DD >] ',:KX6AMM"U6/0+"W%Y?+^^2:1MD^3\^[.1N*[@&(/)K&TK
MP?:B^MI[7PK)H,T,J2&X^W[N 02JJCD,& *_-@8)/M7?[TVEMR[1U.>!2[U*
M;]PV]<YXH HZ?HUAI3W#V4'E-<.9)B'8[W/5CD\GWZU3LO"'A[3=6?5;/2;:
M&]<DF5%Z$]2!T!/L!6SO3YOF7Y?O<]/K2AE*;@P*XSG/&* ,6;PAX>N-;&LR
MZ3;-J 8-YQ7DL.A(Z$CU(S5M=#T]-0N+](&6[N5V32K*X9U'0'GMV].U6Y'>
M2V=K5HVD*GRRQRN[MG';-1V#77]G6YU!K<W91?.-OGRR_?;GG&>F: ,__A%-
M$_LN/3/L*_88W\Q+?S&V*V<Y SZ\_7FFZKX0\/ZW<P7.IZ7!=3PJ%223);'H
M3GYA['-;!8M&_E,A89 R<C/O5?3FO?[-MSJ;6QO-H$QML^66_P!G=SCZT 12
M:)ITNHP:@UL/M4">7%(KL-B]U !P![5"/#&C"RO;,V*-;WS%[F-V9A*QZL<G
M[W YZ\"M565L[6!P<'![T@=&9E5E)7J >E $=K:06-K';6T2Q0QC"HO05G7?
MA?0[Z_FOKK3+>6YGC\J5V7[ZXQR.AXXSU%:]-WIN"[EW'D#/6@#*A\+Z+;R6
M4D-BD;V*E;4HS#R@>NWGOW]>])K/A30O$$\,^JZ9!=2PC".P(8#TR,9'L>*U
MBZJ<%@#QU/KTH+J'"%@&/09Y- !'''#$D42*D:*%5%& H'0 =A6=<^']+N[F
M>XFMBSW "S@2.%F & '4'##'&"#6ED9QGFJFJ&_&FSG2VM1>@#RS=;O*'/.[
M;STS0!2UCPIH6OR02:IID%S) ,1NP(*CTR,9'MTK1DL;673WL'MXS:/$83"%
MPNPC&W [8XJ8NJ[0[*">!SU/M56<W_\ :5E]G:T^PD/]I\S=YA./DV8XZYSG
MMTH EELK::R:REMXWM63RS"R@J5QC&/3%9>F>$=!T>UN;?3M-BMH[D;9O+9@
M6'INSG')XSCFMDNH8*6 8] 3R:4L!U(% &9_PCFD?V&VBFQC;36&/LS$E ,Y
MXR>.>>.],M?"^AV=XEW;Z9;I<)%Y*R;<MLYR"3UZGD\\UJAU*;PPVXSNSQBE
M5E<95@P]0<T 9=EX;TC3I(WM+-8Q$2T2;V*1$]2B$[4ZG[H'6IXM'L(=4FU.
M.#;>3*%DEWMEU'0'G&!V':KK.J#+,%!..3BL#5=;O+'Q=X?TR*.W:SU(SB1S
MDNICC+C';KCUH ETWPAX?TC4I-1T_2;:WNY,YD1>F>NT=%S[8IV@^'[;0FOV
MMH8X!>3F9HHB2JG&,\]2>IZ=AVK85E==RL&'J#FF&0R0L;=HV;!"DG*Y]\4
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M-=W4JQ6\*%Y)'. JCJ: *FHZ#I>K6<%I>V4<D$#*\*#*^60, J5P1QQQ5?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNWM8? =A)##"DTGF^8R* SXE<#)')QTKH+3PUHEA<6]Q:Z5:136Z%(9%C&Y
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4$X&317(?$*[>UT[2
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M%5C$K>Q?G'JHH [C2]>NK[QGJNEL]K)96]M#/!)"#D[RP.3D@_=[8KHFD1"
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MC+L%ZG Z#U)Z"@!+_3+'5;?[/J%G!=0YSY<\8=<^N#27>EV%_IYL+NS@GM"
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M<=O:K']IV'V9KG[=;>0C;6E\U=JGT)SC-237=M;0>?/<110\?O'<*O/3D\4
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MK2PB$MY=06\9. \T@09^IK@K+4-'DU;QEI'B>X@AEFN.5N9/+\RT,:A I)'
M^;IT)SU-6M,F2'XDQ6LR/%;/HL8TQ)LY"AOWB\_Q_=SWP!F@#LWOK2.V2Y>Z
M@6!\;93( K9Z8/0YI+>_L[N::&VNX)I8#ME2.0,8SZ,!T/UKR34K)(_"6O(4
M0Z<GB.,6&>B*9H_,"'LN[<./0UTUQ;V5A\3)HXHUM8&\.2&46ZA#@3 9 '<
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MVX]\XKS^]:#4_A3X=&DE1J<4MFEHJ_?CN%91(/4$#S"WMDFO4%540(BA548
M P *@CL+.*Z>ZCM($N'^_*L8#M]3U- '&:+8:;=?$KQ>LUK:S,@LF5716VG8
M3D ]\@'/L*S(H;:31OB3;_:ELX?M4NZ5!GRQY*Y.!]#T]Z]'CLK6*8S1VT*2
MG.76,!CGKS6;K6AF[T:ZM=*:WL;J8 >;Y((8!@2K 8)5@"#ST- '*:3)I_B+
MQ#X<O#?Z.)=,LWC-O!>1S/*[*H 4*>%7:3GKGMWJA.EL-#^)\86+8DDI"X&
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M",X_>NWH,G/0GC@5K>%O%)UW4-7TZ7R'FTZ55%Q;_P"JG1AE67DX/!!&3]:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBJ7;<Q QN/J: 'T452BU?39]0DT^'4+62]C!+VZ3*9% [E<Y'4?G0!=HHHH
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MEE*MLRK GT_$=MSP'X7E\)>&_P"S9IA(S3R3!58LL08\("0"< =<#))KIZ*
M.<M= :]U._O/$&FZ7<O*X%LW^N,<0  3YT&.=S''=O:N>\)>"]7\(^+=7OX7
MTZ/0[]B[6J3/F'!)!'R <988XX/M7HE% 'A.F:AJ=II7]JW'@)-0L(KF34/M
M$%Z4M\@G]XD/W1A1P<9XSU-=TWA_4M8^(>B>-(/LT=A'8"/R)799L.KG.-I
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MC^_U/4_#/A"ZUG3O[/OVU91+!G(!!(R/8XS73^(/!6L7'B+1_$VAW=G!JUE
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M[A3Y4#*<HH'!(Y.3@?>/ K7T_0->O_#$VB^)[NR>)[4VNZR#%GR,!V+ 8(]
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MB@5@T0YP"22&R.<X7'H>WHT&@:]J_A>YT?Q/>61\VU-MNLE8ECCB1BV.1@<
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M5D2TA28*)%0!@C9&<=B0/Y5Q?Q$\&ZGXP.EK936D"64QF+3,V7/'& O'3UH
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M7<>Z"ZC9Q&_/S(0P]#USUH ]8HK@]2\5Z\GQ+3PI8KIPAFL_M"3S1.6C.#U
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MDB67^X64@-^&<UXU8^++WPMI\?@SQ]HKIIP7R(;Z)<@*/NL.S8X.1R,#()H
M]RHKA=9\<R)XJGT+39;6)K?3S>//.AD$CG&R-0".NX$GTZ5#%\0+K4#X7L+>
MT6SU+6@[3"X1B+=8\[OER"22IQG\: /0"<#)Z52O=8T[39K2*]O8()+N3RK=
M9' ,C>@]>H_,5YCXYU_Q=;_"^ZEU&&'3;PWALY3",^?">CH=QV9Y!Z^V,U<\
M5ZC>:9?^"(=1M-(U%[F]1%D>T=3!R@#)^\.#AN^1D T >GT5YY=^.M2N]1\6
M)I*VJ6_AR#>_GQLYN) &++D,-H^1AWYY]JK:O\2=030_"NK:1:VC)K,X@DAN
M0Q*-N"D!E(Z'(S@^OM0!Z917$^%O%6JW_C77O#FJK:.^GA)(YK9&0%6QP06/
M]X?K797%Q#:6TMS<2+'#"ADD=C@*H&23^% $5WJ%G8-;K=W$<+7$HAA#G!D<
M]%'J:LUXIXMU>'4/'7@G5)-1@\I[YF$ G4K;1!H]I?!X8Y).>G _AR?:Z *1
MU?3AJXTDWD(U Q^:+?>-Y3UQ5VO/)=5,7QJ%@VF6$C_V:9$NEB87 7GY-V[!
MY'IWH\#>/+OQ9=1HT]E',KR"[L#$R30*,[2I+?./N@\9!/04 >ADX&35+3]8
MTW5O._L^^@NC VR41.&V-Z''0\5=KP_PQ?ZSI,7Q!U/27LA]BU"6>1+F)G\P
M*SD@$,-O ///X4 >QW^KZ=I<EM'?7D-N]U((H%D< R/Z#_/>KM>3Z]XP35;+
MP+JO]E:?/'J-XJ[+J)G:WD#A6*,&'?/4'H#6K?\ C#Q%_P )]JWAJQ33%CMK
M W<<\T3EAPIP0'PWWL=O7M@@'H=4&UK3$U9-*>_MUU!QN2V+@2,,$Y"]2, _
ME7GH^*EU%\*H/$LUG VI37!M$B&1&9,GYL9SC:"<9Z]ZJ7B:E'\=O"RZI-;3
M3_8)/WEO$8U/R39&TD]\\Y_*@#T^RU?3M1N;NWLKR&>:S?R[A(VR8FYX/IT/
MY'TJ[7E?A_Q%<0_\+$N;;3M*M[S2I7D,L,#J+ED\TYD&_OL[$8+$\U':_$CQ
M%]F\(:C=V^F_9-;N3;211(X=/WFS<"6..O3!Z=>> #UBBO/K_P :ZK)XB\3:
M?I\=K!%H5B;@FXC9VG?;NQPPVKCCN>_M70^"M:O/$7A2SU>]6%)+H%PD,;(%
M .,<DYY!Y[C'% '045@^*=7U+2+6S?3K'[09KE(IYB,K;1G[TC#(R!]0/4US
MOAGQO?ZS+XILW:SEETC+6]U%&PCF4AL$KN_V>QYS0!Z!39'6*-I'.%49)]!7
MC\?Q0\2#POHWB*>VTL6MWJ'V.6"..3<1S\P);Y> >.?7VKK;GQ5J=]\19?"N
MD?9(19VGVFYGN8FDW$[<(H#+CAUR>?TY .HTW5].UFW>?3+V"[A1]C/ X<!L
M X)'?!'YU+?7]IIMH]U>W$=O;I]Z61MJK]3VKS?X&Y_X1;5MP ;^U9,@=/N1
MUT_Q(_Y)UKO_ %ZM_2@#H[6ZM[VUBNK69)H)5#1R1ME6'J#4U>0Z5XLU?PEX
M8\%RW LY](OT2V>-(V$L7 PV[=ANYQM'3'O71P^,=4M/B/=^&M9-A!:&U:YL
MKA(G!D &><N1P ^>.=IZ4 =W15#1I;ZXTBVGU(1"ZE0.ZQ1E N>0,$DY Z\]
M:OT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5E>)/#]EXHT*XTF_5O)F PR_>1AR&'N#6K10!R6@:
M3XIT#28-(^U:9>V]LOE074OF)(J#[H9 "&P..&'2JWC'P9J7B6RT>"/4(3)8
MW(NI)IU(,C#L HP!S^6.O6NJU35K#1-/DO\ 4KE+:UCP&D?H,G _6K,4L<\*
M31.KQR*&1E.0P/((H X#6? .L:OXBUG4/[9@2VU&P-FL4D)D: %1D(<@ %AD
MGOD\9YJK??#?5KSP9H&A'4+(/I5P)C+L<!L9PN/Q//'TKTRB@#C)O">HR?$F
M#Q6)K41Q6GV;[.6;)X/.['J?3H*YZ'X7:K%X$U7PV=0LRU_>K=>?AL)]TD8Q
MS]P=^YKT6TUO3+_4;S3[6\BEN[,@7$2GF//3-7Z .+U;PG?ZIH,.DW":==6R
MV*6YCG+#9,H($R, 2#C'&.>F1WH:KH.O:!X<\.:=H&N&.6Q98WB:/)O"2.W.
M%'S$CH!R3Q7H=% !7#:EIC:-\4K+Q*1_H-]:&PN9.T4F04+>@; 7/KCUKMV=
M5)!/(&[ Y./I5'3=8TO7K>9M/NX;R*-C%+LY ..5- '':]X5\:ZCXFDU73O$
MEG8QJABMX_L^\QIG)Y8'D\$D>@'84>,-*O[GP':>$A<F\U?4&BCEF/H'#RRG
MT4$?J!797FM:9IU_96%W>10W5ZQ6VB8\R$=A^8J[L4.7"C>0 6QR0.@_4_G0
M!%96L=C86]G#GRH(EB3/HHP/Y5Q?Q!@TGQ5I]SX7%XBZS"T,\*;3N1F8*#Z=
M"<X/ .:[NJ)ATMM:#F&U.J)#N#E%\X1DD<'KMSF@#"\5^"+;Q'X1AT..<P-:
ME'MIF&[:Z# +>N02#]<TW3_"=R_CA_%>JR0"Z6U6U@M[<EE0?Q,6(!).3QC@
M'O76T4 >1O\ ";6?^$6U#PY%J]BMC-?_ &R)S"QD/ &&YP. .F>>]>JV<<D-
ME!%+M\Q(U5MAR,@8XJ>B@#C_ !GX1O=?U;0-6TZZMXKK2;@RA+A6*2 E2>G/
M\/ZU2T/P/JFD7OBJYFOK2Y?7 2"$9/+;Y^HYX^<]^W?K7>T4 >5-\+=5/@O2
M= &H6>[3[YKOSB&P_4A<8X^\?R%=!>>#]2A\?#Q7H]U:137-M]FO(;E69>@P
MRD8SC:O!QTZ\\=K10!YGIOPKGB\$:QX=U#4H9#?W/VJ.:*(YBDXQG)Y'RCCC
MJ:Z30=*\36FB_8M7U"PN'AMS!#Y",OF<8#2,>^.P []:ZBB@#E?A_P"%KKP?
MX<.DW5Q#<$3-(LD61G=C@@_2LVW\"7,WBO1]=U!K)+NP5O.N;4,'O6*[5W@C
M QSDY.?8=.[W*6*@C< "1GD#_(-+0!P>B>!=4T-/$EO:ZO%';ZJ\LL$J1'S8
M7<$#)SCC/;DX[5DV7PPUFV;PS*^L6+2:-,[X%LP#AF#$D[LLV<\\=OQ]2HH
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MOQ%?FRCO+.%UGFM P-Z[+M#.I "X!/0G.>U=TS!5+'. ,\#-4-+US3-:$_\
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MC&<;5X..G7GCM"RA@I8 GH,]:6@#C_A[X0O/!NEWEG=WL-S]HN3< QH5VD@
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MHANKK1+IK>-T3RQ*2VU<@=/F].U '<ZSJVA6MQ::;K,D.^]<);Q3PEEE;(
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ME 2S=0QW@\<#'0ULW'C+4)/B%X9TRTD0:7K%C]J*O&-ZY1V&#_P$?K0!Z#2
M $D 9/4^M>9Z'XUUO4/"?C"^GF@^U:/),+=UB !"*3\P[YQ6CX)U7Q=XCM-&
MUJ[FTZ/2YHI/M$*HPE=@6"L.P&0.,]!WSP =S+%'/$\4T:R1N-K(XR&'H0:(
M88K>%(88TCB085$4 */0 5E^)[W5-/\ #MY=:-9I=ZA&H,44C!5ZC).2.@R<
M9[5R.@>-;ZY^($NA/<)?64E@+J.41J&5QC*AEPKKU&1^= 'HM%>.2?$3Q')X
M)/B>*2&.5]5^Q+8>0'")CIU#%_QQ["M[6_$OB2P^(ND>&;*:TF%[8F1WEA*A
M9 LF6X.=N4W;<^V>] 'HM%>=W7BC7=(U+P]X:U2X@.J7PEEO+NS@:0+&NXJ(
MTV\L<8)*X&#QWJK=?$'6+#PY:+>V#VVJW.J?V='+-:NBM'D?OQ&>3P1P._Y4
M >G45YY=>*M>M-&\5.T,Z_V6BS6%]<6;1K<(1DJ5( )!XR,5C'QQXJ@'@NZ>
MXL)4U]O):#[.56,DJH;=G)^_G QTQ[T >N45YUH?C/4[?7O%^G:U-%=PZ)#]
MI2:*'RR4"EBN,GMC%1^'_&FNZF?#]]]EFNK;5))$NXH;)Q'9KNQ&RR8P1_>)
M)[]* /2::[I&NYV55]6.!7C\WCGQ6]CXSFAO;.-= NA'&3:[FE7S&7!YP.!G
M./RI_C?7=5U/2? =Q#=BUCU6XMY)H43(\S*,"3GE03]WVY]@#U^BO-/$GC;4
M/#_BN#1=0U!;&"2S#07[VH,4TY/_ "T&?E0=/E.1U)Q7HUJSO:0O(5,C1J6*
MG()QSCVH EHKS+QAXQ\0:(FNS9AL38M$VGQ%5E^UQE@'9Q]Y0,CGY1R!R:D\
M4>-]8T^R\'7VFI#G6FB$UO(N1\X0X#=1]XC/- 'I-%>=Z[XE\2^$]+C75I["
MXOM1U);:SDMX6VPQ-C+,O5B.<#GJ.3TK<\,ZQJEYK&KZ??6URUM:LC6=]-:M
M#YZ,N2"" ,J>. ,^E '445P_Q1\3:IX3\.VNHZ6\0E>[6!EECW*596/X'Y?U
MJ@OB#Q2OQ(G\*O?V)6:S%Q'/]E/[@]P%W?-W')]^V" >CT5YIX8\:^(];^&F
MH:K!9V]YK-I<-;HO"(^-IW$9 X#$XR,XJ;P_XUO+GX@2Z'+=1WE@]@+I)]BA
MD88W ,ORNO7D?F: .WU;6+#0[%KW4KC[/;*0&E*,57/ S@''/'-6;:YAO+6&
MZMW$D$R+)&XZ,I&0?R->*:]XCU?QE\*?$6MR3PPZ>+I8(K,0Y(C$D9#%\YW9
M(]N#QSQTT?BR73;?P1X=MF:)[_3HY9[A(3*\<:Q9 10#DD@C.#@=O0 ]*HKG
M?!NKZGJ^DS-J]E+;75O<O!ND@:+ST&-L@5N@(/Y@UC_$7Q'K/A0Z7J5I+'_9
M+W"PWP,.YXU)SN4_0,.>^/6@#NJ"<#-<7X@\67&@Z)KFOI(EU96^R&SBVC#R
MG +;AU4%@/\ @+>U9]IXPU33O$7ABPU.:.ZAUZS$K,(@A@F(SA<=5Y YR>^>
MU '9:5K^EZV]TFG7:SO:OY<ZA64QMSP00.>#^5:5>)^&]3N]&LOB;J=BZI<V
MNH/(F]=P.'DX(K;_ .$ZUL3> CYD!371B[7RNA!7E>>/O?I0!ZC2$A022 !R
M2>U>:7WBGQ(_CWQ%X?LKRUAM[#3S>1226V]P=J-CJ >6QSV]:P_$7B_6=:^!
M<6L&Y6VN)Y3;77DICS5WE>#GY<@<X_04 >SJRNH92"I&00>"*6N)O=1US1M,
MT*/SHGLYSB]U$A(S;)M&P!6."23[],8R163H/CC5]3\&>*[N62/[;HK3"&?R
M=OF!%+#<AZ'C!Z=: /2G=8T9W8*J@DD] *P!XX\-G1$UG^U(_P"SFE,(N-C[
M0X['C(_&N;\+ZOXQ\1:'IVMS7&FPZ=+;3F>,1$RLXW!6&<C&0./0=\\<+JVJ
M/K'P!-T]K:6Q_M(+Y=I"(D'/7:._- 'OJ.LD:NARK $'U!IU>=:SXFU?PWXG
M\,0SSQ#P_J2I$[>4-\<FT#!;T)*GZ;O2NRT6:[N8[JXN)Q+"]PXM@$"XC4[0
M3CKD@D'TQ0!IT5S'B?5M4T_4],@@"6VESEQ=7Y9"T38^155NI)[8)/05QEI\
M1-<N?A5K&O;H%U'3+P6X?ROEE7<@RR]CA^WH* /6JJZCJ-KI5C)>WLOE6T0S
M))M+!1ZG /'O7GFG>,?$">,/"UC?SVD]KKFGBX:.*#88F*%N#DD]![<GBL[4
M_$VK>+?#OCB:&XAM],TY)+:* P[C* #N9FSD'CC' [YH ]5T_4+75+"&^L9E
MFMIEW1R+G##\:LUR?PR_Y)OH?_7O_P"S&NLH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#\7^&X_
M%OAB[T:2X:W\_:5E"[MK*P8<=QQ6Y6?K.MZ?X?T]K_5+@V]JK!6D\MF"D\#.
MT''- '.7O@::_L- >;48SJNB2I);W @Q&P7:"A3=G!VC)SG.>W%7O#OA-=&U
MG5]:N9UGU'5) TC(FU(T'1%!)/U)ZX'2NAM[B*[MHKF!]\,J"1&QC*D9!_*I
M* .<\<>%5\9>&9=)-R;9RZR1R[=P#+ZCCC!-9=AX'U&#QM;>)[S6H;B>.T^S
M20I:;%(P1\IWDC\<]_H.WHH \X'PPNO[+\3V1UJ'_B?7 G=_LA_<D.7( W\]
M<5;OOAY--9>&9+74XXM5T!$CAN&@)CF10!AEW9'3L>Y]>.\JCK&L6.@Z5-J>
MI3^1:0@;WVEL9( X )/)% '*Z7X EM_$.NZIJ.J1WB:S 8+B!;;RP%*@':=Q
MQW['CN3S4OA#P?J_A:!=-;7Q<Z1#(7@A^S;91DYVE\_=SR0!S[#BNMM;J&]L
MX+NVD$D$\:R1N.C*PR#^1J:@#D_"O@^?PYKVO:E)J,=R-7G\]HU@*>6VYC@'
M<<CYSV[56\0>!)?$LT::A>6\EO'>?:8I/LY^T0IG)B5]W0^XX]#@8[6LO3_$
M>E:IJEYIEG=>9>V?_'Q"8W4I_P!] ?I0!CCP;-!\0Y_%5IJ0C%U;K!<6[0;B
M0-OW6SQG8O4'OZ\<S>?"*ZO-)U73Y/$KM'>WWVU2UJ"0_3YVW9;@]B!WKU*B
M@#CM0\%W>H>+]#U]]5B#Z7%Y9B^S']Z2"&.=_P O7@<X]ZHZ=\,U@TOQ)IU_
MJ2W,.N2F9C'!Y9A?<6!&6.<'!_"N_HH \WD^&VKW<'AN*[\0VY70)%:WV61^
M=5*[=WS]?E XQQ^=>D#ISUHHH XS0_ ]SH%UKQM=51K75)7F6)[;+1NP/5MW
M*C/0 '@<]<X3_"2X?P1:>&O[=B$=M?&\$_V,Y)P0%QO]SS]*[O6/$FDZ!);)
MJ=T;<W+B.$F)V#,>V0" ?K6K0!Q6L>";Z?Q?;>*-&U:.QU(0B"Y62W\R*9?I
MN!';C/8=,5UUI#);VJ1S3M/*.7E88W$G)X[#T'847E[;V%LUQ=2K%$"!N/<D
MX  ZDD\ #DFLG7/&6@>&C;KK&H+:-<*6C5HW)(&,\ ''7O0!0O?!LTWCZW\4
MV>I"WD6V^S30O!OW+ZJ<C!^H/TJE8^!=1T3Q/J6H:)KBVMAJ<GFW-K);"1E;
M))*-G /)QD$#/(.*Z/3O$ND:K!:3V=X'AO"PMY&C9%E*D@@%@.>#QUX/I6M0
M!R3>#9S\1(O%0U%-L=M]F%LT!)*X/._=UY]*7Q+X.GU_Q-H6L1ZC';C29#(L
M30%_,)*DY.X8^Z.U=910!P,?P\NH[KQ9,-7A_P"*AC:-A]E/[G.1Q\_/#'TY
MQ]*NZ9X.OM*\,:=HJ:C:W,-JDL<T=Q:DQ7*.<X9=W!![\_3DUV-9>G>(M*U7
M4]0TZRNQ+=Z>X2YC"D;"<]R,'H>GI0!4\'>%XO".@+ID4WFDRO,[!=J[F/10
M2< # ZGI5?5O"C7/BVQ\3Z?<1PZA;0M Z2H62:,@XS@@@@DG-:VIZYINCZ9)
MJ5]=".SB;9),JLX4[MN#M!Q\W'UXJW:7<%_907EM)YEO/&LL;@$;E89!Y]C0
M!Q"?#5(? FH>'8-1 N-2F\ZZO'@SN;<#\J[A@?* .3WKK- TV31M L-,EG6<
MVD"0"14V;@H !QDXZ>M:-% ')ZSX-FU#QOIGBBSU(6MS9P-;LCP>8&0[N1R,
M-\[=<CIQV-1_ =TWBO7]<7580=7LVM/*-J3Y0*JH;._D_+[=>U=O39)(X8VD
ME=4C499F. !ZDT ><3_"VXG^'=KX1_MJ,1P7)G^T?9#E@2QQMW^K'G-:_B/P
M9>>(["XL+N^LWMIEC"^9:EFMW4 %XSOXSCI^O7.]?>(]*TW5[/2KNZ\J]O3B
MWC,;GS#[,!C]:U* (+*TCL+"WLX2QC@B6)"QR<*,#/Y5G:7I%U:W5_<:A<6U
MW)=3>8I6W*&-0H4)RS9  ]N23WK8HH X3P_X&N?"OB;5M;@U:+['?%I)K)+0
M@+R6!4[SR,GMW(KA-)U#Q7IVC#Q"FE^&+^)7DN?M4G%S(23D@;AAR.  ,]!C
MM7L.K>)-)T2:""^N]MS.<0V\:-++)_NHH+'ZXJM:ZKX?N-7BA2)(=3FRR1SV
MC0S$ $EL,H...O2@#+7PI=W_ (ZT_P 9/=K;LEFL)L7@)900207W=06/;M3O
M%/@NXUCQ#IOB'2=3&GZM8*8P[Q>8DD9S\I&1_>;\Z["B@#C/$_@:X\2Z58B7
M5VBUBQG^TP7J0X57XX"9X7A<<D\9YYS/JWA?5=>\(7NCZEK,375X$5YTM<1H
MJL#\J;NIQR2?PXKK** ."D^'EU)=>%)_[7A!\/1+&H^RG]]C R?GXX4>O.:F
MTWX??9M1\43WU^ES;^( 1-"D!0QYW=&W'/#'MV%=O10!Q_A#PIK/AFTCTV?7
MEN],MB3;QBVV/@Y(#-N/R@G.!^>.*QA\+;K_ (1_Q#I1UN+&M72W+R"S/[HA
M]Y &_GD"O2:* .'U7P!-J%AX66/5$BO?#[(8I3;EHY=NWJFX$?<7^+UJ;6-,
MUQO&>@W=EKMSY,0$=W9!,1NGS%I&P<#/  (ZXQT..RHH CGACN;>6"4;HY4*
M,/4$8-<3X(T2+3O#]QX.UJVAN!9SNT23QADN(&?>L@!X."<'T(^E=U10!Q2_
M#?2X?'=IXCM8K.WM[>#8+&.S55\P$D29!P&&1VSQUI-/TMM9^)ESXHQ_H-G9
MBQLW[3-DEW7U4;BN>AYQTKMJ* ,W7==L/#FEOJ.I2M%;(RHS*A;!8X' ^M87
M@;PS8Z))K5]8'=!J-ZTL)'01C@!?;=OP>XVUUDL44T31S1I)&P^97 (/U!K-
MT'Q!I/B*P>[T>Z6>VBD,)94*A67'&"!V(_.@#D9?AA_Q*-2T"VU%8=$U"]6\
M>/R<RQ\J2BMG&,JN"1Q[UH:SX&DNO$6A:SI%]%93:3";=(Y8#*ACP5' 8<@$
M]_3TKL8Y$FB22-U>-P&5E.0P/0@TZ@#@=)^'5SI6@>(]*&LI-_;1<F9[7!CW
M@@Y ;#<'VYKH_"6A2>&?#-GH\ETMS]F!595CV;@23R,GGGUK;HH PO&'AZ3Q
M3X8NM'COGLFGV_O57=P"#@C(R#CUK"TOP#=:9XML_$$NN?:'@L1:2QFT"[P!
M@;=I^4<#C!/7GGCNJ* /"]-O_%-MILWB&'3O#&H0K/+=?:KCY;ASN/.-PVM@
M8 QD# KOQX7O-9\8Z'XTDN5M)(+)4:P> LR[U;<"VX<CS".G:NM^P6?VC[1]
MD@\_KYOEC=^?6K% '(^+_!<NOZGI>LZ;J/\ 9^K:<Q,4IC\Q74_PL,CW_,U'
MXE\#S^*?#T-K?:L5U2"<7,5Y%#M6-P,85,\+^.<\Y[5V$<D<JEHW5U#%25.1
MD'!'U!!'X4Z@#E;SPWK&K>%+[2M4UJ*6ZNX1"9H[7;&B]R$W<L?7..F .^/+
M\-KJ2V\)PC680?#TGF(?LA_?$,K#/S\?= KN;^_MM+L)[Z\<QVT"%Y7"%MJC
MJ< $X%,TO5++6M-AU'3YQ/:3 F.0*1NP2#P0#U!H YBP\!F#Q/X@U6[OX[BW
MUJ$PS6RP%-JD8X;<<\>U'A#P=J_A:%=-.OBYT>&0R00_9]LHR<[2^?NYY( Y
M]AQ79T4 ><CX977V'Q5;'6H?^*@F$SM]D/[DARQ ^?G[V*MZE\/);_P[X<L%
MU5([O0GC>&<V^4DV8 W)NS_"._K7=T4 <?XD\'WOB.RN;&ZU"UFMKB- //M2
MS02#K)&0PP3Z>W7KGI]/LH]-TVUL82QBMH4A0L<DA0 ,^_%6:* /.=3^&%UJ
M-UXE<^(I%@ULHQC-LK%"C;E!8G)4=,#'&/2K6I?#V[U&P\+6QUB)6T$HP<VA
M/G%-N.-XP,*/6N\HH YGQMX/C\8Z+%:-=-:75O*L]O<(N=CCVSTY]?2M+1+/
M5K6WSK&II?7.T+F*'RD '?&3ECW/Y =]2LJW\2:3=Z]/H<-T3J=NGF26[1.I
M5>.<D $?,.A[T 97CWP?)XUT:WTY+];)8K@7!<P^820I 'WAC[QJ(^#KP_$
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MNOLJE%E$>S(SGD9/K6Q110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7"?&/_ ))AJG^_#_Z-6N[K
M \9>&SXM\-SZ-]L%HDS(7D\KS#A6#8 R.X% &%X-UY-?FL[/3-7"V^F6,"7<
M C4F60J,;21D*,$$CJ>F.IYZY\7^*9+OQQ#;ZI##'H0\R!C:HSL,M\I[=!UQ
M721?#V6T\1:7KEAJZ6MW:6B6MP%M<K=JHVY8;^. !^ /:H_^%<2^?XHE_ME,
M^(%VR#[)_J>3T^?G@D?K[4 9UU\0-2DT#P6D/EPZCXAE2.6<("(E#*KLJGC)
MW#&<CK5NR\2ZW>:WXJ\+0W0;4M.C$UC=M$N7! .UP %ZL!D =:N'X=1GP_H-
MC_: ^W:%,)K.[\CCAL[63=R#@9P1T%:F@>%(](UK5=;N+@7.I:DX,CK'L1$
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MR?8FBCM)2NY0K;1E3]WDMTSFO0:Y3PEX4U/PU:PV-SX@>^L+;(MH1;B,J#G
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M\B1U&&9CR7'H=W-5_"7A;4_#EI#8W7B![ZQM05MHA;B,J.<!FR2P&>!Q^@P
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MAE\IBLB@$J<=0""/SKQKPO\ ;+GX'^(K^YU">;SH[DM$X4C><$ONQN)/N<4
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M/,3%(%(#[\EMV-Q)]R: /1Z*** "BBB@ J*2V@E;=)!&[=,L@)J6B@ HHHH
M*:R(^-ZJV#D9&<'UIU% !1110 4444 %%%% !1110 4444 %%%% $8@A64RK
M$@D/5PHR?QJ2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *:B)&NU%51G. ,4ZB@ HHHH *9)#',H$L:.!R R@T^B@!J1I$@2
M-%11T"C IU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4G<#CJ5!_.GZGX#DG\46_B/2M;GT[4EA$%Q(85E%PH&/F4X&< >W XXKLJ*
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M=]H-V^JRK)H\WGH7C#F:0LK$L<CC*C@ 8[=L=;10!RFD>"4TOQ#KFJO?&?\
MMC(FA\K:%ZXVG/H34?A_P5<>&O#5WHVGZ[.JOO\ LTQ@0F L<YQ_$?KC\*Z^
MB@".!'CMXTDE,LBJ TA !<XY.!TS4E%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<_KB:S%
M%J5];ZG]FM[>V+PPK C%F5226+ \=!CVKH*RO$TT4'A?57ED2-/LDHW,<#[A
MH Q/#,GB#5]#T75I-8W+=PB2YA^SQ@ ,AP4..H;:><\5'X+\707/AW3%UK5[
M=M5NY9D59&5&DQ,ZKA1@=% 'KBK?P\N(&^'6B.LT96.S0.0PPI YSZ8K@8;B
MR3X+V4BRVZR#5E<L& .X7AY^NW]/:@#UG4-:TW2O^/Z]AM_EW'>V-JYQN/H,
M]SQ5Q'61%=&#(PRK*<@CU%>;W&JZ79>+O$>G^)-0ELH-0$<EK(7VQ7$!B5"H
M..Q#<?[1Q7:Z1:1VGAFVM=-CE@BC@VVRSDEE&/EW9Y].#R.E $K:[I27BVCW
M]NL[2>4%+CE_[F>F[_9ZUA^(/$L-MXETW0AJ*VBW"327,RLN^/:J[5&X$#);
M/3M7(Q2PWOP6FT67_D-Q9MVM&/[_ .U^;D<=<DX;/H<UT%_<QP?$CPI!=741
MN4T^Y67+@$L1'_/!Q]* (+?5[ZYUJ;PO+XG5;NVM<K?0Q1J\L[2,%!4@CY0J
MY QDDUU=IK5E$]KIUWJMK+J141L5P@EE4?,%'3.<G;G(KG;:ZB?XJZ[#!<Q"
MX.E0(@WC(<,_&/;(_.L#PY=:!JN@:3HVJW-Z=:L)HPVFLY61;F,_?  Z=6+9
MQ@G- 'H+>*-!2Y%NVL67G&86X03*29#T3Z^U3Q:UIL]VEK%>Q-.Y8(@/WROW
MMOKC!SCI7*^%AI]SXZ\9#_1I91=V[+]UB-L2\CZ-G\:S?#MQ/INHZ#;6-]!K
M.@7CN;0.!]JL#L8X)'WE )4YY&0/3(!VWB.YBMM$G:368]'+8"WC[#L.0< -
MP20",>]27>O:187#V]WJ=K#/'%YKQO*H94R!N([#)'YUSWQ5DB3X;ZMYCJNX
M1A=QQD^8O2H;JXL9?B]I;&:W<C1YBAW \F1,$?AG\,T =?8:A9ZI91WEA<Q7
M-M)]R6)MRGG!Y^M9?_"4:=+XFF\/QW"K=QPAV;/1F. HSU/!/Y5D_#F:"2QU
MU()(V5-;N\!&! 4OD=.U-6\MK+XN7JW4R0M<:3 (0YQYA$CYQZXZGT'- !X0
M\6P2:-;QZYK%N=1GO)X8Q*RHTFV5E4!1@=L#UK?^TQOXJ$":TF]+1B^F+L+?
M>'[T_P 0Z@8Z<UY<UQ9+\&-0D66W$AU9GW!ADG[6"#]=OZ5V,EU:GXQ6H6>(
MLVA2 8<9.9E('Y9- '3PZUIMQ=+:Q7D3S/NV(#]_;][;ZX[XZ5?KS7PS<7&G
M:CH%G97T&M:!=AS9,P N; ",G#$<,H!VG/() ],]EXEUF/1M)9_M$,5U<,MO
M:^:P ,KD*IY[ G)]@: ,C3_%LUSX_N=&FB"6$T!.GS?\]9(F*S#\_P!$SWKJ
M+J\MK*-9+F9(E9@B[CRS'H .I/L*\Z\8Z->:!X9T[6(=1AE;P_)'- IA$;2)
MPKJ6W'.Y<D^I%7?%&N:8\GA/Q'!J5NL*7+M'YS[875XF#;F .U@#QQU./4@
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M"KD]!DUPBZA:V_BSP9=SW,:PRZ1+&DA;AW(B^4'NQ].M=KKNDPZ[H5]I<_\
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M^'M*+QF\G:72VDD(='#%O/7/(4')'KD ?>H [)]<TJ*.ZDDU&U2.T;9<,\H
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MO'=-<A6&>-4"[ J%!M/K@GKGFM/1--DTC28+&2]ENS"@02R*JG:  !A1CH*
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MSGL, <YS;7P*\']AE]>O9&T8D6Q\N,?NRFS:?EZ[>,]?3'6@#$FU;Q+)X?\
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MD9[U)38XTBB2.-0J( JJ.@ Z"G4 %%%% !1110 4444 %%%% !1110 4444
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MF-V+7[6N -LD>[;E3GU]<4_1=9M==L6N[02*BRO"RR+A@R,58?F* -&BBB@
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MR1SVKJ#M;!92K J02H/(["K.G:5]B8RS7ES?7)7:9[DKN"]< *%4#Z#G SG
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445%<
M3QVMK+<2G$<2%W/H ,F@"6BN*\'B;Q;HJ^(=6EN";UW:VM8YWCCMX@Q51A2-
MS'&2QR>>,5#XFO\ 4/!>C7;VEW)<SZE>PV^GFZ<R>0SJ%()/) VEAGN><T =
MW17/7/AC&ENMKJ-^FIK&3'>M=.6,F."RD[2I/5<8QT KC+W6=6\8?#[1-5TJ
MYN+'69+AHV6WE95>2..5BA4'!#%!USUH ]4HKG=/\5V]_P""8?$,2;C)""(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWH!266J)=W,MJ\$MO<Q*K-')CE3G!!!((X(H OT444 %%%% !1110 ZBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBD=@B,QR0!DX!)_(=: %HK @\9Z)<Q7$T$UU)%;2-%,ZV,Y6
M-U^\&.S ([^E;%G>VVH6<5W9W$=Q;RC<DL;!E8>Q% $]%%% #3QR:8\T<0!D
MD5 >['%8WB74KFU2RL[)@ES?W @60C/EC!+-]0!Q5FST+3[0!O)$\W5IYSYD
MC'UR>GT'% %Y+F"4XCFC<^BL#4N15272M/FYDLK=STRT2G^E1KI%O$@6V>>W
MP./+E; _X"<K^E %^BL_RM2A'[FYBN .T\>TG_@2\?\ CM!U">''VFPF4=WB
MQ*H_ ?,?^^: ,SQOI=WJWAN6*Q7?=0R1SQ)TW%&!Q^6:GT_Q/I=[I\ET+E8S
M"I,\,GRR1$=0RGD?UJ:?Q+I5N=CW2^=V@ /FG/;9][]*S9O#T'B*^6\U;3H$
M@0?NX64&1SZNP[>B@_6@"32+F*SAN-4U2>*VEOY/-"S.%*1@81>>^.?J:Q?&
M%]-J\FBV-I!(()]00F>>,K&Q4$@8.&([],>]=;9:#I6G$-:6%O$_]]4&[\^M
M8WC,K$="G?B.+5(BS>@((Z^E &Q8Z4+>9KJXF>YNVX,LG11Z*O11]/QS5@27
M?V]HC;J+41Y6;S,DMGIMQQ]<UA)XGNM59QX?TX7<*,4-W/)Y4)(X.W@EN_(&
M/>G^$_$D_B".^^T1VT4EK<& K#(6)(ZD@@'% &Y>W<5A937<S;8H4,CGV R:
MPM)M;C785U356D$4XW06:N0B(>A8#[S$=<\#TKG?%WB:ZOKK6_#MO8YCM+99
MY90225RK$8^A/Y5WUM<0/IT5Q$R>08PRL#\NW% &/+:Q:7XBTW[&/)BNO,CE
MB4_(Q"[@VWH",=?>IO&$RP^$=6<D#_17'/J1@?SJM:3-KGB!=1C7.GV4;);R
M8XF=N&8?[( P#WR:Y#Q)?RWL>KZ;J4LRW;WT4%K:ARBM"6&' 'WL]\_I0!WO
MAFW:T\+Z7;N3OCM8U;/KM&:;XL=$\(ZJ7&1]DD&/4E2!3VTN:W1?[/OIHBHP
M$F)F0_7<=P_ BL7Q-?SS>&=3L+NW\J[%NSIM.4E"\DJ?Y@\CWZT =!H4!M=
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUPJO"WF01VZC;$WJ2P.X]N@'M5Y--U-XQ%<ZM^['_/M (V8>A)+?H!6OBC%
M&4/#NEEUEDM$EG7I/)EI/^^SS^M2MHUA( );9)0.@E^?^=:&*,4 8NK>&[35
M)[2YWO;W=D2UO-$!\F>V"""/PJ1+36D15&J6KXZM)9G)_)P/TK6Q1B@#,_LR
MXE(-SJ=R_P#L18B7]/F_6K-M86UIN,$*HS?>?JS?5CR?QJUBC% "T444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %(RJXPR@C.>12T4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTTCPWJ;V6JV]MJ=O"716VLP;&0,'C)[9H ZJBLZ/5;:VTZSEOKJ*.2:$/\[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD\@$; Y5E3##'8D'FNSGMX+E D\,<J Y"R*&&?7FG)&D8(C15!)8[1C)/4T
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MGO6C3(XHX@1&BH&8L0HQDGJ?K3Z "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<7K03:=JS0I;K/'N68RX,8VD=^#STQ0!L1R)-$DL3J\;J&5U.0P/0@]Q7&>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_DO^%&[Q7_SST;_ON7_"@#=HK"W>*_\ GGHW_?R7_"C=XK_YYZ-_WW+_ (4
M;M<MXA_Y';PC_P!=KK_T0:N;O%?_ #ST;_OY+_A6'J!U<^.?"G]IK8A?-N=G
MV8N3GR&SG<*TI_%\G^3(J;?-?F=S7 ?&E+U_A;JOV$RAAL:3RVP?+##?GVQU
MKOZKWUM]LL9[82&,RH5#A%?;[X8$'Z$5F6<?B'Q+XZL;-MSVOAZ%+F1<90W4
MB_N\]LJN6'<%@17FVO2W&LZT_B:*%;Z>RU-;V>':&EM+&UEV!$!R5+,'<@$
M\FO;="T&TT"TDAMFEEDFD,T\\[;I)G/5F/\ 08 [5>BM+>!Y7B@BC:4[I&5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3\.P:;X2A9]*T.!9KFS\TPVA5'02*3YH[KZ_C0M0/3**P/#LNEV.C$6QTN"
M,[D6">7%P!N./7IG\*VXYHIBXC=6,;;6P>AQG'ZT 24444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)_PAWA?_ *%O2/\ P!C_ /B:/^$.\+_]"WI'_@#'_P#$UMT4 8G_  AWA?\
MZ%O2/_ &/_XFC_A#O"__ $+>D?\ @#'_ /$UMT4 8G_"'>%_^A;TC_P!C_\
MB:/^$.\+_P#0MZ1_X Q__$UMT4 8G_"'>%_^A;TC_P  8_\ XFC_ (0[PO\
M]"WI'_@#'_\ $UMT4 8\7A+PW!*DL7A_2HY$8,CI9Q@J1R"#C@UL444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !116-KG
MB6WT*6")[+4+R:8,PCL;8S,JC'+ =!S0!LT5C:!XDMO$)NQ!9W]J]JZI*EY
M8F!(W 8//0@_B*V: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J
M.62*WCDN)2J*B%G<]E&3S].:DJGJVG)JVE7.GR2/'%<(8Y&3KM/WA^(R/QH
MSO",,G]A+?3J5N-2E:^D!ZCS#E5/^ZFQ?^ UNTBJ%4*H  & !VI: "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBJ.KZI;Z-I5QJ%RZ+'$O\;A 6)PHW'@9) R>.: +U%<\G
MB.X33+6XN["&.XO;E;>TBANQ*LI89#;PN ,!B< \+WZ4VX\76UIIE]/<+#%=
M6ET+-X9;@(AE(!7YV  4JP;)'3/'% '1T5A?V]<I'IL-Q811ZCJ$C+#;K<[T
M"JI8N7"],#L#R0/<0W'BM(O#DVJI9M(]O<&UG@\P#RY!)Y;<XY )R..1B@#H
MZ*RM0UD6FJVVFQI$;BXAEG4SR^6FU-N0#@Y/S9QC@ FJ>H^+(;#P:/$'V25R
M]K]HCM2=KM\F\@GM@ DGV[\"@#H:*Y_6]=U33(IKFVT5+FS@@\Z6:2[$70$D
M*NTDX&.?4XJ36/$7]C6%E+-:,]S<RPQM K_ZO>Z(6)QT4N!TY./P -RBH/MM
MI^]_TJ']S_K?W@^3Z^GXU%J%U=0VRMI]HMY/(<(K2^6@&,Y9L' ^@/)% %RB
MLK0-8;6K"2:6T:TN()WMYX&8-L=#@X8?>'<&M6@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/F&5&<=LD8]ZVJ* ,GP\R_V:52QN[15D;/VM5$DK'YF<@$]6)_'/&,5K444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
-10 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495508912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Aug. 14, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LISATA THERAPEUTICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-2343568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">110 Allen Road, 2nd Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Basking Ridge<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">842-0100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LSTA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000320017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,142,357<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495206912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 23,690<span></span>
</td>
<td class="nump">$ 32,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">33,936<span></span>
</td>
<td class="nump">37,072<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">3,797<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">61,423<span></span>
</td>
<td class="nump">71,876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">233<span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">410<span></span>
</td>
<td class="nump">528<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">62,365<span></span>
</td>
<td class="nump">73,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">775<span></span>
</td>
<td class="nump">2,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">3,581<span></span>
</td>
<td class="nump">3,728<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,356<span></span>
</td>
<td class="nump">6,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">327<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">4,651<span></span>
</td>
<td class="nump">6,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 14)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, authorized 33,333,333 shares; issued 8,133,095 and 7,866,799 shares at June 30, 2023 and December 31, 2022, respectively; and outstanding, 8,132,357 and 7,866,061 shares at June 30, 2023 and December 31, 2022, respectively</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">576,173<span></span>
</td>
<td class="nump">574,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost; 738 shares at June 30, 2023 and December 31, 2022</a></td>
<td class="num">(708)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(517,455)<span></span>
</td>
<td class="num">(507,241)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Lisata Therapeutics, Inc. stockholders' equity</a></td>
<td class="nump">57,968<span></span>
</td>
<td class="nump">66,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests</a></td>
<td class="num">(254)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">57,714<span></span>
</td>
<td class="nump">66,324<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, non-controlling interests and stockholders' equity</a></td>
<td class="nump">$ 62,365<span></span>
</td>
<td class="nump">$ 73,034<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495270336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">33,333,333<span></span>
</td>
<td class="nump">33,333,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">8,133,095<span></span>
</td>
<td class="nump">7,866,799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Number of common shares of the combined company owned by Cend stockholders</a></td>
<td class="nump">8,132,357<span></span>
</td>
<td class="nump">7,866,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (shares)</a></td>
<td class="nump">738<span></span>
</td>
<td class="nump">738<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407587261168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">$ 3,162<span></span>
</td>
<td class="nump">$ 3,234<span></span>
</td>
<td class="nump">$ 6,341<span></span>
</td>
<td class="nump">$ 6,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">3,713<span></span>
</td>
<td class="nump">3,486<span></span>
</td>
<td class="nump">7,378<span></span>
</td>
<td class="nump">6,824<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">6,875<span></span>
</td>
<td class="nump">6,720<span></span>
</td>
<td class="nump">13,719<span></span>
</td>
<td class="nump">13,340<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(6,875)<span></span>
</td>
<td class="num">(6,720)<span></span>
</td>
<td class="num">(13,719)<span></span>
</td>
<td class="num">(13,340)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income, net</a></td>
<td class="nump">668<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">1,338<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(150)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="nump">518<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">1,175<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before benefit from income taxes and noncontrolling interests</a></td>
<td class="num">(6,357)<span></span>
</td>
<td class="num">(6,626)<span></span>
</td>
<td class="num">(12,544)<span></span>
</td>
<td class="num">(13,331)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="num">(2,330)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,330)<span></span>
</td>
<td class="num">(2,479)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(4,027)<span></span>
</td>
<td class="num">(6,626)<span></span>
</td>
<td class="num">(10,214)<span></span>
</td>
<td class="num">(10,852)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity', window );">Less - net income attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Lisata Therapeutics, Inc. common stockholders</a></td>
<td class="num">$ (4,027)<span></span>
</td>
<td class="num">$ (6,626)<span></span>
</td>
<td class="num">$ (10,214)<span></span>
</td>
<td class="num">$ (10,852)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_EPSAbstract', window );"><strong>Basic and diluted loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Caladrius Biosciences, Inc. common stockholders - basic (in usd per share)</a></td>
<td class="num">$ (0.50)<span></span>
</td>
<td class="num">$ (1.64)<span></span>
</td>
<td class="num">$ (1.28)<span></span>
</td>
<td class="num">$ (2.69)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Caladrius Biosciences, Inc. common stockholders - diluted (in usd per share)</a></td>
<td class="num">$ (0.50)<span></span>
</td>
<td class="num">$ (1.64)<span></span>
</td>
<td class="num">$ (1.28)<span></span>
</td>
<td class="num">$ (2.69)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic shares</a></td>
<td class="nump">8,021<span></span>
</td>
<td class="nump">4,035<span></span>
</td>
<td class="nump">8,004<span></span>
</td>
<td class="nump">4,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted shares</a></td>
<td class="nump">8,021<span></span>
</td>
<td class="nump">4,035<span></span>
</td>
<td class="nump">8,004<span></span>
</td>
<td class="nump">4,036<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_EPSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EPS</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_EPSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495297472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (4,027)<span></span>
</td>
<td class="num">$ (6,626)<span></span>
</td>
<td class="num">$ (10,214)<span></span>
</td>
<td class="num">$ (10,852)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Available for sale securities - net unrealized gain</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive loss</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders</a></td>
<td class="num">$ (4,025)<span></span>
</td>
<td class="num">$ (6,500)<span></span>
</td>
<td class="num">$ (10,235)<span></span>
</td>
<td class="num">$ (10,852)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407488117152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Lisata Therapeutics, Inc. Stockholders' Equity</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Non- Controlling Interest in Subsidiary</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,986,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 92,000<span></span>
</td>
<td class="nump">$ 92,254<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 546,044<span></span>
</td>
<td class="num">$ (70)<span></span>
</td>
<td class="num">$ (453,016)<span></span>
</td>
<td class="num">$ (708)<span></span>
</td>
<td class="num">$ (254)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(10,852)<span></span>
</td>
<td class="num">(10,852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">960<span></span>
</td>
<td class="nump">960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuances of common stock</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,038,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">82,137<span></span>
</td>
<td class="nump">82,391<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">547,033<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="num">(463,868)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,035,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">88,241<span></span>
</td>
<td class="nump">88,495<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">546,637<span></span>
</td>
<td class="num">(196)<span></span>
</td>
<td class="num">(457,242)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(6,626)<span></span>
</td>
<td class="num">(6,626)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,626)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">367<span></span>
</td>
<td class="nump">367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuances of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain on marketable securities</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,038,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">$ 82,137<span></span>
</td>
<td class="nump">82,391<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">547,033<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="num">(463,868)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">7,866,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,867,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 66,324<span></span>
</td>
<td class="nump">66,578<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">574,548<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(507,241)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Proceeds from option exercises (in shares)</a></td>
<td class="nump">1,227,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,999,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 60,703<span></span>
</td>
<td class="nump">60,957<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">575,137<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="num">(513,428)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">7,866,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,867,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 66,324<span></span>
</td>
<td class="nump">66,578<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">574,548<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="num">(507,241)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(10,214)<span></span>
</td>
<td class="num">(10,214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">1,173<span></span>
</td>
<td class="nump">1,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuances of common stock</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from option exercises</a></td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Proceeds from option exercises (in shares)</a></td>
<td class="nump">82,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">$ (22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain on marketable securities</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="nump">8,132,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,133,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">$ 57,714<span></span>
</td>
<td class="nump">57,968<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">576,173<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="num">(517,455)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, beginning balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,999,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="nump">60,703<span></span>
</td>
<td class="nump">60,957<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">575,137<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="num">(513,428)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(4,027)<span></span>
</td>
<td class="num">(4,027)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,027)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">584<span></span>
</td>
<td class="nump">584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuances of common stock</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from option exercises</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Proceeds from option exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain on marketable securities</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="nump">8,132,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,133,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">$ 57,714<span></span>
</td>
<td class="nump">$ 57,968<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 576,173<span></span>
</td>
<td class="num">$ (50)<span></span>
</td>
<td class="num">$ (517,455)<span></span>
</td>
<td class="num">$ (708)<span></span>
</td>
<td class="num">$ (254)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407496678432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (10,214)<span></span>
</td>
<td class="num">$ (10,852)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Share-based compensation</a></td>
<td class="nump">1,258<span></span>
</td>
<td class="nump">1,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of fixed assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion on marketable securities</a></td>
<td class="num">(426)<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and other current assets</a></td>
<td class="num">(1,161)<span></span>
</td>
<td class="num">(744)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities', window );">Accounts payable, accrued liabilities and other liabilities</a></td>
<td class="num">(2,052)<span></span>
</td>
<td class="num">(1,268)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(12,380)<span></span>
</td>
<td class="num">(10,704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(60,836)<span></span>
</td>
<td class="num">(30,291)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Sale of marketable securities</a></td>
<td class="nump">64,400<span></span>
</td>
<td class="nump">60,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Investment in Cend Therapeutics</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">3,564<span></span>
</td>
<td class="nump">19,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_ProceedsFromExerciseOfOptionsFinancingActivities', window );">Proceeds from exercise of options</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Tax withholding payments on net share settlement equity awards</a></td>
<td class="num">(85)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">367<span></span>
</td>
<td class="num">(139)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(8,464)<span></span>
</td>
<td class="nump">8,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">32,154<span></span>
</td>
<td class="nump">24,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 23,690<span></span>
</td>
<td class="nump">$ 33,348<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_ProceedsFromExerciseOfOptionsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from exercise of options, Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_ProceedsFromExerciseOfOptionsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407494934320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Business<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_BusinessTextBlock', window );">The Business</a></td>
<td class="text">The Business<div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lisata Therapeutics, Inc. (together with its subsidiaries, the &#8220;Company&#8221;) is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. The Company's lead investigational product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to penetrate solid tumors more effectively. LSTA1 actuates this active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs more efficiently penetrating and accumulating in the tumor, while normal tissues are not expected to be affected. LSTA1 also has the potential to modify the tumor microenvironment (&#8220;TME&#8221;), thereby making tumors more susceptible to immunotherapies. The Company and its collaborators have amassed significant non-clinical data demonstrating enhanced delivery of a range of existing and emerging anti-cancer therapies, including chemotherapeutics, immunotherapies and RNA-based therapeutics. To date, LSTA1 has also demonstrated favorable safety, tolerability and activity in completed and ongoing clinical trials designed to enhance delivery of standard-of-care chemotherapy for pancreatic cancer. The Company is exploring the potential of LSTA1 to enable a variety of treatment modalities to treat a range of solid tumors more effectively. In addition, the Company has development programs based on its autologous CD34+ cell therapy technology platform that it is seeking to partner while incurring no additional capital outlay.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's leadership team has decades of collective biopharmaceutical and pharmaceutical product development experience across a variety of therapeutic categories and at all stages of development from preclinical through to product registration and launch. Its goal is to develop and commercialize products that address important unmet medical needs. The Company&#8217;s current development pipeline includes: </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LSTA1, the subject of Phase 1b/2a and 2b clinical studies being conducted globally in a variety of solid tumor types, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a variety of anti-cancer regimens.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger with Cend Therapeutics, Inc. and Name Change</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 15, 2022, the Company, then operating as Caladrius Biosciences, Inc. (&#8220;Caladrius&#8221;), completed its acquisition of Cend Therapeutics, Inc. (&#8220;Cend&#8221;), a Delaware corporation (the &#8220;Merger&#8221;), in accordance with the terms of the Agreement and Plan of Merger and Reorganization (the &#8220;Merger Agreement&#8221;), dated as of April 26, 2022, by and among Caladrius, Cend and CS Cedar Merger Sub, Inc. (&#8220;Merger Sub&#8221;).</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms set forth in the Merger Agreement and effective September 15, 2022 (the &#8220;Effective Time&#8221;): (i) Merger Sub merged with and into Cend, with Cend surviving as a wholly owned subsidiary of Caladrius, (ii) Caladrius changed its name to Lisata Therapeutics, Inc., and (iii) Caladrius effected a 1:15 reverse stock split of its common stock (&#8220;Reverse Stock Split&#8221;) prior to the Effective Time. At the Effective Time, each share of Cend's common stock outstanding immediately prior to the Effective Time was converted into the right to receive shares of Lisata&#8217;s common stock based on an exchange ratio of 0.5338, after taking into account the Reverse Stock Split (the &#8220;Exchange Ratio&#8221;). In connection with the Merger close, the Company issued an aggregate of 3,772,768 shares of common stock, based on the Exchange Ratio, to holders of Cend, in exchange for all of the Cend capital stock outstanding immediately prior to the closing of the Merger.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, Lisata assumed all of the outstanding and unexercised options to purchase shares of Cend capital stock under the 2016 Equity Incentive Plan (the &#8220;Cend Plan&#8221;), and, in connection with the Merger, such options were converted into options to purchase shares of Lisata&#8217;s common stock based on the Exchange Ratio. At the closing of the Merger at the Effective Time, the Company assumed Cend's stock options to purchase an aggregate of 1,227,776 shares of the Company's common stock. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Caladrius was considered to be the accounting acquirer based on the terms of the Merger Agreement and certain factors including: (i) Caladrius owned approximately 52% of the Company's outstanding shares of common stock immediately following the close of the Merger; (ii) although both entities contributed to the new management team of Lisata, the Caladrius team provided a vast majority of the individuals on the management team and holds the chief executive officer (&#8220;CEO&#8221;), chief medical officer (&#8220;CMO&#8221;) and other senior management roles; (iii) Caladrius paid a premium to acquire Cend&#8217;s assets; and (iv) Caladrius was significantly larger than Cend regarding total assets, operations, and research and development activities. The Merger was accounted for as an asset acquisition as substantially all of the fair value is concentrated in in-process research and development (&#8220;IPR&amp;D&#8221;). Cend&#8217;s assets (except for cash and working capital) were measured and recognized as an allocation of the transaction price based on their relative fair values as of the transaction date with any value associated with IPR&amp;D with no </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">alternative future use being expensed as reported in the consolidated statement of operations. Operating results presented in the consolidated statements of operations and comprehensive loss prior to the Merger are solely related to Caladrius Biosciences, Inc. and subsidiaries.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coronavirus Considerations</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lisata's Phase 2b FREEDOM Trial of XOWNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. experienced delays in enrolling patients as a result of COVID-19. While early enrollment proceeded to plan with the first patient treated in January 2021, the impact of the COVID-19 pandemic contributed to a general slowing of enrollment, supply chain disruptions affecting the availability of qualified catheters used in the diagnosis of CMD and/or administration of XOWNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as with a contrast agent typically used in many catheter laboratories. In May 2022, the Company announced that enrollment in the FREEDOM Trial was suspended and that it intended to conduct an interim analysis of the data from not less than the first 20 patients enrolled using the 6-month follow-up data to evaluate the efficacy and safety of XOWNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in subjects with CMD. Following this analysis along with Key Opinion Leaders&#8217; input, the Company determined that execution of a redesigned FREEDOM-like trial would be the appropriate next step, but the cost of such a trial would be prohibitively expensive to undergo without a strategic partner. Accordingly, the Company&#8217;s board of directors concluded that XOWNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> development will only be continued if a strategic partner that can contribute the necessary capital for a redesigned trial is identified and secured. There can be no assurance that we will be able to identify such a partner and enter into an agreement with such partner on acceptable terms or at all.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reverse Stock Split</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 14, 2022, in connection with the Merger, the Company implemented the Reverse Stock Split, as authorized at the annual meeting of stockholders on September 13, 2022. The Reverse Stock Split became effective on September 14, 2022 at 5:00 pm and the Company's common stock began trading on The Nasdaq Capital Market on a post-split basis at the open of business on September 15, 2022. As of September 14, 2022, every fifteen shares of the Company&#8217;s issued and outstanding common stock (and such shares held in treasury) were automatically converted into one share of common stock, without any change in the par value per share. In addition, proportionate adjustments were made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options, stock appreciation rights, convertible notes and warrants to purchase shares of common stock, the number of shares issuable upon the vesting of all restricted stock awards, and the number of shares of common stock reserved for issuance pursuant to the Company&#8217;s equity incentive compensation plans. Any stockholder who would otherwise be entitled to a fractional share of common stock created as a result of the Reverse Stock Split received a cash payment equal to the product of such resulting fractional interest in one share of common stock multiplied by the closing trading price of the common stock on September 15, 2022. The Reverse Stock Split was effectuated in order to increase the per share trading price of our common stock to satisfy the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All share and per share amounts of common stock, options and warrants in the accompanying financial statements have been restated for all periods presented to give retroactive effect to the Reverse Stock Split. Accordingly, the consolidated statements of equity reflect the impact of the Reverse Stock Split by reclassifying from &#8220;common stock&#8221; to &#8220;additional paid-in capital&#8221; in an amount equal to the par value of the decreased shares resulting from the Reverse Stock Split.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#8217;s financial position as of June&#160;30, 2023, and the results of its operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2022 and 2021 included in our 2022 Form 10-K. Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values and the valuation of the Merger which was accounted for as an asset acquisition as substantially all of the fair value is concentrated in in-process research and development (&#8220;IPR&amp;D&#8221;). Accordingly, actual results could differ from those estimates and assumptions.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements include the accounts of Lisata Therapeutics, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Remeasurement</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The functional currency of Lisata Therapeutics Australia Pty Ltd. which is a foreign subsidiary of the Company is the Australian Dollar. The assets and liabilities of Lisata Therapeutics Australia Pty Ltd. are translated into U.S. Dollars at the exchange rates in effect at each balance sheet date, and the results of operations are translated using the average exchange rates prevailing throughout the reporting period. Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive income (loss) in stockholders' equity.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_BusinessTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Business [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_BusinessTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495506032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents include short-term, highly liquid, investments with maturities of ninety days or less when purchased. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risks</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to credit risk from its portfolio of cash, cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. Cash is held at major banks in the United States and may exceed federally insured limits. The goals of the Company's investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the appropriate classification of its marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. All of the Company's marketable securities are considered as available-for-sale and carried at estimated fair values and reported in cash equivalents and marketable securities. Unrealized gains and losses on available-for-sale securities are excluded from net income and reported in accumulated other comprehensive income (loss) as a separate component of stockholders' equity. Other income (expense), net, includes interest, dividends, amortization of purchase premiums and discounts, realized gains and losses on sales of securities and other-than-temporary declines in the fair value of securities, if any. The cost of securities sold is based on the specific identification method. The Company regularly reviews all of its investments for other-than-temporary declines in fair value. The Company's review includes the consideration of the cause of the impairment, including the creditworthiness of the security issuers, the number of securities in an unrealized loss position, the severity and duration of the unrealized losses, whether the Company has the intent to sell the securities and whether it is more likely than not that it will be required to sell the securities before the recovery of their amortized cost basis. When the Company determines that the decline in fair value of an investment is below its accounting basis and this decline is other-than-temporary, it reduces the carrying value of the security it holds and records a loss for the amount of such decline.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost of property and equipment is depreciated over the estimated useful lives of the related assets. Depreciation is computed on the straight-line method. Repairs and maintenance expenditures that do not extend original asset lives are charged to expense as incurred. The estimated useful lives of property and equipment are as follows:</span></div><div style="margin-bottom:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life of lease</span></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets consist of property and equipment. The assets are amortized on a straight line basis over their respective useful lives. The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds the fair value of the asset. If other events or changes in circumstances indicate that the carrying amount of an asset that the Company expects to hold and use may not be recoverable, the Company will estimate the undiscounted future cash flows expected to result from the use of the asset and/or its eventual disposition, and recognize an impairment loss, if any. The impairment loss, if determined to be necessary, would be measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses all share-based payment awards to employees, directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate, expected volatility, expected dividend yield and expected life of the options or warrants. Stock based compensation expense also includes an estimate, which is made at the time of the grant, of the number of awards that are expected to be forfeited. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the date of grant. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss Per Share</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic loss per share is based on the weighted effect of all common shares issued and outstanding and is calculated by dividing net loss attributable to common stockholders by the weighted average shares outstanding during the period. Diluted loss per share is calculated by dividing net loss attributable to common stockholders by the weighted average number of common shares used in the basic loss per share calculation plus the number of common shares that would be issued assuming conversion of all potentially dilutive securities outstanding. Diluted loss per share is not presented as such potentially dilutive securities are anti-dilutive to losses incurred in all periods presented. </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Stock</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treasury stock purchases are accounted for under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock. Gains or losses on the subsequent reissuance of shares are credited or charged to additional paid in capital.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development (&#8220;R&amp;D&#8221;) expenses include salaries, benefits, and other headcount related costs, clinical trial and related clinical manufacturing costs, contract and other outside service fees including sponsored research agreements, and facilities and overhead costs. The Company expenses the costs associated with research and development activities when incurred.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To further drive the Company&#8217;s initiatives, the Company will continue targeting key governmental agencies, congressional committees and not-for-profit organizations to contribute funds for the Company&#8217;s research and development programs. The Company accounts for such grants as a deduction to the related expense in research and development operating expenses when earned.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In-process Research and Development Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upfront payments that relate to the acquisition of a new drug compound, as well as pre-commercial milestone payments, are immediately expensed as IPR&amp;D in the period in which they are incurred, provided that the new drug compound did not also include processes or activities that would constitute a &#8220;business&#8221; as defined under U.S. GAAP, the drug has not achieved regulatory approval for marketing and, absent obtaining such approval, has no established alternative future use. The Company accounts for contingent consideration payable upon achievement of certain regulatory, development or sales milestones in such asset acquisitions when the underlying contingency is probable and estimable. Milestone payments made to third parties subsequent to regulatory approval will be capitalized as intangible assets and amortized over the estimated remaining useful life of the related product.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Asset</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible asset consists of a single asset, Cend&#8217;s license agreement with Qilu Pharmaceutical, Co., Ltd. (&#8220;Qilu&#8221;) acquired in the Merger, with a value of $0.4&#160;million. The intangible asset is stated at fair value and is amortized using the straight-line method over its estimated useful life of 5 years. Amortization expense was $18&#160;thousand for the three months ended June&#160;30, 2023 and $35&#160;thousand for the six months ended June&#160;30, 2023. The intangible asset is reviewed for potential impairment when events or circumstances indicate that carrying amounts may not be recoverable.  The projected amortization expense is $71&#160;thousand per year for the next five years. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates license and collaboration arrangements to determine whether units of account within the arrangement exhibit the characteristics of a vendor and customer relationship. For arrangements and units of account where a customer relationship exists, the Company applies the revenue recognition guidance. The Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations. At contract inception, the Company assesses the goods or services promised within each contract and assesses whether each promised good or service is distinct and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Taxes imposed by governmental authorities on the Company's revenue, such as sales taxes and withholding taxes, are excluded from net revenue.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. If licenses are bundled with other performance obligations, the Company would utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. There was no revenue recognized for the three and six months ended June&#160;30, 2023 and 2022.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Milestones</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the inception of each arrangement that includes milestone payments (variable consideration), the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company or the Company&#8217;s collaboration partner&#8217;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts the Company&#8217;s estimate of the overall transaction price. Any such adjustments are allocated on a cumulative catch-up basis to satisfied and partially satisfied performance obligations, with the consideration allocated to an ongoing performance obligation being recognized over the period of performance. For the three and six months ended June&#160;30, 2023 and June&#160;30, 2022, the Company has not recognized revenue related to milestones.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and for which the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized any royalty revenue from any collaborative arrangement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407498979168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAbstract', window );"><strong>Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionTextBlock', window );">Merger</a></td>
<td class="text">Merger<div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger was accounted for as an asset acquisition as substantially all of the fair value was concentrated in IPR&amp;D. Cend&#8217;s assets (except for cash and working capital) were measured and recognized as an allocation of the transaction price based on their relative fair values as of the transaction date with any value associated with IPR&amp;D being expensed. The fair value of total consideration was $36.1&#160;million. The following table is a summary of the purchase price calculation (in thousands except per share data).</span></div><div style="margin-bottom:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:60.25pt"></td><td style="width:1.0pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of common shares of the combined company owned by Cend stockholders</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,772,768&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multiplied by the fair value per share of Lisata common stock on September 15, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.25</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23,580</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of Lisata's cost method investment in Cend</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental fair value of Cend's fully vested stock options</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lisata transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$36,098</span></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The allocation of the purchase price was as follows (amounts in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:60.25pt"></td><td style="width:1.0pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,062</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net working capital (excluding cash)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,690)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$36,098</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407497465264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Available-for-Sale-Securities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-Sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Available-for-Sale-Securities</a></td>
<td class="text">Available-for-Sale-Securities<div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of available-for-sale securities recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:507.00pt"><tr><td style="width:1.0pt"></td><td style="width:94.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,430&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,758&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated fair values of available-for-sale securities are generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:360.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our portfolio of available-for-sale securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:361.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than one year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,430&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407494911200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and Equipment<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:505.50pt"><tr><td style="width:1.0pt"></td><td style="width:363.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:60.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:72.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(417)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s results included depreciation expense of approximately $60&#160;thousand and $13&#160;thousand for the six months ended June&#160;30, 2023 and 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407499727328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Income (Loss) Per Share</a></td>
<td class="text">Income (Loss) Per Share<div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2023 and 2022, the Company incurred net losses and therefore no common stock equivalents were utilized in the calculation of diluted loss per share as they are anti-dilutive. At June&#160;30, 2023 and 2022, the Company excluded the following potentially dilutive securities (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407494973008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of financial assets and liabilities that are being measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price). The Company is required to classify fair value measurements in one of the following categories:</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 inputs are defined as quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 inputs are defined as inputs other than quoted prices included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 inputs are defined as unobservable inputs for the assets or liabilities. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financial assets and liabilities that were accounted for at fair value on a recurring basis as of June&#160;30, 2023 and December&#160;31, 2022 (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:116.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities - available for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,478&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,936&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,414&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,668&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,072&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,740&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of accounts payable and accrued expenses approximate fair value as of June&#160;30, 2023 and December&#160;31, 2022, due to the short maturity nature of these items.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407497658768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities</a></td>
<td class="text">Accrued Liabilities<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities as of June&#160;30, 2023 and December&#160;31, 2022 were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:507.75pt"><tr><td style="width:1.0pt"></td><td style="width:313.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:97.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries, employee benefits and related taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical and R&amp;D related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting &amp; tax consulting liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities &#8212; current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,728&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407494975440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Operating Leases</a></td>
<td class="text">Operating LeasesThe Company adopted ASU No. 2016-02, Leases (Topic 842) on January 1, 2019 and recognized leases with duration greater than 12 months on the balance sheet using the modified retrospective approach. The Company has an operating lease for one office which expires in 2025. The Company estimates its incremental borrowing rate at lease commencement to determine the present value of lease payments as most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. The Company's lease includes an option for the Company to extend the lease term and/or sub-lease space in whole or in part.<div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities and right-of-use assets were recorded in the following captions of our balance sheet as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:325.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-Use Assets:</span></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-542"><span style="-sec-ix-hidden:f-543">Other assets</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Right-of-Use Asset</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Lease Liabilities:</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-548"><span style="-sec-ix-hidden:f-549">Accrued liabilities</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-552"><span style="-sec-ix-hidden:f-553">Other long-term liabilities</span></span></span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Lease Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2023, the weighted average remaining lease term for our operating lease was 2.3 years, and the weighted average discount rate for our operating lease was 9.625%. As of December&#160;31, 2022, the weighted average remaining lease term for our operating leases was 1.5 years, and the weighted average discount rate for our operating leases was 9.625%.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under the lease agreement as of June&#160;30, 2023 were as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:60.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amounts representing interest</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407494997232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' Equity<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reverse Stock Split</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 14, 2022, in connection with the Merger, we implemented the Reverse Stock Split, as described in Note 1. All share and per share amounts of common stock, options and warrants in the accompanying financial statements have been restated for all periods presented to give retroactive effect to the Reverse Stock Split. Accordingly, the consolidated statements of equity reflect the impact of the Reverse Stock Split by reclassifying from &#8220;common stock&#8221; to &#8220;additional paid-in capital&#8221; in an amount equal to the par value of the decreased shares resulting from the Reverse Stock Split.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Issuances</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">At The Market Offering Agreement</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 4, 2021, the Company entered into an At The Market Offering Agreement (the &#8220;ATM Agreement&#8221;) with H.C. Wainwright &amp; Co., LLC, as sales agent, in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and sell shares of its common stock, having an aggregate offering price of up to $50.0&#160;million. Subsequent to the filing of our Form 10-K on March 22, 2022, the aggregate market value of our outstanding common stock held by non-affiliates was approximately $43.6&#160;million. Pursuant to General Instruction I.B.6 of Form S-3, since the aggregate market value of our outstanding common stock held by non-affiliates was below $75.0&#160;million at the time of such Form 10-K filing, the aggregate amount of securities that we are permitted to offer and sell was reduced to $17,698,943, which was equal to one-third of the aggregate market value of our common stock held by non-affiliates as of September 21, 2022. During the six months ended June&#160;30, 2023, the Company issued 64,394 shares of common stock under the ATM Agreement  for net proceeds of $270,774.  Since inception, the Company has issued 64,394 shares of common stock under the ATM Agreement for net proceeds of $270,774.  </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger closing on September 15, 2022, the Company issued an aggregate of 3,772,768 shares of common stock, based on the Exchange Ratio, to holders of Cend, in exchange for all of the Cend capital stock outstanding immediately prior to the closing of the Merger.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options and Warrants</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger and after giving effect to the Reverse Stock Split, the Company assumed 1,227,776 options outstanding of Cend. The options granted under the Cend Plan are exercisable at various dates as determined upon grant and will expire no more than ten years from their original date of grant. The Cend Plan stock options generally vest over a four-year term. The following table summarizes the activity for stock options and warrants for the six months ended June&#160;30, 2023:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:22.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.127%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrants</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aggregate Intrinsic Value (In Thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aggregate Intrinsic Value (In Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,391,352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.03</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,423,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.37</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes during the period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">175,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(82,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(142,694)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">224.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding at June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,338,734&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.79&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">376.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,421,744&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested at June 30, 2023<br/>or expected to vest in the future</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,333,367&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.82&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.43</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">373.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,421,744&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.51&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested at June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,222,064&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.02&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">337.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,421,744&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.51&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023 and 2022, the Company issued restricted stock for services as follows (in thousands, except share data):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:483.75pt"><tr><td style="width:1.0pt"></td><td style="width:322.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:72.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:4.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of restricted stock issued</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value of restricted stock issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vesting terms of restricted stock issuances are generally between <span style="-sec-ix-hidden:f-633">one</span> and four years.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023 and 2022, the Company issued restricted stock units for services as follows (in thousands, except share data):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:498.00pt"><tr><td style="width:1.0pt"></td><td style="width:343.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:72.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of restricted stock units issued</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,990&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value of restricted stock units issued </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The weighted average estimated fair value of restricted stock issued for services in the six months ended June&#160;30, 2023 and 2022 was $3.00 and $13.76 per share, respectively. The fair value of the restricted stock units was determined using the Company&#8217;s closing stock price on the date of issuance. The vesting terms of restricted stock unit issuances are generally one year, or upon the achievement of performance-based milestones.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407494969280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-Based Payment Arrangement, Noncash Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize share-based compensation in the form of stock options, restricted stock, and restricted stock units.&#160;The following table summarizes the components of share-based compensation expense for the three and six months ended June&#160;30, 2023 and 2022 (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:44.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.386%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total compensation cost related to unvested awards not yet recognized and the weighted-average periods over which the awards were expected to be recognized at June&#160;30, 2023 were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.81</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total fair value of shares vested and the weighted average estimated fair values of shares granted for the six months ended June&#160;30, 2023 and 2022 were as follows (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:378.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average estimated fair value of shares granted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation Assumptions</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options at the date of grant was estimated using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#8217;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant and exercise of options for all employees. The expected term for the warrants is based upon the contractual term of the warrants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407494867200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, including the net operating loss carryforwards (NOLs), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets.  Based on its assessment, the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had approximately $281.0&#160;million of Federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% over a 3-year testing period on January 25, 2021. As a result, $168.8&#160;million of the $281.0&#160;million of Federal NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $112.3&#160;million of remaining Federal NOLs.  The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact to the balance sheet or income statement. Losses incurred before the ownership change on January 25, 2021 will be subject to an annual limitation of $173&#160;thousand under Internal Revenue Code Section 382. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company had approximately $34.0&#160;million of Federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% on September 15, 2022. As a result of the ownership change, $88.2&#160;million of Federal </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $34.0&#160;million of remaining Federal NOLs.  The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact to the balance sheet or income statement. Losses incurred before the ownership change on September 15, 2022 will be subject to an annual limitation of zero while losses incurred after September 15, 2022 will not be subject to limitations. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, Cend Therapeutics had approximately $10.9&#160;million of Federal NOLs available to offset future taxable income. The Company performed an analysis and determined that there was an ownership change of greater than 50% on September 15, 2022. As of September 15, 2022 Cend has approximately $10.7&#160;million of Federal and $15.0&#160;million of state NOLs. The state NOLs will expire from the 2036 through 2042 tax years.  Using a fair market value of $36.1&#160;million and applying an applicable federal rate of 2.54% Cend will have an annual limitation of approximately $917 thousand each year. The Federal NOL of $106&#160;thousand incurred in the post-acquisition period September 15, 2022 to December 31, 2022 is not subject to limitation, and does not expire. Cend&#8217;s wholly owned Australian subsidiary has $1.8&#160;million of NOLs which will be carried forward and do not expire. There is a full valuation allowance against the NOLs.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, the Company had State NOLs available in New Jersey of $35.5&#160;million and $97.0&#160;million, respectively, California of $10.0&#160;million and $69.5&#160;million, respectively, and New York City of $1.9&#160;million and $13.0&#160;million, respectively, to offset future taxable income expiring from 2032 through 2042. In accordance with Section 382 of the Internal Revenue code, the usage of the Company&#8217;s NOLs is limited given the change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period when those temporary differences become deductible.  </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the FASB&#8217;s provisions for uncertain tax positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties associated with uncertain tax positions as a component of income tax expense.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022 and 2021, the Company&#8217;s uncertain tax positions were $344&#160;thousand and $0, respectively. Due to the acquisition of Cend, the Company&#8217;s uncertain tax positions increased by $344&#160;thousand related to Federal and state credits and certain state NOLs. The Company will continue to evaluate its uncertain tax positions in future periods. As of June&#160;30, 2023, the Company does not believe there will be any material changes in its unrecognized tax positions over the next year.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For years prior to 2019, the federal statute of limitations is closed for assessing tax. The Company&#8217;s state tax returns remain open to examination for a period of three to four years from the date of filing.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 5, 2023, the Company received final approval from the New Jersey Economic Development Authority (&#8220;NJEDA&#8221;) under the Technology Business Tax Certificate Transfer Program (&#8220;Program&#8221;) to sell a percentage of its New Jersey net operating losses (&#8220;NJ NOLs&#8221;), which were subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $2.2&#160;million. The $2.3&#160;million of NJ NOLs related tax benefits has been recorded as a benefit from income taxes and the loss on sale of $0.1&#160;million recorded in other income (expense).</span></div>On August 16, 2022, the Inflation Reduction Act was signed into law. The Inflation Reduction Act includes various tax provisions, which are effective for tax years beginning on or after January 1, 2023. For tax years beginning after December 31, 2021, the Tax Cuts &amp; Jobs Act of 2017 eliminated the option to deduct research and development expenditures as incurred and instead required taxpayers to capitalize and amortize them over five or 15 years beginning in 2022. Since the Company is in a net operating loss position, the capitalization of research and development costs did not have a material impact on the Company&#8217;s results of operations for the year ended December 31, 2022. The Company will continue to monitor future impact of changes in tax legislation.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407494943552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Australia Research and Development Tax Incentive<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_ResearchAndDevelopmentTaxIncentiveTextBlock', window );">Australia Research and Development Tax Incentive</a></td>
<td class="text">Australia Research and Development Tax IncentiveThe Company&#8217;s Australian subsidiary, which conducts core research and development activities, is eligible to receive a refundable tax incentive between 43.5% to 48.5% (depending upon the income tax rate) for qualified research and development activities. As of the six months ended June&#160;30, 2023, $1.1&#160;million was recorded as an income tax incentive receivable in  prepaid and other current assets in the consolidated balance sheets, as the Company determined that the expenses met the eligibility criteria and the amounts claimed are expected to be received shortly after the related tax returns are filed.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_ResearchAndDevelopmentTaxIncentiveTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development Tax Incentive</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_ResearchAndDevelopmentTaxIncentiveTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407494951728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text">Contingencies<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is subject to legal proceedings and claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not believe that the outcome of any pending claims will have a material adverse effect on the Company's financial condition or operating results. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Cend received a written threat of litigation on behalf of a Chinese entity called Lingmed Limited (&#8220;Lingmed&#8221;) claiming Lingmed was entitled to a success fee based on Cend&#8217;s Collaboration and License Agreement with Qilu Pharmaceuticals. Cend responded by denying that Lingmed is entitled to a success fee under the terms of their agreement. In May 2022, Cend was served with a complaint filed by Lingmed in the San Diego County Superior Court, alleging claims for breach of contract, fraud and declaratory relief. Cend&#8217;s response to the complaint was filed on June 6, 2022. Lingmed filed an answer to Cend&#8217;s response on July 11, 2022. At a Case Management Conference held on August 4, 2023, the Court set a trial date in the matter for August 2, 2024. The Company denies these allegations made by Lingmed and intends to vigorously defend itself.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407499739904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>License Agreements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">License Agreements</a></td>
<td class="text">License Agreements<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sanford Burnham Prebys</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2015, Cend entered into a license agreement with Sanford Burnham Prebys (&#8220;SBP&#8221;) under which Cend was granted an exclusive, worldwide, royalty-bearing license to certain patent rights and know-how controlled by SBP related to the development of LSTA1. At the time the license agreement was entered into, Cend&#8217;s founding shareholder was an executive at SBP. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. As consideration for the license, Cend issued a total of 382,030 shares of common stock, as adjusted for the Reverse Stock Split and Exchange Ratio. The Company is required to pay an annual license maintenance fee of $10,000 increasing to $20,000 on year seven of the agreement. The Company could also be required to make milestone payments to SBP upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $10.6&#160;million. The Company has also agreed to pay SBP royalties of 4% of net sales of products sold by the Company, or through a sublicense, subject to certain reductions. Additionally, the Company is obligated to pay SBP 25% of any sublicensing income. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, Cend entered into a license agreement with SBP under which Cend was granted an exclusive, royalty-bearing license to certain patent rights and know-how controlled by SBP. The agreement provides Cend with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. The Company is required to pay an annual license maintenance fee of $20,000, increasing to $30,000 on year four of the agreement. Further, the Company could be required to make milestone payments to SBP upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $23.2&#160;million. The Company is obligated to pay SBP royalties of 4% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company is obligated to pay SBP varying sublicense fees, ranging from 10% to 25%, dependent on when the related milestones are reached. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements will expire upon the later of (i) the final abandonment of all pending patent applications within the licensed patents or (ii) the expiration of the last to expire patent within the licensed patents. The agreements may be terminated in their entirety by the Company at any time by giving SBP sixty days&#8217; prior written notice. The agreements may be terminated in their entirety by SBP if the Company, at any time, defaults in the payment of any sum when due and fails to make such payment within thirty days after receipt of written notice. The agreements may be terminated in their entirety by SBP or the Company (i) in the event of an uncured material breach by the other party, or (ii) in the event the other party (a) files for, or is involuntarily petitioned with, bankruptcy (other than dissolution or winding up for the purposes of reconstruction or amalgamation), (b) makes an assignment of all or substantially all of its assets for the benefit of creditors, or (c) has a receiver or trustee is appointed and is unable to secure a dismissal, stay or other suspension of such proceedings within thirty days. Upon termination of the agreements for any reason, all rights and obligations of the Company with respect to the patents and patent applications shall terminate and revert to SBP.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SBP owned 382,030 shares of the Company&#8217;s common stock as of June&#160;30, 2023 and is a related party. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">University of California at San Diego</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, Cend entered into a license agreement with the University of California at San Diego (&#8220;UCSD&#8221;) under which Cend was granted an exclusive, royalty-bearing license to certain patent rights related to the development of nano-particles to modulate immune response. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell and otherwise exploit the patent rights. The Company could be required to make milestone payments to UCSD upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $1.2&#160;million. The Company has also agreed to pay UCSD royalties of 1.5% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company agreed to pay UCSD varying sublicense fees, ranging from 10% to 20%, dependent on when the related milestones are reached. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement will expire upon the expiration of the longest-lived patent rights. The agreement may be terminated in its entirety by the Company at any time by giving UCSD ninety days&#8217; prior written notice. The agreement may be terminated in its entirety by UCSD if the Company, at any time, (i) fails to perform or violates any term of the agreement and fails to cure the default within sixty days. Upon termination of the agreement for any reason, UCSD may terminate a sublicensee but will allow the Company to assign any sublicenses to UCSD provided a) that the sublicensee is in good standing upon termination of the agreement with the Company; and b) the sublicensee is not currently involved in litigation as an adverse party to UCSD.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Massachusetts Institute of Technology</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, Cend entered into a license agreement with the Massachusetts Institute of Technology ("MIT") under which Cend was granted an exclusive, royalty-bearing license to certain patent rights related to the development of tissue specific delivery of interfering RNA. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. As consideration for the license, Cend issued a total of 43,236 shares of common stock, as adjusted for the Reverse Stock Split and Exchange Ratio. The Company is required to pay an annual license maintenance fee of $20,000, increasing to $25,000 for year two and three of the agreement, increasing to $50,000 on year four of the agreement and thereafter until the first commercial sale, and increasing to $150,000 each year of the agreement after the first sale. Further, the Company could be required to make milestone payments to MIT upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $5.0&#160;million. The Company has also agreed to pay MIT royalties of 2% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company is obligated to pay MIT varying sublicense fees, ranging from 3% to 20%, depending on when the related milestones are reached. In connection with the close of the Merger, the Company was required to pay MIT a change of control fee of $0.3&#160;million.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement expires upon the expiration or abandonment of all valid claims. The agreement may be earlier terminated in its entirety by the Company at any time by giving MIT six months prior written notice. The agreement may also be terminated in its entirety by MIT if the Company, at any time, (i) defaults in the payment of any sum when due and fails to make such payment within thirty days after receipt of written notice, or (ii) commits a material breach of its obligations under the agreement (aside from item (i)) and fails to cure that breach within sixty days after receipt of written notice. Upon termination of the agreement for any reason, the rights and licenses granted to the Company shall terminate and revert to MIT. Upon termination of the agreement for any reason, MIT may terminate a sublicensee but will allow the Company to assign any sublicenses to MIT provided that the sublicensee is in good standing upon termination of the agreement with the Company.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2023, in accordance with the provisions of the license agreement, the Company provided notice to MIT that the license agreement would terminate effective December 30, 2023. Until such date, the license remains in full force and effect.</span></div>MIT owned 43,236 shares of the Company&#8217;s common stock as of June&#160;30, 2023Research Collaboration and License Agreement<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exclusive License and Collaboration Agreement</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Cend entered into an Exclusive License and Collaboration Agreement (the &#8220;Qilu Agreement&#8221;) in which Cend granted an exclusive license to Qilu for the development and commercialization of LSTA1 in the Territory (defined as the Greater Area of China including China, Macau, Hong Kong, and Taiwan). Under the terms of the agreement, Qilu is solely responsible for the development of LSTA1 in its Territory. In consideration for the license, Qilu made an upfront payment of $10&#160;million to Cend, which was recognized as revenue by Cend prior to the Merger. In addition, Cend received and recognized as revenue a $5&#160;million development milestone prior to the Merger. The Company is eligible to receive additional developmental and commercial milestone payments up to $95&#160;million and $125&#160;million, respectively, tiered royalties on net sales ranging from 10% to 15%, and tiered sublicensing revenues ranging from 12% to 35%.</span></div>Unless terminated early, the Qilu Agreement will continue in effect until the expiration of all Qilu payment obligations. Either party may terminate the Qilu Agreement if an undisputed material breach by the other party is not cured within a defined period of time, or upon notice for insolvency-related events of the other party that are not discharged within a defined time period. Qilu may terminate the Qilu Agreement in its entirety, at any time with at least sixty days written notice. All rights and obligations of Qilu with respect to such licensed patents and patent applications would terminate.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407499739904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Collaboration and License Agreement<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Research Collaboration and License Agreement</a></td>
<td class="text">License Agreements<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sanford Burnham Prebys</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2015, Cend entered into a license agreement with Sanford Burnham Prebys (&#8220;SBP&#8221;) under which Cend was granted an exclusive, worldwide, royalty-bearing license to certain patent rights and know-how controlled by SBP related to the development of LSTA1. At the time the license agreement was entered into, Cend&#8217;s founding shareholder was an executive at SBP. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. As consideration for the license, Cend issued a total of 382,030 shares of common stock, as adjusted for the Reverse Stock Split and Exchange Ratio. The Company is required to pay an annual license maintenance fee of $10,000 increasing to $20,000 on year seven of the agreement. The Company could also be required to make milestone payments to SBP upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $10.6&#160;million. The Company has also agreed to pay SBP royalties of 4% of net sales of products sold by the Company, or through a sublicense, subject to certain reductions. Additionally, the Company is obligated to pay SBP 25% of any sublicensing income. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, Cend entered into a license agreement with SBP under which Cend was granted an exclusive, royalty-bearing license to certain patent rights and know-how controlled by SBP. The agreement provides Cend with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. The Company is required to pay an annual license maintenance fee of $20,000, increasing to $30,000 on year four of the agreement. Further, the Company could be required to make milestone payments to SBP upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $23.2&#160;million. The Company is obligated to pay SBP royalties of 4% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company is obligated to pay SBP varying sublicense fees, ranging from 10% to 25%, dependent on when the related milestones are reached. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements will expire upon the later of (i) the final abandonment of all pending patent applications within the licensed patents or (ii) the expiration of the last to expire patent within the licensed patents. The agreements may be terminated in their entirety by the Company at any time by giving SBP sixty days&#8217; prior written notice. The agreements may be terminated in their entirety by SBP if the Company, at any time, defaults in the payment of any sum when due and fails to make such payment within thirty days after receipt of written notice. The agreements may be terminated in their entirety by SBP or the Company (i) in the event of an uncured material breach by the other party, or (ii) in the event the other party (a) files for, or is involuntarily petitioned with, bankruptcy (other than dissolution or winding up for the purposes of reconstruction or amalgamation), (b) makes an assignment of all or substantially all of its assets for the benefit of creditors, or (c) has a receiver or trustee is appointed and is unable to secure a dismissal, stay or other suspension of such proceedings within thirty days. Upon termination of the agreements for any reason, all rights and obligations of the Company with respect to the patents and patent applications shall terminate and revert to SBP.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SBP owned 382,030 shares of the Company&#8217;s common stock as of June&#160;30, 2023 and is a related party. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">University of California at San Diego</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, Cend entered into a license agreement with the University of California at San Diego (&#8220;UCSD&#8221;) under which Cend was granted an exclusive, royalty-bearing license to certain patent rights related to the development of nano-particles to modulate immune response. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell and otherwise exploit the patent rights. The Company could be required to make milestone payments to UCSD upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $1.2&#160;million. The Company has also agreed to pay UCSD royalties of 1.5% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company agreed to pay UCSD varying sublicense fees, ranging from 10% to 20%, dependent on when the related milestones are reached. </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement will expire upon the expiration of the longest-lived patent rights. The agreement may be terminated in its entirety by the Company at any time by giving UCSD ninety days&#8217; prior written notice. The agreement may be terminated in its entirety by UCSD if the Company, at any time, (i) fails to perform or violates any term of the agreement and fails to cure the default within sixty days. Upon termination of the agreement for any reason, UCSD may terminate a sublicensee but will allow the Company to assign any sublicenses to UCSD provided a) that the sublicensee is in good standing upon termination of the agreement with the Company; and b) the sublicensee is not currently involved in litigation as an adverse party to UCSD.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Massachusetts Institute of Technology</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, Cend entered into a license agreement with the Massachusetts Institute of Technology ("MIT") under which Cend was granted an exclusive, royalty-bearing license to certain patent rights related to the development of tissue specific delivery of interfering RNA. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. As consideration for the license, Cend issued a total of 43,236 shares of common stock, as adjusted for the Reverse Stock Split and Exchange Ratio. The Company is required to pay an annual license maintenance fee of $20,000, increasing to $25,000 for year two and three of the agreement, increasing to $50,000 on year four of the agreement and thereafter until the first commercial sale, and increasing to $150,000 each year of the agreement after the first sale. Further, the Company could be required to make milestone payments to MIT upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $5.0&#160;million. The Company has also agreed to pay MIT royalties of 2% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company is obligated to pay MIT varying sublicense fees, ranging from 3% to 20%, depending on when the related milestones are reached. In connection with the close of the Merger, the Company was required to pay MIT a change of control fee of $0.3&#160;million.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement expires upon the expiration or abandonment of all valid claims. The agreement may be earlier terminated in its entirety by the Company at any time by giving MIT six months prior written notice. The agreement may also be terminated in its entirety by MIT if the Company, at any time, (i) defaults in the payment of any sum when due and fails to make such payment within thirty days after receipt of written notice, or (ii) commits a material breach of its obligations under the agreement (aside from item (i)) and fails to cure that breach within sixty days after receipt of written notice. Upon termination of the agreement for any reason, the rights and licenses granted to the Company shall terminate and revert to MIT. Upon termination of the agreement for any reason, MIT may terminate a sublicensee but will allow the Company to assign any sublicenses to MIT provided that the sublicensee is in good standing upon termination of the agreement with the Company.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2023, in accordance with the provisions of the license agreement, the Company provided notice to MIT that the license agreement would terminate effective December 30, 2023. Until such date, the license remains in full force and effect.</span></div>MIT owned 43,236 shares of the Company&#8217;s common stock as of June&#160;30, 2023Research Collaboration and License Agreement<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exclusive License and Collaboration Agreement</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Cend entered into an Exclusive License and Collaboration Agreement (the &#8220;Qilu Agreement&#8221;) in which Cend granted an exclusive license to Qilu for the development and commercialization of LSTA1 in the Territory (defined as the Greater Area of China including China, Macau, Hong Kong, and Taiwan). Under the terms of the agreement, Qilu is solely responsible for the development of LSTA1 in its Territory. In consideration for the license, Qilu made an upfront payment of $10&#160;million to Cend, which was recognized as revenue by Cend prior to the Merger. In addition, Cend received and recognized as revenue a $5&#160;million development milestone prior to the Merger. The Company is eligible to receive additional developmental and commercial milestone payments up to $95&#160;million and $125&#160;million, respectively, tiered royalties on net sales ranging from 10% to 15%, and tiered sublicensing revenues ranging from 12% to 35%.</span></div>Unless terminated early, the Qilu Agreement will continue in effect until the expiration of all Qilu payment obligations. Either party may terminate the Qilu Agreement if an undisputed material breach by the other party is not cured within a defined period of time, or upon notice for insolvency-related events of the other party that are not discharged within a defined time period. Qilu may terminate the Qilu Agreement in its entirety, at any time with at least sixty days written notice. All rights and obligations of Qilu with respect to such licensed patents and patent applications would terminate.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407496655600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Departure of Director</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 11, 2023, the Company announced that Erkki Ruoslahti, M.D., Ph.D., had decided to retire from its Board of Directors. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assignment of Tumor Penetrating Nanocomplex (TPN) platform</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 21, 2023, the Company entered into a Technology Transfer Agreement with Impilo Therapeutics, Inc. (&#8220;Impilo&#8221;), pursuant to which the Company will, subject to the satisfaction of customary closing conditions, transfer the rights to the Tumor Penetrating Nanocomplex (TPN) platform to Impilo (the &#8220;Transfer&#8221;). In exchange, on the closing date of the Transfer (the &#8220;Closing Date&#8221;) and pursuant to an Equity Purchase Agreement, by and between the Company and Impilo, to become effective on the Closing Date, Impilo will issue to the Company 768,500 shares of its pre-seed preferred stock.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495453536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#8217;s financial position as of June&#160;30, 2023, and the results of its operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2022 and 2021 included in our 2022 Form 10-K. Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that </span></div>are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values and the valuation of the Merger which was accounted for as an asset acquisition as substantially all of the fair value is concentrated in in-process research and development (&#8220;IPR&amp;D&#8221;). Accordingly, actual results could differ from those estimates and assumptions.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">Principles of ConsolidationThe Consolidated Financial Statements include the accounts of Lisata Therapeutics, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Remeasurement</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Remeasurement</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reporting currency is the U.S. Dollar. The functional currency of Lisata Therapeutics Australia Pty Ltd. which is a foreign subsidiary of the Company is the Australian Dollar. The assets and liabilities of Lisata Therapeutics Australia Pty Ltd. are translated into U.S. Dollars at the exchange rates in effect at each balance sheet date, and the results of operations are translated using the average exchange rates prevailing throughout the reporting period. Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive income (loss) in stockholders' equity.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Risks</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risks</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to credit risk from its portfolio of cash, cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. Cash is held at major banks in the United States and may exceed federally insured limits. The goals of the Company's investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In-process Research and Development Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upfront payments that relate to the acquisition of a new drug compound, as well as pre-commercial milestone payments, are immediately expensed as IPR&amp;D in the period in which they are incurred, provided that the new drug compound did not also include processes or activities that would constitute a &#8220;business&#8221; as defined under U.S. GAAP, the drug has not achieved regulatory approval for marketing and, absent obtaining such approval, has no established alternative future use. The Company accounts for contingent consideration payable upon achievement of certain regulatory, development or sales milestones in such asset acquisitions when the underlying contingency is probable and estimable. Milestone payments made to third parties subsequent to regulatory approval will be capitalized as intangible assets and amortized over the estimated remaining useful life of the related product.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Asset</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s intangible asset consists of a single asset, Cend&#8217;s license agreement with Qilu Pharmaceutical, Co., Ltd. (&#8220;Qilu&#8221;) acquired in the Merger, with a value of $0.4&#160;million. The intangible asset is stated at fair value and is amortized using the straight-line method over its estimated useful life of 5 years. Amortization expense was $18&#160;thousand for the three months ended June&#160;30, 2023 and $35&#160;thousand for the six months ended June&#160;30, 2023. The intangible asset is reviewed for potential impairment when events or circumstances indicate that carrying amounts may not be recoverable.  The projected amortization expense is $71&#160;thousand per year for the next five years. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates license and collaboration arrangements to determine whether units of account within the arrangement exhibit the characteristics of a vendor and customer relationship. For arrangements and units of account where a customer relationship exists, the Company applies the revenue recognition guidance. The Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations. At contract inception, the Company assesses the goods or services promised within each contract and assesses whether each promised good or service is distinct and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Taxes imposed by governmental authorities on the Company's revenue, such as sales taxes and withholding taxes, are excluded from net revenue.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. If licenses are bundled with other performance obligations, the Company would utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. There was no revenue recognized for the three and six months ended June&#160;30, 2023 and 2022.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Milestones</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the inception of each arrangement that includes milestone payments (variable consideration), the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company or the Company&#8217;s collaboration partner&#8217;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts the Company&#8217;s estimate of the overall transaction price. Any such adjustments are allocated on a cumulative catch-up basis to satisfied and partially satisfied performance obligations, with the consideration allocated to an ongoing performance obligation being recognized over the period of performance. For the three and six months ended June&#160;30, 2023 and June&#160;30, 2022, the Company has not recognized revenue related to milestones.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and for which the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized any royalty revenue from any collaborative arrangement.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates license and collaboration arrangements to determine whether units of account within the arrangement exhibit the characteristics of a vendor and customer relationship. For arrangements and units of account where a customer relationship exists, the Company applies the revenue recognition guidance. The Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations. At contract inception, the Company assesses the goods or services promised within each contract and assesses whether each promised good or service is distinct and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Taxes imposed by governmental authorities on the Company's revenue, such as sales taxes and withholding taxes, are excluded from net revenue.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. If licenses are bundled with other performance obligations, the Company would utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. There was no revenue recognized for the three and six months ended June&#160;30, 2023 and 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407500256624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAbstract', window );"><strong>Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionTableTextBlock', window );">Asset Acquisition</a></td>
<td class="text">The following table is a summary of the purchase price calculation (in thousands except per share data).<div style="margin-bottom:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:60.25pt"></td><td style="width:1.0pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of common shares of the combined company owned by Cend stockholders</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,772,768&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Multiplied by the fair value per share of Lisata common stock on September 15, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.25</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23,580</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of Lisata's cost method investment in Cend</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental fair value of Cend's fully vested stock options</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lisata transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#bfe4ff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$36,098</span></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The allocation of the purchase price was as follows (amounts in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:60.25pt"></td><td style="width:1.0pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,062</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net working capital (excluding cash)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,690)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired in-process research and development </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$36,098</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495505680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Available-for-Sale-Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-Sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Available-for-sale Securities Reconciliation</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of available-for-sale securities recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:507.00pt"><tr><td style="width:1.0pt"></td><td style="width:94.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:46.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Municipal debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,430&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,758&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated fair values of available-for-sale securities are generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:360.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Investments Classified by Contractual Maturity Date</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our portfolio of available-for-sale securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:361.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than one year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,430&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407494951728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:505.50pt"><tr><td style="width:1.0pt"></td><td style="width:363.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:60.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:72.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(417)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495011168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text">At June&#160;30, 2023 and 2022, the Company excluded the following potentially dilutive securities (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407494867200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text">as of June&#160;30, 2023 and December&#160;31, 2022 (in thousands):<div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:116.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:42.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities - available for sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,478&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,936&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,414&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,668&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,072&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,740&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of accounts payable and accrued expenses approximate fair value as of June&#160;30, 2023 and December&#160;31, 2022, due to the short maturity nature of these items.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407488175504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities as of June&#160;30, 2023 and December&#160;31, 2022 were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:507.75pt"><tr><td style="width:1.0pt"></td><td style="width:313.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:97.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries, employee benefits and related taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical and R&amp;D related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting &amp; tax consulting liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities &#8212; current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,581&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,728&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495400944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock', window );">Schedule of Operating Lease Liabilities and Right-of-Use Assets on Balance Sheet</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities and right-of-use assets were recorded in the following captions of our balance sheet as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:325.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-Use Assets:</span></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-542"><span style="-sec-ix-hidden:f-543">Other assets</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Right-of-Use Asset</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Lease Liabilities:</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-548"><span style="-sec-ix-hidden:f-549">Accrued liabilities</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-552"><span style="-sec-ix-hidden:f-553">Other long-term liabilities</span></span></span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Lease Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments Under Lease Agreements</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under the lease agreement as of June&#160;30, 2023 were as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:60.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amounts representing interest</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407494900256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option and Warrants Activity</a></td>
<td class="text">The following table summarizes the activity for stock options and warrants for the six months ended June&#160;30, 2023:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:22.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.952%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.127%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrants</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aggregate Intrinsic Value (In Thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aggregate Intrinsic Value (In Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,391,352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.03</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,423,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.37</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes during the period:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">175,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(82,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(142,694)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">224.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding at June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,338,734&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.79&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">376.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,421,744&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested at June 30, 2023<br/>or expected to vest in the future</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,333,367&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.82&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.43</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">373.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,421,744&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.51&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested at June 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,222,064&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.02&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">337.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,421,744&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.51&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023 and 2022, the Company issued restricted stock for services as follows (in thousands, except share data):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:483.75pt"><tr><td style="width:1.0pt"></td><td style="width:322.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:72.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:4.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of restricted stock issued</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value of restricted stock issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2023 and 2022, the Company issued restricted stock units for services as follows (in thousands, except share data):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:498.00pt"><tr><td style="width:1.0pt"></td><td style="width:343.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:72.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of restricted stock units issued</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,990&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value of restricted stock units issued </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495203424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-Based Payment Arrangement, Noncash Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule Share-based Compensation Expense</a></td>
<td class="text">The following table summarizes the components of share-based compensation expense for the three and six months ended June&#160;30, 2023 and 2022 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:44.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.386%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Total Compensation Cost Related to Nonvested Awards</a></td>
<td class="text"><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total compensation cost related to unvested awards not yet recognized and the weighted-average periods over which the awards were expected to be recognized at June&#160;30, 2023 were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.81</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value of Share-based Compensation Awards</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total fair value of shares vested and the weighted average estimated fair values of shares granted for the six months ended June&#160;30, 2023 and 2022 were as follows (in thousands):</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:378.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average estimated fair value of shares granted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495256656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The Business (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 15, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</a></td>
<td class="nump">1,227,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Sale of Stock, Percentage of Ownership after Transaction</a></td>
<td class="nump">52.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=clbs_CENDMember', window );">CEND</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Conversion ratio</a></td>
<td class="nump">0.5338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, Issued</a></td>
<td class="nump">3,772,768<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=clbs_CENDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=clbs_CENDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407496689984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net (Excluding Goodwill)</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Five</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Computer Software, Intangible Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495120768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Merger (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 15, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Number of common shares of the combined company owned by Cend stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,132,357<span></span>
</td>
<td class="nump">7,866,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=clbs_CENDMember', window );">CEND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Number of common shares of the combined company owned by Cend stockholders</a></td>
<td class="nump">3,772,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_AssetAcquisitionSharePrice', window );">Multiplied by the fair value per share of Lisata common stock on September 15, 2022</a></td>
<td class="nump">$ 6.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_AssetAcquisitionConsiderationTransferredEquityValue', window );">Total</a></td>
<td class="nump">$ 23,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Carrying value of Lisata's cost method investment in Cend</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable', window );">Incremental fair value of Cend's fully vested stock options</a></td>
<td class="nump">2,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost', window );">Lisata transaction costs</a></td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Total purchase price</a></td>
<td class="nump">36,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_AssetAcquisitionCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">7,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_AssetAcquisitionNetWorkingCapital', window );">Net working capital (excluding cash)</a></td>
<td class="num">(1,690)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_AssetAcquisitionOtherLiabilities', window );">Other liabilities</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment', window );">Acquired in-process research and development</a></td>
<td class="nump">30,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_AssetAcquisitionIntangibles', window );">License</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Acquired In-Process Research And Development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AssetAcquisitionCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Cash and Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AssetAcquisitionCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AssetAcquisitionConsiderationTransferredEquityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Consideration Transferred, Equity Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AssetAcquisitionConsiderationTransferredEquityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AssetAcquisitionIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Intangibles</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AssetAcquisitionIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AssetAcquisitionNetWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Net Working Capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AssetAcquisitionNetWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AssetAcquisitionOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AssetAcquisitionOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AssetAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Share Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AssetAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction cost incurred as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=clbs_CENDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=clbs_CENDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407493425360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">$ 53,430<span></span>
</td>
<td class="nump">$ 64,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">53,414<span></span>
</td>
<td class="nump">64,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">22,135<span></span>
</td>
<td class="nump">44,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">22,123<span></span>
</td>
<td class="nump">44,291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">10,640<span></span>
</td>
<td class="nump">7,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">10,640<span></span>
</td>
<td class="nump">7,953<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">8,309<span></span>
</td>
<td class="nump">4,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">8,309<span></span>
</td>
<td class="nump">4,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">Municipal debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">605<span></span>
</td>
<td class="nump">7,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">605<span></span>
</td>
<td class="nump">$ 7,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_BondsMember', window );">Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">4,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">4,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBillSecuritiesMember', window );">US Treasury Bill Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">6,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 6,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_BondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_BondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBillSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBillSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407496679552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-Sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 19,478<span></span>
</td>
<td class="nump">$ 27,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">33,936<span></span>
</td>
<td class="nump">37,072<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Total</a></td>
<td class="nump">$ 53,414<span></span>
</td>
<td class="nump">$ 64,740<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495258736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis', window );">Less than one year</a></td>
<td class="nump">$ 53,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">Greater than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">53,430<span></span>
</td>
<td class="nump">$ 64,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue', window );">Less than one year</a></td>
<td class="nump">53,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">Greater than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total estimated fair value</a></td>
<td class="nump">$ 53,414<span></span>
</td>
<td class="nump">$ 64,740<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407486211488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(428)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(417)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495590992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income (Loss) Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">1,339<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">1,422<span></span>
</td>
<td class="nump">1,424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407488844976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 19,478<span></span>
</td>
<td class="nump">$ 27,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">33,936<span></span>
</td>
<td class="nump">37,072<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">53,414<span></span>
</td>
<td class="nump">64,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">19,478<span></span>
</td>
<td class="nump">27,668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">19,478<span></span>
</td>
<td class="nump">27,668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">33,936<span></span>
</td>
<td class="nump">37,072<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">33,936<span></span>
</td>
<td class="nump">37,072<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407491224464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Salaries, employee benefits and related taxes</a></td>
<td class="nump">$ 2,125<span></span>
</td>
<td class="nump">$ 2,586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities &#8212; current</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_AccruedGrantFunding', window );">Accounting &amp; tax consulting liabilities</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_ClinicalAndRDRelatedLiabilities', window );">Clinical and R&amp;D related liabilities</a></td>
<td class="nump">924<span></span>
</td>
<td class="nump">785<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 3,581<span></span>
</td>
<td class="nump">$ 3,728<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AccruedGrantFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Grant Funding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AccruedGrantFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_ClinicalAndRDRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Clinical and R&amp;D Related Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_ClinicalAndRDRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407488757040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term for operating leases (in years)</a></td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">1 year 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate for operating leases (percent)</a></td>
<td class="nump">9.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407493414304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Balance Sheet Presentation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_OperatingLeaseRightOfUseAssetAbstract', window );"><strong>Right-of-Use Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">$ 387<span></span>
</td>
<td class="nump">$ 487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Right-of-use assets, balance sheet line item</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Operating Lease Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, noncurrent</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">$ 383<span></span>
</td>
<td class="nump">$ 485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating lease liabilities, current, balance sheet line item</a></td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating lease liabilities, noncurrent, balance sheet line item</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OperatingLeaseRightOfUseAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OperatingLeaseRightOfUseAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495230736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Future Minimum Lease Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Minimum Lease Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Amounts representing interest</a></td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 383<span></span>
</td>
<td class="nump">$ 485<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407489011968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Equity Issuances (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 15, 2022</div></th>
<th class="th"><div>Jun. 04, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Number of common shares of the combined company owned by Cend stockholders</a></td>
<td class="nump">8,132,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,866,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">$ 297,000<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=clbs_CENDMember', window );">CEND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Number of common shares of the combined company owned by Cend stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,772,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_AtTheMarketOfferingAgreementMember', window );">ATM Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement', window );">Aggregate offering amount authorized per agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common Stock, Value, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_SaleOfStockAvailableForSale', window );">Sale of Stock Available for Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,698,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued (shares)</a></td>
<td class="nump">64,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">$ 270,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockAvailableForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock Available for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockAvailableForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=clbs_CENDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=clbs_CENDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_AtTheMarketOfferingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_AtTheMarketOfferingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407496528624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Options and Warrants (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Stock Options, Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options, Outstanding, Beginning of Period (in shares)</a></td>
<td class="nump">1,391,352<span></span>
</td>
<td class="nump">1,391,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options, Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options, Exercised (in shares)</a></td>
<td class="num">(1,227,776)<span></span>
</td>
<td class="num">(82,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options, Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(142,694)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options, Expired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,520)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options, Outstanding, End of Period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,338,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options, Vested and expected to vest (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,333,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options, Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,222,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Stock Options, Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options, Outstanding. Beginning of Period (in dollars per share)</a></td>
<td class="nump">$ 10.83<span></span>
</td>
<td class="nump">$ 10.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options, Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options, Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options, Forfeited (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Options, Expired (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options, Outstanding, End of Period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options, Vested and expected to vest (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Options, Vested (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Stock Options, Weighted Average Contractual Term and Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">7 years 10 days<span></span>
</td>
<td class="text">6 years 5 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options, Vested and expected to vest, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 5 months 4 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_OptionsVestedweightedAverageRemainingContractualTerm', window );">Options, Vested, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 2 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 376,100<span></span>
</td>
<td class="nump">$ 187,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Options, Vested and expected to vest, Aggregate Intrinsic Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Options, Vested, Aggregate Intrinsic Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 337,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Warrants, Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CommonStockWarrantsShares', window );">Warrants, Outstanding, Beginning of Period (in shares)</a></td>
<td class="nump">1,423,774<span></span>
</td>
<td class="nump">1,423,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WarrantsGranted', window );">Warrants, Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WarrantsExercised', window );">Warrants, Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WarrantsCanceled', window );">Warrants, Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WarrantsExpired', window );">Warrants, Expired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CommonStockWarrantsShares', window );">Warrants, Outstanding, End of Period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,421,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_Sharesvestedandexpectedtovest', window );">Warrants, Vested and expected to vest (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,421,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WarrantsVested', window );">Warrants, Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,421,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WarrantsWeightedAverageExercisePriceRollForward', window );"><strong>Warrants, Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsOutstanding', window );">Warrants Outstanding, Beginning of Period (in dollars per share)</a></td>
<td class="nump">$ 42.57<span></span>
</td>
<td class="nump">$ 42.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsGranted', window );">Warrants, Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsExercised', window );">Warrants, Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsCanceled', window );">Warrants, Forfeited (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsExpired', window );">Warrants, Expired (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsOutstanding', window );">Warrants Outstanding, End of Period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest', window );">Weighted Average Exercise Price, Warrants Vested And Expected To Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsExercisable', window );">Warrants, Vested, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WarrantsOtherDisclosuresAbstract', window );"><strong>Warrants, Weighted Average Contractual Term and Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding', window );">Warrants, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">3 years 4 months 13 days<span></span>
</td>
<td class="text">3 years 2 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest', window );">Warrants, Vested and expected to vest, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 2 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_WeightedAverageRemainingContractualTermwarrantsvested', window );">Warrants, Vested, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 2 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_AggregateIntrinsicValueWarrantsOutstanding', window );">Warrants Outstanding, Aggregate Intrinsic Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest', window );">Warrants, Vested and expected to vest, Aggregate Intrinsic Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_AggregateIntrinsicValueWarrantsvested', window );">Warrants, Vested, Aggregate Intrinsic Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateIntrinsicValueWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateIntrinsicValueWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateIntrinsicValueWarrantsvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Warrants vested</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateIntrinsicValueWarrantsvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Warrants vested and expected to vest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_CommonStockWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock Warrants, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_CommonStockWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OptionsVestedweightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Options, Vested, weighted Average Remaining Contractual Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OptionsVestedweightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_Sharesvestedandexpectedtovest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>shares, vested and expected to vest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_Sharesvestedandexpectedtovest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsCanceled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Canceled</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsCanceled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Expired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Other Disclosures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants, Vested</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsWeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Weighted Average Exercise Price [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsWeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsCanceled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Canceled</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsCanceled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Exercisable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Expired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Vested And Expected To Vest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Term warrant outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageRemainingContractualTermwarrantoutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageRemainingContractualTermwarrantsvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>weighted Average Remaining Contractual Term, warrants vested</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageRemainingContractualTermwarrantsvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407488798240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Restricted Stock and Restricted Stock Units (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of shares issued</a></td>
<td class="nump">159,950<span></span>
</td>
<td class="nump">70,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Value of shares issued</a></td>
<td class="nump">$ 480<span></span>
</td>
<td class="nump">$ 973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value</a></td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="nump">$ 13.76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting terms (years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting terms (years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of shares issued</a></td>
<td class="nump">188,850<span></span>
</td>
<td class="nump">91,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Value of shares issued</a></td>
<td class="nump">$ 567<span></span>
</td>
<td class="nump">$ 1,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting terms (years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495090480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Share-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 584<span></span>
</td>
<td class="nump">$ 367<span></span>
</td>
<td class="nump">$ 1,258<span></span>
</td>
<td class="nump">$ 1,128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 844<span></span>
</td>
<td class="nump">$ 769<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 357<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407496698896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Compensation Cost Not Yet Recognized (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">1 year 7 months 17 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">1 year 21 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">1 year 9 months 21 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407488234400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (Details) - Stock Options - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value of shares vested</a></td>
<td class="nump">$ 641<span></span>
</td>
<td class="nump">$ 385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value of shares granted</a></td>
<td class="nump">$ 2.11<span></span>
</td>
<td class="nump">$ 0.61<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407493157616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 05, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 15, 2022</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 344,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition', window );">Unrecognized Tax Benefits, Increase Resulting from Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 344,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_ProceedsFromSaleOfNOLS', window );">Proceeds From Sale of NOLS</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="num">$ (2,330,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (2,330,000)<span></span>
</td>
<td class="num">$ (2,479,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_LossOnSaleOfNOL', window );">Loss On Sale of NOL</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=clbs_CENDMember', window );">CEND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.54%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_FairValueMarketOfTaxNOLs', window );">Fair Value Market of Tax NOLs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_OperatingLossCarryforwardsBeforeWriteDown', window );">Net operating loss carryforwards, prior to write down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,300,000<span></span>
</td>
<td class="nump">281,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | CEND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,900,000<span></span>
</td>
<td class="nump">$ 10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_OperatingLossCarryforwardsPostAcquisition', window );">Operating Loss Carryforwards, Post Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority | CEND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | CEND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | New Jersey</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_FairValueMarketOfTaxNOLs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Market of Tax NOLs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_FairValueMarketOfTaxNOLs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_LossOnSaleOfNOL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss On Sale of NOL</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_LossOnSaleOfNOL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OperatingLossCarryforwardsBeforeWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Before Write Down</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OperatingLossCarryforwardsBeforeWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OperatingLossCarryforwardsPostAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Post Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OperatingLossCarryforwardsPostAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_ProceedsFromSaleOfNOLS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale of NOLS</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_ProceedsFromSaleOfNOLS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=clbs_CENDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=clbs_CENDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407488764880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Australia Research and Development Tax Incentive (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayLineItems', window );"><strong>Income Tax Holiday [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_IncomeTaxIncentiveReceivable', window );">Income Tax Incentive Receivable</a></td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayLineItems', window );"><strong>Income Tax Holiday [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research tax credit rate</a></td>
<td class="nump">43.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayLineItems', window );"><strong>Income Tax Holiday [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research tax credit rate</a></td>
<td class="nump">48.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_IncomeTaxIncentiveReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Incentive Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_IncomeTaxIncentiveReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxHolidayLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxHolidayLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407488504384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>License Agreements (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale', window );">Annual license maintenance fee, after first sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=clbs_SanfordBurnhamPrebysMember', window );">Sanford Burnham Prebys | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_SharesIssuedUnderLicenseAgreement', window );">Shares issued under license agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee', window );">Annual license maintenance fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven', window );">Annual license maintenance fee, year seven</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct', window );">Potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,200,000<span></span>
</td>
<td class="nump">$ 10,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales', window );">Royalties, net of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees', window );">Sublicensing fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour', window );">Annual license maintenance fee, year four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_SharesHeldByThirdParty', window );">Shares held by third party</a></td>
<td class="nump">382,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=clbs_SanfordBurnhamPrebysMember', window );">Sanford Burnham Prebys | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees', window );">Sublicensing fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=clbs_SanfordBurnhamPrebysMember', window );">Sanford Burnham Prebys | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees', window );">Sublicensing fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=clbs_UniversityOfCaliforniaAtSanDiegoMember', window );">University of California at San Diego | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct', window );">Potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales', window );">Royalties, net of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=clbs_UniversityOfCaliforniaAtSanDiegoMember', window );">University of California at San Diego | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees', window );">Sublicensing fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=clbs_UniversityOfCaliforniaAtSanDiegoMember', window );">University of California at San Diego | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees', window );">Sublicensing fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=clbs_MassachusettsInstituteOfTechnologyMember', window );">Massachusetts Institute of Technology | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee', window );">Annual license maintenance fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct', window );">Potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales', window );">Royalties, net of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour', window );">Annual license maintenance fee, year four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_SharesHeldByThirdParty', window );">Shares held by third party</a></td>
<td class="nump">43,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree', window );">Annual license maintenance fee, years two and three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee', window );">Change of control fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=clbs_MassachusettsInstituteOfTechnologyMember', window );">Massachusetts Institute of Technology | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees', window );">Sublicensing fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=clbs_MassachusettsInstituteOfTechnologyMember', window );">Massachusetts Institute of Technology | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees', window );">Sublicensing fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee After First Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Starting at Year Seven</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Year Two and Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Change of Control Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Royalties Net of Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Sublicensing Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SharesHeldByThirdParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Held by Third Party</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SharesHeldByThirdParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SharesIssuedUnderLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Issued Under License Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SharesIssuedUnderLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=clbs_SanfordBurnhamPrebysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=clbs_SanfordBurnhamPrebysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=clbs_UniversityOfCaliforniaAtSanDiegoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=clbs_UniversityOfCaliforniaAtSanDiegoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=clbs_MassachusettsInstituteOfTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=clbs_MassachusettsInstituteOfTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407495091488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Research Collaboration and License Agreement (Details) - Qilu - License - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 14, 2022</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer', window );">Revenue from contract</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=clbs_QiluMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount', window );">Variable consideration amounts, milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_RevenuePerformanceObligationPercentageOfNetSale', window );">Percentage of net sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues', window );">Percentage of sublicensing revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=clbs_QiluMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount', window );">Variable consideration amounts, milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_RevenuePerformanceObligationPercentageOfNetSale', window );">Percentage of net sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues', window );">Percentage of sublicensing revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_RevenuePerformanceObligationPercentageOfNetSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Performance Obligation, Percentage of Net Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_RevenuePerformanceObligationPercentageOfNetSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Performance Obligation, Percentage of Sublicensing Revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Variable Consideration Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479428/808-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=clbs_QiluMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=clbs_QiluMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140407486177104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details)<br></strong></div></th>
<th class="th">
<div>Jul. 21, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Impilo</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Investment Owned, Balance, Shares</a></td>
<td class="nump">768,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of investment owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=clbs_ImpiloMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=clbs_ImpiloMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>clbs-20230630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:clbs="http://www.caladrius.com/20230630"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="clbs-20230630.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2023-08-14</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">clbs:CENDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-15</startDate>
            <endDate>2022-09-15</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">clbs:CENDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-15</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2022-09-15</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2022-09-15</startDate>
            <endDate>2022-09-15</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:BondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-04</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">clbs:CENDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">clbs:CENDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-15</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">clbs:CENDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-15</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">clbs:CENDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">clbs:CENDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2023-04-05</startDate>
            <endDate>2023-04-05</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:SanfordBurnhamPrebysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:SanfordBurnhamPrebysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:SanfordBurnhamPrebysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:SanfordBurnhamPrebysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:SanfordBurnhamPrebysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:UniversityOfCaliforniaAtSanDiegoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:UniversityOfCaliforniaAtSanDiegoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:UniversityOfCaliforniaAtSanDiegoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:QiluMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:QiluMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-14</startDate>
            <endDate>2022-09-14</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:QiluMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:QiluMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">clbs:ImpiloMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-21</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-25">0000320017</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-26">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-27">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-28">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-29">false</dei:AmendmentFlag>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-542">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-3" id="f-543">http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-3" id="f-548">http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-3" id="f-549">http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-3" id="f-552">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-3" id="f-553">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-113" id="f-633">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-33650</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">LISATA THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">22-2343568</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">110 Allen Road, 2nd Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Basking Ridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">07920</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">908</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">842-0100</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">LSTA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">8142357</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-30" unitRef="usd">23690000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-31" unitRef="usd">32154000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities contextRef="c-3" decimals="-3" id="f-32" unitRef="usd">33936000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">37072000</us-gaap:MarketableSecurities>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-34" unitRef="usd">3797000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-35" unitRef="usd">2650000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-36" unitRef="usd">61423000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-37" unitRef="usd">71876000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-38" unitRef="usd">233000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-39" unitRef="usd">296000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-3" decimals="-3" id="f-40" unitRef="usd">299000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-41" unitRef="usd">334000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-3" id="f-42" unitRef="usd">410000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">528000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-44" unitRef="usd">62365000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-45" unitRef="usd">73034000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-46" unitRef="usd">775000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-47" unitRef="usd">2655000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-48" unitRef="usd">3581000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-49" unitRef="usd">3728000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-50" unitRef="usd">4356000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-51" unitRef="usd">6383000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-3" id="f-52" unitRef="usd">295000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">327000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-54" unitRef="usd">4651000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">6710000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-56" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-57" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-58"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-59"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-60" unitRef="shares">33333333</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-61" unitRef="shares">33333333</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-62" unitRef="shares">8133095</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-63" unitRef="shares">7866799</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-64" unitRef="shares">8132357</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-65" unitRef="shares">7866061</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-66" unitRef="usd">8000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">8000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-3" decimals="-3" id="f-68" unitRef="usd">576173000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">574548000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="INF" id="f-70" unitRef="shares">738</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-3" decimals="INF" id="f-71" unitRef="shares">738</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-3" decimals="-3" id="f-72" unitRef="usd">708000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="-3" id="f-73" unitRef="usd">708000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-74" unitRef="usd">-517455000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">-507241000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-76" unitRef="usd">-50000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-77" unitRef="usd">-29000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-78" unitRef="usd">57968000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-79" unitRef="usd">66578000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-3" decimals="-3" id="f-80" unitRef="usd">-254000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-4" decimals="-3" id="f-81" unitRef="usd">-254000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-3" id="f-82" unitRef="usd">57714000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-83" unitRef="usd">66324000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-84" unitRef="usd">62365000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-85" unitRef="usd">73034000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-5" decimals="-3" id="f-86" unitRef="usd">3162000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-6" decimals="-3" id="f-87" unitRef="usd">3234000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-1" decimals="-3" id="f-88" unitRef="usd">6341000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="c-7" decimals="-3" id="f-89" unitRef="usd">6516000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-90" unitRef="usd">3713000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-91" unitRef="usd">3486000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-92" unitRef="usd">7378000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-7" decimals="-3" id="f-93" unitRef="usd">6824000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-5" decimals="-3" id="f-94" unitRef="usd">6875000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-6" decimals="-3" id="f-95" unitRef="usd">6720000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-96" unitRef="usd">13719000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-7" decimals="-3" id="f-97" unitRef="usd">13340000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-3" id="f-98" unitRef="usd">-6875000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-3" id="f-99" unitRef="usd">-6720000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-100" unitRef="usd">-13719000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-3" id="f-101" unitRef="usd">-13340000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNet contextRef="c-5" decimals="-3" id="f-102" unitRef="usd">668000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c-6" decimals="-3" id="f-103" unitRef="usd">94000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c-1" decimals="-3" id="f-104" unitRef="usd">1338000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c-7" decimals="-3" id="f-105" unitRef="usd">158000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-106" unitRef="usd">-150000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-107" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-108" unitRef="usd">-163000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-109" unitRef="usd">-149000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-110" unitRef="usd">518000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-111" unitRef="usd">94000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-112" unitRef="usd">1175000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-113" unitRef="usd">9000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-114" unitRef="usd">-6357000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-115" unitRef="usd">-6626000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-116" unitRef="usd">-12544000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-3" id="f-117" unitRef="usd">-13331000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-118" unitRef="usd">-2330000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-119" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-120" unitRef="usd">-2330000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-3" id="f-121" unitRef="usd">-2479000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-122" unitRef="usd">-4027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-123" unitRef="usd">-6626000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-124" unitRef="usd">-10214000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-125" unitRef="usd">-10852000</us-gaap:ProfitLoss>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="c-5" decimals="-3" id="f-126" unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="c-6" decimals="-3" id="f-127" unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="c-1" decimals="-3" id="f-128" unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="c-7" decimals="-3" id="f-129" unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-130" unitRef="usd">-4027000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-131" unitRef="usd">-6626000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-132" unitRef="usd">-10214000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-133" unitRef="usd">-10852000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-134"
      unitRef="usdPerShare">-0.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-135"
      unitRef="usdPerShare">-0.50</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-136"
      unitRef="usdPerShare">-1.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-137"
      unitRef="usdPerShare">-1.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-138"
      unitRef="usdPerShare">-1.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-139"
      unitRef="usdPerShare">-1.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-140"
      unitRef="usdPerShare">-2.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-141"
      unitRef="usdPerShare">-2.69</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-3" id="f-142" unitRef="shares">8021000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-3" id="f-143" unitRef="shares">8021000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-3" id="f-144" unitRef="shares">4035000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-3" id="f-145" unitRef="shares">4035000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-146" unitRef="shares">8004000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-147" unitRef="shares">8004000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-3" id="f-148" unitRef="shares">4036000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-3" id="f-149" unitRef="shares">4036000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-150" unitRef="usd">-4027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-151" unitRef="usd">-6626000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-152" unitRef="usd">-10214000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-153" unitRef="usd">-10852000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-5" decimals="-3" id="f-154" unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-6" decimals="-3" id="f-155" unitRef="usd">126000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-156" unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-7" decimals="-3" id="f-157" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-5" decimals="-3" id="f-158" unitRef="usd">-10000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-6" decimals="-3" id="f-159" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-160" unitRef="usd">-22000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-7" decimals="-3" id="f-161" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-3" id="f-162" unitRef="usd">2000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-6" decimals="-3" id="f-163" unitRef="usd">126000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-3" id="f-164" unitRef="usd">-21000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-7" decimals="-3" id="f-165" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-166" unitRef="usd">-4025000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-167" unitRef="usd">-6500000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-168" unitRef="usd">-10235000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-3" id="f-169" unitRef="usd">-10852000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="-3" id="f-170" unitRef="shares">4035000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-8" decimals="-3" id="f-171" unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-9" decimals="-3" id="f-172" unitRef="usd">546637000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-10" decimals="-3" id="f-173" unitRef="usd">-196000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-11" decimals="-3" id="f-174" unitRef="usd">-457242000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-12" decimals="-3" id="f-175" unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-13" decimals="-3" id="f-176" unitRef="usd">88495000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-14" decimals="-3" id="f-177" unitRef="usd">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-15" decimals="-3" id="f-178" unitRef="usd">88241000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-16" decimals="-3" id="f-179" unitRef="usd">-6626000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-17" decimals="-3" id="f-180" unitRef="usd">-6626000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-181" unitRef="usd">-6626000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-18" decimals="-3" id="f-182" unitRef="shares">-1000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-19" decimals="-3" id="f-183" unitRef="usd">367000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-17" decimals="-3" id="f-184" unitRef="usd">367000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-6" decimals="-3" id="f-185" unitRef="usd">367000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-18" decimals="-3" id="f-186" unitRef="shares">4000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-19" decimals="-3" id="f-187" unitRef="usd">29000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-17" decimals="-3" id="f-188" unitRef="usd">29000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-17" decimals="-3" id="f-189" unitRef="usd">29000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-20" decimals="-3" id="f-190" unitRef="usd">126000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-17" decimals="-3" id="f-191" unitRef="usd">126000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-6" decimals="-3" id="f-192" unitRef="usd">126000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-21" decimals="-3" id="f-193" unitRef="shares">4038000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-21" decimals="-3" id="f-194" unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-22" decimals="-3" id="f-195" unitRef="usd">547033000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-23" decimals="-3" id="f-196" unitRef="usd">-70000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-24" decimals="-3" id="f-197" unitRef="usd">-463868000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-3" id="f-198" unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-3" id="f-199" unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-26" decimals="-3" id="f-200" unitRef="usd">82391000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-3" id="f-201" unitRef="usd">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-3" id="f-202" unitRef="usd">82137000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-29" decimals="-3" id="f-203" unitRef="shares">3986000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-3" id="f-204" unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-3" id="f-205" unitRef="usd">546044000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="-3" id="f-206" unitRef="usd">-70000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-32" decimals="-3" id="f-207" unitRef="usd">-453016000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-33" decimals="-3" id="f-208" unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-34" decimals="-3" id="f-209" unitRef="usd">92254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-35" decimals="-3" id="f-210" unitRef="usd">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-36" decimals="-3" id="f-211" unitRef="usd">92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-37" decimals="-3" id="f-212" unitRef="usd">-10852000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-38" decimals="-3" id="f-213" unitRef="usd">-10852000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-214" unitRef="usd">-10852000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-39" decimals="-3" id="f-215" unitRef="shares">48000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-40" decimals="-3" id="f-216" unitRef="usd">960000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-38" decimals="-3" id="f-217" unitRef="usd">960000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-7" decimals="-3" id="f-218" unitRef="usd">960000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-39" decimals="-3" id="f-219" unitRef="shares">4000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-40" decimals="-3" id="f-220" unitRef="usd">29000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-38" decimals="-3" id="f-221" unitRef="usd">29000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-7" decimals="-3" id="f-222" unitRef="usd">29000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-21" decimals="-3" id="f-223" unitRef="shares">4038000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-21" decimals="-3" id="f-224" unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-22" decimals="-3" id="f-225" unitRef="usd">547033000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-23" decimals="-3" id="f-226" unitRef="usd">-70000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-24" decimals="-3" id="f-227" unitRef="usd">-463868000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-3" id="f-228" unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-26" decimals="-3" id="f-229" unitRef="usd">82391000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-3" id="f-230" unitRef="usd">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-3" id="f-231" unitRef="usd">82137000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-41" decimals="-3" id="f-232" unitRef="shares">7999000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-41" decimals="-3" id="f-233" unitRef="shares">7999000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-41" decimals="-3" id="f-234" unitRef="usd">8000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-41" decimals="-3" id="f-235" unitRef="usd">8000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-42" decimals="-3" id="f-236" unitRef="usd">575137000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-42" decimals="-3" id="f-237" unitRef="usd">575137000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-43" decimals="-3" id="f-238" unitRef="usd">-52000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-43" decimals="-3" id="f-239" unitRef="usd">-52000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-44" decimals="-3" id="f-240" unitRef="usd">-513428000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-45" decimals="-3" id="f-241" unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-45" decimals="-3" id="f-242" unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-46" decimals="-3" id="f-243" unitRef="usd">60957000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-46" decimals="-3" id="f-244" unitRef="usd">60957000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-47" decimals="-3" id="f-245" unitRef="usd">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-47" decimals="-3" id="f-246" unitRef="usd">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-48" decimals="-3" id="f-247" unitRef="usd">60703000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-48" decimals="-3" id="f-248" unitRef="usd">60703000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-49" decimals="-3" id="f-249" unitRef="usd">-4027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-50" decimals="-3" id="f-250" unitRef="usd">-4027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-50" decimals="-3" id="f-251" unitRef="usd">-4027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-252" unitRef="usd">-4027000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-253" unitRef="usd">-4027000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-51" decimals="-3" id="f-254" unitRef="shares">-25000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-52" decimals="-3" id="f-255" unitRef="usd">584000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-50" decimals="-3" id="f-256" unitRef="usd">584000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-5" decimals="-3" id="f-257" unitRef="usd">584000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-51" decimals="-3" id="f-258" unitRef="shares">76000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-52" decimals="-3" id="f-259" unitRef="usd">297000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-50" decimals="-3" id="f-260" unitRef="usd">297000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-5" decimals="-3" id="f-261" unitRef="usd">297000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-51" decimals="-3" id="f-262" unitRef="shares">83000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-52" decimals="-3" id="f-263" unitRef="usd">155000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-50" decimals="-3" id="f-264" unitRef="usd">155000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-5" decimals="-3" id="f-265" unitRef="usd">155000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-53" decimals="-3" id="f-266" unitRef="usd">-10000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-50" decimals="-3" id="f-267" unitRef="usd">-10000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-5" decimals="-3" id="f-268" unitRef="usd">-10000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-53" decimals="-3" id="f-269" unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-53" decimals="-3" id="f-270" unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-50" decimals="-3" id="f-271" unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-50" decimals="-3" id="f-272" unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-5" decimals="-3" id="f-273" unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-5" decimals="-3" id="f-274" unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-54" decimals="-3" id="f-275" unitRef="shares">8133000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-54" decimals="-3" id="f-276" unitRef="shares">8133000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-54" decimals="-3" id="f-277" unitRef="usd">8000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-54" decimals="-3" id="f-278" unitRef="usd">8000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-55" decimals="-3" id="f-279" unitRef="usd">576173000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-55" decimals="-3" id="f-280" unitRef="usd">576173000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-56" decimals="-3" id="f-281" unitRef="usd">-50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-56" decimals="-3" id="f-282" unitRef="usd">-50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-57" decimals="-3" id="f-283" unitRef="usd">-517455000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-57" decimals="-3" id="f-284" unitRef="usd">-517455000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-58" decimals="-3" id="f-285" unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-58" decimals="-3" id="f-286" unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-59" decimals="-3" id="f-287" unitRef="usd">57968000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-59" decimals="-3" id="f-288" unitRef="usd">57968000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-60" decimals="-3" id="f-289" unitRef="usd">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-60" decimals="-3" id="f-290" unitRef="usd">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-3" id="f-291" unitRef="usd">57714000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-3" id="f-292" unitRef="usd">57714000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-61" decimals="-3" id="f-293" unitRef="shares">7867000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-61" decimals="-3" id="f-294" unitRef="usd">8000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-62" decimals="-3" id="f-295" unitRef="usd">574548000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-63" decimals="-3" id="f-296" unitRef="usd">-29000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-64" decimals="-3" id="f-297" unitRef="usd">-507241000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-65" decimals="-3" id="f-298" unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-66" decimals="-3" id="f-299" unitRef="usd">66578000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-67" decimals="-3" id="f-300" unitRef="usd">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-301" unitRef="usd">66324000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-68" decimals="-3" id="f-302" unitRef="usd">-10214000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-69" decimals="-3" id="f-303" unitRef="usd">-10214000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-304" unitRef="usd">-10214000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-70" decimals="-3" id="f-305" unitRef="shares">107000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-71" decimals="-3" id="f-306" unitRef="usd">1173000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-69" decimals="-3" id="f-307" unitRef="usd">1173000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-3" id="f-308" unitRef="usd">1173000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-70" decimals="-3" id="f-309" unitRef="shares">76000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-71" decimals="-3" id="f-310" unitRef="usd">297000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-69" decimals="-3" id="f-311" unitRef="usd">297000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-1" decimals="-3" id="f-312" unitRef="usd">297000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-70" decimals="-3" id="f-313" unitRef="shares">83000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-71" decimals="-3" id="f-314" unitRef="usd">155000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-69" decimals="-3" id="f-315" unitRef="usd">155000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-316" unitRef="usd">155000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-72" decimals="-3" id="f-317" unitRef="usd">-22000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-318" unitRef="usd">-22000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-319" unitRef="usd">-22000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-72" decimals="-3" id="f-320" unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-69" decimals="-3" id="f-321" unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-322" unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-54" decimals="-3" id="f-323" unitRef="shares">8133000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-54" decimals="-3" id="f-324" unitRef="usd">8000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-55" decimals="-3" id="f-325" unitRef="usd">576173000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-56" decimals="-3" id="f-326" unitRef="usd">-50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-57" decimals="-3" id="f-327" unitRef="usd">-517455000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-58" decimals="-3" id="f-328" unitRef="usd">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-59" decimals="-3" id="f-329" unitRef="usd">57968000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-60" decimals="-3" id="f-330" unitRef="usd">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-3" id="f-331" unitRef="usd">57714000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-332" unitRef="usd">-10214000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-333" unitRef="usd">-10852000</us-gaap:ProfitLoss>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-1" decimals="-3" id="f-334" unitRef="usd">1258000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-7" decimals="-3" id="f-335" unitRef="usd">1128000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-336" unitRef="usd">95000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-7" decimals="-3" id="f-337" unitRef="usd">14000</us-gaap:DepreciationAndAmortization>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-1" decimals="-3" id="f-338" unitRef="usd">-3000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-7" decimals="-3" id="f-339" unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-1" decimals="-3" id="f-340" unitRef="usd">426000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-7" decimals="-3" id="f-341" unitRef="usd">-900000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-342" unitRef="usd">1161000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-7" decimals="-3" id="f-343" unitRef="usd">744000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-1" decimals="-3" id="f-344" unitRef="usd">-117000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-7" decimals="-3" id="f-345" unitRef="usd">-118000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities contextRef="c-1" decimals="-3" id="f-346" unitRef="usd">-2052000</clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities>
    <clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities contextRef="c-7" decimals="-3" id="f-347" unitRef="usd">-1268000</clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-348" unitRef="usd">-12380000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-3" id="f-349" unitRef="usd">-10704000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-1" decimals="-3" id="f-350" unitRef="usd">60836000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-7" decimals="-3" id="f-351" unitRef="usd">30291000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-1" decimals="-3" id="f-352" unitRef="usd">64400000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-7" decimals="-3" id="f-353" unitRef="usd">60070000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-1" decimals="-3" id="f-354" unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-7" decimals="-3" id="f-355" unitRef="usd">10000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-356" unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-7" decimals="-3" id="f-357" unitRef="usd">235000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-358" unitRef="usd">3564000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-3" id="f-359" unitRef="usd">19544000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <clbs:ProceedsFromExerciseOfOptionsFinancingActivities contextRef="c-1" decimals="-3" id="f-360" unitRef="usd">155000</clbs:ProceedsFromExerciseOfOptionsFinancingActivities>
    <clbs:ProceedsFromExerciseOfOptionsFinancingActivities contextRef="c-7" decimals="-3" id="f-361" unitRef="usd">0</clbs:ProceedsFromExerciseOfOptionsFinancingActivities>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-362" unitRef="usd">85000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-7" decimals="-3" id="f-363" unitRef="usd">168000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-364" unitRef="usd">297000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-7" decimals="-3" id="f-365" unitRef="usd">29000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-366" unitRef="usd">367000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-3" id="f-367" unitRef="usd">-139000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-368" unitRef="usd">-15000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-3" id="f-369" unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-370" unitRef="usd">-8464000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-3" id="f-371" unitRef="usd">8701000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-372" unitRef="usd">32154000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-36" decimals="-3" id="f-373" unitRef="usd">24647000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-374" unitRef="usd">23690000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-28" decimals="-3" id="f-375" unitRef="usd">33348000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <clbs:BusinessTextBlock contextRef="c-1" id="f-376">The Business&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lisata Therapeutics, Inc. (together with its subsidiaries, the &#x201c;Company&#x201d;) is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. The Company's lead investigational product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to penetrate solid tumors more effectively. LSTA1 actuates this active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs more efficiently penetrating and accumulating in the tumor, while normal tissues are not expected to be affected. LSTA1 also has the potential to modify the tumor microenvironment (&#x201c;TME&#x201d;), thereby making tumors more susceptible to immunotherapies. The Company and its collaborators have amassed significant non-clinical data demonstrating enhanced delivery of a range of existing and emerging anti-cancer therapies, including chemotherapeutics, immunotherapies and RNA-based therapeutics. To date, LSTA1 has also demonstrated favorable safety, tolerability and activity in completed and ongoing clinical trials designed to enhance delivery of standard-of-care chemotherapy for pancreatic cancer. The Company is exploring the potential of LSTA1 to enable a variety of treatment modalities to treat a range of solid tumors more effectively. In addition, the Company has development programs based on its autologous CD34+ cell therapy technology platform that it is seeking to partner while incurring no additional capital outlay.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's leadership team has decades of collective biopharmaceutical and pharmaceutical product development experience across a variety of therapeutic categories and at all stages of development from preclinical through to product registration and launch. Its goal is to develop and commercialize products that address important unmet medical needs. The Company&#x2019;s current development pipeline includes: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;LSTA1, the subject of Phase 1b/2a and 2b clinical studies being conducted globally in a variety of solid tumor types, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a variety of anti-cancer regimens.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Merger with Cend Therapeutics, Inc. and Name Change&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 15, 2022, the Company, then operating as Caladrius Biosciences, Inc. (&#x201c;Caladrius&#x201d;), completed its acquisition of Cend Therapeutics, Inc. (&#x201c;Cend&#x201d;), a Delaware corporation (the &#x201c;Merger&#x201d;), in accordance with the terms of the Agreement and Plan of Merger and Reorganization (the &#x201c;Merger Agreement&#x201d;), dated as of April 26, 2022, by and among Caladrius, Cend and CS Cedar Merger Sub, Inc. (&#x201c;Merger Sub&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the terms set forth in the Merger Agreement and effective September 15, 2022 (the &#x201c;Effective Time&#x201d;): (i) Merger Sub merged with and into Cend, with Cend surviving as a wholly owned subsidiary of Caladrius, (ii) Caladrius changed its name to Lisata Therapeutics, Inc., and (iii) Caladrius effected a 1:15 reverse stock split of its common stock (&#x201c;Reverse Stock Split&#x201d;) prior to the Effective Time. At the Effective Time, each share of Cend's common stock outstanding immediately prior to the Effective Time was converted into the right to receive shares of Lisata&#x2019;s common stock based on an exchange ratio of 0.5338, after taking into account the Reverse Stock Split (the &#x201c;Exchange Ratio&#x201d;). In connection with the Merger close, the Company issued an aggregate of 3,772,768 shares of common stock, based on the Exchange Ratio, to holders of Cend, in exchange for all of the Cend capital stock outstanding immediately prior to the closing of the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Merger Agreement, Lisata assumed all of the outstanding and unexercised options to purchase shares of Cend capital stock under the 2016 Equity Incentive Plan (the &#x201c;Cend Plan&#x201d;), and, in connection with the Merger, such options were converted into options to purchase shares of Lisata&#x2019;s common stock based on the Exchange Ratio. At the closing of the Merger at the Effective Time, the Company assumed Cend's stock options to purchase an aggregate of 1,227,776 shares of the Company's common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Caladrius was considered to be the accounting acquirer based on the terms of the Merger Agreement and certain factors including: (i) Caladrius owned approximately 52% of the Company's outstanding shares of common stock immediately following the close of the Merger; (ii) although both entities contributed to the new management team of Lisata, the Caladrius team provided a vast majority of the individuals on the management team and holds the chief executive officer (&#x201c;CEO&#x201d;), chief medical officer (&#x201c;CMO&#x201d;) and other senior management roles; (iii) Caladrius paid a premium to acquire Cend&#x2019;s assets; and (iv) Caladrius was significantly larger than Cend regarding total assets, operations, and research and development activities. The Merger was accounted for as an asset acquisition as substantially all of the fair value is concentrated in in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;). Cend&#x2019;s assets (except for cash and working capital) were measured and recognized as an allocation of the transaction price based on their relative fair values as of the transaction date with any value associated with IPR&amp;amp;D with no &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;alternative future use being expensed as reported in the consolidated statement of operations. Operating results presented in the consolidated statements of operations and comprehensive loss prior to the Merger are solely related to Caladrius Biosciences, Inc. and subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Coronavirus Considerations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lisata's Phase 2b FREEDOM Trial of XOWNA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. experienced delays in enrolling patients as a result of COVID-19. While early enrollment proceeded to plan with the first patient treated in January 2021, the impact of the COVID-19 pandemic contributed to a general slowing of enrollment, supply chain disruptions affecting the availability of qualified catheters used in the diagnosis of CMD and/or administration of XOWNA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as well as with a contrast agent typically used in many catheter laboratories. In May 2022, the Company announced that enrollment in the FREEDOM Trial was suspended and that it intended to conduct an interim analysis of the data from not less than the first 20 patients enrolled using the 6-month follow-up data to evaluate the efficacy and safety of XOWNA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in subjects with CMD. Following this analysis along with Key Opinion Leaders&#x2019; input, the Company determined that execution of a redesigned FREEDOM-like trial would be the appropriate next step, but the cost of such a trial would be prohibitively expensive to undergo without a strategic partner. Accordingly, the Company&#x2019;s board of directors concluded that XOWNA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; development will only be continued if a strategic partner that can contribute the necessary capital for a redesigned trial is identified and secured. There can be no assurance that we will be able to identify such a partner and enter into an agreement with such partner on acceptable terms or at all.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reverse Stock Split&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 14, 2022, in connection with the Merger, the Company implemented the Reverse Stock Split, as authorized at the annual meeting of stockholders on September 13, 2022. The Reverse Stock Split became effective on September 14, 2022 at 5:00 pm and the Company's common stock began trading on The Nasdaq Capital Market on a post-split basis at the open of business on September 15, 2022. As of September 14, 2022, every fifteen shares of the Company&#x2019;s issued and outstanding common stock (and such shares held in treasury) were automatically converted into one share of common stock, without any change in the par value per share. In addition, proportionate adjustments were made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options, stock appreciation rights, convertible notes and warrants to purchase shares of common stock, the number of shares issuable upon the vesting of all restricted stock awards, and the number of shares of common stock reserved for issuance pursuant to the Company&#x2019;s equity incentive compensation plans. Any stockholder who would otherwise be entitled to a fractional share of common stock created as a result of the Reverse Stock Split received a cash payment equal to the product of such resulting fractional interest in one share of common stock multiplied by the closing trading price of the common stock on September 15, 2022. The Reverse Stock Split was effectuated in order to increase the per share trading price of our common stock to satisfy the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All share and per share amounts of common stock, options and warrants in the accompanying financial statements have been restated for all periods presented to give retroactive effect to the Reverse Stock Split. Accordingly, the consolidated statements of equity reflect the impact of the Reverse Stock Split by reclassifying from &#x201c;common stock&#x201d; to &#x201c;additional paid-in capital&#x201d; in an amount equal to the par value of the decreased shares resulting from the Reverse Stock Split.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#x2019;s financial position as of June&#160;30, 2023, and the results of its operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2022 and 2021 included in our 2022 Form 10-K. Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values and the valuation of the Merger which was accounted for as an asset acquisition as substantially all of the fair value is concentrated in in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;). Accordingly, actual results could differ from those estimates and assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Consolidated Financial Statements include the accounts of Lisata Therapeutics, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Remeasurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reporting currency is the U.S. Dollar. The functional currency of Lisata Therapeutics Australia Pty Ltd. which is a foreign subsidiary of the Company is the Australian Dollar. The assets and liabilities of Lisata Therapeutics Australia Pty Ltd. are translated into U.S. Dollars at the exchange rates in effect at each balance sheet date, and the results of operations are translated using the average exchange rates prevailing throughout the reporting period. Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive income (loss) in stockholders' equity.&lt;/span&gt;&lt;/div&gt;</clbs:BusinessTextBlock>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="c-73"
      decimals="INF"
      id="f-377"
      unitRef="number">0.5338</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:SharesIssued
      contextRef="c-74"
      decimals="INF"
      id="f-378"
      unitRef="shares">3772768</us-gaap:SharesIssued>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c-75"
      decimals="INF"
      id="f-379"
      unitRef="shares">1227776</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction contextRef="c-76" decimals="2" id="f-380" unitRef="number">0.52</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-381">&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#x2019;s financial position as of June&#160;30, 2023, and the results of its operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2022 and 2021 included in our 2022 Form 10-K. Operating results for the three and six months ended June&#160;30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-382">&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that &lt;/span&gt;&lt;/div&gt;are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values and the valuation of the Merger which was accounted for as an asset acquisition as substantially all of the fair value is concentrated in in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;). Accordingly, actual results could differ from those estimates and assumptions.</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-383">Principles of ConsolidationThe Consolidated Financial Statements include the accounts of Lisata Therapeutics, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-384">&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Remeasurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reporting currency is the U.S. Dollar. The functional currency of Lisata Therapeutics Australia Pty Ltd. which is a foreign subsidiary of the Company is the Australian Dollar. The assets and liabilities of Lisata Therapeutics Australia Pty Ltd. are translated into U.S. Dollars at the exchange rates in effect at each balance sheet date, and the results of operations are translated using the average exchange rates prevailing throughout the reporting period. Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of accumulated other comprehensive income (loss) in stockholders' equity.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-385">Summary of Significant Accounting Policies&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents include short-term, highly liquid, investments with maturities of ninety days or less when purchased. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to credit risk from its portfolio of cash, cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. Cash is held at major banks in the United States and may exceed federally insured limits. The goals of the Company's investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the appropriate classification of its marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. All of the Company's marketable securities are considered as available-for-sale and carried at estimated fair values and reported in cash equivalents and marketable securities. Unrealized gains and losses on available-for-sale securities are excluded from net income and reported in accumulated other comprehensive income (loss) as a separate component of stockholders' equity. Other income (expense), net, includes interest, dividends, amortization of purchase premiums and discounts, realized gains and losses on sales of securities and other-than-temporary declines in the fair value of securities, if any. The cost of securities sold is based on the specific identification method. The Company regularly reviews all of its investments for other-than-temporary declines in fair value. The Company's review includes the consideration of the cause of the impairment, including the creditworthiness of the security issuers, the number of securities in an unrealized loss position, the severity and duration of the unrealized losses, whether the Company has the intent to sell the securities and whether it is more likely than not that it will be required to sell the securities before the recovery of their amortized cost basis. When the Company determines that the decline in fair value of an investment is below its accounting basis and this decline is other-than-temporary, it reduces the carrying value of the security it holds and records a loss for the amount of such decline.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost of property and equipment is depreciated over the estimated useful lives of the related assets. Depreciation is computed on the straight-line method. Repairs and maintenance expenditures that do not extend original asset lives are charged to expense as incurred. The estimated useful lives of property and equipment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.398%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life of lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets consist of property and equipment. The assets are amortized on a straight line basis over their respective useful lives. The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds the fair value of the asset. If other events or changes in circumstances indicate that the carrying amount of an asset that the Company expects to hold and use may not be recoverable, the Company will estimate the undiscounted future cash flows expected to result from the use of the asset and/or its eventual disposition, and recognize an impairment loss, if any. The impairment loss, if determined to be necessary, would be measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expenses all share-based payment awards to employees, directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate, expected volatility, expected dividend yield and expected life of the options or warrants. Stock based compensation expense also includes an estimate, which is made at the time of the grant, of the number of awards that are expected to be forfeited. The fair value of the Company&#x2019;s restricted stock and restricted stock units is based on the closing market price of the Company&#x2019;s common stock on the date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic loss per share is based on the weighted effect of all common shares issued and outstanding and is calculated by dividing net loss attributable to common stockholders by the weighted average shares outstanding during the period. Diluted loss per share is calculated by dividing net loss attributable to common stockholders by the weighted average number of common shares used in the basic loss per share calculation plus the number of common shares that would be issued assuming conversion of all potentially dilutive securities outstanding. Diluted loss per share is not presented as such potentially dilutive securities are anti-dilutive to losses incurred in all periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Treasury stock purchases are accounted for under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock. Gains or losses on the subsequent reissuance of shares are credited or charged to additional paid in capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development (&#x201c;R&amp;amp;D&#x201d;) expenses include salaries, benefits, and other headcount related costs, clinical trial and related clinical manufacturing costs, contract and other outside service fees including sponsored research agreements, and facilities and overhead costs. The Company expenses the costs associated with research and development activities when incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To further drive the Company&#x2019;s initiatives, the Company will continue targeting key governmental agencies, congressional committees and not-for-profit organizations to contribute funds for the Company&#x2019;s research and development programs. The Company accounts for such grants as a deduction to the related expense in research and development operating expenses when earned.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;In-process Research and Development Expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upfront payments that relate to the acquisition of a new drug compound, as well as pre-commercial milestone payments, are immediately expensed as IPR&amp;amp;D in the period in which they are incurred, provided that the new drug compound did not also include processes or activities that would constitute a &#x201c;business&#x201d; as defined under U.S. GAAP, the drug has not achieved regulatory approval for marketing and, absent obtaining such approval, has no established alternative future use. The Company accounts for contingent consideration payable upon achievement of certain regulatory, development or sales milestones in such asset acquisitions when the underlying contingency is probable and estimable. Milestone payments made to third parties subsequent to regulatory approval will be capitalized as intangible assets and amortized over the estimated remaining useful life of the related product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Asset&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s intangible asset consists of a single asset, Cend&#x2019;s license agreement with Qilu Pharmaceutical, Co., Ltd. (&#x201c;Qilu&#x201d;) acquired in the Merger, with a value of $0.4&#160;million. The intangible asset is stated at fair value and is amortized using the straight-line method over its estimated useful life of 5 years. Amortization expense was $18&#160;thousand for the three months ended June&#160;30, 2023 and $35&#160;thousand for the six months ended June&#160;30, 2023. The intangible asset is reviewed for potential impairment when events or circumstances indicate that carrying amounts may not be recoverable.  The projected amortization expense is $71&#160;thousand per year for the next five years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates license and collaboration arrangements to determine whether units of account within the arrangement exhibit the characteristics of a vendor and customer relationship. For arrangements and units of account where a customer relationship exists, the Company applies the revenue recognition guidance. The Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations. At contract inception, the Company assesses the goods or services promised within each contract and assesses whether each promised good or service is distinct and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Taxes imposed by governmental authorities on the Company's revenue, such as sales taxes and withholding taxes, are excluded from net revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a license to the Company&#x2019;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. If licenses are bundled with other performance obligations, the Company would utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. There was no revenue recognized for the three and six months ended June&#160;30, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Milestones&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the inception of each arrangement that includes milestone payments (variable consideration), the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company or the Company&#x2019;s collaboration partner&#x2019;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts the Company&#x2019;s estimate of the overall transaction price. Any such adjustments are allocated on a cumulative catch-up basis to satisfied and partially satisfied performance obligations, with the consideration allocated to an ongoing performance obligation being recognized over the period of performance. For the three and six months ended June&#160;30, 2023 and June&#160;30, 2022, the Company has not recognized revenue related to milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Royalties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and for which the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized any royalty revenue from any collaborative arrangement.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-386">&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to credit risk from its portfolio of cash, cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. Cash is held at major banks in the United States and may exceed federally insured limits. The goals of the Company's investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-77" id="f-387">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-78" id="f-388">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-79" id="f-389">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-390">&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;In-process Research and Development Expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upfront payments that relate to the acquisition of a new drug compound, as well as pre-commercial milestone payments, are immediately expensed as IPR&amp;amp;D in the period in which they are incurred, provided that the new drug compound did not also include processes or activities that would constitute a &#x201c;business&#x201d; as defined under U.S. GAAP, the drug has not achieved regulatory approval for marketing and, absent obtaining such approval, has no established alternative future use. The Company accounts for contingent consideration payable upon achievement of certain regulatory, development or sales milestones in such asset acquisitions when the underlying contingency is probable and estimable. Milestone payments made to third parties subsequent to regulatory approval will be capitalized as intangible assets and amortized over the estimated remaining useful life of the related product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Asset&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s intangible asset consists of a single asset, Cend&#x2019;s license agreement with Qilu Pharmaceutical, Co., Ltd. (&#x201c;Qilu&#x201d;) acquired in the Merger, with a value of $0.4&#160;million. The intangible asset is stated at fair value and is amortized using the straight-line method over its estimated useful life of 5 years. Amortization expense was $18&#160;thousand for the three months ended June&#160;30, 2023 and $35&#160;thousand for the six months ended June&#160;30, 2023. The intangible asset is reviewed for potential impairment when events or circumstances indicate that carrying amounts may not be recoverable.  The projected amortization expense is $71&#160;thousand per year for the next five years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates license and collaboration arrangements to determine whether units of account within the arrangement exhibit the characteristics of a vendor and customer relationship. For arrangements and units of account where a customer relationship exists, the Company applies the revenue recognition guidance. The Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations. At contract inception, the Company assesses the goods or services promised within each contract and assesses whether each promised good or service is distinct and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Taxes imposed by governmental authorities on the Company's revenue, such as sales taxes and withholding taxes, are excluded from net revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a license to the Company&#x2019;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. If licenses are bundled with other performance obligations, the Company would utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. There was no revenue recognized for the three and six months ended June&#160;30, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Milestones&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the inception of each arrangement that includes milestone payments (variable consideration), the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company or the Company&#x2019;s collaboration partner&#x2019;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint, and if necessary, adjusts the Company&#x2019;s estimate of the overall transaction price. Any such adjustments are allocated on a cumulative catch-up basis to satisfied and partially satisfied performance obligations, with the consideration allocated to an ongoing performance obligation being recognized over the period of performance. For the three and six months ended June&#160;30, 2023 and June&#160;30, 2022, the Company has not recognized revenue related to milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Royalties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For arrangements that include sales-based royalties, including milestone payments based on the level of sales, and for which the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized any royalty revenue from any collaborative arrangement.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-3" decimals="-3" id="f-391" unitRef="usd">400000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-5" decimals="-3" id="f-392" unitRef="usd">18000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-3" id="f-393" unitRef="usd">35000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-3" decimals="-3" id="f-394" unitRef="usd">71000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-395">&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates license and collaboration arrangements to determine whether units of account within the arrangement exhibit the characteristics of a vendor and customer relationship. For arrangements and units of account where a customer relationship exists, the Company applies the revenue recognition guidance. The Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To determine revenue recognition for contracts with customers the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations. At contract inception, the Company assesses the goods or services promised within each contract and assesses whether each promised good or service is distinct and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Taxes imposed by governmental authorities on the Company's revenue, such as sales taxes and withholding taxes, are excluded from net revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a license to the Company&#x2019;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. If licenses are bundled with other performance obligations, the Company would utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. There was no revenue recognized for the three and six months ended June&#160;30, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:AssetAcquisitionTextBlock contextRef="c-1" id="f-396">Merger&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Merger was accounted for as an asset acquisition as substantially all of the fair value was concentrated in IPR&amp;amp;D. Cend&#x2019;s assets (except for cash and working capital) were measured and recognized as an allocation of the transaction price based on their relative fair values as of the transaction date with any value associated with IPR&amp;amp;D being expensed. The fair value of total consideration was $36.1&#160;million. The following table is a summary of the purchase price calculation (in thousands except per share data).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:448.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:60.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of common shares of the combined company owned by Cend stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,772,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Multiplied by the fair value per share of Lisata common stock on September 15, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$6.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$23,580&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of Lisata's cost method investment in Cend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental fair value of Cend's fully vested stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lisata transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$36,098&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The allocation of the purchase price was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:448.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:60.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$7,062&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net working capital (excluding cash)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired in-process research and development &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$36,098&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AssetAcquisitionTextBlock>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c-73" decimals="-5" id="f-397" unitRef="usd">36100000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:AssetAcquisitionTableTextBlock contextRef="c-1" id="f-398">The following table is a summary of the purchase price calculation (in thousands except per share data).&lt;div style="margin-bottom:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:448.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:60.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of common shares of the combined company owned by Cend stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,772,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Multiplied by the fair value per share of Lisata common stock on September 15, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$6.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$23,580&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of Lisata's cost method investment in Cend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental fair value of Cend's fully vested stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lisata transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$36,098&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The allocation of the purchase price was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:448.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:60.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$7,062&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net working capital (excluding cash)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,690)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired in-process research and development &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$36,098&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AssetAcquisitionTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-74" decimals="0" id="f-399" unitRef="shares">3772768</us-gaap:CommonStockSharesOutstanding>
    <clbs:AssetAcquisitionSharePrice
      contextRef="c-74"
      decimals="2"
      id="f-400"
      unitRef="usdPerShare">6.25</clbs:AssetAcquisitionSharePrice>
    <clbs:AssetAcquisitionConsiderationTransferredEquityValue contextRef="c-74" decimals="-3" id="f-401" unitRef="usd">23580000</clbs:AssetAcquisitionConsiderationTransferredEquityValue>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-73" decimals="-3" id="f-402" unitRef="usd">10000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable contextRef="c-73" decimals="-3" id="f-403" unitRef="usd">2136000</us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable>
    <us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost contextRef="c-73" decimals="-3" id="f-404" unitRef="usd">382000</us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c-73" decimals="-3" id="f-405" unitRef="usd">36098000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <clbs:AssetAcquisitionCashAndCashEquivalents contextRef="c-74" decimals="-3" id="f-406" unitRef="usd">7062000</clbs:AssetAcquisitionCashAndCashEquivalents>
    <clbs:AssetAcquisitionNetWorkingCapital contextRef="c-74" decimals="-3" id="f-407" unitRef="usd">1690000</clbs:AssetAcquisitionNetWorkingCapital>
    <clbs:AssetAcquisitionOtherLiabilities contextRef="c-74" decimals="-3" id="f-408" unitRef="usd">22000</clbs:AssetAcquisitionOtherLiabilities>
    <clbs:AssetAcquisitionAcquiredInProcessResearchAndDevelopment contextRef="c-74" decimals="-3" id="f-409" unitRef="usd">30393000</clbs:AssetAcquisitionAcquiredInProcessResearchAndDevelopment>
    <clbs:AssetAcquisitionIntangibles contextRef="c-74" decimals="-3" id="f-410" unitRef="usd">355000</clbs:AssetAcquisitionIntangibles>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c-73" decimals="-3" id="f-411" unitRef="usd">36098000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock contextRef="c-1" id="f-412">Available-for-Sale-Securities&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of available-for-sale securities recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:507.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:94.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:32pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Municipal debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated fair values of available-for-sale securities are generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:360.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:70.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:70.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our portfolio of available-for-sale securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:361.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:70.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:70.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock contextRef="c-1" id="f-413">&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of available-for-sale securities recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:507.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:94.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:46.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:32pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Municipal debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-80" decimals="-3" id="f-414" unitRef="usd">22135000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-80" decimals="-3" id="f-415" unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-80" decimals="-3" id="f-416" unitRef="usd">14000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-80" decimals="-3" id="f-417" unitRef="usd">22123000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-81" decimals="-3" id="f-418" unitRef="usd">44308000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-81" decimals="-3" id="f-419" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-81" decimals="-3" id="f-420" unitRef="usd">17000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-81" decimals="-3" id="f-421" unitRef="usd">44291000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-82" decimals="-3" id="f-422" unitRef="usd">10640000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-82" decimals="-3" id="f-423" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-82" decimals="-3" id="f-424" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-82" decimals="-3" id="f-425" unitRef="usd">10640000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-83" decimals="-3" id="f-426" unitRef="usd">7953000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-83" decimals="-3" id="f-427" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-83" decimals="-3" id="f-428" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-83" decimals="-3" id="f-429" unitRef="usd">7953000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-84" decimals="-3" id="f-430" unitRef="usd">8309000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-84" decimals="-3" id="f-431" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-84" decimals="-3" id="f-432" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-84" decimals="-3" id="f-433" unitRef="usd">8309000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-85" decimals="-3" id="f-434" unitRef="usd">4871000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-85" decimals="-3" id="f-435" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-85" decimals="-3" id="f-436" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-85" decimals="-3" id="f-437" unitRef="usd">4871000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-86" decimals="-3" id="f-438" unitRef="usd">4833000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-86" decimals="-3" id="f-439" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-86" decimals="-3" id="f-440" unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-86" decimals="-3" id="f-441" unitRef="usd">4830000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-87" decimals="-3" id="f-442" unitRef="usd">6908000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-87" decimals="-3" id="f-443" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-87" decimals="-3" id="f-444" unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-87" decimals="-3" id="f-445" unitRef="usd">6907000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-88" decimals="-3" id="f-446" unitRef="usd">605000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-88" decimals="-3" id="f-447" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-88" decimals="-3" id="f-448" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-88" decimals="-3" id="f-449" unitRef="usd">605000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-89" decimals="-3" id="f-450" unitRef="usd">7626000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-89" decimals="-3" id="f-451" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-89" decimals="-3" id="f-452" unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-89" decimals="-3" id="f-453" unitRef="usd">7625000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-3" decimals="-3" id="f-454" unitRef="usd">53430000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-3" decimals="-3" id="f-455" unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-3" decimals="-3" id="f-456" unitRef="usd">18000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-3" decimals="-3" id="f-457" unitRef="usd">53414000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-4" decimals="-3" id="f-458" unitRef="usd">64758000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-4" decimals="-3" id="f-459" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-4" decimals="-3" id="f-460" unitRef="usd">18000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-4" decimals="-3" id="f-461" unitRef="usd">64740000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="c-1" id="f-462">&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated fair values of available-for-sale securities are generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:360.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:70.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:70.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-463" unitRef="usd">19478000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-464" unitRef="usd">27668000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities contextRef="c-3" decimals="-3" id="f-465" unitRef="usd">33936000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-4" decimals="-3" id="f-466" unitRef="usd">37072000</us-gaap:MarketableSecurities>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="c-3" decimals="-3" id="f-467" unitRef="usd">53414000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="c-4" decimals="-3" id="f-468" unitRef="usd">64740000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="c-1" id="f-469">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our portfolio of available-for-sale securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:361.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:70.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:70.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis contextRef="c-3" decimals="-3" id="f-470" unitRef="usd">53430000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue contextRef="c-3" decimals="-3" id="f-471" unitRef="usd">53414000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis contextRef="c-3" decimals="-3" id="f-472" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue contextRef="c-3" decimals="-3" id="f-473" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-3" decimals="-3" id="f-474" unitRef="usd">53430000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-3" decimals="-3" id="f-475" unitRef="usd">53414000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-476">Property and Equipment&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:505.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:363.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:60.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:72.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s results included depreciation expense of approximately $60&#160;thousand and $13&#160;thousand for the six months ended June&#160;30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-477">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:505.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:363.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:60.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:72.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-77" decimals="-3" id="f-478" unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-90" decimals="-3" id="f-479" unitRef="usd">25000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-78" decimals="-3" id="f-480" unitRef="usd">589000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-91" decimals="-3" id="f-481" unitRef="usd">589000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-92" decimals="-3" id="f-482" unitRef="usd">72000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-93" decimals="-3" id="f-483" unitRef="usd">99000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="-3" id="f-484" unitRef="usd">661000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-485" unitRef="usd">713000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-486" unitRef="usd">428000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-487" unitRef="usd">417000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-488" unitRef="usd">233000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-489" unitRef="usd">296000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-5" decimals="-3" id="f-490" unitRef="usd">60000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-6" decimals="-3" id="f-491" unitRef="usd">13000</us-gaap:Depreciation>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-492">Income (Loss) Per Share&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended June&#160;30, 2023 and 2022, the Company incurred net losses and therefore no common stock equivalents were utilized in the calculation of diluted loss per share as they are anti-dilutive. At June&#160;30, 2023 and 2022, the Company excluded the following potentially dilutive securities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.689%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.713%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-493">At June&#160;30, 2023 and 2022, the Company excluded the following potentially dilutive securities (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.689%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.713%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-94" decimals="-3" id="f-494" unitRef="shares">1339000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-95" decimals="-3" id="f-495" unitRef="shares">174000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-96" decimals="-3" id="f-496" unitRef="shares">1422000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-97" decimals="-3" id="f-497" unitRef="shares">1424000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-98" decimals="-3" id="f-498" unitRef="shares">252000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-99" decimals="-3" id="f-499" unitRef="shares">96000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-500">Fair Value Measurements&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of financial assets and liabilities that are being measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price). The Company is required to classify fair value measurements in one of the following categories:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 inputs are defined as quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 inputs are defined as inputs other than quoted prices included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 inputs are defined as unobservable inputs for the assets or liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement requires &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's financial assets and liabilities that were accounted for at fair value on a recurring basis as of June&#160;30, 2023 and December&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:116.50pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:12.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable securities - available for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of accounts payable and accrued expenses approximate fair value as of June&#160;30, 2023 and December&#160;31, 2022, due to the short maturity nature of these items.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-501">as of June&#160;30, 2023 and December&#160;31, 2022 (in thousands):&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:116.50pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:12.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:42.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable securities - available for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of accounts payable and accrued expenses approximate fair value as of June&#160;30, 2023 and December&#160;31, 2022, due to the short maturity nature of these items.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-100" decimals="-3" id="f-502" unitRef="usd">19478000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-101" decimals="-3" id="f-503" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-102" decimals="-3" id="f-504" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-103" decimals="-3" id="f-505" unitRef="usd">19478000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-104" decimals="-3" id="f-506" unitRef="usd">27668000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-105" decimals="-3" id="f-507" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-106" decimals="-3" id="f-508" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-107" decimals="-3" id="f-509" unitRef="usd">27668000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-100" decimals="-3" id="f-510" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-101" decimals="-3" id="f-511" unitRef="usd">33936000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-102" decimals="-3" id="f-512" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-103" decimals="-3" id="f-513" unitRef="usd">33936000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-104" decimals="-3" id="f-514" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-105" decimals="-3" id="f-515" unitRef="usd">37072000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-106" decimals="-3" id="f-516" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="c-107" decimals="-3" id="f-517" unitRef="usd">37072000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-100" decimals="-3" id="f-518" unitRef="usd">19478000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-101" decimals="-3" id="f-519" unitRef="usd">33936000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-102" decimals="-3" id="f-520" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-103" decimals="-3" id="f-521" unitRef="usd">53414000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-104" decimals="-3" id="f-522" unitRef="usd">27668000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-105" decimals="-3" id="f-523" unitRef="usd">37072000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-106" decimals="-3" id="f-524" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-107" decimals="-3" id="f-525" unitRef="usd">64740000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-526">Accrued Liabilities&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities as of June&#160;30, 2023 and December&#160;31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:507.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:313.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:97.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:88.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries, employee benefits and related taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical and R&amp;amp;D related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounting &amp;amp; tax consulting liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities &#x2014; current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-527">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities as of June&#160;30, 2023 and December&#160;31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:507.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:313.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:97.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:88.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries, employee benefits and related taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical and R&amp;amp;D related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounting &amp;amp; tax consulting liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities &#x2014; current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-528" unitRef="usd">2125000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-529" unitRef="usd">2586000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <clbs:ClinicalAndRDRelatedLiabilities contextRef="c-3" decimals="-3" id="f-530" unitRef="usd">924000</clbs:ClinicalAndRDRelatedLiabilities>
    <clbs:ClinicalAndRDRelatedLiabilities contextRef="c-4" decimals="-3" id="f-531" unitRef="usd">785000</clbs:ClinicalAndRDRelatedLiabilities>
    <clbs:AccruedGrantFunding contextRef="c-3" decimals="-3" id="f-532" unitRef="usd">201000</clbs:AccruedGrantFunding>
    <clbs:AccruedGrantFunding contextRef="c-4" decimals="-3" id="f-533" unitRef="usd">0</clbs:AccruedGrantFunding>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-534" unitRef="usd">160000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-535" unitRef="usd">180000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-536" unitRef="usd">171000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-537" unitRef="usd">177000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-538" unitRef="usd">3581000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-539" unitRef="usd">3728000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-540">Operating LeasesThe Company adopted ASU No. 2016-02, Leases (Topic 842) on January 1, 2019 and recognized leases with duration greater than 12 months on the balance sheet using the modified retrospective approach. The Company has an operating lease for one office which expires in 2025. The Company estimates its incremental borrowing rate at lease commencement to determine the present value of lease payments as most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. The Company's lease includes an option for the Company to extend the lease term and/or sub-lease space in whole or in part.&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities and right-of-use assets were recorded in the following captions of our balance sheet as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:325.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:88.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:88.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-Use Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-542"&gt;&lt;span style="-sec-ix-hidden:f-543"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Right-of-Use Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Lease Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-548"&gt;&lt;span style="-sec-ix-hidden:f-549"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-552"&gt;&lt;span style="-sec-ix-hidden:f-553"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Operating Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2023, the weighted average remaining lease term for our operating lease was 2.3 years, and the weighted average discount rate for our operating lease was 9.625%. As of December&#160;31, 2022, the weighted average remaining lease term for our operating leases was 1.5 years, and the weighted average discount rate for our operating leases was 9.625%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under the lease agreement as of June&#160;30, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:448.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:60.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Amounts representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock contextRef="c-1" id="f-541">&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities and right-of-use assets were recorded in the following captions of our balance sheet as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:325.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:88.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:88.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-Use Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-542"&gt;&lt;span style="-sec-ix-hidden:f-543"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Right-of-Use Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Lease Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-548"&gt;&lt;span style="-sec-ix-hidden:f-549"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-552"&gt;&lt;span style="-sec-ix-hidden:f-553"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Operating Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-544" unitRef="usd">387000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-545" unitRef="usd">487000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-546" unitRef="usd">387000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-547" unitRef="usd">487000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-550" unitRef="usd">160000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-551" unitRef="usd">180000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-554" unitRef="usd">223000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-555" unitRef="usd">305000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-556" unitRef="usd">383000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-557" unitRef="usd">485000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-3" id="f-558">P2Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-3" decimals="5" id="f-559" unitRef="number">0.09625</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-28" id="f-560">P1Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-3" decimals="5" id="f-561" unitRef="number">0.09625</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-562">&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under the lease agreement as of June&#160;30, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:448.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:60.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Amounts representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-563" unitRef="usd">95000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-564" unitRef="usd">190000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-565" unitRef="usd">143000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-566" unitRef="usd">428000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-567" unitRef="usd">45000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-568" unitRef="usd">383000</us-gaap:OperatingLeaseLiability>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-569">Stockholders' Equity&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reverse Stock Split&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 14, 2022, in connection with the Merger, we implemented the Reverse Stock Split, as described in Note 1. All share and per share amounts of common stock, options and warrants in the accompanying financial statements have been restated for all periods presented to give retroactive effect to the Reverse Stock Split. Accordingly, the consolidated statements of equity reflect the impact of the Reverse Stock Split by reclassifying from &#x201c;common stock&#x201d; to &#x201c;additional paid-in capital&#x201d; in an amount equal to the par value of the decreased shares resulting from the Reverse Stock Split.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Issuances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;At The Market Offering Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 4, 2021, the Company entered into an At The Market Offering Agreement (the &#x201c;ATM Agreement&#x201d;) with H.C. Wainwright &amp;amp; Co., LLC, as sales agent, in connection with an &#x201c;at the market offering&#x201d; under which the Company from time to time may offer and sell shares of its common stock, having an aggregate offering price of up to $50.0&#160;million. Subsequent to the filing of our Form 10-K on March 22, 2022, the aggregate market value of our outstanding common stock held by non-affiliates was approximately $43.6&#160;million. Pursuant to General Instruction I.B.6 of Form S-3, since the aggregate market value of our outstanding common stock held by non-affiliates was below $75.0&#160;million at the time of such Form 10-K filing, the aggregate amount of securities that we are permitted to offer and sell was reduced to $17,698,943, which was equal to one-third of the aggregate market value of our common stock held by non-affiliates as of September 21, 2022. During the six months ended June&#160;30, 2023, the Company issued 64,394 shares of common stock under the ATM Agreement  for net proceeds of $270,774.  Since inception, the Company has issued 64,394 shares of common stock under the ATM Agreement for net proceeds of $270,774.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger closing on September 15, 2022, the Company issued an aggregate of 3,772,768 shares of common stock, based on the Exchange Ratio, to holders of Cend, in exchange for all of the Cend capital stock outstanding immediately prior to the closing of the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options and Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger and after giving effect to the Reverse Stock Split, the Company assumed 1,227,776 options outstanding of Cend. The options granted under the Cend Plan are exercisable at various dates as determined upon grant and will expire no more than ten years from their original date of grant. The Cend Plan stock options generally vest over a four-year term. The following table summarizes the activity for stock options and warrants for the six months ended June&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.952%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.127%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aggregate Intrinsic Value (In Thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aggregate Intrinsic Value (In Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,391,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;187.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,423,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Changes during the period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;175,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(82,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(142,694)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;224.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,338,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.44&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;376.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,421,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested at June 30, 2023&lt;br/&gt;or expected to vest in the future&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,333,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.43&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;373.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,421,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,222,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;337.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,421,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2023 and 2022, the Company issued restricted stock for services as follows (in thousands, except share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:483.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:322.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:72.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:4.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:73.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of restricted stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Value of restricted stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The vesting terms of restricted stock issuances are generally between &lt;span style="-sec-ix-hidden:f-633"&gt;one&lt;/span&gt; and four years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2023 and 2022, the Company issued restricted stock units for services as follows (in thousands, except share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:498.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:343.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:72.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:73.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of restricted stock units issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Value of restricted stock units issued &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The weighted average estimated fair value of restricted stock issued for services in the six months ended June&#160;30, 2023 and 2022 was $3.00 and $13.76 per share, respectively. The fair value of the restricted stock units was determined using the Company&#x2019;s closing stock price on the date of issuance. The vesting terms of restricted stock unit issuances are generally one year, or upon the achievement of performance-based milestones.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement contextRef="c-108" decimals="-5" id="f-570" unitRef="usd">50000000</clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement>
    <us-gaap:CommonStockValueOutstanding contextRef="c-108" decimals="-5" id="f-571" unitRef="usd">43600000</us-gaap:CommonStockValueOutstanding>
    <clbs:SaleOfStockAvailableForSale contextRef="c-108" decimals="0" id="f-572" unitRef="usd">17698943</clbs:SaleOfStockAvailableForSale>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-109"
      decimals="INF"
      id="f-573"
      unitRef="shares">64394</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-109" decimals="0" id="f-574" unitRef="usd">270774</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-109"
      decimals="INF"
      id="f-575"
      unitRef="shares">64394</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-109" decimals="0" id="f-576" unitRef="usd">270774</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-74" decimals="0" id="f-577" unitRef="shares">3772768</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-110"
      decimals="INF"
      id="f-578"
      unitRef="shares">1227776</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-579">The following table summarizes the activity for stock options and warrants for the six months ended June&#160;30, 2023:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.952%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.127%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aggregate Intrinsic Value (In Thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Aggregate Intrinsic Value (In Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,391,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.03&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;187.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,423,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Changes during the period:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;175,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(82,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(142,694)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;224.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,338,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.44&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;376.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,421,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested at June 30, 2023&lt;br/&gt;or expected to vest in the future&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,333,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.43&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;373.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,421,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested at June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,222,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;337.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,421,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="INF" id="f-580" unitRef="shares">1391352</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-581"
      unitRef="usdPerShare">10.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-110" id="f-582">P7Y10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="2" id="f-583" unitRef="usd">187600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <clbs:CommonStockWarrantsShares contextRef="c-4" decimals="INF" id="f-584" unitRef="shares">1423774</clbs:CommonStockWarrantsShares>
    <clbs:WeightedAverageExercisePriceWarrantsOutstanding
      contextRef="c-4"
      decimals="2"
      id="f-585"
      unitRef="usdPerShare">42.57</clbs:WeightedAverageExercisePriceWarrantsOutstanding>
    <clbs:WeightedAverageRemainingContractualTermwarrantoutstanding contextRef="c-110" id="f-586">P3Y4M13D</clbs:WeightedAverageRemainingContractualTermwarrantoutstanding>
    <clbs:AggregateIntrinsicValueWarrantsOutstanding contextRef="c-4" decimals="-3" id="f-587" unitRef="usd">0</clbs:AggregateIntrinsicValueWarrantsOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="c-1" decimals="INF" id="f-588" unitRef="shares">175096</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-589"
      unitRef="usdPerShare">3.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsGranted contextRef="c-1" decimals="INF" id="f-590" unitRef="shares">0</clbs:WarrantsGranted>
    <clbs:WeightedAverageExercisePriceWarrantsGranted
      contextRef="c-1"
      decimals="2"
      id="f-591"
      unitRef="usdPerShare">0</clbs:WeightedAverageExercisePriceWarrantsGranted>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="INF" id="f-592" unitRef="shares">82500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-593"
      unitRef="usdPerShare">1.88</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsExercised contextRef="c-1" decimals="INF" id="f-594" unitRef="shares">0</clbs:WarrantsExercised>
    <clbs:WeightedAverageExercisePriceWarrantsExercised
      contextRef="c-1"
      decimals="2"
      id="f-595"
      unitRef="usdPerShare">0</clbs:WeightedAverageExercisePriceWarrantsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="INF" id="f-596" unitRef="shares">142694</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-597"
      unitRef="usdPerShare">3.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsCanceled contextRef="c-1" decimals="INF" id="f-598" unitRef="shares">0</clbs:WarrantsCanceled>
    <clbs:WeightedAverageExercisePriceWarrantsCanceled
      contextRef="c-1"
      decimals="2"
      id="f-599"
      unitRef="usdPerShare">0</clbs:WeightedAverageExercisePriceWarrantsCanceled>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="c-1" decimals="INF" id="f-600" unitRef="shares">2520</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-601"
      unitRef="usdPerShare">224.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsExpired contextRef="c-1" decimals="INF" id="f-602" unitRef="shares">2000</clbs:WarrantsExpired>
    <clbs:WeightedAverageExercisePriceWarrantsExpired
      contextRef="c-1"
      decimals="2"
      id="f-603"
      unitRef="usdPerShare">88.35</clbs:WeightedAverageExercisePriceWarrantsExpired>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-3" decimals="INF" id="f-604" unitRef="shares">1338734</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-3"
      decimals="2"
      id="f-605"
      unitRef="usdPerShare">10.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-606">P6Y5M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-3" decimals="2" id="f-607" unitRef="usd">376100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <clbs:CommonStockWarrantsShares contextRef="c-3" decimals="INF" id="f-608" unitRef="shares">1421744</clbs:CommonStockWarrantsShares>
    <clbs:WeightedAverageExercisePriceWarrantsOutstanding
      contextRef="c-3"
      decimals="2"
      id="f-609"
      unitRef="usdPerShare">42.51</clbs:WeightedAverageExercisePriceWarrantsOutstanding>
    <clbs:WeightedAverageRemainingContractualTermwarrantoutstanding contextRef="c-1" id="f-610">P3Y2M1D</clbs:WeightedAverageRemainingContractualTermwarrantoutstanding>
    <clbs:AggregateIntrinsicValueWarrantsOutstanding contextRef="c-3" decimals="-3" id="f-611" unitRef="usd">0</clbs:AggregateIntrinsicValueWarrantsOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="c-3" decimals="INF" id="f-612" unitRef="shares">1333367</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c-3"
      decimals="2"
      id="f-613"
      unitRef="usdPerShare">10.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-614">P6Y5M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c-3" decimals="2" id="f-615" unitRef="usd">373000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <clbs:Sharesvestedandexpectedtovest contextRef="c-3" decimals="INF" id="f-616" unitRef="shares">1421744</clbs:Sharesvestedandexpectedtovest>
    <clbs:WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest
      contextRef="c-3"
      decimals="2"
      id="f-617"
      unitRef="usdPerShare">42.51</clbs:WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest>
    <clbs:WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest contextRef="c-1" id="f-618">P3Y2M1D</clbs:WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest>
    <clbs:AggregateIntrinsicValueWarrantsvestedandexpectedtovest contextRef="c-3" decimals="-3" id="f-619" unitRef="usd">0</clbs:AggregateIntrinsicValueWarrantsvestedandexpectedtovest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c-3" decimals="INF" id="f-620" unitRef="shares">1222064</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c-3"
      decimals="2"
      id="f-621"
      unitRef="usdPerShare">11.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <clbs:OptionsVestedweightedAverageRemainingContractualTerm contextRef="c-1" id="f-622">P6Y2M8D</clbs:OptionsVestedweightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="c-3" decimals="2" id="f-623" unitRef="usd">337700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <clbs:WarrantsVested contextRef="c-3" decimals="INF" id="f-624" unitRef="shares">1421744</clbs:WarrantsVested>
    <clbs:WeightedAverageExercisePriceWarrantsExercisable
      contextRef="c-3"
      decimals="2"
      id="f-625"
      unitRef="usdPerShare">42.51</clbs:WeightedAverageExercisePriceWarrantsExercisable>
    <clbs:WeightedAverageRemainingContractualTermwarrantsvested contextRef="c-1" id="f-626">P3Y2M1D</clbs:WeightedAverageRemainingContractualTermwarrantsvested>
    <clbs:AggregateIntrinsicValueWarrantsvested contextRef="c-3" decimals="-3" id="f-627" unitRef="usd">0</clbs:AggregateIntrinsicValueWarrantsvested>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="c-1" id="f-628">&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2023 and 2022, the Company issued restricted stock for services as follows (in thousands, except share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:483.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:322.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:72.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:4.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:73.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of restricted stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Value of restricted stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c-111"
      decimals="INF"
      id="f-629"
      unitRef="shares">159950</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c-112"
      decimals="INF"
      id="f-630"
      unitRef="shares">70745</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-111" decimals="-3" id="f-631" unitRef="usd">480000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-112" decimals="-3" id="f-632" unitRef="usd">973000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-114" id="f-634">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock contextRef="c-1" id="f-635">&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2023 and 2022, the Company issued restricted stock units for services as follows (in thousands, except share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:498.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:343.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:72.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:73.00pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of restricted stock units issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Value of restricted stock units issued &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c-115"
      decimals="INF"
      id="f-636"
      unitRef="shares">188850</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c-116"
      decimals="INF"
      id="f-637"
      unitRef="shares">91990</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-115" decimals="-3" id="f-638" unitRef="usd">567000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-116" decimals="-3" id="f-639" unitRef="usd">1265000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-111"
      decimals="2"
      id="f-640"
      unitRef="usdPerShare">3.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-112"
      decimals="2"
      id="f-641"
      unitRef="usdPerShare">13.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-115" id="f-642">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-643">Share-Based Compensation&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We utilize share-based compensation in the form of stock options, restricted stock, and restricted stock units.&#160;The following table summarizes the components of share-based compensation expense for the three and six months ended June&#160;30, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.568%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.827%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.149%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.827%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total compensation cost related to unvested awards not yet recognized and the weighted-average periods over which the awards were expected to be recognized at June&#160;30, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.856%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.856%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected weighted-average period in years of compensation cost to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.06&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.81&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total fair value of shares vested and the weighted average estimated fair values of shares granted for the six months ended June&#160;30, 2023 and 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:378.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:61.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:3.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:61.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average estimated fair value of shares granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Valuation Assumptions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of stock options at the date of grant was estimated using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#x2019;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant and exercise of options for all employees. The expected term for the warrants is based upon the contractual term of the warrants.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-644">The following table summarizes the components of share-based compensation expense for the three and six months ended June&#160;30, 2023 and 2022 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.568%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.827%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.149%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.827%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-117" decimals="-3" id="f-645" unitRef="usd">227000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-118" decimals="-3" id="f-646" unitRef="usd">141000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-119" decimals="-3" id="f-647" unitRef="usd">414000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-120" decimals="-3" id="f-648" unitRef="usd">359000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-121" decimals="-3" id="f-649" unitRef="usd">357000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-122" decimals="-3" id="f-650" unitRef="usd">226000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-123" decimals="-3" id="f-651" unitRef="usd">844000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-124" decimals="-3" id="f-652" unitRef="usd">769000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-3" id="f-653" unitRef="usd">584000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-6" decimals="-3" id="f-654" unitRef="usd">367000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-655" unitRef="usd">1258000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-3" id="f-656" unitRef="usd">1128000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="c-1" id="f-657">&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total compensation cost related to unvested awards not yet recognized and the weighted-average periods over which the awards were expected to be recognized at June&#160;30, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.856%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.856%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.824%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected weighted-average period in years of compensation cost to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.06&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.81&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-125" decimals="-3" id="f-658" unitRef="usd">321000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-126" decimals="-3" id="f-659" unitRef="usd">278000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-127" decimals="-3" id="f-660" unitRef="usd">597000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-128" id="f-661">P1Y7M17D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-115" id="f-662">P1Y21D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-111" id="f-663">P1Y9M21D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-664">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total fair value of shares vested and the weighted average estimated fair values of shares granted for the six months ended June&#160;30, 2023 and 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:378.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:61.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:3.25pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td style="width:61.75pt"&gt;&lt;/td&gt;&lt;td style="width:1.0pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average estimated fair value of shares granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c-128" decimals="-3" id="f-665" unitRef="usd">641000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c-129" decimals="-3" id="f-666" unitRef="usd">385000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-128"
      decimals="2"
      id="f-667"
      unitRef="usdPerShare">2.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-129"
      decimals="2"
      id="f-668"
      unitRef="usdPerShare">0.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-669">Income Taxes&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In assessing the realizability of deferred tax assets, including the net operating loss carryforwards (NOLs), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets.  Based on its assessment, the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had approximately $281.0&#160;million of Federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% over a 3-year testing period on January 25, 2021. As a result, $168.8&#160;million of the $281.0&#160;million of Federal NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $112.3&#160;million of remaining Federal NOLs.  The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact to the balance sheet or income statement. Losses incurred before the ownership change on January 25, 2021 will be subject to an annual limitation of $173&#160;thousand under Internal Revenue Code Section 382. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the Company had approximately $34.0&#160;million of Federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% on September 15, 2022. As a result of the ownership change, $88.2&#160;million of Federal &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $34.0&#160;million of remaining Federal NOLs.  The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact to the balance sheet or income statement. Losses incurred before the ownership change on September 15, 2022 will be subject to an annual limitation of zero while losses incurred after September 15, 2022 will not be subject to limitations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, Cend Therapeutics had approximately $10.9&#160;million of Federal NOLs available to offset future taxable income. The Company performed an analysis and determined that there was an ownership change of greater than 50% on September 15, 2022. As of September 15, 2022 Cend has approximately $10.7&#160;million of Federal and $15.0&#160;million of state NOLs. The state NOLs will expire from the 2036 through 2042 tax years.  Using a fair market value of $36.1&#160;million and applying an applicable federal rate of 2.54% Cend will have an annual limitation of approximately $917 thousand each year. The Federal NOL of $106&#160;thousand incurred in the post-acquisition period September 15, 2022 to December 31, 2022 is not subject to limitation, and does not expire. Cend&#x2019;s wholly owned Australian subsidiary has $1.8&#160;million of NOLs which will be carried forward and do not expire. There is a full valuation allowance against the NOLs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and 2021, the Company had State NOLs available in New Jersey of $35.5&#160;million and $97.0&#160;million, respectively, California of $10.0&#160;million and $69.5&#160;million, respectively, and New York City of $1.9&#160;million and $13.0&#160;million, respectively, to offset future taxable income expiring from 2032 through 2042. In accordance with Section 382 of the Internal Revenue code, the usage of the Company&#x2019;s NOLs is limited given the change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period when those temporary differences become deductible.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the FASB&#x2019;s provisions for uncertain tax positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties associated with uncertain tax positions as a component of income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022 and 2021, the Company&#x2019;s uncertain tax positions were $344&#160;thousand and $0, respectively. Due to the acquisition of Cend, the Company&#x2019;s uncertain tax positions increased by $344&#160;thousand related to Federal and state credits and certain state NOLs. The Company will continue to evaluate its uncertain tax positions in future periods. As of June&#160;30, 2023, the Company does not believe there will be any material changes in its unrecognized tax positions over the next year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For years prior to 2019, the federal statute of limitations is closed for assessing tax. The Company&#x2019;s state tax returns remain open to examination for a period of three to four years from the date of filing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 5, 2023, the Company received final approval from the New Jersey Economic Development Authority (&#x201c;NJEDA&#x201d;) under the Technology Business Tax Certificate Transfer Program (&#x201c;Program&#x201d;) to sell a percentage of its New Jersey net operating losses (&#x201c;NJ NOLs&#x201d;), which were subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $2.2&#160;million. The $2.3&#160;million of NJ NOLs related tax benefits has been recorded as a benefit from income taxes and the loss on sale of $0.1&#160;million recorded in other income (expense).&lt;/span&gt;&lt;/div&gt;On August 16, 2022, the Inflation Reduction Act was signed into law. The Inflation Reduction Act includes various tax provisions, which are effective for tax years beginning on or after January 1, 2023. For tax years beginning after December 31, 2021, the Tax Cuts &amp;amp; Jobs Act of 2017 eliminated the option to deduct research and development expenditures as incurred and instead required taxpayers to capitalize and amortize them over five or 15 years beginning in 2022. Since the Company is in a net operating loss position, the capitalization of research and development costs did not have a material impact on the Company&#x2019;s results of operations for the year ended December 31, 2022. The Company will continue to monitor future impact of changes in tax legislation.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:OperatingLossCarryforwards contextRef="c-130" decimals="-6" id="f-670" unitRef="usd">281000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-130" decimals="-5" id="f-671" unitRef="usd">168800000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards contextRef="c-130" decimals="-6" id="f-672" unitRef="usd">281000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-131" decimals="-5" id="f-673" unitRef="usd">112300000</us-gaap:OperatingLossCarryforwards>
    <clbs:OperatingLossCarryforwardsBeforeWriteDown contextRef="c-132" decimals="-3" id="f-674" unitRef="usd">34000000</clbs:OperatingLossCarryforwardsBeforeWriteDown>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-4" decimals="-5" id="f-675" unitRef="usd">88200000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <clbs:OperatingLossCarryforwardsBeforeWriteDown contextRef="c-132" decimals="-3" id="f-676" unitRef="usd">34000000</clbs:OperatingLossCarryforwardsBeforeWriteDown>
    <us-gaap:OperatingLossCarryforwards contextRef="c-133" decimals="-5" id="f-677" unitRef="usd">10900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-134" decimals="-5" id="f-678" unitRef="usd">10700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-135" decimals="-5" id="f-679" unitRef="usd">15000000</us-gaap:OperatingLossCarryforwards>
    <clbs:FairValueMarketOfTaxNOLs contextRef="c-136" decimals="-5" id="f-680" unitRef="usd">36100000</clbs:FairValueMarketOfTaxNOLs>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-136" decimals="4" id="f-681" unitRef="number">0.0254</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <clbs:OperatingLossCarryforwardsPostAcquisition contextRef="c-133" decimals="-3" id="f-682" unitRef="usd">106000</clbs:OperatingLossCarryforwardsPostAcquisition>
    <us-gaap:OperatingLossCarryforwards contextRef="c-137" decimals="-5" id="f-683" unitRef="usd">1800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-138" decimals="-5" id="f-684" unitRef="usd">35500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-139" decimals="-5" id="f-685" unitRef="usd">97000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-140" decimals="-5" id="f-686" unitRef="usd">10000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-141" decimals="-5" id="f-687" unitRef="usd">69500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-142" decimals="-5" id="f-688" unitRef="usd">1900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-143" decimals="-5" id="f-689" unitRef="usd">13000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-3" id="f-690" unitRef="usd">344000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-36" decimals="INF" id="f-691" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition contextRef="c-110" decimals="-3" id="f-692" unitRef="usd">344000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <clbs:ProceedsFromSaleOfNOLS contextRef="c-144" decimals="-5" id="f-693" unitRef="usd">2200000</clbs:ProceedsFromSaleOfNOLS>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-144" decimals="-5" id="f-694" unitRef="usd">2300000</us-gaap:IncomeTaxExpenseBenefit>
    <clbs:LossOnSaleOfNOL contextRef="c-144" decimals="-5" id="f-695" unitRef="usd">100000</clbs:LossOnSaleOfNOL>
    <clbs:ResearchAndDevelopmentTaxIncentiveTextBlock contextRef="c-1" id="f-696">Australia Research and Development Tax IncentiveThe Company&#x2019;s Australian subsidiary, which conducts core research and development activities, is eligible to receive a refundable tax incentive between 43.5% to 48.5% (depending upon the income tax rate) for qualified research and development activities. As of the six months ended June&#160;30, 2023, $1.1&#160;million was recorded as an income tax incentive receivable in  prepaid and other current assets in the consolidated balance sheets, as the Company determined that the expenses met the eligibility criteria and the amounts claimed are expected to be received shortly after the related tax returns are filed.</clbs:ResearchAndDevelopmentTaxIncentiveTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-145" decimals="3" id="f-697" unitRef="number">0.435</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch contextRef="c-146" decimals="3" id="f-698" unitRef="number">0.485</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <clbs:IncomeTaxIncentiveReceivable contextRef="c-3" decimals="-5" id="f-699" unitRef="usd">1100000</clbs:IncomeTaxIncentiveReceivable>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-700">Contingencies&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company is subject to legal proceedings and claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not believe that the outcome of any pending claims will have a material adverse effect on the Company's financial condition or operating results. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, Cend received a written threat of litigation on behalf of a Chinese entity called Lingmed Limited (&#x201c;Lingmed&#x201d;) claiming Lingmed was entitled to a success fee based on Cend&#x2019;s Collaboration and License Agreement with Qilu Pharmaceuticals. Cend responded by denying that Lingmed is entitled to a success fee under the terms of their agreement. In May 2022, Cend was served with a complaint filed by Lingmed in the San Diego County Superior Court, alleging claims for breach of contract, fraud and declaratory relief. Cend&#x2019;s response to the complaint was filed on June 6, 2022. Lingmed filed an answer to Cend&#x2019;s response on July 11, 2022. At a Case Management Conference held on August 4, 2023, the Court set a trial date in the matter for August 2, 2024. The Company denies these allegations made by Lingmed and intends to vigorously defend itself.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-701">License Agreements&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sanford Burnham Prebys&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2015, Cend entered into a license agreement with Sanford Burnham Prebys (&#x201c;SBP&#x201d;) under which Cend was granted an exclusive, worldwide, royalty-bearing license to certain patent rights and know-how controlled by SBP related to the development of LSTA1. At the time the license agreement was entered into, Cend&#x2019;s founding shareholder was an executive at SBP. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. As consideration for the license, Cend issued a total of 382,030 shares of common stock, as adjusted for the Reverse Stock Split and Exchange Ratio. The Company is required to pay an annual license maintenance fee of $10,000 increasing to $20,000 on year seven of the agreement. The Company could also be required to make milestone payments to SBP upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $10.6&#160;million. The Company has also agreed to pay SBP royalties of 4% of net sales of products sold by the Company, or through a sublicense, subject to certain reductions. Additionally, the Company is obligated to pay SBP 25% of any sublicensing income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, Cend entered into a license agreement with SBP under which Cend was granted an exclusive, royalty-bearing license to certain patent rights and know-how controlled by SBP. The agreement provides Cend with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. The Company is required to pay an annual license maintenance fee of $20,000, increasing to $30,000 on year four of the agreement. Further, the Company could be required to make milestone payments to SBP upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $23.2&#160;million. The Company is obligated to pay SBP royalties of 4% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company is obligated to pay SBP varying sublicense fees, ranging from 10% to 25%, dependent on when the related milestones are reached. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The agreements will expire upon the later of (i) the final abandonment of all pending patent applications within the licensed patents or (ii) the expiration of the last to expire patent within the licensed patents. The agreements may be terminated in their entirety by the Company at any time by giving SBP sixty days&#x2019; prior written notice. The agreements may be terminated in their entirety by SBP if the Company, at any time, defaults in the payment of any sum when due and fails to make such payment within thirty days after receipt of written notice. The agreements may be terminated in their entirety by SBP or the Company (i) in the event of an uncured material breach by the other party, or (ii) in the event the other party (a) files for, or is involuntarily petitioned with, bankruptcy (other than dissolution or winding up for the purposes of reconstruction or amalgamation), (b) makes an assignment of all or substantially all of its assets for the benefit of creditors, or (c) has a receiver or trustee is appointed and is unable to secure a dismissal, stay or other suspension of such proceedings within thirty days. Upon termination of the agreements for any reason, all rights and obligations of the Company with respect to the patents and patent applications shall terminate and revert to SBP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SBP owned 382,030 shares of the Company&#x2019;s common stock as of June&#160;30, 2023 and is a related party. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;University of California at San Diego&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, Cend entered into a license agreement with the University of California at San Diego (&#x201c;UCSD&#x201d;) under which Cend was granted an exclusive, royalty-bearing license to certain patent rights related to the development of nano-particles to modulate immune response. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell and otherwise exploit the patent rights. The Company could be required to make milestone payments to UCSD upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $1.2&#160;million. The Company has also agreed to pay UCSD royalties of 1.5% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company agreed to pay UCSD varying sublicense fees, ranging from 10% to 20%, dependent on when the related milestones are reached. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The agreement will expire upon the expiration of the longest-lived patent rights. The agreement may be terminated in its entirety by the Company at any time by giving UCSD ninety days&#x2019; prior written notice. The agreement may be terminated in its entirety by UCSD if the Company, at any time, (i) fails to perform or violates any term of the agreement and fails to cure the default within sixty days. Upon termination of the agreement for any reason, UCSD may terminate a sublicensee but will allow the Company to assign any sublicenses to UCSD provided a) that the sublicensee is in good standing upon termination of the agreement with the Company; and b) the sublicensee is not currently involved in litigation as an adverse party to UCSD.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Massachusetts Institute of Technology&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, Cend entered into a license agreement with the Massachusetts Institute of Technology ("MIT") under which Cend was granted an exclusive, royalty-bearing license to certain patent rights related to the development of tissue specific delivery of interfering RNA. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. As consideration for the license, Cend issued a total of 43,236 shares of common stock, as adjusted for the Reverse Stock Split and Exchange Ratio. The Company is required to pay an annual license maintenance fee of $20,000, increasing to $25,000 for year two and three of the agreement, increasing to $50,000 on year four of the agreement and thereafter until the first commercial sale, and increasing to $150,000 each year of the agreement after the first sale. Further, the Company could be required to make milestone payments to MIT upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $5.0&#160;million. The Company has also agreed to pay MIT royalties of 2% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company is obligated to pay MIT varying sublicense fees, ranging from 3% to 20%, depending on when the related milestones are reached. In connection with the close of the Merger, the Company was required to pay MIT a change of control fee of $0.3&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The agreement expires upon the expiration or abandonment of all valid claims. The agreement may be earlier terminated in its entirety by the Company at any time by giving MIT six months prior written notice. The agreement may also be terminated in its entirety by MIT if the Company, at any time, (i) defaults in the payment of any sum when due and fails to make such payment within thirty days after receipt of written notice, or (ii) commits a material breach of its obligations under the agreement (aside from item (i)) and fails to cure that breach within sixty days after receipt of written notice. Upon termination of the agreement for any reason, the rights and licenses granted to the Company shall terminate and revert to MIT. Upon termination of the agreement for any reason, MIT may terminate a sublicensee but will allow the Company to assign any sublicenses to MIT provided that the sublicensee is in good standing upon termination of the agreement with the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2023, in accordance with the provisions of the license agreement, the Company provided notice to MIT that the license agreement would terminate effective December 30, 2023. Until such date, the license remains in full force and effect.&lt;/span&gt;&lt;/div&gt;MIT owned 43,236 shares of the Company&#x2019;s common stock as of June&#160;30, 2023Research Collaboration and License Agreement&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Exclusive License and Collaboration Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, Cend entered into an Exclusive License and Collaboration Agreement (the &#x201c;Qilu Agreement&#x201d;) in which Cend granted an exclusive license to Qilu for the development and commercialization of LSTA1 in the Territory (defined as the Greater Area of China including China, Macau, Hong Kong, and Taiwan). Under the terms of the agreement, Qilu is solely responsible for the development of LSTA1 in its Territory. In consideration for the license, Qilu made an upfront payment of $10&#160;million to Cend, which was recognized as revenue by Cend prior to the Merger. In addition, Cend received and recognized as revenue a $5&#160;million development milestone prior to the Merger. The Company is eligible to receive additional developmental and commercial milestone payments up to $95&#160;million and $125&#160;million, respectively, tiered royalties on net sales ranging from 10% to 15%, and tiered sublicensing revenues ranging from 12% to 35%.&lt;/span&gt;&lt;/div&gt;Unless terminated early, the Qilu Agreement will continue in effect until the expiration of all Qilu payment obligations. Either party may terminate the Qilu Agreement if an undisputed material breach by the other party is not cured within a defined period of time, or upon notice for insolvency-related events of the other party that are not discharged within a defined time period. Qilu may terminate the Qilu Agreement in its entirety, at any time with at least sixty days written notice. All rights and obligations of Qilu with respect to such licensed patents and patent applications would terminate.</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <clbs:SharesIssuedUnderLicenseAgreement
      contextRef="c-147"
      decimals="INF"
      id="f-702"
      unitRef="shares">382030</clbs:SharesIssuedUnderLicenseAgreement>
    <clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee contextRef="c-147" decimals="-3" id="f-703" unitRef="usd">10000000</clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee>
    <clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven contextRef="c-147" decimals="-3" id="f-704" unitRef="usd">20000000</clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven>
    <clbs:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct contextRef="c-147" decimals="-5" id="f-705" unitRef="usd">10600000</clbs:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct>
    <clbs:CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales
      contextRef="c-147"
      decimals="INF"
      id="f-706"
      unitRef="number">0.04</clbs:CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales>
    <clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees contextRef="c-147" decimals="INF" id="f-707" unitRef="usd">0.25</clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees>
    <clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee contextRef="c-148" decimals="-3" id="f-708" unitRef="usd">20000000</clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee>
    <clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour contextRef="c-148" decimals="-3" id="f-709" unitRef="usd">30000000</clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour>
    <clbs:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct contextRef="c-148" decimals="-5" id="f-710" unitRef="usd">23200000</clbs:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct>
    <clbs:CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales
      contextRef="c-148"
      decimals="INF"
      id="f-711"
      unitRef="number">0.04</clbs:CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales>
    <clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees contextRef="c-149" decimals="INF" id="f-712" unitRef="usd">0.10</clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees>
    <clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees contextRef="c-150" decimals="INF" id="f-713" unitRef="usd">0.25</clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees>
    <clbs:SharesHeldByThirdParty
      contextRef="c-151"
      decimals="INF"
      id="f-714"
      unitRef="shares">382030</clbs:SharesHeldByThirdParty>
    <clbs:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct contextRef="c-152" decimals="-5" id="f-715" unitRef="usd">1200000</clbs:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct>
    <clbs:CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales
      contextRef="c-152"
      decimals="INF"
      id="f-716"
      unitRef="number">0.015</clbs:CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales>
    <clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees contextRef="c-153" decimals="INF" id="f-717" unitRef="usd">0.10</clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees>
    <clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees contextRef="c-154" decimals="INF" id="f-718" unitRef="usd">0.20</clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees>
    <clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee contextRef="c-155" decimals="-3" id="f-719" unitRef="usd">20000000</clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee>
    <clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree contextRef="c-155" decimals="-3" id="f-720" unitRef="usd">25000000</clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree>
    <clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour contextRef="c-155" decimals="-3" id="f-721" unitRef="usd">50000000</clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour>
    <clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale contextRef="c-156" decimals="-3" id="f-722" unitRef="usd">150000000</clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale>
    <clbs:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct contextRef="c-155" decimals="-5" id="f-723" unitRef="usd">5000000</clbs:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct>
    <clbs:CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales
      contextRef="c-155"
      decimals="INF"
      id="f-724"
      unitRef="number">0.02</clbs:CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales>
    <clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees contextRef="c-157" decimals="INF" id="f-725" unitRef="usd">0.03</clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees>
    <clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees contextRef="c-158" decimals="INF" id="f-726" unitRef="usd">0.20</clbs:CollaborativeArrangementRightsAndObligationsSublicensingFees>
    <clbs:CollaborativeArrangementRightsAndObligationsChangeOfControlFee contextRef="c-155" decimals="-5" id="f-727" unitRef="usd">300000</clbs:CollaborativeArrangementRightsAndObligationsChangeOfControlFee>
    <clbs:SharesHeldByThirdParty
      contextRef="c-159"
      decimals="INF"
      id="f-728"
      unitRef="shares">43236</clbs:SharesHeldByThirdParty>
    <us-gaap:ContractWithCustomerLiability contextRef="c-160" decimals="-6" id="f-729" unitRef="usd">10000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer contextRef="c-161" decimals="-3" id="f-730" unitRef="usd">5000000</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <clbs:RevenueRemainingPerformanceObligationVariableConsiderationAmount contextRef="c-162" decimals="-6" id="f-731" unitRef="usd">95000000</clbs:RevenueRemainingPerformanceObligationVariableConsiderationAmount>
    <clbs:RevenueRemainingPerformanceObligationVariableConsiderationAmount contextRef="c-163" decimals="-6" id="f-732" unitRef="usd">125000000</clbs:RevenueRemainingPerformanceObligationVariableConsiderationAmount>
    <clbs:RevenuePerformanceObligationPercentageOfNetSale
      contextRef="c-162"
      decimals="INF"
      id="f-733"
      unitRef="number">0.10</clbs:RevenuePerformanceObligationPercentageOfNetSale>
    <clbs:RevenuePerformanceObligationPercentageOfNetSale
      contextRef="c-163"
      decimals="INF"
      id="f-734"
      unitRef="number">0.15</clbs:RevenuePerformanceObligationPercentageOfNetSale>
    <clbs:RevenuePerformanceObligationPercentageOfSublicensingRevenues
      contextRef="c-162"
      decimals="INF"
      id="f-735"
      unitRef="number">0.12</clbs:RevenuePerformanceObligationPercentageOfSublicensingRevenues>
    <clbs:RevenuePerformanceObligationPercentageOfSublicensingRevenues
      contextRef="c-163"
      decimals="INF"
      id="f-736"
      unitRef="number">0.35</clbs:RevenuePerformanceObligationPercentageOfSublicensingRevenues>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-737">Subsequent Events&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Departure of Director&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 11, 2023, the Company announced that Erkki Ruoslahti, M.D., Ph.D., had decided to retire from its Board of Directors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assignment of Tumor Penetrating Nanocomplex (TPN) platform&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 21, 2023, the Company entered into a Technology Transfer Agreement with Impilo Therapeutics, Inc. (&#x201c;Impilo&#x201d;), pursuant to which the Company will, subject to the satisfaction of customary closing conditions, transfer the rights to the Tumor Penetrating Nanocomplex (TPN) platform to Impilo (the &#x201c;Transfer&#x201d;). In exchange, on the closing date of the Transfer (the &#x201c;Closing Date&#x201d;) and pursuant to an Equity Purchase Agreement, by and between the Company and Impilo, to become effective on the Closing Date, Impilo will issue to the Company 768,500 shares of its pre-seed preferred stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:InvestmentOwnedBalanceShares contextRef="c-164" decimals="0" id="f-738" unitRef="shares">768500</us-gaap:InvestmentOwnedBalanceShares>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>78
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !'@0Y78.%_+-H%  #4'@  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+69:W/B-A2&_XJ&=CKM3 BV#"39)LPX#NFRW<VR@6UGV^D'80OPQ+:H+$/R
M[WMD@TU2^<!XEGP(ONB\UJ/K*^EZ(^13NN1<D><X2M*;UE*IU;M.)_67/&;I
MN5CQ!-[,A8R9@ENYZ*0KR5F0!\51AUI6OQ.S,&D-KO-G8SFX%IF*PH2/)4FS
M.&;RY99'8G/3LEN[!X_A8JGT@\[@>L46?,+5U]58PEVG5 G"F"=I*!(B^?RF
MY=KO/(?J@#S%'R'?I'O71*/,A'C2-Z/@IF7I'/&(^TI+,/A9<X]'D5:"?/R[
M%6V5W]2!^]<[]?L<'F!F+.6>B/X, [6\:5VV2,#G+(O4H]B\YUN@GM;S193F
M_\FF2-OMMHB?I4K$VV#(01PFQ2][WA;$?H!=$T"W ?1-@%WW!6<;X.2@1<YR
MK#NFV.!:B@V1.C6HZ8N\;/)HH D378T3)>%M"'%JX(DUEZ1-TB63/+WN*-#4
M;SK^-OZVB*<U\7WR221JF9)A$O#@=7P'\E)FB.XR=$M1P0]9<DX<ZXQ0BSJ&
M_'AXN)LMSHG=-86_RHY3EH^3ZSEH^?SMSE(EH<G]8RJA0J%K5M#]\%VZ8CZ_
M:4%'2[E<\];@IQ_LOO6K">\[B;V"[9:P74Q]<"?\#+JH(M.7%3>1XN&VU?YB
M0D*C&B+U2J3><4A?,B85E]$+>>0K(94)#Y=2,C,5BH=&-<3KEWC]X_#&7(8B
MT+V0P#A@K#Q<J>QWM1T/C6_(>5%R7AS9,B6#*22? >KK$=>:LR@U5B0:UA#P
ML@2\1#,U3%2H7LA]&''RD,4S+DU@N(9EV6W'Z?<L$QP:VA#NJH2[.@;ND2]"
M/8Q"-3ZPV-A&<9V/HXD[=<GT_?#1'0^_3D?>Y(R,'KQS$S JU1#8MJIIU3H&
M>93X0D(S9;K%GI&)@KY)A"2>R!(E7^ W,);# ?6[H8D8#VJ*O.<D[&.0I^R9
MC +HJ^$\]'-NI$$?D*2T39VNT^M?&GG1X*:\M.*EQ_"Z00#JZ=GN@GR$=.1S
M8JY77-*V+>)&$8?!3;  3 P,Y_>1$*:R\W"MIOB5,;)1*_(_?$_?0=.>BDUB
M1,?E;EGZ%"8+\A@&"^/HC,<WQ:VLD8V;F[>X95<>2[$.$]]<W;CFPP<CZ"G\
MDET9)ANW.6]!QR)5+")_A:OZT0I7M"ZNJ'%.PN.:DE;>R<8M3]YB75C\UH/A
M E>6>5PZA5.R*ZMDX_[FH_"AOL9+D6!6XH#(99>V+=LR5]LIC))=.24;MSG3
M4(%)$G-BTY]GOY )]S,)-6F$Q)4\$<<P/4V4\)_.R(I)LF91QLF/UCEX*;*"
ME5^^+C86PBD,E5TY*ANW0N"# SU<3E[BF8B,[ >\U&3J&KE.X9MHY9LH[FQV
MM4F&S_Z2)0M>:Q4/"#VXDSO7N!S% YL25C:)'F63O$Q*O: I5C%Y5<*,DAFW
M8 XH?C-NW'AX5%/.RA[1H^S1*(%5=[%9IU>F; =NY,05ZSA/X8-HY8/H43Y(
MK]S UX,I6 AI'(P.Z#R(I,U\GX,,B 2%H)'W%$:(5D:('F6$)C&+(G*;I? Z
M-;=:7*=N.P4/:XI7V1]ZE/T9QEPN=*_\#134$AQ"O&*)N5YQP=KM!CRN*6CE
M?BAN7G;UN.10CQ@>+E./=PH71"L71'$#LQMF8:B18(=&2<"?R>_<C(A+6?#G
M4' $%T;.4[@A6KDA>L##;.>1^S#5MN\;!Q>#[0(>D&NW;=IV;"/H*1P/K1P/
MQ0U+N06X3WH/#\V##RY6>[AP"O?C5.['.;"O\X9QNZM;2WE [@LUGC"<PO\X
ME?]Q<+?B F!00$9L8:3"!6I''#RN*5AE>)RC#,_K1<4D/U<CGS,%J^A$6W8C
M\7>R,-MR*-1ZN9H^QUT/+NTN=7HP?JWW$3M[YX9ZOLN/4U/BZ\W)X@BQ?%H>
MV;KY066G2EZ<]WYB>KI,2<3G$&J=7\#797&$6MPHL<I/(6="*1'GETO. BYU
M G@_%T+M;O0'RH/LP7]02P,$%     @ 1X$.5\R:P 3$!0  ZA8  !@   !X
M;"]W;W)K<VAE971S+W-H965T,BYX;6RM6&UOVS80_BN$5VPM8,<B94E6XQA(
MW1;+T'9!G6Z?&8FQB4BB2U))LU^_HZQ(MDG)+IH/;23K[O@<7^YYCK-'(>_5
MFC&-?N19H2X&:ZTW;\=CE:Q93M69V+ "OMP)F5,-KW(U5AO):%HYY=F8>%XX
MSBDO!O-9]=NUG,]$J3->L&N)5)GG5#Z]8YEXO!C@P?,/7_EJK<T/X_EL0U=L
MR?2WS;6$MW$3)>4Y*Q07!9+L[F)PB=\N2&0<*HM_.'M4.\_(I'(KQ+UYN4HO
M!IY!Q#*6:!."PI\'MF!99B(!CN]UT$$SIG'<?7Z._K%*'I*YI8HM1/8O3_7Z
M8C =H)3=T3+37\7CGZQ.*##Q$I&IZG_T6-MZ Y242HN\=@8$.2^V?^F/>B)V
M'/"DPX'4#N14![]V\*M$M\BJM-Y33><S*1Z1--80S3Q4<U-Y0S:\,,NXU!*^
M<O#3\X4HE,AX2C5+T3N:T2)A:&G"*31"WY;OT>M7;] KQ MTLQ:EHD6J9F,-
M(QO_<5*/\FX["ND8Y:^R.$.^-T3$([[#?='O_IXEX(XK=[+O/H9\FZ1)DS2I
MXOD=\2Z7RP\W2U<:6[^)V\\<J;=J0Q-V,8 SHYA\8(/Y[[_AT#MW)?5"P?92
M])L4_;[H\P55:P2+A1+SP+Z7_(%FK-#.Q=N&"JM0YMP_S(D?QMYL_+";CFWE
M$QQ,&JL]G),&YZ07YV<J[YFFMQE#BB6EY)HS)\9MF&!W=#_VPP.,#JO(BX@;
M8]!@#'HQ7DNVH3RMIE/H-9-P,*6$R414*>:>TL !)(X.T-I&) P\-]BP 1OV
M@KT1FF8G  RML4,\,8=S#Z%M%>%I%+HA1@W$Z,A\ @M)_51-J-F:&^ %/40%
MTRZDD3U+_B%.ATW<@7+:H)SVHOS("Z[9Z!.P3(JN"DV+%3?;]+*:TB'ZXD8[
M=2")#]#:-K[?<8[B!FW<B_;O:E]V+W=L#3G!AP?<M@G(U T+>RV_>"?LQVY@
MM?O>1H3J$QQ@<YA%OM<U:WB'_G O%7SB])9GG56G]GXA0GBI:/NYMJR'>QEG
M?IDDH@0*0!OZ9"JN,V%BSW-D+89M!(4KZ%B+EK)P/V<!/EG"8<N.K(EO'Y]@
MB@\Q.JRBSNW<TA7NYZO]\GH,J4U'$S\XY"R'5>A/_0ZD+6GA?M;:5H1,%*N1
M9C(_BM5!1K&U\ Y:(U$'TI:Q\"F4=0R?3463,+!6W4%K$>Z@5-P2%NYGK(7(
M<ZX-2ZF*M$ U:UZL6)$ 6O3ZB] ,X<D;)^[>R.XSCYS%X]<#[6??$B&>]M;(
MI1;)_5ID*9/J#_0!"%L_.5/M)=2?+I8O%&T_Z99/<3^AFB6'-E.9W(?HE7?F
M>1@*IT2@HTLV1+34:R'Y?U"O?'_H;_\AM:8 YAQQI4PEFPXQ?/#BH-HUT7 :
MAL,HCFLS1#6"SH@UG5%E!<T.RV_AZ#XW/$-HE]6&5?UN]G2^E:&E5J!(4MB$
MPVH4,O2#:&<4+\2_,HIS>6U],#T\?GTF^ZU:*R!(OX"X3%-N.GXH$4:%CZ 3
M3>B&0\EP-G"V3@BB$$>'@M%I-PDF77!;04%Z27Q^(QE5I7QZWCDP^XE0^AQ%
M_O3G5L29'K9@CR+O<!F.6>VGMM,U']4/95YFU55!RNYXPIT*F-CJ8!1@F-Q#
M-G$:0K<VP1U(6R5!CBJ)!FG=L8D<RL3:W#\],&!%Y2098HN&47 HDUU&).Z
MW H+<HJP^,05U13= &2Z8:7F"70:5T5RMMU.31%FG468V&HBB.+0VB(.T1$&
M4=<>:54'Z5<=7T0Q2H =I<C@TPKQ L0'4V[M3VPY,2([-PHUU"-6^TA;U4%.
M41TG3ZLM+((HPA96A_X(?=(%MA4@I%^ 6!()NN6NF:ZJR<EY1=:MCJO]<IBY
MVJ_QSD6DN07^3.6*%PIE[ [\O+,()D9N+U:W+UILJKO)6Z&UR*O'-:, VAC
M]SL!TJI^,=>=S?7V_']02P,$%     @ 1X$.5S&'6H?F @  !P@  !@   !X
M;"]W;W)K<VAE971S+W-H965T,RYX;6RM56MOFS 4_2L6FZ9.Z@*! &F71&I3
M5=ND35&SQX=I'QRX*5:-S6R3-/OUNP:*\B!9*RT?@A_W')]C7_N.UE(]Z S
MD,><"SUV,F.*2]?5208YU3U9@,"9I50Y-=A5]ZXN%-"T N7<]3TO<G/*A#,9
M56,S-1G)TG F8*:(+O.<JLTU<+D>.WWG:>".W6?&#KB344'O80[F6S%3V'-;
MEI3E(#23@BA8CIVK_N4TMO%5P'<&:[W5)M;)0LH'V_F8CAW/"@(.B;$,%#\K
MF +GE@AE_&XXG79)"]QN/['?5M[1RX)JF$K^@Z4F&SM#AZ2PI"4W=W+] 1H_
MH>5+)-?5/UG7L7'HD*341N8-&!7D3-1?^MCLPQ:@/S@"\!N _UQ T ""RFBM
MK+)U0PV=C)1<$V6CD<TVJKVIT.B&"7N*<Z-PEB'.3*92:,E92@VDY)IR*A(@
M<TNGR=F,*A F \,2RO5;\HZ\)B[1&0[KD6MP>4OB)LU2U_52_I&E/I6B1P+O
MG/B>'W3 IZ?A-Y @O%_!_5VXBZ9;YW[KW*_X@B-\<X.>,1\-D4MRRP0Z9Y23
MF=2L2K"?5PMM%*;9KRZK-?>@F]M>O4M=T 3&#MXM#6H%SN3-JW[DO>\R_I_(
M=K8A:+<A.,6."9#GZ!83+7DX)P559$5Y">2,"5+JE!2@ZA-_V[4--7=<<=L'
M8S7Q>I[7'[FK;7__BMH1/FB%#UX@O$Y*0DN32<7^0-JEMB8,MW0$S6]/\#,"
M=S2'K>;PY9J9UF6WWO! QK ?!-Y%N"?W,"X>1E%\<=&M-FK51B?5?BGS!9X^
M7H^DT5T+Q@%\%.S@ A&I;114;(A<V]YB0Z8@TMID)GD*JO.QB+K,^4$8[YD[
MC+/FO.A(^L2MN?BDN:]8\W2I-K5.<E9[ZTSR^%!!,-Q3>3JF5NAN/=.V1'ZF
MZIX)33@L$>7U;%%1==FI.T86U<N]D ;K0-7,L%*#L@$XOY32/'5L,6AK_^0O
M4$L#!!0    ( $>!#E?C"A-VQ@4  *4;   8    >&PO=V]R:W-H965T<R]S
M:&5E=#0N>&ULK5EMD]HV$/XK&IKI)#,)6+(Q<+UC)@=.FT[29G))\UG8 CRQ
M)6H)[OKONW[!!FOM<"U? )MG'^G97:W6UNVCRK[KK1"&/*6)U'>#K3&[F]%(
MAUN1<CU4.R'AG[7*4F[@,MN,]"X3/"J,TF3$',<?I3R6@_EM<>]3-K]5>Y/$
M4GS*B-ZG*<_^N1>)>KP;T,'QQN=XLS7YC='\=L<WXD&8K[M/&5R-:I8H3H74
ML9(D$^N[P5MZ$S"6&Q2(OV+QJ$]^DUS*2JGO^<7[Z&[@Y#,2B0A-3L'AZR 6
M(DER)IC'WQ7IH!XS-SS]?61_5X@',2NNQ4(EW^+(;.\&TP&)Q)KO$_-9/?XF
M*D'CG"]4B2X^R6.%=08DW&NCTLH89I#&LOSF3Y4C3@R !S=@E0%K&W@=!FYE
MX%XZ@E<9>)>.,*X,"NFC4GOAN"4W?'Z;J4>2Y6A@RW\4WB^LP5^QS!/EP63P
M;PQV9KY04JLDCK@1$7DP\ 598#11:_+G3F0\CZ8F;\C7AR5Y^>(5T5N>"4UB
M2;YLU5YS&>G7Y,79]>W(P,1R^E%83>*^G 3KF(1+/BIIMIH$,A(18K_LM_=[
M[$?@D-HK[.B5>]9+^/M>#HGKO";,82XRG\7EY@R3\_]&#_[SZ&?.<.L4<0L^
MMX.OR@.Y(<$3U"<M] T6XI+$PTGR>G>C=SP4=P,H:%ID!S&8__P3]9U?,/]>
MDVQY3;+@2F1GD?#J2'A][///P,BS<$M@F4$U/$"9W^7+%0M'R>073/EN<9B[
MU(=T.)RZ&0$QUSL'+6V0[WKT'!0@H#'U:]"9W'$M=]PK]U<A(?.20BV/H/C%
MVN29>!"8X))K?*IE0MV68 3D3?V68!LT<2?3EF ;Y$^9APOV:\%^K^ ORH!<
M5:\W4:TW3*Z/C#\9M^0BH ES6G)M$ 7/S5IZ,93K.;C@22UXTBNX*2V)TJC,
MB37L&T0GAK*%(BA,*0KKE#JMI4[[JZC9B@SVR5"E@KRL(OL*K:33:U;2:Y(M
MKTD67(GL+!JS.AJSWL1[+P]"F[QV5B%Y3:1 Z^C,7D)^JQ8L;,RL741M".14
MNZ8@H/$43SOJ- V>T[_&BL2K$JY39D5RGO7CU@I:(*CV(D.)_%8=#E"4-^O0
M>M+,TDL**+K44-74FL:8MJ.+@*SP(AA*VV4JP)@Z)+-&,NN5_ <\3.;%DZP$
M/#8*^))B'1NRSE1Z]('A3]"SY]NH5'!'FDPE25YU8VD$+"Z#]^P,J:KN>-)V
M#P;S67M3Q6"4C3VO[2,,Y[HN[7!4T\72WM9L?M_E&%2[:\^"N:ZU'FR8M1XN
M8@I0F#?I2H^F8Z3]+>,Q/5"1GCVFYS KP @,"S "HPZC5H!1W'3,.J0VW2+M
M;Q<_")T_J4*!.X:7&Y/%J[WAJP1BK9Z7_7:#9T7_AY#ECR%!+^3<%4T?2?L;
MR;HHM#WP(=;<<'A6A[YK)_8F#N'Q_;T,AP0<EBI)M%'A]ZU*(I'A;O&M1A_-
M&02&Y0P"0W,&Q77G3--_TDEO5W;/=1R6CU-QLL_?@11N@[:T?-.!NJ"WIWUN
M?W95MN55V8)KL9T'I^F8:6\+.%_PA$=9O-?D/E8ZC(4,14^ZPMI?%>%\&4NR
MUU$317SO+P>?GN:4,VP_66 H.O2M_1^%L7:#A\'8T.^J\DTW2_O;V>=[ZICN
M%_IJ=I&O$!3F*Q1F^PJ!=?N*-?TP<WJ7_+?BW3%(YP<H@AM1.ZA\LZGV1ALH
M"+!!8)Y@O<WV<Q?_5=F65V4+KL5V'J:FE6?]K7Q9F<N@H(&P>^DI[!RME$10
MGN.V$G>)<CGM30CGZGC'Q9H&GO4W\,MJ)?9(M5MB3*J-PJ1B7+94E*LM=71R
M[)"*;%.<]VA83WMIRM?+]=WZ3.EM<9+2NG]/;Q84N;^D-T%Y8M30EP=8'WFV
MB:4FB5C#4,YP E/-RC.A\L*H77'HL5+&J+3XN14<BE\.@/_72IGC13Y ?3(W
M_Q=02P,$%     @ 1X$.5_,6,N&0 P  Z L  !@   !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6RM5E%OVS80_BN$5A0=T$2R9,M&:@M(; _KT Y!TVX/0Q]H
MZ6QQH4B/I.QVOWY'2=%LB1:"+2\227WW'>_CB7?SHU2/.@<PY%O!A5YXN3'[
M&]_7:0X%U==R#P*_;*4JJ,&IVOEZKX!FE5'!_3 (8K^@3'C)O%J[5\E<EH8S
M ?>*Z+(HJ/I^!UP>%][(>UKXQ':YL0M^,M_3'3R ^;*_5SCS6Y:,%2 TDX(H
MV"Z\V]'->F;Q%> W!D=],B8VDHV4CW;R/EMX@=T0<$B-9:#X.L 2.+=$N(V_
M&DZO=6D-3\=/[#]5L6,L&ZIA*?GO+#/YPIMY)(,M+;GY)(\_0Q//Q/*EDNOJ
M28X--O!(6FHCB\88=U P4;_IMT:'$P/D<1N$C4'8-1A?,(@:@^BY'L:-P?BY
M'B:-016Z7\=>";>BAB9S)8]$632RV4&E?F6->C%A\^3!*/S*T,XD2RFTY"RC
M!C+R8/"%26 TD5NRE 6F7FYSX@#D@]2:7)$O#RORYM6/Y!5A@GS.9:FIR/3<
M-[@7R^BGC=^[VF]XP6]$/DIA<DW6(H/,8;\:MH\'['W4H!4B?!+B+APD_*44
MUR0*WI(P""/'?I;/-P]=X?P_[^O_[/U,C*C-BJCBBR[PM8G0SX/W(I4%D#]N
M-]HH_,V_NLZ^9A^[V>W5=Z/W-(6%A\0:U &\Y/4/HSAXYQ+^)<E6+TFV?B&R
MLR,:MT<T'F)/?L4:PO&?=,E?6\:5I2T4A^1J'(33N7\XU=6!BN,P/D>M'*A1
M$([&Y["U$S:;A"WL+,A)&^1D,,C; V6<;C@0K(A$4QQH2$O%# -[&PD4H118
M'SG[&^^O'=9%EQZUD\G)YD9A1PP7I"N% ]-1H8\(W +$K0#QH !8#+'4":P$
M2H%(OQ/\YX3FM"ZRV9]8(.QOZ@HZ[NT%3Z03=1_30:P<+&%'N_40RUG4TS;J
MZ6#4GZ6AG$B3@R+IV>US*>.GO2UT#[B/Z!]P'W,5=H^XC[D0[*P-=C88[+(7
M(*'&*+8I397Y1I(/3&-MQW(+BNZA-"S5;^U%?&W5*3 3L$U('W/),U!.>6;.
M"V'2D<B!BB=!-R,<*+P0H@[9V@GK7PC^2>M2@-I5/:/&N$IAZGK5KK9MZ6W5
MC776[T8WRY%C?85M;-UU_DM?]\ ?J=HQH0F'+;H*KJ=XJ*KN*^N)D?NJ<=I(
M@VU8-<RQ%0=E ?A]*Z5YFE@';7.?_ -02P,$%     @ 1X$.5Z=?E(,X#0
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MMM.?80W=;>_T#C+J3ND*:!F@W;$ND?4V=,;C=5*!/8"?==/98^Q60-[2]YM
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M"=$D/9$:11XRRBQ1-T$+I**L@ 2/\]U2*U')''+0.D3:NO\^4=K$Z';10-#
M%99MP]]DC>57:J<K@$H3]^@["*]ZI*RT6M3?-D'D]X8:0S$RYT2>A1,=3,-N
M$FP(DZ5ZGWL4&?0%U<K$_%L+A>E*J7_%VULZT8&T%?7;DUJ<4-_S])+0B,TG
M4/*U!DDWY602C3APWC7ZUGJ:9$2LCI((\  9I65%H_KCQS=OKM^_4Y]\'-7\
M\_UOOURBH)X]??0\J?GK\F8Y&ACP5$WO G.2!ME>D9%:[,'*,^,6DW%A?_^/
MM]?'9_^Q5+_Q1 1Q#>WDO32.*="ABZHMU?1<H=?6 P/CRC(0$N/_I)N>"#R:
MB-B/H_G7THXSJL9-J4TN:2R[C\Y:;4P#NX!K1,RGJ6 6BDA!V](D=TLEJ;3!
M][&PRD0U50E]JVV59G-8X@\@,^#)$)?!]QUQN#X,$0,O;1K4>^$\[Z[)?R>$
M)G%<['..31RAB9A4%?\O_3OK0Q4"J$NVV;5Q]IQVJRF5DA J#U4Y1,!SW^G=
M_>X<TC2 N((GEV @(R]%^:?QPH#<!V1:&8$CS\20)DWT:9QZ$(S0Q]Y2C=+5
M+EJ!S4)\DF='-,.N" (9TX<@.#\=(DS$PN)]2'YX<ES3:5RLX<=]*TO2R)'@
MA/"%'N.)NRZD2Y;YZES0Q^%.-#;<M%0_CL@!G1<D!71%K38_]S>S VC C7#@
MSS+!BWB,-=N^FYJZ)+_ Z=G64J+%^91 >68;;7Y<V<]&!KJ \+XJ,_<B)@0T
M(27!MSL@D6G18O217[H@YSU$<_7^ GAU:U=6AJ@1-?DDQ G_WCA6#E0*[\J,
M>L/C)YYR@L3R$ 1VJ783_7(E6CD49!X3HM0+LZ/"1Y.UJ/G$^N-B=V>I=#:0
M:\58BZRC;LNNYT21M< +1JD>21B55$*+U%YP^1Y;6&P";P(KL0OG+T<(7.+I
M\(0:?L.+KPR7'E!OSY,?WO7.B*QTX))..V2E73)[DI)'(I0%L6LE:IY8,$<1
M/Y^>YK-[JN"RK'!H'T>PR]D^=SJ#>Y0F0]_H@29-+<W5:BET![KI!:-\C[CP
M0A(DU  ?P#]0"=-%2&66G9O9B6@7(IK0K#E-5J:@L<LP0')SJM'>CY^= A[J
MB$"'&ADLN"%,\9H)(CZFG7_1H=1_H,9*;+S3_C,8'1E>M<B<8YG2@-M0LHN:
M="V$E%NE V0W-_=$;C"^S7G#\,'+VJX[@Z5FN["<0'G&4$X:FNG 2&A FNX$
MM365U!S/M&X721X=<M2ZR\>4TS:W,<-P:#JNR!#0[.)<+!4$1&HD;"TU _3Z
MWE$,@1/H%YU[T,EO^7L?.J%)PCL!E(D%Y254&AM$:ID<V_1L2 HLT9.,P[G1
MM[$=RF\2C%;5M D<M\B+^"O!IR&FR7=M:&@5%LDT?':)DA2//NZT1]9WAR8!
M4YO]27GY*%V2A<3%0T"C0@@EBX=-R]BUS"ZYW]+&JQ;2I?!^A%/MWE1G/\J,
M3%=LGJX08T4M$+,0+0-ON(3[1QE-<]582;@7O+-,OZ4EKA+16GMA^<2UYJ)+
M%9'7[1''0X.\.$ZD7I);FE;OY$2+N%>.I'C6E.K><%8_$H?9".Q-L7PP^%5-
M+V)G[+C:328V"4DD1J/(TW'J/# <0CSB4P)W?6*Z**Z&NP3+YSW!["7*/1E<
M[Z<RX%WR8HB'^_]VM@18$MNLT86OT)/+J]YP,RZG>-0NYGI;Q;/RKP$F8J-*
M_N43R"R@KJEIGLF/-*F:)%9$%6JU.3[98_EBTJC%XJL!*T)/\J#.73FDH#[%
ME>-V#2;84$Q[TWD7KWJ(G5.\S'ACAMM\I=^+^>/-NN)E[[4DLQ6.7B@JL DP
M!0E.4.#8XH^M%;M\DC9^.SI+IL'*,=5W\4AZUO((7<R_EQP9LQ/]-A);9<*4
M<;JX^K"%7NM(XB>7R3[M>[!O= ]Q:58YMN#LC;/!L? ?))4TV#]K&\T;$;Y8
M!)0EI)Z.AB[,FH:^Z]>&M^=]Y.2L1I04.@]4_O/R\D.>;C%RQE9EB#[;R$70
M=&R=292ERQM]D0>O=&=2G9T>_YT?NT09*8#X9Z>T[T>SX5L]A S'_TP.N'ES
M]>U-[P<DN@C''5,\JA[/FO:E73O7226+F<YP-F.Q>=,*),B)ZVQ&<M47=B0M
M$.08AH*+^VG][5"8$J)\1VAZ\>YN:XE@T_ G1=EB8H]X42J.M>)MC#$-&0VT
MAUZ![RMP3//\JMK-5LW!$."*>?X'N7_J44_29<ZA>*=)4CSTVQL2\3D@E;0U
MWX!+M_;NX9D4D"&I)K TCY;0COK:;6K[Z!*SFMYII*W0VM*,0*XD?FO1/?<D
M<7=&>^K1J;^[ACVY]EV<);9.%R1.S\^2BZ3(H6;QMRES_C8W?LNW&+=HF*0_
MLU]4+;=P9;^)V?.=N.15R_<M^(:EC,(G/N%.KM;<;.9;=&.E: ^29U^IBZ7Z
M5?CF&Q3*FA'F$W,0PJ\\T)FUH;1EE*E4/=@//&TC.$J)&B8C?D=7[2!AWHH/
M_.DH*)W\\)V86-U8OSC]'%7B.![FRS=6QE?I>@_=. 6_Z1,38B3@R?B!=[HT
MP1E1H&^$SG)D*;X!]PUQXS WJ++/%\SD.48ISH_I?32:10=.J,%0<,,HOL<7
MH/)AQMB.*P/.=YM/N:A .KF^-AQ,%M87?4W]19$N 8]27* IWA4SL8=<\V$)
M#^!_[\N-A(%>N32M 1-B>,P%^H#=Q<TQPBF=*;K1RVB?[V'% QID5[%_WY)B
M"&#CK=P0.QQ--/V,DZK<0<7+C=*9Y,E^A#@9MXT."M()"AOC_\$YRJ3(\BWA
M*CNU8/PL+<+5)VI$QX0'[;<$,\HUE$:^DVOXXI%OE<%4S$;GK*.#YT/WLBCV
M)_=>Z,/A.'%Z%2;?[5NO$5^DB!!ZYB/I<OIP-#8B:4B2FJZ6B>F+L7HT-$79
MV33JBJ_9%3NPGWC,Q$[X-%-1A[0NTDLV#*<0UW0_.-X]7?=-ZN3RL_-F49<]
MS0NAF?H Y7_N@!82CWPW?QW%G-X,FHS$1(2\3#,1Y$"&_GE98B/7A$KG:<Q(
MW0RRX_LP1LY?!#AI?DQW>U:Z8HXL?]0DEXUGN,>8=TRW'B;J\+"GOU38VQ-%
MC8X\Y"F^VIF0ZSX@7XY(UGY'$;?D#Z+YY_QYH&C>LX\W$T+!(!&7S6OE/0E=
MLF@+/DRI6]?$,\!\\]ZDJC ]O,,^KC;J 1WB/>33@M&,\_O8""[G_L+E9/2W
M2GR-C?XBBT&EZ>3/EO*G^8^^+N5OG8;'Y2_&T'5OT':HRJSQZNGRZ>,CF5VE
M7SK7\E\^K5S7N9I_W/*9!#V [ZD=2+_0!OE/X5[]+U!+ P04    " !'@0Y7
MC"D(I1\3   9-P  &    'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;+5;:W/;
M.++]*RCOU$Q2)<N.DWE47E5.9F8W6Y/:W'CF[H>M_0"1D(2$)+0 :%OSZ_=T
MHP&2$N7,UMW[);$H/!K=IT\_0+V\<_YSV!H3U7W;=.'5V3;&W?.+BU!M3:O#
MTNU,AV_6SK<ZXJ/?7(2=-[KF26US<75Y^=U%JVUW]OHE/_O@7[]T?6QL9SYX
M%?JVU7[_QC3N[M79D[/\X*/=;",]N'C]<J<WYL;$WW8?/#Y=E%5JVYHN6-<I
M;]:OSJZ?/'_SC,;S@/^UYBZ,_E9TDI5SG^G#N_K5V24)9!I315I!X[];\]8T
M#2T$,?XE:YZ5+6GB^.^\^L]\=IQEI8-YZYJ_VSIN7YW]<*9JL]9]$S^ZN[\8
M.<^WM%[EFL#_JKLT]MG3,U7U(;I6)D."UG;I?WTO>AA-^.'RQ(0KF7#%<J>-
M6,H?==2O7WIWISR-QFKT!Q^59T,XVY%1;J+'MQ;SXNN;9 SEUNK&;CJ[MI7N
MHKJN*M=WT78;]<$UMK(FO+R(V(]F752R]INT]M6)M;]3[UT7MT']U-6FGLZ_
M@)Q%V*LL[)NK!Q?\:]\MU=/+A;JZO'KZP'I/R^&?\GI/3ZPW<TKUC^M5B!Y@
M^>?<@=-ZS^;7(P=Z'G:Z,J_.X"'!^%MS]OKK/SWY[O+% ](^*](^>VCU_Z.I
M_EMKJ[<Z;)7NZO3'3__J[:UN3!='WU3TAQE]8[NJZ6NCPM;Y>!Z-;Q=J"W]I
M]JJQ&%<O,.36A-CR\#L;MP!Y[+V-M"6DZB!PW*M:[_'1J\8$#-N:3NUZ7VWA
MEO52O75=A?E>L[]CTD<;/@?UZ];@JW:GN[VR ?2S^@1*4-&IRIO:1N4Q3*V]
M:Y7%YCN(N,9A':U )UD<GX<."7U]-E&O&AS+5"+J4OT&K'M>:#@1UH3R]@L5
M1Z(TMJ51NB4-Y]&FQA\0L=J.%E6K?1%5DS$663E[TEL-EH#I-M[UN[$>5=SO
M#(MJ0^B-7RAS7YE=5*#R\>K\;4V;D'B_+6^6:N-NC>]HD66R*O2V-4VM=,36
MGQPQ8?>9A$YS.DN2WT0=35;.GG?#T[6!0G0#4]LN]#B&G'S)AMDXW;"!1ZKY
M9E9WV,MYTBT&[[QUZ?C:XX@!1VH07L)S%?2:<$(RB L6-&!25]F=;OC;&L'
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M3UA]B"29AE!2_FZ8(0<#$BE-P_S<EX6"62(<M3-0:6!NO',]U+$B,M"IM)"
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MCW*=>SX8+2]*L<9/Z/\L;RWM1AU**@O43AH-%K/+Z&IR=CUC^2#P1>+&]=;
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ME-V$WB4]&([Z+EG52,OE"CS:Z4*FI*$B=L%=3A+%<'(T2N+D'*YKU*Q%(/6
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M^JSX@].V%8 !5P[L8U<DLFJ_7)#P%#MMZ0I1KI!\&^-(=9G9W>Q:PC^8!'Z
M,5.6\-]GM]U"(P&(L#X#EK(D-2@TG6(T%UD8'/^3P1S(ANO4,%S;L.6XL=A'
MO<D>4L<9 ;504Z'L^<P*4>:4XW53'_,EV02$1K&#Z+95S;W$.!;E SM(8G^Z
M]?>Z4Y1/UMN?12T44O>J1L?OW(9<^6\@#NO6\=OCV&-:(OU^D*\+.O*P@W2R
MY93U26 W$M"Z V=;&AV]C[GK2Y'$1=8IE"\,F )0Z+W4*M&X*FGZAO4H-<@1
ME$:7N=6#,/6F\YDW3Q"\RS:2V)1Y4XMC4TB5#R7^,BW?0P6WB;F=+%2\E"(^
M>]O9)"0S6MZSRITA!)TA7+$/)X#]:I?H&I"8)EX\3W9R?\\95T^DME??MMG7
M" -IE F16\6#* V\-$V0\38=Z)\=,OMV"T3R VU?.@C7)Z]>&KHL*QMMZW!O
M8D]V2^\168_*G\6P&7GI=/9,#)X]Z^9D@=#>W6<%KU?HYAP.>90I_8F"%"^Q
M9;;YB4%L&*E]$I' ,&9ZCG8+2E:5R*4K:70DZ/;M9A/G<B=ZOZ?HP\XYX/-P
M#GB9-Q+E2\P*&NL$_,UAOD\F!FX'5UGH15$*!J>;P\AN.#TCOIU!@\"*_(/J
M-C<L*=<E[0QJ6-P+E4G-%Z6@)G''P4.'(]-00KDP5.4U0;0(S>*Y,Q!:"]1;
M"92Z014I:FB -3CD/ B./1J&L40CPR23-/WS/A,LD/-UZU&_1X/OKI=B=^YP
M9F+-'5&)/>[4,>$S\LPA+)L2/<\6M8W$W?7D?VW#$NX.1H.?\F/?QMYICI:_
MW15.'B7")@EN74I_ME<R:%W 84QH9+'E6+!K._:^6K\1=(TE[R]AE.X)U!4_
M(CIV^"\B\@C%/!31%20D+J<9^V0[XB%2[V.!/4,D$/Q_\.'#3E(BI]Z*S'6*
MN._ R.-XCK])Q XP@/Q9S%(_B.EAEF)2AEX24:-(\$L2^9.4Q7Z<XH$.+6&$
MDY"M=B3GMI&[0_0)^[G/]S"=>,%\"LU)L-$;/@<R<G8XB[Q)$!SA1C";?26'
M";D4DN .PR3" $N. #B-GP"D,H 8T"*@15%"'N,Q(/#9S(\GCVG9RRFB))YY
M:9PX2M(YF_H)/<3IU \M):&7)@,E(?P(=RGYA JA?OL4;NS%T[2G.B+<V.+&
M.!_\!=P(+3^86G]#/R#<<$ZX<>JGW\:] 2XRD;!=-7WW4+8E^^S 45M<5^BV
MY'$CE9EK:*Y5:'9HKVY]SGHT0C#1^CL@>A0_0IG#C]T7#(_\L*G\6V=3&PWM
M*\N]1^%D[LV1A#1ODTE?,2_(@[!9@/_S-+:]C7J?90:UJ)]5=-<9<G[;-1?"
MK.G&B</5UWS_7M.9_4>QWEGT_QWWSOZP [.9-\,.H.?,Y\$+.["G=< FKFJ\
M:#IA3[UK&>^\_ZIHTM-;/KH'X=CL7H5M?MV\2+QP[\^VXNXM)&XQ&(^:E6()
M5=3_9,24>[/G'DS3VK=IB\:8IK)?"\$QTTD Z\NF,<,#&=B\7CW_$U!+ P04
M    " !'@0Y7H>&YZH4$  "7"P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q
M."YX;6R=5EEOXS80_BL#;;!H@<2VY#-9VT"\W5[ MD&RQT/1!UH:6T0H4B4I
M*^ZO[W D.T[B9+-]H4C.S#?WB-/:V%N7(WJX*Y1VLRCWOKSH=EV:8R%<QY2H
MB;(RMA">CG;==:5%D;%0H;I)KS?J%D+J:#[ENRL[GYK**ZGQRH*KBD+8[0*5
MJ6=1'.TNKN4Z]^&B.Y^68HTWZ#^75Y9.W3U*)@O43AH-%E>SZ#*^6 P"/S-\
MD5B[@ST$3Y;&W(;#;]DLZ@6#4&'J X*@SP;?HU(!B,SXI\6,]BJ#X.%^A_XS
M^TZ^+(7#]T9]E9G/9]$D@@Q7HE+^VM2_8NO/,."E1CE>H6YX1[T(TLIY4[3"
M9$$A=?,5=VT<#@0FSPDDK4#"=C>*V,J?A!?SJ34UV,!-:&'#KK(T&2=U2,J-
MMT25).?G-[FP>+8@OS)X;PK*M1,A7-.N)_3 TTU;I$6#E#R#-(*/1OO<P0>=
M8?90ODM6[4U+=J8MDA<!?Z]T!_J]4TAZ2?\%O/[>U3[C]5_AZI784F5YN+16
MZ#6&_2G\870J7 X?[D(8$/ZZ7#IOJ6[^/A:-1MG@N++02Q>N%"G.(FH6AW:#
MT?SMFWC4>_>"*X.]*X.7T+\K:_\/"9XE?$6HO%3R7P3'/$OF20]YI :?(X29
M 68%5,7I+9@RT-PI]3*%5::>I)AR"D)G3VZATI+F#7QB($730^HU>+%4V(X0
M,L&QGJ#;:,JA8VW/685M7LDL%O.Y163=3MY!T50OANH%JCW<UQZST":!']@Q
M4SFZ<3]>D&T!X;#N[R5O"/,XA3$9[WYW334B;)JSK@PW-"U+KM 32)(QK?$@
MIG40#VCM#\_A%]1HA6)^D=%DD*%6PX@C\IB$1C 9#& \.H=/QA/C-\-R L,)
MHX]8WVDRG/ W3B8MQ .QU#A/25,B9,P;2M>&,DA[40N;.=#&PQ8#2VK6FG*5
ML:TA\#7/2LS.Q(9\6".4:*4A&4-GJ'-)<0A\+5*-%MG*M%6UQ >H_E%HF5^X
MMFK<DZS=<'G]V91CB/RN[AK"YU!WQZX/=#Z-!,4M"1E*QB%JP_,QCQ&6?\;=
MT"5;2CH7[5/ )W[&G5&?EMZ(EDG<IF0EI(6-4!7N2]_!+A&/P@T[_426!>?M
M7MP=R*]I*#*U;937ML?W!?XU#?)M)T]@Q)W1GPQI-+W"T2-^4M8Z<0#I=48Q
M?"&N)@^7C@9-:RV/H8<@AU,M5&$(54;: I&AH:9@W-M0.9Y@Q+50(KT]NTES
MHT+@&0)**K? 4)@,53/W]D6_,=1G-'3]%J2#IHDKFGF04]L;$J0H'?"0 4%-
MF-M";]^^F23Q^)UK+'Z$[)%F]"[1.V<>ZC#+\/]J0D+(]$.L2!UY13!*E(%O
MB;Y&U(_<#X6!=VA3Z?AV!Q_4":4 BU*9+:)[R2:: 0'LL5'-W-?\?V9SL/G7
M'(ITCOUJNP>/I0+MFI^$CK J[9MWT_YV_^J\;!Y;]^S-D_6CL&M)_BA<D6BO
M,QY&8)MG8'/PIN2GU])X>LCQ-J>7,]K 0/25,7YW" KV;_'Y?U!+ P04
M" !'@0Y7.^1U-5 )  #-&@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX
M;6S=66UOVT82_BL+U2T2P-:K[=B);<!V$C1!FP9)>L7A<!]6Y%#:"\E5=I>6
ME5]_S\R2%"5+3H/>E^L76Z1V9YZ9>>9E5Q=+ZS[[.5%0]T5>^LO>/(3%\\'
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M<VAE970R,"YX;6RM5=MN&S<0_97!I@U:P-!**]EQ'4F ;#=H"@0PG+1]*/I
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M5"O-.]$,4&NL\]$\V6&$)-&E%Y3'V.((/"HR!%+4ZM1Y"8O"_G)IN,-Z19[
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MNNCIGLI1FR<PS<N62ZWD;%?IQM!E'CO$K8$@@6H&DC*"[6TOO8FB/A['MH<
M0)!12I$S8*M42DNM)ZR:CII);'I O;@(QN[&<)W;7?D!N0P1 @SL8T9<Z!;%
MQ>CP<3!K.?XM3:4%I*UC2.U7T;82I-(!_R.^F[OL)(/$H.1W%>(=AX!,LV +
MW>*<D[GZ:R:.O3K2:M-HKL\0O:!$<!NV*CWE LDLAW'Q/I?8/.*0D#11Q&4A
MS5RY/[;@P5YJGZYW%#->RGGQ!KG>B[[\"R?T:RFS=M+2;WJ7+'[-_9_<-9Z.
M"A=/B"K7XQ%,^1I'\17R0&($5:1X]1.E-=!>X=CD0%OY^MZVO0?F-;;,J$PC
M9QI=/^>Z"S(MM"@'HL5[@^'": 2,$KB[7<Z;.#DP^\;Z '?^1 V!N(C8COW<
MA*T"4+ <BAZ^V3-8AGI"5,JQ5Q/=M679N^@:WMO2<.@.ZI.JP_@ORSM9:^;$
M0GN-Z&=2=_2/7?S;9KI4HK;:C=XB%=IZ .6):C7B\/!E"1)@K]UR\X&^25''
MQ)B7X]7@V1K9*=X/WK28W"ZTVQ@HJ7DZHHG&1Q+,] L^<ZAJTJ '_L?O<Y3Q
MNF_&X7236TZP7<6$(B/N;<E@=/F8V06..4J=,?1T6^6@&S4*=F\*=O/'X1!-
M0<JHA=RJ;*0JV.J9L#''@48\AY>1?@!WFU#A<J>?JN#E\-V/6;P'\)/>E*(P
M 307=W4]Y<)GQ//8JT97'MR#S29EF\6;!;(:GI;KP[Z+=[*P^ #27 U2@X5=
M<'A^:^K)7^O8KBFV'$J1WZQL5/N46R4@RCB<>S"Q8TBUSS!5RK??C=/C)Z?;
MID\-O9$( P;5Z2"#L5$1VXVJF8/=*"7'R"[\ZW#!O6"7YJ1O#]&I)Y!?1D=N
M5U,;COV-5IH5J3,QQ-6(GU34$4I42UQ85Y8N;BG3!MUL5WM9H'C*+_&I=!U(
M8[D@I<HK1VW2E%#."-20E NN+\3V()>WD2(,WS,3,<5*?!D]N%=^-/@JT>T)
M'[XG1>F-4TZ8G@\?]TPG9\9&+T90?[5%1O?=')P<#U]U/=[;\9_HM$Q^D_5W
MK_*M7_.M7_.M7_.M7_.M7_.M7_.M7_.M7_-_WJ^9(FM'HY\H-7052C_$HO(=
M<"._5LI/\X^]SN0G3L-P^:78.^56!N%0ZR6F'L\?/SPHG/SX2CX$V_$/GA8V
M(,_QGVNMD.1I -[3;RG2!]H@_P3NY7\!4$L#!!0    ( $>!#E=S#T;;E0,
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M;$!]JM=2]]Q>)>4E5,A%121D<V?AGR\C8V\-/G-H\:A-3"9;(6Y-9Y7.'<\
M00&),@I,?_9P 45AA#3&W4'3Z4,:Q^/V@_I;F[O.9<L0+D3QA:<JGSN10U+(
M6%.H:]&^@T,^4Z.7B +M/VD[VY Z)&E0B?+@K E*7G5?=G]8AR,'ZC_A0 \.
MU')W@2SE)5,LGDG1$FFLM9IIV%2MMX;CE=F4C9)ZEFL_%=_D0)8-ZE%$\N(2
M%.,%OIRY2FL;"S<YZ"P['?J$S@;J,?&G(T(]2@GF3 (^5G$U68]'>SQJ92=/
MR"X0=6$NDKN&([?;^/6]-B$K!25^&\+L],Z&]4R)GV/-$I@[NH81Y!Z<^/DS
M/_!>GZ"=]+234^KQ1HGDEEQ#W<@DUZ5"UE+L)"M'Y*HIMR")R,C&+@U9-"H7
MDO^ E"A!MG#DE0ZEU06>VL#FH.UCG](P#(.9NQ\@/NN)STX3LP(LE2$?D37(
M!"JE3Z,9_-A6(#'G-6&9TO0WDE7([&D:0NPBO3I"],93.LPW[?FF)_DNWEQ=
M#L4ZZ?67NQST3,$_KLG@/]"&/6UX>@5%M=>[:.]0IFF'^#H%WWN\=9-)Y/WZ
M^<,;&?48T>E"LV4_(BO$9KC"HS\J?!*&- RBWP*[1Y>=>3<^,+GC%9(",NWI
MC4,M(;N[N.LH4=O[;RN4ODUM,]?/%TACH.<S(=1#QURI_8,8_P102P,$%
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MZ>Z5C]T-)YOJK8E[PCG)JLLUCI:8E@;B^Q4A_.6F?!&C>?%F_C]02P,$%
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MIS&:5/755G>,+-WM,),&[QK7S/%K )0-P.<+*<U3QUXX[?=%^AM02P,$%
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ME_1JQ!>5A+)'.IK_\1MTK+^Z$)D,YAD*5L-'2GQ$%GU>@ONT3Y.4S_X@6E^
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MF:MNRU-J@^GW2*82UAD*CV2K>J2S*MORZ-JX4/\\,NJ*)I6'YK>4K?,?'TC
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MY ,  .H5   9    >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;,687X^;.!#
MOXK%554KM<M_DMTF2$G@KJVZTFK3WCU4]^"$24 %G+.=9/?;UP9"(&'1YNIJ
M7Q(P,[_QS)C!GM&>T!\L!N#H(4MS-M9BSC<WNLZ6,62879$-Y.+)BM ,<W%+
MUSK;4,!1H92ENF48GI[A)-?\43%V1_T1V?(TR>&.(K;-,DP?IY"2_5@SM</
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M=^-=K:J4%JRD#8)*P$\S=@0U[QT$7E"#T? ,]O<.*G!KY9+5+&Y]UY(I'M[
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M&.M\'X49H/LGG*M5Q4Q0_H/H_P-02P,$%     @ 1X$.5^K[WIG; @  )@<
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M"M485.-0S8=J@:/Y\I6NKD QA/8;H30U3$W%AF.NV'@^1[P3*Q(*F8OOVOA
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MY1)J4%=EVV_'_G[[=.5R_[4%_RZWSBIH1P]*2Z!H;O)MUQ_CDY=+4*, E$9
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M AO<N#3!? @I,8_$Q"*YE(6J@0VNE#$?V!UH9Q&N(<3##!(3*^2""\T>>=4
MNP9N&KWI4T(\S!TQL3Q<(]6-Z^VN!&^SNIW7#S-&3*P,;UA7*A?LR@6NRX5)
M(B:VQ-2JXFFIJA*T^:MM%_8E9,/<$!/+H7WUAZ<N7&4K?Y"F/2CDPTP1$ZOB
MM;$^\)_=^L3$$!.;X:0Q5O-*<'8/!K@NEFV'=PYKJ-2J#M-E3!D)L3)<<N(;
M \BBVT833!$)L2*NW&'2 #M9:-CKV!)T>$&LA?_J\LP-,_E,Z?:0MF8]=(B)
MZ2$AUL.TF1GXT7BO?EOOQ@\30T(L!C2I^YZ$F)@D$F));-(Z-GCPR50G*4DP
M1R3$CD#S.S8(,3%=),2Z.)3A]403LT;R-M;83?&VG"$F)I*$6"0'4KT>S!03
M24H]]MA/^?IJ/,6\DA)[93?WZP7$])(2ZZ4O">R%1&>OJ.5R(!M\!0TQ,=6D
MQ*H)9S38X!RLZSN[0<0,DQ(;!A=A&F)BQDF)C;,585_X,,6DQ(K!33@,,3'%
MI,2*03$[Z4Z**2:E'JN@F.'+F&&*R8@5<RBO>'TY0TS,,AFQ90[F%1O.$!-S
M34;LFH-YQ3XF9IN,V#:]>45/=Y2A:R7$KME++(;LAFM?M/;U'F)BTLG>>.[+
M889K9"$F)IV,6#H]F!>-=2\HN_8KPB$FYJ",>E:L+UD;;O]<AIB8@S+J=91^
MS+:8W88+>1GFH(S800<P[\%8+0H;KC=B#LJ)'70P^1VVO7R(B3DH)W80@KF[
M>HLY**<>[QS&]'H*,3$'Y<0."N>7>^638_+)J1=;L)GF3I*9HTOUQ/+9G]3M
M#R5FGIS8/.CT;C>4F'ER:O/L3N_V1Q*S3MY:9[3]>JF$N1LHES?N\L:5%[PJ
M[C3S/YN5V"SWBRGSIJK.7-FMO%*\W'X,M?V0Z^MO4$L#!!0    ( $>!#E<3
M)^RZ[P$  *4B   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-VKM.
MZT 4A>%7B?P 3/8MP!&AHJ%%O( 5)A>1Q)8]"'A[HE"$95&<!LVJK+'E[;_Z
M9(U]]Y3W;=EUQW&[Z\?9QV%_')?-MI3^7TKC:IL/[7C5]?EXNK+NAD-;3LMA
MD_IV]=IN<M+Y?)&&GS.:^[N?,V?/GWW^GXG=>KU;Y8=N]7;(Q_++X/3>#:_C
M-N?2S)[;89/+LDD?^\OI,9T/<G6:W,P>7Y;-\/@B3:H=I!"D]8,,@JQ^D$.0
MUP\*"(KZ00L(6M0/NH:@Z_I!-Q!T4S_H%H)NZP?)'&6<$R1-L";06I!K(?!:
M$&PA$%N0;"$P6Q!M(5!;D&TA<%L0;B&06Y!N(;!;$&\AT%M1;R706U%O)=!;
M)R_;!'HKZJT$>BOJK01Z*^JM!'HKZJT$>BOJK01Z*^JM!'HKZJT$>AOJ;01Z
M&^IM!'H;ZFT$>MMDLX1 ;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V-0&]#O8U
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ME/7)VO5?_]O0W_/6U-U[/AM^(+EZ!5!+ 0(4 Q0    ( $>!#E<'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ 1X$.5ZE8\UWO    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ 1X$.5YE<G",0!@  G"<  !,
M         ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !'
M@0Y78.%_+-H%  #4'@  &               @($."   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ 1X$.5\R:P 3$!0  ZA8  !@
M         ("!'@X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0
M   ( $>!#E<QAUJ'Y@(   <(   8              " @1@4  !X;"]W;W)K
M<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !'@0Y7XPH3=L8%  "E&P
M&               @($T%P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!
M A0#%     @ 1X$.5_,6,N&0 P  Z L  !@              ("!,!T  'AL
M+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( $>!#E>G7Y2#. T
M *N/   8              " @?8@  !X;"]W;W)K<VAE971S+W-H965T-BYX
M;6Q02P$"% ,4    " !'@0Y7)),AA0 &  #1&   &               @(%D
M+@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ 1X$.5^O*
M[545%   %C<  !@              ("!FC0  'AL+W=O<FMS:&5E=',O<VAE
M970X+GAM;%!+ 0(4 Q0    ( $>!#E>,*0BE'Q,  !DW   8
M  " @>5(  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " !'
M@0Y7XOS1#SX$   9"0  &0              @($Z7   >&PO=V]R:W-H965T
M<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( $>!#E>0OME?,00  .\*   9
M          " @:]@  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#
M%     @ 1X$.5[3(D1+W @  FP8  !D              ("!%V4  'AL+W=O
M<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !'@0Y7R'V0==T"  !B
M!@  &0              @(%%:   >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM
M;%!+ 0(4 Q0    ( $>!#E<1+,;6YP0  $D,   9              " @5EK
M  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ 1X$.5Y?K
M<-RW @  . 8  !D              ("!=W   'AL+W=O<FMS:&5E=',O<VAE
M970Q-2YX;6Q02P$"% ,4    " !'@0Y7#2VBGN\$   C#   &0
M    @(%E<P  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    (
M $>!#E=&XH:>$@@  &H5   9              " @8MX  !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&UL4$L! A0#%     @ 1X$.5Z'AN>J%!   EPL  !D
M             ("!U(   'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"
M% ,4    " !'@0Y7.^1U-5 )  #-&@  &0              @(&0A0  >&PO
M=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( $>!#E?A?"X!30,
M &T'   9              " @1>/  !X;"]W;W)K<VAE971S+W-H965T,C N
M>&UL4$L! A0#%     @ 1X$.5]9@-C%P!   L@D  !D              ("!
MFY(  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " !'@0Y7
MW<'HP4T+  "P*   &0              @(%"EP  >&PO=V]R:W-H965T<R]S
M:&5E=#(R+GAM;%!+ 0(4 Q0    ( $>!#E=J1RXE5@L  .0H   9
M      " @<:B  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%
M  @ 1X$.5V?5'^R+ P  X <  !D              ("!4ZX  'AL+W=O<FMS
M:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !'@0Y7,,\V6 D0   .-P
M&0              @($5L@  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+
M 0(4 Q0    ( $>!#E=S#T;;E0,  'D'   9              " @57"  !X
M;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ 1X$.5Q#ZI#F+
M!   70P  !D              ("!(<8  'AL+W=O<FMS:&5E=',O<VAE970R
M-RYX;6Q02P$"% ,4    " !'@0Y7K/DH]+0"   -!@  &0
M@('CR@  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( $>!
M#E=OA,@RG@(  +X%   9              " @<[-  !X;"]W;W)K<VAE971S
M+W-H965T,CDN>&UL4$L! A0#%     @ 1X$.5W52;[L5 P  )@<  !D
M         ("!H]   'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
M    " !'@0Y7'.;S_,8"   Y!@  &0              @('OTP  >&PO=V]R
M:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( $>!#E=!/=W23P,  $,(
M   9              " @>S6  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL
M4$L! A0#%     @ 1X$.5_YN&:=:!   %PP  !D              ("!<MH
M 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " !'@0Y7'WHO
M4?@#  #/"@  &0              @($#WP  >&PO=V]R:W-H965T<R]S:&5E
M=#,T+GAM;%!+ 0(4 Q0    ( $>!#E=,JR/[J0(  !P'   9
M  " @3+C  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @
M1X$.5YZ[T+RV P  'A   !D              ("!$N8  'AL+W=O<FMS:&5E
M=',O<VAE970S-BYX;6Q02P$"% ,4    " !'@0Y7!W%",[8$  #,%@  &0
M            @('_Z0  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4
M Q0    ( $>!#E?9_5KQA@4  (0C   9              " @>SN  !X;"]W
M;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ 1X$.5ZXH2P*% @
M@08  !D              ("!J?0  'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6Q02P$"% ,4    " !'@0Y7@D !@]@"  #;"0  &0              @(%E
M]P  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( $>!#E>&
M?7)PRP,  $ 4   9              " @73Z  !X;"]W;W)K<VAE971S+W-H
M965T-#$N>&UL4$L! A0#%     @ 1X$.5P8#IDD@ P  Y0P  !D
M     ("!=OX  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $>!#E=Y7ZV<P (  .X(   9              "
M@:\. 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ 1X$.
M5PF 1U*4!   UQP  !D              ("!IA$! 'AL+W=O<FMS:&5E=',O
M<VAE970T."YX;6Q02P$"% ,4    " !'@0Y7 &.!2/T'   "0@  &0
M        @(%Q%@$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0
M   ( $>!#E?XIR2A_0,  ,,2   9              " @:4> 0!X;"]W;W)K
M<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ 1X$.5QD_V!7D P  ZA4
M !D              ("!V2(! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q0
M2P$"% ,4    " !'@0Y7Z^_$0C8#  !-#   &0              @('T)@$
M>&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( $>!#E?J^]Z9
MVP(  "8'   9              " @6$J 0!X;"]W;W)K<VAE971S+W-H965T
M-3,N>&UL4$L! A0#%     @ 1X$.5[7CN#AX"0  *7P  !D
M ("!<RT! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " !'
M@0Y7@N'\"*\"  !C"   &0              @($B-P$ >&PO=V]R:W-H965T
M<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( $>!#E=HL,C<< <  -])   9
M          " @0@Z 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#
M%     @ 1X$.5YZ)G%E] P  E0\  !D              ("!KT$! 'AL+W=O
M<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " !'@0Y7VXX&?10"  #
M!   &0              @(%C10$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM
M;%!+ 0(4 Q0    ( $>!#E<G'9)940,  +05   -              "  :Y'
M 0!X;"]S='EL97,N>&UL4$L! A0#%     @ 1X$.5Y>*NQS     $P(   L
M             ( !*DL! %]R96QS+RYR96QS4$L! A0#%     @ 1X$.5PE"
MQ:JJ!   3"8   \              ( !$TP! 'AL+W=O<FMB;V]K+GAM;%!+
M 0(4 Q0    ( $>!#E<3)^RZ[P$  *4B   :              "  >I0 0!X
M;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( $>!#E=B(^<8
MV $  $@B   3              "  1%3 0!;0V]N=&5N=%]4>7!E<UTN>&UL
64$L%!@    !" $( !1(  !I5 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>164</ContextCount>
  <ElementCount>277</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>49</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ConsolidatedStatementsofEquity</Role>
      <ShortName>Consolidated Statements of Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - The Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/TheBusiness</Role>
      <ShortName>The Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Merger</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/Merger</Role>
      <ShortName>Merger</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Available-for-Sale-Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AvailableforSaleSecurities</Role>
      <ShortName>Available-for-Sale-Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Property and Equipment (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.caladrius.com/role/PropertyandEquipmentNotes</Role>
      <ShortName>Property and Equipment (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Income (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/IncomeLossPerShare</Role>
      <ShortName>Income (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AccruedLiabilities</Role>
      <ShortName>Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Operating Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/OperatingLeases</Role>
      <ShortName>Operating Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Australia Research and Development Tax Incentive</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentive</Role>
      <ShortName>Australia Research and Development Tax Incentive</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/LicenseAgreements</Role>
      <ShortName>License Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Research Collaboration and License Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreement</Role>
      <ShortName>Research Collaboration and License Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954701 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954702 - Disclosure - Merger (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/MergerTables</Role>
      <ShortName>Merger (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/Merger</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954703 - Disclosure - Available-for-Sale-Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AvailableforSaleSecuritiesTables</Role>
      <ShortName>Available-for-Sale-Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/AvailableforSaleSecurities</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954704 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/PropertyandEquipmentNotes</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954705 - Disclosure - Income (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/IncomeLossPerShareTables</Role>
      <ShortName>Income (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/IncomeLossPerShare</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954706 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/FairValueMeasurements</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954707 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/AccruedLiabilities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954708 - Disclosure - Operating Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/OperatingLeasesTables</Role>
      <ShortName>Operating Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/OperatingLeases</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954709 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/StockholdersEquity</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954710 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/ShareBasedCompensation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954711 - Disclosure - The Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/TheBusinessDetails</Role>
      <ShortName>The Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/TheBusiness</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954712 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954713 - Disclosure - Merger (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/MergerDetails</Role>
      <ShortName>Merger (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/MergerTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954714 - Disclosure - Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails</Role>
      <ShortName>Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954715 - Disclosure - Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails</Role>
      <ShortName>Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954716 - Disclosure - Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954717 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/PropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954718 - Disclosure - Income (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/IncomeLossPerShareDetails</Role>
      <ShortName>Income (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/IncomeLossPerShareTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954719 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954720 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/AccruedLiabilitiesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954721 - Disclosure - Operating Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/OperatingLeasesNarrativeDetails</Role>
      <ShortName>Operating Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954722 - Disclosure - Operating Leases - Balance Sheet Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails</Role>
      <ShortName>Operating Leases - Balance Sheet Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954723 - Disclosure - Operating Leases - Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Operating Leases - Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954724 - Disclosure - Stockholders' Equity - Equity Issuances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails</Role>
      <ShortName>Stockholders' Equity - Equity Issuances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954725 - Disclosure - Stockholders' Equity - Stock Options and Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails</Role>
      <ShortName>Stockholders' Equity - Stock Options and Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954726 - Disclosure - Stockholders' Equity - Restricted Stock and Restricted Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails</Role>
      <ShortName>Stockholders' Equity - Restricted Stock and Restricted Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954727 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails</Role>
      <ShortName>Share-Based Compensation - Share-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954728 - Disclosure - Share-Based Compensation - Compensation Cost Not Yet Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails</Role>
      <ShortName>Share-Based Compensation - Compensation Cost Not Yet Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954729 - Disclosure - Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails</Role>
      <ShortName>Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954730 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/IncomeTaxes</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954731 - Disclosure - Australia Research and Development Tax Incentive (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails</Role>
      <ShortName>Australia Research and Development Tax Incentive (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentive</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954732 - Disclosure - License Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/LicenseAgreementsDetails</Role>
      <ShortName>License Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/LicenseAgreements</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954733 - Disclosure - Research Collaboration and License Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails</Role>
      <ShortName>Research Collaboration and License Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreement</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="clbs-20230630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954734 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.caladrius.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.caladrius.com/role/SubsequentEvents</ParentRole>
      <Position>58</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="clbs-20230630.htm">clbs-20230630.htm</File>
    <File>clbs-20230630.xsd</File>
    <File>clbs-20230630_cal.xml</File>
    <File>clbs-20230630_def.xml</File>
    <File>clbs-20230630_lab.xml</File>
    <File>clbs-20230630_pre.xml</File>
    <File>clbs-ex311_20230630xq2.htm</File>
    <File>clbs-ex32_20230630q2.htm</File>
    <File>ex101slackseveranceagm05.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>clbs-20230630_g1.jpg</File>
    <File>clbs-20230630_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="624">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>84
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "clbs-20230630.htm": {
   "axisCustom": 0,
   "axisStandard": 19,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 624,
    "http://xbrl.sec.gov/dei/2023": 29
   },
   "contextCount": 164,
   "dts": {
    "calculationLink": {
     "local": [
      "clbs-20230630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "clbs-20230630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "clbs-20230630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "clbs-20230630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clbs-20230630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "clbs-20230630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 433,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2023": 7,
    "http://xbrl.sec.gov/dei/2023": 5,
    "total": 12
   },
   "keyCustom": 57,
   "keyStandard": 220,
   "memberCustom": 7,
   "memberStandard": 39,
   "nsprefix": "clbs",
   "nsuri": "http://www.caladrius.com/20230630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.caladrius.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Merger",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.caladrius.com/role/Merger",
     "shortName": "Merger",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Available-for-Sale-Securities",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.caladrius.com/role/AvailableforSaleSecurities",
     "shortName": "Available-for-Sale-Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Property and Equipment (Notes)",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.caladrius.com/role/PropertyandEquipmentNotes",
     "shortName": "Property and Equipment (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Income (Loss) Per Share",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.caladrius.com/role/IncomeLossPerShare",
     "shortName": "Income (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.caladrius.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Accrued Liabilities",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.caladrius.com/role/AccruedLiabilities",
     "shortName": "Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Operating Leases",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.caladrius.com/role/OperatingLeases",
     "shortName": "Operating Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Stockholders' Equity",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.caladrius.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Share-Based Compensation",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.caladrius.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.caladrius.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.caladrius.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:ResearchAndDevelopmentTaxIncentiveTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Australia Research and Development Tax Incentive",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentive",
     "shortName": "Australia Research and Development Tax Incentive",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:ResearchAndDevelopmentTaxIncentiveTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Contingencies",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.caladrius.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - License Agreements",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.caladrius.com/role/LicenseAgreements",
     "shortName": "License Agreements",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Research Collaboration and License Agreement",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreement",
     "shortName": "Research Collaboration and License Agreement",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.caladrius.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954701 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "25",
     "role": "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetAcquisitionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954702 - Disclosure - Merger (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.caladrius.com/role/MergerTables",
     "shortName": "Merger (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetAcquisitionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954703 - Disclosure - Available-for-Sale-Securities (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.caladrius.com/role/AvailableforSaleSecuritiesTables",
     "shortName": "Available-for-Sale-Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954704 - Disclosure - Property and Equipment (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.caladrius.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954705 - Disclosure - Income (Loss) Per Share (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.caladrius.com/role/IncomeLossPerShareTables",
     "shortName": "Income (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954706 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.caladrius.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954707 - Disclosure - Accrued Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.caladrius.com/role/AccruedLiabilitiesTables",
     "shortName": "Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954708 - Disclosure - Operating Leases (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.caladrius.com/role/OperatingLeasesTables",
     "shortName": "Operating Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954709 - Disclosure - Stockholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.caladrius.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954710 - Disclosure - Share-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.caladrius.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-75",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954711 - Disclosure - The Business (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.caladrius.com/role/TheBusinessDetails",
     "shortName": "The Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-75",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954712 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954713 - Disclosure - Merger (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.caladrius.com/role/MergerDetails",
     "shortName": "Merger (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-74",
      "decimals": "2",
      "lang": "en-US",
      "name": "clbs:AssetAcquisitionSharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954714 - Disclosure - Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails",
     "shortName": "Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954715 - Disclosure - Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails",
     "shortName": "Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.caladrius.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954716 - Disclosure - Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails",
     "shortName": "Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954717 - Disclosure - Property and Equipment (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.caladrius.com/role/PropertyandEquipmentDetails",
     "shortName": "Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-94",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954718 - Disclosure - Income (Loss) Per Share (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.caladrius.com/role/IncomeLossPerShareDetails",
     "shortName": "Income (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-94",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-103",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954719 - Disclosure - Fair Value Measurements (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.caladrius.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-103",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954720 - Disclosure - Accrued Liabilities (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.caladrius.com/role/AccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954721 - Disclosure - Operating Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.caladrius.com/role/OperatingLeasesNarrativeDetails",
     "shortName": "Operating Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954722 - Disclosure - Operating Leases - Balance Sheet Presentation (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails",
     "shortName": "Operating Leases - Balance Sheet Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954723 - Disclosure - Operating Leases - Future Minimum Lease Payments (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails",
     "shortName": "Operating Leases - Future Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954724 - Disclosure - Stockholders' Equity - Equity Issuances (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
     "shortName": "Stockholders' Equity - Equity Issuances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-108",
      "decimals": "-5",
      "lang": "en-US",
      "name": "clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-4",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954725 - Disclosure - Stockholders' Equity - Stock Options and Warrants (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails",
     "shortName": "Stockholders' Equity - Stock Options and Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ProfitLoss",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Statements of Comprehensive Loss",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-111",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954726 - Disclosure - Stockholders' Equity - Restricted Stock and Restricted Stock Units (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails",
     "shortName": "Stockholders' Equity - Restricted Stock and Restricted Stock Units (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-111",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954727 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails",
     "shortName": "Share-Based Compensation - Share-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-5",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-125",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954728 - Disclosure - Share-Based Compensation - Compensation Cost Not Yet Recognized (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails",
     "shortName": "Share-Based Compensation - Compensation Cost Not Yet Recognized (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-125",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-128",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954729 - Disclosure - Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails",
     "shortName": "Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-128",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954730 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.caladrius.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-4",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "clbs:IncomeTaxIncentiveReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954731 - Disclosure - Australia Research and Development Tax Incentive (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails",
     "shortName": "Australia Research and Development Tax Incentive (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-3",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "clbs:IncomeTaxIncentiveReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-156",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954732 - Disclosure - License Agreements (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.caladrius.com/role/LicenseAgreementsDetails",
     "shortName": "License Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-156",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "clbs:CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-160",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954733 - Disclosure - Research Collaboration and License Agreement (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails",
     "shortName": "Research Collaboration and License Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-160",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-164",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentOwnedBalanceShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "9954734 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.caladrius.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-164",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentOwnedBalanceShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-29",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.caladrius.com/role/ConsolidatedStatementsofEquity",
     "shortName": "Consolidated Statements of Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-29",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:BusinessTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - The Business",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.caladrius.com/role/TheBusiness",
     "shortName": "The Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:BusinessTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "clbs-20230630.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 49,
   "tag": {
    "clbs_AccruedGrantFunding": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Grant Funding",
        "label": "Accrued Grant Funding",
        "terseLabel": "Accounting &amp; tax consulting liabilities"
       }
      }
     },
     "localname": "AccruedGrantFunding",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AggregateIntrinsicValueWarrantsOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value, Warrants Outstanding",
        "label": "Aggregate Intrinsic Value, Warrants Outstanding",
        "terseLabel": "Warrants Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "AggregateIntrinsicValueWarrantsOutstanding",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AggregateIntrinsicValueWarrantsvested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value, Warrants vested",
        "label": "Aggregate Intrinsic Value, Warrants vested",
        "terseLabel": "Warrants, Vested, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "AggregateIntrinsicValueWarrantsvested",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value, Warrants vested and expected to vest",
        "label": "Aggregate Intrinsic Value, Warrants vested and expected to vest",
        "terseLabel": "Warrants, Vested and expected to vest, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "AggregateIntrinsicValueWarrantsvestedandexpectedtovest",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AssetAcquisitionAcquiredInProcessResearchAndDevelopment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Acquired In-Process Research And Development",
        "label": "Asset Acquisition, Acquired In-Process Research And Development",
        "terseLabel": "Acquired in-process research and development"
       }
      }
     },
     "localname": "AssetAcquisitionAcquiredInProcessResearchAndDevelopment",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AssetAcquisitionCashAndCashEquivalents": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Cash and Cash Equivalents",
        "label": "Asset Acquisition, Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "AssetAcquisitionCashAndCashEquivalents",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AssetAcquisitionConsiderationTransferredEquityValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Consideration Transferred, Equity Value",
        "label": "Asset Acquisition, Consideration Transferred, Equity Value",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferredEquityValue",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AssetAcquisitionIntangibles": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Intangibles",
        "label": "Asset Acquisition, Intangibles",
        "terseLabel": "License"
       }
      }
     },
     "localname": "AssetAcquisitionIntangibles",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AssetAcquisitionNetWorkingCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Net Working Capital",
        "label": "Asset Acquisition, Net Working Capital",
        "negatedTerseLabel": "Net working capital (excluding cash)"
       }
      }
     },
     "localname": "AssetAcquisitionNetWorkingCapital",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AssetAcquisitionOtherLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Other Liabilities",
        "label": "Asset Acquisition, Other Liabilities",
        "negatedTerseLabel": "Other liabilities"
       }
      }
     },
     "localname": "AssetAcquisitionOtherLiabilities",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AssetAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Share Price",
        "label": "Asset Acquisition, Share Price",
        "terseLabel": "Multiplied by the fair value per share of Lisata common stock on September 15, 2022"
       }
      }
     },
     "localname": "AssetAcquisitionSharePrice",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_AtTheMarketOfferingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At The Market Offering Agreement",
        "label": "At The Market Offering Agreement [Member]",
        "terseLabel": "ATM Agreement"
       }
      }
     },
     "localname": "AtTheMarketOfferingAgreementMember",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_BusinessTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Business [Text Block]",
        "label": "The Business [Text Block]",
        "terseLabel": "The Business"
       }
      }
     },
     "localname": "BusinessTextBlock",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/TheBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "clbs_CENDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CEND",
        "label": "CEND [Member]",
        "terseLabel": "CEND"
       }
      }
     },
     "localname": "CENDMember",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails",
      "http://www.caladrius.com/role/MergerDetails",
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
      "http://www.caladrius.com/role/TheBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_ClinicalAndRDRelatedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical and R&amp;D Related Liabilities",
        "label": "Clinical and R&amp;D Related Liabilities",
        "terseLabel": "Clinical and R&amp;D related liabilities"
       }
      }
     },
     "localname": "ClinicalAndRDRelatedLiabilities",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee",
        "label": "Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee",
        "terseLabel": "Annual license maintenance fee"
       }
      }
     },
     "localname": "CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFee",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee After First Sale",
        "label": "Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee After First Sale",
        "terseLabel": "Annual license maintenance fee, after first sale"
       }
      }
     },
     "localname": "CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeAfterFirstSale",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Starting at Year Seven",
        "label": "Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Starting at Year Seven",
        "terseLabel": "Annual license maintenance fee, year seven"
       }
      }
     },
     "localname": "CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeStartingAtYearSeven",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Year Four",
        "label": "Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Year Four",
        "terseLabel": "Annual license maintenance fee, year four"
       }
      }
     },
     "localname": "CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearFour",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Year Two and Three",
        "label": "Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Year Two and Three",
        "terseLabel": "Annual license maintenance fee, years two and three"
       }
      }
     },
     "localname": "CollaborativeArrangementRightsAndObligationsAnnualLicenseMaintenanceFeeYearTwoAndThree",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_CollaborativeArrangementRightsAndObligationsChangeOfControlFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Rights and Obligations, Change of Control Fee",
        "label": "Collaborative Arrangement, Rights and Obligations, Change of Control Fee",
        "terseLabel": "Change of control fee"
       }
      }
     },
     "localname": "CollaborativeArrangementRightsAndObligationsChangeOfControlFee",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product",
        "label": "Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product",
        "terseLabel": "Potential milestone payments"
       }
      }
     },
     "localname": "CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Rights and Obligations, Royalties Net of Sales",
        "label": "Collaborative Arrangement, Rights and Obligations, Royalties Net of Sales",
        "terseLabel": "Royalties, net of sales"
       }
      }
     },
     "localname": "CollaborativeArrangementRightsAndObligationsRoyaltiesNetOfSales",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_CollaborativeArrangementRightsAndObligationsSublicensingFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Rights and Obligations, Sublicensing Fees",
        "label": "Collaborative Arrangement, Rights and Obligations, Sublicensing Fees",
        "terseLabel": "Sublicensing fee"
       }
      }
     },
     "localname": "CollaborativeArrangementRightsAndObligationsSublicensingFees",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_CommonStockWarrantsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Warrants, Shares",
        "label": "Common Stock Warrants, Shares",
        "periodEndLabel": "Warrants, Outstanding, End of Period (in shares)",
        "periodStartLabel": "Warrants, Outstanding, Beginning of Period (in shares)"
       }
      }
     },
     "localname": "CommonStockWarrantsShares",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_EPSAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EPS",
        "label": "EPS [Abstract]",
        "terseLabel": "Basic and diluted loss per share"
       }
      }
     },
     "localname": "EPSAbstract",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "clbs_FairValueMarketOfTaxNOLs": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Market of Tax NOLs",
        "label": "Fair Value Market of Tax NOLs",
        "terseLabel": "Fair Value Market of Tax NOLs"
       }
      }
     },
     "localname": "FairValueMarketOfTaxNOLs",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_ImpiloMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impilo",
        "label": "Impilo [Member]",
        "terseLabel": "Impilo"
       }
      }
     },
     "localname": "ImpiloMember",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_IncomeTaxIncentiveReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Incentive Receivable",
        "label": "Income Tax Incentive Receivable",
        "terseLabel": "Income Tax Incentive Receivable"
       }
      }
     },
     "localname": "IncomeTaxIncentiveReceivable",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities",
        "label": "Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities",
        "terseLabel": "Accounts payable, accrued liabilities and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]",
        "label": "Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Liabilities and Right-of-Use Assets on Balance Sheet"
       }
      }
     },
     "localname": "LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "clbs_LossOnSaleOfNOL": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss On Sale of NOL",
        "label": "Loss On Sale of NOL",
        "terseLabel": "Loss On Sale of NOL"
       }
      }
     },
     "localname": "LossOnSaleOfNOL",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_MassachusettsInstituteOfTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Massachusetts Institute of Technology",
        "label": "Massachusetts Institute of Technology [Member]",
        "terseLabel": "Massachusetts Institute of Technology"
       }
      }
     },
     "localname": "MassachusettsInstituteOfTechnologyMember",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_OperatingLeaseRightOfUseAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset",
        "label": "Operating Lease, Right-Of-Use Asset [Abstract]",
        "terseLabel": "Right-of-Use Assets:"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAbstract",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "clbs_OperatingLossCarryforwardsBeforeWriteDown": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Before Write Down",
        "label": "Operating Loss Carryforwards, Before Write Down",
        "terseLabel": "Net operating loss carryforwards, prior to write down"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsBeforeWriteDown",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_OperatingLossCarryforwardsPostAcquisition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Post Acquisition",
        "label": "Operating Loss Carryforwards, Post Acquisition",
        "terseLabel": "Operating Loss Carryforwards, Post Acquisition"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsPostAcquisition",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_OptionsVestedweightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options, Vested, weighted Average Remaining Contractual Term",
        "label": "Options, Vested, weighted Average Remaining Contractual Term",
        "terseLabel": "Options, Vested, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "OptionsVestedweightedAverageRemainingContractualTerm",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clbs_ProceedsFromExerciseOfOptionsFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from exercise of options, Financing Activities",
        "label": "Proceeds from exercise of options, Financing Activities",
        "terseLabel": "Proceeds from exercise of options"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfOptionsFinancingActivities",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_ProceedsFromSaleOfNOLS": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Sale of NOLS",
        "label": "Proceeds From Sale of NOLS",
        "terseLabel": "Proceeds From Sale of NOLS"
       }
      }
     },
     "localname": "ProceedsFromSaleOfNOLS",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_QiluMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Qilu",
        "label": "Qilu [Member]",
        "terseLabel": "Qilu"
       }
      }
     },
     "localname": "QiluMember",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_ResearchAndDevelopmentTaxIncentiveTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Tax Incentive",
        "label": "Research and Development Tax Incentive [Text Block]",
        "terseLabel": "Australia Research and Development Tax Incentive"
       }
      }
     },
     "localname": "ResearchAndDevelopmentTaxIncentiveTextBlock",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentive"
     ],
     "xbrltype": "textBlockItemType"
    },
    "clbs_RevenuePerformanceObligationPercentageOfNetSale": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Performance Obligation, Percentage of Net Sale",
        "label": "Revenue, Performance Obligation, Percentage of Net Sale",
        "terseLabel": "Percentage of net sale"
       }
      }
     },
     "localname": "RevenuePerformanceObligationPercentageOfNetSale",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_RevenuePerformanceObligationPercentageOfSublicensingRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Performance Obligation, Percentage of Sublicensing Revenues",
        "label": "Revenue, Performance Obligation, Percentage of Sublicensing Revenues",
        "terseLabel": "Percentage of sublicensing revenues"
       }
      }
     },
     "localname": "RevenuePerformanceObligationPercentageOfSublicensingRevenues",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_RevenueRemainingPerformanceObligationVariableConsiderationAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Remaining Performance Obligation, Variable Consideration Amount",
        "label": "Revenue, Remaining Performance Obligation, Variable Consideration Amount",
        "terseLabel": "Variable consideration amounts, milestones"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationVariableConsiderationAmount",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement",
        "label": "Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement",
        "terseLabel": "Aggregate offering amount authorized per agreement"
       }
      }
     },
     "localname": "SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_SaleOfStockAvailableForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of Stock Available for Sale",
        "label": "Sale of Stock Available for Sale",
        "terseLabel": "Sale of Stock Available for Sale"
       }
      }
     },
     "localname": "SaleOfStockAvailableForSale",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_SanfordBurnhamPrebysMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanford Burnham Prebys",
        "label": "Sanford Burnham Prebys [Member]",
        "terseLabel": "Sanford Burnham Prebys"
       }
      }
     },
     "localname": "SanfordBurnhamPrebysMember",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_SharesHeldByThirdParty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Held by Third Party",
        "label": "Shares Held by Third Party",
        "terseLabel": "Shares held by third party"
       }
      }
     },
     "localname": "SharesHeldByThirdParty",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_SharesIssuedUnderLicenseAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Issued Under License Agreement",
        "label": "Shares Issued Under License Agreement",
        "terseLabel": "Shares issued under license agreement"
       }
      }
     },
     "localname": "SharesIssuedUnderLicenseAgreement",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_Sharesvestedandexpectedtovest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "shares, vested and expected to vest",
        "label": "shares, vested and expected to vest",
        "terseLabel": "Warrants, Vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "Sharesvestedandexpectedtovest",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_UniversityOfCaliforniaAtSanDiegoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "University of California at San Diego",
        "label": "University of California at San Diego [Member]",
        "terseLabel": "University of California at San Diego"
       }
      }
     },
     "localname": "UniversityOfCaliforniaAtSanDiegoMember",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_WarrantsCanceled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Canceled",
        "label": "Warrants Canceled",
        "negatedLabel": "Warrants, Forfeited (in shares)"
       }
      }
     },
     "localname": "WarrantsCanceled",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Exercised",
        "label": "Warrants Exercised",
        "negatedTerseLabel": "Warrants, Exercised (in shares)"
       }
      }
     },
     "localname": "WarrantsExercised",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Expired",
        "label": "Warrants Expired",
        "negatedTerseLabel": "Warrants, Expired (in shares)"
       }
      }
     },
     "localname": "WarrantsExpired",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Granted",
        "label": "Warrants Granted",
        "terseLabel": "Warrants, Granted (in shares)"
       }
      }
     },
     "localname": "WarrantsGranted",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Other Disclosures",
        "label": "Warrants Other Disclosures [Abstract]",
        "terseLabel": "Warrants, Weighted Average Contractual Term and Intrinsic Value"
       }
      }
     },
     "localname": "WarrantsOtherDisclosuresAbstract",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "clbs_WarrantsVested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants, Vested",
        "label": "Warrants, Vested",
        "terseLabel": "Warrants, Vested (in shares)"
       }
      }
     },
     "localname": "WarrantsVested",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsWeightedAverageExercisePriceRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Weighted Average Exercise Price [Roll Forward]",
        "label": "Warrants Weighted Average Exercise Price [Roll Forward]",
        "terseLabel": "Warrants, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "WarrantsWeightedAverageExercisePriceRollForward",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsCanceled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Canceled",
        "label": "Weighted Average Exercise Price, Warrants Canceled",
        "terseLabel": "Warrants, Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsCanceled",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Exercisable",
        "label": "Weighted Average Exercise Price, Warrants Exercisable",
        "terseLabel": "Warrants, Vested, Weighted Average Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsExercisable",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Exercised",
        "label": "Weighted Average Exercise Price, Warrants Exercised",
        "terseLabel": "Warrants, Exercised (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsExercised",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Expired",
        "label": "Weighted Average Exercise Price, Warrants Expired",
        "terseLabel": "Warrants, Expired (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsExpired",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Granted",
        "label": "Weighted Average Exercise Price, Warrants Granted",
        "terseLabel": "Warrants, Granted (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsGranted",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Outstanding",
        "label": "Weighted Average Exercise Price, Warrants Outstanding",
        "periodEndLabel": "Warrants Outstanding, End of Period (in dollars per share)",
        "periodStartLabel": "Warrants Outstanding, Beginning of Period (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsOutstanding",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Vested And Expected To Vest",
        "label": "Weighted Average Exercise Price, Warrants Vested And Expected To Vest",
        "terseLabel": "Weighted Average Exercise Price, Warrants Vested And Expected To Vest"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest",
        "label": "Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest",
        "terseLabel": "Warrants, Vested and expected to vest, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clbs_WeightedAverageRemainingContractualTermwarrantoutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Term warrant outstanding",
        "label": "Weighted Average Remaining Contractual Term warrant outstanding",
        "terseLabel": "Warrants, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualTermwarrantoutstanding",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clbs_WeightedAverageRemainingContractualTermwarrantsvested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "weighted Average Remaining Contractual Term, warrants vested",
        "label": "weighted Average Remaining Contractual Term, warrants vested",
        "terseLabel": "Warrants, Vested, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualTermwarrantsvested",
     "nsuri": "http://www.caladrius.com/20230630",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.caladrius.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r163",
      "r164",
      "r263",
      "r269",
      "r408",
      "r566",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails",
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [
      "r231",
      "r232",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r250",
      "r251",
      "r252",
      "r253",
      "r301",
      "r442",
      "r475",
      "r495",
      "r496",
      "r548",
      "r550",
      "r551",
      "r552",
      "r554",
      "r560",
      "r561",
      "r573",
      "r577",
      "r582",
      "r590",
      "r648",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails",
      "http://www.caladrius.com/role/LicenseAgreementsDetails",
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r250",
      "r251",
      "r252",
      "r253",
      "r301",
      "r442",
      "r475",
      "r495",
      "r496",
      "r548",
      "r550",
      "r551",
      "r552",
      "r554",
      "r560",
      "r561",
      "r573",
      "r577",
      "r582",
      "r590",
      "r648",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails",
      "http://www.caladrius.com/role/LicenseAgreementsDetails",
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r199",
      "r443",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r563",
      "r578",
      "r589",
      "r610",
      "r644",
      "r645",
      "r649",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r199",
      "r443",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r563",
      "r578",
      "r589",
      "r610",
      "r644",
      "r645",
      "r649",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r250",
      "r251",
      "r252",
      "r253",
      "r294",
      "r301",
      "r331",
      "r332",
      "r333",
      "r418",
      "r442",
      "r475",
      "r495",
      "r496",
      "r548",
      "r550",
      "r551",
      "r552",
      "r554",
      "r560",
      "r561",
      "r573",
      "r577",
      "r582",
      "r590",
      "r593",
      "r642",
      "r648",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails",
      "http://www.caladrius.com/role/LicenseAgreementsDetails",
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r250",
      "r251",
      "r252",
      "r253",
      "r294",
      "r301",
      "r331",
      "r332",
      "r333",
      "r418",
      "r442",
      "r475",
      "r495",
      "r496",
      "r548",
      "r550",
      "r551",
      "r552",
      "r554",
      "r560",
      "r561",
      "r573",
      "r577",
      "r582",
      "r590",
      "r593",
      "r642",
      "r648",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails",
      "http://www.caladrius.com/role/LicenseAgreementsDetails",
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r163",
      "r164",
      "r263",
      "r269",
      "r408",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails",
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r231",
      "r232",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r19",
      "r588"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedTerseLabel": "Accretion on marketable securities"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails",
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "terseLabel": "Accrued Liabilities [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r42",
      "r133",
      "r459"
     ],
     "calculation": {
      "http://www.caladrius.com/role/PropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r30",
      "r75",
      "r139",
      "r455",
      "r480",
      "r481"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r2",
      "r10",
      "r30",
      "r372",
      "r375",
      "r407",
      "r476",
      "r477",
      "r621",
      "r622",
      "r623",
      "r627",
      "r628",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r70",
      "r588",
      "r677"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r491",
      "r627",
      "r628",
      "r629",
      "r661",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r335",
      "r347"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r6",
      "r38",
      "r40"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails",
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "AssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails",
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
      "http://www.caladrius.com/role/TheBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "auth_ref": [
      "r584",
      "r657",
      "r658",
      "r659"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.",
        "label": "Asset Acquisition, Consideration Transferred",
        "terseLabel": "Total purchase price"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable": {
     "auth_ref": [
      "r657",
      "r658",
      "r659"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.",
        "label": "Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable",
        "terseLabel": "Incremental fair value of Cend's fully vested stock options"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost": {
     "auth_ref": [
      "r584",
      "r657",
      "r658",
      "r659"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction cost incurred as part of consideration transferred in asset acquisition.",
        "label": "Asset Acquisition, Consideration Transferred, Transaction Cost",
        "terseLabel": "Lisata transaction costs"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferredTransactionCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails",
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails",
      "http://www.caladrius.com/role/TheBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionLineItems": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Asset Acquisition [Line Items]",
        "terseLabel": "Asset Acquisition [Line Items]"
       }
      }
     },
     "localname": "AssetAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails",
      "http://www.caladrius.com/role/TheBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionTable": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset acquisition.",
        "label": "Asset Acquisition [Table]",
        "terseLabel": "Asset Acquisition [Table]"
       }
      }
     },
     "localname": "AssetAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails",
      "http://www.caladrius.com/role/TheBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionTableTextBlock": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of asset acquisition.",
        "label": "Asset Acquisition [Table Text Block]",
        "terseLabel": "Asset Acquisition"
       }
      }
     },
     "localname": "AssetAcquisitionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/MergerTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AssetAcquisitionTextBlock": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for asset acquisition.",
        "label": "Asset Acquisition [Text Block]",
        "terseLabel": "Merger"
       }
      }
     },
     "localname": "AssetAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/Merger"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r105",
      "r135",
      "r161",
      "r192",
      "r195",
      "r197",
      "r234",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r365",
      "r369",
      "r389",
      "r452",
      "r517",
      "r588",
      "r601",
      "r646",
      "r647",
      "r664"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r129",
      "r140",
      "r161",
      "r234",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r365",
      "r369",
      "r389",
      "r588",
      "r646",
      "r647",
      "r664"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.caladrius.com/role/FairValueMeasurementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Assets, fair value disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r204"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r205"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r201",
      "r242",
      "r451"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails",
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis": {
     "auth_ref": [
      "r633"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year",
        "verboseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "auth_ref": [
      "r634"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "verboseLabel": "Greater than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "auth_ref": [
      "r634"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "Greater than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r202",
      "r242",
      "r445",
      "r631"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "totalLabel": "Total estimated fair value",
        "verboseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesAvailableforSaleSecuritiesbyContractualMaturityDetails",
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails",
      "http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security, in which the authorized issuer owes the holder a debt and is obliged to repay the principal and interest (the coupon).",
        "label": "Bonds [Member]",
        "terseLabel": "Bonds"
       }
      }
     },
     "localname": "BondsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CaliforniaFranchiseTaxBoardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of California.",
        "label": "California Franchise Tax Board [Member]",
        "terseLabel": "California"
       }
      }
     },
     "localname": "CaliforniaFranchiseTaxBoardMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r32",
      "r131",
      "r565"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/FairValueMeasurementsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "terseLabel": "Available-for-Sale-Securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r620"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r32",
      "r85",
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r1",
      "r85"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r618",
      "r673"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r191",
      "r267",
      "r268",
      "r269",
      "r271",
      "r274",
      "r279",
      "r281",
      "r483",
      "r484",
      "r485",
      "r486",
      "r577",
      "r608",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r113",
      "r115",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "License Agreements",
        "verboseLabel": "Research Collaboration and License Agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreements",
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement.",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement"
       }
      }
     },
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails",
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r95",
      "r595",
      "r596",
      "r597",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r25",
      "r65",
      "r453",
      "r504"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies (Note 14)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r94",
      "r248",
      "r249",
      "r559",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r591",
      "r592",
      "r593",
      "r595",
      "r596",
      "r597",
      "r598",
      "r627",
      "r628",
      "r661",
      "r676",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "verboseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r69",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r11",
      "r69",
      "r505",
      "r523",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common stock, ending balance (in shares)",
        "periodStartLabel": "Common stock, beginning balance (in shares)",
        "terseLabel": "Number of common shares of the combined company owned by Cend stockholders"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals",
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity",
      "http://www.caladrius.com/role/MergerDetails",
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r69",
      "r454",
      "r588"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value, authorized 33,333,333 shares; issued 8,133,095 and 7,866,799 shares at June 30, 2023 and December 31, 2022, respectively; and outstanding, 8,132,357 and 7,866,061 shares at June 30, 2023 and December 31, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r69",
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "terseLabel": "Common Stock, Value, Outstanding"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r31",
      "r146",
      "r148",
      "r153",
      "r447",
      "r466"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer Equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/PropertyandEquipmentDetails",
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r564",
      "r640",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Computer Software, Intangible Asset"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r67",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Risks"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r61",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r283",
      "r284",
      "r293"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract with customer, liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r579",
      "r581",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r6",
      "r41"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r6",
      "r41"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r302",
      "r305",
      "r336",
      "r337",
      "r339",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r8",
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "terseLabel": "Schedule of Total Compensation Cost Related to Nonvested Awards"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r154",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r179",
      "r181",
      "r183",
      "r184",
      "r185",
      "r189",
      "r380",
      "r381",
      "r448",
      "r467",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Caladrius Biosciences, Inc. common stockholders - basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r154",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r181",
      "r183",
      "r184",
      "r185",
      "r189",
      "r380",
      "r381",
      "r448",
      "r467",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Caladrius Biosciences, Inc. common stockholders - diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r178",
      "r186",
      "r187",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r654",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "terseLabel": "Research tax credit rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Salaries, employee benefits and related taxes"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Expected weighted-average period in years of compensation cost to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails",
      "http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails",
      "http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r11",
      "r126",
      "r149",
      "r150",
      "r151",
      "r165",
      "r166",
      "r167",
      "r169",
      "r175",
      "r177",
      "r190",
      "r235",
      "r236",
      "r282",
      "r340",
      "r341",
      "r342",
      "r356",
      "r357",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r379",
      "r392",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r407",
      "r476",
      "r477",
      "r478",
      "r491",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [
      "r383",
      "r384",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r63",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Assets Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r264",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r384",
      "r415",
      "r416",
      "r417",
      "r575",
      "r576",
      "r579",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r383",
      "r384",
      "r385",
      "r386",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r264",
      "r295",
      "r300",
      "r384",
      "r415",
      "r579",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r264",
      "r295",
      "r300",
      "r384",
      "r416",
      "r575",
      "r576",
      "r579",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r264",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r384",
      "r417",
      "r575",
      "r576",
      "r579",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r12",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r264",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r415",
      "r416",
      "r417",
      "r575",
      "r576",
      "r579",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r382",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finance Minimum Lease Payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r244",
      "r245",
      "r265",
      "r279",
      "r377",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r465",
      "r574",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r91"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r90",
      "r444"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Remeasurement"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and Fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/PropertyandEquipmentDetails",
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r6"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Loss on disposal of fixed assets"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity": {
     "auth_ref": [
      "r59",
      "r103"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less - net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r76",
      "r108",
      "r192",
      "r194",
      "r196",
      "r198",
      "r449",
      "r461",
      "r572"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Net loss before benefit from income taxes and noncontrolling interests"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r246",
      "r247",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r247",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r162",
      "r348",
      "r352",
      "r354",
      "r355",
      "r358",
      "r360",
      "r361",
      "r362",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r111",
      "r123",
      "r176",
      "r177",
      "r193",
      "r350",
      "r359",
      "r468"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Benefit from income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations",
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxHolidayLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Holiday [Line Items]",
        "terseLabel": "Income Tax Holiday [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxHolidayLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxHolidayTable": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax-exemptions and reductions which may be granted by a taxing authority for a specified period. Such \"tax holidays\" are typically granted to induce business investment in the tax jurisdiction.",
        "label": "Income Tax Holiday [Table]",
        "terseLabel": "Income Tax Holiday [Table]"
       }
      }
     },
     "localname": "IncomeTaxHolidayTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AustraliaResearchandDevelopmentTaxIncentiveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r37",
      "r39"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Net (Excluding Goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r80",
      "r82"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "terseLabel": "Investment income, net"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedBalanceShares": {
     "auth_ref": [
      "r493",
      "r494",
      "r549",
      "r553",
      "r555",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of investment owned.",
        "label": "Investment Owned, Balance, Shares",
        "terseLabel": "Investment Owned, Balance, Shares"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceShares",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Investments Classified by Contractual Maturity Date"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r383"
     ],
     "calculation": {
      "http://www.caladrius.com/role/FairValueMeasurementsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Marketable securities - available for sale"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "auth_ref": [
      "r6"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/PropertyandEquipmentDetails",
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments Under Lease Agreements"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r663"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: Amounts representing interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r21",
      "r161",
      "r234",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r366",
      "r369",
      "r370",
      "r389",
      "r503",
      "r571",
      "r601",
      "r646",
      "r664",
      "r665"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r74",
      "r107",
      "r458",
      "r588",
      "r626",
      "r639",
      "r662"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, non-controlling interests and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r23",
      "r130",
      "r161",
      "r234",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r366",
      "r369",
      "r370",
      "r389",
      "r588",
      "r646",
      "r664",
      "r665"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicenseMember": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.",
        "label": "License [Member]",
        "terseLabel": "License"
       }
      }
     },
     "localname": "LicenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r66",
      "r619"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      },
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesClassificationofAvailableforSaleSecuritiesDetails",
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r28",
      "r106",
      "r161",
      "r234",
      "r254",
      "r256",
      "r257",
      "r258",
      "r261",
      "r262",
      "r389",
      "r457",
      "r507"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r85",
      "r86",
      "r87"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r77",
      "r87",
      "r109",
      "r128",
      "r144",
      "r147",
      "r151",
      "r161",
      "r168",
      "r170",
      "r171",
      "r172",
      "r173",
      "r176",
      "r177",
      "r182",
      "r192",
      "r194",
      "r196",
      "r198",
      "r234",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r381",
      "r389",
      "r463",
      "r525",
      "r541",
      "r542",
      "r572",
      "r599",
      "r646"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss)",
        "totalLabel": "Net loss attributable to Lisata Therapeutics, Inc. common stockholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewJerseyDivisionOfTaxationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of New Jersey.",
        "label": "New Jersey Division of Taxation [Member]",
        "terseLabel": "New Jersey"
       }
      }
     },
     "localname": "NewJerseyDivisionOfTaxationMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of New York.",
        "label": "New York State Division of Taxation and Finance [Member]",
        "terseLabel": "New York"
       }
      }
     },
     "localname": "NewYorkStateDivisionOfTaxationAndFinanceMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r59",
      "r282",
      "r627",
      "r628",
      "r629",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non- Controlling Interest in Subsidiary"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Activity"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating Expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r192",
      "r194",
      "r196",
      "r198",
      "r572"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r402"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Operating lease liabilities",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails",
      "http://www.caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability [Abstract]",
        "terseLabel": "Operating Lease Liabilities:"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r402"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities \u2014 current",
        "verboseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails",
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating lease liabilities, current, balance sheet line item"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r402"
     ],
     "calculation": {
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating lease liabilities, noncurrent, balance sheet line item"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r401"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Right-of-use assets, balance sheet line item"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesBalanceSheetPresentationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r405",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate for operating leases (percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r404",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term for operating leases (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/OperatingLeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r141",
      "r142",
      "r143"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized gain on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r11",
      "r17",
      "r145",
      "r148",
      "r152",
      "r392",
      "r393",
      "r398",
      "r446",
      "r464",
      "r621",
      "r622"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Total other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r141",
      "r143",
      "r230"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Available for sale securities - net unrealized gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Lisata Therapeutics, Inc. Stockholders' Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r609",
      "r624"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Investment in Cend Therapeutics"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Tax withholding payments on net share settlement equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchase of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r110",
      "r657",
      "r658",
      "r659"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Carrying value of Lisata's cost method investment in Cend"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/MergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "terseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r620"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r4"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Net proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Sale of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r4",
      "r15"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from option exercises"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r128",
      "r144",
      "r147",
      "r156",
      "r161",
      "r168",
      "r176",
      "r177",
      "r192",
      "r194",
      "r196",
      "r198",
      "r234",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r364",
      "r367",
      "r368",
      "r381",
      "r389",
      "r449",
      "r462",
      "r490",
      "r525",
      "r541",
      "r542",
      "r572",
      "r585",
      "r586",
      "r600",
      "r623",
      "r646"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.caladrius.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity",
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/PropertyandEquipmentDetails",
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r92",
      "r118",
      "r121",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/PropertyandEquipmentNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r93",
      "r132",
      "r460"
     ],
     "calculation": {
      "http://www.caladrius.com/role/PropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/PropertyandEquipmentDetails",
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r7",
      "r450",
      "r460",
      "r588"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.caladrius.com/role/PropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets",
      "http://www.caladrius.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/PropertyandEquipmentDetails",
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, Plant and Equipment, Useful Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r653"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails",
      "http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r71",
      "r99",
      "r456",
      "r479",
      "r481",
      "r487",
      "r506",
      "r588"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r126",
      "r165",
      "r166",
      "r167",
      "r169",
      "r175",
      "r177",
      "r235",
      "r236",
      "r340",
      "r341",
      "r342",
      "r356",
      "r357",
      "r371",
      "r373",
      "r374",
      "r376",
      "r379",
      "r476",
      "r478",
      "r491",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer": {
     "auth_ref": [
      "r112",
      "r660"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606.",
        "label": "Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer",
        "terseLabel": "Revenue from contract"
       }
      }
     },
     "localname": "RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r124",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock, Name of Transaction [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.",
        "label": "Sale of Stock, Percentage of Ownership after Transaction",
        "terseLabel": "Sale of Stock, Percentage of Ownership after Transaction"
       }
      }
     },
     "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/TheBusinessDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Available-for-sale Securities Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails",
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule Share-based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/PropertyandEquipmentDetails",
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails",
      "http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails",
      "http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r13",
      "r14",
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option and Warrants Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Share-based Compensation Awards"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r97",
      "r98",
      "r99",
      "r136",
      "r137",
      "r138",
      "r191",
      "r267",
      "r268",
      "r269",
      "r271",
      "r274",
      "r279",
      "r281",
      "r483",
      "r484",
      "r485",
      "r486",
      "r577",
      "r608",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative Expenses [Member]"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Noncash Expense [Abstract]",
        "terseLabel": "Share-based Payment Arrangement, Noncash Expense [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting terms (years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average estimated fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Warrants, Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails",
      "http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails",
      "http://www.caladrius.com/role/ShareBasedCompensationShareBasedCompensationExpenseDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Stock Options, Weighted Average Contractual Term and Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Options, Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Options, Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options, Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average estimated fair value of shares granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Options, Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options, Outstanding, End of Period (in shares)",
        "periodStartLabel": "Options, Outstanding, Beginning of Period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Stock Options, Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options, Outstanding, End of Period (in dollars per share)",
        "periodStartLabel": "Options, Outstanding. Beginning of Period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Stock Options, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest [Abstract]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Options, Vested, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Options, Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Options, Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Options, Vested and expected to vest, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Options, Vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options, Vested and expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationCompensationCostNotYetRecognizedDetails",
      "http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails",
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, Expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r302",
      "r309",
      "r328",
      "r329",
      "r330",
      "r331",
      "r334",
      "r343",
      "r344",
      "r345",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options, Vested and expected to vest, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of shares vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ShareBasedCompensationFairValueofSharesVestedandWeightedAverageEstimatedFairValueofSharesGrantedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "terseLabel": "Shares, Issued"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/TheBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r88",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r11",
      "r26",
      "r126",
      "r149",
      "r150",
      "r151",
      "r165",
      "r166",
      "r167",
      "r169",
      "r175",
      "r177",
      "r190",
      "r235",
      "r236",
      "r282",
      "r340",
      "r341",
      "r342",
      "r356",
      "r357",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r379",
      "r392",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r407",
      "r476",
      "r477",
      "r478",
      "r491",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r190",
      "r443",
      "r482",
      "r492",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r505",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r524",
      "r526",
      "r527",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r543",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r190",
      "r443",
      "r482",
      "r492",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r505",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r524",
      "r526",
      "r527",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r543",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r11",
      "r68",
      "r69",
      "r99",
      "r483",
      "r543",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock issued (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity",
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r11",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Number of shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r11",
      "r68",
      "r69",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r11",
      "r68",
      "r69",
      "r99",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Options, Exercised (in shares)",
        "terseLabel": "Proceeds from option exercises (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity",
      "http://www.caladrius.com/role/StockholdersEquityStockOptionsandWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r11",
      "r68",
      "r69",
      "r99",
      "r491",
      "r543",
      "r556",
      "r600"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Net proceeds from issuances of common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r11",
      "r68",
      "r69",
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross",
        "terseLabel": "Value of shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityRestrictedStockandRestrictedStockUnitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r55",
      "r68",
      "r69",
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/TheBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r69",
      "r72",
      "r73",
      "r89",
      "r507",
      "r523",
      "r544",
      "r545",
      "r588",
      "r601",
      "r626",
      "r639",
      "r662",
      "r678"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.",
        "label": "Equity, Attributable to Parent",
        "totalLabel": "Total Lisata Therapeutics, Inc. stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r59",
      "r60",
      "r62",
      "r126",
      "r127",
      "r150",
      "r165",
      "r166",
      "r167",
      "r169",
      "r175",
      "r235",
      "r236",
      "r282",
      "r340",
      "r341",
      "r342",
      "r356",
      "r357",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r379",
      "r392",
      "r394",
      "r398",
      "r407",
      "r477",
      "r478",
      "r489",
      "r507",
      "r523",
      "r544",
      "r545",
      "r557",
      "r600",
      "r626",
      "r639",
      "r662",
      "r678"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets",
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r96",
      "r160",
      "r266",
      "r268",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r282",
      "r378",
      "r546",
      "r547",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity.",
        "label": "Equity [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Conversion ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/TheBusinessDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [
      "r399",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r399",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r399",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r399",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r399",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r409",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/StockholdersEquityEquityIssuancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r265",
      "r279",
      "r377",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r465",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock (shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r27",
      "r50",
      "r51"
     ],
     "calculation": {
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "negatedTerseLabel": "Treasury stock, at cost; 738 shares at June 30, 2023 and December 31, 2022"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/LicenseAgreementsDetails",
      "http://www.caladrius.com/role/ResearchCollaborationandLicenseAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r579",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "Municipal debt securities"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryBillSecuritiesMember": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one year or less, are interest bearing, and are backed by the full faith and credit of the United States government.",
        "label": "US Treasury Bill Securities [Member]",
        "terseLabel": "US Treasury Bill Securities"
       }
      }
     },
     "localname": "USTreasuryBillSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/AvailableforSaleSecuritiesScheduleofAvailableforSaleSecuritiesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r349",
      "r353"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition",
        "terseLabel": "Unrecognized Tax Benefits, Increase Resulting from Acquisition"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r34",
      "r35",
      "r36",
      "r114",
      "r116",
      "r119",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [
      "r591",
      "r592",
      "r595",
      "r596",
      "r597",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r180",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r179",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.caladrius.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479428/808-10-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org//606/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "https://asc.fasb.org//808/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org//260/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(4)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org//718/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org//740/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iv)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(i)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org//830/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//842-20/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org//855/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(14))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(15))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(17))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(19))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(9))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479908/805-50-55-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r602": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r603": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r604": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r605": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r606": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r607": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r611": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r612": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r613": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r614": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r615": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r616": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r617": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org//320/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org//450/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "808",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(18))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org//235/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org//360/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org//440/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-12A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org//505/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>85
<FILENAME>0000320017-23-000055-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000320017-23-000055-xbrl.zip
M4$L#!!0    ( $>!#E?PIW2WP1P! )8>#P 1    8VQB<RTR,#(S,#8S,"YH
M=&WLO6MWXDBR*/K]_ I=9I\SU>L"1A)/5S5G438US6R7[3'4])[[959:2HRF
MA$3KX4?_^AN1DG@*D$! "G+6WM55(%*9\8[(>'SYO^]C4WJECFO8UJ\%N5PI
M2/^W_>7_*97^Y^O3G71K:_Z86IYTXU#B45UZ,[R1Y(VH]+OM_#1>B?1H$F]H
M.^-2B?WJQIY\.,;+R).4BJ)&3X5?.M=#N?5<U^NU4FLXU$I5.FR52+/6*LF*
M3*HZ:;44Y;GX<EVO5:O-2KU5TA5%*56'#;G4)+I:(FJM*5=U2BN*7-2OM6&3
M5,A0&58;<K6I:ZVFUB(Z52M4UI1A<XBO'7EP/CBCY?Y:&'G>Y/KJZNWMK?RF
MEFWGY4INM5I7[_A,(7CH^OW9,75C^BS^DSVI5"KUJ^#+Z%'3L'XN+#K_L'J%
M7S\3ET:/&^]>R:7:PB_@W^47^_7*L.!IBB"_\AQBN0A1X@%*8"FY5JHT2ZH<
MK>,ZWG2-(7&?V1OAPRN$^-S+XK>VZ4U*I511 !?SL# VG-"P7(]8VO2$[RL0
M60 S?AL]JIG/BPC1B$ETQ_#=LF:/V5$J=;4R/8YK5Q6YL6DOP1/1#W2ZA,,(
MTO#%$J#6+2JK<\":'M$UX@X(6Y"O_N?[75\;T3$I+0/&=TLOA$Q6T19^,=O1
MM4FLEU\+U"K]Z!> >BG1VU_&U",2_K1$__"-UU\+-[;E 5>6!A\3>(<6_.O7
M@D??O2M&S%?M__6__M<7S_!,VD90ER* ?KD*/OQR%2S];.L?[2^Z\2JYWH=)
M?RWHACLQR<>U95L4-F"\7^.#U G^:N@ZM=A?X?M[$ V.H07O?_>>Z/#7@E8"
M.K7(&%>BQG77@M=]W,#N'&+V+)V^_S?]*$B&_FMA6%)JA78%_J<B]!I?KA96
M3?&2&]]QX W?#!>(Z%^4.%U+OP5I59 "XOZU -QPK<,GI3&L,BKI9+:'>J$M
M*U>JO/OK(QDY>_\W^,2=OJ%1:"/TLWK!(SQNZXNO:!;:_U!V?T$'5M?9&TSR
M,EVT56@/B>G25.M6HW5#RKY^F% 'Y(OU<D=!%CZA:G@8_G!IQW6IU_< *?CB
MA^$WPP*.,>!\MFN@/.J^ U&[QK-)[PS7BW95JRJ%]B8N^LL#:">'K>[>VY86
MT$:J,Z@'/X-ZZC/<&>39,)$U@[5W.41SRR$ZFN;X5(]>95#WAL^#M+@ZR SA
M.YREEH@[YDYR8/+:[S")V&3_P\CRRG'Z(^+0KW 2_<8>3V!SS$3J.& QO;!3
M?/V8/?)(/O"CSAMQ=/;'/ZF+H @DM1R=IZ[">1[E?ZWL[6I1LSIT2.$,&G5C
M# *TH:Y=9F7 [B5F4UU[8 ;\6G"-\<1$DX-]-G+8X>9U?_G=U6&)J\4U@O?/
M7AKNP;5]A_V+&8'7(<3845![1)]3IN"C?QDZ_GMH4$=BZ]-88_>F]]^+BG_Y
MQ^WHH\75)PR>T;_ PG(\5/-,NY8J,OQ?]+O9=]-MZG./UDMH""U^$_T[>LG5
MPKGCP:!P (; U/3"DS5+<G6Z4/A-LI/YEA$<RT6Z=J<G&P,_^PYMAX!E7T9+
M1-]%_\8UXB&E<@>I>1K8$5(^8Z=%4(1NR/6/_FUZ*%7Y@A*Z@B55WA]*( B9
MM)P>#_P-V-;\HTP8$L]V=@3HRN_QPUMJV6-0-C'+)B7GA26N%G>_%9\U#O"Y
M+":KQQ>3==[ H"0'@Y(=&!H<@B&ITLP0#,U#@R$\#7U!HRSXIPXO>Y^8AF9X
MW^GX&5ZA&V,T.3'F.;7Y(@NU^X>/#@48?K8%_W0[[P;HP^@Q^'QL6WW/UGX&
M:WVYBGW%%!K3G:25OA5U9^F["/)6SD'>T77F)X#'0 R]9]V0B>$1,R_@ERMY
MA[^F^6/?Q L YG+A<PX=X6JOM&=I]ICF!A<'=UT.C(LGZA'#HGJ7.!;XF&YN
M ']P9^G @!\XS#S\8)(_4 *Y@?W!W:\#P_Z18% G-^ ^N!]W8'!C' U.Y-BF
M"2*F!V<#+RD_X.?![3K0T0[N2N5>>W'@Z,D']_1R*FYYP(UP/SE'D'!6\X,L
M17BV.45<WMW@(T;A=K\I6H)YWCW@$X7A,H-_WKU@#L)PF>$B[R[RL<-PF0'^
MX,[Q@0%_@C!<9K#/N_=^G#!<9N#.NQM^FC!<9N _N*=]NJ/EW4<]EO4L[Y-!
MM)1!EGM7\P36<Y;PS[O'>&KK.4M<Y-V3/*KUG"7@\^Y"'MMZSA+V>7<9CV ]
M9PGNO#N*)[">LP0_#TFS!SI:WOVRXU]BGR!-5\W[1>FQ+K%/@1OA?_*-H*IP
M5G.$K+Q[ML>*YJC9);)5\^[!GB*:DR7\\^[(GCJ:DR4N\N[8'C6:DR7@\^[B
M'CN:DR7LQ5WH4<&==Y_[!-&<+,'/V5UHED?+NR]ZY&C.:4KP:WEW2(\2S3D1
M;H3_R3F"A+.:(V0)SS:GB,N[&WS$,%Q6B6RUO'O )PK#90;_O'O!'(3A,L-%
MWEWD8X?A,@-\WF^:3Q"&RPSV>??>CQ.&RPK<];R[X:<)PV4&?N%I)X/Y7IT_
MEV NG.?3PE_XP_S@(N\N[I&K7K,#?-[]W.-7O68'^[S[N$>I>LT.W'EW8T]2
M]9H=^//NS![_.O0$@QOJPNWE%C>-O/O(1[T./06"\NY%G^PZ]!3(RKW[S<-U
MZ"D0QZW?SN;2=33 6C"]*\ 73IJZONG>WQZ^1J15DFM)L+'T:#IL3.?76#YN
M?,T\I G\-5H@^9R?!K=Q@*/C=K%!RSRZ]K'"&_RU@,[L:#P4!I^$(Y?@P*V?
M^^C8<!#OX]$$''<L'?7;!-?X^H'S>A?5VS<?W"P/Q 8\^,UXQ[_EYN*VP:VO
MFPH%:%'X'G6F#^4&_MQZL3O!OV\/O3?P:WL60.0%IX$R;907;#2Y]5NG\U9[
M<#S'QU\O8\"9V Y(XEOZ[/6IYCMLG&IN(,^M0\HEY#.,=C:Y]2X30'X\I@Z;
M0DS@R+FA=6[=0JX@GB6-<^NL;87X=]NB']^)\Y-ZWWQ+SX] Y_:ZEB^09TGE
MW-[2;@7Y5SM/I,VMV[H5SC_Z41;"5\,T<V@F<NNN)@ ]BY:[X$H]VB9 72-F
MWW_&0=2X4GY0P*W'RC<*,A3T+6[=5+[C9EFB@%M_E>.X69;PY]9K307_.U#&
M=&2;>F\\<>Q7=I>:&TW0XM:/Y1P'6?(!MYYM!U;0#=/WC%<Z,S2[[YKIZU3_
MYMCC0/@0O*-\&$:Y:H_4Z8^(0[]^Q"^PB+ON>&+:'Y2R3)V'"2YUEID$+6Z]
MZ3-%\VG:6+:X]>"/@N;?B>.0,TV);'$;-#@CU)Z(:[D-2AP%M4\4O&U#\ZC.
MQ/,/\.G<I_Z/\^1B;H,?9XSJTW"U7.$VRO*-&,X_B>D#UJ9__0U6)(XV^KBC
MK]1<"K1$#_4LH "7/2%O0=HNF_D>9$_B:;XY] ^?6MK'FIW,/>H^(;4Y0(UY
M<7SE"K?1G^-AXZC4JN2'-+@-3)TI::CY(0UNXV47*<.YC9P)]7[:F*I<X3;:
M=J8R_+#J/5/2X#9"=Z:D<5CUGBEI<!OANT@9SFU0KN\_NX9N$.>C3TSZ,&2A
ME+DBO8XW&-$@_?!A.*0(]<Z+0^G!K^=EM*XJU6S SVV@C"_P<Q#3E.6#![H.
M"XCY,1C[ 8+;L$[GC3CZ:NK"4CSV3,F3VX@*%U@Y471<YBZ8X3K>]1.Q7D)L
MX#^_&Y8Q]L=9V;-<X/M47,A=N"0.W^1=X#LC?',; TF&E;.^AI9E;L,07&'G
M5+J1VTA T&QIVK;ISM;(K$7,'*XHAF@Z  ,,P=@L=;;[/H'5SG-NC2QS&RW@
M'F-*<HQERF/<!ABXQ]B)=);";3X-]Q@[D1Y3N(V'),)8G[+VPW^C%G6("7CK
MZ&-P",$0(9CD%J+N/(>%R@JW49,<X>Y$NDWA+K:2"G=;D':FVHV[^$B.<'8J
M_9:W&,=1ZJ .E&^EB)#%D0'.;13B5''50P&:V^#!*<4(%TJ9VR !-Y@YD>I5
M.0\&#,A[Q_=&M@-;6T31+7SK>H9V8_N6YWP<.",GNX0HE7-GG@^(+['#?A#G
MW 7G!>(9TCAWCK-.C>L[^D+,+MM/NE[\ I_<.=67B,_,YA[(*K<.]S:(L_!)
MQ](Q>F+^W7<,5P=/9;MY=EB"X@BSW'GWQP8L#PFL*K<N_S;^^F8[U'BQD@DT
M[G!_*/7';6#A9.)R_0;NR7C)F;ZG;W^GCDL_;L,&GP]#^ $Y>-0T4Q+@-H(A
M2.!(CGLUMZ$2+DC@AIC&T'8L@WQSB*6-#!=_\-4FCIX;*5#-;>SFHDD@4RF0
MVV 2%R0 BN!?MO.3[655%[ &U-@\_  7W8<2"=R%N@0]G%0^'#Q4MH,/7"U5
M$LV47'IT+Q^XREV,:>?"M.-&(3*[VZMR%PO:N50LKQC@+@Z$(&?!'>I,  9S
M$IF%9?K$ @--_^H[UHB,'QWZ_+$MMS.Q.L!;]H=A!_O/OK ,N.41"*9)GNT@
MW6WNJ0'\S25,,?UN>*-'W/7 7O?T(?6$7,]23W 74Q*DL9\)4<F,-+B+-9V
M- Y?12Z(;I[H:MQ%MS@ANFQ+V071+1 ==_$TH03W((TLDWEKW,79MI#&#PL@
M[;BPTX?A+-#9\8!D;@WZ8@LR.42XI<9=^.UPAHL@0!X)D+O4N,,9,8( >21
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MH6\&H?II35"PN$#N<9'K,MV&+1>+"YX=LC@:KB#&Y[Q#K(G\L$/THOWOV*;
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M37H0>==*Q#./G:>!U"M)WWKWG?N;7N=.ZMU_>WCZWL&JM\2S( \!CJ-IOX2
M K6&PW/73<)(0V]#]K_<T4K@#,5!X'@'7U]*N9XL#@>3(]D+>VXEN;V PVJ_
M3:.C_:D1?AUC0)P<[]ND03:PCC>%#XC<1,:@9:?#JUIHU];@<%]MF:7TRD:
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MKBW#_+7@.=B0;ZF+W^Q<V,QO_E136F1=\Y?(D(<<M.R@5,T 2HVU4,HDV?
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M&ZI*N8&.Y,1V#<3AM4--XAFO]/.;H7NCB+_F?A@ _KHR^PEYADT :ZS]"2^
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M(QFUNYBHM:PCL/E(PLI#_H18X^@Y*5&#!F #NOFUXLG%)P5@!6#S]:0 [&D
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MVXW?!#/L^W@-GE$O>\=^6TZ S15(.K!7]/"(R48!/A)#+QD6^_L-F1@>?"X
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M,HTN20O\O35G0VC.'-*1X/8\8&FO -@AF+W)&[-?2.[<Q+$!9KHK#1U[+!F
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M[+5>;K5VW<_Q]UI1:KG9:[V:;-5XKUIM)?"J3QJ9:B1L\1 7QSBLJ]Y* JC
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M^9,%%Y(_-W%L@)GN2D/''DL&8!G;]KB2/<2P&C8;=A-VQ.0MK)9A4/V,V/\
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MG:C*3"<V8N;-\Z@3P_R":!<1+FJ,Z>)Y=NOM-B_W\RDV.@=D%2"IVSX6PBQ
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M\RY(P;-G'KPT(1\8?2MBRPC'IPN>X)RA._>IL')W%KR:^>S&<$R$C,< %YT
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MWB/!81R;6J^&8UN,9CZ%]#WXWHUHF]&]0Y\_ "@_<:?S0'=]5Z,3S\! &+S
M&(]]RYX2Y0)EL2,C4P&GF^0993TN,R* $S+&D=0ZRR%#^ ,PX:16*>(H24>>
MU>D87)$(@M0:(;1U^-@TD'V0X(GDL"1PEA!NN%-0@Z."(NIE 4W3?18Q&S#(
MVI&T$;S%6Y .2Z=B"S[==TK/6"8LS3\+![:E.>Y@:&#XF.T=G2CR"L=G$Q3(
MD'K ^)YMPBIL2N1'2!NL@N&#I2<" $WJ,2(#)K%>;+;1"#:> ^A=9,(0-@N@
M :%DZ<312_80 .#0^9-^,/$!6,(<)@]U*H/0(OZ A8#R0$HS(EB@+5@^."][
M-SL9D5Y1;'KLW3.A!"1(PN&X*/[P\WFD;6'K'K"JKC.',!#'T=X0SG/"$\75
MBT/&KA3@"+4Q7O_Z &?[Q?9=Z>96K?Z_DD9-4XI X%%M9.'WP*G E'@'$$@K
MP\.SNY0&Y ]BB#B>A7J"<2G0CN\X@<L\W1X*?* 6#X'C>R;Y6.\DYTE[KFH*
MZK@C8P+ (^,0"]K_S]Z[-JF-9 G#?T7!SNS8$10-XF[/2T3Y-H]G[;;753W]
MS*<G!$H*30N)T:7*S*]_SSF9J;L0 E$E0!&[/2X0J<R3YWZ%#UU>B&V:_.Z4
MN6$GQ"&B<N(C*6.B%XF\#M (D5D#7N6Z"<0*B4]!H?I@.Y)"N9A12!;3=J++
M4M'XQF$A$:T<VW]8T>V*;3CLP>#<!M '5S0UWUJL  L!E1YL^)%!2"S63<EK
M)E=RA=#3=1 G+K 3E#[(XGQ@ND 2I!"8BH65LS&2(X5W_!98)B 8;CN&XL:&
MX04)WL7<-\I%H!C)G5%@]#W_%J0G^@8#PV]Z@\X082&T'60ZH!7^2U0=?:>^
MT[WY+ZI&]Z_.0[[L>B!18%-S1NS:MA 7@!D]F/:<5 A2/"+('&%^BK?=Q.42
M8(J&+C= ] B?QB61F.#2;&#J"\."TRNOUM\_W+Y_W1;"8VY8'(E)KXV],BH.
M$=\!LW:X\TJC47]4(S/F*Z@ 4KE/3<<0-@#>X:]@/BKO*7?W(@CJFZ7<@8[&
MUG,X?6_85M2NJL;$)_T1FVX, E(S-=TQ0%2^,VQW02PXL)2D%22?"77%4%<A
M@8N-G;D#%[$M#^K!>O!]N)2F?& F=DX"5<5V-L(Y &9::(;Q*PU_@A2U@(=U
MTG[HIDG99<[:%>)"N7UP&&_.A)>-O:;Q&X$<I-HQVWG0+&EPI=\7+A&^F7O'
M-7K+[<8Q3$4=24C/A4H'&N!#"-<V!P=^\_X._@VZF=S%G3]/0";\0K[R,O2)
M[[Z#72(\:0OSFW)!*H+ZA48XMXJ2<.<ZO=0,,] [=FL?@P=Q[Q* ;Y17QNL(
MQ!4T$> ..9-$6\6"3>$=M2,\P_6=1U#,.8UHH ':R,GM)U2\ V\!L=;(1;\R
MX$TA0?&Z $XAZ*O"P^>Z);@? %:(+<&$S0=;Z+WI#8%W@YH/DHB:WBCN!E1L
M\A20N16VPPGPZ8=XGIIR*'?X?.#+ .Q% <0O) Z[CG+K97S<5IBV6(GN9X+.
M_Y)X,VC!9(&0K;M&G0<H!HWB_+<I3QHN8F$J"Q/W@4]1@@O^!/0WA@_3BXGT
M.!A#O2FZ@\ 4 #2/5@L;-OXR-_O(\A&S4H4EL<3 S[]^2F8@$62QKQ3 ^2-U
M@4-7)GU*X'Y/YW+A53]P"[T@KZ@;NBC'K5FW,^SWTWE%@!48_U$\;I(3:)#S
M^1:_GXS[C9.$/#^]/. I:&#!.2VV"/6%"/TM3-ME<<.+7!/(Q13M :CS 7TS
MNZ#)KRH%S4$1-.EGG^EE^Z5G1<!(7<W'8[4]SNC7%4&>*+:T0W0AQ(S!"^UU
M1=RMQ'<2/@%:H3F-UH>0.<0ZI#U8@AX0X*+6)+R&R^3\21;?EBQ1@TM?(XJ%
MX(S"#KFC;\D>N+KL@$N&G)P+$UYQQD50L(&65;N]D<)I%5DO^C: N9"&$*4=
M6@,_C:@JXO[S::<-T@%8I-S=$R.M)L;:=N]\+\Z61M6 8V>B$AK)6>P\2N$2
M_H*I"^S-V.NQ/&"X#T?]P>3[OG,7SZ_$GK\M.8>X];V5[0 :ZO?V.Q8^7)YI
M8,OYMJJ.@7&DIQA'[B4"JH3(ZUR&/1XJ'4(<@XY#'F_N?<;S"\G#>R[1*!<G
MCI,Q!3Q3F0,#U-. @I8 8?3]!88O5]/"37!52]ML'/LGW!WQS+*R.U8DI*;P
M#% !\ FO\#MP%=BA]H!=?.'%Y.NZ1<E[CU$$_KH >V[4 'TFW=9LJ*;PYL]I
MC(GRLFQ1%!,/2QM#)](#2P(Y#M>W7-O43" $=&@!CJT49&7D<T5 .,;<CX2?
M+$ 30!(X(UT&.?("?B-800!]^C;HNX6N!-?CX20C<,C!W0&J&[J/7FF! ,D7
MX)6C .5!BL7*8.BP9PN?F)"-01- D< N_/@M8F'2P])IEGKT:_!H).#E,@NE
M:F07CFTR]VU*K]YH!AYKX["UX:]Y/(L06I&V*7%?C%9X\'.NFC]&5T BB80Q
MX,I,C?#= Z[,Y0^R2$?GOF3RWM!J;6E_ X5QI1]P@6G O^B/J.LO;&S&W872
MLX$F"2=%##*@"N(25\;U8[:XQD.;Z(0TR!45$:Y+S7#@7DV?H7\3$ 8I@,<M
M@#Z!:U'G3=?-WYZ\B\_??_RWMMZ\_1#JEQE05%Z!U@0&'&TXZ,3P9#NDV0I9
M_9I+S#73P  3@1#0_FV \W^XW8WG!-)8!%%2'@P-J!05JP6+L24#?5X\$2UR
M:E=8\<G?HX4OC<.M !"<P%X8!!OZ)C@Q_].RDZE@B1R!)EFNMR-9KLE[.\>\
MM_PT&#4S#:9?D :3H1J]$+*"3&6.)?B%[P$C4GP0O]R_CX$JR^6\R&$8X>$,
MD^1;-(,VR)OE\SHDR^\HWP+W*\\Z<%$,N<PJ7,B-KR0#4?#K%6P)=VMBX"QF
M64K]WZ%4"M0L'-X3&Q_8Y?O5+#V6%G.<-5J;X,![V[$M[=%P,#8L=%PM/DOE
MG)5XKLV!NLD#5NI<^?3CX\</W[XJ]XX(X/_?;[__>GN2J-L((VA[A-U2 @\K
MK6[Z].MD.1N<@K/0__ZOWGCP@M'"UDP2YV^=NTXD7DV)*2"DR"]D@;YI\HD1
MGL%+T=%]S F='!/?_O'YPTUOVE%^IZ0"T*R )OGO9$8#ME;F!+I!GT3@85@:
M#FCA8F6>4\%9QM\U8,+.%CWB(G1I@-G!(Y>DUXN78D11Q\RFI'V@*0\,K![T
ME0BK Q-K@DVA4V.SP62H%=INNN$ZOG ,\*0D::=HCYIARO066.+?8!N @LS0
M%P/?>^A'$PU\14J<]F !.G"?S=</R'5^07U69%PY@9;78.VA6*NA%\HTZ7]Y
M7)@N'PTZT+80D;8;D>LFKV:-FJ^\,25(XB([Y+.E?-6VZ=@B7)T%%LF",J6H
M_T* TN*RXYR(["??!6&J"ST_R,$!26@) A#1=-3Z\6/'0)-2,[<"90B'T'E(
M>1Z8,V>BQ4(F6$@Q:C<D1[XM6-QW)=*.;L $!\!PD_O&W_ E,<4)M7\T!_ Q
MRO#3%CS&Q_.Y&L0\DIV*# N!F<  .LJGB.,#DSGE;6LF1E7IN?]A6U"B@$$
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M8;+,S1++W(-.2PXE7P=@>;312#$I32?X4 :[E:W!A'0*OC.%W<2;-?!7VDZ
MG!W1VH4C1^9547EN$-#%"7+BW.TP^9UZDB52+@*D;<N_PO"LI#<J5':8DICK
M#CBU9$;0]R"-[^ET_V03L R2H^$X;BJ,+IM3B=N-]:9*32-.]*J*UCW368^<
M?%0;$?4%8ZC?<3SD*NKF.F>!@"UX%B+X'S2J2B(#7X')$9NRR9R\][ G74:#
M09X5"&J.N1"),*#^$&W2A'3&=2H@$][U5'8@C>*4;/PH\@:#W<@J"MG!+O+6
M2$&\+)CX8)@4P4R?]91["ZD[#JUH=_-YUAW(3?&^>;Z;X!7QU7@?5ZEVRIM
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ME_V$-<RQ79+SGRNW06\ZSG1I)YCY3AO@#D)=5!MXMK/E]3N/8I@'=[$(6QF
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M7(7I-DZO0=748^NXBR?8D$"W(@-$5DKAL^2%0G=+P$@ERHI.HUQVPD[)RU+
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M=;X7\6NFO]N^AU\A'_0U\ZOFH0&W_:!Y[!Z92D::P717FD%]DPH*@OH8F=^
MB(%'#+LXUV"^)6 +L"EK ;?# _AG%J\_8?B[>WA(_F7B]7MO^ !_0J%W:GJ>
M<>K\>'TVD-1>-4D-912R>D,P*-=1L%YGCY2'O8Y^52 ,\\P^89X9Q8^:? D
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M(U69SAPW;BW]H\"">QL_.CJ8T5-Y,*/?[H].,":B !5>.&![8IRN&W\Y9@I
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MX9B62-A25LRD%PL'\B >@ -H*%2RIWC$ 2CX** (; %-!(2-^+%*/Q[$'7N
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M#[O/NNU^MJ[4CE1=8T;12M1T2Q]/R'.(CU!X 3L57H0:%5-%$ET994::267
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M7(9$7MO=/<PM.<E"1$L0-CV21R)&RYE:]#>> @K.%'&7'CME(@H\651&GN9
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M'4?\73;][!=-/UNQE)=!T=]B5VJ)I]S"[AZ?QHJ;V#]F(V3&,^LDS<SD A]
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M$]I J73'FP8?^*=LML6X:<"(!CXJ:83.P%\%H5UNTP/^H)[\-/'=72G+EXI
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M+J;BM)/<-=),!L+)5:+BKS-O#M-$#_&UM[_D;91W _*APZ[ I1.%S6S/]#(
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M@8PEX*HV7?(EF*D_%8+#G9J:0_&5"5LXW,J 1@G(6*Z#)MD:QCR3A$!29A\
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MH_Z?#4OYE5%-5J31IK FVXM:LN+&]VKU4N/S&A"4;PPIO>#C]\+'U=)!=6-
MMRT"9MRFZ7'K:AC+_;1=SH5:1A/DC4W!6I$NC5*S58PXWO)#JAV6FOMO?\SQ
MVQ,0)G"5%X]ZS*BB-\B%C=;!9O!Q6V1K[?@1[=4::P _/^'QY'=,OE;E^7I]
M8L]W5O3$+YC,\7J/ROF:+KGVO/1YRRF"RS1ZV/%W^FNE>:C@_9=:W53LJZJ4
MV6*_/>\CY8)4:RK5<]AMJ27'[2/%L%@&ZT_"H,P)OTS[)*[MEVKE,%N$OR??
M&?3\M(])'GH2)X'P83)%A+TKV>Q/R>ECM3]6X^-SJ$9F',+E^Y?\M:D0Q-Q$
M&'.N<.#=4Q5++)*X-/>M3VZO%PE5RI^;H/S(W]KS@"J]D1L,N7O-.A%Z-GW(
M]]RNY_/I8#/ <#;7V#"9RMU(-3X#I]8EIU9-Y^VZG'JX :?631;X.9ET P9\
M0OZK&=)L:ZWKDVF'4^W&[JIV>,AI7U=#Z*[WABG (+[*[97"2X?E?O%"SG7V
M\#/PVTD:];"9<O%'=Z2R=$X</OY8ZA88P:%5QOE"YY+;JT:5(G9+@',$J]]Y
MB?)=>[OO0:+DUIIL*E&J5J.H['^//=++R(:J>%G76GLQ5COWJ)0X'KF1,-5'
MR'OMFW.G/8P$%2;)<N,LM +6T)!6%?<BZH&]D*V0GD,ZR./RQ+VGKD\L),..
M6=5S,G&G; K(.N>9+M. ;R"N&BY2DOB\2E4&=4<8 XB<H!H2=Z2N:4[V/9Z!
MZC8#U18PD!& V*;YX)F]]/&\4E7NHDI<JY[O,DW\,/RY$\QW$SIC(6L8XQ'8
MUVP/A\ "B8C&8!DK<@0H!*@Z$9V 'G548(]O?E5C:8$&Y98TJ_^8^QK& O90
M<;AM4!8]XV_-ZWMAZO>59^&XNF+2F80)-K(CCHD4?O3-ON@FCG8Y["7 #9ND
M7=!I7#[HW6+5IKYS,7>9!R**1]Z$%OP)/D?U>UVIV_1/5=<&NQ*P?J#BB+JR
MIU;_,M!&(E6QKZ&W- +!*<@Q&;M3^/]/$. )>.'8!I_Z";E,*5VJR$51K$MY
MX2KW$,>%J(OG%.->7#@\W^?.E;X84]VC1 6P:DF9,* \X":/W9Y(*0S'P (!
MTL?W?E('>8QN([AE@IC422?P6G@H*#@02V$4E^1I*+$TE%@(<8($E1W^DJ[P
M8^8'()*JLB4VQ@[T^P1OEOR <QMB@PHX8].2WC"2)PA!N<#)W[J>3_M&T /W
M%HY$$P%6--!4N"1;B_VZ*=(P["8NG'V<(OR0X1_U#F8P=/@B5FB,Z7 +C( N
MH#L8(-/C/>DJO +3GUYQ_A @/[&;R8]#0JGQ @6-('Z6J!T(74K@-WA#R1E&
MKG**XYZ'# QGS@(:+BF="**G4.\G*G<%T#,,84$!RB'LM0*2]]2M&F L5G7+
M6]WYYC*A%]_W_)3@*08IP??0PKO"]P3\+!FYO$.ZRD#?$=%@80DZ;5@$]&/F
M4WQJ'B[8@-G3%VZ<$%\$<.I.K:[TF(;EFK-B<#F&B8BW2 KS 0_2)(W,Q<B4
M7:.B,G<)%Q=&HH<+(!< U\[<[<PP]@Q?)PA;P67$@4NOPQL/'Y<$1L /,833
M@S\$,:ILE!!$2RSE1C,X@:O]E0\%%FWQ)'@"0#TO'DDJ>P'Q:$;:9.017KHR
MR"XDZZ<P3=2?\?[+]<!R?42%BB(,>HQU&T'V.DJI,9#W01F%<=%1ENDH:Q0
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M_8%G$/0CR$-")Y[W68F=D>F<XM&8@[W=O?V\6/XK/0Z[1\/WP?M#[R@,?>\
MA4<>_'AXY'7WNO @@$='>WO#?X^.WQ\>''S<?7_D!7M[>]Y!^*'K?83!O@?W
M#S]V#P*$=O>Z"O21'3-_C"80B*[%[/B1G73&G$^/=W8>'A[>/>R_(W2TL[>[
MV]WY[?IJH(IVLK(1CG^LE'X<TB@OO[\C?QY"AO+B?C1<!?=A! .*$_;.)Y,=
MV=_=]_N[>7$)AFO@<<PXC/T%?,"IQ^=3Q+KE0N+W'?F[K&C7V^UZ>UU-U"RY
MY^WN>_M"$G).\3#AZ$*P=XY"F$3\I)/$/Q,8X1"C0*A&A"3Y*P4*/W-(1XC?
MP EB4^@CFZ'Y_ 8 21F>3 GE(-9D0\B&JLV,<B76 2F]5\2'7&FM+,E$4=4]
MK?P.BCB3WSSY[=TC"SH[]K4FS!M!.'6JN2B3UIY=<6E!05>[1T='.X]2^<I;
M4*I,JKPG/XJ9)/AUJ+9**^WK%M^\7&X3;5A./+<VY'+/;$/I1*O2!9.D^LZ>
MVXS%K'5N1B;IU P%Q)#_;D1F.P'"-M-AO;C\4#(!8!P3KN3EE>S:=(KCD*07
MQ"5)XW'.Y1T*\_546ZY+)HSZ<PRI3TEDF%T[4TJFB'*,6'&I5P!CBL*3CESP
MO7SM^B."PW>B)7D1K8)5A90_[P@1%%TM>Y++2C)..DP0$*%T;)K<\2E%KAT7
M(DSL'(KHOWS_Q5[FVG\AXB?1WZ/[ 0I=NR]$<(R?T'LI?2]^!S@XZ9P18:EV
M@+SV]>ZRQKQ0=::E<[@<<-F2S[OJ7Q=X2ZO6 TKJT\YZV364A*'@-OZL/J^K
M=B:<%:D17-,):[G5P2P5RR[FHU<[IC$C$0ZD,7\J!E'LV(,Q0IPYC',5@G'L
M]\2 #\3(H<7@+Z% A@52L%=*..M#*GHU1AR+=FZ H#4\(UW[]G2!MZO@_VHI
M?XOA8B2\%8NL:MK3J*N ,K)V4,?:$A20$"QA7^D*S\A$=&R,8H9GZ(JPY[.F
M(QK).[0G;P4=2/A7$L,O/Q/,Y\]F+H,QTO7>GJX4\I6B\ RR\45$'C8POQ9(
M1J(^.,PK@0H4;(O(NA^CTX3A&#DL>T49(P$?I=F-F1\1EE DO@AID(NW:* '
MR60"Z9R$ SR*<2B,I9CW?)\D,<?QJ"]TTA=^F34'EG!&>H[6Z<F Y80H0(,E
M-LC!6T3>-:(C!X\T*VX:_.[N^N"G@BT:V-X,X@@.(Q02.H 1&B _H9B[S(0:
M"",!W74"%F">0/,DG+?$:Q$O_312-(=Q(.V7J=PD;PAWH*4:P<C*WCHK.180
M8&"!!MXJO#9YG)>Q&%_E4?01'8R%YVW-1XFHD8C]=2)2$/!6POP+"""@D%K$
MP 7$]!N,$G2-H!P493U:DU N;>3A8)T'B0,4$"@BM8@'88_0! 57& YQY+AA
MZ*)&!@ZUC2(% 064%HU^%C^*1U="^QR&?EW...[OU\=]@0!2B!8-^H 3_\>8
M1 &BS#'<42)J'/H/FF=0 /EG^\(::J<[%3H7R  <BIEJCST%Y>)&&C3_60%Y
M"@D4H5I$16J&W,-'AZ6G*&,<=,TKS@P?)=ZB@>XEC%,887@G>@&I/Q8&^#F:
MH8@H"UP,AQ@8\0'/[ U1%TP347N:![U !SF\<AH*%4@2P:**%I%Y1E3\!L5.
M@:95*2,AFD>](M^BT;["0L,8ZHTH<G02=$GCJ&L><X8!EB M&OI\YI^1*()#
MDF8ZQ2JP/K#6C%@#&HG2/.K%*K6"K=8LC<,643A(A@S]3$0'OLR<)H\F:*1$
M<ZZ7$"#%:-6XVZ05MI2ML,E:'!T='GS8U789^ZP%>)M_:E/@,$TLW,O(MCUK
M*T)&3K0]*!4';U. -HUV=4K"D0$CD)$5;<.IS7"TD:RR1(4C33401H*T[:<J
MV=$^9O24A2,OE0!&5K1X;T7FHXVTE"8Q')FIPS"2HP6%*](A;21'3VZX;CE5
M $9:M(!Q28ZDC92L)3T<^2B7-I*AA8W7$R=M9$)/@SB240E@Y$,_9U6236DE
M)Z5Y$5=>ZD!,W.C'L*I2+&WDIW#8\QQQX3L\Z9QH+FKD0O/LB\=%P=L,ITT$
MV,5.7+EQ0S72ICG_+@&9%I*:QD9<25N5,I*B^?YY1*:% UX=29%/!@F2")&P
MNLP=\DGL"QM6]<*5MFW4;21?BRO4!W[$C,W:(J>L7A84RJZVZ%6=5N@ZBR!C
M:KF35=41NSDU<J_3J#[Z@3>#^JRVP:Q$KUI3Y*7ZE^%<9M I]'D"HVO(Y>7Y
MYE3GB14;]4>+T9CTIUY;AG-0: W(F]-*+2J+-KLJ1!V&D5LMT%,5LFXA.7K(
MV96::@0C,5K0IS)JW4)F2D/.KN34@ACYT8) E8'K%O*C!YZ==[E*!!,S)><(
MRV+7+61E+?Q\ ZG\.G->U4PX1H:TP) 6T/;  O65*L2*3X#I%SKV3.9,L$8B
MM5!1"9$KSY@!Q6I>F47L(A'6+[H6^)-DHB[UX?Q)VYDSL)%=+>94PFY:#<CJ
M2:^#O*97@BUX^*.[-8H%]"O)?U+V,?W_DK%$KG;N,7Q;0".A^AG8LNRDEW]8
M5/#*HQH0=>5V*O&9<(&_2S/D":NQ,["15RV*5\&KN@RRBI07GU?URK :HSO$
M.,6^>@Z1^$V,T-J5KZ+R#1#N5H^1?RT*5\'_LI),%:0*:!=5W>U4B-+S!>57
MOSS*C\X.TC.J,*J!?BMOU0&'FI^R2E_Y7PS)ZF<F'V_R.^(R.S:*\?]0L!D5
ML*W%J 76=Q*KN_8*7V6M0%0+1+U@6?&K)BR&:!$6)*$JP+Z)M1,%<LM&\I48
M*.C-A(4\0E\8QQ/Y[#E-XE>YW6Y*9S;?'J-VZ0?<JK6K$/:4YT-4?2!M8FI\
M9(T$62O!HIGEHEE;6ZF0A?O:GY9I6!$UT;RO!4J+=\:WD@"'^]F= ]KNT$8"
M]4>>.=XQWTJ2M7NR7:FL!# 29G%O=RLIL;TIVY4I5UPC@<^ZY[N5U*[?Q.U^
MN+5<WDB5^5[POSL?GW96W\N3?E]Y=X]\<T_V@C#%EGQIR!^I)28#@RCX&@>(
MZ@];@$.F#O"<=$(8R3>/R/</919UO62,(W4TZ*3#:2)?62)?L'8\1123X%Z]
M5"1]"94HR@1A'/-$-O972I+I22<MC3F:=$#Z"I+T"DLK%M<EQO)-15K?UFWF
M1T1]S%"?BH;F<;+;A,L6R/?I5?;4&6?3_5Z^:$Z"J(&WZ/Z=L 3B!/41E:_[
MDW'?VV&$1TH?Q$5I%HC>W(8WB,MC6Y7==\;9;O=E?1:]/Q.31+[9HA<'=^=W
M*))>R,I3!RMZ:Y1SZ%WZTS!-BHIV411@-UV?D%@L6W3NKNUW: )%3^)1X?S=
M/:*3AU1AB;O>NR":!RE(TNW3:3ARH8T/!YLI+W9#0[% >_EA^-(?]+(N%3N7
M-B?MVTJ1+;581J3CD45[O\98O>V4SV_#,_GB2D)C#'MB98G/,1J1:S09RB=Z
MEW?%5GKCO2PL40&1NF&S0GVY.:_O3K%$(YK<X_=C= WI#\1OPQ!)3A?;?7U7
M;"0;T<5\0__R.,6T;D58+[>MF6-K[0A'G\ID_3E*_U[&V4U;K _GLF'9T;@L
M'\#$!G?+Q])L,V^*&\%V&:"UG3- PRUNG!F36332R/BBW$LSGEK@LSQ$C,3@
MRZP?)_*2P6ZOE'IIFST;Y&^&_7BMV NW>A&1743;[I"/\$PVJ6Y2U0@]W<S<
MZF3I,89XS_^98*:\5.LEQ"SX%S&L2]T_X]KA@K'-?=#!?\R.E:13[,'. *X<
M@*>!O;S]? T9@_XX$<K+V66<UB"<W7ODCV,2D=&\WNZQEV^&]6.AI_G%YVE[
M :4A^I[9,&H:7B3UKG%IV:8N8'G<NE>9A;I'C_PT(OZ/FB"0 \8V">5Y-38&
M$HS$5%.'H'HCX6V,H)QZF?<QD?9K+^%C0N6IB#ZB%C'/)P,V53?ZE/@(!>R"
MDDD^)6_#;+6^P+%H@^R;+QBNW]_=@9KJ#UQ.IC@R!!I6RVQ/WQVB"60B^JA4
M,U]B4TN_.M)9+?'23H#%_G$F-2%ZYB:T!&G*'K1F)=\@_IW0'](V@E/,861M
M7Y=(-M2E*&139Z@GB1FI$G>2/Q5*6*0;Q+=8&(=9INE:S R.Y,J"+E"UG[4Q
M_*:NX;DVUVG\G1B$"T(?( VJUC1GF)>.%:^KO)IDJIG6LZ0HTHRLW<*NN(SE
M.##LJU-SW^WR%);2#5T)\N>%F<W1DI)-,3H=G)_:\) S3C/TUS)3MAK DX^S
M4'%(3K[5Q2XW _[R484LI;YH?VEN_1ND6#93OOH:!R@%3[T,4Z[^&<!-W>26
M3W#(DDC"][RYO:HV;ZL%GN%X;+>/\G$?MW'J9(JF5G9-*]=45VI#IM?O"-(+
MDM!MFWC+>IHZ"^R]G^U[.*[9JD+L)']FU$7Z\"JK>(LFTU CYK\X2NJ#!\42
MC8CZ7@E+"J'5.\ZKGA>AGJ1K-M"> ]D42\YE51DDXK-<4D1GQ4I2%W5Y#FA3
MUR4KO\,^1_U4N(8N"1O:GGHA1_0"4U9_7G-+M355]=*8Y7]0%)S.[\>8!GU(
MY2MV:X\_Z,5?..2Y'IA8L<WO!8<L1%2,8WKKMYH-UD$.*ZRFTNNBS=?P43ZT
M9+%Z7.-(+ NBKOSY)<(=ZE,2)'[UTK.U^IHZP.O:(I9<T6></L??4L-69!JZ
M"-O$4]* 02\/&*#@WBD>X8;9C'C-.I7JHU"XRUAE]!@KS_Q:JX8U7D/5IIC7
M7'C< ZLT:+%X4SWT 8Q#0H/3A,9C.!%6^7#.ZKV7.HE&>#,&X]'FCA\7B(;J
MK<L^=C:6O]Z&*HQ*HDTET\I@F[H+VD7;#4?"73 :DG!>>NB$L3/1R'F8IO=8
MG[#B.EYSLL\:H:%393&MY9'4Y6VDS'3CC%GNI3.D&XR+WC\04?Y^3+>?:=>J
M:^JBH3E:D$FS1OZ1OM5,[/_J'=BV?EJ%>$.GS8;8'HCJY/+1XY+W@4Q@;5O!
M2JMLJI*MQE!53V_#KPREVF-8HBR%_TKKU!V9PTB>(+R123UI8V\FV%J*VXA;
MF:MWV%/Y^@_TG8HJSLG#4_9H#:&ABXW#X?,_X8"Y8W#/]@[Z8KP_DZG6[>>!
M_KF*K9Y&P?PQFL#/;_X/4$L#!!0    ( $>!#E<1&F4\AA@  &CH   5
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M::R29E0A_AXMYJO!KC.!J$P1B>('ERU%@^@LA.1HS$6E(E-1PK<FQF4,V]!
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M'<%;D>J$#D7_F0OPB*684CACK9?C; 7L(3CY72EUG9-OI[%V'OT4&@4:%ZW
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M]9FB7F\#%1U30&-PAMR.E*7U.L0FP,>4,3X(QMY=[8,Q]@OLKP<Q,<PQM-H
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M">+I#G8;8&$)1CI':5>LI5(=-$2;(B1M4\Z9B?;'@GT3U*C<S"!<::N7-EO
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MO=JSG3%](2#C-(L(]"X.*\4;8EQV]=TQ7UX+,I8P&TP;(KY][:9X1V>AWU+
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M#J')#K)OUQW&M0CJ%Z/)M)=E(>$8!R:G6M4OD95%MA;0NL7) ).L:'L@ MZ
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MQ)153!7>VD'=)PGN*U:T)PYL(N76-L"+5^]>7C1V#ESEP#+D:!/!*+36A9R
MN6!4P)BYR6NM]5?7/$!!D 8B'NTNGX/%.-RH61*&>5D5DZ:A#YO=LIN(B!V&
MW2A08E&?+$PPUPIF-,.$!=')I#S%1:.+JZ]\"-_K6R=_A'&^V@)3*4IGR=50
MEM/4PJ*"6!+-+T5GCKG8()MO!^Z,NM-#EAM*G-]YT8%3).[)4(X@RCRB6]5>
M=H&>2.=06Q*B8JT[5VZ'] !NS7Z9N-&)31N%=E$[>CGJ^5GS:M!.,ZF4-N0)
M&"2?0%CPM7>-9,(I'ZSEHOD3NPW0GR1LKLXN=NRVE=EY/.!5+_7WTR\X_OPE
M#!=5"R?_7BO:3=X,%U+X._9/O]#P3[[A.)SB_,.788J7D9X])K6WW'+0K/;2
MF&?.1,[!9IX"$X4^;-W4_F@&__2>E6.1_$:TZV!'9&M!S'_\)TTKEQ,-[SF?
M>;8Q QI)8_%9@C=,0Y&1<9E+-LUK,[;$__,IV)?R.VW >^^H)JN&M=CT=)GK
M6,LL*:UH(!PEA*059!FL084\I=R:Q:W [RN>X=#$/8BRCR548@'_HH-DSHE$
MF3QP1$'/7:TJ9V4$8W2(RBD>2_/CB^L CN#<8I\<N+F]N;4N#F%,KQ3$U3"&
MN3:<NU9->)TQ=15FT<%X#G2TLCU--EVS]Z7CA\)?$Z5)11?@W&1:9V3=7_$"
M:@PD,LF4\GOWZXZ&M_>=!ATW;3=1;?>%ZB^ZZPKFT3H-#$L$A8GL8.<*1$GF
M,/,Y8FEM/BX%<H3>3.<ZOKN8_18*ZF#7]>X*^XE%ZW,Q(&1M!Y<P@..>0\I(
M3U_,)KC6UMR1M3<X=A;MH+"&<]!D/.U]K!)9M $J-A7G'!2K4QU>!.>" UU\
M37Q/9-.NU;:1KGJ-,?3;%5M^N.'3M/FWEWG#C;M+$!>SV1HP-C'/UZ% ^ZGA
M?DMZ!^'?5-\.DNOB";Z HU%)80*P* PH&P+XQ!0$I:47+C*':U4W.[0"5YB4
M'>AO X$UUMMO)*FSV=DY$(.".6\(O8X!E#&TKC":4 PW,3#M%8JU/(Q[-/?#
M3?>W+N\D]E$+F34TPN9 PI_7@/CHO8K10N&%+(,D#7A?LRA=*9(S8=1Z733N
M4][UFSY Y6TMLY5/7N.HL*7VP/)W7_U97^(N 6';WZU)+%BCP1Y/&)C3+!M1
M"J")M!XXPR%Z0::TX,BS-1YCZU3APX>!G0SFW\%\I^9Z-!G*9(2F9=+2,XN8
MP9=@P"CII(@FI=*ZS\]ZR([0-VS+M%N;_>T5UD585S,G*8IYA0$.1=1BT4('
MB$%F"-$5%C"JK)MGWC[!D]!=*'D891_+2>B;(:V)^&E*SV2]W-OZ!Q=)"\Z@
M="Y;T(;70BJV@'>B@"C2>RQD:);6<8IWP'GX.R8;\>-6=[0V>NI@$W\%M/-]
MPW7 =73X>2>PPYQB-E/C>O3800?[)TKF-BE-:[[P"E3QDOQ9(T%)[JV.IC#>
MVH ] $'N.2X\$#\V$'TWIX!(%ZPM15_6.OFCKQ7CN2UXX7;3?T:Y&MQDR"(L
MQ2\.":QT1G.N7)(=G G>!VO_]GM#1=X^I&FJA0[L\G_'(8[#@!">Y#,2]60Z
M#K6']X\@.;+""@807(CZG%@(*M!SHH7"I,B/X*VILA:PQT26]IKH(A@&!_31
MZ3U8)Q?<3EHX;2*8,"^/7A,ZO-%02C8LV&JB-8]RV03@8Z)/=YI9>4ZXC\W2
M'U]/IN]&T__">0.0TV$M1-M\OW3=&W:W9;K5D(]GUY3I*)0WC*8D9*!"SN22
M"05,%.;H$V7:)X0>?-?T%1%N]!WQ$XZ_]1,N!_1N-._'C8N8D,GGT30,[E-V
M+V7NBW(2BD\.%(\.7"P)O(HT+;#(4FJ=OM+98![DWNPF?+XY*1\'+3HP&SL;
MV")QY_5H?/Y6_1[O>1M==%*#9\74YDX,O(@*)),ABU TQ];;9OL=X<\GXW@(
MU(79W&S#T]9-3>,MR*3),"R)['\4$E"@B$9%09;=S]./@U+[,,H^EM./'Z/S
M49)CFDAP)BA/;DU!"%PDP.B5=<DIDUHW/7QD>6 ;<>#./+!-=/%0\FC6&=//
M/+"-\L VHLD^$FJVT?%#X:^3P:2(!>@ISJ"D*1"3<R"#Q)BM5$7]S -[F+3=
M1+4=T/72P*[I(8LR(.=[?\)R6X2-8)()H+0-$+UFD)TQH42G&;;>S%\)Y@C]
MGLYUO<H3VDE1>\\),]E$PXR!D,H\J"R#Q]KRA2<F#&?H2^N9ZRGDA.W"I'8*
MVUM>*O*<?,B$)V=%%)<,7(P),GE;1GO.G6N]L?.8\U(;LF<+!1WTH.BR>-5H
MX7)-_G.^<Q2&-\M=O9I,^V<U7O;67\P+875PI-0>6G>'3QV+\7B.J2R/*1;/
M0;*:(JN\!(?"@:O/2)'!IM(\C/C@QU3SR\?[$<2;",[KR"W(<%%'[E+SO*=X
MH8DF2)"TD("*18(O24(RQH6<:%HJS;<E.QK+$2X%;=F\U/LY-"FZ2#G85JQ;
M%DTT/!A=C*4E-SM0)C((T9H:R:5#T=JZYA;QGH?X-!^-(Z7041]321^\CAA!
M:%[/3Z( 'T."XES@UCL66//4N2=X3+43MP^B[.,\IK)<Y62B!2?J2B6<AA"*
M Z-B]#HS9Y+Z>4S5C -W'E-MHHN'LLV_SIA^'E-M=$RU$4WVL=^_C8X?#']=
MUI:G5%,3JB6O"[C@%&2O"A,IHTQ[SX0_&MYN=$QU?+3=0+5[/::R7$:93()L
M10%5)%G%WA8"QK0P%AF&M4H/_3RFVD[7:Q]3;:*HE6Y^VRWB19K%Y_ G[M)A
M:\E56FR\W@>NT1[I>[(#0ZV%_W8TF;P(X_'W,AK/XRBO_(>2@PHJ&7 LUN*I
M(D#0(D**O*;Y&\ULZ\*.:\#:J8_>ZNL_1WJ%?Q_WI_0\_#'L%9:DMG7(L3:Y
M8)*>!D\T+I9F98[HT>K[*++9+?<_C;0FP0\M^;H1=0<[@:N!]I"54KB58&L?
M615%+?BO$FCFN5)H361I;T_ X^%'8\EW87B4@JEFQEU.QQ_#%%^,AH1V1H#/
MD8^&DQZ/7AAF.;A2ST!+8N"E#"!21*\M*Y$USSY8&]WCXTQ'FFE8[O2>V>_#
M:'*]\VDO%,V$2JKF6;H:FL;!TX0(%ETH&'C!FZOLQ@O-C5L^'E)T*.K;A-BY
MW\_OP_%E(@KQ]CD.2?33FD[ T$7CH!9VIKF.ICG/9:WN'22OM!6^=<C="BB/
MAQDM97Z;"JHC*M"<-D9RV6H#SMF@BN4U2>PZA6/D%C%;<)C)22N.;"7&+>B4
M%0JMK<][XLJ]6)\,F=IJ[3;;]$XKT8?Q*-&])Q73IU!W\]^]?_NIYU0* 76
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MIY'QC"@\$VZ]ID;'7B#@2 RM[87?,$KY9K[H.C >7W6!C82_(CM]&\EU6%V
MT6Q6A*&I36.NF1L!0K0,G$&>L.AHC'H("ERKND +_6TBL$ZK"SC+;;2& :9:
MJ40%#L%CHA%A5EXEI+FF@>:.I+K 1F)?65U@$YEU6EU >72.\U#C:&I&JHBU
MS(P"+JPM+F+RS+=0WG%4%]A:>5O+;$_5!2[JMUTS$,B6'.:;&<@[%!W8]!8M
M:A'L-*QC+%&0"[+(5 (C.)GMV68BD6)DAF$2*:7"Q5J56!Y8B8(K+,/IF"Y:
M'8T7L\ET=%:3Y$/L#_K3[SWM'"LE*RA2%7JNI +/2@;!D]<N6>:,:"Z<.P ]
M\%BY3;AVVUELI:@.VDA\K*F^,WQ-XELEL%=_IL$L]X>G/WSW]IAZ!!YC* &$
MK2=-D1S9F+P'89+1F@7K96O.-83_A!EZ*!*T/FX\Q_81J_@)ZP<<E]'XK,8_
M7X6D_F<8]ZO?3N@G_8R+=?#DK![']3)#1*L10N:*P$<!SF</5D9?(PUMXNL=
M2>^*Y F2<?\:;%VTX!S\4LST9BT@&VHL]#M<1.!+'I.JW0J9-K4N7D"2$CDN
M!)*&8 +Y,^OEV6YXXR=.KD[TT[IXP+I8KZ< G__-I&>T81:5@"QKU0,6%<3:
M>(C7.5F6&E6V7AK/+BA^LJQCS36L&=#A[GC)3-LD++ L-$W(-D%@2!(E^6KG
M939NK9*+/U,C]FD1'I@(ATZ-N/M(F]FLG X&3)*UG+C6-!*GR,0-Q0<=R=1M
MW7_AL0<K;42.M8*5-E'2$<24K /W9[#23DK>,;AD&PT= ;%LM))9D<$J\L(5
M^3^U"# '&47P*3.OQ5IG@0^-4%L%*^V33YLHIO&9X]+,$UM+^BG!:.PT;.60
M0Y2>0_9&^QBBDB:N0Y2GG?6WS4+61"4--S,VBUA?!^03SOK;2(=;)71MHX##
M9?TEFD2STJ"MK=T:&3T?T3E@==J-D24NGF#67_<DV43NK;?E_W=_,#M?](3(
M(7(,4(J/M4"=A)!,!A\8BZ8H%<)Z!9*NKGFTF3R;2'RTN[@:A[:<5U!]/_Z$
MXV_]=!YKA;HDM Q$M//L) W1,D&_1EG3#:V7:S47N^?I77;OGS;"[BII'#MZ
MCJ>._QS1Y*+SZQJ@&MH$*X'LWP;874>W%=Y(P(W7_-7@@B$6&V' ZH"@C!"U
M+IHFNFN6C6%*L[6JX1R7UN]8T_>D]$WDVL'.PT51L<72A(5I3Z,BSS6D.CP#
MOG9GUD5([ZW)P<IUE+S!OL(/ /:[[#=2RJB51#O+ \D:46M;<\0+61Q,<W"*
M0&01E? 8O&W2WNPQYH%LNZQO)_R&IW\W(WO7@?'X\D V$OZ*/()M)-=A'HCT
M6= J@Y!0J1JB[<ASD A!2"YM\44WV=([CCR0%OK;1&"=YH%P$9+EK! &6EJ4
MKRTSA5>0?.2Y9CLXZQIH[DCR0#82^\H\D$UDUFD>"!?*2H<*!/+:[I(G\#4&
M+6?NR"IT*0O>0GG'D0>RM?*VEMF>\D ^S>($_SFKP:_?<+<FDZLNU2*O8RV8
MC?(W;MSK[66LB0])1UZUKLG^4MIQ\"D8$"GEI+/S6K4._5Z%95<WY\WP&TZF
MU<1[_\<0\W.2^##AHH9]+Y-9[SEY<2%X62T[&F?F]",Z;[FPBMO6H1]WX=E_
MC%T3!MST@YJ)O(,$B1L#/F\H;YQ#)ES=E[4TV*C 6RW!1%8"LR[(]6;X[>F^
MU["T3I2^LV"/)4CLYD#HS^8&J9:2>U7C"(P*H$@8-98S@W71LE*28Z%U"]T5
M4 [F9.^LXGLXLXVH.]@96P+K?'=H'6 =A76M!'68 *XFJKN?#CO(?:_$R&32
M,A021-TL5($ >ED<Q&!\(4<F.+E6KOCQ$N*> *S]\F$3<7?/@XO<=VM--*F
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M.N?<\]QRUDSF7]^7;XQWCG>.\8Z9)Z&-T^8 SAN&)H8 '1T=</?X!="F@&L
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MXY6L*H9*IDSB7$BQO=<$T[V:.MW.?&7)4NY*44:G@XW@9J08GR,I:E^;U4B
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M3<AZ1G(\YGI 'NX_5WSH_&&E+$NX_\^FI'E<Q_>AS9R2<M11<NM':P3 6F?
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M2RRF ;[KHE;6E!+5=8UMY,\'%:B;D8WX!;;'W4 JE4'"ORWW&7K#'Z_4-L-
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M9E""U7P=BBST:17)$U G1#;Y59&V[3S@L^WV:[#(9S\\-\>=7DWNEKYE8H'
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M%#C$E!Z3W2Z&#6ECE6R4%RB[X:Z@*/ S%5PTT2!1"'(3?T@6CJ4Y4,-Z+7*
M.G0?ZO<7**'$;1SA%:2JJ*"WU_E,I8=CQ2H6.?-R\QB6_;E.0T5P(!0!0+[N
M?W&":U+<CY68"/RE&M+L[5V,;]X4Y),F^PAKX9=B9&'87V:0SZ.1Q(ZC1;2P
M:UF(->\!>(FMMX6@J:8"YW>^S-J7KRD_+_G-.#>OBGVP9N@WQ/?XLT")&89Y
M J>!6F"T.8QMCU4J7I^'?+FU8CX#".-^_L&-Z]7K6S%^=6&^A4[R-&WPTO0W
M#;<XB1T>BM-W;U0>?PFOSA[3*8'!FA^^",+!"BYF%'LD4K0FD(Y@N0^DT(.O
MGA@B(/6=U2EL7AE^YS?T=')GCT*?-G1G1HI-RI"R!_CH-1(-?V:W*OF$$GN^
M<^.^$1%<L':&Y\Q*])>$[ MI6(RBK!S:+[QYMI@&E^I?D-A3#O@$N$D&N&AX
M(RNQV6"4 %CZ >HZ8D44F8#P(&X<-!96T)KS3=,EN#$;ZKCJ'9QZT-L(VDK\
M871:UFK&CZ):U_,%!U9VNE!+<^D-#.-;\.PA'9<@"8H\OO>TZ=33C-8WBCN%
MYSR"$%8_I&(KSD3L ?1&Z77OI$OAK$[#]GX>8<TUV2!7;,_)B'',MYHXO(28
M?U<!=R@ C<3<$"RB=[QXFSBJ-B9Q9%C58B++XVJZ,'%M9$_@VV7EI'G:..."
M&B!\P2DKN9>1)P&A: PX3_9E^/;@QP:F$WH;Q3.3U/E9OG>P;\&"U;8^GA<W
M0F/-U&$U1\@KC[D<E7IZ2'?[58K\6T"4E=%T<^M4DG#[;%-3BI-T:L-U.?'I
M'+:F%ZE2T0T+[ITDM#7L>L-[#YD4(9/P%^DT&TW221WIZ'3(R?V)L/>?4N^/
M/Z\^X9%_12KW[.N=3XM\"K+?OHWOL/IWXNDPE9W14%<4#:/^QK%?P*C%9)'[
MP^I)=)  /I:;F^P%.6D .1E9 ."0R#T^6+>:O6GBP HLSD IL5;SZB^O>B1\
M^WC8*QYY^'&&1-")[.?9^Y1$@$I_80F*U,&"\5[K4*Q,(]%H8]#63/0";G>,
M $"[^A!!96%9QJNY#V </XB* !A4T"8 R*3@..]H[!-_-@(@S3L=3PV&8O<]
MGCQDLB;^<#&Z#;H[^)@ :.G?(0 X,_$,P& "8"4MEP (3%W *Y@DT)^;[B0
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M2_;S)538@^?U?<?5%VFKUBYT VI,92PSLFS' W,EW/8LQG,O#B7(AF'L^KV
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MA"A75IVPZ[J(W<M@-W\NK/$\,$JC1! [C DW0IN%!4=^MJNCE*);$UV_WND
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MHL'J9-%-!'/9"),3CR( :+&N>A-<K^>WW/9+XQC5D\B#TA"/:$Q#&I]!6^Y
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MI\^_W*G!3OUN'5UU*;HK8G49+94QO)Y% /1="\CE6#_:(@!(3]JZ%DH[7Z'
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MNGK+]OTSUN5'0)C*@1L67-@Y&6.K=Y6B?F'K?5-7D6D;O>=]S].<<QJO6U=
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M]R*U0D*V=MB,T3GY>;/K.L;\0A]/LT>%5T69$RD_!=:>IQX1O9T/LEE %#[
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M>9 *Y)^U()Z"."C3[/%<W_ZC?34.+=$''V%$&H&?"0#[MB.6/^QS:L?[P01
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M44NE7=?S@+5A9-5;G'6YIRKX.@UIF:!=?O)Y8T86,A*.?O9F;X?HL,W$-?+
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MX1D?0X%I_CC^MO""TS_>V8&.FX<T8B;<C?'[+XME"I''5WT;LN%%$./)[X2
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M-Z>?%2+7_9*F/GQLKX: Q&Z>G8RRJ4 PSO2"VBT81XVS5/G?V"::,/J1:C5
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MB.%08D:V6C#=B\;H*LA6?5IYZ'!H^7'AH)NA19T?YI?D>TZ#GQ^)<DND $Z
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MZ1\,%('CZG.&&85P>_6YFPNULDPY4N:64]^0#EWZ+1U;+$\J9JTO ,RMC@.
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M_T:-1G7NA9*N\5@&:\!U2$ [&]6Q5><=>1ZOL+V=M#]\3@:6>KX4'(CZX3;
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MG<*/%L_3(5G3M$Q&UV38/6_5P).XD^3<0NRM>.V_A[+H7^Z\*?2B5T2?W'5
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M3F3<8M%YTYXGY:O<ZRH7\P1IC@>^?(Q'Q<E+3)T,T$1+D:<X]B;-(M3%_//
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M3MC-Q%N,&=WQ:L<,WOP42NKLY#1K@57DDX7W8<&E,*PX28<LK"G:2.!:7SE
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M0Y=-NM(ASYZG*&S,>HN=_*F,N26L<H+A$,  L^\,D@S0KL'_RL!"5D7;G>A
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M_FG29G/)'+ B%;!](/;?A([9 R>2N]WD)?RX17P86:;DYB9P0L#M2?#M0T#
MR;S7"=E6R.H]:6PC3[4TF[VWAQM3VY 1B%0R#?R!'C.Z^?IF0GOT6;OC1>)?
M#)4!++>SM\TNYXOL66X[DG5:$10XTT!N:'<3)MEY/*OF]IC8QS'_IL2U-63,
M#Y@C0UL3C>6/Q_YRNQD&[A? KF>QR#1PZ:,E*J.:Q(?Y,7]T>QR(C>>SG!BK
MZ1*&2-QEH="Z:RRW+L]/85ST7S*9W$!J,;BY<91WZKB&GDXZ! 1F?RMZ*)-B
MFKG'M^5([9N8B97\:;_*OU6J^&L9Z26O#$:Y+S;8:VPW56OB_@SZWT2[.6 _
M4#/2Y.-51U*UY(J<^+\$EY+U7TT@\_+?]OVX4#V%:D'*JY7'UIAF'0*VMDVI
MB_)*]DG4PD,"G (8/9+##;IK9$@$77)>DR6U':3]%K1XBF 7/IH2VL=W")AF
MRO[7;2"TC@3Y8V%XNK[?P.@>!5YROG^D2'ZDW7^$D64@62,)RWW D*5PI+X/
M^HOZ_N^',IN=XX 5UIMM=/]%N/\(Q24P_([!*_"6%!1-!;'C7W3>_<6:I?>Y
MU2%4B"K"J"A.>F-$^30'[I8^4NZ_<I ]&40ULF54DPWVHWX&3#Y6^2^["_S1
M/)W]C&389=31O@2_>;7CS\;\97>!\T>["[2CB#2VOSE5A>K4_S'[JA#4TH/V
M)O$QKM1"0.XNOB_F8U/&>?&\FO)X7QJU:Y#/<JM9D(U+V8P#EM\36U?/EG]^
MZJE\Z5JGT(Z"[/1X&48,9IR;\MBY/JFVD$0EJ]JI<'[#$ -P>)9F;7T=[-+%
M-<\QETIAP6.)-^L?%:DFRKHR'RN#- .K [._-G'IZ<-:**($-? DXD=M^,I,
MO=WH"^E?] E73LVR9>-ZE?OZ4/3J^L7$2BPEHV#9N]0%NEQU:SSP _U$JD!M
M4%WG=-1J\:]G;QXM;!JY#I8U-<IM.2HQ3%\(R117<GA7MN[EA%+T5XH 3><*
MTN$_)::G5$[#^1=K*I3C0%66YI?C)H,U1QOS-212_Y'7&PG=;7Y3D0@83+#R
M1 KHL??+R;:XFQ>S6#Y<OM(6_C#&E=9W.Y")F:7[F?[M')_ O  ZL8M?38K%
MC>]VZUOG_Y,1XD3]%1/"&?\7N?][[#OPI>;$9;Q ;(F/"9$!=][BULN;=7SZ
ME3>_:5]CEO).B/=[%33J=Z\A)^"6E;"5(*O5N>#!.U<.:KN[/,12?ZWT7@7!
MUOP)8$;*-VOU8>=/]7@$7L_G4PMO%G]P9_7\&S%2B1]S?9_CS*+J'EE;)_CK
MD.<PB)R12T[;?6# -'W)*-FN9@\W8]N/+-[2>-Y!.?U@6O_VI%XT#$"^F8A1
MD-H%CBHVBQC*ZGIX5#'ZI;?^ ]<3\E<M9YI,VYS4Y5Q.U*1[#04%H*W*7&'#
MA0+!7X4+.U?1O_RVKR#$4G 7BY)"S,8F-<T$$A_AJS-Y%#$330H;(/,_,S3P
M3R% B8F7]6TK7:(\@$WK9/]G61LT-%Y\M '%T<8_1^7 ".B/$34<AWTUU3SC
M(/A0ANC?_GBT76ET-'COH @E7E"82C>7$A"9OW3/??Q2HKL^W&0;W3R%-SP$
MA 6)$#BSDCT^$5-;%MW'0%4*ELJT);9G7>P^N;_/DHMAW+CZ"S&V8W"0)PG7
ME"5?36W%?$0F?8(F3)F$.5WWBA(75&SNJ(^@V;U#+T9Y<)JHU^R#YDYW61]*
MX,4D F> !RX68_"Y+*'OY<J,?4N5K^X5Z.9_&XM!;#N5JEHOVQ:!"C98F"ON
M:!M80WW[4KE/CF5*V3W8M,]!(5*3="VU@QH7IJK$6@X![,0<=$N#6 1V9#LZ
M,:!._F=>IBO=@W0MXZCWC(GF03E-[,CG!Z^"@%#P#:)YUH6!M9QAA=5[;[<9
M7M=!C/,I&B_4"\[*4 A"&XKH085M\]/#Y3S0D5)(MY4:+(U<V?KS+)U9VO"7
M9VO.\MD2'M7C*:LBR:F0B:;UT@0M#K/W 05_>&KWOW(<LS4X!,1W'@* LQ"'
M<D]JQT>.)U"T:XJS/LWJ'>G.G+_^QSN]").OAX#JCN  -T*E"1'\*5:'Y-V6
M'S.I>_9ZKT_XP1-MW/76^(PBEKK)T?4@26B&,=ZGQ8 =PB>5X5N\K%ACS,_/
MSV!6GV[Y4K']A-TI83=CZ/1Q@^-(#N1!>I P^0+1"P_'B:8Y3@H1%$,*14L#
M/RPVJ+?<@U7+(A;E(K-[)*JTK[>^HG_B$7*UK_$YL7X:$F@<*'NT,Z7D[4F7
MRI[G^R7'[>9Z%66Y.QUWA.4/;'#Y+Q%JQ?H?EY#2/SQ[[G*:IGS;-'EY\?65
M;RG:C[ZP=7;^0JEOBX(Y'<#5=*&/IS,]6H.$T-5JSP9C4Z(O_YI [#CJ"9G,
MLK4\_A;_>I>SJ*8""IJIC=D"LA$A]PAQ]8> T[UCM^T\FR2W>371.\JL\]VF
MXKS!5@<JO.H_U(#O-<\3@[$P^L6:AK@FG+[PS<&U"*Y=BUBR*4$_(:%\XH6S
MRO16D5]^6_P).S_-S&(':UD\)?OCTM7JY.V1PA.&5L>&6E>P8%Z@9SH1_(5*
M;D'GH/361% Q%,G"T9+SD^C^JZ,/OY;*5>B5VR<RV,FNY_,R@"[JYO5F61V&
MA!"+VJGCFAW +V,NS%!0!SO4%?K-RGAGL(V+-:T$Y^&2DJCV;/2$R(=S3T_K
M]+RFHSU>OI--EH33' *:Y0X!IX!DT2#@T28!O2303NU.'O#I)JS^U_IHXY@*
MG!/OL_HZ2W5H6]RSB>4&EVF6F" P;F>SS=#RX^S3S%HN4DYKR=7.R%-BZ@H!
M';ED,0(\#&9'3WB>.PUCG23RZQ-#?'TD0Y%)\O4/6-;@YU](/=,:RUS(Y]<I
MZ%&F<$+'#-&3F_IXI4CY,<OX*+>EE$GO2#?N!#L]SK37^=U\LT\/^F]Y@[0R
M<*DAW&TT+3IM&%8";](WOFM#'TC69%N7I,8@MUZ9&P'&^"?$]U [8N-U06%9
MWQNW5-^ (%,QJQL^+KTJ[1*SZZ/S-ZCDK)'T)4B9:(*39B/V&K"//VQ:R1*T
M[)938YE8 D(R6)V,VE=)F^^8(<%XI2\'UX($:U\&>.60[]81;@9=2-FR),)T
M*A03Q]GJI=L_*B"/)X0^<98;<[X8U3%QBN#_)1$:36';)L##+:TWD7T'*0TE
M=,L]E/EDE/>ZX_-ZEN!#0!4GJFV5OST]\U<R,&Q57:YX?#%)5W(A3>"<88_,
MD\C/C[)4VE71;90K>+/6"9]F3<[*X0"V,OO]N,P9GK5/^/5PA)@+<X(- +2<
MDS(I)_*QOMOEV7)=X$!@[8XOT0"G?V-ZO2.;<8G/ZE>P/T[ XWY<6[7E Z$'
M[.;7\XKKCG?JDEJ$2VG*IVZ0($19*W86=L40W%MU%L7WGD,$SQHV)O6N1*6$
M7WO-LMH3[9=MXZJ77,E/\$R]B/2SFDKXV8:Q[EFI]/3J^GI9F*LV\,@HY .B
M"ZZ/C\BPX_:#PM>!]S=%JWO9>._[V^\CXX7M5I >73NI#<*=%T/:@>LL=R%=
M9*OI[,CT^5?J%Y\508&6@PI,:NUL$_I8%!/Q]B037S, AM828:M*Y)J7;$HE
M337?9@ &@ .<B#X?E]D7E9 :^+9/Q1S(FRERRXI=JKKO',7!KHZ$F.=P2#8'
M@A<;Z"#)_X#@'9JWM.FTL45:O<WC#'1KQBD^ZA +#NX)$":<F9Z/K)9DV<FM
MB_^JVC:96P1)D<YK6/103W63')2K1G6G&E[1O4.(0>OB#5H:LIM)X,@&V];X
ML*P+A#(X3J]89?5I2$N^26W3*_A:0EI',F]HQ.6*BM4O:U0(C$H2]+Y&XH*Q
M-03OE\CSF^KPE9#"&SM-Q-XI,6_RS+LG%;/$/7S[>2Q%&*K+^"QY%Y*2:V],
M0T/JO7*K;P0I1+3$"_K#PKRMCQ/ZPC7%,)#/T(@))E"+GV3X*+M5O5[;D$BM
M.(<4ZR$@+TO[.*XB@(8D7TC4*W&8%,6#8ZM0G&TS-R2S"O,6SO_:F3QQ4^;;
MSL"JK]-N8_E&R-."Z=4VFO)])6PVMYVU_""L*D"CU'Y_)QO1L=,DNZ064<M<
MW'2*5S"MU&&O;T=;4#%JLR.!F'VM-N0N9#NQHS46V_;#1:%&K37) !+Z"&K,
M^^8,8L,_D/?:N;\^<$4?&80!L6P? J+ E08Q 3+8:)95#7?2"LRV>C,W/*C[
MIP@L2_L^STV;+@&9$904##MU"! \!"S<. 1\:PNG+DIPS-_DAO;)V1$R#_1/
M&7[@J9K8-JBPXEOQ,W=\=D?]K%#*_-QPZE?@&(L^,8VEE=]*U!+&?<.A1J]
M)S#OQ2/S5@B_UB]?Q^/!NV\VCBT=@X.&48]!&&ZK8;B7Q/H)W]W:I*;6C4,
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M=$#RN73PKC,*KPJC2,43;\BCUB9@TYY4ZK!R-KK* \.'V<,F&@X!7ZB()3:
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MCR>GH5M92-2>>K$9@^*$;$D)8#$/D%SWYXW:"A7R<V"%JX\^&[4.>CACLAO
M?QPAGFB'"@5NF2#X#P$A) .*"O@=4O0@:BOE(#N 8>80P+"$QH15>ME"J-V
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M;R9:+8F>OVEB/,T!83L:.!-Q>>%,'$#W[7$LVX;"Y/K?M ,!*Q#L&G,!< J
MC@*(BF^!FR>IE>NB7K';V"5;GN&("I<K?0_8%>!;IP#.PB[B0L(]H/0KQM$1
M%Y+\6>)[!A[=[CIM5'D6]HG[1FQH/Z QH"K7S0M4NMG"C62RESG3P#F5L\)5
MM;?>@YK8"$GVC?2IK9MJ(?7?.]*AGJ]G;V9KN$,8.M(PE&H!$@Q3/FSS2]Z&
M9^3OP9 7,"8]U0F\\AUV4V<MM]SZ;43Z,/J%F?[],V55K\E72/%M4B5+5==]
MH#":>5DI4SGG2IS2@4.)3R>-RAW V+0""\$  S_IG=J:?FG '57BP'LY4;I"
M'5&N+H#FD7*4-0TOEJJ:HBYZ[CTWJ_JZX3*A[!%>H2IO"A4JWOF([65"=*&7
MI3B=^GG6C(1;:3U]3\_+/&% G":L8G,I@+5M/,-<?DO?25)FG;0?E*8R*@^]
MD2 D(9C)MC1KYGF^].G9<)G6#";!J &8#]+_NP(KH0RW_Z!NI'QON+Q67DNM
M 36T(7Z$N%E^RY1C+IG/X\#L,0C*JZ(X)W'(D$?N!C.4)^^$K<.N7W!;-H[9
MJZCK\7+N'?,YJ2'&29\6L&0]4R4<:;7HU8XZ"0/BN5O1!J%RJAB"A*G)HV!U
M7[N%.&5>W5<A40.&0J&*YA4MP.2O\_WL"JZXS:9?ET<PX$!-8/8?A#PP%2$<
M4BKCH+]B;.II-&"F[H.#>Q?/3/?24I]H:$<*XE!K*%Q?$[H]_M-R^@5SCQQV
M1PFH!'?AUQ=&$VX<EU+TH_G27</IULT^/5+\S;W1U(N@OX]U#T6'P7.]6BT'
MX6W(ND[OF",0XPW>[O0M)^+H4I+-CUV<]V:ACO-"0]4,F8JPC(%.2!GCM"(5
MV%;1(C%[.K-3C')@'_NQH'C]RFGCNS,7M[9C8U 5"28?+*K[0F<JH#%R>GCV
MUFE^W%B8G/*L(]BX[LC!]E"_5D:9^_T _54Q#HM[P%1;>7G!O9KP'<O6'W=T
M]PI/(AU@7H/[J[P_5WG4%*#62&1?"2$PESP"9MF9X#'NA;+U%$^L#'0P;A'B
M!F<,Q3HXGT=+2L5^\Q24O?EHG2:L7=.A$C^S;IE+U"(D8Y"LWC%-3%\(_J,]
M+]9V'";4KYMA3^DTF,1\*:O3J KUIH\OCW8[.J<L[2)Y7F</\41MM2 AO5++
MMCA\^A5^9P)5.C9V3+D-?AOK'X2/Z#A,BBCO8UKAY1WV<$@606)J1[(;@M(J
M9^^SH2^_>K;H IMWO=67:K CJ.RI/7?G<3Z7+FYZ9<!WG>Q2_=E-F>YC>WI$
MWS$\GED>AH=C,,7S#C6?951B@9LBSV,;O+2)=+178H:B&UZ1O&;[(LBGABLT
MP,UDGAK^@^>RMG-5WE@JEK2,+SP!AV/+%=IC[N\]UKGV-;^"JFN"LJ O(FU6
M9,BLW6'8CY9<>^^,(=@!GXDD2-V^ZX: -R?_)T')XLVBNIA>!#?,&-?Q:E?=
M3\JTUOM*=40/E;D=RZ4KKDV*<F]]/26V(&T]["UL-6-[26\\3'RGKNY&^"7<
M+C5&/:DUI/ZR-Q>=GDPJ([AA( 0E.5#^<DS5.EWNHK7T*15I)]^Y_/[3RW:/
ML:'/?I+2KA["C,&RKLO[:9Q(%B$]M4'=^'!HP@P$DDS<U8;T%[$N40!(T*\7
MT^,I@+W\7K@#W.TXXG\%E]?]Q3_0:@=)"3Y/ 9 ^_A_]12.; NB&MAR.)EB+
MR"UX'E:1M2@ =-PV_-#K. 9J!']X*7AX)RN?Y/?K/7KBL6-4 5R/^9O?8G;W
MR9FH+3AY&%P)7IZ9HP  9)<EY!(V'#PV\^M]^2X*X.@Q^0<%D ^/(5(?=&2A
MLL./(SX(_-=;\@(4P+K2D24YC0S& 1=YP\G1U[+_.R-S>S%KDOHF:L'P,2)%
M58[*M!U1;">9Q2!H1-]%]U6I2[[K,LJ_0##5%BF\4)4ND4C_N(/?Z3;G@Z:3
M+\]!SK4F)_ *: ??8([D\U41>R@WTR/J4N644N@PA;!KJ?,S"+ER'?-EP#7>
MX%VJZP+9<"UI<C/?RE\"=HG , >,?K(R0-#\QETYQ*<F(G<P>FD[CE71Z;9G
M%6\[2@ELE::$#0ER]\ )M*+.S*!)KT4)":NR@]BKH?!N>OZH]R>R-^)\0**/
MI3P090*-MOY4!"WC(26A,:G#BK:^U ^(LI#K3CD4P)C$&56+-<$?A=LOD-</
M<RR-NC[MFLH#W6+D[CY5U&\PU8P4"-;PE18_&%(S4YL>=3HTT=L/.O;K-?TY
M_G?X]?_A"X),_E*@4_F7LIVL]+:.9UGA@D_^*Q4UC#Q_.GZ54J4 $F="=HMN
M+"!:OT]CE%ETZ?XK14#_6KOQ5_4YGG^55PD*8W2R&E!F';7]1RO\GVE&?\E;
M^VSZY[*=Q4_5YR>/)]7Y]C='DM1 ,C,W\&!_!([3]J( VC]2 &_:6\A^NQ B
MB^GQ2A?\,87[UA<* .%G0 '0L,.)]C&$1R_ BS-Z%$"3\@P%P/6'//'? ?W_
M!BBU >\78?SUK'WR7'&\NVS,H;41&/=N'-['HWX\*@E,=*KE^?-%)DOYONS,
M?.3SJ:('<Y_@LZ6+Q\')  5 KY%$Q ^C<$9NQU-9(>=^1"\=^O7LKN'1X^C6
M(0VY?'JN:]VWY%\!QK[S\I-0=<)Y*UL3MF30L$3JM1_("3.]JO//2 OWZ#OR
MUD#F3PV_MS"^4E]E98&27L3(<B?/;LVGW\B*VMO<%];* 6.NEU( Z3))9 81
M.&$*]+=3+57@@FD,DJ]YOYS0&RI"?H8MZ<-+5\YRY-(9)3R%,V1>^V'-?^$E
MWM3#\TDA5[_>]=H\+^TBS3I68TV\K]@_H&O5+'Q,1^<?=Y*@_KW/_Z@^)QJ2
ML!,<Q,FF3^D(KX<U"@VQ(Q3 ;S2ET/A/3[.)DR_S_@01KTJ"MC<+*(#9K&-+
M'*5]##8JA'BT@B)<JSVVFGK5RHI7_QV=_B55W_+XC\(ADGQ:Y!CM" CW_@>\
MKZ&0 G@=@2)+_"&9]W= _U<!)9CH#!?M^$END+>TK@Z."J3;22:BPW/?SY[0
M!,A?HQ;[!]O  DP"?]2L<+.JK'H@OM5KSROLY\2T*D9#U^3;>P'7;XZOS]Z=
M74Q_75LOH!MB/.2(+!K$WA$Y^R#"R_%*>09H4_ER8>:>-2TZ('GF;^>E^AOB
M]!?<*L%GRQG5.[@0@>M(8M^YY<J!:=-QG]M D>MW5*8-S/LR+%1=[H:A_L&6
M5'SU:"^9X)._DB09;[]OIER<(5X8I2U>FS^46<LO&K=O(<HO^8!VL5& EG5%
MNH\O]NYWK=] R/Y;EA2Z9I0W5 [SW3:>5';CJASL__H,F*?J;WLNX;?KH:.#
M]XA,7#G)E3^]F3/%U#$J@VC]E2MWZ=.2C#_2;T^]QW-S3<;=_U',8D]YY?>"
MMW4G7%N!+W-S"=OW\(4.^FCA_8FK Q)L0QXT6U8Q75_U:.*%LCVIF0SXTBNT
MIQB=GAPO3EXWV7L%0A"J/D;H#F_6L:8 Y#Q$B6Q/CQ>K9BRKID+\]O_W#E>Q
ME/WX]RZ_=_F?VD5L#69@5?7@$5>B]'+N%&\'.7D4]1M;HE/^E[M<3_]+O<P_
M<G5+^5M^^T_P;^S,'PI,_X&E^$/YZ#\#SG\TPOM7WG4WK!C0LI@KF4>4[V5F
M_2!*!8LRJWX\_BO!X>@A+3XV(73K=L.XS(6@=_<G?.<N[("O(IL09V!G4[38
MO"?TON#-(K52,?6BFN^9BT]0\P]:*NCR@6_*Q>6<B70ZFFB;9AF"N6'25!5'
M9H]4TN#G@G4W9(-UQ@, @3]>.<Q!F>%-8-@##XT:4'CY1-H5^K,4@+U/20\7
MFX#3.4ZUD^DK]-*-/3 5OU>MNL4E+!^/-,2W_!T*5FKE=P;(/JU&GC<J+UG8
M]NNY#QTA>_QR1T1B_+BU1/>L"=G8F-"9"IKBPD]3XED;[3^G;<VYGU56&G9W
ML-@-:)M: GSGY^?'IA/F(&4S:V.Y1(:JFEJ'ED)"\-8MEOT&L]9HN?D.KJV[
M IS\V^7.,@:E8U6QYK<X'@D:YF]V51ZB%^M;O@KI,YR:B_3ZD#._6X^$;J&^
M'[/WD'FY^;]5D"^(((0X2&R^DM. 0EGB)S7R3%4O:%^W\;QU\S1@/LZ[L?AU
M.."@;':F!<RRA"I32&"E $)AVGNYN-8O56\VA5[,15_GFAI6+C<N:E?D W35
MWNE]:? 6)DT0^+1J &'*Q(L&>JA6#)&YIDUJS Q[N)3\]H+'F7&W1#A*L]T^
MW.0$Q!34Z1TI>;,WO=RHR%Y)"<[>6V>;$JFX4MJ_B>0K"QHN[1)ZV[P4KLL<
M-Q63>PMEVT?550A_;F0ODUCELW='])NM,2LY)VO:>HHEJ&C6@RI$TY9SBW4T
M'COET.C/5(6/:9%=-WE<B7O1?RPWJ_[<P[NKB5^WT]A&A)_<5S?:.PDM5POF
M@]XY<;SM_IAIYKT]2+YH!B$DJ8R6CR4U&5LG34B82%M^'RBCYK313GK,+CCL
MA?0<1MGUA;R4[YFJ_UGX44DB\MSD3&9_Q0EWPGQOBT<H>*#TE(M(2[36A3%+
M+#C4C >'")QI,TXL/.,/,IQ+@&8RRG26LIY[WVH>F1IQ[7%&?&PX@&#2#&>"
M:>'V,:9](>(F(- $T:$"3W_$V'J/8*<BYA(O0B2]G9!3[G:Z$E'2QX%4)13A
M#%H5% C3V]ZK#\KP16FH  ^:BKHA<<$(AP?%W=AK9+N\[Q2 6$(+=><E14ZD
M.YYV_3KNJ$6F(3M_QG[?9*<R2D*VT$]DP]=4.J>]K3KM\JUFS9>R)V2Q<7"T
M Z:H(=?-ELS_W;.J,/^IO9JY*]I=2CCR_GZ6F%-1Y^K%=I<'+Q% [Z%9U6AQ
M1$@#M0(S#A%:M"NOWOP$P<9@XC.(W6T88HDY.1^9_)#S1#:L3:6?"5 T$PX^
M ^E L(G[(D)X:4>%_#GK:OBY*HJ*H]S,SXPQN+9V7MX:0'E1W=AZ=6(Q\2=*
M62Q=]?(7.?:Y'@8L;[+;1V__HZ-[O=,;#IQ6QT[-BP')<6:FC ^\MT\!+>R"
M^H+KU'#/L1USUNL+^RV^4ZI-7%I11>,G;,]/9PSE5+SM+%'A>QXWJ;'-&F6D
M=.M.5V%-1W.]J5##)6^4&BZOR@$KW<!G_'390"W_J:(;"5%SVTS\!H=JB-^D
M9:34U-QZQ":OK3$T2KR/?G+&Q__B\'IN;7G9EI6"E?99?D>,9Z25\P,!N>?E
MNW_^7AF-^9>,^]+_C++_TY^(U!D594+D0$R%8EN?O5:['R]X6V1$0(@][I0T
M->+A08[_C\&E!F:"*5RB,GY.%9]7<C6!E)O%G28SRE@FY#LJ&(I6X8-?3.C2
M"0SL&)B^5I:JC>M%VCFE6[?NN2ES63%^[[S+*<>D]9*@,'-L6'-SB?P$YOP8
M.G6O H)ZJY1,>J'YJ4R;GZKTU6KL#N+?(HUT9T\=8@.R5T1C9LJMDQI)JLTR
M=X?X1B20S--^B3U.FXGM@V<Y67-27)$EJN_K6<,6\8%FA&J\6(L_#YZMQ _7
MHA;<IU2><FA2B7_FX-MI&>/O&&Y<'OF#L;6D5>;9![P2-BUALRU-Y%M'*X1*
M5$XU\W.;38C.2/F2!S<L9K>R67J<;DWM:U@]%>L\"@A^#N$@Z)#9S_:[IZDV
M-]"-R<E[Y=OZ,PQ7>!?G^E9? CQ\^ VO(D7[^%'D#W]-&H#7*+QB.I=][4B@
MK1[2A/8+CG!A$^]1F#"-PVYLS/9:&!II9-TXH<33A C8]Y/M&^^86ZA:I\61
MYUKI<WFHM<OJ$MOWU>+F>GWMF$^><@SU>0*\<=-5UJ!WFH>40N8C1#3!J15
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MNTT!-%J3%7=?SG22?_HQ*,-V_ZXGZ+>P2/'OX?UR% ".$_[6SZQJ"UR-N#<
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MM"DQ$XIB0!*5,#WJ;6"F=06T1+VH1GDBZ?P"1AO*7SE0*%>0[WSR.MIG3HX
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MH8G2N'E/],EIUBJV6SXOK[1LQG4]?'W9,OY;]*V)?(XV#_&N7SG <EY[M11
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MM*I_%F*W[PP9UZS%5E?&6D4K[^H_400]!%3\Z4#""%T56CY%HP29;G&H33"
MOB?1ZNC)V6%%"<I$60]8AGCCR3"33+=&8@V9%3O-B4O_A&=^7%T=MV@?_'W,
MS3K,LI]J\L@90!3<]K^"+3@P$TG42^C?^U$0ONRN;@J9/"R\XMF7T;WUP\).
MG3D,<>7.[DJ?_1#,,=-^*-31XP[_>]RYL"?3C1=L<$4U.!0K\4H];OK#_NB^
M _RDDGN&BO;PRSD!OK&4-86SA 8_^UX_R3TEX;:"X&@5Z><Q><!B)NE]UK8X
MO).Y4*^T)#Q(UT'#3%BVW<RDH4]/H#A%[,5S T7S:5$:G70&WPV4:.?.0\$^
M<7@,[[EA9)T.U,<_':3%M#)WO[IF-"\8S5G\D%:;F?V@% B8_<![(ZD5BE9O
M!)TA"ILC9QSVC*.B=M'C$_#G9B;?!DL\#*R_AW-:3N=V"MA*7T;I*5@="V3P
M2(,T4;8_;V@.A>\(63<FLWRMV):X5B(D<E=-<2HJ4HNQ_W#87X:P. L/0;T(
MU,5+AM>TU3D([(FG]"143 :\NG%B4H,K,O"MT;MSTZ]DT8)!D&@4D_^PT )^
M,5AX]XSUFO5H$6RI=ZKU=ACPHD='KKL_)]XS:$Y#ZDBU!3V:AK0[^@YW&!+)
M_AKAO%+;'QL;VVY+;1:.CPFF "JJ6OK"4I(BBQPEZ,6]88+7U"?6[3(K*]UO
MBUL8SF_3C5>[)*+]K>=2-B>P2:_'E&M'N=L.3R]+Q@D9L"_JA'0&36P4=M7:
MQ_]@OLNCS+I@=H.4K\#KK44^YS./ITG,SO5^3=:0X;'4K*]*;$???_S=)O7[
MZ5<G9*SFHP4+\."VF)/>5P]E1<]Y=[<<TJS%AL7-Z(Y<K(S-YG^%,6VZ\4!N
M9[:?UD#960SFBC--_^0']<,R\FF65%16U7(5C9985 [FC&]](Q,[J3K.+!6,
M'Z@;F&1X1SS$ZR<QY6?9>[YL3Y6$%?8H8 2"<,Z>->>9Z#I.O1*W_=/%%1&C
M"I=-EN',[A &R9F=52-^3W#S >D'\9Y:1\W8!Y@>?BQ&@7DU0MS >:6&<2C^
MQ9CG-UC9<.OW5$U5"\T'AURX*3?LJ4]([UGO/)T+QN$]%SI+%BTX&M$ @?SN
MPY3#IVS:-[K1:OEL:44S9*I#7JWFH7;EL0_9-UPC%NQ(10DCB5.P@7U'UNV0
MU_Y",$4"$GM_J'Q9:,=7^6##J:A(R><6R4J(@?>5ET+C6 E,@Q"21P01? N\
MD8;A6]N:@Q8&R<*LO%XT":>H;W^2-A^.WIW#?HEO5KN7;;!6\Q)Q/=G:P[6Z
M/<%'Q*LHOM:LQD2G**NNI04%<D_3:?=L8!UU%X8VU8RLQ]NSW5K]!%TPNQ=X
MFR/WM9WE%56AW$"J7D&U!GF8M".?WG!1G0>F_MZ$>N Z^_,^@\IWK=6GI<QQ
MM>^#./F$&KV*^3J.)?([C.=(#29S')B19-O!N 0[XZOQWM/Z4Y;:E55Q]"6U
M74G[0?H:*,F>\:93]=3WQ]QGSB]['J;'?C1>J7%LW@C>:K=.X3SEDN#!?^[M
M2RY _9^LD)G-D3+L*>0U^+0'F/FSG?R\JS)-46WZE=C),_X,]:A9B9BC1U6M
M4< F"@ 73Y0<29$E73$VZ>%<MTP3S5AY&/RD:2@^B,^Y<_Z5X';AG->ZWAPH
M)OW"H#OTG&+>Q,3R/J,KMU;8W/:'XA$1SA_6BC!+$&RL[[E/CK-+@J"$9+D?
M.,>_K9%(;Q"ZVM\AW>SMW;<?6_M3S>'YY_+$KKP=OZ&J5:>H0N/50_GH3Y87
M4[[MT6T\>^MN.Z5TG:C(ZHH2)A\[D2@V<0K@#,$&T_?FQ<Y$Q,=77TJ3BXP=
M/DE)_T")K5$IGE8P.S&?0F+&I:SZ4Q.>0^5L/G=AY>U[!]6G'JYP6$:*W4BR
M"F.YO/Y8LMCE@]6<Q$C =_-H2&W$@/TAI&36!7+*XNL3@[:1H/RKF2P3J>%P
M9OU2$Z=-+ZMRSW5;Y T<M",9YH*I![?J@X%UVE#,Q"JT4KE@^JF=]KU+:!-?
M8!54.V#*>S,@WJ02Q%7'[I*];+ _?66@7'^XB&:-K>JP'O'>0KC*V7;!W9E[
M83*R.UW,K/H ,ZG]M"^L08 @V^3P?/H2_GE(IC#6)['GT\KCB;"QF&2I+Y/2
M%V*TC=)Y"2V9WME8?>1LD;R3 &K(?=5/>U-7931>26KR5DVUD$O?%'5_"F##
M%GD++[!^:5:4B="MA/LR]F+7%*J+<I0N<N_N]DEO:RYCJX;<%+>7C/W G#Y"
M&P&W!P=-,^.*"XMCN&UEAE^Z^UN.VW%5?-Z_G>YRP>YG5*^S\VVQP+N\A<K.
M-V$O">YDGD&)6@0WP4OCRXC%MJ-5PTA1UO:M5ROT\31OTSY3W>$[51LAVRG!
M8.A49!/]$VUU7EE<A(?G0:>U>=-)+Q8JB3^>3-&;N6!GT%*8JH#=JT.[<'8[
MW(S*]U*3YI\V80%-!G1,0VO.#ITH)V04.J1EYO3R-'N_4_J0_FA+?=MWX;!+
ME4]/L$3K5M^96BJ:.862%<1N^U_TYIHQR&29KX)"E;8G]\-Y34PQSOU/XJ;J
MDQ(1/_V["()8U2 RGQ$WDM&ATKCU(=5;DX><<[W./ I;Z<"33 F#8S]%F\'!
MA\B6F-/@MC3+UJC9T(RH5*6(;E&%0JF3 @EO'PGW'P:F WK\<K%(=&H++PT!
ME$'4&/F\RY FH+MU^4CA?6RW^).:DAM>-6>NJYQ<K#I1_^+_M?>=04VUZ]I!
M$$1 0"E*BTI3:2*]1D5*1)I*+U&1&D)$6H"0B/0N312$* A(E]XBO0@(2(<@
M):%)3VA&",G'N^>;^<XY^\R9O=^9\^OS1W[DSF1=S[JONUSWK+6>57HC4U&]
M"M^K9C<]'N#>B!:>[JYP?1NBXL&QD _%'9;L3R./3#:XS).0QD>YE O$/ ,B
M;//]>%HR2C)-N;)C^+Z2K^[I.T6"PZ>4<O6Z?X=SR\2 G ?8R&)=#^N;JK 9
M\D?NL[=3))TJZI+ZW[R(,1$74UA.N*([O\EI1]K-*S"Q"=SJ9*=W:90T8K5%
M-.C4D%CT/L<JZD^TS]BS9G$/L+9E91J=%QA7FH?@@O'A+]4UBER3R,-:(PO#
MG#'U[F\+<'U^PC'4%>$;,4U,BR)>\G2KR>;IUJ@A(*OXYZ$23!<*6,V7+*'.
MV9O?@I40;%(4"&U#YHG3!5T@U%NC(U$<V+&X>*:H2G"5]YLI04T-'9YW=U5D
M?S^N<0=.'S?.CUEU;#+S3$%[ ]R@L.-AB^?G>/V!>D*&)LO$#.SGC9]<0I8!
MGQ8\,U-Z*!9'N4@@T:E+Z#A4&V7234@"+Y5%JN(4HWY<X+F^P^-]+2>](.RP
MN(N+;DW>7*,8>8=8&K97:  T(RG&YZS^>J.("URD&/\P2@HJ5WS4E]1%7_P<
M<N988S:=I!@0%PYRDSYUL'T#N4IESTQ;:R,96%LFNI9>%?B<O?"&E0-\XH6&
M:M3.FR9G>'B9RX'Z 29:WO9LX/UIZ4<5V%&8W<V8*2V>*/.8DDTEB11Q9;%Z
M'7(\_LJN9Z%2E+SI4./H/K!&\#8G$TX)MNV[.;7D/N_NF2E[4Y";N\,9R$>A
M(^3#YX?473ZX2CUFL?EQA#&.##'.OY0C[J-XXKKU^[TB&H"!@B3ZML.!KE0N
M8G^.4)WF6WON7=QKC+H2S[UR6>-HD>>RTJ<6.&03_GKG_=^]5,R]C+I,7GQ/
M=IIG#]?DG[9<+8?6[U6FFHUS6+E7:=]<"$<N %_MWF?4(<C91=X4<.J AZH:
M=;*?P3GC^CHVJHI+/L _94_4"[^]!.MA=GA<F8EU^F$Z$(EAW]V*RJ0?0XH7
M&GC#\UP_^YWK=>RIN+8@D._PB%VPI81^/Y.<44K1)&Z%[LZRV%A;((([K/9*
M@F"?;-M%]664?%9> E,F;^*M7QII?2>AY$@U[:4A(&YY]"F7^@4,IW6'JEBV
M8LJ9&CB480P76ZFC_>V5R-W'KU[5.IQ7_MW\WJF"7(.7"<=Z$!?5SQ5I:_3'
M"US7%HB^&H? ">:JF([SVW S"6^W=#S_3NVO'D(DW2.=R9M'<T/3J/%.4KD)
MGU;/6O(.8SMPVYWY;I^VN><J>\6'U<<3D0KDIOET(!^"W9#D&R.S>_3@H6/5
MF+K:/(2])$.@ B:PDFJV3U YY?FB_.Y4<ES8E^5.._5Q=2;B<*?=U;'=6,49
M6YZAI>VAF2[CQ!5WX;@;7Y]*,>@H/KG^D)'^L/,%+X&W94.-$![LU72&'&PV
M*GV_=1MWN$&JY/QA),]6I[\1W=LF],%$-_?:0$?I7SQ 3M$ K6K%-G:XR< "
MEH$;+8,BL^?"35+-SHMX=AD2&A$DIG:CR-DS5#JR_;S@K]@IN\R-]5)O&=8,
MS4%)H;&5$4F>8\V8,NA@HY+RBWN!;X24MS'J,@=B7:NQP@0O:EX>4M<[X,)Q
M\84M.YL)RV+-M\.[%U\^,U]M]KSIZL\>V^2H(=,Q(T(RRW<BP#S;GI'KQ]2,
M."Q68NFBCCA])%#;XK)U]SX\%;YXL(TD[.Q;DB!A%.B\H%9K<5YC2J&EY>3*
M;78N5Q0P_9XUXIY)4;03O]1WDQJV2P,,O@IQLT3C*[M?Q+I,1KS@9R!LYKIU
MHY+K7J!S+(7IEI=O7:S&0L1_27\UY&=B+:K=7=VD 5RW>'\>G$DM7,L\0:P)
M*]K3D#BT^KYFIUE3[9(<4W0M;-8O)9458/OF(B];RBG_-*&31W%>&S*MOF!"
M*1=4=2O&FV5-X\E:.^>]A%X8VKVHK!>>K,$=A9'7W/SH&;4^/B?8:J?[*:^#
M/4*BL"A7!ZM:),.?;]O EGT3YA,TP!&<Z9GVV[.=!J@VBJ'HEX+SR=9FJ3K?
MW0G?'6J&ERJK4^:4SE7Z7K/-%JVHC%G^\:0Q[BB+ B:=:SL(#T'CS]6,9A,K
MD_IH &;&'/P734&MAS7&P=T6Q8OFK$7MFY<$7F#MR6]<;^$')I7TB Y?=E&"
MI*Z87;.1-(+MO;8 F*3O]K?GV]T,U5NG-:]_R(H] ^#NMZ0VH\]4PBOZLEV%
M+@YYLXA605E^ELS[22X'X;0SE'2>?^L_3"D/43Q1PGB#RD\=40W%1!Q+^56K
M+_'Q#J,4?>D$-G*4@<S]8?QV[Z?&R@"O$\9:,E^Y+5CW%> =D&K'G(]KJ0>*
ML<3#0U_3Z(X^O!H4O9$ WX]D>#QFV\?,G.A1N2SH:RQEV'3O*)&B )^/EN%S
MM9JI*D)4"UIZ^U6IS# <WHOF31$PC.0PC>15?HA[;@C>F"*C\6=B\7WZ7>;5
MXTH#,C'' O:@]S)W)!8CP?F8D7$&!?M!-9W'@38BCWT5%XHG2ZK+*6 B%/1M
M'6T-^S6T6=/.EYFQ?NNCEZA0;'[__H+[K4YVN3G05*8N&5YHZTKE;<"TF_'X
M>W>^=?(HT!8YF&M([;TMI.:<<,$Z;(KG"IO18R)DO0T/.;$J=!);UCA:(D+T
MP7CG3HB.#-[HXVYYLO3H,O\;=^6I2O]@8PM4+TIH>'?X@RY!ANLX%7D;'2',
MTEEE%B>3RQ#1NGS]I,6I7W )&0WE\PN[,E,GP$@_/)IM;4;H^^Y:;(!QX'5K
M%SNIZE'XNNB%"7<8(=Y5PK[@Z\2 .LG6:3V;Q (AIQ#'C4>18/11-IJG#NV8
MY"?;$9&=7"#-^?"9VKQXW7L%)20]\:X,8,8%SAN#M2QT.3"MJQK>S;A-E76!
M"TU_N*O-Y0@K #R0?17SU+//? P%6/EE)SF.U3X6E>UV;$WC\P]''VBES79C
M'6RC+X'GDD6"=)2Z*@^7T_;XKG#NK%([A$X/%<V,MUG-1F*!;)VOO*SQV3,=
MZ6O/U]<=Y+0OS5BF+QDT(>+>F5L2N_;AQ('6> ZMPA7S^ISI=G]6(2'.6?US
MG3 "K*==TM4W:619J/6+510CDO2!V@8Z0U'!'T%T/]>-?:@9J4J'N5JJDY'M
M 3Z.45R:9@PW&Y[=<D?MJ5D=A:'XH?6S<576P86BX]$]5>.IZK=@%O<J>%[X
MV;@G<$<$SLWG2ORTNL*2R>9Y""3[FM:20L?*" /<:[Z-5X:&=;&UV-I*1@DO
M+V^.(I^OD2^#8S\^1W3W!3A&YVA_<-[G@S6HM3@Q^) J0WBN17&=>\'X3./:
M!M<IB2XTM.FW4CP/>BJ/FM)FUV$SW@ZG<Z$!SF'Y/R&<'J8MS;0>]NZ(5#A8
MZG3SW'K9TU9PYCTI;;/9+ [(JU.Y'Y,UF^6266T2F1?\[?-$6A.K.#-(6V3R
MMX9VX,KQ/,-+I &HP4(B-$!S.OJO+5*N0]IH@ -61!(-< +VUVXGJ&YJC4/@
MXB_@\"SI[ WVI53JB8&7:Q--3XU^*Z.9:8"I66JB 02,;CM) =$ [[LB042Q
M61H@QAQ,7-[7):+;@!=<J&)#>U+/"=2N;]OSV$R>B*W8;!66LYEQ_IS]$L'
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M=\+%EH;P9^X[8YB@)89G3BTL\"VD[CL1-XN+7%5K8A1L(5VXV*54L:@*Z "
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MKZ7S)IS\&$%\<V$_9$:@\^X"2&M8?5R;F$K0_#*_Q?:3%S?P4L'HC,$GE_P
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MP1C5F 9XL$,#'#"DXJE.([OFO4 B*3YL=I>!9$X]88W>UOZG[\=@'ZAYRS3
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M%\WSKJ"SFB!T*W\V6<>(SG9F)L+Z#C;1DC&%[[V+G6[J\D24T&UKLNX%0L-
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M!Z<2QO]'/]O$<J&?/@(M#['_ ?@#\ ?@#\ ?@#\ ?P#^ /P!^ /P!^ /P!^
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M&@I^91P];:?R886%NZ-+^M[C<]6;=0Z=9TW6J\EFB-DNXJ\<?*^AP[F)0((
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MD>7F4$,'%E0LX4&0>JK.M:-U=]YG^ =T##V1O/,%QX@+WBH5ZU#J0_NF1].
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M5S7O9_8RG<;X%3Z84RY,9A:T-@;^LSL8+P(5_HX5:X/X+O!-%KF[HZ6%O6G
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MS<&\2D07P6)C+EO\=WI0I,+@4Y] #]>*D9JXU'O5?2=.G;F*/1EH4VVR4.>
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MI%6=B-92OC<;!K,1%&BB*E<3(ZDJQ)ET[-D[R0H7BVX)(-M@U:%%?)J?SA^
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MFLY>TOA+]ZDWI:Y9_E7PF[W%<CZLC@*L)DY%Q=DF=RHJ(S6.:F8?*,B\>QD
MF.B+]-3H#V27V,<4VPT.<$R,V2/<6*_(.)D:(179$)%E;]DN!JC.8JRR_%4>
M$^!+MS-)3!87<V.(G'BIVK*QG.51B1(1#5^1BM6)IT$WGE0QG1+E[)2'MJQ^
M;[U"BO/%ZW(@/4W[42?P8_?Z7WUP%&@43%P\M%_:^H"6/A<]E[]WK"X\VR[3
M4]EG$M8@Y89;K6<DJ+^33GX%%T[AJB,\C9\Q_$2A[@6)?C-Y)UK2O38)G+F
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MJ25/G"[/W/ ^_KPPU%W/DKEXI2%2@0[\<1'WR[J6YZ\856$R[8E+ZC=]\>'
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M>;)KN5D:TK/@D[J#6NS0N/5,V\VU\?SX)[HG29\ 7[QWO&/77%:AL[]85CA
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MH:,V]ONU98DVI=4D>X%5I8K])I,'?W[<YPA8H(IQM-" AFS"!'F]CP80W'Q
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MK#C':]_9(TW;D$<G*36 $H>B#>%\ZX#AT=Y61[8$'9%F+@?+:5?Z@B?Q6I<
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M(I1\*0''2V%-EP?_* "C7L^F"K41(JA!G?R@$[%GT( 3QM,S7.@W5<9K[32
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M$+P2NM3KI>WB8G]38N.>XD^ +R!^[0,"/(.030VB 7SH2>Z\GP"?2>1"%UR
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MIL,I!2"^I\"R-^/A7Q&^A?%K_WDS*-'X#POE0C?68.U@NZ= =)N!46U'!.L
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M\+8,?#0(<\V(<101GDXD,*T@>)R/#(\M3C#V.(HRIH\Q7V\2CZ51R;-GO<=
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M_!>JE-T1.S-DY_!1S#[2M:H'/&\CZJG)5GD7.Q)/\X^)^0'MGQC]S\/HCFB
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MNBCT6R89,<NY6%B[_)W!ZJESO3Q[<RQK<+_$K\NFUGBIGR_5Y>>S1XF/=@/
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M]9UB\N5'/]P_'^NP9[B3>N7-#T-6L)UG@%A%IR#T7B$P&5*H4?PH?O)[SW5
M\>6C_.> @B!)9PFYY=0.GDIX^$&,UHAN!4[@@Z)"43MZ$=N1ZOL<WZ:V&7^%
MTN%%0%R7"'>[A1TV#C\]1A* YAQ!D#0!7^WCH8$B^EE#!KR>D'NV:N/@NKH/
M7.2\%-2- X4F4]C"K29T@/O#<40=^XE%+<1K[LF0QXD(GXG9C+9\2NP-ZWK7
ME?=IK(\H@6L_?K"G[._\ GUGM_G,/.1(XK,.%<[5/919Q(S;IBB2%AK%:=?%
MHSWASPFAV"!U0FC9JLG:J*<V/2'IB41 N/%0@>HVKYKXLDK;$^BBRO>>AGO[
M*$V?_18$/H$^$H2^$D2]L8"Y.<K\'?J<0T^<DN>^F4^.BU#W[M%,XPU<[,%W
MI[F:\ _[<^R$E:?U6)E"=)-D>\,M2_7)V+3KAP8CE]XI1L.</XB*3"D\RWZ=
M^-C.7HJR,'<FL(MTO7ET<<)V JE*DDQZ'F4 %#IY>H&@P7Y=^?+-78J71C$Y
MPJ\RT'._#MN:><:$$;(X^@\(B,I41Q#V(T?9HW4JGQV9US?QW^L?*5SA>43%
M]&FNEN7M?DN8".;48LZXVC3 W(.CA*7J@VC*(HI/]!;C_6N07FL%SBMO?/=G
M+YSF5Y_GTM#W;0TV<Z$'+;1@S-1=%R+(ISC#G6O?K<B+-=;0?LY**/3E#R4_
M'?8H],!OPU8+)MQ$+-'TA>?%,<67+M)EZ]45G[:&K=+\W_+VI+P6GS:-!R9_
MX-G4Q.Z=&*))V5+IB-%9&H2IQDTI'*1>V<M#EC6"6;!?]9<>KG0G E0M T?/
MQ:6W!,,Z,R]A@3%V.>W%[46$G+%%IP]?>CY]/*V\N"KY7>!]ZU?+*Z#7&CML
M:\<&J0+OI&E=4-X&M?(?$$,7'KJ(A.BR#N,T?T8\XP>Y7;(];*4(+FXZW[*!
M=FZV)JR3*:&P4W<M\%H+!*PVE%]7S9R@WF^V3>,,%^"+;DQI1:WOMX3R7/:
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M:Z'? Q;F-!N= <*C_67. %D"D2U8AJDS0.*=_\1T7.:R1'\ ^NL1DUH@SW*
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MXE>3O,/:N0GW@E3&Y8,7A5N+\%7/.6R5I_81VNX,X'\>:9G _WY7#'F5O<X
MUB] *\/29P!CR:!CZH2)?S\7GG]_ ;.8ZT'_^#_]09+L>>C^P.7]O]GH'T-@
MO HY*>#&'X _ '\ _@#\ ?@#\ ?@#\ ?@#\ ?P#^ /P!^#\-<-'/\&V@)%1,
MFW [D(LPT,9>T^28>3/),FQ'?9RA.WEV\K[,U4&U> KKE3BDDAS.1*BYF9LU
MHFBT.?98!G$ _JE^V?$G/H!Q03;$GP84FXU-#3G0$!'K(#&G/KCG:%)IUDLQ
MK!YK-_LMRZ;#4>8%Y^+VE@[4%#5'F=I^[,'-1W I_^+8PY7HR,X3\?-NP TY
M>KXW':3SQ;HN#!K&#1DIT@HIR-T^+E;?[IELW,CF1@&#_(!?,O#(<4L+7$NL
M(@A-,>*O66(R:5_#7G+-CSFAL"T2SLP?$U+94U%D%]CZ#3G^&E1]&(N 729D
MM%M>E=+'L81*QRBBQFO2]<L_X6O)WIO.E+1?6$I(S77M,3(,=O!=(D7VC\N*
M.>Z,+7QW:>AM7;_OQ>D[7GT&N*;XT'WY*+4']8PU_C3SAJ6ME]W28G1FP$;2
MB1@]3]A'#T1&TUB9DY()HD'I8*8*5-(*83I>]329^+!ST!("O(KU;^88O?6^
MW3<VU\\ML+XC2B[46.;CT656ZFZ!I,%733P=+8BN#K^-*#ZL5I(+.H[2J)TI
M+"JO)LJA*"!=2IF5L<_9>"9"M"O6:"(TJ"T GF$,R=!QN)%RC;R+SQZ=ZK7Y
MN?BHJG^GJ7LYVY+5L<3UMC%&Y?*/:R(Y1OC*4)M?+,[#E-0H>F!!=0KE%PT_
M=3<O2,D,W&>F44DLL(EYZN-JL;^:TAF <4/L?4LU. 3>XK!SV?\A 58X"S75
M)W7Y*6D8Q*C5-H]>I\Y%0A,H!^)??F-[G'./G(J=IZ8F";,3+B,O$.W/B^OJ
M")3 "GQ83&%U+^\62%R7T//0NC9R,?SRY04*;W@T0N3-CD'8+$=*1)=+8Z]1
M5JQ28ZSJT7-K/^XOQ?"R=0;["@=:'TD'-ZV)9[]3@28]/5_[6;)>%67!\,IN
MPIGB'2,=>LF)9N4BYF]*)B?&C%L&N]:+G^MI0T0::E=U^2KX/B<I7S<<YFK]
M;WW#\/_>H#K[_?\!4$L#!!0    ( $>!#E>G,=8&6,<  #*""  5    8VQB
M<RTR,#(S,#8S,%]L86(N>&ULW+U[D^,XDB?X_WX*7J_93;59H(L/D 1Z9V8M
M*A_=>9>5F9L9U;UC96<R/",XK9"B22DJ8S[] 20E42\*H  &:\VZLR(4).#^
M@_"#.^!P_]?_^?UQ'CR+LBJ6BW_[0_2G\ ^!6+ E+Q;W__:'7^[> _2'__GO
M_^V__>O_!<#__NGKQ^#MDJT?Q6(5O"D%60D>_%:L'H+5@PC^OBS_43R3X,N<
MK.2R? 3@W^O7WBR?7LKB_F$5Q&&<;![;_+7\LXPPS7B6 BPE U!(# A*,8CB
MB$!.,(YC>G/_YRR%$(49!CR.8P!E'@%$> )(DJ((<B'".*H;G1>+?_Q9_T-)
M)0*EWJ*J?_VW/SRL5D]__O''WW[[[4_?:3G_T[*\_S$.P^3'S=-_:!__?O3\
M;TG]=(0Q_K'^Z_;1JCCUH&HV^O%___SQ&WL0CP04BVI%%DQW4!5_KNH//RX9
M6=6H7Y0K./N$_@UL'@/Z(X4;2*(_?:_X'_[]OP5! T>YG(NO0@;ZO[]\_7"V
M2_RC?N+'A;C78_M%E,62?UN1<O614#%7TM>MK5Z>Q+_]H2H>G^9B\]E#*>3I
M9N=EN=>JEE*/+H@R+>5_/]?9CU>([TC>U;&L#H2KU?WD2L8^3#\Y$_=.,83P
M+W"GFZM%;KY0[Q9\K._NMJNK1?<OL:NOQ7)%YB-\+7;==$2>ZP\^JI_:;G1#
M/61:]]-2=T=4\7TE%EPT;+G7=%#P?_N#^FFVKL ](4\S3>9\/1>?Y2UCY5JA
M6!!:S(M5(:H[0N?B3C7VTWS)_C&C&%/,U1H5HHP#2#(!,*412&"4Q6F.<<+D
M;+7]ML_$ OSR;2-8W?O0KO]@@<;JS*PN1;5<EVRW'C[.3RUR:GW3*R+Z<4$>
M1?5$VA>4_-IX:%3Z]XWDP5(&K>Q!1_A__7&GLM,1F+\BKO-7A33XM98\T*('
MM>S_WUF4EVQ/RKFV29;E(6!+=@5@N]E?*5UKM"2I:*UNV^J/VC+\4<Q7U>83
MH#^I*6! QS\>?9%NRXV>I&071K!]XD>V5 ;;TPKL#:8LEX_7 K):7OL=; 9+
M"?J'8%ER42K#_8321[/GN/DWZ[)4QOP,,QR)A&(@488 C(FRQE.9@41(GM"(
M9J'(;>CJ;$]38Z?-])D/9:3SF(91& F<9(!AIC"-P@P0QCG(*(H(83@.!9NM
MMBO;2)B>6;!=8EJOU@'QAZP9M3O!RS.3GV#OFZ 5TQUG7T3"$46?[V=41KZH
M[B$!7W[!CF^K<C7[JH99_"P>J2AG.81A*$D..(D2 'D> R1S!AB/H80Q2E+(
M3=CUH-VI<:GRW5=%M2J8FOT_"U*M2U'O%/WZ=OE(BL5Y(Z07O/[)?@4DOHVT
MH6@83^\SNO=-9O5*9R*KWW:3^+"U4:;L&14V$_3<GX>9/Q\6K%0#(=Z*YK\?
M%I^?1*E&:7'_ACP5:M&ZI=6J)&PU@VDLHYARP""+U-J=<("9^HE+ =,\21&/
MC&:L?==3F]1O'C3^55 L@N5&Y(!4E5A5 5GL+>]_MEO?+8;#;,'W [)GFM@(
M'?RP$?N/&NNMY$$K>O#K1GB'SIP]8HXL!8N.1S4=[ $YM"4&M#",S;X]D%+\
MI'K@;Y:/3V)1U8<)MV6IYZM>::J?7G;/?"$O^K/;WTC)ZW_N5*^W"_Y%?1D_
MJ:]GLRC-6"["E$$((*4A@+F$@.9A!&+!$Q3Q!,H(6FU;>1!R:@Q92QIH42TM
M':\C:;C]]<KCX]N]LA@:^YTPC]BYVC/S(>*XNVL>03[:A_/9E[T'^>Z?ZV+U
M\K-8/2SYA\6SJ%9"=*F:B8A&8=H<^L*4,(#2, -9)+*8LHA%U(BJ+W<U-<)M
M)-3@WP1:R@$.Y@5L+_N<[A#S;E_:@F7E?YKA<(5+>J&#T;Q4,T6[CJOA&W;$
MP.:T:HBJJEODR@<3WY\$4S^NEOJC&>2Q^E^8@XP2#F#"<T $8B"*).(A3Q$E
MB0DQ7.YJ:L3P=Z*Y>E7=!'^K!:X=U(W(P6H9:*&#'Y1[5=5J_=&,, PP[R<,
MMTAZ)HP&FIO@^3R$SF#C;3!9O=".!-]>G].$T9B!S9%I&%@_7]-KF"5A3;$&
M+8Q"L>::;"C6XHUA#O:;Y5S]NM2^^[/H6(%WZJ=*^>_JZ_/W8O7PA92KE[OE
MN:?;76R>D"3E$ '.8PD@QAD@"2= "DYC3%$>,V3C6+L4;FHTOB=MT!'W)NBH
MUP2>U@KJ"77V)3M?W.F@F_G@KS64GM<1MZ,8_-HHZ-!_]X&[([_=J6BC^NL^
M0#WTT[WT,7 35ID1=6N?Y;?5DOWC83E7+U>-Z;\]OD@5PT<RA" /.0:0Z=#U
M,*1 (I9BFC*4))'5KJI)KU-C]:W0.FJM*_:_!(W@)B<<5PR"X8:H:V@]LZP3
M5.VW/FU0<K67:=3GN)N3-C <[39:O3R0GG:1A<^DF.M8PO?+\AN9BV^"K<OZ
MU/:KT-H6\Z)VB Z":+-<$B+R#&0H00 F& (*609P%H51)#C""1L8QCQ(H,F1
M6C<2=Z,1D,L25$JG8*=4L*_5X*CG8<-HR'TC#HYO6CP[+M]ZQV6LT.FK\'4?
M4#U,G-<*L[X*O)[@Z^O:'<;0[Z043"T![[ZS.M#FJUH4/B_>D.I!_U\O!L]*
ME,5*R:!6A$)O;N@_W"[X_@>=)V<TPUDF0@D8I!F %$M (B0!36D:YI"Q)+,Z
MQ/<@X]1XO%%1LX5HE0R4PR "UD8_*69@2@,[VO8QMF9,_LHCYIG<=X.UT2_0
M"NI!TD+?U/\&'=EO@IU:[2-Z/_;@P_TWWBP7JV*QUA%8;0#/<G$^@-UZ+? X
M0HZ6!Q\2CKIB>(3X<!'QV=7@JS[+M6KF"WG1R]7VG@^*6"II!"C">B>",D!2
MF@-,8IP11*,P3"WO^9SH9FKLOI$R>&K$M+Z'<@I*,R:^'B#/9+K%II70S_63
M'@S<W3TYU<G8%T]Z%#UQZZ3OZ:&'5H]/:S6G-),\=8XB,,^QQ)E0-F'& (0P
M5Q,?QB#EL4PQ)S(+C8("+O0SM9F_$3/8RFE[''0:3M.3G:M!\GY(<XB/EX.6
M7AB<G9F<[F7DXX]>58]/,OH?MP\:W+FSQ^%'NH-S04FWWXMJQB5,49A+$$L<
M TCR%%!&0\"IB",HHCR+L6E(X36"3(U%CF/HM)06X897C4H_UXR)M6<RLH79
M*E#1!497A#%>U?UH08XN0.J&0#II;Z@A5#[I0U_Q5M#5;BNO7;^E2".<20AD
M+O7]/BD B=,40,K3,%3_5]:2G3G4T]O4Z&PK;,"5M$&U%=?6-NI#V-1"<H2;
M=SMI YD6M'M^X,-<,L#$F='4U]?(II.!VL<&E,E+PQCDTW*QO?'Z8<&6C^+=
M=WTK1,R@1!G/A:*+D"MG*J3:F6(,A DF>1Y3GD%AD]GC;$]6S#%:9H_EZD%Y
M#$4M:/"#:$0UC*6^#*X9<3B!S#-I=&4,/K1PO;L$ES5?7(3"$5><[V=4GKBH
M[B%'7'YA\%;+8U&;,=7M@C?G!?=BP13_S'(2DTQ0#FBB<__@, 2()0R@"&$>
M01:',K/<;CG7U_2LBZVH]2G+GK#!#Y^6:A&-H"5=]&%MO!?C D'_^S'GP7.Z
M(W,)#'>[,F=[&GMGYI+*)W9G+KXRV+1H[BSLCG_J&+#F.L,M6Q7/RB\Z".*)
M\BB$E*8@%$SG2<XS@%*I. 4S&O$<AIFPBL4:(L34R*8;Y],YSJWU"#8J6%LF
M]F-C;+1X1=R_/=/>9CJ"NM%@B[C7,*IK4'1G"MF+,+:5-!BD$P;4\+:&QM4?
M1L1JN^%M4;'Y4F?2VLT\$:84,I*"B/($0,ES@$*2 \@Q%XP*AIE=QA+3GB='
MA2>"OVWCZ$U!-Z,[+U!ZYKA-T+R? %!;0)R%SIOV.W+XO"4<QR'TM@UX2K5T
M+B_(YZ<Z;*RYC:YLR'?M_=2[I?[H\WJEJT+H4ANW]_=EG>K\PT(Q[*(JV-_(
M?"UF$,*,81J"/&:ALOD8!"@3&&1AA&0$*<]3JVNCKZ;)U-BRU:<W4\!-L%4F
MV&H3U.HX3O#D[?MC2-2_AV^%9^*O%02UAD$7A;U+J/0EZ#[70A'46-P$I[Y3
M[SK?J;_5WZD.*D.^8.[35/D>W+%R67G38UH)KWP/EW56+.\"#5NTOY1+)@2O
MWBN(/U356I=?^BSUGLYR41L.,T0DDZ'( 4L375%*%Y[B+ *20QS27'#"K39I
M+_8XM47PDU@%3ZW0@?XJ!D4KMMY/8;7@0:4EMUOO+D-OMBXY!=3S^O%E#\</
M'1P;>9N-$G>T;HR-(_J]W-^H-&FL_B&=F;\XC'9T%L#/LD./=0P70<J2IP@!
M%B89@$DB 2%$DPXE<2+B%,=6X;<G>YD:O9Q/YJ$MH^[OG^L3Y=4#61QD +$)
MM.L? 3/&N1I7[^=#OB&U)J)>R!R1S^D^1B6<7C4/2:;_X<'9ZY>/XHY\/[4A
MAR"F@K$$P%CF )($ 9KC!,0R992C/,8RMLQ7?[:SJ=%,&UFAA+6-8.N%U(PP
M7 'EF3=V& 4[03WM<II XBZ-_/FNQDX<?U'I$ZGB+[\S(#WHWX6NMJM\KF=1
MDGOQ[KLH65&)+V7!Q"9%9ONA/K.9$1HG4F<(C3$) 4QUTO>01R 3(HTS%B>Q
M,-ID'-+YU,CD,(7H3;!1*&@U"C8J!;5.=3I1KE?8L@J>U));)WZTR2QJ.US]
MQ.1[$#P3U06TU7"TX@<=^3V";9&AU"/H(^4L=0N^71;3@>CUYC6U;7.\3*<#
MM=W+?3JTC2O-S[\NYP4G+Q^+A?BP$H_53- LSH5@@&84 0@Q!R25'*0A93')
MD4SM8AW/]C2UM:)C5+6B!K]J88-:6DNO]3R^EH;H-:B-9X5: 3;<!#T'AFO[
M\ZB?US$^SZE[UO(\^\+ @_(UK<0_U_IFU[-.R*E::2LJ9'$D8Q%RD*2)<E!A
MB !F) ,TCI7!F1(9,J.KI1=[FAI)[ 0-:DFO*A1T%E[#<UX7H/D^AQV&E_VQ
MZ"4L7!U;GNUGW&/%2^H>'?M=?&%@PC-2+HK%??5%E/6QX=MBOE9&S(SF""5A
M2H%,LU#GR,T PCP%0F99AGF8QL)JA_Q,/U.CAS=D3GA9K*O@IV)9L4*HT53.
MIR+H/^T=P+513@$(>*-([7>N*V[M<UX:"#,J<0"O9R+92!@H$9NHC9N@E=)A
M&J]^&%REXCK3R[CIM/I5/4J)=>'Q:Q/:?BGUI:[5BRZWM=+1!9L4&G4<\DPP
M)AF!(> HHP!R2@"B @+EF(B$9A&7T"[EMF''4^.7C;0W02UO$Y.TR_52RVQK
MA9B.@:%1X@%9S]1R':A7Y(TU0\AY?M@+W;Y2'E@S,,[G>S5\?ZHAPWW;/[,D
M)V&>$0A8E"0 XDC17Q9E(*<9B^(LYCBQVI-Y776F1JHFP<-7G0M, _;)1 ^[
M^F[X=EU?)83XPJ;][RF0V&2<?S?1Q+W*_!\64FPR<./'%1M)-6QY?T^*L@Y2
M_K!X4AU^%,]BGK29C\(TCU*$<I#EE &8$.UZI 1PCJ!D/-&9=FW6WIZ^IK8P
MUK(%B=TBUX>EV0KD""'/RX.6LKG<H?=WM* W00N8ARQ2!I@XHM*^GD;E.0.5
M#TG(Y)6!<<"E(-6Z?*ECBMOPXOJ^]"P,0\IIG %.) $PPPA@F,> ADA GD>A
MQ':QP.=ZFAH[; 1M=C2#'ZR*\%[&U8PKG*#EF2FV0-5"WK0W"&[:+ L.0W<O
M8>$J?/=L/^.&\%Y2]RB,]^(+K[,YT+%Q/JWK=9)D,1,YRY2ED6, *<D ">,<
M0(ES)4(<PBB=*2^T6/)O*U*NQO'ZC^2TF6.'TH[@SN_Y53^)^V*AM[#U'9XO
MM3#VI</]C3C*,<*2Q8#G4(UX&!- N3XO@W$:,_43%5D[XN\6_'<SWAM9QQYM
MU>\TQWF</9BK1NYWM*VR-^:-IM/9(#D["!/9\SB6[W>UC7$67M<[$^<[LC,7
MN"B4"4)T.]]>'NER/DNC3$0LS('0-81ADE% J0A!FO$4H4RB6!JE@#MJ>7JN
M0BU<T$AGQL''</5SYU4@>/< C/0WIJBSNIZ@EDJP/]TOGW]4[S2LHG[8D<EQ
M2Z.0P%D%-I/W_ .>;/3J @O\I0[ _K!H3(K><Q8F<,YHQ@&7.H*:,P(03$(0
MI2*/E?U.8F*U(S"B[%,CCNU*7ZO0ADEY/X9S^%UP9.^]S@A/P!*L3$W!!H%
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M A&E5!"4Y1Q%-G1TC3!38ZJ.+L%.&9V<H%OP>N]LWHZUKAHY,T(;:SP\<]V
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M?MP&?RA_@U,4,Y#$@@.8BPQ0&88 49S&-$V3&%D5B;O<Y=0F=&]JO"M";PS
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M8+]9+NKXJS69WXGR<5.1\&^UUT 6O(G-62WU!S.,J<Q1!$$HA"(&F6. *,L
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M/8#1!LKW9H'O,;+?57 "K:OMA^N$&7>?P@EP1QL:;EIU%-Z^S8"12(AQ2C-
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MS4]M"6VD&[P'>X"=V:;$<$0\+U?F8%AO)YS6V=%VP4'CHVX'G%;LT-T_\]0
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M5=*RGKZFMKCNB:J75"VD]4)Y'EI3RG "F'?&Z&*EA;L)&D';7]IT$U[33AA
MY8Q*SO<T,I-<5/F82"Z_,C OHO("/LN:HKZ(4G="[M4'GY71658/Q=.M=B[O
M2K*H=*##<C'+TAR'&&/%)@E5IKLD $=Q!'(%N!0<YH@9Y8X8*L#4&*>NOZB(
MIEUX=SKH#[=:M$YZ1P_+9(FVPV1&5#[!]\Q>SG&WSXLX$#Q7&1%MNQ\W%^)
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M1*'+V79-^3I%;BU N%CZUN9>7TI:\'_^6,ST'543Z#W%>12I(L40\9Q I+"
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MC6#W)3VHZ."1DM[G$MNQ\T@6KF<"]UPS]U"X_M$,%2S7HZ3#AM/U#_E)P-T
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M>'*&&VYD/X*NP^?,C$OY0T]:/LM=CS)-_W5WW:F,LZC(4@8C)I6I,8T@39&
M*19Y+%6LD$(N1I[-I&,S]IIPM$4=<,OW10<S+;4;J5J!;D>;H:'LF1B;@.4#
M><%!UN]^!\5P#.B"4B".LYIR4!9S >&8IYSN]0VN;3/?S'EG]>/];/'G+LT@
M%RIA:2Y@40BIMYEZ2X\QHK#("Q07*94X=ZL7V#'9Z,R[;:9F?19?_0"UN#8>
M,G>@+8VU0/#U;8;Y(^<1-'<=DF"A<!U3#1S@=EWIT[ UBWL\^WE5E5SMGF64
MH(1B4X N10E$D= _B32'64KBF.<HBF.G!H:'PX^-)NZ^?GWW\-6Q.]8A8'8O
MOS\,/;_NC6"]O-WG=0[5*>IP\&&;.YU5[*0?T_FK/(*.NAH,;%P5[WX^E4LI
MIJI *<]S"K,H2R$25$'&]7]&&<X(CSDFJ=5'WW7BL;W9&_$FH!7PI@XTSLO0
MS0I]@COTR>1AJY;)SG?6RMX3P X15CT!/5 (5CC W>*U/%#K#.AR&6^XB"\/
M+0]"PGSNO\%.N^/_6I=5G:OY9J&WE*)N_KJ8/^B)*B67>II-5D.3J?"AJM9:
MNKDP/Q@?V)0*QO170,$L$0*B.-$&GF()S'$A>:Y$0B.GX]U <HWM^Z&WZLO:
MXJ8SH&BY!,]TMJY/"][(N?BW"JCU;/8"GK4N^MVL,R[!HO$Y>IB3 =;5P0X=
M=K6&,&#!GDH3<* 4V--JKQY HQAH-*L/?3:Z!3: PX$=TG(.(-7P)G<X*,_:
MZ@&']PS+:9MV?Y$SO=T7#XL'^O._RM4/DZ]6SK^_7RS/'WA,BX(5G(H$)B*+
M]:8]R2#&<00929,$1U02*J=S^;T>U2%RQU,>*W8@#3N<2-7C:03]"?[<B0^>
M6O6 )HFYYI!Z0P#T@[":-0ZP)G,>4%-#P9'5O9?2CL9[79F!HEH:%29UIZ,]
MV2?GR[GL#H(#!KO<B&*H0!A?,88-DKD1K), FEO'\^/8CR5EY:SI;+T]*,E8
M2O.,P)@5FCY33"&6IAYXGM,$IQP+[&02GYEC;.;MGHANQ'8./SO.NA&5GNEH
M3[I>G*$=V@>BD7,S#,H0'2H>O_Q=EWK&9#S5UMK\^T>I&>.+V95_5G]4LK;L
M]HY/WI=S.N<EG=TO&E/OW<^5.9S5UMO'LEI-B4RS.(MRF*.T@(@G,22RR" 5
M^I>)H(+$3EP02*ZQ\4>M"%PHN*XDH+6G>[*I@*(-*:G-*3VS!*76SS'.(]!"
MVI'2*RQ/ST2VU0C4*DW =JFT6J#6:P(.#GFWNH&-<N#;3CWP;KY^;'=" ?DP
M,/"A E "235LC$I8*$_"6 (/[YVRHLJ5"9V9\CR312(4Y%0R<\05Z]VNB""5
M J<QB5&:1([I$^W08XN?,V%=[I%R>U!A:JS9)(&,)0(B1%-(,H9ADJ(,:Q"9
M(DX9C)Y0#?!!NADJRXVW%P ]4[[1_2@@< 05L4ZA"I<XLAEXZ#21(X7.)(4<
M7^''=GI%39R/'N^Y%%+\]J+Y5GR8MQ0[_]Z&-6OS>5H4HI"4"8@5-LED.=-$
MF$8P931+99XFA6E\8\^&]E./D2VY"5A[:F4WM8%_61LW4CG_%:B-!H!N57!C
M"X=5L6.3?K >@&WJN,#[?9C_V,"\%1[<78?9F53<$0M$.@X3#TI*[H <DY;'
M"'ZD]IZ6RW^84]0F,NIW;4ZNEU)\GG^1?+U<ZJE^HU59[9*@(HHYC[F N> 4
MHDPAR @5,"4RYI(6J2R<6O:X"C V&V<_9ZV-V]OH8(J,&?7 /YICZCG8Z@1J
MI=R8SGFI[/BNSP7HF?5VX$Y.L#]%N]?4-%\4 S&A\_2#\J$O.,>LZ#V.'S>^
M63P^EJOZ0.1N+MYHPUS/(#7_RFI7DGWWNN%$1IR3 D:1Q!#)>@N<8*BT-9CR
M1&CF=/)2NDT_-EX\D->-Z!QQMZ.Y_M#LF>3V!*]#8@Y$W^N,T5/C1#_< M&:
MX^2#DIH?,,>4YCF*3\!Z&_GXQAP'S*28\H01P7D.I32U,G&:0Z:,\RY*22ZC
M-*>$;@)4NAGK[/@> 2<]4](N_/S]8JEDN6H#T)M264Y1Y\=8=G.0/SX#Q8]O
MHI4WLMT"A4L0^ V0#!7I;0V-8R3W!=6[P[6/;QHP)ON"O(>!UY<NNBWT3K^M
M>B/,I135>RU5G<+[86ZB? _].R)%16&:T* BEA#%:0IIACG,\RQ*L-ZSJA3=
M$'%G*88'[PT1:-=(6A\O:LHS\=+@02M G^1Z57+/2#K;E;'TX_< ]*!Q<Q50
MBR7X92,\,._0KVUOLZT"O;C@/*$+'"QG._NKQ,@Y0G,I-,YU& ]+[8M\EO.U
MO)=+_3@]&B[]S&;E]_I+IW_)S5?ONZFTLM:_YN8X=_Z]O<=TPTWSHN 2$HP%
M1"1*(4-9#%E:)"*/TBQ.N76NX2V2C&U#NI/7N.JJ/8G!LA79P>RY:8TLK,6A
MD.^9&%N1)F!/$;#3I/[]WJKL:P.^#+PJ#H;K4*LSD)';ZRJYV<4AD.VTH6^:
M8#A[.P0.![9YD '][/@O<D7+N13OZ-)TT:LVO3IP(16/"\BQJ6HAE( XB3C,
M(B:2-"V4R)Q*X9R?9FR?H3NN7^EU'5X/WDI5\M*QQNH%-.U,[-LQZOV#T0@(
M-A(&K-%O!T(@F_C")(.:OMV*'ENX5Z[V,&2/,_@^:(Z9?S?!A]4T0B(CD>!0
M)IF"*)4"$B$B&*421PD5F@_L:V)T3#2V]_]C3:Z6'2FOHFAA20;"IN?W_DS&
M\)Z@@=!RL/ "H3:0 >>)GIMI9@%)I^75=?]PAI6%%@=VD\WUGL4CGFDY,Q$)
M)JV.SN17<XA=.P_>2K;ZG:[:__HB'S4O"]-[X'U9<3K[;TF7=X\FA/1_3!I>
MM:I/O:<\9461<05CEB.(>!%!%L4,"LRPT(3*>2&GSW+)%M9E),)*Z/+B[,O9
M(QG+J@*K'W0.%G,)7K34CG4B B^AG1'WBLO2\U? R ]VZDS 5E6H=RW0**M_
MM]$ &!4FH%7X1?]E5E-86SOBJS9B9G+[9_!6_V4"MJ T638&%O#?70OO7F&B
MG^4)56DBL'3#5ISH!]J3RA,]37-KZX%WCT^SQ8O4\BR?M1EY/A>[?0GT3Y_5
M%\D7W^=&F/NZ[[H1:2] 4&*9Q@5#,(UC;8,S):&I60%3F2J>)21&D5,L9V^2
MCLV(WP9]-F416%T685\U4_?+WLSO?Z7M/BRC6+^>/S%7.QJT*]=\0][0IW)%
M9T:O^L.SUE</T^&@IQ4(WO@@M)ROU ^A)[@OMTGH:T+/O0CG2UG/V'R]VCE-
M")IYYDULVOU2/I;KQVH72%!-E9!)G$89)%00B/*$0<H%@D46(<$B2CDM/"(N
M_*09:>#%5AD3DOY(E_^43;I?M34J'/<<?DMEN;7H#_F!_$A;M'_95^%78^UO
MM:BI?:/'!.QI$G 7<!.2H8Q]/R&&M>EO NK$=+]MM-OK%\U%W>K&5$S2Y-+4
MIIM&24$8$@(R'.40)2B"5% "\X@RC&)"\Z)PR0>]-J&3O3Q8SYG93NH)F"_F
M<#_7N6QSG9N7L]I3Z=_:FF_^-9'.KHD=(89$NF?JVZ^6M&E'V(':3=62NJ#H
MH732V>E>K8Y2E_)=194Z[POC0S;^B9VWXHR',2<LHSS)H9*80J1R!9EI*:MH
M2K!B21;E3AVP7 48&S,9P6[S^5Z%W,^I&Q+(\7EM^_.VVN+6DSOUZO2OZB^U
M!>>:0]1Z',]*&XOY8E/@J*FATCIE=M4A>832B',H,X*U024CB(DFM(S3),JY
M)%PZ>2ZOSC@V#V035%ZV!69D(^RO_^%8.^,JSG;<%12]GLEJ7]9M@9Y6W%][
MJ3)IC4ZHJAA7YQNV&(:M^B<U,*QOO*%C:)-);NHNK9=+O16<*H6)XJJ 68$U
MLU 50\P+ 1/%,L11I-(L=ZHU>6Z6<;))4S+2HP/H"8AVM'$S-#U318/*75M(
M<R=BX':>EQ (V;_S9([A&W9>4O-LA\Z+%_>83O-)KHQM,XV*B.5%4])&,X"(
M<\@(8K#(,(DD25&$1? ,FG;RL1'#8>!_79"?=G3CN!W\;N;H&]*>"<4QS\(4
M]?K:+]P]Y+QXP#[.-)>K\/>3V7*$7Y!DELV8X\M?.=+6*V7E>(P>BI5/&4FY
MI"*%12$%1%F.(,U)8=)6ZA9=7"+L%ES9.=_X0B7/%!</6$,\1&7P$1&]1;WO
M@:IVAS8F.^<:3X7MB\:EU4U^!++)F]'4M(GF*#4;)D442:F@_I^)RHX99#&+
M($T53E3"HH@[57L^.\O8S,8W=$;%LEQ7X+=R4?%2ZA6M#]KYWX#>R#\NY@<G
M?  "9M2HJ_&L*^'<"K9[">RXY69@>^:4;4*<%K").YS4=0UY.";IA" 0@YR?
M8U#FZ%3SF#&Z+_:.MC+!"'K8^\6LY =MCU2!DM@4C4Z5J:-?<$T7-(.%HB)F
MN<H4R9PZ@5Z<:FR<L9,4;$2U<<>Z FQY&A<$MIX9P1,QGU"F*V"$"U>Z--'0
M(4E7%#X3=G3M#L_@?VJ"1>NX@4_Z4?BLZL:7IECZ8OYV8=(/IHH)_7^Y9@O)
M*$18<(A%CJ&2!-.4<DHQ=8KBOSKEV*C#2%P7IC R3X"1VOSGGMS@6R.Y(X]8
MH&_')V$Q[9E7#N"\CIQ[D+LU&*&BU:]/.&S8N34 )_'C]G=ZAC)*O1.2A]ND
M30S3RZX]Y)F\IRF*5)P*QJ#,8L-#'$'"4 (C&F&,>6R8R*ECH[<H8^,G_4 F
MCM&+_LM@1TC#@-LS435*3,")NV6KR<1TU6$2W--2#)'[>3NLH:(G_049-J[R
M9L!.(BYO']&-.H4LI^^T[;=ZN1-"/][5&_WCY^7#XL_Y-(X(1C2/8$XIAX@3
M;9M%/(*1B"5+*$\5MXHFZ)AC;&37B E:.2? 2*IQ!$96.Q+L K2;W0+!U+<G
MQP<A:RJRP. ,QU22_^W[XOG?]=T-O>@?=JS2->8@=&&AU(8';"[UW(L9_P\[
MR=';)8_^]K*[I&6:.].G_O.3N;#ZAZQ64MS-A8ECXG5_;?.KS^M5M:)STQCN
MOZ3Q2.MKGC5[?9<-2^G?F[KP9C.YIK,'N7R,IS%E.)8BAQG.4FUK26DZ+1*8
M1MK,8@)GQ*T+SWA4&QN=M0I.0*-BG5DA6R6-<6%RB"9@HQUHU0-;_<">@L!H
MZ+@#'<W"V.YT1R/PB!A_/^G\H$S 'BZF8]O9Y'0#CK%Q3Y_#=WO/X3_JYW /
MIC /I?OF?G3K'\J),![%AG56C$?O2TZ1\4EX@X%Q6@3@1)'?W!1Y]U,N>5F9
M_(U/Z[I8J& 1$_H?,">J@"@E!&(N&4Q((;.4D2)!3H?20PD^=N/ N9O,X"OO
M\!$?V7K^W_*)W@-A AH8 G]]!URXD-_6(<0>_LLYX&*<_2X..;]OF\5YM9B5
MHHGK-,>G+[O"523#(L]I O,\S2#*]>>*XEA!I51&LT2F^@OFUE3Q\F1C^[K<
M+\LY+Y]FLC+^Z@/)71LJ=B!L]T4(A5O/+'X@YJ0)BW@!W]I_]]0@\3HRP=HA
M=DPU<//#ZTJ?MCJTN"=$[/;6V_^F21[ZNJ*KFN^,L[]NH$UG]XNFG.^[GRO3
MZT!SV<>R6DTQ%Q&B*(8LYL:O5D20*"1@2E'">9*1E#O132C!QD9-NQ.WF5'L
ML+1+F[,U 8S.ZAR+ZH>4*WW-7()2*WQ+W/@-:VM'=*^Q8CV38M?QZ)O-6FTU
M:\Y&6]W 1CGP;:<>>#=?/]9#+D*&A81&OI>0]QO$>L7H^-O![ ZD#S"^^YGK
MVS9KK Z!J8?^(I\6R]4TE@6)(LW?-#%1<3C&D&@[$::,,R2%0D5J1>)=DXR-
MD#=R@IV@H)'4_LSU(J#7#UU#P-0S"WH@Y'3F>@T"KT/7BX,.=NIZ3:W]8]>K
MU_IG;V]=KF>S ?]!EZ79CQH3LQ3MIZDIUSLE(DT5%@54(C)L("@D>2IA(1/!
M<X1SD5M%U >19FRTL1$5\'U9 :V%U:;<8ZEWGZO%W*<+G_^2=?/-X O1,S%M
MTY)WQW.7$I2WRW6@45N8>L@5<L\;'V2EADXD[VO%O#++;T;8)M7<?Y+!<\]O
MQN-<,OKM@WI\ ]_3<OD/.EO+W^ORT9_5 _WYZ?/':HHR$T?(*40"QQ!%F$&F
M8@EEFD2FCA$A(K+^MEV:96S?+",GJ 4%C:1UK@?]"8RP#B1X$56+ST\(K'K^
MK/0.D\,W( 1< W&['VQNA'T-CDXBOGCS< 1[3?X#XKQZ<8#&DO4QUOVRY'*:
MHISQG,=0),)0(I>0\32#<9'&2,9<;P:D=U_)W3QC(\7?U[-5^30KI3"'U*L?
M$BCS(#_7#_(VG=X\RQ_+BJ[H01J^Z4SP52]ZW? 3Q-D$V&>L7%L/"S(-@W+/
M='JFQ6(M)Z@%#8/5#?TI_3![O?:4-MC=UI[R%!&G[I1[M[]><\I3'3I[4YZY
MW.\\[7ZYX%**ZKT6SZ0<WLW%IHW>9_7[MH?)K@3P-)()*O(BAHI2I&F7*<B(
M.:>/4EXDF<P3B5P.SIPE&!LA;Y)H W1\<5\-NZ.N7C'NF8XWL@/S!M5EVNIP
MJVVS1XW\3H.]XN3ACJN\T0MT+N4^_Z '4-[P')\T^0_D&XYD#*,ZQ;KFT^IN
MO?JQ6)KZYE,693DN6 Q9$J<044FA_D\.L2Q4A@F71>*4=M,QU]CX[,V>O3AI
M@UP!W8KK&I!T&6,[[@J$7,\LU8+6UJ5H! 5WUT'S"$*Z"D>P&*3+,PT<@G15
MY=,(I.NW]-'+>^_+'$=,\H@74*;"5(_,N=F>:HN)1$D<89X2(D(VZ?;[> ]3
M4O)=M2H?ZW;-.Z=+R/[;>[ G.,Z4R;[.,AIIL.,$$IZE,$L5CU+)4YFEM[2]
M"0'Z<(VXY!;XG9.@)^#MV+P/.'NF=HNF-T.U%._-Q+2>=D1-P*\;E,[W>S@H
M]^KTW'W_OJR[C7Y62B[+^??F/&CWZ;F7RSM]21TO-4TC(=,HS:$B"86(I9DV
M+I6$<8PHYDG!6%18NR]]I1B;[;D57F_K&NG;"(4] [1V<M*-!@[^..^ELO!L
M#K$ /?-<O;7^O*VMMEN*C1Z;MM@[3>H*I7=#+H6#XW2()1G(K=K?TKAY7F^%
MM-,OZSWX<%[;6_4_\.G>/)C'U^K-8J9_7IAPA6>YEQ]6U\<V?2MW$0[ZO^9K
M;::6W'1B^IV:MJTFP%>^E]+44'KX<Z&O?]!+*J=1+%5NHF\CQC)S%(>AWN P
MB/-<;W>T^8V9?>1=/S*.[DM72PYFC>C@<2<[4*;2V8L6OP*K/Q>UMW-E5'#@
MUY[6V>)#^/JKU[NG9T_!_9SAMO9_TY)W3TO-U\U:MXJ"/4V!5K4N3 <>VI5^
M&,=*.WQG7W_%!_H*O^K*NWVH^UV3SL]X3U,/]Y'O%[L#$Z#GJ;QKUB_74NSU
MLVYS??3XNSYMVS+K3"%$HTS C.8Y1$0Q2&(A(.4HCQ%G"<V=BL&Z33^ZSWHC
M/=AOT7Y#;7N7A;!TP/4&;\_?74]D?6K@>P 4KBZ^R^1#U\KW .9,_7R?4?RH
M;!N1V'29U%/LS?N[I-5Z*<7G^1?C":RW7;4,R\U_UAVN/Y9S^6$E'ZMI(6A!
MJ8Q@3 IB K%SO<%1,928H*B(951PXL)T0:4;&Q'N#GHF;6/5VLC9?WLW*H(Z
M/Z_5JKYJ7\VZ]8U^U8VFH%;5D4;#/@1V+/MJ2]LS";_*JCI3>"_H!V+XL+(-
M^@'H!=;C[T,_DX0YZS\\-=)?LO7C>F9.5_^^7%35'UH*.C/>NK]KZ_PWJ19+
M^4!_3EFA\CQ"$404<8@0R:'^BNC/1I:AC"NA_^84,!E$JK%]+FI9P4Y88*1U
MC)X,LUQ^Y]B]+\+K'W+KW^W4 F<7; )8K9M)H^GO3/PFK'LZ,/>3Z55/TV^"
M\=I1^VV#>\>R/\GEZN5>/]EF._'N7^ORZ7%_B\R+A"F51+!@0D)$1 1-MU^8
MJB3'DD9)Q+EC['KWC&.CV8W $U"+W!2NW CM[:BX#KP=J0:%LV?"O!E)GS!T
M.W3"A9U?F6_H,',[]<^$E5O>Z'&@^F'.EZ8NTEO9_/O#O&T06-W3%\.'K;_#
M%-:<5[+VZ:Y^R.6>43M5*M:F(46PB(AF)80*2!.4P"1+HD(*662)E0<UE$!C
M(ZV- N"IT6 ":.L+W"M&5[^ "Z/)_F\=#M)"K*3%^>C Z],S"VZT 1MUP(<Y
MV*Y7JQ'8N&XW.H$[<TY6K]7'5ULKAQ/.@==LH./,0=;.[=@R(-"=9Y0AYAGN
M0#(@*@>GCR'']72PB/^SKE9UG[:'Q1=IP"AG\I-<:=$6C_*CWBH\+-[0ZH?^
MAC^70HK?7OZHI/@PWQ8EO..K\KG98VQL31&1@IM2KERQ%*(LIY#E5,$"$TJR
M*$8X<ZKLVH>0H_O$[G0T]>N7&RW!W)1S-3M]_5OS,]=Z@K4IB5_.P6);;I1N
M-?P/1Y]-'T^ I0OGE=>U[_/2PR7=*@BTAJ!1$?QBE/S5_-GH"3:*FL(2O_S1
M+/*O>STW=_KV<_+:XX*$<OOT(>*P7J >03YQ"O4YE\=F;5?*5L_\ABZ7+VJQ
M-&T0JL8%]5_+<B7?FN:3G,=8*1'!F.$$(A832$C$(9593%(5JXS8E]NRGG9L
M7P7#%#N.KS\#?%_\"7A:EHNEX8\_C0Y 6'?^=%P/BXU5+RCWS-%[];H-N&\.
MP6WD!K7@X&U?T#KL@WJ!>*#=3BBHW38TSHAU;EOL1QMN<^*LX<$6Q/WNFTL]
MU(?+>QW?IC16D=XO%% I'$&4I@DD,<T@QRSEJ=X^D-RQ\<S%N<9&\(=5"]JX
MCCUYO6L]G(!L9Y('@JYGUO9&[99B#Y?P"%_LX62FURKV<$GECF(/%V_QL!;_
MBYJ [%5UU!*R;8K55-_ZLIC-WC>,-:58$OWLY# M]#]0(01D!48PCK,TUG]0
M!"?6-J/CY&,CEHWX9UK3;E1P+J?GNAX6-F./*/?,01O)K^$+OAGY0:N Y;FN
M%]P.=F2/L ]D38:&W\VJ],2OT[9T'7,X"]-3VP,[TW<,S^Z^YE/T8S'3=U3F
MM'GU\FFQDDTUHJ=9N7JSF.OY*],UPSRG\32CF&0Y2R#.20(1T?]@B&+]$5$H
MB0E*(^Q4;<Q5@+%]/G;R@;JRNF.+75?X[8S3/D'M^6NQ+_J_@49X8*2?-%8L
MJ!68@#W<OW3B[MZNUA.\4&UG7:<?MGVL)S@G;6!]Q_$]O1-U,5HZNZ>E^#!_
M0Y_*%9U-<RDD$HQ"HKAFLPP1S68)A5%6D @76:(_/&X'<&?G&1MI[<0$3UI.
M6,X!;R1U/1([#ZOMJ=;-8/5^,+7%R8AH#A+?7,')XRBI$X5@IT'G9QGX0*=3
MU=,SF>[+7Z^HR)W2;^G[<EFM3 #QE*,<<T8Y+,Q9/LJ+#!)3UR_)9)12B0G.
MK&)U^Q-Q= 1TI:0(-=(#9<0'55?5NJ&6V&*'_NH+U[LO,71-B5I54.L*.FL3
M#K7*PY<2\5_MOVPE$>M5?Y4Z(N<79(@R(D<S_^6JB)Q'KH\B(A=FNL$#\J&J
MUE*\72^;)FKE0M3N^2^R6BU+OI*BJ7UF'"YU5M!4%ESF.$IABE,*D2QBR'*$
MH'Z?!.-Y3*F'&\15BK%]U9L.50NUJ<1>UOIX>$2<E\/!+=(GR$/X1D"C &@T
M (T*V[.]G1JMNZ169-+D0 ;VD?@B&=)1XBS#\-X27YC.NDR\!_,DQS6KY+_6
MFJ+?/9L>RGJ4NY]E-4TS(54L4ZA2SB J\@Q29+H]"JS2.*.",NQ$?^?G&1O!
M[<0$M9S " J^&5$=\Q O 6M)9+?#U3=5^2#E3D/=.(0BF@NS#$LEW:J>D,65
MRP.TX#)$\_FIMM4VAU-B2A@521$5$&<TA2A6%#*>%##*,!,TSG/+:%3K&<=&
M$8<]H!:UM$"VTM[28^LLW'9T$13$GHGCJ(=6;<.TXFX/K /VJ+&&IH\&66?G
M>[V&6%WJ=S; ZKS1=U=&5_76\+-J(O#UYO#-XO%I*7_H_:#>/;:_W>31$$QE
MA#318&8:UR")(5-I;@P2%D6B4!&R:E'@.?_86&@KOMF-'<B]R:?Q+:#@NC"V
M.[/>X.Y]3Q8 :8_]EQ=>P79>;K,/O.?R@N9TM^4WC"?=&8?);U3SIIE#3U#[
MP/8\9-5O+[MK[NE+713"[/):WGV_6"I9KM;ZT?XP;S:&70%$4Y(G$>(%@[%@
M=8%("5F:(9B(+$&X4+*05F7P7TN!L1%NJ\4$M'I( 7XIYT 8A^>RVC6[_M61
M;8=^+BSI>L2KW3??&[5@K1?85W[_:*0R6:G[%[8(;)QQQP_+NG:6SK>^/-]
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MGGTLE;;.,LJ$RC&,(Q-=2ED$B4QRR!/"%5,\3R1VH4&+.<?&?$>=J X;44U
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M7G1]6%SS\FT30NW:@?';S6XE51WK]_F>;79:F0F6O#-+HQP5'(,TAP7 &1&
M"8@!+TLE-"00:>J5N>C8\-*8II[X?#_F7'\?C.:=!KD;U<0 ,C+G].7%M*U.
M6F8'#A#T "ID"*%+L_,'&7J T1N&Z'-_()V8.\YDABKVH2D"6)49X'E.0$YH
MB5,BM>;:9P'6:6&9*ZU&HUP=[)PH#C-6%&9!--(5@XFH !-K9G)Z_O,JOER=
M?70N'%];Y4G6W4=E9C(KL5?RD)5W_D'KRCKQX-U&W-NIT&M5_VU^7C_(RD0S
M)F^^**LT_D9K96;KI4:<$&)61+!0 ",N $60F;61$%4MM11S'[:8U_RE4=&O
M9M1^(0]VOTQ6!T]LWI,(5PAFQJ^'&P<NM],C$ZQUY::G+DWC;%)?8CO^R8?G
M=]0H)$<8DA='(%[>)"<LDB,853&(I(8C;,F;^;LQ8.V<&8V?O0C/_!W35\WG
M&:P(*;AZJ/ML9L>T("H#NF!FBBPH DS)%)1IF=IR&(1!+PG%H<:6MCP?T@_U
MJJ;MA+3;^!$*O\AL/P6Z0.*K5ZMSAY-?G;-^MX_3;A*LD^I\'Q]MIG.6QC[<
M;Q_-TEV^^O';3AD.>[O:L(TPK'4K]JO':@_]M/M-(,F0AO:8H<  4\( A04$
M0N6(I;F&TJTR\7@3ED8XU5Q'K[?_W26VPQ-]-#UA)]L]CR!&](L;$<5%.S(]
MV<5'!?;1?*O0\,)Z8-8?+Y.3$TGC1903C/$@!N*S$0;,RG+C 7K*?1.>-(X1
M[8QN_\-J)&PW9EIW&.51EF6YR$L B;!2LS #W$RD0(X*;$]=$<^]CCYZ6UD:
MK]5&)B<K1TZ?^A%UHZO).$5F)'^(O,EF$() ?-+?QJR4,>CF4U88OGADN?>J
MA#3C:_7)AI]6G'*7FLE,CI$ E#$(<($*P$LSV6%8TCPK&*%^$M-]C2SMM6]L
M3'8G(SVKO?=AZ?;&3T4H\@O? N?3=7#\:[P/>!^JPGM?$_/6=Q]PLE/=?>C:
MD;EH>[97MQOYWO3&^A_FF3NY$O;,\I 0@2&5*-6V4"@L <ZP ERP$C!I_IT1
M+0CR6N!<:6]IKW]EKF<NVA5$W=[\@#A%)H'*TFK'N[(U:1L;(<G$$9A026I7
M6ILW5<W-]4["FN-M0:OX=2IJO6*[E;C365H012DH!<ULC@D%%-'"_)%B1EFN
ME%\U&Z_6ET8NE5$AZ_== -V-<:)!&9E_/&OW5>9'K]PWC%K<NGT7VEY"U;YA
M6!QK]EUYB+\8QIO-WBZ@ZL29C^K[]MX&>%C:?-C=F54.8AE'@*<9 Y@H 1C*
M(4A3#05.2\Q@YJJ-,=30TLBIMC4Y&)N<K$UJ<]V5,P;1'::FD)C%WOL8"9>7
MS(8+%J-4-P8?/)L(AXM[;4T.I^O'S6I>;3?R6%P[+V":%0H#6C .<)KG@&L;
M9BFQ( 6$3(K29\[2>O;27OK*-+^I2!LIMXG&2/\CO\"551'6*SW>!AK^VT^>
M=7#O<>GIT-UWR<2(Y_K@]_UVM[M3&!6<2@B@9 7 J"P AT*"3!))2"8HA&)4
MS'/3AM>;.4.H81/;NS;6C8QU;D'H]JI.!";R*]M@<@C5>&$-O%R.8'S0<]?]
MT&'/K1:>)_"YZ^+%T.>>2T=(D/YKM7XXC!M(<9ARH0#-"S/'YEC8 T4K>T6@
MH)H(E*?."J/-<Y<VNEK+/!0K6P -OZT3W([\AEJCKH^I@ZY[:'&.@V FJ<W!
MSO<3TNSZ.:B3V;I\/AG,KHUG*I<]OQY!(7VYYJ^8@5VH3U^5VG\P'7CLV<_V
MV*31A8.*I!DL.<AXH0&&BAGRR1DH)2YMZG@F)'*FG/%V+(VB/HFO2C[4.MT#
M.>1U@+O=G0%;#7XSOZQE^)/M)CDXGE2>>[SS$SK3@1[GZ:+(='I1(.,,\Z3M
M2_)'Y4TR3C1Y0I]X\/8\?3,3ST?N([^18CJR@R/+A,?/-Q)-Q^!LY KPN)&9
M@K;N&M_:9A]5NU31[49:W:<+OZYRCUEUWK=[O]JH=WOU;7='A8"$B!(4-+5Q
MRQA9Q6=EIMV*R#0O64F]]K1"&K>T,?',MW9-M&H4;/]<"Z/MO[)-<G[3']:Y
MI/+.,UXP:*^[+?J?JR\C#YYS=:-_'EX$O$-EV84T;=X<N@B@=C+D8K0Q(8S+
M/KQYV57&,*0% 9"G)<!"9X##E "6V?^PS*6?0$VWB:41]<G""7S; Z0;:TZ#
M)S+W>2(S+BBKU_F0<5CG#<P?>M7K8&^T5?^5D:HH7RE5^6^ULS$4&VD5*VRJ
M[N>M_:@5/U$'5MR)G!:%,EPA<B4!YC('3 L.!!$RQ06A.G7:$IG;\*71T*D4
M;NU -;U0!Q>L?N6C^;BJI%Q'?H4NGQSJZ^!(>POLY-ADZE NV;5:<NLK\J;U
M%;$?WYS'K=4PS%@G.7#'S54?.939RZJ+'+@SO.LAAV[_>8;"6RDK<3:V?KW:
MB?76:NPW.<-(ZE)8<0B%<PJP0F:NS$D!,HH8*01-"^6E?Q_5VJ4->I_V6_%G
MPVN=H-Q?MIO*[@>V3CY;C7U+>>_,9ZN-#8*NJA[,.Q .?QGF&?V"=?'?:,AK
M?$Y:3D=)39^E>Q8RL W;^K<:S9Q@#SV$N34Z4E3XD:W6]BS@[?;>UN]MLO=>
M*[[_)]L??KK]9D-8_[(N[/8G*H)0EQ2+#,A<FG&IQ!!PF$% (>1(*:0+XK4N
MFV3-TL:=DY&)M=)3>'A2M[B-$+.!'7D$L-:VDGP-C1\= WI[#ZQKYK.SSKA)
MWIHWR=#\[XK=)P=7XZBH!T$YE+[Q)%OF%3T. 5M'"3G(0\=N@YM9Z$=U5"/_
M<+_]<L^^G2<.'72C_K*+E%>JN5C>I0RGN= (F/E_"G!*-: %1D @J(I"*$E%
M[K=C/L&:I1%M/<%O#$P.[MQT\^T:GP[E6EIN^>[&3^E/UXW[F7HI^AY_W X:
M<2@0 -A@YP=3;)GYJ"$ ;-U3B1 /'2FK9X]"S4I_NUY7P>.&K=1N?PCO+63*
M,Z0P@-S0+<ZEF=<R+('$7!&H-$MSZ26@-]#8TBC5V KJC9':VN1HKA60MF5F
M5W+%[G]XBN4-H>W&B*$PC$QXYV8VX(7/X7(!))28W5!3\\K6.3C=$:ASN><2
MB[3[Z[WYU\\_'3\Q?W!#1#__]']02P,$%     @ 1X$.5S\"\6J/=   W$(%
M !4   !C;&)S+3(P,C,P-C,P7W!R92YX;6SDO5EW6TF2)OC>OR(FYW4LP_>E
M3E7UD112=IQ6A#22HK-K7G!\,9<P"0(J %1(]>O''. FDB"Q^.5UY=3)4I @
M>:^YV>?F9N:V_.M__WHV^^D++E?3Q?S?_L+_RO[R$\[3(D_G'__M+W]\> 7N
M+__]W__;?_O7_P/@?S]_]_JG7Q;I_ SGZY]>+#&L,?_TYW3]Z:?U)_SI[XOE
M/Z9?PD]O9V%=%LLS@'_?_-F+Q>=OR^G'3^N?!!/R\M<N?[K\E\)]--EH\*4D
M4%@\!*<]<,&#RL%[(>+_]?%?C%;*,>,A"R% %<O!A2PA2.VXRHA,\,U#9]/Y
M/_ZE_A/#"G^BY<U7FV__[2^?UNO/__+SSW_^^>=?O\;E[*^+Y<>?!6/RY\O?
M_LO%KW^]\_M_RLUO<^_]SYN?7OWJ:GK?+])C^<__^[?7[],G/ LPG:_689[J
M"U;3?UEM/GR]2&&]X?JC=/VT\S?J=W#Y:U _(KZ!Y'_]NLI_^??_]M-/6W8L
M%S-\A^6G^M\_WOWZW2M3F(6\G)ZO_IH69S_7W_CYQ8(00;1N_G;][3/^VU]6
MT[//,[S\[-,2R[_])<WB"JI0F9&LOO'_W/[AS]<O_KS$%:%EL]#7],'%W]>W
M'$$$?EWC/.-V99>OF"W2=[\TJWQ=7/WE+$2<;3Z=9)Q.-D]]%E?K94CKB7?1
M6J$\<8PC*%XX1$W8<Y:+4 S+!L7W:ZXTKXCHC1A6F/[Z<?'E9WKPSY4/]8L-
M0S;,N/.Z+6..H_MRWWV@WYUH3F@WUH*3&$ 1*,$KVCQ>\**\CL(5=1+9-]_V
M/=4W!?ILF7Y:+#,N27%<OBXLTQWA?@_9B]_X^7-8TH,@?9K.\N5?E^7BK(6L
MUHL&G-N*A<C]RT^TZH++)>;76ZGL7-QF96M2I[CYS182_[_/PY*>./OV#C\O
MENM)3E9ZKQ%RT 54"A$B*PC<2*>$YYA3:"+\6R_>"P>B?QR<PL].(/$6E]-%
M?CG/O] 1/&&%%2>4@9#I>%1:!@@Q)TC1).6X8,ZR)H#X[K5[P4'V#X?C>=D)
M&#XLPWPUK8R_ '01*DN?",$9%2AF%00F'60=0HR!S"A;VIP.M]Z\%R14_Y X
MB:,CH^+E?#U=?WLUG>'OYV<1EQ-K318I9$#4C.QFAA MUZ 1HS/"2!OT26BX
M_<:]4*#[1<%)'.Q"^N_PX[0R8;[^/9PA_2#'HH6'F%EUL*2!2$H.$D;EBPXI
M"]\  =^_=2\4F-Y1< (GNT#"K^3*+TF%;1C_GOB/+Q;G\_7RVXM%QDF24OEJ
M# OKR:4V(H(3I-92*$&)H+B+K@$P'B1B+YS8WG'2CL]=P.9#^/IK)O9-RW0;
MH[C0A"4E$;C/X$HB4UF7 MXCH^U@N40Z"0N>9FD^^/J]H.)ZATH+WG8!DF<Y
MDPA6%_]Y/9TCGPC%M>5&@#,QDJ&$=%0Z,IG(V;:N!"?0G19/V?GJO<#A>P?'
MJ3SM"1@OZ,LWRP^+/^<37ES(/@=PTI(%Y;.&Z$TB,XIH1ZNU3@UA<?WB_4)7
M[ =!Q9$,[0D3FZ/QS?+M<O%E.D\XL4Y;%"Y4=XK6P;0#GST">B>25$D8?5H@
M\Z&W[X>.CB.;S5C;$T3>+E;K,/M_II^WIE-0QFFF0>420"DE(0C2@$XZ],:P
M5%H>*-^]>S]X=!SP;,36D<%1M=ZS)88-W4:0!^;(B$Z1TUF8.2,NY (E(#/6
MLZ!/]%ANOFT_ '0<XCR:=2.+O-Z,SMY^6LPO(S#2!1M#$."=YG3<"3KXD%E@
MCB4;$K?:Q)/$?ON-^XF^XU#F22P<6?SO,9TO";I<Q _3]0PG/&=A;); 3+WZ
MEXS6[VV Y'R2H60E6#Y)_+??N)_X.XYAGL3"D<7_81EJ]LG[;V=Q,9LPRYUE
MSH&T2&I+)@ZA. V./&1:O$M>GQ:\_.YU^PF^X[#E\<SK9-.__)H^A?E'W,1;
M@S?9DX8BOZ9D4$8F(#66 <E^42;F8/)I\:;[WKH?!CH.29[,RB[<@1?GR\JN
M[0U<A33)X'PUX01:U$R!"#814Q(YO8%S\-ZB8DEZQ?A)D'CH[?M!H_L09 /6
M=@&17^?T-&+'] O^$M;A8ED3QDPJ1B3(5I)S0VXP.)T9>;Y)&E<D+_&T^^^'
MWKX?1+H/1#9@;1<0J=>XRQ=AC1\7RV\3$:L9[!)81:>@\L[6[*\(NOC@DN2!
M86IT%W[UTOW2IKJ/01[/R"YP\/XLS&;/SU?3.:Y6Y QQ$ZPG[Z<0Y8H6 U[D
M!"A-+DQZ>H)I@(/O7KH?#KJ/-A[/R"YP\/(,EQ_IR/O;<O'G^M.+Q=GG,/\V
M4=Y:)EP!S1+9R45)\HX$ \:CC2IHA>FT^,(#+]\/%]V'&4]G;!?X>/\)9[-+
MZE$Z94B,8#62S>Q3@>"R@F*M1^N=<JS%<7'SG?NAH>.8XXEL[ ($+XA3RS#[
M=9[QZ__$;Q,F661%"N FU_R-$L QIL';D(TL&#1K<5S<>NU^4.@X!GDZ,\>^
M>MA:O:^FJQ1F_X%A>9DEK+AP&$.&$KVLB$:(*!0D9;UWF'TX$1"[WKP?)CH.
M3#9A:2>)U]>+>$6?D/_L?<G!&!":TQ)R)%!+.O$,1AMB<BRK-E4YMUZ\'R@Z
M#EJV8&A7F-C6%&P7$8WWBGPB2#*0R\S5IKPQ@61%125T\"=>7NQ\]7ZXZ#B0
MV8:I(R/C&:T@;U8Q"Q\G.8M Y!7@HM2L#&8A2!4(TI+;I I';T]"PW>OVP\!
M'<<KCV=>'X;DXNRLY@,OTC_>?R*6K=Z<KVLA<+VBF9ABLO8Q@[1%U83/!"'3
MMRS;S+'P4!BVL"H?H&$_?'0?K&S&YF:@^=>?[W#T-7UP0D'V?+6837.MN'].
M/YXG)!<+UZOO*=^W2'O7PUH5;N]%[(G%W.<K^!C"Y\DF[ZVJB#?EU71.+YO2
M4;'8EF]=X<LX;;7# B9F#<KY J[P"#JSL@E9JO#0K5$)J[B1^,5+MQL.9^O5
MY2?7.^\0NH[5,)?O>+9:$5NO5AEC-(&K#+Z6&)!K)<A>"H+\*_*YE?9,\(<J
M@X]9Y?<4C%,J/A@2+C5- W:/>!Q=4O\BK#X]F^?ZGY?_>3[]$F;$JM6S]8NP
M7'XC3?F_PNP<)\98XXI64 S/H&0FRRH'A*Q)0Y=BO(T/G4K'8&@OPL:%UBF2
M7PPMA@ZP]5M8_@/7(<[P(OE@BJM)$"[K0%:YY88.]8B9C/3HP3-6= B8XW58
MNQ&4[J-CG+X% R#G9"9W )2W2_P<IOGEU\\X7R'M@S?K3V0';IAT><GL(N/>
M60?*<U+1P66(/A?0PDEK/&V-TOJPWH.L<?H=# "CUB+H %7?$V]+=D)+ RE[
M"TIH(CYR!BRBX0E3CNZA)/'CS:!#D-(\;C\ 4HYGZ_&86*S#K)&F67S&Y?K;
M6W) UH3R>MA^KM;A[[B>E."U9BY!+)% ;@6K]5.QUM2Q6NL?G93-5<QN>L9I
MF3"(;FG$] Z4"OD0TS6^GG[!_"M)8_YQ2B?OEE=U-38'9X+P4'N#T&IB@:@C
M!ZYL\3D6Z=Q#66;'0.AABL;IN#  B!HRO@,8W3A=?U_,TX4R#1B*UU&#R[CA
M#Q)_A (>O>:Z)!_C0W'@8]!S+R'CM%\8 #2GL[D#K&SIGRCCI/<I@=*);'JE
M3>U/QR!G+KC6*87\T)71\0;,.!T6!K-<#F)D!R;+ZVF(T]G&KZ.S<Q//_K28
M$=-7]1Q=?[MB3=),,F\<!.MH79(3:Z)&T"E((ZVK%EIC@.Q+V[C>]N AP$%$
MU('FN;FNJPWH#6<F2"C%"'("+4*L&Y ^ML45B9ZU-I+O(6/<P-\P\GX 5,<P
MOP/\/$NI-CQ:O0W?:H#JTF<TRL>22P'%G0<5-8>0DB$='J3B6JKD6D>3[Z>D
M'Q0=)>#;Q]OIW.X#,\MS>NLU<RX70HK8!F%2;;9'"W&R]ELDGY$9X0+3DND'
M<V:.A,W]Q(Q[H V G 8\[P \]ZX@96%K7S7';.W.Q\$YF8"C0,Z-D*GY)>^1
M<!DL3-P:+B=RN0.;>N,7WEC&#>=0V:11AD@K,;*6Q);:/\D T@J-"RHF_5 6
M[]$^^+W4C!LT;HV;1ESO2\],5(FZ!%*13M2L0XMD[64G(1NN7:83ULC6^14W
M7C]ND'A S7(07SM0*37=;+H^VUS;S_.+Q;S64"/YFK04G3D+D<Y.]#;6Q%16
M(PYTGB:G77"<)=,\?6(W.?W8+H/Y3JV$T8&J>8!#DCO,3M-Y*VDY9-XGXA F
M8$R1U8:.HW^H$NVX_+630CQ/8N(,AJI&HN@ 5#=R8[>913GPR"SYATER5L==
M./ A9-#91R%23'0$#Z"A;M(P=II@&]G>HXB.9G0'0'F6\R9,&F9OPS3_.G\1
M/D_IQ)P(+G/./M ACW3(6^N))RJ Y])JVD3!J8<:,!WEB]]/RMBAY4%@TX+M
M':#GPQ+#ZGSY;<.E[5;8[@)OM2>++D&1EM:A#8?HHX%H5!1."XRYM<V\BY9Q
MSZV!\-.$\8<#R&\!-,>/-<O_0S,<O<-UF,XQOPS+.1ERJV<IG9^=S^I+?L$R
M3=/U))ODDD(%B=<&IC$ZB,5$<$ZA*<66$ELKI,>I&M=]'PA;C871@9JZL8)-
MB**V*%CB)YROIE^P#G$XP]>+54TS>5,^A*\3G@7/M=DZ,N2@1.V:J84$1MY#
M+MRGHEM?M!Y(XKA1@:$.Q0'%U $*[W)M@I%KI5D&K/T9%5KB%J.#GWQ6243Z
M%$+K8_(N%>-FD V$I1.9W4&\Z;?I?+&\[,F&J_7$F2)]\0I,+7Q6$AFX2.XM
M]\I[DP*3MG4TX#8-X^:-#025DQC=I5XA73D[KV6P;VNG1Q+.>KV<QO--$<F'
M18W*+^9KHH*>^/%JU2%IEC#42<NN.JY>@Q,N@_,!B]12Z@=[[K?11<=0/F[Z
MVI/IK\&%VH'.>RS*-_$BAQ1<@!1J;)?% )%L %"!D7.,M3_E@)>]]]+4SQ7>
MDV0JG2R69C![LFK[MQM)?,+UE/ZJ;>W]K4</7(G_T$*>LB[?.6.9"PJXU73
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M, K'54S#8>M..O1P<NM68;V>ILT0OH]+/#XQZ.Y#VBBN1XCKJBQ>A62B49&
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MJS^GRTE*4<40/?"<1<W^RH!6!C!&8R!_E8?MPNFCL7AG 2.7[H\#@GDKB70
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M,4YX8-ZCP)!9T9L;JO&-\HW9O%4E&F<V>WWABRI/"C<4&28<(T4]%%/E%AS
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M4H;6!K9DMB&?UM9OY5)=C;(2N# )V+L\QB@\2=C"Q^L8?T3< Q:]CMK>LZO
M9[BHXL].VFC!F[=(\N_-)TG,=D94=E[BYSO#79$?6C6$3!A1V/D"6\*QKLGC
M(L!\$C"P(%*N=06@#.VY_8T83&&*TF6)2&'#%G7G<-="!+MXKYR>&\H7LJ3Z
M(H.< QZC3*-YA @\<55:( 3+T[MZAR1]SL/7C++&0G  /P<#%%7L/55K3( "
M2K(UHS*4F\!6['32*C^*0./XWM"^J*#.>3K9@R*(-, Y355%[QF;;JWIY%.E
MARQ6_)R>D =I" >[;,LE'!K" T/5?5=6J>3-YJNBL.T=M6C@^7[&0YR9["RD
MIJCR*W=;5Q[88'R+16MF=+UP(VD:4N>T8LH)0"R\Z:+>0'EQ6NV%R4%R*0PH
MOBT)X,#UC'2D,[2+=,4Z^,:$<70K,S"UO@4P?X2B98GD4@-@)0OT6GX1/84]
M+,']8:"J9GH9@PXN"5\ ) +<A\NN(*HE@U/O14=@+#-XIHX1;-0F1C<" Q9A
M"0K=_L,B6_KVR"H,<<"F>J8P421 JN7DT.]ZF * V!3"BQ23<I3_V) N=1 L
M0%R6!HWSI9'MP'(H6W WJL6N$QW:"5!TX0I>Z PP%S'/]<J"*^L26*@QPU([
M.B<X30=G'7)G>@'VH"'D[SGS*(A2OJ.T,1C)EF'QQ?QN\&Z@CHZ&06?QM2.C
M3"7A(K=L9$O%1?A::/CM6A_T%!%TE0*A9E6"D5!A-?TAR[^!10U-P*S'IAGU
MGD$%FG"IMDHU^8BD]CAP^M+?I60[3HKM+4XV#H#1J>D R&\H;BNJ*>A9K $,
MPF\HAY*\JLL,&&T@3EX:C2$;US +"M]@5!(IC"WZW1@9+"Q\<@+-_L8LHZ:(
MB*,'A,?R;:<E2&()G)K5D2R.\2:W21)D OE^, )5GA,7>2E9#ILBYVOP)R.!
M!NYT;DE!#1;PH"VI0AA #.'8KPX9LWRNT_B_ I/^SI3*\?=,J1QW4RK'/R*E
M<@Q2#T8& #+0V*;X4)<8U-DTIY^@33$+V8F9=<$8=FJ2&/:"EM)J74!&CG36
MI',]%PVW(]7*BQ86NZ,X#VTP_G$%U2/,KE)MJUF.:$9]M5>AEB$RZVBT.*1B
M4T]ECVQF"'9;V"IZ1+_":LAH$B)!^T& ##R'P2)QF;$-P$0^8(NR723>HAY-
M_?!5W:N;BLH@C!:-J;7$4QVG,*Q<H/Y54FK*1GCI ^QM0TI0]H"<:=!+$+M=
MX_E:\H_('5!% \$X&DEVHJBE36Q@37JH5YSJW#0E1A.BLU1R_J])M5:&HFX-
M(XDQ%LY8F6$K"!X^B43VP!ALJ*SP*/@19!&D>OD,KYM+(BQ:E0YU/L_6[5S]
MCFQUU866Q&]WEQUOR0U-GLO\/CZS8SJ^M^TXYT2#;S=L+@;SD%C49_HWJPUG
MEGO7M P0U"O85:YN32+9'>QLW/G'?ZJL/+^^NAWQ3[N- H8$254ZT\#$A 9P
M9<,ZN5I@ P@^V*Q+(A]AM4\.4H_B<8:,RQ+QJ7'=S@Z?.WUC9UA70.O$H9?V
M;*;8FC*RRZZ]QTMW]T'@@,,+B:<T=E,47B0(@^<10TE3]$7#+=,/TN]Q<+.-
M?PJ9<\X)%A0$,.LV\9$:A B8-:O=1T'I=I>Q=DDH #@@3ZQ'LXX>P;>N^[JG
M^3IHUB"YI$;=UZ7-#Y+V2_F4?8A)V2I ")9GZ3S*!*<VHEK\FB);?']FTYF-
MQF%,7N)"9"()6TA[MA6@987U FF:V!IGZBS<MMCZ,>*@=:L5=K!+XC_22RRP
M,C'GSU8]FH4,7^VICY2-:F(TM91F8MD[W2=U'LG#?EY*B4,31TLWR]38QF[4
MQ0I;1*D'''[@EG-6*J^H:U^WM6S]H#E;Q@5H+%'84MX#^1_L5XQG&]QR;1_K
M)V>MB (? <O?F)1H>3S@?GRP46 1N>F8*CF-^A)6#:Q,2(]6B_08)TK2O-W6
M@YS'UN652PCVR(](H]/L>88]DO#16B<5T;V1$*@K_P\:5!FM#O524!L5Z48!
M$*)9&$6C0\202)VVV9L[$KJ#TD<@&KHL,@3*6/Z7J@MN/F4#13\&5%S%9;CN
M@:D!N^.*"%C?]\\9-.63NBQMZ%WW.Q#P#'ACN$VQF+FP"ID24]+<;^^8:I98
MVSO@;390S7Q>M]& :W:2,?'=4A?687(PT8Q?0@SHN-5-A@@<J4B3C?E&=L1+
M;F,-CC[8*%Y1/)O1H@HW,F=6VI4W$D\;^!)!_@ S5U)-OF[Y@6'\YXNZ&[F'
MW[@^:[(L*7*$!;-GFS^H4X_D4UYPE;G(P"Y 6K-\$Y!BIDPAO[JYRW87K!(F
M8TCP?&L7]',)(F4NW+CW:B'MK>7Y"P8!";]QZPG(:EKRC\XN8#W*S6Z6F0 9
M<'9ECFC5?;<"WTS[<9_\G6'PR?<,@T^Z8?#)CPB#3S ,EJ1Q(<4:-;-0W$>P
M$/#U2FY0GRT"#9P+M*$<>BJZC/ XC/.P6F(!)\1819 COBE6ZTG3Q(7KK[XL
M64..?)L3R. SFTF/G6)3W7#]_%3#F#52]VA#J><.5;=I6K,Z"N(^BURJ6QXJ
ME7PT^(M%O.H>+[/=.EX?IY3% _6D\M"1D5]^@;_8IGCX@*H\03=7V0Q,@%V(
MQ[VE6E#N@]KZZSV[5:X5 RFE-T$8*YV#9%1P)7Q.P&RX7%9#$;T4]["5S;N-
MHETWG/(#KJG&+'FUX@9 +S"B519/TQ"V0(&<2FV,E('/QMHNV(, Q8@JJ4M@
M.C9Q\) 4J0A$#-3:E*BN=CK$8>81<^<X%$<)"&Z^]LS=D$))FD8NDJV3U@@L
MJ.M#&&U%T+:?U2AP! #HLDDN&,[ONP\ME,<:I5*WW.@]"CF',WQY>DJ*,'QY
M-@S4/=H<]64R<8D >JM^B1O63H^WC,E?OQKRUR,(LF"S$+8A,7"==5N86]<'
MT%P0037Q@G%UC1%?8U<R^.'!P<N@V:EQ"Z_GC/4F*3@2Q'<0U5&'-K\$2SJ#
M%=/AA< 9MP(&!P]9UTRE!=$5347J!U;M.EK'^K)-]SPU>TJ/GE6DOZ9'C0X.
M[Q#FL\'T]FUV=N8UD\#@Z+*?<_H4#F)>!;E*X7_@=6Z8QU4NJ:@8CQN;B#/Q
M&F6$3^H5.(LIP).N#.96*P T!2;*0, 6'*_6XVDZ?HEM:O@;07DP?-3W$+$)
MC(SF@D C,K7M'MPP'> Q)VV[ "CSB?&@.PIMEXBJ[RP^/Y@ZVP*&QLR3>,[]
M$[-$VKR(\FUP@^^NM>UJ +>RUK@*V+V?@2!Z1AA'E@BA=$7E0SM+Z,1UY'C?
M=&/,UVU":Q,&O8+0[4$/&A&==!P'MET6Q\_P_#T?]2#WAK19F]9KF%(&1K**
MX!L([@+;/"2G4; GG,0!;"3&$I9+UH<Q6NWIRNV72>^<BZ:#')0DI3F:[KQO
M2,\"-7O SFW)VB9UAB?'ATUC:OM^RRTG;7?<\<UZ!!<^V%Q($5C(@YT:G'UP
M8,:U0)M'#,S0$DB@*%'G0-UYGBAH+O:OK98DJ"!H8N]*4!_&U^/;T96Z'5^-
M1W=C=7DSOE/7-_=J_*_[\?6ENK]1%U>CR:<[=?]Q= ]_C=7%[?AR<G]SJQ3\
MQ^]-KC^HSZ/;^]_K]_]Y??,5'[C[[>[S^.(>!QK_:W)WKR;7ZN/D#K_Z.(8Q
MWH^^P(\R]/WDTUC=O(<GQQ>_W>.H^*E=&]XA@:L(U.0]C7^-ETA\G'Q2,EJ@
MOM[\=G6I/HZ^C-6GT?WX=C*ZNOI=C=Z_AR6,+_V)[\;W]U=\;<77R?U'13-=
MCM_AQMR^X!7:UL %D7]CX'+Z/0.7TV[@<OHC I=3J85=MSK#RL[1_X9@VPQ/
M*T=+/H>4E[MQ*&%F,V1T*K 128BS2IX\Y]9N29,1N'HMF9^^0(AC"1M9/'$R
M1U*&=<X/7G-@H3=2LWD!ZO>QL-)T4DF2*74=2?1-_:O7S"*=3!3U2T!%?3F8
M?;;%H49'1<%Y9@*VKK TLPTD7M;/]+/617M!&R\[@^>'<]UXKFY*\;CXY+44
MKMO62X+QSFJ6=@M1TO?$-R_(CH7D)!T B:4'B$:,)*HT%-A0 @I0!QWVXR8P
MZX)=$CCHG)MQH!7;U7Q'U75]S7L@^#0-IV=M#J"1&I:%HT_DO+2]'R:&12U3
MR9K;[67NJ@1B<Z,C'EN&$/L/U,?L@3.:F^=/O0@Q6;"QL@!KW5,.4KN4,\:O
M85BM=(VJB#_/':WAFC$EK,FUNA3RUEP"9\"%@[Q=*Z)XDPC U;"^#F)J6*^;
MAS.8H4]5JES99E+274,];;5XUB<WHF>E<(5: +#.Q,VX0D2T:1LYG40ZU;:5
MU$E#!X9[UW*?\5B )H)6G0$P)^B&GM,)5QAE#D3CNBE@=="KBD2$+W'!VBZ#
MYV:W6F\?Z3HV[O!O?;-2>V7<(SPUH:[D,#M5+M9BZ;",#J\='P2NONR?7.]Z
M# Y<_U14S2;8)BZ*3MJ"J3 %1,]'L3#H:5?5:IGC_GU<TP/,L-G#DXT[A\-=
M%8%SQ^EY.B%D'(ED<F7#(U*/K_"*(_6-#7SB@ZI_KH64Y0,>-=&6*WD0JH<Q
M6_^<JAR])XSB&8-NZF5!>=@YDXWPO1/N@I>^ Y7V5AU<]X).>&"*A;L-\9AX
MHG:D-X^Z#FW2P)4^0"7C52Q59+D;:Q>>ELM[LIGLPK6@=[9^CZJ,0&6!B_8.
MHKM3Y+VG,^K#*][XHKSVA%/C4+Y%@%NT?_ZL']S:#-&.59QGE/Y=+^W4NF^+
MFR9<PR2Y)H[.ZBY$J>^CTT&W(L(@-52DJ/1.<Z@O9Z"D\./T;DQWGGA*=>/9
MBXOZS!3"HSI0%3>'D=M:)[331I&BTU8JIS:>WA"E-&#FD%,GN,; T\WZ@(K+
MDB(]UYJC>I>W@ITW#H_!L'C$R1^TGV:DU78%IC&_>7+V)Z>G47D!=LS6R0]+
MHB<ZJ*B%BH^;1EY:B7&>@"MNBZE ^'-*D=:R1UVU_"1WV)"7?"0;'/9=-A,H
M/CTOY>"<?B7E3#:4A<?.''O4Q:.DJ[S6^$/B^AD?1*C)Y#OC+?2P9UNDEX([
M#PB(8-&[5:OE!7@2Q+=:@)A3)ZK%PPZ&=N83_VK PC[&RVK)<7NI^*1,6;I>
M#CR[+<BIK?D>Q7IOT6L<G6*Z^2#9@0I'1RJ:UMWFX-Q0(74B";8>S6XXO/JZ
MCR?L97W\O["!5UXW K@23 /02E8*Z=ZN;G#H1 M'%<>!/0LO1&W3U"8WNM!M
M"VIKN[K.<3!N'J%>7L9=(7+ I'..2\!L@54I-S6<<>C23NCQV8V(ATEDKK:L
MVSY"KZ+L6D*[Y, Z4T,Y?-W@!K1DTU023V2YYD!"^W?F+<Z^9][BK)NW./L1
M>8LSI4Y@ON'+X[/C]0#O9E(G S5.L7Y12]3^IRRBU!PR9/\K!2'[%XM,L,N5
M?MA77_ &@?TQ,@YV81WOOKJS%]QL/Y_="K%:UV%L/?^J_L0!V*!C>BKL.C61
M]%G9H)^S'%09QCL0E^#V=6HR*J;Q^5!,^]KC@B[_6G3NBFLD.%J IR\[RXKB
M7?U$FLOTKV]3>6*6 0 R!1J<Q_:*A5PM/785BBNY':-+2H\-GECGL-=A8.=7
M'DNW6J08?:)9XKA$V@IQQ#)C4#H#]"OG&.7PWF=J8;%FS[!$^+<$/'E44CJ,
MZ<(Y\L>YJ^C+/7&V>ZAQ=(GL-MTE2MD*"90S.6?G3YFWE[K%T;063N/4PS3N
M44%*-'?1X^'J^-0>)MR6P*[/934VACVW>!50'C4OO\7\"E,2E(=1J47]<\X#
M<!@M@1I5?&P:!^0^A= D,7)E2>?\>;-Q#6_[($M%&1\*\V>./=) S/>4Y!X-
M9G0PBP]I8:K'V@@<@Z,C>[.8-[M[6QYWG8/;?5+,XJ6DL5"\J'7?\+J[! 5#
M(#H6UUG-DS@EM7E8M<[B2+A>/X[1Z-18I:'^V@IK=$@-NONF7+2/V-=CZU3J
M_G0.%B%OXWF\:@8OQRVSN>'\7^<J8MQLH9>&=">O)!F1^A<@U+>-R>LDE.Y%
MD1/4H'HU]4NN\^7=QB:".\V-=1MB;>'Y*5V^IC/"+E>C0GB,73N><"?"-M)!
MVZ+'FHVN+[7=L2F8[)R.!CN@9 <&6>EO\>P(R32V)[S9"O9W=/*F,<VDJI5+
M=?$%=K"$H]U6@DK/9EA5CZBA-PXI,4 FC>MBC8S8EF0<#'N\V[HBF]/G9%W6
M68+7*>>Q7*!"2758>+(YI]]W3G95ZN[&KE%:*N$-'P#C)?-)R]0[Q2N.!5G2
MR5YU<@9H5NCF[;Z\-%]L_;B*^0(\O-OZ\) OMV:#Y"YK<9?O<I:H<U=>ZY:0
M5HZCV<%EDQPW:$<%R>*8G&AKM)LW[Z@4A::UQ*6_',Y8\>TT>"GEI\^CZ]_Q
MQW<;K$1.RN*U^H)XZ3.0D%!,H#Y62]"S6U, %ZGA23'&R9=HVV@AK!6C&BQ%
M5-?$/]>C3V/\%W?$G_Y0\-OZ!_\? O2_%,#_9\'_ U!+ 0(4 Q0    ( $>!
M#E?PIW2WP1P! )8>#P 1              "  0    !C;&)S+3(P,C,P-C,P
M+FAT;5!+ 0(4 Q0    ( $>!#E>K6<#"A@\  -2P   1              "
M ? < 0!C;&)S+3(P,C,P-C,P+GAS9%!+ 0(4 Q0    ( $>!#E<1&F4\AA@
M &CH   5              "  :4L 0!C;&)S+3(P,C,P-C,P7V-A;"YX;6Q0
M2P$"% ,4    " !'@0Y7"M[P*^TW  ",:P( %0              @ %>10$
M8VQB<RTR,#(S,#8S,%]D968N>&UL4$L! A0#%     @ 1X$.5VI]L ):>P$
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M+3(P,C,P-C,P7W!R92YX;6Q02P$"% ,4    " !'@0Y7+S8/5OT&  #H)
M&@              @ $ -P4 8VQB<RUE>#,Q,5\R,#(S,#8S,'AQ,BYH=&U0
M2P$"% ,4    " !'@0Y7_#G^N5@%  !R&@  &               @ $U/@4
M8VQB<RUE>#,R7S(P,C,P-C,P<3(N:'1M4$L! A0#%     @ 1X$.5^IMA]Y0
M'P  NF   !P              ( !PT,% &5X,3 Q<VQA8VMS979E<F%N8V5A
>9VTP-2YH=&U02P4&      L "P#F @  36,%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
